Citrus Sinensis ID: 017860

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-----
Protein Sequence
MKMDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccEEEEEEcccccEEEEEEEEcccccEEEEEEEEccccccHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEEEcccccccccccccccccccccccccHHHccccccccccccEEcHHHHHHHHHHccccccccccHHHHHHHHccccEEEEEccccccccHHHHHHHHHHccccccccccHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccHcHHHHHHHHHEccccccEEEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccccEEEEcccEEEEccccccccccccHHHHcHHHHHHcHccccccEEEHHHHEEEEEEccccccccccccHHHHHHHHccEEEEccccccccccHHHHHHHHHHHcccccHcccHHHHHccccHcccccccccccHHHHHHHHcccHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHccccccccEcHHHHHHcccccccEEEccc
Coil and Loop (DISEMBL)
mkmdrasltvgpamdmpimhdsdrydfvrdigsgnfgvARLMRDKVTKELVAVKYIERGDKIDENVQREIINhrslrhpnivrfkeviltpTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKlentlldgspaprlkicdfgyskssvlhsqpkstvgtpayiapevllrheydgkiadVWSCGVTLYVMLVggypfedpdepkdFRKTIQRILSVqysvpdtnpisqECRDLISRIfvadpaaritipeIMKHQWFLknlpadlvdektmssqyeepdqpmqsVDVIMQIIAEasipavgthglncymtdnldmddddmddldseseldidssgeiiyal
Flexible Loop (DISEMBL)
mkmdrasltvgpamdmpimHDSDRYDFVRDIGSGNfgvarlmrdkVTKELVAVkyiergdkidenvQREIinhrslrhpnivrfKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSvlhsqpkstvgtpAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILsvqysvpdtnpiSQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDseseldidssgEIIYAL
Low Complexity Region (SEG)
MKMDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYmtdnldmddddmddldseseldidssgeiiYAL
Disordered region (IsUnstruct)
*********************SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH****STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED****KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV******************VDVIMQIIAEASIPAVGTHGLNCYMT*******************************
Disordered Region (DISOPRED)
************************YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD*****************VDVIM*******************MTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL
Disordered Region (DISEMBL)
MKMDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL
Disordered Region (DISPRO)
************AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKMDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	365	2.2.26 [Sep-21-2011]
Q39193	361	Serine/threonine-protein	yes	no	0.989	1.0	0.837	1e-175
Q75H77	362	Serine/threonine-protein	yes	no	0.991	1.0	0.829	1e-174
Q940H6	362	Serine/threonine-protein	no	no	0.989	0.997	0.804	1e-169
Q39192	362	Serine/threonine-protein	no	no	0.991	1.0	0.807	1e-169
Q75V57	361	Serine/threonine-protein	no	no	0.986	0.997	0.780	1e-166
Q7Y0B9	371	Serine/threonine-protein	no	no	0.873	0.859	0.852	1e-164
A2YNT8	339	Serine/threonine-protein	N/A	no	0.832	0.896	0.786	1e-143
Q0D4J7	339	Serine/threonine-protein	no	no	0.832	0.896	0.782	1e-142
Q75LR7	342	Serine/threonine-protein	no	no	0.824	0.880	0.767	1e-139
P43291	363	Serine/threonine-protein	no	no	0.816	0.820	0.755	1e-138

>sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1

 Score =  615 bits (1586), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 304/363 (83%), Positives = 332/363 (91%), Gaps = 2/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct: 1   MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS EC  LISRIFVADPA RI+IPEI  H WFLKNLPADL++E    SQ++EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IMQII+EA+IPAV    L+ +MT +    DDDMDD DSESE+DIDSSGEI+
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMT-DNLDLDDDMDDFDSESEIDIDSSGEIV 358

Query: 363 YAL 365
           YAL
Sbjct: 359 YAL 361

Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1

 Score =  612 bits (1578), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 301/363 (82%), Positives = 331/363 (91%), Gaps = 1/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA+LTVGP MDMPIMHD DRY+ VRDIGSGNFGVARLMR +   +LVAVKYIERGDKI
Sbjct: 1   MDRAALTVGPGMDMPIMHDGDRYELVRDIGSGNFGVARLMRSRADGQLVAVKYIERGDKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPK+FRKTIQRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS ECRDLI+RIFVA+PA RI+IPEI  H WFLKNLPADL+D+  MSSQYEEP
Sbjct: 241 SIPDYVHISPECRDLIARIFVANPATRISIPEIRNHPWFLKNLPADLMDDSKMSSQYEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IMQI+AEA+IPA G+ G+N ++  +    DDDM+DLDS+ +LD++SSGEI+
Sbjct: 301 EQPMQSMDEIMQILAEATIPAAGSGGINQFLN-DGLDLDDDMEDLDSDPDLDVESSGEIV 359

Query: 363 YAL 365
           YA+
Sbjct: 360 YAM 362

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1

 Score =  595 bits (1534), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 293/364 (80%), Positives = 329/364 (90%), Gaps = 3/364 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           ++PD   IS ECR LISRIFVADPA RI+IPEI  H+WFLKNLPADL+++ TM++Q++E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDD-DMDDLDSESELDIDSSGEI 361
           DQP QS++ IMQIIAEA++P  GT  LN Y+T +LD+DDD + D      +LDIDSSGEI
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSGEI 358

Query: 362 IYAL 365
           +YA+
Sbjct: 359 VYAM 362

Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1

 Score =  594 bits (1532), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 293/363 (80%), Positives = 325/363 (89%), Gaps = 1/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MD A+ +    +D+PIMHDSDRYDFV+DIGSGNFGVARLM D+VTKELVAVKYIERG+KI
Sbjct: 1   MDPATNSPIMPIDLPIMHDSDRYDFVKDIGSGNFGVARLMTDRVTKELVAVKYIERGEKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPE+LLR EYDGK+ADVWSCGVTLYVMLVG YPFEDP EP+D+RKTIQRILSV Y
Sbjct: 181 TPAYIAPEILLRQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSVTY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+P+   +S ECR LISRIFVADPA RITIPEI   +WFLKNLP DL+DE  M SQ++EP
Sbjct: 241 SIPEDLHLSPECRHLISRIFVADPATRITIPEITSDKWFLKNLPGDLMDENRMGSQFQEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IMQII+EA+IP V    L+ +M  +    DDDMDD DSESE+D+DSSGEI+
Sbjct: 301 EQPMQSLDTIMQIISEATIPTVRNRCLDDFMA-DNLDLDDDMDDFDSESEIDVDSSGEIV 359

Query: 363 YAL 365
           YAL
Sbjct: 360 YAL 362

Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1

 Score =  583 bits (1503), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 284/364 (78%), Positives = 331/364 (90%), Gaps = 4/364 (1%)

Query: 3   MDRASLTVGP-AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK 61
           M+RA+   GP  M+MPIMHD DRY+ V++IGSGNFGVARLMR++ + +LVAVKYI+RG+K
Sbjct: 1   MERAA--AGPLGMEMPIMHDGDRYELVKEIGSGNFGVARLMRNRASGDLVAVKYIDRGEK 58

Query: 62  IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 121
           IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDEA
Sbjct: 59  IDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDEA 118

Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
           RFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKSTV 178

Query: 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
           GTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQ+IL VQ
Sbjct: 179 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGVQ 238

Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEE 301
           YS+PD   IS ECRDLI+RIFV +PA+RIT+PEI  H WF+KN+PADL+D+  +S+QYEE
Sbjct: 239 YSIPDYVHISPECRDLITRIFVGNPASRITMPEIKNHPWFMKNIPADLMDDGMVSNQYEE 298

Query: 302 PDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEI 361
           PDQPMQ+++ IMQI+AEA+IPA GT G+N ++T +    DDDM+D+DS+ +LDI+SSGEI
Sbjct: 299 PDQPMQNMNEIMQILAEATIPAAGTSGINQFLT-DSLDLDDDMEDMDSDLDLDIESSGEI 357

Query: 362 IYAL 365
           +YA+
Sbjct: 358 VYAM 361

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1

 Score =  578 bits (1489), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 272/319 (85%), Positives = 296/319 (92%)

Query: 4   DRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
           DRA+LTVGP MDMPIMHDSDRY+ VRDIGSGNFGVARLMRD+ T ELVAVKYIERG+KID
Sbjct: 12  DRAALTVGPGMDMPIMHDSDRYELVRDIGSGNFGVARLMRDRRTMELVAVKYIERGEKID 71

Query: 64  ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 123
           +NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC   RFSEDEAR+
Sbjct: 72  DNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDEARY 131

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
           FFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT
Sbjct: 132 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 191

Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243
           PAYIAPEVLL+ EYDGK ADVWSCGVTLYVM+VG YPFEDP+EPK+FRKTIQRIL+VQYS
Sbjct: 192 PAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNVQYS 251

Query: 244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 303
           +P+   IS ECR LISRIFV DP+ RITIPEI  H WFLKNLPADL+D+ +MSSQYEEPD
Sbjct: 252 IPENVDISPECRHLISRIFVGDPSLRITIPEIRSHGWFLKNLPADLMDDDSMSSQYEEPD 311

Query: 304 QPMQSVDVIMQIIAEASIP 322
           QPMQ++D IMQI+ EA+IP
Sbjct: 312 QPMQTMDQIMQILTEATIP 330

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2

 Score =  506 bits (1304), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 239/304 (78%), Positives = 265/304 (87%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
           +RY+ ++DIGSGNFGVA+L+RD  TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2   ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           DVWSCGVTLYVMLVG YPFEDPDEP++FRKTI RILSVQY VPD   +S ECR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241

Query: 263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIP 322
           VA+P  RITIPEI  H WFLKNLP ++ DE  MS Q  + + P Q ++ IM II EA  P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301

Query: 323 AVGT 326
             G+
Sbjct: 302 GDGS 305

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1

 Score =  506 bits (1302), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 238/304 (78%), Positives = 265/304 (87%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
           +RY+ ++DIGSGNFGVA+L+RD  TKEL AVK+IERG KIDENVQREI+NHRSLRHPNIV
Sbjct: 2   ERYEVIKDIGSGNFGVAKLVRDVRTKELFAVKFIERGQKIDENVQREIMNHRSLRHPNIV 61

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           RFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDEARFFFQQLISGVSYCH+MQ+CH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDEARFFFQQLISGVSYCHSMQICH 121

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKSTVGTPAYIAPEVLARKEYDGKVA 181

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           DVWSCGVTLYVMLVG YPFEDPDEP++FRKTI RILSVQY VPD   +S ECR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSVQYMVPDYVRVSMECRHLLSRIF 241

Query: 263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIP 322
           VA+P  RITIPEI  H WFLKNLP ++ DE  MS Q  + + P Q ++ IM II EA  P
Sbjct: 242 VANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMNDINTPSQGLEEIMAIIQEARKP 301

Query: 323 AVGT 326
             G+
Sbjct: 302 GDGS 305

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1

 Score =  494 bits (1273), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 231/301 (76%), Positives = 260/301 (86%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
           +RY+ +RDIGSGNFGVA+L+RD  T  L AVK+IERG KIDE+VQREI+NHRSL+HPNI+
Sbjct: 2   ERYEVMRDIGSGNFGVAKLVRDVATNHLFAVKFIERGLKIDEHVQREIMNHRSLKHPNII 61

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDEARFFFQQLISGVSYCH+MQVCH
Sbjct: 62  RFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 121

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLKLENTLLDGS  PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLSRKEYDGKVA 181

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           DVWSCGVTLYVMLVG YPFEDPD+P++FRKTI RILSVQYS+PD   +S +CR L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSVQYSIPDYVRVSADCRHLLSRIF 241

Query: 263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIP 322
           V +P  RITIPEI  H WFLKNLP ++ DE   S Q  + + P QS++ +M II EA  P
Sbjct: 242 VGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLADMNTPSQSLEEVMAIIQEARKP 301

Query: 323 A 323
            
Sbjct: 302 G 302

May play a role in signal transduction of hyperosmotic response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43291|SRK2A_ARATH Serine/threonine-protein kinase SRK2A OS=Arabidopsis thaliana GN=SRK2A PE=1 SV=1

 Score =  491 bits (1265), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 229/303 (75%), Positives = 266/303 (87%), Gaps = 5/303 (1%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
           D+Y+ V+DIG+GNFGVARLM+ K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct: 2   DKYELVKDIGAGNFGVARLMKVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           RFKEV+LTPTHLAI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct: 62  RFKEVVLTPTHLAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK+A
Sbjct: 122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKMA 181

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           DVWSCGVTLYVMLVG YPFED ++PK+FRKTIQ+I++VQY +PD   ISQ+C++L+SRIF
Sbjct: 182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFRKTIQKIMAVQYKIPDYVHISQDCKNLLSRIF 241

Query: 263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY---EEPDQPMQSVDVIMQIIAEA 319
           VA+   RITI EI KH WFLKNLP +L +  T  + Y   E P   +Q+V+ IM+I+A+A
Sbjct: 242 VANSLKRITIAEIKKHSWFLKNLPRELTE--TAQAAYFKKENPTFSLQTVEEIMKIVADA 299

Query: 320 SIP 322
             P
Sbjct: 300 KTP 302

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	365
357518557	363	Serine/threonine protein kinase SAPK3 [M	0.991	0.997	0.853	0.0
217072176	363	unknown [Medicago truncatula]	0.991	0.997	0.851	0.0
255562649	362	Serine/threonine-protein kinase SAPK10,	0.991	1.0	0.870	0.0
225428695	363	PREDICTED: serine/threonine-protein kina	0.994	1.0	0.840	0.0
255561655	363	Serine/threonine-protein kinase SAPK10,	0.994	1.0	0.829	0.0
147788088	363	hypothetical protein VITISV_025025 [Viti	0.994	1.0	0.837	1e-180
356563656	360	PREDICTED: serine/threonine-protein kina	0.983	0.997	0.832	1e-180
449460610	363	PREDICTED: serine/threonine-protein kina	0.994	1.0	0.884	1e-180
359475222	371	PREDICTED: serine/threonine-protein kina	0.994	0.978	0.822	1e-180
224084266	362	predicted protein [Populus trichocarpa]	0.991	1.0	0.862	1e-180

>gi|357518557|ref|XP_003629567.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|355523589|gb|AET04043.1| Serine/threonine protein kinase SAPK3 [Medicago truncatula] gi|388521379|gb|AFK48751.1| unknown [Medicago truncatula]

 Score =  651 bits (1679), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 310/363 (85%), Positives = 335/363 (92%), Gaps = 1/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA++TVGP MD+PIMHDSDRYD VRDIGSGNFG+ARLM+DK TKELVAVKYIERGDKI
Sbjct: 1   MDRAAMTVGPGMDLPIMHDSDRYDLVRDIGSGNFGIARLMQDKQTKELVAVKYIERGDKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI NAG FSEDEAR
Sbjct: 61  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERISNAGHFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP PRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPTPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LSVQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGSYPFEDPNEPKDFRKTIQRVLSVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   I+ ECR LISRIFV DPA RIT+PEI KH+WFLKNLP DL+DEK M +Q+EEP
Sbjct: 241 SIPDNVQITPECRHLISRIFVFDPAERITMPEIWKHKWFLKNLPMDLMDEKIMGNQFEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IMQII+EA+IPA GT  L+ +M DNLDM DD+ DDL+ ESELDIDSSGEI+
Sbjct: 301 EQPMQSIDTIMQIISEATIPAAGTCSLDQFMADNLDM-DDEFDDLEYESELDIDSSGEIV 359

Query: 363 YAL 365
           YA+
Sbjct: 360 YAM 362

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|217072176|gb|ACJ84448.1| unknown [Medicago truncatula]

 Score =  647 bits (1668), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 309/363 (85%), Positives = 334/363 (92%), Gaps = 1/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA++TVGP MD+PIMHDSDRYD VRDIGSGNFG+ARLM+DK TKELVAVKYIERGDKI
Sbjct: 1   MDRAAMTVGPGMDLPIMHDSDRYDLVRDIGSGNFGIARLMQDKQTKELVAVKYIERGDKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI NAG FSEDEAR
Sbjct: 61  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERISNAGHFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP PRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPTPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LSVQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGSYPFEDPNEPKDFRKTIQRVLSVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   I+ E R LISRIFV DPA RIT+PEI KH+WFLKNLP DL+DEK M +Q+EEP
Sbjct: 241 SIPDNVQITPEGRHLISRIFVFDPAERITMPEIWKHKWFLKNLPMDLMDEKIMGNQFEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IMQII+EA+IPA GT  L+ +M DNLDM DD+ DDL+ ESELDIDSSGEI+
Sbjct: 301 EQPMQSIDTIMQIISEATIPAAGTCSLDQFMADNLDM-DDEFDDLEYESELDIDSSGEIV 359

Query: 363 YAL 365
           YA+
Sbjct: 360 YAM 362

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562649|ref|XP_002522330.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538408|gb|EEF40014.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 316/363 (87%), Positives = 336/363 (92%), Gaps = 1/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           M+R+++TVGP MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1   MNRSAITVGPGMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICN GRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNGGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQRILSVQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQRILSVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS EC DLISRIF+ DPAARITIP+I  H+WFLKNLP DL+DE+TM + +EEP
Sbjct: 241 SIPDVVQISPECCDLISRIFIFDPAARITIPQIKTHEWFLKNLPMDLMDERTMGNHFEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           DQPMQS+D IMQII+EA+IPA G HGLN +M  +    DDDM D DSESELD+DSSGEI+
Sbjct: 301 DQPMQSIDTIMQIISEATIPAAGDHGLNRFMA-DNLDMDDDMMDFDSESELDVDSSGEIV 359

Query: 363 YAL 365
           YAL
Sbjct: 360 YAL 362

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera]

 Score =  643 bits (1658), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 305/363 (84%), Positives = 333/363 (91%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR+++TVGPAMD+PIMHDSDRY+ VRDIGSGNFGVARLMRDK T ELVAVKYIERG+KI
Sbjct: 1   MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F KTIQRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS ECR LISRIFVADPA RITI EI  H+WFLKNLPADL+DE  M +QYEEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETKMDNQYEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IM+II EA IPA GT  LN Y+T +LD+DD+  +DL+++ +LDIDSSGEI+
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360

Query: 363 YAL 365
           YA+
Sbjct: 361 YAM 363

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis]

 Score =  639 bits (1647), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 301/363 (82%), Positives = 338/363 (93%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR++LT+GP MD+PIMHDSDRY+ V+DIG+GNFGVARLMRDK T ELVAVKYIERG+KI
Sbjct: 1   MDRSALTIGPGMDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQTDELVAVKYIERGEKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS EC+ LISRIFVADPA RI+IPEI  H+WFLKNLPADL+D+KT+++Q++EP
Sbjct: 241 SIPDYVHISPECQHLISRIFVADPAKRISIPEIKNHEWFLKNLPADLMDDKTINNQFDEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QP+QS+D IMQII+EA+IPA GT   N Y+T +LD+DDD  +DL+S+ ELD+DSSGEI+
Sbjct: 301 EQPVQSIDEIMQIISEATIPAAGTGNPNQYLTGSLDIDDDMEEDLESDPELDMDSSGEIV 360

Query: 363 YAL 365
           YA+
Sbjct: 361 YAM 363

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera]

 Score =  638 bits (1646), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 304/363 (83%), Positives = 331/363 (91%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR+++TVGPAMD+PIMHDSDRY+ VRDIGSGNFGVARLMRDK T ELVAVKYIERG+KI
Sbjct: 1   MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F KTIQRIL VQY
Sbjct: 181 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS ECR LISRIFVADPA RITI EI  H WFLKNLPADL+DE  M +QYEEP
Sbjct: 241 SIPDYVHISPECRHLISRIFVADPATRITIAEIRNHDWFLKNLPADLMDETKMDNQYEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IM+II EA IPA GT  LN Y+T +LD+DD+  +DL+++ +LDIDSSGEI+
Sbjct: 301 EQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGEIV 360

Query: 363 YAL 365
           YA+
Sbjct: 361 YAM 363

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356563656|ref|XP_003550077.1| PREDICTED: serine/threonine-protein kinase SRK2I-like isoform 1 [Glycine max]

 Score =  638 bits (1645), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 303/364 (83%), Positives = 334/364 (91%), Gaps = 5/364 (1%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA+LTVGP MDMPIMHDSDRYD VRDIGSGNFGVARLM+DK TKELVAVKYIERGDKI
Sbjct: 1   MDRAALTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMQDKQTKELVAVKYIERGDKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE+ICNAGRF+EDEAR
Sbjct: 61  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFEKICNAGRFTEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPKDFRKTIQR+LSVQY
Sbjct: 181 TPAYIAPEVLLKQEYDGKLADVWSCGVTLYVMLVGAYPFEDPNEPKDFRKTIQRVLSVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS ECR LISRIFV DPA RIT+ EI  H+WFLKNLPADL+DEK M +Q+EEP
Sbjct: 241 SIPDGVQISPECRHLISRIFVFDPAERITMSEIWNHEWFLKNLPADLMDEKIMGNQFEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL-DMDDDDMDDLDSESELDIDSSGEI 361
           DQPMQS+D IMQII+EA++PAVGT+  + +M + + D++ +     D+ES+LDIDSSGEI
Sbjct: 301 DQPMQSIDTIMQIISEATVPAVGTYSFDQFMEEQIYDLESES----DAESDLDIDSSGEI 356

Query: 362 IYAL 365
           +YA+
Sbjct: 357 VYAI 360

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449460610|ref|XP_004148038.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus] gi|449502711|ref|XP_004161721.1| PREDICTED: serine/threonine-protein kinase SRK2I-like [Cucumis sativus]

 Score =  635 bits (1639), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 321/363 (88%), Positives = 335/363 (92%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA++TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDK TKELVAVKYIERGDKI
Sbjct: 1   MDRATITVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKHTKELVAVKYIERGDKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILT THLAIVMEYASGGELFERI NAGRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTTTHLAIVMEYASGGELFERISNAGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDPDEPKDFRKTIQRIL VQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKDFRKTIQRILGVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS ECR LISRIF ADPA RITIPEI  H WFLKNLP+DL+DE TM +Q+EEP
Sbjct: 241 SIPDCVQISLECRHLISRIFEADPATRITIPEIKNHSWFLKNLPSDLMDENTMGNQFEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           DQPMQS+D IMQIIAEA+IPAVG+HGL C   +    DDDDMDDLD ESELDI+SSGEI+
Sbjct: 301 DQPMQSLDAIMQIIAEATIPAVGSHGLMCMADNLDMDDDDDMDDLDDESELDIESSGEIV 360

Query: 363 YAL 365
           YA+
Sbjct: 361 YAI 363

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475222|ref|XP_003631617.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 3 [Vitis vinifera]

 Score =  635 bits (1639), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 305/371 (82%), Positives = 333/371 (89%), Gaps = 8/371 (2%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR+++TVGPAMD+PIMHDSDRY+ VRDIGSGNFGVARLMRDK T ELVAVKYIERG+KI
Sbjct: 1   MDRSAITVGPAMDVPIMHDSDRYELVRDIGSGNFGVARLMRDKQTGELVAVKYIERGEKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE-- 120
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE  
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEVL 120

Query: 121 ------ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174
                 ARFFFQQL+SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH
Sbjct: 121 MQLAHLARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 180

Query: 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
           SQPKSTVGTPAYIAPEVLL+ EYDGKIADVWSCGVTLYVMLVG YPFEDP+EPK+F KTI
Sbjct: 181 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTI 240

Query: 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 294
           QRIL VQYS+PD   IS ECR LISRIFVADPA RITI EI  H+WFLKNLPADL+DE  
Sbjct: 241 QRILKVQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETK 300

Query: 295 MSSQYEEPDQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELD 354
           M +QYEEP+QPMQS+D IM+II EA IPA GT  LN Y+T +LD+DD+  +DL+++ +LD
Sbjct: 301 MDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLD 360

Query: 355 IDSSGEIIYAL 365
           IDSSGEI+YA+
Sbjct: 361 IDSSGEIVYAM 371

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224084266|ref|XP_002307247.1| predicted protein [Populus trichocarpa] gi|222856696|gb|EEE94243.1| predicted protein [Populus trichocarpa]

 Score =  635 bits (1638), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 313/363 (86%), Positives = 334/363 (92%), Gaps = 1/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR+++TVGP MDMPIMHDSDRYD VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI
Sbjct: 1   MDRSAMTVGPGMDMPIMHDSDRYDLVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 60

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA+GGELFERIC +GRFSEDEAR
Sbjct: 61  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAAGGELFERICKSGRFSEDEAR 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLD SPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 121 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDDSPAPRLKICDFGYSKSSVLHSQPKSTVG 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGK+ADVWSCGVTLYVMLVG YPFEDP EPKDFRKTIQR+++VQY
Sbjct: 181 TPAYIAPEVLLRQEYDGKVADVWSCGVTLYVMLVGSYPFEDPAEPKDFRKTIQRVINVQY 240

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD+  I+ EC  LISRIF ADPA RITIPEI  H+WFLKNLPADL+DEKTM SQ+EEP
Sbjct: 241 SIPDSILITPECCHLISRIFDADPATRITIPEIRNHEWFLKNLPADLMDEKTMGSQFEEP 300

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           DQPMQSVD IMQI++EA++PAVG HGLN     +    DDDMD LDSESELDIDSSGEI+
Sbjct: 301 DQPMQSVDAIMQIVSEATVPAVGVHGLN-RCMMDNLDMDDDMDGLDSESELDIDSSGEIV 359

Query: 363 YAL 365
           YAL
Sbjct: 360 YAL 362

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	365
TAIR|locus:2174999	361	SNRK2.3 "sucrose nonfermenting	0.879	0.889	0.866	4.1e-152
TAIR|locus:2118929	362	OST1 "OPEN STOMATA 1" [Arabido	0.898	0.906	0.833	6.2e-149
TAIR|locus:2160559	360	SNRK2.5 "SNF1-related protein	0.838	0.85	0.750	2.4e-124
TAIR|locus:2206046	361	SNRK2.10 "SNF1-related protein	0.824	0.833	0.748	3.1e-122
TAIR|locus:2159597	353	SNRK2.1 "SNF1-related protein	0.830	0.858	0.740	1.3e-121
TAIR|locus:2140104	350	SNRK2.7 "SNF1-related protein	0.832	0.868	0.720	8.8e-118
TAIR|locus:2032075	343	SNRK2-8 "SNF1-RELATED PROTEIN	0.827	0.880	0.723	1.1e-117
TAIR|locus:2045319	339	SNRK2.9 "SNF1-related protein	0.819	0.882	0.688	6.8e-111
TAIR|locus:2102132	535	KIN10 "AT3G01090" [Arabidopsis	0.695	0.474	0.454	1.2e-51
TAIR|locus:2094672	512	KIN11 "SNF1 kinase homolog 11"	0.695	0.496	0.451	3.1e-51

TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1484 (527.5 bits), Expect = 4.1e-152, P = 4.1e-152
 Identities = 279/322 (86%), Positives = 302/322 (93%)

Query:     3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
             MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERGDKI
Sbjct:     1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGDKI 59

Query:    63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
             DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct:    60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119

Query:   123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
             FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct:   120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

Query:   183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
             TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILSV+Y
Sbjct:   180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239

Query:   243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
             S+PD   IS EC  LISRIFVADPA RI+IPEI  H WFLKNLPADL++E    SQ++EP
Sbjct:   240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

Query:   303 DQPMQSVDVIMQIIAEASIPAV 324
             +QPMQS+D IMQII+EA+IPAV
Sbjct:   300 EQPMQSLDTIMQIISEATIPAV 321

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0009789 "positive regulation of abscisic acid mediated signaling pathway" evidence=IGI

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0009739 "response to gibberellin stimulus" evidence=IGI

GO:0010029 "regulation of seed germination" evidence=IGI;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0009414 "response to water deprivation" evidence=IGI

TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1454 (516.9 bits), Expect = 6.2e-149, P = 6.2e-149
 Identities = 275/330 (83%), Positives = 304/330 (92%)

Query:     3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
             MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct:     1 MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58

Query:    63 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
             DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct:    59 DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118

Query:   123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
             FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct:   119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178

Query:   183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
             TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct:   179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238

Query:   243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
             ++PD   IS ECR LISRIFVADPA RI+IPEI  H+WFLKNLPADL+++ TM++Q++E 
Sbjct:   239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298

Query:   303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCY 332
             DQP QS++ IMQIIAEA++P  GT  LN Y
Sbjct:   299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHY 328

GO:0004672 "protein kinase activity" evidence=IEA;IDA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009414 "response to water deprivation" evidence=IGI;IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IDA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0009931 "calcium-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:2000377 "regulation of reactive oxygen species metabolic process" evidence=IMP

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0010118 "stomatal movement" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005985 "sucrose metabolic process" evidence=IMP

GO:0006636 "unsaturated fatty acid biosynthetic process" evidence=IMP

GO:0019432 "triglyceride biosynthetic process" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0048366 "leaf development" evidence=IMP

GO:0042744 "hydrogen peroxide catabolic process" evidence=RCA

TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1222 (435.2 bits), Expect = 2.4e-124, P = 2.4e-124
 Identities = 232/309 (75%), Positives = 266/309 (86%)

Query:    23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             D+Y+ V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct:     2 DKYEVVKDLGAGNFGVARLLRHKETKELVAMKYIERGRKIDENVAREIINHRSLRHPNII 61

Query:    83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct:    62 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAEARYFFQQLICGVDYCHSLQICH 121

Query:   143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
             RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK A
Sbjct:   122 RDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181

Query:   203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
             DVWSCGVTLYVMLVGGYPFEDPD+P++FRKTIQRI++VQY +PD   ISQECR L+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAVQYKIPDYVHISQECRHLLSRIF 241

Query:   263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQY--EEPDQPMQSVDVIMQIIAEAS 320
             V + A RIT+ EI KH W+LKNLP +L  E   ++ Y  E P   +QSV+ IM+I+ EA 
Sbjct:   242 VTNSAKRITLKEIKKHPWYLKNLPKELT-EPAQAAYYKRETPSFSLQSVEDIMKIVGEAR 300

Query:   321 IPAVGTHGL 329
              PA  ++ +
Sbjct:   301 NPAPSSNAV 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1202 (428.2 bits), Expect = 3.1e-122, P = 3.1e-122
 Identities = 226/302 (74%), Positives = 262/302 (86%)

Query:    23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             D+Y+ V+DIG+GNFGVARLMR K +KELVA+KYIERG KIDENV REIINHRSLRHPNI+
Sbjct:     2 DKYELVKDIGAGNFGVARLMRVKNSKELVAMKYIERGPKIDENVAREIINHRSLRHPNII 61

Query:    83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDEAR+FFQQLISGVSYCHAMQ+CH
Sbjct:    62 RFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDEARYFFQQLISGVSYCHAMQICH 121

Query:   143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
             RDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKSTVGTPAYIAPEVL R EYDGK+A
Sbjct:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKSTVGTPAYIAPEVLSRGEYDGKMA 181

Query:   203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
             DVWSCGVTLYVMLVG YPFED ++PK+F+KTIQRI++V+Y +PD   ISQ+C+ L+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAVKYKIPDYVHISQDCKHLLSRIF 241

Query:   263 VADPAARITIPEIMKHQWFLKNLPADLVD-EKTMSSQYEEPDQPMQSVDVIMQIIAEASI 321
             V +   RITI +I KH WFLKNLP +L +  +    + E P   +QSV+ IM+I+ EA  
Sbjct:   242 VTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRKENPTFSLQSVEEIMKIVEEAKT 301

Query:   322 PA 323
             PA
Sbjct:   302 PA 303

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA;RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0048527 "lateral root development" evidence=IMP

GO:0070300 "phosphatidic acid binding" evidence=IDA

TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1196 (426.1 bits), Expect = 1.3e-121, P = 1.3e-121
 Identities = 226/305 (74%), Positives = 261/305 (85%)

Query:    23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             D+YD V+D+G+GNFGVARL+R K TKELVA+KYIERG KIDENV REIINHRSL+HPNI+
Sbjct:     2 DKYDVVKDLGAGNFGVARLLRHKDTKELVAMKYIERGRKIDENVAREIINHRSLKHPNII 61

Query:    83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE EAR+FFQQLI GV YCH++Q+CH
Sbjct:    62 RFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAEARYFFQQLICGVDYCHSLQICH 121

Query:   143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
             RDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKSTVGTPAYIAPEVL R EYDGK A
Sbjct:   122 RDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKSTVGTPAYIAPEVLSRREYDGKHA 181

Query:   203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
             DVWSCGVTLYVMLVG YPFEDP++PK+FRKTIQRI++VQY +PD   ISQEC+ L+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAVQYKIPDYVHISQECKHLLSRIF 241

Query:   263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ-PMQSVDVIMQIIAEASI 321
             V + A RIT+ EI  H W+LKNLP +L+ E   ++ Y+      +QSV+ IM+I+ EA  
Sbjct:   242 VTNSAKRITLKEIKNHPWYLKNLPKELL-ESAQAAYYKRDTSFSLQSVEDIMKIVGEARN 300

Query:   322 PAVGT 326
             PA  T
Sbjct:   301 PAPST 305

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)]

 Score = 1160 (413.4 bits), Expect = 8.8e-118, P = 8.8e-118
 Identities = 222/308 (72%), Positives = 257/308 (83%)

Query:    23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             +RYD +RD+GSGNFGVA+L+R+K   E  AVKYIERG KIDE+VQREIINHR L+HPNI+
Sbjct:     2 ERYDILRDLGSGNFGVAKLVREKANGEFYAVKYIERGLKIDEHVQREIINHRDLKHPNII 61

Query:    83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE R++F+QLISGVSYCHAMQ+CH
Sbjct:    62 RFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDEGRYYFKQLISGVSYCHAMQICH 121

Query:   143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
             RDLKLENTLLDGSP+  LKICDFGYSKSSVLHSQPKSTVGTPAY+APEVL R EY+GKIA
Sbjct:   122 RDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKSTVGTPAYVAPEVLSRKEYNGKIA 181

Query:   203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
             DVWSCGVTLYVMLVG YPFEDP++P++ R TIQRILSV Y++PD   IS EC+ L+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSVHYTIPDYVRISSECKHLLSRIF 241

Query:   263 VADPAARITIPEIMKHQWFLKN-LPADLVDEKT---MSSQYEEPDQPMQSVDVIMQIIAE 318
             VADP  RIT+PEI KH WFLK  L     +EK    +  + EE ++  QSV+ I++II E
Sbjct:   242 VADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVEEEEEEEEKCRQSVEEIVKIIEE 301

Query:   319 ASIPAVGT 326
             A     GT
Sbjct:   302 ARKGVNGT 309

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006970 "response to osmotic stress" evidence=IGI;IDA

GO:0009651 "response to salt stress" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)]

 Score = 1159 (413.0 bits), Expect = 1.1e-117, P = 1.1e-117
 Identities = 222/307 (72%), Positives = 255/307 (83%)

Query:    23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             +RY+ V+DIGSGNFGVA+L+RDK +KEL AVK+IERG KIDE+VQREI+NHRSL HPNI+
Sbjct:     2 ERYEIVKDIGSGNFGVAKLVRDKFSKELFAVKFIERGQKIDEHVQREIMNHRSLIHPNII 61

Query:    83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             RFKEV+LT THLA+VMEYA+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCH++Q+CH
Sbjct:    62 RFKEVLLTATHLALVMEYAAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICH 121

Query:   143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
             RDLKLENTLLDGS APR+KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL   EYDGKIA
Sbjct:   122 RDLKLENTLLDGSEAPRVKICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIA 181

Query:   203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
             DVWSCGVTLYVMLVG YPFEDP +PKDFRKTI RIL  QY++PD   +S ECR L+SRIF
Sbjct:   182 DVWSCGVTLYVMLVGAYPFEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIF 241

Query:   263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIP 322
             VA+P  RITI EI  H WFLKNLP ++ +   M +    P    Q+V+ I+ II EA  P
Sbjct:   242 VANPEKRITIEEIKNHSWFLKNLPVEMYEGSLMMNG---PST--QTVEEIVWIIEEARKP 296

Query:   323 AVGTHGL 329
                  GL
Sbjct:   297 ITVATGL 303

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0080167 "response to karrikin" evidence=IEP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=IGI

TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)]

 Score = 1095 (390.5 bits), Expect = 6.8e-111, P = 6.8e-111
 Identities = 210/305 (68%), Positives = 247/305 (80%)

Query:    23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             ++Y+ V+D+G GNFG+ARLMR+K T ELVAVK+I+RG KIDENV REIINHR+L HPNIV
Sbjct:     2 EKYEMVKDLGFGNFGLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIV 61

Query:    83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             RFKEV+LTPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y HA+Q+CH
Sbjct:    62 RFKEVVLTPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICH 121

Query:   143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
             RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV  R EYDGK  
Sbjct:   122 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSV 181

Query:   203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
             DVWSCGV LYVMLVG YPFEDP +P++FRKT+Q+I++V Y +P    IS++CR L+SRIF
Sbjct:   182 DVWSCGVALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIF 241

Query:   263 VADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPM----QSVDVIMQIIAE 318
             VA+P  R T+ EI  H WFLKNLP +L  E   +  Y+     +    Q V+ IM+I+ E
Sbjct:   242 VANPLHRSTLKEIKSHAWFLKNLPREL-KEPAQAIYYQRNVNLINFSPQRVEEIMKIVGE 300

Query:   319 A-SIP 322
             A +IP
Sbjct:   301 ARTIP 305

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=IGI

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)]

 Score = 536 (193.7 bits), Expect = 1.2e-51, P = 1.2e-51
 Identities = 121/266 (45%), Positives = 156/266 (58%)

Query:    25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
             Y   R +G G+FG  ++    +T   VA+K + R      +++E V+REI   R   HP+
Sbjct:    42 YKLGRTLGIGSFGRVKIAEHALTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 101

Query:    81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
             I+R  EVI TPT + +VMEY + GELF+ I   GR  EDEAR FFQQ+ISGV YCH   V
Sbjct:   102 IIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 161

Query:   141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
              HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+    Y G 
Sbjct:   162 VHRDLKPENLLLDSKC--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 219

Query:   201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
               DVWSCGV LY +L G  PF+D + P  F+K    I    Y++P  + +S   RDLI R
Sbjct:   220 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLP--SHLSPGARDLIPR 273

Query:   261 IFVADPAARITIPEIMKHQWFLKNLP 286
             + V DP  R+TIPEI +H WF  +LP
Sbjct:   274 MLVVDPMKRVTIPEIRQHPWFQAHLP 299

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000152 "nuclear ubiquitin ligase complex" evidence=IPI

GO:0003006 "developmental process involved in reproduction" evidence=IMP

GO:0010050 "vegetative phase change" evidence=IMP

GO:0010260 "organ senescence" evidence=IMP

GO:0080022 "primary root development" evidence=IMP

GO:0009594 "detection of nutrient" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0010182 "sugar mediated signaling pathway" evidence=IMP

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2094672 KIN11 "SNF1 kinase homolog 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 532 (192.3 bits), Expect = 3.1e-51, P = 3.1e-51
 Identities = 120/266 (45%), Positives = 156/266 (58%)

Query:    25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
             Y   + +G G+FG  ++    VT   VA+K + R      +++E V+REI   R   HP+
Sbjct:    20 YKLGKTLGIGSFGKVKIAEHVVTGHKVAIKILNRRKIKNMEMEEKVRREIKILRLFMHPH 79

Query:    81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
             I+R  EVI T + + +VMEY   GELF+ I   GR  EDEAR FFQQ+ISGV YCH   V
Sbjct:    80 IIRQYEVIETTSDIYVVMEYVKSGELFDYIVEKGRLQEDEARNFFQQIISGVEYCHRNMV 139

Query:   141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
              HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+    Y G 
Sbjct:   140 VHRDLKPENLLLDSRC--NIKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 197

Query:   201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
               DVWSCGV LY +L G  PF+D + P  F+K    I    Y++P  + +S E RDLI R
Sbjct:   198 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLP--SHLSSEARDLIPR 251

Query:   261 IFVADPAARITIPEIMKHQWFLKNLP 286
             + + DP  RITIPEI +H+WF  +LP
Sbjct:   252 MLIVDPVKRITIPEIRQHRWFQTHLP 277

GO:0004672 "protein kinase activity" evidence=IEA;ISS;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9C958	SRK2B_ARATH	2, ., 7, ., 1, 1, ., 1	0.7266	0.8493	0.8587	no	no
Q9FFP9	SRK2H_ARATH	2, ., 7, ., 1, 1, ., 1	0.7435	0.8465	0.8583	no	no
A2ZAB5	SAPK3_ORYSI	2, ., 7, ., 1, 1, ., 1	0.6890	0.8986	0.9820	N/A	no
Q0D4J7	SAPK2_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7828	0.8328	0.8967	no	no
Q5N942	SAPK4_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7317	0.8082	0.8194	no	no
Q02066	AAIP_WHEAT	2, ., 7, ., 1, 1, ., 1	0.7666	0.8136	0.8945	N/A	no
Q9M9E9	SRK2C_ARATH	2, ., 7, ., 1, 1, ., 1	0.73	0.8082	0.8600	no	no
Q7XQP4	SAPK7_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7107	0.8767	0.8913	no	no
Q9SMQ4	SRK2F_ARATH	2, ., 7, ., 1, 1, ., 1	0.7142	0.8328	0.8685	no	no
Q75LR7	SAPK1_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7674	0.8246	0.8801	no	no
P43292	SRK2G_ARATH	2, ., 7, ., 1, 1, ., 1	0.7272	0.8438	0.8725	no	no
P43291	SRK2A_ARATH	2, ., 7, ., 1, 1, ., 1	0.7557	0.8164	0.8209	no	no
Q39193	SRK2I_ARATH	2, ., 7, ., 1, 1, ., 1	0.8374	0.9890	1.0	yes	no
Q39192	SRK2D_ARATH	2, ., 7, ., 1, 1, ., 1	0.8071	0.9917	1.0	no	no
A2YNT8	SAPK2_ORYSI	2, ., 7, ., 1, 1, ., 1	0.7861	0.8328	0.8967	N/A	no
Q940H6	SRK2E_ARATH	2, ., 7, ., 1, 1, ., 1	0.8049	0.9890	0.9972	no	no
Q75H77	SAPKA_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8292	0.9917	1.0	yes	no
Q6ZI44	SAPK6_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7409	0.8164	0.8164	no	no
Q7Y0B9	SAPK8_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.8526	0.8739	0.8598	no	no
Q75V57	SAPK9_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7802	0.9863	0.9972	no	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	365
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-101
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-89
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-66
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-62
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-62
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-60
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-56
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-56
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-53
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-53
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-48
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-45
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-45
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-45
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-45
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-45
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-42
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-42
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-42
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-41
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-41
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-41
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-41
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-40
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-40
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-40
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-39
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-39
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-39
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-39
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-39
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-39
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-38
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-38
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-38
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-37
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-36
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-36
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-36
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-36
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-36
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-35
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-35
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-35
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-35
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-35
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-35
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-34
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-34
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-34
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-34
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-34
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-34
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	4e-34
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-34
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-34
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-34
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-33
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-33
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-33
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-33
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-33
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-33
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-33
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-33
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-33
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-32
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-32
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-32
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-32
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-31
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-31
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-31
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-31
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-31
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-31
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-31
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-30
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-30
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-29
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-29
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-29
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-29
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-29
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-28
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-28
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-28
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-28
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-28
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-28
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-28
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-27
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-27
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-27
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-27
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-27
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-27
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-27
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-26
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-26
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-26
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-26
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	5e-26
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-26
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-26
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-26
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-25
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-25
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-25
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-25
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-25
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-24
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-24
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-24
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-24
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-24
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-24
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-24
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-24
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-24
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-23
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-23
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-23
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-23
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-23
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-23
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-23
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	9e-23
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-22
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-22
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-22
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-22
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-22
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-22
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-22
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-21
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-21
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-21
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-21
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	7e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-21
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-20
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-20
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-20
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-20
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-20
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-20
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-20
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-20
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-20
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-20
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-20
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-20
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-19
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-19
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-19
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-19
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-18
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-18
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-18
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-17
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-17
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-17
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	9e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-16
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-16
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-16
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-16
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-15
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-15
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-15
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-15
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-15
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-14
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-14
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-13
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-13
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-11
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-11
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-11
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-11
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-10
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-09
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-09
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-09
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	5e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	5e-08
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	7e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-08
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-08
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-07
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-07
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-07
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-06
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-06
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-05
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  299 bits (768), Expect = e-101
 Identities = 104/260 (40%), Positives = 149/260 (57%), Gaps = 9/260 (3%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
           Y+ +  +G G+FG   L RDK T +LVA+K I  ++  K  E + REI   + L+HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           R  +V      L +VMEY  GG+LF+ +   GR SEDEARF+ +Q++S + Y H+  + H
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLK EN LLD      +K+ DFG ++      +  + VGTP Y+APEVLL   Y   + 
Sbjct: 121 RDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV- 177

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDLISRI 261
           D+WS GV LY +L G  PF   D+     +  ++I   +   P     IS E +DLI ++
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL---ELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 262 FVADPAARITIPEIMKHQWF 281
            V DP  R+T  E ++H +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  268 bits (688), Expect = 4e-89
 Identities = 108/263 (41%), Positives = 149/263 (56%), Gaps = 9/263 (3%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPNI 81
           Y+ +R +GSG+FG     + K T ++VAVK +       K D+  +REI   R L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           VR  +      HL +VMEY  GG+LF+ +   G  SEDEA+    Q++ G+ Y H+  + 
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGK 200
           HRDLK EN LLD +    +KI DFG +K  +  S   +T VGTP Y+APEVLL     G 
Sbjct: 121 HRDLKPENILLDEN--GVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTNPISQECRDLI 258
             DVWS GV LY +L G  PF   +   D  + I+RIL   +++  P  +  S+E +DLI
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENIL-DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 259 SRIFVADPAARITIPEIMKHQWF 281
            +    DP+ R T  EI++H WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  209 bits (533), Expect = 2e-66
 Identities = 93/252 (36%), Positives = 126/252 (50%), Gaps = 42/252 (16%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI 88
           +G G FG   L RDK T + VA+K I++ D     E + REI   + L HPNIV+   V 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 89  LTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
               HL +VMEY  GG L + +  N G+ SEDE      Q++ G+ Y H+  + HRDLK 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKP 120

Query: 148 ENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
           EN LLD S   ++K+ DFG SK  +   S  K+ VGTPAY+APEVLL   Y  + +D+WS
Sbjct: 121 ENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
            GV LY +                                      E +DLI ++   DP
Sbjct: 180 LGVILYEL-------------------------------------PELKDLIRKMLQKDP 202

Query: 267 AARITIPEIMKH 278
             R +  EI++H
Sbjct: 203 EKRPSAKEILEH 214

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  200 bits (511), Expect = 1e-62
 Identities = 97/261 (37%), Positives = 136/261 (52%), Gaps = 21/261 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
           +G G+FG   L+R K T +L A+K +++   I        +  R+    + HP IV+   
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              T   L +V+EYA GGELF  +   GRFSE+ ARF+  +++  + Y H++ + +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 147 LENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
            EN LLD  G     +K+ DFG +K      S+  +  GTP Y+APEVLL   Y GK  D
Sbjct: 121 PENILLDADG----HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVD 175

Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263
            WS GV LY ML G  PF   D      +  ++IL      P+   +S E RDLIS +  
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKDPLRFPEF--LSPEARDLISGLLQ 229

Query: 264 ADPAARIT---IPEIMKHQWF 281
            DP  R+      EI  H +F
Sbjct: 230 KDPTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  200 bits (511), Expect = 1e-62
 Identities = 87/264 (32%), Positives = 140/264 (53%), Gaps = 20/264 (7%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
           +Y+ ++ IG G+FG   L+R K   +L  +K I      +K  E+   E+   + L HPN
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 136
           I+++ E       L IVMEYA GG+L ++I    +    F E++   +F QL   + Y H
Sbjct: 61  IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
           + ++ HRD+K +N  L       +K+ DFG SK   S+V  +  K+ VGTP Y++PE+  
Sbjct: 121 SRKILHRDIKPQNIFLT--SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQ 176

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
              Y+ K +D+WS G  LY +    +PFE     ++  +   +IL  QY  P  +  S E
Sbjct: 177 NKPYNYK-SDIWSLGCVLYELCTLKHPFEG----ENLLELALKILKGQYP-PIPSQYSSE 230

Query: 254 CRDLISRIFVADPAARITIPEIMK 277
            R+L+S +   DP  R +I +I++
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  195 bits (498), Expect = 1e-60
 Identities = 87/261 (33%), Positives = 133/261 (50%), Gaps = 18/261 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK-- 85
           +G G+FG   L  DK T EL+AVK +E     +E +   +REI    SL+HPNIVR+   
Sbjct: 8   LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           E       L I +EY SGG L   +   G+  E   R + +Q++ G++Y H+  + HRD+
Sbjct: 68  ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127

Query: 146 KLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           K  N L+D      +K+ DFG +K            S  GTP ++APEV +R E  G+ A
Sbjct: 128 KGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV-IRGEEYGRAA 184

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISR 260
           D+WS G T+  M  G  P+ +   P      + +I S      +P+   +S+E +D + +
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSSGEPPEIPEH--LSEEAKDFLRK 239

Query: 261 IFVADPAARITIPEIMKHQWF 281
               DP  R T  E+++H + 
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  185 bits (473), Expect = 2e-56
 Identities = 94/275 (34%), Positives = 151/275 (54%), Gaps = 34/275 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR----SLR 77
           D ++F++ +G+G+FG   L+R K + +  A+K + +  KI +  Q E ++N +    S+R
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIR 59

Query: 78  HPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           HP +V     F++     ++L +VMEY  GGELF  +  +GRF E  ARF+  Q++  + 
Sbjct: 60  HPFLVNLYGSFQD----DSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE 115

Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           Y H++ + +RDLK EN LLD  G     +KI DFG++K   +  +  +  GTP Y+APE+
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGY----IKITDFGFAK--RVKGRTYTLCGTPEYLAPEI 169

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
           +L   Y GK  D W+ G+ +Y ML G  PF D D P    +  ++IL  +   P  +  S
Sbjct: 170 ILSKGY-GKAVDWWALGILIYEMLAGYPPFFD-DNP---IQIYEKILEGKVRFP--SFFS 222

Query: 252 QECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
            + +DLI  +   D   R+      + +I  H WF
Sbjct: 223 PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  184 bits (469), Expect = 4e-56
 Identities = 87/292 (29%), Positives = 138/292 (47%), Gaps = 49/292 (16%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
           + F + IG G+F    L ++K T +  A+K      + +  K+    +++E++  R   H
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVL-TRLNGH 61

Query: 79  PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           P I++    F++      +L  V+EYA  GEL + I   G   E   RF+  +++  + Y
Sbjct: 62  PGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVL 173
            H+  + HRDLK EN LLD      +KI DFG +K                         
Sbjct: 118 LHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233
             +  S VGT  Y++PE LL  +  GK +D+W+ G  +Y ML G  PF   +E      T
Sbjct: 176 RRRFASFVGTAEYVSPE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY----LT 230

Query: 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWF 281
            Q+IL ++YS P   P   + +DLI ++ V DP  R+ +     E+  H +F
Sbjct: 231 FQKILKLEYSFPPNFP--PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  175 bits (446), Expect = 7e-53
 Identities = 90/267 (33%), Positives = 134/267 (50%), Gaps = 23/267 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIVRFKE 86
           I  G +G   L + K T ++ A+K I++ D I +N   +++  R      + P +V+   
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                 +L +VMEY  GG+L   + N G   ED AR +  +++  + Y H+  + HRDLK
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120

Query: 147 LENTLLDGSPAPRLKICDFGYSK---------SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            +N L+D +    LK+ DFG SK          +    + K  VGTP YIAPEV+L   +
Sbjct: 121 PDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K  D WS G  LY  LVG  PF   + P    +  Q IL+ +   P+   +S E  DL
Sbjct: 179 -SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQNILNGKIEWPEDVEVSDEAIDL 233

Query: 258 ISRIFVADPAARI---TIPEIMKHQWF 281
           IS++ V DP  R+   +I EI  H +F
Sbjct: 234 ISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  175 bits (445), Expect = 9e-53
 Identities = 78/260 (30%), Positives = 126/260 (48%), Gaps = 12/260 (4%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVR 83
           ++ +  IG G FG     R K T + VA+K I     +  E +  EI   +  +HPNIV+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
           +    L    L IVME+ SGG L + + +  +  +E +  +  ++L+ G+ Y H+  + H
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
           RD+K  N LL  DG     +K+ DFG S          + VGTP ++APEV+    YD K
Sbjct: 122 RDIKAANILLTSDGE----VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            AD+WS G+T   +  G  P+ +    K   K      +    + +    S E +D + +
Sbjct: 178 -ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKK 233

Query: 261 IFVADPAARITIPEIMKHQW 280
               +P  R T  +++KH +
Sbjct: 234 CLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  167 bits (422), Expect = 3e-48
 Identities = 93/281 (33%), Positives = 138/281 (49%), Gaps = 28/281 (9%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHP- 79
           Y  +R +G G+FG   L RD+   +LVA+K + +  +          REI    SL HP 
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCH 136
           NIV+  +       L +VMEY  GG L + +      G  SE EA F   Q++S + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAP 189
           +  + HRD+K EN LLD      +K+ DFG +K       +S + + P ++VGTP Y+AP
Sbjct: 119 SKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 190 EVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------- 240
           EVLL     Y    +D+WS G+TLY +L G  PFE         +T++ IL +       
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             S  +   IS+   DL+ ++   DP  R++    + H   
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278

Length = 384

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  163 bits (416), Expect = 4e-48
 Identities = 92/303 (30%), Positives = 137/303 (45%), Gaps = 67/303 (22%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
           Y+ +  +G G +GV    RDK T E+VA+K I R D  +E +     REI   + L+HPN
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
           IV+  +VI T   L +V EY    +L + +    G  S +  +    QL+ G++YCH+ +
Sbjct: 60  IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLR- 194
           + HRDLK +N L++      LK+ DFG +++      P  T    V T  Y APE+LL  
Sbjct: 119 ILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVVTLWYRAPEILLGS 173

Query: 195 HEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED--PD------- 225
             Y   + D+WS G     M+ G                    G P E+  P        
Sbjct: 174 KHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232

Query: 226 -------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
                   PKD  K + R             +  E  DL+S++   +PA RI+  E +KH
Sbjct: 233 KPTFPKFPPKDLEKVLPR-------------LDPEGIDLLSKMLQYNPAKRISAKEALKH 279

Query: 279 QWF 281
            +F
Sbjct: 280 PYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  158 bits (401), Expect = 2e-45
 Identities = 97/277 (35%), Positives = 143/277 (51%), Gaps = 27/277 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSLRHPNIV 82
           +G G FG   L+R+K T +  A+K I + + I   + ++ + H        ++ RHP + 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMK-ILKKEVI---IAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+  V +
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVY 118

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
           RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL  ++Y G+ 
Sbjct: 119 RDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRA 175

Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            D W  GV +Y M+ G  PF + D  K F    + IL  +   P T  +S E + L++ +
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLAGL 229

Query: 262 FVADPAARI-----TIPEIMKHQWFLKNLPADLVDEK 293
              DP  R+        EIM+H++F      D+V +K
Sbjct: 230 LKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKK 266

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  157 bits (400), Expect = 2e-45
 Identities = 89/299 (29%), Positives = 138/299 (46%), Gaps = 47/299 (15%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
             +  ++ +G G+ G   L+R K T +L A+K +++ + I  N       ++EI+   +L
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL--ATL 58

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 134
            HP +        T T+L +VM+Y  GGELF   +       SE+ ARF+  +++  + Y
Sbjct: 59  DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 135 CHAMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQP 177
            H + + +RDLK EN LL  S                 P P  K    G  +SSV     
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178

Query: 178 -----------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
                       S VGT  YIAPEV+    +   + D W+ G+ LY ML G  PF+    
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKG--- 234

Query: 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI----TIPEIMKHQWF 281
             +  +T   IL  + + P + P+S   RDLI ++ V DP+ R+       EI +H +F
Sbjct: 235 -SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  156 bits (397), Expect = 2e-45
 Identities = 85/269 (31%), Positives = 138/269 (51%), Gaps = 17/269 (6%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
            + Y  +  IG G  G      D+ T + VA+K +    +  E +  EI+  +  +HPNI
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI 77

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           V + +  L    L +VMEY  GG L + I  N  R +E +  +  ++++ G+ Y H+  V
Sbjct: 78  VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137

Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            HRD+K +N LL  DGS    +K+ DFG++ + +   S+  S VGTP ++APEV+ R +Y
Sbjct: 138 IHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY 193

Query: 198 DGKIADVWSCGVTLYVMLVGGYP--FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
             K+ D+WS G+    M   G P    +P     F  T + I  ++    +    S E +
Sbjct: 194 GPKV-DIWSLGIMCIEM-AEGEPPYLREPPLRALFLITTKGIPPLK----NPEKWSPEFK 247

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKN 284
           D +++  V DP  R +  E+++H  FLK 
Sbjct: 248 DFLNKCLVKDPEKRPSAEELLQHP-FLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  155 bits (395), Expect = 3e-45
 Identities = 81/260 (31%), Positives = 128/260 (49%), Gaps = 14/260 (5%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
           +G G FG   L++ K      A+K +++   ++   Q  I + +       HP IV+   
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                 ++ ++MEY  GGEL+  + + G F E  ARF+   ++    Y H   + +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            EN LLD +    +K+ DFG++K      +  +  GTP Y+APE++L   YD    D WS
Sbjct: 121 PENLLLDSN--GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYWS 177

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
            G+ LY +L G  PF + DE  D  +    IL     +   N I +  +DLI ++   +P
Sbjct: 178 LGILLYELLTGRPPFGEDDE--DPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP 235

Query: 267 AARI-----TIPEIMKHQWF 281
             R+      I +I KH+WF
Sbjct: 236 EERLGNLKGGIKDIKKHKWF 255

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  154 bits (391), Expect = 8e-45
 Identities = 84/270 (31%), Positives = 131/270 (48%), Gaps = 34/270 (12%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI--ERGD-KIDENVQREIINHRSLRHPNIVRFKEV 87
           IG G FG      +  T EL+AVK I  +  D K  + +  E+     L+HPN+V++  V
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEA--RFFFQQLISGVSYCHAMQVCHRDL 145
            +    + I MEY SGG L E +   GR   DE   R +  QL+ G++Y H+  + HRD+
Sbjct: 68  EVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125

Query: 146 KLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
           K  N  LD +    +K+ DFG +      ++ +  + +S  GTPAY+APEV+   +  G 
Sbjct: 126 KPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGH 183

Query: 201 I--ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--------PDTNPI 250
              AD+WS G  +  M  G  P+ + D              + + V        PD+  +
Sbjct: 184 GRAADIWSLGCVVLEMATGKRPWSELDNE----------FQIMFHVGAGHKPPIPDSLQL 233

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQW 280
           S E +D + R   +DP  R T  E+++H +
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  151 bits (384), Expect = 9e-43
 Identities = 95/298 (31%), Positives = 135/298 (45%), Gaps = 49/298 (16%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RH 78
           D ++ ++ IG G FG   L+RDK T ++ A+K + + D I  N    +   R +      
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 79  PNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           P IV+    F++      HL +VMEY  GG+L   +     F E+ ARF+  +L+  +  
Sbjct: 61  PWIVKLYYSFQDE----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDS 116

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------------------------- 169
            H +   HRD+K +N L+D      +K+ DFG  K                         
Sbjct: 117 VHKLGFIHRDIKPDNILIDADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174

Query: 170 -SSVLHSQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
                H Q +    STVGTP YIAPEVL    Y  +  D WS GV LY ML G  PF   
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD 233

Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-IPEIMKHQWF 281
              + + K I    S+++  P   P+S E  DLI R  + DP  R+    EI  H +F
Sbjct: 234 TLQETYNKIINWKESLRF--PPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF 288

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  148 bits (375), Expect = 3e-42
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 14/260 (5%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
           V+ +G G+ GV   +R K T ++ A+K I      +   Q  RE+   RS   P +V+  
Sbjct: 6   VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRD 144
                   ++IV+EY  GG L + +   G+  E    +  +Q++ G+ Y H    + HRD
Sbjct: 66  GAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRD 125

Query: 145 LKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
           +K  N L+   G      KI DFG SK         +T VGT  Y++PE  ++ E     
Sbjct: 126 IKPSNLLINSKGEV----KIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQGESYSYA 180

Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTNPISQECRDLISR 260
           AD+WS G+TL    +G +PF  P +P  F + +Q I      S+P     S E RD IS 
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPPPSLPA-EEFSPEFRDFISA 238

Query: 261 IFVADPAARITIPEIMKHQW 280
               DP  R +  E+++H +
Sbjct: 239 CLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  148 bits (376), Expect = 3e-42
 Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 36/288 (12%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNI 81
           Y  +  IG G +GV    RDK+T E+VA+K I+     + I +   REI   + L HPNI
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
           ++  +V      L +V E+    +L++ I +  R   E   + +  QL+ G+++CH+  +
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEY 197
            HRDLK EN L++      LK+ DFG ++S    S  +     V T  Y APE+LL  + 
Sbjct: 120 LHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVTRWYRAPELLLGDKG 175

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDE---------------PKDFRKTIQRILSVQY 242
                D+WS G     +L     F    E               P+ + K      + ++
Sbjct: 176 YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235

Query: 243 SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
           S P    +         S +  DL+S++   DP  RIT  + + H +F
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  147 bits (373), Expect = 3e-42
 Identities = 87/263 (33%), Positives = 128/263 (48%), Gaps = 28/263 (10%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---VQREIINHRSLRHPNIVRFKEV 87
           IG G FGV     +  T + VA+K I      +E    + +EI   ++L+HPNIV++   
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
           I T   L I++EYA  G L + I   G F E     +  Q++ G++Y H   V HRD+K 
Sbjct: 68  IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127

Query: 148 ENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
            N L   DG     +K+ DFG + K + +     S VGTP ++APEV+         +D+
Sbjct: 128 ANILTTKDGV----VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA-SDI 182

Query: 205 WSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLI 258
           WS G T+  +L G  P+ D +     FR  I         V D +P     IS E +D +
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAALFR--I---------VQDDHPPLPEGISPELKDFL 231

Query: 259 SRIFVADPAARITIPEIMKHQWF 281
            + F  DP  R T  +++KH W 
Sbjct: 232 MQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 1e-41
 Identities = 83/269 (30%), Positives = 139/269 (51%), Gaps = 22/269 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
           D  + ++ +G+G FG   L+RD++++   A+K +   + I     ++V  E    + + H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P I+R          L ++MEY  GGELF  + N+GRFS     F+  +++  + Y H+ 
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           ++ +RDLK EN LLD      +K+ DFG++K   L  +  +  GTP Y+APEV+    + 
Sbjct: 121 EIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPEVIQSKGH- 175

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-NPISQECRDL 257
            K  D W+ G+ +Y MLVG  PF D D P       ++IL+ +   P   +  +   +DL
Sbjct: 176 NKAVDWWALGILIYEMLVGYPPFFD-DNPFGI---YEKILAGKLEFPRHLDLYA---KDL 228

Query: 258 ISRIFVADPAARI-----TIPEIMKHQWF 281
           I ++ V D   R+        ++  H+WF
Sbjct: 229 IKKLLVVDRTRRLGNMKNGADDVKNHRWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  146 bits (370), Expect = 2e-41
 Identities = 83/275 (30%), Positives = 133/275 (48%), Gaps = 32/275 (11%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
           + +  +  IG G+FG      DK T ++VA+K I   E  D+I++ +Q+EI      R P
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED-IQQEIQFLSQCRSP 59

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            I ++    L  + L I+MEY  GG   + +   G+  E    F  ++++ G+ Y H   
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEEG 118

Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
             HRD+K  N LL  +G     +K+ DFG S   +   S+  + VGTP ++APEV+ +  
Sbjct: 119 KIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQRILSVQYSVPDTNP 249
           YD K AD+WS G+T   +  G  P  D          PK+   +++            N 
Sbjct: 175 YDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEG-----------NK 222

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            S+  +D +S     DP  R +  E++KH+ F+K 
Sbjct: 223 FSKPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  147 bits (372), Expect = 3e-41
 Identities = 96/287 (33%), Positives = 143/287 (49%), Gaps = 25/287 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
           +G G+FG   L   K T EL AVK +++   + D++V+  +   R L    +HP + +  
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
               T   L  VMEY +GG+L   I  +GRF E  ARF+  +++ G+ + H   + +RDL
Sbjct: 63  SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
           KL+N LLD      +KI DFG  K  +L     ST  GTP YIAPE+L    Y G   D 
Sbjct: 123 KLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
           W+ GV LY ML G  PFE  DE + F    Q IL  +   P    +S+E + ++      
Sbjct: 180 WALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYPRW--LSKEAKSILKSFLTK 233

Query: 265 DPAARITIP-----EIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPM 306
           +P  R+        +I  H +F + +  D ++ K +    + P +P 
Sbjct: 234 NPEKRLGCLPTGEQDIKGHPFF-REIDWDKLERKEI----KPPFKPK 275

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  145 bits (368), Expect = 4e-41
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 37/290 (12%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
           RY  +  IG G  G+    +D+ T E VA+K +        I     REI   ++ +HP 
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
           +V+  +V    +   +VMEY    +L E + +  R   E + + + + L+ GV+Y HA  
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL-RHE 196
           + HRDLK  N L+  S    LKI DFG ++  S          V T  Y APE+L    +
Sbjct: 120 IMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSVPDTN 248
           YD  + D+W+ G     +L  G P    +   +    + R L            S+PD N
Sbjct: 178 YDPGV-DLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 249 PI-----------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
            I                 S E  DL+  + V DP+ R++  E ++H +F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  145 bits (367), Expect = 2e-40
 Identities = 89/273 (32%), Positives = 137/273 (50%), Gaps = 22/273 (8%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
           +  +  +G G +G   L + K T E+VA+K +++      N  R ++  R +    +   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +V+         +L + MEY  GG+    + N G  SED ARF+  ++   V   H +  
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRDLK EN L+D S    +K+ DFG SK  V  +   S VG+P Y+APEVL    YD  
Sbjct: 123 IHRDLKPENFLIDAS--GHIKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFT 178

Query: 201 IADVWSCGVTLYVMLVGGYPF--EDPDEP----KDFRKTIQRILSVQYSVPDTNPISQEC 254
           + D WS G  LY  L G  PF    P+E     K +++T+QR +      P  N +S E 
Sbjct: 179 V-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD---PRFN-LSDEA 233

Query: 255 RDLISRIFVADPAARI-TIPEIMKHQWFLKNLP 286
            DLI+++ + DP+ R  ++ +I  H +F K + 
Sbjct: 234 WDLITKL-INDPSRRFGSLEDIKNHPFF-KEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  144 bits (364), Expect = 4e-40
 Identities = 105/330 (31%), Positives = 161/330 (48%), Gaps = 30/330 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
           +G G FG   L+R+K + +  A+K +++   I  + V   +   R L   RHP +   K 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              T   L  VMEY +GGELF  +     FSED  RF+  +++S + Y H+ ++ +RDLK
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122

Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVW 205
           LEN +LD      +KI DFG  K  +  +   K+  GTP Y+APEVL  ++Y G+  D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
             GV +Y M+ G  PF + D  K F    + IL      P T  +S + + L+S + + D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEDIKFPRT--LSADAKSLLSGLLIKD 233

Query: 266 PAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEAS 320
           P  R+        EIM+H +F      D+ D+K +      P +P  + +   +   E  
Sbjct: 234 PNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVP-----PFKPQVTSETDTRYFDEEF 288

Query: 321 IPAVGTHGLNCYMTDNLDMDDDDMDDLDSE 350
                T      +T     D+D MD +D+E
Sbjct: 289 TAQTIT------ITPPEKYDEDGMDCMDNE 312

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  141 bits (358), Expect = 6e-40
 Identities = 75/265 (28%), Positives = 129/265 (48%), Gaps = 16/265 (6%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPN 80
           ++ +R IG G FG   +++ + TK++ A+KY+ +   +++   R ++N R     L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +V          ++ +V++   GG+L   +    +FSE++ +F+  +++  + Y H+  +
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K +N LLD      + I DF  +      +   ST GTP Y+APEVL R  Y   
Sbjct: 122 IHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SV 178

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI--SQECRDLI 258
             D WS GVT Y  L G  P+         R    +I + Q +     P   S E  D I
Sbjct: 179 AVDWWSLGVTAYECLRGKRPYRGHS-----RTIRDQIRAKQETADVLYPATWSTEAIDAI 233

Query: 259 SRIFVADPAARI--TIPEIMKHQWF 281
           +++   DP  R+   + ++  H +F
Sbjct: 234 NKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  140 bits (356), Expect = 2e-39
 Identities = 79/275 (28%), Positives = 127/275 (46%), Gaps = 33/275 (12%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
           Y+ +  IG G+FG  R +R K   +++  K I+ G  + E  ++++++     R L+HPN
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYG-NMTEKEKQQLVSEVNILRELKHPN 60

Query: 81  IVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSY 134
           IVR+  + +  +   L IVMEY  GG+L + I           E+       QL+  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 135 CH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIA 188
           CH        V HRDLK  N  LD +    +K+ DFG +K     S    T VGTP Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           PE L    YD K +D+WS G  +Y +     PF      ++  +   +I   ++      
Sbjct: 179 PEQLNHMSYDEK-SDIWSLGCLIYELCALSPPF----TARNQLQLASKIKEGKFR----- 228

Query: 249 PI----SQECRDLISRIFVADPAARITIPEIMKHQ 279
            I    S E  ++I  +   DP  R +  E+++  
Sbjct: 229 RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  141 bits (357), Expect = 3e-39
 Identities = 94/273 (34%), Positives = 142/273 (52%), Gaps = 19/273 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
           +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP +   K 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+  V +RD+K
Sbjct: 63  AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122

Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
           LEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL  ++Y G+  D W
Sbjct: 123 LENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWW 179

Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
             GV +Y M+ G  PF + D  + F    + IL  +   P T  +S E + L++ +   D
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLAGLLKKD 233

Query: 266 PAARI-----TIPEIMKHQWFLKNLPADLVDEK 293
           P  R+        E+M+H++FL     D+V +K
Sbjct: 234 PKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 266

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  141 bits (356), Expect = 4e-39
 Identities = 90/283 (31%), Positives = 137/283 (48%), Gaps = 22/283 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVRFKE 86
           IG G+FG    +R + T+ + A+K I +   +  +     +  R++      P IV  K 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              +P  L +V+ + +GGELF  +   GRF    ARF+  +L+  +   H   V +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVW 205
            EN LLD      + +CDFG  K ++      +T  GTP Y+APE+LL H Y  K  D W
Sbjct: 121 PENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177

Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
           + GV LY ML G  PF D +  + +RK +Q  L      PD     ++ +DL+  +   D
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPL----RFPDG--FDRDAKDLLIGLLSRD 231

Query: 266 PAARITI---PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 305
           P  R+      EI  H +F     + L  +K +    + P +P
Sbjct: 232 PTRRLGYNGAQEIKNHPFF-----SQLSWKKLLMKGIQPPFKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  141 bits (356), Expect = 4e-39
 Identities = 94/264 (35%), Positives = 140/264 (53%), Gaps = 28/264 (10%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
           +G G+FG   L   K T E  A+K +++ D +  D++V+  ++  R L     HP +   
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKK-DVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
                T  HL  VMEY +GG+L   I ++GRF E  ARF+  ++I G+ + H   + +RD
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIAD 203
           LKL+N LLD      +KI DFG  K ++      ST  GTP YIAPE+L   +Y+  + D
Sbjct: 122 LKLDNVLLDKD--GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV-D 178

Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLI 258
            WS GV LY ML+G  PF   DE + F            S+ +  P     IS+E +D +
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGEDEDELF-----------DSILNDRPHFPRWISKEAKDCL 227

Query: 259 SRIFVADPAARITIP-EIMKHQWF 281
           S++F  DP  R+ +  +I +H +F
Sbjct: 228 SKLFERDPTKRLGVDGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  139 bits (351), Expect = 6e-39
 Identities = 89/260 (34%), Positives = 131/260 (50%), Gaps = 12/260 (4%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDEN-VQREIINHRSLRHPN 80
           +Y+ +R +G G FG+  L R K  ++LV +K I  E+  K +    Q E    + L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
           I+ + E  L    L IVMEYA GG L E I         ED    FF Q++  + + H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + HRDLK +N LLD      +KI DFG SK     S+  + VGTP YI+PE+     Y+
Sbjct: 121 LILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYN 179

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K +D+W+ G  LY +      FE  + P      + +I+S  ++ P ++  S + R LI
Sbjct: 180 QK-SDIWALGCVLYELASLKRAFEAANLP----ALVLKIMSGTFA-PISDRYSPDLRQLI 233

Query: 259 SRIFVADPAARITIPEIMKH 278
             +   DP+ R  + +IM  
Sbjct: 234 LSMLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  139 bits (351), Expect = 6e-39
 Identities = 88/267 (32%), Positives = 133/267 (49%), Gaps = 29/267 (10%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE----------RGDKIDENVQREIINHRSLRHPN 80
           IGSG+FG   L  +  + EL+AVK +E          R   + + + REI   + L+H N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV++    L   HL I +EY  GG +   + N G F E   R F +Q++ G++Y H   +
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVLL 193
            HRD+K  N L+D      +KI DFG SK       S+  +    S  G+  ++APEV+ 
Sbjct: 128 IHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPD-TNPIS 251
           +  Y  K AD+WS G  +  ML G +PF D  +       +Q I  + + + P+  + IS
Sbjct: 186 QTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ-------LQAIFKIGENASPEIPSNIS 237

Query: 252 QECRDLISRIFVADPAARITIPEIMKH 278
            E  D + + F  D   R T  E++KH
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKH 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  140 bits (354), Expect = 1e-38
 Identities = 88/273 (32%), Positives = 132/273 (48%), Gaps = 19/273 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-----LRHPNIVRFK 85
           IG G+FG   L + K   +  AVK +++   + +  Q+ I+  R+     ++HP +V   
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
               T   L  V++Y +GGELF  +     F E  ARF+  ++ S + Y H++ + +RDL
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
           K EN LLD      L   DFG  K  + HS+  ST  GTP Y+APEVL +  YD +  D 
Sbjct: 123 KPENILLDSQGHVVLT--DFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTVDW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
           W  G  LY ML G  PF   D  + +   + + L ++ +      IS   R L+  +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN------ISVSARHLLEGLLQK 233

Query: 265 DPAARI----TIPEIMKHQWFLKNLPADLVDEK 293
           D   R+       EI  H +F      DLV++K
Sbjct: 234 DRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKK 266

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  140 bits (353), Expect = 1e-38
 Identities = 96/274 (35%), Positives = 144/274 (52%), Gaps = 20/274 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPNIVRFKE 86
           +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RHP +   K 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDL 145
              T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+   V +RDL
Sbjct: 63  SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
           KLEN +LD      +KI DFG  K  +   +  K+  GTP Y+APEVL  ++Y G+  D 
Sbjct: 123 KLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
           W  GV +Y M+ G  PF + D  K F    + IL  +   P T  +S E + L+S +   
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEAKSLLSGLLKK 233

Query: 265 DPAARI-----TIPEIMKHQWFLKNLPADLVDEK 293
           DP  R+        EIM+H++F   +  D+ ++K
Sbjct: 234 DPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKK 267

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  137 bits (348), Expect = 4e-38
 Identities = 91/302 (30%), Positives = 133/302 (44%), Gaps = 64/302 (21%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQ-REIINHRSLR----H 78
           Y  ++ +G G FG   L R+K T ELVA+K +++     +E +  RE+   +SLR    H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREV---KSLRKLNEH 57

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCH 136
           PNIV+ KEV      L  V EY   G L++ +       FSE   R    Q++ G+++ H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
                HRDLK EN L+  S    +KI DFG ++   + S+P  T  V T  Y APE+LLR
Sbjct: 117 KHGFFHRDLKPENLLV--SGPEVVKIADFGLARE--IRSRPPYTDYVSTRWYRAPEILLR 172

Query: 195 H-EYDGKIADVWSCG------VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------- 240
              Y   + D+W+ G       TL  +  G     + D+       + +I SV       
Sbjct: 173 STSYSSPV-DIWALGCIMAELYTLRPLFPGS---SEIDQ-------LYKICSVLGTPTKQ 221

Query: 241 ------------QYSVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQ 279
                        +  P   P          S E  DLI  +   DP  R T  + ++H 
Sbjct: 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281

Query: 280 WF 281
           +F
Sbjct: 282 YF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  135 bits (342), Expect = 3e-37
 Identities = 85/294 (28%), Positives = 135/294 (45%), Gaps = 41/294 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKY---IERGDKIDENVQREIINHRSLRHP 79
           ++Y+ +  +G G +GV    R+K T E+VA+K     E  + + +   RE+   R LRH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 80  NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           NIV  KE       L +V EY      EL E   + G    D  R +  QL+  ++YCH+
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIAYCHS 118

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLL 193
             + HRD+K EN L+  S +  LK+CDFG++++  L ++P S     V T  Y APE+L+
Sbjct: 119 HNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRARPASPLTDYVATRWYRAPELLV 174

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPF---EDPDEPKDFRKTIQRILSVQYSVPDTNP- 249
                GK  DVW+ G  +  +L G   F    D D+    +K +  +      +  +NP 
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234

Query: 250 ------ISQECRDLISRIFVA----------------DPAARITIPEIMKHQWF 281
                       + + R +                  DP  R+T  E+++H +F
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  134 bits (338), Expect = 1e-36
 Identities = 86/262 (32%), Positives = 134/262 (51%), Gaps = 17/262 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSL----RHPNIVRFK 85
           +G G+FG   L   K   E  AVK +++    ID++V+  ++  R L     +P +    
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
               T  HL  VME+ +GG+L   I + GRF    A F+  +++ G+ + H+  + +RDL
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
           KL+N +LD      +KI DFG  K +V      ST  GTP YIAPE+L   +Y   + D 
Sbjct: 123 KLDNVMLDRD--GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV-DW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFV 263
           WS GV LY ML+G  PF   DE + F        S++   P     I++E +D++ ++F 
Sbjct: 180 WSFGVLLYEMLIGQSPFHGDDEDELFE-------SIRVDTPHYPRWITKESKDILEKLFE 232

Query: 264 ADPAARITIPEIMKHQWFLKNL 285
            DP  R+ +   ++   F K +
Sbjct: 233 RDPTRRLGVVGNIRGHPFFKTI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  134 bits (339), Expect = 1e-36
 Identities = 82/260 (31%), Positives = 132/260 (50%), Gaps = 20/260 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHPNIVRFKE 86
           +G+G+FG  R+ + K T E  A+K +++ + +     + +   +S    L HP IV    
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                  +  ++E+  GGELF  +  AGRF  D A+F+  +L+    Y H+  + +RDLK
Sbjct: 86  SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLK 145

Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            EN LLD      +K+ DFG++K   +  +  +  GTP Y+APEV ++ +  GK  D W+
Sbjct: 146 PENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEV-IQSKGHGKAVDWWT 200

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
            GV LY  + G  PF D D P  FR   ++IL+ +   P  N      RDL+  +   D 
Sbjct: 201 MGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFP--NWFDGRARDLVKGLLQTDH 254

Query: 267 AARI-TIP----EIMKHQWF 281
             R+ T+     ++  H +F
Sbjct: 255 TKRLGTLKGGVADVKNHPYF 274

Length = 329

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  133 bits (335), Expect = 4e-36
 Identities = 88/286 (30%), Positives = 147/286 (51%), Gaps = 29/286 (10%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHPNIVRFK 85
           +G G+FG   L   K T +  A+K +++   + D++V+  ++  R L     HP +    
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
               T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ + H+  + +RDL
Sbjct: 63  CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
           KL+N LLD      +KI DFG  K ++L      T  GTP YIAPE+LL  +Y+  + D 
Sbjct: 123 KLDNILLDTD--GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV-DW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQECRDLIS 259
           WS GV LY ML+G  PF   DE + F+           S+   NP     +++E +D++ 
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQ-----------SIRMDNPCYPRWLTREAKDILV 228

Query: 260 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 305
           ++FV +P  R+ +   ++   F + +    ++E+    + E P +P
Sbjct: 229 KLFVREPERRLGVKGDIRQHPFFREIDWSALEER----EIEPPFKP 270

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 4e-36
 Identities = 83/299 (27%), Positives = 134/299 (44%), Gaps = 54/299 (18%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE----NVQREIINHRSLRHPN 80
           Y+ +  IG G +G     R+K T ELVA+K I R +   E       REI   + LRHPN
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPN 59

Query: 81  IVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           IVR KE++ +    +I  V EY     +G  L +      +F+E + + + +QL+ G+ Y
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQY 115

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRD+K  N L++      LK+ DFG ++     +    T  V T  Y  PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 193 L-RHEYDGKIADVWSCGVTLYVMLVG--------------------GYP----FEDPDEP 227
           L    Y  ++ D+WS G  L  + +G                    G P    +    + 
Sbjct: 174 LGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232

Query: 228 KDF-----RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             F     +K  +R L   +     + I     DL+ ++   DP  RI+  + ++H++F
Sbjct: 233 PWFENLKPKKPYKRRLREFFK----HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  132 bits (335), Expect = 6e-36
 Identities = 89/269 (33%), Positives = 136/269 (50%), Gaps = 22/269 (8%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RH 78
           ++F+  +G G+FG   L   K T EL A+K I + D I  D++V+  ++  R L    + 
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIK-ILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P + +      T   L  VMEY +GG+L   I   G+F E  A F+  ++  G+ + H+ 
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
            + +RDLKL+N +LD      +KI DFG  K ++   +   T  GTP YIAPE++    Y
Sbjct: 121 GIIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
            GK  D W+ GV LY ML G  PF+  DE + F    Q I+    S P +  +S+E   +
Sbjct: 179 -GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPKS--LSKEAVSI 231

Query: 258 ISRIFVADPAARITI-----PEIMKHQWF 281
              +    PA R+        +I +H +F
Sbjct: 232 CKGLLTKHPAKRLGCGPTGERDIREHAFF 260

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  130 bits (328), Expect = 1e-35
 Identities = 83/266 (31%), Positives = 128/266 (48%), Gaps = 24/266 (9%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIV 82
           ++ I  G FG   L + + T +  A+K +++ D I +N    +   R++       P + 
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           +      +  +L +VMEY +GG+    I   G   ED A+ +  +++ GV   H   + H
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RD+K EN L+D      LK+ DFG S++ +     K  VGTP Y+APE +L    D K++
Sbjct: 121 RDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-DDKMS 174

Query: 203 DVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLI 258
           D WS G  ++  L G  PF  E PD           ILS + + P+      S E  DLI
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDA------VFDNILSRRINWPEEVKEFCSPEAVDLI 228

Query: 259 SRIFVADPAARI---TIPEIMKHQWF 281
           +R+   DPA R+      EI  H +F
Sbjct: 229 NRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  131 bits (331), Expect = 2e-35
 Identities = 87/281 (30%), Positives = 140/281 (49%), Gaps = 18/281 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSLRH-PNIVR 83
           IG G FG    +R K T+ + A+K + + + + +        +R I+    L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            K    T + L +V +Y SGGELF  +   GRFSED A+F+  +L+  + + H   + +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
           DLK EN LLD +    + +CDFG SK+++  ++  +T  GT  Y+APEVLL  +   K  
Sbjct: 121 DLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           D WS GV ++ M  G  PF   D  + +R     I   +   P  N +S E R  +  + 
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRFP-KNVLSDEGRQFVKGLL 233

Query: 263 VADPAARITI---PEIMKHQWFLKNLPADLVDEKTMSSQYE 300
             +P  R+        +K   F  ++  DL+ +K ++  ++
Sbjct: 234 NRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFK 274

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  129 bits (326), Expect = 2e-35
 Identities = 81/268 (30%), Positives = 127/268 (47%), Gaps = 21/268 (7%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
            Y  +R +G G FG A L R      LV  K +     + E  +R+ +N       L+HP
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHP 59

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHA 137
           NI+ +    +    L I MEYA+GG L+++I       F E+   ++  Q++S VSY H 
Sbjct: 60  NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLR 194
             + HRD+K  N  L  + A  +K+ DFG SK   S    ++  + VGTP Y++PE+   
Sbjct: 120 AGILHRDIKTLNIFL--TKAGLIKLGDFGISKILGSEYSMAE--TVVGTPYYMSPELCQG 175

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
            +Y+ K +D+W+ G  LY +L     F+  +      K +Q   +     P  +  S E 
Sbjct: 176 VKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-----PVVSVYSSEL 229

Query: 255 RDLISRIFVADPAARITIPEIMKHQWFL 282
             L+  +   DP  R T  E++  Q  L
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVLD-QPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  131 bits (331), Expect = 2e-35
 Identities = 89/264 (33%), Positives = 131/264 (49%), Gaps = 23/264 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHR------SLRHPNIVR 83
           +G G+FG   L   K T EL A+K +++GD I  + V+  +   R      S RHP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                 T  H+  VMEYA+GG+L   I +   FSE  A F+   ++ G+ Y H  ++ +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
           DLKL+N LLD      +KI DFG  K  +      ST  GTP ++APEVL    Y  +  
Sbjct: 126 DLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAV 182

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           D W  GV +Y MLVG  PF   DE + F      I++ +   P    +S+E   ++ R+ 
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVF----DSIVNDEVRYPRF--LSREAISIMRRLL 236

Query: 263 VADPAARI-----TIPEIMKHQWF 281
             +P  R+        ++ K  +F
Sbjct: 237 RRNPERRLGSGEKDAEDVKKQPFF 260

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  129 bits (326), Expect = 3e-35
 Identities = 81/265 (30%), Positives = 147/265 (55%), Gaps = 24/265 (9%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
           +Y  V+ IG G+FG A L++ K   +   +K I   +   K  E  ++E+    +++HPN
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
           IV+++E      +L IVM+Y  GG+L+++I NA R   F ED+   +F Q+   + + H 
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 192
            ++ HRD+K +N  L  DG+    +K+ DFG ++  VL+S     ++ +GTP Y++PE+ 
Sbjct: 120 RKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEIC 173

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
               Y+ K +D+W+ G  LY M    + F    E  + +  + +I+   Y  P ++  S 
Sbjct: 174 ENRPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVLKIIRGSYP-PVSSHYSY 227

Query: 253 ECRDLISRIFVADPAARITIPEIMK 277
           + R+L+S++F  +P  R ++  I++
Sbjct: 228 DLRNLVSQLFKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  128 bits (324), Expect = 7e-35
 Identities = 78/270 (28%), Positives = 137/270 (50%), Gaps = 23/270 (8%)

Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLRHPN 80
           +++ ++G+GN GV   +  + T +++AVK I     I+E +Q++I     I H+    P 
Sbjct: 4   EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKC-NSPY 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH-A 137
           IV F         ++I MEY  GG L    +    GR  E         ++ G++Y H  
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEK 119

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++     ++K+CDFG S   V +S  K+ VGT +Y+APE +  ++Y
Sbjct: 120 HKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV-NSLAKTFVGTSSYMAPERIQGNDY 176

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVP--DTNPISQE 253
             K +D+WS G++L  +  G +P+   ++P D    I  +L   V    P   +   S +
Sbjct: 177 SVK-SDIWSLGLSLIELATGRFPYPPENDPPD---GIFELLQYIVNEPPPRLPSGKFSPD 232

Query: 254 CRDLISRIFVADPAARITIPEIMKHQWFLK 283
            +D ++   + DP  R +  E+++H +  K
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 1e-34
 Identities = 88/271 (32%), Positives = 131/271 (48%), Gaps = 26/271 (9%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           + Y+ ++ IGSG +G     RD  T ELVA+K I  E GD  +  +Q+EI   +  RHPN
Sbjct: 3   EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEI-IQQEISMLKECRHPN 61

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           IV +    L    L IVMEY  GG L +      G  SE +  +  ++ + G++Y H   
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121

Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIAPEVL-- 192
             HRD+K  N LL  DG     +K+ DFG S    +++  ++ KS +GTP ++APEV   
Sbjct: 122 KIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAV 175

Query: 193 -LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP---DTN 248
             +  YDGK  D+W+ G+T   +     P  D   P    + +  I    +  P   D  
Sbjct: 176 ERKGGYDGK-CDIWALGITAIELAELQPPMFDLH-P---MRALFLISKSNFPPPKLKDKE 230

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQ 279
             S    D I +    DP  R T  ++++H 
Sbjct: 231 KWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  127 bits (322), Expect = 1e-34
 Identities = 78/259 (30%), Positives = 123/259 (47%), Gaps = 22/259 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVK---YIERGDKIDENVQ---REIINHRSLRHPNIVRF 84
           +GSG+FG      +    +  AVK     + G    E V+   +EI     L+HPNIV++
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
                   +L I +E   GG L + +   G F E   R + +Q++ G+ Y H     HRD
Sbjct: 68  LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
           +K  N L+D +    +K+ DFG +K  V  S  KS  G+P ++APEV+ +    G  AD+
Sbjct: 128 IKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADI 185

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-----VPDTNPISQECRDLIS 259
           WS G T+  M  G  P+   +        +  +  +  S     +PD   +S E +D I 
Sbjct: 186 WSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPDH--LSDEAKDFIL 236

Query: 260 RIFVADPAARITIPEIMKH 278
           +    DP+ R T  E+++H
Sbjct: 237 KCLQRDPSLRPTAAELLEH 255

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  128 bits (322), Expect = 1e-34
 Identities = 78/263 (29%), Positives = 126/263 (47%), Gaps = 21/263 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDEN----VQREIINHRSLRHPNIVRF 84
           +G G FG   L  D  T   +AVK +         +     ++ EI   ++L+H  IV++
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
              +     L+I MEY  GG + +++   G  +E   R + +Q++ GV Y H+  + HRD
Sbjct: 70  YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRD 129

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGK 200
           +K  N L D   A  +K+ DFG SK    + S     KS  GTP +++PEV+    Y G+
Sbjct: 130 IKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GR 186

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRILSVQYSVPDTNPISQECRDLI 258
            ADVWS G T+  ML    P+ +  E     F+   Q        +P    +S + R+ +
Sbjct: 187 KADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIATQ---PTNPQLPSH--VSPDARNFL 240

Query: 259 SRIFVADPAARITIPEIMKHQWF 281
            R FV +   R +  E+++H + 
Sbjct: 241 RRTFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  129 bits (327), Expect = 2e-34
 Identities = 88/276 (31%), Positives = 138/276 (50%), Gaps = 26/276 (9%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRS 75
           ++ +D ++ IG G FG  +L+R K +K++ A+K + + + I  +       +R+I+ H +
Sbjct: 42  AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
                IV+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   
Sbjct: 102 --SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAI 158

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEV 191
           H+M   HRD+K +N LLD S    LK+ DFG       + ++     + VGTP YI+PEV
Sbjct: 159 HSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVGTPDYISPEV 214

Query: 192 LLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           L       Y G+  D WS GV LY MLVG  PF        + K +    S+ +  PD  
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--PDDI 272

Query: 249 PISQECRDLISRIFVADPAARI---TIPEIMKHQWF 281
            IS++ +DLI   F+ D   R+    + EI  H +F
Sbjct: 273 EISKQAKDLI-CAFLTDREVRLGRNGVDEIKSHPFF 307

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  128 bits (324), Expect = 2e-34
 Identities = 84/266 (31%), Positives = 144/266 (54%), Gaps = 27/266 (10%)

Query: 31  IGSGNFGVARLMRDKVTKE----LVAVKYIERG-----DKIDENVQREIINHRSLRHPNI 81
           +G G+FG   L+R K+T      L A+K +++      D++   ++R+I+    + HP I
Sbjct: 4   LGQGSFGKVFLVR-KITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAE--VNHPFI 60

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + H++ + 
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGK 200
           +RDLK EN LLD      +K+ DFG SK S+ H  +  S  GT  Y+APEV+ R  +  +
Sbjct: 121 YRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            AD WS GV ++ ML G  PF+     KD ++T+  IL  +  +P    +S E + L+  
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMPQF--LSPEAQSLLRA 231

Query: 261 IFVADPAARI-----TIPEIMKHQWF 281
           +F  +PA R+      + EI +H +F
Sbjct: 232 LFKRNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  128 bits (323), Expect = 2e-34
 Identities = 89/288 (30%), Positives = 140/288 (48%), Gaps = 39/288 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
           + ++ ++ I +G +G   L+R K T++  A+K I + + I  N      V+R+I+     
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE- 59

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            +P +V       T  HL +VMEY  GG+    + N G    D AR +F + +  + Y H
Sbjct: 60  -NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKST 180
              + HRDLK +N L+  +    +K+ DFG SK  ++                    K  
Sbjct: 119 NYGIVHRDLKPDNLLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176

Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRIL 238
            GTP YIAPEV+LR  Y GK  D W+ G+ LY  LVG  PF  + P+E   F + I    
Sbjct: 177 CGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI---- 229

Query: 239 SVQYSVPDTN-PISQECRDLISRIFVADPAARITIP---EIMKHQWFL 282
           S     P+ +  +  + +DLISR+   +P  R+      E+ +H++FL
Sbjct: 230 SDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  126 bits (319), Expect = 3e-34
 Identities = 69/265 (26%), Positives = 109/265 (41%), Gaps = 25/265 (9%)

Query: 27  FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
             + +G G FG         +    +  VAVK + + D  ++ ++   RE    R L HP
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           NIV+   V      L IVMEY  GG+L  + R       S  +   F  Q+  G+ Y  +
Sbjct: 62  NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVL 192
               HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L
Sbjct: 122 KNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKGGKLPI---RWMAPESL 176

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
              ++  K +DVWS GV L+ +   G          +  + +++     Y +P       
Sbjct: 177 KEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG----YRLPKPPNCPP 231

Query: 253 ECRDLISRIFVADPAARITIPEIMK 277
           E   L+ + +  DP  R T  E+++
Sbjct: 232 ELYKLMLQCWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  129 bits (325), Expect = 4e-34
 Identities = 91/312 (29%), Positives = 141/312 (45%), Gaps = 70/312 (22%)

Query: 26  DF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLR----- 77
           DF  ++ IG G FG  RL++ K T  + A+K + + + +    ++E + H R+ R     
Sbjct: 2   DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML----EKEQVAHVRAERDILAE 57

Query: 78  --HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
             +P +V+         +L ++MEY  GG++   +     F+E+E RF+  + I  +   
Sbjct: 58  ADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSI 117

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------------------SSVLH 174
           H +   HRD+K +N LLD      +K+ DFG                             
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175

Query: 175 SQPK------------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216
           S+P                   STVGTP YIAPEV L+  Y  K  D WS GV +Y MLV
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLV 234

Query: 217 GGYPF--EDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITI 272
           G  PF  ++P E      T ++I++ + ++  PD  P+S E +DLI R    +   R+  
Sbjct: 235 GYPPFCSDNPQE------TYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCCEAERRLGN 287

Query: 273 P---EIMKHQWF 281
               EI  H +F
Sbjct: 288 NGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  126 bits (317), Expect = 4e-34
 Identities = 87/265 (32%), Positives = 136/265 (51%), Gaps = 23/265 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHPN 80
           RY+ ++ IG G+FG   L + K   E   +K I   +   K  E  ++E+I    ++HPN
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA 137
           IV F         L IVMEY  GG+L +RI N  R   FSED+   +F Q+  G+ + H 
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 192
            ++ HRD+K +N  L  +G  A   K+ DFG ++   L+       + VGTP Y++PE+ 
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSMELAYTCVGTPYYLSPEIC 174

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
               Y+ K  D+WS G  LY +    +PFE      +  + + +I    ++ P +   S+
Sbjct: 175 QNRPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVLKICQGYFA-PISPNFSR 228

Query: 253 ECRDLISRIFVADPAARITIPEIMK 277
           + R LIS++F   P  R +I  I+K
Sbjct: 229 DLRSLISQLFKVSPRDRPSITSILK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  128 bits (323), Expect = 4e-34
 Identities = 88/308 (28%), Positives = 127/308 (41%), Gaps = 66/308 (21%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRHPN 80
           RY+ ++ IGSG +GV     DK T   VA+K I     D ID + + REI   R LRH N
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 81  IVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNAGRFSEDEARFFFQ 126
           I+   +++  P+      + IV E           S   L          ++D  ++F  
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL----------TDDHIQYFLY 110

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 182
           Q++ G+ Y H+  V HRDLK  N L++ +    LKICDFG ++        K      V 
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVV 168

Query: 183 TPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVG--------------------GYPF 221
           T  Y APE+LL    Y   I D+WS G     +L                      G P 
Sbjct: 169 TRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPS 227

Query: 222 EDPDEPKDFRKTIQRILSVQYS--------VPDTNPISQECRDLISRIFVADPAARITIP 273
           E+  +     K    + S+            P  +P   E  DL+ ++ V DP  RIT  
Sbjct: 228 EEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP---EAIDLLEKMLVFDPKKRITAD 284

Query: 274 EIMKHQWF 281
           E + H + 
Sbjct: 285 EALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  126 bits (318), Expect = 8e-34
 Identities = 87/277 (31%), Positives = 140/277 (50%), Gaps = 15/277 (5%)

Query: 13  AMDMPIMHDSDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQRE 69
           A+ + +     R        IG G+ G+  +  DK T   VAVK ++ R  +  E +  E
Sbjct: 7   ALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE 66

Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
           ++  R  +HPNIV      L    L +VME+  GG L + I    R +E++       ++
Sbjct: 67  VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVL 125

Query: 130 SGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAY 186
             +S+ HA  V HRD+K ++ LL  DG    R+K+ DFG+ ++ S    + KS VGTP +
Sbjct: 126 KALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181

Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           +APEV+ R  Y G   D+WS G+ +  M+ G  P+ + + P    K I+  L  +  + +
Sbjct: 182 MAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LKN 237

Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
            + +S   R  + R+ V DPA R T  E++ H +  K
Sbjct: 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  127 bits (319), Expect = 1e-33
 Identities = 89/268 (33%), Positives = 137/268 (51%), Gaps = 20/268 (7%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
           ++F+  +G G+FG   L   K T EL A+K +++   I D++V+  ++  R L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            + +      T   L  VMEY +GG+L  +I   GRF E  A F+  ++  G+ + H+  
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYD 198
           + +RDLKL+N +LD      +KI DFG  K ++      K+  GTP YIAPE++    Y 
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY- 178

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK  D W+ GV LY ML G  PFE  DE + F    Q I+    + P +  +S+E   + 
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYPKS--MSKEAVAIC 232

Query: 259 SRIFVADPAARITI-PE----IMKHQWF 281
             +    P  R+   PE    I +H +F
Sbjct: 233 KGLMTKHPGKRLGCGPEGERDIKEHAFF 260

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  125 bits (316), Expect = 1e-33
 Identities = 81/264 (30%), Positives = 118/264 (44%), Gaps = 20/264 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE------RGDKIDENVQREIINHRSLRHPNIVRF 84
           +G G FG     + K T ++ A K ++      R  +     +++I+   S R   IV  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF--IVSL 58

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
                T   L +VM   +GG+L   I N G   F E  A F+  Q+I G+ + H  ++ +
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLK EN LLD     R  I D G +       + K   GTP Y+APEVL    YD    
Sbjct: 119 RDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS-V 175

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           D ++ G TLY M+ G  PF    E  +  +  +R L +    PD    S E +DL   + 
Sbjct: 176 DWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKF--SPEAKDLCEALL 233

Query: 263 VADPAARI-----TIPEIMKHQWF 281
             DP  R+     +  E+ +H  F
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 2e-33
 Identities = 79/264 (29%), Positives = 126/264 (47%), Gaps = 29/264 (10%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRH---PNIVRFK 85
           IG G +G     +   T  +VA+K I      D+  ++QRE+     LR    PNI ++ 
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
              L    L I+MEYA GG +   +  AG  +E       ++++  + Y H + V HRD+
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDI 127

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR-HEYDGKIAD 203
           K  N L+  +    +K+CDFG +     +S  +ST VGTP ++APEV+     YD K AD
Sbjct: 128 KAANILV--TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTK-AD 184

Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRD 256
           +WS G+T+Y M  G  P+ D D                  +P + P        S+  R+
Sbjct: 185 IWSLGITIYEMATGNPPYSDVDA-----------FRAMMLIPKSKPPRLEDNGYSKLLRE 233

Query: 257 LISRIFVADPAARITIPEIMKHQW 280
            ++     +P  R++  E++K +W
Sbjct: 234 FVAACLDEEPKERLSAEELLKSKW 257

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  124 bits (314), Expect = 2e-33
 Identities = 83/292 (28%), Positives = 140/292 (47%), Gaps = 24/292 (8%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGD-----KIDENV--QREIINH 73
           ++ +R +G+G +G   L+R KV      +L A+K +++       K  E+   +R+++  
Sbjct: 2   FELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
              R P +V       T T L ++++Y +GGELF  +     F+E E R +  +++  + 
Sbjct: 61  VR-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
           + H + + +RD+KLEN LLD      + + DFG SK  +   + +  S  GT  Y+APEV
Sbjct: 120 HLHQLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 192 LLRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           +        K  D WS GV  + +L G  PF    E     +  +RIL  +   P T  +
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKT--M 235

Query: 251 SQECRDLISRIFVADPAARI---TIPEIMKHQWFLKNLPADLVDEKTMSSQY 299
           S E RD I ++   DP  R+      EI  H  F + +  D +  K + + +
Sbjct: 236 SAEARDFIQKLLEKDPKKRLGANGADEIKNHP-FFQGIDWDDLAAKRIPAPF 286

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  124 bits (313), Expect = 2e-33
 Identities = 70/264 (26%), Positives = 111/264 (42%), Gaps = 24/264 (9%)

Query: 27  FVRDIGSGNFGVARL----MRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
             + +G G FG         +    K  VAVK + + D  ++ ++   RE    R L HP
Sbjct: 3   LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDHP 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
           N+V+   V      L IVMEY  GG+L   +  N  + S  +   F  Q+  G+ Y  + 
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
              HRDL   N L+  +    +KI DFG     Y          K  +    ++APE L 
Sbjct: 122 NFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPESLK 176

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
             ++  K +DVWS GV L+ +   G         ++  + ++      Y +P       E
Sbjct: 177 EGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG----YRLPQPPNCPPE 231

Query: 254 CRDLISRIFVADPAARITIPEIMK 277
             DL+ + +  DP  R T  E+++
Sbjct: 232 LYDLMLQCWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  125 bits (315), Expect = 3e-33
 Identities = 75/221 (33%), Positives = 107/221 (48%), Gaps = 13/221 (5%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-----SLRHPNIVRFK 85
           IG G+FG   L + K      AVK +++   + +  Q  I+  R     +L+HP +V   
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
               T   L  V++Y +GGELF  +     F E  ARF+  ++ S + Y H++ + +RDL
Sbjct: 63  YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
           K EN LLD      + + DFG  K  V   +  ST  GTP Y+APEVL +  YD +  D 
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTVDW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
           W  G  LY ML G  PF      +D  +    IL     +P
Sbjct: 180 WCLGAVLYEMLYGLPPFYS----RDVSQMYDNILHKPLQLP 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  125 bits (315), Expect = 4e-33
 Identities = 95/290 (32%), Positives = 144/290 (49%), Gaps = 28/290 (9%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIV 82
           R +G G+FG   L R K +  L AVK +++ D I  D++V+  +   R L     HP + 
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKK-DVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           +      TP  L  VME+ +GG+L   I  + RF E  ARF+  ++ S + + H   + +
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKI 201
           RDLKL+N LLD       K+ DFG  K  + + +  ST  GTP YIAPE+L    Y G  
Sbjct: 120 RDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPS 176

Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            D W+ GV LY ML G  PFE  +E   F    + IL+ +   P    +SQ+  D++   
Sbjct: 177 VDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPTW--LSQDAVDILKAF 230

Query: 262 FVADPAARITI------PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 305
              +P  R+          I++H +F K L  + ++ + +    E P +P
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFF-KELDWEKLNRRQI----EPPFRP 275

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  123 bits (310), Expect = 4e-33
 Identities = 84/261 (32%), Positives = 137/261 (52%), Gaps = 19/261 (7%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           +Y+ +R +G G+FG A L++   + +  A+K I   +     E+ ++E +    ++HPNI
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
           V FKE      HL IVMEY  GG+L ++I    G+ F ED    +F Q+  GV + H  +
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR 120

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLRH 195
           V HRD+K +N  L  +   ++K+ DFG   S+ L + P +     VGTP Y+ PE+    
Sbjct: 121 VLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y+ K +D+WS G  LY +    +PF    +   ++  I ++    Y  P  +  S E R
Sbjct: 176 PYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYK-PLPSHYSYELR 229

Query: 256 DLISRIFVADPAARITIPEIM 276
            LI ++F  +P +R +   I+
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  122 bits (309), Expect = 7e-33
 Identities = 80/256 (31%), Positives = 117/256 (45%), Gaps = 18/256 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEV 87
           +G G++G    ++     +  A+K ++ G    K  E+   EI    S+ HPNI+ +KE 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67

Query: 88  ILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHR 143
            L    L IVMEYA  G+L + I    +      E E    F QL+ G+   H  ++ HR
Sbjct: 68  FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHR 127

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIA 202
           DLK  N LL       +KI D G SK  VL     K+ +GTP Y+APEV     Y  K +
Sbjct: 128 DLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAPEVWKGRPYSYK-S 182

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           D+WS G  LY M     PF    E +  +    ++   +Y  P     SQ+ ++ I  + 
Sbjct: 183 DIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSML 237

Query: 263 VADPAARITIPEIMKH 278
              P  R    +I+  
Sbjct: 238 QVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  124 bits (312), Expect = 8e-33
 Identities = 83/252 (32%), Positives = 129/252 (51%), Gaps = 15/252 (5%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
           ++F+  +G G+FG   L   K T EL A+K +++   I D++V+  ++  R L    + P
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            + +      T   L  VMEY +GG+L   I   G+F E +A F+  ++  G+ + H   
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
           + +RDLKL+N +LD      +KI DFG  K  ++      T  GTP YIAPE++    Y 
Sbjct: 122 IIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY- 178

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK  D W+ GV LY ML G  PF+  DE + F    Q I+    S P +  +S+E   + 
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPKS--LSKEAVSIC 232

Query: 259 SRIFVADPAARI 270
             +    P+ R+
Sbjct: 233 KGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  122 bits (307), Expect = 2e-32
 Identities = 85/273 (31%), Positives = 124/273 (45%), Gaps = 20/273 (7%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
           D Y+ +  IG G   V          E VA+K I+  +K   +V    +E+       HP
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDL-EKCQTSVDELRKEVQAMSQCNHP 59

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCH 136
           N+V++    +    L +VM Y SGG L +        G   E       ++++ G+ Y H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAP 189
           +    HRD+K  N LL  DGS    +KI DFG S S            K+ VGTP ++AP
Sbjct: 120 SNGQIHRDIKAGNILLGEDGS----VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175

Query: 190 EVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           EV+   H YD K AD+WS G+T   +  G  P+      K    T+Q       +  D  
Sbjct: 176 EVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             S+  R +IS     DP+ R T  E++KH++F
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  122 bits (308), Expect = 3e-32
 Identities = 79/299 (26%), Positives = 127/299 (42%), Gaps = 44/299 (14%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLR 77
           RY+  + +G G + V    RDK T  +VA+K I+ G++      I+    REI   + L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYC 135
           HPNI+   +V    +++ +V E+       E++        +  + + +    + G+ Y 
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEV 191
           H+  + HRDLK  N L+       LK+ DFG ++S      P       V T  Y APE+
Sbjct: 119 HSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQVVTRWYRAPEL 173

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--------VQYS 243
           L    + G   D+WS G  ++  L+   PF   D   D    I   L            S
Sbjct: 174 LFGARHYGVGVDMWSVGC-IFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 244 VPDTNPI---------------SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 287
           +PD                   S +  DL+ R+   +P  RIT  + ++H +F  N PA
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF-SNDPA 290

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  121 bits (306), Expect = 4e-32
 Identities = 88/291 (30%), Positives = 131/291 (45%), Gaps = 48/291 (16%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVR 83
           V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L HPNIV+
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 84  FKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             +VI T   L +V E+     + F              + +  QL+ G+++CH+ +V H
Sbjct: 64  LLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLH 123

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLRHEYD 198
           RDLK +N L++   A  +K+ DFG +++  +   P  T    V T  Y APE+LL  +Y 
Sbjct: 124 RDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVVTLWYRAPEILLGCKYY 178

Query: 199 GKIADVWSCGVTLYVML--------------------VGGYPFED--------PDEPKDF 230
               D+WS G     M+                      G P E         PD    F
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF 238

Query: 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            K  ++       VP   P+ ++ RDL+S++   DP  RI+    + H +F
Sbjct: 239 PKWARQ--DFSKVVP---PLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  120 bits (303), Expect = 6e-32
 Identities = 73/264 (27%), Positives = 127/264 (48%), Gaps = 19/264 (7%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
            + +D +  +G G++G       K T ++VA+K +   + + + + +EI   +    P I
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYI 60

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           V++       T L IVMEY   G + +  +I N    +E+E      Q + G+ Y H+ +
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
             HRD+K  N LL+       K+ DFG S + +   ++  + +GTP ++APEV+    Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NP--ISQEC 254
            K AD+WS G+T   M  G  P+ D          ++ I  +    P T  +P   S E 
Sbjct: 178 NK-ADIWSLGITAIEMAEGKPPYSD-------IHPMRAIFMIPNKPPPTLSDPEKWSPEF 229

Query: 255 RDLISRIFVADPAARITIPEIMKH 278
            D + +  V DP  R +  ++++H
Sbjct: 230 NDFVKKCLVKDPEERPSAIQLLQH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  121 bits (305), Expect = 8e-32
 Identities = 93/307 (30%), Positives = 137/307 (44%), Gaps = 66/307 (21%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
           D Y+ +  I  G +GV    RDK T E+VA+K +    K+++  +       REI     
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL----KMEKEKEGFPITSLREINILLK 60

Query: 76  LRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDEARFFFQQL 128
           L+HPNIV  KEV++      + +VMEY    E     L E +     F + E +    QL
Sbjct: 61  LQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSEVKCLMLQL 115

Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAY 186
           +SGV++ H   + HRDLK  N LL  +    LKICDFG ++   S L    +  V T  Y
Sbjct: 116 LSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172

Query: 187 IAPEVLL-RHEYDGKIADVWSCG------VTLYVMLVG--------------GYPFED-- 223
            APE+LL   EY   I D+WS G      +T   +  G              G P E   
Sbjct: 173 RAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231

Query: 224 PDEPKDFRKTIQRILSVQYSVPDTNPISQECR---------DLISRIFVADPAARITIPE 274
           P     F + +       ++    N + ++           DL++R+   DPA RI+  +
Sbjct: 232 P----GFSE-LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAED 286

Query: 275 IMKHQWF 281
            +KH +F
Sbjct: 287 ALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  121 bits (304), Expect = 1e-31
 Identities = 84/273 (30%), Positives = 136/273 (49%), Gaps = 19/273 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
           IG G+FG   L R K  ++  AVK +++   + +  ++ I++ R++     +HP +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
               T   L  V++Y +GGELF  +     F E  ARF+  ++ S + Y H++ + +RDL
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
           K EN LLD      + + DFG  K ++ H+   ST  GTP Y+APEVL +  YD +  D 
Sbjct: 123 KPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTVDW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
           W  G  LY ML G  PF   +  + +   + + L ++   P+   I+   R L+  +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITNSARHLLEGLLQK 233

Query: 265 DPAARI----TIPEIMKHQWFLKNLPADLVDEK 293
           D   R+       EI  H +F      DL+++K
Sbjct: 234 DRTKRLGAKDDFMEIKNHIFFSPINWDDLINKK 266

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 83/271 (30%), Positives = 126/271 (46%), Gaps = 33/271 (12%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-----------VQREIINHRSLRHP 79
           IG G +G   L  +  T E++AVK +E    I              ++ EI   + L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIV++     T  +L+I +EY  GG +   +   GRF E   RFF +Q++ G++Y H+  
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAYIAPEV--LLR 194
           + HRDLK +N L+D       KI DFG SK S     + Q  S  G+  ++APEV     
Sbjct: 129 ILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--LSVQYSVP----DTN 248
             Y  K+ D+WS G  +  M  G  P+ D        + I  +  L  + S P    D +
Sbjct: 187 QGYSAKV-DIWSLGCVVLEMFAGRRPWSD-------EEAIAAMFKLGNKRSAPPIPPDVS 238

Query: 249 P-ISQECRDLISRIFVADPAARITIPEIMKH 278
             +S    D ++  F  +P  R T  E+++H
Sbjct: 239 MNLSPVALDFLNACFTINPDNRPTARELLQH 269

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  119 bits (301), Expect = 2e-31
 Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 30/275 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           D ++ + ++G G FG     + K T    A K I+   +    D  V+ +I++    +HP
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILS--ECKHP 62

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
           NIV   E       L I++E+  GG L   +    R  +E + R+  +Q++  +++ H+ 
Sbjct: 63  NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-- 193
           +V HRDLK  N LL  DG     +K+ DFG S  +    Q + T +GTP ++APEV+   
Sbjct: 123 KVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178

Query: 194 ---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--- 247
               + YD K AD+WS G+TL  +     P  + +        ++ +L +  S P T   
Sbjct: 179 TFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELN-------PMRVLLKILKSEPPTLDQ 230

Query: 248 -NPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            +  S    D +    V DP  R T  E++KH + 
Sbjct: 231 PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  120 bits (302), Expect = 2e-31
 Identities = 73/207 (35%), Positives = 108/207 (52%), Gaps = 11/207 (5%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL----RHPNIVRF 84
           +G G+FG   L   K T E+ A+K +++ D I  D++V   +   R L    +HP +   
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKK-DVILQDDDVDCTMTEKRILALAAKHPFLTAL 61

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
                T   L  VMEY +GG+L  +I  + +F E  +RF+  ++   + + H   V +RD
Sbjct: 62  HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIAD 203
           LKL+N LLD       K+ DFG  K  +L+    +T  GTP YIAPE+L   EY   + D
Sbjct: 122 LKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSV-D 178

Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDF 230
            W+ GV +Y M+ G  PFE  +E   F
Sbjct: 179 WWALGVLMYEMMAGQPPFEADNEDDLF 205

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  120 bits (302), Expect = 3e-31
 Identities = 74/221 (33%), Positives = 115/221 (52%), Gaps = 17/221 (7%)

Query: 67  QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 126
           +R I+   +++HP IV       T   L +++EY SGGELF  +   G F ED A F+  
Sbjct: 50  ERNIL--EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 185
           ++   + + H   + +RDLK EN LLD      +K+ DFG  K S+       T  GT  
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIE 165

Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
           Y+APE+L+R  + GK  D WS G  +Y ML G  PF   +     +KTI +IL  + ++P
Sbjct: 166 YMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKILKGKLNLP 220

Query: 246 DTNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
               ++ E RDL+ ++   +P++R+        E+  H +F
Sbjct: 221 PY--LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  120 bits (302), Expect = 3e-31
 Identities = 86/310 (27%), Positives = 146/310 (47%), Gaps = 39/310 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSL 76
             +D    +G G+FG  +++R+K T ++ A+K +++   + +        +R+I++  + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
             P I + +       +L +VMEY  GG+L   +     +F ED A+F+  +L+  +   
Sbjct: 60  -SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV 118

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLL 193
           H M   HRD+K EN L+D +    +K+ DFG +   ++      K  VGTP YIAPEVL 
Sbjct: 119 HQMGYVHRDIKPENVLIDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT 176

Query: 194 RHEYDGKIA-----DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PD 246
               DGK       D WS GV  Y M+ G  PF +        KT   I++ Q  +  P+
Sbjct: 177 TMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPE 232

Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWF-------LKNLPADLV-----DEKT 294
              +S +  DLI  + +     R+    +  H +F       ++N     V     D+ T
Sbjct: 233 DPKVSSDFLDLIQSL-LCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDT 291

Query: 295 MSSQYEEPDQ 304
             S ++EP++
Sbjct: 292 --SNFDEPEK 299

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  118 bits (296), Expect = 6e-31
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 19/265 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
           +G+G F      RD  T  L+AVK +          +++ E +++EI     L HP+I+R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                   +H  + +E+ +GG +   +   G F E     + +QL+ G+SY H  Q+ HR
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHR 127

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLRHE 196
           D+K  N L+D S   RL+I DFG   ++ L ++           +GT A++APEV LR E
Sbjct: 128 DVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEFQGQLLGTIAFMAPEV-LRGE 183

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
             G+  DVWS G  +  M     P+ + ++  +    I +I S   +      +S   RD
Sbjct: 184 QYGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242

Query: 257 LISRIFVADPAARITIPEIMKHQWF 281
           +  R     P  R    E++KH  F
Sbjct: 243 VTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  119 bits (299), Expect = 8e-31
 Identities = 81/275 (29%), Positives = 136/275 (49%), Gaps = 24/275 (8%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG-----DKIDENV--QREIINH 73
           ++ ++ +G+G +G   L+R KVT     +L A+K +++       K  E+   +R ++ H
Sbjct: 2   FELLKVLGTGAYGKVFLVR-KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
              + P +V       T   L ++++Y SGGE+F  +     FSEDE RF+  ++I  + 
Sbjct: 61  VR-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALE 119

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
           + H + + +RD+KLEN LLD      + + DFG SK  +   + +  S  GT  Y+APE+
Sbjct: 120 HLHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
           +      GK  D WS G+ ++ +L G  PF    E     +  +RIL      P    I 
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF--IG 235

Query: 252 QECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
            E +DL+ ++   DP  R+        EI +H +F
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  116 bits (291), Expect = 3e-30
 Identities = 76/254 (29%), Positives = 122/254 (48%), Gaps = 20/254 (7%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPN 80
           ++ +  IG G+FGV   +  K  K + A+K I+   K++   + E I+       L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-SKMNRREREEAIDEARVLAKLDSSY 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAM 138
           I+R+ E  L    L IVMEYA  G+L + +         ED+   FF Q++ G+++ H+ 
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
           ++ HRD+K  N  LD      +KI D G +K  +L        + VGTP Y++PE+    
Sbjct: 121 KILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y+ K +DVW+ GV LY    G +PF+  ++     K I+ +       P +   SQ+  
Sbjct: 177 PYNEK-SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP-----PVSQMYSQQLA 230

Query: 256 DLISRIFVADPAAR 269
            LI +    D   R
Sbjct: 231 QLIDQCLTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  115 bits (290), Expect = 7e-30
 Identities = 81/290 (27%), Positives = 136/290 (46%), Gaps = 38/290 (13%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHP 79
           +Y+ +  IG G +G     +++ T E+VA+K + R D  DE V     REI   + L+H 
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 59

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHA 137
           NIVR  +V+ +   L +V EY    +  ++  ++  G    +  + F  QL+ G+++CH+
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS 117

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
             V HRDLK +N L++ +    LK+ DFG +++  +      + V T  Y  P+VL   +
Sbjct: 118 HNVLHRDLKPQNLLINKNG--ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 197 -YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSVPDT 247
            Y   I D+WS G     +   G P    ++  D  K I R+L             +PD 
Sbjct: 176 LYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234

Query: 248 NP----------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P                ++   RDL+  + V +P  RI+  E ++H +F
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  115 bits (289), Expect = 1e-29
 Identities = 90/293 (30%), Positives = 145/293 (49%), Gaps = 41/293 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           D+Y+ V  IG G +GV    RD+VT E +A+K I R ++ DE V     REI   + ++H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQH 60

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQQLISGVSYCH 136
            NIVR ++V+ +   L +V EY    +L + + ++  F+++    + +  Q++ G++YCH
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVL 192
           + +V HRDLK +N L+D      LK+ DFG +++  +   P  T    V T  Y APE+L
Sbjct: 120 SHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFGI---PVRTFTHEVVTLWYRAPEIL 175

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------SV 244
           L   +     D+WS G  ++  +V   P    D   D    I RIL            S+
Sbjct: 176 LGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL 234

Query: 245 PD---TNP-------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
           PD     P             +     DL+S++   DP+ RIT    ++H++F
Sbjct: 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  114 bits (287), Expect = 2e-29
 Identities = 82/294 (27%), Positives = 123/294 (41%), Gaps = 49/294 (16%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKY-IERGDKIDE-NVQREIINHRSLR-HPNI 81
           Y  +  IG G F      + + T +  A+K   +    +++ N  REI   R L  HPNI
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60

Query: 82  VRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAM 138
           +R  EV+       LA+V E      L+E I    R   E   + +  QL+  + + H  
Sbjct: 61  LRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
            + HRD+K EN L+       LK+ DFG  +   ++S+P  T  + T  Y APE LL   
Sbjct: 120 GIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 197 YDGKIADVWSCGVTLYVML--------------------VGGYPFEDPDEPKDFRKTIQR 236
           Y G   D+W+ G   + +L                    V G P  D +  K FRK+   
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP--DAEVLKKFRKSRHM 232

Query: 237 ILSVQYSVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
                Y+ P              S E  DL+ ++   DP  RIT  + ++H +F
Sbjct: 233 ----NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  113 bits (285), Expect = 7e-29
 Identities = 81/270 (30%), Positives = 130/270 (48%), Gaps = 13/270 (4%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK 85
           IG G+FG   L + K+  +  AVK +++   ++   Q+ I+  R++     +HP +V   
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
               T   L  V+++ +GGELF  +     F E  ARF+  ++ S + Y H++ + +RDL
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDL 122

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADV 204
           K EN LLD      + + DFG  K  +  S   +T  GTP Y+APEV+ +  YD  + D 
Sbjct: 123 KPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTV-DW 179

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN-PISQECRDLISRIFV 263
           W  G  LY ML G  PF   D  + +   + + L ++     T   I +E   L+ +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEE---LLEKDRQ 236

Query: 264 ADPAARITIPEIMKHQWFLKNLPADLVDEK 293
               A+    EI +H +F      DL  +K
Sbjct: 237 RRLGAKEDFLEIQEHPFFESLSWTDLEQKK 266

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  114 bits (286), Expect = 7e-29
 Identities = 80/269 (29%), Positives = 134/269 (49%), Gaps = 25/269 (9%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDEN------VQREIINHRSLR 77
           ++F+R +G+G+FG   L   K      VA+K  E+   I +        +R+I+N+  + 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY--IN 89

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HP  V         ++L +V+E+  GGE F  +    RF  D   F+  Q++    Y  +
Sbjct: 90  HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS 149

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           + + +RDLK EN LLD      +K+ DFG++K  V+ ++  +  GTP YIAPE+LL   +
Sbjct: 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEYIAPEILLNVGH 205

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
            GK AD W+ G+ +Y +LVG  PF   +    ++K ++ I+     + D N     C+ L
Sbjct: 206 -GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFL-DNN-----CKHL 258

Query: 258 ISRIFVADPAARI-----TIPEIMKHQWF 281
           + ++   D   R          + +H WF
Sbjct: 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  114 bits (288), Expect = 7e-29
 Identities = 89/309 (28%), Positives = 132/309 (42%), Gaps = 65/309 (21%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
           ++ IG G FG   L+R   T  L A+K + + D +  N       +R+I+      +  +
Sbjct: 6   IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD--NEWV 63

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+         +L  VM+Y  GG++   +   G F ED ARF+  +L   +   H M   
Sbjct: 64  VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFI 123

Query: 142 HRDLKLENTLLDGSPAPRLKICDFG-------------YSK---------------SSVL 173
           HRD+K +N L+D      +K+ DFG             Y K               S + 
Sbjct: 124 HRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181

Query: 174 HSQPK----------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
             + K                S VGTP YIAPEVLLR  Y  ++ D WS GV LY MLVG
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVG 240

Query: 218 GYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARI---TI 272
             PF     P +   T  ++++ + +  +P    +S+E  DLI R+       R+     
Sbjct: 241 QPPFLAD-TPAE---TQLKVINWETTLHIPSQAKLSREASDLILRL-CCGAEDRLGKNGA 295

Query: 273 PEIMKHQWF 281
            EI  H +F
Sbjct: 296 DEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  113 bits (284), Expect = 1e-28
 Identities = 92/315 (29%), Positives = 138/315 (43%), Gaps = 54/315 (17%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHP 79
            RY  + +IGSG +GV     D  + + VA+K I     +    +R   E+   R  +H 
Sbjct: 5   SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64

Query: 80  NIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           NI+  ++++  P      + +VM+     +L   I +    +E+  R+F  QL+ G+ Y 
Sbjct: 65  NIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PKSTVGTPAYIAPE 190
           H+  V HRDLK  N L++      L+I DFG     S S   H       V T  Y APE
Sbjct: 124 HSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 191 VLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSV-------- 240
           +LL   EY   I D+WS G     ML     F     P K++   ++ ILSV        
Sbjct: 182 LLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQLKLILSVLGSPSEEV 235

Query: 241 ----------QY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQ 279
                     +Y  ++P   P+         S E  DL+S++   DP  RIT+ + ++H 
Sbjct: 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295

Query: 280 WFLKNLPADLVDEKT 294
            FL     D  DE T
Sbjct: 296 -FLAQYH-DPDDEPT 308

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  111 bits (280), Expect = 1e-28
 Identities = 76/255 (29%), Positives = 129/255 (50%), Gaps = 14/255 (5%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G +G+    RD  T+  +A+K I ER  +  + +  EI  H  L+H NIV++     
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 90  TPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                 I ME   GG L           + +E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135

Query: 147 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYD-GKIADV 204
            +N L++ + +  +KI DFG SK  + ++   ++  GT  Y+APEV+ +     G  AD+
Sbjct: 136 GDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADI 194

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           WS G T+  M  G  PF +  EP+   F+  + +I      +P++  +S E ++ I R F
Sbjct: 195 WSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPES--LSAEAKNFILRCF 249

Query: 263 VADPAARITIPEIMK 277
             DP  R +  ++++
Sbjct: 250 EPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  112 bits (282), Expect = 1e-28
 Identities = 88/294 (29%), Positives = 132/294 (44%), Gaps = 43/294 (14%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           IG G +G+    RD  + E+VA+K +    ER D I  +  REI    +LRHPNIV  KE
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKE 73

Query: 87  VILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+    HL    +VMEY       L + +     FSE + +    QL+ G+ Y H   + 
Sbjct: 74  VV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLRGLQYLHENFII 130

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYDGK 200
           HRDLK+ N LL       LKI DFG +++  L ++P +  V T  Y APE+LL       
Sbjct: 131 HRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-------RI--------LSVQYSVP 245
             D+W+ G  L  +L          E +     IQ        I        L  ++++P
Sbjct: 189 AIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLP 248

Query: 246 DTNP----------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN-LPAD 288
              P          +S+    L++ + + DP  R T  E ++  +F +  LP +
Sbjct: 249 K-QPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  113 bits (284), Expect = 2e-28
 Identities = 84/269 (31%), Positives = 131/269 (48%), Gaps = 19/269 (7%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVK--YIERGDKIDENVQREIINHRSLRHPNIVRFK 85
           V  IGSG  G    +  + T  L A+K  Y    D +   + REI   R + HPN+V+  
Sbjct: 79  VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCH 138

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           ++      + +++E+  GG L        +F  D AR    Q++SG++Y H   + HRD+
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIVHRDI 194

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL---LRH-EYDGK 200
           K  N L++   A  +KI DFG S+       P  S+VGT AY++PE +   L H  YDG 
Sbjct: 195 KPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGY 252

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLI 258
             D+WS GV++    +G +PF    +  D+   +  I     S P   P   S+E R  I
Sbjct: 253 AGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMCAIC---MSQPPEAPATASREFRHFI 308

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPA 287
           S     +PA R +  ++++H + L+  P 
Sbjct: 309 SCCLQREPAKRWSAMQLLQHPFILRAQPG 337

Length = 353

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  111 bits (280), Expect = 2e-28
 Identities = 92/291 (31%), Positives = 136/291 (46%), Gaps = 42/291 (14%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
           Y  V  IG G +GV    RDK+T E+VA+K I R +  DE V     REI   + L HPN
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIREISLLKELNHPN 59

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAM 138
           IVR  +V+ +   L +V E+    +L + + ++     D      +  QL+ G++YCH+ 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEVLLR 194
           +V HRDLK +N L+D   A  LK+ DFG +++      P  T    V T  Y APE+LL 
Sbjct: 119 RVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLG 173

Query: 195 HEYDGKIADVWSCGVTLYVML--------------------VGGYPFED--PD--EPKDF 230
                   D+WS G     M+                      G P ED  P      D+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233

Query: 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
           + T  +      S    N + ++  DL+S++ V DPA RI+    ++H +F
Sbjct: 234 KPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  111 bits (278), Expect = 3e-28
 Identities = 83/264 (31%), Positives = 133/264 (50%), Gaps = 26/264 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
           IG G+FG      D  T+++VA+K I+  +  DE  ++Q+EI        P + ++    
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 89  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
           L  T L I+MEY  GG   + +  AG F E +     ++++ G+ Y H+ +  HRD+K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAA 130

Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWS 206
           N LL  S    +K+ DFG +   +  +Q K  + VGTP ++APEV+ +  YD K AD+WS
Sbjct: 131 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK-ADIWS 186

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISR 260
            G+T  + L  G P      P          + V + +P  NP       S+  ++ I  
Sbjct: 187 LGITA-IELAKGEPPNSDMHP----------MRVLFLIPKNNPPTLTGEFSKPFKEFIDA 235

Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
               DP+ R T  E++KH++ +KN
Sbjct: 236 CLNKDPSFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  111 bits (278), Expect = 3e-28
 Identities = 83/286 (29%), Positives = 129/286 (45%), Gaps = 44/286 (15%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           +G G +      R++ T E+VA+K I    E G        REI   + L+H NIVR  +
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTP--STAIREISLMKELKHENIVRLHD 65

Query: 87  VILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           VI T   L +V EY      +  +     G    +  + F  QL+ G+++CH  +V HRD
Sbjct: 66  VIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRD 125

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIA 202
           LK +N L++      LK+ DFG +++  +  +   + V T  Y AP+VLL    Y   I 
Sbjct: 126 LKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSI- 182

Query: 203 DVWSCGVTLYVMLVG-----GYPFED-----------PDE---------PKDFRKTIQRI 237
           D+WS G  +  M+ G     G   ED           P E         P+ ++ T  R 
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE-YKPTFPRY 241

Query: 238 --LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
               +Q   P  +P+     DL+ R+   +P  RI+  + ++H WF
Sbjct: 242 PPQDLQQLFPHADPLGI---DLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 3e-28
 Identities = 68/263 (25%), Positives = 107/263 (40%), Gaps = 26/263 (9%)

Query: 31  IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFK 85
           +G G FG     +L         VAVK ++     +E     +E    + L HPN+VR  
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62

Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GVSYCH 136
            V      L +V+EY  GG+L  + R       S +++    + L+S       G+ Y  
Sbjct: 63  GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLL 193
           + +  HRDL   N L+       +KI DFG S+        +   G    I   APE L 
Sbjct: 123 SKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLK 180

Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
              +  K +DVWS GV L+ +  +G  P+          + ++ +    Y +P       
Sbjct: 181 DGIFTSK-SDVWSFGVLLWEIFTLGATPYPG----LSNEEVLEYLRK-GYRLPKPEYCPD 234

Query: 253 ECRDLISRIFVADPAARITIPEI 275
           E  +L+   +  DP  R T  E+
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  110 bits (275), Expect = 1e-27
 Identities = 80/290 (27%), Positives = 145/290 (50%), Gaps = 29/290 (10%)

Query: 25  YDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDE-------NVQREIINH 73
           ++ ++ +G+G +G   L+R KV    + +L A+K +++   + +         +R+++ H
Sbjct: 2   FELLKVLGTGAYGKVFLVR-KVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
              + P +V       T T L ++++Y +GGELF  +    RF E E + +  +++  + 
Sbjct: 61  IR-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALE 119

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEV 191
           + H + + +RD+KLEN LLD +    + + DFG SK        +  S  GT  Y+AP++
Sbjct: 120 HLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177

Query: 192 LLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTN 248
           +   +  +D K  D WS GV +Y +L G  PF    E     +  +RIL  +   P + +
Sbjct: 178 VRGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 236

Query: 249 PISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEK 293
            ++   +D+I R+ + DP  R+        EI KH +F K    DL  +K
Sbjct: 237 ALA---KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKK 283

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  110 bits (276), Expect = 2e-27
 Identities = 90/324 (27%), Positives = 150/324 (46%), Gaps = 39/324 (12%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRH 78
           ++RY  ++ +G G FG+    RD++T + VA+K I +      + +   RE+   + LRH
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 79  PNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            NI+   ++ ++P   +  V E    G    R+  +    +   ++F  Q++ G+ Y H+
Sbjct: 69  ENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHS 126

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HE 196
             V HRDLK  N L++ +    LKICDFG ++  +   Q    V T  Y APE++L   +
Sbjct: 127 AGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYYRAPEIMLTWQK 182

Query: 197 YDGKIADVWSCGVTLYVMLVGG--YPFEDP------------DEPKDFRKTI--QRILSV 240
           YD ++ D+WS G     ML G   +P +D               P D   TI  +  L  
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241

Query: 241 QYSVPDTN--PISQ-------ECRDLISRIFVADPAARITIPEIMKHQWF-LKNLPADL- 289
             S+P     P S+          DL+ ++ V DP  RI+  E + H +    + P D  
Sbjct: 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEP 301

Query: 290 VDEKTMSSQYEEPDQPMQSVDVIM 313
           V E+     + + D P+ +  V+M
Sbjct: 302 VAEEKFDWSFNDADLPVDTWKVMM 325

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 84/300 (28%), Positives = 129/300 (43%), Gaps = 56/300 (18%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSLR-- 77
           Y+ + +IG G +G     RD  T   VA+K +     E G  I  +  REI   + L   
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58

Query: 78  -HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLIS 130
            HPNIVR  +V   P       L +V E+       +   C       +  +   +QL+ 
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 131 GVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
           GV + H+ ++ HRDLK +N L+  DG    ++KI DFG ++         S V T  Y A
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMALTSVVVTLWYRA 174

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPFEDPDEPK 228
           PEVLL+  Y   + D+WS G     +                     V G P E+ + P+
Sbjct: 175 PEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE-EWPR 232

Query: 229 D-------FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
           +       F     R  S +  VP+   I +E  DL+ ++   +P  RI+  E ++H +F
Sbjct: 233 NVSLPRSSFPSYTPR--SFKSFVPE---ICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  109 bits (273), Expect = 2e-27
 Identities = 83/270 (30%), Positives = 142/270 (52%), Gaps = 24/270 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           IG G+ G+  + R+K +   VAVK ++ R  +  E +  E++  R  +H N+V   +  L
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 90  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
               L ++ME+  GG L + I +  R +E++     + ++  + Y H+  V HRD+K ++
Sbjct: 89  VGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDS 147

Query: 150 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            L  LDG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+ R  Y  ++ D+WS
Sbjct: 148 ILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV-DIWS 202

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKT-IQRILSVQYSVP----DTNPISQECRDLISRI 261
            G+ +  M+ G        EP  F  + +Q +  ++ S P    + + IS   RD + R+
Sbjct: 203 LGIMVIEMVDG--------EPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254

Query: 262 FVADPAARITIPEIMKHQWFLK-NLPADLV 290
              +P  R T  E++ H + L+  LP  LV
Sbjct: 255 LTREPQERATAQELLDHPFLLQTGLPECLV 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  108 bits (270), Expect = 2e-27
 Identities = 82/266 (30%), Positives = 126/266 (47%), Gaps = 22/266 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD-KIDENVQREIINH--RSLR 77
           RY   + +G G+FG   L++DK       L  +K I  G+   +E VQ          L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 133
           HP IV+F    L      I+ EY  G +L  ++          SE++   +F QL+ GV 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
           Y H  ++ HRDLK +N  L  +    LKI DFG S+  +      +T  GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEAL 177

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPIS 251
               YD K +D+WS G  LY M    + FE     ++F   + RI+     S+P+T    
Sbjct: 178 KHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPETYS-- 230

Query: 252 QECRDLISRIFVADPAARITIPEIMK 277
           ++   ++  +   DP+ R +  EI++
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEILR 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  108 bits (270), Expect = 3e-27
 Identities = 77/264 (29%), Positives = 129/264 (48%), Gaps = 26/264 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
           IG G+FG      D  T+++VA+K I+  +  DE  ++Q+EI        P + ++    
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 89  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
           L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y H+ +  HRD+K  
Sbjct: 72  LKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAA 130

Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWS 206
           N LL  S    +K+ DFG +   +  +Q K    VGTP ++APEV+ +  YD K AD+WS
Sbjct: 131 NVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWS 186

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISR 260
            G+T  + L  G P      P          + V + +P  NP       S+  ++ +  
Sbjct: 187 LGITA-IELAKGEPPHSELHP----------MKVLFLIPKNNPPTLEGNYSKPLKEFVEA 235

Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
               +P+ R T  E++KH++ ++ 
Sbjct: 236 CLNKEPSFRPTAKELLKHKFIVRF 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  110 bits (275), Expect = 3e-27
 Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
           ++ Y+ V+ IG G FG  +L+R K T+++ A+K + + + I  +        R +     
Sbjct: 42  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H+
Sbjct: 102 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 160

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 161 MGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 216

Query: 194 RHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
                 Y G+  D WS GV LY MLVG  PF        + K +    S+ +  PD N I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 274

Query: 251 SQECRDLISRIFVADPAARI---TIPEIMKHQWF 281
           S+E ++LI   F+ D   R+    + EI +H +F
Sbjct: 275 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  107 bits (268), Expect = 9e-27
 Identities = 89/293 (30%), Positives = 132/293 (45%), Gaps = 40/293 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
           ++++ +  +G G +GV    R K TKE+VA+K     E  +++ E   RE+   R+L+  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 80  NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           NIV  KE       L +V EY      EL E + N      ++ R +  QLI  + +CH 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCHK 118

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
             + HRD+K EN L+  S    LK+CDFG++++    S    T  V T  Y +PE+LL  
Sbjct: 119 NDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL--------SVQYSVPD- 246
            Y GK  D+WS G  L   L  G P    +   D   TIQ++L         + YS P  
Sbjct: 177 PY-GKAVDMWSVGCILG-ELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234

Query: 247 --------TNPISQECR----------DLISRIFVADPAARITIPEIMKHQWF 281
                    +P S E R          DL+  +   +P  R    + + H  F
Sbjct: 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  105 bits (265), Expect = 2e-26
 Identities = 72/266 (27%), Positives = 122/266 (45%), Gaps = 22/266 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
             +   + IG G F V       +   +VA+K ++  + +D    ++  +EI   + L H
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSY 134
           PN++++    +    L IV+E A  G+L   I +  +      E     +F QL S + +
Sbjct: 62  PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 189
            H+ ++ HRD+K  N  +  +    +K+ D G      SK++  HS     VGTP Y++P
Sbjct: 122 MHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL----VGTPYYMSP 175

Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
           E +  + Y+ K +D+WS G  LY M     PF    +  +     ++I    Y     + 
Sbjct: 176 ERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEKCDYPPLPADH 232

Query: 250 ISQECRDLISRIFVADPAARITIPEI 275
            S+E RDL+SR    DP  R  I  +
Sbjct: 233 YSEELRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  105 bits (264), Expect = 2e-26
 Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 21/224 (9%)

Query: 27  FVRDIGSGNFGV---ARL-MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPN 80
             + +G G FG      L    + T+  VAVK ++ G  ++  E    E    + L HPN
Sbjct: 3   LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 81  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           IVR   V      L IV EY  GG+L  F R  +  + +  +      Q+  G+ Y  + 
Sbjct: 63  IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQIAKGMEYLESK 121

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 193
              HRDL   N L+  +    +KI DFG S+   ++            +     APE L 
Sbjct: 122 NFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQR 236
             ++  K +DVWS GV L+ +   G  P+      ++  + ++ 
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLELLED 219

Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 3e-26
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 57/293 (19%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---- 77
           +  ++ V  IG G +G     R K T +LVA+K ++  +  +E ++ E      LR    
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEY---NILRKYSN 61

Query: 78  HPNIVRFKEVILTPTH------LAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQ 127
           HPNI  F    +          L +VME   GG   +L + +   G R  E+   +  ++
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 128 LISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST----- 180
            + G++Y H  +V HRD+K +N LL  +      +K+ DFG S      +Q  ST     
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLVDFGVS------AQLDSTLGRRN 171

Query: 181 --VGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFED--PDEPKDFR 231
             +GTP ++APEV+         YD + +DVWS G+T   +  G  P  D  P       
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPM------ 224

Query: 232 KTIQRILSVQYSVPDT----NPISQECRDLISRIFVADPAARITIPEIMKHQW 280
           + + +I     + P T       S++  D IS   + +   R  + E+++H +
Sbjct: 225 RALFKIPR---NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  106 bits (265), Expect = 3e-26
 Identities = 95/310 (30%), Positives = 128/310 (41%), Gaps = 67/310 (21%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           D++D +  IG G +G     RDK T ELVA+K + R D   E       REI   R L H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV-RLDNEKEGFPITAIREIKILRQLNH 65

Query: 79  PNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNAGRFSEDEARFF 124
            NIV  KE I+T    A           +V EY      G L   + +   FSED  + F
Sbjct: 66  RNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSF 121

Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 182
            +QL+ G++YCH     HRD+K  N LL+     ++K+ DFG ++          T  V 
Sbjct: 122 MKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNSEESRPYTNKVI 179

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPFE 222
           T  Y  PE+LL  E  G   DVWSCG  L  +                     + G P  
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239

Query: 223 D--PD----------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 270
              PD          +PK   K  +R L  ++S      I     DL+  +   DP+ R 
Sbjct: 240 AVWPDVIKLPYFNTMKPK---KQYRRRLREEFSF-----IPTPALDLLDHMLTLDPSKRC 291

Query: 271 TIPEIMKHQW 280
           T  E +   W
Sbjct: 292 TAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  106 bits (265), Expect = 4e-26
 Identities = 83/291 (28%), Positives = 143/291 (49%), Gaps = 27/291 (9%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREI-INHRSLRHPNIVR 83
           R IG G++    L+  K T+ + A+K I++    D+     VQ E  +   +  HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                 T + L  V+E+ SGG+L   +    +  E+ ARF+  ++   +++ H   + +R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
           DLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   +Y   + 
Sbjct: 121 DLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177

Query: 203 DVWSCGVTLYVMLVGGYPF------EDPDE-PKDFRKTIQRILSVQYSVPDTNPISQECR 255
           D W+ GV ++ M+ G  PF      ++PD+  +D+    Q IL  Q  +P +  +S +  
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY--LFQVILEKQIRIPRS--LSVKAS 233

Query: 256 DLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKTMSSQYE 300
            ++      DP  R+         +I  H +F +N+  DL+++K +   Y+
Sbjct: 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF-RNIDWDLLEQKQVLPPYK 283

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  105 bits (263), Expect = 5e-26
 Identities = 84/261 (32%), Positives = 136/261 (52%), Gaps = 15/261 (5%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           IG G+ G+  +   K + +LVAVK ++ R  +  E +  E++  R  +H N+V      L
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 90  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
               L +VME+  GG L + I    R +E++       ++  +S  HA  V HRD+K ++
Sbjct: 88  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDS 146

Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APE++ R  Y G   D+WS
Sbjct: 147 ILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWS 201

Query: 207 CGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
            G+ +  M+ G  P F +P  P    K I+  L  +  + + + +S   +  + R+ V D
Sbjct: 202 LGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPK--LKNLHKVSPSLKGFLDRLLVRD 257

Query: 266 PAARITIPEIMKHQWFLKNLP 286
           PA R T  E++KH +  K  P
Sbjct: 258 PAQRATAAELLKHPFLAKAGP 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  104 bits (261), Expect = 6e-26
 Identities = 79/262 (30%), Positives = 124/262 (47%), Gaps = 24/262 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVI 88
           IG G+FG      D  TKE+VA+K I+  +  DE  ++Q+EI        P I R+    
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 89  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
           L  T L I+MEY  GG   + +   G   E       ++++ G+ Y H+ +  HRD+K  
Sbjct: 72  LKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 130

Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSC 207
           N LL  S    +K+ DFG +         ++T VGTP ++APEV+ +  YD K AD+WS 
Sbjct: 131 NVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK-ADIWSL 187

Query: 208 GVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDLISRI 261
           G+T   +  G  P  D              + V + +P  +P       S+  ++ +   
Sbjct: 188 GITAIELAKGEPPNSDLHP-----------MRVLFLIPKNSPPTLEGQYSKPFKEFVEAC 236

Query: 262 FVADPAARITIPEIMKHQWFLK 283
              DP  R T  E++KH++  +
Sbjct: 237 LNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  107 bits (269), Expect = 7e-26
 Identities = 85/270 (31%), Positives = 131/270 (48%), Gaps = 18/270 (6%)

Query: 42  MRDKVTKELVAVKYIERGDKIDENVQR-EIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
            R    KE V  K++   D+      R E+    +  H  IV+  +   +   L ++MEY
Sbjct: 87  TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146

Query: 101 ASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP 156
            SGG+L ++I    +    F E E    F Q++  +   H+ ++ HRDLK  N  L   P
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL--MP 204

Query: 157 APRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYV 213
              +K+ DFG+SK    SV      S  GTP Y+APE+  R  Y  K AD+WS GV LY 
Sbjct: 205 TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYE 263

Query: 214 MLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 273
           +L    PF+ P +    R+ +Q++L  +Y  P   P+S   + L+  +   +PA R T  
Sbjct: 264 LLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCPVSSGMKALLDPLLSKNPALRPTTQ 318

Query: 274 EIMKHQWFLKNLPADLVDEKTMSSQYEEPD 303
           +++ H  FLK + A+L  +    S+   P 
Sbjct: 319 QLL-HTEFLKYV-ANLFQDIVRHSETISPH 346

Length = 478

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  104 bits (261), Expect = 9e-26
 Identities = 78/275 (28%), Positives = 121/275 (44%), Gaps = 30/275 (10%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFK 85
           +  +G G  G     R K T  + A+K I       + + + RE+  ++S + P IV++ 
Sbjct: 6   LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65

Query: 86  EVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDEARFFFQQLISGVSYCHAM 138
              L    + + I MEY  GG L + I        GR  E       + ++ G+SY H+ 
Sbjct: 66  GAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           ++ HRD+K  N LL       +K+CDFG S   V  S   +  GT  Y+APE +    Y 
Sbjct: 125 KIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTFTGTSFYMAPERIQGKPYS 181

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI-------- 250
              +DVWS G+TL  +    +PF     P +    +  I  + Y V   NP         
Sbjct: 182 IT-SDVWSLGLTLLEVAQNRFPF-----PPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235

Query: 251 ---SQECRDLISRIFVADPAARITIPEIMKHQWFL 282
              S+E +D I +    DP  R T  ++++H W  
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  105 bits (264), Expect = 9e-26
 Identities = 82/302 (27%), Positives = 136/302 (45%), Gaps = 49/302 (16%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-- 80
           D ++ ++ IG G FG  RL++ K T  + A+K + + D +++     I   R +      
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 81  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             +V+         +L ++ME+  GG++   +      SE+  +F+  + +  +   H +
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK--------- 178
              HRD+K +N LLD      +K+ DFG               ++ H+ P          
Sbjct: 121 GFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 179 ----------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
                           STVGTP YIAPEV ++  Y+ K+ D WS GV +Y ML+G  PF 
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFC 237

Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQ 279
                + +RK +    ++ +  P   PIS++ +DLI R F  D   RI    + EI  H 
Sbjct: 238 SETPQETYRKVMNWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHP 294

Query: 280 WF 281
           +F
Sbjct: 295 FF 296

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  105 bits (264), Expect = 1e-25
 Identities = 82/274 (29%), Positives = 135/274 (49%), Gaps = 22/274 (8%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
           ++ YD V+ IG G FG  +L+R K ++++ A+K + + + I  +        R +     
Sbjct: 42  AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 101

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P +V+         +L +VMEY  GG+L   + N     E  A+F+  +++  +   H+
Sbjct: 102 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 160

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           M + HRD+K +N LLD      LK+ DFG      ++ ++     + VGTP YI+PEVL 
Sbjct: 161 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLK 216

Query: 194 RH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
                 Y G+  D WS GV L+ MLVG  PF        + K +    S+ +  P+   I
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEI 274

Query: 251 SQECRDLISRIFVADPAARI---TIPEIMKHQWF 281
           S+  ++LI   F+ D   R+    + EI +H +F
Sbjct: 275 SKHAKNLIC-AFLTDREVRLGRNGVEEIKQHPFF 307

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  103 bits (260), Expect = 1e-25
 Identities = 62/212 (29%), Positives = 99/212 (46%), Gaps = 17/212 (8%)

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +PN ++    + T     ++M+Y   G+LF+ +   G+ SE E +   +QL+  ++  H 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + H D+KLEN L D +   R+ +CD+G  K       P    GT  Y +PE +  H Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFE-DPDE---PKDFRKTIQRILSVQYSVPDTNPISQE 253
           D    D W+ GV  Y +L G +PF+ D DE    +   K  Q+       +P    +S+ 
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK------KLPFIKNVSKN 236

Query: 254 CRDLISRIFVADPAAR-ITIPEIMKHQWFLKN 284
             D +  +   +   R     EI+KH  FLK 
Sbjct: 237 ANDFVQSMLKYNINYRLTNYNEIIKHP-FLKI 267

Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  102 bits (255), Expect = 4e-25
 Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 22/263 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
           +G G FG   L  D  T   +AVK ++   +  E  +       EI   ++L H  IV++
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 85  KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
              +  P    L+I ME+  GG + +++ + G  +E+  R + +Q++ GVSY H+  + H
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVH 129

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           RD+K  N L D      +K+ DFG SK      +  +  KS  GTP +++PEV+    Y 
Sbjct: 130 RDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY- 186

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDL 257
           G+ AD+WS G T+  ML    P+ + +      K     ++ Q + P   P +S  CRD 
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQPTNPVLPPHVSDHCRDF 241

Query: 258 ISRIFVADPAARITIPEIMKHQW 280
           + RIFV +   R +  E+++H +
Sbjct: 242 LKRIFV-EAKLRPSADELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  103 bits (257), Expect = 4e-25
 Identities = 80/266 (30%), Positives = 126/266 (47%), Gaps = 18/266 (6%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA+K +    +   E +  EI+  R  +HPNIV
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQVIH 138

Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ R  Y  
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 200 KIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           K+ D+WS G+    M+ G  P+  E+P      R       +    + +   +S   RD 
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTPELQNPEKLSAIFRDF 248

Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++H  FLK
Sbjct: 249 LNRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  103 bits (258), Expect = 4e-25
 Identities = 83/286 (29%), Positives = 143/286 (50%), Gaps = 27/286 (9%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
           R IG G++    L+R K T+ + A+K +++      + ID     + +  ++  HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                 T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   + +R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
           DLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   +Y G   
Sbjct: 121 DLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177

Query: 203 DVWSCGVTLYVMLVGGYPF------EDPDE-PKDFRKTIQRILSVQYSVPDTNPISQECR 255
           D W+ GV ++ M+ G  PF      ++PD+  +D+    Q IL  Q  +P +  +S +  
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRS--LSVKAA 233

Query: 256 DLISRIFVADPAARI-TIPE-----IMKHQWFLKNLPADLVDEKTM 295
            ++      DP  R+   P+     I  H +F +N+  DL+++K +
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDLMEQKQV 278

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  102 bits (256), Expect = 6e-25
 Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 45/290 (15%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHP 79
            +  +R+IG G+FG     RD  T E+VA+K +    K      ++II      + LRHP
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 80  NIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           N + +K   L      +VMEY   S  ++ E   +     E E        + G++Y H+
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHS 133

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---R 194
            +  HRD+K  N LL  +    +K+ DFG   S+ L S   S VGTP ++APEV+L    
Sbjct: 134 HERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPANSFVGTPYWMAPEVILAMDE 188

Query: 195 HEYDGKIADVWSCGVT----------LYVM--LVGGYPFEDPDEPKDFRKTIQRILSVQY 242
            +YDGK  DVWS G+T          L+ M  +   Y     D P     T+        
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP-----TLS------- 235

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
               +N  S   R+ +       P  R +  E++KH++ L+  P  ++ +
Sbjct: 236 ----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIID 281

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  101 bits (252), Expect = 1e-24
 Identities = 71/276 (25%), Positives = 130/276 (47%), Gaps = 18/276 (6%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
           + D+G+GN G    ++   T  ++A K +  G K   +V+++I+    + H    P IV 
Sbjct: 10  ISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVS 67

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCH 142
           F    L   ++ + ME+   G L       G    +        ++ G++Y +   ++ H
Sbjct: 68  FYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMH 127

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RD+K  N L++     ++K+CDFG S   +++S   + VGT  Y++PE +   +Y  K +
Sbjct: 128 RDIKPSNILVNS--RGQIKLCDFGVS-GELINSIADTFVGTSTYMSPERIQGGKYTVK-S 183

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-VQYSVPDTNP------ISQECR 255
           DVWS G+++  + +G +PF   +   D +     IL  +Q  V +  P        ++ R
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLR 243

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           D +    + DP  R T  ++     F++ L A  VD
Sbjct: 244 DFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVD 279

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  101 bits (254), Expect = 2e-24
 Identities = 87/297 (29%), Positives = 139/297 (46%), Gaps = 47/297 (15%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKID-ENVQREIINHRSLRHPN 80
           +Y  ++ IG G +G+    ++  T E VA+K I     ++ID +   REI   R L H N
Sbjct: 6   KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65

Query: 81  IVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           ++  K+ I+ P H      + IV E     +L + I ++   S+D  ++F  QL+ G+ Y
Sbjct: 66  VIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLL 193
            H+  V HRDLK  N LL+ +    LKICDFG ++ +S         V T  Y APE+LL
Sbjct: 124 IHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLL 181

Query: 194 R-HEYDGKIADVWSCG---------------------VTLYVMLVGG-----YPFEDPDE 226
              EY   I DVWS G                     + L   L+G        F   ++
Sbjct: 182 NCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            + + +++       ++   P  NP++    DL+ ++ V DP+ RIT+ E + H + 
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAI---DLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  100 bits (250), Expect = 2e-24
 Identities = 80/271 (29%), Positives = 119/271 (43%), Gaps = 28/271 (10%)

Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI------------ERGDKIDENVQREII 71
           Y  +  +GSG FG V ++ +    + L+A+K I            ER   I + V    I
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQ 127
               LRHPNIVR+ +  L    L IVM+   G  L E   +      RF+E+     F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 128 LISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
           ++  + Y H   ++ HRDL   N +L      ++ I DFG +K     S+  S VGT  Y
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQPESKLTSVVGTILY 179

Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
             PE++    Y G+ ADVW+ G  LY M     PF       +      +I+   Y    
Sbjct: 180 SCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLSLATKIVEAVYEPLP 234

Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMK 277
               S++  D+I+     D  AR   P+I++
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR---PDIIQ 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  100 bits (250), Expect = 3e-24
 Identities = 83/290 (28%), Positives = 139/290 (47%), Gaps = 39/290 (13%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
           Y  +  IG G +GV    R+K T ++VA+K I R +  +E V     REI   + L+HPN
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPN 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           IV  ++V++  + L ++ E+ S    +  + +        +  + +  Q++ G+ +CH+ 
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEY 197
           +V HRDLK +N L+D      +K+ DFG +++  +  +  +  V T  Y APEVLL    
Sbjct: 121 RVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD--FRKTIQRILSVQ--------YSVPD- 246
                D+WS G T++  +    P    D   D  FR  I RIL            S+PD 
Sbjct: 179 YSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRILGTPTEDVWPGVTSLPDY 235

Query: 247 --TNP-------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             T P             + ++  DL+ ++ + DPA RI+  + + H +F
Sbjct: 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  101 bits (253), Expect = 4e-24
 Identities = 81/311 (26%), Positives = 141/311 (45%), Gaps = 48/311 (15%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN---- 80
           ++ ++ IG G FG  RL++ K T  + A+K + + D +++     I   R +        
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +V+         +L ++ME+  GG++   +      +E+E +F+  + +  +   H +  
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKS-----------SVLHSQPK----------- 178
            HRD+K +N LLD      +K+ DFG               ++ HS P            
Sbjct: 123 IHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180

Query: 179 --------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
                         STVGTP YIAPEV ++  Y+ K+ D WS GV +Y ML+G  PF   
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP--EIMKHQWFL 282
              + ++K +    ++ +  P   PIS++ +DLI R F  +   RI  P  E +K   F 
Sbjct: 240 TPQETYKKVMNWKETLIF--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFF 296

Query: 283 KNLPADLVDEK 293
           + +  + + E+
Sbjct: 297 EGVDWEHIRER 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  100 bits (249), Expect = 4e-24
 Identities = 82/261 (31%), Positives = 137/261 (52%), Gaps = 22/261 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           IG G+ G+  +  +K T + VAVK ++ R  +  E +  E++  R   H N+V      L
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 90  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
               L +VME+  GG L + I    R +E++       ++  +SY H   V HRD+K ++
Sbjct: 90  VGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDS 148

Query: 150 TLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            LL  DG    R+K+ DFG+ ++ S    + KS VGTP ++APEV+ R  Y G   D+WS
Sbjct: 149 ILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP----DTNPISQECRDLISRIF 262
            G+ +  M+ G  P+   +EP      +Q +  ++ ++P    D++ +S   R  +  + 
Sbjct: 204 LGIMVIEMIDGEPPYF--NEPP-----LQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256

Query: 263 VADPAARITIPEIMKHQWFLK 283
           V +P+ R T  E+++H  FLK
Sbjct: 257 VREPSQRATAQELLQHP-FLK 276

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =   99 bits (249), Expect = 4e-24
 Identities = 76/249 (30%), Positives = 117/249 (46%), Gaps = 14/249 (5%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPN---IVRFKE 86
           +G G FG     + + T +L A K + +   K  +  +  ++  R L   +   IV    
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCH 142
              T T L +VM   +GG+L   I N       F E  A F+  Q+ISG+ + H  ++ +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           RDLK EN LLD      ++I D G + +     S+ K   GTP ++APE+L   EYD  +
Sbjct: 121 RDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSV 178

Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            D ++ GVTLY M+    PF    E  + ++  QRIL+   + PD    S   +     +
Sbjct: 179 -DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDK--FSPASKSFCEAL 235

Query: 262 FVADPAARI 270
              DP  R+
Sbjct: 236 LAKDPEKRL 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 37/291 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDK--IDENVQREIINHRSLRHP 79
           ++Y+ +  IG G++GV    R++ T ++VA+K ++E  D   I +   REI   + L+HP
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           N+V   EV      L +V EY     L E   N     E   +    Q +  V++CH   
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTPAYIAPEVLLRHE 196
             HRD+K EN L+  +   ++K+CDFG+++  +L          V T  Y APE+L+   
Sbjct: 121 CIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPF----EDPDEPKDFRKTI-------QRILSVQ---- 241
             G   DVW+ G  ++  L+ G P      D D+    RKT+       Q+I S      
Sbjct: 177 QYGPPVDVWAIGC-VFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235

Query: 242 -YSVP---DTNPISQECRDLISR-------IFVADPAARITIPEIMKHQWF 281
             S+P      P+  +  ++ S            DP  R++  E+++H +F
Sbjct: 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 99.0 bits (246), Expect = 7e-24
 Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 8/201 (3%)

Query: 15  DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIIN 72
           D+   +  + ++ ++ IGSG +G     R+  T EL A+K I  E G+     VQ+EII 
Sbjct: 1   DLSRRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIM 59

Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            +  +H NIV +    L    L I ME+  GG L +     G  SE +  +  ++ + G+
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEV 191
            Y H+    HRD+K  N LL  +    +K+ DFG S   +   ++ KS +GTP ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177

Query: 192 LLRHEYDG--KIADVWSCGVT 210
                  G  ++ D+W+ G+T
Sbjct: 178 AAVERKGGYNQLCDIWAVGIT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.6 bits (245), Expect = 8e-24
 Identities = 81/260 (31%), Positives = 129/260 (49%), Gaps = 20/260 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQREIINHRSLRHPNIVRF 84
           +G G FG   L  D  T   +AVK +      +   K    ++ EI   ++LRH  IV++
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 85  KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
              +  P    L+I +EY  GG + +++   G  +E+  R + +Q++ GVSY H+  + H
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVH 129

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
           RD+K  N L D   A  +K+ DFG SK   ++  S    KS  GTP +++PEV+    Y 
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY- 186

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ ADVWS   T+  ML    P+ + +      K   +       +PD   +S  CRD +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM--LPDG--VSDACRDFL 242

Query: 259 SRIFVADPAARITIPEIMKH 278
            +IFV +   R T   +++H
Sbjct: 243 KQIFVEE-KRRPTAEFLLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 20/262 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR------EIINHRSLRHPNIVRF 84
           +G G FG   L  D  T   +A K ++   +  E  +       EI   ++L+H  IV++
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 85  KEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
              +       L I MEY  GG + +++   G  +E   R + +Q++ G+SY H+  + H
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVGTPAYIAPEVLLRHEYD 198
           RD+K  N L D   A  +K+ DFG SK   ++  S    +S  GTP +++PEV+    Y 
Sbjct: 130 RDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY- 186

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ ADVWS G T+  ML    P+ + +        I +I +   +    + IS+  RD +
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPTNPQLPSHISEHARDFL 242

Query: 259 SRIFVADPAARITIPEIMKHQW 280
             IFV +   R +  E+++H +
Sbjct: 243 GCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 98.6 bits (246), Expect = 1e-23
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 16/211 (7%)

Query: 27  FVRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
           F++ +G G+FG   L R       T E VAVK +     ++   + +REI   R+L H N
Sbjct: 8   FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67

Query: 81  IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
           IV++K V   P    L ++MEY   G L + +  +  + +      F  Q+  G+ Y  +
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA-YIAPEVLL 193
            +  HRDL   N L++      +KI DFG +K           K    +P  + APE L 
Sbjct: 128 QRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
             ++    +DVWS GVTLY +   G P + P
Sbjct: 186 TSKFSSA-SDVWSFGVTLYELFTYGDPSQSP 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score =  102 bits (255), Expect = 1e-23
 Identities = 82/245 (33%), Positives = 117/245 (47%), Gaps = 41/245 (16%)

Query: 16  MPIMHDS-----DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQR- 68
           MP  +D      + Y+ ++ IG+G FG   L++ K T+E    K I  RG K  E  Q  
Sbjct: 1   MPGKYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV 60

Query: 69  -EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GRFSEDEA 121
            E+   R L+H NIVR+ +  L   +  L I+ME+   G+L   I       G+  E   
Sbjct: 61  IEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120

Query: 122 RFFFQQLISGVSYCHAMQ-------VCHRDLKLENTLLDG---------------SPAPR 159
               +QL+  ++YCH ++       V HRDLK +N  L                 +  P 
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLV 216
            KI DFG SK+  + S   S VGTP Y +PE+LL HE   YD K +D+W+ G  +Y +  
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLL-HETKSYDDK-SDMWALGCIIYELCS 238

Query: 217 GGYPF 221
           G  PF
Sbjct: 239 GKTPF 243

Length = 1021

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 83/297 (27%), Positives = 118/297 (39%), Gaps = 48/297 (16%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHP 79
             RY  +  IG G +G+      K T   VA+K I   +     +   REI   R  +H 
Sbjct: 4   GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYC 135
           NI+   + I+ P       +     EL E    ++      S D  ++F  Q++ G+ Y 
Sbjct: 64  NIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYI 122

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 191
           H+  V HRDLK  N LL+      LKICDFG ++ +             V T  Y APE+
Sbjct: 123 HSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEI 180

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSV--QYSVPDTN 248
           +L  +   K  D+WS G  L  ML     F     P KD+   +  IL V    S  D N
Sbjct: 181 MLNSKGYTKAIDIWSVGCILAEMLSNRPLF-----PGKDYLHQLNLILGVLGTPSQEDLN 235

Query: 249 PI-SQECR--------------------------DLISRIFVADPAARITIPEIMKH 278
            I S   R                          DL+ ++   +P  RIT+ E + H
Sbjct: 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 98.3 bits (244), Expect = 2e-23
 Identities = 83/268 (30%), Positives = 131/268 (48%), Gaps = 22/268 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA+K I  +     E +  EI+  + L++PNIV
Sbjct: 20  KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQV 140
            F +  L    L +VMEY +GG L + +        DEA+     ++ +  + + HA QV
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQV 136

Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
            HRD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ R  Y
Sbjct: 137 IHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECR 255
             K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   R
Sbjct: 193 GPKV-DIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSPIFR 246

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLK 283
           D ++R    D   R +  E+++H  FLK
Sbjct: 247 DFLNRCLEMDVEKRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 81/268 (30%), Positives = 126/268 (47%), Gaps = 21/268 (7%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +R+IG G+FG     RD  T E+VA+K +    K      ++II      + ++HPN + 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 84  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           +K   L      +VMEY   S  +L E   +     E E        + G++Y H+  + 
Sbjct: 90  YKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
           HRD+K  N LL  +   ++K+ DFG   S+ + S   S VGTP ++APEV+L     +YD
Sbjct: 148 HRDIKAGNILL--TEPGQVKLADFG---SASIASPANSFVGTPYWMAPEVILAMDEGQYD 202

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK+ DVWS G+T  + L    P   P    +    +  I   +     +N  S   R+ +
Sbjct: 203 GKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLP 286
                  P  R T  E++KH + L+  P
Sbjct: 258 DSCLQKIPQDRPTSEELLKHMFVLRERP 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 97.1 bits (241), Expect = 6e-23
 Identities = 77/266 (28%), Positives = 132/266 (49%), Gaps = 18/266 (6%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 143 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+  + VGTP ++APEV+ R  Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDL 257
           K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   RD 
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFRDF 249

Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++HQ FLK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQ-FLK 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 96.1 bits (239), Expect = 7e-23
 Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 18/209 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRSLRHPNIVR 83
           +G G +G           +L+AVK +E         +K  E +Q E+   +SL+H NIV+
Sbjct: 8   LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
           +    L    ++I ME+  GG +   +   G   E     + +Q++ GV+Y H   V HR
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP-KSTVGTPAYIAPEVLLRHE 196
           D+K  N +L   P   +K+ DFG ++          HS   KS  GTP ++APEV+    
Sbjct: 127 DIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPD 225
           Y G+ +D+WS G T++ M  G  P    D
Sbjct: 185 Y-GRKSDIWSIGCTVFEMATGKPPLASMD 212

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 97.0 bits (241), Expect = 9e-23
 Identities = 82/298 (27%), Positives = 143/298 (47%), Gaps = 27/298 (9%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHPNIVR 83
           R IG G++    L+R K   ++ A+K +++      + ID     + +  ++  +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                 T + L +V+EY +GG+L   +    +  E+ ARF+  ++   +++ H   + +R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDGKIA 202
           DLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   EY G   
Sbjct: 121 DLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177

Query: 203 DVWSCGVTLYVMLVGGYPF----EDPD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           D W+ GV ++ M+ G  PF    ++PD   +D+    Q IL     +P    +S +   +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDY--LFQVILEKPIRIPRF--LSVKASHV 233

Query: 258 ISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVD 310
           +      DP  R+     T    +K   F +++  DL+++K    Q   P +P  + D
Sbjct: 234 LKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKK----QVTPPFKPQITDD 287

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 95.1 bits (236), Expect = 2e-22
 Identities = 64/191 (33%), Positives = 102/191 (53%), Gaps = 8/191 (4%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
           Y+ ++ +GSG +G     R+  T EL AVK I  E GD     +Q+EI   +  +H NIV
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNIV 69

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            +    L+   L I MEY  GG L +     G  SE +  +  ++ + G++Y H+    H
Sbjct: 70  AYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH 129

Query: 143 RDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG-- 199
           RD+K  N LL  +    +K+ DFG  +K +   ++ KS +GTP ++APEV    +  G  
Sbjct: 130 RDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 200 KIADVWSCGVT 210
           ++ D+W+ G+T
Sbjct: 188 QLCDIWAVGIT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 80/325 (24%), Positives = 129/325 (39%), Gaps = 74/325 (22%)

Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
            + P   +  +Y+ +  IG G FG     R K TK++VA+K +     + EN +      
Sbjct: 3   YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPIT 57

Query: 68  --REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG-RF 116
             REI   + L+H N+V   E+  T             +V E+    +L   + N   +F
Sbjct: 58  ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF 116

Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLH 174
           +  E +   + L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++  L 
Sbjct: 117 TLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLS 172

Query: 175 SQPKST-----VGTPAYIAPEVLLRHEYDGKIADVWSCG--------------------- 208
              K       V T  Y  PE+LL     G   D+W  G                     
Sbjct: 173 KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232

Query: 209 VTLYVMLVGG-----YP-------FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           +TL   L G      +P       F+  + P+  ++ ++  L                 D
Sbjct: 233 LTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVK-------DPHALD 285

Query: 257 LISRIFVADPAARITIPEIMKHQWF 281
           LI ++ V DPA RI     + H +F
Sbjct: 286 LIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 95.6 bits (237), Expect = 2e-22
 Identities = 78/266 (29%), Positives = 128/266 (48%), Gaps = 18/266 (6%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA+K +  +     E +  EI+  R  ++PNIV
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQVIH 138

Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ R  Y  
Sbjct: 139 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDL 257
           K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   RD 
Sbjct: 195 KV-DIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNGTPELQNPERLSAVFRDF 248

Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++H  FLK
Sbjct: 249 LNRCLEMDVDRRGSAKELLQHP-FLK 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 79/320 (24%), Positives = 122/320 (38%), Gaps = 66/320 (20%)

Query: 24  RYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIE----RGDKIDENVQREIINHRSLR 77
           +Y+    IG G +G     + K     +  A+K  +    +   I ++  REI   R L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 78  HPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEARFFFQQLISG 131
           H N+V   EV L     ++ +  +YA         F R            +    Q+++G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 132 VSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS------TVGT 183
           V Y H+  V HRDLK  N L+  +G     +KI D G ++  + ++  K        V T
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLADLDPVVVT 178

Query: 184 PAYIAPEVLL--RHEYDGKIADVWSCG------VTLY----------------------- 212
             Y APE+LL  RH Y   I D+W+ G      +TL                        
Sbjct: 179 IWYRAPELLLGARH-YTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 213 VMLVGGYPFED--PD-----EPKDFRKTIQRILSVQYSVPD----TNPISQECRDLISRI 261
           +  V G P E   PD     E     K  +       S+            +  DL+ ++
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 262 FVADPAARITIPEIMKHQWF 281
              DP  RIT  E ++H +F
Sbjct: 297 LEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 95.5 bits (237), Expect = 3e-22
 Identities = 76/274 (27%), Positives = 126/274 (45%), Gaps = 21/274 (7%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +R+IG G+FG     RD    E+VA+K +    K      ++II      + LRHPN ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 84  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           ++   L      +VMEY   S  +L E   +     E E        + G++Y H+  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV+L     +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK+ DVWS G+T   +     P  + +        +  I   +     +   S+  R+ +
Sbjct: 193 GKV-DVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNESPALQSGHWSEYFRNFV 247

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
                  P  R T   ++KH++ L+  P  ++ +
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (240), Expect = 3e-22
 Identities = 82/316 (25%), Positives = 137/316 (43%), Gaps = 65/316 (20%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDE----NVQREIINHRSL 76
           + +  V+ IG G FG  RL++ K T ++ A+K + + +  K D+      +R+++     
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
             P +V          +L ++ME+  GG+L   +     FSED  RF+  + +  +   H
Sbjct: 60  -SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFG-------------YSK-------------- 169
            +   HRD+K +N L+D      +K+ DFG             Y K              
Sbjct: 119 KLGFIHRDIKPDNILIDRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 170 --------SSVLHSQPK-------------STVGTPAYIAPEVLLRHEYDGKIADVWSCG 208
                   +  + S+ +             STVGTP YIAPE+ L+  Y G+  D WS G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLG 235

Query: 209 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 268
             ++  L+G  PF   +  + +RK I    ++ +  PD   +S E  DLI R+ + +   
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYF--PDDIHLSVEAEDLIRRL-ITNAEN 292

Query: 269 RI---TIPEIMKHQWF 281
           R+      EI  H +F
Sbjct: 293 RLGRGGAHEIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 93.9 bits (233), Expect = 5e-22
 Identities = 77/267 (28%), Positives = 121/267 (45%), Gaps = 26/267 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
           IG G FG     R   T ++ A+K +++     +  +   +N R +         P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                 TP  L  +++  +GG+L   +   G FSE E RF+  ++I G+ + H   V +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +     
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGTAYD 174

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
             AD +S G  L+ +L G  PF    + KD  +  +  L+V   +PD+   S E + L+ 
Sbjct: 175 SSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPDS--FSPELKSLLE 231

Query: 260 RIFVADPAARITI-----PEIMKHQWF 281
            +   D + R+        E+ +H +F
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFF 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 93.8 bits (233), Expect = 7e-22
 Identities = 70/281 (24%), Positives = 131/281 (46%), Gaps = 24/281 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D  + + ++G GN+G    +  + T   +A+K I    ++DE+   +II    + H    
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRL--ELDESKFNQIIMELDILHKAVS 58

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           P IV F         + + MEY   G   +L+          ED  R     ++ G+ + 
Sbjct: 59  PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 136 -HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
                + HRD+K  N L++G+   ++K+CDFG S  +++ S  K+ +G  +Y+APE +  
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKS 175

Query: 195 HEYDGKI-----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
              +        +DVWS G+++  M +G YP+     P+ +     ++ ++    P T P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP----PETYANIFAQLSAIVDGDPPTLP 231

Query: 250 --ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
              S + +D +++     P  R T  ++++H W +K   AD
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 58/184 (31%), Positives = 103/184 (55%), Gaps = 17/184 (9%)

Query: 94  LAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
           +A+V++YA+ G+L + I +  +    F E EA   F Q++  V + H+  + HRD+K  N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173

Query: 150 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            LL  +    +K+ DFG+SK   ++V     ++  GTP Y+APE+  R  Y  K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230

Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQECRDLISRIFVAD 265
            GV LY +L    PF+     ++  + + + L+ +Y  +P +  IS E +++++ +  +D
Sbjct: 231 LGVLLYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPPS--ISPEMQEIVTALLSSD 284

Query: 266 PAAR 269
           P  R
Sbjct: 285 PKRR 288

Length = 496

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 77/293 (26%), Positives = 134/293 (45%), Gaps = 41/293 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDKIDENVQ----REIINHRSLR 77
           ++Y+ +  +G G++G+    + K T ++VA+K ++E  D  D+ V+    REI   + LR
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 135
           H N+V   EV      L +V E+     L   E+  N     E   R +  Q++ G+ +C
Sbjct: 59  HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFC 116

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
           H+  + HRD+K EN L+  S +  +K+CDFG+++ ++       T  V T  Y APE+L+
Sbjct: 117 HSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLV 173

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPF---EDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
                G+  D+W+ G  +  ML G   F    D D+     K +  ++     +   NP+
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 251 SQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
               R                      DL  +    DP  R +  +++ H++F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 91.9 bits (228), Expect = 3e-21
 Identities = 74/278 (26%), Positives = 123/278 (44%), Gaps = 24/278 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNIVR 83
           +G G FG    ++ K T ++ A K +++       G+K+   +++EI+    +  P IV 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKM-ALLEKEIL--EKVNSPFIVN 57

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCHAMQVC 141
                 + THL +VM   +GG+L   I N G    +  R   +  Q+  G+ + H+M + 
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV 117

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +RD+K EN LLD     RL   D G +             GT  Y+APE+L    Y   +
Sbjct: 118 YRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            D ++ G ++Y M+ G  PF+D  E     +  +R L  +      N  ++E +D+    
Sbjct: 176 -DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQN-FTEESKDICRLF 233

Query: 262 FVADPAARITIPEI----MKHQWF----LKNLPADLVD 291
               P  R+   E      KH++F       L A L+ 
Sbjct: 234 LAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIP 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.4 bits (229), Expect = 4e-21
 Identities = 66/192 (34%), Positives = 100/192 (52%), Gaps = 17/192 (8%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQ---REIINHRSLRHPNIVR 83
           + +IG G+FG      +  T E+VAVK +   G + +E  Q   +E+   + L+HPN + 
Sbjct: 26  LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85

Query: 84  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           +K   L      +VMEY   S  +L E   +     E E        + G++Y H+  + 
Sbjct: 86  YKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
           HRD+K  N LL  +   ++K+ DFG   S+   S   S VGTP ++APEV+L     +YD
Sbjct: 144 HRDIKAGNILL--TEPGQVKLADFG---SASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198

Query: 199 GKIADVWSCGVT 210
           GK+ DVWS G+T
Sbjct: 199 GKV-DVWSLGIT 209

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 91.5 bits (227), Expect = 4e-21
 Identities = 76/252 (30%), Positives = 117/252 (46%), Gaps = 23/252 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNIVR 83
           IG G FG     R   T ++ A+K +++     +  +   +N R +         P IV 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                 TP  L+ +++  +GG+L   +   G FSE E RF+  ++I G+ + H   V +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 144 DLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYD 198
           DLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   YD
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVAYD 174

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
              AD +S G  L+ +L G  PF    + KD  +  +  L++   +PD+   S E R L+
Sbjct: 175 SS-ADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLL 230

Query: 259 SRIFVADPAARI 270
             +   D   R+
Sbjct: 231 EGLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 90.9 bits (225), Expect = 6e-21
 Identities = 70/257 (27%), Positives = 119/257 (46%), Gaps = 22/257 (8%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
           + IG G F         + ++ VA+K ++  + +D   +++ +      + L HPN++++
Sbjct: 8   KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKY 67

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
            +  +    L IV+E A  G+L + I    +      E     +F QL S V + H+ +V
Sbjct: 68  LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRV 127

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
            HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++PE +  +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y+ K +D+WS G  LY M     PF    +  +     Q+I    Y    T   S++ R
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLFSLCQKIEQCDYPPLPTEHYSEKLR 238

Query: 256 DLISRIFVADPAARITI 272
           +L+S     DP  R  I
Sbjct: 239 ELVSMCIYPDPDQRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 90.8 bits (225), Expect = 7e-21
 Identities = 78/270 (28%), Positives = 132/270 (48%), Gaps = 26/270 (9%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNI 81
           + ++ + ++G G FG     ++K T  L A K I+ + ++  E+   EI    S  HPNI
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
           V+  +      +L I++E+ +GG +   +    R  +E + R   +Q +  ++Y H  ++
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKI 124

Query: 141 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL---- 193
            HRDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV++    
Sbjct: 125 IHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180

Query: 194 -RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----N 248
               YD K ADVWS G+TL  M          + P      ++ +L +  S P T    +
Sbjct: 181 KDRPYDYK-ADVWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLAQPS 232

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKH 278
             S E +D + +    +  AR T  ++++H
Sbjct: 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 92.4 bits (229), Expect = 7e-21
 Identities = 85/312 (27%), Positives = 128/312 (41%), Gaps = 67/312 (21%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNI 81
           ++ +G G FG   L     T  L A+K + + D ++ N       +R+I+      +  +
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD--NEWV 63

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+         +L  VM+Y  GG++   +     F E  ARF+  +L   +   H M   
Sbjct: 64  VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123

Query: 142 HRDLKLENTL--LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK----- 178
           HRD+K +N L  LDG     +K+ DFG             Y K S +     +P      
Sbjct: 124 HRDIKPDNILIDLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179

Query: 179 ---------------------------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
                                      S VGTP YIAPEVLLR  Y  ++ D WS GV L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVIL 238

Query: 212 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA--DPAAR 269
           + MLVG  PF  P   +   K I    ++   +P    +S E  DLI+++  +  +   R
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKLCCSAEERLGR 296

Query: 270 ITIPEIMKHQWF 281
               +I  H +F
Sbjct: 297 NGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 90.9 bits (225), Expect = 8e-21
 Identities = 79/280 (28%), Positives = 128/280 (45%), Gaps = 33/280 (11%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +      R K+T+ LVA+K I  E  +       RE+   ++L+H NIV   ++I
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 89  LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
            T   L +V EY    +L + + N G   S    + F  QL+ G+SYCH  ++ HRDLK 
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKP 131

Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
           +N L++      LK+ DFG +++  + ++  S  V T  Y  P+VLL   EY   I D+W
Sbjct: 132 QNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI-DMW 188

Query: 206 SCGVTLYVMLVG--------------------GYPFEDP----DEPKDFRKTIQRILSVQ 241
             G  LY M  G                    G P E+        ++FR  +      Q
Sbjct: 189 GVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQ 248

Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             +     +  +  DL+S + + +  +RI+    ++H +F
Sbjct: 249 PLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 93/354 (26%), Positives = 148/354 (41%), Gaps = 83/354 (23%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGDKIDENVQREIINHRSLR---- 77
           RY+ ++++G G +G+    R+  T   E VA+K      KI     ++I+  R+LR    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIK------KITNVFSKKILAKRALRELKL 54

Query: 78  ------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RICNAG-RFSEDEARFFF 125
                 H NI    ++ I+ P +   +  Y    EL E    +I  +G   ++   + F 
Sbjct: 55  LRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQIIRSGQPLTDAHFQSFI 111

Query: 126 QQLISGVSYCHAMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKS-SVLH--SQPKST 180
            Q++ G+ Y H+  V HRDLK  N L   D      LKICDFG ++  S     +    T
Sbjct: 112 YQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLARGFSENPGENAGFMT 167

Query: 181 --VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF---ED------------ 223
             V T  Y APE++L  +   K  DVWS G  L   L+G  P    +D            
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL-AELLGRKPVFKGKDYVDQLNQILQVL 226

Query: 224 --PDEPKDFRKTIQRILS-----------------VQYSVPDTNPISQECRDLISRIFVA 264
             PDE     +T+ RI S                  +   P+ NP      DL+ ++   
Sbjct: 227 GTPDE-----ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANP---LALDLLEKLLAF 278

Query: 265 DPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 318
           DP  RI++ E ++H +    +  D  DE      ++   +   S++ +  +I E
Sbjct: 279 DPTKRISVEEALEHPYL--AIWHDPDDEPVCQKPFDFSFESEDSMEELRDMIIE 330

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 86/293 (29%), Positives = 126/293 (43%), Gaps = 40/293 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
           + Y  +  +G G++      R K+T +LVA+K I    E G        RE    + L+H
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPF--TAIREASLLKDLKH 62

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHA 137
            NIV   ++I T   L +V EY    +L + + + G   S    R F  QL+ G++YCH 
Sbjct: 63  ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ 121

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RH 195
            +V HRDLK +N L+  S    LK+ DFG +++  + S+  S  V T  Y  P+VLL   
Sbjct: 122 RRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS---------------- 239
           EY   + D+W  G   Y M  G   F    + +D    I R+L                 
Sbjct: 180 EYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238

Query: 240 VQYSVPDTNP-----------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             YS P   P                 +L  +    +P  RI+  E MKH +F
Sbjct: 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 82/298 (27%), Positives = 127/298 (42%), Gaps = 45/298 (15%)

Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSL 76
           H   +Y+ ++ +G G +G+     D+ TKE+VA+K I    +   + QR   EI+  + L
Sbjct: 4   HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQEL 63

Query: 77  R-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISG 131
             HPNIV+   VI       I + +    E  E     +  A    +   R+   QL+  
Sbjct: 64  GDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKA 119

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPA 185
           + Y H+  V HRDLK  N LL+     R+K+ DFG ++S     +          V T  
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177

Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE---------------DPDEPKD- 229
           Y APE+LL      K  D+WS G  L  ML+G   F                 P   +D 
Sbjct: 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237

Query: 230 ------FRKTIQRILSV--QYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKH 278
                 F  T+   L    +  + +  P  S +  DL+ ++ V +P  R+T  E ++H
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 90.8 bits (225), Expect = 2e-20
 Identities = 88/310 (28%), Positives = 126/310 (40%), Gaps = 63/310 (20%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
           ++ +G G FG   L R   TK L A+K + + D +  N    +   R +     +  +VR
Sbjct: 6   IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVR 65

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
                    +L  VM+Y  GG++   +   G F ED ARF+  +L   V   H M   HR
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHR 125

Query: 144 DLKLENTLLD--------------------------GSPAPRLKICDFGYS--------- 168
           D+K +N L+D                               R    DF            
Sbjct: 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRC 185

Query: 169 ---------KSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
                    +++  H +    S VGTP YIAPEVLLR  Y  ++ D WS GV LY MLVG
Sbjct: 186 GDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVG 244

Query: 218 GYPF--EDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVA--DPAARIT 271
             PF  + P E      T  ++++ Q S  +P    +S E  DLI ++     D   +  
Sbjct: 245 QPPFLAQTPLE------TQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNG 298

Query: 272 IPEIMKHQWF 281
             EI  H +F
Sbjct: 299 ADEIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 26/271 (9%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
           ++ ++ + ++G G FG     ++K T  L A K IE   + + E+   EI    +  HP 
Sbjct: 11  NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPY 70

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
           IV+          L I++E+  GG +   +    R  +E + +   +Q++  + Y H+M+
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130

Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL--- 193
           + HRDLK  N LL  DG     +K+ DFG S  +V   Q + S +GTP ++APEV++   
Sbjct: 131 IIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 194 --RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT---- 247
                YD K AD+WS G+TL  M          + P      ++ +L +  S P T    
Sbjct: 187 MKDTPYDYK-ADIWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238

Query: 248 NPISQECRDLISRIFVADPAARITIPEIMKH 278
           +  S E RD +       P  R +  ++++H
Sbjct: 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 82/314 (26%), Positives = 139/314 (44%), Gaps = 52/314 (16%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 123 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPD---------------------EPK-------- 228
             + +D+WS G++L  M +G YP   PD                      P+        
Sbjct: 180 SVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238

Query: 229 -----DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMK 277
                D R  +     + Y V +  P         E +D +++  + +PA R  + ++M 
Sbjct: 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298

Query: 278 HQWFLKNLPADLVD 291
           H  F+K   A+ VD
Sbjct: 299 HA-FIKRSEAEEVD 311

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 24/276 (8%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
           SD ++ +  IG G +G    + +K      AVK ++    IDE ++ E    ++L  HPN
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPN 76

Query: 81  IVRF-----KEVILTPTHLAIVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
           +V+F     K+ +     L +V+E  +GG   +L +     G R  E    +   + + G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAP 189
           + + H  +  HRD+K  N LL  +    +K+ DFG S   +S    +  ++VGTP ++AP
Sbjct: 137 LQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQLTSTRLRR-NTSVGTPFWMAP 193

Query: 190 EVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
           EV+     L   YD +  DVWS G+T   +  G  P  D    +   K I R        
Sbjct: 194 EVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFK-IPRNPPPTLHQ 251

Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
           P+    S E  D I +    D   R T+ ++++H +
Sbjct: 252 PEL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 88.9 bits (220), Expect = 4e-20
 Identities = 79/281 (28%), Positives = 128/281 (45%), Gaps = 33/281 (11%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +      R K+T  LVA+K I  E  +       RE+   + L+H NIV   ++I
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 89  LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
            T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  +V HRDLK 
Sbjct: 74  HTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKP 132

Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
           +N L++      LK+ DFG +++  + ++  S  V T  Y  P++LL   +Y  +I D+W
Sbjct: 133 QNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI-DMW 189

Query: 206 SCGVTLYVMLVGG--YPFEDPDEPKDF---------RKTIQRILS----VQYSVPDTNP- 249
             G   Y M  G   +P    +E   F          +T   ILS      Y+ P     
Sbjct: 190 GVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD 249

Query: 250 --------ISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
                   +  +  +L+S++   +   RI+  E MKH +F 
Sbjct: 250 CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 86/298 (28%), Positives = 136/298 (45%), Gaps = 39/298 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK------YIERGDKIDENVQREIINHRSL 76
           D ++ ++ IG G FG   +++ K T ++ A+K       ++R +      +R+++ +   
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 135
           R   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  RW--ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSV 118

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAP 189
           H +   HRD+K +N LLD +   RL   DFG    S L      T      VGTP YI+P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISP 172

Query: 190 EVLLRHEYDGK-----IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
           E+L   E DGK       D WS GV +Y ML G  PF      + + K +      Q+  
Sbjct: 173 EILQAME-DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP- 230

Query: 245 PDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWF-------LKNLPADLVDE 292
           PD   +S+E +DLI R+ +  P  R+    + +   H +F       ++N  A  V E
Sbjct: 231 PDVTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPE 287

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 88.1 bits (218), Expect = 4e-20
 Identities = 75/265 (28%), Positives = 126/265 (47%), Gaps = 19/265 (7%)

Query: 25  YDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDEN--VQREIINHRSLRHPNI 81
           Y FVR +G G++G   L+R +   K+ V  K   R     E    ++E      L+HPNI
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGVSYCHAM 138
           V ++E        L IVM +  GG+L+ ++    G+   E++   +F Q+   + Y H  
Sbjct: 62  VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRH 195
            + HRDLK +N  L  +    +K+ D G ++  VL +Q     + +GTP Y++PE+    
Sbjct: 122 HILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y+ K +DVW+ G  +Y M    + F      KD    + RI+  +   P     S E  
Sbjct: 178 PYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRIIEGKLP-PMPKDYSPELG 231

Query: 256 DLISRIFVADPAARITIPEIMKHQW 280
           +LI+ +    P  R ++  I++  +
Sbjct: 232 ELIATMLSKRPEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 76/283 (26%), Positives = 131/283 (46%), Gaps = 33/283 (11%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
           +D ++ +  IG G +G    + +K    L AVK ++    +DE ++ E    +SL  HPN
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80

Query: 81  IVRFKEVILTPTHLA-----IVMEYASGG---ELFERICNAG-RFSEDEARFFFQQLISG 131
           +V+F  +      L      +V+E  +GG   EL + +   G R  E    +     + G
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPE 190
           + + H  ++ HRD+K  N LL       +K+ DFG S   +    +  ++VGTP ++APE
Sbjct: 141 LQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198

Query: 191 VL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
           V+       + YD +  DVWS G+T            D D P      ++ +  +  + P
Sbjct: 199 VIACEQQYDYSYDAR-CDVWSLGIT-------AIELGDGDPPLFDMHPVKTLFKIPRNPP 250

Query: 246 DT--NPISQECRD---LISRIFVADPAARITIPEIMKHQWFLK 283
            T  +P  + CR     IS+  + D  AR ++  +++H  F+K
Sbjct: 251 PTLLHP-EKWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 88.9 bits (220), Expect = 5e-20
 Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 35/281 (12%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +      R K+T+ LVA+K I  E  +       RE+   + L+H NIV   +++
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 89  LTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
            T   L +V EY    +L + + + G   S    + F  Q++ G++YCH  +V HRDLK 
Sbjct: 74  HTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKP 132

Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYDGKIADVW 205
           +N L++      LK+ DFG +++  + ++  S  V T  Y  P+VLL   EY  +I D+W
Sbjct: 133 QNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI-DMW 189

Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------------QYSVPDTNP 249
             G   + M   G P       +D    I R+L                   Y+ P   P
Sbjct: 190 GVGCIFFEM-ASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKP 248

Query: 250 ---------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                    +  E  +L+++    +   RI+  E MKH +F
Sbjct: 249 QPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 88.2 bits (219), Expect = 8e-20
 Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 27/283 (9%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRH 78
           D +  + + +IGSG  G    MR K T  ++AVK + R    +EN +R +++       H
Sbjct: 13  DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSH 71

Query: 79  --PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSY 134
             P IV+     +T + + I ME  S    +L +RI   G   ED        ++  + Y
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHY 129

Query: 135 C---HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPE 190
               H   V HRD+K  N LLD S    +K+CDFG S   V  S+ K+ + G  AY+APE
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPE 184

Query: 191 VL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
            +       +YD + ADVWS G++L  +  G +P+++     +F + + +IL  +     
Sbjct: 185 RIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLP 240

Query: 247 TN-PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
            N   S +    +      D   R    E+++H +  +   A+
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 88.5 bits (219), Expect = 9e-20
 Identities = 82/320 (25%), Positives = 144/320 (45%), Gaps = 40/320 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSL 76
           D ++ ++ IG G FG   +++ K T+ + A+K + + + +          +R ++ +   
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYC 135
           +   I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   
Sbjct: 61  QW--ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118

Query: 136 HAMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
           H +   HRD+K +N LLD +   R       LK+   G  +SSV        VGTP YI+
Sbjct: 119 HQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYIS 171

Query: 189 PEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
           PE+L   E      G   D WS GV +Y ML G  PF      + + K +      Q+  
Sbjct: 172 PEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPS 231

Query: 245 PDTNPISQECRDLISRIFVADPA--ARITIPEIMKHQWF-------LKNLPADL---VDE 292
             T+ +S+E +DLI R+  +      +  I +  KH +F       ++NL A     V  
Sbjct: 232 HITD-VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSS 290

Query: 293 KTMSSQYEEPDQPMQSVDVI 312
            + +S ++  D  +++ ++ 
Sbjct: 291 PSDTSNFDVDDDVLRNPEIA 310

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 81/303 (26%), Positives = 125/303 (41%), Gaps = 43/303 (14%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLR 77
           +D Y+ +  +G G++      + KV  +LVA+K I    E G        RE    + L+
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPF--TAIREASLLKGLK 61

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           H NIV   ++I T   L +V EY           + G    +  + F  QL+ G+SY H 
Sbjct: 62  HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE 196
             + HRDLK +N L+  S    LK+ DFG +++  + S   S  V T  Y  P+VLL   
Sbjct: 122 RYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGST 179

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-----------YSVP 245
                 D+W  G     M+ G   F      KD +  ++RI  V            +S+P
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGM---KDIQDQLERIFLVLGTPNEDTWPGVHSLP 236

Query: 246 DTNP------ISQECR-------------DLISRIFVADPAARITIPEIMKHQWFLKNLP 286
              P        +  R             DL S++    P  R++    + H++F  +LP
Sbjct: 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF-SDLP 295

Query: 287 ADL 289
             L
Sbjct: 296 PRL 298

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 84/308 (27%), Positives = 132/308 (42%), Gaps = 56/308 (18%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
           RY     IG G++GV     D  T E VA+K I   + + E+V       REI   R LR
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI---NDVFEHVSDATRILREIKLLRLLR 57

Query: 78  HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
           HP+IV  K ++L P+      + +V E     +L + I      + +  +FF  QL+  +
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIA 188
            Y H   V HRDLK +N L +     +LKICDFG ++ +   +         V T  Y A
Sbjct: 117 KYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 189 PEVL--LRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFEDP-- 224
           PE+      +Y   I D+WS G     +L G                    G P  +   
Sbjct: 175 PELCGSFFSKYTPAI-DIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233

Query: 225 ----DEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
               ++ + +  ++++   V +S   P+ +P++     L+ R+   DP  R T  E +  
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLAL---RLLERLLAFDPKDRPTAEEALAD 290

Query: 279 QWFLKNLP 286
            +F K L 
Sbjct: 291 PYF-KGLA 297

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 84/307 (27%), Positives = 123/307 (40%), Gaps = 61/307 (19%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           D Y+ +  IG G +G     RDK T +LVA+K   R +  +E +     REI   + L  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKT-RLEMDEEGIPPTALREISLLQMLSE 59

Query: 79  -PNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGR-----FSEDEARFFFQQ 127
              IVR  +V           L +V EY    +L + + + GR           + F  Q
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 186
           L+ GV++CH   V HRDLK +N L+D      LKI D G  ++ S+        + T  Y
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIVTLWY 177

Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------ 240
            APEVLL   +     D+WS G     M      F    E       +Q++L +      
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------LQQLLHIFKLLGT 230

Query: 241 --------------------------QYSVPDTNPISQECRDLISRIFVADPAARITIPE 274
                                       +VPD   +S E  DL+ ++   DPA RI+   
Sbjct: 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKA 287

Query: 275 IMKHQWF 281
            + H +F
Sbjct: 288 ALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 82/323 (25%), Positives = 142/323 (43%), Gaps = 47/323 (14%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
           DRY  ++ +GSG +G      D+ T   VA+K + R    +   +   RE+   + ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 80  NIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           N++   +V      L       +VM +   G    ++    + SED  +F   Q++ G+ 
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           Y HA  + HRDLK  N  L  +    LKI DFG ++ +   S+    V T  Y APEV+L
Sbjct: 133 YIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYVVTRWYRAPEVIL 188

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQRILS 239
              +  +  D+WS G  +  ML G   F+  D                K+F + +Q   +
Sbjct: 189 NWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248

Query: 240 VQYS--------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK-N 284
             Y               +P+ NP++    +++ ++ V D  +RIT  E + H +F + +
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAV---NVLEKMLVLDAESRITAAEALAHPYFEEFH 305

Query: 285 LPADLVDEKTMSSQYEEPDQPMQ 307
            P D  +       ++E DQ ++
Sbjct: 306 DPEDETEAPPYDDSFDEVDQSLE 328

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 74/268 (27%), Positives = 119/268 (44%), Gaps = 30/268 (11%)

Query: 28  VRDIGSGNFGVARLMR----DKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
           +R +G G+FG   L      +  T E+VAVK ++R  G +     ++EI   ++L H NI
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 82  VRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           V++K          L ++MEY   G L + +    + +  +   F QQ+  G++Y H+  
Sbjct: 69  VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQH 127

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAY-IAPEVLLRH 195
             HRDL   N LLD      +KI DFG +K+      + + +    +P +  A E L  +
Sbjct: 128 YIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKEN 185

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------------RILSVQYS 243
           ++    +DVWS GVTLY +L      + P  PK F + I              +L     
Sbjct: 186 KF-SYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEMIGPKQGQMTVVRLIELLERGMR 242

Query: 244 VPDTNPISQECRDLISRIFVADPAARIT 271
           +P      QE   L+   +  +   R T
Sbjct: 243 LPCPKNCPQEVYILMKNCWETEAKFRPT 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 11/208 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   ++ K +  ++A K I    +I   ++ +II    + H    
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y    
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            Q+ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 123 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPD 225
             + +D+WS G++L  + +G YP   PD
Sbjct: 180 SVQ-SDIWSMGLSLVELAIGRYPIPPPD 206

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 85.1 bits (210), Expect = 6e-19
 Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 22/254 (8%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRF 84
           + IG G F         +    VA+K ++  D +D   + + I      + L HPN++++
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQV 140
               +    L IV+E A  G+L   I +  +      E     +F QL S + + H+ +V
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRV 127

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
            HRD+K  N  +  +    +K+ D G      SK++  H    S VGTP Y++PE +  +
Sbjct: 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHEN 181

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y+ K +D+WS G  LY M     PF    +  +     ++I    Y    ++  S+E R
Sbjct: 182 GYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238

Query: 256 DLISRIFVADPAAR 269
            L++     DP  R
Sbjct: 239 QLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 80/303 (26%), Positives = 116/303 (38%), Gaps = 46/303 (15%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
             RY  +R +G G+ G+     D    + VAVK I   D    ++  REI   R L H N
Sbjct: 4   GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDN 63

Query: 81  IVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
           IV+  EV+              T L    IV EY         +   G  SE+ AR F  
Sbjct: 64  IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLFMY 121

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVG 182
           QL+ G+ Y H+  V HRDLK  N  ++ +    LKI DFG ++    H   K      + 
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF------------ 230
           T  Y +P +LL      K  D+W+ G     ML G   F    E +              
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240

Query: 231 --RKTIQRILSVQYSVPDTNP----------ISQECRDLISRIFVADPAARITIPEIMKH 278
             R  +  ++          P          ++ E  D + +I   +P  R+T  E + H
Sbjct: 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300

Query: 279 QWF 281
            + 
Sbjct: 301 PYM 303

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 85.5 bits (212), Expect = 8e-19
 Identities = 77/314 (24%), Positives = 131/314 (41%), Gaps = 52/314 (16%)

Query: 26  DFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPN 80
           + +  IG       +  L + K T  LVAVK I       E++   Q+EII  R L+HPN
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60

Query: 81  IVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           I+ +    +  + L +V   M Y S  +L +     G   E    F  + +++ + Y H+
Sbjct: 61  ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPAYIAP 189
               HR +K  + LL G    ++ +    YS        +  V+H  PKS+V    +++P
Sbjct: 120 KGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177

Query: 190 EVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----DFRKTIQRIL----- 238
           EVL +    Y+ K  D++S G+T   +  G  PF+D    +      R T+  +L     
Sbjct: 178 EVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTY 236

Query: 239 ------SVQYSVPDTNPISQECRDLIS-RIFVA------------DPAARITIPEIMKHQ 279
                   Q    + +P +++  D    R F              DP +R +  +++ H 
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS 296

Query: 280 WF--LKNLPADLVD 291
           +F   K     L+D
Sbjct: 297 FFKQCKRRNTSLLD 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 83.8 bits (207), Expect = 1e-18
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 22/220 (10%)

Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +  +  VA+K I+ G   ++    E      L H  +V+   
Sbjct: 8   FLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + IV EY S G      C      E   RF   QL+        G++Y  + Q
Sbjct: 67  VCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ 120

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L+D      +K+ DFG S+  VL  +  S+VG+     +  PEVLL  +
Sbjct: 121 FIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSK 177

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 235
           +  K +DVW+ GV ++ V  +G  P+E  +  +   K  Q
Sbjct: 178 FSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 32/276 (11%)

Query: 28  VRDIGSGNFGVARLMR-----DKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           +RD+G G+FG   L R     D  T E VAVK +  E G     ++++EI   R+L H N
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67

Query: 81  IVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHA 137
           IV++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  +
Sbjct: 68  IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLL 193
            Q  HRDL   N L++     ++KI DFG +K+     +    K  + +P +  APE L+
Sbjct: 128 RQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------------RILSVQ 241
           + ++    +DVWS GVTLY +L   Y   +      F K I             R+L   
Sbjct: 186 QSKF-YIASDVWSFGVTLYELLT--YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242

Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
             +P      +E   L+ + +   P+ R T   +++
Sbjct: 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 66/259 (25%), Positives = 122/259 (47%), Gaps = 25/259 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFKE 86
           +G GN G        +T+ ++AVK I     I   +Q++I++   + +    P I+ F  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 87  VILTPTHLAIVMEYASGGEL--FERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCH 142
                  ++I  E+  GG L  + +I     GR +          ++ G++Y  ++++ H
Sbjct: 67  AFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIA--------VAVVKGLTYLWSLKILH 118

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RD+K  N L++     ++K+CDFG S   V +S  K+ VGT AY+APE +   +Y G  +
Sbjct: 119 RDVKPSNMLVNTRG--QVKLCDFGVSTQLV-NSIAKTYVGTNAYMAPERISGEQY-GIHS 174

Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI---SQECRDLIS 259
           DVWS G++   + +G +P+    + +     +Q +  +    P   P+   S++    I+
Sbjct: 175 DVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234

Query: 260 RIFVADPAARITIPEIMKH 278
           +     P  R     +M H
Sbjct: 235 QCMRKQPKERPAPENLMDH 253

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 83.2 bits (206), Expect = 3e-18
 Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 23/273 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
           D  + + ++G G +GV   MR   T  ++AVK I       E  Q+ +     I+ RS+ 
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVD 58

Query: 78  HPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE--ARFFFQQLISGVS 133
            P  V F   +     + I ME    S  + ++++ + G    ++   +     ++  + 
Sbjct: 59  CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALE 117

Query: 134 YCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE-- 190
           Y H+ + V HRD+K  N L++     ++K+CDFG S   V         G   Y+APE  
Sbjct: 118 YLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERI 175

Query: 191 --VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
              L +  YD K +DVWS G+T+  +  G +P++    P  F++  Q +      +P   
Sbjct: 176 NPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSPQLPA-E 231

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             S E +D +++    +   R   PE+++H +F
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 83.6 bits (206), Expect = 5e-18
 Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 22/273 (8%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIINHRSLRH 78
           ++ ++ IG G FG   +++ K   ++ A+K + + + +          +R+++ +   + 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
             I           +L +VM+Y  GG+L   +     R  ED ARF+  +++  +   H 
Sbjct: 63  --ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRH 195
           +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+PE+L   
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178

Query: 196 EYDGK-----IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           E DGK       D WS GV +Y ML G  PF      + + K +      Q+    T+ +
Sbjct: 179 E-DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTD-V 236

Query: 251 SQECRDLISRIFVADP--AARITIPEIMKHQWF 281
           S++ +DLI R+  +      +  I +  +H +F
Sbjct: 237 SEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 83.5 bits (207), Expect = 6e-18
 Identities = 79/306 (25%), Positives = 124/306 (40%), Gaps = 66/306 (21%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR----- 77
           DRY  +  +GSG +G      D  T   VA+K      K+    Q  I   R+ R     
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK------KLSRPFQSAIHAKRTYRELRLL 68

Query: 78  ----HPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
               H N++   +V    + L       +V     G +L   I    + S+D  +F   Q
Sbjct: 69  KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQ 126

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
           ++ G+ Y H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTGYVATRW 180

Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG--YPFED--------------PDEPKD 229
           Y APE++L   +  +  D+WS G  +  +L G   +P  D              PDE  +
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE--E 238

Query: 230 FRKTIQ--RILSVQYSVPDT------------NPISQECRDLISRIFVADPAARITIPEI 275
             + I      +   S+P              NP++    DL+ ++ V DP  RIT  E 
Sbjct: 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAI---DLLEKMLVLDPDKRITAAEA 295

Query: 276 MKHQWF 281
           + H + 
Sbjct: 296 LAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 38/290 (13%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPN 80
           Y  +  +G G++        ++  +LVA+K I    K +E V     RE    + L+H N
Sbjct: 7   YLNLEKLGEGSYATVYKGISRINGQLVALKVISM--KTEEGVPFTAIREASLLKGLKHAN 64

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV   ++I T   L  V EY         I + G       R F  QL+ G++Y H   +
Sbjct: 65  IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHEYD 198
            HRDLK +N L+  S    LK+ DFG +++  + SQ  S+ V T  Y  P+VLL   +Y 
Sbjct: 125 LHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------VPDTNP- 249
             + D+W  G     ML G   F    +  +  + I  +L V           +P+  P 
Sbjct: 183 SAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPE 241

Query: 250 ----------------ISQ--ECRDLISRIFVADPAARITIPEIMKHQWF 281
                           +S+  +  DL S++ +  P  RI+  + + H +F
Sbjct: 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 53/296 (17%)

Query: 30  DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRFK 85
           ++G+GN GV   +  + +  ++A K I    +I   ++ +II    + H    P IV F 
Sbjct: 8   ELGAGNGGVVTKVLHRPSGLIMARKLIHL--EIKPAIRNQIIRELKVLHECNSPYIVGFY 65

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRD 144
               +   ++I ME+  GG L + +  AGR  E+        ++ G++Y     ++ HRD
Sbjct: 66  GAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRD 125

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
           +K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y  + +D+
Sbjct: 126 VKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHYTVQ-SDI 181

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------YSVPDTNP- 249
           WS G++L  M +G YP   PD      K ++ +                     PD+   
Sbjct: 182 WSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRP 236

Query: 250 ----------------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
                                  S E +D + +    +P  R  + E+ KH +  +
Sbjct: 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 72/334 (21%), Positives = 123/334 (36%), Gaps = 83/334 (24%)

Query: 22  SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDE-----N 65
           S+RY      +G G +G      D +T ++VA+K +          +    +        
Sbjct: 7   SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFT 66

Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 125
             RE+     ++H NI+   +V +    + +VM+  +  +L + +    R +E + +   
Sbjct: 67  TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCIL 125

Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------H 174
            Q+++G++  H     HRDL   N  ++       KI DFG ++                
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDET 183

Query: 175 SQPK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG------------- 217
            Q +    S V T  Y APE+L+  E      D+WS G     +L G             
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243

Query: 218 -------GYPFED---------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
                  G P ED               P +PKD +                   S +  
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPN-------------ASDDAI 290

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKN-LPAD 288
           DL+  +   +P  RI+  E +KH++F  + LP D
Sbjct: 291 DLLQSLLKLNPLERISAKEALKHEYFKSDPLPCD 324

Length = 335

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 81.2 bits (200), Expect = 2e-17
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 18/214 (8%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
           ++ V  +G+G +G     R   T +L A+K ++  +  +E ++ EI +  +   H NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 84  FKEVILT---PTH---LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
           +    +    P H   L +VME+   G + + + N       ED   +  ++++ G+++ 
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
           HA +V HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 138 HAHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 195 HE-----YDGKIADVWSCGVTLYVMLVGGYPFED 223
            E     YD + +D+WS G+T   M  G  P  D
Sbjct: 196 DENPDATYDYR-SDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 81.9 bits (202), Expect = 2e-17
 Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 47/295 (15%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPN 80
           RY  ++ +GSG +G      DK T E VA+K + R    +   +   RE+   + ++H N
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75

Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           ++   +V  +           +VM Y       ++I      SED+ ++   Q++ G+ Y
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKVQYLVYQMLCGLKY 132

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  L  +    LKI DFG ++ +   ++    V T  Y APEV+L 
Sbjct: 133 IHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILN 188

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--------------------------EPK 228
             +  +  D+WS G  +  ML G   F+  D                            K
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248

Query: 229 DFRKTIQRILSVQYSV--PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            + K++ +     +S   P  +P +    DL+ ++   D   R+T  E ++H +F
Sbjct: 249 SYIKSLPKYPRKDFSTLFPKASPQAV---DLLEKMLELDVDKRLTATEALEHPYF 300

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 80.3 bits (198), Expect = 3e-17
 Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 10/201 (4%)

Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++GSG FGV  L + +   + VA+K I  G   +E+   E      L HP +V+   
Sbjct: 8   FMKELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 87  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           V      L IV E+   G L   +    G+ S+D      Q +  G+ Y       HRDL
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
              N L+  S    +K+ DFG ++  VL  +  S+ G      +  PEV    +Y  K +
Sbjct: 127 AARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK-S 182

Query: 203 DVWSCGVTLY-VMLVGGYPFE 222
           DVWS GV ++ V   G  PFE
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 80.6 bits (199), Expect = 3e-17
 Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 21/201 (10%)

Query: 27  FVRDIGSGNFGVARLMR-DKV---TKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
           F++ +G GNFG   L R D +   T E+VAVK ++        + +REI   +SL+H NI
Sbjct: 8   FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67

Query: 82  VRFKEVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           V++K V  +    +L +VMEY   G L +    +  R    +   +  Q+  G+ Y  + 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPA-----YIAPEV 191
           +  HRDL   N L++     R+KI DFG +K   +  Q K    V  P      + APE 
Sbjct: 128 RYVHRDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEYYKVREPGESPIFWYAPES 182

Query: 192 LLRHEYDGKIADVWSCGVTLY 212
           L   ++    +DVWS GV LY
Sbjct: 183 LTESKFS-VASDVWSFGVVLY 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.6 bits (196), Expect = 6e-17
 Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 21/270 (7%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
           R +G G FG     + + T ++ A K +E+       G+ +  N +++I+   + +   +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQF--V 62

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
           V       T   L +V+   +GG+L   I N G   F E+ A F+  +++ G+   H   
Sbjct: 63  VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN 122

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
             +RDLK EN LLD      ++I D G +         +  VGT  Y+APEVL    Y  
Sbjct: 123 TVYRDLKPENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-T 179

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
              D W  G  +Y M+ G  PF    E     +  +R+L  +     +   S+E + +  
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY--SAKFSEEAKSICK 237

Query: 260 RIFVADPAARITIPE----IMKHQWFLKNL 285
            +   DP  R+   E     +K   F +N+
Sbjct: 238 MLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 57/305 (18%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VAVK + R  +   + +R   E++  + + H N
Sbjct: 22  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81

Query: 81  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
           I+    V  TP         + +VME          +C       D  R  +   Q++ G
Sbjct: 82  IISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQMLCG 135

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEV 193

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  ++ G   F+  D    + K I+++              
Sbjct: 194 ILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT 252

Query: 238 -------------LSVQYSVPD---------TNPISQECRDLISRIFVADPAARITIPEI 275
                        +S +   PD             + + RDL+S++ V DP  RI++ E 
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312

Query: 276 MKHQW 280
           ++H +
Sbjct: 313 LRHPY 317

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 79.3 bits (195), Expect = 9e-17
 Identities = 69/253 (27%), Positives = 115/253 (45%), Gaps = 21/253 (8%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQREIINHRSLRHPNI 81
           R +G G FG     + + T ++ A K +E+       G+ +  N +++I+   + R   +
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSRF--V 62

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ 139
           V       T   L +V+   +GG+L   I + G   F E  A F+  ++  G+   H  +
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER 122

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           + +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y  
Sbjct: 123 IVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDL 257
              D W+ G  LY M+ G  PF+   + K  R+ ++R++     V +  +   S + R L
Sbjct: 181 S-PDWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVK---EVQEEYSEKFSPDARSL 235

Query: 258 ISRIFVADPAARI 270
              +   DP  R+
Sbjct: 236 CKMLLCKDPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 79.7 bits (197), Expect = 9e-17
 Identities = 75/320 (23%), Positives = 118/320 (36%), Gaps = 77/320 (24%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
             Y+ +  +G G FG     R   T  +VA+K I    E+ D       REI   + L+H
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKH 66

Query: 79  PNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICNAGRFSEDEARFF 124
           PN+V   ++ +            + +V  Y     SG  L E   +    + +E + + +
Sbjct: 67  PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV----KLTESQIKCY 120

Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK------ 178
             QL+ G++Y H   + HRD+K  N L+D      LKI DFG ++       P       
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--PYDGPPPNPKGGG 176

Query: 179 --------STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG------------- 217
                   + V T  Y  PE+LL         D+W  G     M                
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 218 -------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
                  G P E+        P  E         R L  ++       +  E  DL+S++
Sbjct: 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG-----KLGPEGLDLLSKL 291

Query: 262 FVADPAARITIPEIMKHQWF 281
              DP  R+T  + ++H +F
Sbjct: 292 LSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 36/286 (12%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 79
           R +G G FG     + + T ++ A K +E+       G+ +  N ++  E +N R     
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF---- 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
            +V       T   L +V+   +GG+L   I N G   F E+ A F+  ++  G+   H 
Sbjct: 62  -VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR 120

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
            ++ +RDLK EN LLD      ++I D G +   +   +  +  VGT  Y+APEV+    
Sbjct: 121 ERIVYRDLKPENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNER 177

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDTNPISQEC 254
           Y     D W  G  +Y M+ G  PF    E     +  +R+   Q  YS       S+  
Sbjct: 178 Y-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS----EKFSEAA 232

Query: 255 RDLISRIFVADPAARI-----TIPEIMKHQWF----LKNLPADLVD 291
           R +  ++   DP  R+        E+  H +F     K L A +++
Sbjct: 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLE 278

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 78/298 (26%), Positives = 124/298 (41%), Gaps = 50/298 (16%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSLR--- 77
           +Y+ V +IG G +G     RD  +   VA+K +      D +  +  RE+   + L    
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60

Query: 78  HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 130
           HPNIVR  +V  T      T + +V E+         +++   G    +  +   +Q + 
Sbjct: 61  HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119

Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
           G+ + HA  + HRDLK EN L+  +   ++K+ DFG ++           V T  Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177

Query: 191 VLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPFEDPDEPKD- 229
           VLL+  Y   + D+WS G     M                     + G P ED D P+D 
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED-DWPRDV 235

Query: 230 ------FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                 F     R   VQ  VP+   I +    L+  +   +P  RI+    ++H +F
Sbjct: 236 TLPRGAFSPRGPR--PVQSVVPE---IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 76/305 (24%), Positives = 129/305 (42%), Gaps = 57/305 (18%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84

Query: 81  IVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISG 131
           I+    V  TP         + IVME          +C   +   D  R  +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCG 138

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  M+ GG  F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 255

Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                         S +   PD         N + + + RDL+S++ V D + RI++ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315

Query: 276 MKHQW 280
           ++H +
Sbjct: 316 LQHPY 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.2 bits (192), Expect = 2e-16
 Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 30/273 (10%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
           ++ V  +G+G +G     R   T +L A+K ++     +E +++EI +  +   H NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 84  FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
           +    +          L +VME+   G + + I N       E+   +  ++++ G+S+ 
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
           H  +V HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 128 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 195 HE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF----RKTIQRILSVQYSVP 245
            E     YD K +D+WS G+T   M  G  P  D    +      R    R+ S ++   
Sbjct: 186 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW--- 241

Query: 246 DTNPISQECRDLISRIFVADPAARITIPEIMKH 278
                S++ +  I    V + + R T  ++MKH
Sbjct: 242 -----SKKFQSFIESCLVKNHSQRPTTEQLMKH 269

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 10/208 (4%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
                  V++IGSG FG+  L    + K  VA+K I  G   +E+   E      L HP 
Sbjct: 2   HPSELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V    + + +V E+   G L + +    G+FS++        +  G++Y  +  
Sbjct: 61  LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
           V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV    +
Sbjct: 121 VIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 178 YSSK-SDVWSFGVLMWEVFSEGKTPYEN 204

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 48/156 (30%), Positives = 85/156 (54%), Gaps = 10/156 (6%)

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGV 132
           +++ HP+++R K+ +++     +V+ + S  +L+  +   +     D+A    +Q++ G+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGL 170

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            Y HA ++ HRD+K EN  ++     ++ I D G ++  V+        GT    APEVL
Sbjct: 171 RYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL 228

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYP---FEDPD 225
            R +Y+ K AD+WS G+ L+ ML   YP   FEDP 
Sbjct: 229 ARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDPP 261

Length = 357

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 81/314 (25%), Positives = 133/314 (42%), Gaps = 68/314 (21%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------REIINHRSLR 77
           RY  ++ IGSG  G+     D VT + VA+K + R     +NV       RE++  + + 
Sbjct: 17  RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF---QNVTHAKRAYRELVLMKLVN 73

Query: 78  HPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQL 128
           H NI+    V  TP         + +VME   A+  ++ +   +  R S     +   Q+
Sbjct: 74  HKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQM 127

Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
           + G+ + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y A
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRA 185

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR--------ILSV 240
           PEV+L   Y   + D+WS G  +  M+ G   F   D    + K I++        +  +
Sbjct: 186 PEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244

Query: 241 QYSV-------------------PDTN-PISQE---------CRDLISRIFVADPAARIT 271
           Q +V                   PD   P   E          RDL+S++ V DP  RI+
Sbjct: 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS 304

Query: 272 IPEIMKH----QWF 281
           + + ++H     W+
Sbjct: 305 VDDALQHPYINVWY 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 77.1 bits (190), Expect = 3e-16
 Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 10/201 (4%)

Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++GSG FGV  L + +  K  VA+K I  G   +++   E      L HPN+V+   
Sbjct: 8   FLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 87  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           V      + IV EY + G L   +    G+   +        +   + Y  +    HRDL
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDL 126

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKIA 202
              N L+       +K+ DFG ++  VL  Q  S+ GT   +    PEV     +  K +
Sbjct: 127 AARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK-S 182

Query: 203 DVWSCGVTLYVMLVGG-YPFE 222
           DVWS GV ++ +   G  P+E
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 76/292 (26%), Positives = 116/292 (39%), Gaps = 51/292 (17%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
           R IG G FGV   + D    + VA+K +     + +N      V RE+      +H N++
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMP---NVFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 83  RFKEVILTPTHLAIVMEYASGGELFER-----ICNAGRFSEDEARFFFQQLISGVSYCHA 137
              + IL P H+    E     EL +      I +    S D  + F  Q++ G+ Y H+
Sbjct: 63  SALD-ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL-- 193
             + HRD+K  N L++ +    LKICDFG ++          T  V T  Y APE+L+  
Sbjct: 122 AGILHRDIKPGNLLVNSN--CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFE----------------DPDEPKDFRK----T 233
           RH Y   + D+WS G     +L     F+                 P   +  R      
Sbjct: 180 RH-YTSAV-DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL-EAMRSACEGA 236

Query: 234 IQRILSVQYSVPDTN-------PISQECRDLISRIFVADPAARITIPEIMKH 278
              IL   +  P            + E   L+ R+ V DP  RI+  + + H
Sbjct: 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 76.3 bits (188), Expect = 7e-16
 Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 28/211 (13%)

Query: 30  DIGSGNFGVARLMRDKVTKEL-----VAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
            +G G+FGV R  R + +        VAVK   + DK+ + +    +E     SL H N+
Sbjct: 2   KLGDGSFGVVR--RGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
           +R   V+LT   L +V E A  G L +R+  +A G F       +  Q+ +G+ Y  + +
Sbjct: 59  IRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTP-AYIAPEVLL 193
             HRDL   N LL  +   ++KI DFG  ++   +      +    V  P A+ APE  L
Sbjct: 118 FIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES-L 172

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
           R       +DVW  GVTL+ M   G   E+P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYG---EEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 66/253 (26%), Positives = 108/253 (42%), Gaps = 21/253 (8%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIER-------GDKIDENVQR--EIINHRSLRHP 79
           R +G G FG     + + T ++ A K +E+       G+ +  N +R  E +N R     
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF---- 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
            +V       T   L +V+   +GG+L   I N G   F E  A F+  +L  G+     
Sbjct: 62  -VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ +RDLK EN LLD      ++I D G +         +  VGT  Y+APEV+   +Y
Sbjct: 121 ERIVYRDLKPENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
                D W  G  +Y M+ G  PF    E     +  +R+   Q     +   S++ + +
Sbjct: 179 TFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY--SEKFSEDAKSI 235

Query: 258 ISRIFVADPAARI 270
              +   +P  R+
Sbjct: 236 CRMLLTKNPKERL 248

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 18/207 (8%)

Query: 29  RDIGSGNFGVAR--LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRS----LRHPNI 81
           +++G GNFG     +   K  KE+ VAVK +++ + I    ++E +   S    L HP I
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ-EHIAAG-KKEFLREASVMAQLDHPCI 58

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           VR   V      L +VME A  G L + +         + +    Q+  G++Y  +    
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEVLLRHEY 197
           HRDL   N LL      + KI DFG S++        ++T     P  + APE +   ++
Sbjct: 118 HRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 198 DGKIADVWSCGVTLYVML-VGGYPFED 223
             K +DVWS GVTL+     G  P+ +
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 75.9 bits (186), Expect = 2e-15
 Identities = 74/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ E ++H +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 77/317 (24%), Positives = 128/317 (40%), Gaps = 59/317 (18%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76

Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 77  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 135

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 136 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 189

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
           L   +  +  D+WS G  +  +L G   F   D   D  K I R++    +       S+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELLKKISSE 248

Query: 253 ECR--------------------------DLISRIFVADPAARITIPEIMKHQWFLKNLP 286
             R                          DL+ ++ V D   RIT  + + H +F     
Sbjct: 249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF----- 303

Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 304 ----------AQYHDPD 310

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 69/251 (27%), Positives = 108/251 (43%), Gaps = 19/251 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           IG G FG   +M      + VAVK ++      +    E     +LRHPN+V+   V+L 
Sbjct: 14  IGKGEFG--DVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 91  PTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
              L IV EY + G L + + + GR   +  +   F   +  G+ Y       HRDL   
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR 131

Query: 149 NTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSC 207
           N L+        K+ DFG +K +       K  V    + APE L   ++  K +DVWS 
Sbjct: 132 NVLVSEDLVA--KVSDFGLAKEASQGQDSGKLPV---KWTAPEALREKKFSTK-SDVWSF 185

Query: 208 GVTLY-VMLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
           G+ L+ +   G  P+  P  P KD    +++    +   P+  P   E   ++   +  D
Sbjct: 186 GILLWEIYSFGRVPY--PRIPLKDVVPHVEK--GYRMEAPEGCP--PEVYKVMKDCWELD 239

Query: 266 PAARITIPEIM 276
           PA R T  ++ 
Sbjct: 240 PAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 76/321 (23%), Positives = 131/321 (40%), Gaps = 67/321 (20%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D   ++ VAVK + R  +         RE+   + ++H 
Sbjct: 15  ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74

Query: 80  NIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V    T +    E        G +L   I    + S++  +F   QL+ G+ Y
Sbjct: 75  NVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQFLIYQLLRGLKY 133

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L 
Sbjct: 134 IHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVATRWYRAPEIMLN 189

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------------- 240
             +  +  D+WS G  +  +L G   F       D+   ++RI+ V              
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKALFPG----NDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 241 ----QY--SVP------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
               +Y  S+P              NP++    DL+ ++ V D   RI+  E + H +F 
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAI---DLLEKMLVLDSDKRISASEALAHPYF- 301

Query: 283 KNLPADLVDEKTMSSQYEEPD 303
                         SQY +P+
Sbjct: 302 --------------SQYHDPE 308

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 75.3 bits (185), Expect = 8e-15
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 6/146 (4%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
           V+ I  G FG   L R K   +L AVK +++ D I++N+  ++   R      + P IV 
Sbjct: 9   VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
               + +  ++ +VMEY  GG++   +   G F E+ A  +  ++   + Y H   + HR
Sbjct: 69  LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHR 128

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK 169
           DLK +N L+  S    +K+ DFG SK
Sbjct: 129 DLKPDNMLI--SNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 73.6 bits (181), Expect = 9e-15
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 30/210 (14%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
           IG G FG    M  K +  ++AVK I R    ++  +R +++     RS   P IV+F  
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 87  VILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 135
            +       I ME    S  + ++ +    +          ++++  ++           
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 193
             +++ HRD+K  N LLD +    +K+CDFG S   V  S  K+   G   Y+APE +  
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERIDP 181

Query: 194 --RHEYDGKIADVWSCGVTLYVMLVGGYPF 221
             R  YD + +DVWS G+TLY +  G +P+
Sbjct: 182 SARDGYDVR-SDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 74.0 bits (182), Expect = 3e-14
 Identities = 85/334 (25%), Positives = 131/334 (39%), Gaps = 75/334 (22%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR------ 77
           RYD +R IG G  G   L  D V    VA+K I R D  +      ++  R LR      
Sbjct: 3   RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSEN----PLLKKRFLREAKIAA 57

Query: 78  ---HPNIVRFKEVILTPTHLAIVMEYASG---GELFERICNAGRFSEDEAR------FF- 124
              HP IV    +      +   M Y  G     L + +      S++ A       F  
Sbjct: 58  DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117

Query: 125 -FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------Y 167
            F ++ + + Y H+  V HRDLK +N LL       + I D+G                 
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175

Query: 168 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
            + ++ +S    P   VGTP Y+APE LL         D+++ GV LY ML   +P+   
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR- 233

Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPIS--QECRDLISRI----FVADPAARIT-----IP 273
              K  RK     +S +  +     ++  +E    +S+I       DPA R +       
Sbjct: 234 ---KKGRK-----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285

Query: 274 EIMKH-----QWFLKNLPADLVDEKTMSSQYEEP 302
           ++  H     +W +K   A L+ +K    ++ EP
Sbjct: 286 DLEPHLQGSPEWTVK---ATLMTKKKSCWKFYEP 316

Length = 932

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 72.0 bits (176), Expect = 8e-14
 Identities = 52/194 (26%), Positives = 91/194 (46%), Gaps = 18/194 (9%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           R + S N G  +       + L+A K ++ G +    ++ EI+    L H NI++ +E++
Sbjct: 180 RGVNSTNQGKPK------CERLIA-KRVKAGSRAAIQLENEILALGRLNHENILKIEEIL 232

Query: 89  LTPTHLAIVMEYASGGELFERICNAGRFSED-----EARFFFQQLISGVSYCHAMQVCHR 143
            +  +  ++ +     +L+  + +     +D     + R   +QL+  V Y H  ++ HR
Sbjct: 233 RSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHR 291

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKI 201
           D+KLEN  L+      L   DFG +       +      VGT A  +PE+L    Y  +I
Sbjct: 292 DIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEI 348

Query: 202 ADVWSCGVTLYVML 215
            D+WSCG+ L  ML
Sbjct: 349 TDIWSCGLILLDML 362

Length = 501

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 83/314 (26%), Positives = 130/314 (41%), Gaps = 68/314 (21%)

Query: 31  IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
           +G G +G    A+    K  KE  A+K IE G  I  +  REI   R L+HPN++  ++V
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEY-ALKQIE-GTGISMSACREIALLRELKHPNVIALQKV 66

Query: 88  ILTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHA 137
            L+ +   + ++ +YA         F R   A +          +    Q++ G+ Y HA
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126

Query: 138 MQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIA 188
             V HRDLK  N L+  +G    R+KI D G+++   L + P          V T  Y A
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRA 183

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVML-----------------------------VGGY 219
           PE+LL   +  K  D+W+ G     +L                             V G+
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF 243

Query: 220 P----FED----PDEP---KDFRKTIQRILS-VQYSVPDTNPISQECRDLISRIFVADPA 267
           P    +ED    P+ P   KDFR+T     S ++Y          +   L+ ++   DP 
Sbjct: 244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPT 303

Query: 268 ARITIPEIMKHQWF 281
            RIT  + ++  +F
Sbjct: 304 KRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 76/302 (25%), Positives = 122/302 (40%), Gaps = 72/302 (23%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           IG+G+FGV        T E VA+K + +  +      RE++  ++L H NI+  K+   T
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---NRELLIMKNLNHINIIFLKDYYYT 130

Query: 91  PT--------HLAIVMEYASGG-----ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
                      L +VME+         + + R  N         + +  QL   ++Y H+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS 188

Query: 138 MQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
             +CHRDLK +N L+D    P    LK+CDFG +K+ +   +  S + +  Y APE++L 
Sbjct: 189 KFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244

Query: 195 HEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED----------- 223
                   D+WS G  +  M++G                    G P ED           
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD 304

Query: 224 ---PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 279
              PD +PKD +K            P   P   +  + IS+    +P  R+   E +   
Sbjct: 305 IKFPDVKPKDLKKVF----------PKGTP--DDAINFISQFLKYEPLKRLNPIEALADP 352

Query: 280 WF 281
           +F
Sbjct: 353 FF 354

Length = 440

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 67.8 bits (166), Expect = 5e-13
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 19/204 (9%)

Query: 29  RDIGSGNFG-VAR-LMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFK 85
           R +GSG FG V   L +++V    VA+K ++  D +  ++ Q+E+   + LRH +++   
Sbjct: 12  RKLGSGYFGEVWEGLWKNRVR---VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLF 68

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHR 143
            V      + I+ E    G L   + +        A       Q+  G++Y       HR
Sbjct: 69  AVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128

Query: 144 DLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           DL   N L+        K+ DFG +   K  V L S  K       + APE      +  
Sbjct: 129 DLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGTFST 183

Query: 200 KIADVWSCGVTLY-VMLVGGYPFE 222
           K +DVWS G+ LY +   G  P+ 
Sbjct: 184 K-SDVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 82/301 (27%), Positives = 122/301 (40%), Gaps = 56/301 (18%)

Query: 27  FVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERG--DKIDENVQR 68
           FV  +G G FG   L     ++D   K            LVAVK +     D   E+  +
Sbjct: 9   FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68

Query: 69  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICNAGRFS 117
           E+     L  PNI R   V      L ++MEY   G+L  F +          CN+   S
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 177
                +   Q+ SG+ Y  ++   HRDL   N L+       +KI DFG S++  L+S  
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN--LYSSD 184

Query: 178 KSTVG--TPAYI---APEVLLRHEYDGKIADVWSCGVTLY--VMLVGGYPFED-PDEP-- 227
              V    P  I   A E +L  ++  K +DVW+ GVTL+  + L    P+E   D+   
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVI 243

Query: 228 ----KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
                 FR   ++I      +P      ++  +L+   +  D   R T  EI  H  FL+
Sbjct: 244 ENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HL-FLQ 295

Query: 284 N 284
            
Sbjct: 296 R 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 67.3 bits (165), Expect = 8e-13
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)

Query: 28  VRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
            R +G+G FG V     +  TK  VAVK ++ G    E   +E    + LRH  +V+   
Sbjct: 11  ERKLGAGQFGEVWMGTWNGTTK--VAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI-------SGVSYCHAM 138
           V      + IV EY S G L + +         E +     QL+        G++Y  + 
Sbjct: 69  VCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP-AYIAPEVLLR 194
              HRDL   N L+  +     KI DFG ++  ++       +     P  + APE    
Sbjct: 123 NYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANY 178

Query: 195 HEYDGKIADVWSCGVTLYVMLVGG---YP 220
             +  K +DVWS G+ L  ++  G   YP
Sbjct: 179 GRFTIK-SDVWSFGILLTEIVTYGRVPYP 206

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYI-----ERGDKIDENVQREIINH-RSL 76
           +Y+ V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61

Query: 77  RHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLI 129
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 120

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
            G+ + H+ +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178

Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML 215
           EVLL+  Y   + D+WS G     M 
Sbjct: 179 EVLLQSSYATPV-DLWSVGCIFAEMF 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 71/246 (28%), Positives = 104/246 (42%), Gaps = 25/246 (10%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IG G FG   +++ + T + VAVK I    K D   Q    E      L H N+VR   V
Sbjct: 14  IGEGEFGA--VLQGEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDL 145
           IL    L IVME  S G L   +   GR      +   F   +  G+ Y  + ++ HRDL
Sbjct: 68  ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADV 204
              N L+  S     K+ DFG ++   + S        P  + APE L   ++  K +DV
Sbjct: 127 AARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEALKHKKFSSK-SDV 180

Query: 205 WSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263
           WS GV L+ V   G  P+     PK   K ++  +   Y +        +   L++  + 
Sbjct: 181 WSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWE 235

Query: 264 ADPAAR 269
            +P  R
Sbjct: 236 TEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 66/248 (26%), Positives = 103/248 (41%), Gaps = 19/248 (7%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
           IG GNFG     R +     VAVK     + +  +++ + +      +   HPNIVR   
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 87  VILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           V      + IVME   GG+    +   G R    E     +   +G+ Y  +    HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLRHEYDGKIA 202
              N L+       LKI DFG S+     +++        P  + APE L    Y  + +
Sbjct: 121 AARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE-S 177

Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           DVWS G+ L+    +G  P+ +    +  R+ I++   V+   P+  P       L+ R 
Sbjct: 178 DVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCPELCP--DAVYRLMERC 232

Query: 262 FVADPAAR 269
           +  DP  R
Sbjct: 233 WEYDPGQR 240

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 65.3 bits (159), Expect = 4e-12
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 24/219 (10%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR 77
           D+      + IG+G FG     R K+   +E+ VA+K ++ G    E  +R+ ++  S+ 
Sbjct: 2   DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG--YTEKQRRDFLSEASIM 59

Query: 78  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 131
               HPNI+  + V+     + IV EY   G L  F R  + G+F+  +     + + SG
Sbjct: 60  GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASG 118

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
           + Y   M   HRDL   N L++ +     K+ DFG S+  VL   P++   T        
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIR 174

Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
           + APE +   ++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 35/214 (16%)

Query: 31  IGSGNFG---VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
           IG G FG     RL      +  VA+K ++ G  DK   +   E        HPNI+R +
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI-------SGVSYCH 136
            V+     + I+ EY   G L  F R        E++ +F   QL+       SG+ Y  
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-----PA-YIAPE 190
            M   HRDL   N L++ +     K+ DFG S+   L    ++T  T     P  + APE
Sbjct: 124 EMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKIPIRWTAPE 178

Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
             + +      +DVWS G+ ++ VM  G  P+ D
Sbjct: 179 A-IAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 80/313 (25%), Positives = 126/313 (40%), Gaps = 66/313 (21%)

Query: 31  IGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +G     + K  K+    A+K IE G  I  +  REI   R L+HPN++  ++V 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 89  LTPT--HLAIVMEYASGGEL----FERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
           L+     + ++ +YA         F R   A +          +    Q++ G+ Y HA 
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP-------KSTVGTPAYIAP 189
            V HRDLK  N L+  +G    R+KI D G+++   L + P          V T  Y AP
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFNSPLKPLADLDPVVVTFWYRAP 184

Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML-----------------------------VGGYP 220
           E+LL   +  K  D+W+ G     +L                             V G+P
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244

Query: 221 ----FED----PDEP---KDFRKTIQRILS-VQYSVPDTNPISQECRDLISRIFVADPAA 268
               +ED    P+     KDFR+      S ++Y          +   L+ ++   DP  
Sbjct: 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 304

Query: 269 RITIPEIMKHQWF 281
           RIT  + M+  +F
Sbjct: 305 RITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 53/186 (28%), Positives = 75/186 (40%), Gaps = 17/186 (9%)

Query: 47  TKELVAVKYIERGDKIDE-----NVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY 100
           T   VA+K + R D  +E       +RE      L HPNIV         P  L  V EY
Sbjct: 2   TGHEVAIKLL-RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APR 159
             G  L E +   G     E      Q++  ++  H   + HRDLK +N ++  +   P 
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 160 LKICDFGYSK-----SSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTL 211
            K+ DFG             +    T   +GTP Y APE  LR E     +D+++ G+  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAWGLIF 179

Query: 212 YVMLVG 217
              L G
Sbjct: 180 LECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 72/272 (26%), Positives = 106/272 (38%), Gaps = 48/272 (17%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFK 85
             IG GNFG       K     VAVK   R     +  ++ +     L    HPNIV+  
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
            V +    + IVME   GG L   +       + + R   ++L+       +G+ Y  + 
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAAAGMEYLESK 112

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KSTVGTPAYIA 188
              HRDL   N L+  +    LKI DFG         Y+ S  L   P K T       A
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKWT-------A 163

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVP 245
           PE L    Y  + +DVWS G+ L+     G   YP     + ++  ++  R+       P
Sbjct: 164 PEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-----PAP 217

Query: 246 DTNPISQECRDLISRIFVADPAARITIPEIMK 277
              P  +E   L+ + +  DP  R +  EI  
Sbjct: 218 QLCP--EEIYRLMLQCWAYDPENRPSFSEIYN 247

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 57/193 (29%), Positives = 90/193 (46%), Gaps = 15/193 (7%)

Query: 30  DIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           ++GSGNFG  +  + + K +++ VAVK I + D  D  ++ E++      + L +P IVR
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
               I       +VME A  G L + +      +E        Q+  G+ Y       HR
Sbjct: 61  MIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDG 199
           DL   N LL        KI DFG SK   +   + + K+    P  + APE +  +++  
Sbjct: 120 DLAARNVLL--VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177

Query: 200 KIADVWSCGVTLY 212
           K +DVWS GV ++
Sbjct: 178 K-SDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 21/214 (9%)

Query: 24  RYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----R 74
             + ++ +GSG FG     V     +KV K  VA+K +   ++      +EI++      
Sbjct: 8   ELEKIKVLGSGAFGTVYKGVWIPEGEKV-KIPVAIKVLR--EETSPKANKEILDEAYVMA 64

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 133
           S+ HP++VR   + L+     ++ +    G L + +  +           +  Q+  G+S
Sbjct: 65  SVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPE 190
           Y    ++ HRDL   N L+  +P   +KI DFG +K   V   +  +  G  P  ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
            +L   Y  K +DVWS GVT++ +M  G  P+E 
Sbjct: 182 SILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 22/208 (10%)

Query: 31  IGSGNFG-VAR-LMRDKVTKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           IG+G FG V R +++    KE+ VA+K ++ G    E  +++ ++  S+     H NI+R
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG--YTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 84  FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + V+       I+ EY   G L + +  + G FS  +     + + +G+ Y   M   H
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVH 130

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHE 196
           RDL   N L++ +     K+ DFG S+  VL   P+ T  T        + APE +   +
Sbjct: 131 RDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +    +DVWS G+ ++ VM  G  P+ D
Sbjct: 187 FTSA-SDVWSFGIVMWEVMSFGERPYWD 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)

Query: 31  IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
           IG+G FG     RL      +  VA+K ++ G    E  +R+ ++  S+     HPNI+ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLSEMNYV 128

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 193
           HRDL   N L++ +     K+ DFG S+   L         T +        + APE + 
Sbjct: 129 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184

Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
             ++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 185 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 64/278 (23%), Positives = 107/278 (38%), Gaps = 49/278 (17%)

Query: 29  RDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRHP 79
           R++G G+FG     +A+ +     +  VA+K +     + E    E +N  S        
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCH 69

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF--------FFQ--- 126
           ++VR   V+ T     +VME  + G+L  + R     R   +            F Q   
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQKFIQMAA 126

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P 184
           ++  G++Y  A +  HRDL   N ++       +KI DFG ++        +       P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 185 A-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDF---RKTIQRI 237
             ++APE L    +  K +DVWS GV L+ M       Y     +E   F      +   
Sbjct: 185 VRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDL- 242

Query: 238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 275
                  P+  P   +  +L+   +  +P  R T  EI
Sbjct: 243 -------PENCP--DKLLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 37/278 (13%)

Query: 27  FVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
             R++G G FG   L     +  +  KELVAVK ++    +   ++ +RE     + +H 
Sbjct: 9   LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERI--------------CNAGRFSEDEARFFF 125
           NIV+F  V        +V EY   G+L + +                 G  +  +     
Sbjct: 69  NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
            Q+ SG+ Y  +    HRDL   N L+       +KI DFG S+   +++     VG   
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSRD--VYTTDYYRVGGHT 184

Query: 186 -----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILS 239
                ++ PE ++  ++  + +DVWS GV L+ +   G  P+      +      Q  L 
Sbjct: 185 MLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL 243

Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            +   P T P   E  D++   +  DP  RI I +I +
Sbjct: 244 QR---PRTCP--SEVYDIMLGCWKRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 28/214 (13%)

Query: 31  IGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRFK 85
           IG G  +     L R K T E V V+ I      +E V   Q E+   +   HPNIV ++
Sbjct: 6   IGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYR 65

Query: 86  EVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    L +V  + + G   + IC       SE    +  Q ++  + Y H M   HR
Sbjct: 66  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHR 125

Query: 144 DLKLENTL--LDGSPAPRLKICDFGY----------SKSSVLHSQPKSTVGTPAYIAPEV 191
            +K  + L  +DG      K+   G            +  V+H  PK +V    +++PEV
Sbjct: 126 SVKASHILISVDG------KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEV 179

Query: 192 LLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 223
           L ++   YD K +D++S G+T   +  G  PF+D
Sbjct: 180 LQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 18/205 (8%)

Query: 30  DIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKIDENVQREIINHRSLRH----PNIVR 83
           ++GSGNFG  +    K+ K+   VA+K ++  +  +++V+ E++    + H    P IVR
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVR 59

Query: 84  FKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
              V      L +VME ASGG L + +       +         Q+  G+ Y       H
Sbjct: 60  MIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLRHEYD 198
           RDL   N LL        KI DFG SK+      + + +S    P  + APE +   ++ 
Sbjct: 119 RDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 199 GKIADVWSCGVTLYVML-VGGYPFE 222
            + +DVWS G+T++     G  P++
Sbjct: 177 SR-SDVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 73/270 (27%), Positives = 110/270 (40%), Gaps = 42/270 (15%)

Query: 31  IGSGNFG------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPN 80
           +GSG FG         ++        VAVK + +G    E  ++E +    L     HPN
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS-------GVS 133
           IV+   V L      I+ME   GG+L   + +A            ++L+        G  
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTPAYI 187
           Y   M   HRDL   N L+   G  A R +KI DFG ++    S  + +    +    ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 188 APEVLLRHEYDGKI---ADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQ 241
           APE LL    DGK    +DVWS GV ++ +L  G   YP  +  E         R+    
Sbjct: 181 APESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQK-- 234

Query: 242 YSVPDTNPISQECRDLISRIFVADPAARIT 271
              P+  P   +   L++  +  DP+ R T
Sbjct: 235 ---PENCP--DKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 60/186 (32%), Positives = 83/186 (44%), Gaps = 13/186 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           IG G FG   L   +  K  VAVK I + D   +    E      LRH N+V+   VI+ 
Sbjct: 14  IGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 91  P-THLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
               L IV EY + G L + + + GR     D    F   +   + Y  A    HRDL  
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130

Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWS 206
            N L+  S     K+ DFG +K +   S  + T   P  + APE L   ++  K +DVWS
Sbjct: 131 RNVLV--SEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTK-SDVWS 184

Query: 207 CGVTLY 212
            G+ L+
Sbjct: 185 FGILLW 190

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 71/285 (24%), Positives = 120/285 (42%), Gaps = 49/285 (17%)

Query: 31  IGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVR 83
           +G G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRFSEDEARFFFQ 126
                     L +++EYA  G L  F R                 ++   + DE      
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 173
            LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+      S V 
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRK 232
            S+ +  V    ++A E L  H Y  + +DVWS GV L+ ++ +GG P+     P    +
Sbjct: 186 RSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY-----PGIAPE 236

Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            +  +L   Y +      S+E  +L+   +  +P  R T  +I K
Sbjct: 237 RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 25/214 (11%)

Query: 21  DSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
           D      +R +G+G FG V   + +  T   VAVK ++ G    ++   E    + LRHP
Sbjct: 4   DRTSIQLLRKLGAGQFGEVWEGLWNNTTP--VAVKTLKPGTMDPKDFLAEAQIMKKLRHP 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
            +++   V      + IV E    G L E +                QLI       SG+
Sbjct: 62  KLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAAQVASGM 116

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 189
           +Y  A    HRDL   N L+  +     K+ DFG ++  +     ++  G    I   AP
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFPIKWTAP 173

Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
           E  L + +  K +DVWS G+ L  ++  G   YP
Sbjct: 174 EAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYP 206

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 23/252 (9%)

Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
           + +G+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +V+   V
Sbjct: 12  KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69

Query: 88  ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           + T   + I+ E+ + G L  F +     +    +   F  Q+  G+++       HRDL
Sbjct: 70  V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 128

Query: 146 KLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
           +  N L+  S +   KI DFG ++             K  +    + APE +    +  K
Sbjct: 129 RAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KWTAPEAINFGSFTIK 183

Query: 201 IADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
            +DVWS G+ L  ++  G  P+     P+     + R L   Y +P      +E  +++ 
Sbjct: 184 -SDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIMM 237

Query: 260 RIFVADPAARIT 271
           R +   P  R T
Sbjct: 238 RCWKNRPEERPT 249

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 43/229 (18%)

Query: 23  DRYDFVRDIGSGNFGVARL-----MRDKVTKE-----------LVAVKYIERGDKIDENV 66
            R  F   +G G FG   L     M   + K+           LVAVK + R D  ++N 
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDA-NKNA 62

Query: 67  Q----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 111
           +    +EI     L+ PNI+R   V +T   L ++ EY   G+L + +            
Sbjct: 63  RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122

Query: 112 NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
           +    S     F   Q+ SG+ Y  ++   HRDL   N L+  +    +KI DFG S++ 
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN- 179

Query: 172 VLHSQPKSTVGTPA-----YIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
            L+S     +   A     +++ E +L  ++    +DVW+ GVTL+ +L
Sbjct: 180 -LYSGDYYRIQGRAVLPIRWMSWESILLGKFT-TASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 71/249 (28%), Positives = 104/249 (41%), Gaps = 42/249 (16%)

Query: 31  IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFK 85
           +G GNFG      ++DK     VAVK  +  D   E   + +   R L+   HPNIV+  
Sbjct: 3   LGKGNFGEVFKGTLKDKTP---VAVKTCKE-DLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAM 138
            V      + IVME   GG+    +    R  +DE +   +QL+       +G++Y  + 
Sbjct: 59  GVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESK 112

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
              HRDL   N L+  +    LKI DFG S+        SS L   P        + APE
Sbjct: 113 NCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK------WTAPE 164

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
            L    Y  + +DVWS G+ L+     G   YP     + ++  +   R+   Q    D 
Sbjct: 165 ALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDV 223

Query: 248 NPISQECRD 256
             + Q C D
Sbjct: 224 YKVMQRCWD 232

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 64/256 (25%), Positives = 108/256 (42%), Gaps = 18/256 (7%)

Query: 23  DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +    V+ +G+G FG V     +  TK  VAVK ++ G    +    E    ++L+H  +
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKL 63

Query: 82  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           VR   V+     + I+ EY + G L  F +    G+    +   F  Q+  G++Y     
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    
Sbjct: 124 YIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +  K +DVWS G+ LY ++  G  P+     P      +   L   Y +P       E  
Sbjct: 181 FTIK-SDVWSFGILLYEIVTYGKIPY-----PGMSNSDVMSALQRGYRMPRMENCPDELY 234

Query: 256 DLISRIFVADPAARIT 271
           D++   +      R T
Sbjct: 235 DIMKTCWKEKAEERPT 250

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 13/169 (7%)

Query: 51  VAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 110
           VAVK ++      E   +E    + ++HPN+V+   V        I+ E+ + G L + +
Sbjct: 34  VAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 93

Query: 111 CNAGRFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
               R   +     +   Q+ S + Y       HRDL   N L+       +K+ DFG S
Sbjct: 94  RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLS 151

Query: 169 K-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
           +     +   H+  K  +    + APE L  +++  K +DVW+ GV L+
Sbjct: 152 RLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SDVWAFGVLLW 196

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 13/208 (6%)

Query: 23  DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKY--IERGDKIDENVQREIINHRSLR 77
           +     R IG G FG       M  +  K  VAVK         + E   +E    R   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
           HP+IV+   VI T   + IVME A  GEL   +  N           +  QL + ++Y  
Sbjct: 66  HPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-P-AYIAPEVLLR 194
           + +  HRD+   N L+  SP   +K+ DFG S+     S  K++ G  P  ++APE +  
Sbjct: 125 SKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +    +DVW  GV ++ ++++G  PF
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPF 209

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 33/222 (14%)

Query: 24  RYDFV--RDIGSGNFGVARLM--------RDKVTKELVAVKYI-ERGDKIDENVQREIIN 72
           R++ V  R++G G FG   L         +DK+   LVAVK + +  D   ++  RE   
Sbjct: 4   RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLKDASDNARKDFHREAEL 60

Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------------RFSED 119
             +L+H +IV+F  V +    L +V EY   G+L + +   G               ++ 
Sbjct: 61  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQS 120

Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 176
           +     QQ+ +G+ Y  +    HRDL   N L+  +    +KI DFG S+   S+  +  
Sbjct: 121 QMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRV 178

Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
              T+    ++ PE ++  ++  + +DVWS GV L+ +   G
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYG 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 56.8 bits (137), Expect = 4e-09
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 35/225 (15%)

Query: 20  HDSDRYDFVRDIGSGNFGV---ARLMRDKVTKE--LVAVKYIERG--DKIDENVQREIIN 72
           +  +  ++VRDIG G FG    AR       +   +VAVK ++      +  + QRE   
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------------------RICN 112
                HPNIV+   V      + ++ EY + G+L E                    R C 
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 113 AGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK- 169
                 S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S+ 
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRN 179

Query: 170 --SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
             S+  +   ++      ++ PE +  + Y  + +DVW+ GV L+
Sbjct: 180 IYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 60/240 (25%), Positives = 103/240 (42%), Gaps = 21/240 (8%)

Query: 30  DIGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHPNIVRF 84
           +IG G  N     L R   T  LV V+  +  +  +E++   Q E++     RHPNI+  
Sbjct: 5   EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64

Query: 85  KEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
             V  T + L ++   M Y S   L +     G  SE          + G++Y H     
Sbjct: 65  WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNGYI 123

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTPAYIAPEVLLR- 194
           HR++K  + L+ G     L      YS      K+ V++  P+ +     +++PE+L + 
Sbjct: 124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183

Query: 195 -HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
            + Y+ K +D++S G+T   +  G  PF+D    +     +Q++    YS  D      E
Sbjct: 184 LYGYNVK-SDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITTFPCE 239

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 20/208 (9%)

Query: 29  RDIGSGNFG-VAR-LMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPNIVR 83
           R +G+G FG + R  ++    +EL VA+  +  G  DK       E +      H NIVR
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + VI     + IV EY S G L  F R  + G+    +       L SG+ Y   M   
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYLSEMGYV 129

Query: 142 HRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIAPEVLLRHE 196
           H+ L     L++       KI  F      KS  +++    KS V    + APE +  H 
Sbjct: 130 HKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAAPEAIQYHH 184

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +    +DVWS G+ ++ VM  G  P+ D
Sbjct: 185 FSSA-SDVWSFGIVMWEVMSYGERPYWD 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 52/186 (27%), Positives = 82/186 (44%), Gaps = 24/186 (12%)

Query: 50  LVAVKYIERGDKIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
           LVAVK + R D + +  +    +EI     L++PNI+R   V ++   L ++ EY   G+
Sbjct: 46  LVAVKML-RAD-VTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 106 L------------FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD 153
           L            F    N    S     +   Q+ SG+ Y  ++   HRDL   N L+ 
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163

Query: 154 GSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210
                 +KI DFG S+   S   +      V    ++A E +L  ++    +DVW+ GVT
Sbjct: 164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVT 220

Query: 211 LYVMLV 216
           L+ M  
Sbjct: 221 LWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 6e-09
 Identities = 56/217 (25%), Positives = 91/217 (41%), Gaps = 33/217 (15%)

Query: 31  IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
           IG GNFG  +   ++    +   A+K ++  +   ++  R+      +      HPNI+ 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 84  FKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEARFFFQQ 127
                    +L + +EYA  G L +     R+             A   S  +   F   
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 185
           +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++   K T+G  P  
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTMGRLPVR 176

Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++A E L    Y    +DVWS GV L+ ++ +GG P+
Sbjct: 177 WMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 33/217 (15%)

Query: 31  IGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVR 83
           IG GNFG  +  +++    K   A+K ++  +   EN  R+      +      HPNI+ 
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQLI----- 129
                    +L I +EYA  G L + +  +     D A             QQL+     
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 130 --SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-PA- 185
             +G+ Y    Q  HRDL   N L+  + A   KI DFG S+   ++   K T+G  P  
Sbjct: 128 VATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKTMGRLPVR 183

Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++A E L    Y  K +DVWS GV L+ ++ +GG P+
Sbjct: 184 WMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 48/281 (17%)

Query: 29  RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREI-------INHRSLRH 78
           + +G G FG     +L +D  ++  VAVK +    K+D +   EI          +   H
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 79  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI--- 129
           PN+++   V    + L       +++ +   G+L   +    R      +   Q L+   
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLGGLPEKLPLQTLLKFM 119

Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKST 180
                G+ Y       HRDL   N +L       + +C  DFG SK   S   + Q +  
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLSKKIYSGDYYRQGRIA 175

Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRI 237
                +IA E L    Y  K +DVW+ GVT++ +   G   YP  +  E  D+ +   R+
Sbjct: 176 KMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRL 234

Query: 238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
                  P+      E  DL+   + ADP  R T  ++ + 
Sbjct: 235 -----KQPEDCL--DELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 72/274 (26%), Positives = 120/274 (43%), Gaps = 35/274 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDEN----VQRE 69
           +   F + +G+G FG  +++          D V K  VAVK ++      E      + +
Sbjct: 35  NNLSFGKTLGAGAFG--KVVEATAYGLSKSDAVMK--VAVKMLKPTAHSSEREALMSELK 90

Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
           I++H    H NIV           + ++ EY   G+L  F R       + ++   F  Q
Sbjct: 91  IMSHLG-NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 185
           +  G+++  +    HRDL   N LL  +    +KICDFG ++  +  S    K     P 
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207

Query: 186 -YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKD--FRKTIQRILSVQ 241
            ++APE +    Y  + +DVWS G+ L+ +  +G  P+  P  P D  F K I+     +
Sbjct: 208 KWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPY--PGMPVDSKFYKLIKE--GYR 262

Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIPEI 275
            + P+  P   E  D++   + ADP  R T  +I
Sbjct: 263 MAQPEHAP--AEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 29/212 (13%)

Query: 27  FVRDIGSGNFG-VAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHP 79
           F+ ++G G FG V +       ++++   VA+K ++     K+ +  ++E      L+HP
Sbjct: 9   FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFE------RICNAGRFSED-------EARFFFQ 126
           NIV    V        ++ EY + G+L E         + G  S D       +   F  
Sbjct: 69  NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128

Query: 127 ---QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
              Q+ +G+ Y  +    HRDL   N L+       +KI DFG S+   S+  +     +
Sbjct: 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY 212
           +    ++ PE +L  ++  + +D+WS GV L+
Sbjct: 187 LLPVRWMPPEAILYGKFTTE-SDIWSFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 42/274 (15%)

Query: 31  IGSGNFG---VARL--MRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHPNI 81
           +G G FG   +A+   + ++  + LV VK +++    DEN+Q    RE+   R L H N+
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNV 70

Query: 82  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS-------GV 132
           VR   +        +++EY   G+L  F R   +            +Q ++       G+
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 133 SYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 187
            +    +  HRDL   N L+            L      Y+            +    ++
Sbjct: 131 DHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SKDVYNSEYYKLRNALIPL---RWL 185

Query: 188 APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED-PDEPKDFRKTIQRILS--VQYS 243
           APE +   ++  K +DVWS GV ++ V   G  PF    DE     + + R+ +  ++  
Sbjct: 186 APEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQAGKLELP 239

Query: 244 VPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
           VP+  P       L++R +  +P  R +  E++ 
Sbjct: 240 VPEGCPSR--LYKLMTRCWAVNPKDRPSFSELVS 271

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 64/231 (27%), Positives = 100/231 (43%), Gaps = 34/231 (14%)

Query: 17  PIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVK----YIERGDKIDENVQRE 69
           P++  +D   F   IG GNFG    AR+ +D +  +  A+K    Y  + D  D   + E
Sbjct: 2   PVLEWND-IKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELE 59

Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNA 113
           ++  +   HPNI+          +L + +EYA  G L + +                  A
Sbjct: 60  VLC-KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118

Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
              S  +   F   +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEV 176

Query: 174 HSQPKSTVGT-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           +   K T+G  P  ++A E L    Y    +DVWS GV L+ ++ +GG P+
Sbjct: 177 YV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 52.7 bits (126), Expect = 7e-08
 Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 33/216 (15%)

Query: 30  DIGSGNFG------VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIV 82
           ++G G FG         L+ ++  K LVAVK + E  +   ++ QRE      L+H +IV
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQ-DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV 70

Query: 83  RFKEVILTPTHLAIVMEYASGGEL--FER-------------ICNAGRFSEDEARFFFQQ 127
           RF  V      L +V EY   G+L  F R                 G+ +  +      Q
Sbjct: 71  RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-- 185
           + SG+ Y  ++   HRDL   N L+       +KI DFG S+   ++S     VG     
Sbjct: 131 IASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRD--IYSTDYYRVGGRTML 186

Query: 186 ---YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
              ++ PE +L  ++  + +D+WS GV L+ +   G
Sbjct: 187 PIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYG 221

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 38/283 (13%)

Query: 24  RYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYIERGD-KIDENVQREIINHRS 75
           R D V  R++G G FG   L     +     K LVAVK ++       ++ QRE     +
Sbjct: 4   RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 63

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER--------------ICNAGRFSED 119
           L+H +IV+F  V      L +V EY   G+L  F R                  G     
Sbjct: 64  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 176
           +      Q+ SG+ Y  +    HRDL   N L+  +    +KI DFG S+   S+  +  
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 181

Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 235
              T+    ++ PE ++  ++  + +DVWS GV L+ +   G  P+      +      Q
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 240

Query: 236 -RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            R+L      P      +E  D++   +  +P  R+ I EI K
Sbjct: 241 GRVLERPRVCP------KEVYDIMLGCWQREPQQRLNIKEIYK 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 52.5 bits (126), Expect = 8e-08
 Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 17/250 (6%)

Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
           V+ +G+G FG   +       + VA+K +++G    E    E    + L+HP +VR   V
Sbjct: 11  VKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 88  ILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           + T   + I+ EY   G L  F +     + + ++      Q+  G+++       HRDL
Sbjct: 70  V-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDL 128

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
           +  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K +
Sbjct: 129 RAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-S 184

Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           DVWS G+ L  ++  G  P+     P+     + + L   Y +P  +   +E  +L+   
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPE-----VIQNLERGYRMPRPDNCPEELYELMRLC 239

Query: 262 FVADPAARIT 271
           +   P  R T
Sbjct: 240 WKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 55/246 (22%), Positives = 103/246 (41%), Gaps = 24/246 (9%)

Query: 41  LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 100
           L+ D  T++   +K + +  +     +  II H     PN+V   + I++   + +V+++
Sbjct: 11  LVMDTRTQQTFILKGLRKSSEYSRE-RLTIIPHCV---PNMVCLHKYIVSEDSVFLVLQH 66

Query: 101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
           A GG+L+  I       E+  + +  +++  +   H   +  RDL   N LLD     +L
Sbjct: 67  AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126

Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220
                 +S+ S +            Y APEV    E + +  D WS G  L+ +L G   
Sbjct: 127 TY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLTGKTL 181

Query: 221 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI-----TIPEI 275
            E    P      I        ++P+   +S+E R L+ ++   +P  R+      + +I
Sbjct: 182 VE--CHPSG----INT--HTTLNIPEW--VSEEARSLLQQLLQFNPTERLGAGVAGVEDI 231

Query: 276 MKHQWF 281
             H +F
Sbjct: 232 KSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 54/221 (24%), Positives = 87/221 (39%), Gaps = 34/221 (15%)

Query: 29  RDIGSGNFG------VARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
            +IG+G FG        R M     V KEL A    +      + VQ     +R L HPN
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ----PYRELNHPN 56

Query: 81  IVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEARFFFQQLISGVSYC 135
           +++     +      +V+E+   G+L       R   A    +D  +    ++ SG+ + 
Sbjct: 57  VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP-AYIAPEVL 192
           H     H DL L N  L    +  +KI D+G    +    +   K     P  ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 193 LRHEYDGKIAD------VWSCGVTLYVMLVGGYPFEDPDEP 227
                D    D      +WS GVT++ +      F   D+P
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL------FTAADQP 209

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 25/237 (10%)

Query: 29  RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVR 83
           R IG G+FG      L+     K   AVK + R   ++E  Q  +E I  +   HPN++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 84  FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVC 141
              + L       +V+ Y   G+L   I +     +  +   F  Q+  G+ Y  + +  
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFV 120

Query: 142 HRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
           HRDL   N +LD S    +K+ DFG     Y K   S   H+  K  V    ++A E L 
Sbjct: 121 HRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPV---KWMALESLQ 175

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
             ++  K +DVWS GV L+ ++  G   YP  D  +   +    +R+L  +Y  PD 
Sbjct: 176 TQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY-CPDP 230

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.9 bits (124), Expect = 1e-07
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 23  DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +    ++ +G+G FG V     +  TK  VAVK ++ G    E+   E    + LRH  +
Sbjct: 6   ESLQLIKKLGNGQFGEVWMGTWNGNTK--VAVKTLKPGTMSPESFLEEAQIMKKLRHDKL 63

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQLISGVSYC 135
           V+   V+ +   + IV EY S G L + + +  GR  +     D A     Q+ +G++Y 
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQVAAGMAYI 118

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPE 190
             M   HRDL+  N L+        KI DFG ++   L    + T    A     + APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPE 173

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG---YP 220
             L   +  K +DVWS G+ L  ++  G   YP
Sbjct: 174 AALYGRFTIK-SDVWSFGILLTELVTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 24/203 (11%)

Query: 31  IGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G FG V     +  T+  VA+K ++ G    E   +E    + LRH  +V+   V+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTR--VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 70

Query: 90  TPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLISGVSYCHAMQVCHRDL 145
           +   + IV EY S G L + +   G   +     +      Q+ SG++Y   M   HRDL
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGK 200
           +  N L+  +     K+ DFG ++   L    + T    A     + APE  L   +  K
Sbjct: 129 RAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 201 IADVWSCGVTLYVMLVGG---YP 220
            +DVWS G+ L  +   G   YP
Sbjct: 184 -SDVWSFGILLTELTTKGRVPYP 205

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 45/172 (26%), Positives = 69/172 (40%), Gaps = 30/172 (17%)

Query: 74  RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 117
             L H NI       L   H+ I        +  Y + G L  F + C      N    S
Sbjct: 63  YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115

Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 174
             +      Q+  G+SY H   V H+D+   N ++D     ++KI D   S+       H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173

Query: 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPD 225
               +      ++A E L+  EY    +DVWS GV L+ +M +G  P+ + D
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEID 224

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 44/237 (18%)

Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           R++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 9   RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 67

Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDE 120
           ++   +     +H NI+           L +++EYAS G L E +  A R     +S D 
Sbjct: 68  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDI 126

Query: 121 AR-----FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
           AR       F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG +
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLA 184

Query: 169 K--SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           +  +++ + +  +    P  ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 185 RDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 24/215 (11%)

Query: 28  VRDIGSGNFG-----VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLRH 78
           +R +G G FG     + R       +  VAVK +       D+ D  ++  I++     H
Sbjct: 11  LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMS--KFNH 68

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQQLISG 131
            NIVR   V        I++E  +GG+L  F R       R S     +  F  + +  G
Sbjct: 69  QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKG 128

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVGTPAYI 187
             Y       HRD+   N LL      R+ KI DFG ++    +  + +    +    ++
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 188 APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            PE  L   +  K  DVWS GV L+ +  +G  P+
Sbjct: 189 PPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 15/206 (7%)

Query: 28  VRDIGSGNFGVAR----LMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
           V+ +GSG FG       +   +  K  VA+K +    G K +     E +   S+ HP++
Sbjct: 12  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           VR   V L+PT + +V +    G L + +  +           +  Q+  G+ Y    ++
Sbjct: 72  VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 130

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEY 197
            HRDL   N L+  SP   +KI DFG ++      +  +  G      ++A E +   ++
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFE 222
             + +DVWS GVT++ +M  GG P++
Sbjct: 189 THQ-SDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 41/160 (25%), Positives = 75/160 (46%), Gaps = 21/160 (13%)

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
           Q+  G+ +  + +  HRDL   N LL  S    +KICDFG ++   ++  P    K +  
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237

Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 237
            P  ++APE +    Y  + +DVWS GV L+ +  +G  P+      ++F + ++   R+
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296

Query: 238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            + + + P+   I   C       +  DP  R T   +++
Sbjct: 297 RAPENATPEIYRIMLAC-------WQGDPKERPTFSALVE 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 50.2 bits (120), Expect = 8e-07
 Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 11/182 (6%)

Query: 43  RDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102
                ++ V VK +  G    +   REI   +++ H  I+         + + +VM    
Sbjct: 114 HGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169

Query: 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162
             +LF  +  +G    ++A    ++L+  ++Y H   + HRD+K EN  LD      L  
Sbjct: 170 C-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG- 227

Query: 163 CDFGYSKSSVLHS-QPKST--VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
            DFG +     H   P+     GT    +PE+L    Y  K  D+WS G+ L+ M V   
Sbjct: 228 -DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNV 285

Query: 220 PF 221
             
Sbjct: 286 TL 287

Length = 392

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 25/241 (10%)

Query: 31  IGSGNFGVAR----LMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNIV 82
           +GSG FG       +      K  VA+K I+  D+      +EI +H     SL H  IV
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           R   +    + L +V + +  G L + +  +           +  Q+  G+ Y    ++ 
Sbjct: 73  RLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMV 131

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTP-AYIAPEVLLRHE 196
           HR+L   N LL  S +  ++I DFG +   +L+   K    S   TP  ++A E +L   
Sbjct: 132 HRNLAARNILLK-SDS-IVQIADFGVA--DLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 197 YDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
           Y  + +DVWS GVT++ M+  G   Y    P E  D  +  +R+   Q    D   +  +
Sbjct: 188 YTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK 246

Query: 254 C 254
           C
Sbjct: 247 C 247

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 21/163 (12%)

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 181
           F  Q+  G+S+  +    HRDL   N LL  +     KICDFG ++     S    K   
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 182 GTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKD--FRKTIQ-- 235
             P  ++APE +    Y  + +DVWS G+ L+ +  +G  P+  P  P D  F K I+  
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPY--PGMPVDSKFYKMIKEG 333

Query: 236 -RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            R+LS + +  +   I + C D       ADP  R T  +I++
Sbjct: 334 YRMLSPECAPSEMYDIMKSCWD-------ADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 45/234 (19%)

Query: 23  DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDENVQREI 70
           DR    + +G G FG      A  + +      VAVK +       +  D + E    ++
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------- 123
           I     +H NI+    V      L +V+EYA+ G L + +  A R   + A         
Sbjct: 72  IG----KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPE 126

Query: 124 ----------FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
                     F  Q+  G+ +  + +  HRDL   N L+  +    +KI DFG ++   +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--I 182

Query: 174 HSQP---KSTVGTPAY--IAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           H      K+T G      +APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 21/161 (13%)

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
           Q+  G+ +  + +  HRDL   N LL  S    +KICDFG ++   ++  P    K    
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242

Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 237
            P  ++APE +    Y  + +DVWS GV L+ +  +G  P+      ++F + ++   R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301

Query: 238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            +  Y+ P+      +C       +  +P+ R T  E+++H
Sbjct: 302 RAPDYTTPEMYQTMLDC-------WHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)

Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 177
           +QL+S + Y H   + HRD+K EN L++G       IC  DFG       S S+  H   
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322

Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK--DFRKTI 234
             TV T    APEVL    Y   + D+WS G+ ++   V     F      +   +   I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378

Query: 235 QRILSVQYSVPDTNPISQECRDLISR 260
            RI+       D  P     R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403

Length = 461

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 40/151 (26%), Positives = 72/151 (47%), Gaps = 13/151 (8%)

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
           F  Q+  G+ +  +    HRDL   N LL  +    +KICDFG ++  ++H     + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298

Query: 184 P----AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRIL 238
                 ++APE +  + Y   ++DVWS G+ L+ +  +GG P+        F   I+   
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-- 355

Query: 239 SVQYSVPDTNPISQECRDLISRIFVADPAAR 269
             + + PD     QE  D++ + + ++P  R
Sbjct: 356 GYRMAKPDHAT--QEVYDIMVKCWNSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 48.1 bits (114), Expect = 2e-06
 Identities = 55/236 (23%), Positives = 100/236 (42%), Gaps = 34/236 (14%)

Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-------ENVQREIINHRSLRHPNI 81
           + +G G FG   +M  ++ ++   +K   +  KI        E+   E +  +   HPN+
Sbjct: 5   KTLGEGEFG--SVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62

Query: 82  VRFKEVILTPTHL------AIVMEYASGGEL-----FERICNAGRFSEDEARF-FFQQLI 129
           +R   V L            +++ +   G+L     + R+ +  ++   +    F   + 
Sbjct: 63  MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGTP 184
           SG+ Y  +    HRDL   N +L+ +    + +C  DFG SK   +   + Q +      
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178

Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRI 237
            +IA E L    Y  K +DVWS GVT++ +   G   YP  +  E  D+ +   R+
Sbjct: 179 KWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.5 bits (115), Expect = 2e-06
 Identities = 47/179 (26%), Positives = 80/179 (44%), Gaps = 17/179 (9%)

Query: 44  DKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM-EYAS 102
           D  T E V +K  +RG    E     I+  R++ HP+I++ K          +++  Y +
Sbjct: 113 DNKTCEHVVIKAGQRGGTATE---AHIL--RAINHPSIIQLKGTFTYNKFTCLILPRYKT 167

Query: 103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI 162
             +L+  +      +  +     + ++  + Y H  ++ HRD+K EN  ++  P     +
Sbjct: 168 --DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN-HPG---DV 221

Query: 163 C--DFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
           C  DFG +   V  +  K     GT A  APE+L R  Y G   D+WS G+ L+ M   
Sbjct: 222 CLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 6/102 (5%)

Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
           +GTP Y+APE+LL   + G   D W+ GV L+  L G  PF D    + F    Q IL+ 
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVF----QNILNR 595

Query: 241 QYSVPDTNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
               P+    +S   ++ I  +   DP  R  + E+ +H  F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 37/225 (16%)

Query: 29  RDIGSGNFGVARLM------RDKVTKEL-VAVKYIERGDKIDENVQREIINHRSLR---- 77
           + +G G FG   +       +DK  K + VAVK + + D  D+++   +     ++    
Sbjct: 18  KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVSEMEMMKMIGK 76

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQQ 127
           H NI+           L +++EYAS G L E +  A R     +S D     E +  F+ 
Sbjct: 77  HKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKS 179
           L+S       G+ Y  + +  HRDL   N L+       +KI DFG ++    +    K+
Sbjct: 136 LVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKKT 193

Query: 180 TVG--TPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 21/161 (13%)

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 182
           Q+  G+ +  + +  HRDL   N LL  S    +KICDFG ++   ++  P    K    
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236

Query: 183 TP-AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ---RI 237
            P  ++APE +    Y  + +DVWS GV L+ +  +G  P+      ++F + ++   R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295

Query: 238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +Y+ P+   I  +C          +P  R T  E+++ 
Sbjct: 296 RAPEYATPEIYSIMLDCWH-------NNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 7/117 (5%)

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 180
           F  Q+ +G+ +  +    HRDL   N L+       +KICDFG ++  +  S      ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 236
                ++APE +  + Y   ++DVWS G+ L+ +  +GG P+ +    + F   I+R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)

Query: 29  RDIGSGNFGVARL--MRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
           ++IG+G FG   L  +    T   V VK +     + E ++   E   +RSL+H N+++ 
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 85  KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ---QLISGVSYCHAMQ 139
                  T   +VME+   G+L  + R C        +     +   ++  G+ + H   
Sbjct: 61  LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEV 191
             H DL L N LL       +KI D+G S     H++ K               +IAPE+
Sbjct: 121 FIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYVTPDQLWVPLRWIAPEL 173

Query: 192 LLRHEYDG--------KIADVWSCGVTLYVML-VGGYPF 221
           +   E  G        K ++VWS GVT++ +  +G  P+
Sbjct: 174 V--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 47.3 bits (112), Expect = 5e-06
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 25/166 (15%)

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQ 126
           +H NI+    V      L +++EYA+ G L E +  A R     ++ D     E +  F+
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFK 134

Query: 127 QLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQP 177
            L+S       G+ Y  + +  HRDL   N L+       +KI DFG ++    + + + 
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKK 192

Query: 178 KSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            S    P  ++APE L    Y  + +DVWS G+ ++ +  +GG P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 64/235 (27%), Positives = 100/235 (42%), Gaps = 45/235 (19%)

Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIER-------GDKIDENV 66
           DR    + +G G FG   +           ++VTK  VAVK ++         D I E  
Sbjct: 18  DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTK--VAVKMLKSDATEKDLSDLISEME 75

Query: 67  QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED--- 119
             ++I     +H NI+           L +++EYAS G L E    R      +  +   
Sbjct: 76  MMKMIG----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131

Query: 120 --EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
             E +  F+ L+S       G+ Y  + +  HRDL   N L+       +KI DFG ++ 
Sbjct: 132 VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARD 189

Query: 171 -SVLHSQPKSTVG--TPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
              +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 49/241 (20%), Positives = 91/241 (37%), Gaps = 31/241 (12%)

Query: 43  RDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 102
                +  V +K +    +              L H ++V+   V +   ++ +V EY  
Sbjct: 25  VGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVK 83

Query: 103 GGEL-----FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL----- 152
            G L      E+   +  +  D A    +QL S + Y    ++ H ++  +N L+     
Sbjct: 84  FGPLDVFLHREKNNVSLHWKLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGL 139

Query: 153 DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA-DVWSCGVTL 211
           +    P +K+ D G   + +   +    +    +IAPE +   +    IA D WS G TL
Sbjct: 140 NEGYVPFIKLSDPGIPITVLSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTL 196

Query: 212 YVMLVGG-YPFE--DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAA 268
             +   G  P       E + F +   R+      +PD   ++     LI++ +  DP  
Sbjct: 197 LEICSNGEEPLSTLSSSEKERFYQDQHRL-----PMPDCAELAN----LINQCWTYDPTK 247

Query: 269 R 269
           R
Sbjct: 248 R 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 46.4 bits (110), Expect = 1e-05
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 24/168 (14%)

Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 176
           +D  RF  Q +  G+ +  +    HRD+   N LL DG  A   KICDFG ++  +  S 
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267

Query: 177 --PKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRK 232
              K     P  ++APE +    Y  + +DVWS G+ L+ +  +G  P+        F K
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326

Query: 233 TIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIPEI 275
            ++R    Q S PD  P     I + C +L       +P  R T  +I
Sbjct: 327 MVKR--GYQMSRPDFAPPEIYSIMKMCWNL-------EPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 30/220 (13%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           + R+  +  +G G FG      D+  KE  AVK +    K   + + EI     +R  + 
Sbjct: 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADP 187

Query: 82  V-RFKEVILT------PTHLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGV 132
             RF  + +         H+ IVM +Y  G  L + I   G FS    A+  FQ  ++ +
Sbjct: 188 ADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQTGVA-L 244

Query: 133 SYCHA-MQVCHRDLKLENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQP 177
            Y H  + + H DLK EN L++ S             P P R++ICD G       HS+ 
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR- 302

Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
            + V T  Y +PEV+L   +     D+WS G  +Y +  G
Sbjct: 303 TAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTG 341

Length = 467

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 28  VRDIGSGNFGVAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           V+ +GSG FG       +   +  K  VA+K +      K ++ +  E      +  P +
Sbjct: 12  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 71

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            R   + LT T + +V +    G L + +  N  R    +   +  Q+  G+SY   +++
Sbjct: 72  CRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRL 130

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLRHEY 197
            HRDL   N L+  SP   +KI DFG ++   +        G      ++A E +L   +
Sbjct: 131 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFE 222
             + +DVWS GVT++ +M  G  P++
Sbjct: 189 THQ-SDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 19/208 (9%)

Query: 28  VRDIGSGNFGVAR----LMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 12  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 71

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            R   + LT T + ++ +    G L + +  +           +  Q+  G++Y    ++
Sbjct: 72  CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRL 130

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRH 195
            HRDL   N L+       +KI DFG +K  +L +  K            ++A E +L  
Sbjct: 131 VHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMALESILHR 186

Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFE 222
            Y  + +DVWS GVT++ +M  G  P++
Sbjct: 187 IYTHQ-SDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 66/263 (25%), Positives = 109/263 (41%), Gaps = 26/263 (9%)

Query: 31  IGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G FG   +   +  TK  VA+K ++ G  + E   +E    + LRH  +V    V+ 
Sbjct: 14  LGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV- 70

Query: 90  TPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
           +   + IV E+   G L  F +  +       +      Q+  G++Y   M   HRDL+ 
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRA 130

Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGKIA 202
            N L+  +     KI DFG ++   L    + T    A     + APE  L   +  K +
Sbjct: 131 ANILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-S 184

Query: 203 DVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           DVWS G+ L  ++  G  P+     P    + +   +   Y +P      +   +L+   
Sbjct: 185 DVWSFGILLTELVTKGRVPY-----PGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC 239

Query: 262 FVADPAARITIPEIMKHQWFLKN 284
           +  DP  R T   I   Q FL++
Sbjct: 240 WKKDPDERPTFEYI---QSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 5e-05
 Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 45/226 (19%)

Query: 29  RDIGSGNFG------------VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL 76
           ++IG+G FG            VAR+    V KEL A        K      ++   +R L
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARV----VVKELKA----NASSKEQNEFLQQGDPYRIL 52

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QLISGV 132
           +HPNI++     +      +V EY   G+L   +        +      Q    ++ +GV
Sbjct: 53  QHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAYIA 188
           ++ H     H DL L N  L       +K+ D+G      K   + ++    V    ++A
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL-RWLA 169

Query: 189 PEVLLRHEYDG-------KIADVWSCGVTLYVMLVGGYPFEDPDEP 227
           PE L+   + G       K ++VW+ GVTL+ +      FE+  +P
Sbjct: 170 PE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 43.4 bits (102), Expect = 8e-05
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 31/218 (14%)

Query: 29  RDIGSGNFGVAR---LMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIV 82
           R +G G FG  R   L  +  + + VAVK ++       +++   RE    +   HPN++
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 83  RFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFSEDEARFFFQQLI------- 129
           +   V L       L I M    +   G+L   +    R  E+      Q L+       
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGTP 184
           SG+ Y  +    HRDL   N +L+ +    + +C  DFG SK   S   + Q  ++    
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLSKKIYSGDYYRQGCASKLPV 179

Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            ++A E L  + Y    +DVW+ GVT++ +M  G  P+
Sbjct: 180 KWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 43.4 bits (102), Expect = 9e-05
 Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 37/195 (18%)

Query: 50  LVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 105
           LVAVK I R D  ++N + + +        L+ PNI+R   V +    L ++ EY   G+
Sbjct: 48  LVAVK-ILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 106 LFERICNAGRFSEDEAR--------------------FFFQQLISGVSYCHAMQVCHRDL 145
           L  +  ++    + E                          Q+ SG+ Y  ++   HRDL
Sbjct: 106 L-NQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLLRHEYDGK 200
              N L+  +    +KI DFG S++  L++     +   A     ++A E +L  ++   
Sbjct: 165 ATRNCLVGENLT--IKIADFGMSRN--LYAGDYYRIQGRAVLPIRWMAWECILMGKFT-T 219

Query: 201 IADVWSCGVTLYVML 215
            +DVW+ GVTL+ +L
Sbjct: 220 ASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 27/187 (14%)

Query: 49  ELVAVKYIERGDKIDE--NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 106
           +LVA+K ++  +   +    Q+E      L HPNIV    V+     + ++ EY + G+L
Sbjct: 35  QLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94

Query: 107 FERI----------CNAG-----RFSEDEARFFFQ--QLISGVSYCHAMQVCHRDLKLEN 149
            E +          C++      + S D   F     Q+ +G+ Y  +    H+DL   N
Sbjct: 95  HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154

Query: 150 TLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
            L+       +KI D G S+    +     QPKS +    ++ PE ++  ++    +D+W
Sbjct: 155 ILI--GEQLHVKISDLGLSREIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIW 210

Query: 206 SCGVTLY 212
           S GV L+
Sbjct: 211 SFGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.9 bits (98), Expect = 2e-04
 Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 28/187 (14%)

Query: 49  ELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 104
           + VA+K ++  DK +    E  + E +    L+HPNIV    V+     L+++  Y S  
Sbjct: 36  QAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHS 93

Query: 105 ELFERIC------NAGRFSEDE--------ARFF--FQQLISGVSYCHAMQVCHRDLKLE 148
           +L E +       + G   +D+        A F     Q+ +G+ +  +  V H+DL   
Sbjct: 94  DLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153

Query: 149 NTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVW 205
           N L+       +KI D G  +   ++  +    +++    +++PE ++  ++    +D+W
Sbjct: 154 NVLV--FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIW 210

Query: 206 SCGVTLY 212
           S GV L+
Sbjct: 211 SYGVVLW 217

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 39.7 bits (93), Expect = 8e-04
 Identities = 29/92 (31%), Positives = 41/92 (44%), Gaps = 13/92 (14%)

Query: 135 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
             A++  HR  K  N LL  DG           G    SV    P+ +   P ++APEV+
Sbjct: 27  LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP 224
               Y  K AD++S G+TLY  L    P+ + 
Sbjct: 77  QGQSYTEK-ADIYSLGITLYEALDYELPYNEE 107

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 24/175 (13%)

Query: 53  VKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 112
           VK I   + I  +   EI +   L+HPNIV+   +  +     ++ EY  G  L E + N
Sbjct: 720 VKEINDVNSIPSS---EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN 776

Query: 113 AGRFSEDEARFFFQQLISGVS------YCH-AMQVCHRDLKLENTLLDGSPAPRLKICDF 165
                  E R   +++  G++      +C  +  V   +L  E  ++DG   P L++   
Sbjct: 777 LSW----ERR---RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL--- 826

Query: 166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP 220
             S   +L +  K  + + AY+APE     +   K +D++  G+ L  +L G  P
Sbjct: 827 --SLPGLLCTDTKCFISS-AYVAPETRETKDITEK-SDIYGFGLILIELLTGKSP 877

Length = 968

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	365
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
PLN00181	793	protein SPA1-RELATED; Provisional	100.0
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.91
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.9
PRK10345	210	hypothetical protein; Provisional	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
smart00090	237	RIO RIO-like kinase.	99.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.76
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.69
KOG1243	690	consensus Protein kinase [General function predict	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.5
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.33
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.26
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.24
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.21
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.09
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.08
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.92
COG4248	637	Uncharacterized protein with protein kinase and he	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.9
PRK09902	216	hypothetical protein; Provisional	98.81
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.76
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.68
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.61
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.58
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.52
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.43
PLN02876	822	acyl-CoA dehydrogenase	98.41
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.4
PF01636	239	APH: Phosphotransferase enzyme family This family	98.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.3
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.27
PRK10593	297	hypothetical protein; Provisional	98.11
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.09
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.06
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.05
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.97
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.81
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.76
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.69
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.64
KOG2270	520	consensus Serine/threonine protein kinase involved	97.6
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.56
PRK05231	319	homoserine kinase; Provisional	97.55
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.44
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.38
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.09
PLN02236	344	choline kinase	97.08
PRK12396	409	5-methylribose kinase; Reviewed	97.01
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.92
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.9
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.86
PLN02756	418	S-methyl-5-thioribose kinase	96.84
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.61
PRK11768	325	serine/threonine protein kinase; Provisional	96.58
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.54
PTZ00384	383	choline kinase; Provisional	96.1
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.07
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.0
COG2334	331	Putative homoserine kinase type II (protein kinase	95.77
PRK06148	1013	hypothetical protein; Provisional	95.51
PTZ00296	442	choline kinase; Provisional	95.34
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.29
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.03
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.58

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-64  Score=451.88  Aligned_cols=261  Identities=38%  Similarity=0.612  Sum_probs=230.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--------ccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--------IDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      .++.|.+.+.||+|+||.|-+|..+.+|+.||||++.+...        ....+.+|+.+|++|+|||||+++++|..+.
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            35689999999999999999999999999999999976321        1123579999999999999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-~~~~vkl~Dfgla~~~  171 (365)
                      .+|+||||++||+|.+.+..++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+ ....+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999766 3346999999999988


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccc--cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCC
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDT  247 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~  247 (365)
                      .....+.+.||||.|.|||++.+..  ++..++||||||||+|.+++|.+||.+......+.+   .+..+.+  ..+.|
T Consensus       330 g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e---QI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  330 GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE---QILKGRYAFGPLQW  406 (475)
T ss_pred             ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH---HHhcCcccccChhh
Confidence            8888899999999999999997654  344458999999999999999999988766553333   3344544  33678


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ..+|+++++||.+||..||++|||++|+|+||||+..
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            8899999999999999999999999999999999743

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-61  Score=450.45  Aligned_cols=254  Identities=37%  Similarity=0.627  Sum_probs=234.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeec----CCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .+|...+.||+|||+.+|.+++..+|+.||+|++.+    .....+.+.+|+.+++.|+|||||+++++|++.+++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            579999999999999999999999999999999987    4556688999999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      |+|..++|..++++.+.++|.+++.++.||+.||.|||+++|+|||||..|+|++++-.  |||+|||||+..... +..
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk  175 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERK  175 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCccccc
Confidence            99999999999999999999999999999999999999999999999999999987765  999999999876644 777


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      .+.||||.|.|||++...++.-. +||||+|||+|.|++|++||+..    .+.++...+....+.+|.  .+|.++++|
T Consensus       176 ~TlCGTPNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFetk----~vkety~~Ik~~~Y~~P~--~ls~~A~dL  248 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFETK----TVKETYNKIKLNEYSMPS--HLSAEAKDL  248 (592)
T ss_pred             ceecCCCcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCcccc----hHHHHHHHHHhcCccccc--ccCHHHHHH
Confidence            88999999999999998888777 99999999999999999999864    455677777778888887  499999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      |.+||++||.+|||++++|.|+||.+..
T Consensus       249 I~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  249 IRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             HHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence            9999999999999999999999996554

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-60  Score=422.11  Aligned_cols=261  Identities=29%  Similarity=0.479  Sum_probs=231.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeec--CCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC-EEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~e   99 (365)
                      ++.+.++.||+|..|+||+++|+.+++.+|+|.+..  +....+++.+|+.+++..+|||||++|++|..+. .++|+||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            378889999999999999999999999999999943  3445578899999999999999999999999999 5999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||.+|+|...+...++++|..+..++.++++||.|||. ++||||||||+|||++..+.  |||||||+++..... ...
T Consensus       159 YMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~  235 (364)
T KOG0581|consen  159 YMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IAN  235 (364)
T ss_pred             hcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hcc
Confidence            99999999999999999999999999999999999995 99999999999999987665  999999999865444 678


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhcccc-CCCCCCCCCHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-DEPKDFRKTIQRILSVQY-SVPDTNPISQECRD  256 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  256 (365)
                      +.+||..|||||.+.+..|+.+ +||||||+.++|++.|+.||... .....+.+.+..|...+. ..|.. .+|+++++
T Consensus       236 tfvGT~~YMsPERi~g~~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~  313 (364)
T KOG0581|consen  236 TFVGTSAYMSPERISGESYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRS  313 (364)
T ss_pred             cccccccccChhhhcCCcCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHH
Confidence            8999999999999999999888 99999999999999999999875 323455667777777443 44444 58999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCCCCC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNLPAD  288 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~  288 (365)
                      ||..||++||.+|||+.|+++|||+++.....
T Consensus       314 FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~  345 (364)
T KOG0581|consen  314 FVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN  345 (364)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence            99999999999999999999999998765443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2e-59  Score=416.64  Aligned_cols=254  Identities=35%  Similarity=0.602  Sum_probs=223.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++++.||+|+||+|+.++.+.+++.||+|++++...    ..+...+|..+|..++||+||+++..|++...+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4689999999999999999999999999999999987532    235678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      +||+.||.|+..|++.+.|+|..++.++..|+.||.|||++|||||||||+|||+|.++  +++|+||||++..... ..
T Consensus       104 ld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G--Hi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG--HIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             EeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC--cEEEeccccchhcccCCCc
Confidence            99999999999999999999999999999999999999999999999999999998666  5999999999965544 44


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ..+.|||+.|||||++.+.+|+.. +|+||||+++|+|++|.+||...+...    ....+...... ..+..+|.++++
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~----~~~~I~~~k~~-~~p~~ls~~ard  255 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKK----MYDKILKGKLP-LPPGYLSEEARD  255 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHH----HHHHHhcCcCC-CCCccCCHHHHH
Confidence            556799999999999999988765 999999999999999999999877644    44444444421 122238999999


Q ss_pred             HHHHhcccCCCCCC----CHHHHhcCccccc
Q 017860          257 LISRIFVADPAARI----TIPEIMKHQWFLK  283 (365)
Q Consensus       257 li~~~l~~dp~~R~----t~~ell~h~~f~~  283 (365)
                      ||+++|+.||++|.    .+.++.+||||..
T Consensus       256 ll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            99999999999996    7899999999975

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-58  Score=413.20  Aligned_cols=259  Identities=36%  Similarity=0.591  Sum_probs=229.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .++|.+.++||+|+||+||+|+++.++..||||.+.+..   +..+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            347999999999999999999999999999999997653   34466789999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CC---CCEEEecCCCcccccCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVLH  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-~~---~~vkl~Dfgla~~~~~~  174 (365)
                      |||.||+|..++++.++++|..++.++.||+.||++||+++||||||||.||||+.. ..   ..+||+|||+|+....+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999999999999999999999999999999999999999999999999764 22   56999999999999888


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC-CCCCCCHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQE  253 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~  253 (365)
                      ....+.||+|.|||||++....|+.| +|+||+|+|+|++++|++||...+..+.+. .+   .......| .+..++..
T Consensus       169 ~~a~tlcGSplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~---~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  169 SMAETLCGSPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL-YI---KKGNEIVPVLPAELSNP  243 (429)
T ss_pred             hHHHHhhCCccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH-HH---hccccccCchhhhccCc
Confidence            88899999999999999999999988 899999999999999999999877655443 22   22222222 22336778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +.+|+...|+.+|..|.+..+.+.|+++..+.
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88999999999999999999999999887654

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-57  Score=425.90  Aligned_cols=257  Identities=50%  Similarity=0.838  Sum_probs=233.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC-----C-cccHHHHHHHHHHhcCC-CCCcceeceEEEeCCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----D-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~   93 (365)
                      ...+|.+.+.||+|+||+|+.|.+..++..||+|++.+.     . ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999999999999999999999987663     1 23567779999999999 9999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc-c
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-V  172 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~-~  172 (365)
                      +|+|||||.||+|++++.+.++++|.+++.+++|++.|++|||++||+||||||+|||++.+. +.+||+|||++... .
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPG  173 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999998773 45999999999977 4


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ......+.+||+.|+|||++.+.. |.++++||||+|+++|.|++|+.||...+....    ...+....+.+|.+.. |
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l----~~ki~~~~~~~p~~~~-S  248 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL----YRKIRKGEFKIPSYLL-S  248 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH----HHHHhcCCccCCCCcC-C
Confidence            667889999999999999999988 999999999999999999999999998655443    3446777888888744 9


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +++++|+.+||..||.+|+|+.+++.||||+.
T Consensus       249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999999999997

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-58  Score=398.64  Aligned_cols=259  Identities=25%  Similarity=0.463  Sum_probs=221.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|+.+.++|+|+||+|++++++.||+.||||+|..++.   ..+...||+++|++++|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            589999999999999999999999999999999965443   34677899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~~~  178 (365)
                      ||+..-|.++-.-...+++..++.+++|++.|+.|+|++++|||||||+||||+.++.  +||||||+|+... ++...+
T Consensus        82 ~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   82 YCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             ecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchhh
Confidence            9987545444333456899999999999999999999999999999999999987765  9999999999766 666778


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc----------c-----cC
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------Q-----YS  243 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------~-----~~  243 (365)
                      ..+.|.||+|||.+.+...+++.+||||+||++.||++|.+.|.+.++..++..+...+...          .     ..
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            88999999999999996666677999999999999999999999998887766555432111          1     12


Q ss_pred             CCCC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          244 VPDT----------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       244 ~~~~----------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +|..          ..+|.-+.+|+++||+.||++|++.+++|.|+||..
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            2222          236778999999999999999999999999999943

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-58  Score=422.10  Aligned_cols=266  Identities=31%  Similarity=0.453  Sum_probs=231.4

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc--HHHHHHHHHHhcCC-CCCcceeceEEEeCC-
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLR-HPNIVRFKEVILTPT-   92 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~-   92 (365)
                      +.+...+||.++++||.|+||.||+|+.+.+|+.||||.+++.-..-  -.-.||+..|++++ |||||++.+++.++. 
T Consensus         4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~   83 (538)
T KOG0661|consen    4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR   83 (538)
T ss_pred             eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence            44556789999999999999999999999999999999987643322  33568999999999 999999999999888 


Q ss_pred             EEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      .+|+|||||+ ..|+.+++..+ .|++..++.|+.||++||+|+|++|+.||||||||||+..+.  .|||+|||+||..
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~--~iKiaDFGLARev  160 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND--VIKIADFGLAREV  160 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc--eeEeccccccccc
Confidence            9999999995 48999998654 599999999999999999999999999999999999997544  4999999999999


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------  241 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  241 (365)
                      ......+.++.|+||+|||++.+..+++.+.||||+|||++|+.+-++.|.+.++..++.++..-+..+.          
T Consensus       161 ~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  161 RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            9999999999999999999998887777779999999999999999999999998888877765432221          


Q ss_pred             -----cCCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          242 -----YSVPDT---------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       242 -----~~~~~~---------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                           +.+|..         ...+.++.+||.+||..||++||||.++|+||||+...
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence                 222221         23688999999999999999999999999999997543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-57  Score=426.22  Aligned_cols=254  Identities=39%  Similarity=0.735  Sum_probs=236.5

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      |++.+.||.|+-|.|.+|+|..||+.+|||++.+.    ......+.+|+.+|+.+.||||++++++|+...++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            99999999999999999999999999999999764    23346789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      ++||.|++++.+.+++++.++..+++||+.|+.|||..+|+||||||+|+|++..+.  |||+|||+|.....+....+.
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeTS  171 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLETS  171 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCcccccc
Confidence            999999999999999999999999999999999999999999999999999998876  999999999988888889999


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR  260 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  260 (365)
                      ||+|.|.|||++.+..|++.++||||.|||+|.|++|+.||.+.+-    +..+.++..+.+.+|..  +|+++.+||.+
T Consensus       172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi----r~LLlKV~~G~f~MPs~--Is~eaQdLLr~  245 (786)
T KOG0588|consen  172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI----RVLLLKVQRGVFEMPSN--ISSEAQDLLRR  245 (786)
T ss_pred             CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH----HHHHHHHHcCcccCCCc--CCHHHHHHHHH
Confidence            9999999999999999999999999999999999999999986443    55666677788888855  99999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccccCCC
Q 017860          261 IFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       261 ~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      ||.+||.+|+|.+|+++|||+.....
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCCC
Confidence            99999999999999999999987543

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.8e-57  Score=416.16  Aligned_cols=257  Identities=33%  Similarity=0.572  Sum_probs=226.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|+++++||+|+||.||+|+.+.||+.||+|+++++.-.    .+.++.|-.+|....+|+||+++..|++..++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            356899999999999999999999999999999999886532    2567788899999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC---
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~---  173 (365)
                      ||||++||++..+|.+.+.|++..++.++.+++.|+..||+.|+|||||||+|+|||..|  |+||+|||||.....   
T Consensus       219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G--HiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG--HIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC--CEeeccccccchhhhhhh
Confidence            999999999999999999999999999999999999999999999999999999998665  599999999852110   


Q ss_pred             -------------------CC-C-------------------------CCCCcCCCCCCCchhhcccccCCccceeehhh
Q 017860          174 -------------------HS-Q-------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG  208 (365)
Q Consensus       174 -------------------~~-~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  208 (365)
                                         .. .                         ..+.+|||.|||||++.+.+|.-. +|+||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHH
Confidence                               00 0                         123579999999999999998655 9999999


Q ss_pred             HHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017860          209 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK  283 (365)
Q Consensus       209 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---t~~ell~h~~f~~  283 (365)
                      ||+||||.|.+||.+.+..+.+++++..  ...+.+|....+|++++|||.+||. ||++|.   +++|+.+||||+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            9999999999999998887777666543  3346778888899999999999998 999998   5999999999975

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.3e-56  Score=378.82  Aligned_cols=260  Identities=28%  Similarity=0.463  Sum_probs=226.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|...++||+|.||.||+|++..+|+.||||.++.++.   ......||++.|+.++||||+.+.++|-....+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            589999999999999999999999999999999987643   35778999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |++ .+|...++... .++..+++.++.+++.||+|||+++|+||||||.|+||+.++.  +||+|||+|+.........
T Consensus        82 fm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~  158 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQ  158 (318)
T ss_pred             ecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCccc
Confidence            996 48988887654 5899999999999999999999999999999999999987765  9999999999766554433


Q ss_pred             -CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCCC----------
Q 017860          179 -STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD----------  246 (365)
Q Consensus       179 -~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~----------  246 (365)
                       ..+.|.||+|||.+.+...++..+||||.|||+.||+-|.+-|.+.++.+++..++.....+.. .+|.          
T Consensus       159 ~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~  238 (318)
T KOG0659|consen  159 THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKI  238 (318)
T ss_pred             ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHH
Confidence             3478999999999998776666699999999999999999999999998888777765544332 2222          


Q ss_pred             -----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          247 -----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       247 -----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                                 ....|+++.+|+.+||..||.+|+|+.|+|+|+||.+..
T Consensus       239 ~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  239 QQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             hcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence                       122467889999999999999999999999999998743

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-56  Score=412.14  Aligned_cols=252  Identities=34%  Similarity=0.576  Sum_probs=220.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .+|.+.+.||+|+|++|++|+++.+++.||||++.+.-..    .+-+.+|-.+|..| .||.|++|+-.|+++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            4799999999999999999999999999999998764221    23456677778788 899999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC---
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---  174 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~---  174 (365)
                      +||+++|+|.++|++.+.|++..++.++.+|+.||.|||++|||||||||+|||+++++  ++||+|||.|+.....   
T Consensus       153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm--hikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG--HIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC--cEEEeeccccccCChhhcc
Confidence            99999999999999999999999999999999999999999999999999999998766  4999999988742211   


Q ss_pred             ---------C--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC
Q 017860          175 ---------S--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS  243 (365)
Q Consensus       175 ---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  243 (365)
                               .  ...+++||..|++||++..+..+ +.+|||+||||+|+|+.|++||.+.++-.    +.++|....+.
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~Neyl----iFqkI~~l~y~  305 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYL----IFQKIQALDYE  305 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHH----HHHHHHHhccc
Confidence                     1  12568999999999999776654 45999999999999999999999988754    45556666666


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       244 ~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +|..  +++.+++||+++|..||.+|+|++++..||||..
T Consensus       306 fp~~--fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  306 FPEG--FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             CCCC--CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            6665  7899999999999999999999999999999975

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-56  Score=385.77  Aligned_cols=252  Identities=32%  Similarity=0.613  Sum_probs=228.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      -++|++++.||.|+||.|.+++++.+|..||+|++++....    .+...+|..+|+.+.||+++++++.|.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            45899999999999999999999999999999999876532    25567899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||++||.|++++.+.++|++..++.++.||+.||.|||+++|++|||||+|||+|.+|.  +||+|||+|+....  ..
T Consensus       123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~--rT  198 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG--RT  198 (355)
T ss_pred             EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecC--cE
Confidence            999999999999999999999999999999999999999999999999999999987765  99999999986543  36


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      .+.||||.|+|||++...+|. +++|+||||+++|||++|.+||...+.    .++..+|......+|..  +|+++++|
T Consensus       199 ~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~fP~~--fs~~~kdL  271 (355)
T KOG0616|consen  199 WTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVKFPSY--FSSDAKDL  271 (355)
T ss_pred             EEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCcccCCcc--cCHHHHHH
Confidence            788999999999999988875 559999999999999999999998776    45667777888888776  89999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          258 ISRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      |.++|+.|-.+|.     ...++..||||..-
T Consensus       272 l~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  272 LKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             HHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            9999999999994     57899999999853

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.3e-56  Score=405.45  Aligned_cols=272  Identities=28%  Similarity=0.450  Sum_probs=230.4

Q ss_pred             ccCCCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceec
Q 017860            9 TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFK   85 (365)
Q Consensus         9 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~   85 (365)
                      ++|.....-+....+.|+.+++||+|+||.||+|++..+|+.||+|.+....   .......|||.||++|+||||+++.
T Consensus       103 ~~ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~  182 (560)
T KOG0600|consen  103 VAGEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLE  182 (560)
T ss_pred             ccccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCccccee
Confidence            3444444333445678999999999999999999999999999999997643   3446788999999999999999999


Q ss_pred             eEEEeC--CEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEE
Q 017860           86 EVILTP--THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI  162 (365)
Q Consensus        86 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl  162 (365)
                      +.....  ..+|+|+|||+. +|.-++... -+|++.+++.+|+||+.||.|||++||+|||||.+|||||.++.  +||
T Consensus       183 eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKi  259 (560)
T KOG0600|consen  183 EIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKI  259 (560)
T ss_pred             eEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEe
Confidence            999877  689999999976 777777664 37999999999999999999999999999999999999987665  999


Q ss_pred             ecCCCcccccCCC--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc
Q 017860          163 CDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       163 ~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      +|||||+.+....  ..+..+-|+||+|||.+.+...++.++|+||+|||+.||+.|++.|.+.++.+++.++.+-...+
T Consensus       260 aDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP  339 (560)
T KOG0600|consen  260 ADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSP  339 (560)
T ss_pred             ccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCC
Confidence            9999999554433  56788899999999999998777777999999999999999999999999988888777654332


Q ss_pred             cc------CCCC-----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          241 QY------SVPD-----------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       241 ~~------~~~~-----------------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ..      .+|.                 ...+++.+.+|+..||..||.+|.||.++|.|+||..
T Consensus       340 ~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  340 TEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             ChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            21      1111                 1235788999999999999999999999999999943

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8e-57  Score=378.43  Aligned_cols=260  Identities=35%  Similarity=0.617  Sum_probs=228.8

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      +.-.+.|++.+.||+|+|+.|+++.+..+|+.+|+|++....   ..-+.+.+|+.|-+.|+|||||++++.+.+....|
T Consensus         7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence            344578999999999999999999999999999999986432   23478899999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~~  174 (365)
                      +|+|++.|++|..-|.....++|..+-.+++||++||.|+|.+||||||+||+|+++.+.. ..-+||+|||+|.....+
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            9999999999987776666789999999999999999999999999999999999995432 335999999999988766


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCCCCH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQ  252 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~  252 (365)
                      ......+|||.|||||++...+|..+ +||||.|+|+|-|+.|++||.+.+...    +.++|..+.+.+  |.+..+|+
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~r----lye~I~~g~yd~~~~~w~~is~  241 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHR----LYEQIKAGAYDYPSPEWDTVTP  241 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHH----HHHHHhccccCCCCcccCcCCH
Confidence            66778899999999999988888655 999999999999999999999866644    344455555544  56889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ++++|+++||..||.+|+|+.|+|+|||+.+
T Consensus       242 ~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  242 EAKSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            9999999999999999999999999999975

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.4e-55  Score=406.72  Aligned_cols=251  Identities=33%  Similarity=0.623  Sum_probs=227.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc---HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|.+.+.||+|+||.||+++.+.+.+.||+|.+.+..+..   +.+.+|+.+++.++|||||.++++|++..++++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            58999999999999999999999999999999998755443   568899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC-C
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~-~  178 (365)
                      ||.| +|+.++...+.++|+.++.++.|++.||.|||+++|+|||+||.|||++.++.  +|+||||+|+........ +
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeee
Confidence            9987 99999999999999999999999999999999999999999999999986665  999999999976655443 3


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      +..|||.|||||...+..|+.. +|+||||||+||++.|++||..    ..+.+.++.|...+..+|.  ..|..++.|+
T Consensus       159 sikGtPlYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a----~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl  231 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYA----RSITQLVKSILKDPVKPPS--TASSSFVNFL  231 (808)
T ss_pred             eccCcccccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchH----HHHHHHHHHHhcCCCCCcc--cccHHHHHHH
Confidence            4569999999999998888877 9999999999999999999975    4456677777777766666  5899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccc
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ..+|.+||.+|.|+.+++.|||.+.
T Consensus       232 ~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  232 QGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHhhcChhhcccHHHHhcChHHhh
Confidence            9999999999999999999999865

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-54  Score=390.28  Aligned_cols=259  Identities=32%  Similarity=0.501  Sum_probs=214.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCcceeceEEEeCC--EEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~   98 (365)
                      ..+|...+.||+|+||.||++.++.+|..+|+|.+...... .+.+.+|+.+|+.++|||||++++......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            35799999999999999999999999999999998765221 356899999999999999999999754444  699999


Q ss_pred             eecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEecCCCcccccC---
Q 017860           99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL---  173 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~-~~~~~vkl~Dfgla~~~~~---  173 (365)
                      ||+++|+|.+.+.+.+ +|+|..++.+.+||++||+|||++|+|||||||+|||++. ++.  +||+|||++.....   
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGT  173 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccc
Confidence            9999999999999877 7999999999999999999999999999999999999987 344  99999999876542   


Q ss_pred             -CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCC-CChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          174 -HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-DEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       174 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                       ........||+.|||||++.++....+++|||||||++.||+||+.||... .....+..    +.......+.+..+|
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~----ig~~~~~P~ip~~ls  249 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLL----IGREDSLPEIPDSLS  249 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHH----HhccCCCCCCCcccC
Confidence             233456789999999999986444444699999999999999999999873 22222211    222221113334489


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      +++++||.+||+.+|.+||||.++|.|||..+..+
T Consensus       250 ~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  250 DEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999999977654

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-54  Score=383.50  Aligned_cols=265  Identities=30%  Similarity=0.429  Sum_probs=222.2

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeec---CCcccHHHHHHHHHHhcCCCCCcceeceEEEe-----C
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILT-----P   91 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-----~   91 (365)
                      ....+|..++.||+|+||.|+.|.++.+|+.||||.+..   .....+...+|+++|+.++|+||+.+.+++..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            334577778999999999999999999999999999863   23344678899999999999999999999976     2


Q ss_pred             CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +.+|+|+|+| +.+|...++.+..+++..++.++.||+.||+|+|+.|++||||||+|+|++.+..  +||||||+|+..
T Consensus        99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~  175 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYL  175 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeec
Confidence            5699999999 5689998888888999999999999999999999999999999999999987765  999999999977


Q ss_pred             cC---CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------
Q 017860          172 VL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------  240 (365)
Q Consensus       172 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------  240 (365)
                      ..   ....+..+.|.||+|||++.....++++.||||+|||+.||++|++.|.+.+...++..++.-+..+        
T Consensus       176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i  255 (359)
T KOG0660|consen  176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI  255 (359)
T ss_pred             cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence            54   4556778899999999999876666777999999999999999999999987665543333211110        


Q ss_pred             -----------ccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          241 -----------QYSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       241 -----------~~~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                                 ....|      .....++.+.+|+++||..||.+|+|++|+|.|||+.....+
T Consensus       256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp  319 (359)
T KOG0660|consen  256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP  319 (359)
T ss_pred             ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence                       01111      123578999999999999999999999999999999875533

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.1e-56  Score=379.49  Aligned_cols=244  Identities=30%  Similarity=0.469  Sum_probs=208.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceece-EEEeCCE-EEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKE-VILTPTH-LAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~-~~~~~~~-~~l   96 (365)
                      ...|+|+++||+|+||.||++++..+|+.+|.|.+.-+.   .....+..|+.+|++|+|||||++++ .|..++. ++|
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            457999999999999999999999999999999987432   33467889999999999999999998 6666655 999


Q ss_pred             EEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           97 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~--~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      |||||.+|+|...++.    .+.++|..+|.++.|++.||.+||+  .+  |+||||||.||+++.++.  |||+|||++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~  175 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLG  175 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhH
Confidence            9999999999998864    3459999999999999999999999  45  999999999999987765  999999999


Q ss_pred             ccccCC-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          169 KSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      +..... ....+.+|||+||+||++...+|+.+ ||||||||++|||+.-++||.+.+-    ....++|....++.-..
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~n~----~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGDNL----LSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccccH----HHHHHHHHcCCCCCCcH
Confidence            865443 33567899999999999999999888 9999999999999999999998733    34445555554431122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCH
Q 017860          248 NPISQECRDLISRIFVADPAARITI  272 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~  272 (365)
                      ..+|.++..+|..|+.+||+.||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            4589999999999999999999984

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-54  Score=400.43  Aligned_cols=257  Identities=29%  Similarity=0.502  Sum_probs=227.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ....|....+||+|+-|.||.|+...+++.||||.+..... ..+-+.+|+.+|+..+|+|||++++.|...+.+++|||
T Consensus       271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            35679999999999999999999999999999999986543 34668899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      |++||+|.+.+... .++|.++..+++.++.||+|||.+||+|||||.+|||++.++.  +||+|||++....... ...
T Consensus       351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~  427 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRS  427 (550)
T ss_pred             ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccc
Confidence            99999999887654 4899999999999999999999999999999999999987776  9999999987655444 678


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      +.+|||+|||||++....|..+ +||||||++++||+-|.+||-..+....+   ..-..++.+.+..+..+|+.+++||
T Consensus       428 TmVGTPYWMAPEVvtrk~YG~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAl---yLIa~ng~P~lk~~~klS~~~kdFL  503 (550)
T KOG0578|consen  428 TMVGTPYWMAPEVVTRKPYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRAL---YLIATNGTPKLKNPEKLSPELKDFL  503 (550)
T ss_pred             cccCCCCccchhhhhhcccCcc-ccchhhhhHHHHHhcCCCCccCCChHHHH---HHHhhcCCCCcCCccccCHHHHHHH
Confidence            8899999999999999999877 99999999999999999999876554333   2223455667777788999999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .+||+.|+.+|++|.|||.||||...
T Consensus       504 ~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  504 DRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHHhhcchhcCCCHHHHhcChhhhhc
Confidence            99999999999999999999999543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.2e-53  Score=370.93  Aligned_cols=264  Identities=29%  Similarity=0.400  Sum_probs=225.4

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC--C
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--T   92 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~   92 (365)
                      .+-.-+.|+.+.+|++|+||.||+|+++.+++.||+|+++-+.   ...-.-.|||.+|.+++|||||.+.++....  +
T Consensus        71 gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   71 GCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             CcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            3444567999999999999999999999999999999987533   2345678999999999999999999988754  5


Q ss_pred             EEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      .+|+|||||+. +|..++...+ +|++.+++.++.|++.|++|||.++|+||||||+|+|++..|.  +||||||+||.+
T Consensus       151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~y  227 (419)
T KOG0663|consen  151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREY  227 (419)
T ss_pred             eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhh
Confidence            69999999976 8888888755 7999999999999999999999999999999999999987665  999999999976


Q ss_pred             cCC-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CC-----
Q 017860          172 VLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV-----  244 (365)
Q Consensus       172 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----  244 (365)
                      ... ...+..+-|.||+|||.+.+...++.+.|+||+|||+.||+++++.|.+.....++.++++....+.- .+     
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            544 34566788999999999999877777799999999999999999999999998888877765433221 01     


Q ss_pred             -CC-------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 -PD-------------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 -~~-------------------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                       |.                   ...+|+...+|+..+|..||.+|.||.++|+|.||.+.
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence             10                   01156889999999999999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-52  Score=379.04  Aligned_cols=272  Identities=29%  Similarity=0.447  Sum_probs=227.3

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .+-...+.|++.+.||.|.-++||+|+...++..||||++..+.-  .-..+.+|+..|+.++||||++++.+|..+..+
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            344556789999999999999999999999999999999976432  236789999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           95 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      |+||.||.+|++.++++..-  .+.|..+..++++++.||.|||++|.||||||+.||||+.+|.  |||+|||++....
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~  177 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLF  177 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeec
Confidence            99999999999999998743  4999999999999999999999999999999999999988776  9999999875432


Q ss_pred             CCCC-----CCCCcCCCCCCCchhhcc--cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----
Q 017860          173 LHSQ-----PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----  241 (365)
Q Consensus       173 ~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----  241 (365)
                      ..+.     ..+.+|||+|||||++..  .+|+.| +||||||++..||.+|..||........+...++.-....    
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSG  256 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccccc
Confidence            2221     156689999999999543  467777 9999999999999999999998877665554444321100    


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCCCcch
Q 017860          242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD  291 (365)
Q Consensus       242 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~~~~  291 (365)
                      ........++..++.++..||+.||.+|||++++|+|+||++....+...
T Consensus       257 ~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~~  306 (516)
T KOG0582|consen  257 LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYLV  306 (516)
T ss_pred             CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhcc
Confidence            11122345678899999999999999999999999999999877665543

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-52  Score=392.68  Aligned_cols=260  Identities=37%  Similarity=0.621  Sum_probs=232.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~   95 (365)
                      ..+.|++.+.||+|.||.||.++++.+|+.+|+|.+.+...    ..+.+.+|+.+|+.+. |||||.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            35689999999999999999999999999999999976443    2368999999999998 999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~--~~vkl~Dfgla~~~~~  173 (365)
                      +|||+|.||.|++.+... .++|..+..++.|++.|++|||+.|++||||||+|+|+.....  +.+|++|||++.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999999877 4999999999999999999999999999999999999975533  4799999999998777


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      +......+|||.|+|||++....|... +||||+|+++|.|++|.+||.+.+....+.++...  ...+..+.+..+|..
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISES  268 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHH
Confidence            667788899999999999988888766 99999999999999999999998876665544332  223455678889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +++||.+||..||.+|+|+.++|+|||+...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999864

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-53  Score=387.49  Aligned_cols=258  Identities=36%  Similarity=0.632  Sum_probs=223.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------------ccHHHHHHHHHHhcCCCCCcceece
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------IDENVQREIINHRSLRHPNIVRFKE   86 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~~~~~e~~~l~~l~hpnIv~l~~   86 (365)
                      -++|++.+.||+|.||.|.+|++..+++.||||++.+...               -.+.+.+||.+|++++|||||++++
T Consensus        96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE  175 (576)
T KOG0585|consen   96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE  175 (576)
T ss_pred             hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence            3579999999999999999999999999999999975321               1157889999999999999999999


Q ss_pred             EEEeC--CEEEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 017860           87 VILTP--THLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        87 ~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                      +..+.  +.+|+|+|||..|.+...- ..+. +++.+++.++++++.||.|||.+|||||||||+|+||++++  +|||+
T Consensus       176 vLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g--~VKIs  252 (576)
T KOG0585|consen  176 VLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG--TVKIS  252 (576)
T ss_pred             eecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC--cEEee
Confidence            99765  5799999999999886533 3334 89999999999999999999999999999999999998775  59999


Q ss_pred             cCCCcccccCC------CCCCCCcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHH
Q 017860          164 DFGYSKSSVLH------SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       164 Dfgla~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  234 (365)
                      |||++.....+      ......+|||.|+|||.+.+   ..+.+++.||||+||++|-|+.|+.||-+...    .+..
T Consensus       253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~~l~  328 (576)
T KOG0585|consen  253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----LELF  328 (576)
T ss_pred             ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----HHHH
Confidence            99998755332      22345789999999999977   45778889999999999999999999987554    4556


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       235 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      .+|...+..+|....+++++++||.+||++||++|++..++..|||......
T Consensus       329 ~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  329 DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            6677788888888889999999999999999999999999999999987643

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-53  Score=379.79  Aligned_cols=252  Identities=38%  Similarity=0.679  Sum_probs=230.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .||++.+.||+|.||+|-+|.....|+.||||.++++....    -.+++|+.||..|+||||+.+|++|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            47999999999999999999999999999999998754333    35789999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||..+|.|++++.+.+.|+|.+++.+++||++|+.|||+++++|||||.+|||+|.+++  +||+|||++..+......+
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLq  210 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQ  210 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHH
Confidence            99999999999999999999999999999999999999999999999999999998887  9999999999888888899


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ++||+|.|.+||++++..|.++.+|-||||+++|.|+.|..||++.+-    ...+++|..+.+.-|..   +.++.-||
T Consensus       211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~~---PSdA~gLI  283 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPET---PSDASGLI  283 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCCC---CchHHHHH
Confidence            999999999999999999999999999999999999999999998654    44556666676655543   46788999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccc
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +.||.+||++|.|++++-.|=|..-
T Consensus       284 RwmLmVNP~RRATieDiAsHWWvNw  308 (668)
T KOG0611|consen  284 RWMLMVNPERRATIEDIASHWWVNW  308 (668)
T ss_pred             HHHHhcCcccchhHHHHhhhheeec
Confidence            9999999999999999999988753

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-53  Score=357.04  Aligned_cols=252  Identities=37%  Similarity=0.650  Sum_probs=228.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|.+.+.||+|-||.||+|+.+.++-.||+|++.++.    ....++.+|+.|...|+||||+++|++|.+....|+++
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil  101 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL  101 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence            58999999999999999999999999999999998754    23467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           99 EYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~--~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ||..+|+|+..++  ...++++..++.++.|++.||.|+|.++++||||||+|+|++..+.  +||+|||.+...+ ...
T Consensus       102 Eya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~k  178 (281)
T KOG0580|consen  102 EYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNK  178 (281)
T ss_pred             EecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CCC
Confidence            9999999999998  6678999999999999999999999999999999999999987665  9999999987665 666


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ..+.|||..|.+||...+..++.. +|+||+|++.||++.|.+||+..+..    +..+++....+.+|  ..+|.++.|
T Consensus       179 R~tlcgt~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~----etYkrI~k~~~~~p--~~is~~a~d  251 (281)
T KOG0580|consen  179 RKTLCGTLDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHS----ETYKRIRKVDLKFP--STISGGAAD  251 (281)
T ss_pred             ceeeecccccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhH----HHHHHHHHccccCC--cccChhHHH
Confidence            788999999999999999999877 99999999999999999999987643    45555666666666  459999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ||.+||..+|.+|.+..|++.|||+...
T Consensus       252 lI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  252 LISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999998653

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-52  Score=369.39  Aligned_cols=260  Identities=28%  Similarity=0.413  Sum_probs=221.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCC-cceeceEEEeCC-----
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPN-IVRFKEVILTPT-----   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~-----   92 (365)
                      ...|..+++||+|+||+||+|+++.+|+.||+|++.....   ......+|+.+++.|+|+| |+++++++.+.+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            4469999999999999999999999999999999986543   5578899999999999999 999999999888     


Q ss_pred             -EEEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           93 -HLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        93 -~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                       .+++|+||+. -+|..++....    .++...++.++.||+.||+|||+++|+||||||+||||+.++.  +||+|||+
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGl  166 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGL  166 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--Eeeeccch
Confidence             8999999995 48999887654    4788999999999999999999999999999999999987654  99999999


Q ss_pred             cccccCC-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCC
Q 017860          168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVP  245 (365)
Q Consensus       168 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~  245 (365)
                      |+..... ...+..++|.||+|||++.+...++...||||+|||++||+++++.|.+..+..++..+.+-+..+.. .+|
T Consensus       167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            9976533 33677889999999999999855555599999999999999999999999887777666654332211 111


Q ss_pred             -------------CC----------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          246 -------------DT----------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       246 -------------~~----------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                   .+          ...+++..+++.+||+.+|.+|.|+..+|.||||...
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence                         11          1123588999999999999999999999999999765

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-52  Score=396.17  Aligned_cols=256  Identities=34%  Similarity=0.561  Sum_probs=224.1

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcC-CCCCcceeceEEEeCCE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTH   93 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~   93 (365)
                      ....++|.++++||+|+||+|+++..+.+++.||||+++++...    -+....|-.|+... +||.++.++.+|+++.+
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            34456899999999999999999999999999999999986533    25566777777766 49999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-  172 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-  172 (365)
                      +|+||||+.||++. .++..+.|++..++.+++.|+.||.|||++|||+||||.+|||+|..|  ++||+|||+++... 
T Consensus       444 l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG--h~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG--HVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC--cEEecccccccccCC
Confidence            99999999999944 445567899999999999999999999999999999999999998665  59999999999766 


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .+....+.||||.|||||++.+..|+.. +|+|||||++|||+.|..||.+.+..+    +...|.......|.+  +|.
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee----~FdsI~~d~~~yP~~--ls~  593 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEE----VFDSIVNDEVRYPRF--LSK  593 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCCc--ccH
Confidence            5566778899999999999999998766 999999999999999999999877754    445566666666666  899


Q ss_pred             HHHHHHHHhcccCCCCCCC-----HHHHhcCcccccC
Q 017860          253 ECRDLISRIFVADPAARIT-----IPEIMKHQWFLKN  284 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t-----~~ell~h~~f~~~  284 (365)
                      ++.++++++|.++|++|+.     +.++.+||||+.-
T Consensus       594 ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i  630 (694)
T KOG0694|consen  594 EAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI  630 (694)
T ss_pred             HHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence            9999999999999999994     6889999999753

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-53  Score=362.26  Aligned_cols=255  Identities=33%  Similarity=0.540  Sum_probs=224.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC------c---ccHHHHHHHHHHhcC-CCCCcceeceEEEeCC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------K---IDENVQREIINHRSL-RHPNIVRFKEVILTPT   92 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~---~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~   92 (365)
                      ..|.-.+.||+|..++|..+.++.+|+.+|+|++....      .   ..+.-.+|+.||+++ .||+|+++.++|+++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            36888999999999999999999999999999986421      1   124556799999998 5999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+++|+|.|+.|.|++++...-.++|...+.+|+|+++|+.|||.++||||||||+|||++++-+  +||+|||+|+...
T Consensus        97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~  174 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccC
Confidence            99999999999999999999889999999999999999999999999999999999999987765  9999999999999


Q ss_pred             CCCCCCCCcCCCCCCCchhhccc-----ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--cCCC
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVP  245 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  245 (365)
                      .+......||||+|.|||.+...     .-+++.+|+||+|+|+|.|+.|.+||........    ++.+..+.  +..|
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM----LR~ImeGkyqF~sp  250 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM----LRMIMEGKYQFRSP  250 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH----HHHHHhcccccCCc
Confidence            99999999999999999998643     2234559999999999999999999987544333    33344444  4668


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .|..+|...++||.+||+.||.+|.|++|+|.||||.+
T Consensus       251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            89999999999999999999999999999999999954

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-51  Score=382.76  Aligned_cols=251  Identities=30%  Similarity=0.544  Sum_probs=217.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++..+..+|+|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            358999999999999999999999999999999997542    2235678999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||+.+|+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  ..
T Consensus        97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RT  172 (329)
T ss_pred             EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--Cc
Confidence            999999999999998889999999999999999999999999999999999999986654  99999999875432  23


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...    ....+......+|.  .++..+++|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~----~~~~i~~~~~~~p~--~~~~~~~~l  245 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFR----IYEKILAGRLKFPN--WFDGRARDL  245 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCcCCCC--CCCHHHHHH
Confidence            45679999999999988777655 999999999999999999998755432    23333444444443  378999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      |.+||+.||.+||+     +++++.||||..
T Consensus       246 i~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        246 VKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            99999999999997     799999999976

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-51  Score=377.51  Aligned_cols=250  Identities=32%  Similarity=0.588  Sum_probs=216.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+|.++.+++.||+|++....    ...+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999987532    22356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+.+|+|.+++.+.+.+++..++.++.|++.||+|||++|++||||||+|||++.++  .+||+|||+++....  ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--~~kl~Dfg~~~~~~~--~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--HIKLTDFGFAKKLRD--RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC--CEEEEecCcchhccC--Ccc
Confidence            9999999999999888899999999999999999999999999999999999997665  499999999875432  234


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......++.  .+++.+++||
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li  229 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGI----YEKILAGKLEFPR--HLDLYAKDLI  229 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCcCCCc--cCCHHHHHHH
Confidence            5679999999999988777655 9999999999999999999987655332    2333333333333  3689999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          259 SRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       259 ~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      ++||+.||.+||+     ++++++||||..
T Consensus       230 ~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         230 KKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            9999999999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-50  Score=370.90  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=215.9

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .|++.+.||+|+||.||++.++.+++.||+|.+.+..    .....+.+|+.+++.++|+||+++++++...+.+++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4889999999999999999999999999999987532    122457789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860          100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |+.+|+|...+...  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||++.........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETV  158 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCee
Confidence            99999998887643  35899999999999999999999999999999999999986654  999999998765444444


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+.....  .....+|+++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~l  235 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSI  235 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHHHH
Confidence            56689999999999988888766 99999999999999999999876553332233333322222  2334589999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCcccccC
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~~  284 (365)
                      +.+||+.||.+||+     ++++++||||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         236 CRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            99999999999997     8999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.9e-50  Score=372.68  Aligned_cols=260  Identities=27%  Similarity=0.443  Sum_probs=209.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++.++||+|+||.||+|+++.+++.||+|++....  .....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999999999999999987543  223467889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCC
Q 017860          100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~  177 (365)
                      |+. ++|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++.... ....
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccC
Confidence            996 577777655 456899999999999999999999999999999999999986654  99999999874322 2233


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CC-----------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SV-----------  244 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~-----------  244 (365)
                      ....||+.|+|||++.+......++|||||||++|+|++|..||.+..+.....+.+........  .+           
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP  240 (303)
T ss_pred             CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccccc
Confidence            45678999999999876554445599999999999999999999876554332222221111100  00           


Q ss_pred             -------C-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 -------P-------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 -------~-------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                             +       .....++.+.+|+.+||+.||.+|||+.++++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence                   0       001245789999999999999999999999999999764

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.2e-50  Score=383.40  Aligned_cols=256  Identities=28%  Similarity=0.481  Sum_probs=214.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997532    22246778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---  175 (365)
                      ||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++  ++||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~--~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG--HVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC--CEEEeeccCccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999998665  49999999986432110   


Q ss_pred             ---------------------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCC
Q 017860          176 ---------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE  222 (365)
Q Consensus       176 ---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  222 (365)
                                                       .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCC
Confidence                                             0124579999999999988888766 999999999999999999998


Q ss_pred             CCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCC---CCCCHHHHhcCcccccC
Q 017860          223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA---ARITIPEIMKHQWFLKN  284 (365)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~---~R~t~~ell~h~~f~~~  284 (365)
                      +.+....+.++..  ......+|....+|+++++||.+|+. +|.   .||+++|+++||||...
T Consensus       238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         238 SETPQETYKKVMN--WKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             CCCHHHHHHHHHc--CcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            7665443333221  11233455555689999999999775 444   46899999999999754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.5e-51  Score=378.07  Aligned_cols=247  Identities=36%  Similarity=0.602  Sum_probs=211.4

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +.||+|+||.||+|+++.+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+||||+.+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997532    12245678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcCC
Q 017860          105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT  183 (365)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~gt  183 (365)
                      +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecC
Confidence            99999988888999999999999999999999999999999999999986654  99999999875322 2333456799


Q ss_pred             CCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017860          184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV  263 (365)
Q Consensus       184 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  263 (365)
                      +.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+......+|  ..+++++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~----~~~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (323)
T cd05571         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEEIRFP--RTLSPEAKSLLAGLLK  231 (323)
T ss_pred             ccccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHHHHHHcc
Confidence            99999999988777766 999999999999999999998755433    2223333333333  3589999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCcccccC
Q 017860          264 ADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       264 ~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .||.+||     ++.++++||||...
T Consensus       232 ~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         232 KDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            9999999     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-51  Score=384.48  Aligned_cols=256  Identities=33%  Similarity=0.568  Sum_probs=216.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||+||+|+++.+++.||||++.+..    .....+.+|+.+++.++||||++++++|.++..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997632    22345778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---  175 (365)
                      ||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++.......   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceecccccccc
Confidence            99999999999988888999999999999999999999999999999999999987664  9999999986432110   


Q ss_pred             ------------------------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCC
Q 017860          176 ------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY  219 (365)
Q Consensus       176 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  219 (365)
                                                          .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~  237 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCC
Confidence                                                1123469999999999988887766 999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccC
Q 017860          220 PFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLKN  284 (365)
Q Consensus       220 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t---~~ell~h~~f~~~  284 (365)
                      ||...+......++..  .......+....+|+++++||.+||. +|.+|++   +.+++.||||...
T Consensus       238 Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         238 PFCSDNPQETYRKIIN--WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCCCCCHHHHHHHHHc--CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            9987665433322221  11223445555689999999999996 9999998   9999999999753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-51  Score=366.04  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=223.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      -+.|++++.||.|.-|+||+|+.+.++..+|+|++.+....    ..+...|-.||..++||.++++|..|+++...|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            45799999999999999999999999999999999875432    24566788999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc---
Q 017860           98 MEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---  172 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~---  172 (365)
                      ||||+||+|..++++.  +.|++..++.++..++.||+|||-+|||.|||||+||||.++|  +|.|.||.|+....   
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG--HIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG--HIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC--cEEeeeccccccCCCCC
Confidence            9999999999998764  4699999999999999999999999999999999999998766  59999999864110   


Q ss_pred             ---------------------------------C---------------------CCCCCCCcCCCCCCCchhhcccccC
Q 017860          173 ---------------------------------L---------------------HSQPKSTVGTPAYIAPEVLLRHEYD  198 (365)
Q Consensus       173 ---------------------------------~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~  198 (365)
                                                       .                     .....+.+||=.|.|||++.+.+.+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                             0                     0111345799999999999999987


Q ss_pred             CccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHH
Q 017860          199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT----IPE  274 (365)
Q Consensus       199 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t----~~e  274 (365)
                      .. +|+|+|||++|||+.|..||.+.+..+.+    .+++..+..+|....+|..++|||+++|.+||.+|..    |+|
T Consensus       314 sA-VDWWtfGIflYEmLyG~TPFKG~~~~~Tl----~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~e  388 (459)
T KOG0610|consen  314 SA-VDWWTFGIFLYEMLYGTTPFKGSNNKETL----RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAE  388 (459)
T ss_pred             ch-hhHHHHHHHHHHHHhCCCCcCCCCchhhH----HHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHH
Confidence            66 99999999999999999999999886544    4566677788888789999999999999999999997    999


Q ss_pred             HhcCcccccC
Q 017860          275 IMKHQWFLKN  284 (365)
Q Consensus       275 ll~h~~f~~~  284 (365)
                      +.+||||..-
T Consensus       389 IK~HpFF~gV  398 (459)
T KOG0610|consen  389 IKRHPFFEGV  398 (459)
T ss_pred             hhcCccccCC
Confidence            9999999753

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.9e-50  Score=368.82  Aligned_cols=258  Identities=28%  Similarity=0.476  Sum_probs=211.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ..++|+++++||.|+||.||+++++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++......++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            3568999999999999999999999999999999986532  23456789999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860           99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      ||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~  159 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKT  159 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCcc
Confidence            99975 8988887644 4799999999999999999999999999999999999986654  999999998754322 22


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------  241 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  241 (365)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+........               
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07871         160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS  239 (288)
T ss_pred             ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence            34457899999999987644334459999999999999999999988765544433332211100               


Q ss_pred             cCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          242 YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       242 ~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ...+.         ...+++++++||.+||+.||.+|||++|+++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            00111         12468899999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.7e-50  Score=382.34  Aligned_cols=256  Identities=30%  Similarity=0.460  Sum_probs=214.4

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .|++++.||+|+||+||+|+++.+++.||+|++.+...    ....+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            69999999999999999999999999999999976432    23467889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-----
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----  174 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-----  174 (365)
                      |+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~--~~kL~DFGl~~~~~~~~~~~~  159 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG--HIKLTDFGLCTGFRWTHNSKY  159 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC--CEEEeeCcCCccccccccccc
Confidence            999999999999888899999999999999999999999999999999999997655  5999999987532100     


Q ss_pred             -------------------------------------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHH
Q 017860          175 -------------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL  211 (365)
Q Consensus       175 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  211 (365)
                                                                 ....+.+||+.|+|||++.+..++.+ +|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il  238 (381)
T cd05626         160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVIL  238 (381)
T ss_pred             ccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHH
Confidence                                                       00124579999999999988777766 9999999999


Q ss_pred             HHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHhcCcccccC
Q 017860          212 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF--VADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       212 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l--~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |||++|..||...+......++..  .......+....+++++.+||.+|+  ..+|..|+++++++.||||...
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            999999999987665443332221  1223345555668999999999965  4455569999999999999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-50  Score=376.36  Aligned_cols=255  Identities=30%  Similarity=0.461  Sum_probs=217.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999997542    12345778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.  +||+|||+++....  ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccC
Confidence            99999999999988888999999999999999999999999999999999999986654  99999999875433  345


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC----CCCCHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----NPISQEC  254 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~s~~~  254 (365)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+......  ......|..    ..+++++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~s~~~  233 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYDDPRFNLSDEA  233 (333)
T ss_pred             CcccCccccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCCccccccCHHH
Confidence            6679999999999988877766 99999999999999999999876554333222211  111112222    2568999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .+||.+||..+|.+||++.++++||||...
T Consensus       234 ~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         234 WDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            999999999999999999999999999753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.7e-50  Score=366.90  Aligned_cols=256  Identities=28%  Similarity=0.442  Sum_probs=211.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++.+.||+|+||.||+++++.+++.||+|++....   ...+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999987543   234567899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--CC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--~~  177 (365)
                      |+.++.+..+......+++..++.++.|++.||.|||+.|++||||||+||+++.++.  +||+|||+++......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~  158 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANY  158 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCcccccccccccc
Confidence            9998877666555567999999999999999999999999999999999999986654  9999999987643322  22


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc------------c---cc
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS------------V---QY  242 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~------------~---~~  242 (365)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|++||...+..............            .   ..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            34578999999999988777655 99999999999999999999876654433222111000            0   00


Q ss_pred             CCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          243 SVPD-----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       243 ~~~~-----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ..+.           ...+|.++.+||.+||+.||++|||++++|+||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            1111           12368889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-50  Score=383.12  Aligned_cols=255  Identities=31%  Similarity=0.501  Sum_probs=213.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+...    ....+.+|+.+++.++||||++++++|.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            479999999999999999999999999999999875321    2245778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---  175 (365)
                      ||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeecccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999986654  9999999985321100   


Q ss_pred             ---------------------------------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHH
Q 017860          176 ---------------------------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT  210 (365)
Q Consensus       176 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~i  210 (365)
                                                                   .....+||+.|+|||++.+..++.+ +|||||||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvi  237 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAI  237 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchh
Confidence                                                         0013579999999999988877666 999999999


Q ss_pred             HHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCccccc
Q 017860          211 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR---ITIPEIMKHQWFLK  283 (365)
Q Consensus       211 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R---~t~~ell~h~~f~~  283 (365)
                      +|||++|..||...+....+..+...  .....+|....++.++.+||.+||. +|.+|   +|+.+++.||||..
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            99999999999876654433332211  1223445555689999999999997 67765   59999999999974

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-52  Score=378.96  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=223.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ....|+.++.||+|+||.||+|.+..+++.||+|++.....  ..+++.+|+.++.+++++||.++|+.|.....++++|
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            34579999999999999999999999999999999986543  4478899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      |||.||++.+.++..+.+.|..+..++++++.||.|||+.+.+|||||+.|||+..++.  +||+|||++...... ...
T Consensus        91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr  168 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRR  168 (467)
T ss_pred             HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhcc
Confidence            99999999999998888899999999999999999999999999999999999987754  999999998754333 334


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      .+++|||.|||||++.+..|+.+ +||||||++.+||++|.+||.......    .+-.|....+.. ....+|+.+++|
T Consensus       169 ~tfvGTPfwMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmr----vlflIpk~~PP~-L~~~~S~~~kEF  242 (467)
T KOG0201|consen  169 KTFVGTPFWMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMR----VLFLIPKSAPPR-LDGDFSPPFKEF  242 (467)
T ss_pred             ccccccccccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcce----EEEeccCCCCCc-cccccCHHHHHH
Confidence            78899999999999998899988 899999999999999999998776621    111122222211 123689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +..||.+||+.||+|.++|+|+|+++..
T Consensus       243 V~~CL~k~P~~RpsA~~LLKh~FIk~a~  270 (467)
T KOG0201|consen  243 VEACLDKNPEFRPSAKELLKHKFIKRAK  270 (467)
T ss_pred             HHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence            9999999999999999999999997643

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.2e-50  Score=383.06  Aligned_cols=255  Identities=34%  Similarity=0.512  Sum_probs=215.2

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +|+++++||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            6999999999999999999999999999999987642    123467889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-----
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----  174 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-----  174 (365)
                      ||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~  159 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKY  159 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCccccccccccc
Confidence            9999999999988888999999999999999999999999999999999999986654  999999997522100     


Q ss_pred             -------------------------------------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHH
Q 017860          175 -------------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTL  211 (365)
Q Consensus       175 -------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il  211 (365)
                                                                 ....+.+||+.|+|||++.+..++.+ +|||||||++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil  238 (382)
T cd05625         160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVIL  238 (382)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHHH
Confidence                                                       00123479999999999988888766 9999999999


Q ss_pred             HHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccC
Q 017860          212 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLKN  284 (365)
Q Consensus       212 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t---~~ell~h~~f~~~  284 (365)
                      |||++|+.||...+......++..  .......|....+++++.++|.+|+ .+|.+|++   ++++++||||...
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            999999999987665443333221  1223345555678999999999987 59999997   9999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.3e-50  Score=376.64  Aligned_cols=252  Identities=30%  Similarity=0.507  Sum_probs=215.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCC-cEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..++|++.+.||+|+||.||+|.++.++ ..||+|.+.+..    ...+.+.+|+.+++.++||||+++++++.....+|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            4568999999999999999999977654 689999987532    22356778999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      +||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++....  
T Consensus       108 lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~--~ikL~DFG~a~~~~~--  183 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG--FIKMTDFGFAKVVDT--  183 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEecCCCCeecCC--
Confidence            9999999999999999888999999999999999999999999999999999999997665  499999999875432  


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+......+|  ..+++.+.
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~  256 (340)
T PTZ00426        184 RTYTLCGTPEYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLI----YQKILEGIIYFP--KFLDNNCK  256 (340)
T ss_pred             CcceecCChhhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHH
Confidence            2345679999999999987777655 9999999999999999999987655332    333333333333  34789999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017860          256 DLISRIFVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      ++|++||+.+|.+|+     +++++++||||..
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999999999995     8999999999975

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-50  Score=378.38  Aligned_cols=255  Identities=35%  Similarity=0.574  Sum_probs=219.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||+||+|++..+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997532    23356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---  175 (365)
                      ||+.+++|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++......   
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCccc
Confidence            99999999999988888999999999999999999999999999999999999987664  9999999987543332   


Q ss_pred             ---------------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH
Q 017860          176 ---------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK  228 (365)
Q Consensus       176 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  228 (365)
                                                 ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                       2344579999999999988877766 999999999999999999998876543


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccc
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-IPEIMKHQWFLK  283 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t-~~ell~h~~f~~  283 (365)
                      ...++...  ......|....+++++.+||.+||. +|.+||+ ++++++||||..
T Consensus       238 ~~~~i~~~--~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         238 TYNKIINW--KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHHHhcc--CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            33332221  1333455555579999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.7e-51  Score=362.57  Aligned_cols=259  Identities=30%  Similarity=0.478  Sum_probs=221.6

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC-----EEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~   98 (365)
                      .|+-.+.+|.|+||.||.+....+++.||||.+-.+.+..   .+|+.+|+.++|||||++.-+|....     .+.+||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            5889999999999999999999999999999987765433   47999999999999999999887542     456899


Q ss_pred             eecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||++ .+|...+..    +.+++.-.++-++.||++||+|||+.||+||||||.|||+|.+ .+.+||||||.|+....+
T Consensus       102 eymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~-tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  102 EYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPD-TGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             Hhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCC-CCeEEeccCCcceeeccC
Confidence            9995 488888874    5679999999999999999999999999999999999999855 457999999999998888


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------------
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------------  241 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------  241 (365)
                      +...+...|+.|+|||.+.+...++.+.||||.|||+.||+-|++.|.+.+...++..+++-+..+.             
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            8889999999999999999876666669999999999999999999999888877777665332211             


Q ss_pred             cCCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          242 YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       242 ~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ...|          .....++++.+|+.++|+.+|++|.++.|+|.||||.+...+
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            0111          123468999999999999999999999999999999876544

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-50  Score=370.57  Aligned_cols=245  Identities=33%  Similarity=0.574  Sum_probs=210.0

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ||+|+||.||+++++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999999999999999987532    2234577899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCCCcCCCC
Q 017860          107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA  185 (365)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~~~gt~~  185 (365)
                      .+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ......+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCcc
Confidence            999988888999999999999999999999999999999999999986664  999999998753222 22345679999


Q ss_pred             CCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccC
Q 017860          186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD  265 (365)
Q Consensus       186 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d  265 (365)
                      |+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+......++  ..+++++++||.+||..|
T Consensus       159 y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         159 YLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNE----MYRKILQEPLRFP--DGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             cCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHH----HHHHHHcCCCCCC--CcCCHHHHHHHHHHcCCC
Confidence            999999988777666 999999999999999999998765433    3333444444433  348899999999999999


Q ss_pred             CCCCC---CHHHHhcCcccccC
Q 017860          266 PAARI---TIPEIMKHQWFLKN  284 (365)
Q Consensus       266 p~~R~---t~~ell~h~~f~~~  284 (365)
                      |.+||   ++.+++.||||.+.
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCC
Confidence            99997   58999999999764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-51  Score=373.78  Aligned_cols=256  Identities=37%  Similarity=0.681  Sum_probs=232.4

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      =|.+.+.||+|-|++|.+|+|..+|..||||++.+..   .....+.+|+.-|+.++|||||++|++..+...+|+|.|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            5999999999999999999999999999999998743   3346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      -.+|+|+++|.+. ..+.|..++.++.||+.|+.|||+..+|||||||+|+.+-.. .|-|||.|||++....++....+
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~kL~T  177 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKKLTT  177 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcchhhc
Confidence            9999999999764 469999999999999999999999999999999999987532 34699999999999999999999


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      .||+..|-|||++.+..|+.+++||||||||+|-|+||++||+..++.+.+.    .|+...+.+|..  +|.+|++||.
T Consensus       178 sCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----mImDCKYtvPsh--vS~eCrdLI~  251 (864)
T KOG4717|consen  178 SCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----MIMDCKYTVPSH--VSKECRDLIQ  251 (864)
T ss_pred             ccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----hhhcccccCchh--hhHHHHHHHH
Confidence            9999999999999999999999999999999999999999999988866543    455566666655  8999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      .||..||.+|.+.+++..|+|++..-+
T Consensus       252 sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHhcCchhhccHHHHhccccccCCCC
Confidence            999999999999999999999976443

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-51  Score=377.57  Aligned_cols=255  Identities=31%  Similarity=0.497  Sum_probs=229.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCE-EEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-~~lv   97 (365)
                      .++|.+++++|+|+||.+++++++..++.|++|.+....   .......+|+.++++++|||||.+.+.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            468999999999999999999999999999999997543   344578899999999999999999999999988 9999


Q ss_pred             EeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      |+||+||+|.+.+.+.+  .|+|+.++.|+.|++.|+.|||+++|+|||||+.|||++.++.  |||+|||+|+......
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED  160 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCch
Confidence            99999999999997644  5899999999999999999999999999999999999988776  8999999999877766


Q ss_pred             -CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                       ...+.+|||.||.||++.+.+|..| +|||||||++|||++-+++|...+-.....++.+..     ..|.+..+|.++
T Consensus       161 ~~a~tvvGTp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----~~Plp~~ys~el  234 (426)
T KOG0589|consen  161 SLASTVVGTPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----YSPLPSMYSSEL  234 (426)
T ss_pred             hhhheecCCCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----CCCCCccccHHH
Confidence             6788899999999999999999888 999999999999999999999887766666655543     345666789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +.+|+.||..+|..||++.++|.+|..+..
T Consensus       235 ~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  235 RSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            999999999999999999999999887643

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.5e-50  Score=381.23  Aligned_cols=255  Identities=33%  Similarity=0.518  Sum_probs=214.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++.|..++.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999986532    22356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC----
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~----  174 (365)
                      ||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++......    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCcccccccccc
Confidence            99999999999998888999999999999999999999999999999999999986654  999999997422100    


Q ss_pred             ----------------------------------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHH
Q 017860          175 ----------------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM  214 (365)
Q Consensus       175 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  214 (365)
                                                              ......+||+.|+|||++.+..++.+ +|||||||++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyel  237 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEM  237 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeeh
Confidence                                                    00123479999999999988877766 9999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017860          215 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK  283 (365)
Q Consensus       215 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---t~~ell~h~~f~~  283 (365)
                      ++|+.||...+......++..  .......+....+++++.+||.+|+ .+|.+|+   |+.++++||||..
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999988765433322211  1122344555568999999999987 5999999   9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-51  Score=354.03  Aligned_cols=259  Identities=35%  Similarity=0.543  Sum_probs=224.7

Q ss_pred             CCCCcce-ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEe----CCEE
Q 017860           21 DSDRYDF-VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT----PTHL   94 (365)
Q Consensus        21 ~~~~y~~-~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~----~~~~   94 (365)
                      ..++|++ .++||-|-.|.|..+.++.+++.+|+|++...    ...++|+.+.-.. .|||||.++++|+.    ...+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL  134 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL  134 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence            3567888 47999999999999999999999999988653    4567888777555 69999999998864    3578


Q ss_pred             EEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccc
Q 017860           95 AIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS  171 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~  171 (365)
                      .+|||.++||.|++.++..+.  |+|.++..|++||..|+.|||+.+|.||||||+|+|+.... +..+||+|||+|+..
T Consensus       135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence            899999999999999998765  99999999999999999999999999999999999996443 456999999999987


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCC
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNP  249 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  249 (365)
                      .......+.|.||+|.|||++...+|+ +.+|+||+||++|.|+||++||........--....+|..+++.+|  .|..
T Consensus       215 ~~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~  293 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC  293 (400)
T ss_pred             CCCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence            777888999999999999999777776 4499999999999999999999987654433345556677777665  5778


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +|+.++++|+++|..+|.+|.|+.+++.|||+.+.
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            99999999999999999999999999999999764

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-50  Score=382.03  Aligned_cols=256  Identities=30%  Similarity=0.423  Sum_probs=219.2

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-C-----CCcceeceEEEeCCEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h-----pnIv~l~~~~~~~~~~~lv   97 (365)
                      ||.|++.||+|+||+|.+|.+..|++.||||+++.......+...|+.+|..|+ |     -|+|+++++|...+++|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            789999999999999999999999999999999988777778889999999997 3     3899999999999999999


Q ss_pred             EeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      +|++ ..+|+++++.++  .|+...++.++.||+.||.+||+.||||+|||||||||...+...|||+|||.|+....  
T Consensus       267 fELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q--  343 (586)
T KOG0667|consen  267 FELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ--  343 (586)
T ss_pred             ehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC--
Confidence            9999 569999998765  48999999999999999999999999999999999999877777899999999886533  


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------  241 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------  241 (365)
                      ...+.+-++.|+|||++.+.+|+.+ .||||||||++||++|.+.|.+.+...++..++.-+..++              
T Consensus       344 ~vytYiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff  422 (586)
T KOG0667|consen  344 RVYTYIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFF  422 (586)
T ss_pred             cceeeeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceeh
Confidence            3347888999999999999999888 9999999999999999999999887766654443211000              


Q ss_pred             ----------------------------------cCCC-CCC--------CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          242 ----------------------------------YSVP-DTN--------PISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       242 ----------------------------------~~~~-~~~--------~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                                                        ...| ...        .-...+.+||++||..||.+|+|+.++|+|
T Consensus       423 ~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  423 TSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             hccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                                              0011 000        012457999999999999999999999999


Q ss_pred             ccccc
Q 017860          279 QWFLK  283 (365)
Q Consensus       279 ~~f~~  283 (365)
                      |||..
T Consensus       503 pfl~~  507 (586)
T KOG0667|consen  503 PFLTG  507 (586)
T ss_pred             ccccc
Confidence            99984

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.5e-49  Score=370.69  Aligned_cols=246  Identities=35%  Similarity=0.608  Sum_probs=210.4

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +.||+|+||.||+++++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997642    22346778999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcCC
Q 017860          105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT  183 (365)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~gt  183 (365)
                      +|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCC
Confidence            99999988888999999999999999999999999999999999999986654  99999999875322 2233456799


Q ss_pred             CCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017860          184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV  263 (365)
Q Consensus       184 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  263 (365)
                      +.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+......+|  ..+++++.+||.+||+
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~----~~~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (328)
T cd05593         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEK----LFELILMEDIKFP--RTLSADAKSLLSGLLI  231 (328)
T ss_pred             cCccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHH----HHHHhccCCccCC--CCCCHHHHHHHHHHcC
Confidence            99999999987777655 999999999999999999998755432    2233333333333  3589999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCccccc
Q 017860          264 ADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       264 ~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      .||.+|+     ++.++++||||..
T Consensus       232 ~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         232 KDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            9999997     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=369.44  Aligned_cols=252  Identities=32%  Similarity=0.453  Sum_probs=212.0

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCCcE-EEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeCC-
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL-VAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPT-   92 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-   92 (365)
                      +..+.+...+.+.||.|+||+||++.+.  |+. ||+|++......   .+.+.+|+.+|++++|||||++++++..+. 
T Consensus        36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3444567788888999999999999885  555 999999764432   458999999999999999999999999887 


Q ss_pred             EEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           93 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~-ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      .+++||||+++|+|..++.+  ...++...+..++.||+.|+.|||+++ ||||||||+|||++.+. .++||||||+++
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr  192 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSR  192 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccce
Confidence            79999999999999999988  577999999999999999999999999 99999999999998775 259999999998


Q ss_pred             cccCC-CCCCCCcCCCCCCCchhhc--ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          170 SSVLH-SQPKSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       170 ~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      ..... ...+...||+.|||||++.  ...|+.+ +||||||+++|||+||+.||.........    ..+.....+.+.
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~----~~v~~~~~Rp~~  267 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVA----SAVVVGGLRPPI  267 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcCCCCCC
Confidence            65544 4445578999999999998  4577777 99999999999999999999987763322    222222222233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +...++.+..|+.+||..||.+||++.+++.
T Consensus       268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            3347899999999999999999999999875

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.5e-49  Score=371.31  Aligned_cols=257  Identities=30%  Similarity=0.524  Sum_probs=212.6

Q ss_pred             CcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC-----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~   94 (365)
                      +|++++.||+|+||.||++++.   .+++.||+|++.+..     ...+.+.+|+.+++.+ +||||+++++++..+..+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4899999999999999998874   478999999987532     2234577899999999 589999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ++||||+.+|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~  158 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSE  158 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCcccccc
Confidence            999999999999999988888999999999999999999999999999999999999987654  999999998754332


Q ss_pred             C--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          175 S--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       175 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .  .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||...............+.......  +..+++
T Consensus       159 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  236 (332)
T cd05614         159 EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF--PSFIGP  236 (332)
T ss_pred             CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCH
Confidence            2  223457999999999997655344559999999999999999999975443322223333333333333  345889


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          253 ECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .+.+|+.+||+.||.+||     +++++++||||...
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999999     88899999999763

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4e-49  Score=368.41  Aligned_cols=260  Identities=26%  Similarity=0.461  Sum_probs=215.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++++.||+|+||.||+++++.++..||+|.+....  .....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999999999999999987542  233578899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |+++++|.+++.....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.  +||+|||++..... ....
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~  160 (331)
T cd06649          84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN  160 (331)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-cccc
Confidence            999999999998888899999999999999999999986 5999999999999986654  99999999875432 2334


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHH------------------------
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI------------------------  234 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~------------------------  234 (365)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+... +...+                        
T Consensus       161 ~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (331)
T cd06649         161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGR  238 (331)
T ss_pred             cCCCCcCcCCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccc
Confidence            5679999999999988777666 999999999999999999997544321 11111                        


Q ss_pred             -------------------HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          235 -------------------QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       235 -------------------~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                                         ..+............+++++++||.+||+.||++|||+.++++||||.....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             cccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence                               1111111111112236889999999999999999999999999999986543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.4e-49  Score=370.20  Aligned_cols=247  Identities=35%  Similarity=0.605  Sum_probs=210.6

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +.||+|+||.||+++++.+|+.||+|++....    .....+.+|+.+++.++||||++++++|.....+|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997632    12245678999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcCC
Q 017860          105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT  183 (365)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~gt  183 (365)
                      +|..++...+.+++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++.... ........||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCC
Confidence            99999988888999999999999999999999999999999999999986654  99999999875322 2223456799


Q ss_pred             CCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017860          184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV  263 (365)
Q Consensus       184 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  263 (365)
                      +.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.....    ..+......+|  ..+++++.+||.+||.
T Consensus       159 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~----~~~~~~~~~~p--~~~~~~~~~li~~~L~  231 (323)
T cd05595         159 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFP--RTLSPEAKSLLAGLLK  231 (323)
T ss_pred             cCcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHHHHHHHcc
Confidence            99999999988777665 99999999999999999999876543322    22333333333  3588999999999999


Q ss_pred             cCCCCCC-----CHHHHhcCcccccC
Q 017860          264 ADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       264 ~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .||.+|+     ++.++++|+||.+.
T Consensus       232 ~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         232 KDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999998     89999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.8e-50  Score=372.98  Aligned_cols=255  Identities=29%  Similarity=0.496  Sum_probs=215.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||+++++.+|+.||+|++.....    ....+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            479999999999999999999999999999999976432    3356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860           99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      ||+++|+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCce
Confidence            999999999999876 67999999999999999999999999999999999999986654  99999999875433222 


Q ss_pred             -CCCCcCCCCCCCchhhcc------cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          177 -PKSTVGTPAYIAPEVLLR------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       177 -~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                       .....||+.|+|||++..      ..++.+ +|||||||++|+|++|+.||...+....+.++...  .....+|....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~  235 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVE-CDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPK  235 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCc-ceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCC
Confidence             233579999999999863      344444 99999999999999999999877665444333221  11224455556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +++++.+||.+||. +|.+|||+++++.||||..
T Consensus       236 ~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         236 VSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             CCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            89999999999997 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.3e-49  Score=375.03  Aligned_cols=259  Identities=30%  Similarity=0.487  Sum_probs=214.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|++.+.||+|+||.||+++++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++..+..+|+
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999999999999999987532    223457789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||||+++|+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++....... 
T Consensus       121 v~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGM  197 (370)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCc
Confidence            99999999999988654 6899999999999999999999999999999999999986654  9999999987543222 


Q ss_pred             -CCCCCcCCCCCCCchhhcccc---cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                       ...+.+||+.|+|||++.+..   +.+.++|||||||++|+|++|+.||...+....+.++...  .....+|....++
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s  275 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEIS  275 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCC
Confidence             224567999999999997543   2344599999999999999999999876654443333221  1234455555689


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCcccccC
Q 017860          252 QECRDLISRIFVADPAA--RITIPEIMKHQWFLKN  284 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~~  284 (365)
                      ..+++++.+||+.++.+  |+|+.++++||||...
T Consensus       276 ~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         276 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            99999999999865544  8899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.5e-49  Score=375.04  Aligned_cols=258  Identities=32%  Similarity=0.499  Sum_probs=215.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|++.+.||+|+||.||+++++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.++..+|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3568999999999999999999999999999999997532    222457789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||||++||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||++....... 
T Consensus       121 v~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         121 VMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGM  197 (370)
T ss_pred             EEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCc
Confidence            9999999999998865 46899999999999999999999999999999999999986654  9999999987543322 


Q ss_pred             -CCCCCcCCCCCCCchhhcccc---cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                       .....+||+.|+|||++.+..   ..+.++|||||||++|+|++|+.||...+....+.++...  .....+|....+|
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s  275 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEIS  275 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCC
Confidence             224567999999999986532   2344599999999999999999999886654433333221  1224455555689


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017860          252 QECRDLISRIFVADPAA--RITIPEIMKHQWFLK  283 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~  283 (365)
                      .++.+||.+||+.+|.+  |+|++++++||||..
T Consensus       276 ~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             HHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            99999999999999988  999999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-49  Score=375.73  Aligned_cols=256  Identities=30%  Similarity=0.521  Sum_probs=215.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+++++.+++.||+|++....    .....+.+|+.++..++||||+++++.+.....+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997532    22356778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC----
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~----  174 (365)
                      ||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++  ++||+|||+++.....    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~--~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG--HVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--CEEEeeccCCcccccccccc
Confidence            9999999999999888899999999999999999999999999999999999997665  4999999998643211    


Q ss_pred             --------------------------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCC
Q 017860          175 --------------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE  222 (365)
Q Consensus       175 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  222 (365)
                                                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~  237 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFC  237 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCC
Confidence                                            01124579999999999988888766 999999999999999999998


Q ss_pred             CCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccC
Q 017860          223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLKN  284 (365)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---t~~ell~h~~f~~~  284 (365)
                      ..+......++..  ......+|....+++++++||.+|+ .+|.+|+   +++++++||||...
T Consensus       238 ~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         238 SETPQETYRKVMN--WKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             CCCHHHHHHHHHc--CCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence            7765443333221  1122344555568999999999987 4999998   58999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.4e-49  Score=384.51  Aligned_cols=260  Identities=26%  Similarity=0.397  Sum_probs=210.6

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeC--------C
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP--------T   92 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--------~   92 (365)
                      ...+|++.+.||+|+||.||+|.+..+++.||||.+....   ....+|+.+++.++||||++++++|...        .
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            3468999999999999999999999999999999886543   3356799999999999999999987542        2


Q ss_pred             EEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           93 HLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      .+++||||+++ +|..++.    ....+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+|
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla  218 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSA  218 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-Cceeeeccccc
Confidence            57899999975 6666554    345699999999999999999999999999999999999997543 24999999999


Q ss_pred             ccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------
Q 017860          169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------  241 (365)
Q Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------  241 (365)
                      +...........+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+.++++......       
T Consensus       219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~  298 (440)
T PTZ00036        219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM  298 (440)
T ss_pred             hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            8765555556678999999999987654334449999999999999999999998776665555544321110       


Q ss_pred             ------cCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          242 ------YSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       242 ------~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                            ..++.          +...++++++||.+||+.||.+|||+.|+|+||||....
T Consensus       299 ~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~  358 (440)
T PTZ00036        299 NPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR  358 (440)
T ss_pred             chhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence                  01111          123678999999999999999999999999999997543

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.2e-49  Score=367.27  Aligned_cols=247  Identities=33%  Similarity=0.534  Sum_probs=209.0

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||+||+|+++.+++.||+|++.+..    .....+.+|..+++.+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987532    2234566788777766 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|..++.+.+.+++..++.++.|++.||+|||++|++||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCccccccc
Confidence            999999988888999999999999999999999999999999999999987664  99999999875322 223345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+.......+.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~i~~~~~~~~~--~~~~~~~~li~~~L  231 (320)
T cd05590         159 TPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDD----LFEAILNDEVVYPT--WLSQDAVDILKAFM  231 (320)
T ss_pred             CccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHH----HHHHHhcCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999987777666 999999999999999999998766533    23333334333333  47899999999999


Q ss_pred             ccCCCCCCCH------HHHhcCcccccC
Q 017860          263 VADPAARITI------PEIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~t~------~ell~h~~f~~~  284 (365)
                      +.||.+||++      +++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         232 TKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             ccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            9999999998      999999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.3e-49  Score=367.21  Aligned_cols=250  Identities=29%  Similarity=0.487  Sum_probs=208.2

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+++++.+++.||+|++.+...    ....+.+|..+++.+ +||||++++++|.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            469999999999999999999999999986321    224567888998888 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~~~~~~g  182 (365)
                      |+|..++.+.+++++..++.++.||+.||.|||++|++||||||+|||++.++.  +||+|||+++... ........+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccC
Confidence            999999988889999999999999999999999999999999999999986654  9999999987532 2333445679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----DFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......     ......+.+.......|  ..++.++.++
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~l  235 (329)
T cd05588         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKASSV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC--CCCCHHHHHH
Confidence            999999999988777766 999999999999999999996422111     11112233334444444  3488999999


Q ss_pred             HHHhcccCCCCCCC------HHHHhcCccccc
Q 017860          258 ISRIFVADPAARIT------IPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t------~~ell~h~~f~~  283 (365)
                      |.+||+.||.+|+|      ++++++||||..
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99999999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.4e-49  Score=367.95  Aligned_cols=247  Identities=36%  Similarity=0.592  Sum_probs=209.9

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +.||+|+||.||++.++.+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++..+..+|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997632    12245678899999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      +|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccC
Confidence            999999888889999999999999999999997 89999999999999986664  99999999875322 223345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|  ..+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~li~~~L  231 (325)
T cd05594         159 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKL----FELILMEEIRFP--RTLSPEAKSLLSGLL  231 (325)
T ss_pred             CcccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHH----HHHHhcCCCCCC--CCCCHHHHHHHHHHh
Confidence            999999999988777665 9999999999999999999987654332    222333333333  347899999999999


Q ss_pred             ccCCCCCC-----CHHHHhcCcccccC
Q 017860          263 VADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      +.||.+|+     ++.++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            99999997     99999999999763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.7e-49  Score=365.39  Aligned_cols=252  Identities=32%  Similarity=0.543  Sum_probs=213.1

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCC-CCcceeceEEEeCCEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~   98 (365)
                      +|++++.||+|+||.||+|+++.+++.||+|++.+..    ...+.+..|..+++.++| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4899999999999999999999999999999997532    223456788888888876 46888999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~  177 (365)
                      ||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCce
Confidence            99999999999988888999999999999999999999999999999999999986654  99999999874322 2233


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....    ...+.......|  ..+++++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~l  231 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDEL----FQSIMEHNVSYP--KSLSKEAVSI  231 (324)
T ss_pred             eeecCCccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHH
Confidence            45679999999999988777666 9999999999999999999987665333    233333333333  3588999999


Q ss_pred             HHHhcccCCCCCCCH-----HHHhcCcccccC
Q 017860          258 ISRIFVADPAARITI-----PEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t~-----~ell~h~~f~~~  284 (365)
                      +.+||..||.+|++.     +++++||||...
T Consensus       232 i~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999976     899999999763

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-48  Score=358.07  Aligned_cols=255  Identities=25%  Similarity=0.396  Sum_probs=215.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +|++.+.||+|+||.||++.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            58999999999999999999999999999999875321    22456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860          100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |+.+|+|...+...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG--HIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC--CEEEeeCCCceecCCCCcc
Confidence            99999999887653  4589999999999999999999999999999999999998665  4999999998765444444


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+|++.|+|||++.+..++.+ +||||+||++|+|++|..||.+.............+.......  ...++..+.+|
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l  235 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSEAARSI  235 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc--CcccCHHHHHH
Confidence            55689999999999987777666 8999999999999999999987655433333333333322222  33488999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHhcCccccc
Q 017860          258 ISRIFVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      +.+||..||.+||     +++++++||||.+
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            9999999999999     8999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-48  Score=364.40  Aligned_cols=248  Identities=31%  Similarity=0.543  Sum_probs=210.3

Q ss_pred             ecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC-----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++.||+|+||.||++++.   .+++.||+|++.+..     .....+.+|+.+++.++||||++++++|..+..+|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999874   478899999987532     223456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~  178 (365)
                      |+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++..... ....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG--HVKLTDFGLCKESIHEGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC--CEEEeeCcCCeecccCCCccc
Confidence            999999999999888899999999999999999999999999999999999998665  4999999998743322 2234


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+.......|  ..+++.+.+||
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~~li  231 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKK----TIDKILKGKLNLP--PYLTPEARDLL  231 (323)
T ss_pred             ccCCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHHH
Confidence            4579999999999987777655 999999999999999999998766533    3333444443333  34789999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          259 SRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       259 ~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .+||+.+|.+||     ++++++.||||...
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.8e-49  Score=373.26  Aligned_cols=254  Identities=20%  Similarity=0.289  Sum_probs=206.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      ..+|++++.||+|+||.||+|.+..+++.||+|....     ..+.+|+.+++.++||||++++++|......++|+|++
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            3579999999999999999999999999999997543     35689999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC--CCCCCC
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKS  179 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~--~~~~~~  179 (365)
                      . ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....  ......
T Consensus       166 ~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        166 K-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             C-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCccccccccccccccc
Confidence            5 689988888888999999999999999999999999999999999999986654  99999999864322  122345


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHh--------------
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQRIL--------------  238 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~--------------  238 (365)
                      .+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....       ...+..++....              
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~  321 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL  321 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence            679999999999988777655 9999999999999999988754321       111111111110              


Q ss_pred             --------ccccC----CCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          239 --------SVQYS----VPD---TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       239 --------~~~~~----~~~---~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                              .....    .+.   ...++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                    00000    011   11246789999999999999999999999999999763

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-48  Score=364.12  Aligned_cols=246  Identities=31%  Similarity=0.505  Sum_probs=208.7

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+|+++.+++.||+|++.+..    .....+..|..+++.+ +||||++++++|..+..+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999997632    2224466788888755 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      ++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence            999999988888999999999999999999999999999999999999987654  99999999875332 223345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+    ..+.......|.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~ll~~~L  231 (321)
T cd05591         159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLF----ESILHDDVLYPV--WLSKEAVSILKAFM  231 (321)
T ss_pred             CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence            999999999988777766 99999999999999999999876654333    333334333333  37899999999999


Q ss_pred             ccCCCCCC-------CHHHHhcCccccc
Q 017860          263 VADPAARI-------TIPEIMKHQWFLK  283 (365)
Q Consensus       263 ~~dp~~R~-------t~~ell~h~~f~~  283 (365)
                      +.+|.+||       +++++++||||..
T Consensus       232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         232 TKNPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             ccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            99999999       9999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.9e-49  Score=367.93  Aligned_cols=257  Identities=29%  Similarity=0.427  Sum_probs=205.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC-----CEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLA   95 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~   95 (365)
                      +|++.+.||+|+||.||+++++.+++.||+|.+....   .....+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6999999999999999999999999999999986432   1224578899999999999999999988643     3589


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      +||||+. ++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~  157 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDT  157 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCcccccccccc
Confidence            9999995 689999988888999999999999999999999999999999999999986654  9999999987532221


Q ss_pred             ----CCCCCcCCCCCCCchhhcc--cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH--------------
Q 017860          176 ----QPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ--------------  235 (365)
Q Consensus       176 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~--------------  235 (365)
                          ......||+.|+|||++.+  ..++.+ +|||||||++|+|++|++||.+.+..........              
T Consensus       158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (338)
T cd07859         158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVR  236 (338)
T ss_pred             CccccccCCCCCCCcCCHHHHhccccccCch-hHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence                1234579999999999865  455545 9999999999999999999987654322211110              


Q ss_pred             ---------HHhcccc-CC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          236 ---------RILSVQY-SV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       236 ---------~~~~~~~-~~-~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                               .+..... .. .....+++.+.++|.+||..+|++|||++++++||||...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         237 NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence                     0000000 00 0112467889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.5e-48  Score=364.11  Aligned_cols=250  Identities=29%  Similarity=0.495  Sum_probs=206.9

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+++++.+++.||+|++.+...    ....+.+|+.++..+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999986421    224466788887766 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|..++...+++++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999987664  99999999875322 223345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC-----hHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----PKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....     ..........+......+|  ..++..+.+|
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~~~~~~~l  235 (329)
T cd05618         159 TPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLSVKAASV  235 (329)
T ss_pred             CccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC--CCCCHHHHHH
Confidence            999999999988877666 9999999999999999999963211     1111112233333444444  3478999999


Q ss_pred             HHHhcccCCCCCCC------HHHHhcCccccc
Q 017860          258 ISRIFVADPAARIT------IPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t------~~ell~h~~f~~  283 (365)
                      |.+||+.||.+|||      ++++++||||..
T Consensus       236 l~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99999999999998      589999999965

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.1e-48  Score=364.25  Aligned_cols=250  Identities=34%  Similarity=0.566  Sum_probs=208.9

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHH---hcCCCCCcceeceEEEeCCEEEEE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l---~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      |++++.||+|+||.||++.++.+++.||+|++.+..    ...+.+.+|+.++   +.++||||+++++++.....+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            789999999999999999999999999999997532    1224455665544   567899999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~  176 (365)
                      |||+++++|...+.. +.+++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++.... ...
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCc
Confidence            999999999887754 56999999999999999999999999999999999999987664  99999999875332 223


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.....    ..+.......|  ..+++.+.+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~  230 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVF----DSIVNDEVRYP--RFLSREAIS  230 (324)
T ss_pred             ccccccCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHH
Confidence            345679999999999988777666 99999999999999999999876553332    23333333333  347899999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          257 LISRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       257 li~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      ||.+||+.||.+||     ++.++++||||...
T Consensus       231 li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         231 IMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            99999999999999     79999999999753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-48  Score=356.79  Aligned_cols=255  Identities=28%  Similarity=0.428  Sum_probs=206.1

Q ss_pred             CCcceecccccCCCeEEEEEEEcc-CCcEEEEEEeecCC---cccHHHHHHHHHHhcC---CCCCcceeceEEE-----e
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL-----T   90 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~-----~   90 (365)
                      .+|++++.||+|+||.||+|++.. +++.||+|.+....   .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            379999999999999999999854 56889999987532   2234566777776655   6999999999985     3


Q ss_pred             CCEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           91 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      ...+++||||+. ++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+|||++.++.  +||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccce
Confidence            456899999996 5898888653  35899999999999999999999999999999999999986654  999999998


Q ss_pred             ccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCC--
Q 017860          169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP--  245 (365)
Q Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~--  245 (365)
                      +............||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+....+.++........ ..++  
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            76554444556679999999999988777666 9999999999999999999998777665555543321100 0000  


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          246 ------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       246 ------------------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                                        ....+++.+.+|+.+||+.||++|||+.++|+||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                              012367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.6e-48  Score=366.86  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=209.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCC------
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT------   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------   92 (365)
                      .++|++.+.||+|+||.||++.+..+|+.||+|.+....   .....+.+|+.+++.++||||+++++++....      
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            468999999999999999999999999999999986532   23356778999999999999999999987543      


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|+||||+.+ +|...+.  ..+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~  174 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAC  174 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccc
Confidence            57999999975 5655553  34899999999999999999999999999999999999987654  9999999998655


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH---------------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI---------------  237 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  237 (365)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+.....               
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            4444556789999999999988888776 999999999999999999998766543332222111               


Q ss_pred             ---hccccCC--------------C----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          238 ---LSVQYSV--------------P----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       238 ---~~~~~~~--------------~----~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                         .......              +    .....++++++||.+||+.||.+|||+.|+|.||||.....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence               0000000              0    01124678999999999999999999999999999986554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.3e-48  Score=362.66  Aligned_cols=247  Identities=33%  Similarity=0.526  Sum_probs=206.7

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhc-CCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+++++.+|+.||+|++.+..    ........|..++.. ++||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997632    222445667777764 5899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|..++...+++++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCC
Confidence            999999988888999999999999999999999999999999999999986654  99999999874322 223345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......+.  .++.++++||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~----~~~~~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05620         159 TPDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDEL----FESIRVDTPHYPR--WITKESKDILEKLF  231 (316)
T ss_pred             CcCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHHHHHc
Confidence            999999999988877766 9999999999999999999987654332    2222223333333  37899999999999


Q ss_pred             ccCCCCCCCH-HHHhcCcccccC
Q 017860          263 VADPAARITI-PEIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~t~-~ell~h~~f~~~  284 (365)
                      +.||.+||++ +++++||||...
T Consensus       232 ~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         232 ERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             cCCHHHcCCChHHHHcCCCcCCC
Confidence            9999999998 588899999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.7e-48  Score=369.37  Aligned_cols=259  Identities=32%  Similarity=0.513  Sum_probs=213.6

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|++.+.||+|+||.||+++++.+++.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3579999999999999999999999999999999987532    122456789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...... 
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~--~ikL~DfG~a~~~~~~~~  197 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG--HLKLADFGTCMKMNKEGM  197 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC--CEEEEeCCceeEcCcCCc
Confidence            99999999999988654 589999999999999999999999999999999999998665  49999999987543322 


Q ss_pred             -CCCCCcCCCCCCCchhhcccc---cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                       .....+||+.|+|||++.+..   ..+.++|||||||++|+|++|..||...+....+.++...  .....+|....++
T Consensus       198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s  275 (371)
T cd05622         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDIS  275 (371)
T ss_pred             ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCC
Confidence             224567999999999987543   2334599999999999999999999876654433333221  1223456666789


Q ss_pred             HHHHHHHHHhcccCCCC--CCCHHHHhcCcccccC
Q 017860          252 QECRDLISRIFVADPAA--RITIPEIMKHQWFLKN  284 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~~  284 (365)
                      ..+++||.+||..++.+  |++++++++|+||...
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            99999999999844443  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-48  Score=362.03  Aligned_cols=251  Identities=32%  Similarity=0.535  Sum_probs=212.4

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      +|++.+.||+|+||.||+++++.+++.||+|++.+...    .......|..++..+ +||+|+++++++.....+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            48999999999999999999999999999999976421    123455677777666 5899999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~  177 (365)
                      ||+++|+|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... ....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCcc
Confidence            99999999999988888999999999999999999999999999999999999987664  99999999875332 2233


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|  ..++.++.+|
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~~l  231 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYP--KSMSKEAVAI  231 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCC--CcCCHHHHHH
Confidence            45679999999999988888766 9999999999999999999987655333    333333443333  3489999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      +.+||+.+|.+|++     ..+++.||||+.
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         232 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            99999999999997     489999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.7e-48  Score=362.06  Aligned_cols=258  Identities=28%  Similarity=0.479  Sum_probs=213.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++.++||+|+||.||++.++.++..+|+|.+....  .....+.+|+.+++.++||||++++++|...+.+++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999999999999999987542  233568899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |+.+++|.+++.+.+.+++..++.++.|++.||.|||++ +++||||||+|||++.++.  +||+|||++..... ....
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~  160 (333)
T cd06650          84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMAN  160 (333)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hccc
Confidence            999999999998888899999999999999999999985 7999999999999986654  99999999874422 2234


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHH-------------------------
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT-------------------------  233 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~-------------------------  233 (365)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ....                         
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPVEGDPAESETSPRPRPPGRPL  238 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhH-HHHHhcCcccCCccccccCcccCCccchh
Confidence            4578999999999987777666 999999999999999999997643311 1111                         


Q ss_pred             ----------------HHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          234 ----------------IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       234 ----------------~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                      ...+............++.++++|+.+||+.||++|||+.|++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                            111111111111112367899999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.8e-48  Score=364.96  Aligned_cols=258  Identities=28%  Similarity=0.460  Sum_probs=209.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|+++++||+|+||.||+++++.+++.||+|++....  .....+.+|+.+++.++|+||+++++++.....+++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            457999999999999999999999999999999986543  233568899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      |+.+++|...    ...++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... ...
T Consensus       153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceeccccccccc
Confidence            9999998643    34578889999999999999999999999999999999987654  9999999987543322 234


Q ss_pred             CCcCCCCCCCchhhcc----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          179 STVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ...||+.|+|||++..    ..+.+.++|||||||++|+|++|+.||...... .+......+... ........++.++
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~l  304 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLMCAICMS-QPPEAPATASREF  304 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHHHHHhcc-CCCCCCCccCHHH
Confidence            5679999999998743    234444599999999999999999999743322 222222222211 1122234578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ++||.+||..||.+|||+.|+++||||.+..+.
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~  337 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILRAQPG  337 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence            999999999999999999999999999887544

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.9e-48  Score=364.26  Aligned_cols=260  Identities=27%  Similarity=0.428  Sum_probs=211.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC------
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------   91 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------   91 (365)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++....   .....+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3579999999999999999999999999999999987532   2335677899999999999999999988643      


Q ss_pred             CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ..+|+||||+.+ +|...+..  .+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~  176 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA  176 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCcccc
Confidence            357999999965 67666643  4889999999999999999999999999999999999986654  999999999865


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-----------  240 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------  240 (365)
                      ..........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+++..+...           
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT  255 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH
Confidence            55444556689999999999988887766 999999999999999999998876655544443321110           


Q ss_pred             -------ccC--------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          241 -------QYS--------------V----PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       241 -------~~~--------------~----~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                             ...              .    ......+..+++||.+||+.||.+|||+.++|+||||.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~  326 (364)
T cd07875         256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  326 (364)
T ss_pred             HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence                   000              0    001123567899999999999999999999999999976443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.2e-48  Score=361.41  Aligned_cols=247  Identities=35%  Similarity=0.565  Sum_probs=209.4

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||+||++.++.+++.||+|++.+..    .....+.+|..+++.+ +||||+++++++.....+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998642    2234566788888777 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|...+.+.+++++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence            999999988888999999999999999999999999999999999999987664  99999999875322 222344579


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+.......+  ..++.++.+||.+||
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (318)
T cd05570         159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDEL----FQSILEDEVRYP--RWLSKEAKSILKSFL  231 (318)
T ss_pred             CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCCCC--CcCCHHHHHHHHHHc
Confidence            999999999988888766 9999999999999999999987654332    223333333333  347899999999999


Q ss_pred             ccCCCCCCCH-----HHHhcCcccccC
Q 017860          263 VADPAARITI-----PEIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~t~-----~ell~h~~f~~~  284 (365)
                      ..||.+|||+     .+++.||||...
T Consensus       232 ~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         232 TKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             cCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            9999999999     999999999763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.7e-48  Score=361.54  Aligned_cols=247  Identities=32%  Similarity=0.534  Sum_probs=206.1

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHH-HHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||+||+++++.+|+.||+|++.+...    ....+.+|. .+++.++||||+++++++.....+|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            469999999999999999999999999975321    123344444 356789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccC
Confidence            999999998888999999999999999999999999999999999999987654  99999999875322 223345579


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+.......+  ..+++.+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (323)
T cd05575         159 TPEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEM----YDNILNKPLRLK--PNISVSARHLLEGLL  231 (323)
T ss_pred             ChhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHHHHHHh
Confidence            999999999988777666 9999999999999999999987654332    333333333332  347899999999999


Q ss_pred             ccCCCCCCCH----HHHhcCcccccC
Q 017860          263 VADPAARITI----PEIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~t~----~ell~h~~f~~~  284 (365)
                      +.||.+||++    .++++||||...
T Consensus       232 ~~~p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         232 QKDRTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             hcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999999987    699999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.9e-48  Score=359.36  Aligned_cols=246  Identities=36%  Similarity=0.588  Sum_probs=204.7

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhc-CCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+|++..+++.||+|++....    ...+....|..++.. .+||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997532    122334556666654 5899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|..++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999986654  99999999875332 233345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....    ...+.......|  ..++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~~--~~~~~~~~~ll~~~l  231 (316)
T cd05592         159 TPDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDEL----FDSILNDRPHFP--RWISKEAKDCLSKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHHHHHHc
Confidence            999999999988777766 9999999999999999999987665332    223333333333  347899999999999


Q ss_pred             ccCCCCCCCH-HHHhcCccccc
Q 017860          263 VADPAARITI-PEIMKHQWFLK  283 (365)
Q Consensus       263 ~~dp~~R~t~-~ell~h~~f~~  283 (365)
                      ..+|.+||++ .+++.||||..
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         232 ERDPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             cCCHHHcCCChHHHHcCcccCC
Confidence            9999999986 58889999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-50  Score=377.02  Aligned_cols=257  Identities=28%  Similarity=0.444  Sum_probs=223.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeec-CCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +.+-|.|+..||.|+||.||+|.++.++-..|.|++.. +...-+++.-||.||..+.||+||++++.|..++.++++.|
T Consensus        30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE  109 (1187)
T KOG0579|consen   30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE  109 (1187)
T ss_pred             HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence            45679999999999999999999999998889999864 33445778889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc-ccCCCCC
Q 017860          100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~-~~~~~~~  177 (365)
                      ||.||.....+..-+ .|++.+++.+++|++.||+|||+++|||||||..|||++.+|.  |+|+|||++.. .......
T Consensus       110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhh
Confidence            999999988887754 5999999999999999999999999999999999999988876  99999998753 3334456


Q ss_pred             CCCcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          178 KSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .+++|||+|||||+..     ..+|+++ +||||||+++.||..+.+|....+...-+.++.   ...++.+..+..+|.
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKia---KSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLLQPSHWSR  263 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHh---hcCCCcccCcchhhh
Confidence            7889999999999974     4578888 899999999999999999988766544333332   234455666777999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+.||+++||.+||..||+++++|+||||..
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            9999999999999999999999999999974

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-51  Score=353.98  Aligned_cols=260  Identities=24%  Similarity=0.415  Sum_probs=225.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      +-|.++++||+|+||.||+|.|+.+|+.+|||.+..... .+++.+|+.+|.+++.|+||++|+.+.....+++|||||.
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD-LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD-LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch-HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            448999999999999999999999999999999876543 3678999999999999999999999999999999999999


Q ss_pred             CCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc-cCCCCCCCC
Q 017860          103 GGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST  180 (365)
Q Consensus       103 ~g~L~~~l~-~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~-~~~~~~~~~  180 (365)
                      .|++.+.+. ++++++|.++..+++..+.||+|||...-+|||||..|||++.++  +.||+|||+|... .+-....+.
T Consensus       112 AGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G--~AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  112 AGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG--IAKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             CCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc--hhhhhhccccchhhhhHHhhCcc
Confidence            999999986 466799999999999999999999999999999999999996555  5999999998642 334456778


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR  260 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  260 (365)
                      +|||.|||||++..-+|+.+ +||||||++..||..|++||.......   .+.--..++++.+..+..+|.++.+|+++
T Consensus       190 IGTPFWMAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTFKKPEEWSSEFNDFIRS  265 (502)
T ss_pred             ccCcccccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence            99999999999999999988 899999999999999999998765522   22222223344555666689999999999


Q ss_pred             hcccCCCCCCCHHHHhcCcccccCCCCCc
Q 017860          261 IFVADPAARITIPEIMKHQWFLKNLPADL  289 (365)
Q Consensus       261 ~l~~dp~~R~t~~ell~h~~f~~~~~~~~  289 (365)
                      ||.++|++|-|+-++++|||++.....+.
T Consensus       266 CLiK~PE~R~TA~~L~~H~FiknA~g~~I  294 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCEHTFIKNAPGCDI  294 (502)
T ss_pred             HhcCCHHHHHHHHHHhhhhhhcCCCcccH
Confidence            99999999999999999999987655543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.4e-48  Score=359.78  Aligned_cols=247  Identities=33%  Similarity=0.554  Sum_probs=206.6

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhc-CCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||+||+++++.+++.||+|++....    ........|..+++. ++||||+++++++.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997642    223445667777765 5899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|...+....++++.+++.++.|++.||.|||++|++||||||+|||++.++.  +||+|||+++.... ........|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecC
Confidence            999999988888999999999999999999999999999999999999987654  99999999875322 223345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+.......+.  .++.++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~----~~~i~~~~~~~~~--~~~~~~~~li~~~l  231 (316)
T cd05619         159 TPDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEEL----FQSIRMDNPCYPR--WLTREAKDILVKLF  231 (316)
T ss_pred             CccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHHHHHHh
Confidence            999999999988777666 9999999999999999999987654332    2222222223333  37899999999999


Q ss_pred             ccCCCCCCCHH-HHhcCcccccC
Q 017860          263 VADPAARITIP-EIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~t~~-ell~h~~f~~~  284 (365)
                      +.+|.+||++. +++.||||...
T Consensus       232 ~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         232 VREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             ccCHhhcCCChHHHHcCcccCCC
Confidence            99999999996 89999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.6e-48  Score=353.51  Aligned_cols=248  Identities=30%  Similarity=0.423  Sum_probs=206.8

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ||+|+||+||++.++.+++.||+|.+.+...    ..+.+..|+.+++.++||||+++.+++..+..+|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            7999999999999999999999999875422    124567899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCCCc
Q 017860          107 FERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV  181 (365)
Q Consensus       107 ~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~~~  181 (365)
                      ...+..    ...+++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||++....... ......
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccC
Confidence            887743    346899999999999999999999999999999999999976554  9999999987543322 233457


Q ss_pred             CCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       182 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      ||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+......  .+..+++.+.+++.+|
T Consensus       159 g~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~  235 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT--YPDKFSPASKSFCEAL  235 (280)
T ss_pred             CCcCccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC--CcccCCHHHHHHHHHH
Confidence            9999999999988887766 999999999999999999998755433333333333333322  2345889999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCccccc
Q 017860          262 FVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       262 l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      |+.||.+||     +++++++||||..
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            999999999     8899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-49  Score=345.68  Aligned_cols=253  Identities=38%  Similarity=0.643  Sum_probs=223.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|..++.||+|.||+|-+++.+.+++.||||++++.....    ..-..|-.+|+..+||.+..+.-.|++...+|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            468999999999999999999999999999999998765433    2345678899999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~  176 (365)
                      |||..||.|+-.+.+...|+|..++.+-..|+.||.|||+++||.||||.+|+|+|.++.  +||+|||+++... .+..
T Consensus       247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccce
Confidence            999999999999999889999999999999999999999999999999999999987764  9999999998644 3455


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ..+.||||.|.|||++....|... +|+|.+|+++|||+||+.||...+....+.    -|+.....+|..  +|++++.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgra-VDWWG~GVVMYEMmCGRLPFyn~dh~kLFe----LIl~ed~kFPr~--ls~eAkt  397 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRA-VDWWGVGVVMYEMMCGRLPFYNKDHEKLFE----LILMEDLKFPRT--LSPEAKT  397 (516)
T ss_pred             eccccCChhhcCchhhccccccce-eehhhhhHHHHHHHhccCcccccchhHHHH----HHHhhhccCCcc--CCHHHHH
Confidence            788999999999999998888655 999999999999999999999877655443    334444455554  8999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017860          257 LISRIFVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       257 li~~~l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      |+..+|.+||.+|.     .+.|+..|+||..
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            99999999999998     5899999999975

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-48  Score=379.36  Aligned_cols=262  Identities=25%  Similarity=0.381  Sum_probs=207.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC------CCcceeceEEEeC-CEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTP-THL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h------pnIv~l~~~~~~~-~~~   94 (365)
                      .++|++++.||+|+||+||+|.+..+++.||||++............|+.+++.++|      +++++++++|... .++
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~  207 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM  207 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence            468999999999999999999999999999999997644444556677777776654      4588999988765 578


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCC--------------CC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPA--------------PR  159 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~--------------~~  159 (365)
                      |+||+++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++.              ..
T Consensus       208 ~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        208 CIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             EEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            9999998 77899999888889999999999999999999998 59999999999999976542              24


Q ss_pred             EEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc
Q 017860          160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      +||+|||.+...  .......+||+.|+|||++.+..++.+ +|||||||++|||++|+.||...+....+..+...+..
T Consensus       287 vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~  363 (467)
T PTZ00284        287 VRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR  363 (467)
T ss_pred             EEECCCCccccC--ccccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence            999999987532  223456789999999999988888766 99999999999999999999876654433222111100


Q ss_pred             cc-------------------cC-CCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          240 VQ-------------------YS-VPD----------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       240 ~~-------------------~~-~~~----------------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+                   .. .+.                ....++.+.+||.+||+.||.+|||++|+|+||||.+
T Consensus       364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence            00                   00 000                0001456789999999999999999999999999987


Q ss_pred             CCCC
Q 017860          284 NLPA  287 (365)
Q Consensus       284 ~~~~  287 (365)
                      ..+.
T Consensus       444 ~~~~  447 (467)
T PTZ00284        444 YYPE  447 (467)
T ss_pred             cCCc
Confidence            6543

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2e-48  Score=361.70  Aligned_cols=248  Identities=31%  Similarity=0.551  Sum_probs=209.6

Q ss_pred             ecccccCCCeEEEEEEEc---cCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           28 VRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      ++.||+|+||.||++++.   .+|+.||+|++.+...   ....+.+|+.+++.++||||+++++++..+..+|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            367999999999999873   5789999999975321   2245678999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCCC
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~~  180 (365)
                      .+|+|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ......
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~  158 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSF  158 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecc
Confidence            99999999988888999999999999999999999999999999999999986654  999999998754333 233456


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR  260 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  260 (365)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+.......|  ..+++++.+||.+
T Consensus       159 ~g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~li~~  231 (318)
T cd05582         159 CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKET----MTMILKAKLGMP--QFLSPEAQSLLRA  231 (318)
T ss_pred             cCChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHHHHH
Confidence            79999999999987777655 9999999999999999999987654332    233333333333  3478999999999


Q ss_pred             hcccCCCCCCC-----HHHHhcCcccccC
Q 017860          261 IFVADPAARIT-----IPEIMKHQWFLKN  284 (365)
Q Consensus       261 ~l~~dp~~R~t-----~~ell~h~~f~~~  284 (365)
                      ||+.||.+||+     +.+++.||||...
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            99999999999     7789999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.3e-48  Score=352.08  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=205.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcC---CCCCcceeceEEEe-----CC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVILT-----PT   92 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~-----~~   92 (365)
                      +|++++.||+|+||+||+|+++.+++.||+|.+....   .......+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5999999999999999999999999999999987532   2234566777766655   79999999998864     34


Q ss_pred             EEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           93 HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      .+++||||+.+ +|..++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++.
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARI  157 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCcccc
Confidence            68999999975 888888664  34899999999999999999999999999999999999986654  99999999886


Q ss_pred             ccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCC----
Q 017860          171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP----  245 (365)
Q Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~----  245 (365)
                      ...........||+.|+|||++.+..++.+ +|||||||++|+|++|++||........+.++........ ..++    
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07863         158 YSCQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVT  236 (288)
T ss_pred             ccCcccCCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence            554444455678999999999988777666 9999999999999999999987766554444433221100 0000    


Q ss_pred             ----------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          246 ----------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       246 ----------------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                                      ....+++.+.+||.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                            012467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-48  Score=359.48  Aligned_cols=258  Identities=27%  Similarity=0.490  Sum_probs=208.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+..    ...+.+.+|+.+++.++||||++++++|..+..+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997532    22345778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860           99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      ||+.+|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTV  158 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCc
Confidence            99999999999976 457999999999999999999999999999999999999976654  99999999865433222 


Q ss_pred             -CCCCcCCCCCCCchhhcc----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC-CCCCC
Q 017860          177 -PKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPI  250 (365)
Q Consensus       177 -~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  250 (365)
                       .....||+.|+|||++.+    ....+.++|||||||++|+|++|+.||..........++...  ......+ ....+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~  236 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDV  236 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCC
Confidence             223469999999999863    222334499999999999999999999876554433332221  1112222 22347


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCcccccC
Q 017860          251 SQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN  284 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~~  284 (365)
                      ++.+++||.+||..++++  |+++.++++||||...
T Consensus       237 ~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         237 SEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             CHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            999999999998654444  7899999999999653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.8e-48  Score=356.20  Aligned_cols=261  Identities=26%  Similarity=0.450  Sum_probs=211.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ..++|++.++||+|+||.||+++++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++..+..+++||
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            3568999999999999999999999999999999987532  23356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-C
Q 017860           99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~  176 (365)
                      ||+.+ +|..++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.  +||+|||+++...... .
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~  160 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKT  160 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCccc
Confidence            99975 787777654 45899999999999999999999999999999999999986654  9999999987533222 2


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q  241 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~  241 (365)
                      .....+|+.|+|||++.+....+.++|||||||++|+|++|+.||...+....+..+.......               .
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07872         161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN  240 (309)
T ss_pred             cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence            3345689999999998765433445999999999999999999998776544433332211100               0


Q ss_pred             cCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          242 YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       242 ~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ...+         ....+++++++||.+||+.||.+|||+.|+++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            0011         112468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-48  Score=362.52  Aligned_cols=247  Identities=32%  Similarity=0.524  Sum_probs=203.6

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcC---CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      ||+|+||+||+|+++.+++.||+|++.+....    ......|..++..+   +||||+++++++.....+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999753211    12334455555544   799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCccC
Confidence            999999998889999999999999999999999999999999999999987654  99999999875332 233445679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+....+.++|||||||++|+|++|+.||...+...    ....+......++.. .+++++.+||.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~-~~~~~~~~li~~~L  233 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ----MYRNIAFGKVRFPKN-VLSDEGRQFVKGLL  233 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH----HHHHHHcCCCCCCCc-cCCHHHHHHHHHHc
Confidence            9999999999765433445999999999999999999998765433    233333333444432 37899999999999


Q ss_pred             ccCCCCCC----CHHHHhcCcccccC
Q 017860          263 VADPAARI----TIPEIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~----t~~ell~h~~f~~~  284 (365)
                      ..||.+||    ++.++++||||...
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcCccccCC
Confidence            99999998    79999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.8e-48  Score=367.49  Aligned_cols=258  Identities=25%  Similarity=0.388  Sum_probs=210.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCC-----EEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA   95 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~   95 (365)
                      +|++.++||+|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4889999999999999999999999999999986432   12356789999999999999999999998876     799


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-  174 (365)
                      +||||+. ++|...+...+.+++..++.++.||+.||.|||++|++||||||+|||++.++.  +||+|||+++..... 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~  157 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDE  157 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCc
Confidence            9999996 578888888888999999999999999999999999999999999999986654  999999998754322 


Q ss_pred             -CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHH-----------------
Q 017860          175 -SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-----------------  236 (365)
Q Consensus       175 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~-----------------  236 (365)
                       .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+...                 
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence             22334568999999999987554445599999999999999999999877654433322211                 


Q ss_pred             --HhccccCC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          237 --ILSVQYSV-------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       237 --~~~~~~~~-------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                        +.......       ......++++.+||.+||+.||.+|||+.+++.||||...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence              11111111       1123457899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-47  Score=357.49  Aligned_cols=252  Identities=31%  Similarity=0.541  Sum_probs=212.2

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      +|++.+.||+|+||.||+|+++.+|+.||+|++.+..    ...+.+..|..+++.+. |++|+++++++.....+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4888999999999999999999999999999987532    12245667888888775 578889999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~  177 (365)
                      ||+++|+|..++.+.+.+++.+++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccc
Confidence            99999999999988888999999999999999999999999999999999999987654  9999999987533222 23


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ..+.+.......|  ..++.++.++
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~----~~~~i~~~~~~~p--~~~~~~~~~l  231 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDE----LFQSIMEHNVSYP--KSLSKEAVSI  231 (323)
T ss_pred             cCccCCccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCC--ccCCHHHHHH
Confidence            45579999999999988777665 999999999999999999998765533    2333333443333  3478999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCcccccC
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~~  284 (365)
                      +.+||+.+|.+|++     ..++++||||...
T Consensus       232 i~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             HHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            99999999999997     5799999999753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.9e-48  Score=360.15  Aligned_cols=247  Identities=30%  Similarity=0.513  Sum_probs=206.3

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHH-HHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||+||+|+++.+|+.||+|++.+..    .....+.+|. .+++.++||||+++++++..+..+|+||||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999997532    1223344554 456789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      |+|..++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.... .......+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccC
Confidence            999999988888999999999999999999999999999999999999987664  99999999875322 233345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+.    .+.......  ....+..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~ll~~ll  231 (325)
T cd05604         159 TPEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYD----NILHKPLVL--RPGASLTAWSILEELL  231 (325)
T ss_pred             ChhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHH----HHHcCCccC--CCCCCHHHHHHHHHHh
Confidence            999999999988888766 999999999999999999998766543333    333333222  2347899999999999


Q ss_pred             ccCCCCCCCH----HHHhcCcccccC
Q 017860          263 VADPAARITI----PEIMKHQWFLKN  284 (365)
Q Consensus       263 ~~dp~~R~t~----~ell~h~~f~~~  284 (365)
                      ..+|.+||++    .++++||||...
T Consensus       232 ~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         232 EKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             ccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            9999999976    599999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1e-47  Score=358.25  Aligned_cols=251  Identities=28%  Similarity=0.474  Sum_probs=207.9

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+++++.+++.||+|++.+...    ....+.+|+.++..+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            469999999999999999999999999986422    224567888888877 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~~~~~~g  182 (365)
                      |+|..++...+.+++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++... ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccC
Confidence            999999988888999999999999999999999999999999999999987665  9999999987532 2233445679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH---HHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|..||.......   ......+.+.......|  ..++..+.++|.
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~  235 (327)
T cd05617         159 TPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLK  235 (327)
T ss_pred             CcccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHHHHHHHH
Confidence            999999999988877666 999999999999999999996432111   11112223333333333  347899999999


Q ss_pred             HhcccCCCCCCC------HHHHhcCcccccC
Q 017860          260 RIFVADPAARIT------IPEIMKHQWFLKN  284 (365)
Q Consensus       260 ~~l~~dp~~R~t------~~ell~h~~f~~~  284 (365)
                      +||..||.+|++      +++++.||||...
T Consensus       236 ~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            999999999998      5699999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.5e-47  Score=361.09  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=209.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC------
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------   91 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------   91 (365)
                      ..++|++++.||+|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            3569999999999999999999999999999999987532   2235677899999999999999999998654      


Q ss_pred             CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ..+|+||||+.+ +|...+..  .+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~  169 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTA  169 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccC
Confidence            357999999975 56666643  4899999999999999999999999999999999999986654  999999999865


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-----------  240 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------  240 (365)
                      ..........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+.+......           
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH
Confidence            55444556789999999999988877766 999999999999999999998766544433332221100           


Q ss_pred             -------ccC--------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          241 -------QYS--------------V----PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       241 -------~~~--------------~----~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                             ...              .    ......+.++++||.+||+.||.+|||+.|+|+||||....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence                   000              0    01112456889999999999999999999999999997554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1e-47  Score=357.93  Aligned_cols=246  Identities=31%  Similarity=0.549  Sum_probs=204.9

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHH-HHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||+||+|+++.+++.||+|++.+...    ....+.+|. .+++.++||||+++++++...+.+|+||||+.+
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            469999999999999999999999999975321    122333443 456889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~g  182 (365)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.... .......+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~--~~kl~DfG~a~~~~~~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC--CEEEccCCCCcccccCCCCcccccC
Confidence            99999998888899999999999999999999999999999999999998665  499999999875322 223445679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+..    +......  ....++..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~--~~~~~~~~~~~li~~~l  231 (325)
T cd05602         159 TPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQ--LKPNITNSARHLLEGLL  231 (325)
T ss_pred             CccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCcC--CCCCCCHHHHHHHHHHc
Confidence            999999999988777666 9999999999999999999987665443332    2222222  23358899999999999


Q ss_pred             ccCCCCCCCHH----HHhcCccccc
Q 017860          263 VADPAARITIP----EIMKHQWFLK  283 (365)
Q Consensus       263 ~~dp~~R~t~~----ell~h~~f~~  283 (365)
                      +.+|.+|+++.    ++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         232 QKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             ccCHHHCCCCCCCHHHHhcCcccCC
Confidence            99999999876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-49  Score=365.78  Aligned_cols=259  Identities=29%  Similarity=0.465  Sum_probs=221.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ...|.-++.||.|+||.||.|+++.+.+.||||.+..+.+.    -.++.+|+..|++++|||++.+.+||..+...|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            34588899999999999999999999999999998754332    25789999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ||||- |+-.+++.- .+++.+.++..|+.+.+.||+|||+.+.||||||..|||+++.+.  |||+|||.|..   ...
T Consensus       105 MEYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi---~~P  178 (948)
T KOG0577|consen  105 MEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASI---MAP  178 (948)
T ss_pred             HHHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhh---cCc
Confidence            99995 466676653 456899999999999999999999999999999999999987665  99999998764   345


Q ss_pred             CCCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          177 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      .++++|||+|||||++.   .+.|+++ +||||||+++.||...++|+..++....+.-+.+.   ..+.++ ...+|..
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN---esPtLq-s~eWS~~  253 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN---ESPTLQ-SNEWSDY  253 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHHHHHHhc---CCCCCC-CchhHHH
Confidence            67899999999999985   4789999 89999999999999999999887765544433321   222222 3458999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccCCCCCcch
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD  291 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~~~~  291 (365)
                      ++.|+..||++-|..|||.+++|+|+|.....|....-
T Consensus       254 F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~  291 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIM  291 (948)
T ss_pred             HHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHH
Confidence            99999999999999999999999999999888776543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-48  Score=357.56  Aligned_cols=253  Identities=27%  Similarity=0.436  Sum_probs=218.9

Q ss_pred             CCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        15 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ..++..+...++++++||+|-||.||.+..+ ....||+|.+.......+.+.+|+.+|++|+|+|||++++++..+..+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            4556666677899999999999999999996 445799999988777778999999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           95 AIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ||||||++.|+|.++++.  .+.+...+...++.||++|++||+++++|||||-..||||+.+..  +||+|||||+...
T Consensus       277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~  354 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIG  354 (468)
T ss_pred             EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccC
Confidence            999999999999999987  456999999999999999999999999999999999999987764  9999999999432


Q ss_pred             CCCCCCCCcC---CCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          173 LHSQPKSTVG---TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       173 ~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      . .......|   ...|.|||.+..+.++.+ ||||||||+|+||+| |+.||.+.+..+.+.     .+...+++|.+.
T Consensus       355 d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~GyRlp~P~  427 (468)
T KOG0197|consen  355 D-DEYTASEGGKFPIKWTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGYRLPRPE  427 (468)
T ss_pred             C-CceeecCCCCCCceecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccCcCCCCC
Confidence            2 22222222   346999999999999888 999999999999998 899999888754332     234456788888


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..++++.+++..||..+|++|||++.+..
T Consensus       428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  428 GCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             CCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            89999999999999999999999997753

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-47  Score=347.47  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=206.0

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ||+|+||.||+++++.+|+.||+|.+.....    ....+..|+.+++.++||||+++++++..+..+|+||||+.|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            7999999999999999999999999865321    223456799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCC
Q 017860          107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP  184 (365)
Q Consensus       107 ~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~  184 (365)
                      ..++...+  .+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||++.............|++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCC
Confidence            98886543  4889999999999999999999999999999999999986654  9999999987654444444567999


Q ss_pred             CCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017860          185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA  264 (365)
Q Consensus       185 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  264 (365)
                      .|+|||++.+..++.+ +|||||||++|+|++|+.||.......................+ ...+++++++|+.+||+.
T Consensus       159 ~y~aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         159 GYMAPEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CccCHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhcc
Confidence            9999999988877666 99999999999999999999765443222233333333222222 235789999999999999


Q ss_pred             CCCCCCCH----HHHhcCccccc
Q 017860          265 DPAARITI----PEIMKHQWFLK  283 (365)
Q Consensus       265 dp~~R~t~----~ell~h~~f~~  283 (365)
                      ||.+||++    ++++.||||..
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcC
Confidence            99999999    67889999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.9e-48  Score=347.77  Aligned_cols=253  Identities=38%  Similarity=0.636  Sum_probs=210.3

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccH---HHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE---NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      |++++.||+|+||+||++++..+++.||+|++........   ...+|+.+++.++||||+++++++.....+++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            8899999999999999999999999999999987654333   2345999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc-cCCCCCCCC
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~-~~~~~~~~~  180 (365)
                      .+++|.+++...+.+++..++.++.||+.||.+||++|++||||||+||+++.++.  ++|+|||.+... .........
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~  158 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPF  158 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc
Confidence            99999999998888999999999999999999999999999999999999986554  999999998742 233444567


Q ss_pred             cCCCCCCCchhhc-ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCCCCHHHHHH
Q 017860          181 VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQECRDL  257 (365)
Q Consensus       181 ~gt~~y~aPE~~~-~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  257 (365)
                      .+++.|+|||++. +..++.+ +||||||+++|+|++|..||......... ...........  ........+..+.++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~-~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l  236 (260)
T PF00069_consen  159 VGTPEYMAPEVLQQGKKYTRK-SDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRPLPSSSQQSREKSEELRDL  236 (260)
T ss_dssp             SSSGGGSCHHHHTTTSSBSTH-HHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTHHHHHTTSHTTSHHHHHHH
T ss_pred             ccccccccccccccccccccc-ccccccccccccccccccccccccchhhh-hhhhhcccccccccccccchhHHHHHHH
Confidence            7899999999997 5555555 99999999999999999999876322222 22222221111  111122234899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017860          258 ISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      |.+||+.||++|||+.++++||||
T Consensus       237 i~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  237 IKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-47  Score=356.65  Aligned_cols=256  Identities=25%  Similarity=0.490  Sum_probs=208.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.++||+|+||.||+++++.+++.||+|++.+..    .....+.+|+.+++.++|+||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999986522    12234778899999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860           99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      ||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++........ 
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcc
Confidence            99999999999977 467999999999999999999999999999999999999986654  99999999865432222 


Q ss_pred             -CCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCC
Q 017860          177 -PKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNP  249 (365)
Q Consensus       177 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  249 (365)
                       ....+||+.|+|||++..     ..++.+ +|||||||++|+|++|+.||...+....+.++....  ....+|. ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  235 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTD  235 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCc-CCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCcccc
Confidence             233579999999999862     334444 999999999999999999998766544333322211  1122222 235


Q ss_pred             CCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017860          250 ISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK  283 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~  283 (365)
                      +++++++||.+||..++.+  |++++++++||||..
T Consensus       236 ~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         236 VSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             CCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            7999999999999765544  689999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2e-47  Score=355.48  Aligned_cols=246  Identities=32%  Similarity=0.529  Sum_probs=205.2

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHH-HHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+|+++.+++.||+|++.+...    ....+.+|. .+++.++||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            469999999999999999999999999875321    123344454 467889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCCCCCCcC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~~~~~~g  182 (365)
                      ++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++... ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccC
Confidence            999999988888999999999999999999999999999999999999987654  9999999987532 2233345679


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...    ....+.......+  ...+..+.++|.+||
T Consensus       159 t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~--~~~~~~~~~li~~~l  231 (321)
T cd05603         159 TPEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQ----MYDNILHKPLQLP--GGKTVAACDLLVGLL  231 (321)
T ss_pred             CcccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHH----HHHHHhcCCCCCC--CCCCHHHHHHHHHHc
Confidence            999999999988777766 999999999999999999998765432    2333333333333  347889999999999


Q ss_pred             ccCCCCCCCH----HHHhcCccccc
Q 017860          263 VADPAARITI----PEIMKHQWFLK  283 (365)
Q Consensus       263 ~~dp~~R~t~----~ell~h~~f~~  283 (365)
                      +.+|.+||++    .++++|+||..
T Consensus       232 ~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         232 HKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            9999999975    59999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.6e-47  Score=347.82  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=211.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .|++.+.||+|+||.||++.++.+++.||+|.+.....    ....+.+|+.+++.++|+||+++++.+.....+++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            48889999999999999999999999999999875432    12346789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860          100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||++.........
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccc
Confidence            99999999888653  35899999999999999999999999999999999999986654  999999998765444444


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....|++.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ......... ........+++++.+|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~l  235 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKE-VQEEYSEKFSPDARSL  235 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchH-HHHHhhhhh-hhhhcCccCCHHHHHH
Confidence            55689999999999988777665 99999999999999999999875432111 111111111 0111233478999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      +.+||+.||.+|||     ++++++||||.+
T Consensus       236 i~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         236 CKMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            99999999999999     999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.9e-47  Score=355.84  Aligned_cols=256  Identities=27%  Similarity=0.493  Sum_probs=209.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.+..    .....+.+|..+++.++|+||+++++++..++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987532    12244678899999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860           99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      ||+.||+|..++.+ .+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++....... 
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCce
Confidence            99999999999987 467999999999999999999999999999999999999986654  99999999875433222 


Q ss_pred             -CCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC-CCC
Q 017860          177 -PKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNP  249 (365)
Q Consensus       177 -~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  249 (365)
                       .....||+.|+|||++.+     ..++.+ +|||||||++|+|++|+.||...+....+.++...  .....+|. ...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~  235 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITD  235 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCc-ccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCcccc
Confidence             223579999999999865     334444 99999999999999999999876554333322211  11122222 234


Q ss_pred             CCHHHHHHHHHhcccCCCC--CCCHHHHhcCccccc
Q 017860          250 ISQECRDLISRIFVADPAA--RITIPEIMKHQWFLK  283 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~  283 (365)
                      +++++++||.+||...+.+  |++++++++||||..
T Consensus       236 ~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         236 VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             CCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            7899999999999876554  469999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-48  Score=364.09  Aligned_cols=257  Identities=40%  Similarity=0.674  Sum_probs=232.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..|.+.+.||+|.|++|.++++..++..||||.+++....   ...+.+|+.+|+.|+|||||+++.+.+.+..+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            4699999999999999999999999999999999875432   2457899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      |+.+|.+++++.+.++..+..++.++.|++.|++|||+++|||||||++|||++.+-+  +||+|||++..........+
T Consensus       136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccc
Confidence            9999999999999999999999999999999999999999999999999999987765  99999999999998899999


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      .||++.|.|||++.+..|+++.+|+||+|+++|-|++|..||++.+-..    .-.+.+...+.+|..  +|.+|.++|+
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~----Lr~rvl~gk~rIp~~--ms~dce~lLr  287 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE----LRPRVLRGKYRIPFY--MSCDCEDLLR  287 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc----ccchheeeeecccce--eechhHHHHH
Confidence            9999999999999999999999999999999999999999999865422    233445555666655  8899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ++|..+|.+|++.+++.+|.|.......
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchhhhh
Confidence            9999999999999999999998655433

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.3e-47  Score=345.41  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=215.0

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .|+..+.||+|+||+||++.+..+++.||+|.+.....    ....+.+|+.+++.++|+||+++.+.+..++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            48889999999999999999999999999999875432    22446789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860          100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |+.+++|...+...  .++++..+..++.|++.||.|||++||+||||||+||+++.++  .+||+|||++.........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG--HIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC--CEEEecCCcceecCCCCcc
Confidence            99999998887653  3699999999999999999999999999999999999998665  4999999998755444444


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....|++.|+|||++.+..++.+ +|+|||||++|+|++|..||...............+......  ....++.++.+|
T Consensus       159 ~~~~g~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l  235 (285)
T cd05632         159 RGRVGTVGYMAPEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV--YSAKFSEEAKSI  235 (285)
T ss_pred             cCCCCCcCccChHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--cCccCCHHHHHH
Confidence            55679999999999988777666 899999999999999999998765433333333333222222  234578899999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCcccccC
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~~  284 (365)
                      +.+||+.+|.+||+     +.+++.|+||...
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            99999999999999     8899999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-47  Score=358.50  Aligned_cols=253  Identities=25%  Similarity=0.418  Sum_probs=202.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      ..+|++++.||+|+||.||+|++..+++.||+|+....     ....|+.+++.++||||+++++++......++|||++
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            45799999999999999999999999999999975443     2357899999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      . ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...........
T Consensus       140 ~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        140 S-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             C-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCcccccc
Confidence            5 578777765 456999999999999999999999999999999999999976654  999999998754444444556


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCC-CCCCCCh---------HHHHHHHHHHhccccCCC-----
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEP---------KDFRKTIQRILSVQYSVP-----  245 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~---------~~~~~~~~~~~~~~~~~~-----  245 (365)
                      .||+.|+|||++.+..++.+ +|||||||++|+|+++..| |......         ..+.+.+......+..++     
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  295 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGS  295 (357)
T ss_pred             cccccccCCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCcc
Confidence            79999999999988888766 9999999999999986544 4432211         111111111110000111     


Q ss_pred             -----------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          246 -----------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       246 -----------------------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                                             ....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        296 RLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                   11235677889999999999999999999999999974

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-46  Score=339.56  Aligned_cols=252  Identities=29%  Similarity=0.453  Sum_probs=213.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+.....      ....+.+|+.+++.++||||+++++++..+..+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            479999999999999999999999999999999865321      12457889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      |+||+++++|.+.+...+.+++..++.++.|++.||+|||+.|++||||+|+||+++.++.  ++|+|||+++.......
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecccccc
Confidence            9999999999999988888999999999999999999999999999999999999986654  99999999874332211


Q ss_pred             C----CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          177 P----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       177 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .    ....|++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......+    ..........+..++.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  234 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSP  234 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCH
Confidence            1    33568899999999988776655 9999999999999999999987655433322    2222222233445789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+.++|.+||..+|.+|||+.++++|+||
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         235 DARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-47  Score=357.97  Aligned_cols=258  Identities=24%  Similarity=0.421  Sum_probs=206.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC------C
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------T   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~   92 (365)
                      .++|++++.||+|+||+||++.+..+++.||+|.+.....   ....+.+|+.+++.++||||++++++|...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            4689999999999999999999999999999999875321   234577899999999999999999988643      4


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|++++++ +++|..++. .+++++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+++...
T Consensus        94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~  169 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQAD  169 (343)
T ss_pred             cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecC
Confidence            579999998 778887764 456999999999999999999999999999999999999987654  9999999987543


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-----------  241 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  241 (365)
                        .......||+.|+|||++.+....+.++|||||||++|+|++|+.||...+....+...........           
T Consensus       170 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         170 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             --CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence              2344567999999999997744444559999999999999999999987654433332221110000           


Q ss_pred             --------cCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          242 --------YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       242 --------~~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                              ...+      .....++.+.+||.+||..||.+|||+.++|.||||.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence                    0001      0123567889999999999999999999999999998654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-48  Score=336.17  Aligned_cols=263  Identities=30%  Similarity=0.480  Sum_probs=223.2

Q ss_pred             cce-ecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeec
Q 017860           25 YDF-VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        25 y~~-~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      |++ -+.||+|+|+.|--+....+|..||||++.+... ....+.+|+.++...+ |+||+.++++|+++..+|+|||.+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm  158 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM  158 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence            555 3689999999999999999999999999987654 4477899999998885 999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCccccc--------
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV--------  172 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~--------  172 (365)
                      .||+|...|++...|+|.++..++++|+.||.+||.+||.||||||+|||-...+ ..-||||||.+.....        
T Consensus       159 ~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa  238 (463)
T KOG0607|consen  159 RGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA  238 (463)
T ss_pred             cCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence            9999999999999999999999999999999999999999999999999986433 2349999999875322        


Q ss_pred             CCCCCCCCcCCCCCCCchhhc----ccccCCccceeehhhHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHH
Q 017860          173 LHSQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKTIQRI  237 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~  237 (365)
                      ......+.+|+..|||||+..    ...++.|++|.||||+|+|.|++|++||.+.-.           ..-..+....|
T Consensus       239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI  318 (463)
T KOG0607|consen  239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI  318 (463)
T ss_pred             CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence            122345678999999999863    344556779999999999999999999986432           12234555667


Q ss_pred             hccccCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          238 LSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       238 ~~~~~~~~--~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ..+.+.+|  +|..+|.++++++..+|..++.+|.++.++++|||+....+.
T Consensus       319 QEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  319 QEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             hccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence            77778777  477899999999999999999999999999999999875543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1e-46  Score=347.33  Aligned_cols=261  Identities=26%  Similarity=0.450  Sum_probs=211.6

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ..++|+++++||+|+||.||+++++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++..+..+++||
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            3468999999999999999999999999999999987532  23356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-C
Q 017860           99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~  176 (365)
                      ||+. ++|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++....... .
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~  160 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKT  160 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCc
Confidence            9997 5888887653 46899999999999999999999999999999999999987654  9999999987543222 2


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q  241 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~  241 (365)
                      .....+++.|+|||++.+....+.++|||||||++|+|++|++||...+.......+.......               .
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (301)
T cd07873         161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS  240 (301)
T ss_pred             ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence            2345678999999998765544455999999999999999999998766544333222211100               0


Q ss_pred             cCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          242 YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       242 ~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ...+.         ...+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            01111         12468899999999999999999999999999999653

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-47  Score=307.77  Aligned_cols=259  Identities=27%  Similarity=0.491  Sum_probs=217.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .+|...++||+|.||+|++++++.+++.||+|.+..++   .......+|+-+++.++|+|||+++++.+.+..+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            46888999999999999999999999999999997643   345789999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-C
Q 017860          100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~  177 (365)
                      ||. .+|..+... ++.++.+.++.++.|++.||.++|++++.||||||.|+||+.++.  +||+|||+++.....-. .
T Consensus        82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcy  158 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEee
Confidence            995 478877765 567999999999999999999999999999999999999987765  99999999986544432 2


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc-CCCC------C--
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY-SVPD------T--  247 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~------~--  247 (365)
                      ...+.|.||++|.++.+.+.++...|+||.|||+.|+.. |++.|.+.+-..++.++.+....... .+|.      .  
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            345679999999999998877776899999999999986 77888887766666666654432221 1111      1  


Q ss_pred             --------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          248 --------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       248 --------------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                    ..++..-++|++++|.-+|.+|++++++++||||...
T Consensus       239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                          1134557899999999999999999999999999753

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.1e-46  Score=341.11  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=211.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++.+.||+|+||.||++.++.+++.||+|.+....   ...+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47999999999999999999999999999999986533   233567899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      |++++.|..++.....+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG--QIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC--cEEECccccceecCCCccccc
Confidence            999998888877777899999999999999999999999999999999999998665  49999999987544333 233


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccC
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QYS  243 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  243 (365)
                      ...++..|+|||++.+....+.++|||||||++|+|++|+.||.+.................               ...
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            45688999999998764433444999999999999999999998766544433322211100               000


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          244 VPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       244 ~~~----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+.          ...++..+.+|+.+||+.+|++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            111          12467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-46  Score=381.85  Aligned_cols=260  Identities=31%  Similarity=0.509  Sum_probs=213.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~   95 (365)
                      ..++|++++.||+|+||+||+|+++.++..||+|.+....   .....+..|+.+++.++|||||+++++|..  ...+|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            3458999999999999999999999999999999987532   223568889999999999999999999864  45799


Q ss_pred             EEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCcEEecCC---------
Q 017860           96 IVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-------QVCHRDLKLENTLLDGS---------  155 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~-------~ivHrDlkp~NIli~~~---------  155 (365)
                      +||||+.+++|..++..    .+.+++..++.|+.||+.||.|||+.       +||||||||+||||+..         
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            99999999999998865    35699999999999999999999985       49999999999999642         


Q ss_pred             ------CCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhccc--ccCCccceeehhhHHHHHHHhCCCCCCCCCCh
Q 017860          156 ------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP  227 (365)
Q Consensus       156 ------~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  227 (365)
                            +.+.+||+|||++............+||+.|+|||++.+.  .++.+ +||||||||+|+|++|..||......
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~K-SDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCch-hHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                  2335899999999865544445566899999999998643  34444 99999999999999999999876655


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      ..+...+..    ....+. ...+.++.+||.+||..+|.+||++.++|.|+|+....+
T Consensus       250 ~qli~~lk~----~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        250 SQLISELKR----GPDLPI-KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHHHHHHhc----CCCCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            444333222    112222 246899999999999999999999999999999975543

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.3e-46  Score=339.61  Aligned_cols=254  Identities=26%  Similarity=0.431  Sum_probs=210.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeC------CE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP------TH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~------~~   93 (365)
                      ..++|++.+.||+|+||.||++.+..+++.||+|.+.........+.+|+.+++.+ +||||+++++++...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            35689999999999999999999999999999999987665567788999999988 699999999998753      46


Q ss_pred             EEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +|+||||+.+++|.+++...  ..+++..++.++.|++.||+|||+++++||||||+||+++.++.  +||+|||++...
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~  161 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL  161 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceec
Confidence            89999999999999998763  46899999999999999999999999999999999999987665  999999998754


Q ss_pred             cCC-CCCCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 017860          172 VLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       172 ~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  245 (365)
                      ... .......|++.|+|||++.+     ..++.+ +|||||||++|+|++|+.||..........    ..........
T Consensus       162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGv~l~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~  236 (272)
T cd06637         162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF----LIPRNPAPRL  236 (272)
T ss_pred             ccccccCCcccccccccCHhHhccccCcCCCCCch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH----HHhcCCCCCC
Confidence            322 23345678999999999863     245545 999999999999999999997654332221    1122222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ....++..+.+|+.+||..+|.+|||+.++++||||
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            334578999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.3e-46  Score=367.47  Aligned_cols=253  Identities=29%  Similarity=0.458  Sum_probs=211.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccC-CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..|.+.+.||+|+||.||+|.+..+ +..||+|.+..... ....+.+|+.+++.++||||++++++|..+..+|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3599999999999999999998877 78899998755432 224577899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860          101 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus       101 ~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      +++|+|.+.+..    ..++++.++..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccc
Confidence            999999887753    346899999999999999999999999999999999999986654  9999999987543322 


Q ss_pred             --CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       176 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                        .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+...... +.+..++.+
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~----~~~~~~~~~~-~~~~~~s~~  298 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREI----MQQVLYGKYD-PFPCPVSSG  298 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCC-CCCccCCHH
Confidence              2345679999999999988777665 9999999999999999999987654332    2233222221 233457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +.+||.+||..+|++|||+++++.|+|+..
T Consensus       299 ~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        299 MKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999999853

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-46  Score=341.77  Aligned_cols=255  Identities=27%  Similarity=0.460  Sum_probs=206.6

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++++.||+|+||.||++.++.+++.||+|.+....   .....+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4899999999999999999999999999999986532   2235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-C
Q 017860          101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-Q  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~---~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~  176 (365)
                      +. ++|.+++...   ..+++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||++....... .
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~  157 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRV  157 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCccc
Confidence            97 5788877542   46899999999999999999999999999999999999987664  9999999987543222 2


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------c
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------Y  242 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~  242 (365)
                      .....+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+................              .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (285)
T cd07861         158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKN  237 (285)
T ss_pred             ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence            23446789999999987654434459999999999999999999987655433322222111000              0


Q ss_pred             CC---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          243 SV---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       243 ~~---------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ..         .....+++++.+||.+||+.||.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            00         1123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.6e-46  Score=342.98  Aligned_cols=255  Identities=29%  Similarity=0.501  Sum_probs=204.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||+|+||.||+|+++.+|+.||+|.+....   .....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            6999999999999999999999999999999987532   2335678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      +.+ +|.+++.. .+++++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||+++...... ...
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcC
Confidence            974 78777765 567999999999999999999999999999999999999986654  9999999987543222 223


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------c--
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------Y--  242 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~--  242 (365)
                      ...+++.|+|||++.+....+.++|||||||++|+|++|..||..........+.+.......              .  
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPY  237 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccccc
Confidence            456789999999987755444559999999999999999888654443322222211111000              0  


Q ss_pred             -CC-------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          243 -SV-------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       243 -~~-------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                       ..       .....+++++++||.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         238 PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence             00       0112468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.2e-46  Score=347.59  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=193.3

Q ss_pred             ecccccCCCeEEEEEEEc--cCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEEEEEeecCC
Q 017860           28 VRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG  103 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~  103 (365)
                      .++||+|+||.||+|+++  .+++.||+|.+.... ....+.+|+.+++.++||||++++++|..  ...+|++|||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            468999999999999976  467899999986543 34567899999999999999999999864  467899999995 


Q ss_pred             CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCCEEEecCCCccccc
Q 017860          104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV  172 (365)
Q Consensus       104 g~L~~~l~~~---------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~--~~~~vkl~Dfgla~~~~  172 (365)
                      ++|..++...         ..+++..++.++.||+.||+|||++||+||||||+|||+...  ..+.+||+|||+++...
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            4787776422         248999999999999999999999999999999999999532  23469999999987543


Q ss_pred             CCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHHh-
Q 017860          173 LHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKTIQRIL-  238 (365)
Q Consensus       173 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~~~~~~~-  238 (365)
                      ...    ......||+.|+|||++.+....+.++|||||||++|+|++|++||......         ..+..+..... 
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            221    2345678999999999987554445599999999999999999999754321         11111111000 


Q ss_pred             -----------------------ccccCC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          239 -----------------------SVQYSV--------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       239 -----------------------~~~~~~--------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                                             ......        ......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                                   000000        0011235678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-46  Score=356.81  Aligned_cols=255  Identities=23%  Similarity=0.354  Sum_probs=207.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEc--cCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..+|++++.||+|+||.||++...  .++..||+|.+...    ....+|+.+++.++||||+++++++.....+|+|||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            457999999999999999999764  35678999988653    345689999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---  176 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---  176 (365)
                      ++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++.......   
T Consensus       167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCccccccc
Confidence            995 688888877788999999999999999999999999999999999999986654  99999999875433222   


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccc------------
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQ------------  241 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~------------  241 (365)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....   ..+..++..+....            
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  322 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLC  322 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHH
Confidence            234579999999999988877766 99999999999999999999765432   22222222111111            


Q ss_pred             -------------cCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          242 -------------YSVPD---TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       242 -------------~~~~~---~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                   +..+.   ...++.++.+||.+||..||.+|||+.++|.||||.+.
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        323 KHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             HHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                         01110   12346789999999999999999999999999999764

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.4e-46  Score=338.65  Aligned_cols=256  Identities=27%  Similarity=0.417  Sum_probs=210.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..++|++.+.||+|+||.||+|++..+++.||+|.+..... ....+.+|+.+++.++||||+++++++.....+|+|||
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            45689999999999999999999999999999999876432 22457789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~  178 (365)
                      |+++++|.+++...+.+++.+++.++.|++.||+|||++|++|+||||+||+++.++.  +||+|||++...... ....
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccc
Confidence            9999999999988888999999999999999999999999999999999999976654  999999998643322 2224


Q ss_pred             CCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          179 STVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ...|++.|+|||++.   ...++.+ +|+|||||++|+|++|..||................. ..........++..+.
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~-~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  242 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQL-CDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF-QPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccCcccccChhhhccccCCCCCch-hhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCC-CCCcccccCCCCHHHH
Confidence            457899999999974   3345444 9999999999999999999976554332222111110 0111122234788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQW  280 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~  280 (365)
                      +|+.+||+.+|++|||+++++.|||
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-46  Score=367.39  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=212.8

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCC----
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----   92 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----   92 (365)
                      ...++|++.+.||+|+||+||++++..+++.||+|++.....   ....+.+|+..+..++|+||+++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            446799999999999999999999999999999999976432   2245778999999999999999988775432    


Q ss_pred             ----EEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 017860           93 ----HLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD  164 (365)
Q Consensus        93 ----~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~D  164 (365)
                          .+++||||+.+|+|.+++..    ...+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~D  186 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGD  186 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEe
Confidence                47899999999999998864    246899999999999999999999999999999999999987654  99999


Q ss_pred             CCCcccccC---CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc
Q 017860          165 FGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ  241 (365)
Q Consensus       165 fgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  241 (365)
                      ||+++....   .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    +..+....
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~----~~~~~~~~  261 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEV----MHKTLAGR  261 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHhcCC
Confidence            999875432   222345679999999999988877766 9999999999999999999987654332    22333222


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       242 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      . .+.+..+++++.+++.+||+.+|.+||++.++++|||++.
T Consensus       262 ~-~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        262 Y-DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             C-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            2 1334458899999999999999999999999999999865

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-48  Score=348.73  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=225.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      +.|+.-+.||+|+||.||-++-+.||+.||+|.+.+..    ....-..+|-.+|..++.+.||.+-..|++.+.+++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            46899999999999999999999999999999986532    23345678999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           99 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ..|+||+|.-.|.+.+  .|++..++.++.+|+.||.+||+.+||.|||||+|||+|+.+.  |+|+|+|||.....+..
T Consensus       265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCc
Confidence            9999999988887766  6999999999999999999999999999999999999987664  99999999998888888


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....+||.+|||||++.+..|+.. .|+|||||++|||+.|+.||..........++-+.+...+...+  ..+|+++++
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eaks  419 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKS  419 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHH
Confidence            888899999999999999998877 89999999999999999999875543333344444454444444  569999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017860          257 LISRIFVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       257 li~~~l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      +.+.+|++||.+|.     +++++.+||||+.
T Consensus       420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            99999999999998     6789999999976

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-46  Score=351.96  Aligned_cols=252  Identities=22%  Similarity=0.374  Sum_probs=202.1

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEe
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   90 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~   90 (365)
                      ....++|++.++||+|+||.||+|.+.     .+++.||+|.+.....  ....+.+|+.+++.+ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            345679999999999999999999752     3457899999875332  235688999999999 89999999998876


Q ss_pred             C-CEEEEEEeecCCCChHHHHHhc--------------------------------------------------------
Q 017860           91 P-THLAIVMEYASGGELFERICNA--------------------------------------------------------  113 (365)
Q Consensus        91 ~-~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------  113 (365)
                      . ..+++||||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 4689999999999999988642                                                        


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---CCCCcCCC
Q 017860          114 ------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP  184 (365)
Q Consensus       114 ------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~  184 (365)
                            ..+++..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.......   .....+++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~--~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC--cEEEeecccccccccCcchhcccCCCCCc
Confidence                  2377888999999999999999999999999999999998665  499999999875432211   22334678


Q ss_pred             CCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017860          185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV  263 (365)
Q Consensus       185 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  263 (365)
                      .|+|||++.+..++.+ +|||||||++|||++ |..||........+...+.   .. .....+...++.+.+++.+||+
T Consensus       241 ~y~aPE~~~~~~~~~~-sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~l~~li~~cl~  315 (338)
T cd05102         241 KWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---DG-TRMRAPENATPEIYRIMLACWQ  315 (338)
T ss_pred             cccCcHHhhcCCCCcc-cCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---cC-CCCCCCCCCCHHHHHHHHHHcc
Confidence            8999999988777766 999999999999997 9999987654443333222   11 1222334578999999999999


Q ss_pred             cCCCCCCCHHHHhc
Q 017860          264 ADPAARITIPEIMK  277 (365)
Q Consensus       264 ~dp~~R~t~~ell~  277 (365)
                      .||.+|||+.++++
T Consensus       316 ~dp~~RPs~~el~~  329 (338)
T cd05102         316 GDPKERPTFSALVE  329 (338)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.8e-46  Score=340.56  Aligned_cols=251  Identities=35%  Similarity=0.628  Sum_probs=215.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.+..    .....+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999987532    22356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.  +||+|||++......  ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CC
Confidence            99999999999998889999999999999999999999999999999999999987654  999999998765333  34


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...|++.|+|||.+.+..++.+ +||||||+++|+|++|+.||...+...    ..+.+.......+  ..++..+.++|
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~--~~~~~~l~~li  229 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFP--SFFSPDAKDLI  229 (290)
T ss_pred             CCCCCccccChhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHhcCCccCC--ccCCHHHHHHH
Confidence            5578999999999977766555 999999999999999999998765322    2222333333333  34689999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          259 SRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       259 ~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .+||..+|.+|+     +++++++||||...
T Consensus       230 ~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         230 RNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            999999999999     99999999999653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.6e-46  Score=343.22  Aligned_cols=256  Identities=29%  Similarity=0.503  Sum_probs=211.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+.....  ....+.+|+.+++.++||||++++++|..+..+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            379999999999999999999999999999999865422  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      +++++|.+++.+.+++++..++.++.|++.||.|||+ .+++||||||+|||++.++.  +||+|||++..... .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~  157 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANS  157 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-ccccc
Confidence            9999999999888889999999999999999999997 58999999999999986654  99999999865422 22345


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH------------------------
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ------------------------  235 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~------------------------  235 (365)
                      ..|++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||...+. ........                        
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (308)
T cd06615         158 FVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDSPR  235 (308)
T ss_pred             CCCCcCccChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCccc
Confidence            678999999999877776655 9999999999999999999975442 11111111                        


Q ss_pred             ---------HHhcc-ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          236 ---------RILSV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       236 ---------~~~~~-~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                               .+... ....| ...++.++.+|+.+||..+|++|||+.++++||||.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         236 PMAIFELLDYIVNEPPPKLP-SGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             hhhHHHHHHHHhcCCCccCc-CcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                     00000 00111 11267889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.4e-46  Score=338.93  Aligned_cols=254  Identities=24%  Similarity=0.416  Sum_probs=208.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++++.||+|+||.||++.+..+++.||+|.+..+.  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36899999999999999999999999999999987642  2235688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      +++++|..+    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.  +||+|||++..... ......
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~-~~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVN-SIAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceeccc-ccccCC
Confidence            999998654    35789999999999999999999999999999999999987654  99999999875432 233456


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---FRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      .||+.|+|||++.+..++.+ +|+|||||++|+|++|+.||........   .......+.............++++.+|
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  232 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHF  232 (279)
T ss_pred             CCChhhcCceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHH
Confidence            79999999999988777666 9999999999999999999975332111   1122222222222111233478899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +.+||+.+|.+||++++++.||||...
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-46  Score=358.80  Aligned_cols=254  Identities=20%  Similarity=0.264  Sum_probs=203.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ...+|.+.+.||+|+||.||++.+..+++.||+|....     ..+.+|+.+++.++|||||++++++......++|||+
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35589999999999999999999999999999996432     3467899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---C
Q 017860          101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---Q  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---~  176 (365)
                      +. ++|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......   .
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceeccccccccc
Confidence            95 6888887654 46999999999999999999999999999999999999976654  9999999987543221   1


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC-------hHHHHHHHHHHhccc--------
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------PKDFRKTIQRILSVQ--------  241 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-------~~~~~~~~~~~~~~~--------  241 (365)
                      .....||+.|+|||++.+..++.+ +|||||||++|||++|..|+.....       ...+.++++......        
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence            224569999999999988887766 9999999999999998765533221       122233332211000        


Q ss_pred             ------------------cC---CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          242 ------------------YS---VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       242 ------------------~~---~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                                        ..   +.....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                              00   1111245678999999999999999999999999999964

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.3e-46  Score=341.04  Aligned_cols=257  Identities=28%  Similarity=0.453  Sum_probs=216.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..+|++.+.||.|+||.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.....+|+|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            3579999999999999999999999999999999875432 345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-CCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~~~  179 (365)
                      +.+++|..++... .+++.++..++.|++.||+|||++|++||||||+||+++.++.  +||+|||++........ ...
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          98 LAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             cCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCC
Confidence            9999999988654 6899999999999999999999999999999999999986654  99999998875433222 234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+..........   ........+..+++.+.+||.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             cCCCccccCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cCCcccCCcccCCHHHHHHHH
Confidence            568999999999987777666 9999999999999999999987665443322211   122223344558899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +||..+|.+|||+.++++||||....
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHhhhcc
Confidence            99999999999999999999997654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-47  Score=376.17  Aligned_cols=259  Identities=31%  Similarity=0.491  Sum_probs=221.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|.|++.||+|+||.|.+++++.+++.||+|++.+-    .....-|+.|-.+|.--+.+=|+.++-.|.++.++|+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl  152 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL  152 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence            357899999999999999999999999999999999762    2233557778888888889999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ||||++||+|..++.+..+++|.-+++++..|+.||..||+.|+|||||||+|||||..|  ||||+|||.+-.....+.
T Consensus       153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G--HikLADFGsClkm~~dG~  230 (1317)
T KOG0612|consen  153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG--HIKLADFGSCLKMDADGT  230 (1317)
T ss_pred             EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC--cEeeccchhHHhcCCCCc
Confidence            999999999999999988999999999999999999999999999999999999997665  599999998765544443


Q ss_pred             --CCCCcCCCCCCCchhhcc---c-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          177 --PKSTVGTPAYIAPEVLLR---H-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       177 --~~~~~gt~~y~aPE~~~~---~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                        ....+|||.|++||++..   + +.+++.+|+||+||++|||++|..||+..+-...+.+++..  ...+.+|....+
T Consensus       231 V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h--k~~l~FP~~~~V  308 (1317)
T KOG0612|consen  231 VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH--KESLSFPDETDV  308 (1317)
T ss_pred             EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch--hhhcCCCccccc
Confidence              345689999999999953   1 33455599999999999999999999986665555555443  235677766779


Q ss_pred             CHHHHHHHHHhcccCCCCCCC---HHHHhcCcccccC
Q 017860          251 SQECRDLISRIFVADPAARIT---IPEIMKHQWFLKN  284 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t---~~ell~h~~f~~~  284 (365)
                      |+++++||.+++. +|+.|..   ++++..||||..-
T Consensus       309 SeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  309 SEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             CHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCC
Confidence            9999999999985 8999998   9999999999754

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-45  Score=335.86  Aligned_cols=256  Identities=30%  Similarity=0.481  Sum_probs=215.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++.+.||.|+||.||++++..+++.||+|.+.....  ....+.+|+.+++.++||||+++++++.....+|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            479999999999999999999999999999999876432  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~  179 (365)
                      +.+++|.+++... ++++..++.++.|++.||.|||+++++||||+|+||+++.++.  ++|+|||+++..... .....
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeeccccccccc
Confidence            9999999998765 7899999999999999999999999999999999999987665  999999998765433 23345


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+....    ...+............+++.+.+++.
T Consensus       158 ~~~~~~y~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         158 FVGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRV----LFLIPKNNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHH----HHHhhhcCCCCCcccccCHHHHHHHH
Confidence            578999999999987776655 9999999999999999999987554322    22222221111111227889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      +||..+|++|||++++++||||.+...
T Consensus       233 ~~l~~~p~~Rpt~~~il~~~~~~~~~~  259 (274)
T cd06609         233 LCLNKDPKERPSAKELLKHKFIKKAKK  259 (274)
T ss_pred             HHhhCChhhCcCHHHHhhChhhcCCCc
Confidence            999999999999999999999987543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4.1e-47  Score=329.68  Aligned_cols=263  Identities=27%  Similarity=0.408  Sum_probs=210.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCc----EEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEe-CCEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHL   94 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~   94 (365)
                      ..|+++..||+|+||.||+|..++++.    .+|||.|+.+   .......-+|+.++|.++||||+.+..+|.+ +..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            469999999999999999997765543    7899999754   2455788999999999999999999999988 8899


Q ss_pred             EEEEeecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEecCCC
Q 017860           95 AIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGY  167 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~--~~~vkl~Dfgl  167 (365)
                      ++++||.+. +|...|.-     ...++...++.++.||+.|+.|||++.|+||||||.|||+..++  .|+|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999976 78877752     23589999999999999999999999999999999999997653  35799999999


Q ss_pred             cccccCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh---------HHHHHHH
Q 017860          168 SKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKTI  234 (365)
Q Consensus       168 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~~~  234 (365)
                      ++.....-    .....+.|.||+|||.+.+...++++.||||+|||+.||++-.+.|.+.+..         .++.+++
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf  262 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF  262 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence            98654332    2344578999999999999998889999999999999999999888764321         1122222


Q ss_pred             HHHhccc--cCCCC------------------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          235 QRILSVQ--YSVPD------------------------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       235 ~~~~~~~--~~~~~------------------------------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      . ++..+  -.+|.                              ...-++...+|+.+||+.||.+|.|++++|+|+||+
T Consensus       263 ~-vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~  341 (438)
T KOG0666|consen  263 E-VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFT  341 (438)
T ss_pred             H-HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccc
Confidence            1 11111  01111                              111245588999999999999999999999999998


Q ss_pred             cCCCC
Q 017860          283 KNLPA  287 (365)
Q Consensus       283 ~~~~~  287 (365)
                      +..-+
T Consensus       342 ~d~lp  346 (438)
T KOG0666|consen  342 EDPLP  346 (438)
T ss_pred             cCCCC
Confidence            76433

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-45  Score=342.60  Aligned_cols=255  Identities=33%  Similarity=0.541  Sum_probs=216.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++.+......|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            379999999999999999999999999999999976432    2246788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||+.+++|.+++.+.  ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||++....... 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhccccccc
Confidence            999999999998754  56899999999999999999999999999999999999987654  9999999876432211 


Q ss_pred             -----------------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC
Q 017860          176 -----------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE  226 (365)
Q Consensus       176 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  226 (365)
                                                   ......||..|+|||++.+..++.+ +|||||||++|+|++|+.||...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCch-HHHHHHHHHHHHHhhCCCCCCCCch
Confidence                                         1123468899999999987777655 9999999999999999999987766


Q ss_pred             hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC----HHHHhcCcccccC
Q 017860          227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT----IPEIMKHQWFLKN  284 (365)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t----~~ell~h~~f~~~  284 (365)
                      ...+.+.    .......+....+++.+.++|.+||..+|++|||    +++++.||||...
T Consensus       238 ~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         238 DETFSNI----LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHHH----hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            5444333    3333444544457899999999999999999999    9999999999763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.2e-46  Score=336.52  Aligned_cols=255  Identities=27%  Similarity=0.410  Sum_probs=208.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||+|+||.||+++++.+++.||+|++..... ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            5679999999999999999999999999999999875432 234677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +++++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.  +||+|||++....... ....
T Consensus        88 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          88 CGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCc
Confidence            999999999988888999999999999999999999999999999999999976654  9999999987543222 2234


Q ss_pred             CcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          180 TVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ..|++.|+|||.+..   ..++ .++|+|||||++|+|++|+.||................. .....+....++..+.+
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNF-QPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             cccCccccCHhHcccccCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCC-CCCCCccccccCHHHHH
Confidence            568999999999842   3344 449999999999999999999975543222111111100 11112223357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcc
Q 017860          257 LISRIFVADPAARITIPEIMKHQW  280 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~  280 (365)
                      |+.+||..+|++|||++++++|+|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.5e-45  Score=338.07  Aligned_cols=260  Identities=27%  Similarity=0.436  Sum_probs=213.3

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      +.+++.|+++++||+|+||.||++++..+++.||+|.+..... ....+.+|+.+++.++||||+++++++..+..+|+|
T Consensus         8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644           8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            4556889999999999999999999999999999999876432 335678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-C
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-S  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~  175 (365)
                      |||+++++|..++.+ ...+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||++...... .
T Consensus        88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~  165 (292)
T cd06644          88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG--DIKLADFGVSAKNVKTLQ  165 (292)
T ss_pred             EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC--CEEEccCccceecccccc
Confidence            999999999887755 45689999999999999999999999999999999999997655  4999999987643221 2


Q ss_pred             CCCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          176 QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ......+++.|+|||++.+     ..++.+ +|||||||++|+|++|..||...+......+..   .......+....+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~  241 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLSQPSKW  241 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCch-hhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh---cCCCccCCCCccc
Confidence            2234568899999999853     234444 999999999999999999997755433222211   1111223334567


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +.++.++|.+||..+|++||+++++++||||...
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            8999999999999999999999999999999653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-46  Score=337.94  Aligned_cols=257  Identities=29%  Similarity=0.456  Sum_probs=213.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +.++|+++++||.|+||.||++.+..+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++.+..+..+|+|||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            35789999999999999999999988999999999875432 23568889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCC
Q 017860          100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      |+++++|..++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...... ...
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhccccccc
Confidence            99999999998764 46999999999999999999999999999999999999986654  999999987643322 222


Q ss_pred             CCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCCCCCCCC
Q 017860          178 KSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNPIS  251 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s  251 (365)
                      ....+++.|+|||.+..     ..++.+ +|+|||||++|+|++|+.||...+......+    +.... ........++
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~-sDi~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  235 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYK-ADIWSLGITLIELAQMEPPHHELNPMRVLLK----ILKSEPPTLDQPSKWS  235 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCcc-ccHHHHHHHHHHHHhCCCCcccCCHHHHHHH----HhcCCCCCcCCcccCC
Confidence            34568999999999853     234444 9999999999999999999987654332222    22221 1223344578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .++.+++.+||+.+|.+||++.++++||||.+.
T Consensus       236 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         236 SSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-45  Score=338.39  Aligned_cols=258  Identities=27%  Similarity=0.451  Sum_probs=215.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..+|++.+.||+|+||.||++.+..+++.||+|.+..... ....+.+|+.+++.++||||+++++.|......|+||||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            4589999999999999999999999999999999876432 235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +.+++|.+++.+ ..+++.++..++.|++.||+|||++|++||||||+||+++.++.  +||+|||++....... ....
T Consensus        99 ~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             cCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccCc
Confidence            999999998864 45899999999999999999999999999999999999986654  9999999887543222 2234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+.........   .......+....++..+.+++.
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             ccCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh---cCCCCCCCCccccCHHHHHHHH
Confidence            578999999999987776655 999999999999999999998765433222211   1222223334558899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      +||..+|.+|||+.+++.||||....+
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhhccCC
Confidence            999999999999999999999976543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.4e-46  Score=334.23  Aligned_cols=252  Identities=28%  Similarity=0.483  Sum_probs=215.4

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +|++.+.||.|+||.||++++..+++.||+|.+.+..    ...+.+.+|+.+++.++||||+++++++.....+++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5999999999999999999999999999999997543    234678889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      |+.+++|...+....++++..+..++.||++||.|||++|++|+||+|+||+++.++.  ++|+|||++...........
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccc
Confidence            9999999999988778999999999999999999999999999999999999987664  99999999876554444455


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|+..|+|||++.+..++.+ +|+||||+++|+|++|..||...... ..............  ..+..++..+.++|.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~  234 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADV--LYPATWSTEAIDAIN  234 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccc--cCcccCcHHHHHHHH
Confidence            678999999999987776656 99999999999999999999876642 11112222221222  233347899999999


Q ss_pred             HhcccCCCCCCCH--HHHhcCccc
Q 017860          260 RIFVADPAARITI--PEIMKHQWF  281 (365)
Q Consensus       260 ~~l~~dp~~R~t~--~ell~h~~f  281 (365)
                      +||..+|.+||++  .++++||||
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHccCChhHcCCccHHHHhcCCCC
Confidence            9999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-45  Score=333.03  Aligned_cols=250  Identities=34%  Similarity=0.493  Sum_probs=210.3

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----------cHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------DENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      +|.+.+.||+|+||.||+|.+..+++.||+|.+......          .+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588899999999999999999989999999988653221          1457789999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      .++||||+++++|.+++.+.+.+++..++.++.|++.||+|||++|++||||+|+||+++.++.  +||+|||+++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~  158 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEA  158 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCccccc
Confidence            9999999999999999988888999999999999999999999999999999999999976654  99999999875432


Q ss_pred             CC-------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          174 HS-------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       174 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      ..       ......|++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||...+......+.    ... .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~-~~~~~  232 (267)
T cd06628         159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI----GEN-ASPEI  232 (267)
T ss_pred             ccccCCccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH----hcc-CCCcC
Confidence            11       1123458899999999988777666 99999999999999999999876543332221    111 11122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ...++..+.++|.+||+.+|.+||++.++++||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         233 PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            33478999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-45  Score=333.24  Aligned_cols=253  Identities=31%  Similarity=0.485  Sum_probs=212.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++.+.||.|+||+||++....++..+|+|++....  .....+.+|+..++.++|+||+++++.+.....+++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47999999999999999999998899999999986533  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860          101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~---~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      +.+++|.+++...   ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDR  158 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccc
Confidence            9999999999764   45899999999999999999999999999999999999987654  99999998865433222 


Q ss_pred             ----CCCCcCCCCCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC---CC
Q 017860          177 ----PKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD---TN  248 (365)
Q Consensus       177 ----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~  248 (365)
                          .....|++.|+|||++... .++.+ +|+|||||++|+|++|+.||...+....+.+....   .....+.   ..
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  234 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYK  234 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcc-cchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccccc
Confidence                2344689999999998776 44444 99999999999999999999876654444333332   1111211   23


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+++.+.+++.+||..||++|||+.+++.||||
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            578999999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1e-45  Score=339.95  Aligned_cols=260  Identities=26%  Similarity=0.416  Sum_probs=212.7

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....      ....+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            58999999999999999999999999999999976432      234567899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      |||+ +++|.+++.... .+++..++.++.||++||+|||++|++||||||+||+++.++.  +||+|||+++...... 
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc
Confidence            9999 899999998766 7999999999999999999999999999999999999987654  9999999987544332 


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C-----------
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-S-----------  243 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----------  243 (365)
                      ......+++.|+|||.+.+....+.++|||||||++|+|++|.+||...+....+.+.......... .           
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            2334467889999999866544445599999999999999998888876665444333322110000 0           


Q ss_pred             -------C---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          244 -------V---PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       244 -------~---~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                             .   ......+..+.+||.+||..+|++|||+.+++.|+||.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~  290 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA  290 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence                   0   001235788999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-45  Score=332.09  Aligned_cols=253  Identities=27%  Similarity=0.454  Sum_probs=213.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .++|++.+.||+|+||.||++++..+++.||+|.+..... .+.+.+|+.+++.++||||+++++++.....+|+++||+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            4689999999999999999999998899999999876543 578899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       102 ~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      .+++|.+++.. ...+++..++.++.|++.||.|||+.+++||||+|+||+++.++.  +||+|||++....... ....
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCcccccc
Confidence            99999999875 456899999999999999999999999999999999999987654  9999999987544332 2334


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|+..|+|||++.+..++.+ +||||||+++|+|++|+.||............ .  ............++.++.+++.
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-P--NKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             ccCCccccCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-c--cCCCCCCCchhhcCHHHHHHHH
Confidence            458899999999988777666 99999999999999999999875543322111 1  1111122233347789999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccc
Q 017860          260 RIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +||+.+|.+|||+.+++.||||
T Consensus       235 ~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=5.1e-46  Score=346.82  Aligned_cols=254  Identities=24%  Similarity=0.416  Sum_probs=201.4

Q ss_pred             eecccccC--CCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           27 FVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        27 ~~~~LG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      +++.||+|  +||+||++.++.+|+.||+|.+....   .....+.+|+.+++.++||||++++++|..++.+++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            57889999  78899999999999999999987542   22356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC----
Q 017860          102 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----  175 (365)
Q Consensus       102 ~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~----  175 (365)
                      ++|+|.+++...  ..+++..++.++.|++.||+|||++|++||||||+|||++.++.  ++++||+.+.......    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhcccccccccc
Confidence            999999998653  45899999999999999999999999999999999999987664  9999998643221111    


Q ss_pred             ----CCCCCcCCCCCCCchhhccc--ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------
Q 017860          176 ----QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------  241 (365)
Q Consensus       176 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------  241 (365)
                          ......++..|+|||++.+.  .++.+ +|||||||++|+|++|+.||....................        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                11223567889999999753  35545 9999999999999999999986544332222211100000        


Q ss_pred             --------------------------------cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          242 --------------------------------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       242 --------------------------------~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                                                      ...+....+++.+.+||.+||+.||++|||++++++||||++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                            000112235778999999999999999999999999999965

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-45  Score=331.44  Aligned_cols=255  Identities=32%  Similarity=0.472  Sum_probs=213.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||.|+||.||++.+..+++.+|+|.+..... ....+.+|+.+++.++||||+++++++.....+|++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            4689999999999999999999998999999999876432 346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      +.+++|.+++... .++++..++.++.|++.||+|||++|++|+||||+||+++.++.  +||+|||++....... ...
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~  159 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRK  159 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccc
Confidence            9999999998776 78999999999999999999999999999999999999987654  9999999987543322 234


Q ss_pred             CCcCCCCCCCchhhccc---ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          179 STVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ...++..|+|||.+.+.   .++.+ +|+|||||++|+|++|+.||...+.............. .........++.++.
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~~~-~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  237 (262)
T cd06613         160 SFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFP-PPKLKDKEKWSPVFH  237 (262)
T ss_pred             cccCCccccCchhhcccccCCcCch-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCC-CccccchhhhhHHHH
Confidence            45789999999998765   66655 99999999999999999999876644333222111111 111122334678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQW  280 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~  280 (365)
                      +|+.+||..+|..|||+.+++.|+|
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-45  Score=336.73  Aligned_cols=260  Identities=24%  Similarity=0.437  Sum_probs=216.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++++.||+|+||+||++.+..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            468999999999999999999999999999999886543  234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |+++++|..++.+.+.+++..++.++.+++.||.|||+ .+++||||||+||+++.++  .++|+|||++..... ....
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~d~gl~~~~~~-~~~~  160 (284)
T cd06620          84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG--QIKLCDFGVSGELIN-SIAD  160 (284)
T ss_pred             cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC--cEEEccCCcccchhh-hccC
Confidence            99999999999888889999999999999999999997 6899999999999998665  499999998764322 2223


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh-------HHHHHHHHHHhccccCCCCCCCCC
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------KDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ...|+..|+|||++.+..++.+ +|||||||++|+|++|..||......       ..+......+............++
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             ccccCcccCCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            4578999999999987777666 99999999999999999999865432       112223333332221111122367


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .++.+|+.+||+.||.+|||+.|+++|+||.+..
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            8999999999999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-45  Score=337.02  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=211.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++++.||+|+||.||++++..+++.||+|.+....  .....+.+|+.+++.++||||+++++++.....+|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47999999999999999999999999999999886532  2235688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860          101 ASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~---~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      +++++|..++...   ..+++..++.++.|++.||.|||+ .|++||||||+||+++.++  .+||+|||++..... ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-Cc
Confidence            9999998888763   368999999999999999999997 5999999999999998754  499999999875422 23


Q ss_pred             CCCCcCCCCCCCchhhccccc-----CCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCCCCCCC
Q 017860          177 PKSTVGTPAYIAPEVLLRHEY-----DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNPI  250 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  250 (365)
                      .....+++.|+|||.+.+...     .+.++|||||||++|+|++|+.||........+ ..+..+.... ...  +..+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~--~~~~  234 (286)
T cd06622         158 AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGDPPTL--PSGY  234 (286)
T ss_pred             cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcCCCCC--Cccc
Confidence            344568899999999854432     234499999999999999999999765443322 2223222222 222  2337


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      +.++.+||.+||+.+|.+||++++++.||||.....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            899999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-47  Score=322.35  Aligned_cols=259  Identities=28%  Similarity=0.440  Sum_probs=214.9

Q ss_pred             CCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeC--
Q 017860           15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTP--   91 (365)
Q Consensus        15 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--   91 (365)
                      ..++..+++||++.++||+|||+.||++++..+++.||+|++.... ...+...+|+...++++||||++++++...+  
T Consensus        13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~   92 (302)
T KOG2345|consen   13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK   92 (302)
T ss_pred             CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence            4566788999999999999999999999999999999999997655 4557789999999999999999998876544  


Q ss_pred             ---CEEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEE
Q 017860           92 ---THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKI  162 (365)
Q Consensus        92 ---~~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl  162 (365)
                         ...|++++|...|+|.+.+...    ..++|.++..|+.+|++||.+||+..  +.||||||.|||+.+++.  ++|
T Consensus        93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl  170 (302)
T KOG2345|consen   93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVL  170 (302)
T ss_pred             cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEE
Confidence               3499999999999999988642    35899999999999999999999999  999999999999987554  999


Q ss_pred             ecCCCcccccCCCCCC----------CCcCCCCCCCchhhccc---ccCCccceeehhhHHHHHHHhCCCCCCCCCChHH
Q 017860          163 CDFGYSKSSVLHSQPK----------STVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD  229 (365)
Q Consensus       163 ~Dfgla~~~~~~~~~~----------~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  229 (365)
                      .|||.++.....-...          ....|..|+|||.+.-.   ..+.+ +|||||||++|.|+.|..||+..-..-.
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~Gg  249 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQGG  249 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence            9999887554432222          23479999999998543   34455 9999999999999999999974221000


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                        ...-.+.+.++.+|....+|+.+.+||+.||++||.+||++.+++.+
T Consensus       250 --SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  250 --SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             --eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence              01112455677889888899999999999999999999999999864

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.6e-45  Score=334.80  Aligned_cols=256  Identities=28%  Similarity=0.443  Sum_probs=211.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      +-|++.+.||+|+||.||++.+..++..+++|.+.... ...+.+.+|+.+++.++||||+++++++......|+|+||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            35799999999999999999999999999999986543 23356788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCC
Q 017860          102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  179 (365)
Q Consensus       102 ~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~  179 (365)
                      .+++|...+.+ ..++++..++.++.|++.||.|||+.|++||||||+||+++.++.  +||+|||++...... .....
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEcccccccccccccccccc
Confidence            99999888765 456899999999999999999999999999999999999976654  999999998653222 22344


Q ss_pred             CcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          180 TVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       180 ~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ..+++.|+|||++.     +..++.+ +|||||||++|+|++|++||...+......+...   ......+.+..++.++
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~  238 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEF  238 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCcc-chhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCccccCHHH
Confidence            56899999999984     2334444 9999999999999999999987654333322221   1112233344578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .+||.+||..+|.+|||++++++||||...
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999999999765

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=349.33  Aligned_cols=255  Identities=33%  Similarity=0.582  Sum_probs=221.5

Q ss_pred             ccee--cccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           25 YDFV--RDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        25 y~~~--~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      |+|.  +.||+|-||+||-++++.+|+.||||++.+-   .+....+++|+.||..+.||.||.+.-.|++.+.+++|||
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVME  643 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVME  643 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEeh
Confidence            6664  7899999999999999999999999999763   3345778999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEecCCCcccccCCCCC
Q 017860          100 YASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~-~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      .+.|.-|...+. ..+++++...+.++.||+.||.|||-+||+|+||||+|||+.+. .-+++||||||+|+........
T Consensus       644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            997755555554 46789999999999999999999999999999999999999654 3458999999999988888888


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      .+.+|||.|.|||++.+.+|+.. -|+||+|+|+|.-++|..||...++..   ..++. ....+....|..+|+++.+|
T Consensus       724 rsVVGTPAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdIn---dQIQN-AaFMyPp~PW~eis~~Aidl  798 (888)
T KOG4236|consen  724 RSVVGTPAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDIN---DQIQN-AAFMYPPNPWSEISPEAIDL  798 (888)
T ss_pred             hhhcCCccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccchh---HHhhc-cccccCCCchhhcCHHHHHH
Confidence            89999999999999999999876 899999999999999999998655432   33332 12223334577899999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |..+|+..-.+|.|++..|.|||++..
T Consensus       799 In~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  799 INNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHHHHHhcchHhhccchhhhcc
Confidence            999999999999999999999999764

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.6e-45  Score=336.31  Aligned_cols=256  Identities=28%  Similarity=0.445  Sum_probs=211.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....   .....+.+|+.+++.++||||+++++++.....+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5999999999999999999999999999999987643   2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--CC
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  177 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--~~  177 (365)
                      + +++|.+++.. ...+++.+++.++.||+.||+|||+.|++|+||||+||+++.++.  ++|+|||++.......  ..
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  157 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLY  157 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCcc
Confidence            9 9999998865 456899999999999999999999999999999999999987554  9999999987554332  23


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------------  242 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------  242 (365)
                      ....|+..|+|||.+.+....+.++|||||||++|+|++|.+||........+............               
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            44578999999999876555455699999999999999999888776655444443332111100               


Q ss_pred             CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          243 SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       243 ~~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      ..+         .....+..+.+||.+||..+|.+|||+++++.||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            000         0123578899999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.4e-45  Score=332.06  Aligned_cols=256  Identities=29%  Similarity=0.451  Sum_probs=212.1

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      +|+..+.||+|+||.||++.+..+++.||+|.+.....       ....+.+|+.+++.++||||+++++++.....+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            58899999999999999999999999999999875321       23568899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      |+||+.+++|.+++.+.+++++..++.++.|++.||+|||++|++||||+|+||+++.++. .+||+|||++........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccc
Confidence            9999999999999988888999999999999999999999999999999999999975532 499999999865433211


Q ss_pred             -----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          177 -----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       177 -----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                           .....|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||.......... .+...............++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhC
Confidence                 123468899999999977776655 999999999999999999997654332222 2222222222222333478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      +++.+++.+||..+|.+|||+.++++||||+
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            9999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.8e-45  Score=328.69  Aligned_cols=250  Identities=26%  Similarity=0.483  Sum_probs=208.0

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe-CCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e   99 (365)
                      +|++.+.||+|++|.||++.++.+++.||+|.+.....   ..+.+.+|+.+++.++|||++++++.+.. ...+|++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            59999999999999999999999999999999875432   23467889999999999999999998864 456899999


Q ss_pred             ecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860          100 YASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus       100 ~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      |+++++|.+++..  ...+++.+++.++.|++.||++||++|++||||||+||+++.++.  ++|+|||++...... ..
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDM  158 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCc
Confidence            9999999998876  345899999999999999999999999999999999999976654  999999998754322 22


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      .....|++.|+|||++.+..++.+ +|||||||++++|++|+.||...+......    .+..... .+....+++.+.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~  232 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVY----RIIEGKL-PPMPKDYSPELGE  232 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHhcCC-CCCccccCHHHHH
Confidence            334568999999999988777666 899999999999999999998655433222    2222221 1223457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccc
Q 017860          257 LISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      |+.+||+.+|.+|||+.++++||||
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-45  Score=335.38  Aligned_cols=254  Identities=26%  Similarity=0.428  Sum_probs=208.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEe------CCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT------PTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~------~~~   93 (365)
                      ..++|++.+.||.|+||.||+++++.+++.+|+|.+.........+..|+.+++.+ +||||+++++++..      ...
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            45689999999999999999999999999999999877655556788899988888 69999999999853      467


Q ss_pred             EEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           94 LAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +|++|||+.+|+|.+++...  ..+++..++.++.||+.||+|||+.|++||||||+||+++.++.  ++|+|||++...
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~  171 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL  171 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhh
Confidence            89999999999999988753  45889999999999999999999999999999999999986654  999999998754


Q ss_pred             cCC-CCCCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 017860          172 VLH-SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       172 ~~~-~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  245 (365)
                      ... .......|++.|+|||.+..     ..++.+ +|||||||++|+|++|..||...........    +........
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~-~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~  246 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKL  246 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcc-cchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCC
Confidence            322 22345678999999999852     345555 9999999999999999999976544322221    111111112


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ....++.++.+||.+||..||.+|||+.++++||||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            233578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.8e-45  Score=334.53  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=210.7

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeC-----CE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTP-----TH   93 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~-----~~   93 (365)
                      ...++|++.+.||+|+||.||++.++.+++.+|+|.+.........+.+|+.+++.+ +|||++++++++...     ..
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            346789999999999999999999999999999999876555556788899999988 899999999998754     36


Q ss_pred             EEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           94 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +|+||||+.+++|.+++..    ..++++..++.++.|++.||+|||+.|++||||||+||+++.++.  +||+|||++.
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~  176 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSA  176 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccch
Confidence            8999999999999988753    456899999999999999999999999999999999999986654  9999999987


Q ss_pred             cccCCC-CCCCCcCCCCCCCchhhcccc-----cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC
Q 017860          170 SSVLHS-QPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS  243 (365)
Q Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  243 (365)
                      ...... ......|+..|+|||++....     ++.+ +|||||||++|+|++|+.||..........+...   .....
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~  252 (291)
T cd06639         177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDAR-CDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPT  252 (291)
T ss_pred             hcccccccccCccCCccccChhhhcCCCCcccccCCc-cchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCC
Confidence            543222 223456899999999985432     3444 9999999999999999999987655433322211   11222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       244 ~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      ......++..+.+||.+||+.+|++||++.+++.||||+
T Consensus       253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            233345778999999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-45  Score=337.90  Aligned_cols=260  Identities=27%  Similarity=0.439  Sum_probs=215.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ...+|++++.||+|+||.||++.+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.....+|+|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            34689999999999999999999999999999999875432 33567889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-CC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~~  178 (365)
                      |+++++|.+++.+ ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||++........ ..
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~  173 (297)
T cd06656          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRS  173 (297)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcC
Confidence            9999999998865 45899999999999999999999999999999999999986654  99999999875433222 23


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...+++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||...+........   ..........+..++..+.+|+
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li  249 (297)
T cd06656         174 TMVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRDFL  249 (297)
T ss_pred             cccCCccccCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHHHH
Confidence            4568999999999987777655 99999999999999999999775543222111   1111222223445788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+||..+|++||++.++++||||....+.
T Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             HHHccCChhhCcCHHHHhcCchhcccccc
Confidence            99999999999999999999999866543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.2e-45  Score=333.45  Aligned_cols=257  Identities=28%  Similarity=0.521  Sum_probs=213.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++.+.||+|+||.||++.++.+++.+|+|.+....  .....+.+|+.+++.++||||+++++++.....+++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            37999999999999999999999999999999987643  2335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      +.+++|.+++... ..+++..++.++.|++.||+|||+ .|++||||||+||+++.++  .++|+|||.+........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~--~~~l~d~g~~~~~~~~~~-~  157 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLVNSLA-K  157 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC--CEEEeecccchhhHHHHh-h
Confidence            9999999999876 779999999999999999999999 9999999999999998755  499999998865432222 2


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC-hHHHHHHHHHHhcccc-CCCCCCCCCHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-PKDFRKTIQRILSVQY-SVPDTNPISQECRD  256 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~  256 (365)
                      ...++..|+|||.+.+..++.+ +|||||||++|+|++|..||..... ........+.+..... ..+.. .++.++.+
T Consensus       158 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  235 (265)
T cd06605         158 TFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSG-KFSPDFQD  235 (265)
T ss_pred             cccCChhccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChh-hcCHHHHH
Confidence            2678899999999988777666 9999999999999999999976531 1112223333332221 11211 27889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +|.+||..+|.+|||+.+++.||||++.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.2e-45  Score=328.08  Aligned_cols=253  Identities=31%  Similarity=0.501  Sum_probs=213.7

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ||++.+.||+|+||.||++.+..+++.||+|.+.....   ....+.+|+.+++.++|+||+++++++.....+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            69999999999999999999998999999999876544   346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC---
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~---  177 (365)
                      +.+++|.+++.+...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.  +||+|||++.........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~  158 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGE  158 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccc
Confidence            999999999988777999999999999999999999999999999999999987554  999999998754332221   


Q ss_pred             --CCCcCCCCCCCchhhcccc---cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          178 --KSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       178 --~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                        ....+++.|+|||++.+..   ++.+ +||||||+++|++++|+.||............+.  .......|....+++
T Consensus       159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~-~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  235 (264)
T cd06626         159 EVQSLAGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG--AGHKPPIPDSLQLSP  235 (264)
T ss_pred             cccCCcCCcCccChhhccCCCCCCCCcc-cchHHHHHHHHHHHhCCCCccCCcchHHHHHHHh--cCCCCCCCcccccCH
Confidence              2346789999999987655   5555 9999999999999999999976543322211111  123334555555689


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+.+||.+||+.+|.+|||+.+++.|||+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.5e-45  Score=334.41  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=208.1

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEE-----eCCE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTH   93 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~-----~~~~   93 (365)
                      ...++|++++.||+|+||.||++.++.+++.+|+|++.........+.+|+.+++.+ +||||+++++++.     ....
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            456799999999999999999999999999999999876544456788899999999 6999999999874     3467


Q ss_pred             EEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           94 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +++||||+++++|.+++..    ...+++..++.++.|++.||.|||+++++||||||+||+++.++.  +||+|||+++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~  172 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSA  172 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCcee
Confidence            8999999999999987752    346899999999999999999999999999999999999987654  9999999987


Q ss_pred             cccCCC-CCCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC
Q 017860          170 SSVLHS-QPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS  243 (365)
Q Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  243 (365)
                      ...... ......|++.|+|||++..     ..++.+ +|||||||++|+|++|+.||..........+...   .....
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~  248 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPPT  248 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccch-hhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCCc
Confidence            543222 2334568999999999853     234444 9999999999999999999987654333222111   11112


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       244 ~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ......++..+.+|+.+||+.+|++|||+.++++|+||
T Consensus       249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            22333467899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.5e-45  Score=327.94  Aligned_cols=250  Identities=29%  Similarity=0.465  Sum_probs=210.7

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||+|++|.||++.++.+++.|++|.+...   ......+.+|+.+++.++||||+++++++.....+|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            488999999999999999999999999999998753   23346688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-C
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~  177 (365)
                      +++++|.+++...  ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||+++....... .
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchh
Confidence            9999999998764  56899999999999999999999999999999999999986654  99999999875443322 2


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....|++.|+|||++.+..++.+ +|+|||||++++|++|+.||...+......    .+..... .+....++..+.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~  232 (256)
T cd08529         159 NTIVGTPYYLSPELCEDKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVF-PPVSQMYSQQLAQL  232 (256)
T ss_pred             hccccCccccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCC-CCCccccCHHHHHH
Confidence            34468999999999988777666 999999999999999999998766433222    2222221 11222578899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017860          258 ISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +.+||+.+|++||++.+++.|||+
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhCCCC
Confidence            999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.8e-45  Score=336.13  Aligned_cols=257  Identities=26%  Similarity=0.470  Sum_probs=210.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++.+.||+|+||.||++.++.+++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++......|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            479999999999999999999998999999999865332   23567889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      |+.+++|..+......+++..++.++.|++.||+|||+.|++||||+|+||+++.++.  ++|+|||++....... ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccC
Confidence            9999999887776667999999999999999999999999999999999999987654  9999999987543322 223


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccC
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QYS  243 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  243 (365)
                      ...++..|+|||++.+....+.++|||||||++|+|++|++||...........+.......               ...
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            45688999999998765444455999999999999999999998665443333322111000               000


Q ss_pred             CC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          244 VP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       244 ~~----------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+          ....++..+.+|+.+||..+|.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            01          123468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.2e-45  Score=333.75  Aligned_cols=253  Identities=29%  Similarity=0.462  Sum_probs=204.5

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCC-CCCcceeceEEEeC--CEEEEEEe
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVME   99 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~e   99 (365)
                      |+++++||+|+||.||++.++.+++.||+|.+.....  ......+|+..++++. ||||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            7889999999999999999999999999999875322  2234457888888885 99999999999988  88999999


Q ss_pred             ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |+.+ +|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.   +.+||+|||+++.........
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~---~~~kl~dfg~~~~~~~~~~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD---DILKLADFGSCRGIYSKPPYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC---CCeEEEecccccccccCCCcC
Confidence            9974 78777765 456899999999999999999999999999999999999987   459999999988655444445


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc--------------cccCC
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--------------VQYSV  244 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~  244 (365)
                      ...+++.|+|||++......+.++|||||||++|+|++|+.||...+....+.........              ..+..
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            5678999999998765554455599999999999999999999876654433222211100              01111


Q ss_pred             CC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          245 PD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       245 ~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +.         ...++..+.+||.+||..+|.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            11         12468999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-45  Score=331.44  Aligned_cols=255  Identities=27%  Similarity=0.475  Sum_probs=210.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCC------E
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPT------H   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~------~   93 (365)
                      .+++|++.+.||+|+||.||+|.++.+++.+++|.+.........+.+|+.+++.+ +||||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            35799999999999999999999998999999999987665567889999999998 7999999999997654      4


Q ss_pred             EEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           94 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +++||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  +||+|||++.
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~  161 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSA  161 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccce
Confidence            8999999999999998865    357999999999999999999999999999999999999987654  9999999886


Q ss_pred             cccCC-CCCCCCcCCCCCCCchhhccc-----ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC
Q 017860          170 SSVLH-SQPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS  243 (365)
Q Consensus       170 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  243 (365)
                      ..... .......|++.|+|||++...     .++.+ +|||||||++|+|++|+.||..........+...   .....
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~  237 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPT  237 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCcccc-ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCC
Confidence            43322 223445689999999997532     23444 9999999999999999999986544333322221   11222


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       244 ~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ......+++++++||.+||..||.+|||+.++++|||+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            33333478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=8.1e-45  Score=326.24  Aligned_cols=251  Identities=34%  Similarity=0.525  Sum_probs=213.0

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.+++.++||||+++++.+.....+++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            5999999999999999999999999999999987543   2335688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      +++++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++ ..+||+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK-MVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEccCCCceecCCCcccc
Confidence            9999999999763  3489999999999999999999999999999999999997543 248999999988655444445


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...|++.|+|||.+.+..++.+ +||||||+++|+|++|+.||...+......+...    ... .+....+++++.+++
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~l~~li  233 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKIMS----GTF-APISDRYSPDLRQLI  233 (256)
T ss_pred             ccccCCcccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh----cCC-CCCCCCcCHHHHHHH
Confidence            5678999999999987776655 9999999999999999999987665443322221    111 122334789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccc
Q 017860          259 SRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+||..+|.+|||+.+++.||||
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4e-45  Score=331.59  Aligned_cols=255  Identities=31%  Similarity=0.463  Sum_probs=208.1

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-----------ccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------IDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      +|.+.+.||+|+||.||++.+..+|+.||+|.+.....           ..+.+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            68899999999999999999998999999998864211           1135778999999999999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+++||||+.+++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++.  ++|+|||+++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~  159 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSD  159 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999986654  9999999987533


Q ss_pred             CCC---CCCCCcCCCCCCCchhhcccc--cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          173 LHS---QPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       173 ~~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      ...   ......|+..|+|||.+....  ++.+ +|+||||+++|+|++|..||..........+...............
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAK-VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             ccccccccccccCCccccCHHHhccccCCCCcc-chhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            211   123446889999999987654  4444 9999999999999999999976544332222211111111111122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ..++..+.+++.+||..+|.+|||++++++||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            3468999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.8e-45  Score=333.82  Aligned_cols=255  Identities=30%  Similarity=0.497  Sum_probs=208.1

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++++.||.|++|.||+|+++.+++.||+|.+.....   ....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            48999999999999999999999999999998865332   235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CC
Q 017860          101 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  177 (365)
Q Consensus       101 ~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~  177 (365)
                      +. ++|..++..  ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCcccc
Confidence            96 588888765  356899999999999999999999999999999999999987665  9999999987543222 22


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------cC
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------YS  243 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~  243 (365)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|+.||...+......+.........              ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07860         158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS  237 (284)
T ss_pred             ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence            3345789999999987655444559999999999999999999987665444433332211100              00


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          244 VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       244 ~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ++.         ...++++++++|.+||+.||.+|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             cccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            010         12367899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.9e-45  Score=329.17  Aligned_cols=251  Identities=28%  Similarity=0.430  Sum_probs=206.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA   95 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~   95 (365)
                      +|++.+.||+|+||.||++.+..+++.||+|.+.....      ....+.+|+.+++.++||||+++++++..  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            79999999999999999999999999999999864321      12457789999999999999999999875  36789


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-  174 (365)
                      +++||+++++|.+++.+.+.+++..++.++.|++.||+|||+++++||||||+||+++.++.  +||+|||+++..... 
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~  160 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCcccccccc
Confidence            99999999999999988888999999999999999999999999999999999999976654  999999998743221 


Q ss_pred             ---CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 ---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                         .......++..|+|||.+.+..++.+ +|||||||++|+|++|+.||..........+    .............++
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~  235 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHIS  235 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhcC
Confidence               11223458899999999987777665 9999999999999999999987654333322    211111111123467


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      +.+.+++ +||..+|++||+++++++||||.
T Consensus       236 ~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         236 EHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            8899999 67778999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.3e-45  Score=328.62  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=208.9

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      +|++.+.||+|+||.||++... +++.+|+|.+.....       ....+.+|+.+++.++|+||+++++++.....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            5889999999999999999874 788999999865321       12457889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC---
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~---  173 (365)
                      |+||+++++|.+++.+.+++++..++.++.|++.||+|||+.|++|+||+|+||+++.++.  ++|+|||++.....   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccc
Confidence            9999999999999988888999999999999999999999999999999999999986654  99999998764321   


Q ss_pred             ----CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 ----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                          ........|+..|+|||++.+..++.+ +|+|||||++|+|++|..||...+..........   ......+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~  233 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---HRGLMPRLPDS  233 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh---ccCCCCCCCCC
Confidence                112234568999999999987777666 9999999999999999999987654433222111   10111123345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ++.++.+||.+||..+|.+||++.++++||||
T Consensus       234 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            78999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6e-45  Score=328.61  Aligned_cols=248  Identities=32%  Similarity=0.550  Sum_probs=210.0

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ||.|+||.||++++..+++.||+|++.+..    ...+.+.+|+.+++.++||||+++++.+..+..+|+|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999999899999999997643    2335688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCC
Q 017860          107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY  186 (365)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y  186 (365)
                      .+++.+...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.  ++|+|||++.............|++.|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCc
Confidence            999988888999999999999999999999999999999999999987654  999999998865444334456789999


Q ss_pred             CCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCC
Q 017860          187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP  266 (365)
Q Consensus       187 ~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp  266 (365)
                      +|||.+.+..++.+ +|+||||+++|+|++|..||.......  .+....+.......+.+...++++.++|.+||..+|
T Consensus       159 ~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         159 VAPEIILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             cChhHhcCCCCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCCh
Confidence            99999887777666 999999999999999999998765211  122333332222222333358899999999999999


Q ss_pred             CCCCC-----HHHHhcCccccc
Q 017860          267 AARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       267 ~~R~t-----~~ell~h~~f~~  283 (365)
                      .+||+     ++|+++||||..
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhC
Confidence            99999     999999999975

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.8e-45  Score=336.94  Aligned_cols=261  Identities=30%  Similarity=0.458  Sum_probs=209.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~   95 (365)
                      ..++|++.+.||+|+||.||++.++.+|+.||+|.+.....   ......+|+.+++.++|+||+++++++...  ..++
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            45689999999999999999999999999999999875432   223567899999999999999999999765  5689


Q ss_pred             EEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+.+ +|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+||+++.++  .+||+|||++......
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~--~~kL~dfg~~~~~~~~  161 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG--CLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC--CEEECccceeeecCCc
Confidence            99999965 78887765 35689999999999999999999999999999999999998665  4999999998755433


Q ss_pred             C-CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------
Q 017860          175 S-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------------  240 (365)
Q Consensus       175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------  240 (365)
                      . ......+++.|+|||++.+....+.++|||||||++|+|++|++||...+....+..+.......             
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            2 22334568899999998765444455999999999999999999998877655544433321110             


Q ss_pred             --ccCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          241 --QYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       241 --~~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                        .+..+.         ....++.+.+||.+||+.||.+|||+.+++.||||.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence              000000         11257889999999999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.8e-45  Score=332.24  Aligned_cols=248  Identities=31%  Similarity=0.453  Sum_probs=207.6

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ||+|+||+||+|.++.+|+.||+|.+....    .....+.+|+.+++.++||||+++++++.....+|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999999999999999987532    2234567899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCC
Q 017860          107 FERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP  184 (365)
Q Consensus       107 ~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~  184 (365)
                      .+++.+.+  .+++..++.++.|++.||.|||++|++||||+|+||+++.++.  +||+|||++.............++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCC
Confidence            99987765  6999999999999999999999999999999999999986654  9999999987554444444567889


Q ss_pred             CCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017860          185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA  264 (365)
Q Consensus       185 ~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  264 (365)
                      .|+|||++.+..++.+ +|||||||++|+|++|+.||.....................  ..+..+++.+.++|.+||+.
T Consensus       159 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         159 GYMAPEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV--EYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CcCCHHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc--cCCccCCHHHHHHHHHHccC
Confidence            9999999987776655 99999999999999999999876543222223322222222  23344789999999999999


Q ss_pred             CCCCCC-----CHHHHhcCccccc
Q 017860          265 DPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       265 dp~~R~-----t~~ell~h~~f~~  283 (365)
                      +|.+||     ++.+++.||||.+
T Consensus       236 ~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         236 DPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             ChhHccCCCcccHHHHHhChhhhc
Confidence            999999     8999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-45  Score=340.76  Aligned_cols=261  Identities=30%  Similarity=0.440  Sum_probs=205.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeC-----CEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~   94 (365)
                      .++|++.+.||+|+||.||++.++.+|+.||+|.+....  .....+.+|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999999999999999986422  2335678899999999999999999987654     358


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |+|+||+.+ +|...+. .+++++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++......
T Consensus        84 ~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~  159 (336)
T cd07849          84 YIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPE  159 (336)
T ss_pred             EEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeecccc
Confidence            999999964 7877664 457999999999999999999999999999999999999986654  999999998754322


Q ss_pred             C----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----------c
Q 017860          175 S----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-----------S  239 (365)
Q Consensus       175 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----------~  239 (365)
                      .    ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+........           .
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            2    123357899999999876544334559999999999999999999977554332221111000           0


Q ss_pred             ---------c--ccCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          240 ---------V--QYSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       240 ---------~--~~~~~---~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                               .  ....+   ....+++++.+|+.+||+.+|.+|||+.+++.||||.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~  300 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD  300 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence                     0  00000   01235788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=7.2e-45  Score=335.79  Aligned_cols=254  Identities=32%  Similarity=0.543  Sum_probs=211.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||++.++.+++.||+|.+.....    ....+.+|+.+++.++||||+++++.+..+..+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            379999999999999999999999999999999876432    2245778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---  175 (365)
                      ||++|++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++......   
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCcccc
Confidence            99999999999988888999999999999999999999999999999999999986654  9999999876321110   


Q ss_pred             -------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          176 -------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       176 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                                   ......|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||.+.+.....    ........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~----~~~~~~~~  233 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELF----GQVISDDI  233 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhccc
Confidence                         1112457889999999987777666 99999999999999999999875543222    22222222


Q ss_pred             CCCCC-CCCCHHHHHHHHHhcccCCCCCCC---HHHHhcCccccc
Q 017860          243 SVPDT-NPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLK  283 (365)
Q Consensus       243 ~~~~~-~~~s~~~~~li~~~l~~dp~~R~t---~~ell~h~~f~~  283 (365)
                      ..+.. ..++.++.++|.+||+.+|.+||+   +.+++.||||..
T Consensus       234 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         234 EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence            22221 247899999999999999999997   799999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-45  Score=333.10  Aligned_cols=257  Identities=30%  Similarity=0.495  Sum_probs=205.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++.+.||+|+||.||++.++.+++.||+|.+.....  ....+.+|+.+++.++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            3589999999999999999999998999999999875432  23456789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CC
Q 017860          100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~  177 (365)
                      |+.+ +|.+++.+. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++...... ..
T Consensus        84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccc
Confidence            9975 898888764 46899999999999999999999999999999999999987664  9999999987533221 12


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------------  241 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  241 (365)
                      ....+++.|+|||++.+....+.++||||+||++|+|++|+.||..........+.+.......                
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP  240 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccc
Confidence            3345788999999987644333449999999999999999999977653322222221111100                


Q ss_pred             cCC---------CCCCCCC--HHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          242 YSV---------PDTNPIS--QECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       242 ~~~---------~~~~~~s--~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ...         .....++  .++.+++.+||+.+|.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000         0011234  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.3e-45  Score=344.19  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=209.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC------C
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~   92 (365)
                      .++|++++.||+|+||.||++++..+++.||+|.+.+..   .....+.+|+.+++.++||||++++++|...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            468999999999999999999999999999999986532   2234577899999999999999999998654      3


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ..|+||||+. ++|...+...  +++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++...
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~  169 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  169 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCC
Confidence            5799999996 4788877654  899999999999999999999999999999999999987654  9999999998654


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc------------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------  240 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------  240 (365)
                      .........+++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+....+.++.......            
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CCCCCCCCcccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            4444455678999999999988887766 999999999999999999998765544333322211100            


Q ss_pred             ------cc--------------CCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          241 ------QY--------------SVPD-----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       241 ------~~--------------~~~~-----~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                            ..              .++.     ....++.+++||.+||+.||.+|||+.|+|.||||..++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence                  00              0000     1124667899999999999999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.1e-45  Score=332.75  Aligned_cols=238  Identities=21%  Similarity=0.210  Sum_probs=198.7

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEe----CCEEEEEEee
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEY  100 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~e~  100 (365)
                      ..||+|++|.||++..  +|+.||+|.+.......    +.+.+|+.++++++||||+++++++.+    ...+++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999987  68999999997654333    556799999999999999999999877    3578999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      +.+|+|.+++.+.+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.  +||+|||+++....  ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~~~~  179 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--PPFK  179 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--cccc
Confidence            9999999999888889999999999999999999998 49999999999999987654  99999999875422  2235


Q ss_pred             CcCCCCCCCchhhcc--cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          180 TVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ..||+.|+|||++.+  ..++.+ +|||||||++|||++|+.||...+.....    ..+.......+.+...++.+.+|
T Consensus       180 ~~~~~~y~aPE~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~l~~l  254 (283)
T PHA02988        180 NVNFMVYFSYKMLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIY----DLIINKNNSLKLPLDCPLEIKCI  254 (283)
T ss_pred             ccCcccccCHHHhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcCCCCCCCCcCcHHHHHH
Confidence            678999999999975  456655 99999999999999999999876543322    22222222333333578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017860          258 ISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+||+.||++|||+.++++
T Consensus       255 i~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        255 VEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCcccCcCHHHHHH
Confidence            99999999999999999986

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.5e-45  Score=326.01  Aligned_cols=251  Identities=31%  Similarity=0.473  Sum_probs=211.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      +|+..+.||+|+||.||+|.+..+++.||+|.+.....      ..+.+.+|+.+++.++||||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            58889999999999999999998999999999865331      235688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      +||+++++|.+++.+.+.+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.  +||+|||++.........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccc
Confidence            999999999999988888999999999999999999999999999999999999986654  999999998765444434


Q ss_pred             CCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....|++.|+|||.+.... ++.+ +|+|||||++|+|++|+.||..........+    ..........+..+++.+.+
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~-~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLA-ADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHH
Confidence            5567899999999987665 5545 9999999999999999999977653322222    11111111123347899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccc
Q 017860          257 LISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      |+.+||+.+|.+||++.+++.|||+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1e-44  Score=332.82  Aligned_cols=258  Identities=29%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCcceeceEEEeCCE-----
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTH-----   93 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~-----   93 (365)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++ ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47999999999999999999999999999999886532   22356888999999995 6999999999987665     


Q ss_pred             EEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           94 LAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      .|+||||+++ +|..++...     ..+++..++.++.||+.||.|||++|++||||||+||+++.+ .+.+||+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~-~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQ-KGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecC-CCeEEEeecccc
Confidence            8999999986 788877542     357999999999999999999999999999999999999862 235999999998


Q ss_pred             ccccCC-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C---
Q 017860          169 KSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-S---  243 (365)
Q Consensus       169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~---  243 (365)
                      +..... .......+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+......++...+..... .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG  238 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            754322 22234467899999999876444344599999999999999999999887766655544433211110 0   


Q ss_pred             ---------CC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          244 ---------VP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       244 ---------~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                               .+         ....+++++.+||.+||..+|.+|||+.+++.||||.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                     00         0124788999999999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-44  Score=325.74  Aligned_cols=250  Identities=31%  Similarity=0.505  Sum_probs=212.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++++.||.|+||.||.+++..+++.+++|.+....   .....+.+|+.+++.++|+||+++++++.....++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            6999999999999999999999999999999986532   3335678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CC
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~  177 (365)
                      +++++|.+++.+.  ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++.  +||+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccc
Confidence            9999999999764  46899999999999999999999999999999999999987654  9999999987543332 23


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....|++.|+|||.+.+..++.+ +|+|||||++|+|++|..||...+......    .+....+. +....++.++.++
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~  232 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVV----KIVQGNYT-PVVSVYSSELISL  232 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCC-CCccccCHHHHHH
Confidence            45578999999999987776655 999999999999999999998755433332    22233222 2234578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017860          258 ISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +.+||..+|.+|||+.++++|+|+
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCcCC
Confidence            999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.4e-44  Score=331.39  Aligned_cols=256  Identities=27%  Similarity=0.454  Sum_probs=203.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..+|++++.||+|+||.||++.++.+++.||+|.+....  .....+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            358999999999999999999999999999999986543  223467889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCC
Q 017860          100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      |+. ++|...+.. ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.  +||+|||+++..... ...
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCC
Confidence            996 567666654 456889999999999999999999999999999999999986654  999999998753222 223


Q ss_pred             CCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc---------------
Q 017860          178 KSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ---------------  241 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------------  241 (365)
                      ....+++.|+|||.+.+.. ++.+ +|||||||++|+|++|..||...................+               
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~-~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGATDYSSA-LDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CCccccccccCCceeecCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            3456799999999987644 4444 9999999999999999999987654322211111111000               


Q ss_pred             ---c--CCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          242 ---Y--SVP-------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       242 ---~--~~~-------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                         .  ..+       .....+..+.+++.+||..||.+|||+.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence               0  000       001235789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-45  Score=332.83  Aligned_cols=256  Identities=29%  Similarity=0.522  Sum_probs=210.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++.+.||+|+||.||+|.++.+++.||+|.+...   ......+.+|+.+++.++||||+++++++.....+++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3799999999999999999999999999999998653   2334678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--CC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--~~  177 (365)
                      |+.++.+..+..+...+++..++.++.||+.||.|||++|++||||+|+||+++.++.  +||+|||++.......  ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~  158 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPL  158 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccc
Confidence            9998777776666677999999999999999999999999999999999999987554  9999999987654433  33


Q ss_pred             CCCcCCCCCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------c--
Q 017860          178 KSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------Y--  242 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------~--  242 (365)
                      ....+++.|+|||++.+. .++. ++||||||+++|+|++|++||....................            +  
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~-~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGK-PVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            456789999999999877 4544 49999999999999999999987655443332222110000            0  


Q ss_pred             -CCC-----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          243 -SVP-----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       243 -~~~-----------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                       ..+           ....++.++++||++||..+|++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence             000           112247899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-44  Score=332.62  Aligned_cols=257  Identities=32%  Similarity=0.458  Sum_probs=209.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l   96 (365)
                      .++|++.+.||+|+||.||+|.++.+++.+|+|.++....   ....+.+|+.+++.++||||+++++++...  ..+|+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            3579999999999999999999999999999999975432   234567899999999999999999999887  89999


Q ss_pred             EEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-
Q 017860           97 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  174 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-  174 (365)
                      ||||+.+ +|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++...... 
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  160 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPL  160 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCc
Confidence            9999974 8988887644 5899999999999999999999999999999999999987654  999999998755443 


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------  240 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------  240 (365)
                      .......+++.|+|||.+.+....+.++||||||+++|+|++|..||...+......+........              
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            223345678999999998765544455999999999999999999998876654444333221100              


Q ss_pred             ---cc--------CCCCCC-CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          241 ---QY--------SVPDTN-PISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       241 ---~~--------~~~~~~-~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                         ..        ...... .+++.+.++|++||+.+|++|||+.|++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence               00        000011 158889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=353.36  Aligned_cols=251  Identities=31%  Similarity=0.501  Sum_probs=211.5

Q ss_pred             ccccCCCeEEEEEEEccCCcEEEEEEeec-CCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCChHH
Q 017860           30 DIGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE  108 (365)
Q Consensus        30 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~  108 (365)
                      .||+|.||+||.+++..+...+|||.+.. .....+-+..|+.+.+.|+|.|||++++++..++++-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            59999999999999999999999999864 34445668899999999999999999999999999999999999999999


Q ss_pred             HHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCCCCcCCC
Q 017860          109 RICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTP  184 (365)
Q Consensus       109 ~l~~~-~~l--~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~~~~gt~  184 (365)
                      ++... +++  .|..+-.+.+||++||.|||.+.|||||||-.|+||+. ..|.+||+|||-++.... ..-..++.||.
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT-ySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT-YSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-ccceEEecccccchhhccCCccccccccch
Confidence            99764 566  78899999999999999999999999999999999973 456799999998875433 33345678999


Q ss_pred             CCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017860          185 AYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV  263 (365)
Q Consensus       185 ~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  263 (365)
                      .|||||++..+ .-+++++|||||||++.||.||++||.....+...+-.+ ...+..+  |.+..+|.+++.||.+|+.
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-GmyKvHP--~iPeelsaeak~FilrcFe  817 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-GMYKVHP--PIPEELSAEAKNFILRCFE  817 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-cceecCC--CCcHHHHHHHHHHHHHHcC
Confidence            99999999643 445777999999999999999999998776654332111 1222223  3445589999999999999


Q ss_pred             cCCCCCCCHHHHhcCcccccC
Q 017860          264 ADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       264 ~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ++|..||+|.++|..||++.+
T Consensus       818 pd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  818 PDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcccCccHHHhccCcccccC
Confidence            999999999999999999754

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-44  Score=326.16  Aligned_cols=252  Identities=30%  Similarity=0.477  Sum_probs=207.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTP--THL   94 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~   94 (365)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+.....      ....+.+|+.+++.++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            479999999999999999999999999999998864321      124677899999999999999999998764  568


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +++|||+++++|.+++.+.+.+++..+..++.|++.||+|||++|++|+||||+||+++.++.  ++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~  159 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccc
Confidence            899999999999999988888999999999999999999999999999999999999986654  999999988743221


Q ss_pred             ----CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          175 ----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       175 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                          .......|+..|+|||++.+..++.+ +|||||||++|+|++|+.||..........    ...........+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~  234 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHV  234 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhh
Confidence                12234568999999999987776655 999999999999999999998754433322    222222122223457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      +..+.++|.+||. +|++||+++++++|||+.
T Consensus       235 ~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         235 SDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            8889999999994 999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-46  Score=361.11  Aligned_cols=254  Identities=29%  Similarity=0.465  Sum_probs=212.2

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCcceeceEE-EeC-----
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVI-LTP-----   91 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~-~~~-----   91 (365)
                      ...-+++|.+.|.+|||+.||+|++...|..||+|++-..+ .....+.+|+.+|+.|+ |||||.+++.. ...     
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~  113 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG  113 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence            34567899999999999999999999888999999876543 33467899999999997 99999999943 221     


Q ss_pred             -CEEEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           92 -THLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        92 -~~~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                       -.+.|.||||.||.|.+++..  ..+|+|.+++.|+.|+++|+++||...  |||||||-|||||+.++.  .||||||
T Consensus       114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFG  191 (738)
T KOG1989|consen  114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFG  191 (738)
T ss_pred             eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCccc
Confidence             357899999999999999874  345999999999999999999999998  999999999999987765  9999999


Q ss_pred             CcccccCCCCC----------CCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHH
Q 017860          167 YSKSSVLHSQP----------KSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT  233 (365)
Q Consensus       167 la~~~~~~~~~----------~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  233 (365)
                      .++........          .....|+.|+|||++.   +...+.| +|||+|||+||.|+....||+.....      
T Consensus       192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~l------  264 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKL------  264 (738)
T ss_pred             ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence            88743322211          1234799999999973   4455555 99999999999999999999976432      


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       234 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                        .|+...|.+|...++|..+.+||..||+.||.+||++.+++.+-+-..+
T Consensus       265 --aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 --AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             --eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence              4678899999998999999999999999999999999999987554433

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.4e-44  Score=329.76  Aligned_cols=255  Identities=26%  Similarity=0.440  Sum_probs=203.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHH-HhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++++.||+|+||.||+++++.+|+.||+|.+.....  ....+..|+.+ ++.++||||+++++++..+...|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            479999999999999999999999999999999876432  22345556554 677899999999999999999999999


Q ss_pred             ecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860          100 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus       100 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |++ ++|.+++..    ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.  +||+|||+++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecccccccccc
Confidence            996 577776653    34689999999999999999999997 9999999999999987654  999999998755433


Q ss_pred             CCCCCCcCCCCCCCchhhcc----cccCCccceeehhhHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhccccCCCCCCC
Q 017860          175 SQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      .......|+..|+|||.+.+    ..++.+ +|+|||||++|+|++|+.||...... .......   .......+. ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~-~~  232 (283)
T cd06617         158 VAKTIDAGCKPYMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV---EEPSPQLPA-EK  232 (283)
T ss_pred             cccccccCCccccChhhcCCcccccccCcc-ccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH---hcCCCCCCc-cc
Confidence            33344578999999998864    234444 99999999999999999999754332 2222111   111222222 24


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +|.++.+||.+||..+|.+|||+.+++.||||.+..
T Consensus       233 ~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         233 FSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            789999999999999999999999999999998754

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=346.79  Aligned_cols=241  Identities=31%  Similarity=0.459  Sum_probs=214.0

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      ...-++.||+|+.|.||+++.+  ++.||||+++.      .-..+|+-||+|+||||+.|.++|...-.||||||||..
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~  196 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ  196 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc--CceehhHHHhh------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence            3445789999999999999874  78899997743      335688999999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT  183 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt  183 (365)
                      |.|+..++...+++......|..+|+.|++|||.+.|||||||.-||||..+..  |||+|||-++.........+++||
T Consensus       197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGT  274 (904)
T KOG4721|consen  197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGT  274 (904)
T ss_pred             ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhh
Confidence            999999999999999999999999999999999999999999999999987665  999999998866555666778999


Q ss_pred             CCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcc
Q 017860          184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV  263 (365)
Q Consensus       184 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~  263 (365)
                      ..|||||++.+.....| +||||||||||||+||..||...+.    ..++..+....+.+|-+...++.++=||++||+
T Consensus       275 VaWMAPEvIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVds----sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             HhhhCHHHhhcCCcccc-cceehhHHHHHHHHhcCCCccccch----heeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence            99999999988888777 9999999999999999999987665    345555555666777777788999999999999


Q ss_pred             cCCCCCCCHHHHhcCc
Q 017860          264 ADPAARITIPEIMKHQ  279 (365)
Q Consensus       264 ~dp~~R~t~~ell~h~  279 (365)
                      ..|..||++.++|.|-
T Consensus       350 sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  350 SKPRNRPSFRQILLHL  365 (904)
T ss_pred             cCCCCCccHHHHHHHH
Confidence            9999999999999984

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-44  Score=326.05  Aligned_cols=256  Identities=30%  Similarity=0.501  Sum_probs=216.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++.+.||+|++|.||+|++..+++.||+|.+.....  ....+.+|+..++.++||||+++++++.....+++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            369999999999999999999999999999999876542  346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC-C
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-K  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~-~  178 (365)
                      +++++|.+++.....+++..++.++.|++.||+|||+ +|++||||+|+||+++.++.  ++|+|||++......... .
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCccc
Confidence            9999999999888889999999999999999999999 99999999999999987654  999999998755433332 2


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC-CCHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDL  257 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~l  257 (365)
                      ...++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...... ...+....+..... .+.... ++..+.++
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l  235 (264)
T cd06623         159 TFVGTVTYMSPERIQGESYSYA-ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGPP-PSLPAEEFSPEFRDF  235 (264)
T ss_pred             ceeecccccCHhhhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCCC-CCCCcccCCHHHHHH
Confidence            4568899999999987766655 99999999999999999999876521 12223333332222 122233 78999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      |.+||..+|++|||+.+++.||||+.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-44  Score=326.91  Aligned_cols=249  Identities=27%  Similarity=0.486  Sum_probs=201.7

Q ss_pred             CCcceeccc--ccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhc-CCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDI--GSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~L--G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++.+.+  |+|+||.||++.++.++..+|+|.+........    |+..... .+||||++++++|..++.+|+|||
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            467777776  999999999999999999999999876432111    2222222 279999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      |+++++|.+++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++ +.++|+|||+++....   ...
T Consensus        90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~---~~~  165 (267)
T PHA03390         90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIGT---PSC  165 (267)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecCC---Ccc
Confidence            999999999998887899999999999999999999999999999999999998665 2599999998875432   234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|++.|+|||++.+..++.+ +|||||||++|+|++|+.||........-........  ....+....+|+.+.+||.
T Consensus       166 ~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~  242 (267)
T PHA03390        166 YDGTLDYFSPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQ  242 (267)
T ss_pred             CCCCCcccChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHH
Confidence            568999999999988777666 9999999999999999999985543221111122111  1222333468999999999


Q ss_pred             HhcccCCCCCCC-HHHHhcCcccc
Q 017860          260 RIFVADPAARIT-IPEIMKHQWFL  282 (365)
Q Consensus       260 ~~l~~dp~~R~t-~~ell~h~~f~  282 (365)
                      +||+.+|.+||+ ++++|+||||.
T Consensus       243 ~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        243 SMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             HHhccChhhCCchHHHHhcCCccc
Confidence            999999999996 69999999995

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-44  Score=335.61  Aligned_cols=251  Identities=26%  Similarity=0.398  Sum_probs=191.2

Q ss_pred             cccccCCCeEEEEEEEcc--CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDKV--TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g  104 (365)
                      .+||+|+||.||+|+++.  ++..||+|.+.... ....+.+|+.+++.++||||+++++++..  +..+++||||+.+ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            589999999999999754  56899999887543 34567899999999999999999999854  5678999999965 


Q ss_pred             ChHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCCEEEecCCCcccccC
Q 017860          105 ELFERICN---------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVL  173 (365)
Q Consensus       105 ~L~~~l~~---------~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~--~~~~vkl~Dfgla~~~~~  173 (365)
                      +|.+++..         ...+++..++.++.||+.||.|||++|++||||||+|||+..+  ..+++||+|||+++....
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~  164 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS  164 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence            77776642         1248899999999999999999999999999999999999532  234699999999875432


Q ss_pred             CC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh---------HHHHHHHHHHh--
Q 017860          174 HS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKTIQRIL--  238 (365)
Q Consensus       174 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~~~~~~~--  238 (365)
                      ..    ......||+.|+|||++.+....+.++|||||||++|+|++|++||......         ....+......  
T Consensus       165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (317)
T cd07867         165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP  244 (317)
T ss_pred             CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence            21    2234578999999999977554445599999999999999999999754321         11111111000  


Q ss_pred             ----------------------ccccC--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          239 ----------------------SVQYS--------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       239 ----------------------~~~~~--------~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                                            .....        .......+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                  00000        00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-44  Score=325.11  Aligned_cols=250  Identities=30%  Similarity=0.539  Sum_probs=210.6

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++++.||+|+||.||++++..+|+.||+|.+....   .....+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            6999999999999999999999999999999987532   2335788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-C
Q 017860          101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~  177 (365)
                      +.+++|.+.+....  .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++........ .
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhh
Confidence            99999999887543  5899999999999999999999999999999999999976654  99999998875433221 2


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....|++.|+|||++.+..++.+ +|+|||||++++|++|+.||...+......+    +..... .+....++.++.++
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~l  232 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLK----IIRGSY-PPVSSHYSYDLRNL  232 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHH----HhcCCC-CCCcccCCHHHHHH
Confidence            23468899999999987777666 9999999999999999999987654333322    222222 12234578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017860          258 ISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      |.+||+.+|.+||++.++++||||
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhCcCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-44  Score=333.16  Aligned_cols=253  Identities=24%  Similarity=0.357  Sum_probs=199.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc----------------CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcce
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR   83 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~   83 (365)
                      .++|++.++||+|+||.||+|.+..                ++..||+|.+.....  ....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            4689999999999999999998642                344799999875432  2356889999999999999999


Q ss_pred             eceEEEeCCEEEEEEeecCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecC
Q 017860           84 FKEVILTPTHLAIVMEYASGGELFERICNAG-------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRD  144 (365)
Q Consensus        84 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------------~l~~~~~~~i~~qil~al~~LH~~~ivHrD  144 (365)
                      +++++......++||||+.+|+|.+++....                   .+++..++.++.||+.||.|||+.|++|||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d  163 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD  163 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            9999999999999999999999999886432                   367788999999999999999999999999


Q ss_pred             CCCCcEEecCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh--CCC
Q 017860          145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGY  219 (365)
Q Consensus       145 lkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~  219 (365)
                      |||+|||++.++.  +||+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++  +..
T Consensus       164 lkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         164 LATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             cchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCC
Confidence            9999999986654  99999999875432221   223446788999999987777666 999999999999986  567


Q ss_pred             CCCCCCChHHHHHHHHHHhcc--ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          220 PFEDPDEPKDFRKTIQRILSV--QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       220 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ||...+...............  ......+...++.+.+|+.+||+.+|.+|||+.++.+
T Consensus       241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            887765433322221111111  1111223346789999999999999999999999954

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-44  Score=338.93  Aligned_cols=262  Identities=27%  Similarity=0.430  Sum_probs=209.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEe----CCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT----PTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~   94 (365)
                      .++|++.+.||+|+||.||++.++.+|+.||+|.+....   .....+.+|+.+++.++||||++++++|..    ...+
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            468999999999999999999999999999999987542   234567789999999999999999998863    3578


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ++||||+. ++|...+...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||++......
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~  160 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSS  160 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeeccc
Confidence            99999995 589998887788999999999999999999999999999999999999987664  999999998754322


Q ss_pred             CC-----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh-----------
Q 017860          175 SQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL-----------  238 (365)
Q Consensus       175 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----------  238 (365)
                      ..     .....|+.+|+|||.+.+.....+++|||||||++|+|++|+.||...+....+..+.....           
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            21     23457899999999986644344559999999999999999999987654332221111100           


Q ss_pred             --------c-cc--cCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          239 --------S-VQ--YSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       239 --------~-~~--~~~~---~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                              . ..  ...+   .....++++.++|.+||+.+|.+|||+.+++.||||.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~  302 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD  302 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccC
Confidence                    0 00  0000   01336889999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.2e-45  Score=333.80  Aligned_cols=260  Identities=28%  Similarity=0.481  Sum_probs=214.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..+.|.....||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++.+......|+|||
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            3457888899999999999999999899999999986533 233567899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      |+++++|.+++.. +++++..++.++.||+.||+|||++|++||||||+||+++.++.  ++|+|||++....... ...
T Consensus       100 ~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~  176 (292)
T cd06658         100 FLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRK  176 (292)
T ss_pred             CCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCc
Confidence            9999999988754 46899999999999999999999999999999999999986654  9999999986432222 223


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...|++.|+|||.+.+..++.+ +||||||+++|+|++|+.||........+.. +....  ....+....++..+.+++
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~li  252 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDNL--PPRVKDSHKVSSVLRGFL  252 (292)
T ss_pred             eeecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhcC--CCccccccccCHHHHHHH
Confidence            4568999999999987777655 9999999999999999999987655433322 22111  222333445788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+||..+|.+|||++++++||||....++
T Consensus       253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         253 DLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999999865433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2e-44  Score=328.88  Aligned_cols=255  Identities=28%  Similarity=0.475  Sum_probs=208.6

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      +|+++++||.|++|.||++++..+|+.||+|.+.....  ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            59999999999999999999999999999999876432  2356778999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CC
Q 017860          102 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  177 (365)
Q Consensus       102 ~~g~L~~~l~~~---~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~  177 (365)
                      .+ +|.+++...   .++++..+..++.|++.||.|||++|++||||||+||+++.++.  ++|+|||+++...... ..
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCcccc
Confidence            75 888877654   35899999999999999999999999999999999999986654  9999999987543322 22


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------cC
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------YS  243 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~  243 (365)
                      ....+++.|+|||++.+....+.++|||||||++|+|++|+.||...+......++........              ..
T Consensus       158 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPT  237 (284)
T ss_pred             ccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccc
Confidence            3456789999999987654444559999999999999999999998776555444332211000              00


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          244 VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       244 ~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+.         ....++.+.+++.+||+.+|.+||++.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            010         12357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.6e-45  Score=345.64  Aligned_cols=252  Identities=23%  Similarity=0.358  Sum_probs=203.4

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccC-----CcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEe
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   90 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~   90 (365)
                      ....++|++.+.||+|+||.||++++...     +..||+|++.....  ....+.+|+.+++.+ +||||+++++++..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            34567899999999999999999986443     35799999875432  235678899999999 89999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhc---------------------------------------------------------
Q 017860           91 PTHLAIVMEYASGGELFERICNA---------------------------------------------------------  113 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~---------------------------------------------------------  113 (365)
                      ...+++|||||.+|+|.+++...                                                         
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            99999999999999999988542                                                         


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---C
Q 017860          114 -------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---P  177 (365)
Q Consensus       114 -------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---~  177 (365)
                                   .++++..++.++.||+.||.|||++|++||||||+|||++.++  .+||+|||+++.......   .
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~--~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC--eEEEeeceeeeeccCCcceeec
Confidence                         2478889999999999999999999999999999999998655  499999999875433221   1


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||........+.+...    .....+....+++++.+
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~  346 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVK----RGYQMSRPDFAPPEIYS  346 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHH----cccCccCCCCCCHHHHH
Confidence            12235668999999987777666 999999999999997 9999987654433333322    22222333346899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017860          257 LISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++.+||+.+|.+|||+.++++
T Consensus       347 li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         347 IMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.4e-44  Score=328.37  Aligned_cols=259  Identities=28%  Similarity=0.459  Sum_probs=208.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~   98 (365)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+.....  ....+.+|+.+++.++||||++++++|...  ..+|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            479999999999999999999999999999999875433  345688999999999999999999998654  4789999


Q ss_pred             eecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||+++++|.+++..    ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.  ++|+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~  158 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNS  158 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeecccccccccc
Confidence            99999999887653    345899999999999999999999999999999999999986654  999999998654322


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhccc-cCC----CCCC
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQ-YSV----PDTN  248 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~----~~~~  248 (365)
                      . .....++..|+|||.+.+..++.+ +|||||||++|+|++|+.||...... ....+....+.... ...    +...
T Consensus       159 ~-~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd06621         159 L-AGTFTGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI  236 (287)
T ss_pred             c-cccccCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence            2 234567889999999988777766 99999999999999999999865220 01111222222211 111    1113


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .+++.+.+|+.+||..+|.+|||+.|+++||||.+..
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             chHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            4578899999999999999999999999999996544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-44  Score=329.81  Aligned_cols=259  Identities=29%  Similarity=0.471  Sum_probs=208.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++.+.||+|++|.||++.++.+|+.||+|.+....   .....+.+|+.+++.++||||+++++++.....+|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            47999999999999999999999999999999986532   223567889999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860          100 YASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      |++ ++|...+.....  +++..++.++.||+.||+|||++|++||||+|+||+++..+ ..+||+|||++...... ..
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~-~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT-NALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-CEEEEcccccccccCCCccc
Confidence            996 578777765433  58889999999999999999999999999999999997543 25899999998754322 22


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--------------
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------------  242 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------  242 (365)
                      .....+++.|+|||++.+......++|||||||++|+|++|+.||...+......+..........              
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence            234567899999999876544344499999999999999999999877665555444322111100              


Q ss_pred             CCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          243 SVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       243 ~~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ..+         ....+++.+.+++.+||+.+|.+||++.+++.||||..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~  289 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD  289 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence            000         01346889999999999999999999999999999965

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.4e-44  Score=328.21  Aligned_cols=247  Identities=30%  Similarity=0.460  Sum_probs=197.8

Q ss_pred             ccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHH---HhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIIN---HRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        30 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~---l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .||+|+||.||++.+..+++.+|+|.+.+....    .....+|..+   +...+||||+++++.+..++.+++||||+.
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999999999999999998754321    1223344433   334579999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcC
Q 017860          103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  182 (365)
Q Consensus       103 ~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~g  182 (365)
                      +++|..++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||++...... ......|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence            9999999988888999999999999999999999999999999999999986654  999999998644322 2234579


Q ss_pred             CCCCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          183 TPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       183 t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      |+.|+|||.+.++ .++.+ +||||+||++|+|++|..||........ ...........  ...+..++.++.++|.+|
T Consensus       158 ~~~y~aPE~~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVN--VELPDSFSPELKSLLEGL  233 (279)
T ss_pred             CcCccCHHHhcCCCCCCch-hhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCC--cCCccccCHHHHHHHHHH
Confidence            9999999998643 34444 9999999999999999999976443221 11111111222  222344789999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCccccc
Q 017860          262 FVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       262 l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      |..||.+||     |+.++++||||+.
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhCccccC
Confidence            999999999     6999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.5e-44  Score=327.36  Aligned_cols=258  Identities=29%  Similarity=0.500  Sum_probs=214.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..+|...+.||+|++|.||++.++.+++.+|+|.+..... ..+.+.+|+.+++.++||||+++++++......++++||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence            3467778999999999999999998999999998865332 234578899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +.+++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||++....... ....
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~  174 (285)
T cd06648          98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKS  174 (285)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCccccc
Confidence            999999998877 67899999999999999999999999999999999999986654  9999999876433222 2233


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|++.|+|||.+.+..++.+ +|||||||++|+|++|+.||...+...........   ..........++..+.+|+.
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         175 LVGTPYWMAPEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN---LPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             ccCCccccCHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc---CCCCCcccccCCHHHHHHHH
Confidence            568999999999987777666 99999999999999999999875543333222111   11122233347889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      +||..+|++|||+.+++.||||.+..+
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             HHcccChhhCcCHHHHccCcccccCCC
Confidence            999999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3e-44  Score=331.72  Aligned_cols=263  Identities=27%  Similarity=0.443  Sum_probs=206.0

Q ss_pred             CCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC
Q 017860           15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP   91 (365)
Q Consensus        15 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~   91 (365)
                      +.+.....++|++.++||+|+||.||+|.++.+++.||+|.+....   .....+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865           4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            3455566678999999999999999999999999999999986532   2234567899999999999999999998765


Q ss_pred             C--------EEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEE
Q 017860           92 T--------HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI  162 (365)
Q Consensus        92 ~--------~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl  162 (365)
                      .        ..++||||+.+ +|...+... ..+++.+++.++.||+.||+|||++|++|+||||+||+++.++.  +||
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl  160 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKL  160 (310)
T ss_pred             cccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEE
Confidence            3        45999999964 787777654 36899999999999999999999999999999999999986654  999


Q ss_pred             ecCCCcccccCCCC-----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 017860          163 CDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI  237 (365)
Q Consensus       163 ~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  237 (365)
                      +|||++........     .....++..|+|||.+.+....++++||||||+++|+|++|..||...+...... .+..+
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~-~~~~~  239 (310)
T cd07865         161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT-LISQL  239 (310)
T ss_pred             CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHH
Confidence            99999875433221     1234678899999998765433445999999999999999999998765433222 22221


Q ss_pred             hccc----------------cCCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          238 LSVQ----------------YSVPD-----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       238 ~~~~----------------~~~~~-----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ....                ...+.           ....+..+.+||.+||..||.+|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            1100                00000           01135678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-44  Score=337.81  Aligned_cols=260  Identities=30%  Similarity=0.438  Sum_probs=213.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCC-----EEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA   95 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~   95 (365)
                      +|++.+.||+|+||.||++++..+++.||+|.+....   ...+.+.+|+.+++.++||||+++++++....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6999999999999999999999899999999987542   23467889999999999999999999998775     789


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      +||||+. ++|..++.+..++++..++.++.||+.||+|||++|++||||||+|||++.++  .++|+|||++.......
T Consensus        81 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~  157 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDE  157 (330)
T ss_pred             EEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccc
Confidence            9999997 58999888877899999999999999999999999999999999999998764  59999999987654432


Q ss_pred             ----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------
Q 017860          176 ----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------  242 (365)
Q Consensus       176 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  242 (365)
                          ......+++.|+|||++.+....+.++|+|||||++|+|++|++||...+....+..+.........         
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  237 (330)
T cd07834         158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE  237 (330)
T ss_pred             cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence                2345578999999999987733344599999999999999999999887655444333321110000         


Q ss_pred             -------------CC---CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          243 -------------SV---PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       243 -------------~~---~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                                   ..   .....++.++.+||.+||+.+|.+|||+++++.||||.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                         00   001236788999999999999999999999999999976543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-44  Score=343.16  Aligned_cols=251  Identities=25%  Similarity=0.379  Sum_probs=203.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEE-----ccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEeCC
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPT   92 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~   92 (365)
                      ..++|++.+.||+|+||.||+|++     ..++..||+|++.....  ..+.+.+|+.+++.+ +||||+++++++....
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            356899999999999999999974     34667899999865332  235678999999999 8999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcC----------------------------------------------------------
Q 017860           93 HLAIVMEYASGGELFERICNAG----------------------------------------------------------  114 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  114 (365)
                      ..++|||||++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999886422                                                          


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860          115 -----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus       115 -----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                                       .+++..++.++.||+.||+|||++|++||||||+|||++.++  .+||+|||+++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC--cEEEecCccceeccCcccc
Confidence                             367888999999999999999999999999999999998655  4999999998754332211


Q ss_pred             ---CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          178 ---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       178 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                         ....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||........+.+.+..    ......+...+.+
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~-sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  345 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRMLSPECAPSE  345 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCC-CCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCCCCCCCCHH
Confidence               12334667999999988777766 999999999999998 88999876554444333332    1122223346789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+|+.+||+.||++|||+.++++.
T Consensus       346 l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         346 MYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHHHHHccCChhHCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=327.21  Aligned_cols=254  Identities=29%  Similarity=0.499  Sum_probs=209.3

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCC---CCCcceeceEEEeCCEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .|++++.||+|+||.||++.+..+++.||+|.+....  ...+.+.+|+.+++.++   |||++++++++.....+++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            5889999999999999999999999999999986532  23356788999998886   999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~  177 (365)
                      ||+.+++|.+++.. +.+++..++.++.|++.||.|||+.|++||||+|+||+++.++  .++|+|||++....... ..
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~--~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG--NVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC--CEEEccCCceeecCCCcccc
Confidence            99999999998865 4789999999999999999999999999999999999998755  49999999987543332 22


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~  256 (365)
                      ....|++.|+|||.+.++...+.++|+|||||++|+|++|..||.........    ..+.... ...+ ...++.++.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~  233 (277)
T cd06917         159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM----MLIPKSKPPRLE-DNGYSKLLRE  233 (277)
T ss_pred             ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh----hccccCCCCCCC-cccCCHHHHH
Confidence            34468999999999876554444599999999999999999999865443221    1111111 1111 1237789999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ++.+||+.+|.+||++.+++.|+||++..
T Consensus       234 ~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         234 FVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.2e-44  Score=326.01  Aligned_cols=249  Identities=22%  Similarity=0.327  Sum_probs=204.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ++.+|++.+.||+|+||.||++.++   ..+..||+|.+.....  ....+.+|+..++.++||||+++++++..+...+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3568999999999999999999875   3567899999876432  2356889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+||+++.++  .+|++|||.+......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~--~~~l~dfg~~~~~~~~  160 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL--VCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC--cEEECCCccccccccc
Confidence            999999999999998764 5789999999999999999999999999999999999997665  4999999987643222


Q ss_pred             CCC--CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 SQP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ...  ....+++.|+|||++.+..++.+ +|||||||++|++++ |..||.......... .   +.. ....+.+..++
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~p~~~~~~~~~~~-~---~~~-~~~~~~~~~~~  234 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIK-A---VED-GFRLPAPRNCP  234 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-H---HHC-CCCCCCCCCCC
Confidence            211  12335678999999988777766 999999999999775 999998765533222 2   221 22334455578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..+.+++.+||+.+|.+|||+.++++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.5e-44  Score=336.86  Aligned_cols=260  Identities=29%  Similarity=0.435  Sum_probs=208.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC-----CE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP-----TH   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~   93 (365)
                      ..+|++.+.||+|+||+||++++..+++.||+|.+....   .....+.+|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            458999999999999999999999999999999986532   2234567899999999999999999988654     35


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +|+|+||+. ++|.+++...+++++..++.++.|++.||.|||+++++||||||+||+++.++.  +||+|||++.....
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~  160 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSE  160 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCC
Confidence            899999995 689999988888999999999999999999999999999999999999986654  99999999875543


Q ss_pred             C-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH---------------
Q 017860          174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI---------------  237 (365)
Q Consensus       174 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~---------------  237 (365)
                      . .......++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+....               
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            3 223445689999999998654334445999999999999999999998764332221111100               


Q ss_pred             --------hccc-cC-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          238 --------LSVQ-YS-VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       238 --------~~~~-~~-~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                              .... .. ......+++++.+||.+||+.+|.+|||+.++++||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                    0000 00 00123478999999999999999999999999999999754

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-44  Score=333.53  Aligned_cols=257  Identities=26%  Similarity=0.375  Sum_probs=202.1

Q ss_pred             CcceecccccCCCeEEEEEEEcc--CCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKV--TKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLA   95 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~   95 (365)
                      +|++.++||+|+||.||+|.++.  +++.||+|.+....    ...+.+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            58999999999999999999988  89999999987632    3346778899999999999999999999988  8899


Q ss_pred             EEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEecCCCc
Q 017860           96 IVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYS  168 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~--~~~vkl~Dfgla  168 (365)
                      +||||+.+ +|.+.+...     ..+++..++.++.|++.||+|||+++++||||||+||+++.++  .+.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 666665421     3689999999999999999999999999999999999997611  345999999998


Q ss_pred             ccccCCCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH---------HHHHHHH
Q 017860          169 KSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---------DFRKTIQ  235 (365)
Q Consensus       169 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---------~~~~~~~  235 (365)
                      +.......    .....+++.|+|||++.+.....+++|||||||++|+|++|++||.......         .+.+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            75432221    2345688999999998765433455999999999999999999998654322         1111111


Q ss_pred             HHh----------------------ccccCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          236 RIL----------------------SVQYSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       236 ~~~----------------------~~~~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+.                      ......+         .....+.++.+++.+||+.||.+|||+.+++.||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            000                      0000001         011467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-45  Score=347.81  Aligned_cols=258  Identities=25%  Similarity=0.449  Sum_probs=217.4

Q ss_pred             CCCCCCc-ceecccccCCCeEEEEEEEccCCcEEEEEEee-----cCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           19 MHDSDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        19 ~~~~~~y-~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      ..+..|| +.-..||+|+|-+||+|.|..+|..||.-.++     +.....+.+..|+.+|+.|+||||++++++|.+..
T Consensus        35 ~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~  114 (632)
T KOG0584|consen   35 KDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD  114 (632)
T ss_pred             cCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC
Confidence            4556777 55689999999999999999999999976553     23333478899999999999999999999998775


Q ss_pred             E--EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           93 H--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        93 ~--~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      .  +.+|+|++..|+|..|+++.++.+...++.|++||+.||.|||++.  |||||||.+||||+++ .|.|||+|+|||
T Consensus       115 n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLA  193 (632)
T KOG0584|consen  115 NKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLA  193 (632)
T ss_pred             CceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHH
Confidence            5  8899999999999999999999999999999999999999999987  9999999999999854 467999999999


Q ss_pred             ccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      +... .......+|||.|||||... ..|+.. +||||||+++.||+|+.+||.....+.++.+.+-...++.   ....
T Consensus       194 tl~r-~s~aksvIGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~---sl~k  267 (632)
T KOG0584|consen  194 TLLR-KSHAKSVIGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA---ALSK  267 (632)
T ss_pred             HHhh-ccccceeccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH---Hhhc
Confidence            8653 34455689999999999885 667666 9999999999999999999998888776655443322211   1112


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      --.+++++||.+||.. ...|||+.|||+||||...
T Consensus       268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            2358999999999988 9999999999999999874

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-44  Score=327.55  Aligned_cols=254  Identities=30%  Similarity=0.476  Sum_probs=207.8

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      |++.+.||.|++|.||++.++.+|+.||+|++....   .....+.+|+.+++.++|||++++++++......|++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            788999999999999999999999999999987543   22356888999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       102 ~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      . ++|.+++....  .+++..++.++.|++.||+|||+++++||||+|+||+++.++  .++|+|||++....... ...
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~  157 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYT  157 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccC
Confidence            5 68999887765  689999999999999999999999999999999999998755  49999999987543222 223


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------------cCC
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------------YSV  244 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~~  244 (365)
                      ...+++.|+|||++.+......++||||||+++|+|++|+.||...+......+..+......              ...
T Consensus       158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07835         158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTF  237 (283)
T ss_pred             ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhc
Confidence            346789999999887654434449999999999999999999987665444444332211000              000


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          245 ---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       245 ---------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                               .....++..+.++|.+||+.+|.+|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         238 PKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             ccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     1123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.6e-44  Score=335.43  Aligned_cols=262  Identities=24%  Similarity=0.371  Sum_probs=211.7

Q ss_pred             CCCCccee-cccccCCCeEEEEEEEccCCcEEEEEEeecCCccc---------------HHHHHHHHHHhcCCCCCccee
Q 017860           21 DSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---------------ENVQREIINHRSLRHPNIVRF   84 (365)
Q Consensus        21 ~~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------------~~~~~e~~~l~~l~hpnIv~l   84 (365)
                      ..+||..+ +.||+|+||+||++.++.+++.||+|.+.......               ..+.+|+.+++.++||||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            35689765 67999999999999999999999999986543221               247789999999999999999


Q ss_pred             ceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 017860           85 KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD  164 (365)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~D  164 (365)
                      ++++......++||||+. ++|.+++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.  +||+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~d  162 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIAD  162 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECC
Confidence            999999999999999996 589999988888999999999999999999999999999999999999986654  99999


Q ss_pred             CCCcccccC---------------CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHH
Q 017860          165 FGYSKSSVL---------------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD  229 (365)
Q Consensus       165 fgla~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  229 (365)
                      ||+++....               ........+++.|+|||.+.+....+.++|||||||++|+|++|++||...+....
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~  242 (335)
T PTZ00024        163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ  242 (335)
T ss_pred             ccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            998864331               11122345788999999987655434559999999999999999999988776554


Q ss_pred             HHHHHHHHhcccc-CCC---------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          230 FRKTIQRILSVQY-SVP---------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       230 ~~~~~~~~~~~~~-~~~---------------------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ...+......... .++                     .....+..+.++|.+||+.+|.+|||+++++.||||+...
T Consensus       243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence            4433332211110 000                     0123578899999999999999999999999999998653

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.3e-44  Score=322.04  Aligned_cols=246  Identities=25%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      ++|++.+.||+|+||.||++..+ .+..+|+|.+.........+.+|+.+++.++||||+++++++.....+++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            57999999999999999999886 55679999987665556788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC--CC
Q 017860          103 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KS  179 (365)
Q Consensus       103 ~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~--~~  179 (365)
                      +|+|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++........  ..
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccCC
Confidence            9999999875 356899999999999999999999999999999999999986654  999999988754322221  22


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..++..|+|||++.+..++.+ +||||||+++|+|++ |+.||...+.......+    .... ....+...+..+.+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i----~~~~-~~~~~~~~~~~~~~li  234 (256)
T cd05114         161 AKFPVKWSPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI----SRGF-RLYRPKLASMTVYEVM  234 (256)
T ss_pred             CCCchhhCChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCC-CCCCCCCCCHHHHHHH
Confidence            235668999999987777666 999999999999999 89999876654333322    2221 1222334678999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017860          259 SRIFVADPAARITIPEIMK  277 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~  277 (365)
                      .+||+.+|.+|||++++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-44  Score=322.73  Aligned_cols=247  Identities=33%  Similarity=0.502  Sum_probs=201.3

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHH-HHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      ++.||+|+||.||+|.+..+++.||+|.+.+....    ...+..|.. ..+..+|||++++++++.....+|+|+||+.
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            36799999999999999999999999998754321    122334443 3455689999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcC
Q 017860          103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  182 (365)
Q Consensus       103 ~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~g  182 (365)
                      +++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  +||+|||+++....   .....|
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~  155 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVG  155 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCC
Confidence            9999999988888999999999999999999999999999999999999986654  99999998875322   334568


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCCHHHHHHHHH
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDLISR  260 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~  260 (365)
                      ++.|+|||.+.+..++.+ +||||||+++|+|++|..||...+....+..    +.......+  ....+++++.+++.+
T Consensus       156 ~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~  230 (260)
T cd05611         156 TPDYLAPETILGVGDDKM-SDWWSLGCVIFEFLFGYPPFHAETPDAVFDN----ILSRRINWPEEVKEFCSPEAVDLINR  230 (260)
T ss_pred             CcCccChhhhcCCCCcch-hhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcccCCCCcccccCCHHHHHHHHH
Confidence            899999999987776555 9999999999999999999987655333222    222222222  223478999999999


Q ss_pred             hcccCCCCCCC---HHHHhcCcccccC
Q 017860          261 IFVADPAARIT---IPEIMKHQWFLKN  284 (365)
Q Consensus       261 ~l~~dp~~R~t---~~ell~h~~f~~~  284 (365)
                      ||+.+|++||+   ++|+++||||.+.
T Consensus       231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         231 LLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             HccCCHHHccCCCcHHHHHcChHhhcC
Confidence            99999999994   5799999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.8e-44  Score=330.17  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=205.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|...+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.++.++. ||||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            478889999999999999999999999999999875432  2346788999998886 9999999999999999999999


Q ss_pred             ecCCCChHHH---HH--hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860          100 YASGGELFER---IC--NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus       100 ~~~~g~L~~~---l~--~~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |+.. ++.++   +.  ..+.+++..+..++.|++.||+|||+. +++||||||+||+++.++.  +||+|||+++....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhcc
Confidence            9864 44433   22  245699999999999999999999975 9999999999999986654  99999999875544


Q ss_pred             CCCCCCCcCCCCCCCchhhccc---ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCC--CCC
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSV--PDT  247 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--~~~  247 (365)
                      ........|++.|+|||++.+.   .++.+ +|||||||++|+|++|+.||.....   ..+.+....... ...  ...
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDPPILSNSEE  236 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcch-hhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCCCcCCCcCC
Confidence            4444555789999999999766   45544 9999999999999999999976542   112222222221 111  122


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ..++.++.+|+.+||+.+|.+|||++++++||||....
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~  274 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE  274 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence            35789999999999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.8e-44  Score=319.08  Aligned_cols=252  Identities=33%  Similarity=0.507  Sum_probs=214.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~   98 (365)
                      +|++.+.||+|++|.||++.+..+++.|++|++....   ...+.+.+|+.++++++||||+++++.+...  ..+++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            5889999999999999999999999999999987654   2346788999999999999999999999988  8999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--  176 (365)
                      ||+++++|.+++.+...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++  .++|+|||.+........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  158 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG--VVKLADFGCAKRLGDIETGE  158 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC--CEEEcccccEEecccccccc
Confidence            9999999999998887899999999999999999999999999999999999998755  499999999876554443  


Q ss_pred             -CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                       .....++..|+|||.+.+...+.+ +||||||+++|+|++|..||........   ....+.........+..++..+.
T Consensus       159 ~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T cd06606         159 GTGSVRGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAK  234 (260)
T ss_pred             cccCCCCCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHH
Confidence             445678999999999977776666 9999999999999999999987663222   22222211122223344689999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +|+.+||+.+|.+||++.+++.||||
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         235 DFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.9e-44  Score=325.60  Aligned_cols=254  Identities=30%  Similarity=0.472  Sum_probs=210.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..|+..+.||.|+||.||++.+..++..||+|.+....  .....+.+|+.+++.++||||+++++++.....+|+||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            46899999999999999999999899999999987543  2235688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +.+++|.+++.. +++++.++..++.|++.||+|||+++++|+||+|+||+++.++.  ++|+|||++....... ....
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCcccccc
Confidence            999999998864 56899999999999999999999999999999999999986654  9999999986543322 1233


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..++..|+|||++.+..++.+ +|+|||||++|+|++|+.||...+......    .+... ........++..+.+++.
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~li~  234 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLF----LIPKN-NPPTLTGEFSKPFKEFID  234 (277)
T ss_pred             ccCcccccCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhh----hhhcC-CCCCCchhhhHHHHHHHH
Confidence            468889999999987777666 999999999999999999998765432221    11111 111122346788999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +||..+|.+||++.++++|+||.+..
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         235 ACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             HHcccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.3e-44  Score=329.43  Aligned_cols=257  Identities=26%  Similarity=0.475  Sum_probs=212.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ...|+....||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..+..+|+|+||
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            345777889999999999999999899999999986533 2345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +++++|...+.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++....... ....
T Consensus       100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~  176 (297)
T cd06659         100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKS  176 (297)
T ss_pred             CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccc
Confidence            999999887654 56899999999999999999999999999999999999986654  9999999986433222 2234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.......... .+...  ..........++..+.++|.
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         177 LVGTPYWMAPEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDS--PPPKLKNAHKISPVLRDFLE  252 (297)
T ss_pred             eecCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHhcc--CCCCccccCCCCHHHHHHHH
Confidence            578999999999987777655 999999999999999999998765433322 22111  11122233457889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +||+.+|.+||++.++++||||.+..
T Consensus       253 ~~l~~~P~~Rps~~~ll~~~~~~~~~  278 (297)
T cd06659         253 RMLTREPQERATAQELLDHPFLLQTG  278 (297)
T ss_pred             HHhcCCcccCcCHHHHhhChhhccCC
Confidence            99999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-45  Score=312.00  Aligned_cols=259  Identities=25%  Similarity=0.364  Sum_probs=213.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +..+++..||.|+.|+|++++.+.+|...|||.+.+...  ..++++..+.++... .+|+||+-+++|..+..+++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            356778899999999999999999999999999987542  234566666655544 48999999999999999999999


Q ss_pred             ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860          100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      .|. ..+..++.+ .++++|..+-.+...++.||.||.. +||+|||+||+|||+|..++  +||||||++.........
T Consensus       172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAh  248 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAH  248 (391)
T ss_pred             HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeeccccc
Confidence            984 344455544 4569999999999999999999985 67999999999999988776  999999998776666667


Q ss_pred             CCCcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          178 KSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      +...|.+.|||||.+.-   ..|+.. +||||||+.++||.||+.||.+.+..-+....+..  ..++.++....+|+.+
T Consensus       249 trsAGC~~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~L~~~~gFSp~F  325 (391)
T KOG0983|consen  249 TRSAGCAAYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPLLPGHMGFSPDF  325 (391)
T ss_pred             ccccCCccccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCCCCcccCcCHHH
Confidence            77889999999999853   467766 89999999999999999999986554443333322  3445667777799999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ++|+..||++|+.+||...++|+|||+...-+.
T Consensus       326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a  358 (391)
T KOG0983|consen  326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETA  358 (391)
T ss_pred             HHHHHHHhhcCcccCcchHHHhcCcceeecchh
Confidence            999999999999999999999999999765443

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-43  Score=319.95  Aligned_cols=250  Identities=32%  Similarity=0.516  Sum_probs=208.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~   98 (365)
                      +|++.+.||.|+||.||++.+..+++.||+|.+.....   ..+.+.+|+.+++.++||||+++++.+..  ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            58999999999999999999999999999999875432   23457789999999999999999998764  45689999


Q ss_pred             eecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        99 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH-----~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      ||+++++|.+++.+    ..++++..++.++.||+.||+|||     +.+++|+||||+||+++.++  .+||+|||++.
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~--~~kl~d~g~~~  158 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN--NVKLGDFGLAK  158 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC--CEEEecccccc
Confidence            99999999999865    357899999999999999999999     89999999999999998665  49999999988


Q ss_pred             cccCCCC-CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          170 SSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       170 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      ....... .....|++.|+|||++.+..++.+ +|+||||+++++|++|+.||...+. ..+   .+.+..... .+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~-~~~---~~~~~~~~~-~~~~~  232 (265)
T cd08217         159 ILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQ-LQL---ASKIKEGKF-RRIPY  232 (265)
T ss_pred             cccCCcccccccccCCCccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCH-HHH---HHHHhcCCC-CCCcc
Confidence            6544333 344578999999999987776655 9999999999999999999987653 222   222222222 12233


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .++..+.+++.+||..+|.+|||+.++++|||+
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            578999999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.1e-43  Score=323.74  Aligned_cols=249  Identities=29%  Similarity=0.450  Sum_probs=200.5

Q ss_pred             ccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHH---HHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           30 DIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        30 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~---~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .||+|+||.||++.+..+++.||+|.+.+....    ......|.   ..++...||||+++++++.....+++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998764321    11233333   34455689999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcC
Q 017860          103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  182 (365)
Q Consensus       103 ~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~g  182 (365)
                      |++|..++.+.+.+++..++.++.|++.||+|||+++++||||||+||+++.++.  +||+|||++..... .......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~-~~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCc-cCCcCcCC
Confidence            9999999988888999999999999999999999999999999999999986654  99999999875432 22345579


Q ss_pred             CCCCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          183 TPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       183 t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      ++.|+|||++.++ .++.+ +||||+||++|+|++|+.||........ ..............+  ..+|.++.+++.+|
T Consensus       158 ~~~y~aPE~~~~~~~~~~~-~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~--~~~s~~~~~li~~~  233 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP--DSFSPELRSLLEGL  233 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcc-cchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCC--CcCCHHHHHHHHHH
Confidence            9999999998755 45544 9999999999999999999987533211 112222222222333  34689999999999


Q ss_pred             cccCCCCCC-----CHHHHhcCcccccCC
Q 017860          262 FVADPAARI-----TIPEIMKHQWFLKNL  285 (365)
Q Consensus       262 l~~dp~~R~-----t~~ell~h~~f~~~~  285 (365)
                      |..+|.+||     ++.++++||||....
T Consensus       234 l~~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         234 LQRDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             hhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence            999999999     999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.4e-44  Score=321.08  Aligned_cols=251  Identities=33%  Similarity=0.548  Sum_probs=210.1

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||+|+||.||++.++.+|..+|+|.+....   ...+.+.+|+.+++.++||||+++++.+.....+++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5899999999999999999999999999999987532   2345678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-C
Q 017860          101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-P  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~  177 (365)
                      +.+++|.+++.+..  .+++..++.++.|++.||.|||+.+++|+||||+||+++.++. .+||+|||.+........ .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccc
Confidence            99999999987643  4799999999999999999999999999999999999986543 479999998875433222 2


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....|++.|+|||++.+..++.+ +|+||||+++++|++|..||...+.......    ...... .+....++.++.++
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~  233 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGYF-APISPNFSRDLRSL  233 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HhcccC-CCCCCCCCHHHHHH
Confidence            23468999999999887777666 9999999999999999999986554333322    222221 12233478899999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccc
Q 017860          258 ISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +.+||..+|++|||+.++++||||
T Consensus       234 i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         234 ISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.3e-44  Score=326.66  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=204.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCC-----cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTK-----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ++|++++.||+|+||.||++.+...+     ..||+|.+.....  ....+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            47999999999999999999986555     6899998865332  2356889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           96 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      ++|||+++++|.+++...                ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--
Confidence            999999999999998764                45788999999999999999999999999999999999986654  


Q ss_pred             EEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 017860          160 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~  235 (365)
                      +||+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|||++ |..||.+..... ...   
T Consensus       163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~-~~~---  237 (283)
T cd05048         163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQE-VIE---  237 (283)
T ss_pred             EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH---
Confidence            9999999987543222   1234457889999999987777666 999999999999998 999998765533 222   


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+.... ..+....+++++.+|+.+||+.+|.+||++.+++++
T Consensus       238 ~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         238 MIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222221 223344578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-44  Score=329.10  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=214.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.....+|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            468999999999999999999998899999999986432 2345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +++++|.+++.+. .+++.++..++.|++.||+|||++|++||||||+||+++.++.  +||+|||++....... ....
T Consensus        98 ~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          98 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             CCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceeccccccccccc
Confidence            9999999988653 5889999999999999999999999999999999999986654  9999999876443322 2234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|++.|+|||.+.+..++.+ +|+|||||++|++++|+.||...+........   ........+....++..+++++.
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccCChhhcCchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHH
Confidence            468899999999987777665 99999999999999999999875543322111   11122233344457889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +||..+|.+||++.+++.|+||+...
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHhcCc
Confidence            99999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.1e-43  Score=318.99  Aligned_cols=247  Identities=32%  Similarity=0.516  Sum_probs=206.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      +|++.+.||+|+||.||+++++.+++.||+|.+....  ...+.+.+|+.+++.++||||+++++.+.....+|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            5899999999999999999999999999999986432  23366788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          102 SGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       102 ~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      ++++|.+++..  ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.  ++|+|||+++...... ...
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccc
Confidence            99999998864  345899999999999999999999999999999999999986654  9999999987543322 223


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...|++.|+|||++.+..++.+ +|+||||+++|+|++|..||...+....    ...+..... .+.+..++..+.+|+
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~li  232 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNL----ILKVCQGSY-KPLPSHYSYELRSLI  232 (255)
T ss_pred             cccCCccccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHH----HHHHhcCCC-CCCCcccCHHHHHHH
Confidence            4568999999999987777666 9999999999999999999986544322    222222222 123345788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 017860          259 SRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+||+.+|.+|||+.+++..
T Consensus       233 ~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         233 KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHhCCcccCCCHHHHhhc
Confidence            99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.6e-44  Score=330.07  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=204.5

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC----
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP----   91 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~----   91 (365)
                      ....++|++.++||+|+||.||++.++.+++.+|+|.+.....   ....+.+|+.+++.++||||+++++++...    
T Consensus         4 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (311)
T cd07866           4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS   83 (311)
T ss_pred             CcccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccc
Confidence            3446799999999999999999999999999999999865332   234678899999999999999999987543    


Q ss_pred             ----CEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           92 ----THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        92 ----~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                          ..+++|+||+.+ +|...+.. ...+++..++.++.|+++||+|||++|++||||||+||+++.++.  +||+|||
T Consensus        84 ~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg  160 (311)
T cd07866          84 KRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFG  160 (311)
T ss_pred             cccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCc
Confidence                357999999965 66666654 457999999999999999999999999999999999999987654  9999999


Q ss_pred             CcccccCCCC------------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHH
Q 017860          167 YSKSSVLHSQ------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       167 la~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  234 (365)
                      +++.......            .....+++.|+|||.+.+......++|||||||++|+|++|++||.+.+.......+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9874332211            1223578899999998665433444999999999999999999998776655444333


Q ss_pred             HHHhcccc-C------------------CC-----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          235 QRILSVQY-S------------------VP-----DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       235 ~~~~~~~~-~------------------~~-----~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ........ .                  .+     ....+++.+.+||.+||+.+|.+|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            22110000 0                  00     012345789999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.2e-44  Score=327.77  Aligned_cols=253  Identities=29%  Similarity=0.446  Sum_probs=209.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +.|++++.||+|+||.||++.+..++..||+|.+....  ...+.+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            46899999999999999999999899999999987433  2335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-CCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~~~  179 (365)
                      +++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++........ ...
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhc
Confidence            999999988754 56899999999999999999999999999999999999986654  99999999875433221 223


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..|+..|+|||.+.+..++.+ +|+|||||++|+|++|..||..........    .+.... ........+.++.+++.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~  234 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLF----LIPKNS-PPTLEGQYSKPFKEFVE  234 (277)
T ss_pred             ccCcccccCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHh----hhhcCC-CCCCCcccCHHHHHHHH
Confidence            468899999999987777666 999999999999999999997654432211    111111 11122346789999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +||..+|++|||+.++++||||.+.
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         235 ACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             HHccCCcccCcCHHHHHHhHHHHHH
Confidence            9999999999999999999999653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=8.5e-44  Score=320.94  Aligned_cols=248  Identities=23%  Similarity=0.374  Sum_probs=206.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..++|+++++||+|+||.||++.+. ++..||+|.+.......+.+.+|+.+++.++||||+++++++......+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            4568999999999999999999975 567799999876555557889999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--
Q 017860          101 ASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  176 (365)
Q Consensus       101 ~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--  176 (365)
                      +.+++|.+++.+  ...+++..++.++.|++.||+|||+++++||||||+||+++.++.  +||+|||+++.......  
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTA  160 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceec
Confidence            999999999865  346889999999999999999999999999999999999986654  99999999875432221  


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||......... ..+.    .....+....++.++.
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~  234 (261)
T cd05072         161 REGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVM-SALQ----RGYRMPRMENCPDELY  234 (261)
T ss_pred             cCCCccceecCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHH-HHHH----cCCCCCCCCCCCHHHH
Confidence            122345678999999987777655 999999999999998 99999775543322 2221    1233444456889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||..+|++|||++++.+
T Consensus       235 ~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         235 DIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHccCCcccCcCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-43  Score=320.86  Aligned_cols=248  Identities=21%  Similarity=0.333  Sum_probs=206.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      ...|++.+.||+|+||.||++.++.+++.||+|.+..+......+.+|+.+++.++||||+++++++.....++++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            34699999999999999999999999999999998765544567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC--
Q 017860          102 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--  177 (365)
Q Consensus       102 ~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~--  177 (365)
                      .+++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++.........  
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~  162 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAH  162 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeecc
Confidence            999999998754  35899999999999999999999999999999999999976654  999999998754332211  


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.+....+ +.+.    ..+..+....++.++.+
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         163 AGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLE----KGYRMERPEGCPPKVYE  236 (263)
T ss_pred             CCCCCccccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHH----CCCCCCCCCCCCHHHHH
Confidence            12234568999999987777666 999999999999998 99999875543322 2221    12223334557899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017860          257 LISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++.+||..+|++|||+.++++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999976

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-43  Score=315.81  Aligned_cols=251  Identities=31%  Similarity=0.507  Sum_probs=213.3

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .|++.+.||+|++|.||++.+..+++.+++|++..... ....+.+|+..++.++||||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            48899999999999999999998999999999976543 44678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCc
Q 017860          103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV  181 (365)
Q Consensus       103 ~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~  181 (365)
                      +++|.+++... ..+++..++.++.|++.||++||++|++||||+|+||+++.++.  ++|+|||.+.............
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeecccccccccccccccee
Confidence            99999998776 57999999999999999999999999999999999999987654  9999999987654443345567


Q ss_pred             CCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       182 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      ++..|+|||.+.+..++.+ +|+||||+++|+|++|..||...+..........   ......+....++..+.++|.+|
T Consensus       159 ~~~~~~~PE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         159 GTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cCCcccCHHHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHHHHHHH
Confidence            8999999999987776555 9999999999999999999987654332222111   22223333333589999999999


Q ss_pred             cccCCCCCCCHHHHhcCcc
Q 017860          262 FVADPAARITIPEIMKHQW  280 (365)
Q Consensus       262 l~~dp~~R~t~~ell~h~~  280 (365)
                      |+.+|.+|||+.++++|||
T Consensus       235 l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         235 LQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ccCChhhCCCHHHHhcCCC
Confidence            9999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=6.9e-44  Score=321.31  Aligned_cols=246  Identities=35%  Similarity=0.562  Sum_probs=209.2

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ||.|+||.||++.+..+|+.+|+|.+.....    ..+.+.+|+.+++.++||||+++++.+.....+|+++||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999998999999999875432    345688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---------CC
Q 017860          107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QP  177 (365)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---------~~  177 (365)
                      .+++.+.+.+++..++.++.||+.||+|||++|++||||+|+||+++.++.  ++|+|||++.......         ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~  158 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKED  158 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccc
Confidence            999988778999999999999999999999999999999999999987665  9999999987543332         12


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||........    ...+.......+....++..+.+|
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd05579         159 KRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEI----FQNILNGKIEWPEDVEVSDEAIDL  233 (265)
T ss_pred             cCcccCccccCHHHhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHhcCCcCCCccccCCHHHHHH
Confidence            33467889999999987776555 9999999999999999999987664332    233333344445444468999999


Q ss_pred             HHHhcccCCCCCCCH---HHHhcCccccc
Q 017860          258 ISRIFVADPAARITI---PEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t~---~ell~h~~f~~  283 (365)
                      +.+||+.+|.+|||+   .++++||||.+
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence            999999999999999   99999999964

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-44  Score=324.40  Aligned_cols=254  Identities=30%  Similarity=0.503  Sum_probs=207.2

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEEEEEEe
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVME   99 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e   99 (365)
                      |++++.||+|+||.||++.+..+++.+|+|.+....   .....+.+|+.+++.++|||++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            788999999999999999999999999999998652   2345688899999999999999999999988  89999999


Q ss_pred             ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--C
Q 017860          100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  176 (365)
Q Consensus       100 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--~  176 (365)
                      |+++ +|..++.+. ..+++..++.++.||+.||+|||++|++|+||||+||+++.++.  +||+|||++.......  .
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~  157 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSAD  157 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCccc
Confidence            9975 888888765 57999999999999999999999999999999999999987654  9999999987544332  2


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCCC---------
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD---------  246 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~---------  246 (365)
                      .....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+................. .++.         
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            334567889999998765443344599999999999999999999887655444433322111100 0010         


Q ss_pred             --------------CCC-CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          247 --------------TNP-ISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       247 --------------~~~-~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                                    ... .+..+.+++.+||..+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                          011 37899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.5e-43  Score=327.23  Aligned_cols=257  Identities=29%  Similarity=0.456  Sum_probs=208.9

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ....+|++.+.||+|+||.||++.+..+++.||+|.+.....    ....+.+|+.+++.++||||+++++++......|
T Consensus        12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~   91 (307)
T cd06607          12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW   91 (307)
T ss_pred             CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence            335679999999999999999999998999999999865332    1245788999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +|+||+. |+|.+.+.. .+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.  +||+|||++..... 
T Consensus        92 lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~-  167 (307)
T cd06607          92 LVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP-  167 (307)
T ss_pred             EEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC-
Confidence            9999997 467666654 456899999999999999999999999999999999999987664  99999998864422 


Q ss_pred             CCCCCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 SQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                        .....+++.|+|||++.   ...++.+ +||||||+++|+|++|+.||...+.........   ....... ....++
T Consensus       168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~---~~~~~~~-~~~~~~  240 (307)
T cd06607         168 --ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNDSPTL-SSNDWS  240 (307)
T ss_pred             --CCCccCCccccCceeeeccCCCCCCcc-cchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh---cCCCCCC-CchhhC
Confidence              23456889999999874   2345545 999999999999999999998765433222111   1111111 122367


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ..+.++|.+||..+|.+||++.+++.||||.+..++
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  276 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPP  276 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCCc
Confidence            899999999999999999999999999999876544

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-44  Score=353.93  Aligned_cols=259  Identities=22%  Similarity=0.356  Sum_probs=194.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCc-EEEEE------------------EeecCCcccHHHHHHHHHHhcCCCCCcce
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKE-LVAVK------------------YIERGDKIDENVQREIINHRSLRHPNIVR   83 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~-~vaiK------------------~~~~~~~~~~~~~~e~~~l~~l~hpnIv~   83 (365)
                      ++|+++++||+|+||+||++..+.... ..+.|                  .+.........+.+|+.+++.++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            579999999999999999987653322 22222                  12222223356789999999999999999


Q ss_pred             eceEEEeCCEEEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           84 FKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        84 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      +++++......|+|++++. ++|..++...     .......++.++.||+.||.|||++||+||||||+|||++.++. 
T Consensus       228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-  305 (501)
T PHA03210        228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-  305 (501)
T ss_pred             EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence            9999999999999999995 4677766432     22456778899999999999999999999999999999986654 


Q ss_pred             CEEEecCCCcccccCCC--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCC-CCCCC--ChHHHHHH
Q 017860          159 RLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPD--EPKDFRKT  233 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~--~~~~~~~~  233 (365)
                       +||+|||+++......  .....+||+.|+|||++.+..++.+ +|||||||++|||++|..+ |....  ....+.+.
T Consensus       306 -vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        306 -IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             -EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence             9999999997543322  2234679999999999988888766 9999999999999998754 43322  22233333


Q ss_pred             HHHHhccccCCC--------------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          234 IQRILSVQYSVP--------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       234 ~~~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +..+......+|                          ....++.++.++|.+||+.||.+|||+.|+|.||||....
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            222110000000                          1123567788999999999999999999999999997653

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-44  Score=334.60  Aligned_cols=255  Identities=25%  Similarity=0.388  Sum_probs=203.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~l   96 (365)
                      ....|+++++||+||.+.||++... +.+.||+|.+...   .....-+.+|+..|.+|+ |.+||+++++=..++.+|+
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            4556999999999999999999986 4566777766432   223356889999999995 8999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||- ..+|..+|.+.... +...++.+..|+|.|+.++|..||||.||||.|+|+-.+   ++||+|||+|.......
T Consensus       438 vmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDT  513 (677)
T ss_pred             Eeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEee---eEEeeeechhcccCccc
Confidence            99976 56999999887664 446899999999999999999999999999999999633   49999999998665443


Q ss_pred             C---CCCCcCCCCCCCchhhcccccC----------CccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          176 Q---PKSTVGTPAYIAPEVLLRHEYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       176 ~---~~~~~gt~~y~aPE~~~~~~~~----------~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                      .   ..+.+||+.|||||.+....++          +.++||||||||+|+|+.|++||.....   +...+..+..+..
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---QIAKLHAITDPNH  590 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---HHHHHHhhcCCCc
Confidence            3   3466899999999999654433          3349999999999999999999975322   2344555555544


Q ss_pred             CCCCCCCCC-HHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          243 SVPDTNPIS-QECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       243 ~~~~~~~~s-~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .++.+..-+ .++.++++.||..||++|||+.++|+|||++-
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            322222122 34999999999999999999999999999864

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=318.56  Aligned_cols=251  Identities=31%  Similarity=0.480  Sum_probs=208.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC------cccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL   94 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~   94 (365)
                      .+|++.+.||+|+||.||++.++.+++.||+|.+....      .....+.+|+.+++.++||||+++++++...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999875321      1224678899999999999999999998764  568


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ++++||+++++|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++.  ++|+|||+++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~  159 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTI  159 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccc
Confidence            999999999999999988778999999999999999999999999999999999999986654  999999998754321


Q ss_pred             ----CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          175 ----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       175 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                          .......|+..|+|||.+.+..++.+ +|+|||||++|+|++|+.||........+.    .+.........+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~p~~~  234 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIF----KIATQPTKPMLPDGV  234 (264)
T ss_pred             cccCccccccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHH----HHHcCCCCCCCCccc
Confidence                12234568999999999987776655 999999999999999999998765443332    222222222234458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ++.+.+++.+||+ +|.+||++.+++.|||.
T Consensus       235 ~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         235 SDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            8999999999998 68999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.8e-44  Score=324.31  Aligned_cols=250  Identities=34%  Similarity=0.583  Sum_probs=212.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ++|.+.+.||+|+||.||++.+..+++.||+|++.+..    .....+.+|+.+++.++ ||||+++++++.....+++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999987532    22356788999999998 99999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--  175 (365)
                      |||+.+++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.  ++|+|||++.......  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCcccc
Confidence            999999999999998888999999999999999999999999999999999999976654  9999999876432221  


Q ss_pred             -------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHH
Q 017860          176 -------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       176 -------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  236 (365)
                                         ......++..|+|||++.+..++.+ +|+||||++++++++|+.||...+....+.    .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~  233 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS-SDLWALGCIIYQMLTGKPPFRGSNEYLTFQ----K  233 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChh-hhHHHHHHHHHHHHhCCCCCCCccHHHHHH----H
Confidence                               1223457899999999877666555 999999999999999999998776433332    2


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCH----HHHhcCccc
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITI----PEIMKHQWF  281 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~----~ell~h~~f  281 (365)
                      +.......+  ..+++.+.+||.+||+.+|.+|||+    +++++||||
T Consensus       234 ~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         234 ILKLEYSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHhcCCCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            222333333  3478999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.3e-44  Score=333.53  Aligned_cols=253  Identities=21%  Similarity=0.356  Sum_probs=203.0

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEe
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   90 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~   90 (365)
                      ..+.++|++.+.||+|+||.||+|.+.     .+++.||+|++.....  ....+.+|+.+++.+ +||||+++++++..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            445679999999999999999999753     3457899999875332  224577899999999 89999999998764


Q ss_pred             -CCEEEEEEeecCCCChHHHHHhc--------------------------------------------------------
Q 017860           91 -PTHLAIVMEYASGGELFERICNA--------------------------------------------------------  113 (365)
Q Consensus        91 -~~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------  113 (365)
                       ...++++|||+++++|.+++...                                                        
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             46789999999999999988542                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---CCCCcCCCC
Q 017860          114 -----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA  185 (365)
Q Consensus       114 -----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~  185 (365)
                           .++++..+..++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.......   .....++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~--~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC--cEEEeccccchhcccCcchhhccCCCCCcc
Confidence                 2578899999999999999999999999999999999998665  499999999875432221   223345678


Q ss_pred             CCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017860          186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA  264 (365)
Q Consensus       186 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  264 (365)
                      |+|||++.+..++.+ +|||||||++|+|++ |..||.+......+...+...    .........++++.+++.+||+.
T Consensus       241 y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         241 WMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG----TRMRAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             ccCcHHhcCCCCCcc-ccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhcc----CCCCCCccCCHHHHHHHHHHccC
Confidence            999999988888777 999999999999998 999998755444333333221    12222345788999999999999


Q ss_pred             CCCCCCCHHHHhcC
Q 017860          265 DPAARITIPEIMKH  278 (365)
Q Consensus       265 dp~~R~t~~ell~h  278 (365)
                      +|.+||++.++++|
T Consensus       316 ~p~~RPs~~ell~~  329 (337)
T cd05054         316 NPEDRPTFSELVEI  329 (337)
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-43  Score=333.08  Aligned_cols=259  Identities=30%  Similarity=0.407  Sum_probs=205.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeC---------
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP---------   91 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~---------   91 (365)
                      ..+|++.+.||.|+||.||++.++.+|+.||+|.+..... ..+.+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            4699999999999999999999999999999999865432 335688899999999999999999876654         


Q ss_pred             -----CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           92 -----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        92 -----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                           ..+|+||||+. ++|.+.+.. +++++..++.++.||+.||.|||+.|++||||||+||+++..+ ..+||+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcc
Confidence                 35899999997 588877754 4689999999999999999999999999999999999997433 248999999


Q ss_pred             CcccccCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc---
Q 017860          167 YSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS---  239 (365)
Q Consensus       167 la~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---  239 (365)
                      +++......    ......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+..............   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            987432211    1223467899999998765444445599999999999999999999877654444333221100   


Q ss_pred             ------------------cccCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          240 ------------------VQYSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       240 ------------------~~~~~~---~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                                        .....+   ....++.++.+||.+||+.||.+|||+.+++.||||+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                              000000   01246789999999999999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.2e-43  Score=323.12  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=204.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ..+|.+.+.||+|+||.||++.+..     +++.||+|.+......  ...+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4579999999999999999998753     4678999998764332  36788999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           95 AIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      ++||||+++++|.+++...+              .+++..+..++.|++.||+|||++|++||||||+||+++.++.  +
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--V  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--E
Confidence            99999999999999987542              3788999999999999999999999999999999999987654  9


Q ss_pred             EEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 017860          161 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       161 kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  236 (365)
                      ||+|||+++......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||...+......    .
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~----~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE----C  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----H
Confidence            999999987432221   1233456788999999988887766 999999999999998 999998766543222    2


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +...... +....++..+.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         237 ITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2222221 223457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-44  Score=334.83  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=208.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCC-----
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT-----   92 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----   92 (365)
                      ..++|++++.||+|+||.||++.+..+++.||+|.+.+...   ....+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            45689999999999999999999999999999999865322   2346788999999999999999999987654     


Q ss_pred             -EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 -~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                       .+++||||+ +++|..++.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++  .+||+|||++...
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~--~~kl~dfg~~~~~  168 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC--ELKILDFGLARQT  168 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeccccccc
Confidence             468999999 7788877754 5699999999999999999999999999999999999998655  4999999998754


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------  241 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  241 (365)
                      .  .......+++.|+|||.+.+....+.++|+|||||++|+|++|..||...+......++........          
T Consensus       169 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         169 D--SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             c--cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            3  2234456799999999987643334559999999999999999999987655443333322110000          


Q ss_pred             ------cCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          242 ------YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       242 ------~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                            ...+         ....+++.+.++|.+||..||.+|||+.+++.||||.....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                  0000         11346788999999999999999999999999999987543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.4e-43  Score=322.43  Aligned_cols=257  Identities=29%  Similarity=0.495  Sum_probs=217.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..+.|++.+.||+|+||.||++.+..+++.||+|++.......+.+.+|+..++.++|+||+++++++......|+|+||
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            45679999999999999999999998899999999987554456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      +.+++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.  ++|+|||++....... ...
T Consensus        97 ~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          97 MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhc
Confidence            99999999998876 8999999999999999999999999999999999999986654  9999999876433221 223


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...+++.|+|||++.+..++.+ +|+|||||++|+|++|+.||.............   .......+....++..+.+||
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHHH
Confidence            3457899999999987777666 999999999999999999998655433222211   112222233334788999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccc
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+||+.+|.+|||+.+++.|+||.+
T Consensus       251 ~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHhccChhhCcCHHHHhhChHhhc
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=314.70  Aligned_cols=250  Identities=32%  Similarity=0.493  Sum_probs=213.1

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||+|++|.||++++..+++.||+|.+.....   ....+.+|+.+++.++|||++++++++.....++++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            58999999999999999999998999999999976543   346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-CCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~~~  179 (365)
                      +++++|.+++.+.+.+++..++.++.|++.||.|||++|++||||||+||+++.++  .++|+|||++........ ...
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~  158 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDAS  158 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccc
Confidence            99999999998888899999999999999999999999999999999999998654  599999999875443332 234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..++..|+|||.+.+..++.+ +||||||+++|+|++|..||..........+..   ....  .+....+++.+.+++.
T Consensus       159 ~~~~~~y~~pe~~~~~~~~~~-~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~i~  232 (254)
T cd06627         159 VVGTPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV---QDDH--PPLPEGISPELKDFLM  232 (254)
T ss_pred             cccchhhcCHhhhcCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---ccCC--CCCCCCCCHHHHHHHH
Confidence            568999999999877665555 999999999999999999998765433222221   1111  1233457899999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccc
Q 017860          260 RIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +||..+|++|||+.++++||||
T Consensus       233 ~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHhCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-43  Score=326.03  Aligned_cols=256  Identities=31%  Similarity=0.482  Sum_probs=205.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCC-------
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPT-------   92 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------   92 (365)
                      ++|++.+.||+|+||.||++.++.+|+.||+|.+....   .....+.+|+.+++.++||||+++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            57999999999999999999999999999999987543   23356788999999999999999999987655       


Q ss_pred             ---EEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           93 ---HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        93 ---~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                         .+++|+||+++ ++...+... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.  +||+|||++
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~  163 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLA  163 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCccccc
Confidence               79999999976 666666543 46899999999999999999999999999999999999987654  999999998


Q ss_pred             ccccCCCC--CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CC-
Q 017860          169 KSSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV-  244 (365)
Q Consensus       169 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-  244 (365)
                      ........  .....+++.|+|||.+.+......++|||||||++++|++|++||...+....+............ .+ 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            75433321  223356888999998865443344599999999999999999999876655444433332111100 00 


Q ss_pred             ----------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          245 ----------------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       245 ----------------------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                                            .....++..+.+++.+||..+|.+|||+.+++.||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                  0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.3e-43  Score=327.04  Aligned_cols=249  Identities=24%  Similarity=0.357  Sum_probs=200.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcE--EEEEEeecCC--cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++.+.||+|+||.||+|.++.++..  +|+|.+....  .....+.+|+.++..+ +||||+++++++...+.+|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            35899999999999999999999877764  4777665422  2235678899999999 89999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           97 VMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      ||||+++++|.+++.+.+                .+++..++.++.|++.||+|||++|++||||||+|||++.++.  +
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~  163 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--A  163 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--E
Confidence            999999999999986542                4789999999999999999999999999999999999986654  9


Q ss_pred             EEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhc
Q 017860          161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       161 kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      ||+|||++.............++..|+|||++.+..++.+ +|||||||++|+|++ |..||...+......    .+ .
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~-~  237 (303)
T cd05088         164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-P  237 (303)
T ss_pred             EeCccccCcccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHH----HH-h
Confidence            9999999864322222222234667999999877666555 999999999999998 999998665433222    11 1


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .....+.+..+++++.+|+.+||+.+|.+||++++++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            122223344578999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.7e-43  Score=318.60  Aligned_cols=251  Identities=27%  Similarity=0.411  Sum_probs=204.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||+++++.+++.||+|.+.....    ....+.+|+.+++.++||||+++++++...+.+++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            479999999999999999999999999999998864322    2245788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||+++++|.+++..    ...+++..++.++.|++.||+|||++|++||||||+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~  159 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccch
Confidence            99999999988753    344899999999999999999999999999999999999987654  999999988754332


Q ss_pred             CC-CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       175 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      .. .....|++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||.......  ......+............++..
T Consensus       160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNL--FSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             hHHHhcCCCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCccccccH--HHHHHHHhcCCCCCCChhhcCHH
Confidence            21 234568899999999987777666 999999999999999999997543221  12222222222111112346789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+++.+||..+|.+|||+.++++.
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHH
Confidence            9999999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.6e-43  Score=318.18  Aligned_cols=254  Identities=29%  Similarity=0.475  Sum_probs=203.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      +.......||+|+||.||++++..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   87 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQV   87 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecC
Confidence            344455689999999999999998999999998875432 3356889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCC
Q 017860          102 SGGELFERICNA-GRF--SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus       102 ~~g~L~~~l~~~-~~l--~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      .+++|.+++... ..+  ++..+..++.||+.||+|||++|++||||||+||+++.+. +.++|+|||++...... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~  166 (268)
T cd06624          88 PGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCT  166 (268)
T ss_pred             CCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCcc
Confidence            999999998764 445  8889999999999999999999999999999999997532 35999999988644322 222


Q ss_pred             CCCcCCCCCCCchhhcccc--cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ....|++.|+|||++.+..  ++ .++|+||||+++|+|++|+.||............. .........  +..+++++.
T Consensus       167 ~~~~~~~~~~aPE~~~~~~~~~~-~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~  242 (268)
T cd06624         167 ETFTGTLQYMAPEVIDKGPRGYG-APADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV-GMFKIHPEI--PESLSAEAK  242 (268)
T ss_pred             ccCCCCccccChhhhccccccCC-chhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh-hhhccCCCC--CcccCHHHH
Confidence            3346899999999986543  44 44999999999999999999997654322211111 111111122  234788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +|+.+||..+|.+|||+.+++.||||
T Consensus       243 ~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         243 NFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-43  Score=318.88  Aligned_cols=247  Identities=23%  Similarity=0.393  Sum_probs=203.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .+|++.+.||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++||||+++++++.....+++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            57999999999999999999876 45569999987655555778999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC--CC
Q 017860          103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KS  179 (365)
Q Consensus       103 ~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~--~~  179 (365)
                      +++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++  .+||+|||+++........  ..
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~--~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG--CVKVSDFGLSRYVLDDEYTSSVG  160 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC--CEEECCCccceecCCCceeecCC
Confidence            99999998764 4689999999999999999999999999999999999998665  4999999998754332211  12


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..++..|+|||.+.+..++.+ +|||||||++|+|++ |+.||...+.......+    .... ..+.....+..+.+++
T Consensus       161 ~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~li  234 (256)
T cd05113         161 SKFPVRWSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGL-RLYRPHLASEKVYAIM  234 (256)
T ss_pred             CccChhhCCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCC-CCCCCCCCCHHHHHHH
Confidence            335678999999987777666 999999999999998 99999876553322222    2221 1122334689999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 017860          259 SRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+||..+|.+|||+.+++.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.4e-43  Score=328.86  Aligned_cols=249  Identities=20%  Similarity=0.349  Sum_probs=203.2

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcE----EEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ...+|++.+.||+|+||.||+|++..++..    ||+|.+....  .....+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            356899999999999999999998766654    8999986432  2345788899999999999999999998765 56


Q ss_pred             EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++....
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~  161 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGA  161 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccC
Confidence            7999999999999998774 45899999999999999999999999999999999999986654  99999999986543


Q ss_pred             CCCC---CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 HSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ....   ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.... .+....    ......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~-~~~~~~----~~~~~~~~~~~  235 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPAS-EISSIL----EKGERLPQPPI  235 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHH----hCCCCCCCCCC
Confidence            3322   22234678999999988777766 999999999999997 99999865432 222222    22333344455


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+.++.+++.+||..+|.+|||+.+++.+
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            78899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.8e-43  Score=337.29  Aligned_cols=263  Identities=24%  Similarity=0.370  Sum_probs=209.2

Q ss_pred             cccCCCCCCC----CCCCCCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcC
Q 017860            8 LTVGPAMDMP----IMHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL   76 (365)
Q Consensus         8 ~~~~~~~~~~----~~~~~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l   76 (365)
                      ...+..|.+|    +-.+.++|++.+.||+|+||.||++.+..     ++..||+|++.....  ..+.+.+|+.+++.+
T Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l   97 (400)
T cd05105          18 YIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHL   97 (400)
T ss_pred             eeeeccccCCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhc
Confidence            3445556655    34456789999999999999999998743     234799999865432  235688999999999


Q ss_pred             C-CCCcceeceEEEeCCEEEEEEeecCCCChHHHHHhc------------------------------------------
Q 017860           77 R-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA------------------------------------------  113 (365)
Q Consensus        77 ~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------------------------------  113 (365)
                      . ||||+++++++.....+|+|||||++|+|.+++...                                          
T Consensus        98 ~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (400)
T cd05105          98 GPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDY  177 (400)
T ss_pred             CCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccc
Confidence            6 999999999999999999999999999999887542                                          


Q ss_pred             ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcC
Q 017860          114 ------------------------------------------------------GRFSEDEARFFFQQLISGVSYCHAMQ  139 (365)
Q Consensus       114 ------------------------------------------------------~~l~~~~~~~i~~qil~al~~LH~~~  139 (365)
                                                                            ..+++..+..++.||+.||+|||+++
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  257 (400)
T cd05105         178 MDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN  257 (400)
T ss_pred             cccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence                                                                  23778888999999999999999999


Q ss_pred             CeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh
Q 017860          140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV  216 (365)
Q Consensus       140 ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  216 (365)
                      ++||||||+|||++.++.  +||+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++
T Consensus       258 ivH~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwSlGvil~ellt  334 (400)
T cd05105         258 CVHRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTL-SDVWSYGILLWEIFS  334 (400)
T ss_pred             eeCCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCch-hhHHHHHHHHHHHHH
Confidence            999999999999987654  99999999875432221   223456788999999987777666 999999999999997


Q ss_pred             -CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          217 -GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       217 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                       |..||........+...+.    .....+....++.++.+++.+||+.+|++|||+.++.+
T Consensus       335 ~g~~P~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         335 LGGTPYPGMIVDSTFYNKIK----SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCCCcccchhHHHHHHHh----cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence             9999987544333322222    22233344567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-43  Score=317.27  Aligned_cols=248  Identities=24%  Similarity=0.348  Sum_probs=205.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..++|++.+.||+|+||.||++.+. +++.||+|.+.......+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            3468999999999999999999975 567899999877655567789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC-
Q 017860          101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~-  177 (365)
                      +.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++........ 
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccc
Confidence            99999999987644  6899999999999999999999999999999999999987664  999999998755422111 


Q ss_pred             -CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       178 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                       .....+..|+|||++.+..++.+ +||||||+++|+|++ |+.||.+.+...... .+.    .....+.....+..+.
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~  234 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-QVD----QGYRMPCPPGCPKELY  234 (261)
T ss_pred             cCCCcCceeccCccccccCCCCch-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHH----cCCCCCCCCcCCHHHH
Confidence             11123457999999987777666 999999999999999 999998765433222 221    1222334445789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||+.+|.+||++.++++
T Consensus       235 ~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         235 DIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHhhcCcccCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3e-43  Score=322.49  Aligned_cols=258  Identities=29%  Similarity=0.520  Sum_probs=211.5

Q ss_pred             CcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC-----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~   94 (365)
                      +|++.+.||.|+||.||+|.+.   .+|+.||+|++....     ...+.+.+|+.+++.+ +||||+++++++..+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999885   478999999987532     2235678899999999 589999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |+||||+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+|||++.++  ++||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~  158 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG--HVVLTDFGLSKEFHED  158 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC--CEEEeeCccceecccc
Confidence            99999999999999998888899999999999999999999999999999999999998665  5999999998754332


Q ss_pred             C--CCCCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 S--QPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 ~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      .  ......|+..|+|||.+.+.. ....++||||||+++|+|++|..||...............+.....  +....++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (290)
T cd05613         159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMS  236 (290)
T ss_pred             cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCC--CCCccCC
Confidence            2  223456899999999986532 2234499999999999999999999754433333334443333322  2234478


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccCC
Q 017860          252 QECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNL  285 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~-----t~~ell~h~~f~~~~  285 (365)
                      +.+.+++.+||..+|.+||     ++++++.||||.+..
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            9999999999999999997     899999999997653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-46  Score=313.75  Aligned_cols=270  Identities=26%  Similarity=0.398  Sum_probs=219.7

Q ss_pred             CCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeec---CCcccHHHHHHHHHHhcCCCCCcceeceEEE
Q 017860           13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVIL   89 (365)
Q Consensus        13 ~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~   89 (365)
                      -|..|.+...+.|..+.+||+|.||.||+|+.+++|+.||+|++--   .........+|+.+|..|+|+|++.++++|.
T Consensus         7 s~~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~   86 (376)
T KOG0669|consen    7 SMYEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR   86 (376)
T ss_pred             cccCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHh
Confidence            3567788888899999999999999999999999999999987643   2345678899999999999999999998875


Q ss_pred             eC--------CEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           90 TP--------THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        90 ~~--------~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      ..        ..+|+||.+|+. +|.-++... .+++..+++.+++++++||.|+|.+.|+|||+||+|+||+.++.  +
T Consensus        87 tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--l  163 (376)
T KOG0669|consen   87 TKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--L  163 (376)
T ss_pred             hccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--E
Confidence            42        358999999976 788887665 57999999999999999999999999999999999999987665  9


Q ss_pred             EEecCCCcccccCCCC-----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 017860          161 KICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       161 kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  235 (365)
                      ||+|||+++......+     .+..+.|.||++||.+.+...+++..|||..|||+.||++|.+-|.+.++..++..+..
T Consensus       164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~  243 (376)
T KOG0669|consen  164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ  243 (376)
T ss_pred             EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence            9999999975443322     34456799999999999877777779999999999999999999998777665433322


Q ss_pred             HHhcccc-CCCCC----------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          236 RILSVQY-SVPDT----------------------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       236 ~~~~~~~-~~~~~----------------------------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      -...... .+|..                            -.-.+++.+|+.++|..||.+|+++++++.|.||.+..
T Consensus       244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp  322 (376)
T KOG0669|consen  244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP  322 (376)
T ss_pred             HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence            1111110 11110                            00145788999999999999999999999999997643

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-43  Score=332.64  Aligned_cols=260  Identities=25%  Similarity=0.403  Sum_probs=209.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCE-----
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH-----   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-----   93 (365)
                      .++|++.+.||+|+||.||++++..+++.||+|.+....   .....+.+|+.+++.++||||+++++++.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            468999999999999999999999999999999986532   223556789999999999999999998876654     


Q ss_pred             -EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           94 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        94 -~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                       +++|+||+ +++|.+++.. .++++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++....
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~  169 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTD  169 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccc
Confidence             89999999 6689888765 56999999999999999999999999999999999999987654  9999999987543


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-----------  241 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  241 (365)
                      .  ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||...+....+..+........           
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             c--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence            2  244557899999999986543334459999999999999999999987665444333222110000           


Q ss_pred             --------cCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          242 --------YSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       242 --------~~~------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                              ...      ......++.+.+||.+||..+|.+|||+.+++.||||.+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                    000      0012358899999999999999999999999999999876544

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-43  Score=357.29  Aligned_cols=250  Identities=28%  Similarity=0.383  Sum_probs=202.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.++||+|+||.||+|.+..+++.||+|++.....    ....+.+|+.+++.++||||+++++++...+..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            589999999999999999999999999999999875322    2356889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           99 EYASGGELFERICNA-----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        99 e~~~~g~L~~~l~~~-----------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      ||++|++|.+++.+.           ..++...+..++.||+.||+|||++||+||||||+||+++.++.  +||+|||+
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGL  159 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGA  159 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCc
Confidence            999999999988642           23456778899999999999999999999999999999986665  99999999


Q ss_pred             cccccCC-------------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH
Q 017860          168 SKSSVLH-------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK  228 (365)
Q Consensus       168 a~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  228 (365)
                      ++.....                   ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            8754110                   01123469999999999988777665 999999999999999999998744322


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ...   ...............+++.+.+++.+||..||++|++..+.+.+
T Consensus       239 i~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        239 ISY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            111   11111122222334578999999999999999999877665543

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=6e-43  Score=326.83  Aligned_cols=260  Identities=26%  Similarity=0.406  Sum_probs=204.8

Q ss_pred             CcceecccccCCCeEEEEEEEccC--CcEEEEEEeecCC---cccHHHHHHHHHHhcC-CCCCcceeceEEEeC----CE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVT--KELVAVKYIERGD---KIDENVQREIINHRSL-RHPNIVRFKEVILTP----TH   93 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~----~~   93 (365)
                      +|++.+.||+|+||.||++++..+  +..||+|.+....   ...+.+.+|+.+++.+ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            589999999999999999999888  8999999986432   2235677899999988 599999999875432    45


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +|++++|+. ++|..++....++++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||+++....
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~  157 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSE  157 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccc
Confidence            789999985 689999988888999999999999999999999999999999999999987654  99999999875432


Q ss_pred             CC-----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc---------
Q 017860          174 HS-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS---------  239 (365)
Q Consensus       174 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---------  239 (365)
                      ..     ......||+.|+|||++.+....+.++|||||||++|+|++|++||...+....+...+.....         
T Consensus       158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (332)
T cd07857         158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI  237 (332)
T ss_pred             ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            21     1234578999999998866433344499999999999999999999876543322222211100         


Q ss_pred             --------------cc-cCCC-CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          240 --------------VQ-YSVP-DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       240 --------------~~-~~~~-~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                                    .. ..++ .....+..+.+|+.+||+.+|.+|||+.+++.||||++...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                          00 0000 11235789999999999999999999999999999987643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=372.33  Aligned_cols=255  Identities=31%  Similarity=0.446  Sum_probs=216.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      -||+-..+||.|.||.||.|.+..+|...|+|.+.-..   +.-..+.+|+.++..++|||+|+++++=.++..++|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            47888889999999999999999999999999875432   233567899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-----
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----  174 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-----  174 (365)
                      ||++|+|.+.+..++-.+|...+.+..|++.|++|||+.|||||||||+||+++.++.  +|++|||.|......     
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCC
Confidence            9999999999988888899999999999999999999999999999999999987775  999999998754333     


Q ss_pred             CCCCCCcCCCCCCCchhhccccc--CCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      ...+...|||.|||||++.+..-  ...++||||||||+.||+||+.||...+..-.++=.+...  ..+.+|..  +|+
T Consensus      1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g--h~Pq~P~~--ls~ 1468 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG--HKPQIPER--LSS 1468 (1509)
T ss_pred             HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc--CCCCCchh--hhH
Confidence            23456789999999999986542  2345899999999999999999999877755443333221  22233444  999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +.++||.+||+.||++|.++.|++.|.|-..
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence            9999999999999999999999999987543

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3.1e-43  Score=317.77  Aligned_cols=247  Identities=23%  Similarity=0.345  Sum_probs=202.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..++|++.++||+|+||.||+|++..+ ..||+|++.......+.+.+|+.+++.++||||+++++.+. ....++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            456899999999999999999998755 46999999875555577899999999999999999999875 4567999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC-
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~-  177 (365)
                      +.+|+|.+++.+.  ..+++..+..++.|++.||+|||+++++||||||+||+++.++.  +||+|||.++........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeecccccccc
Confidence            9999999999763  35899999999999999999999999999999999999986654  999999998754332221 


Q ss_pred             -CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       178 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                       ....++..|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+.. ....+....++..+.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~  233 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVER-GYRMPCPPECPESLH  233 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHH----HHhc-CCCCCCccccCHHHH
Confidence             23346678999999887777666 999999999999999 888998765433222    2211 122333455789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||+.+|.+|||+.+++.
T Consensus       234 ~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         234 DLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHccCCcccCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-43  Score=316.86  Aligned_cols=247  Identities=23%  Similarity=0.398  Sum_probs=204.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .+|++.+.||+|+||.||++.++ ++..+|+|.+.........+.+|+.+++.++||||+++++++......|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46999999999999999999886 56789999987665555678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC--CC
Q 017860          103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KS  179 (365)
Q Consensus       103 ~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~--~~  179 (365)
                      +++|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++........  ..
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCC
Confidence            99999998763 46899999999999999999999999999999999999987654  999999998754322211  11


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..++..|+|||.+.+..++.+ +|||||||++|+|++ |+.||...+......    .+. .....+.+...+..+.+++
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li  234 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVS-AGYRLYRPKLAPTEVYTIM  234 (256)
T ss_pred             CCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHH----HHH-cCCcCCCCCCCCHHHHHHH
Confidence            223457999999988777766 999999999999998 899998655433222    221 1222333445789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 017860          259 SRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+||..+|.+|||+.++++.
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3e-43  Score=329.55  Aligned_cols=259  Identities=30%  Similarity=0.436  Sum_probs=207.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcC-CCCCcceeceEEEeC--CEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~--~~~~   95 (365)
                      .++|++.+.||+|+||.||++.+..+++.+|+|.+...   ......+.+|+.+++.+ +||||+++++++...  ..+|
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            35899999999999999999999989999999988542   22234577899999999 999999999998654  4689


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      +||||+. ++|..++... .+++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||++.......
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~  161 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELE  161 (337)
T ss_pred             EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhcccccc
Confidence            9999997 5898888765 7899999999999999999999999999999999999987665  9999999987543322


Q ss_pred             ------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc----------
Q 017860          176 ------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------  239 (365)
Q Consensus       176 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~----------  239 (365)
                            ......||+.|+|||++.+....+.++|||||||++|+|++|+.||..........+.......          
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                  2233568999999998866554445599999999999999999999876554433322221100          


Q ss_pred             -------------ccc-C-CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          240 -------------VQY-S-VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       240 -------------~~~-~-~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                   ... . ......++.++.+||.+||+.+|.+|||+.+++.||||.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                         000 0 00112368899999999999999999999999999999764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.9e-43  Score=318.35  Aligned_cols=250  Identities=26%  Similarity=0.404  Sum_probs=205.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||+++++.+++.+|+|.+.....    ....+.+|+.+++.++||||+++++++..+...+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            479999999999999999999999999999998865322    2356788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++|+||||+||+++.++  .++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~dfg~~~~~~~~  159 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSSK  159 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC--CEEECcchhhhccccC
Confidence            99999999998863    34589999999999999999999999999999999999998665  4999999988754332


Q ss_pred             CC-CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          175 SQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       175 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      .. .....|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||......  .......+....+.......+++.
T Consensus       160 ~~~~~~~~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             CcccccccCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHH
Confidence            22 234568999999999987777665 99999999999999999999754332  122222322222221223347889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017860          254 CRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+++.+||..+|.+|||+.++++
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHH
Confidence            999999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.3e-43  Score=316.48  Aligned_cols=241  Identities=27%  Similarity=0.399  Sum_probs=196.6

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      +.||+|+||.||+++++.+++.||+|.+....  .....+.+|+.+++.++||||+++++++.....+++||||+.+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999999999999999876432  2335688999999999999999999999999999999999999999


Q ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC---CCCcC
Q 017860          107 FERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG  182 (365)
Q Consensus       107 ~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~---~~~~g  182 (365)
                      .+++.+.+ .+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||++.........   ....+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN--VLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC--cEEECccccCcccccccccccCCCCCC
Confidence            99987644 589999999999999999999999999999999999997665  4999999998753321111   11123


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      +..|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ....+.    .....+.....+..+.+|+.+|
T Consensus       159 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~li~~~  232 (252)
T cd05084         159 PVKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQ-TREAIE----QGVRLPCPELCPDAVYRLMERC  232 (252)
T ss_pred             ceeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHH-HHHHHH----cCCCCCCcccCCHHHHHHHHHH
Confidence            456999999988777666 999999999999998 889997655432 222221    1122233445789999999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 017860          262 FVADPAARITIPEIMK  277 (365)
Q Consensus       262 l~~dp~~R~t~~ell~  277 (365)
                      |+.+|++|||+.++++
T Consensus       233 l~~~p~~Rps~~~~~~  248 (252)
T cd05084         233 WEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.6e-43  Score=315.15  Aligned_cols=250  Identities=34%  Similarity=0.576  Sum_probs=211.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||.|+||.||++.+..+++.||+|.+....   .....+.+|+.+++.++|||++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5999999999999999999999899999999987643   2345688899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860          101 ASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus       101 ~~~g~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      +++++|.+.+.+.    ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~  158 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVD  158 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcc
Confidence            9999999998764    67999999999999999999999999999999999999986554  9999999987543332 


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ......|++.|+|||.+.+..++.+ +|+||+|+++++|++|..||...+...    .......... .+.+..++..+.
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~  232 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLE----LALKILKGQY-PPIPSQYSSELR  232 (258)
T ss_pred             eecceeeeecccChhHhccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHH----HHHHHhcCCC-CCCCCCCCHHHH
Confidence            2334578999999999887777666 999999999999999999997765332    2222222221 122335789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +++.+||..+|.+|||+.++|.||||
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-43  Score=314.90  Aligned_cols=242  Identities=26%  Similarity=0.431  Sum_probs=204.4

Q ss_pred             cccccCCCeEEEEEEEccC---CcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||++.+...   +..||+|.+......  ...+.+|+..++.++|+||+++++++.....+++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4799999999999999866   899999998765433  46788999999999999999999999999999999999999


Q ss_pred             CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860          104 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus       104 g~L~~~l~~~---------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ++|.+++...         ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||.+......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~  158 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDD  158 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEcccccccccccc
Confidence            9999999875         67999999999999999999999999999999999999987654  999999998765443


Q ss_pred             C---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          175 S---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       175 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      .   ......+++.|+|||.+....++.+ +|||||||++|+|++ |..||..........    .+.. ....+....+
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~  232 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLE----YLRK-GYRLPKPEYC  232 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCccC
Confidence            2   2344567889999999987776655 999999999999999 699998875433222    2222 2233444557


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.++.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            8999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-44  Score=323.14  Aligned_cols=287  Identities=28%  Similarity=0.499  Sum_probs=227.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..+|.++..||+|+||+|-++..+.+.+.||||+++++....    +--..|-++|... +-|.+++++.+|++-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457999999999999999999999999999999998753222    1112344444433 57899999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||||+.||+|-..+++.++|.|..+..++..|+-||-+||++||+.||||..|||++..+  +|||+|||+++...... 
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG--HiKi~DFGmcKEni~~~~  505 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIFDGV  505 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC--ceEeeecccccccccCCc
Confidence            999999999999999999999999999999999999999999999999999999997655  59999999998655544 


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ...+.||||.|+|||++...+|. +.+|+||+|+++|||+.|++||++.+..+.+..+...    ...+  +..+|.++.
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh----nvsy--PKslSkEAv  578 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH----NVSY--PKSLSKEAV  578 (683)
T ss_pred             ceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----cCcC--cccccHHHH
Confidence            35678999999999999887775 5599999999999999999999998887666554443    3333  345899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCcccccCCCCCcchhhhcccCCCCCCCCCCCHHHHHHHHHH
Q 017860          256 DLISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAE  318 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t-----~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (365)
                      ++.+..|.+.|.+|+.     -.++-.||||+.- ..+-.....+.+++..........+.....|.+
T Consensus       579 ~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i-DWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~  645 (683)
T KOG0696|consen  579 AICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI-DWEKLERREIQPPFKPKIKCGRDAENFDKFFTR  645 (683)
T ss_pred             HHHHHHhhcCCccccCCCCccccchhhCcchhhc-cHHHHhhccCCCCCCCccccCCchhhhhHHHhc
Confidence            9999999999999984     4688899999753 222222233334443333233344444444433

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-43  Score=322.13  Aligned_cols=254  Identities=31%  Similarity=0.467  Sum_probs=207.9

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      |++++.||+|++|.||++.+..+++.+|+|.+.....   ....+.+|+.+++.++||||+++++++..+..+++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            7788999999999999999998999999999875432   2457788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       102 ~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      .+ +|...+.. ...+++..+..++.|++.||.|||++|++|+||||+||+++.++  .+||+|||.+....... ....
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~--~~~l~df~~~~~~~~~~~~~~~  157 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG--VLKLADFGLARSFGSPVRPYTH  157 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC--cEEEeeeeeeEecCCCcccccC
Confidence            75 78777766 45789999999999999999999999999999999999998655  49999999887554333 2234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------------CC
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------------SV  244 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~  244 (365)
                      ..++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+....+.+..........               ..
T Consensus       158 ~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05118         158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSF  237 (283)
T ss_pred             ccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhh
Confidence            568889999999877633344499999999999999999999887765544443332211100               00


Q ss_pred             C---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          245 P---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       245 ~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +         ....++.++++||.+||..+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             ccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            0         112367899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-43  Score=330.44  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC------
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------   91 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------   91 (365)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++.+...   ..+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            34789999999999999999999999999999999875322   235677899999999999999999988643      


Q ss_pred             CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ...|++++++ +++|.+++.. .++++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++..
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~  170 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT  170 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccc
Confidence            3478888887 7789877754 46999999999999999999999999999999999999987664  999999998753


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-----------
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-----------  240 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-----------  240 (365)
                      .  .......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+......++.......           
T Consensus       171 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         171 D--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             c--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            2  233455789999999998664333444999999999999999999997765544333222211000           


Q ss_pred             --------ccCCCC------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          241 --------QYSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       241 --------~~~~~~------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                              ....+.      ....++++.+||.+||+.+|.+|||+.+++.||||.+...+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                    000000      12357889999999999999999999999999999875543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.1e-43  Score=322.13  Aligned_cols=257  Identities=30%  Similarity=0.482  Sum_probs=211.4

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .|....+||+|+||.||++.++.+++.||+|.+.... .....+.+|+.+++.++||||+++++.+......++||||++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            4555678999999999999999999999999886432 233567889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCCCc
Q 017860          103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV  181 (365)
Q Consensus       103 ~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~~~  181 (365)
                      +++|.+++.. +++++..++.++.|++.||+|||++|++||||+|+||+++.++.  ++|+|||++....... ......
T Consensus       101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccc
Confidence            9999987644 46899999999999999999999999999999999999987654  9999999876543322 223456


Q ss_pred             CCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       182 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      |++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||......... ..+....  .........++..+.+++.+|
T Consensus       178 ~~~~y~~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         178 GTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAM-KMIRDNL--PPKLKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             cCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhhC--CcccCCcccCCHHHHHHHHHH
Confidence            8999999999877666655 99999999999999999999875543322 2222211  122223345789999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccccCCCC
Q 017860          262 FVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       262 l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      |+.+|.+||++.+++.||||.+..++
T Consensus       254 l~~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         254 LVRDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             HhCCcccCcCHHHHhcChHHhccCCC
Confidence            99999999999999999999877643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.9e-43  Score=320.49  Aligned_cols=251  Identities=21%  Similarity=0.315  Sum_probs=204.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .++|++.+.||+|+||.||+|.++.     ++..||+|.+.....  ....+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4679999999999999999999987     778999998864322  234688899999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEecCC
Q 017860           95 AIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFG  166 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~-~~vkl~Dfg  166 (365)
                      ++||||+.+++|.+++.+.+       .+++..+..++.||+.||+|||+++++||||||+||+++.++. ..+||+|||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence            99999999999999987653       4899999999999999999999999999999999999986542 358999999


Q ss_pred             CcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          167 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       167 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                      +++.......   ......++.|+|||++.+..++.+ +|||||||++|+|++ |..||...+.... .+.+.   . ..
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~---~-~~  238 (277)
T cd05036         165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEV-MEFVT---G-GG  238 (277)
T ss_pred             cccccCCccceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHH---c-CC
Confidence            9875422111   112234568999999988777766 999999999999997 9999987655332 22221   1 11


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ....+..++..+.+++.+||+.+|++|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         239 RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            222334578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.7e-43  Score=324.07  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=200.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCc--EEEEEEeecCC--cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ++|++.+.||+|+||.||++..+.++.  .+++|.+....  ...+.+.+|+.+++++ +||||+++++++.....+|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            589999999999999999999877665  46888776422  2235688899999989 799999999999999999999


Q ss_pred             EeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 017860           98 MEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK  161 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vk  161 (365)
                      +||+++++|.+++....                .+++..++.++.|++.||+|||++|++||||||+|||++.++.  +|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~k  159 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SK  159 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EE
Confidence            99999999999986532                4788999999999999999999999999999999999986654  99


Q ss_pred             EecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 017860          162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       162 l~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      |+|||++..............+..|+|||++.+..++.+ +|||||||++|+|++ |..||..........+.    .. 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----~~-  233 (297)
T cd05089         160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----PQ-  233 (297)
T ss_pred             ECCcCCCccccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----hc-
Confidence            999999864322222222233557999999987777666 999999999999997 99999876654333222    11 


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       241 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ....+.+..++..+.+|+.+||..+|.+|||++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            12223344588999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.3e-43  Score=330.84  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=198.7

Q ss_pred             ecccccC--CCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           28 VRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        28 ~~~LG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      ...||.|  +||+||++++..+|+.||+|++.....   ..+.+.+|+.+++.++||||++++++|.....+++|+||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567777  999999999999999999999875432   23567889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC----
Q 017860          103 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----  176 (365)
Q Consensus       103 ~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~----  176 (365)
                      +++|.+++.+.  ..+++..++.++.|++.||+|||++|++||||||+||+++.++  .++++||+.+........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~--~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG--LVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC--cEEEechHHHhhhhccCccccc
Confidence            99999998764  3489999999999999999999999999999999999998665  499999985432211111    


Q ss_pred             ----CCCCcCCCCCCCchhhccc--ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh------------
Q 017860          177 ----PKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL------------  238 (365)
Q Consensus       177 ----~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~------------  238 (365)
                          .....++..|+|||++.+.  .++ .++|||||||++|+|++|+.||.................            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                1112356679999998764  244 449999999999999999999987654433322211000            


Q ss_pred             -----------------------------ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          239 -----------------------------SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       239 -----------------------------~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                                   ......+.....++.+.+|+.+||+.||++|||+.++++||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence                                         0000111223356789999999999999999999999999999654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-43  Score=318.90  Aligned_cols=253  Identities=30%  Similarity=0.462  Sum_probs=205.9

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcC---CCCCcceeceEEEeCCE-----
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSL---RHPNIVRFKEVILTPTH-----   93 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~-----   93 (365)
                      |++.+.||+|+||.||+++++.+++.||+|.+.....   ....+.+|+.+++.+   +||||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            7889999999999999999998899999999874322   223566777766555   69999999999988776     


Q ss_pred             EEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ++++|||+.+ +|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++  .+||+|||++...
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceec
Confidence            9999999975 7888887643  589999999999999999999999999999999999998775  5999999998765


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCC-----
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP-----  245 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-----  245 (365)
                      ..........+++.|+|||++.+..++.+ +|+|||||++|+|++|.+||...+....+.++........ ..++     
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSL  236 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence            54444455568899999999988777666 9999999999999999999988776555554443221100 0000     


Q ss_pred             ------C---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          246 ------D---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       246 ------~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                            .         ...+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             chhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                  0         11346788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.4e-43  Score=320.01  Aligned_cols=250  Identities=19%  Similarity=0.294  Sum_probs=200.6

Q ss_pred             CCCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ..++|++.+.||+|+||.||++.++.     ++..||+|.+.....  ....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45689999999999999999998652     456899998864332  23457889999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 017860           94 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                      .++||||+++++|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+||+++.++.  +||+
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~  161 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIG  161 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEEC
Confidence            999999999999999986532          2567889999999999999999999999999999999986654  9999


Q ss_pred             cCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhc
Q 017860          164 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       164 Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      |||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||......... +   .+..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~-~---~~~~  236 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVL-R---FVME  236 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-H---HHHc
Confidence            9999874322211   122345788999999987777665 999999999999998 78899876543222 2   1222


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ... .+.....+..+.+++.+||+.+|.+|||+.+++++
T Consensus       237 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         237 GGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            211 12234478899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4e-43  Score=320.51  Aligned_cols=248  Identities=20%  Similarity=0.340  Sum_probs=201.9

Q ss_pred             CCcceecccccCCCeEEEEEEEc----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      +.|++.+.||+|+||+||+|...    .++..||+|.+.....  ....+.+|+.+++.++||||+++++++......|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            57999999999999999999853    3567899999875332  22467889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           97 VMEYASGGELFERICNA-----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      ||||+.+++|.+++...                 ..+++.++..++.|++.||+|||++|++||||||+|||++.++.  
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--
Confidence            99999999999988532                 23788999999999999999999999999999999999986654  


Q ss_pred             EEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 017860          160 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~  235 (365)
                      +||+|||+++......   ......++..|+|||++.+..++.+ +|||||||++|+|++ |..||.+.... ...+.+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~-~~~~~~~  240 (283)
T cd05090         163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQ-EVIEMVR  240 (283)
T ss_pred             EEeccccccccccCCcceecccCCCccceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH
Confidence            9999999987543221   1233446778999999987777665 999999999999998 99999775432 2222222


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                          .....+.+..+++.+.+++.+||+.+|.+||++.+++++
T Consensus       241 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         241 ----KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             ----cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence                122233444578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.3e-43  Score=315.67  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=202.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..++|+++++||+|+||.||++.+. .+..+|+|.+.......+.+.+|+.+++.++|||++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            4568999999999999999999876 5677999999876555678899999999999999999999875 4568899999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC-
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~-  177 (365)
                      +.+++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||+++.++  .++|+|||++......... 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~--~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL--VCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc--eEEeCCceeeeeccCccccc
Confidence            9999999998753  3589999999999999999999999999999999999998665  4999999998754332211 


Q ss_pred             -CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          178 -KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       178 -~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                       ....++..|+|||.+.+..++.+ +||||||+++|+|++ |..||...+......    .+. .....+.....+..+.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~  233 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLE----QVE-RGYRMPCPQDCPISLH  233 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHH-cCCCCCCCCcCCHHHH
Confidence             22335668999999877777655 999999999999999 899998765433222    221 1223344455789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +|+.+||..+|.+|||++++..
T Consensus       234 ~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         234 ELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.5e-43  Score=319.23  Aligned_cols=253  Identities=27%  Similarity=0.453  Sum_probs=209.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +-|++++.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.+++.++||||+++++++..+..+|+||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            358899999999999999999998999999998865332  235678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +.+++|..++.+ +.+++..+..++.|++.|+.|||++|++|+||||+||+++.++.  ++|+|||++....... ....
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhcc
Confidence            999999988864 46899999999999999999999999999999999999986654  9999999886543222 1233


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      ..++..|+|||.+.+...+.+ +|+|||||++|+|++|..||........    ...+..... ......++.++.+++.
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~~i~  234 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKV----LFLIPKNNP-PTLEGNYSKPLKEFVE  234 (277)
T ss_pred             ccCCccccChhhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHH----HHHHhcCCC-CCCCcccCHHHHHHHH
Confidence            468899999999977666655 9999999999999999999976543222    111211111 1122346889999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +||+.+|.+||++.++++||||.+.
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHHHhhh
Confidence            9999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-43  Score=330.54  Aligned_cols=258  Identities=27%  Similarity=0.414  Sum_probs=204.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC------C
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~   92 (365)
                      .++|.+.+.||+|+||.||+|.++.+|+.||+|.+.+..   .....+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            358999999999999999999999899999999986532   2335678999999999999999999998754      3


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+++|+||+.. +|...+  ...+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++...
T Consensus        94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--~~kL~dfg~~~~~~  168 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--ELKILDFGLARHAD  168 (342)
T ss_pred             eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC--CEEEeeCCCCcCCC
Confidence            57999999964 666554  34689999999999999999999999999999999999998765  49999999987542


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh--------------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL--------------  238 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------------  238 (365)
                        .......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+....+..++....              
T Consensus       169 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (342)
T cd07879         169 --AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA  246 (342)
T ss_pred             --CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccc
Confidence              2234457889999999987644334449999999999999999999987654443333222100              


Q ss_pred             -----ccccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          239 -----SVQYSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       239 -----~~~~~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                           ......+      .....+..+.+||.+||+.||.+||++++++.||||....+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             hHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                 0000000      01236788999999999999999999999999999977644

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-43  Score=320.15  Aligned_cols=254  Identities=31%  Similarity=0.475  Sum_probs=207.2

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeec
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      |++.+.||+|+||.||+|+...+++.||+|.+.....  ......+|+..++.++ ||||+++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            7889999999999999999998999999999865432  2234567899999999 999999999999999999999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       102 ~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                       +++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.  ++|+|||++...........
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCC
Confidence             789998887754  6899999999999999999999999999999999999987654  99999999876554444455


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccCC
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QYSV  244 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~  244 (365)
                      ..++..|+|||++.+....+.++|+||||+++++|++|++||..........+........               ....
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF  237 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence            6789999999988654433455999999999999999999998776555443332211000               0000


Q ss_pred             CC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          245 PD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       245 ~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +.         ....+..+.+||.+||+.+|.+|||+.|++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00         11236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.5e-43  Score=320.56  Aligned_cols=249  Identities=26%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ...+|.+.+.||+|+||.||++...     .++..+|+|.+.... .....+.+|+.+++.++||||+++++++.....+
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            3467999999999999999999853     345679999886543 2345688999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 017860           95 AIVMEYASGGELFERICNAG-------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK  161 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~-------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vk  161 (365)
                      ++||||+.+++|.+++...+             .+++..++.++.|++.||+|||++|++||||||+||+++.++  .+|
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~--~~k  160 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL--LVK  160 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--cEE
Confidence            99999999999999987543             389999999999999999999999999999999999998665  499


Q ss_pred             EecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHH
Q 017860          162 ICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRI  237 (365)
Q Consensus       162 l~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  237 (365)
                      |+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||........    ...+
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~----~~~i  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEV----IECI  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHH
Confidence            999999875432221   223445778999999987777665 999999999999998 9999987654332    2222


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       238 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..... .+.....+.++.+|+.+||+.+|.+|||+.+++.
T Consensus       236 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         236 TQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22221 1223457899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-44  Score=338.00  Aligned_cols=245  Identities=35%  Similarity=0.542  Sum_probs=209.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHH-hcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .+.|.+...+|.|+|+.|..+.++.+++.+++|++.+..   .+..+|+.++ +.-+||||+++++.+....+.|+|||+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            568999999999999999999999999999999998752   2344566444 445799999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      +.|+.+.+.+.....+. .++..|+.+|+.|+.|||++|+|||||||+|||++ +..++++|+|||.++.....  ..+.
T Consensus       398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~-~~~g~lrltyFG~a~~~~~~--~~tp  473 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD-GSAGHLRLTYFGFWSELERS--CDTP  473 (612)
T ss_pred             ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-CCCCcEEEEEechhhhCchh--hccc
Confidence            99999999887766555 78889999999999999999999999999999996 34446999999998865444  4566


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR  260 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  260 (365)
                      +-|..|.|||++....|+.. +||||||+++|+|++|+.||........   +...+..+.++    ..+|+++++||.+
T Consensus       474 ~~t~~y~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~~s----~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  474 ALTLQYVAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPKFS----ECVSDEAKDLLQQ  545 (612)
T ss_pred             chhhcccChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCccc----cccCHHHHHHHHH
Confidence            77899999999998888766 9999999999999999999998776533   33333333333    5599999999999


Q ss_pred             hcccCCCCCCCHHHHhcCccc
Q 017860          261 IFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       261 ~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ||+.||.+||++.+++.||||
T Consensus       546 LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hccCChhhCcChhhhccCcch
Confidence            999999999999999999999

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=7.9e-43  Score=319.49  Aligned_cols=255  Identities=20%  Similarity=0.329  Sum_probs=203.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ..++|++.+.||+|+||.||++.++.     .+..||+|.+......  ...+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45689999999999999999997652     3458999988654322  2356789999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 017860           94 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                      .|+||||+.+|+|.+++.+.+          .++...+..++.|++.||.|||++|++||||||+||+++.++.  +||+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~  161 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIG  161 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEEC
Confidence            999999999999999997532          2466788999999999999999999999999999999986654  9999


Q ss_pred             cCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhc
Q 017860          164 DFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       164 Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      |||+++.......   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||....... ..   ..+..
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~-~~---~~~~~  236 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQ-VL---KFVMD  236 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHH-HH---HHHHc
Confidence            9999875432221   122345678999999987777666 999999999999998 788997654432 22   22222


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc------Cccccc
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK------HQWFLK  283 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~------h~~f~~  283 (365)
                      .. ..+.....++.+.+++.+||+.+|.+|||+.++++      ||||..
T Consensus       237 ~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         237 GG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            21 12223346789999999999999999999999987      777753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.8e-43  Score=320.45  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=204.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCC----------------cEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcce
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTK----------------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVR   83 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~   83 (365)
                      ..+|++++.||+|+||.||++.+...+                ..||+|.+....  ...+.+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            468999999999999999999876544                468999987543  23457888999999999999999


Q ss_pred             eceEEEeCCEEEEEEeecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           84 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        84 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      +++++..+...+++|||+.+++|..++.+..           .+++..++.++.|++.||+|||++|++||||||+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili  163 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence            9999999999999999999999999997765           68999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh--CCCCCCCCCCh
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEP  227 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~  227 (365)
                      +.++  .++|+|||+++......   ......+++.|+|||.+.+..++.+ +|||||||++|+|++  +..||...+..
T Consensus       164 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         164 GKNY--TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             cCCC--ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            8765  49999999987543222   1233456788999999987777655 999999999999998  77899776554


Q ss_pred             HHHHHHHHHHh--ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          228 KDFRKTIQRIL--SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       228 ~~~~~~~~~~~--~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..+........  ......+.....+.++.+++.+||+.+|.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            43332221110  111122233446789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.3e-43  Score=314.39  Aligned_cols=247  Identities=22%  Similarity=0.381  Sum_probs=204.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..++|+++++||+|+||.||+|..+ +++.||+|.+.........+.+|+.+++.++||||+++++++. ...++++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3568999999999999999999875 6788999999876655678899999999999999999999874 5568999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--  176 (365)
                      +.+++|.+++...  ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.  ++|+|||++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCccc
Confidence            9999999988653  35899999999999999999999999999999999999987654  99999999875432221  


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....++..|+|||++....++.+ +||||||+++|+|++ |+.||.+.+...... .+.    .....+.....+.++.
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~  233 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ-NLE----RGYRMPRPDNCPEELY  233 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHH-HHH----cCCCCCCCCCCCHHHH
Confidence            122345678999999987777655 999999999999998 999998765533222 221    2223344455788999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||..+|++|||+++++.
T Consensus       234 ~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         234 ELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHccCChhhCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.2e-43  Score=313.05  Aligned_cols=249  Identities=31%  Similarity=0.470  Sum_probs=210.2

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +|++.+.||+|+||.||++.++.+++.+|+|.+.....   ....+.+|+.+++.++||||+++++++.....+|+|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            58999999999999999999999999999999876432   234567899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860          101 ASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus       101 ~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      +++++|..++.+    ...+++..++.++.|++.||+|||++|++||||+|+||+++.++  .+||+|||++...... .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~--~~kl~d~g~~~~~~~~-~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND--LVKIGDLGISKVLKKN-M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC--cEEEeeccchhhhccC-C
Confidence            999999998866    35689999999999999999999999999999999999998755  4999999998765444 3


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      .....+++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+.....    ..+....+. +.....+.++++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~  231 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLR----YKVQRGKYP-PIPPIYSQDLQN  231 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCCC-CCchhhCHHHHH
Confidence            344568999999999987777655 99999999999999999999876543221    222222221 222357889999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccc
Q 017860          257 LISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ++.+||..+|++|||+.++++||++
T Consensus       232 li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         232 FIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.5e-43  Score=318.71  Aligned_cols=251  Identities=28%  Similarity=0.406  Sum_probs=197.9

Q ss_pred             CCc-ceecccccCCCeEEEEEE----EccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeC--CE
Q 017860           23 DRY-DFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP--TH   93 (365)
Q Consensus        23 ~~y-~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~   93 (365)
                      +|| ++++.||+|+||+||++.    ...+++.||+|.+.....  ....+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            466 999999999999998765    345788999999876432  346788999999999999999999987653  46


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +++||||+++++|.+++... .+++.+++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||+++....
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~~l~dfg~~~~~~~  159 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC--cEEEeecccccccCC
Confidence            89999999999999998764 599999999999999999999999999999999999998665  499999999875433


Q ss_pred             CCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHH-HH---------HHHHHHhc
Q 017860          174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FR---------KTIQRILS  239 (365)
Q Consensus       174 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~---------~~~~~~~~  239 (365)
                      ...    .....++..|+|||.+.+..++.+ +|||||||++|+|++|..||........ ..         ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            221    122345677999999987777666 9999999999999999999865432100 00         00001111


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .....+.....+..+.+++.+||+.+|++|||+++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            11122334457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-45  Score=336.54  Aligned_cols=254  Identities=30%  Similarity=0.505  Sum_probs=227.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .+++++..||-|+||.|-+++.+.....+|+|++++.    .+..+.+..|-.+|..++.|.||++|-.|.++..+|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4688899999999999999998766667999998763    334466778999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |-|-||.|+..+...+.|.+..++.++..+++|+.|||++|||.|||||+|++++.++.  +||.|||+|+....+....
T Consensus       500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTw  577 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTW  577 (732)
T ss_pred             HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCcee
Confidence            99999999999999999999999999999999999999999999999999999987776  9999999999999999999


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ++||||.|.|||++.+.+.+.. +|.||||+++|||++|.+||.+.+.......+++.+-.    +.-+..++..+.+||
T Consensus       578 TFcGTpEYVAPEIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~----i~~Pr~I~k~a~~Li  652 (732)
T KOG0614|consen  578 TFCGTPEYVAPEIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK----IEFPRRITKTATDLI  652 (732)
T ss_pred             eecCCcccccchhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh----hhcccccchhHHHHH
Confidence            9999999999999999999877 89999999999999999999998886655555554432    223356889999999


Q ss_pred             HHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          259 SRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       259 ~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      +++...+|.+|..     +.++.+|.||..
T Consensus       653 k~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  653 KKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            9999999999985     899999999953

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.6e-43  Score=316.02  Aligned_cols=246  Identities=22%  Similarity=0.355  Sum_probs=206.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .+|+++++||.|+||.||++.++. ++.+|+|.+..... ....+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            469999999999999999999986 88999999876544 3467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-CC
Q 017860          102 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PK  178 (365)
Q Consensus       102 ~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~~  178 (365)
                      ++++|.+++...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||++........ ..
T Consensus        85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCcccccc
Confidence            999999999753  45899999999999999999999999999999999999986654  99999999875432221 12


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...++..|+|||++.+..++.+ +||||||+++|+|++ |+.||........+....     .....+.+...++.+.++
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-----AGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             CCCCceEecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-----hCCcCCCCCCCCHHHHHH
Confidence            3345678999999987777666 999999999999998 899998765443333222     222334445688999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017860          258 ISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+||+.+|.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-44  Score=335.33  Aligned_cols=259  Identities=26%  Similarity=0.382  Sum_probs=217.2

Q ss_pred             CCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCc---E-EEEEEeecCC----cccHHHHHHHHHHhcCCCCCcce
Q 017860           12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---L-VAVKYIERGD----KIDENVQREIINHRSLRHPNIVR   83 (365)
Q Consensus        12 ~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~   83 (365)
                      |+-..+|...+++-.+.++||+|+||.||+++.+..+.   . ||+|....+.    ....++.+|.++|+.++|||||+
T Consensus       146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            55567777788888888999999999999999876433   3 8999887522    23367889999999999999999


Q ss_pred             eceEEEeCCEEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEE
Q 017860           84 FKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI  162 (365)
Q Consensus        84 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl  162 (365)
                      ++|+...+..+++|||+|.||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.  +||
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKI  303 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKI  303 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEe
Confidence            9999999999999999999999999999887 4999999999999999999999999999999999999986654  799


Q ss_pred             ecCCCcccccCCCCCC-CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 017860          163 CDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       163 ~Dfgla~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      +|||+++......... ...-...|+|||.+....|+.+ +|||||||++||+++ |..||.+.....    ....+...
T Consensus       304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV~sfGV~~~Eif~~g~~Py~g~~~~~----v~~kI~~~  378 (474)
T KOG0194|consen  304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDVWSFGVLLWEIFENGAEPYPGMKNYE----VKAKIVKN  378 (474)
T ss_pred             CccccccCCcceeeccccccCcceecChhhhccCccccc-cchhheeeeEEeeeccCCCCCCCCCHHH----HHHHHHhc
Confidence            9999998654222222 1123468999999998888777 999999999999998 788999877643    33344455


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       241 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+..+.+...+.++..++.+||..+|++|||+.++.+
T Consensus       379 ~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  379 GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            5666666677889999999999999999999999875

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-43  Score=317.38  Aligned_cols=249  Identities=21%  Similarity=0.307  Sum_probs=203.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccC-----CcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ..++|++.+.||+|+||.||++.++..     +..||+|.+.....  ....+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            457899999999999999999998644     37899999865432  23467889999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 017860           94 LAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                      .++||||+++++|.+++....          .+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEEC
Confidence            999999999999999986432          3678899999999999999999999999999999999987665  9999


Q ss_pred             cCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhc
Q 017860          164 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       164 Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      |||+++......   ......++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...+... ..+.+.   .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~---~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEE-VLKFVI---D  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHH-HHHHHh---c
Confidence            999987543222   2233456789999999987777666 999999999999998 999998755433 222222   1


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      . ...+.+...+.++.+++.+||+.+|++|||+.+++.
T Consensus       237 ~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         237 G-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             C-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            1 122233446899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-42  Score=312.77  Aligned_cols=250  Identities=28%  Similarity=0.444  Sum_probs=205.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||++.+..+|+.||+|.+....    ...+.+.+|+.+++.++|+||+++++++......++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            58999999999999999999999999999999886422    22457889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           99 EYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||+++++|..++..    ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.  ++|+|||++......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~  159 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCC
Confidence            99999999998864    245899999999999999999999999999999999999986654  999999998754332


Q ss_pred             C-CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          175 S-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      . ......+++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||......  ..+....+............++..
T Consensus       160 ~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         160 TTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CcccceecCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCCCCCCChhhcCHH
Confidence            2 2234568999999999987777666 99999999999999999999654421  112222222222211112257789


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017860          254 CRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.++|.+||..+|.+|||+.++++
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHH
Confidence            999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-42  Score=317.18  Aligned_cols=248  Identities=20%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCc----EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ..++|++.++||+|+||+||+|++..+++    .||+|.+.....  ....+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence            34689999999999999999999877776    489998865322  235678899999999999999999998754 46


Q ss_pred             EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +++++|+++|+|.+.+... +.+++..+..++.|++.||+|||++|++||||||+|||++.++.  +||+|||+++....
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~  161 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDI  161 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeeccc
Confidence            7999999999999998764 56899999999999999999999999999999999999976554  99999999875433


Q ss_pred             CCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 HSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ...   .....+++.|+|||.+.+..++.+ +|||||||++|||++ |..||...... .....+.    .....+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~----~~~~~~~~~~  235 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPAR-EIPDLLE----KGERLPQPPI  235 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH----CCCcCCCCcc
Confidence            222   122345678999999988777766 999999999999998 89999765432 2222222    2222333445


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+.++.+++.+||..||++||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-42  Score=314.28  Aligned_cols=249  Identities=24%  Similarity=0.383  Sum_probs=204.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccC---CcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++.+.||+|+||.||+|.++.+   ...||+|.+.....  ....+.+|+.+++.++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            35799999999999999999998654   45899998865432  23567889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||+.+++|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.++.  ++|+|||+++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~  160 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhcccccc
Confidence            99999999999998764 46899999999999999999999999999999999999986654  9999999988653111


Q ss_pred             C---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          176 Q---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       176 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      .   .....+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.........    ..+.. ....+.....+
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~----~~~~~-~~~~~~~~~~~  234 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI----KAVED-GYRLPPPMDCP  234 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHH----HHHHc-CCCCCCCCCCC
Confidence            1   112234678999999987777666 999999999999997 99999765543322    22221 22233444578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+.+|+.+||+.+|++||++.+++++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-42  Score=319.22  Aligned_cols=253  Identities=24%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccC-----CcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL   89 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~   89 (365)
                      +....++|++.+.||+|+||.||++.++..     ...+|+|.+.....  ....+.+|+.+++.+ +||||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            445567999999999999999999998643     37899998875322  224577899999999 8999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 017860           90 TPTHLAIVMEYASGGELFERICN----------------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD  153 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~----------------~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~  153 (365)
                      ....++++|||+.+|+|..++..                ...+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence            99999999999999999999864                24588999999999999999999999999999999999998


Q ss_pred             CCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHH
Q 017860          154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD  229 (365)
Q Consensus       154 ~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  229 (365)
                      .++  .+||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||........
T Consensus       167 ~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         167 EDH--VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             CCC--eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            665  499999999875433221   122234678999999877777666 999999999999997 9999987654332


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      . +.+.    .......+...+..+.+|+.+||..+|++|||+.+++++
T Consensus       244 ~-~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 F-KLLK----EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             H-HHHH----cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            2 2221    122223334568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-42  Score=312.10  Aligned_cols=245  Identities=27%  Similarity=0.417  Sum_probs=204.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ...+|++.+.||.|+||.||++...  |+.||+|.+.........+.+|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            3468999999999999999999874  78899999977654456788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      +++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++......  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~--~  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ--D  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc--c
Confidence            99999999997765  6899999999999999999999999999999999999986654  9999999987653221  2


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...++..|+|||.+....++.+ +||||||+++|+|++ |..||..... ..+...+..    .+.......+++.+.++
T Consensus       158 ~~~~~~~~~ape~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~l  231 (256)
T cd05039         158 SGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPHVEK----GYRMEAPEGCPPEVYKV  231 (256)
T ss_pred             cCCCcccccCchhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhc----CCCCCCccCCCHHHHHH
Confidence            3345667999999987777665 999999999999997 9999976543 222222221    12222334578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017860          258 ISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~  277 (365)
                      |.+||..+|.+|||+.++++
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHhccChhhCcCHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=321.66  Aligned_cols=259  Identities=31%  Similarity=0.465  Sum_probs=214.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC--C----CcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--P----NIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--p----nIv~l~~~~~~~~~~~   95 (365)
                      ..||.++..||+|.||.|..+.+..++..||+|+++.-....+...-|+.++.++.+  |    -+|.+.++|...++.|
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC  167 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC  167 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence            569999999999999999999999999999999998777777888899999999842  3    3788999999999999


Q ss_pred             EEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----------------
Q 017860           96 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----------------  156 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-----------------  156 (365)
                      +|+|.+ |-|+++.+.+++  +++-.+++.+.+|+++++++||+++++|-||||+|||+.++.                 
T Consensus       168 ivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~  246 (415)
T KOG0671|consen  168 IVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPL  246 (415)
T ss_pred             EEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccC
Confidence            999999 669999998765  589999999999999999999999999999999999984211                 


Q ss_pred             -CCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 017860          157 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       157 -~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  235 (365)
                       ...|+++|||.|+...  ....+.+.|..|+|||++.+-+++.+ +||||+|||++||.+|...|+.-++.+.+ .+++
T Consensus       247 ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMe  322 (415)
T KOG0671|consen  247 KSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMME  322 (415)
T ss_pred             CCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHH
Confidence             2358999999987543  33366788999999999999999888 99999999999999999999988766543 3343


Q ss_pred             HHhccc------------------cCCCCCC--------------------CC---CHHHHHHHHHhcccCCCCCCCHHH
Q 017860          236 RILSVQ------------------YSVPDTN--------------------PI---SQECRDLISRIFVADPAARITIPE  274 (365)
Q Consensus       236 ~~~~~~------------------~~~~~~~--------------------~~---s~~~~~li~~~l~~dp~~R~t~~e  274 (365)
                      .++.+.                  ..+++..                    ..   -.++.+||++||..||.+|+|+.|
T Consensus       323 rIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~E  402 (415)
T KOG0671|consen  323 RILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLRE  402 (415)
T ss_pred             HhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHH
Confidence            333221                  1111100                    00   134789999999999999999999


Q ss_pred             HhcCcccccCC
Q 017860          275 IMKHQWFLKNL  285 (365)
Q Consensus       275 ll~h~~f~~~~  285 (365)
                      +|.||||....
T Consensus       403 AL~HpFF~~~~  413 (415)
T KOG0671|consen  403 ALSHPFFARLT  413 (415)
T ss_pred             HhcCHHhhcCC
Confidence            99999997653

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-42  Score=318.68  Aligned_cols=261  Identities=27%  Similarity=0.398  Sum_probs=207.9

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~   95 (365)
                      ....++|++.+.||+|+||.||++.+..+++.||+|.+.....  ....+.+|+.++..+ .||||+++++++.....+|
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            4456789999999999999999999998899999999976432  224456677656555 5999999999999999999


Q ss_pred             EEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++|||+. ++|.+++.. ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++  .+||+|||++.....
T Consensus        91 ~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~--~~kL~dfg~~~~~~~  167 (296)
T cd06618          91 ICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLVD  167 (296)
T ss_pred             EEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC--CEEECccccchhccC
Confidence            9999985 467766655 4578999999999999999999997 5999999999999998665  499999999875443


Q ss_pred             CCCCCCCcCCCCCCCchhhcccc----cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-ccCCCCCC
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVPDTN  248 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~  248 (365)
                      ........+++.|+|||.+.+..    ++.+ +||||||+++|+|++|+.||........   ....+... ....+...
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~  243 (296)
T cd06618         168 SKAKTRSAGCAAYMAPERIDPPDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCKTEFE---VLTKILQEEPPSLPPNE  243 (296)
T ss_pred             CCcccCCCCCccccCHhhcCCCCCccccccc-hhHHHHHHHHHHHHhCCCCCCcchhHHH---HHHHHhcCCCCCCCCCC
Confidence            33344456888999999986543    4545 9999999999999999999976433222   22222222 22333333


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      .++.++.+|+.+||..+|.+|||+++++.||||....+
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            57899999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=310.32  Aligned_cols=242  Identities=38%  Similarity=0.615  Sum_probs=206.6

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ||.|+||.||++.+..+++.||+|.+.+...    ....+.+|+.+++.++||||+++++.+..+...|+||||+.+++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            7999999999999998899999999876543    234688899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCCCcCCCC
Q 017860          107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA  185 (365)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~~~gt~~  185 (365)
                      .+++...+.+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.  ++|+|||++...... .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCcc
Confidence            999988888999999999999999999999999999999999999987654  999999998754333 23345568899


Q ss_pred             CCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccC
Q 017860          186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD  265 (365)
Q Consensus       186 y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~d  265 (365)
                      |+|||.+.+...+.+ +|+||||+++|+|++|..||...+...    ....+.....  +.+...+..+.+++++||..|
T Consensus       159 ~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         159 YLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKE----IYEKILKDPL--RFPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             ccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCC--CCCCCCCHHHHHHHHHHhcCC
Confidence            999999977766555 999999999999999999997665422    2233333333  333346899999999999999


Q ss_pred             CCCCCCH---HHHhcCccc
Q 017860          266 PAARITI---PEIMKHQWF  281 (365)
Q Consensus       266 p~~R~t~---~ell~h~~f  281 (365)
                      |.+||++   +++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.7e-42  Score=323.22  Aligned_cols=261  Identities=28%  Similarity=0.472  Sum_probs=206.9

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEe-CCEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHL   94 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~   94 (365)
                      ....++|++++.||.|+||.||++.++.+++.||+|.+.+..   ...+.+.+|+.+++.++||||++++++|.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            345678999999999999999999999999999999886432   234677889999999999999999999876 5678


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |+++||+ +++|..++.. .++++..+..++.|++.||+|||++|++||||+|+||+++.++  .+||+|||++....  
T Consensus        86 ~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~--~~~l~dfg~~~~~~--  159 (328)
T cd07856          86 YFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC--DLKICDFGLARIQD--  159 (328)
T ss_pred             EEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC--CEEeCccccccccC--
Confidence            9999999 5688877654 4689999999999999999999999999999999999998655  49999999987432  


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH-----------------
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-----------------  237 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~-----------------  237 (365)
                      .......+++.|+|||++.+....++++|||||||++|+|++|+.||...+....+.......                 
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence            223445678999999998664433455999999999999999999998765432221111100                 


Q ss_pred             ---hccc--cCCC---CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          238 ---LSVQ--YSVP---DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       238 ---~~~~--~~~~---~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                         ....  ...+   ....+++.+.++|.+||+.+|++|||+++++.||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence               0000  0001   1123678999999999999999999999999999997544

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=316.68  Aligned_cols=254  Identities=33%  Similarity=0.518  Sum_probs=208.0

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      |++.+.||+|+||.||++++..+++.||+|.+...   ....+.+.+|+.+++.++||||+++++++.....+++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            67889999999999999999999999999998764   334467788999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          102 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       102 ~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      . ++|.+++.+. ..+++..++.++.|++.||+|||++|++||||+|+||+++.++.  +||+|||+++...... ....
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~  157 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTH  157 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCc
Confidence            7 5899999876 57999999999999999999999999999999999999987654  9999999987544332 2334


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc--------------ccCCC
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------QYSVP  245 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~  245 (365)
                      ..++..|+|||.+.+....+.++|||||||++|+|++|.+||...+....+.++.......              ....+
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd07829         158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFP  237 (282)
T ss_pred             cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccc
Confidence            4567889999998776333444999999999999999999998766554443333211000              00001


Q ss_pred             C---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          246 D---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       246 ~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .         ...++..+.++|.+||..+|.+||++.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         238 KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            0         11247889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.1e-42  Score=318.60  Aligned_cols=256  Identities=28%  Similarity=0.451  Sum_probs=208.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..+.|...++||+|+||+||++++..+++.||+|.+.....    ....+.+|+.+++.++|||++++++++.+....|+
T Consensus        19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   98 (313)
T cd06633          19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL   98 (313)
T ss_pred             HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence            34568888999999999999999999999999999875332    22457789999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||+. ++|.+.+.. ..++++.+++.++.||+.||.|||++|++||||+|+||+++.++.  +||+|||++...   .
T Consensus        99 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~---~  172 (313)
T cd06633          99 VMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKS---S  172 (313)
T ss_pred             EEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCccc---C
Confidence            999996 577777654 456899999999999999999999999999999999999986654  999999987643   2


Q ss_pred             CCCCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          176 QPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      ......|++.|+|||++.   ...++.+ +|||||||++|+|++|..||...+..........    ..........++.
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~-sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  247 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----NDSPTLQSNEWTD  247 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh----cCCCCCCccccCH
Confidence            234567899999999984   2344444 9999999999999999999987655443332221    1111112234678


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+.+|+.+||+.+|.+||++.+++.||||....+.
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~  282 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPA  282 (313)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCchh
Confidence            89999999999999999999999999999875433

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.3e-42  Score=319.00  Aligned_cols=256  Identities=29%  Similarity=0.458  Sum_probs=209.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ...|+..+.||+|+||.||++++..++..||+|.+.....    ....+.+|+.+++.++|||++++++++......++|
T Consensus        24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            3458999999999999999999999999999999875422    224678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      |||+.| +|.+.+.. ..++++.++..++.|++.||.|||++|++||||+|+||+++.++  .+||+|||++....   .
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~--~~kl~dfg~~~~~~---~  177 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG--QVKLADFGSASIAS---P  177 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC--CEEEecCCCccccC---C
Confidence            999975 77776654 55689999999999999999999999999999999999997655  49999999876432   2


Q ss_pred             CCCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          177 PKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      .....|++.|+|||.+.   ...++.+ +|||||||++|+|++|+.||............    ............+++.
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  252 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNESPTLQSNEWSDY  252 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----HhccCCCCCCccccHH
Confidence            33457899999999974   2345545 99999999999999999999876543332222    2222222233457889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccCCCCC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD  288 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~  288 (365)
                      +++++.+||+.+|.+||++.++++|+|+....+..
T Consensus       253 l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  287 (317)
T cd06635         253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET  287 (317)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence            99999999999999999999999999997765543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-42  Score=320.24  Aligned_cols=252  Identities=24%  Similarity=0.382  Sum_probs=205.9

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEe
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   90 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~   90 (365)
                      -...++|.+.+.||+|+||.||++.+.     .++..||+|.+.....  ..+.+.+|+.+++++ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            344568999999999999999999753     3456899998875432  235688999999999 79999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           91 PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      ...+++||||+.+|+|.+++.+..  .+++.++..++.|++.||+|||+++++|+||||+||+++.++  .+||+|||++
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~  188 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLA  188 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCccc
Confidence            999999999999999999987643  389999999999999999999999999999999999997655  4999999998


Q ss_pred             ccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCC
Q 017860          169 KSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSV  244 (365)
Q Consensus       169 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  244 (365)
                      +.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||........+.+...    .....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~  263 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK----EGYRM  263 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH----cCCcC
Confidence            75433221   122346788999999988777666 999999999999998 9999987665444433332    22222


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.....++++.+|+.+||..+|++|||+.++++
T Consensus       264 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         264 AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            333457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.9e-42  Score=316.87  Aligned_cols=258  Identities=30%  Similarity=0.518  Sum_probs=208.8

Q ss_pred             CcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC-----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~   94 (365)
                      +|++.+.||+|+||.||++++.   .+++.||+|.+.+..     .....+.+|+.+++.+ +||||+++++++.....+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   467899999987532     2234577899999999 599999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |+||||+.+++|...+.....+++..++.++.|++.||.|||+.|++||||||.||+++.++  .++|+|||+++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~~  158 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG--HVVLTDFGLSKEFLAE  158 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC--CEEEEECccccccccc
Confidence            99999999999999998877899999999999999999999999999999999999998665  4999999998754333


Q ss_pred             CC--CCCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 SQ--PKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 ~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ..  .....|++.|+|||.+.+.. ....++||||||+++|+|++|..||.............+.+.....  +.+..++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  236 (288)
T cd05583         159 EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMS  236 (288)
T ss_pred             cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccC
Confidence            22  22346899999999986654 2234499999999999999999999654332222333333333332  3334478


Q ss_pred             HHHHHHHHHhcccCCCCCCC---HHHHhcCcccccCC
Q 017860          252 QECRDLISRIFVADPAARIT---IPEIMKHQWFLKNL  285 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t---~~ell~h~~f~~~~  285 (365)
                      ..+.+++.+||+.+|++|||   +.++|+||||+...
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            89999999999999999998   57789999997643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-42  Score=311.81  Aligned_cols=248  Identities=24%  Similarity=0.345  Sum_probs=206.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +.++|++.++||+|+||.||++.+. +++.||+|.+.......+.+.+|+.+++.++||||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            4578999999999999999999976 567899999987666667899999999999999999999999998999999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--  176 (365)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.  +||+|||++........  
T Consensus        83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~  160 (261)
T cd05034          83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTA  160 (261)
T ss_pred             cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhh
Confidence            9999999999764  36899999999999999999999999999999999999987654  99999999875432211  


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....++..|+|||.+.+..++.+ +|||||||++|+|++ |+.||.+.+......+    +.. .+..+.+...+.++.
T Consensus       161 ~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~  234 (261)
T cd05034         161 REGAKFPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VER-GYRMPRPPNCPEELY  234 (261)
T ss_pred             hhccCCCccccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCCCCHHHH
Confidence            112234578999999987776655 999999999999998 9999977654333322    221 223334445688999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||..+|.+||++++++.
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHH
Confidence            9999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-43  Score=326.09  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=201.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCcceeceEEEeCC-EEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~e   99 (365)
                      .++|.--..||+|+||.||++... +|..||||.+...... ..+|.+|+.++.+++|||+|+++++|.+.+ ..++|+|
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYE  152 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYE  152 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEE
Confidence            467888889999999999999986 4589999988765544 567999999999999999999999999998 5999999


Q ss_pred             ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCCCCCCEEEecCCCcccccC-
Q 017860          100 YASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-  173 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~---ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-  173 (365)
                      |++.|+|.+.+....  .+++.....|+.+++.||+|||...   ||||||||+|||+|.+..  .||+|||+|+.... 
T Consensus       153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEG  230 (361)
T ss_pred             ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCcc
Confidence            999999999997754  7999999999999999999999855   999999999999997776  89999999976655 


Q ss_pred             CCCCCCC-cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCC--ChHHHHH----HH-----HHHhccc
Q 017860          174 HSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD--EPKDFRK----TI-----QRILSVQ  241 (365)
Q Consensus       174 ~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~----~~-----~~~~~~~  241 (365)
                      .....+. .||.+|+|||++..+..+.+ +||||||+++.||++|+.|.....  ....+..    .+     ..+....
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~  309 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPR  309 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCC
Confidence            4443444 89999999999988777777 999999999999999998887532  1111111    11     1111111


Q ss_pred             cCCCCCCCCC-----HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          242 YSVPDTNPIS-----QECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       242 ~~~~~~~~~s-----~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...   ...+     ..+..+..+|++.+|..||++.++++
T Consensus       310 l~~---~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  310 LKE---GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             ccC---CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            110   1222     23667889999999999999999865

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.7e-43  Score=317.85  Aligned_cols=248  Identities=21%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             CCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .+|++.++||+|+||.||++.+..     .++.||+|.+.....  ..+.+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            469999999999999999998754     357899999875432  2356788999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           96 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      +++||+.+++|.+++...                ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--
Confidence            999999999999988531                34788899999999999999999999999999999999986654  


Q ss_pred             EEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 017860          160 LKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~  235 (365)
                      +||+|||+++.......   .....+++.|+|||.+.+..++.+ +|||||||++|||++ |..||.+.....    ...
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQD----VIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHH
Confidence            99999999875432221   223456789999999987777666 999999999999998 888987755432    222


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+..... .+.....+..+.+|+.+||+.+|.+||++.+++..
T Consensus       238 ~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         238 MIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            2222222 22334578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-42  Score=310.63  Aligned_cols=240  Identities=27%  Similarity=0.363  Sum_probs=197.1

Q ss_pred             cccccCCCeEEEEEEEccCC---cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      ++||+|+||.||+|....++   ..+|+|.+.....  ..+.+.+|+.+++.++||||+++++++. ...+++||||+.+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999876555   7899999876543  3467889999999999999999999876 4567999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC----C
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S  179 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~----~  179 (365)
                      ++|.+++.+.+.+++..+..++.|++.||+|||..+++||||||+||+++.++.  +||+|||+++.........    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccC
Confidence            999999988888999999999999999999999999999999999999987664  9999999987543332211    1


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...+.. .+.+.+.   . ....+.+..++..+.+++
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~-~~~~~~~---~-~~~~~~~~~~~~~l~~li  231 (257)
T cd05060         158 GRWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGA-EVIAMLE---S-GERLPRPEECPQEIYSIM  231 (257)
T ss_pred             ccccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHH---c-CCcCCCCCCCCHHHHHHH
Confidence            123467999999987777666 999999999999998 99999876543 2222222   1 122344455789999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017860          259 SRIFVADPAARITIPEIMK  277 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~  277 (365)
                      .+||..+|++|||+.++++
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         232 LSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHhcCChhhCcCHHHHHH
Confidence            9999999999999999985

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.6e-42  Score=310.72  Aligned_cols=240  Identities=25%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             cccccCCCeEEEEEEE--ccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRD--KVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      ++||+|+||.||++..  +.+++.+|+|++.....   ..+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence            3699999999999964  45788999999865432   2356888999999999999999999875 4567899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC----CCC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKS  179 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~----~~~  179 (365)
                      ++|.+++.....+++..+..++.|++.||+|||++|++||||||.||+++.++  .+||+|||+++.......    ...
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH--YAKISDFGLSKALGADENYYKAKTH  157 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC--eEEECCCccccccCCCCCeeeecCC
Confidence            99999998888899999999999999999999999999999999999998665  499999999875433222    122


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..+++.|+|||.+....++.+ +|||||||++|||++ |+.||....... ..+.+.   .. ...+.+...++++.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~i~---~~-~~~~~~~~~~~~l~~li  231 (257)
T cd05116         158 GKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNE-VTQMIE---SG-ERMECPQRCPPEMYDLM  231 (257)
T ss_pred             CCCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH---CC-CCCCCCCCCCHHHHHHH
Confidence            234678999999877666655 999999999999998 999998755432 222222   21 12233345889999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017860          259 SRIFVADPAARITIPEIMK  277 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~  277 (365)
                      .+||+.||.+||+++++..
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            9999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-44  Score=333.66  Aligned_cols=254  Identities=32%  Similarity=0.508  Sum_probs=216.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      -|..++.||-|+||.|++++...+...||+|.+.+.+...    ..++.|-.||....++-||+||-.|.+...+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            4888999999999999999999999999999998755433    346778889999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-----
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----  174 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-----  174 (365)
                      |++||++-.+|.+.+-|.|..++.++..+..|+.+.|..|+|||||||.|||||.++  +|||+||||++.....     
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG--HIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG--HIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC--ceeeeeccccccceecccccc
Confidence            999999999999999999999999999999999999999999999999999998766  5999999998632110     


Q ss_pred             ----CC----------------------------------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh
Q 017860          175 ----SQ----------------------------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV  216 (365)
Q Consensus       175 ----~~----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  216 (365)
                          ..                                  .-..+||+.|+|||++...+|+.- +|+||.|||||||+.
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLV  866 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhh
Confidence                00                                  012369999999999999999877 999999999999999


Q ss_pred             CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCccccc
Q 017860          217 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLK  283 (365)
Q Consensus       217 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~---t~~ell~h~~f~~  283 (365)
                      |++||...+......+++.  +...+.++....+|.++.+||.++. -+++.|+   .++++..||||+.
T Consensus       867 g~~pf~~~tp~~tq~kv~n--w~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  867 GQPPFLADTPGETQYKVIN--WRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             CCCCccCCCCCcceeeeee--hhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            9999998777654443332  2233466777789999999998876 4788998   4778999999974

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.8e-42  Score=315.86  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=202.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..+|++.++||+|+||.||++...     .++..+|+|.+.... .....+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            467999999999999999999743     356789999876533 23457889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           96 IVMEYASGGELFERICNAG---------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~---------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      ++|||+.+++|.+++...+               .+++..++.++.|++.||+|||++|++||||||+|||++.++  .+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~--~~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL--VV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC--CE
Confidence            9999999999999987643               478999999999999999999999999999999999998655  49


Q ss_pred             EEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 017860          161 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       161 kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  236 (365)
                      ||+|||+++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |.+||............   
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---  237 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---  237 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH---
Confidence            9999999874432211   223345788999999988777766 999999999999998 99999776554333222   


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                       .... .......+++.+.+|+.+||+.+|.+||++.+++.
T Consensus       238 -~~~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         238 -TQGR-ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             -HcCc-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             1211 12233457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=318.07  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=200.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccC--------------CcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVT--------------KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFK   85 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~   85 (365)
                      ..+|++.++||+|+||.||++.+..+              ...||+|.+....  .....+.+|+.+++.++||||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            46899999999999999999987543              2358999987532  2234688999999999999999999


Q ss_pred             eEEEeCCEEEEEEeecCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 017860           86 EVILTPTHLAIVMEYASGGELFERICNAG------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD  153 (365)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~  153 (365)
                      +++......++||||+.+++|.+++....            .+++..+..++.|++.||+|||++|++||||||+||+++
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~  163 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence            99999999999999999999999886432            367889999999999999999999999999999999998


Q ss_pred             CCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh--CCCCCCCCCChH
Q 017860          154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEPK  228 (365)
Q Consensus       154 ~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~~  228 (365)
                      .++.  +||+|||++........   .....+++.|+|||++.+..++.+ +|||||||++|+|++  |..||...+...
T Consensus       164 ~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         164 NHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             CCCc--EEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            6654  99999999875432221   122345678999999987777655 999999999999988  668888765544


Q ss_pred             HHHHHHHHHhc--cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          229 DFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       229 ~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...........  ...........++.+.+|+.+||+.+|.+|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            33222221111  11112233346899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.8e-42  Score=318.98  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=207.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ..+|+..+.||+|+||.||+++++.+++.+|+|.+.....    ....+.+|+.+++.++|||++++++++......++|
T Consensus        14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            4569999999999999999999999999999999864321    224577899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      |||+. |+|.+.+.. ...+++..++.++.|++.||.|||+++++||||||+||+++.++  .+||+|||++.....   
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~--~~kl~dfg~~~~~~~---  167 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---  167 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC--cEEECCcccceeecC---
Confidence            99996 577776654 45689999999999999999999999999999999999997665  499999998865432   


Q ss_pred             CCCCcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          177 PKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      .....|++.|+|||.+.+   ..++.+ +|||||||++|+|++|..||...+.........    ...........++..
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  242 (308)
T cd06634         168 ANXFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSGHWSEY  242 (308)
T ss_pred             cccccCCccccCHHHHhhcccCCCCcc-cchHHHHHHHHHHHcCCCCCccccHHHHHHHHh----hcCCCCcCcccccHH
Confidence            234568899999999752   344444 999999999999999999997755433222211    111111223347889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      +.+||.+||..+|.+||++.++++|||+....+.
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~  276 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence            9999999999999999999999999999876543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.4e-42  Score=321.58  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=194.6

Q ss_pred             CCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCChHHHHH
Q 017860           35 NFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC  111 (365)
Q Consensus        35 ~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~  111 (365)
                      ++|.||+++++.+++.||+|++....   .....+.+|+.+++.++||||++++++|......+++|||+.+++|.+++.
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~   91 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK   91 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence            44566777777799999999987642   233578899999999999999999999999999999999999999999987


Q ss_pred             hc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--------CCCCCc
Q 017860          112 NA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------QPKSTV  181 (365)
Q Consensus       112 ~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--------~~~~~~  181 (365)
                      +.  ..+++..++.++.|++.||+|||+++|+||||||+||+++.++.  +||+|||.+.......        ......
T Consensus        92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~  169 (314)
T cd08216          92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSV  169 (314)
T ss_pred             HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeecccccccccccccccccc
Confidence            63  45899999999999999999999999999999999999986654  9999999876432211        123345


Q ss_pred             CCCCCCCchhhccc--ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc------------------
Q 017860          182 GTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ------------------  241 (365)
Q Consensus       182 gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------------------  241 (365)
                      ++..|+|||++.+.  .++.+ +|||||||++|+|++|+.||..........+.........                  
T Consensus       170 ~~~~y~aPE~~~~~~~~~~~~-~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (314)
T cd08216         170 KNLPWLSPEVLQQNLQGYNEK-SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS  248 (314)
T ss_pred             ccccccCHHHhcCCCCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence            78889999998653  35444 9999999999999999999987654433322221110000                  


Q ss_pred             ----------cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          242 ----------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       242 ----------~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                                ...+....++.++.+|+.+||+.||++|||+.++|+||||.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                      00011122356789999999999999999999999999997654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-42  Score=311.99  Aligned_cols=246  Identities=21%  Similarity=0.316  Sum_probs=197.4

Q ss_pred             cceecccccCCCeEEEEEEEccC---CcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeCCE-----
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH-----   93 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-----   93 (365)
                      |++.+.||+|+||.||+|....+   +..||+|.+......   ...+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            67889999999999999987653   478999998754322   2467889999999999999999998866544     


Q ss_pred             -EEEEEeecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           94 -LAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        94 -~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                       .++++||+.+++|..++...      ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM--TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC--eEEECCcc
Confidence             79999999999999887432      3589999999999999999999999999999999999998665  49999999


Q ss_pred             CcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          167 YSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       167 la~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                      +++.......   .....++..|+|||.+.+..++.+ +|||||||++|||++ |..||.+......    ...+.... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~----~~~~~~~~-  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEI----YDYLRHGN-  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHH----HHHHHcCC-
Confidence            9875433221   112335678999999877777665 999999999999999 8899977654332    22222221 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..+.+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            223344578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.6e-42  Score=310.36  Aligned_cols=246  Identities=23%  Similarity=0.344  Sum_probs=201.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .++|++.++||+|+||.||++.+..+ ..+|+|.+.......+.+.+|+.+++.++|||++++++++. ....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            35799999999999999999988754 46999998766655677899999999999999999999875 45678999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--C
Q 017860          102 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P  177 (365)
Q Consensus       102 ~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--~  177 (365)
                      .+++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.  ++|+|||+++.......  .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCccccc
Confidence            9999999997643  4789999999999999999999999999999999999987654  99999999875432221  1


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+......... +   .. .+..+.....+..+.+
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~---~~-~~~~~~~~~~~~~~~~  234 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-V---ER-GYRMPCPQGCPESLHE  234 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H---Hc-CCCCCCCcccCHHHHH
Confidence            22345678999999887776655 999999999999999 8999987655433222 1   11 2222334457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017860          257 LISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++.+||..+|.+||+++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.1e-42  Score=309.97  Aligned_cols=245  Identities=24%  Similarity=0.381  Sum_probs=199.7

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEE-eCCEEEEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVM   98 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~   98 (365)
                      .+.++|++.+.||+|+||.||++...  |..||+|.+.... ..+.+.+|+.+++.++|+|++++++++. .....++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            44568999999999999999999764  7889999886533 3467889999999999999999999754 556789999


Q ss_pred             eecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           99 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ||+++++|.+++.+.+  .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++.....  
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~--  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc--
Confidence            9999999999987644  3789999999999999999999999999999999999987664  999999998753322  


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....++..|+|||++.+..++.+ +|||||||++|+|++ |+.||....... ....+.   . .........+++.+.
T Consensus       156 ~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~-~~~~~~---~-~~~~~~~~~~~~~~~  229 (256)
T cd05082         156 QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPRVE---K-GYKMDAPDGCPPVVY  229 (256)
T ss_pred             CCCCccceeecCHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHh---c-CCCCCCCCCCCHHHH
Confidence            233345678999999987777655 999999999999997 999997654322 222221   1 122223345789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||..+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.7e-42  Score=313.00  Aligned_cols=248  Identities=20%  Similarity=0.314  Sum_probs=197.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCc----EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ..++|++++.||+|+||+||++.+..++.    .+++|.+.....  ....+..|+..++.++||||+++++++. ....
T Consensus         5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            34689999999999999999999987776    467777653221  2246777888999999999999999875 4457


Q ss_pred             EEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++++||+.+|+|.+++.. .+.+++..++.++.||+.||+|||++|++||||||+||+++.++  .+||+|||+++....
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~--~~kl~Dfg~~~~~~~  161 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS--IVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEEcCCccceeccC
Confidence            889999999999999976 45689999999999999999999999999999999999998665  499999999875432


Q ss_pred             CCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 HSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ...   .....++..|+|||.+.+..++.+ +|||||||++|||++ |..||.+.... ...+.+.    .....+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~-~~~~~~~----~~~~~~~~~~  235 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPH-EVPDLLE----KGERLAQPQI  235 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHHH----CCCcCCCCCC
Confidence            221   223456778999999987777666 999999999999998 99999775432 2222222    1122233334


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+.++.+++.+||..+|.+|||+.++++
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            6778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4e-42  Score=314.16  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=200.0

Q ss_pred             CCcceecccccCCCeEEEEEEE----ccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRD----KVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTP--THL   94 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~----~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~   94 (365)
                      .-|++++.||+|+||.||+++.    +.++..||+|.+....  .....+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3579999999999999999984    4578899999986432  2335788999999999999999999998875  578


Q ss_pred             EEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~  161 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCcccccccc
Confidence            99999999999999987653 5899999999999999999999999999999999999986654  99999999875443


Q ss_pred             CCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC-----------hHHHHHHHHHHh
Q 017860          174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKTIQRIL  238 (365)
Q Consensus       174 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----------~~~~~~~~~~~~  238 (365)
                      ...    .....++..|+|||++.+..++.+ +|||||||++|+|+++..|+.....           .......... .
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  239 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-L  239 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-H
Confidence            322    123456778999999987777665 9999999999999998766533211           0001111111 1


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          239 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       239 ~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ......+.+..++..+.+|+.+||+.+|.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         240 EEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             HcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            1222334445588999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.8e-42  Score=348.59  Aligned_cols=146  Identities=31%  Similarity=0.462  Sum_probs=133.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|+++++||+|+||+||+|.+..+++.||||++......    ...+.+|+.+++.++||||+++++++.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            35899999999999999999999999999999999764322    25678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      |||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g--~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG--HIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC--CEEEEeCCCCc
Confidence            99999999999998888899999999999999999999999999999999999997655  59999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.8e-42  Score=315.53  Aligned_cols=253  Identities=25%  Similarity=0.390  Sum_probs=200.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc----------------CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcce
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV----------------TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVR   83 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~   83 (365)
                      .++|++.++||+|+||.||++.+..                ++..||+|.+.....  ....+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4689999999999999999986542                345799999875432  2356889999999999999999


Q ss_pred             eceEEEeCCEEEEEEeecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           84 FKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        84 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      +++++......++||||+.+++|.+++....           .+++..+..++.|++.||+|||++|++||||||+||++
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili  163 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV  163 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence            9999999999999999999999999987542           36678899999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh--CCCCCCCCCCh
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV--GGYPFEDPDEP  227 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~--g~~pf~~~~~~  227 (365)
                      +.++  .++|+|||+++.......   .....+++.|+|||+..+..++.+ +|||||||++|||++  |..||...+..
T Consensus       164 ~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         164 GKNY--TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             cCCC--CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            7655  499999999875432221   122334678999999877777655 999999999999998  77899766554


Q ss_pred             HHHHHHHHHHhc--cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          228 KDFRKTIQRILS--VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       228 ~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ............  .....+.....++.+.+|+.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            333222111111  11123344457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-42  Score=315.68  Aligned_cols=248  Identities=26%  Similarity=0.388  Sum_probs=202.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCcc-cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..+|.+.+.||+|+||.||++.+.     .++..+++|.+...... ...+.+|+.+++.++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            346999999999999999999864     34567899988654322 356889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           96 IVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      +||||+++++|.+++...+                .+++..++.++.||+.||+|||++|++||||||+||+++.++  .
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~--~  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL--L  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC--c
Confidence            9999999999999986542                378999999999999999999999999999999999998665  4


Q ss_pred             EEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 017860          160 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~  235 (365)
                      +||+|||++.......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.........    .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~----~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVI----E  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH----H
Confidence            9999999987543322   1233456889999999987777666 999999999999998 99999776553322    2


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+..... .......+..+.+++.+||+.+|.+|||+.++++
T Consensus       237 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         237 CITQGRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHhCCCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            2222221 1223346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-42  Score=319.50  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=200.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-------CCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEeC
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   91 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~   91 (365)
                      .++|.+.+.||+|+||.||++++..       +...+|+|.+.....  ....+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4689999999999999999998743       235799999875422  224677899999999 799999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 017860           92 THLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS  155 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~  155 (365)
                      ..+|+||||+.+|+|.+++...+                .+++.++..++.|++.||+|||++|++||||||+||+++.+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~  176 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  176 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence            99999999999999999997542                37889999999999999999999999999999999999866


Q ss_pred             CCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHH
Q 017860          156 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR  231 (365)
Q Consensus       156 ~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  231 (365)
                      +  .+||+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..... ..+.
T Consensus       177 ~--~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~  252 (307)
T cd05098         177 N--VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELF  252 (307)
T ss_pred             C--cEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHH
Confidence            5  499999999875432211   112234578999999987777655 999999999999998 8889976443 3333


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+.    .....+.+...+.++.+|+.+||..+|.+|||+.+++++
T Consensus       253 ~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         253 KLLK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHH----cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            3222    122223344578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.4e-43  Score=353.01  Aligned_cols=251  Identities=31%  Similarity=0.481  Sum_probs=200.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCcceeceEEEe----------
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILT----------   90 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----------   90 (365)
                      .+|+.++.||+||||.||+|+++-+|..||||++...  ......+.+|++.+.+|+|||||+++..|.+          
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei  558 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI  558 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence            3578899999999999999999999999999999765  3444678899999999999999999876641          


Q ss_pred             --------------------------------------------------------------------------------
Q 017860           91 --------------------------------------------------------------------------------   90 (365)
Q Consensus        91 --------------------------------------------------------------------------------   90 (365)
                                                                                                      
T Consensus       559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~  638 (1351)
T KOG1035|consen  559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG  638 (1351)
T ss_pred             cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             ---------------------C--------CEEEEEEeecCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCC
Q 017860           91 ---------------------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQV  140 (365)
Q Consensus        91 ---------------------~--------~~~~lv~e~~~~g~L~~~l~~~~~l-~~~~~~~i~~qil~al~~LH~~~i  140 (365)
                                           +        ..+||-||||+..+|.+++.++... ....+|.++++|++||+|+|++||
T Consensus       639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi  718 (1351)
T KOG1035|consen  639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI  718 (1351)
T ss_pred             ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence                                 0        2478999999988888887776654 478899999999999999999999


Q ss_pred             eecCCCCCcEEecCCCCCCEEEecCCCccccc-------------------CCCCCCCCcCCCCCCCchhhcccc---cC
Q 017860          141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLRHE---YD  198 (365)
Q Consensus       141 vHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~  198 (365)
                      |||||||.|||++.++.  |||+|||+|+...                   .....++.+||..|+|||++.+..   |+
T Consensus       719 IHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  719 IHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             eeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999996665  9999999987411                   112345678999999999997654   77


Q ss_pred             CccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017860          199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIM  276 (365)
Q Consensus       199 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~l~~dp~~R~t~~ell  276 (365)
                      .| +|+||||+|++||+   .||...-..   ..++..+..+....+.  ..+--+.-..+|..||+.||.+||||.|+|
T Consensus       797 ~K-iDmYSLGIVlFEM~---yPF~TsMER---a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL  869 (1351)
T KOG1035|consen  797 SK-IDMYSLGIVLFEML---YPFGTSMER---ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELL  869 (1351)
T ss_pred             ch-hhhHHHHHHHHHHh---ccCCchHHH---HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHh
Confidence            66 99999999999999   467643222   2334444444444330  111234567899999999999999999999


Q ss_pred             cCcccc
Q 017860          277 KHQWFL  282 (365)
Q Consensus       277 ~h~~f~  282 (365)
                      ++.||.
T Consensus       870 ~s~llp  875 (1351)
T KOG1035|consen  870 NSELLP  875 (1351)
T ss_pred             hccCCC
Confidence            999985

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-42  Score=324.28  Aligned_cols=253  Identities=22%  Similarity=0.386  Sum_probs=200.3

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEE-----ccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEe
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   90 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~   90 (365)
                      ....++|++.+.||+|+||+||+|.+     ..+++.||+|.+.....  ....+.+|+.++..+ +||||+++++++..
T Consensus         3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            34567999999999999999999985     34678999999975432  224677899999999 68999999998765


Q ss_pred             C-CEEEEEEeecCCCChHHHHHhc--------------------------------------------------------
Q 017860           91 P-THLAIVMEYASGGELFERICNA--------------------------------------------------------  113 (365)
Q Consensus        91 ~-~~~~lv~e~~~~g~L~~~l~~~--------------------------------------------------------  113 (365)
                      . ..+++||||+++|+|.+++...                                                        
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            4 5689999999999999988642                                                        


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---CCC
Q 017860          114 -----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKS  179 (365)
Q Consensus       114 -----------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---~~~  179 (365)
                                 ..++...+..++.|++.||+|||++|++||||||+||+++.++  .+||+|||++........   ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC--cEEEEecccccccccCcchhhcCC
Confidence                       1367788889999999999999999999999999999998665  499999999875422211   122


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..+++.|+|||++.+..++.+ +|||||||++|+|++ |..||........+...+..    ....+.+...++++.+++
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  315 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTM  315 (343)
T ss_pred             CCCCcceECcHHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc----cCCCCCCCCCCHHHHHHH
Confidence            345678999999987777666 999999999999997 99999875543333332221    112222334678999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 017860          259 SRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+||+.+|.+|||+.++++|
T Consensus       316 ~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         316 LDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHccCChhhCcCHHHHHHH
Confidence            99999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.6e-42  Score=314.67  Aligned_cols=246  Identities=24%  Similarity=0.372  Sum_probs=199.6

Q ss_pred             CcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      +|++.+.||+|+||.||++.+..     ....+|+|.+.....  ....+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            48899999999999999998753     335789998865432  22468889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           97 VMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      ++||+.+++|.+++...                        ..+++..++.++.|++.||.|||++|++||||||+|||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            99999999999987642                        247889999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChH
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK  228 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  228 (365)
                      ++++.  +||+|||+++.......   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.... 
T Consensus       161 ~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         161 AEGRK--MKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             cCCCc--EEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            86654  99999999875322221   222345678999999877777655 999999999999998 99999765543 


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+.+..    ......+....++.++.+|+.+||+.+|.+||++.++++
T Consensus       237 ~~~~~~----~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         237 RLFNLL----KTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHH----hCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            222222    222333444567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.7e-42  Score=310.91  Aligned_cols=249  Identities=29%  Similarity=0.472  Sum_probs=203.2

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC------cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ||.+.+.||+|+||.||++++..++..+++|.++...      .....+.+|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            6999999999999999999998877777777765321      1223466789999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.+   .+||+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMG  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCC
Confidence            999999999988753    3568999999999999999999999999999999999999743   499999998875432


Q ss_pred             CC-CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          174 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .. ......|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.........    ..+..... ......++.
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~  231 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVV----LRIVEGPT-PSLPETYSR  231 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCC-CCCcchhcH
Confidence            22 2234568899999999877777666 99999999999999999999765443222    22222211 112235788


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ++.++|.+||..+|.+||++.++++||||
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         232 QLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.7e-42  Score=312.63  Aligned_cols=250  Identities=22%  Similarity=0.390  Sum_probs=206.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .++|++++.||+|+||.||+++.+.     +.+.|++|.+.....  ....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            4689999999999999999999764     346899998865432  235788999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           95 AIVMEYASGGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~---------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                      ++||||+++++|.+++....         .+++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEccc
Confidence            99999999999999997655         6899999999999999999999999999999999999987654  999999


Q ss_pred             CCcccccCCC--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          166 GYSKSSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       166 gla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                      |++.......  ......+++.|+|||.+.+..+..+ +||||||+++|+|++ |..||.......    ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~----~~~~~~~~~~  236 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEE----VLNRLQAGKL  236 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHH----HHHHHHcCCc
Confidence            9876432221  2233456778999999877766555 999999999999998 888997654432    2333333333


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .++....++..+.+++.+||+.+|.+|||+.+++.+
T Consensus       237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            444455688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-42  Score=311.98  Aligned_cols=241  Identities=25%  Similarity=0.358  Sum_probs=194.0

Q ss_pred             cccccCCCeEEEEEEEccCCc--EEEEEEeecCC--cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKVTKE--LVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|+||.||+++++.++.  .+|+|.+....  .....+.+|+.+++.+ +||||+++++++.....+++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            468999999999999987776  46888876422  2335688899999999 799999999999999999999999999


Q ss_pred             CChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860          104 GELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus       104 g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      ++|.+++....                .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl  158 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGL  158 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCC
Confidence            99999987543                4789999999999999999999999999999999999986654  99999999


Q ss_pred             cccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       168 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      +..............++.|+|||++....++.+ +|||||||++|+|++ |..||...+....+..    +. .....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~  232 (270)
T cd05047         159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----LP-QGYRLEK  232 (270)
T ss_pred             ccccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----Hh-CCCCCCC
Confidence            864322222222234567999999977776655 999999999999997 9999977554332222    21 1222233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ....+.++.+++.+||..+|.+|||+.+++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            3457889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.8e-42  Score=307.51  Aligned_cols=247  Identities=25%  Similarity=0.419  Sum_probs=203.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .+|++.+.||+|+||.||++.+. ++..+|+|.+.........+.+|+.+++.++||||+++++++......++||||+.
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            47999999999999999999886 57789999987765556789999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--CCC
Q 017860          103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKS  179 (365)
Q Consensus       103 ~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--~~~  179 (365)
                      +++|.+++... +.+++..++.++.|++.||+|||+.|++||||||+||+++.++  .+||+|||+++.......  ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~--~~~l~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDFGMTRFVLDDQYTSSTG  160 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC--eEEECCCcceeecccCcccccCC
Confidence            99999998764 4689999999999999999999999999999999999997655  499999999875432211  122


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..++..|+|||.+.+..++.+ +||||||+++|+|++ |+.||........    ...+... .........+..+.+|+
T Consensus       161 ~~~~~~~~aPe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~l~  234 (256)
T cd05112         161 TKFPVKWSSPEVFSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYENRSNSEV----VETINAG-FRLYKPRLASQSVYELM  234 (256)
T ss_pred             CccchhhcCHhHhccCCcChH-HHHHHHHHHHHHHHcCCCCCCCcCCHHHH----HHHHhCC-CCCCCCCCCCHHHHHHH
Confidence            335678999999987777655 999999999999998 9999976554322    2222211 12222334689999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 017860          259 SRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+||+.+|.+|||+.+++++
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHcccChhhCCCHHHHHHh
Confidence            99999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.9e-42  Score=307.77  Aligned_cols=247  Identities=23%  Similarity=0.377  Sum_probs=202.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..++|++.++||+|+||.||++.+. .+..+|+|.+.........+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            3568999999999999999999865 55679999887655445678899999999999999999999887 778999999


Q ss_pred             cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--
Q 017860          101 ASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--  176 (365)
                      +++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++  .+||+|||++........  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC--cEEECCCcceeeccCCCccc
Confidence            9999999999763  3578899999999999999999999999999999999997655  499999998875432221  


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....++..|+|||++....++.+ +|+|||||++|++++ |..||...+...... .+    ...+..+.....+.++.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~  233 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIR-AL----ERGYRMPRPENCPEELY  233 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHH-HH----hCCCCCCCcccCCHHHH
Confidence            122345677999999987766655 999999999999998 999998765433222 11    12233344456789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||..+|++||++.++++
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHH
Confidence            9999999999999999998874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=4e-42  Score=311.81  Aligned_cols=246  Identities=21%  Similarity=0.328  Sum_probs=195.0

Q ss_pred             cceecccccCCCeEEEEEEEccCCc--EEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC------CE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKE--LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------TH   93 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~--~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~   93 (365)
                      |.+.+.||+|+||.||++++..++.  .+|+|.++...   ...+.+.+|+.+++.++||||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4577899999999999999877765  68999886542   2235678899999999999999999976432      24


Q ss_pred             EEEEEeecCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           94 LAIVMEYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~------~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      .+++|||+.+|+|..++..      ...+++..+..++.|++.||+|||++||+||||||+|||++.++.  +||+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCc
Confidence            7899999999999888742      234789999999999999999999999999999999999976654  99999999


Q ss_pred             cccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccC
Q 017860          168 SKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS  243 (365)
Q Consensus       168 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  243 (365)
                      ++.......   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |+.||....... ..+   .+.... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~-~~~---~~~~~~-~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSE-IYD---YLRQGN-R  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHH---HHHcCC-C
Confidence            876433221   122346778999999987777666 999999999999999 889997754432 222   222221 2


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       244 ~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+....++..+.+++.+||+.+|.+|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         233 LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            23334578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.8e-42  Score=310.75  Aligned_cols=248  Identities=23%  Similarity=0.375  Sum_probs=202.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCc---EEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..+|++.+.||+|+||.||++.++.++.   .+|+|.+....  ...+.+.+|+.+++.++||||+++++++......|+
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            3589999999999999999999875543   79999886532  223578889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||+++++|.+++.+. +.+++.++..++.|++.||+|||++|++||||||+||+++.++  .++|+|||++.......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~--~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL--VCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC--eEEeCCCCccccccccc
Confidence            99999999999999764 4689999999999999999999999999999999999997655  49999999987543322


Q ss_pred             CC----CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          176 QP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       176 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ..    ....++..|+|||.+.+..++.+ +|+|||||++|++++ |..||..........    .+... ...+....+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~  234 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIK----AIEEG-YRLPAPMDC  234 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHH----HHhCC-CcCCCCCCC
Confidence            11    11223568999999987777666 999999999999886 999998765433222    22221 233444557


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++.+.+++.+||+.+|.+||++.++++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=337.00  Aligned_cols=258  Identities=26%  Similarity=0.451  Sum_probs=225.6

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEe-----CCE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTH   93 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~-----~~~   93 (365)
                      .+.+.|++.+.||.|.+|.||+++++.+++..|+|+.......+++++.|..+++.. .|||++.++++|..     .+.
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            345689999999999999999999999999999999998888889999999999888 59999999999874     468


Q ss_pred             EEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           94 LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ++||||||.|||..+++++  ..++.|..+..|++.++.||.+||.+.++|||||-.|||++.++.  |||+|||++...
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQl  173 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL  173 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeee
Confidence            9999999999999999876  456899999999999999999999999999999999999987765  999999998754


Q ss_pred             c-CCCCCCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 017860          172 V-LHSQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       172 ~-~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  245 (365)
                      . +.....+.+|||.|||||++..     ..|+.. +|+||||++..||.-|.+|+-.......   .++...++++...
T Consensus       174 dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmra---LF~IpRNPPPkLk  249 (953)
T KOG0587|consen  174 DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPRNPPPKLK  249 (953)
T ss_pred             ecccccccCcCCCcccccceeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhh---hccCCCCCCcccc
Confidence            3 3455678899999999999954     345666 8999999999999999999988766433   3333344455566


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+..+|.++.+||..||.+|-.+||+..++|+|||+.+
T Consensus       250 rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e  287 (953)
T KOG0587|consen  250 RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE  287 (953)
T ss_pred             chhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence            67789999999999999999999999999999999873

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.1e-42  Score=310.83  Aligned_cols=247  Identities=23%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCc---EEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .+|++.+.||+|+||.||+|.++.+++   .||+|.+....  .....+.+|+.+++.++||||+++++++.....+++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            469999999999999999999987665   69999987532  2345788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      |||+.+++|.+++.. .+.+++.+++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||++........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCcc
Confidence            999999999999876 35689999999999999999999999999999999999997655  499999998864432221


Q ss_pred             C---CCCc---CCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          177 P---KSTV---GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       177 ~---~~~~---gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      .   ....   .+..|+|||.+.+..++.+ +|||||||++||+++ |..||......... +   .+. .....+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~-~---~i~-~~~~~~~~~~  235 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI-N---AIE-QDYRLPPPMD  235 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHH-H---HHH-cCCcCCCccc
Confidence            1   1111   2357999999988777666 999999999999886 99999876543222 2   221 2233444455


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+..+.+++.+||..+|.+||++.+++.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            7889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.4e-42  Score=312.21  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=198.4

Q ss_pred             CCcceecccccCCCeEEEEEE----EccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLA   95 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~   95 (365)
                      .+|++++.||+|+||.||++.    +..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            479999999999999999997    445788999999875432 23568899999999999999999998754  34689


Q ss_pred             EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+++++|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~  161 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccCC
Confidence            999999999999999764 46899999999999999999999999999999999999976654  999999998854332


Q ss_pred             CCC----CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH-----------HHHHHHHHHhc
Q 017860          175 SQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRKTIQRILS  239 (365)
Q Consensus       175 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----------~~~~~~~~~~~  239 (365)
                      ...    ....++..|+|||++.+..++.+ +|||||||++|||++|..|+.......           .....+.....
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            221    11223456999999987777655 999999999999999877764332110           00011111222


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .....+....++.++.+|+.+||..+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         241 NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            22333445567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.5e-42  Score=328.26  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=204.3

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCC-CCCcceeceEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLR-HPNIVRFKEVIL   89 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~   89 (365)
                      +-...++|.+.++||+|+||.||+|++.     .+++.||+|++.....  ....+.+|+.++..+. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3444567899999999999999999864     3557899999975432  2246788999999997 999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhcC-------------------------------------------------------
Q 017860           90 TPTHLAIVMEYASGGELFERICNAG-------------------------------------------------------  114 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------------------------  114 (365)
                      .+...++||||+.+|+|.+++.+.+                                                       
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            9999999999999999999886532                                                       


Q ss_pred             -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 017860          115 -------------------------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL  151 (365)
Q Consensus       115 -------------------------------------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIl  151 (365)
                                                                 .++...++.++.||+.||+|||+++++||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                       2566778899999999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCCh
Q 017860          152 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP  227 (365)
Q Consensus       152 i~~~~~~~vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  227 (365)
                      ++.++  .+||+|||+++......   ......+++.|+|||.+.+..+..+ +|||||||++|||++ |..||......
T Consensus       272 l~~~~--~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         272 ICEGK--LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EeCCC--EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            98655  49999999987543221   1233457889999999987777655 999999999999998 88999775544


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ....+.+.    .....+.+..++.++.+|+.+||..+|.+||++.+++..
T Consensus       349 ~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIK----RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHH----cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            43332222    222233344578999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.1e-42  Score=317.10  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=200.7

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEcc-------CCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI   88 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~   88 (365)
                      ....++|.+.++||+|+||.||++++..       ....+|+|.+.....  ....+.+|+.+++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            3445789999999999999999998642       345799998875322  224677899999999 699999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           89 LTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        89 ~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      .....+|+||||+.+|+|.+++...                ..+++.++..++.|++.||.|||++|++||||||+||++
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill  167 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV  167 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence            9999999999999999999998653                247889999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChH
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK  228 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  228 (365)
                      +.++  .+||+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.......
T Consensus       168 ~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         168 TEDN--VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             cCCC--cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            8665  499999999875432211   122234567999999987777666 999999999999999 889997655432


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                       +.+.+.   .. ........++.++.+++.+||..+|.+|||+.++++
T Consensus       245 -~~~~~~---~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         245 -LFKLLR---EG-HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             -HHHHHH---cC-CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             222222   11 112223456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.8e-42  Score=309.70  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCc---EEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ++|+..+.||+|+||.||+|+++.+++   .+|+|.+....  .....+.+|+.+++.++||||+++.+++......++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            479999999999999999999876654   79999886542  2235688899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      |||+++++|..++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++  .+||+|||++........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~--~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          85 TEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL--ECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC--cEEECCCccceecccccc
Confidence            9999999999998764 5689999999999999999999999999999999999998655  499999999875432221


Q ss_pred             CC----CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          177 PK----STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       177 ~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ..    ....++.|+|||++.+..++.+ +|||||||++|+|++ |+.||...+.... .+.+.   . ....+.....+
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~-~~~i~---~-~~~~~~~~~~~  236 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEV-MKAIN---D-GFRLPAPMDCP  236 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHH-HHHHh---c-CCCCCCCCCCC
Confidence            11    1123457999999987777666 999999999999997 9999977654332 22222   1 22334445578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       237 ~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         237 SAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1e-41  Score=306.51  Aligned_cols=241  Identities=27%  Similarity=0.410  Sum_probs=198.2

Q ss_pred             cccccCCCeEEEEEEEcc-CCc--EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDKV-TKE--LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      +.||+|++|.||++.+.. +++  .||+|.+.....  ..+.+.+|+.++++++||||+++++.+.. ..+++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 333  689999876543  34678899999999999999999999988 889999999999


Q ss_pred             CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC----C
Q 017860          104 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P  177 (365)
Q Consensus       104 g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~----~  177 (365)
                      ++|.+.+.+..  .+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++.......    .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~--~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD--KVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC--EEEeccccccccccccccceecc
Confidence            99999997754  689999999999999999999999999999999999998765  499999999876533221    1


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||...+....... +   .......+.....+..+.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~  232 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKK-I---DKEGERLERPEACPQDIYN  232 (257)
T ss_pred             cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H---HhcCCcCCCCccCCHHHHH
Confidence            23456788999999987777666 999999999999998 9999976655432222 2   2122233334457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017860          257 LISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++.+||+.+|++|||+.+++.
T Consensus       233 li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         233 VMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHCCCCcccCCCHHHHHH
Confidence            999999999999999999985

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-42  Score=313.93  Aligned_cols=244  Identities=32%  Similarity=0.498  Sum_probs=194.4

Q ss_pred             ceecccccCCCeEEEEEEEc----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           26 DFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        26 ~~~~~LG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .+.+.||.|+||.||+|...    ..+..|+||.+.....  ..+.+.+|+..++.++||||+++++++.....+++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            35789999999999999988    4567899999955332  24678999999999999999999999998888999999


Q ss_pred             ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--
Q 017860          100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  175 (365)
Q Consensus       100 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--  175 (365)
                      |+++|+|.+++...  ..+++..+..++.||+.||+|||+++++|++|+++||+++.++.  +||+|||++.......  
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccc
Confidence            99999999999886  67999999999999999999999999999999999999987664  9999999987552211  


Q ss_pred             -CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                       ......+...|+|||.+.+..++.+ +||||||+++||+++ |+.||....... +   ...+... ...+....++..
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~k-sDVysfG~~l~ei~~~~~~p~~~~~~~~-~---~~~~~~~-~~~~~~~~~~~~  233 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKK-SDVYSFGMLLYEILTLGKFPFSDYDNEE-I---IEKLKQG-QRLPIPDNCPKD  233 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHH-HHHHHHHHHHHHHHTTSSGTTTTSCHHH-H---HHHHHTT-EETTSBTTSBHH
T ss_pred             cccccccccccccccccccccccccc-cccccccccccccccccccccccccccc-c---ccccccc-ccceeccchhHH
Confidence             1233456778999999988777656 999999999999999 789998775433 2   2222122 223334457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017860          254 CRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+++.+||..+|.+|||+.++++
T Consensus       234 ~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  234 IYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHh
Confidence            999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.2e-42  Score=306.68  Aligned_cols=229  Identities=23%  Similarity=0.338  Sum_probs=190.0

Q ss_pred             CCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCChHHHHHhc
Q 017860           34 GNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA  113 (365)
Q Consensus        34 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  113 (365)
                      |.||.||+++++.+++.||+|.+....    ...+|...+....||||+++++++.....+++||||+++|+|.+++.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            899999999999999999999997643    2334455555567999999999999999999999999999999999887


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhc
Q 017860          114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL  193 (365)
Q Consensus       114 ~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~  193 (365)
                      .++++..+..++.|++.||+|||++|++||||||+||+++.++.  ++|+|||.+.....  ......++..|+|||.+.
T Consensus        80 ~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~--~~~~~~~~~~y~aPE~~~  155 (237)
T cd05576          80 LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVED--SCDGEAVENMYCAPEVGG  155 (237)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhcccc--ccccCCcCccccCCcccC
Confidence            78999999999999999999999999999999999999987654  99999998754322  223445678899999987


Q ss_pred             ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCH-
Q 017860          194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI-  272 (365)
Q Consensus       194 ~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~-  272 (365)
                      +..++.+ +|+||+||++|+|++|+.||......      ..  .......|  ..+++.+++||.+||+.||.+||++ 
T Consensus       156 ~~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~------~~--~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         156 ISEETEA-CDWWSLGAILFELLTGKTLVECHPSG------IN--THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCCCCch-hhHHHHHHHHHHHHHCcchhhcCchh------cc--cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            7777665 89999999999999999888643211      00  00111222  3478999999999999999999985 


Q ss_pred             ----HHHhcCccc
Q 017860          273 ----PEIMKHQWF  281 (365)
Q Consensus       273 ----~ell~h~~f  281 (365)
                          +++++||||
T Consensus       225 ~~~~~~~~~h~~~  237 (237)
T cd05576         225 VAGVEDIKSHPFF  237 (237)
T ss_pred             ccchHHHHcCCCC
Confidence                999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.2e-41  Score=305.58  Aligned_cols=245  Identities=28%  Similarity=0.402  Sum_probs=202.5

Q ss_pred             cceecccccCCCeEEEEEEEccCC----cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      +++.+.||.|+||.||++++...+    ..||+|.+.....  ....+.+|+..++.++||||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            467899999999999999998766    8999999876543  3467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           99 EYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ||+++++|.+++.....  +++..+..++.|++.||++||+.|++||||||+||+++.++  .++|+|||+++.......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~--~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--VVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC--eEEEcccCCceecccccc
Confidence            99999999999976554  99999999999999999999999999999999999998765  499999999875543322


Q ss_pred             CC--CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          177 PK--STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       177 ~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      ..  ...+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||...+.......    +.... ..+.....+.+
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~-~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~  232 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKGY-RLPKPENCPPE  232 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcc-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcCC-CCCCCCcCCHH
Confidence            22  1236789999999976666655 999999999999998 7889877544332222    22221 22333447899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017860          254 CRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+++.+||..+|.+|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHh
Confidence            999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6.9e-42  Score=315.66  Aligned_cols=251  Identities=22%  Similarity=0.350  Sum_probs=202.1

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEc-------cCCcEEEEEEeecCC--cccHHHHHHHHHHhcC-CCCCcceeceEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL   89 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~   89 (365)
                      ...++|++.+.||+|+||.||++++.       ..+..||+|.+....  .....+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44678999999999999999999753       234579999886532  2235688999999999 8999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 017860           90 TPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD  153 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~  153 (365)
                      .....|+||||+.+++|.+++.+.                ..++...+..++.||+.||.|||++|++||||||+||+++
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~  171 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT  171 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence            999999999999999999998753                2467888999999999999999999999999999999998


Q ss_pred             CCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHH
Q 017860          154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD  229 (365)
Q Consensus       154 ~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  229 (365)
                      .++  .+||+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||...+... 
T Consensus       172 ~~~--~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-  247 (304)
T cd05101         172 ENN--VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE-  247 (304)
T ss_pred             CCC--cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence            665  499999999875432221   222345678999999988777766 999999999999998 788987654322 


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+.+.   . ..........+..+.+|+.+||..+|.+|||+.++++.
T Consensus       248 ~~~~~~---~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         248 LFKLLK---E-GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHH---c-CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            222221   1 12222334578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-41  Score=308.48  Aligned_cols=243  Identities=21%  Similarity=0.344  Sum_probs=188.5

Q ss_pred             cccccCCCeEEEEEEEcc--CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDKV--TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +.||+|+||.||++....  ....+|+|.+.....  ....+.+|+..++.++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            469999999999996532  345788887754322  2245788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---
Q 017860          105 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---  176 (365)
Q Consensus       105 ~L~~~l~~~~-----~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---  176 (365)
                      +|.+++....     .+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||++........   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheec
Confidence            9999987643     2467888999999999999999999999999999999987664  99999999865332211   


Q ss_pred             CCCCcCCCCCCCchhhccc------ccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCC---C
Q 017860          177 PKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVP---D  246 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~  246 (365)
                      .....+++.|+|||++...      ...++++|||||||++|+|++ |..||..........+.+..   .....+   .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE---QDIKLPKPQL  235 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc---cCccCCCCcc
Confidence            2233467789999997532      223445999999999999999 78899776554433333322   111221   2


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...+++.+.+++..|+ .||.+|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         236 DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            2357888999999998 59999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1e-41  Score=311.91  Aligned_cols=248  Identities=24%  Similarity=0.392  Sum_probs=201.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .++|++.+.||+|+||.||+|.+..     ++..||+|.+.....  ....+.+|+.+++.++||||+++++++.....+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            4689999999999999999999753     678999999875432  235688899999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           95 AIVMEYASGGELFERICNAG----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~----------------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      ++||||+.+++|.+++....                      .+++..++.++.|++.||.|||++|++||||||+||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~  163 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV  163 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence            99999999999999986432                      36788899999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChH
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK  228 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  228 (365)
                      +.++.  +||+|||++........   .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+.....
T Consensus       164 ~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         164 GENMV--VKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             cCCCc--eEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            76654  99999999874332221   122345677999999988777766 999999999999997 888997655433


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..    ..+..... .+.....+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       241 ~~----~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         241 VI----YYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HH----HHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            22    22222221 2223457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.8e-41  Score=307.37  Aligned_cols=243  Identities=24%  Similarity=0.335  Sum_probs=189.1

Q ss_pred             cccccCCCeEEEEEEEc--cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +.||+|+||.||++...  .++..+|+|.+.....  ....+.+|+.+++.++||||+++++++.+...+++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999864  3556899998865432  2246788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC---
Q 017860          105 ELFERICNAG-----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---  176 (365)
Q Consensus       105 ~L~~~l~~~~-----~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~---  176 (365)
                      +|.+++....     .+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++.......   
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~--~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL--TVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC--cEEECCccccccccCcceeec
Confidence            9999986532     356778889999999999999999999999999999998655  499999999864332211   


Q ss_pred             CCCCcCCCCCCCchhhcccc------cCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCC---
Q 017860          177 PKSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD---  246 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  246 (365)
                      .....+++.|+|||++.+..      ..+.++|||||||++|+|++ |..||..............   ......+.   
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVR---EQQLKLPKPRL  235 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhh---cccCCCCCCcc
Confidence            22345788899999986432      12344999999999999996 9999987655433222211   11122221   


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ....++.+.+++.+|+ .+|++|||+++++.
T Consensus       236 ~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         236 KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            1246788999999999 68999999999984

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=308.65  Aligned_cols=248  Identities=22%  Similarity=0.372  Sum_probs=201.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCc----EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ...+|++.+.||+|+||.||++.++.+|+    .+|+|.+.....  ....+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            35689999999999999999999876665    589998765432  23567889999999999999999999987 788


Q ss_pred             EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++||||+.+|+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++....
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~  161 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDV  161 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccC
Confidence            9999999999999998764 46899999999999999999999999999999999999976654  99999999876543


Q ss_pred             CCCCCC---CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 HSQPKS---TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ......   ..++..|+|||.+....++.+ +|+|||||++|++++ |+.||...... .+...+.   . ....+.+..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~-~~~~~~~---~-~~~~~~~~~  235 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAV-EIPDLLE---K-GERLPQPPI  235 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHH-HHHHHHh---C-CCCCCCCCC
Confidence            322211   223567999999877777666 999999999999998 99999876542 2222222   2 122333444


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+..+.+++.+||..+|.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            6789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.9e-41  Score=308.79  Aligned_cols=250  Identities=21%  Similarity=0.284  Sum_probs=202.5

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEcc----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEe-CC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT-PT   92 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~   92 (365)
                      ...++|++.+.||+|+||.||++.+..    ++..||+|.+.....  ....+.+|+.+++.++||||+++++++.. +.
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            356799999999999999999999875    368899998865322  23567889999999999999999998765 56


Q ss_pred             EEEEEEeecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 017860           93 HLAIVMEYASGGELFERICNA--------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD  164 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~--------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~D  164 (365)
                      ..+++++|+.+++|.+++...        ..+++..++.++.|++.||+|||+++++||||||+||+++.++  .+||+|
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~--~~kl~d  160 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL--QVKITD  160 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC--cEEECC
Confidence            789999999999999998653        3589999999999999999999999999999999999998665  499999


Q ss_pred             CCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 017860          165 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       165 fgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      ||+++.......   .....++..|+|||++.+..++.+ +|||||||++|++++ |+.||...+. ......+.    .
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~----~  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDP-FEMAAYLK----D  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHHHHH----c
Confidence            999875432211   123345778999999987777666 999999999999998 9999976543 22222222    2


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       241 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ....+.....++++.+++.+||..+|++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2233334456889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-41  Score=318.45  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=200.9

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccC-------CcEEEEEEeecCC--cccHHHHHHHHHHhcC-CCCCcceeceEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-------KELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL   89 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~   89 (365)
                      ....+|++.+.||+|+||.||+|++...       +..||+|.+....  .....+.+|+.+++.+ +||||+++++++.
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            3445899999999999999999986432       2368999886532  2235688999999999 7999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 017860           90 TPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD  153 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~  153 (365)
                      .....++++||+++|+|.+++.+..                .++...+..++.|++.||+|||++|++||||||+||+++
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~  168 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT  168 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence            9999999999999999999987532                367888999999999999999999999999999999998


Q ss_pred             CCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHH
Q 017860          154 GSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD  229 (365)
Q Consensus       154 ~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  229 (365)
                      .++.  +||+|||+++.......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||...+... 
T Consensus       169 ~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~-  244 (334)
T cd05100         169 EDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEE-  244 (334)
T ss_pred             CCCc--EEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHH-
Confidence            6654  99999999875432221   122234567999999988777766 999999999999998 889997755433 


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +...+   .. ....+.....+.++.+|+.+||..+|.+|||+.+++.+
T Consensus       245 ~~~~~---~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         245 LFKLL---KE-GHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HHHHH---Hc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            22222   11 12223334578899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.8e-41  Score=304.22  Aligned_cols=239  Identities=25%  Similarity=0.369  Sum_probs=190.8

Q ss_pred             ccccCCCeEEEEEEEc--cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCC
Q 017860           30 DIGSGNFGVARLMRDK--VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE  105 (365)
Q Consensus        30 ~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~  105 (365)
                      .||+|+||.||++.+.  ..+..||+|++.....  ..+.+.+|+.+++.++||||+++++++. ...+++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999765  3456799999865432  2356889999999999999999999885 457899999999999


Q ss_pred             hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC----CCCC
Q 017860          106 LFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST  180 (365)
Q Consensus       106 L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~----~~~~  180 (365)
                      |.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++........    ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence            9998875 456899999999999999999999999999999999999976654  99999999874332221    1112


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      .+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||........ ...+..   . ...+.+...++++.+++.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~---~-~~~~~~~~~~~~l~~li~  232 (257)
T cd05115         159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEV-MSFIEQ---G-KRLDCPAECPPEMYALMK  232 (257)
T ss_pred             CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHH-HHHHHC---C-CCCCCCCCCCHHHHHHHH
Confidence            23578999999887776655 999999999999996 9999987655332 222221   1 122233446899999999


Q ss_pred             HhcccCCCCCCCHHHHhc
Q 017860          260 RIFVADPAARITIPEIMK  277 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~  277 (365)
                      +||..+|++||++.++.+
T Consensus       233 ~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-42  Score=309.21  Aligned_cols=240  Identities=20%  Similarity=0.244  Sum_probs=191.5

Q ss_pred             cccccCCCeEEEEEEEccCCc-------EEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           29 RDIGSGNFGVARLMRDKVTKE-------LVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +.||+|+||.||++.++..+.       .+|+|.+.... ...+.+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999999865544       48888876543 2335678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC------CEEEecCCCcccccC
Q 017860          101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVL  173 (365)
Q Consensus       101 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~------~vkl~Dfgla~~~~~  173 (365)
                      +.+|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+||+++.++..      .++++|||++.....
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~  160 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP  160 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC
Confidence            99999999997654 58999999999999999999999999999999999999765532      379999998764432


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCC-CCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                         .....+++.|+|||++.+....+.++|||||||++|+|++|. .||...+.... ..    ........|  ...+.
T Consensus       161 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~----~~~~~~~~~--~~~~~  230 (258)
T cd05078         161 ---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQ----FYEDRHQLP--APKWT  230 (258)
T ss_pred             ---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HH----HHHccccCC--CCCcH
Confidence               234568889999999976543344499999999999999985 66655443221 11    111222223  23568


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ++.+|+.+||+.+|++|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            89999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=303.93  Aligned_cols=274  Identities=28%  Similarity=0.501  Sum_probs=221.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHh-cCCCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~-~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .-.+|++++.||+|+|++|.+++++++.+.||+|++++.-.    .......|-.+.. .-+||.+|.++.+|.++..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            34579999999999999999999999999999999976321    1123445554444 347999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-C
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~  174 (365)
                      +|.||++||+|.-.+++..+++|+.++.+...|..||+|||++|||.||||..|+|++..+  ++||+|+|+++.... +
T Consensus       328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg--hikltdygmcke~l~~g  405 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG--HIKLTDYGMCKEGLGPG  405 (593)
T ss_pred             EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC--ceeecccchhhcCCCCC
Confidence            9999999999998899999999999999999999999999999999999999999997665  599999999986443 4


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCC--CChHH--HHHHHHHHhccccCCCCCCCC
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP--DEPKD--FRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ....+.||||.|.|||++.+..|.-. +|+|+||++++||+.|+.||.-.  +++.+  -.-..+-++..+..+|..  +
T Consensus       406 d~tstfcgtpnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs--l  482 (593)
T KOG0695|consen  406 DTTSTFCGTPNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS--L  482 (593)
T ss_pred             cccccccCCCcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce--e
Confidence            55677899999999999998888665 89999999999999999999632  11111  011223344455555544  7


Q ss_pred             CHHHHHHHHHhcccCCCCCC------CHHHHhcCcccccCCCCCcchhhhcccCCC
Q 017860          251 SQECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKTMSSQYE  300 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~------t~~ell~h~~f~~~~~~~~~~~~~~~~~~~  300 (365)
                      |-.+..+++..|.+||.+|.      ...++..|+||+ ....+....+.+.++|.
T Consensus       483 svkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr-~idwd~leqk~v~ppf~  537 (593)
T KOG0695|consen  483 SVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFR-SIDWDLLEQKQVLPPFQ  537 (593)
T ss_pred             ehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhh-hCCHHHHhhcccCCCCC
Confidence            78888999999999999997      478999999998 45554444444444443

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.6e-42  Score=337.02  Aligned_cols=248  Identities=27%  Similarity=0.406  Sum_probs=211.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ..+-+..+.||+|+||+||+|+-..     ....||||.++....  ...+|++|+.++..++|||||+|++++...+.+
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            3456778999999999999998642     446899999976443  457899999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           95 AIVMEYASGGELFERICNAG--------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~--------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      |+|+|||..|+|..+|...+              .++..+...|+.||+.|+.||-++.+|||||-+.|+||+++-.  |
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--V  642 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--V  642 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--E
Confidence            99999999999999985322              2788999999999999999999999999999999999987765  9


Q ss_pred             EEecCCCcccccCCCCCCCC---cCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 017860          161 KICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       161 kl~Dfgla~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  236 (365)
                      ||+|||+++...........   .-...|||||.+..++++++ |||||+||++||+++ |+.||.+.++.+    .+..
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~E----VIe~  717 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQE----VIEC  717 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHH----HHHH
Confidence            99999999965544433322   23468999999999999988 999999999999998 999999988744    4444


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +..++. ++.+...+.++.+|+..||+.+|.+||++.|+-.
T Consensus       718 i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  718 IRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             HHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            555555 6667778999999999999999999999999854

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-41  Score=309.13  Aligned_cols=252  Identities=28%  Similarity=0.445  Sum_probs=203.6

Q ss_pred             CCcceecccccCCCeEEEEEEEc----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDK----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILT--PTHL   94 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~   94 (365)
                      ..|++.+.||+|+||.||+++..    .+++.||+|.+.....  ....+.+|+.+++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            47899999999999999999864    3588999999976554  35678999999999999999999999887  5679


Q ss_pred             EEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++  .++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~  161 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LVKISDFGLAKVLPE  161 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC--CEEEccccccccccc
Confidence            99999999999999997654 589999999999999999999999999999999999998665  499999999876542


Q ss_pred             CCCC----CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH----------HHHHHHHHHhc
Q 017860          174 HSQP----KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------DFRKTIQRILS  239 (365)
Q Consensus       174 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~----------~~~~~~~~~~~  239 (365)
                      ....    ....++..|+|||.+.+..++.+ +|||||||++|+|++|..||.......          ...........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            2111    12234567999999977776655 999999999999999999987543221          01122222223


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .....+.....+.++.+++.+||..+|.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            33334444556789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3e-41  Score=303.59  Aligned_cols=237  Identities=22%  Similarity=0.239  Sum_probs=192.3

Q ss_pred             cccccCCCeEEEEEEEccCC----------cEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           29 RDIGSGNFGVARLMRDKVTK----------ELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      +.||+|+||.||++.++.++          ..+++|.+.........+.+|+.+++.++||||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            46999999999999998776          358888876654446788899999999999999999999988 7789999


Q ss_pred             eecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-----CEEEecCCCccccc
Q 017860           99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV  172 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~-----~vkl~Dfgla~~~~  172 (365)
                      ||+.+|+|.+++.... .+++..+..++.||+.||+|||++|++||||||+||+++.++..     .+||+|||++....
T Consensus        80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~  159 (259)
T cd05037          80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL  159 (259)
T ss_pred             EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence            9999999999998765 78999999999999999999999999999999999999866522     59999999987543


Q ss_pred             CCCCCCCCcCCCCCCCchhhccc--ccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      .   .....++..|+|||++.+.  .++.+ +|||||||++|+|++ |..||...+... ......    .....+.  .
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~-~Di~slG~~~~~l~~~~~~p~~~~~~~~-~~~~~~----~~~~~~~--~  228 (259)
T cd05037         160 S---REERVERIPWIAPECIRNGQASLTIA-ADKWSFGTTLLEICSNGEEPLSTLSSSE-KERFYQ----DQHRLPM--P  228 (259)
T ss_pred             c---ccccccCCCccChhhhcCCCCCcchh-hHHHHHHHHHHHHHhCCCCCcccCCchh-HHHHHh----cCCCCCC--C
Confidence            3   2344577889999998766  45444 999999999999999 578887664322 111111    1111222  2


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+..+.+++.+||..+|.+|||+.++++
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            3478999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=301.60  Aligned_cols=240  Identities=27%  Similarity=0.373  Sum_probs=197.1

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ++||+|+||.||++.+.. ++.||+|.+.....  ....+.+|+.+++.++||||+++++++......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            479999999999999987 99999998876433  345788999999999999999999999999999999999999999


Q ss_pred             HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC---CCCcC
Q 017860          107 FERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG  182 (365)
Q Consensus       107 ~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~---~~~~g  182 (365)
                      .+++.. ...+++..+..++.+++.||+|||++|++||||||+||+++.++  .+||+|||++.........   ....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN--VLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC--cEEEeeccccccccCCcceeccccCcc
Confidence            999866 34689999999999999999999999999999999999997665  4999999998754321111   12234


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      +..|+|||.+.+..++.+ +|+|||||++|+|++ |..||......... ..+.    .....+.+...+.++.+++.+|
T Consensus       158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~li~~~  231 (251)
T cd05041         158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTR-ERIE----SGYRMPAPQLCPEEIYRLMLQC  231 (251)
T ss_pred             eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHH-HHHh----cCCCCCCCccCCHHHHHHHHHH
Confidence            567999999987777655 999999999999998 88999776543222 2221    1223333445789999999999


Q ss_pred             cccCCCCCCCHHHHhc
Q 017860          262 FVADPAARITIPEIMK  277 (365)
Q Consensus       262 l~~dp~~R~t~~ell~  277 (365)
                      |..+|.+|||+.++++
T Consensus       232 l~~~p~~Rp~~~ell~  247 (251)
T cd05041         232 WAYDPENRPSFSEIYN  247 (251)
T ss_pred             hccChhhCcCHHHHHH
Confidence            9999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.2e-41  Score=300.21  Aligned_cols=240  Identities=25%  Similarity=0.352  Sum_probs=195.3

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      +.||+|+||.||++... +++.+|+|.+.....  ....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46999999999999865 688999998865432  234678899999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC--CCCcCC
Q 017860          107 FERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGT  183 (365)
Q Consensus       107 ~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~--~~~~gt  183 (365)
                      .+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.  +||+|||++.........  ....++
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIP  157 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCc
Confidence            9988753 45899999999999999999999999999999999999986654  999999998643222111  122345


Q ss_pred             CCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       184 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      +.|+|||++.+..++.+ +||||||+++|++++ |..||.......... .+.    ..........++..+.+++.+||
T Consensus       158 ~~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~li~~~l  231 (250)
T cd05085         158 IKWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE-QVE----KGYRMSCPQKCPDDVYKVMQRCW  231 (250)
T ss_pred             ccccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-HHH----cCCCCCCCCCCCHHHHHHHHHHc
Confidence            67999999987777666 999999999999998 999998765433222 121    12222333457899999999999


Q ss_pred             ccCCCCCCCHHHHhc
Q 017860          263 VADPAARITIPEIMK  277 (365)
Q Consensus       263 ~~dp~~R~t~~ell~  277 (365)
                      ..+|.+||++.++++
T Consensus       232 ~~~p~~Rp~~~~l~~  246 (250)
T cd05085         232 DYKPENRPKFSELQK  246 (250)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.8e-41  Score=310.71  Aligned_cols=249  Identities=21%  Similarity=0.356  Sum_probs=200.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCc----EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ...+|++.+.||+|+||.||++.+..++.    .||+|.+.....  ....+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            45689999999999999999999987776    468888765332  223678899999999999999999998754 46


Q ss_pred             EEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++++||+++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++....
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~  161 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEG  161 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccC
Confidence            79999999999999987654 5899999999999999999999999999999999999976654  99999999875432


Q ss_pred             CCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 HSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ...   .....++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+... ....+.+    ......+....
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~  235 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPDLL----EKGERLPQPPI  235 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHH----HCCCCCCCCCC
Confidence            222   223345778999999987777666 999999999999997 8999976542 2222222    22223334445


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+..+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            67899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=6.4e-41  Score=307.90  Aligned_cols=249  Identities=16%  Similarity=0.160  Sum_probs=188.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccC---CcEEEEEEeecCCccc------------HHHHHHHHHHhcCCCCCcceece
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKID------------ENVQREIINHRSLRHPNIVRFKE   86 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~------------~~~~~e~~~l~~l~hpnIv~l~~   86 (365)
                      ..+|++.+.||+|+||+||+|.+..+   +..+|+|+........            .....++..+..+.|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            46899999999999999999998877   6777888644322110            11223345566779999999999


Q ss_pred             EEEeCC----EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEE
Q 017860           87 VILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI  162 (365)
Q Consensus        87 ~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl  162 (365)
                      ++....    ..+++++++. .++.+.+.....+++..++.++.|++.||+|||+++++||||||+|||++.++  .++|
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~--~~~l  167 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN--RGYI  167 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--cEEE
Confidence            776543    3477888774 46667776665678999999999999999999999999999999999997655  4999


Q ss_pred             ecCCCcccccCCC--------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHH--
Q 017860          163 CDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK--  232 (365)
Q Consensus       163 ~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--  232 (365)
                      +|||+|+......        ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........  
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999987543211        1223469999999999988777665 9999999999999999999987643322211  


Q ss_pred             ---HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          233 ---TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       233 ---~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                         .+..+......   ....+.++.+++..|+..+|.+||+++++++
T Consensus       247 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KCDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence               11222222222   2235789999999999999999999999975

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=324.74  Aligned_cols=246  Identities=26%  Similarity=0.423  Sum_probs=198.4

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ...+...+.+.||+|.||+||++++.   ..||||++.-..   ...+.|++|+.++|+-+|.||+-+.+++..+.. .|
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI  464 (678)
T ss_pred             cCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence            33456788999999999999999985   349999987543   344789999999999999999999999988887 99


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC--
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~--  173 (365)
                      |+-+|+|.+|+.++.-. -+|.....+.|++||++|+.|||.++|||||||..|||+.+++.  |||+|||++.....  
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~  542 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWS  542 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeec
Confidence            99999999999998653 46899999999999999999999999999999999999987654  99999999864322  


Q ss_pred             -CCCCCCCcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC---
Q 017860          174 -HSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD---  246 (365)
Q Consensus       174 -~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  246 (365)
                       ........|...|||||++..   ..| ++.+||||||||+|||++|..||. .+...++   +-.+..+ +-.|.   
T Consensus       543 g~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPys-i~~~dqI---ifmVGrG-~l~pd~s~  616 (678)
T KOG0193|consen  543 GEQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYS-IQNRDQI---IFMVGRG-YLMPDLSK  616 (678)
T ss_pred             cccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcC-CCChhhe---EEEeccc-ccCccchh
Confidence             233455668899999999964   344 455999999999999999999998 4443322   1111111 11121   


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 -TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 -~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                       ....+.++++|+..||..++++||++.++|.
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence             2224568999999999999999999999986

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.2e-41  Score=304.07  Aligned_cols=248  Identities=31%  Similarity=0.479  Sum_probs=201.4

Q ss_pred             CcceecccccCCCeEEEEEEEcc-CCcEEEEEEeecCC-----------cccHHHHHHHHHHhc-CCCCCcceeceEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD-----------KIDENVQREIINHRS-LRHPNIVRFKEVILT   90 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~   90 (365)
                      .|++.+.||+|+||.||++.++. +++.+|+|.+....           .....+.+|+.+++. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48999999999999999999987 68899999885321           111346678877764 799999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           91 PTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                      ....+++|||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.  +||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecc
Confidence            9999999999999999888743    3468999999999999999999996 78999999999999986654  999999


Q ss_pred             CCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 017860          166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       166 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  245 (365)
                      |++.............|+..|+|||.+.+..++.+ +|+||||+++|+|++|+.||..........    .+........
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~  233 (269)
T cd08528         159 GLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIVEAVYEPL  233 (269)
T ss_pred             cceeecccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHhhccCCcC
Confidence            99876544444455678999999999987777655 999999999999999999997654433222    2222222222


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ....+++.+.+++.+||+.||++||++.|+..+
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            233578999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.8e-41  Score=303.60  Aligned_cols=240  Identities=22%  Similarity=0.239  Sum_probs=188.5

Q ss_pred             cccccCCCeEEEEEEEcc------------CCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           29 RDIGSGNFGVARLMRDKV------------TKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      +.||+|+||.||++....            ....+|+|.+.... .....+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            469999999999998532            22368899876533 23356788899999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-----CCEEEecCCCcc
Q 017860           96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSK  169 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~-----~~vkl~Dfgla~  169 (365)
                      +||||+++++|..++.+ ...+++..++.++.||+.||+|||++|++||||||+|||++.++.     ..+|++|||++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~  160 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI  160 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCc
Confidence            99999999999888875 356899999999999999999999999999999999999975442     138999999876


Q ss_pred             cccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      ....   .....++..|+|||.+.+....+.++|||||||++|+|+ .|..||....... ...    ......  ....
T Consensus       161 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~----~~~~~~--~~~~  230 (262)
T cd05077         161 TVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-KER----FYEGQC--MLVT  230 (262)
T ss_pred             cccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-HHH----HHhcCc--cCCC
Confidence            4322   234567889999999874443344499999999999998 5888887643321 111    112221  2223


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.++++.+|+.+||+.||.+||++.+++.+
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-41  Score=306.54  Aligned_cols=239  Identities=22%  Similarity=0.281  Sum_probs=189.0

Q ss_pred             ccccCCCeEEEEEEEccC------------------------CcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCccee
Q 017860           30 DIGSGNFGVARLMRDKVT------------------------KELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRF   84 (365)
Q Consensus        30 ~LG~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l   84 (365)
                      .||+|+||.||++....+                        ...||+|.+..... ....+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            699999999999975322                        23588888865322 23567788999999999999999


Q ss_pred             ceEEEeCCEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----CC
Q 017860           85 KEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----AP  158 (365)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-----~~  158 (365)
                      ++++......++||||+++|+|..++.+ .+++++..+..++.||+.||+|||++|++||||||+|||++..+     .+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~  161 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSP  161 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccc
Confidence            9999999999999999999999988865 46789999999999999999999999999999999999997543     22


Q ss_pred             CEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHH-hCCCCCCCCCChHHHHHHHHHH
Q 017860          159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRI  237 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~~  237 (365)
                      .+|++|||++.....   .....+++.|+|||.+.+....+.++|||||||++|+|+ +|+.||........ ....   
T Consensus       162 ~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~---  234 (274)
T cd05076         162 FIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFY---  234 (274)
T ss_pred             eeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHH---
Confidence            489999998754322   223457888999999876443344599999999999985 69999987654322 1111   


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       238 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                       ......+  ...++.+.+++.+||+.+|.+|||+.+++++
T Consensus       235 -~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         235 -EKKHRLP--EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             -HhccCCC--CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence             1122222  2356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-42  Score=327.97  Aligned_cols=247  Identities=30%  Similarity=0.408  Sum_probs=199.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecC--CcccHHHHHHHHHHhcCCCCCcceeceEEEeCC------EEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLA   95 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~~   95 (365)
                      .|..-+.||+|+||.||+++++.+|+.||||.+.+.  .+..+..-+|+.+|++++|||||+++++=++..      .-.
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            466779999999999999999999999999998763  233466779999999999999999998866544      467


Q ss_pred             EEEeecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCCCEEEecCCCccc
Q 017860           96 IVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKS  170 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~---~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~--~~~~vkl~Dfgla~~  170 (365)
                      +|||||.||+|...+.+.   ..|+|.++..++.++..||.|||++||+||||||.||++-.+  +....||+|||.|+.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999999753   459999999999999999999999999999999999998433  344579999999999


Q ss_pred             ccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc-----------
Q 017860          171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-----------  239 (365)
Q Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-----------  239 (365)
                      ...+....+.+||+.|.+||...+..+++..+|.|||||++|+.+||..||..........++...+..           
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~  253 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ  253 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence            988888999999999999999986444444499999999999999999999765544322222222211           


Q ss_pred             --------cccCCCCCCCCCHH----HHHHHHHhcccCCCCCC
Q 017860          240 --------VQYSVPDTNPISQE----CRDLISRIFVADPAARI  270 (365)
Q Consensus       240 --------~~~~~~~~~~~s~~----~~~li~~~l~~dp~~R~  270 (365)
                              ....+|.+..+|+.    +...+..+|..+|.+|.
T Consensus       254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                    11234444445543    45677888899999998

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.8e-41  Score=301.87  Aligned_cols=243  Identities=25%  Similarity=0.385  Sum_probs=198.6

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ...+|++.+.||+|+||.||++..  +++.||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~   79 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL   79 (254)
T ss_pred             cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence            345799999999999999998864  78889999986532 346788999999999999999999998765 47999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860          101 ASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      +.+++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++......  ..
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~  155 (254)
T cd05083          80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VD  155 (254)
T ss_pred             CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CC
Confidence            99999999987643  4799999999999999999999999999999999999976654  999999998753221  22


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....+..|+|||.+.+..++.+ +|+|||||++|+|++ |+.||...+... ....+.   . ....+....++..+.++
T Consensus       156 ~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~---~-~~~~~~~~~~~~~~~~l  229 (254)
T cd05083         156 NSKLPVKWTAPEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKE-VKECVE---K-GYRMEPPEGCPADVYVL  229 (254)
T ss_pred             CCCCCceecCHHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHH-HHHHHh---C-CCCCCCCCcCCHHHHHH
Confidence            3344678999999987777666 999999999999997 999998765432 222221   1 12223334578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhc
Q 017860          258 ISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+||+.+|.+||++++++.
T Consensus       230 i~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         230 MTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.1e-41  Score=304.42  Aligned_cols=248  Identities=24%  Similarity=0.330  Sum_probs=200.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccC---CcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|.+.+.||+|+||.||+|.+...   ...||+|......  ...+.+.+|+.+++.++||||+++++++.. ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            45799999999999999999987644   3468999886543  233578899999999999999999998875 45689


Q ss_pred             EEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||+++++|.+++.+.. .+++..++.++.|++.||+|||+.|++||||||+||+++.++.  +||+|||+++......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~  161 (270)
T cd05056          84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeeccccc
Confidence            999999999999997744 5899999999999999999999999999999999999986654  9999999987543322


Q ss_pred             CC--CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          176 QP--KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       176 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      ..  ....+++.|+|||.+....++.+ +|||||||++|+|++ |..||............    .. ....+.+..++.
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~~-~~~~~~~~~~~~  235 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPP  235 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCch-hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----Hc-CCcCCCCCCCCH
Confidence            11  12234568999999877777666 999999999999986 99999876654333221    11 122234455789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+.+++.+||..+|.+|||+.+++..
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=311.07  Aligned_cols=263  Identities=27%  Similarity=0.425  Sum_probs=217.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc--------HHHHHHHHHHhcCCCCCcceeceEEEe-CC
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--------ENVQREIINHRSLRHPNIVRFKEVILT-PT   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~   92 (365)
                      ++||-++..||+|||+.||+|.+...++.||+|+-..+..+.        +..-+|..|.+.|.||.||++|++|.- ..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            569999999999999999999999999999999876544332        335579999999999999999999975 46


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecC-CCCCCEEEecCCCcc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSK  169 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~-~~~~~vkl~Dfgla~  169 (365)
                      .+|-|.|||+|.+|.-+++..+.++|.+++.|+.||+.||.||....  |||-||||.|||+-. ...|.+||+|||+++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            68999999999999999999999999999999999999999999764  999999999999853 334579999999998


Q ss_pred             cccCCCC--------CCCCcCCCCCCCchhhccc----ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 017860          170 SSVLHSQ--------PKSTVGTPAYIAPEVLLRH----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI  237 (365)
Q Consensus       170 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  237 (365)
                      .......        .....||.||++||.+.-+    ..+.+ +||||+|||+|..+.|+.||........+.+.-.-+
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnK-VDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl  700 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNK-VDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL  700 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccc-eeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh
Confidence            5433322        2345799999999998533    33444 899999999999999999998765544433322223


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       238 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ......+|.-..+|.++++||++||+.--+.|..+.++-.||||....
T Consensus       701 kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  701 KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence            333456777777999999999999999999999999999999997644

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=4.3e-41  Score=304.52  Aligned_cols=243  Identities=25%  Similarity=0.376  Sum_probs=195.8

Q ss_pred             cccccCCCeEEEEEEEccCC------cEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           29 RDIGSGNFGVARLMRDKVTK------ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~------~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +.||+|+||.||+++++...      +.+|+|.+....  .....+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999986543      689999886543  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCCEEEecCCCccc
Q 017860          101 ASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKS  170 (365)
Q Consensus       101 ~~~g~L~~~l~~~-------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~---~~~vkl~Dfgla~~  170 (365)
                      +++++|.+++.+.       ..+++..+..++.|++.||+|||+++++|+||||+||+++.++   ...++|+|||+++.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~  160 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARD  160 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccc
Confidence            9999999998642       2378899999999999999999999999999999999998655   12599999999875


Q ss_pred             ccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          171 SVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       171 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      ......   .....++..|+|||++.+..++.+ +|||||||++|+|++ |..||...+......    .+. .......
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----~~~-~~~~~~~  234 (269)
T cd05044         161 IYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVT-AGGRLQK  234 (269)
T ss_pred             cccccccccCcccCCCccccCHHHHccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHH----HHh-cCCccCC
Confidence            432211   123345788999999988777655 999999999999998 999997655433221    111 1122233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...++..+.+++.+||..+|.+||++.++++
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         235 PENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            4457899999999999999999999999975

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-40  Score=300.82  Aligned_cols=245  Identities=22%  Similarity=0.310  Sum_probs=187.9

Q ss_pred             cccccCCCeEEEEEEEccC--CcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCC
Q 017860           29 RDIGSGNFGVARLMRDKVT--KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +.||+|+||.||++....+  ...+++|.+....  ...+.+.+|+.+++.++||||+++++.+.....+|+||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            4699999999999976433  2356677765433  23457889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC---CCC
Q 017860          105 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP  177 (365)
Q Consensus       105 ~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~---~~~  177 (365)
                      +|.+++.+.    ..+++..++.++.||+.||+|||+++++||||||+|||++.++.  +||+|||++......   ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcc
Confidence            999998753    23567788899999999999999999999999999999976654  999999987642221   122


Q ss_pred             CCCcCCCCCCCchhhccc-------ccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          178 KSTVGTPAYIAPEVLLRH-------EYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ....+++.|+|||++...       .++ .++|||||||++|+|++ |..||........+...................
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQT-KPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELP  237 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCC
Confidence            345688999999997532       223 44899999999999997 577887665544444333221111111112234


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+.+++.+|| .+|++||+++++++
T Consensus       238 ~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         238 YSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            7889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=299.18  Aligned_cols=259  Identities=25%  Similarity=0.387  Sum_probs=209.8

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHH-HHhcCCCCCcceeceEEEeCCEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ....++.+-+..||.|+||+|++..++.+|+..|+|.++....  ...+++.|.. +++.-++||||++++....++..+
T Consensus        60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcW  139 (361)
T KOG1006|consen   60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCW  139 (361)
T ss_pred             ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCcee
Confidence            3445677888999999999999999999999999999987543  3456677774 456668999999999999999999


Q ss_pred             EEEeecCCCChHH---HH--HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           96 IVMEYASGGELFE---RI--CNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        96 lv~e~~~~g~L~~---~l--~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +.||+|. .||..   ++  .+...++|+.+-.+....+.||.||.. ..|||||+||+|||++..+.  |||||||++.
T Consensus       140 iCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcG  216 (361)
T KOG1006|consen  140 ICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICG  216 (361)
T ss_pred             eeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchH
Confidence            9999994 35533   22  234569999999999999999999975 68999999999999987665  9999999987


Q ss_pred             cccCCCCCCCCcCCCCCCCchhhcc--cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC-C
Q 017860          170 SSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-D  246 (365)
Q Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~  246 (365)
                      .....-..+...|...|||||.+..  .+|+-+ ||+||||+++||+.||..|+...+.   +.+.+..+..+.+..- .
T Consensus       217 qLv~SiAkT~daGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~  292 (361)
T KOG1006|consen  217 QLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLF  292 (361)
T ss_pred             hHHHHHHhhhccCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecC
Confidence            5544444566789999999999954  357777 9999999999999999999987654   3444444444443221 1


Q ss_pred             ---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          247 ---TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       247 ---~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                         ...+|..+..||..||.+|-..||...+++++||++-.
T Consensus       293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             cccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence               23478999999999999999999999999999999754

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=296.94  Aligned_cols=256  Identities=27%  Similarity=0.434  Sum_probs=212.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEeCC------
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPT------   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------   92 (365)
                      ..||.-++.+|.|+- .|..|-+...++.||+|.....   ....+...+|...+..++|+||++++++|....      
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            358999999999999 8888999999999999987653   234467889999999999999999999997653      


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ..|+|||++. .+|...+.  -.++-..+..++.|++.|++|||+.||+||||||+||++..+..  +||.|||+|+...
T Consensus        95 e~y~v~e~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTED  169 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccC
Confidence            5899999995 47877776  34788999999999999999999999999999999999976665  9999999999877


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-----------  241 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  241 (365)
                      ..-..+..+.|..|+|||++.+..|... +||||+||++.||++|+..|.+.+...++.+++.......           
T Consensus       170 ~~~~mtpyVvtRyyrapevil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  170 TDFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             cccccCchhheeeccCchheeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            7767788899999999999999887766 8999999999999999999998776665555444321111           


Q ss_pred             ----------------cCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          242 ----------------YSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       242 ----------------~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                      -.+|+         ...-+..+++++.+||..||++|.|++++|+||||.=+
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence                            00111         11124568999999999999999999999999999733

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-40  Score=298.32  Aligned_cols=242  Identities=24%  Similarity=0.333  Sum_probs=189.2

Q ss_pred             cccccCCCeEEEEEEEcc---CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEE-eCCEEEEEEeecC
Q 017860           29 RDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYAS  102 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~~~  102 (365)
                      +.||+|+||.||+|.+..   .+..||+|.+.....  ....+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998753   345799998854322  2356778999999999999999999765 4566899999999


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-----C
Q 017860          103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----Q  176 (365)
Q Consensus       103 ~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-----~  176 (365)
                      +++|.+++.+. ..+++..+..++.|++.||+|||+.+++||||||+|||++.++.  +||+|||+++......     .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecc
Confidence            99999998764 34678888999999999999999999999999999999986654  9999999987432211     1


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....+++.|+|||.+.+..++.+ +|||||||++|+|++| .+||...+... .   ...+.... ..+....+++.+.
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~-~---~~~~~~~~-~~~~~~~~~~~~~  232 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFD-I---TVYLLQGR-RLLQPEYCPDPLY  232 (262)
T ss_pred             cccCcCCccccChhHhccCccchH-HHHHHHHHHHHHHHcCCCCCCCCCCHHH-H---HHHHhcCC-CCCCCCcCCHHHH
Confidence            123345778999999987777666 9999999999999995 56676544322 2   22222221 2222334688999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 017860          256 DLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +++.+||..+|++||++.++++.
T Consensus       233 ~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         233 EVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999863

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.7e-40  Score=298.35  Aligned_cols=246  Identities=21%  Similarity=0.364  Sum_probs=194.0

Q ss_pred             cceecccccCCCeEEEEEEEcc---CCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCC------
Q 017860           25 YDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------   92 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------   92 (365)
                      |++.+.||+|+||.||+|..+.   +++.||+|++.....   ..+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            6788999999999999998653   578999999875432   2346788999999999999999999886542      


Q ss_pred             EEEEEEeecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           93 HLAIVMEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                      ..+++++|+.+|+|..++...      ..+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~--~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM--TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC--CEEECccc
Confidence            347899999999998876432      2478999999999999999999999999999999999997655  49999999


Q ss_pred             CcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          167 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       167 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                      +++......   ......+++.|++||.+....++.+ +|||||||++|+|++ |++||...+......    .+.... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~~~-  232 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGN-  232 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH----HHHcCC-
Confidence            987543222   1223345678999999987777665 999999999999999 889997655432222    121111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ........+..+.+++.+||+.+|.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            112223467899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=333.61  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=208.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCc-----EEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ...+-++.+.||+|+||.||.+.......     .||+|.+.+..  ....+|.+|..+|+.++|||||++++++.....
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            35678889999999999999998765333     48999987753  344689999999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           94 LAIVMEYASGGELFERICNA-------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~-------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                      .+|++|||.||+|..+|++.       ..++......++.||++|++||+++++|||||...|+|++...  .|||+|||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFG  847 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFG  847 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccc
Confidence            99999999999999999875       2489999999999999999999999999999999999998764  59999999


Q ss_pred             CcccccCCCCCCC-CcC--CCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          167 YSKSSVLHSQPKS-TVG--TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       167 la~~~~~~~~~~~-~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                      +|+.......... ..+  ...|||||.+..+.++++ +|||||||++||+++ |..||...++.+-+    .....+. 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtsk-SDvWsFGVllWEifslG~~PY~~~~n~~v~----~~~~~gg-  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVL----LDVLEGG-  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccc-cchhhhHHHHHHHHhCCCCCCCCcchHHHH----HHHHhCC-
Confidence            9994322222111 112  257999999999999888 999999999999999 88999887774432    2222222 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+...++.+.+++..||+.+|++||++..+++
T Consensus       922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            55666668899999999999999999999999997

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.8e-41  Score=280.62  Aligned_cols=258  Identities=23%  Similarity=0.442  Sum_probs=210.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEeC--CEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV   97 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv   97 (365)
                      ..++|++++++|+|.|+.||.+.+..+++.++||+++.-  -.+.+.+|+.+|+.|. ||||++++++..++  ....+|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            467899999999999999999999999999999998753  2467999999999997 99999999999776  457899


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      +||+...+...+-   .+++...++.++.+++.||.|||++||+|||+||.|++|+.... .++|+|+|+|...-++...
T Consensus       114 FE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eY  189 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEY  189 (338)
T ss_pred             hhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCcee
Confidence            9999887665543   45889999999999999999999999999999999999986543 6999999999988877777


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCC-ChHHHHHHHHHH-------------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-EPKDFRKTIQRI-------------------  237 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~~~~~~~~~~~~-------------------  237 (365)
                      ...+.+.+|--||.+.....+...-|+|||||++..|+..+.||-... +..++.++.+-+                   
T Consensus       190 nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~  269 (338)
T KOG0668|consen  190 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQ  269 (338)
T ss_pred             eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChh
Confidence            888899999999998765544444899999999999999998886544 333333322211                   


Q ss_pred             ----hc----ccc---CCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          238 ----LS----VQY---SVPDT-NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       238 ----~~----~~~---~~~~~-~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                          +.    ..+   .-+.. .-+++++.+|+.++|..|-.+|+||.|++.||||...
T Consensus       270 ~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  270 FEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             HhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence                00    000   00111 1247999999999999999999999999999999643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.5e-41  Score=310.83  Aligned_cols=257  Identities=28%  Similarity=0.435  Sum_probs=213.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC------CCcceeceEEEeCCEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH------PNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h------pnIv~l~~~~~~~~~~~l   96 (365)
                      .+|.+....|+|-|++|..|.+...|..||||++..++.+.+.-++|+.+|++|+.      -|+++++..|...+++|+
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            48999999999999999999999999999999999998888999999999999953      489999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           97 VMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |+|-+ ...|.+.+++.++   |....++.++.|++.||..|-..||+|.||||.|||++.+.. .+||||||.|.... 
T Consensus       512 VFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~-  588 (752)
T KOG0670|consen  512 VFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFAS-  588 (752)
T ss_pred             Eehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccc-
Confidence            99988 4589999988664   888999999999999999999999999999999999987654 69999999876543 


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHH-------H-hccc----
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-------I-LSVQ----  241 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~-------~-~~~~----  241 (365)
                      ....+.+..+..|+|||++.+-.|+.. .|+||+||++|||.||+..|.+.++...+.-.+.-       + ..++    
T Consensus       589 eneitPYLVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq  667 (752)
T KOG0670|consen  589 ENEITPYLVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ  667 (752)
T ss_pred             cccccHHHHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence            333455567788999999999999988 89999999999999999999998875543222110       0 0000    


Q ss_pred             -cC----------------------------------------CCC-CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          242 -YS----------------------------------------VPD-TNPISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       242 -~~----------------------------------------~~~-~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                       +.                                        .|. ...+-..+++||.+||..||.+|.|+.++|+||
T Consensus       668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp  747 (752)
T KOG0670|consen  668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP  747 (752)
T ss_pred             hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence             00                                        000 000124589999999999999999999999999


Q ss_pred             cccc
Q 017860          280 WFLK  283 (365)
Q Consensus       280 ~f~~  283 (365)
                      ||+.
T Consensus       748 Fi~~  751 (752)
T KOG0670|consen  748 FITE  751 (752)
T ss_pred             cccC
Confidence            9964

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-39  Score=322.20  Aligned_cols=259  Identities=17%  Similarity=0.210  Sum_probs=179.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccC----CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEE------Ee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI------LT   90 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~------~~   90 (365)
                      ..++|++.+.||+|+||.||+|.+..+    +..||+|.+...... +....+  .++...+.++..+...+      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence            457899999999999999999999988    899999987643211 111111  12222233333332222      34


Q ss_pred             CCEEEEEEeecCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 017860           91 PTHLAIVMEYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT  150 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NI  150 (365)
                      ...+++|+||+.+++|.+++.....                    ..+..++.++.||+.||.|||++||+||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            5679999999999999998865321                    12345678999999999999999999999999999


Q ss_pred             EecCCCCCCEEEecCCCcccccCC--CCCCCCcCCCCCCCchhhcccc----------------------cCCccceeeh
Q 017860          151 LLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLRHE----------------------YDGKIADVWS  206 (365)
Q Consensus       151 li~~~~~~~vkl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~~DiwS  206 (365)
                      |++.+. +.+||+|||+|+.....  ......++|+.|+|||.+....                      ++.+ +||||
T Consensus       287 Ll~~~~-~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k-~DVwS  364 (566)
T PLN03225        287 IFSEGS-GSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR-FDIYS  364 (566)
T ss_pred             EEeCCC-CcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC-cccHH
Confidence            997532 35999999999754322  2335568999999999764322                      2223 69999


Q ss_pred             hhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh----------cccc------CCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 017860          207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL----------SVQY------SVPDTNPISQECRDLISRIFVADPAARI  270 (365)
Q Consensus       207 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----------~~~~------~~~~~~~~s~~~~~li~~~l~~dp~~R~  270 (365)
                      |||++|||+++..|+..  ....+.+.+....          ....      .+.........+.+||.+||+.||.+||
T Consensus       365 lGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~  442 (566)
T PLN03225        365 AGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRI  442 (566)
T ss_pred             HHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCC
Confidence            99999999997666432  2222222222110          0000      0000111234466999999999999999


Q ss_pred             CHHHHhcCcccccCCC
Q 017860          271 TIPEIMKHQWFLKNLP  286 (365)
Q Consensus       271 t~~ell~h~~f~~~~~  286 (365)
                      |+.++|+||||.....
T Consensus       443 ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        443 SAKAALAHPYFDREGL  458 (566)
T ss_pred             CHHHHhCCcCcCCCCc
Confidence            9999999999987544

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.5e-39  Score=311.86  Aligned_cols=262  Identities=19%  Similarity=0.263  Sum_probs=191.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEc----------------cCCcEEEEEEeecCCc-c--------------cHHHHHH
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDK----------------VTKELVAVKYIERGDK-I--------------DENVQRE   69 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~-~--------------~~~~~~e   69 (365)
                      ..++|++.++||+|+||+||++...                ..++.||||.+..... .              .+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4679999999999999999998752                3456899999864321 1              1223346


Q ss_pred             HHHHhcCCCCC-----cceeceEEEe--------CCEEEEEEeecCCCChHHHHHhcC----------------------
Q 017860           70 IINHRSLRHPN-----IVRFKEVILT--------PTHLAIVMEYASGGELFERICNAG----------------------  114 (365)
Q Consensus        70 ~~~l~~l~hpn-----Iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  114 (365)
                      +.++..++|.+     +++++++|..        ....++|+||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66666666554     4667777653        356899999999999998876421                      


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC--CcCCCCCCCch
Q 017860          115 --RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPE  190 (365)
Q Consensus       115 --~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~--~~gt~~y~aPE  190 (365)
                        .+++..++.++.|++.||.|||+++|+||||||+|||++.++.  +||+|||+++..........  ..+|+.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCCccCccccCCCcceeChh
Confidence              2356778899999999999999999999999999999987654  99999999875443332222  23489999999


Q ss_pred             hhccccc--------------------C-CccceeehhhHHHHHHHhCCC-CCCCCCChHHH-------HHHHHHHhccc
Q 017860          191 VLLRHEY--------------------D-GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDF-------RKTIQRILSVQ  241 (365)
Q Consensus       191 ~~~~~~~--------------------~-~~~~DiwSlG~il~ell~g~~-pf~~~~~~~~~-------~~~~~~~~~~~  241 (365)
                      .+.....                    . ....||||+||++|+|++|.. ||.........       .+.+.......
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            9854321                    1 112699999999999999875 77543211110       11122233344


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCC---CCCCCHHHHhcCcccccC
Q 017860          242 YSVPDTNPISQECRDLISRIFVADP---AARITIPEIMKHQWFLKN  284 (365)
Q Consensus       242 ~~~~~~~~~s~~~~~li~~~l~~dp---~~R~t~~ell~h~~f~~~  284 (365)
                      +.++.+...++.+++|+.+||..+|   .+|+|++|+|+||||...
T Consensus       461 ~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        461 YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            5566667789999999999999766   689999999999999643

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=291.44  Aligned_cols=256  Identities=27%  Similarity=0.444  Sum_probs=207.9

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeec---CCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC-----EEEE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAI   96 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~l   96 (365)
                      .+--+.||.|+||+||.+.+..+|+.||+|++..   +-...+.+-+|++++...+|.|++..+++.....     .+|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            4446899999999999999999999999998753   2234467889999999999999999999887654     4688


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ++|++. .+|...+.....++.+.++-+++||++||+|||+.||.||||||.|+|++++.  .+||||||+++...... 
T Consensus       135 ~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC--vLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC--ILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc--eEEecccccccccchhhh
Confidence            999884 48888888888999999999999999999999999999999999999997665  49999999998654433 


Q ss_pred             -CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH-------------------
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-------------------  235 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~-------------------  235 (365)
                       .++..+.|.+|+|||++.+...++.+.||||+|||+.||+.++..|...+...++.-+..                   
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence             345567899999999999987777779999999999999999999987766554322221                   


Q ss_pred             HHhccccCCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          236 RILSVQYSVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       236 ~~~~~~~~~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+++.....|.         ...-..+..+++.++|..+|++|.+.++++.|++.-+
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e  348 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE  348 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence            11222222221         1122356889999999999999999999999998854

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.6e-38  Score=281.73  Aligned_cols=241  Identities=42%  Similarity=0.681  Sum_probs=204.9

Q ss_pred             CCeEEEEEEEccCCcEEEEEEeecCCcc--cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCChHHHHHh
Q 017860           35 NFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN  112 (365)
Q Consensus        35 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  112 (365)
                      +||.||++.+..+++.+|+|++......  ...+.+|+..++.++|+||+++++++......++++||+.+++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            6899999999988999999998765432  47889999999999999999999999999999999999999999999987


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhh
Q 017860          113 AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL  192 (365)
Q Consensus       113 ~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~  192 (365)
                      ...+++..++.++.+++.++.+||+.+++|+||+|.||+++.++  .++|+|||.+.............++..|+|||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence            76689999999999999999999999999999999999998765  4999999998866555455667789999999999


Q ss_pred             cccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC-CCHHHHHHHHHhcccCCCCCCC
Q 017860          193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFVADPAARIT  271 (365)
Q Consensus       193 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~l~~dp~~R~t  271 (365)
                      .+..++.+ +||||||+++++|++|..||..........+.   ............. ++.++.+++.+||..+|++||+
T Consensus       159 ~~~~~~~~-~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      159 LGKGYGKA-VDVWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             ccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            87777665 99999999999999999999874443333222   2222222222222 7889999999999999999999


Q ss_pred             HHHHhcCccc
Q 017860          272 IPEIMKHQWF  281 (365)
Q Consensus       272 ~~ell~h~~f  281 (365)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=309.13  Aligned_cols=268  Identities=24%  Similarity=0.384  Sum_probs=225.3

Q ss_pred             ccccCCCCCCCCCCCCCCcceecccccCCCeEEEEEEEccC-Cc--EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCc
Q 017860            7 SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVT-KE--LVAVKYIERGDK--IDENVQREIINHRSLRHPNI   81 (365)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~-~~--~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnI   81 (365)
                      -.+.+|.....+++..++.++.++||+|+||+|+.+.++.. |+  .||||++.....  ...+|++|+.+|.+|+|||+
T Consensus        94 ~~~~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hl  173 (1039)
T KOG0199|consen   94 NSVANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHL  173 (1039)
T ss_pred             cCCCCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcce
Confidence            34678888889999999999999999999999999998753 33  689999976543  34789999999999999999


Q ss_pred             ceeceEEEeCCEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           82 VRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        82 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      +++|++..+ ....+|||++++|+|.+.+.+.  ..|.......++.||+.|+.||.++++|||||-..|+|+-...  .
T Consensus       174 iRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr--t  250 (1039)
T KOG0199|consen  174 IRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR--T  250 (1039)
T ss_pred             eEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc--e
Confidence            999999987 6788999999999999999873  3488889999999999999999999999999999999997543  4


Q ss_pred             EEEecCCCcccccCCCCCCCCcC----CCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 017860          160 LKICDFGYSKSSVLHSQPKSTVG----TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~  234 (365)
                      ||||||||.+.....+......+    ...|+|||.+....++.+ ||+|++||++|||++ |..||-+.....    ++
T Consensus       251 VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~q----IL  325 (1039)
T KOG0199|consen  251 VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQ----IL  325 (1039)
T ss_pred             eeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHH----HH
Confidence            99999999997666655543332    346999999999999877 999999999999998 789999876632    33


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       235 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +.+- ....++.+...|+++.++++.||..+|.+|||+..+...-+.++
T Consensus       326 ~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  326 KNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             Hhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            3333 44466777778999999999999999999999999875544443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=312.95  Aligned_cols=261  Identities=29%  Similarity=0.437  Sum_probs=221.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc-HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +.++|+.++++|+|+||.||+++++.+++..|+|+++...... .-+..|+.+++..+|||||.+++.+.....+++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            3678999999999999999999999999999999998754333 567789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc-cCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~-~~~~~~~  178 (365)
                      ||.||+|.+.-.-.+.++|.++...++..+.||+|||++|-+|||||-.||++++.++  +||+|||.+... .+-....
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhh
Confidence            9999999998888889999999999999999999999999999999999999987776  999999987643 3345567


Q ss_pred             CCcCCCCCCCchhh---cccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          179 STVGTPAYIAPEVL---LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       179 ~~~gt~~y~aPE~~---~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      +++|||+|||||+.   ..+.|... +|||++|+...|+-.-++|.......... .....-...+....+...+++.+.
T Consensus       171 sfiGtpywmapEvaaverkggynql-cdiwa~gitAiel~eLqpplfdlhpmr~l-~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQL-CDIWALGITAIELGELQPPLFDLHPMRAL-FLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             cccCCccccchhHHHHHhccccccc-ccccccccchhhhhhcCCcccccchHHHH-HHhhccCCCCCcccCCccchHHHH
Confidence            88999999999986   34566666 99999999999999888876554432221 122222222334445567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +|++.+|.++|++|||++.+|.|||....+
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccch
Confidence            999999999999999999999999987653

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=295.96  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=207.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      +.++..++++||+|-||.|.++.-. .+..||+|.++....  ...+|.+|+++|.+|+||||+.++++|..++.+++|+
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            4567899999999999999999864 468999999976432  3478999999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           99 EYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ||++.|+|..++.++.  .+.......++.||+.|++||.+.++|||||.+.|+|++++..  +||+|||+++....+..
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCc
Confidence            9999999999998763  3455667789999999999999999999999999999986665  99999999996544433


Q ss_pred             CC---CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHH--hCCCCCCCCCChHHHHHHHHHHhcccc---CCCCCC
Q 017860          177 PK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--VGGYPFEDPDEPKDFRKTIQRILSVQY---SVPDTN  248 (365)
Q Consensus       177 ~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell--~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~  248 (365)
                      ..   ..+-...|||||.+..++++++ ||+|+||+++||++  |...||...++..- .+........+.   ..+.+.
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ven~~~~~~~~~~~~~l~~P~  770 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VENAGEFFRDQGRQVVLSRPP  770 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HHhhhhhcCCCCcceeccCCC
Confidence            22   2234578999999999999877 99999999999975  67899988776433 333333333332   123344


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      -.+..+.+++.+||..+-.+|||++++..
T Consensus       771 ~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  771 ACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             cCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            46788999999999999999999999964

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=285.38  Aligned_cols=133  Identities=26%  Similarity=0.409  Sum_probs=118.5

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----C---CCcceeceEEEeC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----H---PNIVRFKEVILTP   91 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----h---pnIv~l~~~~~~~   91 (365)
                      ....||.+.++||.|-|++||+|.+..+.+.||+|+++......+....||++|++++     |   .+||+|++.|...
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            3457999999999999999999999999999999999887777888999999998873     3   4799999999754


Q ss_pred             ----CEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEec
Q 017860           92 ----THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLD  153 (365)
Q Consensus        92 ----~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~  153 (365)
                          .++|+|+|++ |..|..+|...  +.++...++.|++|||.||.|||. .||||-||||+|||+-
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence                6899999999 66888888763  459999999999999999999996 6999999999999984

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-38  Score=292.62  Aligned_cols=244  Identities=24%  Similarity=0.352  Sum_probs=202.1

Q ss_pred             cceecccccCCCeEEEEEEEccC----CcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~----~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ..+.+.||.|-||.||++....-    .--||||..+.+.  ...+.|..|..+|+.++||||+++++++. +...+|||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee-ccceeEEE
Confidence            44567899999999999986432    3368999887643  33578999999999999999999999996 45679999


Q ss_pred             eecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |+++-|.|..+++.++ .++.....-++.||..||+|||+.++|||||-..|||+.....  |||+|||++|........
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchh
Confidence            9999999999998764 5899999999999999999999999999999999999976654  999999999977666555


Q ss_pred             CCCcCC--CCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          178 KSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       178 ~~~~gt--~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ....|.  .-|||||.++-..++.. ||||-||+++||++. |..||.+..+..-+.    . +...-+.|.+...++.+
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~----~-iEnGeRlP~P~nCPp~L  621 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIG----H-IENGERLPCPPNCPPAL  621 (974)
T ss_pred             hccccccceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEE----E-ecCCCCCCCCCCCChHH
Confidence            554543  46999999988888766 999999999999886 999999877643221    1 12223566677789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhc
Q 017860          255 RDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..|+.+||..+|.+||++.++..
T Consensus       622 YslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHHH
Confidence            99999999999999998876643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-38  Score=292.67  Aligned_cols=246  Identities=23%  Similarity=0.355  Sum_probs=213.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .+.....+||.|-||.||.+.++.-.-.||||.++.+.-..++|++|..+|+.++|||+|+++++|..+-.+|||+|||.
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~  346 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC  346 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence            34566789999999999999999999999999998766666899999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          103 GGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       103 ~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      .|.|.+++.+..+  ++.-.+.+++-||..|+.||..+++|||||-..|+|+..+.-  ||++||||++... +...+..
T Consensus       347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMt-gDTYTAH  423 (1157)
T KOG4278|consen  347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMT-GDTYTAH  423 (1157)
T ss_pred             CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhc-CCceecc
Confidence            9999999987654  677888899999999999999999999999999999976654  9999999998543 3333333


Q ss_pred             cC---CCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          181 VG---TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       181 ~g---t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      .|   ..-|.|||-+..+.+..+ +|||+|||++||+.| |-.||.+.+..     .+-.++...+.+..+...++...+
T Consensus       424 AGAKFPIKWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVYe  497 (1157)
T KOG4278|consen  424 AGAKFPIKWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVYE  497 (1157)
T ss_pred             cCccCcccccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHHH
Confidence            44   456999999998999888 999999999999998 88899886642     233445566777778889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhc
Q 017860          257 LISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~  277 (365)
                      |+..||+.+|..||+++|+-+
T Consensus       498 LMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  498 LMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHhcCCcccCccHHHHHH
Confidence            999999999999999998853

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-38  Score=300.21  Aligned_cols=248  Identities=24%  Similarity=0.403  Sum_probs=213.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCc---EEEEEEeecC--CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ..-.|.+.||.|.||.||+++.+..|+   .||||.++.+  ++...+|+.|..||-+..||||++|.++......+.||
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            346788999999999999999987664   8999999865  34557899999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      +|||+.|+|..+|.. .+.|+.-++..+++.|+.|++||-++|+|||||...|||++.+-.  +|++|||++|...... 
T Consensus       709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCC
Confidence            999999999999976 467999999999999999999999999999999999999987664  9999999998543322 


Q ss_pred             CC-CCCcC--CCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          176 QP-KSTVG--TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       176 ~~-~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      .. ++..|  ...|.|||.+...++++. |||||+|++|||.++ |..||...++.+-+.    . +...+.+|.+...+
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIk----a-Ie~gyRLPpPmDCP  860 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIK----A-IEQGYRLPPPMDCP  860 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHH----H-HHhccCCCCCCCCc
Confidence            22 22233  257999999999999877 999999999999876 999999988854333    2 23456788888889


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..+.+|+..||++|-.+||.+.+++.+
T Consensus       861 ~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  861 AALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999999999998874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1e-36  Score=322.11  Aligned_cols=242  Identities=20%  Similarity=0.239  Sum_probs=186.3

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      .|...+.||+|+||.||+|+++.++..||+|.+......   ..+|+..+++++|||||++++++......|+||||+++
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~  767 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG  767 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCC
Confidence            466677899999999999999989999999998654322   24568889999999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH---~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      |+|.+++.   .+++..+..++.|++.||+|||   +.+++||||||+||+++.+..  .++. ||......   .....
T Consensus       768 g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~  838 (968)
T PLN00113        768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKC  838 (968)
T ss_pred             CcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCc
Confidence            99999985   3789999999999999999999   679999999999999987665  4443 55443221   12234


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh-HHHHHHHHHHhcc-------ccCCCCC----C
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSV-------QYSVPDT----N  248 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~~----~  248 (365)
                      .||+.|+|||++.+..++.+ +|||||||++|||++|+.||...... ....+..+.....       .......    .
T Consensus       839 ~~t~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  917 (968)
T PLN00113        839 FISSAYVAPETRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ  917 (968)
T ss_pred             cccccccCcccccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence            78999999999988888766 99999999999999999999543211 1111111111100       0000000    0


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ....++.+++.+||+.+|.+|||+.|+++.
T Consensus       918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        918 NEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            112357789999999999999999999874

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-38  Score=290.43  Aligned_cols=200  Identities=29%  Similarity=0.456  Sum_probs=179.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc---------HHHHHHHHHHhcCC---CCCcceeceEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---------ENVQREIINHRSLR---HPNIVRFKEVI   88 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~e~~~l~~l~---hpnIv~l~~~~   88 (365)
                      .-..|..++.||+|+||.|++|.++.+...|+||.+.+++...         ..+-.|+.||..|+   |+||+|++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3456999999999999999999999999999999998754321         12346999999997   99999999999


Q ss_pred             EeCCEEEEEEeec-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           89 LTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        89 ~~~~~~~lv~e~~-~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      ++++.+|++||-- +|.+|+++|....+++|.+++.|++|++.|+++||++||||||||-+|+.++.++-  +||+|||.
T Consensus       639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgs  716 (772)
T KOG1152|consen  639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGS  716 (772)
T ss_pred             ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccc
Confidence            9999999999986 57799999999999999999999999999999999999999999999999987765  99999998


Q ss_pred             cccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCC
Q 017860          168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED  223 (365)
Q Consensus       168 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  223 (365)
                      |... ..+.....+||..|.|||++.+.+|-++.-|||+||+++|.++....||..
T Consensus       717 aa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            7643 345567789999999999999999999999999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=298.70  Aligned_cols=246  Identities=29%  Similarity=0.404  Sum_probs=193.4

Q ss_pred             cceecccccCCCeE-EEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEeecC
Q 017860           25 YDFVRDIGSGNFGV-ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        25 y~~~~~LG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      |.-.+.+|.|+-|+ ||++..  .|+.||||.+-.+  ......+|+..|+.. .|||||++++.=.+++.+||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e--~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE--FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH--hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            45567899999986 577776  6889999987543  234678999999887 59999999999999999999999995


Q ss_pred             CCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCCCEEEecCCCcccccCCC
Q 017860          103 GGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus       103 ~g~L~~~l~~~~~----l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~---~~~~~vkl~Dfgla~~~~~~~  175 (365)
                       .+|.+++...+.    ......+.++.|++.||++||+.+||||||||.||||+.   ++..+++|+|||+++....+.
T Consensus       587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence             499999977421    122456889999999999999999999999999999986   344579999999998654443


Q ss_pred             C----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          176 Q----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       176 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      .    .....||-+|+|||++....... ++||+|||||+|+.++| ..||...-.      ....|+...+..-.....
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~------R~~NIl~~~~~L~~L~~~  738 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLE------RQANILTGNYTLVHLEPL  738 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHH------hhhhhhcCccceeeeccC
Confidence            2    34557999999999998766655 49999999999999886 899976332      222344444433221111


Q ss_pred             -CHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          251 -SQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       251 -s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                       ..++.+||.+|+.++|..||+|.++|.||+|=
T Consensus       739 ~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW  771 (903)
T KOG1027|consen  739 PDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW  771 (903)
T ss_pred             chHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence             12899999999999999999999999999993

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.1e-36  Score=274.82  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=201.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc---CCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ...|.++.+||+|+|++||++.+..   .++.||+|.+.... ....+.+|+..|..+. +.||+++.+++..++...+|
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            3479999999999999999999877   78899999987643 4567999999999885 89999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc------
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS------  171 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~------  171 (365)
                      +||++.....++...   ++-.+++.+++.++.||+++|++|||||||||+|+|++... ++-.|.|||+|...      
T Consensus       114 lp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t-~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT-QRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             ecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc-CCceEEechhHHHHHhhhhh
Confidence            999999888887644   67899999999999999999999999999999999997543 35789999997510      


Q ss_pred             -----------cC--CC--------------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHH
Q 017860          172 -----------VL--HS--------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY  212 (365)
Q Consensus       172 -----------~~--~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  212 (365)
                                 ..  +.                          ......||++|+|||++...+-.+.++||||.|+|+.
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                       00  00                          0012359999999999987766666699999999999


Q ss_pred             HHHhCCCCCCCCCChHHH-HHHH-----------HHHhcc--------------------------ccC--------CCC
Q 017860          213 VMLVGGYPFEDPDEPKDF-RKTI-----------QRILSV--------------------------QYS--------VPD  246 (365)
Q Consensus       213 ell~g~~pf~~~~~~~~~-~~~~-----------~~~~~~--------------------------~~~--------~~~  246 (365)
                      .++++..||-...+.... .++.           ......                          -..        ...
T Consensus       270 slls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~  349 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIG  349 (418)
T ss_pred             hhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccc
Confidence            999999999764332111 0000           000000                          000        000


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ....+..+.+|+.+||..||.+|.|++++|+||||..
T Consensus       350 ~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  350 SDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             cccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence            1123557999999999999999999999999999973

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=248.60  Aligned_cols=203  Identities=27%  Similarity=0.429  Sum_probs=166.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC--CcccHHHHHHHHHH-hcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +.......||+|+||.|-+.++..+|...|+|.+...  ....+...+|+.+. +...+|.+|.+++........++.||
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME  125 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME  125 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence            4455678899999999999999999999999998653  33445667777554 55579999999999999999999999


Q ss_pred             ecCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860          100 YASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus       100 ~~~~g~L~~----~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      .+. .||..    .+.+++.++|..+-.++..++.||.|||+ ..++|||+||+||||+..+  +||+||||.+......
T Consensus       126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G--qVKiCDFGIsG~L~dS  202 (282)
T KOG0984|consen  126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG--QVKICDFGISGYLVDS  202 (282)
T ss_pred             Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC--cEEEcccccceeehhh
Confidence            994 46643    34567789999999999999999999997 4799999999999997665  5999999998654333


Q ss_pred             CCCCCCcCCCCCCCchhhcc----cccCCccceeehhhHHHHHHHhCCCCCCCCCChHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLR----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD  229 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  229 (365)
                      -..+-..|...|||||.+..    ..|+-+ |||||||++++||.+++.||.....+-+
T Consensus       203 iAkt~daGCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tpF~  260 (282)
T KOG0984|consen  203 IAKTMDAGCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTPFQ  260 (282)
T ss_pred             hHHHHhcCCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCHHH
Confidence            33333678899999999853    467667 9999999999999999999987655443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=289.29  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=206.3

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEcc-------CCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV   87 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~   87 (365)
                      +-.+.++..+.+.||+|+||.|+++.-+.       ....||+|.++....  ..+.+..|+.+|+.+ +||||+.++++
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            34444556777899999999999997431       145899999875433  346788999999988 59999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 017860           88 ILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL  151 (365)
Q Consensus        88 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIl  151 (365)
                      +.....+++|+||+..|+|..++...+                .++......++.||+.|++||++..+|||||-..|||
T Consensus       371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL  450 (609)
T ss_pred             eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence            999999999999999999999997765                3888999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCcccccCCCCCC--CCcCC--CCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCC
Q 017860          152 LDGSPAPRLKICDFGYSKSSVLHSQPK--STVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDE  226 (365)
Q Consensus       152 i~~~~~~~vkl~Dfgla~~~~~~~~~~--~~~gt--~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~  226 (365)
                      +..+..  +||+|||+|+.........  ...|+  ..|||||.+....|+.+ +||||+|+++||+++ |..||.+...
T Consensus       451 i~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~  527 (609)
T KOG0200|consen  451 ITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPP  527 (609)
T ss_pred             ecCCCE--EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCc
Confidence            987754  9999999998644433332  22332  34999999999888888 999999999999998 8899987553


Q ss_pred             hHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...+.+    .+........+...++++.++++.||..+|++||++.++..
T Consensus       528 ~~~l~~----~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  528 TEELLE----FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            444333    23334455556667999999999999999999999999975

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-36  Score=255.95  Aligned_cols=268  Identities=24%  Similarity=0.396  Sum_probs=206.7

Q ss_pred             CCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceece-EEE
Q 017860           12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKE-VIL   89 (365)
Q Consensus        12 ~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~-~~~   89 (365)
                      |...++-+.-.+.|.|.+.||+|.||.+-++.|+.++..+++|.+.+.....++|.+|...--.| .|.||+.-|+ .|+
T Consensus        13 ~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq   92 (378)
T KOG1345|consen   13 PMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ   92 (378)
T ss_pred             ccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh
Confidence            44556666677899999999999999999999999999999999988777778899998665555 4899999776 578


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           90 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +.+.+++++||++.|+|.+-+... .+.|...+.++.|+++|+.|||++++||||||.+||||=.....+|||||||+++
T Consensus        93 t~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   93 TSDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             cCceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence            888999999999999999877654 4899999999999999999999999999999999999954444589999999877


Q ss_pred             cccCCCCCCCCcCCCCCCCchhhccc---cc-CCccceeehhhHHHHHHHhCCCCCCCCCChH-HHHHHHHHHhccccCC
Q 017860          170 SSVLHSQPKSTVGTPAYIAPEVLLRH---EY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-DFRKTIQRILSVQYSV  244 (365)
Q Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  244 (365)
                      ...  ......-.+..|.|||.....   .+ -.+.+|+|.||+++|..++|++||+...... ...+..+-........
T Consensus       172 k~g--~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  172 KVG--TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL  249 (378)
T ss_pred             ccC--ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence            432  222223346679999986432   11 2344899999999999999999998432211 1112222112222233


Q ss_pred             C-CCCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccc
Q 017860          245 P-DTNPISQECRDLISRIFVADPAAR---ITIPEIMKHQWFL  282 (365)
Q Consensus       245 ~-~~~~~s~~~~~li~~~l~~dp~~R---~t~~ell~h~~f~  282 (365)
                      | ....+|+.+..+.++-|..+|++|   -++..-.+..|.-
T Consensus       250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            3 345689999999999999999999   5566655566654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-35  Score=265.02  Aligned_cols=263  Identities=27%  Similarity=0.369  Sum_probs=199.6

Q ss_pred             ccccCCCCCCCCC---CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhc--CCCCCc
Q 017860            7 SLTVGPAMDMPIM---HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNI   81 (365)
Q Consensus         7 ~~~~~~~~~~~~~---~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~hpnI   81 (365)
                      +.++|.....|.+   ....+-.+.+.||+|-||.||++++  .|+.||||+|...+  +....+|..|...  |+|+||
T Consensus       192 ~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENI  267 (513)
T KOG2052|consen  192 LETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENI  267 (513)
T ss_pred             hccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc--hhhhhhHHHHHHHHHhccchh
Confidence            4467777777764   2345788999999999999999998  48899999997643  3456677666654  599999


Q ss_pred             ceeceEEEeC----CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----c---CCeecCCCCCc
Q 017860           82 VRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-----M---QVCHRDLKLEN  149 (365)
Q Consensus        82 v~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-----~---~ivHrDlkp~N  149 (365)
                      +.+++.=..+    .+++||++|-+.|||++++.+ ..++.+...+++..++.||+|||.     +   .|.|||||..|
T Consensus       268 LgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKN  346 (513)
T KOG2052|consen  268 LGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKN  346 (513)
T ss_pred             hhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccccc
Confidence            9999876543    469999999999999999988 679999999999999999999994     2   39999999999


Q ss_pred             EEecCCCCCCEEEecCCCcccccCC-----CCCCCCcCCCCCCCchhhcccc-----cCCccceeehhhHHHHHHHhC--
Q 017860          150 TLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRHE-----YDGKIADVWSCGVTLYVMLVG--  217 (365)
Q Consensus       150 Ili~~~~~~~vkl~Dfgla~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwSlG~il~ell~g--  217 (365)
                      ||+..++.  .-|+|+|||-.....     ...+..+||..|||||++...-     -..+.+||||||.|+||++.+  
T Consensus       347 ILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~  424 (513)
T KOG2052|consen  347 ILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE  424 (513)
T ss_pred             EEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence            99987775  999999998643332     3356779999999999985421     124568999999999999853  


Q ss_pred             --------CCCCCCCCCh----HHHHHHHHHHhccccCCCCCCCCCH---HHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          218 --------GYPFEDPDEP----KDFRKTIQRILSVQYSVPDTNPISQ---ECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       218 --------~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~s~---~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                              ++||.+.-+.    +++++.+ -+.+..+..|....-.+   .+..+++.||..||..|.|+--+.+
T Consensus       425 ~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV-Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  425 SGGIVEEYQLPYYDVVPSDPSFEEMRKVV-CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             cCCEehhhcCCcccCCCCCCCHHHHhcce-eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                    3788764322    2222211 12223334444433333   3567789999999999999988765

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=281.67  Aligned_cols=247  Identities=23%  Similarity=0.351  Sum_probs=204.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCc----EEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ....+..++||+|+||+||++.+-..|+    +||||++....  ....++..|+.+|.+++|||++++++++.... +-
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            3346667899999999999999865554    78999886543  34578999999999999999999999998776 78


Q ss_pred             EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||++|+++|+|.++++.. .++-......|..||++|+.|||.+++|||||-..|+|+..-.  ++|+.|||+++.....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~--hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN--HVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC--eEEEEecchhhccCcc
Confidence            999999999999999864 5689999999999999999999999999999999999997555  5999999999876555


Q ss_pred             CCCCCCc---CCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          175 SQPKSTV---GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       175 ~~~~~~~---gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      +......   -.+-|||-|.+....|+.. +||||+||++||++| |..|+.+... .+    +..++....+++.+...
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thq-SDVWsfGVtiWElmTFGa~Py~gi~~-~e----I~dlle~geRLsqPpiC  925 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQ-SDVWSFGVTIWELMTFGAKPYDGIPA-EE----IPDLLEKGERLSQPPIC  925 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCch-hhhhhhhhhHHHHHhcCCCccCCCCH-HH----hhHHHhccccCCCCCCc
Confidence            4433332   2456999999988888877 999999999999998 8899988654 22    23333334446666667


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.++..++.+||..|+..||++.++-.
T Consensus       926 tiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  926 TIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             cHHHHHHHHHHhccCcccCccHHHHHH
Confidence            899999999999999999999988764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-35  Score=265.23  Aligned_cols=257  Identities=25%  Similarity=0.340  Sum_probs=188.9

Q ss_pred             CCCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHh--cCCCCCcceeceEE
Q 017860           11 GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVI   88 (365)
Q Consensus        11 ~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~--~l~hpnIv~l~~~~   88 (365)
                      ||....|.+. ....++++.||+|.||.||+|+.  +++.||||+|....  .+.+.+|-.|.+  .++|+||+++++.=
T Consensus       199 ~~~~sspl~~-l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e  273 (534)
T KOG3653|consen  199 GPAPSSPLLE-LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAE  273 (534)
T ss_pred             CCCCCccccc-CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchh
Confidence            3444444332 45688899999999999999987  46999999997543  345566655554  45899999999876


Q ss_pred             EeCC----EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------cCCeecCCCCCcEEecCC
Q 017860           89 LTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA---------MQVCHRDLKLENTLLDGS  155 (365)
Q Consensus        89 ~~~~----~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~---------~~ivHrDlkp~NIli~~~  155 (365)
                      ....    .++||++|.+.|+|.+++..+ .+++.....++..+++||+|||+         ..|+|||||..|||+..+
T Consensus       274 kr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D  352 (534)
T KOG3653|consen  274 KRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND  352 (534)
T ss_pred             ccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence            5444    799999999999999999765 58999999999999999999996         349999999999999877


Q ss_pred             CCCCEEEecCCCcccccCC---CCCCCCcCCCCCCCchhhcccccC-----CccceeehhhHHHHHHHhCCC--------
Q 017860          156 PAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVGGY--------  219 (365)
Q Consensus       156 ~~~~vkl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~ell~g~~--------  219 (365)
                      ..  ..|+|||+|......   ...-..+||..|||||++.+.-.-     -++.||||+|.|+||++++..        
T Consensus       353 lT--ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  353 LT--CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             Cc--EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            65  899999999765433   223346899999999999764332     245899999999999998643        


Q ss_pred             ----CCCCC----CChHHHHHHHHHHhccccCCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017860          220 ----PFEDP----DEPKDFRKTIQRILSVQYSVPDT---NPISQECRDLISRIFVADPAARITIPEIM  276 (365)
Q Consensus       220 ----pf~~~----~~~~~~~~~~~~~~~~~~~~~~~---~~~s~~~~~li~~~l~~dp~~R~t~~ell  276 (365)
                          ||+..    ...++++..+.. .+..+.+|..   ..--.-+++.+..||..||+.|+|+.=+-
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence                33210    011122222211 1222222221   11235688999999999999999986443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=8.5e-33  Score=239.10  Aligned_cols=209  Identities=44%  Similarity=0.699  Sum_probs=183.0

Q ss_pred             cccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCChHH
Q 017860           31 IGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE  108 (365)
Q Consensus        31 LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~  108 (365)
                      ||+|++|.||++....+++.+++|++.....  ....+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999988899999999887543  24678999999999999999999999999999999999999999999


Q ss_pred             HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEecCCCcccccCCC-CCCCCcCCCC
Q 017860          109 RICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA  185 (365)
Q Consensus       109 ~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~-~~~~~vkl~Dfgla~~~~~~~-~~~~~~gt~~  185 (365)
                      ++... ..++...++.++.+++.+|++||+.|++|+||+|.||+++. ++  +++|+|||.+....... ......+...
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCC
Confidence            98876 56899999999999999999999999999999999999986 44  59999999887543322 1334567889


Q ss_pred             CCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhccc
Q 017860          186 YIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA  264 (365)
Q Consensus       186 y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  264 (365)
                      |++||.+... .++.+ +|+||+|++++++                                     ..+.+++.+|+..
T Consensus       159 ~~~pe~~~~~~~~~~~-~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         159 YMAPEVLLGKGYYSEK-SDIWSLGVILYEL-------------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             ccChhHhcccCCCCch-hhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhC
Confidence            9999998766 44444 8999999999998                                     5678999999999


Q ss_pred             CCCCCCCHHHHhcCc
Q 017860          265 DPAARITIPEIMKHQ  279 (365)
Q Consensus       265 dp~~R~t~~ell~h~  279 (365)
                      +|.+||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-32  Score=238.83  Aligned_cols=204  Identities=40%  Similarity=0.664  Sum_probs=176.4

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      |++.+.||.|++|.||++.+..+++.+|+|.+.....  ..+.+.+|+..++.++|+|++++++++......++++|++.
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            6788999999999999999998899999999976543  35678899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--CCCC
Q 017860          103 GGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS  179 (365)
Q Consensus       103 ~g~L~~~l~~~~~-l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--~~~~  179 (365)
                      +++|.+++..... +++..++.++.+++.++.+||+.+++|+||+|.||+++.++  .++|+|||.+.......  ....
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccc
Confidence            9999999988766 89999999999999999999999999999999999998664  59999999887654432  3345


Q ss_pred             CcCCCCCCCchhh-cccccCCccceeehhhHHHHHHHhCCCCCCC-CCChHHHH
Q 017860          180 TVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFED-PDEPKDFR  231 (365)
Q Consensus       180 ~~gt~~y~aPE~~-~~~~~~~~~~DiwSlG~il~ell~g~~pf~~-~~~~~~~~  231 (365)
                      ..++..|++||.+ ....++.+ +|+||||+++++|++|+.||.. ......+.
T Consensus       159 ~~~~~~~~~pe~~~~~~~~~~~-~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~  211 (225)
T smart00221      159 VKGTPFYLAPEVLLGGKGYGEA-VDIWSLGVILYELLWGPEPFSGEGEFTSLLS  211 (225)
T ss_pred             eeccCCcCCHhHhcCCCCCCch-hhHHHHHHHHHHHHHCCCCccccchhHHHHH
Confidence            6788899999998 55555554 9999999999999999999976 44443333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=100.00  E-value=2e-33  Score=290.33  Aligned_cols=201  Identities=15%  Similarity=0.201  Sum_probs=149.5

Q ss_pred             cCCC-CCcceeceEE-------EeCCEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 017860           75 SLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL  145 (365)
Q Consensus        75 ~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDl  145 (365)
                      .++| +||++++++|       .....+++++|++ +++|.+++.. ...+++.+++.++.||+.||+|||++||+||||
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl  106 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV  106 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence            3455 6888888887       2334677888987 6699999975 345999999999999999999999999999999


Q ss_pred             CCCcEEecC-----------------CCCCCEEEecCCCcccccCC-----------------CCCCCCcCCCCCCCchh
Q 017860          146 KLENTLLDG-----------------SPAPRLKICDFGYSKSSVLH-----------------SQPKSTVGTPAYIAPEV  191 (365)
Q Consensus       146 kp~NIli~~-----------------~~~~~vkl~Dfgla~~~~~~-----------------~~~~~~~gt~~y~aPE~  191 (365)
                      ||+||||+.                 +..+.+|++|||+++.....                 ......+||++|||||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            999999953                 22335788888887642110                 00112468999999999


Q ss_pred             hcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 017860          192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT  271 (365)
Q Consensus       192 ~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t  271 (365)
                      +.+..++.+ +|||||||++|||++|.+|+.....  .+.........     +....-.+...+++.+||.++|.+||+
T Consensus       187 ~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        187 DNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLP-----PQILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             hccCCCCch-hhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcC-----hhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence            988888666 9999999999999999988754221  11111111111     111112456779999999999999999


Q ss_pred             HHHHhcCcccccC
Q 017860          272 IPEIMKHQWFLKN  284 (365)
Q Consensus       272 ~~ell~h~~f~~~  284 (365)
                      +.|+++||||.+.
T Consensus       259 ~~eil~h~~~~~~  271 (793)
T PLN00181        259 MSELLQSEFINEP  271 (793)
T ss_pred             hHHHhhchhhhhh
Confidence            9999999999763

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=1.7e-30  Score=220.33  Aligned_cols=164  Identities=21%  Similarity=0.237  Sum_probs=127.0

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcC
Q 017860          104 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  182 (365)
Q Consensus       104 g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~g  182 (365)
                      |+|.+++.. ...+++.+++.++.|++.||+|||+++      ||+|||++.++.  +|+  ||+++.....    ...|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence            689999986 445999999999999999999999998      999999986654  888  9988754322    2368


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH-HHhcccc-CCCCCCCCCH--HHHHHH
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-RILSVQY-SVPDTNPISQ--ECRDLI  258 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~s~--~~~~li  258 (365)
                      |+.|+|||++.+..++.+ +|||||||++|||++|+.||..........+.+. ....... ..+....++.  ++.+++
T Consensus        67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  145 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM  145 (176)
T ss_pred             cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence            999999999988888766 9999999999999999999976544332222222 1111110 0011222344  699999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccc
Q 017860          259 SRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      .+||..+|.+||++.+++.|+|+.
T Consensus       146 ~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      146 RVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHhcccccccCHHHHHHHHHHH
Confidence            999999999999999999999875

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.9e-31  Score=259.85  Aligned_cols=257  Identities=33%  Similarity=0.537  Sum_probs=203.1

Q ss_pred             Cc-ceecccccCCCeEEEEEEEccCCcEEEEEEee----cCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           24 RY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----RGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        24 ~y-~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~----~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .| .....+|.|++|.|+.+......+.++.|.+.    ....   ....+..|+.+-..++|||++.....+......+
T Consensus       318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~  397 (601)
T KOG0590|consen  318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL  397 (601)
T ss_pred             ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch
Confidence            46 45788999999988888887777777777654    2111   1123556777788899999988777776666666


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      -+||||++ +|+.++.+.++++..++..+++|++.|++|||+.|+.||||||+|+++..++.  +||+|||.+.......
T Consensus       398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc--eEEeecCcceeeccCc
Confidence            66999999 99999999889999999999999999999999999999999999999987765  9999999887544333


Q ss_pred             C-----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-----CCC
Q 017860          176 Q-----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----SVP  245 (365)
Q Consensus       176 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----~~~  245 (365)
                      .     ....+|+..|+|||++.+..|+....||||.|++++.|.+|+.||.............  ......     ...
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--~~~~~~~~~~~~~~  552 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--NYSDQRNIFEGPNR  552 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--ccccccccccChHH
Confidence            3     3456799999999999999999999999999999999999999997655432211000  000010     011


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .+..++.+.+.+|.+||+.+|.+|.|++++++.+||+...
T Consensus       553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             HHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            1233678899999999999999999999999999998654

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=224.45  Aligned_cols=248  Identities=18%  Similarity=0.223  Sum_probs=197.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeC-CE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-TH   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-~~   93 (365)
                      .+|++....+-+|.||.||.+.+..     +.+.|-+|.++....  .-..+..|-..+..+.|||+..+.++..+. ..
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            5678888899999999999997653     223455665544321  224577888999999999999999987655 45


Q ss_pred             EEEEEeecCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           94 LAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~--------~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                      .++++.+..-|.|..++..        .+.++..+...++.|++.|++|||+.|+||.||-..|.+|++.-  +|||+|=
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDs  440 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDS  440 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccc
Confidence            6788889988999998872        12477888899999999999999999999999999999998765  5999999


Q ss_pred             CCcccccCCCCC---CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccc
Q 017860          166 GYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQ  241 (365)
Q Consensus       166 gla~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  241 (365)
                      .++|..-+....   ...-....||+||.+.+..|++. +|+||||+++|||++ |+.|+...++.+.     ...+...
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm-----~~ylkdG  514 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEM-----EHYLKDG  514 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcch-hhhHHHHHHHHHHHhcCCCCccccCHHHH-----HHHHhcc
Confidence            999854333322   22234567999999998888766 999999999999998 8999987766432     2233455


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       242 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++...+.+.++++-.++.-||...|++||+.+|+..
T Consensus       515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            666666778999999999999999999999999864

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=1.1e-28  Score=229.40  Aligned_cols=170  Identities=16%  Similarity=0.107  Sum_probs=132.3

Q ss_pred             CCCCCCCCCCCCCcceecccccCCCeEEEEEEEcc-CCcEEEEEEeecC------CcccHHHHHHHHHHhcCCCCCcce-
Q 017860           12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVR-   83 (365)
Q Consensus        12 ~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~hpnIv~-   83 (365)
                      |+...|.....++|++.+.||+|+||+||+|+++. +++.||||++...      ......+.+|+.+++.++|+|++. 
T Consensus         7 ~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188          7 PLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             CCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            44455556667799999999999999999999876 6778899986532      112356899999999999999985 


Q ss_pred             eceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCCCEEE
Q 017860           84 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKI  162 (365)
Q Consensus        84 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDl-kp~NIli~~~~~~~vkl  162 (365)
                      +++.    ...|+||||+.|++|.. +..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++  ++||
T Consensus        87 l~~~----~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikL  153 (365)
T PRK09188         87 LLAT----GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAV  153 (365)
T ss_pred             EEEc----CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEE
Confidence            4432    45799999999999963 211   11   2567899999999999999999999 99999997554  4999


Q ss_pred             ecCCCcccccCCCC---------CCCCcCCCCCCCchhhcc
Q 017860          163 CDFGYSKSSVLHSQ---------PKSTVGTPAYIAPEVLLR  194 (365)
Q Consensus       163 ~Dfgla~~~~~~~~---------~~~~~gt~~y~aPE~~~~  194 (365)
                      +|||+|+.......         .....+++.|+|||.+..
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999985433221         134568889999999853

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.6e-27  Score=221.46  Aligned_cols=251  Identities=23%  Similarity=0.218  Sum_probs=193.4

Q ss_pred             CcceecccccCCCeEEEEEEEccCC-cEEEEEEeecCCcc-cHHHHHHHHHHhcCCC----CCcceeceEE-EeCCEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKI-DENVQREIINHRSLRH----PNIVRFKEVI-LTPTHLAI   96 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h----pnIv~l~~~~-~~~~~~~l   96 (365)
                      +|++.++||+|+||.||++.+..++ ..+|+|........ ...+..|+.++..+..    +++.++++.+ ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999998764 67899987664322 2268888888888863    6899999999 57888999


Q ss_pred             EEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-C--CCEEEecCCCcc--
Q 017860           97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK--  169 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~--~~vkl~Dfgla~--  169 (365)
                      ||+.+ |.+|.++....  ++|+...+..++.|++.+|.+||+.|++||||||+|+++.... .  ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99998 77999987543  5799999999999999999999999999999999999997653 1  359999999998  


Q ss_pred             cccCCC--------C-CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc
Q 017860          170 SSVLHS--------Q-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       170 ~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      ......        . .....||..|+++.+..+.....+ .|+||++.++.+++.|..||..........+..+.....
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~  256 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKL  256 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhh
Confidence            311111        1 123459999999999988777655 999999999999999999998766543332222221111


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       241 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ... ......+.++..+...+-..+...+|....+..
T Consensus       257 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  257 LTD-RFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             ccc-cccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            111 012224567777877777788889998777765

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=3.3e-27  Score=217.34  Aligned_cols=256  Identities=36%  Similarity=0.588  Sum_probs=203.7

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCC-CcceeceEEEeCCEEEEEEe
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e   99 (365)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.....    ....+.+|+.+++.+.|+ +|+++.+.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            788999999999999999987   7889999876433    356788999999999988 79999999988888999999


Q ss_pred             ecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860          100 YASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~---~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ++.++++...+....   .+++..+..++.|++.++.|+|+.+++|||+||+||+++.... .++++|||.++...... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCc
Confidence            999999997776664   7999999999999999999999999999999999999986552 48999999987433332 


Q ss_pred             ------CCCCCcCCCCCCCchhhccc--ccCCccceeehhhHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhccccCC
Q 017860          176 ------QPKSTVGTPAYIAPEVLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---PKDFRKTIQRILSVQYSV  244 (365)
Q Consensus       176 ------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  244 (365)
                            ......||+.|+|||.+.+.  .......|+||+|++++++++|..||.....   .....+.+..........
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  34667899999999999873  3444559999999999999999999877664   233333332222110111


Q ss_pred             CCCCC----CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 PDTNP----ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 ~~~~~----~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +....    ....+.+++.+++..+|..|.+..+...+++....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            11111    12578999999999999999999999988666543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.1e-29  Score=236.03  Aligned_cols=236  Identities=30%  Similarity=0.526  Sum_probs=195.8

Q ss_pred             ccccCCCeEEEEEEE---ccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeecC
Q 017860           30 DIGSGNFGVARLMRD---KVTKELVAVKYIERGDK---IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        30 ~LG~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .+|.|+||.|++++-   ...+..+|+|+..+...   ....-..|-.++..++ ||.+|+++..|+.+..++++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999987653   45788999998865321   1123345666777776 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcC
Q 017860          103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG  182 (365)
Q Consensus       103 ~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~g  182 (365)
                      ||.|...+.....+++...+.+...++.|+.++|+.+++|||+|++||+++.+|  ++|+.|||+++........   ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G--hi~~tdfglske~v~~~~~---cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG--HIKLTDFGLSKEAVKEKIA---CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC--ccccCCchhhhHhHhhhhc---cc
Confidence            999999999888899999999999999999999999999999999999998666  4999999998865433322   99


Q ss_pred             CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhc
Q 017860          183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF  262 (365)
Q Consensus       183 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  262 (365)
                      |..|||||++.  .+... +|.||+|+++++|++|..||..        .+...|......+|.  .++..+++++..++
T Consensus       156 t~eymApEI~~--gh~~a-~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSA-ADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLF  222 (612)
T ss_pred             chhhhhhHhhh--ccCCc-ccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHH
Confidence            99999999997  33334 8999999999999999999987        344445554444444  48899999999999


Q ss_pred             ccCCCCCCC-----HHHHhcCccccc
Q 017860          263 VADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       263 ~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      ..+|..|..     +.++++|+||..
T Consensus       223 ~r~p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  223 KRNPENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             hhCHHHHhccCcchhHHHhccchhee
Confidence            999999984     579999999964

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6.6e-26  Score=191.40  Aligned_cols=250  Identities=22%  Similarity=0.251  Sum_probs=192.5

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCcceeceEEEeCCEEEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv   97 (365)
                      +....+|+++++||+|+||.+|.+.+..+|..||||+-+.... ...+..|..+.+.|++ ..|..+.-++.+...-.+|
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            3445689999999999999999999999999999997655433 3567888899998875 6788888888888888999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-CEEEecCCCcccccCC-
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLH-  174 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~-~vkl~Dfgla~~~~~~-  174 (365)
                      |++. |-+|.++..= ..+|+...+.-++-|++.-++|+|.+++|||||||+|.|..-+... ++.|+|||+|+..... 
T Consensus        90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            9999 7789888753 4569999999999999999999999999999999999999654332 5899999999753322 


Q ss_pred             -------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--
Q 017860          175 -------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--  245 (365)
Q Consensus       175 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  245 (365)
                             .......||..|.+--...+...+.. .|+-|+|.++.++.-|..||++....... +....|.....+.|  
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~-QKyEkI~EkK~s~~ie  246 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKK-QKYEKISEKKMSTPIE  246 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHH-HHHHHHHHhhcCCCHH
Confidence                   12244579999999777665555444 89999999999999999999987654322 22223333332222  


Q ss_pred             -CCCCCCHHHHHHHHHhcccCCCCCCCH
Q 017860          246 -DTNPISQECRDLISRIFVADPAARITI  272 (365)
Q Consensus       246 -~~~~~s~~~~~li~~~l~~dp~~R~t~  272 (365)
                       ....++.++.-.+.-|-..--++-|..
T Consensus       247 ~LC~G~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  247 VLCKGFPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             HHhCCCcHHHHHHHHHHhhcCCCCCCcH
Confidence             124567888888888866666666653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.93  E-value=2e-26  Score=228.52  Aligned_cols=220  Identities=32%  Similarity=0.556  Sum_probs=169.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .++|..++.+..|+||.||.++|+.+.+.+|+| +.+....    .+-  ++....+|.+|                   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc--cccccCCccee-------------------
Confidence            457999999999999999999999999999995 4433221    111  33333444444                   


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-------
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------  174 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-------  174 (365)
                        |+-...++..++++...        +.+++|||+-||+|||+||+|.+|+.-+  ++|++|||+++.....       
T Consensus       136 --gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG--hiKlTDfgLsk~GLms~atnl~e  203 (1205)
T KOG0606|consen  136 --GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG--HIKLTDFGLSKKGLMSLATNLKE  203 (1205)
T ss_pred             --chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc--cccccchhhhhhhhhhccchhhh
Confidence              56666666666666544        8899999999999999999999997555  5999999997632111       


Q ss_pred             ---------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 017860          175 ---------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       175 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  245 (365)
                               ...+..+|||.|+|||++...+|.-+ +|+|++|+|+||.+-|+.||.+.+..+.+-..+...+    .+|
T Consensus       204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp-vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----~wp  278 (1205)
T KOG0606|consen  204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----EWP  278 (1205)
T ss_pred             cchHHHHHHhhhccccCCccccChhhhhhhccCCC-ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc----ccc
Confidence                     12245689999999999998888655 9999999999999999999999888766655554332    233


Q ss_pred             C-CCCCCHHHHHHHHHhcccCCCCCC---CHHHHhcCcccccC
Q 017860          246 D-TNPISQECRDLISRIFVADPAARI---TIPEIMKHQWFLKN  284 (365)
Q Consensus       246 ~-~~~~s~~~~~li~~~l~~dp~~R~---t~~ell~h~~f~~~  284 (365)
                      + ...+.++++++|.++|+.+|..|.   .+.++.+|+||+..
T Consensus       279 E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  279 EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             ccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            2 345789999999999999999997   67888899999753

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-24  Score=190.94  Aligned_cols=200  Identities=24%  Similarity=0.326  Sum_probs=169.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeecC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .|++.++||+|+||+.+.+.+..+++.||||.-.... ....+..|....+.|. .++|...+-+.....+-.+|+|++ 
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC-CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            7999999999999999999999999999999754432 3456888888888885 689999998888888888999999 


Q ss_pred             CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---CCEEEecCCCcccccCCC---
Q 017860          103 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS---  175 (365)
Q Consensus       103 ~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~---~~vkl~Dfgla~~~~~~~---  175 (365)
                      |-||.++..-. .+|+...+..++.|++.-++|+|++.+|.|||||+|+||...+.   ..|-|+|||+|+......   
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            77898888654 46999999999999999999999999999999999999964333   248899999998654332   


Q ss_pred             -----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC
Q 017860          176 -----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE  226 (365)
Q Consensus       176 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  226 (365)
                           ..++..||..||+--...+...+.. -|+-|||-++++++-|..||.+...
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccC
Confidence                 2345679999999888887776555 8999999999999999999998654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=4.9e-25  Score=191.39  Aligned_cols=169  Identities=15%  Similarity=0.174  Sum_probs=130.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHH----------HHHHHHHHhcCCCCCcceeceEEEeC
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----------VQREIINHRSLRHPNIVRFKEVILTP   91 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~----------~~~e~~~l~~l~hpnIv~l~~~~~~~   91 (365)
                      ..+|++++.||.|+||.||++..  ++..+|+|++.......+.          +.+|+..+.++.||+|..+.+++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            56999999999999999999755  4668999999654322222          57899999999999999999887643


Q ss_pred             --------CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 017860           92 --------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        92 --------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                              ...++||||++|.+|.+..    .+++    ....+++.+|..||+.|++|||+||+||+++.++   ++|+
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~li  176 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRII  176 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEE
Confidence                    3578999999999997763    2333    2456999999999999999999999999997654   9999


Q ss_pred             cCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHH
Q 017860          164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML  215 (365)
Q Consensus       164 Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  215 (365)
                      |||.++........           ..+.....+..+ +|+||||+++..+.
T Consensus       177 Dfg~~~~~~e~~a~-----------d~~vler~y~~~-~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRKAK-----------DRIDLERHYGIK-NEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchhhH-----------HHHHHHhHhccc-ccccceeEeehHHH
Confidence            99977643211111           113344556655 89999999886654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=8.9e-25  Score=187.16  Aligned_cols=137  Identities=20%  Similarity=0.200  Sum_probs=109.7

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----------c-----------------HHHHHHHHHHhcCCCCC
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------D-----------------ENVQREIINHRSLRHPN   80 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~-----------------~~~~~e~~~l~~l~hpn   80 (365)
                      ...||+|+||.||+|.+. +|+.||+|+++.+...          .                 ....+|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            468999999999999997 8999999999754211          0                 12235999999998887


Q ss_pred             cceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCCC
Q 017860           81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        81 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~L-H~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      +........ .. .++||||++|+++.......+.+++..+..++.|++.+|.++ |+.||+||||||+|||++.   ++
T Consensus        81 v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~---~~  155 (190)
T cd05147          81 IPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD---GK  155 (190)
T ss_pred             CCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC---Cc
Confidence            754433322 22 389999999887766555566799999999999999999999 7999999999999999973   35


Q ss_pred             EEEecCCCccc
Q 017860          160 LKICDFGYSKS  170 (365)
Q Consensus       160 vkl~Dfgla~~  170 (365)
                      ++|+|||+|..
T Consensus       156 v~LiDFG~a~~  166 (190)
T cd05147         156 LYIIDVSQSVE  166 (190)
T ss_pred             EEEEEcccccc
Confidence            99999999864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=5.7e-24  Score=182.62  Aligned_cols=139  Identities=18%  Similarity=0.147  Sum_probs=111.6

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---------------------------cHHHHHHHHHHhcCCCC
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------------------------DENVQREIINHRSLRHP   79 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------~~~~~~e~~~l~~l~hp   79 (365)
                      +.+.||+|+||.||+|.+. +|+.||||++..+...                           .....+|...+..+.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999987 8999999998764211                           11235788999999999


Q ss_pred             CcceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCC
Q 017860           80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        80 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~  158 (365)
                      ++.....+....  .|+||||++|+++........++++..+..++.|++.++.+||+ +||+||||||+||+++ +  +
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~--~  154 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D--G  154 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C--C
Confidence            886554444333  48999999988665443345668899999999999999999999 9999999999999997 3  3


Q ss_pred             CEEEecCCCcccc
Q 017860          159 RLKICDFGYSKSS  171 (365)
Q Consensus       159 ~vkl~Dfgla~~~  171 (365)
                      .++|+|||+++..
T Consensus       155 ~~~liDFG~a~~~  167 (190)
T cd05145         155 KPYIIDVSQAVEL  167 (190)
T ss_pred             CEEEEEcccceec
Confidence            5999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=6.2e-25  Score=218.36  Aligned_cols=237  Identities=24%  Similarity=0.403  Sum_probs=176.7

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cc-cHHH---HHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KI-DENV---QREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~-~~~~---~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .|..++.||++-|=+|.+|++. .|. |++|++-+.. .. -..+   .+|++ .+..++||++.+.-+..++...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            6888999999999999999986 344 9999986543 21 1233   34444 55568999999999888888889999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~~  177 (365)
                      +|... +|++++.....+..-+-++|+.||+.||.-+|..||+|||||.+||||+.=+  .+.|+||..-+... +..+.
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN--W~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN--WLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec--hhhhhcccccCCccCCCCCc
Confidence            99965 8999998888889999999999999999999999999999999999997443  58999997543211 11111


Q ss_pred             C-------CCcCCCCCCCchhhcccc----------cCCccceeehhhHHHHHHHh-CCCCCCCCCC-------hHHHHH
Q 017860          178 K-------STVGTPAYIAPEVLLRHE----------YDGKIADVWSCGVTLYVMLV-GGYPFEDPDE-------PKDFRK  232 (365)
Q Consensus       178 ~-------~~~gt~~y~aPE~~~~~~----------~~~~~~DiwSlG~il~ell~-g~~pf~~~~~-------~~~~~~  232 (365)
                      .       +...-..|.|||.+....          .-.++.||||+||+++||++ |++||.-..-       ......
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~  257 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ  257 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence            1       112234699999985421          12355899999999999998 7899963110       000111


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+..+            -+..++.||..|++.||.+|.+|++.|+.
T Consensus       258 ~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  258 LLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            11111            12468899999999999999999999985

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=7.1e-24  Score=190.74  Aligned_cols=195  Identities=28%  Similarity=0.405  Sum_probs=142.9

Q ss_pred             CCCCcceeceEEEe---------------------------CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 017860           77 RHPNIVRFKEVILT---------------------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI  129 (365)
Q Consensus        77 ~hpnIv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil  129 (365)
                      +|||||++...|.+                           +..+|+||.-.. .+|..++.... .+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-CchHHHHHHHHHHH
Confidence            69999999988864                           246899998874 48888886543 57888889999999


Q ss_pred             HHHHHHHHcCCeecCCCCCcEEe--cCCCCCCEEEecCCCcccccC-------CCCCCCCcCCCCCCCchhhcccc----
Q 017860          130 SGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL-------HSQPKSTVGTPAYIAPEVLLRHE----  196 (365)
Q Consensus       130 ~al~~LH~~~ivHrDlkp~NIli--~~~~~~~vkl~Dfgla~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~----  196 (365)
                      +|+.|||++||.|||||.+|||+  +++..+.+.|+|||.+-....       ....-...|.-.-||||+.+...    
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999998  455666899999997642221       11112334778899999985421    


Q ss_pred             -cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCH---
Q 017860          197 -YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITI---  272 (365)
Q Consensus       197 -~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~---  272 (365)
                       .+..++|.|+.|.+.||++....||........-....++   .+ -.+.+..+++.+++++..+|+.||.+|+++   
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe---~q-LPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE---SQ-LPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh---hh-CCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence             2233489999999999999999999873321100011111   11 112344578999999999999999999974   


Q ss_pred             HHHhc
Q 017860          273 PEIMK  277 (365)
Q Consensus       273 ~ell~  277 (365)
                      +.+++
T Consensus       508 ANvl~  512 (598)
T KOG4158|consen  508 ANVLN  512 (598)
T ss_pred             HhHHH
Confidence            45554

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=2.7e-23  Score=176.85  Aligned_cols=186  Identities=16%  Similarity=0.141  Sum_probs=140.2

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccH-----HHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----NVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      +.+...|++|+||+|+.+..  .+..++.+.+........     .+.+|+.+|++|. |++|++++++    ...|++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            45678899999999997766  677888887766554333     5789999999995 5889999886    3469999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDl-kp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      ||+.|.+|...+..       ....++.|++.+|.++|++||+|||| ||+|||++.++  .++|+|||++.........
T Consensus        78 eyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g--~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         78 SYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG--SPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             eeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC--CEEEEECCCceecCCcchH
Confidence            99999998754321       12457889999999999999999999 79999997655  4999999999754433210


Q ss_pred             ----C----------CCcCCCCCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCC
Q 017860          178 ----K----------STVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPD  225 (365)
Q Consensus       178 ----~----------~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~  225 (365)
                          .          ....++.|++|+...-- ..+-.+.++++.|+-+|.++|+..++.+..
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                0          11268889999864322 122133688999999999999998876543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.90  E-value=1.7e-23  Score=187.08  Aligned_cols=230  Identities=21%  Similarity=0.250  Sum_probs=144.9

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCC----------CCcceeceEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRH----------PNIVRFKEVIL   89 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h----------pnIv~l~~~~~   89 (365)
                      .+...+.||.|+++.||.+++..+|+.+|+|++.....    ..+.+++|......+.+          -.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            35667899999999999999999999999999864332    12456666554444322          12222222222


Q ss_pred             ---------eC---C-----EEEEEEeecCCCChHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 017860           90 ---------TP---T-----HLAIVMEYASGGELFERIC---NAGRF----SEDEARFFFQQLISGVSYCHAMQVCHRDL  145 (365)
Q Consensus        90 ---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~l----~~~~~~~i~~qil~al~~LH~~~ivHrDl  145 (365)
                               ..   .     ..+++|+-+ .++|...+.   .....    .......+..|++..+++||+.|+||+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     236677777 457766643   22222    22233456689999999999999999999


Q ss_pred             CCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhccc--------ccCCccceeehhhHHHHHHHhC
Q 017860          146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH--------EYDGKIADVWSCGVTLYVMLVG  217 (365)
Q Consensus       146 kp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~ell~g  217 (365)
                      +|+|++++.++.  ++|+||+.........  .....+..|.+||.....        .++. +.|.|+||+++|.|+||
T Consensus       172 ~~~nfll~~~G~--v~Lg~F~~~~r~g~~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~-~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGG--VFLGDFSSLVRAGTRY--RCSEFPVAFTPPELESCAGQFGQNNAPYTF-ATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS---EEE--GGGEEETTEEE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-H-HHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCC--EEEcChHHHeecCcee--eccCCCcccCChhhhhhhcccCcccceeee-ccCHHHHHHHHHHHHHc
Confidence            999999987765  9999998655332211  113445789999987442        2343 48999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCC
Q 017860          218 GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAAR  269 (365)
Q Consensus       218 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R  269 (365)
                      ..||........          ..+.+.....+++.++.||.++|+.||.+|
T Consensus       247 ~lPf~~~~~~~~----------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEAD----------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGST----------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCcccc----------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999987644221          111222223689999999999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.89  E-value=1.5e-22  Score=175.13  Aligned_cols=137  Identities=18%  Similarity=0.205  Sum_probs=109.3

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcC-----CCCCcceeceEEEeCC---E-E
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---H-L   94 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l-----~hpnIv~l~~~~~~~~---~-~   94 (365)
                      +.-.+.||+|+||.||.  +..++.. +||++.... ...+.+.+|+.+++.+     .||||++++++++++.   . +
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            33467899999999995  7666665 799887542 2346789999999999     6799999999999874   4 3


Q ss_pred             EEEEee--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEecCC--CCCCEEEecCCC
Q 017860           95 AIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHAMQVCHRDLKLENTLLDGS--PAPRLKICDFGY  167 (365)
Q Consensus        95 ~lv~e~--~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al-~~LH~~~ivHrDlkp~NIli~~~--~~~~vkl~Dfgl  167 (365)
                      .+|+||  +.+++|.+++.+. .+++.  ..++.|++.++ +|||+++|+||||||+|||++..  +..+++|+||+-
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            478999  5579999999764 56666  36688888888 99999999999999999999753  334699999553

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=180.21  Aligned_cols=241  Identities=21%  Similarity=0.319  Sum_probs=192.6

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeec---CCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ...+..+|.+...|..|++++.  |..++.|++..   ..+...+|..|.-.|+-..||||+.+++.+..+-++.++..|
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            4556788999999999999985  44566776643   344567889999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860          101 ASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      ++.|+|+..+.....  .+..++..++.+++.|++|||+..  |.---|....++|+++-..++-.+|--++-      +
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------q  342 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------Q  342 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------e
Confidence            999999999987654  578899999999999999999976  444468888999998887777777754332      2


Q ss_pred             CCCCcCCCCCCCchhhcccccC--CccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~--~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      .......|.||+||.+...+-+  ..++|+|||+++++||.|...||....+.+.-+++.-+    ......+..+|...
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale----glrv~ippgis~hm  418 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE----GLRVHIPPGISRHM  418 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc----cccccCCCCccHHH
Confidence            2334557899999999876543  45689999999999999999999987775544444332    22334455689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHh
Q 017860          255 RDLISRIFVADPAARITIPEIM  276 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell  276 (365)
                      ..|++-|+..||.+||.++.++
T Consensus       419 ~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceeh
Confidence            9999999999999999887664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=7.2e-24  Score=209.64  Aligned_cols=261  Identities=31%  Similarity=0.505  Sum_probs=211.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEcc-CCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~   95 (365)
                      ....|.+.+.||+|+|+.|-.+.... ....+|.|.+....   ........|..+.+.+. |+|++++++.......++
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            35689999999999999998887743 44566777765432   33355566888888887 999999999999999999


Q ss_pred             EEEeecCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           96 IVMEYASGGELFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        96 lv~e~~~~g~L~~~l-~~~~-~l~~~~~~~i~~qil~al~~LH-~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++.++. .++++|||+|....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~  176 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYR  176 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhcccc
Confidence            999999999999988 5544 5788899999999999999999 999999999999999987773 49999999998655


Q ss_pred             C-CC---CCCCCcC-CCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          173 L-HS---QPKSTVG-TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       173 ~-~~---~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      . .+   .....+| ++.|+|||...+..+..+..|+||.|+++.-+++|..||............+.. .........+
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  255 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKS-NKGRFTQLPW  255 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecc-cccccccCcc
Confidence            4 22   2344578 999999999988778888899999999999999999999876543321111111 1122234566


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ..++....+++.+++..+|..|.+.+++..++|+..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            778999999999999999999999999999999987

>smart00090 RIO RIO-like kinase

Probab=99.87  E-value=1e-21  Score=173.85  Aligned_cols=143  Identities=18%  Similarity=0.098  Sum_probs=112.2

Q ss_pred             CCcceecccccCCCeEEEEEE-EccCCcEEEEEEeecCCcc-------------------------cHHHHHHHHHHhcC
Q 017860           23 DRYDFVRDIGSGNFGVARLMR-DKVTKELVAVKYIERGDKI-------------------------DENVQREIINHRSL   76 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l   76 (365)
                      --|++.+.||+|+||.||+|. +..+|+.||+|++......                         ...+.+|+.+++.+
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358999999999999999999 6679999999998754210                         02356799999999


Q ss_pred             CCCCcceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCC
Q 017860           77 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-VCHRDLKLENTLLDGS  155 (365)
Q Consensus        77 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~-ivHrDlkp~NIli~~~  155 (365)
                      .+.+ +.+...+... ..++||||+.|++|.........+....+..++.|++.+|.+||+.| ++||||||+||+++ +
T Consensus       108 ~~~~-i~~p~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~  184 (237)
T smart00090      108 YEAG-VPVPKPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D  184 (237)
T ss_pred             HhcC-CCCCeeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence            7532 2222333222 35899999999888766544556677788899999999999999999 99999999999998 3


Q ss_pred             CCCCEEEecCCCccc
Q 017860          156 PAPRLKICDFGYSKS  170 (365)
Q Consensus       156 ~~~~vkl~Dfgla~~  170 (365)
                      +  .++|+|||.+..
T Consensus       185 ~--~i~LiDFg~a~~  197 (237)
T smart00090      185 G--KVVIIDVSQSVE  197 (237)
T ss_pred             C--CEEEEEChhhhc
Confidence            3  599999998763

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=8.4e-23  Score=190.52  Aligned_cols=176  Identities=25%  Similarity=0.324  Sum_probs=135.3

Q ss_pred             CEEEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           92 THLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      .++||.|++|.-.+|.+++.+..   ..+....+.++.|+..|+.|   +|.+|||+||.||+...+.  .+||+|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhhe
Confidence            35899999999999999997544   35778889999999999999   9999999999999997665  4999999998


Q ss_pred             ccccCCC-------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 017860          169 KSSVLHS-------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       169 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      .......       ..+..+||++||+||.+.+..|..+ +||||||+|++||+. -..+|+..       .....+-.+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er~-------~t~~d~r~g  475 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFERI-------ATLTDIRDG  475 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHHH-------HhhhhhhcC
Confidence            7655444       4566789999999999999999877 999999999999997 33333321       122222222


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       241 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      .+...... --++-..|+.+||.+.|.+||++.+.--|+|.
T Consensus       476 ~ip~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  476 IIPPEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             CCChHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            22100111 12345689999999999999988887777764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2.7e-21  Score=195.54  Aligned_cols=194  Identities=23%  Similarity=0.287  Sum_probs=159.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC---CCCcceeceEEEeCCEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++.|.|-+.||+|+||.||+|.+.. |+.||+|+-+....+.-  .--.+++.+|+   -+.|+.+..++...+.-++|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf--YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF--YICLQVMERLKPQMLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee--eehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence            46789999999999999999999986 99999998766544331  11122333343   35677777777788888999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----CCCCEEEecCCCcccc-
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----PAPRLKICDFGYSKSS-  171 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-----~~~~vkl~Dfgla~~~-  171 (365)
                      +||.+.|+|.+++...+.+++..+..+..|++..+.+||..+|||+||||.|.||...     +..-++|+|||.+... 
T Consensus       773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            9999999999999988889999999999999999999999999999999999999522     2234999999987643 


Q ss_pred             --cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCC
Q 017860          172 --VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG  218 (365)
Q Consensus       172 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~  218 (365)
                        ..+......++|-.+-.+|...|..++.. +|.|.|+.+++.|+.|+
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGK  900 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHH
Confidence              22334455678999999999999999988 89999999999999986

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.3e-20  Score=178.76  Aligned_cols=203  Identities=24%  Similarity=0.325  Sum_probs=157.0

Q ss_pred             HhcCCCCCcceeceEEEeCCEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCcE
Q 017860           73 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQV-CHRDLKLENT  150 (365)
Q Consensus        73 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~i-vHrDlkp~NI  150 (365)
                      |+.+.|.|+.++++.+......++|.+||..|+|.+.+.. ..+++......++++|+.||+|||..-| .|+.|+..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4678999999999999999999999999999999999987 4568888899999999999999998765 9999999999


Q ss_pred             EecCCCCCCEEEecCCCcccccC---CCCCCCCcCCCCCCCchhhccccc------CCccceeehhhHHHHHHHhCCCCC
Q 017860          151 LLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEY------DGKIADVWSCGVTLYVMLVGGYPF  221 (365)
Q Consensus       151 li~~~~~~~vkl~Dfgla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlG~il~ell~g~~pf  221 (365)
                      +++....  +||+|||+......   ........-...|.|||.+.....      .+++.||||+|++++|+++..-||
T Consensus        81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9987665  99999998764421   011112223456999999976421      244589999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhc-cc----cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          222 EDPDEPKDFRKTIQRILS-VQ----YSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..........+++..+.. ..    +.........+++..+++.||..+|..||+++++-.
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            875443332334444333 11    122222245668999999999999999999988764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=8.4e-20  Score=159.36  Aligned_cols=134  Identities=22%  Similarity=0.216  Sum_probs=112.4

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++.||+|++|.||++.+  .|..+++|.......         ....+.+|+.++..+.|++|.....++......++||
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999987  677899997653221         1134678999999999999988777777788889999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      ||++|++|.+.+....   . ....++.+++.+|.++|+.|++|||++|.|||++ ++  .++|+|||.++.
T Consensus        79 e~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence            9999999999886543   2 8889999999999999999999999999999998 33  499999998764

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.81  E-value=1.8e-19  Score=155.81  Aligned_cols=134  Identities=22%  Similarity=0.258  Sum_probs=105.9

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-----------------------ccHHHHHHHHHHhcCCCCC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHPN   80 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~hpn   80 (365)
                      .|.+.+.||+|+||.||++.+. +|+.||+|++..+..                       ......+|+.++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4888999999999999999885 799999998765321                       0123567888888887774


Q ss_pred             --cceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           81 --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        81 --Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                        +++.++    ....++||||++|++|.....      ......++.+++.++.++|+.|++||||||+||+++.++  
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--  162 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--  162 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--
Confidence              444433    234589999999999876532      145677889999999999999999999999999998654  


Q ss_pred             CEEEecCCCccc
Q 017860          159 RLKICDFGYSKS  170 (365)
Q Consensus       159 ~vkl~Dfgla~~  170 (365)
                      .++|+|||++..
T Consensus       163 ~~~liDfg~~~~  174 (198)
T cd05144         163 KIYIIDWPQMVS  174 (198)
T ss_pred             cEEEEECCcccc
Confidence            499999998864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.4e-19  Score=153.38  Aligned_cols=129  Identities=21%  Similarity=0.197  Sum_probs=104.7

Q ss_pred             ccccCCCeEEEEEEEccCCcEEEEEEeecCC-cc--------cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           30 DIGSGNFGVARLMRDKVTKELVAVKYIERGD-KI--------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        30 ~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~--------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .||+|+||.||++..  ++..+++|...... ..        ...+.+|+.+++.+.|+++....-++......++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            389999999999984  67889999864321 11        14567899999999988766655556667777999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      ++|++|.+.+.....       .++.+++.+|.+||+.|++|||++|.||+++ +  +.+++.|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~--~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D--DKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C--CcEEEEECCCCcC
Confidence            999999988754321       8899999999999999999999999999998 3  3599999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=1.2e-18  Score=172.61  Aligned_cols=134  Identities=22%  Similarity=0.177  Sum_probs=108.2

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEee-cCCc--------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDK--------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~--------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .|...+.||+|+||+||++.....  .+++|+.. +...        ..+.+.+|+.+++.++|++++....++......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            456688999999999999987533  34444322 1111        124578899999999999999887777777778


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      ++||||++|++|.+++.        ....++.+++.+|.+||+.|++||||||+|||++ ++  .++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence            99999999999998875        4577899999999999999999999999999994 33  499999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.76  E-value=2.2e-18  Score=147.42  Aligned_cols=133  Identities=22%  Similarity=0.285  Sum_probs=95.1

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHH-------------------------HHHHHHHHhcCCCCC--
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------------------------VQREIINHRSLRHPN--   80 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-------------------------~~~e~~~l~~l~hpn--   80 (365)
                      .+.||+|+||+||+|.+. +++.||||++.........                         ...|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999987 8999999998754321111                         124555555554332  


Q ss_pred             cceeceEEEeCCEEEEEEeecCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCC
Q 017860           81 IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        81 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~  158 (365)
                      +.+.+.+    ...++||||++++.+.. .+... ... .+++.++.+++.++.++|. .|++||||||+||+++ ++  
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--  151 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--  151 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--
Confidence            3333332    23589999999854432 12111 111 6788999999999999999 9999999999999998 33  


Q ss_pred             CEEEecCCCccc
Q 017860          159 RLKICDFGYSKS  170 (365)
Q Consensus       159 ~vkl~Dfgla~~  170 (365)
                      .++|+|||.+..
T Consensus       152 ~~~liDfg~a~~  163 (187)
T cd05119         152 KVYIIDVPQAVE  163 (187)
T ss_pred             cEEEEECccccc
Confidence            499999998864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.74  E-value=3.8e-17  Score=144.98  Aligned_cols=133  Identities=20%  Similarity=0.232  Sum_probs=102.5

Q ss_pred             cccc-cCCCeEEEEEEEccCCcEEEEEEeecCC--------------cccHHHHHHHHHHhcCCCCCc--ceeceEEEeC
Q 017860           29 RDIG-SGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNI--VRFKEVILTP   91 (365)
Q Consensus        29 ~~LG-~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~hpnI--v~l~~~~~~~   91 (365)
                      ..|| .|+.|+||.+...  +..+++|.+....              .....+.+|+.++..+.|++|  ++.+++...+
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4577 8899999988774  7789999886421              122457889999999998875  6666664433


Q ss_pred             C-E---EEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           92 T-H---LAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        92 ~-~---~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                      . .   .++|||+++| .+|.+++.. ..+++..    +.+++.+|.+||++||+||||||+|||++.++  .++|+|||
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg  187 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFD  187 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECC
Confidence            2 2   2599999997 688887754 3456543    56899999999999999999999999998655  49999999


Q ss_pred             Cccc
Q 017860          167 YSKS  170 (365)
Q Consensus       167 la~~  170 (365)
                      .++.
T Consensus       188 ~~~~  191 (239)
T PRK01723        188 RGEL  191 (239)
T ss_pred             Cccc
Confidence            8764

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=4.8e-17  Score=133.41  Aligned_cols=132  Identities=23%  Similarity=0.254  Sum_probs=111.5

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC--CCcceeceEEEeCCEEEEEEeecCCC
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      +++.||+|.++.||++....  ..+++|.+..... ...+.+|+..++.++|  .++++++.++...+..+++|||+.|+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            46889999999999999853  7899999866543 5678899999999976  58999998888888899999999988


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860          105 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus       105 ~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~---~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      .+...       +......++.+++.+|++||..   +++|+||+|+||+++..+  .+++.|||.++.
T Consensus        79 ~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAGY  138 (155)
T ss_pred             ecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEecccccC
Confidence            77654       5566778899999999999985   699999999999998643  599999998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=1.1e-17  Score=167.15  Aligned_cols=258  Identities=26%  Similarity=0.378  Sum_probs=201.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .+.+.+.+.+-+|+++.++.+.-..+|...++|.........    +....+-.++-..++|.+++..-.|......+++
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~  882 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV  882 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence            457888899999999999999988888888888765543222    2222333333334567777766666667889999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc-cccC---
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVL---  173 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~-~~~~---  173 (365)
                      ++|..+++|...++..+..+++.++..+..+..++++||...++|||++|.|+++..++.  .+++|||... ....   
T Consensus       883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~  960 (1205)
T KOG0606|consen  883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPT  960 (1205)
T ss_pred             hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCc
Confidence            999999999999999888999999999999999999999999999999999999976654  8999998322 1000   


Q ss_pred             -------C---------------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCC
Q 017860          174 -------H---------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD  225 (365)
Q Consensus       174 -------~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  225 (365)
                             .                     .......||+.|.+||.+.+...... +|+|++|+++++.++|.+||...+
T Consensus       961 ~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~t 1039 (1205)
T KOG0606|consen  961 TDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAET 1039 (1205)
T ss_pred             CCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcc
Confidence                   0                     00122358999999999988887666 899999999999999999999877


Q ss_pred             ChHHHHHHHHHHhccccCCCC-CCCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCcccccCCC
Q 017860          226 EPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVADPAARITIP---EIMKHQWFLKNLP  286 (365)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~li~~~l~~dp~~R~t~~---ell~h~~f~~~~~  286 (365)
                      ...    +.+.+.+....+|. ....+.++.+++.+.|..+|.+|..+.   ++-.|+||+..-.
T Consensus      1040 pq~----~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1040 PQQ----IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred             hhh----hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence            754    44555566655554 345789999999999999999999877   8889999976443

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=4.7e-17  Score=154.87  Aligned_cols=250  Identities=20%  Similarity=0.173  Sum_probs=192.1

Q ss_pred             CCcceeccccc--CCCeEEEEEEE--ccCCcEEEEEEeec---CCcccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEE
Q 017860           23 DRYDFVRDIGS--GNFGVARLMRD--KVTKELVAVKYIER---GDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHL   94 (365)
Q Consensus        23 ~~y~~~~~LG~--G~~g~V~~~~~--~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~   94 (365)
                      ..+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+.   .......-.+|+.-.+.++ |+|.++.+..+...+.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            46778899999  99999999998  88899999997432   1223344556776666664 99999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           95 AIVMEYASGGELFERICNAGR-FSEDEARFFFQQLIS----GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~qil~----al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      |+-+|+|. .+|..+...... +++..++..+.+...    ||.++|+.+++|-|+||.||+...+. ...+++|||+..
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~  271 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVS  271 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeE
Confidence            99999995 678777766544 899999999999999    99999999999999999999998773 248999999877


Q ss_pred             cccCCCCC------CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCC--CChHHHHHHHHHHhccc
Q 017860          170 SSVLHSQP------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP--DEPKDFRKTIQRILSVQ  241 (365)
Q Consensus       170 ~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~--~~~~~~~~~~~~~~~~~  241 (365)
                      ........      ...-|...|++||.+++ .+ ..+.||+|||.++.+-.++..++...  +.+..++...       
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~-~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-------  342 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LA-TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-------  342 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhcc-cc-chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-------
Confidence            54443322      12247778999998753 33 44589999999999999887766554  3332221111       


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       242 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .........+..+...+..|++.+|..|++++.++.|+++.+
T Consensus       343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            111112345667777999999999999999999999998864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.58  E-value=4.1e-14  Score=136.36  Aligned_cols=182  Identities=18%  Similarity=0.262  Sum_probs=136.7

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      |.+ ....-++.+..-.+..+.++..|.+...+.... ......+.+..++.++||||+++++.++.+..+|+|+|-+. 
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~-   92 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR-   92 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc-
Confidence            555 444444444333466677889999998876554 23457788899999999999999999999999999999984 


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-CCCCc
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV  181 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH-~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-~~~~~  181 (365)
                       .|..++.+.   +...+..-+.||+.||.+|| ..+++|++|.-..++++..+.  .||++|.++........ .....
T Consensus        93 -Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~  166 (690)
T KOG1243|consen   93 -PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLY  166 (690)
T ss_pred             -cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccch
Confidence             566666654   47788889999999999997 678999999999999987765  99999988754322221 12222


Q ss_pred             CCCCCCCchhhcccccCCccceeehhhHHHHHHHhC
Q 017860          182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG  217 (365)
Q Consensus       182 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g  217 (365)
                      ---.|..|+.+....+  . .|.|-|||++++++.|
T Consensus       167 ~~~s~~~P~~~~~s~~--s-~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  167 LIESFDDPEEIDPSEW--S-IDSWGLGCLIEELFNG  199 (690)
T ss_pred             hhhcccChhhcCcccc--c-hhhhhHHHHHHHHhCc
Confidence            2334677776533332  2 5999999999999998

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=1.6e-15  Score=144.48  Aligned_cols=248  Identities=20%  Similarity=0.179  Sum_probs=181.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEc-cCCcEEEEEEeecCCccc---HHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..+|..+..||.|.|+.|+.+.-. .++..|++|...++....   ..-..|+.+...+ .|.++++++..|......|+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i  343 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI  343 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence            457999999999999999887654 578899999876543211   1123455555555 58999999999988888899


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      --|||.++++...+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++..++ +..++.|||..+...  ..
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~--~~  420 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLA--FS  420 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccc--ee
Confidence            999999999887775556689999999999999999999999999999999999997653 457999999876421  11


Q ss_pred             CCCCcCCCCCC-Cchhhcc-cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          177 PKSTVGTPAYI-APEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       177 ~~~~~gt~~y~-aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      .......-++. .+|++.. ..+..+ .|++|||.-+.+.+++...-+......       .+...  ..+.....+.++
T Consensus       421 ~~~~~~~~r~~p~~~~~~e~~~~~~~-~~~~sl~~~~~e~~~~~~ls~~~~~~~-------~i~~~--~~p~~~~~~~~~  490 (524)
T KOG0601|consen  421 SGVFHHIDRLYPIAEILLEDYPHLSK-ADIFSLGLSVDEAITGSPLSESGVQSL-------TIRSG--DTPNLPGLKLQL  490 (524)
T ss_pred             cccccccccccccchhhccccccccc-cccccccccccccccCcccCcccccce-------eeecc--cccCCCchHHhh
Confidence            12222333444 2555544 444444 899999999999999865333222211       11111  123333344788


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      ..+.+.+...++..|+.+.++..|.-|-
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchhh
Confidence            8999999999999999999999887653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=2.3e-15  Score=146.58  Aligned_cols=140  Identities=24%  Similarity=0.327  Sum_probs=94.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-----------------------------------ccHH---
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------------------------------IDEN---   65 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------------------~~~~---   65 (365)
                      .|+. +.||+|++|+||+|+.+.+|+.||||+..++-.                                   ..+.   
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4666 899999999999999997799999999875410                                   0111   


Q ss_pred             ---HHHHHHHHhcC----CCCCcceeceEEEe-CCEEEEEEeecCCCChHHH--HHhcC----CCCHHHHHHHHHHHHHH
Q 017860           66 ---VQREIINHRSL----RHPNIVRFKEVILT-PTHLAIVMEYASGGELFER--ICNAG----RFSEDEARFFFQQLISG  131 (365)
Q Consensus        66 ---~~~e~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~----~l~~~~~~~i~~qil~a  131 (365)
                         +.+|+.++.++    .+.+.+.+-.++.+ ....++||||+.|+.+.+.  +...+    .+.+..+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence               22333333333    23333333333322 3445799999999999764  33333    245555666666665  


Q ss_pred             HHHHHHcCCeecCCCCCcEEecCCC--CCCEEEecCCCcccc
Q 017860          132 VSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSS  171 (365)
Q Consensus       132 l~~LH~~~ivHrDlkp~NIli~~~~--~~~vkl~Dfgla~~~  171 (365)
                           ..|++|+|+||.||+++.++  .+++++.|||++...
T Consensus       278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l  314 (537)
T PRK04750        278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL  314 (537)
T ss_pred             -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence                 58999999999999998655  236999999987643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=3.3e-15  Score=132.30  Aligned_cols=202  Identities=17%  Similarity=0.292  Sum_probs=141.9

Q ss_pred             HHHhcCCCCCcceeceEEEeCC-----EEEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--
Q 017860           71 INHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ--  139 (365)
Q Consensus        71 ~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~--  139 (365)
                      -.+-.+.|.|||+++.++.+..     ...+++||++.|+|..+|++.    ..+.....++|+-||+.||.|||+-.  
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            4455667999999999986543     478999999999999998753    34888999999999999999999876  


Q ss_pred             CeecCCCCCcEEecCCCCCCEEEecCCCccc---cc--CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHH
Q 017860          140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SV--LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVM  214 (365)
Q Consensus       140 ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~---~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  214 (365)
                      |+|+++...-|++..++-  +|++----...   ..  .........+.++|.|||.=.....+.. +|||++|....+|
T Consensus       199 iihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHH
Confidence            999999999999986654  66642111000   00  0111122346789999997655555555 9999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          215 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       215 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ..+..--...+........+....   +...     ...-++++.+||+..|..||++.+++.||.+.+
T Consensus       276 ailEiq~tnseS~~~~ee~ia~~i---~~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIANVI---IGLE-----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HHheeccCCCcceeehhhhhhhhe---eecc-----CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            987643322222222222222211   1111     122357899999999999999999999997754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.55  E-value=2.5e-14  Score=120.20  Aligned_cols=127  Identities=19%  Similarity=0.232  Sum_probs=96.5

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcc-eeceEEEeCCEEEEEEeecCCCCh
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ++.|+.|.++.||++...  ++.|++|.............+|+.+++.+.+.+++ +++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            577899999999999874  77899998765543334568899999888655544 4554432  335799999999888


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       107 ~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~i-----vHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      ...        ......++.+++.+|+.||+.++     +|+|++|.||+++ ++  .++++|||.+.
T Consensus        79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~  135 (170)
T cd05151          79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG  135 (170)
T ss_pred             ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence            643        11123467899999999999985     9999999999998 33  49999999765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=3.7e-14  Score=136.47  Aligned_cols=137  Identities=18%  Similarity=0.182  Sum_probs=93.3

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCcc--------------------------c---------------HHHH
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--------------------------D---------------ENVQ   67 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------~---------------~~~~   67 (365)
                      +.||+|++|+||+|+.+ +|+.||||+...+-..                          .               -++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999976 7899999997543100                          0               0133


Q ss_pred             HHHHHHhcC----CCCCcceeceEEE-eCCEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHcCC
Q 017860           68 REIINHRSL----RHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHAMQV  140 (365)
Q Consensus        68 ~e~~~l~~l----~hpnIv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~-al~~LH~~~i  140 (365)
                      +|..++..+    +|.+-+.+-.++. .....++||||++|++|.+..... ..+.   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            455544444    2222233322322 234468999999999998876432 1222   3345555555 4678999999


Q ss_pred             eecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860          141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus       141 vHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +|+|+||.||+++.++  +++|+|||++...
T Consensus       279 ~H~D~hPgNilv~~~g--~i~liDfG~~~~l  307 (437)
T TIGR01982       279 FHADLHPGNIFVLKDG--KIIALDFGIVGRL  307 (437)
T ss_pred             eeCCCCcccEEECCCC--cEEEEeCCCeeEC
Confidence            9999999999997665  4999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.50  E-value=3.8e-13  Score=114.56  Aligned_cols=136  Identities=14%  Similarity=0.163  Sum_probs=99.0

Q ss_pred             ecccccCCCeEEEEEEEcc------CCcEEEEEEeecCC--------------cc---------cHH----HHHHHHHHh
Q 017860           28 VRDIGSGNFGVARLMRDKV------TKELVAVKYIERGD--------------KI---------DEN----VQREIINHR   74 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~--------------~~---------~~~----~~~e~~~l~   74 (365)
                      ...||.|--+.||.|....      .+..+|+|+++.+.              ..         ...    .++|...|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999998653      35789999975311              00         112    337999998


Q ss_pred             cCCC--CCcceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEE
Q 017860           75 SLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTL  151 (365)
Q Consensus        75 ~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~L-H~~~ivHrDlkp~NIl  151 (365)
                      ++..  -++.+.+.+    ..-++||||+.++.+.....+...+++.++..+..+++.+|..| |+.|+||+||+|.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            8853  355555543    34579999997754432222233466677888899999999998 8999999999999999


Q ss_pred             ecCCCCCCEEEecCCCccc
Q 017860          152 LDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus       152 i~~~~~~~vkl~Dfgla~~  170 (365)
                      +..+   .+.|+|||.+..
T Consensus       158 ~~~~---~v~iIDF~qav~  173 (197)
T cd05146         158 WHDG---KVWFIDVSQSVE  173 (197)
T ss_pred             EECC---cEEEEECCCcee
Confidence            9742   499999997653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.33  E-value=1.1e-11  Score=108.52  Aligned_cols=140  Identities=20%  Similarity=0.269  Sum_probs=106.7

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCC--CcceeceEEEeC---CEEEEEEee
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHP--NIVRFKEVILTP---THLAIVMEY  100 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hp--nIv~l~~~~~~~---~~~~lv~e~  100 (365)
                      ++.|+.|..+.||++... +|+.+++|.......  ....+.+|..+++.+.+.  ++.+++.+....   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            367899999999999875 367899999765443  346788999999998763  456677666553   256899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-------------------------------------------  137 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-------------------------------------------  137 (365)
                      ++|.++...+.. ..+++.+...++.+++.+|+.||+                                           
T Consensus        82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (223)
T cd05154          82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL  160 (223)
T ss_pred             eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence            999888765432 356777888888888888888884                                           


Q ss_pred             -------------cCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          138 -------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       138 -------------~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                                   ..++|+|++|.||+++.+..+.+.|+||+.+.
T Consensus       161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         22599999999999986322347899998765

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.30  E-value=3.6e-11  Score=99.35  Aligned_cols=130  Identities=22%  Similarity=0.207  Sum_probs=97.8

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEe-ecC---Ccc-----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYI-ERG---DKI-----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~-~~~---~~~-----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..+++|+-+.++.+..  -|..+++|.- .+.   +..     ...-.+|..+++.++--.|..-.=++.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4578999999998855  3445777753 221   111     1345678899988876666555555667777889999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      |++|..|.+.+...       ...++..+=.-+.-||..||+|+||.++||++..++   +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~---i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR---IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc---EEEEECCcccc
Confidence            99999998888665       245667777778889999999999999999997554   89999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.26  E-value=6.6e-11  Score=97.45  Aligned_cols=143  Identities=19%  Similarity=0.108  Sum_probs=106.1

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEee-cCC--------cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGD--------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~--------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .+..|-+|+-+.|+.+..  .|+.++||.-. +.-        ......++|+..+.++.--.|.--.=+|.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567788999999998876  68888888632 221        1224567888888887655555555566677777899


Q ss_pred             EeecCC-CChHHHHHhcC-CCCHH-HHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC-CEEEecCCCcccc
Q 017860           98 MEYASG-GELFERICNAG-RFSED-EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSS  171 (365)
Q Consensus        98 ~e~~~~-g~L~~~l~~~~-~l~~~-~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~-~vkl~Dfgla~~~  171 (365)
                      |||++| .++.+++.... .-.++ ....++.+|-+.+.-||.++++|+||.++||++..++.. .+.+.|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999977 46777776532 22333 337899999999999999999999999999999766543 3589999997643

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.24  E-value=3.2e-10  Score=106.71  Aligned_cols=210  Identities=18%  Similarity=0.236  Sum_probs=149.4

Q ss_pred             eEEEEEEEccCCcEEEEEEeecCCccc-HHHHHHHHHHhcCCCCCcceeceEEEeC----CEEEEEEeecCC-CChHHHH
Q 017860           37 GVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVILTP----THLAIVMEYASG-GELFERI  110 (365)
Q Consensus        37 g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~----~~~~lv~e~~~~-g~L~~~l  110 (365)
                      .+.|++....+|..|++|++.-..... ...-.-+..++++.|+|||++.++|.+.    ..+++|++|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            577999999999999999994332221 1233456788999999999999999843    568999999865 6777654


Q ss_pred             H---------------hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860          111 C---------------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus       111 ~---------------~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      -               .+.+.+|..+|.++.|+..||.++|+.|+.-+-|.|.+||++++.  +++|.-.|.........
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP  447 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC
Confidence            2               223468999999999999999999999999999999999997554  58887766544322211


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCC-CCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                            +       |-+..    .+.-|.=-||.+++.|.||..- +..... ...  .+..+.         ..+|.++
T Consensus       448 ------~-------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~-~~s--~~~~I~---------~~yS~D~  498 (655)
T KOG3741|consen  448 ------T-------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDST-QSS--HLTRIT---------TTYSTDL  498 (655)
T ss_pred             ------C-------cchhH----HhhhhHHHHHHHHHHHhhcccccccccch-HHH--HHHHhh---------hhhhHHH
Confidence                  0       11221    1226888999999999999532 221111 111  112211         1278899


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 017860          255 RDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +++|.-+...+++. -++.+++.+
T Consensus       499 rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  499 RNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHhcCccc-ccHHHHHHH
Confidence            99999998888886 678888765

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.21  E-value=9.7e-12  Score=120.58  Aligned_cols=153  Identities=18%  Similarity=0.297  Sum_probs=108.9

Q ss_pred             HHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC----------CCCcCCCCCCCchhhcc
Q 017860          126 QQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----------KSTVGTPAYIAPEVLLR  194 (365)
Q Consensus       126 ~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~----------~~~~gt~~y~aPE~~~~  194 (365)
                      .+++.|+.|+|. .++||++|.|++|.++.++.  +||+.|+.+.........          ....-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999996 68999999999999987776  999999976543321111          11124567999999987


Q ss_pred             cccCCccceeehhhHHHHHHH-hCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017860          195 HEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP  273 (365)
Q Consensus       195 ~~~~~~~~DiwSlG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~  273 (365)
                      ...+.. +|++||||++|.+. .|+.-+......... ..... ...-........+++++++-+.++|..++.-||++.
T Consensus       184 ~~~~~~-sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~~~~-~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~  260 (700)
T KOG2137|consen  184 TTNTPA-SDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SFSRN-LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD  260 (700)
T ss_pred             cccccc-ccceeeeeEEEEEecCCcchhhccCCcchh-hhhhc-ccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence            555544 99999999999999 566655544332211 11111 111112223356889999999999999999999999


Q ss_pred             HHhcCccccc
Q 017860          274 EIMKHQWFLK  283 (365)
Q Consensus       274 ell~h~~f~~  283 (365)
                      +++..|||..
T Consensus       261 ~l~~~~ff~D  270 (700)
T KOG2137|consen  261 LLLSIPFFSD  270 (700)
T ss_pred             hhhcccccCC
Confidence            9999999965

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.18  E-value=9.4e-10  Score=98.91  Aligned_cols=129  Identities=14%  Similarity=0.058  Sum_probs=92.4

Q ss_pred             EEEEEEccCCcEEEEEEeecCCc-----------c-cHHHHHHHHHHhcCCCCCcce--eceEEEe-----CCEEEEEEe
Q 017860           39 ARLMRDKVTKELVAVKYIERGDK-----------I-DENVQREIINHRSLRHPNIVR--FKEVILT-----PTHLAIVME   99 (365)
Q Consensus        39 V~~~~~~~~~~~vaiK~~~~~~~-----------~-~~~~~~e~~~l~~l~hpnIv~--l~~~~~~-----~~~~~lv~e   99 (365)
                      |+.+..  .|+.|.||.......           . ...+.+|...+..+...+|..  .+.++..     ....++|||
T Consensus        38 vvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         38 TLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             EEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            444433  677889997643220           0 014778888887775434333  3444432     235789999


Q ss_pred             ecCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-----CCCCCEEEecCCCcc
Q 017860          100 YASGG-ELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK  169 (365)
Q Consensus       100 ~~~~g-~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~-----~~~~~vkl~Dfgla~  169 (365)
                      ++++. +|.+++..  ....++.....++.+++..+.-||..||+|+||++.|||++.     ++...+.|+||+.++
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99875 78888754  344567788899999999999999999999999999999975     234569999999765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.09  E-value=1.2e-09  Score=92.67  Aligned_cols=123  Identities=26%  Similarity=0.310  Sum_probs=81.1

Q ss_pred             EEEEEEEccCCcEEEEEEeecCC--------------c-------------ccHHHHHHHHHHhcCCCC--CcceeceEE
Q 017860           38 VARLMRDKVTKELVAVKYIERGD--------------K-------------IDENVQREIINHRSLRHP--NIVRFKEVI   88 (365)
Q Consensus        38 ~V~~~~~~~~~~~vaiK~~~~~~--------------~-------------~~~~~~~e~~~l~~l~hp--nIv~l~~~~   88 (365)
                      .||.|... +|..+|+|+...+.              .             ......+|..+|..+..-  ++.+++++ 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            38888875 67899999975321              0             013467899999999765  45566543 


Q ss_pred             EeCCEEEEEEeecC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           89 LTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        89 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~-LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                       .+  -+|||||++  |..+..+....  ++......++.+++..+.. +|..|++|+||.+.||+++.+   .+.|+||
T Consensus        79 -~~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~---~~~iIDf  150 (188)
T PF01163_consen   79 -NR--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG---KVYIIDF  150 (188)
T ss_dssp             -ET--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT---CEEE--G
T ss_pred             -eC--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc---eEEEEec
Confidence             23  369999998  65565433221  2245667788888886555 589999999999999999866   3999999


Q ss_pred             CCccc
Q 017860          166 GYSKS  170 (365)
Q Consensus       166 gla~~  170 (365)
                      |.+..
T Consensus       151 ~qav~  155 (188)
T PF01163_consen  151 GQAVD  155 (188)
T ss_dssp             TTEEE
T ss_pred             Cccee
Confidence            97753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.08  E-value=3e-11  Score=116.12  Aligned_cols=242  Identities=20%  Similarity=0.204  Sum_probs=175.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC-cceeceEEEeCCEEEEEEeec
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .-|....-+++|+++++++.+...+...+ .+++...    ....-++.+|.+++||| .+..++-+..+...+++++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~  316 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC  316 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence            34677899999999999999988666555 7776654    44566788999999999 888888888889999999999


Q ss_pred             CCC-Ch-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          102 SGG-EL-FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       102 ~~g-~L-~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      .++ +- .......-.+.+.+...+.+.-+++++++|+.--+|||    ||+..++.   .|..||+............+
T Consensus       317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t  389 (829)
T KOG0576|consen  317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRT  389 (829)
T ss_pred             cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccc---cccccccCCcccCccccccc
Confidence            887 22 21111222355666777888889999999998889999    88876543   79999998776555555677


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--cCCCCCCCCCHHHH-H
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDTNPISQECR-D  256 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~-~  256 (365)
                      ..+|+.++|||+...+.+... .|.||+|.-..++.-|-+|-...-..      ...+....  +........++... +
T Consensus       390 ~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pPr~~P~~~------~~~~g~~p~s~~L~~~~aw~~~~~~~  462 (829)
T KOG0576|consen  390 AIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPPRSSPPAV------LPMIGNGPNSPMLTDKSAWSPVFHRD  462 (829)
T ss_pred             CCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCCCCCCccc------cCCCCCCCCccccchhhhcCcccccC
Confidence            889999999999999999887 89999998777777777665431110      00000000  00000011122222 4


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +...|+..-|..|+....++.|.+|..
T Consensus       463 ~~~~~~~g~P~~pkv~mgacfsKvfng  489 (829)
T KOG0576|consen  463 FPAPCLNGLPPTPKVHMGACFSKVFNG  489 (829)
T ss_pred             CcccccCCCCCCCcchhhHHHHHHhcc
Confidence            788899999999999999999988854

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.92  E-value=1.1e-08  Score=89.80  Aligned_cols=133  Identities=20%  Similarity=0.220  Sum_probs=102.2

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-----------------------ccHHHHHHHHHHhcCCCC--
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----------------------IDENVQREIINHRSLRHP--   79 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~e~~~l~~l~hp--   79 (365)
                      +.+..+||-|--+.||.+.+. .|..+|+|.-+.+..                       ......+|..+|..|...  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            466789999999999999987 788999997643210                       123467899999988654  


Q ss_pred             CcceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           80 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        80 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      .|.+.++    .+.-.+||||++|-.|...-     ++......++..|++-+..+-..|+||+|+++-||+++.++.  
T Consensus       172 ~VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--  240 (304)
T COG0478         172 KVPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--  240 (304)
T ss_pred             CCCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--
Confidence            5666554    34557999999997776432     245666777788888888888999999999999999988765  


Q ss_pred             EEEecCCCcc
Q 017860          160 LKICDFGYSK  169 (365)
Q Consensus       160 vkl~Dfgla~  169 (365)
                      +.++||--+.
T Consensus       241 ~~vIDwPQ~v  250 (304)
T COG0478         241 IVVIDWPQAV  250 (304)
T ss_pred             EEEEeCcccc
Confidence            9999996443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.92  E-value=4.3e-08  Score=90.58  Aligned_cols=239  Identities=14%  Similarity=0.106  Sum_probs=147.7

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcce--------eceEEEeCCEEEEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR--------FKEVILTPTHLAIVM   98 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~--------l~~~~~~~~~~~lv~   98 (365)
                      ..+.||+|+-+.+|-.-..   ...+.|++.....-.+. .+-..+-+.-.||-+-.        +++-- ......+.|
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA-QKVAELAATPDAPLLNYRVAWPQATLHGGR-RGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCchHHH-HHHHHhccCCCCcchhhhhcccHHHhhCCC-ccceeEEec
Confidence            3578999999999966443   22366776554322111 11112222234553322        11111 122378889


Q ss_pred             eecCCCCh-HHHH------HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           99 EYASGGEL-FERI------CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        99 e~~~~g~L-~~~l------~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ..++|..= ..+.      +......+..+.+..+.++.+.+.||..|.+-+|+.++|+|+++++.  |.|.|-..-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeec
Confidence            98877522 2221      11223677889999999999999999999999999999999987765  888886543333


Q ss_pred             cCCCCCCCCcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhC-CCCCCCCCC----hHHHHHHHHH-----
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDE----PKDFRKTIQR-----  236 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~----~~~~~~~~~~-----  236 (365)
                      ..+......+|...|.+||.-+     +..-+.. .|.|.||+++++|+.| +.||.+...    .......+..     
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeee
Confidence            3444455678999999999743     2223344 8999999999999986 889976421    1111101100     


Q ss_pred             ------HhccccCCCCCCCCCHHHHHHHHHhccc--CCCCCCCHH
Q 017860          237 ------ILSVQYSVPDTNPISQECRDLISRIFVA--DPAARITIP  273 (365)
Q Consensus       237 ------~~~~~~~~~~~~~~s~~~~~li~~~l~~--dp~~R~t~~  273 (365)
                            -.......+.+.-+++.+..|..+|+..  ++.-|||++
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence                  0011111122233578889999999864  366899865

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=2.1e-08  Score=87.01  Aligned_cols=108  Identities=18%  Similarity=0.176  Sum_probs=83.9

Q ss_pred             cHHHHHHHHHHhcCCCCC--cceeceEEEeC----CEEEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 017860           63 DENVQREIINHRSLRHPN--IVRFKEVILTP----THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYC  135 (365)
Q Consensus        63 ~~~~~~e~~~l~~l~hpn--Iv~l~~~~~~~----~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~al~~L  135 (365)
                      .....+|...+..|..-+  +.+.+.+....    ...++|+|++++ .+|.+++......+......++.+++..++-|
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence            346778888877775433  33444444442    245899999987 47999888755577888899999999999999


Q ss_pred             HHcCCeecCCCCCcEEecCCC-CCCEEEecCCCccc
Q 017860          136 HAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS  170 (365)
Q Consensus       136 H~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~  170 (365)
                      |.+||+|+|++|.|||++.+. ...+.|+||+-++.
T Consensus       135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999998765 34699999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=1.3e-07  Score=80.94  Aligned_cols=135  Identities=10%  Similarity=0.094  Sum_probs=98.8

Q ss_pred             ccCCCeEEEEEEEccCCcEEEEEEeec----C---CcccHHHHHHHHHHhcCCCCC--cceeceEEE-e----CCEEEEE
Q 017860           32 GSGNFGVARLMRDKVTKELVAVKYIER----G---DKIDENVQREIINHRSLRHPN--IVRFKEVIL-T----PTHLAIV   97 (365)
Q Consensus        32 G~G~~g~V~~~~~~~~~~~vaiK~~~~----~---~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~~~-~----~~~~~lv   97 (365)
                      |+||-+-|+....  .|+.+-+|.-..    +   ......+.+|+..+..|..-+  +.+.. ++. .    ...-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4588888887765  344688887541    1   234578999999998885433  44444 222 1    1346899


Q ss_pred             EeecCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           98 MEYASG-GELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        98 ~e~~~~-g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +|-+.| .+|.+++.+.  .+.++.....++.+++.+++-||..|+.|+|+.+.||+++.++...++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997754 5888887653  34578888899999999999999999999999999999975554459999997655

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.76  E-value=1.8e-07  Score=80.47  Aligned_cols=134  Identities=16%  Similarity=0.200  Sum_probs=87.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccH----------HHHHHHHHHhcCC---CCCcceeceEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE----------NVQREIINHRSLR---HPNIVRFKEVIL   89 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------~~~~e~~~l~~l~---hpnIv~l~~~~~   89 (365)
                      .+|.+.+.+-......|.+..  .+|+.+++|.........+          ...+.+..+..+.   .-....++-+.+
T Consensus        31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            467777777776666665554  3678899998764322111          1223333333332   223333333332


Q ss_pred             e-----CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 017860           90 T-----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD  164 (365)
Q Consensus        90 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~D  164 (365)
                      .     ....+++|||++|..|.+...    +++    .+...+++++.-||+.|++|+|..|.|++++.++   +++.|
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID  177 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIID  177 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEE
Confidence            2     234678999999988876532    333    2445677889999999999999999999998554   99999


Q ss_pred             CCCcc
Q 017860          165 FGYSK  169 (365)
Q Consensus       165 fgla~  169 (365)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            97544

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.68  E-value=1.3e-07  Score=97.08  Aligned_cols=201  Identities=20%  Similarity=0.249  Sum_probs=144.5

Q ss_pred             HHHHHHHHhcCCCCCcceeceEEEeCCEEE----EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 017860           66 VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC  141 (365)
Q Consensus        66 ~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~iv  141 (365)
                      ...|+..+....|+|++.++.+-..+....    +..++|+.-++...++.-+..+...++.+..++++||.|+|+....
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~  308 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE  308 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence            345667778889999999998887665433    4567899999999999999999999999999999999999999665


Q ss_pred             ecCCCCC---cEEecCCCCCCEEEe--cCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCc-cceeehhhHHHHHHH
Q 017860          142 HRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK-IADVWSCGVTLYVML  215 (365)
Q Consensus       142 HrDlkp~---NIli~~~~~~~vkl~--Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwSlG~il~ell  215 (365)
                      |.-|..+   +--.+  +.+.+.+.  ||+.+.............-+..+.|||....+..... ..|+|++|.....+.
T Consensus       309 ~v~L~~s~~~~~~~~--~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  309 HVVLSASSSKESTVD--GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             eeEEecccccccccC--ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            5555444   22222  22335555  8887776555555555566778889998766554322 269999999999998


Q ss_pred             hCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          216 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       216 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .|..+-.....       ...+..       ....+ ...+++.+|+..++++|+++.+++.|+|.+.
T Consensus       387 ~~~~i~~~~~~-------~~~~l~-------~~~~~-~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  387 QGEDISEKSAV-------PVSLLD-------VLSTS-ELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             hcCcccccccc-------hhhhhc-------cccch-hhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            87644322111       111111       11111 6778999999999999999999999998864

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.61  E-value=2.9e-07  Score=89.76  Aligned_cols=137  Identities=20%  Similarity=0.207  Sum_probs=88.0

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc--------------------------cc---------H------HHH
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--------------------------ID---------E------NVQ   67 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~---------~------~~~   67 (365)
                      +.|+.++-|+||+|+.+ +|+.||||+...+-.                          ..         +      ++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            68899999999999997 599999999754310                          00         0      133


Q ss_pred             HHHHHHhcC----CCCCcceeceEE-EeCCEEEEEEeecCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCC
Q 017860           68 REIINHRSL----RHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAMQV  140 (365)
Q Consensus        68 ~e~~~l~~l----~hpnIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l--~~~~~l~~~~~~~i~~qil~al~~LH~~~i  140 (365)
                      +|...+.++    ++.--+++-.++ ...+.-.++|||+.|..+.+..  .. ..++...+.....++.  +..+=..|+
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf  286 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF  286 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence            455555444    222222333333 2345568999999999888773  34 3345333332222211  122334899


Q ss_pred             eecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860          141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus       141 vHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +|.|..|.||+++.++  ++.+.|||+....
T Consensus       287 fHaDpHpGNi~v~~~g--~i~~lDfGi~g~l  315 (517)
T COG0661         287 FHADPHPGNILVRSDG--RIVLLDFGIVGRL  315 (517)
T ss_pred             cccCCCccceEEecCC--cEEEEcCcceecC
Confidence            9999999999998775  5999999987643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.58  E-value=5.5e-07  Score=78.42  Aligned_cols=132  Identities=17%  Similarity=0.174  Sum_probs=89.2

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------------------cc------HHHHHHHHHHhcCCCCC--c
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------------------ID------ENVQREIINHRSLRHPN--I   81 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~------~~~~~e~~~l~~l~hpn--I   81 (365)
                      ..|+.|--+.||+|... ++..+|+|++.....                   ..      ....+|...|+++...+  +
T Consensus        54 g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            35667777889998874 688999999864211                   00      12456888887775333  3


Q ss_pred             ceeceEEEeCCEEEEEEeecCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCC
Q 017860           82 VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        82 v~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      .+-+.+.    .-.+||||+..... .-.|... ++...++..+..++++.+.-|-. .++||+||+.-|||+.++   .
T Consensus       133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~---~  204 (268)
T COG1718         133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDG---E  204 (268)
T ss_pred             CCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECC---e
Confidence            3333322    23689999965411 1122221 23344788889999999999877 999999999999999833   3


Q ss_pred             EEEecCCCcc
Q 017860          160 LKICDFGYSK  169 (365)
Q Consensus       160 vkl~Dfgla~  169 (365)
                      +.++|||-|.
T Consensus       205 p~iID~~QaV  214 (268)
T COG1718         205 PYIIDVSQAV  214 (268)
T ss_pred             EEEEECcccc
Confidence            8999998765

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.52  E-value=1.6e-06  Score=76.29  Aligned_cols=73  Identities=16%  Similarity=0.155  Sum_probs=55.3

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC--cceeceEEEeCCEEEEEEeecCCCC
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE  105 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~  105 (365)
                      ..+||+|..+.||+.    .+..+++|...... ......+|..+++.+..-.  +.+.+.+....+.+++|||+++|.+
T Consensus         6 ~~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         6 WTQTGEGGNGESYTH----KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             heeecCCCCcceeEe----cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            367899999999973    25568899876533 3456789999998886433  4667777777788899999999864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.43  E-value=7.6e-06  Score=70.17  Aligned_cols=129  Identities=21%  Similarity=0.208  Sum_probs=92.6

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCC-----------------cccHHHHHHHHHHhcCC------CCCccee
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------------KIDENVQREIINHRSLR------HPNIVRF   84 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~~~~e~~~l~~l~------hpnIv~l   84 (365)
                      ...||+|+.-.||.-  . .+....||+.....                 ....+..+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            467999999998853  3 34556889886544                 12345666665555554      7899999


Q ss_pred             ceEEEeCCEEEEEEeecCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           85 KEVILTPTHLAIVMEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        85 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      +++.+++.-..+|+|.+..      -+|.+++.+ +.+++ ....   .+-+-..||-..+|+.+||+|.||++.....+
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998732      367777744 34666 3333   34455567899999999999999999765544


Q ss_pred             --CEEEec
Q 017860          159 --RLKICD  164 (365)
Q Consensus       159 --~vkl~D  164 (365)
                        ++.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=98.41  E-value=3.5e-06  Score=87.98  Aligned_cols=79  Identities=19%  Similarity=0.192  Sum_probs=57.5

Q ss_pred             eecccccCCCeEEEEEEEccCC--cEEEEEEeecCCc--ccHHHHHHHHHHhcCC-CCCc--ceeceEEEeC---CEEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTK--ELVAVKYIERGDK--IDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAI   96 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~-hpnI--v~l~~~~~~~---~~~~l   96 (365)
                      -+++|+.|.++.+|+......+  ..+++|+......  ....+.+|..+++.+. |+++  .+++.++.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3688899999999998765332  4688887654332  2356889999999995 6665  6677766554   45789


Q ss_pred             EEeecCCCC
Q 017860           97 VMEYASGGE  105 (365)
Q Consensus        97 v~e~~~~g~  105 (365)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.40  E-value=1.1e-05  Score=68.79  Aligned_cols=125  Identities=19%  Similarity=0.286  Sum_probs=88.9

Q ss_pred             CCCcceecccccCCC-eEEEEEEEccCCcEEEEEEeec----CC------------------cccHHHHHHHHHHhcC--
Q 017860           22 SDRYDFVRDIGSGNF-GVARLMRDKVTKELVAVKYIER----GD------------------KIDENVQREIINHRSL--   76 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~-g~V~~~~~~~~~~~vaiK~~~~----~~------------------~~~~~~~~e~~~l~~l--   76 (365)
                      ...++.++.||.|+- |.||+++-  .|+.||+|++..    ..                  ....-|..|.+...+|  
T Consensus        36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke  113 (207)
T PF13095_consen   36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE  113 (207)
T ss_pred             CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence            378999999999999 99999987  678999999421    00                  0112355666555444  


Q ss_pred             -CCCCc--ceeceEEEeC------------------CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 017860           77 -RHPNI--VRFKEVILTP------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC  135 (365)
Q Consensus        77 -~hpnI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~L  135 (365)
                       .+.++  |+.+++..-.                  ....||.||+....         .++...    +.+|++-+..+
T Consensus       114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~  180 (207)
T PF13095_consen  114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKIL  180 (207)
T ss_pred             ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHH
Confidence             55666  8888887322                  13578888886644         122333    45677777889


Q ss_pred             HHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860          136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus       136 H~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      |..||+-+|+++.|..   ++    ||+|||.+
T Consensus       181 ~k~gI~~~Dv~~~ny~---~G----~lvDfs~~  206 (207)
T PF13095_consen  181 HKLGIVPRDVKPRNYR---GG----KLVDFSSS  206 (207)
T ss_pred             HHCCeeeccCcccccc---CC----EEEecccC
Confidence            9999999999999987   33    99999854

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.39  E-value=2.2e-06  Score=75.38  Aligned_cols=78  Identities=18%  Similarity=0.179  Sum_probs=56.0

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCC--CcceeceEEE---eCCEEEEEEeecC
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEVIL---TPTHLAIVMEYAS  102 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~~~---~~~~~~lv~e~~~  102 (365)
                      ++.|+.|..+.||++....  ..+++|..... .....+.+|..+++.+...  .+.+++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            5789999999999999864  58999987654 3446777888888777533  2455555332   3345799999999


Q ss_pred             CCChHH
Q 017860          103 GGELFE  108 (365)
Q Consensus       103 ~g~L~~  108 (365)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.30  E-value=8.6e-06  Score=72.57  Aligned_cols=76  Identities=12%  Similarity=0.051  Sum_probs=53.5

Q ss_pred             cccccCCC-eEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           29 RDIGSGNF-GVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        29 ~~LG~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ..|-.|.. +.||++...  +..+++|......  .....+|+.+++.+. +--+.+++.+.......++|||+++|.+|
T Consensus         4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555666 788988653  4678889875543  345778888887774 33456677777666678999999998776


Q ss_pred             HH
Q 017860          107 FE  108 (365)
Q Consensus       107 ~~  108 (365)
                      ..
T Consensus        80 ~~   81 (244)
T cd05150          80 AA   81 (244)
T ss_pred             hH
Confidence            53

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=6.9e-06  Score=67.86  Aligned_cols=128  Identities=20%  Similarity=0.167  Sum_probs=90.9

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcce-eceEEEeCCEEEEEEeecCC
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~-l~~~~~~~~~~~lv~e~~~~  103 (365)
                      -++.+.|++|.+|.||++.+.  |..+|+|+- +.+.....+..|.+++..+.-.++-. ++.+-    .-++.|||+.|
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvr-r~ds~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G   96 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVR-RRDSPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDG   96 (201)
T ss_pred             hhhhhhhhcccccEEEEeecc--CceEEEEEe-cCCcchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcC
Confidence            456789999999999999874  668999964 44556688999999999888666544 33222    12355999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC-C-cEEecCCCCCCEEEecCCCcc
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL-E-NTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp-~-NIli~~~~~~~vkl~Dfgla~  169 (365)
                      -+|.+.-...   +    +.-+..++++-.-|-..||-|+.|.- . ||+++ ++  .+.|+||.-|+
T Consensus        97 ~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~--~~~iIDFd~At  154 (201)
T COG2112          97 RPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR--DVYIIDFDSAT  154 (201)
T ss_pred             cchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC--cEEEEEccchh
Confidence            8887654321   2    23344566666668889999999874 3 55554 32  38999998776

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.27  E-value=7.8e-06  Score=79.69  Aligned_cols=136  Identities=18%  Similarity=0.166  Sum_probs=87.8

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCc--------------------------------ccH------HHHHHH
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--------------------------------IDE------NVQREI   70 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------~~~------~~~~e~   70 (365)
                      +.||.-+.|+|++|+.+. |+.||||+-+.+-.                                ..+      ++.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            689999999999999984 99999998654210                                001      233455


Q ss_pred             HHHhcC----CCCC------cceeceEEEeCCEEEEEEeecCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 017860           71 INHRSL----RHPN------IVRFKEVILTPTHLAIVMEYASGGELFER--ICNAGRFSEDEARFFFQQLISGVSYCHAM  138 (365)
Q Consensus        71 ~~l~~l----~hpn------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~l~~~~~~~i~~qil~al~~LH~~  138 (365)
                      ++..+.    .|-+      |.+++-.+  .....++||||.|..+.+.  +.+. .++...+..-+.+...  .-|=..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHhc
Confidence            444333    3444      33333222  2456899999999888665  3333 3555544333332221  123457


Q ss_pred             CCeecCCCCCcEEecCC--CCCCEEEecCCCccc
Q 017860          139 QVCHRDLKLENTLLDGS--PAPRLKICDFGYSKS  170 (365)
Q Consensus       139 ~ivHrDlkp~NIli~~~--~~~~vkl~Dfgla~~  170 (365)
                      |++|+|=.|.||+++.+  +.+.+.+.|||+...
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            89999999999999854  355799999998764

>PRK10593 hypothetical protein; Provisional

Probab=98.11  E-value=6.1e-05  Score=69.20  Aligned_cols=78  Identities=13%  Similarity=0.047  Sum_probs=56.3

Q ss_pred             ceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC---CCcceeceEEEe---CCEEEEEEe
Q 017860           26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---PNIVRFKEVILT---PTHLAIVME   99 (365)
Q Consensus        26 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h---pnIv~l~~~~~~---~~~~~lv~e   99 (365)
                      .-.+.||.|..+.||..... ++ .+.+|..+ .......+.+|...++.+..   -.+.++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~-~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDS-QG-NPMPLMAR-SFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcC-CC-CEEEEEec-ccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            34678999999999998653 23 47778743 32234578899999988853   357777776654   366899999


Q ss_pred             ecCCCCh
Q 017860          100 YASGGEL  106 (365)
Q Consensus       100 ~~~~g~L  106 (365)
                      +++|+++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998754

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.09  E-value=2.1e-07  Score=97.78  Aligned_cols=207  Identities=13%  Similarity=0.064  Sum_probs=141.6

Q ss_pred             HHHHHHhcCCCCCcceeceEEEeC--CEEEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcC--
Q 017860           68 REIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQ--  139 (365)
Q Consensus        68 ~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~qil~al~~LH~~~--  139 (365)
                      .|..-.+...|+++.....-....  ...+.+++|+.+|.+++.+.++-    .+.+.-+.....+.+.+..-+|+..  
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            344455567899988866655433  45688999999999999986542    2445555555566588888888643  


Q ss_pred             ---CeecCCCCCcEEecCCCCCCEEEecCCCcc-cccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHH
Q 017860          140 ---VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML  215 (365)
Q Consensus       140 ---ivHrDlkp~NIli~~~~~~~vkl~Dfgla~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell  215 (365)
                         .+|++||+-|-+|..+..  +|++++|+.+ ............+++.|++|++.+.-.++.+ +|+|..|+-+|.+.
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLRS 1434 (2724)
T ss_pred             CccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHHh
Confidence               799999999999976554  9999999998 4444445566788999999999988787766 99999999999999


Q ss_pred             hCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          216 VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       216 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      .|..+|..     ......+.+....-......-.|.++-.....+|-..-..||.-...+..+.|.
T Consensus      1435 ~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            88777732     222233333322221111111233333444445555556889888888877764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.06  E-value=5.1e-05  Score=67.07  Aligned_cols=75  Identities=15%  Similarity=0.227  Sum_probs=49.9

Q ss_pred             ecccccCCCeEEEEEEEcc-CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC-cceeceEEEeCCEEEEEEeecCCCC
Q 017860           28 VRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGE  105 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~g~  105 (365)
                      ++.|..|-...+|++.... .++.|++|+............+|+.+++.+...+ .++++..+.  .  .++|||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence            4678888888999987543 3578999987654333234457888888885433 344444332  2  47999999876


Q ss_pred             h
Q 017860          106 L  106 (365)
Q Consensus       106 L  106 (365)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.05  E-value=2.4e-05  Score=69.28  Aligned_cols=73  Identities=11%  Similarity=0.003  Sum_probs=45.6

Q ss_pred             ecccccCCCe-EEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCC---CcceeceEEEeC---CEEEEEEee
Q 017860           28 VRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEY  100 (365)
Q Consensus        28 ~~~LG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~l~~~~~~~---~~~~lv~e~  100 (365)
                      ++.|+.|+.. .||++.     ..+++|.... ......+.+|..+++.+...   -+.++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            4567877766 588762     3578887554 22345788999998877532   233333332221   234789999


Q ss_pred             cCCCCh
Q 017860          101 ASGGEL  106 (365)
Q Consensus       101 ~~~g~L  106 (365)
                      ++|.++
T Consensus        76 i~G~~l   81 (235)
T cd05155          76 LEGETA   81 (235)
T ss_pred             ecCCCC
Confidence            998766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.97  E-value=4.8e-05  Score=68.29  Aligned_cols=132  Identities=14%  Similarity=0.092  Sum_probs=76.5

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCccc-HHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEeecCCCCh
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ..+..|-.+.+|++.  .+++.+++|......... -...+|..+++.+....+ .+++...  .  -++|+||++|..+
T Consensus         2 ~~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         2 QTLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVI   75 (256)
T ss_pred             CcCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCccc
Confidence            346678888999887  356788999765432221 245788888888864333 3333332  2  2689999998665


Q ss_pred             HH--------------HHH---hcC----CCCH-HHHHHHHHHH---------HHHHHHHHH--------cCCeecCCCC
Q 017860          107 FE--------------RIC---NAG----RFSE-DEARFFFQQL---------ISGVSYCHA--------MQVCHRDLKL  147 (365)
Q Consensus       107 ~~--------------~l~---~~~----~l~~-~~~~~i~~qi---------l~al~~LH~--------~~ivHrDlkp  147 (365)
                      ..              .+.   ...    +++. ..+..+..++         ...+..+-.        ..++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            31              111   111    1111 1111221111         111222221        2489999999


Q ss_pred             CcEEecCCCCCCEEEecCCCcc
Q 017860          148 ENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       148 ~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      .||+++.++   +.|.||..+.
T Consensus       156 ~Nil~~~~~---~~lIDwE~a~  174 (256)
T TIGR02721       156 YNLVVTPQG---LKLIDWEYAS  174 (256)
T ss_pred             CcEEEeCCC---CEEEeccccC
Confidence            999998654   7899998765

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.81  E-value=0.00056  Score=64.99  Aligned_cols=76  Identities=18%  Similarity=0.110  Sum_probs=52.9

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecC-----C---cccHHHHHHHHHHhcCC---CCCcceeceEEEeCCEEEE
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----D---KIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~---~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~l   96 (365)
                      .+.||.|.+..||++.....++.++||.-...     .   ...+....|...|+.+.   ..++.+++.+  ++...++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            47899999999999998644468999984311     1   12355667777777653   3456777666  4455789


Q ss_pred             EEeecCCCC
Q 017860           97 VMEYASGGE  105 (365)
Q Consensus        97 v~e~~~~g~  105 (365)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.76  E-value=0.00033  Score=64.19  Aligned_cols=136  Identities=18%  Similarity=0.123  Sum_probs=80.7

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC--cceeceE------EEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~e   99 (365)
                      ++.|..|....+|++..  .+..+++|+...  .....+..|+.++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            67788888889998865  345789998764  23355677777777764322  3443331      233456789999


Q ss_pred             ecCCCChHH-----------H---HHhc-CCCC----------HHH--H--------HHHHHHHHHHHHHHHH-------
Q 017860          100 YASGGELFE-----------R---ICNA-GRFS----------EDE--A--------RFFFQQLISGVSYCHA-------  137 (365)
Q Consensus       100 ~~~~g~L~~-----------~---l~~~-~~l~----------~~~--~--------~~i~~qil~al~~LH~-------  137 (365)
                      |++|..+..           .   ++.. ..+.          ...  .        ......+..++.++.+       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999876521           0   1110 0000          000  0        0011123334444443       


Q ss_pred             cCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       138 ~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      .+++|+|+.|.||+++.++.  +.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence            46999999999999986542  5799998654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.69  E-value=0.00039  Score=63.97  Aligned_cols=76  Identities=13%  Similarity=0.138  Sum_probs=50.0

Q ss_pred             ecccccCCCeEEEEEEEcc------CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEee
Q 017860           28 VRDIGSGNFGVARLMRDKV------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~  100 (365)
                      ++.|..|--..+|++....      .++.+++|+............+|..+++.+...++ .+++.++. +   ..|+||
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            4566667777899887543      25789999976654444566788888877754333 34555443 2   358999


Q ss_pred             cCCCChH
Q 017860          101 ASGGELF  107 (365)
Q Consensus       101 ~~~g~L~  107 (365)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9887653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.64  E-value=0.00019  Score=61.13  Aligned_cols=97  Identities=14%  Similarity=0.062  Sum_probs=76.6

Q ss_pred             HHHHHHHhcCCC-CCcceeceEEEeCCEEEEEEeecCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---cC
Q 017860           67 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHA---MQ  139 (365)
Q Consensus        67 ~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~l~~~~~~~i~~qil~al~~LH~---~~  139 (365)
                      ..|..+++.+.+ +++++++|++-    -++|.||...+++...   +......++.....++.++++.+.+++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            458888888876 69999999982    2568899987766421   2222235899999999999999999997   45


Q ss_pred             CeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       140 ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +.-.|++|+|+-++.++.  +|+.|...+.
T Consensus        83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~  110 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF  110 (188)
T ss_pred             EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence            888999999999986654  9999998654

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.60  E-value=0.00053  Score=63.29  Aligned_cols=136  Identities=19%  Similarity=0.207  Sum_probs=93.2

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCC--------------cc-------------cHHHHHHHHHHhcCCCCC
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------KI-------------DENVQREIINHRSLRHPN   80 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~-------------~~~~~~e~~~l~~l~hpn   80 (365)
                      -..|.-|--+-||.|... +|..+|||+++.+-              ++             .-...+|+..|++++...
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345667777889998875 78889999975320              00             013457888888887655


Q ss_pred             cceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCCC
Q 017860           81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        81 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~L-H~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      |.----+...  .-.|||+|+.....-.-..+.-.++...+..+-.|++.-+.-| |..++||.||.--|+|+-++   .
T Consensus       228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG---~  302 (520)
T KOG2270|consen  228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG---K  302 (520)
T ss_pred             CCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---E
Confidence            4332222211  2368999996433322222334578888999999999988887 45789999999999999633   4


Q ss_pred             EEEecCCCcc
Q 017860          160 LKICDFGYSK  169 (365)
Q Consensus       160 vkl~Dfgla~  169 (365)
                      +.++|.+-+.
T Consensus       303 lyiIDVSQSV  312 (520)
T KOG2270|consen  303 LYIIDVSQSV  312 (520)
T ss_pred             EEEEEccccc
Confidence            9999987554

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.56  E-value=5.9e-05  Score=68.30  Aligned_cols=131  Identities=15%  Similarity=0.159  Sum_probs=92.5

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc-----------------------cHHHHHHHHHHhcCCC-C
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-----------------------DENVQREIINHRSLRH-P   79 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~e~~~l~~l~h-p   79 (365)
                      =|.+.++||=|.-+.||++-+. .|+..++|.-..+...                       .-...+|...|+.|.. .
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3678899999999999999886 7888999975432211                       1134467777777742 2


Q ss_pred             C-cceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           80 N-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        80 n-Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      . |.+.++    .+.-++|||++.|-.|...-.      ...+..+...+..-+.-|...|+||+|..--||+++++.. 
T Consensus       172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~-  240 (465)
T KOG2268|consen  172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDK-  240 (465)
T ss_pred             CCCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCC-
Confidence            2 223332    345689999999888765421      2233455566667777889999999999999999986554 


Q ss_pred             CEEEecCCC
Q 017860          159 RLKICDFGY  167 (365)
Q Consensus       159 ~vkl~Dfgl  167 (365)
                       ++++||--
T Consensus       241 -i~vIDFPQ  248 (465)
T KOG2268|consen  241 -IVVIDFPQ  248 (465)
T ss_pred             -EEEeechH
Confidence             99999964

>PRK05231 homoserine kinase; Provisional

Probab=97.55  E-value=0.0019  Score=59.92  Aligned_cols=75  Identities=13%  Similarity=0.086  Sum_probs=44.6

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----CCCcceec---eEEEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK---EVILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~l~---~~~~~~~~~~lv~e   99 (365)
                      ++.|+.|....+|.+...  +..+++|++..  ...+.+..++.+++.|.     .|.+++-.   .+....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT--QGEYVLTLFER--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeC--CCcEEEEEecc--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            566778888899998753  34689998762  12234444555554442     33333211   01223456789999


Q ss_pred             ecCCCCh
Q 017860          100 YASGGEL  106 (365)
Q Consensus       100 ~~~~g~L  106 (365)
                      |++|..+
T Consensus       103 ~l~G~~~  109 (319)
T PRK05231        103 FLEGKWP  109 (319)
T ss_pred             ecCCCCC
Confidence            9988754

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.44  E-value=0.0022  Score=59.14  Aligned_cols=139  Identities=19%  Similarity=0.155  Sum_probs=79.3

Q ss_pred             ceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC--cceeceE------EEeCCEEEEE
Q 017860           26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEV------ILTPTHLAIV   97 (365)
Q Consensus        26 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv   97 (365)
                      ..++.++.|....+|++...  +..+++|+..... ....+..|+.++..|...+  +.+++..      ....+..+++
T Consensus        25 ~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l  101 (307)
T TIGR00938        25 LSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL  101 (307)
T ss_pred             eeccccCCccccceEEEEeC--CCcEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence            34677888888899988653  4468899875532 2345556666666663222  3333321      1124567899


Q ss_pred             EeecCCCChH-----------HH---HHh-cCCCCH-------HHHH----------------HHHHHHHHHHHHHHH--
Q 017860           98 MEYASGGELF-----------ER---ICN-AGRFSE-------DEAR----------------FFFQQLISGVSYCHA--  137 (365)
Q Consensus        98 ~e~~~~g~L~-----------~~---l~~-~~~l~~-------~~~~----------------~i~~qil~al~~LH~--  137 (365)
                      ++|++|.++.           ..   ++. ...++.       ...+                .....+...++++..  
T Consensus       102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~  181 (307)
T TIGR00938       102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW  181 (307)
T ss_pred             EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence            9999885431           11   111 001100       0000                001123334555542  


Q ss_pred             -----cCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          138 -----MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       138 -----~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                           .+++|+|+.+.||+++.++  .+.|.||+.+.
T Consensus       182 ~~~~~~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~  216 (307)
T TIGR00938       182 PRDLPRGVIHADLFPDNVLFDGDS--VKGVIDFYFAC  216 (307)
T ss_pred             hhcCCCccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence                 6799999999999998654  25899998654

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.38  E-value=0.00029  Score=67.59  Aligned_cols=166  Identities=17%  Similarity=0.208  Sum_probs=100.9

Q ss_pred             HHHHHHHHHHhcCCCCCcceeceEEEeC-CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 017860           64 ENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH  142 (365)
Q Consensus        64 ~~~~~e~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivH  142 (365)
                      ..+.-....++.+.|+|...++++-... ....+|||++ +.+|.+.+..+. +....       ++           .|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-----------~~   86 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-----------AH   86 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-----------cc
Confidence            4556667889999999999998887644 3478899999 568988876543 21111       10           22


Q ss_pred             cCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCC
Q 017860          143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE  222 (365)
Q Consensus       143 rDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  222 (365)
                      |=+ +-||         ++.+|- ++...      .+..|                 +++||||+|.++.++.-|...|.
T Consensus        87 ~~~-~~~~---------~~~td~-~~t~~------~~~~~-----------------pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   87 GVL-HLNI---------IYITDH-FLTKY------PSPIG-----------------PKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             ccc-eehh---------hhcccc-ccccC------CCCCC-----------------cchhhhhHHHHHHHHHHhhHHHH
Confidence            211 1122         333441 11110      01111                 24999999999999999887766


Q ss_pred             CCCChHHHHHHHHHHhccccCCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          223 DPDEPKDFRKTIQRILSVQYSVP-------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .....+....+ ...........       ...........++++|+-..|..||...++.+++-|.+.
T Consensus       133 ~~~~s~~l~~i-~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  133 ELTESEYLEIL-LKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHH-HHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            54443332222 11111110000       001134567889999999999999999999999988764

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.09  E-value=0.0097  Score=55.62  Aligned_cols=73  Identities=19%  Similarity=0.158  Sum_probs=46.9

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeec-----C---CcccHHHHHHHHHHhcCC--CC-CcceeceEEEeCCEEEEE
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIER-----G---DKIDENVQREIINHRSLR--HP-NIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~---~~~~~~~~~e~~~l~~l~--hp-nIv~l~~~~~~~~~~~lv   97 (365)
                      +.||.|....||++.+...++.++||.-..     +   .....+..-|...|+...  .| .+.+++.  .++....+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence            357999999999999864446899997421     1   112244556667776553  34 4555443  355566799


Q ss_pred             EeecCC
Q 017860           98 MEYASG  103 (365)
Q Consensus        98 ~e~~~~  103 (365)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02236 choline kinase

Probab=97.08  E-value=0.0078  Score=56.49  Aligned_cols=138  Identities=15%  Similarity=0.185  Sum_probs=79.8

Q ss_pred             eecccccCCCeEEEEEEEcc----CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcc-eeceEEEeCCEEEEEEeec
Q 017860           27 FVRDIGSGNFGVARLMRDKV----TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~  101 (365)
                      -++.|-.|-...+|++....    .++.|++|+........-+-.+|..+++.+..-++- ++++.+.. .   .|.+|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi  115 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFI  115 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEee
Confidence            34566568888999987432    346899998866543333346788888877544433 45555532 2   578998


Q ss_pred             CCCChHHH--------------H---HhcC----C-C-CHHHHHHHHHHH-----------------HHHHHHH----H-
Q 017860          102 SGGELFER--------------I---CNAG----R-F-SEDEARFFFQQL-----------------ISGVSYC----H-  136 (365)
Q Consensus       102 ~~g~L~~~--------------l---~~~~----~-l-~~~~~~~i~~qi-----------------l~al~~L----H-  136 (365)
                      ++.+|...              +   ++..    + . ....+..++.++                 ...+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665311              1   1110    0 1 122333333221                 1111122    1 


Q ss_pred             ---HcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          137 ---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       137 ---~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                         ...++|+|+++.|||++... +.+.++||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~-~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEET-RAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCC-CcEEEEeehhcc
Confidence               22489999999999997532 359999998664

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.01  E-value=0.0065  Score=57.46  Aligned_cols=78  Identities=19%  Similarity=0.157  Sum_probs=51.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEee----cCCc---ccHHHHHHHHHHhcCC--CC-CcceeceEEEeCC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----RGDK---IDENVQREIINHRSLR--HP-NIVRFKEVILTPT   92 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~----~~~~---~~~~~~~e~~~l~~l~--hp-nIv~l~~~~~~~~   92 (365)
                      +.+. ++.||.|.-..||++.+...++.|+||.-.    .++.   ...+..-|...|+.+.  .| ++.+++.  .++.
T Consensus        30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e  106 (409)
T PRK12396         30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSV  106 (409)
T ss_pred             ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcH
Confidence            3444 688999999999999985446789999742    2222   2245566777776653  34 4555543  3555


Q ss_pred             EEEEEEeecCC
Q 017860           93 HLAIVMEYASG  103 (365)
Q Consensus        93 ~~~lv~e~~~~  103 (365)
                      ...+|||+++.
T Consensus       107 ~~~~vMEdL~~  117 (409)
T PRK12396        107 MNCCVMEDLSD  117 (409)
T ss_pred             HhhHHHHhCcc
Confidence            66789998854

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.92  E-value=0.0073  Score=56.37  Aligned_cols=75  Identities=15%  Similarity=0.157  Sum_probs=47.0

Q ss_pred             ecccccCCCeEEEEEEEccC---CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEeecCC
Q 017860           28 VRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      ++.|..|=-..+|++.....   +..|++|+........-+-.+|..+++.+..-++ .+++.++. .+   +|.+|++|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            45555577778998865432   3479999876544333334678888887765444 34555552 22   48899877


Q ss_pred             CCh
Q 017860          104 GEL  106 (365)
Q Consensus       104 g~L  106 (365)
                      ..|
T Consensus        95 ~~l   97 (330)
T PLN02421         95 RTL   97 (330)
T ss_pred             CCC
Confidence            655

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.90  E-value=0.012  Score=54.07  Aligned_cols=141  Identities=18%  Similarity=0.155  Sum_probs=81.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCC--CcceeceEEEeCC--EEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHP--NIVRFKEVILTPT--HLAIV   97 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hp--nIv~l~~~~~~~~--~~~lv   97 (365)
                      ...+++.+..|--..+|.....  ++.++++.-....  .......+|..+++.+.--  -+.+.++++.++.  ..|.|
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             CCceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            4556666655555556666554  7888888221111  2235667888888877532  2333445554444  56999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHH-HHHHHHHHHH----------------------------------------
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQ-QLISGVSYCH----------------------------------------  136 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~-qil~al~~LH----------------------------------------  136 (365)
                      |+|++|..+.+...     +.....+++. .+...|+-||                                        
T Consensus       104 ~~~veGe~~~~~~~-----~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p  178 (321)
T COG3173         104 MEWVEGEVVWSALP-----PESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIP  178 (321)
T ss_pred             EEEecceeccCcCC-----cccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCc
Confidence            99998853322110     0000011111 3333333333                                        


Q ss_pred             ----------Hc--------CCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860          137 ----------AM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus       137 ----------~~--------~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                                .+        .++|+|+.+.||+++.++.  +-+.||+++....+
T Consensus       179 ~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lGDP  231 (321)
T COG3173         179 LADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP--TGVLDWELATLGDP  231 (321)
T ss_pred             hHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe--eEEEeccccccCCc
Confidence                      21        2799999999999987665  89999998875443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.86  E-value=0.0081  Score=54.55  Aligned_cols=31  Identities=23%  Similarity=0.304  Sum_probs=23.8

Q ss_pred             CCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860          139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus       139 ~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      .++|+|++|.|||++.++. ..-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC-EEEEECcHhccc
Confidence            3799999999999985322 246999997653

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.84  E-value=0.02  Score=54.49  Aligned_cols=73  Identities=16%  Similarity=0.187  Sum_probs=49.5

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeec-----CCc---ccHHHHHHHHHHhcCC---CCCcceeceEEEeCCEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDK---IDENVQREIINHRSLR---HPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~---~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~   95 (365)
                      ..+.||.|....||++.+.  ++.++||.-..     +..   .......|...|+.+.   ..++.+++.+..  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            3688999999999999873  45699997542     211   2234445566665553   247777877765  4457


Q ss_pred             EEEeecCC
Q 017860           96 IVMEYASG  103 (365)
Q Consensus        96 lv~e~~~~  103 (365)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            88999977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.61  E-value=0.053  Score=49.92  Aligned_cols=29  Identities=31%  Similarity=0.620  Sum_probs=24.0

Q ss_pred             cCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       138 ~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      .+++|+|+.+.||+++. +  .+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence            57899999999999975 3  38999998543

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.58  E-value=0.077  Score=49.41  Aligned_cols=71  Identities=13%  Similarity=0.070  Sum_probs=43.8

Q ss_pred             CCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC--cce---ece--EEEeCCEEEEEEeecCCCC
Q 017860           34 GNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVR---FKE--VILTPTHLAIVMEYASGGE  105 (365)
Q Consensus        34 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~---l~~--~~~~~~~~~lv~e~~~~g~  105 (365)
                      +.-..||.+... ++..+++|+...+......+..|+..+..|....  ++.   .-+  +...++..+.++++++|..
T Consensus        36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            445678888753 5667999988654444566777877776653211  222   112  2333567788999998764

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.54  E-value=0.029  Score=51.18  Aligned_cols=75  Identities=11%  Similarity=0.069  Sum_probs=48.9

Q ss_pred             ceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC---CCCcceeceEEEeCCEEEEEEeecC
Q 017860           26 DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        26 ~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      +-.+.++.|....+|...  .+++.+.+|+-.  ......+..|..-|+.|.   --.+.+.+.+....+.-|+||||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            446789999999999887  578889999876  333456788887777773   4467788888887777799999997


Q ss_pred             CC
Q 017860          103 GG  104 (365)
Q Consensus       103 ~g  104 (365)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=96.10  E-value=0.057  Score=51.36  Aligned_cols=77  Identities=10%  Similarity=0.006  Sum_probs=45.9

Q ss_pred             eecccccCCCeEEEEEEEccC-CcE-----EEEEEeecCCcccHHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEe
Q 017860           27 FVRDIGSGNFGVARLMRDKVT-KEL-----VAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME   99 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~-~~~-----vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e   99 (365)
                      .++.|..|--..+|++..... +..     |.++.........-+-.+|+.+++.+...++ .++++.|.    -+++.|
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e  129 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE  129 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence            345665688889999875432 122     4444432222222234678888888865544 44555553    268999


Q ss_pred             ecCCCChH
Q 017860          100 YASGGELF  107 (365)
Q Consensus       100 ~~~~g~L~  107 (365)
                      |++|.+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99887663

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.07  E-value=0.092  Score=48.46  Aligned_cols=29  Identities=21%  Similarity=0.266  Sum_probs=24.7

Q ss_pred             CCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       139 ~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +++|+|+.+.|+|+++++.  +.+.||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~--~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG--GYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC--EEEEEhhhcc
Confidence            6999999999999976654  8899998655

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.00  E-value=0.032  Score=52.56  Aligned_cols=61  Identities=16%  Similarity=0.120  Sum_probs=44.7

Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGS  155 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~L-H~~~ivHrDlkp~NIli~~~  155 (365)
                      ..++-+|..|.++..++...+ .+|.-.+.++.-.+.|+--+ --.+++|.|+.|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            456677888888888876543 46666677776666666554 45689999999999999643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.77  E-value=0.17  Score=47.14  Aligned_cols=136  Identities=18%  Similarity=0.188  Sum_probs=79.9

Q ss_pred             cccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC------cceece----EEEeCCEEEEEE
Q 017860           29 RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKE----VILTPTHLAIVM   98 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~l~~----~~~~~~~~~lv~   98 (365)
                      ..|.+ .-..||++... +| .+++|+.... ....++.-|+..+..|.-..      +..+-+    .+......+-++
T Consensus        32 ~~l~s-~eN~~f~~~~~-~g-~~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          32 RGLNS-EENSNFRVQTE-DG-RYILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccccc-ccCceEEEEec-CC-CeEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            44444 55678888775 33 3499998887 55677777887777663211      222211    111123778899


Q ss_pred             eecCCCChHH-H--------------HHh-cCCC-----------CHH----HH---------HHHHHHHHHHHHHHHH-
Q 017860           99 EYASGGELFE-R--------------ICN-AGRF-----------SED----EA---------RFFFQQLISGVSYCHA-  137 (365)
Q Consensus        99 e~~~~g~L~~-~--------------l~~-~~~l-----------~~~----~~---------~~i~~qil~al~~LH~-  137 (365)
                      +|++|..+.. .              +.. ...+           .+.    ..         .....++...+..+.+ 
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999887761 0              110 0001           111    00         0123344555555553 


Q ss_pred             -------cC--CeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          138 -------MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       138 -------~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                             .+  +||+|+.|.||+++.+.. .+.+.||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~-~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTD-VSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCC-eeeEEEccccc
Confidence                   23  999999999999987653 36899998654

>PRK06148 hypothetical protein; Provisional

Probab=95.51  E-value=0.4  Score=51.67  Aligned_cols=139  Identities=15%  Similarity=0.174  Sum_probs=76.4

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhc-------CCCCCcceec-e----EEEe-CC--
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-------LRHPNIVRFK-E----VILT-PT--   92 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~-------l~hpnIv~l~-~----~~~~-~~--   92 (365)
                      ++.|+ |..-.+|++... +|..+++|+..... .......|...+..       +.-|.+++-. +    .... ++  
T Consensus        30 ~~~L~-s~~d~nf~v~~~-~g~~yVLKi~~~~~-~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~  106 (1013)
T PRK06148         30 ATPLD-GERDLNFRLTTD-DGADYILKIVNPSE-PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEP  106 (1013)
T ss_pred             EeecC-CcCCceEEEEeC-CCCeEEEEEcCCcc-chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCce
Confidence            35674 456778888753 67789999987643 22333444444432       3344444422 1    1111 22  


Q ss_pred             EEEEEEeecCCCChHHH-----------------HH----hcC------CCCH-----------------HHHHHHHHHH
Q 017860           93 HLAIVMEYASGGELFER-----------------IC----NAG------RFSE-----------------DEARFFFQQL  128 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~-----------------l~----~~~------~l~~-----------------~~~~~i~~qi  128 (365)
                      .++.+++|++|..+...                 +.    ...      .+.+                 ...+.++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            56778999999776541                 10    000      0001                 1112233333


Q ss_pred             HHHHHH-----HH--HcCCeecCCCCCcEEecCCCCCCEE-EecCCCcc
Q 017860          129 ISGVSY-----CH--AMQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK  169 (365)
Q Consensus       129 l~al~~-----LH--~~~ivHrDlkp~NIli~~~~~~~vk-l~Dfgla~  169 (365)
                      +....-     +.  ..++||+|+.+.|||++.+...++. |.|||-+.
T Consensus       187 ~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        187 LARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             HHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            333321     21  2569999999999999866533455 99999765

>PTZ00296 choline kinase; Provisional

Probab=95.34  E-value=0.16  Score=49.25  Aligned_cols=76  Identities=16%  Similarity=0.029  Sum_probs=47.7

Q ss_pred             eecccccCCCeEEEEEEEcc--------CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcc-eeceEEEeCCEEEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIV   97 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~l~~~~~~~~~~~lv   97 (365)
                      -++.|..|=-..+|++....        .++.|.+|+.-.+...--.-.+|..+++.+...+|- ++++.+.    -+.|
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence            45677677778889887542        156899998765443222445677777777544443 3555542    2457


Q ss_pred             EeecCCCCh
Q 017860           98 MEYASGGEL  106 (365)
Q Consensus        98 ~e~~~~g~L  106 (365)
                      .+|++|-+|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            899987644

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.29  E-value=0.1  Score=45.22  Aligned_cols=55  Identities=16%  Similarity=0.094  Sum_probs=33.0

Q ss_pred             CcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEeecCCCCh
Q 017860           48 KELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        48 ~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ++.|++|+...+...--.-..|..+++.+...++ .++++.+. ++   .|.+|+.|.+|
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~-~g---~v~e~i~g~~l   57 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFE-NG---RVEEFIEGRTL   57 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEET-TE---EEEE--SSEE-
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcC-CC---cEEEEeccccc
Confidence            4678999888775555566778888887764444 44555542 22   46688877654

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.03  E-value=0.096  Score=45.45  Aligned_cols=97  Identities=18%  Similarity=0.117  Sum_probs=60.3

Q ss_pred             EEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 017860           51 VAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL  128 (365)
Q Consensus        51 vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qi  128 (365)
                      ..+|++...+-  ....+..+..++.++.  .|+++..=  ....+.++.|+|-.....             ...++.-=
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~-------------~~N~i~ag  150 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN-------------FSNFITAG  150 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc-------------hhHHHHHh
Confidence            34454443221  2345666777776554  56776632  345688999999432111             01111112


Q ss_pred             HHHHHHHHH--cCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860          129 ISGVSYCHA--MQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus       129 l~al~~LH~--~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                      +.+|.-.|+  .+.+|+|-.|+||+-|+.+.  +||.|=+
T Consensus       151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~  188 (308)
T PF07387_consen  151 IKDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPV  188 (308)
T ss_pred             HHHHHHhhccCCCeecCCCChhheeecCCCC--EEecChh
Confidence            456777784  56999999999999987776  9999975

The function of this family is unknown.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.58  E-value=0.13  Score=48.04  Aligned_cols=71  Identities=25%  Similarity=0.286  Sum_probs=52.8

Q ss_pred             CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      ...|++|++- |+++.- +   ..-..+++..++.+.+..++-+..+ ..-|||+...||||+ +|+  |.|+||-++|.
T Consensus       299 ~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn--vtLIDfklsRl  370 (488)
T COG5072         299 LYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN--VTLIDFKLSRL  370 (488)
T ss_pred             eEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc--eEEEEeeeeec
Confidence            4567778776 445532 1   1235678888888888888777765 488999999999998 444  99999999884

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	365
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-168
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-165
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-164
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-164
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-163
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-158
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-52
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-49
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-49
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-49
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-48
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-48
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-48
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-48
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-48
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-48
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-48
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-48
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-46
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-46
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-46
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-46
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-46
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-45
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-41
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-41
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-41
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-41
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-41
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-41
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-41
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-41
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-41
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-41
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-41
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-41
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-41
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-41
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-41
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-41
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-41
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-41
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-41
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-41
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-41
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-41
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-41
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-41
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-41
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-41
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-41
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-41
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-41
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-41
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-41
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-41
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		6e-41
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-41
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-41
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		6e-41
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-41
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		8e-41
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-41
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-40
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-40
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-40
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-40
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-40
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-40
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-40
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-40
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-40
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-39
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-39
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-39
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-39
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-39
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-39
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-38
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-38
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-38
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-38
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-38
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-38
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-38
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-37
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-37
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-37
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-37
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-37
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-37
3soa_A	444	Full-Length Human Camkii Length = 444		3e-37
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-37
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-37
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-37
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-37
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-37
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-37
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-37
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-37
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-37
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-37
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-37
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-37
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-37
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-36
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-36
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-36
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-36
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-36
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-36
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-36
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-36
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-36
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-36
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-36
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-36
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-36
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-36
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-36
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-36
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-36
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-36
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-36
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-36
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-36
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-36
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-36
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-36
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-36
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-36
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-36
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-36
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-36
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-36
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-36
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-36
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-36
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-35
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-35
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		8e-35
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-35
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-34
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-34
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-34
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-34
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-34
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-34
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-34
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-34
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-34
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-34
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-34
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-34
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-33
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-33
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-33
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-33
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-33
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-33
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-33
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-32
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-31
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-31
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-31
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-31
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-31
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-31
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-31
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-31
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-30
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-30
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-30
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-30
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-30
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-30
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-30
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-30
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-30
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-30
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-30
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-30
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-30
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-30
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-30
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-30
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-30
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-30
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-30
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-30
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-30
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-30
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-30
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-30
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		7e-30
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-30
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-30
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-30
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-30
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-30
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-30
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-30
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-29
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-29
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-29
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-29
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-29
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-29
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-29
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-29
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-29
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-29
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-29
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-29
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-29
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-29
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-29
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-29
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-29
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-29
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-29
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-29
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-29
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-29
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-29
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-29
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-29
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-29
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-29
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-29
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-29
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-29
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-29
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-29
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-29
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-29
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-29
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-29
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-29
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-29
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-29
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-29
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-28
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-28
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-28
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-28
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-28
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-28
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-28
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-28
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-28
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-28
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-28
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-28
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-28
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-28
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-27
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-27
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-27
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-27
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		9e-27
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-26
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-26
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-26
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-26
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		9e-26
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-26
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-25
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-25
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-25
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-25
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-25
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-25
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-25
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-25
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-25
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-25
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-25
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-25
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-25
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-25
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-25
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-25
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-25
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-25
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-25
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-25
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-25
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-25
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-25
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-25
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		5e-25
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-24
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-24
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-24
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-24
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-24
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-24
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-24
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-24
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-24
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-24
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-24
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		7e-24
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-24
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-23
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-23
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-23
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-23
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-23
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-23
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-22
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-22
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-22
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		6e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-22
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		7e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-22
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-22
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-22
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-21
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-21
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-21
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-21
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-21
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-21
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-21
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-21
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-21
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-21
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-21
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-21
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-21
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-21
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-21
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-21
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-21
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-21
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-21
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-21
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-21
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-21
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-21
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-21
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-21
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-21
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-21
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-21
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-21
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-21
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-21
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-21
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-21
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-21
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		3e-21
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-21
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-21
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-21
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-21
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-21
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-21
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-21
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-21
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-21
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-21
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-21
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		7e-21
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-21
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-20
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-20
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-20
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-20
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-20
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-20
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-20
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-20
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-20
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		9e-20
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-19
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-19
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-19
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-19
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-19
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-19
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-19
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-19
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-19
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-19
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-19
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-19
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-19
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-19
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-19
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-18
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-18
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-18
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-18
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-18
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-18
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-18
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-17
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-17
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-17
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-17
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-17
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-17
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-17
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		6e-17
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		6e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		8e-17
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-17
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-17
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-16
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-16
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-16
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-16
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-16
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-16
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-16
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-16
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-16
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-16
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-16
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-16
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-16
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-16
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-16
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-16
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-16
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-16
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-16
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-16
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-16
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-15
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-15
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-15
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-15
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-15
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-15
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-15
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-15
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-15
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-15
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-15
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-15
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-15
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-15
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-15
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-15
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-15
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-15
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-15
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-15
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-15
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-15
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-15
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-15
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-15
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-15
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-15
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-15
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-15
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-15
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-15
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-15
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-15
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-15
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-15
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-15
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-15
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-15
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-15
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-15
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-15
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-15
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-15
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-15
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-15
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-15
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-15
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-15
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-15
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-15
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-15
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-15
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-15
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-15
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-15
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-15
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-15
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-15
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-15
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-15
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-15
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-15
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-15
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-15
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-15
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-15
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-15
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-15
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		7e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		9e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		9e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-14
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-14
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-14
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-14
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-14
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-14
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-14
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-14
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-14
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-14
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-13
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-13
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-13
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		7e-13
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		7e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		7e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-12
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-12
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-12
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-12
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		5e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-12
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-12
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-12
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-12
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-12
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-12
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-12
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		6e-12
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-12
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-12
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-12
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-12
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-12
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-12
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		8e-12
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-12
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-11
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-11
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-11
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-11
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-11
3gni_B	389	Structure Of Strad And Mo25 Length = 389		2e-11
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		3e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-11
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-11
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		3e-11
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		3e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		4e-11
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		4e-11
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		4e-11
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		4e-11
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		4e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-11
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		4e-11
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-11
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		4e-11
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-11
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		4e-11
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		4e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-10
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-10
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		2e-10
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		2e-10
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-10
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-10
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-10
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		5e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-08
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		1e-08
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		6e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-08
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-07
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-07
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-07
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-07
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-07
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-07
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-07
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-07
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-07
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-07
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-07
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-07
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-07
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-07
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-07
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		3e-07
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		3e-07
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		3e-07
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		3e-07
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		3e-07
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		3e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		3e-07
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-07
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		3e-07
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-07
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		3e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-07
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-07
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-07
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-07
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-07
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-06
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-06
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-06
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-06
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-06
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		3e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		6e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		6e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		7e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		9e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		9e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		2e-05
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		3e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		3e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-05
2c47_A	313	Structure Of Casein Kinase 1 Gamma 2 Length = 313		3e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-05
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-05
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-05
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-05
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		5e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-05

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  587 bits (1512), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 278/328 (84%), Positives = 302/328 (92%), Gaps = 1/328 (0%)
Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERG  I
Sbjct: 1   MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239
Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS EC  LISRIFVADPA RI+IPEI  H WFLKNLPADL++E    SQ++EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299
Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLN 330
           +QPMQS+D IMQII+EA+IPAV    L+
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVRNRCLD 327

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  577 bits (1487), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 274/330 (83%), Positives = 303/330 (91%), Gaps = 2/330 (0%)
Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC FGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           ++PD   IS ECR LISRIFVADPA RI+IPEI  H+WFLKNLPADL+++ TM++Q++E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCY 332
           DQP QS++ IMQIIAEA++P  GT  LN Y
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHY 328

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  575 bits (1482), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 273/330 (82%), Positives = 302/330 (91%), Gaps = 2/330 (0%)
Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC FGYSKSSVLHSQPK TVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           ++PD   IS ECR LISRIFVADPA RI+IPEI  H+WFLKNLPADL+++ TM++Q++E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCY 332
           DQP QS++ IMQIIAEA++P  GT  LN Y
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHY 328

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  575 bits (1481), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 273/330 (82%), Positives = 302/330 (91%), Gaps = 2/330 (0%)
Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR +++ GP MD+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KI
Sbjct: 1   MDRPAVS-GP-MDLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKI 58
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
             NV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  AANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 119 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           ++PD   IS ECR LISRIFVADPA RI+IPEI  H+WFLKNLPADL+++ TM++Q++E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCY 332
           DQP QS++ IMQIIAEA++P  GT  LN Y
Sbjct: 299 DQPGQSIEEIMQIIAEATVPPAGTQNLNHY 328

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  572 bits (1474), Expect = e-163,   Method: Compositional matrix adjust.
 Identities = 268/318 (84%), Positives = 293/318 (92%)
Query: 15  DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR 74
           D+PIMHDSDRY+ V+DIGSGNFGVARLMRDK + ELVAVKYIERG+KIDENV+REIINHR
Sbjct: 10  DLPIMHDSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHR 69
Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY
Sbjct: 70  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 129
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
           CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL+
Sbjct: 130 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 189
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
            EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY++PD   IS EC
Sbjct: 190 KEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPEC 249
Query: 255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQ 314
           R LISRIFVADPA RI+IPEI  H+WFLKNLPADL+++ TM++Q+   DQP QS++ IMQ
Sbjct: 250 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQPGQSIEEIMQ 309
Query: 315 IIAEASIPAVGTHGLNCY 332
           IIAEA++P  GT  LN Y
Sbjct: 310 IIAEATVPPAGTQNLNHY 327

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  554 bits (1427), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 263/319 (82%), Positives = 292/319 (91%), Gaps = 2/319 (0%)
Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDR ++  GP MD+PIMHDSDRY+ V+DIG+GNFGVARLMRDK   ELVAVKYIERG+KI
Sbjct: 1   MDRPAVA-GP-MDLPIMHDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKI 58
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 118
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQLISGVSY HAMQV HRDLKLENTLLDGSPAPRLKI DFGYSK+SVLHSQPKS VG
Sbjct: 119 FFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVG 178
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLL+ EYDGK+ADVWSCGVTLYVMLVG YPFEDP+EPK+FRKTI RIL+VQY
Sbjct: 179 TPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQY 238
Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           ++PD   IS ECR LISRIFVADPA RI+IPEI  H+WFLKNLPADL+++ TM++Q++E 
Sbjct: 239 AIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDES 298
Query: 303 DQPMQSVDVIMQIIAEASI 321
           DQP QS++ IMQIIAEA++
Sbjct: 299 DQPGQSIEEIMQIIAEATV 317

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  201 bits (512), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 116/260 (44%), Positives = 155/260 (59%), Gaps = 13/260 (5%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIER----GDKIDENVQREIINHRSLRHPNIVRFKE 86
           +G G+FG  +L     T++ VA+K+I R       +   V+REI   + LRHP+I++  +
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
           VI TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  ++ HRDLK
Sbjct: 77  VITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLK 135
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            EN LLD +    +KI DFG S      +  K++ G+P Y APEV+    Y G   DVWS
Sbjct: 136 PENLLLDDNL--NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWS 193
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
           CG+ LYVMLVG  PF+D   P  F+K    + S  Y +PD   +S   + LI R+ VADP
Sbjct: 194 CGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLIRRMIVADP 247
Query: 267 AARITIPEIMKHQWFLKNLP 286
             RITI EI +  WF  NLP
Sbjct: 248 MQRITIQEIRRDPWFNVNLP 267

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  191 bits (485), Expect = 6e-49,   Method: Compositional matrix adjust.
 Identities = 107/266 (40%), Positives = 148/266 (55%), Gaps = 12/266 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKE 86
           +G G FG  ++   ++T   VAVK + R       +   ++REI N +  RHP+I++  +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
           VI TPT   +VMEY SGGELF+ IC  GR  E EAR  FQQ++S V YCH   V HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            EN LLD       KI DFG S         +++ G+P Y APEV+    Y G   D+WS
Sbjct: 139 PENVLLDAHMNA--KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
           CGV LY +L G  PF+D   P  F+K    I    + +P+   +++    L+  +   DP
Sbjct: 197 CGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMHMLQVDP 250
Query: 267 AARITIPEIMKHQWFLKNLPADLVDE 292
             R TI +I +H+WF ++LP+ L  E
Sbjct: 251 LKRATIKDIREHEWFKQDLPSYLFPE 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+    +YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 262 FVADPAARITIPEIMKHQW 280
            + +P+ R T+ +IMK +W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  191 bits (484), Expect = 7e-49,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+    +YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 262 FVADPAARITIPEIMKHQW 280
            + +P+ R T+ +IMK +W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 149/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+    +YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 262 FVADPAARITIPEIMKHQW 280
            + +P+ R T+ +IMK +W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 149/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T   VA+K I++      ++Q   RE+   + L HPNI
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L ++MEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH  ++ 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 133
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S    +  +  +  G+P Y APE+    +YDG  
Sbjct: 134 HRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ R 
Sbjct: 192 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKRF 245
Query: 262 FVADPAARITIPEIMKHQW 280
            V +P  R T+ +IMK +W
Sbjct: 246 LVLNPIKRGTLEQIMKDRW 264

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 107/266 (40%), Positives = 147/266 (55%), Gaps = 12/266 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKE 86
           +G G FG  ++   ++T   VAVK + R       +   ++REI N +  RHP+I++  +
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
           VI TPT   +VMEY SGGELF+ IC  GR  E EAR  FQQ++S V YCH   V HRDLK
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLK 138
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            EN LLD       KI DFG S         + + G+P Y APEV+    Y G   D+WS
Sbjct: 139 PENVLLDAHMNA--KIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWS 196
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
           CGV LY +L G  PF+D   P  F+K    I    + +P+   +++    L+  +   DP
Sbjct: 197 CGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLLMHMLQVDP 250
Query: 267 AARITIPEIMKHQWFLKNLPADLVDE 292
             R TI +I +H+WF ++LP+ L  E
Sbjct: 251 LKRATIKDIREHEWFKQDLPSYLFPE 276

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  189 bits (481), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 150/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T + VAV+ I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+    +YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 262 FVADPAARITIPEIMKHQW 280
            + +P+ R T+ +IMK +W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/259 (40%), Positives = 148/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T   VA+K I++      ++Q   RE+   + L HPNI
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L ++MEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH  ++ 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+    +YDG  
Sbjct: 137 HRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ R 
Sbjct: 195 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKRF 248
Query: 262 FVADPAARITIPEIMKHQW 280
            V +P  R T+ +IMK +W
Sbjct: 249 LVLNPIKRGTLEQIMKDRW 267

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 110/283 (38%), Positives = 151/283 (53%), Gaps = 12/283 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKE 86
           +G G FG  ++ + ++T   VAVK + R       +   ++REI N +  RHP+I++  +
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
           VI TP+ + +VMEY SGGELF+ IC  GR  E E+R  FQQ++SGV YCH   V HRDLK
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLK 143
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            EN LLD       KI DFG S         + + G+P Y APEV+    Y G   D+WS
Sbjct: 144 PENVLLDAH--MNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWS 201
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
            GV LY +L G  PF+D   P  F+K    I    Y+    NP       L+  +   DP
Sbjct: 202 SGVILYALLCGTLPFDDDHVPTLFKKICDGIF---YTPQYLNP---SVISLLKHMLQVDP 255
Query: 267 AARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSV 309
             R TI +I +H+WF ++LP  L  E    S     D+ ++ V
Sbjct: 256 MKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEV 298

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 149/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T + VAV+ I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S      ++     G+P Y APE+    +YDG  
Sbjct: 136 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKKF 247
Query: 262 FVADPAARITIPEIMKHQW 280
            + +P+ R T+ +IMK +W
Sbjct: 248 LILNPSKRGTLEQIMKDRW 266

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 103/259 (39%), Positives = 149/259 (57%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +VMEYASGGE+F+ +   G   E EAR  F+Q++S V YCH   + 
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIV 128
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S      ++  +  G+P Y APE+    +YDG  
Sbjct: 129 HRDLKAENLLLDAD--MNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ + 
Sbjct: 187 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKKF 240
Query: 262 FVADPAARITIPEIMKHQW 280
            + +P+ R T+ +IMK +W
Sbjct: 241 LILNPSKRGTLEQIMKDRW 259

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 102/259 (39%), Positives = 146/259 (56%), Gaps = 11/259 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y  ++ IG GNF   +L R  +T + VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +V EYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIV 135
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLD      +KI DFG+S      ++  +  G P Y APE+    +YDG  
Sbjct: 136 HRDLKAENLLLDAD--XNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P     S +C +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--XSTDCENLLKKF 247
Query: 262 FVADPAARITIPEIMKHQW 280
            + +P+ R T+ +I K +W
Sbjct: 248 LILNPSKRGTLEQIXKDRW 266

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  182 bits (462), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 108/271 (39%), Positives = 151/271 (55%), Gaps = 13/271 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPN 80
           Y  V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 76  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+    Y G 
Sbjct: 135 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
             DVWSCGV LYVML    PF+D   P  F+     +    Y++P    +S     LI R
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 246
Query: 261 IFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           + + +P  RI+I EIM+  WF  +LP  L++
Sbjct: 247 MLIVNPLNRISIHEIMQDDWFKVDLPEYLLE 277

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 150/270 (55%), Gaps = 13/270 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPN 80
           Y  V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 75  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 133
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+    Y G 
Sbjct: 134 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
             DVWSCGV LYVML    PF+D   P  F+     +    Y++P    +S     LI R
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 245
Query: 261 IFVADPAARITIPEIMKHQWFLKNLPADLV 290
           + + +P  RI+I EIM+  WF  +LP  L+
Sbjct: 246 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 275

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 150/270 (55%), Gaps = 13/270 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPN 80
           Y  V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 70  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 128
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+    Y G 
Sbjct: 129 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
             DVWSCGV LYVML    PF+D   P  F+     +    Y++P    +S     LI R
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 240
Query: 261 IFVADPAARITIPEIMKHQWFLKNLPADLV 290
           + + +P  RI+I EIM+  WF  +LP  L+
Sbjct: 241 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 270

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 108/270 (40%), Positives = 150/270 (55%), Gaps = 13/270 (4%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPN 80
           Y  V+ +G G+FG  +L     T + VA+K I +       +   ++REI   R LRHP+
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I++  +VI +   + +V+EYA G ELF+ I    + SE EAR FFQQ+IS V YCH  ++
Sbjct: 66  IIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKI 124
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRDLK EN LLD      +KI DFG S      +  K++ G+P Y APEV+    Y G 
Sbjct: 125 VHRDLKPENLLLD--EHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
             DVWSCGV LYVML    PF+D   P  F+     +    Y++P    +S     LI R
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----YTLPKF--LSPGAAGLIKR 236
Query: 261 IFVADPAARITIPEIMKHQWFLKNLPADLV 290
           + + +P  RI+I EIM+  WF  +LP  L+
Sbjct: 237 MLIVNPLNRISIHEIMQDDWFKVDLPEYLL 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 110/282 (39%), Positives = 158/282 (56%), Gaps = 17/282 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNI 81
           Y   + IG GNF   +L R  +T   VAVK I++      ++Q   RE+   + L HPNI
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V+  EVI T   L +VMEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH   + 
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK EN LLDG     +KI DFG+S    + ++  +  G+P Y APE+    +YDG  
Sbjct: 137 HRDLKAENLLLDGD--MNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DVWS GV LY ++ G  PF D    K+ R   +R+L  +Y +P    +S +C +L+ ++
Sbjct: 195 VDVWSLGVILYTLVSGSLPF-DGQNLKELR---ERVLRGKYRIPFY--MSTDCENLLKKL 248
Query: 262 FVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 303
            V +P  R ++ +IMK +W       ++  E+     Y EPD
Sbjct: 249 LVLNPIKRGSLEQIMKDRWM------NVGHEEEELKPYTEPD 284

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 150/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTPA++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 158/291 (54%), Gaps = 21/291 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
              +D I R+ V DP  R+TI + ++H W     P D   ++ +SS +  P
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPKDT--QQALSSAWSHP 291

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 158/291 (54%), Gaps = 21/291 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
              +D I R+ V DP  R+TI + ++H W     P D   ++ +SS +  P
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPKDT--QQALSSAWSHP 291

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIX 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 158/291 (54%), Gaps = 21/291 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 188
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 244
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
              +D I R+ V DP  R+TI + ++H W     P D   ++ +SS +  P
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPKDT--QQALSSAWSHP 290

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 158/291 (54%), Gaps = 21/291 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 188
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 244
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
              +D I R+ V DP  R+TI + ++H W     P D   ++ +SS +  P
Sbjct: 245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPKDT--QQALSSAWSHP 290

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  166 bits (419), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 93/269 (34%), Positives = 148/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D Y+   ++GSG F + R  R K T +  A K+I+       R     E ++RE+   R 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H+ ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+ +
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-V 183
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    E K  ++T+  I +V Y   +   +  S
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPF--LGETK--QETLTNISAVNYDFDEEYFSNTS 239
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I R+ V DP  R+TI + ++H W
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 159/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 150/268 (55%), Gaps = 12/268 (4%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRH 78
           ++RY+ V  +G G+FG     +D++T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV LR  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECR 255
           D K  DVWS GV LY++L G  PF   +E       ++R+ + +Y+  +P    IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLK 283
           DLI ++    P+ RIT  + ++H W  K
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 99/277 (35%), Positives = 158/277 (57%), Gaps = 17/277 (6%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP-DEPKDFRKTIQRILSVQ-YSVPDTN 248
           +L R E+  +  DVWSCG+ L  ML G  P++ P D  +++    ++   +  +   D+ 
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSA 236
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 237 PLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 149/269 (55%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
              +D I R+ V DP  R+TI + ++H W
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  165 bits (417), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 158/291 (54%), Gaps = 21/291 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
              +D I R+ V DP  R+TI + ++H W     P D   ++ +SS +  P
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPKD--TQQALSSAWSHP 291

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLD--ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 150/268 (55%), Gaps = 12/268 (4%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRH 78
           ++RY+ V  +G G+FG     +D++T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV LR  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECR 255
           D K  DVWS GV LY++L G  PF   +E       ++R+ + +Y+  +P    IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLK 283
           DLI ++    P+ RIT  + ++H W  K
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 98/270 (36%), Positives = 154/270 (57%), Gaps = 18/270 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIV 82
           +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  ++ L H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
           +F           + +EY SGGELF+RI       E +A+ FF QL++GV Y H + + H
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITH 126
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRHEYDG 199
           RD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE+L R E+  
Sbjct: 127 RDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D+ P++    
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLA---- 238
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNL 285
            L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 239 -LLHKILVENPSARITIPDIKKDRWYNKPL 267

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 158/281 (56%), Gaps = 21/281 (7%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            +  L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSV 244
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +  
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKK 233
Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
            D+ P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 234 IDSAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 269

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 158/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  164 bits (415), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 98/268 (36%), Positives = 150/268 (55%), Gaps = 12/268 (4%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRH 78
           ++RY+ V  +G G+FG     +D++T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 139 QVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEV LR  Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV-LRGTY 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECR 255
           D K  DVWS GV LY++L G  PF   +E       ++R+ + +Y+  +P    IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNE----YDILKRVETGKYAFDLPQWRTISDDAK 254
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLK 283
           DLI ++    P+ RIT  + ++H W  K
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 96/291 (32%), Positives = 157/291 (53%), Gaps = 21/291 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F V +  R+K T    A K+I+       R     E+++RE+   + 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           ++HPN++   EV    T + ++ E  +GGELF+ +      +E+EA  F +Q+++GV Y 
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE+ +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI-V 189
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  S
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNTS 245
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
              +D I R+ V DP  R+TI + ++H W     P D   ++ +SS +  P
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWI---KPKDT--QQALSSAWSHP 291

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 147/269 (54%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D Y+   ++GSG F + R  R K T +  A K+I+       R     E ++RE+   R 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 131
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H+ ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+ +
Sbjct: 132 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-V 190
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    E K  ++T+  I +V Y   +   +  S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPF--LGETK--QETLTNISAVNYDFDEEYFSNTS 246
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I R+ V DP  R+ I + ++H W
Sbjct: 247 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 147/269 (54%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D Y+   ++GSG F + R  R K T +  A K+I+       R     E ++RE+   R 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y 
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 145
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H+ ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE+ +
Sbjct: 146 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEI-V 204
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    E K  ++T+  I +V Y   +   +  S
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASPF--LGETK--QETLTNISAVNYDFDEEYFSNTS 260
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I R+ V DP  R+ I + ++H W
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 9/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
           SDRY   R +G G+FG   L +DK+T +  AVK I +     K D E++ RE+   + L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-LHGT 203
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           YD K  DVWS GV LY++L G  PF   +E  D  K +++     + +P    +S+  +D
Sbjct: 204 YDEK-CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKG-KYTFELPQWKKVSESAKD 260
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI ++    P+ RI+  + + H+W
Sbjct: 261 LIRKMLTYVPSMRISARDALDHEW 284

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 9/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
           SDRY   R +G G+FG   L +DK+T +  AVK I +     K D E++ RE+   + L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 169 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-LHGT 227
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           YD K  DVWS GV LY++L G  PF   +E  D  K +++     + +P    +S+  +D
Sbjct: 228 YDEK-CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEKG-KYTFELPQWKKVSESAKD 284
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI ++    P+ RI+  + + H+W
Sbjct: 285 LIRKMLTYVPSMRISARDALDHEW 308

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 9/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
           SDRY   R +G G+FG   L +DK+T +  AVK I +     K D E++ RE+   + L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 168 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-LHGT 226
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           YD K  DVWS GV LY++L G  PF   +E  D  K +++     + +P    +S+  +D
Sbjct: 227 YDEK-CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEK-GKYTFELPQWKKVSESAKD 283
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI ++    P+ RI+  + + H+W
Sbjct: 284 LIRKMLTYVPSMRISARDALDHEW 307

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 100/279 (35%), Positives = 157/279 (56%), Gaps = 21/279 (7%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
           +P + D   +D V+ +G G  G  +L  ++VT+E VAVK ++    +D  EN+++EI  +
Sbjct: 2   VPFVED---WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN 58
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++GV 
Sbjct: 59  KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGTPAYIAPE 190
           Y H + + HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE
Sbjct: 119 YLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD----EPKDFRKTIQRILSVQYSVPD 246
           +L R E+  +  DVWSCG+ L  ML G  P++ P     E  D+++  ++     +   D
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLNPWKKID 234
Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
           + P++     L+ +I V +P+ARITIP+I K +W+ K L
Sbjct: 235 SAPLA-----LLHKILVENPSARITIPDIKKDRWYNKPL 268

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 146/269 (54%), Gaps = 13/269 (4%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLR 77
           SDRY  V+ +GSG +G   L +DK+T    A+K I++      +    +++     + L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H 
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 122
Query: 138 MQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
             + HRDLK EN LL+      L KI DFG S    +  + K  +GT  YIAPEV LR +
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKK 181
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQEC 254
           YD K  DVWSCGV LY++L G  PF    +    ++ ++R+   ++S   PD   +S E 
Sbjct: 182 YDEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEA 236
Query: 255 RDLISRIFVADPAARITIPEIMKHQWFLK 283
           + L+  +   +P+ RI+  E + H W +K
Sbjct: 237 KQLVKLMLTYEPSKRISAEEALNHPWIVK 265

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 146/269 (54%), Gaps = 13/269 (4%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLR 77
           SDRY  V+ +GSG +G   L +DK+T    A+K I++      +    +++     + L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI++  E      +  +VME   GGELF+ I    +FSE +A    +Q++SG +Y H 
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHK 139
Query: 138 MQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
             + HRDLK EN LL+      L KI DFG S    +  + K  +GT  YIAPEV LR +
Sbjct: 140 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEV-LRKK 198
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQEC 254
           YD K  DVWSCGV LY++L G  PF    +    ++ ++R+   ++S   PD   +S E 
Sbjct: 199 YDEK-CDVWSCGVILYILLCGYPPFGGQTD----QEILKRVEKGKFSFDPPDWTQVSDEA 253
Query: 255 RDLISRIFVADPAARITIPEIMKHQWFLK 283
           + L+  +   +P+ RI+  E + H W +K
Sbjct: 254 KQLVKLMLTYEPSKRISAEEALNHPWIVK 282

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  162 bits (410), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 147/264 (55%), Gaps = 9/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
           SDRY   R +G G+FG   L +DK+T +  AVK I +     K D E++ RE+   + L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEV-LHGT 209
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           YD K  DVWS GV LY++L G  PF   +E  D  K +++     + +P    +S+  +D
Sbjct: 210 YDEK-CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEK-GKYTFELPQWKKVSESAKD 266
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI ++    P+ RI+  + + H+W
Sbjct: 267 LIRKMLTYVPSMRISARDALDHEW 290

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 99/264 (37%), Positives = 145/264 (54%), Gaps = 9/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
           SDRY   R +G G+FG   L +DK+T +  AVK I +     K D E++ RE+   + L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI +  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEV L   
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEV-LHGT 203
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           YD K  DVWS GV LY++L G  PF   +E  D  K +++     + +P    +S+  +D
Sbjct: 204 YDEK-CDVWSTGVILYILLSGCPPFNGANEY-DILKKVEK-GKYTFELPQWKKVSESAKD 260
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI +     P+ RI+  + + H+W
Sbjct: 261 LIRKXLTYVPSXRISARDALDHEW 284

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 97/281 (34%), Positives = 147/281 (52%), Gaps = 10/281 (3%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           D YDF   +G+G F    L  DK T++LVA+K I  E  +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 141 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +  Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K  D WS GV  Y++L G  PF D ++ K F + ++     ++  P  + IS   +D 
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKA--EYEFDSPYWDDISDSAKDF 252
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           I  +   DP  R T  + ++H W   +   D    +++S Q
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 293

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/283 (35%), Positives = 148/283 (52%), Gaps = 14/283 (4%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           D YDF   +G+G F    L  DK T++LVA+K I  E  +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 141 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +  Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECR 255
             K  D WS GV  Y++L G  PF D ++ K F    ++IL  +Y    P  + IS   +
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAK 250
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           D I  +   DP  R T  + ++H W   +   D    +++S Q
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 293

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 99/283 (34%), Positives = 148/283 (52%), Gaps = 14/283 (4%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPN 80
           D YDF   +G+G F    L  DK T++LVA+K I +   +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 77
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 141 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +  Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECR 255
             K  D WS GV  Y++L G  PF D ++ K F    ++IL  +Y    P  + IS   +
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAK 250
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           D I  +   DP  R T  + ++H W   +   D    +++S Q
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 293

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 100/283 (35%), Positives = 148/283 (52%), Gaps = 14/283 (4%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           D YDF   +G+G F    L  DK T++LVA+K I  E  +  + +++ EI     ++HPN
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + +
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 141 CHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            HRDLK EN L   LD     ++ I DFG SK     S   +  GTP Y+APEVL +  Y
Sbjct: 138 VHRDLKPENLLYYSLDED--SKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 195
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECR 255
             K  D WS GV  Y++L G  PF D ++ K F    ++IL  +Y    P  + IS   +
Sbjct: 196 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAK 250
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           D I  +   DP  R T  + ++H W   +   D    +++S Q
Sbjct: 251 DFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQ 293

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 94/279 (33%), Positives = 144/279 (51%), Gaps = 10/279 (3%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIV 82
           ++F   +G+G F    L  +K T +L AVK I +      + +++ EI   R ++H NIV
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             +++  +P HL +VM+  SGGELF+RI   G ++E +A    +Q++  V Y H M + H
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVH 143
Query: 143 RDLKLENTL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           RDLK EN L        ++ I DFG SK         +  GTP Y+APEVL +  Y  K 
Sbjct: 144 RDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPY-SKA 202
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLIS 259
            D WS GV  Y++L G  PF D ++ K F    ++IL  +Y    P  + IS   +D I 
Sbjct: 203 VDCWSIGVIAYILLCGYPPFYDENDSKLF----EQILKAEYEFDSPYWDDISDSAKDFIR 258
Query: 260 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
            +   DP  R T  +  +H W   +   +    +++S+Q
Sbjct: 259 NLMEKDPNKRYTCEQAARHPWIAGDTALNKNIHESVSAQ 297

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 102/305 (33%), Positives = 165/305 (54%), Gaps = 13/305 (4%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR-EIINHRSLRHPN 80
           SD ++   ++G G   +    + K T++  A+K +++   +D+ + R EI     L HPN
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPN 109
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I++ KE+  TPT +++V+E  +GGELF+RI   G +SE +A    +Q++  V+Y H   +
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 141 CHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            HRDLK EN LL  +PAP   LKI DFG SK        K+  GTP Y APE+L    Y 
Sbjct: 170 VHRDLKPEN-LLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY- 227
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRD 256
           G   D+WS G+  Y++L G  PF   DE  D +   +RIL+ +Y    P  + +S   +D
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFY--DERGD-QFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 257 LISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 316
           L+ ++ V DP  R+T  + ++H W +    A+ V   T   + +E +   +    +  ++
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPW-VTGKAANFVHMDTAQKKLQEFNARRKLKAAVKAVV 343
Query: 317 AEASI 321
           A + +
Sbjct: 344 ASSRL 348

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/280 (33%), Positives = 158/280 (56%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCH+ +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 244
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 284

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 93/280 (33%), Positives = 157/280 (56%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  GE+++ +    +F E     +  +L + +SYCH+ +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLXGTLDYLPPEMIEGRMHDEK 191
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 244
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 284

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 90/256 (35%), Positives = 137/256 (53%), Gaps = 6/256 (2%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSLRHPNIVRFK 85
           F+  +GSG F    L++ ++T +L A+K I++     D +++ EI   + ++H NIV  +
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           ++  + TH  +VM+  SGGELF+RI   G ++E +A    QQ++S V Y H   + HRDL
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 146 KLENTL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
           K EN L L      ++ I DFG SK    +    +  GTP Y+APEVL +  Y  K  D 
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPY-SKAVDC 190
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
           WS GV  Y++L G  PF +  E K F K  +     ++  P  + IS+  +D I  +   
Sbjct: 191 WSIGVITYILLCGYPPFYEETESKLFEKIKEGYY--EFESPFWDDISESAKDFICHLLEK 248
Query: 265 DPAARITIPEIMKHQW 280
           DP  R T  + + H W
Sbjct: 249 DPNERYTCEKALSHPW 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 140/264 (53%), Gaps = 8/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           +D Y    ++G G F V R      T +  A K I       +  + ++RE    R L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I       +V +  +GGELFE I     +SE +A    QQ++  V++CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHE 196
            + HRDLK EN LL   S    +K+ DFG +       Q      GTP Y++PEVL +  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y GK  D+W+CGV LY++LVG  PF D D+ + +++   +  +  +  P+ + ++ E +D
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAKD 239
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI+++   +PA RIT  E +KH W
Sbjct: 240 LINKMLTINPAKRITASEALKHPW 263

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 140/264 (53%), Gaps = 8/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           +D Y    ++G G F V R      T +  A K I       +  + ++RE    R L+H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I       +V +  +GGELFE I     +SE +A    QQ++  V++CH  
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLN 122
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHE 196
            + HRDLK EN LL   S    +K+ DFG +       Q      GTP Y++PEVL +  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y GK  D+W+CGV LY++LVG  PF D D+ + +++   +  +  +  P+ + ++ E +D
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAKD 239
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI+++   +PA RIT  E +KH W
Sbjct: 240 LINKMLTINPAKRITASEALKHPW 263

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 94/264 (35%), Positives = 137/264 (51%), Gaps = 8/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           +D Y    DIG G F V R      T    A K I       +  + ++RE    R L+H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            NIVR  + I       +V +  +GGELFE I     +SE +A    QQ++  V +CH M
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 122
Query: 139 QVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHE 196
            V HRDLK EN LL        +K+ DFG +       Q      GTP Y++PEVL +  
Sbjct: 123 GVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y GK  D+W+CGV LY++LVG  PF D D+ K +++   +  +  +  P+ + ++ E ++
Sbjct: 183 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEAKN 239
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI+++   +PA RIT  E +KH W
Sbjct: 240 LINQMLTINPAKRITAHEALKHPW 263

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  154 bits (389), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 90/263 (34%), Positives = 140/263 (53%), Gaps = 12/263 (4%)
Query: 25  YDFVRDIGSGNFGVAR-----LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
           Y    ++G G F V R     L   +   +++  K +   D   + ++RE    R L+HP
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDH--QKLEREARICRLLKHP 81
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIVR  + I    H  ++ +  +GGELFE I     +SE +A    QQ++  V +CH M 
Sbjct: 82  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 141
Query: 140 VCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHEY 197
           V HRDLK EN LL        +K+ DFG +       Q      GTP Y++PEVL +  Y
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
            GK  D+W+CGV LY++LVG  PF D D+ + +++   +  +  +  P+ + ++ E +DL
Sbjct: 202 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEAKDL 258
Query: 258 ISRIFVADPAARITIPEIMKHQW 280
           I+++   +P+ RIT  E +KH W
Sbjct: 259 INKMLTINPSKRITAAEALKHPW 281

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  153 bits (386), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 156/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 156 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 212
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 213 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 265
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 266 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 305

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 156/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 146
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 147 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 203
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 204 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 256
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 257 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 296

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 156/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 242
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 282

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 156/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 244
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 284

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 156/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMHDEK 189
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 242
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 282

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 156/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 279

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 141/266 (53%), Gaps = 12/266 (4%)
Query: 22  SDRYDFVRDIGSGNFGVAR-----LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL 76
           ++ Y    ++G G F V R     L   +    ++  K +   D   + ++RE    R L
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH--QKLEREARICRLL 67
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           +HPNIVR  + I    H  ++ +  +GGELFE I     +SE +A    QQ++  V +CH
Sbjct: 68  KHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 137 AMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLR 194
            M V HR+LK EN LL        +K+ DFG +       Q      GTP Y++PEVL +
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
             Y GK  D+W+CGV LY++LVG  PF D D+ + +++   +  +  +  P+ + ++ E 
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPEWDTVTPEA 244
Query: 255 RDLISRIFVADPAARITIPEIMKHQW 280
           +DLI+++   +P+ RIT  E +KH W
Sbjct: 245 KDLINKMLTINPSKRITAAEALKHPW 270

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 155/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S      S+  +  GT  Y+ PE++    +D K
Sbjct: 131 IHRDIKPENLLL-GS-AGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEK 187
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 188 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 240
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKESASKQ 280

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 155/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE +    +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEXIEGRXHDEK 191
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 244
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 245 LLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKESASKQ 284

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 155/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 155
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 156 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMHDEK 212
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 213 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 265
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 266 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 305

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 155/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTELCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 279

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 92/280 (32%), Positives = 155/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 132 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMHDEK 188
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 189 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 241
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 281

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 145/269 (53%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           + HPNI+   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 136 HAMQVCHRDLKLENT-LLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H  ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  I +V Y   +   +  S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQTS 246
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I ++ V +   R+TI E ++H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 156/280 (55%), Gaps = 16/280 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 131
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI +FG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 132 IHRDIKPENLLL-GS-AGELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 188
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 189 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 241
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQ 298
           +   +P+ R  + E+++H W   N   P++  ++++ S Q
Sbjct: 242 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASKQ 281

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 242
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 141/265 (53%), Gaps = 8/265 (3%)
Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSL 76
           H S+ Y  V+ +GSG +G   L RDKVT    A+K I +       +  +  E+   + L
Sbjct: 34  HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            HPNI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SGV+Y H
Sbjct: 94  DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLH 153
Query: 137 AMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
              + HRDLK EN LL+      L KI DFG S       + K  +GT  YIAPEV LR 
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV-LRK 212
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +YD K  DVWS GV L+++L G  PF    + +  RK  +   +  +  P+   +S+  +
Sbjct: 213 KYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT--FDSPEWKNVSEGAK 269
Query: 256 DLISRIFVADPAARITIPEIMKHQW 280
           DLI ++   D   RI+  + ++H W
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPW 294

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 134 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 191 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 243
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 244 LLKHNPSQRPMLREVLEHPWITAN 267

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 129 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 185
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 186 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 238
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 239 LLKHNPSQRPMLREVLEHPWITAN 262

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 131 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMHDEK 187
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 188 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 240
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           +D  R +G G FG   L R++ +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCH+ +V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS    LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 134 IHRDIKPENLLL-GSNG-ELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 191 V-DLWSLGVLCYEFLVGMPPF----EAHTYQETYRRISRVEFTFPDF--VTEGARDLISR 243
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   + + R+T+ E+++H W   N
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 91/282 (32%), Positives = 156/282 (55%), Gaps = 16/282 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN--LPADLVDEKTMSSQYE 300
           +   +P+ R  + E+++H W   N   P++  ++++ ++  E
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESAAAALE 281

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           +D  R +G G FG   L R++ +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    RF E     +  +L + +SYCH+ +V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS    LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 134 IHRDIKPENLLL-GSNG-ELKIADFGWSVHAP-SSRRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 191 V-DLWSLGVLCYEFLVGMPPF----EAHTYQETYRRISRVEFTFPDF--VTEGARDLISR 243
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   + + R+T+ E+++H W   N
Sbjct: 244 LLKHNASQRLTLAEVLEHPWIKAN 267

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   ++ T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQDTYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 131 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 188 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 240
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 241 LLKHNPSQRPMLREVLEHPWITAN 264

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTXLCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 134
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 135 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 191
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 192 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 244
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 245 LLKHNPSQRPMLREVLEHPWITAN 268

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRDDLCGTLDYLPPEMIEGRMHDEK 189
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 242
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K  K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 126
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 127 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 183
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 184 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 236
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 237 LLKHNPSQRPMLREVLEHPWITAN 260

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRXXLCGTLDYLPPEMIEGRMHDEK 189
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 242
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 146/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI DFG+S  +   S+     GT  Y+ PE++    +D K
Sbjct: 130 IHRDIKPENLLL-GS-AGELKIADFGWSVHAP-SSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 187 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 239
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 240 LLKHNPSQRPMLREVLEHPWITAN 263

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVR 83
           Y     IG G++G  ++   K T+   A K I +    D +  ++EI   +SL HPNI+R
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
             E     T + +VME  +GGELFER+ +   F E +A    + ++S V+YCH + V HR
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 130
Query: 144 DLKLENTL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL      G   
Sbjct: 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPEC 188
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN--PISQECRDLISR 260
           D WS GV +YV+L G  PF  P +     + + +I    ++ P+ +   +S +   LI R
Sbjct: 189 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 261 IFVADPAARITIPEIMKHQWFLKNLPA 287
           +    P  RIT  + ++H+WF K L +
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLSS 271

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 147/281 (52%), Gaps = 19/281 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPN 80
           +D+++ +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+  V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDG 199
            +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL  ++Y G
Sbjct: 127 VYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
           +  D W  GV +Y M+ G  PF + D  + F    + IL  +   P T  +S E + L++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLA 237
Query: 260 RIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTM 295
            +   DP  R+        E+M+H++FL     D+V +K +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 93/267 (34%), Positives = 140/267 (52%), Gaps = 10/267 (3%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVR 83
           Y     IG G++G  ++   K T+   A K I +    D +  ++EI   +SL HPNI+R
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
             E     T + +VME  +GGELFER+ +   F E +A    + ++S V+YCH + V HR
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHR 147
Query: 144 DLKLENTL-LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           DLK EN L L  SP   LK+ DFG +         ++ VGTP Y++P+VL      G   
Sbjct: 148 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EGLYGPEC 205
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN--PISQECRDLISR 260
           D WS GV +YV+L G  PF  P +     + + +I    ++ P+ +   +S +   LI R
Sbjct: 206 DEWSAGVMMYVLLCGYPPFSAPTD----XEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261
Query: 261 IFVADPAARITIPEIMKHQWFLKNLPA 287
           +    P  RIT  + ++H+WF K L +
Sbjct: 262 LLTKSPKQRITSLQALEHEWFEKQLSS 288

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEV 87
           + +G G+F + R    K + +  AVK I +  +++ N Q+EI   +    HPNIV+  EV
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
                H  +VME  +GGELFERI     FSE EA +  ++L+S VS+ H + V HRDLK 
Sbjct: 75  FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKP 134
Query: 148 ENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVW 205
           EN L  D +    +KI DFG+++     +QP K+   T  Y APE+L ++ YD +  D+W
Sbjct: 135 ENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLW 193
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-----YSVPDTNPISQECRDLISR 260
           S GV LY ML G  PF+  D        ++ +  ++     +       +SQE +DLI  
Sbjct: 194 SLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253
Query: 261 IFVADPAARITIPEIMKHQWF 281
           +   DP  R+ +  +  ++W 
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWL 274

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 147/264 (55%), Gaps = 14/264 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPN 80
           ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRHPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ +V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            HRD+K EN LL GS A  LKI +FG+S  +   S+  +  GT  Y+ PE++    +D K
Sbjct: 133 IHRDIKPENLLL-GS-AGELKIANFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           + D+WS GV  Y  LVG  PF    E   +++T +RI  V+++ PD   +++  RDLISR
Sbjct: 190 V-DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDF--VTEGARDLISR 242
Query: 261 IFVADPAARITIPEIMKHQWFLKN 284
           +   +P+ R  + E+++H W   N
Sbjct: 243 LLKHNPSQRPMLREVLEHPWITAN 266

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 147/281 (52%), Gaps = 19/281 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPN 80
           +D+++ +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP 
Sbjct: 10  FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+  V
Sbjct: 70  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDG 199
            +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL  ++Y G
Sbjct: 130 VYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 186
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
           +  D W  GV +Y M+ G  PF + D  + F    + IL  +   P T  +S E + L++
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLA 240
Query: 260 RIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTM 295
            +   DP  R+        E+M+H++FL     D+V +K +
Sbjct: 241 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 281

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 147/281 (52%), Gaps = 19/281 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPN 80
           +D+++ +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+  V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDG 199
            +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL  ++Y G
Sbjct: 127 VYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
           +  D W  GV +Y M+ G  PF + D  + F    + IL  +   P T  +S E + L++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLA 237
Query: 260 RIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTM 295
            +   DP  R+        E+M+H++FL     D+V +K +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 136 HAMQVCHRDLKLENT-LLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H  ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  I SV Y   +   +  S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTS 246
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I ++ V +   R+TI E ++H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 100/294 (34%), Positives = 153/294 (52%), Gaps = 23/294 (7%)
Query: 13  AMDMPI-MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREI 70
           AMD  + M+D   +D+++ +G G FG   L+R+K T    A+K + +   I  + V   +
Sbjct: 2   AMDPKVTMND---FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV 58
Query: 71  INHRSL---RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
              R L   RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +
Sbjct: 59  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 118
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAY 186
           ++S + Y H+  V +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y
Sbjct: 119 IVSALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEY 176
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           +APEVL  ++Y G+  D W  GV +Y M+ G  PF + D  + F    + IL  +   P 
Sbjct: 177 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR 231
Query: 247 TNPISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTM 295
           T  +S E + L++ +   DP  R+        E+M+H++FL     D+V +K +
Sbjct: 232 T--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 283

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 146/281 (51%), Gaps = 19/281 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPN 80
           +D+++ +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+  V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDG 199
            +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL  ++Y G
Sbjct: 127 VYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-G 183
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
           +  D W  GV +Y M+ G  PF + D  + F    + IL  +   P T  +S E + L++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLA 237
Query: 260 RIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTM 295
            +   DP  R+        E+M+H++FL     D+V +K +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 136 HAMQVCHRDLKLENT-LLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H  ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  I SV Y   +   +  S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTS 246
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I ++ V +   R+TI E ++H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 146/281 (51%), Gaps = 19/281 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPN 80
           +D+++ +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+  V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDG 199
            +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL  ++Y G
Sbjct: 127 VYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-G 183
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
           +  D W  GV +Y M+ G  PF + D  + F    + IL  +   P T  +S E + L++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLA 237
Query: 260 RIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTM 295
            +   DP  R+        E+M+H++FL     D+V +K +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 95/281 (33%), Positives = 146/281 (51%), Gaps = 19/281 (6%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RHPN 80
           +D+++ +G G FG   L+R+K T    A+K + +   I  + V   +   R L   RHP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+  V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYDG 199
            +RD+KLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL  ++Y G
Sbjct: 127 VYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-G 183
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
           +  D W  GV +Y M+ G  PF + D  + F    + IL  +   P T  +S E + L++
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPRT--LSPEAKSLLA 237
Query: 260 RIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTM 295
            +   DP  R+        E+M+H++FL     D+V +K +
Sbjct: 238 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLL 278

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 142/269 (52%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 136 HAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H  ++ H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  I SV Y   +   +  S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHTS 246
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I ++ V +   R+TI E ++H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  147 bits (372), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 135/263 (51%), Gaps = 7/263 (2%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           SD YD   ++G G F V R    K T    A K I       +  + ++RE    R L+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCH+ 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K  D+W+CGV LY++LVG  PF D D+ + + +   +  +  Y  P+ + ++ E + L
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 264
Query: 258 ISRIFVADPAARITIPEIMKHQW 280
           I  +   +P  RIT  + +K  W
Sbjct: 265 IDSMLTVNPKKRITADQALKVPW 287

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  147 bits (372), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 135/263 (51%), Gaps = 7/263 (2%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           SD YD   ++G G F V R    K T    A K I       +  + ++RE    R L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCH+ 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K  D+W+CGV LY++LVG  PF D D+ + + +   +  +  Y  P+ + ++ E + L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 258 ISRIFVADPAARITIPEIMKHQW 280
           I  +   +P  RIT  + +K  W
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 136 HAMQVCHRDLKLENT-LLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H  ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  I +V Y   +   +  S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQTS 246
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I ++ V +   R+TI E ++H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 144/269 (53%), Gaps = 16/269 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-------RGDKIDENVQREIINHRS 75
           D YD   ++GSG F + +  R+K T    A K+I+       R     E ++RE+   R 
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y 
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 136 HAMQVCHRDLKLENT-LLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           H  ++ H DLK EN  LLD + P P +K+ DFG +       + K+  GTP ++APE+ +
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI-V 190
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
            +E  G  AD+WS GV  Y++L G  PF    +    ++T+  I +V Y   +   +  S
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQTS 246
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +D I ++ V +   R+TI E ++H W
Sbjct: 247 ELAKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 135/263 (51%), Gaps = 7/263 (2%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           SD YD   ++G G F V R    K T    A K I       +  + ++RE    R L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCH+ 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K  D+W+CGV LY++LVG  PF D D+ + + +   +  +  Y  P+ + ++ E + L
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 241
Query: 258 ISRIFVADPAARITIPEIMKHQW 280
           I  +   +P  RIT  + +K  W
Sbjct: 242 IDSMLTVNPKKRITADQALKVPW 264

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 88/263 (33%), Positives = 135/263 (51%), Gaps = 7/263 (2%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           SD YD   ++G G F V R    K T    A K I       +  + ++RE    R L+H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCH+ 
Sbjct: 64  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 123
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 124 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 183
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K  D+W+CGV LY++LVG  PF D D+ + + +   +  +  Y  P+ + ++ E + L
Sbjct: 184 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPEWDTVTPEAKSL 240
Query: 258 ISRIFVADPAARITIPEIMKHQW 280
           I  +   +P  RIT  + +K  W
Sbjct: 241 IDSMLTVNPKKRITADQALKVPW 263

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 100/315 (31%), Positives = 158/315 (50%), Gaps = 25/315 (7%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERG--------------DKIDENVQREIINH 73
           VR +GSG +G   L ++K      A+K I++               +K  E +  EI   
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           +SL HPNI++  +V     +  +V E+  GGELFE+I N  +F E +A    +Q++SG+ 
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 134 YCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRD+K EN LL+   +   +KI DFG S       + +  +GT  YIAPEV 
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV- 219
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
           L+ +Y+ K  DVWSCGV +Y++L G  PF   ++ +D  K +++     +   D   IS 
Sbjct: 220 LKKKYNEK-CDVWSCGVIMYILLCGYPPFGGQND-QDIIKKVEK-GKYYFDFNDWKNISD 276
Query: 253 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA-DLVDEKTMSSQYEEPDQPMQSVDV 311
           E ++LI  +   D   R T  E +  +W  K     +  D+KT+        +   S   
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGS--- 333
Query: 312 IMQIIAEASIPAVGT 326
             Q +A+A+I  +G+
Sbjct: 334 --QKLAQAAILFIGS 346

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 137/264 (51%), Gaps = 8/264 (3%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           +D Y    ++G G F V R    K   +  A K I       +  + ++RE    R L+H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I       +V +  +GGELFE I     +SE +A     Q++  V++ H  
Sbjct: 90  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH 149
Query: 139 QVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHE 196
            + HRDLK EN LL        +K+ DFG +       Q      GTP Y++PEVL +  
Sbjct: 150 DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y GK  D+W+CGV LY++LVG  PF D D+ K +++   +  +  +  P+ + ++ E ++
Sbjct: 210 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI--KAGAYDFPSPEWDTVTPEAKN 266
Query: 257 LISRIFVADPAARITIPEIMKHQW 280
           LI+++   +PA RIT  + +KH W
Sbjct: 267 LINQMLTINPAKRITADQALKHPW 290

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 149/291 (51%), Gaps = 18/291 (6%)
Query: 18  IMHDS--DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHR 74
           I HD   D YD   ++G+G FGV   + ++ T    A K++    + D E V++EI    
Sbjct: 44  IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 103
Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVS 133
            LRHP +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G+ 
Sbjct: 104 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 163
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           + H     H DLK EN +     +  LK+ DFG +         K T GT  + APEV  
Sbjct: 164 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYSVPDT--NP 249
                G   D+WS GV  Y++L G  PF  E+ DE      T++ + S  +++ D+  + 
Sbjct: 224 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNMDDSAFSG 276
Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFL-KNLPADLVDEKTMSSQY 299
           IS++ +D I ++ +ADP  R+TI + ++H W    N P    D +  SS+Y
Sbjct: 277 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR--DSQIPSSRY 325

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 149/291 (51%), Gaps = 18/291 (6%)
Query: 18  IMHDS--DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHR 74
           I HD   D YD   ++G+G FGV   + ++ T    A K++    + D E V++EI    
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVS 133
            LRHP +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G+ 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           + H     H DLK EN +     +  LK+ DFG +         K T GT  + APEV  
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPDEPKDFRKTIQRILSVQYSVPDT--NP 249
                G   D+WS GV  Y++L G  PF  E+ DE      T++ + S  +++ D+  + 
Sbjct: 330 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNMDDSAFSG 382
Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFL-KNLPADLVDEKTMSSQY 299
           IS++ +D I ++ +ADP  R+TI + ++H W    N P    D +  SS+Y
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR--DSQIPSSRY 431

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 88/269 (32%), Positives = 141/269 (52%), Gaps = 20/269 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
           D +D VR +G G FG   L R+K  K ++A+K + +     + ++  ++REI     LRH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH  
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRH 195
           +V HRD+K EN L+       LKI DFG+S    +H+   + +   GT  Y+ PE++   
Sbjct: 134 KVIHRDIKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            +D K+ D+W  GV  Y  LVG  PF+ P       +T +RI++V    P    +S   +
Sbjct: 188 THDEKV-DLWCAGVLCYEFLVGMPPFDSPSHT----ETHRRIVNVDLKFPPF--LSDGSK 240
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKN 284
           DLIS++    P  R+ +  +M+H W   N
Sbjct: 241 DLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 100/295 (33%), Positives = 145/295 (49%), Gaps = 49/295 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID------------------- 63
           ++Y    +IG G++GV +L  ++      A+K + +   I                    
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 64  --------ENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNA 113
                   E V +EI   + L HPN+V+  EV+  P   HL +V E  + G + E +   
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTL 131
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSK-- 169
              SED+ARF+FQ LI G+ Y H  ++ HRD+K  N L+  DG     +KI DFG S   
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG----HIKIADFGVSNEF 187
Query: 170 --SSVLHSQPKSTVGTPAYIAPEVL--LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD 225
             S  L S   +TVGTPA++APE L   R  + GK  DVW+ GVTLY  + G  PF D  
Sbjct: 188 KGSDALLS---NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-- 242
Query: 226 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
             +       +I S     PD   I+++ +DLI+R+   +P +RI +PEI  H W
Sbjct: 243 --ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 143/270 (52%), Gaps = 20/270 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RH 78
           + +++++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+ 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
           + V +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL  ++
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y G+  D W  GV +Y M+ G  PF + D  K F    + IL  +   P T  +  E + 
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LGPEAKS 378
Query: 257 LISRIFVADPAARIT-----IPEIMKHQWF 281
           L+S +   DP  R+        EIM+H++F
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 143/270 (52%), Gaps = 20/270 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RH 78
           + +++++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+ 
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 270
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
           + V +RDLKLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL  ++
Sbjct: 271 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 328
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y G+  D W  GV +Y M+ G  PF + D  K F    + IL  +   P T  +  E + 
Sbjct: 329 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LGPEAKS 381
Query: 257 LISRIFVADPAARIT-----IPEIMKHQWF 281
           L+S +   DP  R+        EIM+H++F
Sbjct: 382 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 411

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 142/270 (52%), Gaps = 20/270 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RH 78
           + +++++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+ 
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 128
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
           + V +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL  ++
Sbjct: 129 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 186
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y G+  D W  GV +Y M+ G  PF + D  K F    + IL  +   P T  +  E + 
Sbjct: 187 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LGPEAKS 239
Query: 257 LISRIFVADPAARIT-----IPEIMKHQWF 281
           L+S +   DP  R+        EIM+H++F
Sbjct: 240 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 269

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 145/269 (53%), Gaps = 19/269 (7%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           SD Y     IG G++   +    K T    AVK I++  K D + + EI+  R  +HPNI
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDK-SKRDPSEEIEIL-LRYGQHPNI 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           +  K+V     H+ +V E   GGEL ++I     FSE EA F    +   V Y H+  V 
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 142 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLRH 195
           HRDLK  N L +D S  P  L+ICDFG++K   L ++    + TP Y    +APEVL R 
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQ 200
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFED--PDEPKDFRKTIQRILSVQYSVP--DTNPIS 251
            YD +  D+WS G+ LY ML G  PF +   D P++    + RI S ++++   + N +S
Sbjct: 201 GYD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEI---LTRIGSGKFTLSGGNWNTVS 256
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +DL+S++   DP  R+T  ++++H W
Sbjct: 257 ETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 142/270 (52%), Gaps = 20/270 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RH 78
           + +++++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+ 
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 127
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
           + V +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL  ++
Sbjct: 128 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 185
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y G+  D W  GV +Y M+ G  PF + D  K F    + IL  +   P T  +  E + 
Sbjct: 186 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LGPEAKS 238
Query: 257 LISRIFVADPAARIT-----IPEIMKHQWF 281
           L+S +   DP  R+        EIM+H++F
Sbjct: 239 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 268

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 97/269 (36%), Positives = 145/269 (53%), Gaps = 19/269 (7%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           SD Y     IG G++   +    K T    AVK I++  K D + + EI+  R  +HPNI
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDK-SKRDPSEEIEIL-LRYGQHPNI 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           +  K+V     H+ +V E   GGEL ++I     FSE EA F    +   V Y H+  V 
Sbjct: 84  ITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVV 143
Query: 142 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLRH 195
           HRDLK  N L +D S  P  L+ICDFG++K   L ++    + TP Y    +APEVL R 
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLKRQ 200
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFED--PDEPKDFRKTIQRILSVQYSVP--DTNPIS 251
            YD +  D+WS G+ LY ML G  PF +   D P++    + RI S ++++   + N +S
Sbjct: 201 GYD-EGCDIWSLGILLYTMLAGYTPFANGPSDTPEEI---LTRIGSGKFTLSGGNWNTVS 256
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQW 280
           +  +DL+S++   DP  R+T  ++++H W
Sbjct: 257 ETAKDLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 142/270 (52%), Gaps = 20/270 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL---RH 78
           + +++++ +G G FG   L+++K T    A+K +++   +  + V   +  +R L   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+ 
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 129
Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
           + V +RDLKLEN +LD      +KI DFG  K  +      K   GTP Y+APEVL  ++
Sbjct: 130 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDND 187
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y G+  D W  GV +Y M+ G  PF + D  K F    + IL  +   P T  +  E + 
Sbjct: 188 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LGPEAKS 240
Query: 257 LISRIFVADPAARIT-----IPEIMKHQWF 281
           L+S +   DP  R+        EIM+H++F
Sbjct: 241 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 270

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 98/270 (36%), Positives = 144/270 (53%), Gaps = 17/270 (6%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +D Y+   DIG G++ V +    K T    AVK I++  K D   + EI+  R  +HPNI
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTEEIEIL-LRYGQHPNI 78
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           +  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y HA  V 
Sbjct: 79  ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 142 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLRH 195
           HRDLK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL R 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLMTPCYTANFVAPEVLERQ 195
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFED-PDEPKDFRKTIQRILSVQYSVPDT--NPISQ 252
            YD    D+WS GV LY ML G  PF + PD+  +  + + RI S ++S+     N +S 
Sbjct: 196 GYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPE--EILARIGSGKFSLSGGYWNSVSD 252
Query: 253 ECRDLISRIFVADPAARITIPEIMKHQWFL 282
             +DL+S++   DP  R+T   +++H W +
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  140 bits (354), Expect = 8e-34,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 140/269 (52%), Gaps = 20/269 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
           D +D  R +G G FG   L R+K  K ++A+K + +     + ++  ++REI     LRH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH  
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRH 195
           +V HRD+K EN L+       LKI DFG+S    +H+   + +   GT  Y+ PE++   
Sbjct: 135 KVIHRDIKPENLLMGYKGE--LKIADFGWS----VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            +D K+ D+W  GV  Y  LVG  PF+ P       +T +RI++V    P    +S   +
Sbjct: 189 THDEKV-DLWCAGVLCYEFLVGMPPFDSPSHT----ETHRRIVNVDLKFPPF--LSDGSK 241
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKN 284
           DLIS++    P  R+ +  +M+H W   N
Sbjct: 242 DLISKLLRYHPPQRLPLKGVMEHPWVKAN 270

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 134/255 (52%), Gaps = 9/255 (3%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G FG      +  T   +A K I+ RG K  E V+ EI     L H N+++  +   
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 90  TPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
           +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H M + H DLK E
Sbjct: 157 SKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPE 216
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCG 208
           N L     A ++KI DFG ++      + K   GTP ++APEV + +++     D+WS G
Sbjct: 217 NILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDFVSFPTDMWSVG 275
Query: 209 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADP 266
           V  Y++L G  PF   ++     +T+  IL+ ++ + D     IS+E ++ IS++ + + 
Sbjct: 276 VIAYMLLSGLSPFLGDNDA----ETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEK 331
Query: 267 AARITIPEIMKHQWF 281
           + RI+  E +KH W 
Sbjct: 332 SWRISASEALKHPWL 346

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 97/270 (35%), Positives = 142/270 (52%), Gaps = 17/270 (6%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +D Y+   DIG G++ V +    K T    AVK I++  K D   + EI+  R  +HPNI
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDK-SKRDPTEEIEIL-LRYGQHPNI 78
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           +  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y HA  V 
Sbjct: 79  ITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 142 HRDLKLENTL-LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAY----IAPEVLLRH 195
           HRDLK  N L +D S  P  ++ICDFG++K   L ++    + TP Y    +APEVL R 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQ--LRAE-NGLLXTPCYTANFVAPEVLERQ 195
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFED-PDEPKDFRKTIQRILSVQYSVPDT--NPISQ 252
            YD    D+WS GV LY  L G  PF + PD+  +  + + RI S ++S+     N +S 
Sbjct: 196 GYDAA-CDIWSLGVLLYTXLTGYTPFANGPDDTPE--EILARIGSGKFSLSGGYWNSVSD 252
Query: 253 ECRDLISRIFVADPAARITIPEIMKHQWFL 282
             +DL+S+    DP  R+T   +++H W +
Sbjct: 253 TAKDLVSKXLHVDPHQRLTAALVLRHPWIV 282

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  138 bits (348), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 96/293 (32%), Positives = 146/293 (49%), Gaps = 22/293 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDE----NVQREIINH 73
           D Y   + +GSG  G  +L  ++ T + VA+K I +     G   +     NV+ EI   
Sbjct: 16  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 75
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 76  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 134
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 135 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 194
Query: 193 LRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDT-N 248
           +     G  +  D WS GV L++ L G  PF +       +    +I S +Y+ +P+   
Sbjct: 195 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 251
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEKTMSS 297
            +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+  S+
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 304

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 96/293 (32%), Positives = 146/293 (49%), Gaps = 22/293 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDE----NVQREIINH 73
           D Y   + +GSG  G  +L  ++ T + VA+K I +     G   +     NV+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 193 LRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDT-N 248
           +     G  +  D WS GV L++ L G  PF +       +    +I S +Y+ +P+   
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEKTMSS 297
            +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+  S+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 298

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 96/293 (32%), Positives = 146/293 (49%), Gaps = 22/293 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDE----NVQREIINH 73
           D Y   + +GSG  G  +L  ++ T + VA+K I +     G   +     NV+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 193 LRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDT-N 248
           +     G  +  D WS GV L++ L G  PF +       +    +I S +Y+ +P+   
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEKTMSS 297
            +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+  S+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 298

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 96/293 (32%), Positives = 146/293 (49%), Gaps = 22/293 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDE----NVQREIINH 73
           D Y   + +GSG  G  +L  ++ T + VA+K I +     G   +     NV+ EI   
Sbjct: 9   DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 68
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 69  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 127
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 128 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 187
Query: 193 LRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDT-N 248
           +     G  +  D WS GV L++ L G  PF +       +    +I S +Y+ +P+   
Sbjct: 188 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 244
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEKTMSS 297
            +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+  S+
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 297

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 96/293 (32%), Positives = 146/293 (49%), Gaps = 22/293 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDE----NVQREIINH 73
           D Y   + +GSG  G  +L  ++ T + VA+K I +     G   +     NV+ EI   
Sbjct: 10  DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 70  KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 188
Query: 193 LRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDT-N 248
           +     G  +  D WS GV L++ L G  PF +       +    +I S +Y+ +P+   
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 245
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEKTMSS 297
            +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+  S+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 298

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 95/293 (32%), Positives = 146/293 (49%), Gaps = 22/293 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDE----NVQREIINH 73
           D Y   + +GSG  G  +L  ++ T + VA++ I +     G   +     NV+ EI   
Sbjct: 149 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 208
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 209 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 267
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 268 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 327
Query: 193 LRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDT-N 248
           +     G  +  D WS GV L++ L G  PF +       +    +I S +Y+ +P+   
Sbjct: 328 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 384
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEKTMSS 297
            +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+  S+
Sbjct: 385 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEENEST 437

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 144/289 (49%), Gaps = 22/289 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDE----NVQREIINH 73
           D Y   + +GSG  G  +L  ++ T + VA++ I +     G   +     NV+ EI   
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V 
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           Y H   + HRDLK EN LL       L KI DFG+SK     S  ++  GTP Y+APEVL
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVL 313
Query: 193 LRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDT-N 248
           +     G  +  D WS GV L++ L G  PF +       +    +I S +Y+ +P+   
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVWA 370
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEK 293
            +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+
Sbjct: 371 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 419

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 138/266 (51%), Gaps = 12/266 (4%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           D + F R +GSG FG   L+ ++ +     +K I  +R     E ++ EI   +SL HPN
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNA---GR-FSEDEARFFFQQLISGVSYCH 136
           I++  EV     ++ IVME   GGEL ERI +A   G+  SE       +Q+++ ++Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 137 AMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
           +  V H+DLK EN L  D SP   +KI DFG ++         +  GT  Y+APEV  R 
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR- 200
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K  D+WS GV +Y +L G  PF      +  +K   +     Y+V +  P++ +  
Sbjct: 201 DVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYK--EPNYAV-ECRPLTPQAV 256
Query: 256 DLISRIFVADPAARITIPEIMKHQWF 281
           DL+ ++   DP  R +  +++ H+WF
Sbjct: 257 DLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 152/276 (55%), Gaps = 27/276 (9%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG-----DKIDENVQREII 71
           D  +++ ++ +G G+FG   L++ K++    ++L A+K +++      D++   ++R+I+
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 81
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
               + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   
Sbjct: 82  V--EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 139
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPE 190
           + + H++ + +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APE
Sbjct: 140 LDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 197
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           V+ R  +  + AD WS GV ++ ML G  PF+     KD ++T+  IL  +  +P    +
Sbjct: 198 VVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--L 250
Query: 251 SQECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
           S E + L+  +F  +PA R+      + EI +H +F
Sbjct: 251 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 152/276 (55%), Gaps = 27/276 (9%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG-----DKIDENVQREII 71
           D  +++ ++ +G G+FG   L++ K++    ++L A+K +++      D++   ++R+I+
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
               + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   
Sbjct: 81  V--EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPE 190
           + + H++ + +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           V+ R  +  + AD WS GV ++ ML G  PF+     KD ++T+  IL  +  +P    +
Sbjct: 197 VVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--L 249
Query: 251 SQECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
           S E + L+  +F  +PA R+      + EI +H +F
Sbjct: 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 143/260 (55%), Gaps = 22/260 (8%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERG-----DKIDENVQREII 71
           D   ++ ++ +G G+FG   L+R KVT+     L A+K +++      D++   ++R+I+
Sbjct: 26  DPSHFELLKVLGQGSFGKVFLVR-KVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDIL 84
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
               + HP +V+      T   L +++++  GG+LF R+     F+E++ +F+  +L  G
Sbjct: 85  A--DVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALG 142
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPE 190
           + + H++ + +RDLK EN LLD      +K+ DFG SK ++ H +   S  GT  Y+APE
Sbjct: 143 LDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPE 200
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           V+ R  +    AD WS GV ++ ML G  PF+     KD ++T+  IL  +  +P    +
Sbjct: 201 VVNRQGHSHS-ADWWSYGVLMFEMLTGSLPFQG----KDRKETMTLILKAKLGMPQF--L 253
Query: 251 SQECRDLISRIFVADPAARI 270
           S E + L+  +F  +PA R+
Sbjct: 254 STEAQSLLRALFKRNPANRL 273

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 83/276 (30%), Positives = 152/276 (55%), Gaps = 27/276 (9%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVT----KELVAVKYIERG-----DKIDENVQREII 71
           D  +++ ++ +G G+FG   L++ K++    ++L A+K +++      D++   ++R+I+
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDIL 80
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
               + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   
Sbjct: 81  V--EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPE 190
           + + H++ + +RDLK EN LLD      +K+ DFG SK S+ H +   S  GT  Y+APE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 196
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           V+ R  +  + AD WS GV ++ ML G  PF+     KD ++T+  IL  +  +P    +
Sbjct: 197 VVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--L 249
Query: 251 SQECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
           S E + L+  +F  +PA R+      + EI +H +F
Sbjct: 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  131 bits (330), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 88/283 (31%), Positives = 145/283 (51%), Gaps = 33/283 (11%)
Query: 1   MKMDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD 60
           +  +R SL +   ++  I+H        + +G G+FG   L   K T +  A+K +++  
Sbjct: 3   LNKERPSLQIKLKIEDFILH--------KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV 54
Query: 61  KI-DENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 115
            + D++V+  ++  R L     HP +        T  +L  VMEY +GG+L   I +  +
Sbjct: 55  VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK 114
Query: 116 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H 174
           F    A F+  ++I G+ + H+  + +RDLKL+N LLD      +KI DFG  K ++L  
Sbjct: 115 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGD 172
Query: 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
           ++     GTP YIAPE+LL  +Y+  + D WS GV LY ML+G  PF   DE + F    
Sbjct: 173 AKTNXFCGTPDYIAPEILLGQKYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELF---- 227
Query: 235 QRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITI 272
                  +S+   NP     + +E +DL+ ++FV +P  R+ +
Sbjct: 228 -------HSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 263

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 136/259 (52%), Gaps = 25/259 (9%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
           ++  + +G G+FG   L   K T +  A+K +++   + D++V+  ++  R L     HP
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            +        T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ + H+  
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 139
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYD 198
           + +RDLKL+N LLD      +KI DFG  K ++L  ++     GTP YIAPE+LL  +Y+
Sbjct: 140 IVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQKYN 197
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----ISQE 253
             + D WS GV LY ML+G  PF   DE + F           +S+   NP     + +E
Sbjct: 198 HSV-DWWSFGVLLYEMLIGQSPFHGQDEEELF-----------HSIRMDNPFYPRWLEKE 245
Query: 254 CRDLISRIFVADPAARITI 272
            +DL+ ++FV +P  R+ +
Sbjct: 246 AKDLLVKLFVREPEKRLGV 264

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 94/280 (33%), Positives = 144/280 (51%), Gaps = 34/280 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID------ENVQREIINHRSL 76
           D Y+    IG G F V R   ++ T +  AVK ++            E+++RE      L
Sbjct: 24  DVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGEL-FERI--CNAGR-FSEDEARFFFQQLISGV 132
           +HP+IV   E   +   L +V E+  G +L FE +   +AG  +SE  A  + +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 133 SYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAY 186
            YCH   + HRD+K EN LL    + AP +K+ DFG +    +S ++       VGTP +
Sbjct: 144 RYCHDNNIIHRDVKPENVLLASKENSAP-VKLGDFGVAIQLGESGLVAG---GRVGTPHF 199
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           +APEV+ R  Y GK  DVW CGV L+++L G  PF    E     +  + I+  +Y +  
Sbjct: 200 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKM-- 251
Query: 247 TNP-----ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            NP     IS+  +DL+ R+ + DPA RIT+ E + H W 
Sbjct: 252 -NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D+++ +R +G+G+FG   L++ K T    A+K +++   +        +N + ++     
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +V+EYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 25  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 81
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 82  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 141
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 142 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 200
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 201 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 260
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 261 LKTEPTQRMTITEFMNHPWIMQS 283

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  130 bits (326), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 40  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 96
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 97  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 156
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 157 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 215
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 216 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 275
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 276 LKTEPTQRMTITEFMNHPWIMQS 298

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 141 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 199
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 200 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 259
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 260 LKTEPTQRMTITEFMNHPWIMQS 282

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 31  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 87
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 88  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 147
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 148 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 206
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 207 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 266
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 267 LKTEPTQRMTITEFMNHPWIMQS 289

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 30  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 86
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 87  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 146
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 147 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 205
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 206 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 265
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 266 LKTEPTQRMTITEFMNHPWIMQS 288

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 201
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 202 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 261
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 262 LKTEPTQRMTITEFMNHPWIMQS 284

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 126
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 245
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 306 LKTEPTQRMTITEFMNHPWIMQS 328

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 32  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 88
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 89  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 148
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 149 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 207
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 208 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 267
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 268 LKTEPTQRMTITEFMNHPWIMQS 290

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 201
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 202 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 261
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 262 LKTEPTQRMTITEFMNHPWIMQS 284

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 137/263 (52%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 76  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 132
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 133 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 192
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 193 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 251
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 252 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 311
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 312 LKTEPTQRMTITEFMNHPWIMQS 334

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
           RY   R +G G F     + D  TKE+ A K + +   +     E +  EI  H+SL +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H  +
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYD 198
           V HRDLKL N  L+      +KI DFG +       + K T+ GTP YIAPEVL +  + 
Sbjct: 163 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHS 220
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDL 257
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YSVP   NP++     L
Sbjct: 221 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA---L 272
Query: 258 ISRIFVADPAARITIPEIMKHQWF 281
           I R+  ADP  R ++ E++  ++F
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 86/263 (32%), Positives = 136/263 (51%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 24  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 80
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 81  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 140
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+       TP Y+APEVL   +YD K  D
Sbjct: 141 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYD-KSCD 199
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 200 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 259
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 260 LKTEPTQRMTITEFMNHPWIMQS 282

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 90/296 (30%), Positives = 148/296 (50%), Gaps = 21/296 (7%)
Query: 8   LTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ 67
           + +GP+ + P    SD + F++ IG G+FG   L R K  +   AVK +++   + +  +
Sbjct: 25  INLGPSSN-PHAKPSD-FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE 82
Query: 68  REIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           + I++ R++     +HP +V       T   L  V++Y +GGELF  +     F E  AR
Sbjct: 83  KHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR 142
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV- 181
           F+  ++ S + Y H++ + +RDLK EN LLD      + + DFG  K ++ H+   ST  
Sbjct: 143 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFC 200
Query: 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
           GTP Y+APEVL +  YD +  D W  G  LY ML G  PF   +  + +   + + L ++
Sbjct: 201 GTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK 259
Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIP----EIMKHQWFLKNLPADLVDEK 293
              P+   I+   R L+  +   D   R+       EI  H +F      DL+++K
Sbjct: 260 ---PN---ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKK 309

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 87/269 (32%), Positives = 141/269 (52%), Gaps = 17/269 (6%)
Query: 31  IGSGNF-GVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFK 85
           +G G+F GV R        E VA+K I++       + + VQ E+  H  L+HP+I+   
Sbjct: 19  LGKGSFAGVYRAESIHTGLE-VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRD 144
                  ++ +V+E    GE+   + N  + FSE+EAR F  Q+I+G+ Y H+  + HRD
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137
Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           L L N LL  +    +KI DFG +    + H +  +  GTP YI+PE+  R  + G  +D
Sbjct: 138 LTLSNLLL--TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLESD 194
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263
           VWS G   Y +L+G  PF D D  K+   T+ +++   Y +P    +S E +DLI ++  
Sbjct: 195 VWSLGCMFYTLLIGRPPF-DTDTVKN---TLNKVVLADYEMPSF--LSIEAKDLIHQLLR 248
Query: 264 ADPAARITIPEIMKHQWFLKNLPADLVDE 292
            +PA R+++  ++ H +  +N      DE
Sbjct: 249 RNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    DEP    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADEP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 144/295 (48%), Gaps = 35/295 (11%)
Query: 25  YDFVRDIGSGNFGVARLMRD---------KVTKELVAVKYIERGDKIDENVQREIINHRS 75
           +  +R +G+G+FG   L+R          KV K+ + V+  +     DE +   I+ H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-- 65
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
              P I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y 
Sbjct: 66  ---PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
           H+  + +RDLK EN LLD +    +KI DFG++K   +        GTP YIAPEV+   
Sbjct: 123 HSKDIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYXLCGTPDYIAPEVVSTK 178
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y+  I D WS G+ +Y ML G  PF D +      KT ++IL+ +   P     +++ +
Sbjct: 179 PYNKSI-DWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPPF--FNEDVK 231
Query: 256 DLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 305
           DL+SR+   D + R+        ++  H WF      ++V EK +S   E P +P
Sbjct: 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWF-----KEVVWEKLLSRNIETPYEP 281

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLAGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  128 bits (322), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 87/255 (34%), Positives = 131/255 (51%), Gaps = 17/255 (6%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--DENVQREIINHRSL---- 76
           D ++F+R +G G+FG   L R K T +L AVK +++ D I  D++V+  +   R L    
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKK-DVILQDDDVECTMTEKRILSLAR 81
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            HP + +      TP  L  VME+ +GG+L   I  + RF E  ARF+  ++IS + + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRH 195
              + +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L   
Sbjct: 142 DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM 199
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y G   D W+ GV LY ML G  PFE  +E   F    + IL+ +   P    + ++  
Sbjct: 200 LY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPTW--LHEDAT 252
Query: 256 DLISRIFVADPAARI 270
            ++      +P  R+
Sbjct: 253 GILKSFMTKNPTMRL 267

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLXGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 181
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +     +  GTP Y+APE++L   Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGATWTLCGTPEYLAPEIILSKGYN 237
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 238 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 290
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYQM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 147
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 148 DLIYRDLKPENLLID--EQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 203
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 204 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 256
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 257 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
           RY   R +G G F     + D  TKE+ A K + +   +     E +  EI  H+SL +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H  +
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           V HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL +  + 
Sbjct: 163 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 220
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDL 257
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YSVP   NP++     L
Sbjct: 221 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA---L 272
Query: 258 ISRIFVADPAARITIPEIMKHQWF 281
           I R+  ADP  R ++ E++  ++F
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
           RY   R +G G F     + D  TKE+ A K + +   +     E +  EI  H+SL +P
Sbjct: 43  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 102
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H  +
Sbjct: 103 HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 162
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           V HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL +  + 
Sbjct: 163 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHS 220
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDL 257
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YSVP   NP++     L
Sbjct: 221 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA---L 272
Query: 258 ISRIFVADPAARITIPEIMKHQWF 281
           I R+  ADP  R ++ E++  ++F
Sbjct: 273 IRRMLHADPTLRPSVAELLTDEFF 296

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 132/264 (50%), Gaps = 16/264 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
           RY   R +G G F     + D  TKE+ A K + +   +     E +  EI  H+SL +P
Sbjct: 27  RYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNP 86
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           ++V F         + +V+E      L E        +E EAR+F +Q I GV Y H  +
Sbjct: 87  HVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR 146
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           V HRDLKL N  L+      +KI DFG  +K      + K   GTP YIAPEVL +  + 
Sbjct: 147 VIHRDLKLGNLFLNDDMD--VKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS 204
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP-DTNPISQECRDL 257
            ++ D+WS G  LY +LVG  PFE        ++T  RI   +YSVP   NP++     L
Sbjct: 205 FEV-DIWSLGCILYTLLVGKPPFET----SCLKETYIRIKKNEYSVPRHINPVASA---L 256
Query: 258 ISRIFVADPAARITIPEIMKHQWF 281
           I R+  ADP  R ++ E++  ++F
Sbjct: 257 IRRMLHADPTLRPSVAELLTDEFF 280

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 137/269 (50%), Gaps = 20/269 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
           D ++  R +G G FG   L R+K +  +VA+K + +     + ++  ++REI     L H
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI+R          + +++EYA  GEL++ +  +  F E       ++L   + YCH  
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGK 142
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRH 195
           +V HRD+K EN LL       LKI DFG+S    +H+   + K+  GT  Y+ PE++   
Sbjct: 143 KVIHRDIKPENLLLGLKGE--LKIADFGWS----VHAPSLRRKTMCGTLDYLPPEMIEGR 196
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            ++ K+ D+W  GV  Y +LVG  PFE     + +R+ ++  L    SVP         +
Sbjct: 197 MHNEKV-DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTG------AQ 249
Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKN 284
           DLIS++   +P+ R+ + ++  H W   N
Sbjct: 250 DLISKLLRHNPSERLPLAQVSAHPWVRAN 278

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 143/292 (48%), Gaps = 23/292 (7%)
Query: 9   TVGPAMDMPIMHDS----DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE------- 57
           ++GP  ++P    +     +YD    IG G   V R    + T    AVK +E       
Sbjct: 76  SMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLS 135
Query: 58  --RGDKIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 114
             + +++ E  +RE  I  +   HP+I+   +   + + + +V +    GELF+ +    
Sbjct: 136 PEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV 195
Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174
             SE E R   + L+  VS+ HA  + HRDLK EN LLD +   ++++ DFG+S      
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN--MQIRLSDFGFSCHLEPG 253
Query: 175 SQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD 229
            + +   GTP Y+APE+L       H   GK  D+W+CGV L+ +L G  PF    +   
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313
Query: 230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            R  ++     Q+S P+ +  S   +DLISR+   DP AR+T  + ++H +F
Sbjct: 314 LRMIMEG--QYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRF+E  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 181
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 238 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 290
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ IG+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 153
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 154 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 210 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 262
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 263 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 181
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 182 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 237
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 238 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 290
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 291 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 142/289 (49%), Gaps = 11/289 (3%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-NVQREIINHRSLRHPNI 81
           D YD + ++GSG FGV     +K T  +   K+I     +D+  V+ EI     L HP +
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 110
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
           +   +       + +++E+ SGGELF+RI     + SE E   + +Q   G+ + H   +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 170
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R E  G 
Sbjct: 171 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGF 229
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLI 258
             D+W+ GV  YV+L G  PF   D+     +T+Q +    +   +   + +S E +D I
Sbjct: 230 YTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDFI 285
Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQ 307
             +   +P  R+T+ + ++H W LK   ++L   +  SS+Y +  Q ++
Sbjct: 286 KNLLQKEPRKRLTVHDALEHPW-LKGDHSNLT-SRIPSSRYNKIRQKIK 332

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 83/252 (32%), Positives = 130/252 (51%), Gaps = 15/252 (5%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
           ++F+  +G G+FG   L   K T+EL A+K +++   I D++V+  ++  R L    + P
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            + +      T   L  VMEY +GG+L   I   G+F E +A F+  ++  G+ + H   
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRG 140
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYD 198
           + +RDLKL+N +LD      +KI DFG  K  ++     +   GTP YIAPE++    Y 
Sbjct: 141 IIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY- 197
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK  D W+ GV LY ML G  PF+  DE + F    Q I+    S P +  +S+E   + 
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF----QSIMEHNVSYPKS--LSKEAVSIC 251
Query: 259 SRIFVADPAARI 270
             +    PA R+
Sbjct: 252 KGLMTKHPAKRL 263

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 155
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 156 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 211
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 212 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 264
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 265 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
           ++F+  +G G+FG   L   K T EL AVK +++   I D++V+  ++  R L    + P
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            + +      T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ +  +  
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYD 198
           + +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE++    Y 
Sbjct: 142 IIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY- 198
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK  D W+ GV LY ML G  PFE  DE + F    Q I+    + P +  +S+E   + 
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYPKS--MSKEAVAIC 252
Query: 259 SRIFVADPAARITI-PE----IMKHQWF 281
             +    P  R+   PE    I +H +F
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 133/266 (50%), Gaps = 17/266 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 86
           +G G F     + D  TKE+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVW 205
           L N  L+      +KI DFG +       + K T+ GTP YIAPEVL +  +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVA 264
           S G  +Y +LVG  PFE        ++T  RI   +YS+P   NP++     LI ++   
Sbjct: 202 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAA---SLIQKMLQT 254
Query: 265 DPAARITIPEIMKHQWFLKN-LPADL 289
           DP AR TI E++  ++F    +PA L
Sbjct: 255 DPTARPTINELLNDEFFTSGYIPARL 280

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 133/266 (50%), Gaps = 17/266 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 86
           +G G F     + D  TKE+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVW 205
           L N  L+      +KI DFG +       + K T+ GTP YIAPEVL +  +  ++ DVW
Sbjct: 149 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 205
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVA 264
           S G  +Y +LVG  PFE        ++T  RI   +YS+P   NP++     LI ++   
Sbjct: 206 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAA---SLIQKMLQT 258
Query: 265 DPAARITIPEIMKHQWFLKN-LPADL 289
           DP AR TI E++  ++F    +PA L
Sbjct: 259 DPTARPTINELLNDEFFTSGYIPARL 284

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  125 bits (315), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 133/266 (50%), Gaps = 17/266 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 86
           +G G F     + D  TKE+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVW 205
           L N  L+      +KI DFG +       + K T+ GTP YIAPEVL +  +  ++ DVW
Sbjct: 145 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVA 264
           S G  +Y +LVG  PFE        ++T  RI   +YS+P   NP++     LI ++   
Sbjct: 202 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAA---SLIQKMLQT 254
Query: 265 DPAARITIPEIMKHQWFLKN-LPADL 289
           DP AR TI E++  ++F    +PA L
Sbjct: 255 DPTARPTINELLNDEFFTSGYIPARL 280

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +++ DFG++K   +  +     GTP Y+APE+++   Y+
Sbjct: 161 DLIYRDLKPENLIID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIIISKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+AP ++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPAIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 141/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAA-----RITIPEIMKHQWF 281
             +   D        +  + +I  H+WF
Sbjct: 270 RNLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P + + +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P + + +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 146
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +  +  GTP Y+APE++L   Y+
Sbjct: 147 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYN 202
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 203 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 255
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 256 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +  +  GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWTLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++ K T    A+K +++   +        +N +    ++  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 153
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 154 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 209
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 210 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 262
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 263 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 89/268 (33%), Positives = 134/268 (50%), Gaps = 20/268 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-DENVQREIINHRSL----RHP 79
           ++F+  +G G+FG   L   K T EL AVK +++   I D++V+  ++  R L    + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            + +      T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ +  +  
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 462
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYD 198
           + +RDLKL+N +LD      +KI DFG  K ++      K   GTP YIAPE++    Y 
Sbjct: 463 IIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPY- 519
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK  D W+ GV LY ML G  PFE  DE + F    Q I+    + P +  +S+E   + 
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYPKS--MSKEAVAIC 573
Query: 259 SRIFVADPAARITI-PE----IMKHQWF 281
             +    P  R+   PE    I +H +F
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ IG+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GG++F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ IG+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GG++F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IKVADFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEYA GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +K+ DFG +K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLMID--QQGYIKVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 140/268 (52%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP  +APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLID--QQGYIQVTDFGFAKR--VKGRTWXLCGTPEALAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 132/266 (49%), Gaps = 17/266 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 86
           +G G F     + D  TKE+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVW 205
           L N  L+      +KI DFG +       + K  + GTP YIAPEVL +  +  ++ DVW
Sbjct: 169 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 225
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVA 264
           S G  +Y +LVG  PFE        ++T  RI   +YS+P   NP++     LI ++   
Sbjct: 226 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAA---SLIQKMLQT 278
Query: 265 DPAARITIPEIMKHQWFLKN-LPADL 289
           DP AR TI E++  ++F    +PA L
Sbjct: 279 DPTARPTINELLNDEFFTSGYIPARL 304

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 132/266 (49%), Gaps = 17/266 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 86
           +G G F     + D  TKE+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVW 205
           L N  L+      +KI DFG +       + K  + GTP YIAPEVL +  +  ++ DVW
Sbjct: 167 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 223
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVA 264
           S G  +Y +LVG  PFE        ++T  RI   +YS+P   NP++     LI ++   
Sbjct: 224 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAA---SLIQKMLQT 276
Query: 265 DPAARITIPEIMKHQWFLKN-LPADL 289
           DP AR TI E++  ++F    +PA L
Sbjct: 277 DPTARPTINELLNDEFFTSGYIPARL 302

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 132/266 (49%), Gaps = 17/266 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKE 86
           +G G F     + D  TKE+ A K + +   +     E +  EI  HRSL H ++V F  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
                  + +V+E      L E        +E EAR++ +Q++ G  Y H  +V HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYDGKIADVW 205
           L N  L+      +KI DFG +       + K  + GTP YIAPEVL +  +  ++ DVW
Sbjct: 143 LGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 199
Query: 206 SCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD-TNPISQECRDLISRIFVA 264
           S G  +Y +LVG  PFE        ++T  RI   +YS+P   NP++     LI ++   
Sbjct: 200 SIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKHINPVAA---SLIQKMLQT 252
Query: 265 DPAARITIPEIMKHQWFLKN-LPADL 289
           DP AR TI E++  ++F    +PA L
Sbjct: 253 DPTARPTINELLNDEFFTSGYIPARL 278

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P + + +      ++L +VMEYA GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +K+ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLMIDQQGY--IKVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 139/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEYA GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN ++D      +++ DFG +K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLMIDQQGY--IQVTDFGLAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 141/280 (50%), Gaps = 34/280 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID------ENVQREIINHRSL 76
           D Y+    IG G F V R   ++ T +  AVK ++            E+++RE      L
Sbjct: 26  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 85
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGEL-FERI--CNAGR-FSEDEARFFFQQLISGV 132
           +HP+IV   E   +   L +V E+  G +L FE +   +AG  +SE  A  + +Q++  +
Sbjct: 86  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 145
Query: 133 SYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAY 186
            YCH   + HRD+K    LL    + AP +K+  FG +    +S ++       VGTP +
Sbjct: 146 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHF 201
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           +APEV+ R  Y GK  DVW CGV L+++L G  PF    E     +  + I+  +Y +  
Sbjct: 202 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKM-- 253
Query: 247 TNP-----ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            NP     IS+  +DL+ R+ + DPA RIT+ E + H W 
Sbjct: 254 -NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 141/280 (50%), Gaps = 34/280 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID------ENVQREIINHRSL 76
           D Y+    IG G F V R   ++ T +  AVK ++            E+++RE      L
Sbjct: 24  DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGEL-FERI--CNAGR-FSEDEARFFFQQLISGV 132
           +HP+IV   E   +   L +V E+  G +L FE +   +AG  +SE  A  + +Q++  +
Sbjct: 84  KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 133 SYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS----KSSVLHSQPKSTVGTPAY 186
            YCH   + HRD+K    LL    + AP +K+  FG +    +S ++       VGTP +
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAP-VKLGGFGVAIQLGESGLVAG---GRVGTPHF 199
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           +APEV+ R  Y GK  DVW CGV L+++L G  PF    E     +  + I+  +Y +  
Sbjct: 200 MAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKM-- 251
Query: 247 TNP-----ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            NP     IS+  +DL+ R+ + DPA RIT+ E + H W 
Sbjct: 252 -NPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 162 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 217
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 218 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 270
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 271 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 138/268 (51%), Gaps = 20/268 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D+++ ++ +G+G+FG   L++   T    A+K +++   +        +N +    ++  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY  GGE+F  +   GRF E  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSL 160
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K   +  +     GTP Y+APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKR--VKGRTWXLCGTPEYLAPEIILSKGYN 216
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D W+ GV +Y M   GYP    D+P    +  ++I+S +   P  +  S + +DL+
Sbjct: 217 -KAVDWWALGVLIYEM-AAGYPPFFADQP---IQIYEKIVSGKVRFP--SHFSSDLKDLL 269
Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R       + +I  H+WF
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 129/263 (49%), Gaps = 13/263 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 126
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IV E   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 127 LYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRD 186
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL   +YD K  D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCD 245
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISRI 261
            WS GV  Y++L G  PF              RI   QY  P+   + +S+E + LI  +
Sbjct: 246 XWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNL 305
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R TI E   H W  ++
Sbjct: 306 LKTEPTQRXTITEFXNHPWIXQS 328

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/308 (28%), Positives = 152/308 (49%), Gaps = 33/308 (10%)
Query: 25  YDFVRDIGSGNFGVA---RLMRDKVTKELVAVKYIERG-------DKIDENVQREIINHR 74
           ++ +R +G G +G     R +    T ++ A+K +++        D      +R I+   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-- 76
Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            ++HP IV       T   L +++EY SGGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLL 193
            H   + +RDLK EN +L+      +K+ DFG  K S+       T  GT  Y+APE+L+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILM 194
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
           R  ++ +  D WS G  +Y ML G  PF   +     +KTI +IL  + ++P    ++QE
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILKCKLNLPPY--LTQE 247
Query: 254 CRDLISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP-MQ 307
            RDL+ ++   + A+R+        E+  H +F       +  E+ ++ + E P +P +Q
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-----RHINWEELLARKVEPPFKPLLQ 302
Query: 308 SVDVIMQI 315
           S + + Q 
Sbjct: 303 SEEDVSQF 310

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
           ++ Y+ V+ IG G FG  +L+R K T+++ A+K + + + I  +        R +     
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H+
Sbjct: 133 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 191
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 192 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 247
Query: 194 RH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
                 Y G+  D WS GV LY MLVG  PF        + K +    S+ +  PD N I
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 305
Query: 251 SQECRDLISRIFVADPAARI---TIPEIMKHQWF 281
           S+E ++LI   F+ D   R+    + EI +H +F
Sbjct: 306 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  119 bits (297), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
           ++ Y+ V+ IG G FG  +L+R K T+++ A+K + + + I  +        R +     
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H+
Sbjct: 133 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 191
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 192 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 247
Query: 194 RH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
                 Y G+  D WS GV LY MLVG  PF        + K +    S+ +  PD N I
Sbjct: 248 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 305
Query: 251 SQECRDLISRIFVADPAARI---TIPEIMKHQWF 281
           S+E ++LI   F+ D   R+    + EI +H +F
Sbjct: 306 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 338

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/274 (32%), Positives = 137/274 (50%), Gaps = 22/274 (8%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
           ++ Y+ V+ IG G FG  +L+R K T+++ A+K + + + I  +        R +     
Sbjct: 68  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P +V+         +L +VMEY  GG+L   + N     E  ARF+  +++  +   H+
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHS 186
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           M   HRD+K +N LLD S    LK+ DFG     +K  ++     + VGTP YI+PEVL 
Sbjct: 187 MGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLK 242
Query: 194 RH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
                 Y G+  D WS GV LY MLVG  PF        + K +    S+ +  PD N I
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDI 300
Query: 251 SQECRDLISRIFVADPAARI---TIPEIMKHQWF 281
           S+E ++LI   F+ D   R+    + EI +H +F
Sbjct: 301 SKEAKNLIC-AFLTDREVRLGRNGVEEIKRHLFF 333

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 138/292 (47%), Gaps = 16/292 (5%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREI-INHRSLRHPNIVRF 84
           +++G G F V R    K T +  A K+++   RG      +  EI +   +   P ++  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 85  KEVILTPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            EV    + + +++EYA+GGE+F  +C    A   SE++     +Q++ GV Y H   + 
Sbjct: 95  HEVYENTSEIILILEYAAGGEIF-SLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 142 HRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD-- 198
           H DLK +N LL    P   +KI DFG S+      + +  +GTP Y+APE+L    YD  
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL---NYDPI 210
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
               D+W+ G+  Y++L    PF   D  + +    Q  ++V YS    + +SQ   D I
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDYSEETFSSVSQLATDFI 268
Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVD 310
             + V +P  R T    + H W  +    +L   +  SS  +  D  ++S +
Sbjct: 269 QSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSE 320

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 20/267 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREI-INHRSLRHP 79
           +G G   V R    K T +  AVK I          E   ++ E   +E+ I  +   HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NI++ K+   T T   +V +    GELF+ +      SE E R   + L+  +   H + 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-----R 194
           + HRDLK EN LLD      +K+ DFG+S       + +S  GTP+Y+APE++       
Sbjct: 145 IVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDN 202
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
           H   GK  D+WS GV +Y +L G  PF    +    R  +    + Q+  P+ +  S   
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTV 260
Query: 255 RDLISRIFVADPAARITIPEIMKHQWF 281
           +DL+SR  V  P  R T  E + H +F
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  117 bits (293), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 151/308 (49%), Gaps = 33/308 (10%)
Query: 25  YDFVRDIGSGNFGVA---RLMRDKVTKELVAVKYIERG-------DKIDENVQREIINHR 74
           ++ +R +G G +G     R +    T ++ A+K +++        D      +R I+   
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-- 76
Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            ++HP IV       T   L +++EY SGGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLL 193
            H   + +RDLK EN +L+      +K+ DFG  K S+          GT  Y+APE+L+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILM 194
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
           R  ++ +  D WS G  +Y ML G  PF   +     +KTI +IL  + ++P    ++QE
Sbjct: 195 RSGHN-RAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILKCKLNLPPY--LTQE 247
Query: 254 CRDLISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP-MQ 307
            RDL+ ++   + A+R+        E+  H +F       +  E+ ++ + E P +P +Q
Sbjct: 248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF-----RHINWEELLARKVEPPFKPLLQ 302
Query: 308 SVDVIMQI 315
           S + + Q 
Sbjct: 303 SEEDVSQF 310

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 123/267 (46%), Gaps = 20/267 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREI-INHRSLRHP 79
           +G G   V R    K T +  AVK I          E   ++ E   +E+ I  +   HP
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NI++ K+   T T   +V +    GELF+ +      SE E R   + L+  +   H + 
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 131
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-----R 194
           + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE++       
Sbjct: 132 IVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 189
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
           H   GK  D+WS GV +Y +L G  PF    +    R  +    + Q+  P+ +  S   
Sbjct: 190 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTV 247
Query: 255 RDLISRIFVADPAARITIPEIMKHQWF 281
           +DL+SR  V  P  R T  E + H +F
Sbjct: 248 KDLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 123/267 (46%), Gaps = 20/267 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREI-INHRSLRHP 79
           +G G   V R    K T +  AVK I          E   ++ E   +E+ I  +   HP
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NI++ K+   T T   +V +    GELF+ +      SE E R   + L+  +   H + 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN 144
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-----R 194
           + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE++       
Sbjct: 145 IVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDN 202
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
           H   GK  D+WS GV +Y +L G  PF    +    R  +    + Q+  P+ +  S   
Sbjct: 203 HPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDTV 260
Query: 255 RDLISRIFVADPAARITIPEIMKHQWF 281
           +DL+SR  V  P  R T  E + H +F
Sbjct: 261 KDLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 125/260 (48%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE LL  
Sbjct: 151 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPE-LLTE 205
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 259
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 260 DLVEKLLVLDATKRLGCEEM 279

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 82/260 (31%), Positives = 125/260 (48%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE LL  
Sbjct: 155 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPE-LLTE 209
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 263
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 264 DLVEKLLVLDATKRLGCEEM 283

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 150/287 (52%), Gaps = 30/287 (10%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSLRHP 79
           ++Y  ++ IG G+FG A L++         +K I       K  E  +RE+    +++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCH 136
           NIV+++E       L IVM+Y  GG+LF+RI NA +   F ED+   +F Q+   + + H
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEV 191
             ++ HRD+K +N  L  DG+    +++ DFG ++  VL+S     ++ +GTP Y++PE+
Sbjct: 143 DRKILHRDIKSQNIFLTKDGT----VQLGDFGIAR--VLNSTVELARACIGTPYYLSPEI 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
                Y+ K +D+W+ G  LY +    + F    E    +  + +I+S  +  P +   S
Sbjct: 197 CENKPYNNK-SDIWALGCVLYELCTLKHAF----EAGSMKNLVLKIISGSFP-PVSLHYS 250
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
            + R L+S++F  +P  R ++  I++  +  K +      EK +S Q
Sbjct: 251 YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI------EKFLSPQ 291

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 206
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 260
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 261 DLVEKLLVLDATKRLGCEEM 280

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 206
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 260
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 261 DLVEKLLVLDATKRLGCEEM 280

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 206
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 260
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 261 DLVEKLLVLDATKRLGCEEM 280

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 151 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 205
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 259
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 260 DLVEKLLVLDATKRLGCEEM 279

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 152 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANAFVGTAQYVSPE-LLTE 206
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 260
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 261 DLVEKLLVLDATKRLGCEEM 280

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 208
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 262
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 263 DLVEKLLVLDATKRLGCEEM 282

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 208
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 262
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 263 DLVEKLLVLDATKRLGCEEM 282

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 155 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 209
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 263
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 264 DLVEKLLVLDATKRLGCEEM 283

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 208
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 262
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 263 DLVEKLLVLDATKRLGCEEM 282

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 136 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 190
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 191 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 244
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 245 DLVEKLLVLDATKRLGCEEM 264

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 129 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 183
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 237
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 238 DLVEKLLVLDATKRLGCEEM 257

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 130 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 184
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 238
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 239 DLVEKLLVLDATKRLGCEEM 258

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 131 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 185
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 239
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 240 DLVEKLLVLDATKRLGCEEM 259

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 159 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 213
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 214 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 267
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 268 DLVEKLLVLDATKRLGCEEM 287

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 132 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 186
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 187 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 240
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 241 DLVEKLLVLDATKRLGCEEM 260

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 142/265 (53%), Gaps = 14/265 (5%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           IG G+ G+  L R+K +   VAVK ++ R  +  E +  E++  R  +H N+V   +  L
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 90  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN 149
               L ++ME+  GG L + I +  R +E++     + ++  ++Y HA  V HRD+K ++
Sbjct: 113 VGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDS 171
Query: 150 TL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
            L  LDG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+ R  Y  ++ D+WS
Sbjct: 172 ILLTLDG----RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV-DIWS 226
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADP 266
            G+ + + +V G P    D P    K ++   S    + +++ +S   RD + R+ V DP
Sbjct: 227 LGI-MVIEMVDGEPPYFSDSPVQAMKRLRD--SPPPKLKNSHKVSPVLRDFLERMLVRDP 283
Query: 267 AARITIPEIMKHQWFLKN-LPADLV 290
             R T  E++ H + L+  LP  LV
Sbjct: 284 QERATAQELLDHPFLLQTGLPECLV 308

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 208
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F K    I+ ++Y  P+      + R
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIKLEYDFPEK--FFPKAR 262
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 263 DLVEKLLVLDATKRLGCEEM 282

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 142/289 (49%), Gaps = 25/289 (8%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHP 79
           +D +R IG G++    L+R K T  + A++ +++      + ID     + +  ++  HP
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYD 198
           + +RDLKL+N LLD      +K+ D+G  K  +      ST  GTP YIAPE+L   +Y 
Sbjct: 174 IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY- 230
Query: 199 GKIADVWSCGVTLYVMLVGGYPF------EDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
           G   D W+ GV ++ M+ G  PF      ++PD+  +     Q IL  Q  +P +  +S 
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE-DYLFQVILEKQIRIPRS--LSV 287
Query: 253 ECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKTM 295
           +   ++      DP  R+         +I  H +F +N+  D++++K +
Sbjct: 288 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQV 335

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 157 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 211
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P       + R
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPAA--FFPKAR 265
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 266 DLVEKLLVLDATKRLGCEEM 285

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 123/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K       VGT  Y++PE LL  
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANXFVGTAQYVSPE-LLTE 208
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F K    I+ ++Y  P+      + R
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK----IIKLEYDFPEK--FFPKAR 262
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 263 DLVEKLLVLDATKRLGCEEM 282

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 25/290 (8%)
Query: 23  DRYDFVRDIGSGNFGVARLMRD---KVTKELVAVKYIERGDKIDE-------NVQREIIN 72
           + ++ ++ +G+G +G   L+R      T +L A+K +++   + +         +R+++ 
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
           H   + P +V       T T L ++++Y +GGELF  +    RF+E E + +  +++  +
Sbjct: 114 HIR-QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
            + H + + +RD+KLEN LLD +    + + DFG SK  V     ++    GT  Y+AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 191 VLLRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           + +R    G  K  D WS GV +Y +L G  PF    E     +  +RIL  +   P   
Sbjct: 231 I-VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--Q 287
Query: 249 PISQECRDLISRIFVADPAARIT-----IPEIMKHQWFLKNLPADLVDEK 293
            +S   +DLI R+ + DP  R+        EI +H +F K    DL  +K
Sbjct: 288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 337

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 81/260 (31%), Positives = 124/260 (47%), Gaps = 20/260 (7%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRHPN 80
           + F + +G G+F    L R+  T    A+K +E+   I EN    V RE      L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            V+          L   + YA  G L + I   G F E   RF+  +++S + Y H   +
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-----STVGTPAYIAPEVLLRH 195
            HRDLK EN LL+      ++I DFG +K  VL  + K     S VGT  Y++PE LL  
Sbjct: 154 IHRDLKPENILLNED--MHIQITDFGTAK--VLSPESKQARANSFVGTAQYVSPE-LLTE 208
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
           +   K +D+W+ G  +Y ++ G  PF   +E   F    Q+I+ ++Y  P+      + R
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPEK--FFPKAR 262
Query: 256 DLISRIFVADPAARITIPEI 275
           DL+ ++ V D   R+   E+
Sbjct: 263 DLVEKLLVLDATKRLGCEEM 282

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 146/301 (48%), Gaps = 28/301 (9%)
Query: 13  AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQ 67
           AMD   + D   +D +R IG G++    L+R K T  + A+K +++      + ID    
Sbjct: 2   AMDPLGLQD---FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQT 58
Query: 68  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
            + +  ++  HP +V       T + L  V+EY +GG+L   +    +  E+ ARF+  +
Sbjct: 59  EKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE 118
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAY 186
           +   ++Y H   + +RDLKL+N LLD      +K+ D+G  K  +      S   GTP Y
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFCGTPNY 176
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF------EDPDEPKDFRKTIQRILSV 240
           IAPE+L   +Y G   D W+ GV ++ M+ G  PF      ++PD+  +     Q IL  
Sbjct: 177 IAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE-DYLFQVILEK 234
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKT 294
           Q  +P +  +S +   ++      DP  R+         +I  H +F +N+  D++++K 
Sbjct: 235 QIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQ 291
Query: 295 M 295
           +
Sbjct: 292 V 292

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 141/289 (48%), Gaps = 25/289 (8%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHP 79
           +D +R IG G++    L+R K T  + A+K +++      + ID     + +  ++  HP
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 67  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 126
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYD 198
           + +RDLKL+N LLD      +K+ D+G  K  +      S   GTP YIAPE+L   +Y 
Sbjct: 127 IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY- 183
Query: 199 GKIADVWSCGVTLYVMLVGGYPF------EDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
           G   D W+ GV ++ M+ G  PF      ++PD+  +     Q IL  Q  +P +  +S 
Sbjct: 184 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE-DYLFQVILEKQIRIPRS--LSV 240
Query: 253 ECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKTM 295
           +   ++      DP  R+         +I  H +F +N+  D++++K +
Sbjct: 241 KAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF-RNVDWDMMEQKQV 288

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 136/309 (44%), Gaps = 54/309 (17%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLR 77
           +Y     IG G++GV R+  +  T+ + A+K + +        K  E ++ E+   + L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFER--------------------ICNAGRFS 117
           HPNI R  EV     ++ +VME   GG L ++                    IC     +
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 118 ED----------EARFFFQ----------QLISGVSYCHAMQVCHRDLKLENTLLDGSPA 157
           E+          E+  F Q          Q+ S + Y H   +CHRD+K EN L   + +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 158 PRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL-LRHEYDGKIADVWSCGVTL 211
             +K+ DFG SK     ++  +    +  GTP ++APEVL   +E  G   D WS GV L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 212 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 271
           +++L+G  PF   ++     + + + L   +  P+ N +S   RDL+S +   +   R  
Sbjct: 267 HLLLMGAVPFPGVNDADTISQVLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERFD 324
Query: 272 IPEIMKHQW 280
               ++H W
Sbjct: 325 AMRALQHPW 333

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 143/290 (49%), Gaps = 27/290 (9%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKIDENVQREIINHRSLRHP 79
           +D +R IG G++    L+R K T  + A+K +++      + ID     + +  ++  HP
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++Y H   
Sbjct: 82  FLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 141
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEYD 198
           + +RDLKL+N LLD      +K+ D+G  K  +      S   GTP YIAPE+L   +Y 
Sbjct: 142 IIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY- 198
Query: 199 GKIADVWSCGVTLYVMLVGGYPF------EDPDE-PKDFRKTIQRILSVQYSVPDTNPIS 251
           G   D W+ GV ++ M+ G  PF      ++PD+  +D+    Q IL  Q  +P +  +S
Sbjct: 199 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEKQIRIPRS--MS 254
Query: 252 QECRDLISRIFVADPAARI------TIPEIMKHQWFLKNLPADLVDEKTM 295
            +   ++      DP  R+         +I  H +F +N+  D++++K +
Sbjct: 255 VKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFF-RNVDWDMMEQKQV 303

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 94  LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151
           L I+ME   GGELF RI   G   F+E EA    + + + + + H+  + HRD+K EN L
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 160
Query: 152 LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210
                    LK+ DFG++K +  ++  ++   TP Y+APEVL   +YD K  D+WS GV 
Sbjct: 161 YTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVI 218
Query: 211 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAA 268
           +Y++L G  PF             +RI   QY  P+   + +S++ + LI  +   DP  
Sbjct: 219 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 278
Query: 269 RITIPEIMKHQWFLKNL 285
           R+TI + M H W  +++
Sbjct: 279 RLTITQFMNHPWINQSM 295

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  109 bits (272), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 139/280 (49%), Gaps = 18/280 (6%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------IS 251
             + +D+WS G++L  M VG YP   PD  +D R  +     + Y V +  P       S
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFS 239
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
            E +D +++  + +PA R  + ++M H  F+K   A+ VD
Sbjct: 240 LEFQDFVNKCLIKNPAERADLKQLMVHA-FIKRSDAEEVD 278

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 7/197 (3%)
Query: 94  LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL 151
           L I+ME   GGELF RI   G   F+E EA    + + + + + H+  + HRD+K EN L
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLL 141
Query: 152 LDGSPAPR-LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210
                    LK+ DFG++K +  ++  ++   TP Y+APEVL   +YD K  D+WS GV 
Sbjct: 142 YTSKEKDAVLKLTDFGFAKETTQNAL-QTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVI 199
Query: 211 LYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISRIFVADPAA 268
           +Y++L G  PF             +RI   QY  P+   + +S++ + LI  +   DP  
Sbjct: 200 MYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTE 259
Query: 269 RITIPEIMKHQWFLKNL 285
           R+TI + M H W  +++
Sbjct: 260 RLTITQFMNHPWINQSM 276

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 83/274 (30%), Positives = 136/274 (49%), Gaps = 22/274 (8%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----R 77
           ++ YD V+ IG G FG  +L+R K ++++ A+K + + + I  +        R +     
Sbjct: 74  AEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 133
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P +V+         +L +VMEY  GG+L   + N     E  A+F+  +++  +   H+
Sbjct: 134 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHS 192
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           M + HRD+K +N LLD      LK+ DFG      ++ ++H    + VGTP YI+PEVL 
Sbjct: 193 MGLIHRDVKPDNMLLD--KHGHLKLADFGTCMKMDETGMVHCD--TAVGTPDYISPEVLK 248
Query: 194 RH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
                 Y G+  D WS GV L+ MLVG  PF        + K +    S+ +  P+   I
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCF--PEDAEI 306
Query: 251 SQECRDLISRIFVADPAARI---TIPEIMKHQWF 281
           S+  ++LI   F+ D   R+    + EI +H +F
Sbjct: 307 SKHAKNLIC-AFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 26/283 (9%)
Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQRE 69
           P M   I    + +  +  IG G+FG      D  T+++VA+K I+    +   E++Q+E
Sbjct: 12  PGMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQE 71
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
           I          + ++    L  + L I+MEY  GG   + +  AG F E +     ++++
Sbjct: 72  ITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL 130
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYI 187
            G+ Y H+ +  HRD+K  N LL  S    +K+ DFG +   +  +Q K  + VGTP ++
Sbjct: 131 KGLDYLHSEKKIHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWM 187
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
           APEV+ +  YD K AD+WS G+T   +  G  P  D              + V + +P  
Sbjct: 188 APEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSD-----------MHPMRVLFLIPKN 235
Query: 248 NP------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
           NP       ++  ++ I      DP+ R T  E++KH++ +KN
Sbjct: 236 NPPTLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 278

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 16/266 (6%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRF 84
           +F++ IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V  
Sbjct: 24  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 82
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
               L    L +VME+  GG L + I    R +E++       ++  +S  HA  V HRD
Sbjct: 83  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 141
Query: 145 LKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +K ++ LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ R  Y G  
Sbjct: 142 IKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPE 196
Query: 202 ADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            D+WS G+ +  M+ G  P F +P  P    K I+  L  +    + + +S   +  + R
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDR 252
Query: 261 IFVADPAARITIPEIMKHQWFLKNLP 286
           + V DPA R T  E++KH +  K  P
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAKAGP 278

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 16/266 (6%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRF 84
           +F++ IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V  
Sbjct: 35  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 93
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
               L    L +VME+  GG L + I    R +E++       ++  +S  HA  V HRD
Sbjct: 94  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 152
Query: 145 LKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +K ++ LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ R  Y G  
Sbjct: 153 IKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPE 207
Query: 202 ADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            D+WS G+ +  M+ G  P F +P  P    K I+  L  +    + + +S   +  + R
Sbjct: 208 VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDR 263
Query: 261 IFVADPAARITIPEIMKHQWFLKNLP 286
           + V DPA R T  E++KH +  K  P
Sbjct: 264 LLVRDPAQRATAAELLKHPFLAKAGP 289

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G +G+    RD   +  +A+K I ER  +  + +  EI  H+ L+H NIV++     
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 90  TPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR--FFFQQLISGVSYCHAMQVCHRDLK 146
               + I ME   GG L   +    G   ++E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 147 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYD-GKIADV 204
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +     GK AD+
Sbjct: 136 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 194
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
           WS G T+  M  G  PF +  EP+     +  +  V   +P++  +S E +  I + F  
Sbjct: 195 WSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPES--MSAEAKAFILKCFEP 251
Query: 265 DPAARITIPEIMKHQWFLK 283
           DP  R    +++  + FLK
Sbjct: 252 DPDKRACANDLLVDE-FLK 269

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 16/266 (6%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRF 84
           +F++ IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V  
Sbjct: 33  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 91
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
               L    L +VME+  GG L + I    R +E++       ++  +S  HA  V HRD
Sbjct: 92  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 150
Query: 145 LKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +K ++ LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ R  Y G  
Sbjct: 151 IKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPE 205
Query: 202 ADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            D+WS G+ +  M+ G  P F +P  P    K I+  L  +    + + +S   +  + R
Sbjct: 206 VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDR 261
Query: 261 IFVADPAARITIPEIMKHQWFLKNLP 286
           + V DPA R T  E++KH +  K  P
Sbjct: 262 LLVRDPAQRATAAELLKHPFLAKAGP 287

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 16/266 (6%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRF 84
           +F++ IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V  
Sbjct: 28  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 86
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
               L    L +VME+  GG L + I    R +E++       ++  +S  HA  V HRD
Sbjct: 87  YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 145
Query: 145 LKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +K ++ LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ R  Y G  
Sbjct: 146 IKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPE 200
Query: 202 ADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            D+WS G+ +  M+ G  P F +P  P    K I+  L  +    + + +S   +  + R
Sbjct: 201 VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDR 256
Query: 261 IFVADPAARITIPEIMKHQWFLKNLP 286
           + V DPA R T  E++KH +  K  P
Sbjct: 257 LLVRDPAQRATAAELLKHPFLAKAGP 282

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 132/259 (50%), Gaps = 11/259 (4%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G +G+    RD   +  +A+K I ER  +  + +  EI  H+ L+H NIV++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 90  TPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR--FFFQQLISGVSYCHAMQVCHRDLK 146
               + I ME   GG L   +    G   ++E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 147 LENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYD-GKIADV 204
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +     GK AD+
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVA 264
           WS G T+  M  G  PF +  EP+     +  +  V   +P++  +S E +  I + F  
Sbjct: 209 WSLGCTIIEMATGKPPFYELGEPQAAMFKVG-MFKVHPEIPES--MSAEAKAFILKCFEP 265
Query: 265 DPAARITIPEIMKHQWFLK 283
           DP  R    +++  + FLK
Sbjct: 266 DPDKRACANDLLVDE-FLK 283

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 16/266 (6%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRF 84
           +F++ IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V  
Sbjct: 78  NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 136
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
               L    L +VME+  GG L + I    R +E++       ++  +S  HA  V HRD
Sbjct: 137 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 195
Query: 145 LKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +K ++ LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ R  Y G  
Sbjct: 196 IKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPE 250
Query: 202 ADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            D+WS G+ +  M+ G  P F +P  P    K I+  L  +    + + +S   +  + R
Sbjct: 251 VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDR 306
Query: 261 IFVADPAARITIPEIMKHQWFLKNLP 286
           + V DPA R T  E++KH +  K  P
Sbjct: 307 LLVRDPAQRATAAELLKHPFLAKAGP 332

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 127/268 (47%), Gaps = 12/268 (4%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
           ++Y    D+G G FG+     +  +K+    K+++        V++EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
              E   +   L ++ E+ SG ++FERI  +A   +E E   +  Q+   + + H+  + 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--G 199
           H D++ EN +     +  +KI +FG ++        +     P Y APEV   H++D   
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV---HQHDVVS 181
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDL 257
              D+WS G  +YV+L G  PF         ++ I+ I++ +Y+  +     IS E  D 
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNL 285
           + R+ V +  +R+T  E ++H W  + +
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKI 265

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 83/266 (31%), Positives = 138/266 (51%), Gaps = 16/266 (6%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRF 84
           +F++ IG G+ G+  +   + + +LVAVK ++ R  +  E +  E++  R  +H N+V  
Sbjct: 155 NFIK-IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM 213
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
               L    L +VME+  GG L + I    R +E++       ++  +S  HA  V HRD
Sbjct: 214 YNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRD 272
Query: 145 LKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +K ++ LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APE++ R  Y G  
Sbjct: 273 IKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY-GPE 327
Query: 202 ADVWSCGVTLYVMLVGGYP-FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            D+WS G+ +  M+ G  P F +P  P    K I+  L  +    + + +S   +  + R
Sbjct: 328 VDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDR 383
Query: 261 IFVADPAARITIPEIMKHQWFLKNLP 286
           + V DPA R T  E++KH +  K  P
Sbjct: 384 LLVRDPAQRATAAELLKHPFLAKAGP 409

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 121/267 (45%), Gaps = 20/267 (7%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSLR 77
           ++RY  V  +G G      L  D +    VA+K I       ++  +  +RE+ N   L 
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           H NIV   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRH 195
           M++ HRD+K +N L+D +    LKI DFG +K  S    +Q    +GT  Y +PE   + 
Sbjct: 130 MRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE-QAKG 186
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-----I 250
           E   +  D++S G+ LY MLVG  PF          K IQ       SVP+        I
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD------SVPNVTTDVRKDI 240
Query: 251 SQECRDLISRIFVADPAARITIPEIMK 277
            Q   ++I R    D A R    + MK
Sbjct: 241 PQSLSNVILRATEKDKANRYKTIQEMK 267

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 120/264 (45%), Gaps = 28/264 (10%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERG---------DKIDENVQREIINHRSLR--HP 79
           +G G FG          +  VA+K I R          D +   ++  ++        HP
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 80  NIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +   T     +V+E      +LF+ I   G   E  +R FF Q+++ + +CH+ 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
            V HRD+K EN L+D       K+ DFG    ++LH +P +   GT  Y  PE + RH+Y
Sbjct: 159 GVVHRDIKDENILIDLRRG-CAKLIDFG--SGALLHDEPYTDFDGTRVYSPPEWISRHQY 215
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
               A VWS G+ LY M+ G  PFE     +D     Q IL  +   P    +S +C  L
Sbjct: 216 HALPATVWSLGILLYDMVCGDIPFE-----RD-----QEILEAELHFPAH--VSPDCCAL 263
Query: 258 ISRIFVADPAARITIPEIMKHQWF 281
           I R     P++R ++ EI+   W 
Sbjct: 264 IRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSL 76
           M   + +  +  IG G+FG      D  T+++VA+K I+    +   E++Q+EI      
Sbjct: 23  MDPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 82
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
             P + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y H
Sbjct: 83  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLH 141
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLR 194
           + +  HRD+K  N LL  S    +K+ DFG +   +  +Q K  + VGTP ++APEV+ +
Sbjct: 142 SEKKIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQ 198
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP----- 249
             YD K AD+WS G+T  + L  G P      P          + V + +P  NP     
Sbjct: 199 SAYDSK-ADIWSLGITA-IELARGEPPHSELHP----------MKVLFLIPKNNPPTLEG 246
Query: 250 -ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
             S+  ++ +      +P+ R T  E++KH++ L+N
Sbjct: 247 NYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 282

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 26/267 (9%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFK 85
           +  IG G+FG      D  T+++VA+K I+    +   E++Q+EI        P + ++ 
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
              L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y H+ +  HRD+
Sbjct: 87  GSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 145
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIAD 203
           K  N LL  S    +K+ DFG +   +  +Q K    VGTP ++APEV+ +  YD K AD
Sbjct: 146 KAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK-AD 201
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDL 257
           +WS G+T  + L  G P      P          + V + +P  NP       S+  ++ 
Sbjct: 202 IWSLGITA-IELARGEPPHSELHP----------MKVLFLIPKNNPPTLEGNYSKPLKEF 250
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKN 284
           +      +P+ R T  E++KH++ L+N
Sbjct: 251 VEACLNKEPSFRPTAKELLKHKFILRN 277

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 131/267 (49%), Gaps = 26/267 (9%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFK 85
           +  IG G+FG      D  T+++VA+K I+    +   E++Q+EI        P + ++ 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
              L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y H+ +  HRD+
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLRHEYDGKIAD 203
           K  N LL  S    +K+ DFG +   +  +Q K  + VGTP ++APEV+ +  YD K AD
Sbjct: 131 KAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-AD 186
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDL 257
           +WS G+T  + L  G P      P          + V + +P  NP       S+  ++ 
Sbjct: 187 IWSLGITA-IELARGEPPHSELHP----------MKVLFLIPKNNPPTLEGNYSKPLKEF 235
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKN 284
           +      +P+ R T  E++KH++ L+N
Sbjct: 236 VEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 130/267 (48%), Gaps = 26/267 (9%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFK 85
           +  IG G+FG      D  T+++VA+K I+    +   E++Q+EI        P + ++ 
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
              L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y H+ +  HRD+
Sbjct: 72  GSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDI 130
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIAD 203
           K  N LL  S    +K+ DFG +   +  +Q K    VGTP ++APEV+ +  YD K AD
Sbjct: 131 KAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSK-AD 186
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQECRDL 257
           +WS G+T  + L  G P      P          + V + +P  NP       S+  ++ 
Sbjct: 187 IWSLGITA-IELARGEPPHSELHP----------MKVLFLIPKNNPPTLEGNYSKPLKEF 235
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKN 284
           +      +P+ R T  E++KH++ L+N
Sbjct: 236 VEACLNKEPSFRPTAKELLKHKFILRN 262

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/235 (31%), Positives = 119/235 (50%), Gaps = 23/235 (9%)
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG--ELFERICNAGRFSE 118
           + NV++EI   R LRH N+++  +V+       + +VMEY   G  E+ + +    RF  
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPV 108
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---- 174
            +A  +F QLI G+ Y H+  + H+D+K  N LL  +    LKI   G +++  LH    
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL--TTGGTLKISALGVAEA--LHPFAA 164
Query: 175 -SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
               +++ G+PA+  PE+    + + G   D+WS GVTLY +  G YPFE      +  K
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG----DNIYK 220
Query: 233 TIQRILSVQYSVP-DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
             + I    Y++P D  P      DL+  +   +PA R +I +I +H WF K  P
Sbjct: 221 LFENIGKGSYAIPGDCGP---PLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 130/280 (46%), Gaps = 26/280 (9%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE---------NVQREIIN 72
           S +Y  +  +GSG FG      DK   + V VK+I++   +++          V  EI  
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISG 131
              + H NI++  ++        +VME + SG +LF  I    R  E  A + F+QL+S 
Sbjct: 83  LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           V Y     + HRD+K EN ++  +    +K+ DFG +          +  GT  Y APEV
Sbjct: 143 VGYLRLKDIIHRDIKDENIVI--AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
           L+ + Y G   ++WS GVTLY ++    PF + +E            +V+ ++     +S
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------TVEAAIHPPYLVS 248
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           +E   L+S +    P  R T+ +++   W  +  P +L D
Sbjct: 249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ--PVNLAD 286

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 15/262 (5%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIVRF 84
           +F++ IG G+ G+  +  +K T + VAVK ++ R  +  E +  E++  R   H N+V  
Sbjct: 49  NFIK-IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDM 107
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
               L    L +VME+  GG L + I    R +E++       ++  +SY H   V HRD
Sbjct: 108 YSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 166
Query: 145 LKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           +K ++ LL  DG    R+K+ DFG+ ++ S    + K  VGTP ++APEV+ R  Y G  
Sbjct: 167 IKSDSILLTSDG----RIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTE 221
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            D+WS G+ +  M+ G  P+ +    +  R+      S+   V D + +S   R  +  +
Sbjct: 222 VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDLM 278
Query: 262 FVADPAARITIPEIMKHQWFLK 283
            V +P+ R T  E++ H  FLK
Sbjct: 279 LVREPSQRATAQELLGHP-FLK 299

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 78/266 (29%), Positives = 129/266 (48%), Gaps = 18/266 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
           RD+K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ R  Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDL 257
           K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   RD 
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFRDF 249
Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++HQ FLK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/263 (30%), Positives = 126/263 (47%), Gaps = 34/263 (12%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----FKE 86
           +G G  G    + +K T+E  A+K ++   K    V+   ++ R+ + P+IVR    ++ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVE---LHWRASQCPHIVRIVDVYEN 82
Query: 87  VILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           +      L IVME   GGELF RI + G   F+E EA    + +   + Y H++ + HRD
Sbjct: 83  LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRD 142
Query: 145 LKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           +K EN L     P   LK+ DFG++K          T G             +YD K  D
Sbjct: 143 VKPENLLYTSKRPNAILKLTDFGFAKE---------TTG------------EKYD-KSCD 180
Query: 204 VWSCGVTLYVMLVGGYPFEDPD--EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +WS GV +Y++L G  PF            KT  R+   ++  P+ + +S+E + LI  +
Sbjct: 181 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 240
Query: 262 FVADPAARITIPEIMKHQWFLKN 284
              +P  R+TI E M H W +++
Sbjct: 241 LKTEPTQRMTITEFMNHPWIMQS 263

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/301 (29%), Positives = 138/301 (45%), Gaps = 28/301 (9%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINH 73
           +P   + D Y+    IGSG   V +       KE VA+K I  E+     + + +EI   
Sbjct: 8   LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--------AGRFSEDEARFFF 125
               HPNIV +    +    L +VM+  SGG + + I +        +G   E       
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSVLHSQPK 178
           ++++ G+ Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ +
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVR 183
Query: 179 ST-VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 236
            T VGTP ++APEV+ +   YD K AD+WS G+T   +  G  P+      K    T+Q 
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 237 IL-SVQYSVPDTNPI---SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
              S++  V D   +    +  R +IS     DP  R T  E+++H++F K    + + E
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQE 302
Query: 293 K 293
           K
Sbjct: 303 K 303

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 18/266 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV+ R  Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDL 257
           K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   RD 
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFRDF 249
Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++HQ FLK
Sbjct: 250 LNRCLEMDVEKRGSAKELLQHQ-FLK 274

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 18/266 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 139
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV+ R  Y  
Sbjct: 140 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDL 257
           K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   RD 
Sbjct: 196 KV-DIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFRDF 249
Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++HQ FLK
Sbjct: 250 LNRCLDMDVEKRGSAKELLQHQ-FLK 274

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 89/311 (28%), Positives = 139/311 (44%), Gaps = 60/311 (19%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--- 67
           GP +DM      + +  V  IG G +GV    R+K+T E+VA+K I R D   E V    
Sbjct: 1   GPLVDM------ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTA 53
Query: 68  -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARF 123
            REI   + L HPNIV+  +VI T   L +V E+    +  ++  +A   +       + 
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKS 111
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 182
           +  QL+ G+++CH+ +V HRDLK +N L++   A  +K+ DFG +++  V        V 
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVV 169
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML--------------------------- 215
           T  Y APE+LL  +Y     D+WS G     M+                           
Sbjct: 170 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDE 229
Query: 216 -----VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARI 270
                V   P   P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI
Sbjct: 230 VVWPGVTSMPDYKPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRI 280
Query: 271 TIPEIMKHQWF 281
           +    + H +F
Sbjct: 281 SAKAALAHPFF 291

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 18/266 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 140
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
           R++K +N LL  DGS    +K+ DFG+          +ST VGTP ++APEV+ R  Y  
Sbjct: 141 RNIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDL 257
           K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   RD 
Sbjct: 197 KV-DIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFRDF 250
Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++HQ FLK
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+ S     ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 239 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 131/266 (49%), Gaps = 18/266 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPNIV 82
           +Y     IG G  G      D  T + VA++ +  +     E +  EI+  R  ++PNIV
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 81
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
            + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV H
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQVIH 140
Query: 143 RDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           RD+K +N LL  DGS    +K+ DFG+ ++ +   S+    VGTP ++APEV+ R  Y  
Sbjct: 141 RDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDL 257
           K+ D+WS G+    M+ G  P+ + +  +        +++   +    NP  +S   RD 
Sbjct: 197 KV-DIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGTPELQNPEKLSAIFRDF 250
Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           ++R    D   R +  E+++HQ FLK
Sbjct: 251 LNRCLEMDVEKRGSAKELIQHQ-FLK 275

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/299 (29%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+ S     ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 241 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLR--HP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 12  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 130 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXECQHLI 235
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPW 257

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 17  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 135 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 240
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPW 262

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 16  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 74  GVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 134 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 239
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPW 261

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLR--HP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 12  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 130 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 235
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPW 257

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 59  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 116
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 177 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 282
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPW 304

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 17  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 135 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 240
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPW 262

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 17  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 74
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 75  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 135 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 192
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 193 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 240
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 241 RWCLALRPSDRPTFEEIQNHPW 262

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLRH--P 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 44  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 162 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 267
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 16  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 73
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 74  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 134 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 191
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 239
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 240 RWCLALRPSDRPTFEEIQNHPW 261

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLR--HP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 15  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 72
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 73  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 132
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 133 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 190
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 191 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 238
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 239 RWCLALRPSDRPTFEEIQNHPW 260

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 51  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 168
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 169 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 226
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 227 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 274
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 275 RWCLALRPSDRPTFEEIQNHPW 296

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLRH--P 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 59  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 116
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 177 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXECQHLI 282
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPW 304

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 31  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 149 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 254
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPW 276

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 44  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 162 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSSECQHLI 267
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 32  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 150 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 255
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPW 277

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 64  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 121
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 122 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 181
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 182 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 239
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 240 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXECQHLI 287
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 288 RWCLALRPSDRPTFEEIQNHPW 309

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 132/288 (45%), Gaps = 34/288 (11%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHP 79
           +Y+ +  IG G +G     +++ T E+VA+K + R D  DE V     REI   + L+H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 61
Query: 80  NIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           NIVR  +V+ +   L +V E+     + +   CN G    +  + F  QL+ G+ +CH+ 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
            V HRDLK +N L++ +    LK+ +FG +++  +  +  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSVPDTNP 249
                D+WS G     +   G P    ++  D  K I R+L             +PD  P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 250 ----------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                           ++   RDL+  +   +P  RI+  E ++H +F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLRH--P 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 31  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 88
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 89  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 148
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 149 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 206
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 207 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXECQHLI 254
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 255 RWCLALRPSDRPTFEEIQNHPW 276

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 32  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 150 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXECQHLI 255
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 256 RWCLALRPSDRPTFEEIQNHPW 277

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 124/262 (47%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLRH--P 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 45  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 163 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSSECQHLI 268
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 122/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 39  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 96
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 97  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 156
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 157 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 214
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 215 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXECQHLI 262
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 263 RWCLALRPSDRPTFEEIQNHPW 284

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 124/262 (47%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLRH--P 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 44  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 162 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSSECQHLI 267
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 124/262 (47%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLR--HP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 12  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 129
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 130 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 187
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 188 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSSECQHLI 235
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 236 RWCLALRPSDRPTFEEIQNHPW 257

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 45  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 163 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSXECQHLI 268
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 45  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 163 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSSECQHLI 268
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/262 (31%), Positives = 123/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 44  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 101
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 102 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 161
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 162 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 219
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 220 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSXECQHLI 267
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 268 RWCLALRPSDRPTFEEIQNHPW 289

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 124/262 (47%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREIINHRSLRH--P 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++  + +     
Sbjct: 45  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 102
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 103 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 162
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 163 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 220
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E          I+  Q  V     +S EC+ LI
Sbjct: 221 GRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIGGQ--VFFRQRVSXECQHLI 268
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 269 RWCLALRPSDRPTFEEIQNHPW 290

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+S+C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 240 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/288 (27%), Positives = 131/288 (45%), Gaps = 34/288 (11%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRHP 79
           +Y+ +  IG G +G     +++ T E+VA+K + R D  DE V     REI   + L+H 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKHK 61
Query: 80  NIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           NIVR  +V+ +   L +V E+     + +   CN G    +  + F  QL+ G+ +CH+ 
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
            V HRDLK +N L++ +    LK+ DFG +++  +  +  S  V T  Y  P+VL   + 
Sbjct: 121 NVLHRDLKPQNLLINRN--GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSVPDTNP 249
                D+WS G     +     P    ++  D  K I R+L             +PD  P
Sbjct: 179 YSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 250 ----------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                           ++   RDL+  +   +P  RI+  E ++H +F
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/291 (29%), Positives = 134/291 (46%), Gaps = 28/291 (9%)
Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINH 73
           +P   + D Y+    IGSG   V +       KE VA+K I  E+     + + +EI   
Sbjct: 3   LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 62
Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--------AGRFSEDEARFFF 125
               HPNIV +    +    L +VM+  SGG + + I +        +G   E       
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSK-----SSVLHSQPK 178
           ++++ G+ Y H     HRD+K  N LL  DGS    ++I DFG S        +  ++ +
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGS----VQIADFGVSAFLATGGDITRNKVR 178
Query: 179 ST-VGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 236
            T VGTP ++APEV+ +   YD K AD+WS G+T   +  G  P+      K    T+Q 
Sbjct: 179 KTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 237
Query: 237 -ILSVQYSVPDTNPI---SQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
              S++  V D   +    +  R +IS     DP  R T  E+++H++F K
Sbjct: 238 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 121/262 (46%), Gaps = 28/262 (10%)
Query: 31  IGSGNFGVARLMRDKVTKEL-VAVKYIERGDKIDE--------NVQREII--NHRSLRHP 79
           +GSG FG +     +V+  L VA+K++E+ D+I +         V  E++     S    
Sbjct: 32  LGSGGFG-SVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFS 89
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 90  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 149
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 150 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 207
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 208 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSXECQHLI 255
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P  R T  EI  H W
Sbjct: 256 RWCLALRPXDRPTFEEIQNHPW 277

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 239 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 245 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 38/293 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           ++Y  +  IG G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 79  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            NIV+  +VI T   L +V E+      +L + +C  G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRH 195
             +V HRDLK +N L++      LKI DFG +++  +   +    V T  Y AP+VL+  
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------VPDT 247
           +      D+WS G  ++  +V G P        D    I RIL    S        +P  
Sbjct: 176 KKYSTTIDIWSVGC-IFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 248 NP----------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
           +P                + +   DL+S++   DP  RIT  + ++H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 38/293 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           ++Y  +  IG G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 79  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            NIV+  +VI T   L +V E+      +L + +C  G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRH 195
             +V HRDLK +N L++      LKI DFG +++  +   +    V T  Y AP+VL+  
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGS 175
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------VPDT 247
           +      D+WS G  ++  +V G P        D    I RIL    S        +P  
Sbjct: 176 KKYSTTIDIWSVGC-IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 248 NP----------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
           +P                + +   DL+S++   DP  RIT  + ++H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 12/274 (4%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 82
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 143 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 199
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             + +D+WS G++L  M VG YP           + +  I++       +   S E +D 
Sbjct: 200 SVQ-SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 258
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           +++  + +PA R  + ++M H  F+K   A+ VD
Sbjct: 259 VNKCLIKNPAERADLKQLMVHA-FIKRSDAEEVD 291

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/263 (30%), Positives = 125/263 (47%), Gaps = 26/263 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           IG G+FG      D  TKE+VA+K I+    +   E++Q+EI        P I R+    
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 89  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
           L  T L I+MEY  GG   + +   G   E       ++++ G+ Y H+ +  HRD+K  
Sbjct: 87  LKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAA 145
Query: 149 NTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEYDGKIADVWS 206
           N LL  S    +K+ DFG +   +  +Q K    VGTP ++APEV+ +  YD K AD+WS
Sbjct: 146 NVLL--SEQGDVKLADFGVA-GQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFK-ADIWS 201
Query: 207 CGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC------RDLISR 260
            G+T  + L  G P      P          + V + +P  +P + E       ++ +  
Sbjct: 202 LGITA-IELAKGEPPNSDLHP----------MRVLFLIPKNSPPTLEGQHSKPFKEFVEA 250
Query: 261 IFVADPAARITIPEIMKHQWFLK 283
               DP  R T  E++KH++  +
Sbjct: 251 CLNKDPRFRPTAKELLKHKFITR 273

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 137/293 (46%), Gaps = 38/293 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           ++Y  +  IG G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYG-ETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59
Query: 79  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            NIV+  +VI T   L +V E+      +L + +C  G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-VCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRH 195
             +V HRDLK +N L++      LKI DFG +++  +   +    + T  Y AP+VL+  
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------VPDT 247
           +      D+WS G  ++  +V G P        D    I RIL    S        +P  
Sbjct: 176 KKYSTTIDIWSVGC-IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 248 NP----------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
           +P                + +   DL+S++   DP  RIT  + ++H +F +N
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 240 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 178
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 239 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 237 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 239 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 241 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 240 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 62
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 121 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 239 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 68
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 127 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 244
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 245 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 241 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 65
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 124 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 181
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 242 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 237 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 237 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 237 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+ S     +   +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 241 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVD--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 122
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 123 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 180
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 241 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+ S     +   +A   +       + +  QL+ G+++C
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMD--LKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 121
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 122 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 179
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 240 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 134/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 86/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  +   +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK EN L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPENLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 136/282 (48%), Gaps = 33/282 (11%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRH 78
           ++ Y+ +  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 79  PNIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 132
           PNIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 133 SYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTP 184
             CH        V HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKTFVGTP 180
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTIQRILSVQ 241
            Y++PE + R  Y+ K +D+WS G  LY +     PF    + +     R+   R +  +
Sbjct: 181 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
           Y        S E  ++I+R+       R ++ EI+++   L+
Sbjct: 240 Y--------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 136/282 (48%), Gaps = 33/282 (11%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRH 78
           ++ Y+ +  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 79  PNIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 132
           PNIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 133 SYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTP 184
             CH        V HRDLK  N  LDG     +K+ DFG ++  +L+   S  K+ VGTP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLAR--ILNHDTSFAKAFVGTP 180
Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTIQRILSVQ 241
            Y++PE + R  Y+ K +D+WS G  LY +     PF    + +     R+   R +  +
Sbjct: 181 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
           Y        S E  ++I+R+       R ++ EI+++   L+
Sbjct: 240 Y--------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 80  NIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V +CH  
Sbjct: 117 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC 176
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRD+K EN L+D +    LK+ DFG S + +  +      GT  Y  PE +  H Y 
Sbjct: 177 GVLHRDIKDENILIDLNRG-ELKLIDFG-SGALLKDTVYTDFDGTRVYSPPEWIRYHRYH 234
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G+ A VWS G+ LY M+ G  PFE  +E             ++  V     +S EC+ LI
Sbjct: 235 GRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVFFRQRVSSECQHLI 282
Query: 259 SRIFVADPAARITIPEIMKHQW 280
                  P+ R T  EI  H W
Sbjct: 283 RWCLALRPSDRPTFEEIQNHPW 304

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 130/297 (43%), Gaps = 50/297 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 64
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           PNIV+  +VI T   L +V E+     + F              + +  QL+ G+++CH+
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
            +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL  +
Sbjct: 125 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 197 YDGKIADVWSCGVTLYVML--------------------------------VGGYPFEDP 224
           Y     D+WS G     M+                                V   P   P
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 243 SFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 130/297 (43%), Gaps = 50/297 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+K I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           PNIV+  +VI T   L +V E+     + F              + +  QL+ G+++CH+
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
            +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL  +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 197 YDGKIADVWSCGVTLYVML--------------------------------VGGYPFEDP 224
           Y     D+WS G     M+                                V   P   P
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 239 SFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 40/290 (13%)
Query: 2   KMDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK 61
           K+D  SLT  P          + +D +  +G G++G       K T ++VA+K +     
Sbjct: 17  KLDEDSLTKQP---------EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD 67
Query: 62  IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDE 120
           + E + +EI   +    P++V++       T L IVMEY   G + + I       +EDE
Sbjct: 68  LQEII-KEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE 126
Query: 121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKS 179
                Q  + G+ Y H M+  HRD+K  N LL+       K+ DFG + + +   ++   
Sbjct: 127 IATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTE--GHAKLADFGVAGQLTDXMAKRNX 184
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED-----------PDEPK 228
            +GTP ++APEV+    Y+  +AD+WS G+T   M  G  P+ D            + P 
Sbjct: 185 VIGTPFWMAPEVIQEIGYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP 243
Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            FRK            P+    S    D + +  V  P  R T  ++++H
Sbjct: 244 TFRK------------PEL--WSDNFTDFVKQCLVKSPEQRATATQLLQH 279

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +R+IG G+FG     RD    E+VA+K +    K      ++II      + LRHPN ++
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 84  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           ++   L      +VMEY   S  +L E   +     E E        + G++Y H+  + 
Sbjct: 119 YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 176
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV+L     +YD
Sbjct: 177 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 231
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK+ DVWS G+T   +     P  +     +    +  I   +     +   S+  R+ +
Sbjct: 232 GKV-DVWSLGITCIELAERKPPLFN----MNAMSALYHIAQNESPALQSGHWSEYFRNFV 286
Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLV 290
                  P  R T   ++KH++ L+  P  ++
Sbjct: 287 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 105/202 (51%), Gaps = 18/202 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IG+G+FG     R +     VAVK +   D   E V    RE+   + LRHPNIV F   
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 88  ILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQ--QLISGVSYCHAMQ--VCH 142
           +  P +L+IV EY S G L+  +  +G R   DE R       +  G++Y H     + H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           R+LK  N L+D      +K+CDFG S+   S+ L S  KS  GTP ++APEV LR E   
Sbjct: 163 RNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSS--KSAAGTPEWMAPEV-LRDEPSN 217
Query: 200 KIADVWSCGVTLYVMLVGGYPF 221
           + +DV+S GV L+ +     P+
Sbjct: 218 EKSDVYSFGVILWELATLQQPW 239

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+  I R D   E V     REI   + L H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 61
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 120 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 238 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/299 (28%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           + +  V  IG G +GV    R+K+T E+VA+  I R D   E V     REI   + L H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKI-RLDTETEGVPSTAIREISLLKELNH 60
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYC 135
           PNIV+  +VI T   L +V E+    +  ++  +A   +       + +  QL+ G+++C
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           H+ +V HRDLK +N L++   A  +K+ DFG +++  V        V T  Y APE+LL 
Sbjct: 119 HSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 195 HEYDGKIADVWSCGVTLYVML--------------------------------VGGYPFE 222
            +Y     D+WS G     M+                                V   P  
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            P  PK  R+   ++      VP   P+ ++ R L+S++   DP  RI+    + H +F
Sbjct: 237 KPSFPKWARQDFSKV------VP---PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 26/274 (9%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLR 77
           ++  D ++ + ++G G FG     ++K T  L A K I+ + ++  E+   EI    S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 136
           HPNIV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 137 AMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL 193
             ++ HRDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV++
Sbjct: 153 DNKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVM 208
Query: 194 -----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT- 247
                   YD K ADVWS G+TL  M        + + P      ++ +L +  S P T 
Sbjct: 209 CETSKDRPYDYK-ADVWSLGITLIEM-------AEIEPPHHELNPMRVLLKIAKSEPPTL 260
Query: 248 ---NPISQECRDLISRIFVADPAARITIPEIMKH 278
              +  S   +D + +    +  AR T  ++++H
Sbjct: 261 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 294

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 21/272 (7%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +R+IG G+FG     RD    E+VA+K +    K      ++II      + LRHPN ++
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 84  FKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           ++   L      +VMEY   S  +L E   +     E E        + G++Y H+  + 
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL---RHEYD 198
           HRD+K  N LL  S    +K+ DFG   S+ + +     VGTP ++APEV+L     +YD
Sbjct: 138 HRDVKAGNILL--SEPGLVKLGDFG---SASIMAPANXFVGTPYWMAPEVILAMDEGQYD 192
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           GK+ DVWS G+T  + L    P   P    +    +  I   +     +   S+  R+ +
Sbjct: 193 GKV-DVWSLGITC-IELAERKP---PLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 247
Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLV 290
                  P  R T   ++KH++ L+  P  ++
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 134/281 (47%), Gaps = 31/281 (11%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRH 78
           ++ Y+ +  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 79  PNIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 132
           PNIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 133 SYCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 185
             CH        V HRDLK  N  LDG     +K+ DFG ++  + H +   K  VGTP 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLAR-ILNHDEDFAKEFVGTPY 181
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK---DFRKTIQRILSVQY 242
           Y++PE + R  Y+ K +D+WS G  LY +     PF    + +     R+   R +  +Y
Sbjct: 182 YMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 240
Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
                   S E  ++I+R+       R ++ EI+++   L+
Sbjct: 241 --------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 26/274 (9%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLR 77
           ++  D ++ + ++G G FG     ++K T  L A K I+ + ++  E+   EI    S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 136
           HPNIV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 137 AMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLL 193
             ++ HRDLK  N L  LDG     +K+ DFG S  +    Q + S +GTP ++APEV++
Sbjct: 153 DNKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM 208
Query: 194 -----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT- 247
                   YD K ADVWS G+TL  M        + + P      ++ +L +  S P T 
Sbjct: 209 CETSKDRPYDYK-ADVWSLGITLIEM-------AEIEPPHHELNPMRVLLKIAKSEPPTL 260
Query: 248 ---NPISQECRDLISRIFVADPAARITIPEIMKH 278
              +  S   +D + +    +  AR T  ++++H
Sbjct: 261 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 294

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 75/202 (37%), Positives = 103/202 (50%), Gaps = 18/202 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IG+G+FG     R +     VAVK +   D   E V    RE+   + LRHPNIV F   
Sbjct: 45  IGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 88  ILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQ--QLISGVSYCHAMQ--VCH 142
           +  P +L+IV EY S G L+  +  +G R   DE R       +  G++Y H     + H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           RDLK  N L+D      +K+CDFG S+   S  L S  K   GTP ++APEV LR E   
Sbjct: 163 RDLKSPNLLVDKKYT--VKVCDFGLSRLKASXFLXS--KXAAGTPEWMAPEV-LRDEPSN 217
Query: 200 KIADVWSCGVTLYVMLVGGYPF 221
           + +DV+S GV L+ +     P+
Sbjct: 218 EKSDVYSFGVILWELATLQQPW 239

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           ++Y  +  +G G +GV    +D   + +VA+K I R D  DE +     REI   + L H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRI-RLDAEDEGIPSTAIREISLLKELHH 78
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 136
           PNIV   +VI +   L +V E+       +++ +  +    + + + +  QL+ GV++CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRH 195
             ++ HRDLK +N L++   A  LK+ DFG +++  +  +  +  V T  Y AP+VL+  
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF---EDPDE------------PKDFRKTIQRILSV 240
           +      D+WS G     M+ G   F    D D+            P+++ +  +  L  
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 241 Q--YSVPDTNPIS-------QECRDLISRIFVADPAARITIPEIMKHQWF 281
           Q  + V +  P S       QE  DL+S +   DP  RI+  + M H +F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 138/290 (47%), Gaps = 37/290 (12%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           ++Y  +  +G G +GV    +D   + +VA+K I R D  DE +     REI   + L H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGR-IVALKRI-RLDAEDEGIPSTAIREISLLKELHH 78
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 136
           PNIV   +VI +   L +V E+       +++ +  +    + + + +  QL+ GV++CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRH 195
             ++ HRDLK +N L++   A  LK+ DFG +++  +  +  +  V T  Y AP+VL+  
Sbjct: 137 QHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGS 194
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF---EDPDE------------PKDFRKTIQRILSV 240
           +      D+WS G     M+ G   F    D D+            P+++ +  +  L  
Sbjct: 195 KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254
Query: 241 Q--YSVPDTNPIS-------QECRDLISRIFVADPAARITIPEIMKHQWF 281
           Q  + V +  P S       QE  DL+S +   DP  RI+  + M H +F
Sbjct: 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
           R +G G FG     + K T +L A K + +             V+++I+     R   IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF--IV 248
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
                  T T L +VM   +GG++   I N       F E  A F+  Q++SG+ + H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+LL  EY
Sbjct: 309 NIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           D  + D ++ GVTLY M+    PF    E  + ++  QR+L    + PD    S   +D 
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDF 423
Query: 258 ISRIFVADPAARI 270
              +   DP  R+
Sbjct: 424 CEALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
           R +G G FG     + K T +L A K + +             V+++I+     R   IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF--IV 248
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
                  T T L +VM   +GG++   I N       F E  A F+  Q++SG+ + H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+LL  EY
Sbjct: 309 NIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           D  + D ++ GVTLY M+    PF    E  + ++  QR+L    + PD    S   +D 
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDF 423
Query: 258 ISRIFVADPAARI 270
              +   DP  R+
Sbjct: 424 CEALLQKDPEKRL 436

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
           R +G G FG     + K T +L A K + +             V+++I+     R   IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF--IV 248
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
                  T T L +VM   +GG++   I N       F E  A F+  Q++SG+ + H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+LL  EY
Sbjct: 309 NIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           D  + D ++ GVTLY M+    PF    E  + ++  QR+L    + PD    S   +D 
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDF 423
Query: 258 ISRIFVADPAARI 270
              +   DP  R+
Sbjct: 424 CEALLQKDPEKRL 436

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 133/274 (48%), Gaps = 26/274 (9%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLR 77
           ++  D ++ + ++G G FG     ++K T  L A K I+ + ++  E+   EI    S  
Sbjct: 33  LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 92
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 136
           HPNIV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H
Sbjct: 93  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 152
Query: 137 AMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 193
             ++ HRDLK  N L  LDG     +K+ DFG S  +    Q +   +GTP ++APEV++
Sbjct: 153 DNKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVM 208
Query: 194 -----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT- 247
                   YD K ADVWS G+TL  M        + + P      ++ +L +  S P T 
Sbjct: 209 CETSKDRPYDYK-ADVWSLGITLIEM-------AEIEPPHHELNPMRVLLKIAKSEPPTL 260
Query: 248 ---NPISQECRDLISRIFVADPAARITIPEIMKH 278
              +  S   +D + +    +  AR T  ++++H
Sbjct: 261 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 294

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 117/253 (46%), Gaps = 18/253 (7%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSLRHPNIV 82
           R +G G FG     + K T +L A K + +             V+++I+     R   IV
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF--IV 248
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAM 138
                  T T L +VM   +GG++   I N       F E  A F+  Q++SG+ + H  
Sbjct: 249 SLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + +RDLK EN LLD      ++I D G + +     ++ K   GTP ++APE+LL  EY
Sbjct: 309 NIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           D  + D ++ GVTLY M+    PF    E  + ++  QR+L    + PD    S   +D 
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FSPASKDF 423
Query: 258 ISRIFVADPAARI 270
              +   DP  R+
Sbjct: 424 CEALLQKDPEKRL 436

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 85/297 (28%), Positives = 129/297 (43%), Gaps = 29/297 (9%)
Query: 23  DRYDFVRDI-GSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREI-INHRSLRHP 79
           D Y    D+ G G     +   + +T +  AVK IE+    I   V RE+ + ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           N++   E         +V E   GG +   I     F+E EA    Q + S + + H   
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 140 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS--QPKST------VGTPAYIAPE 190
           + HRDLK EN L +  +    +KICDFG      L+    P ST       G+  Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 191 VLLRHEYDGKI----ADVWSCGVTLYVMLVGGYPF---------EDPDE--PKDFRKTIQ 235
           V+     +  I     D+WS GV LY++L G  PF          D  E  P       +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 236 RILSVQYSVPDTN--PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV 290
            I   +Y  PD +   IS   +DLIS++ V D   R++  ++++H W     P + +
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 131/292 (44%), Gaps = 39/292 (13%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDK--IDENVQREIINHRSLRHP 79
           ++Y+ +  IG G++GV    R++ T ++VA+K ++E  D   I +   REI   + L+HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           N+V   EV      L +V EY     L E         E   +    Q +  V++CH   
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN 122
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STVGTPAYIAPEVLLRH 195
             HRD+K EN L+       +K+CDFG+++   L + P       V T  Y +PE+L+  
Sbjct: 123 CIHRDVKPENILITKHSV--IKLCDFGFAR---LLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF----EDPDEPKDFRKTI-------QRILSV-QY- 242
              G   DVW+ G  ++  L+ G P      D D+    RKT+       Q++ S  QY 
Sbjct: 178 TQYGPPVDVWAIG-CVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 243 ---SVPDTNP----------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
               +PD             IS     L+      DP  R+T  +++ H +F
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 150/324 (46%), Gaps = 41/324 (12%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIIN 72
           +H  D ++ ++ IG G FG   +++ K T+ + A+K + + + +          +R+++ 
Sbjct: 71  LHRED-FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLV 129
Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISG 131
           +   +    + +        HL +VM+Y  GG+L   +     +  ED ARF+  +++  
Sbjct: 130 NGDCQWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTP 184
           +   H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP
Sbjct: 188 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTP 240
Query: 185 AYIAPEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            YI+PE+L   E      G   D WS GV +Y ML G  PF      + + K +      
Sbjct: 241 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 300
Query: 241 QYSVPDTNPISQECRDLISRIFVADP--AARITIPEIMKHQWF-------LKNLPADL-- 289
           Q+    T+ +S+E +DLI R+  +      +  I +  KH +F       ++NL A    
Sbjct: 301 QFPSHVTD-VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGLNWENIRNLEAPYIP 359
Query: 290 -VDEKTMSSQYEEPDQPMQSVDVI 312
            V   + +S ++  D  +++ +++
Sbjct: 360 DVSSPSDTSNFDVDDDVLRNTEIL 383

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 132/283 (46%), Gaps = 31/283 (10%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIIN 72
           +H  D ++ ++ IG G FG   +++ K T+ + A+K + + + +          +R+++ 
Sbjct: 87  LHRED-FEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLV 145
Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISG 131
           +   +    + +        HL +VM+Y  GG+L   +     +  ED ARF+  +++  
Sbjct: 146 NGDCQWITALHY--AFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTP 184
           +   H +   HRD+K +N LLD +   R       LK+ D G  +SSV        VGTP
Sbjct: 204 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSV-------AVGTP 256
Query: 185 AYIAPEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            YI+PE+L   E      G   D WS GV +Y ML G  PF      + + K +      
Sbjct: 257 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 316
Query: 241 QYSVPDTNPISQECRDLISRIFVADP--AARITIPEIMKHQWF 281
           Q+    T+ +S+E +DLI R+  +      +  I +  KH +F
Sbjct: 317 QFPSHVTD-VSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 358

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 124/256 (48%), Gaps = 24/256 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEV 87
           +G G FGV  + + K   + VA+K IE     +   +  I+  R L    HPNIV+    
Sbjct: 17  VGRGAFGV--VCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 88  ILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHAMQ---VC 141
            L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y H+MQ   + 
Sbjct: 71  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK  N LL       LKICDFG   +  + +   +  G+ A++APEV     Y  K 
Sbjct: 129 HRDLKPPNLLLVAG-GTVLKICDFG--TACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK- 184
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DV+S G+ L+ ++    PF++   P  FR  I   +      P    + +    L++R 
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKNLPKPIESLMTRC 241
Query: 262 FVADPAARITIPEIMK 277
           +  DP+ R ++ EI+K
Sbjct: 242 WSKDPSQRPSMEEIVK 257

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 133/274 (48%), Gaps = 16/274 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 66
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++       VGT +Y++PE L    Y
Sbjct: 127 HKIMHRDVKPSNILVNSR--GEIKLCDFGVS-GQLIDEMANEFVGTRSYMSPERLQGTHY 183
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             + +D+WS G++L  M VG Y    P  P    + +  I++       +   S E +D 
Sbjct: 184 SVQ-SDIWSMGLSLVEMAVGRY----PRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDF 238
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           +++  + +PA R  + ++M H  F+K   A+ VD
Sbjct: 239 VNKCLIKNPAERADLKQLMVHA-FIKRSDAEEVD 271

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           DRY  +  +G G +G      D VT E VA+K I R +  +E V     RE+   + L+H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            NI+  K VI     L ++ EYA   +L + +      S    + F  QLI+GV++CH+ 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 139 QVCHRDLKLENTLL---DGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLR 194
           +  HRDLK +N LL   D S  P LKI DFG +++  +   Q    + T  Y  PE+LL 
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 195 HEYDGKIADVWSCGVTLYVMLV 216
             +     D+WS       ML+
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLM 233

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/256 (31%), Positives = 124/256 (48%), Gaps = 24/256 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEV 87
           +G G FGV  + + K   + VA+K IE     +   +  I+  R L    HPNIV+    
Sbjct: 16  VGRGAFGV--VCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 88  ILTPTHLAIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQ---VC 141
            L P  + +VMEYA GG L+  +  A     ++   A  +  Q   GV+Y H+MQ   + 
Sbjct: 70  CLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK  N LL       LKICDFG   +  + +   +  G+ A++APEV     Y  K 
Sbjct: 128 HRDLKPPNLLLVAG-GTVLKICDFG--TACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK- 183
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            DV+S G+ L+ ++    PF++   P  FR  I   +      P    + +    L++R 
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPA-FR--IMWAVHNGTRPPLIKNLPKPIESLMTRC 240
Query: 262 FVADPAARITIPEIMK 277
           +  DP+ R ++ EI+K
Sbjct: 241 WSKDPSQRPSMEEIVK 256

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 50/312 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 125
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 186 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 242
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------------------- 228
             + +D+WS G++L  M VG YP   PD  +                             
Sbjct: 243 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 301
Query: 229 ---DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQ 279
              D R  +     + Y V +  P       S E +D +++  + +PA R  + ++M H 
Sbjct: 302 YGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 361
Query: 280 WFLKNLPADLVD 291
            F+K   A+ VD
Sbjct: 362 -FIKRSDAEEVD 372

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 50/312 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------------------- 228
             + +D+WS G++L  M VG YP   PD  +                             
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 229 ---DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQ 279
              D R  +     + Y V +  P       S E +D +++  + +PA R  + ++M H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 280 WFLKNLPADLVD 291
            F+K   A+ VD
Sbjct: 300 -FIKRSDAEEVD 310

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 50/312 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------------------- 228
             + +D+WS G++L  M VG YP   PD  +                             
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 229 ---DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQ 279
              D R  +     + Y V +  P       S E +D +++  + +PA R  + ++M H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 280 WFLKNLPADLVD 291
            F+K   A+ VD
Sbjct: 300 -FIKRSDAEEVD 310

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 125/268 (46%), Gaps = 39/268 (14%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRHPNIVRFK 85
           IG G FG  ++ R     + VAVK        D     ENV++E      L+HPNI+  +
Sbjct: 15  IGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH---AMQVCH 142
            V L   +L +VME+A GG L  R+ +  R   D    +  Q+  G++Y H    + + H
Sbjct: 73  GVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 143 RDLKLENTLL-----DGSPAPR-LKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRH 195
           RDLK  N L+     +G  + + LKI DFG ++    H   K S  G  A++APEV +R 
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLARE--WHRTTKMSAAGAYAWMAPEV-IRA 188
Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN---PISQ 252
               K +DVWS GV L+ +L G  PF   D            L+V Y V       PI  
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-----------LAVAYGVAMNKLALPIPS 237
Query: 253 ECRDLISRI----FVADPAARITIPEIM 276
            C +  +++    +  DP +R +   I+
Sbjct: 238 TCPEPFAKLMEDCWNPDPHSRPSFTNIL 265

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 50/312 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------------------- 228
             + +D+WS G++L  M VG YP   PD  +                             
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 229 ---DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQ 279
              D R  +     + Y V +  P       S E +D +++  + +PA R  + ++M H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 280 WFLKNLPADLVD 291
            F+K   A+ VD
Sbjct: 300 -FIKRSDAEEVD 310

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 50/312 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 124 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------------------- 228
             + +D+WS G++L  M VG YP   PD  +                             
Sbjct: 181 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 229 ---DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQ 279
              D R  +     + Y V +  P       S E +D +++  + +PA R  + ++M H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 280 WFLKNLPADLVD 291
            F+K   A+ VD
Sbjct: 300 -FIKRSDAEEVD 310

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/312 (26%), Positives = 139/312 (44%), Gaps = 50/312 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   +  K +  ++A K I    +I   ++ +II    + H    
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 90
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y    
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            ++ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y
Sbjct: 151 HKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----------------------------- 228
             + +D+WS G++L  M VG YP   PD  +                             
Sbjct: 208 SVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 229 ---DFRKTIQRILSVQYSVPDTNP------ISQECRDLISRIFVADPAARITIPEIMKHQ 279
              D R  +     + Y V +  P       S E +D +++  + +PA R  + ++M H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326
Query: 280 WFLKNLPADLVD 291
            F+K   A+ VD
Sbjct: 327 -FIKRSDAEEVD 337

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 92/347 (26%), Positives = 148/347 (42%), Gaps = 56/347 (16%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQ 67
           M + +   + RY+ +  +G G F      RDK T ++VA+K I+ G      D I+    
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL 60
Query: 68  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFF 125
           REI   + L HPNI+   +     +++++V ++       E I   N+   +    + + 
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD--LEVIIKDNSLVLTPSHIKAYM 118
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----V 181
              + G+ Y H   + HRDLK  N LLD +    LK+ DFG +KS      P       V
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKS---FGSPNRAYXHQV 173
Query: 182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF----EDPDEPKDFRKTIQRI 237
            T  Y APE+L      G   D+W+ G  L  +L+   PF     D D+     +T+   
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTP 232
Query: 238 LSVQY----SVPDT---------------NPISQECRDLISRIFVADPAARITIPEIMKH 278
              Q+    S+PD                +    +  DLI  +F+ +P ARIT  + +K 
Sbjct: 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292
Query: 279 QWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPAVG 325
           ++F  N P       T   Q   P+ P+++       + E S PA+ 
Sbjct: 293 KYF-SNRPG-----PTPGCQLPRPNCPVET-------LKEQSNPALA 326

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 117/263 (44%), Gaps = 28/263 (10%)
Query: 52  AVKYIER-GDKIDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 109
           AVK IE+        V RE+   ++   + NI+   E     T   +V E   GG +   
Sbjct: 42  AVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAH 101
Query: 110 ICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYS 168
           I     F+E EA    + + + + + H   + HRDLK EN L +       +KICDF   
Sbjct: 102 IQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLG 161
Query: 169 KSSVLH------SQPKSTV--GTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLV 216
               L+      + P+ T   G+  Y+APEV+     +  +  K  D+WS GV LY+ML 
Sbjct: 162 SGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLS 221
Query: 217 GGYPFEDP-------DEPKDFR----KTIQRILSVQYSVPDTN--PISQECRDLISRIFV 263
           G  PF          D  +  R    K  + I   +Y  PD +   IS E +DLIS++ V
Sbjct: 222 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLV 281
Query: 264 ADPAARITIPEIMKHQWFLKNLP 286
            D   R++  ++++H W     P
Sbjct: 282 RDAKQRLSAAQVLQHPWVQGQAP 304

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNI 81
           R IG G FG     R   T ++ A+K +++     +  +   +N R +         P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H   V 
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 142 HRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVA 367
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
               AD +S G  L+ +L G  PF    + KD  +  +  L++   +PD+   S E R L
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSL 424
Query: 258 ISRIFVADPAARI 270
           +  +   D   R+
Sbjct: 425 LEGLLQRDVNRRL 437

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/297 (28%), Positives = 128/297 (43%), Gaps = 29/297 (9%)
Query: 23  DRYDFVRDI-GSGNFGVARLMRDKVTKELVAVKYIERG-DKIDENVQREI-INHRSLRHP 79
           D Y    D+ G G     +   + +T +  AVK IE+    I   V RE+ + ++   H 
Sbjct: 12  DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           N++   E         +V E   GG +   I     F+E EA    Q + S + + H   
Sbjct: 72  NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131
Query: 140 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS--QPKST------VGTPAYIAPE 190
           + HRDLK EN L +  +    +KICDF       L+    P ST       G+  Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 191 VLLRHEYDGKI----ADVWSCGVTLYVMLVGGYPF---------EDPDE--PKDFRKTIQ 235
           V+     +  I     D+WS GV LY++L G  PF          D  E  P       +
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251
Query: 236 RILSVQYSVPDTN--PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV 290
            I   +Y  PD +   IS   +DLIS++ V D   R++  ++++H W     P + +
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTL 308

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNI 81
           R IG G FG     R   T ++ A+K +++     +  +   +N R +         P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H   V 
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 142 HRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVA 367
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
               AD +S G  L+ +L G  PF    + KD  +  +  L++   +PD+   S E R L
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSL 424
Query: 258 ISRIFVADPAARI 270
           +  +   D   R+
Sbjct: 425 LEGLLQRDVNRRL 437

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNI 81
           R IG G FG     R   T ++ A+K +++     +  +   +N R +         P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H   V 
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 142 HRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVA 367
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
               AD +S G  L+ +L G  PF    + KD  +  +  L++   +PD+   S E R L
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSL 424
Query: 258 ISRIFVADPAARI 270
           +  +   D   R+
Sbjct: 425 LEGLLQRDVNRRL 437

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 86/311 (27%), Positives = 138/311 (44%), Gaps = 62/311 (19%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR-----EIINHRSL 76
            D Y+ +  IG+G +GV    R ++T + VA+K I     +  N +R     +I+ H   
Sbjct: 54  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--F 111
Query: 77  RHPNIVRFKEVILTPT-------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
           +H NI+  K+ IL PT        + +V++     +L + I ++   + +  R+F  QL+
Sbjct: 112 KHDNIIAIKD-ILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLL 169
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-------KSTVG 182
            G+ Y H+ QV HRDLK  N L++ +    LKI DFG ++   L + P          V 
Sbjct: 170 RGLKYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVA 225
Query: 183 TPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
           T  Y APE++L  HEY   I D+WS G     ML     F      K++   +Q I+ V 
Sbjct: 226 TRWYRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQLFPG----KNYVHQLQLIMMVL 280
Query: 242 --------------------YSVPDTNPISQE---------CRDLISRIFVADPAARITI 272
                                S+P   P+  E            L+ R+   +P+ARI+ 
Sbjct: 281 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA 340
Query: 273 PEIMKHQWFLK 283
              ++H +  K
Sbjct: 341 AAALRHPFLAK 351

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 116/253 (45%), Gaps = 21/253 (8%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNI 81
           R IG G FG     R   T ++ A+K +++     +  +   +N R +         P I
Sbjct: 194 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 253
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H   V 
Sbjct: 254 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 313
Query: 142 HRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           +RDLK  N LLD     R+      CDF   K       P ++VGT  Y+APEVL +   
Sbjct: 314 YRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQKGVA 366
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
               AD +S G  L+ +L G  PF    + KD  +  +  L++   +PD+   S E R L
Sbjct: 367 YDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSL 423
Query: 258 ISRIFVADPAARI 270
           +  +   D   R+
Sbjct: 424 LEGLLQRDVNRRL 436

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 130/271 (47%), Gaps = 25/271 (9%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-YIERGDK--IDENVQREIINHRSLRHP 79
           ++Y+ +  +G G++G+    R+K T  +VA+K ++E  D   + +   REI   + LRH 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           N+V   EV        +V E+     L   E   N   +   +   F  Q+I+G+ +CH+
Sbjct: 85  NLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF--QIINGIGFCHS 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHE 196
             + HRD+K EN L+  S +  +K+CDFG++++     +     V T  Y APE+L+   
Sbjct: 143 HNIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
             GK  DVW+ G  +  M +G     +P  P D    I ++  +   + +  P  QE   
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMG-----EPLFPGD--SDIDQLYHIMMCLGNLIPRHQE--- 250
Query: 257 LISRIFVADPA-ARITIPEIMKHQWFLKNLP 286
               +F  +P  A + +PEI + +   +  P
Sbjct: 251 ----LFNKNPVFAGVRLPEIKEREPLERRYP 277

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 137/307 (44%), Gaps = 54/307 (17%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR-----EIINHRSL 76
            D Y+ +  IG+G +GV    R ++T + VA+K I     +  N +R     +I+ H   
Sbjct: 53  GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKH--F 110
Query: 77  RHPNIVRFKEVILTPT-------HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
           +H NI+  K+ IL PT        + +V++     +L + I ++   + +  R+F  QL+
Sbjct: 111 KHDNIIAIKD-ILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLL 168
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-------KSTVG 182
            G+ Y H+ QV HRDLK  N L++ +    LKI DFG ++   L + P          V 
Sbjct: 169 RGLKYMHSAQVIHRDLKPSNLLVNEN--CELKIGDFGMARG--LCTSPAEHQYFMTEYVA 224
Query: 183 TPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI------- 234
           T  Y APE++L  HEY   I D+WS G     ML     F   +     +  +       
Sbjct: 225 TRWYRAPELMLSLHEYTQAI-DLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283
Query: 235 ---------QRILSVQYSVPDTNPISQE---------CRDLISRIFVADPAARITIPEIM 276
                    +R+ +   S+P   P+  E            L+ R+   +P+ARI+    +
Sbjct: 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAAL 343
Query: 277 KHQWFLK 283
           +H +  K
Sbjct: 344 RHPFLAK 350

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 15/281 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRH 78
           D ++ +R IG G+FG   +++   TK++ A+KY+ +   ++ N  R +       + L H
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V           + +V++   GG+L   +     F E+  + F  +L+  + Y    
Sbjct: 75  PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ 134
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           ++ HRD+K +N LLD      + I DF  +      +Q  +  GT  Y+APE+    +  
Sbjct: 135 RIIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGA 192
Query: 199 GK--IADVWSCGVTLYVMLVGGYPFE--DPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
           G     D WS GVT Y +L G  P+        K+   T +  +     V   +  SQE 
Sbjct: 193 GYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV-----VTYPSAWSQEM 247
Query: 255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTM 295
             L+ ++   +P  R +    +++  ++ ++  D V +K +
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRL 288

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 126/297 (42%), Gaps = 52/297 (17%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +GV      K T E+VA+K IE  DK        REI   +  +H NI+     I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN-I 77
Query: 89  LTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
             P       E     EL +    R+ +    S+D  ++F  Q +  V   H   V HRD
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 145 LKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKS-------TVGTPAYIAPEVLL 193
           LK  N L++ +    LK+CDFG ++    S+  +S+P          V T  Y APEV+L
Sbjct: 138 LKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVML 195
Query: 194 RHEYDGKIADVWSCGVTL------------------YVMLVG--GYPFEDPD----EPKD 229
                 +  DVWSCG  L                   +++ G  G P  D D    E   
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 230 FRKTIQRI-----LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            R+ I+ +       ++   P  NP   +  DL+ R+ V DPA RIT  E ++H + 
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNP---KGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 126/297 (42%), Gaps = 52/297 (17%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +GV      K T E+VA+K IE  DK        REI   +  +H NI+     I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN-I 77
Query: 89  LTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
             P       E     EL +    R+ +    S+D  ++F  Q +  V   H   V HRD
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 145 LKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKST-------VGTPAYIAPEVLL 193
           LK  N L++ +    LK+CDFG ++    S+  +S+P          V T  Y APEV+L
Sbjct: 138 LKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVML 195
Query: 194 RHEYDGKIADVWSCGVTL------------------YVMLVG--GYPFEDPD----EPKD 229
                 +  DVWSCG  L                   +++ G  G P  D D    E   
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 230 FRKTIQRI-----LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            R+ I+ +       ++   P  NP   +  DL+ R+ V DPA RIT  E ++H + 
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNP---KGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 87/297 (29%), Positives = 126/297 (42%), Gaps = 52/297 (17%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +GV      K T E+VA+K IE  DK        REI   +  +H NI+     I
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN-I 77
Query: 89  LTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
             P       E     EL +    R+ +    S+D  ++F  Q +  V   H   V HRD
Sbjct: 78  QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 145 LKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKST-------VGTPAYIAPEVLL 193
           LK  N L++ +    LK+CDFG ++    S+  +S+P          V T  Y APEV+L
Sbjct: 138 LKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVML 195
Query: 194 RHEYDGKIADVWSCGVTL------------------YVMLVG--GYPFEDPD----EPKD 229
                 +  DVWSCG  L                   +++ G  G P  D D    E   
Sbjct: 196 TSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPR 255
Query: 230 FRKTIQRI-----LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            R+ I+ +       ++   P  NP   +  DL+ R+ V DPA RIT  E ++H + 
Sbjct: 256 AREYIKSLPMYPAAPLEKMFPRVNP---KGIDLLQRMLVFDPAKRITAKEALEHPYL 309

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/309 (25%), Positives = 134/309 (43%), Gaps = 58/309 (18%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSL 76
           M  S ++  +  +G+G +       +K T   VA+K +  +  +       REI   + L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-----RICNAGRFSE-DEARFFFQQLIS 130
           +H NIVR  +VI T   L +V E+    +L +      + N  R  E +  ++F  QL+ 
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAP 189
           G+++CH  ++ HRDLK +N L++     +LK+ DFG +++  +  +   S V T  Y AP
Sbjct: 120 GLAFCHENKILHRDLKPQNLLIN--KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFE------- 222
           +VL+         D+WSCG  L  M+ G                    G P E       
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237
Query: 223 -----DPD----EPKDFRKTIQRILSVQYSVPDTN-PISQECRDLISRIFVADPAARITI 272
                +P+     P+D R+ +Q         P T  P+     D +  +   +P  R++ 
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQ---------PHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 273 PEIMKHQWF 281
            + + H WF
Sbjct: 289 KQALHHPWF 297

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH---- 78
           D ++ + ++G+GN GV   ++ + +  ++A K I    +I   ++ +II    + H    
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 73
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HA 137
           P IV F     +   ++I ME+  GG L + +  A R  E+        ++ G++Y    
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            Q+ HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y+APE L    Y
Sbjct: 134 HQIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQLIDSMANSFVGTRSYMAPERLQGTHY 190
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPD 225
             + +D+WS G++L  + VG YP   PD
Sbjct: 191 SVQ-SDIWSMGLSLVELAVGRYPIPPPD 217

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G+FG    M+DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H  ++ H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181
Query: 151 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRHEYDGKIADV 204
           LL  S   R  +CDFG++         KS +      GT  ++APEV++    D K+ D+
Sbjct: 182 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 239
Query: 205 WSCGVTLYVMLVGGYPF 221
           WS    +  ML G +P+
Sbjct: 240 WSSCCMMLHMLNGCHPW 256

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G+FG    M+DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H  ++ H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 197
Query: 151 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRHEYDGKIADV 204
           LL  S   R  +CDFG++         KS +      GT  ++APEV++    D K+ D+
Sbjct: 198 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 255
Query: 205 WSCGVTLYVMLVGGYPF 221
           WS    +  ML G +P+
Sbjct: 256 WSSCCMMLHMLNGCHPW 272

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 114/257 (44%), Gaps = 27/257 (10%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G+FG    M DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 156
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
              + I ME   GG L + +   G   ED A ++  Q + G+ Y H+ ++ H D+K +N 
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 151 LL--DGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRHEYDGKIA 202
           LL  DGS A    +CDFG++         KS +      GT  ++APEV+L    D K+ 
Sbjct: 217 LLSSDGSHA---ALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKV- 272
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI- 261
           DVWS    +  ML G +P+      + FR  +   L +    P    I   C  L ++  
Sbjct: 273 DVWSSCCMMLHMLNGCHPWT-----QFFRGPL--CLKIASEPPPVREIPPSCAPLTAQAI 325
Query: 262 ---FVADPAARITIPEI 275
                 +P  R++  E+
Sbjct: 326 QEGLRKEPIHRVSAAEL 342

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
           ++    +G+G FG       + T E VA+K    E   K  E    EI   + L HPN+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 83  RFKEV-----ILTPTHLAIV-MEYASGGEL------FERICNAGRFSEDEARFFFQQLIS 130
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 132
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRL--KICDFGYSKSSVLHSQPKSTVGTPAYIA 188
            + Y H  ++ HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 191
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
           PE+L + +Y   + D WS G   +  + G  PF
Sbjct: 192 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 223

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/197 (30%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G+FG    M+DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV----RLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H  ++ H D+K +N 
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 151 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRHEYDGKIADV 204
           LL  S   R  +CDFG++         KS +      GT  ++APEV++    D K+ D+
Sbjct: 196 LLS-SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV-DI 253
Query: 205 WSCGVTLYVMLVGGYPF 221
           WS    +  ML G +P+
Sbjct: 254 WSSCCMMLHMLNGCHPW 270

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIV 82
           ++    +G+G FG       + T E VA+K    E   K  E    EI   + L HPN+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 83  RFKEV-----ILTPTHLAIV-MEYASGGEL------FERICNAGRFSEDEARFFFQQLIS 130
             +EV      L P  L ++ MEY  GG+L      FE  C      E   R     + S
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCG---LKEGPIRTLLSDISS 133
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRL--KICDFGYSKSSVLHSQPKSTVGTPAYIA 188
            + Y H  ++ HRDLK EN +L   P  RL  KI D GY+K           VGT  Y+A
Sbjct: 134 ALRYLHENRIIHRDLKPENIVLQPGPQ-RLIHKIIDLGYAKELDQGELCTEFVGTLQYLA 192
Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
           PE+L + +Y   + D WS G   +  + G  PF
Sbjct: 193 PELLEQKKYTVTV-DYWSFGTLAFECITGFRPF 224

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 46/301 (15%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFKE 86
           +G G FG A  +  + T E++ +K + R    DE  QR  +      R L HPN+++F  
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 87  VILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           V+     L  + EY  GG L   I +   ++   +   F + + SG++Y H+M + HRDL
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPK--------------STVGTPAYIAPE 190
              N L+  +    + + DFG ++  V   +QP+              + VG P ++APE
Sbjct: 135 NSHNCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD---EPKDFRKTIQRILSVQYSVPDT 247
           ++    YD K+ DV+S G+ L  ++  G    DPD      DF   ++  L  +Y  P+ 
Sbjct: 193 MINGRSYDEKV-DVFSFGIVLCEII--GRVNADPDYLPRTMDFGLNVRGFLD-RYCPPNC 248
Query: 248 N----PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPD 303
                PI+  C DL       DP  R   P  +K + +L+ L   L     +  Q E+ D
Sbjct: 249 PPSFFPITVRCCDL-------DPEKR---PSFVKLEHWLETLRMHLAGHLPLGPQLEQLD 298
Query: 304 Q 304
           +
Sbjct: 299 R 299

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 129/270 (47%), Gaps = 30/270 (11%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNI 81
           ++ V ++G G FG     ++K T  L A K IE   K +E ++  I+    L    HP I
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHPYI 70
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
           V+          L I++E+  GG +   +    R  +E + +   +Q++  +++ H+ ++
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 130
Query: 141 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHE- 196
            HRDLK  N L  L+G     +++ DFG S  ++   Q + S +GTP ++APEV++    
Sbjct: 131 IHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 197 ----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----N 248
               YD K AD+WS G+TL  M          + P      ++ +L +  S P T    +
Sbjct: 187 KDTPYDYK-ADIWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSDPPTLLTPS 238
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKH 278
             S E RD +      +P  R +  ++++H
Sbjct: 239 KWSVEFRDFLKIALDKNPETRPSAAQLLEH 268

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 33/281 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           +G G +      + K+T  LVA+K I  E  +       RE+   + L+H NIV   ++I
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 89  LTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVCHRDLKL 147
            T   L +V EY    +L + + + G   +    + F  QL+ G++YCH  +V HRDLK 
Sbjct: 70  HTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKP 128
Query: 148 ENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL-RHEYDGKIADVW 205
           +N L++      LK+ DFG +++  + ++   + V T  Y  P++LL   +Y  +I D+W
Sbjct: 129 QNLLIN--ERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQI-DMW 185
Query: 206 SCGVTLYVMLVGG--YPFEDPDEPKDF---------RKTIQRILSVQ----YSVPDTNP- 249
             G   Y M  G   +P    +E   F          +T   ILS +    Y+ P     
Sbjct: 186 GVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAE 245
Query: 250 --------ISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
                   +  +  DL++++   +   RI+  + MKH +FL
Sbjct: 246 ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 112/257 (43%), Gaps = 27/257 (10%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G+FG    M DK T    AVK +    +++     E++    L  P IV     +  
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV----RLEVFRAEELMACAGLTSPRIVPLYGAVRE 137
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
              + I ME   GG L + +   G   ED A ++  Q + G+ Y H+ ++ H D+K +N 
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 151 LL--DGSPAPRLKICDFGYSKSSVLHSQPKSTV------GTPAYIAPEVLLRHEYDGKIA 202
           LL  DGS A    +CDFG++         K  +      GT  ++APEV+L    D K+ 
Sbjct: 198 LLSSDGSHA---ALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKV- 253
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL----I 258
           DVWS    +  ML G +P+      + FR  +   L +    P    I   C  L    I
Sbjct: 254 DVWSSCCMMLHMLNGCHPWT-----QFFRGPL--CLKIASEPPPVREIPPSCAPLTAQAI 306
Query: 259 SRIFVADPAARITIPEI 275
                 +P  R++  E+
Sbjct: 307 QEGLRKEPIHRVSAAEL 323

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 129/270 (47%), Gaps = 30/270 (11%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNI 81
           ++ V ++G G FG     ++K T  L A K IE   K +E ++  I+    L    HP I
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYIVEIEILATCDHPYI 78
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQV 140
           V+          L I++E+  GG +   +    R  +E + +   +Q++  +++ H+ ++
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 141 CHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLRHE- 196
            HRDLK  N L  L+G     +++ DFG S  ++   Q + S +GTP ++APEV++    
Sbjct: 139 IHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 197 ----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT----N 248
               YD K AD+WS G+TL  M          + P      ++ +L +  S P T    +
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEM-------AQIEPPHHELNPMRVLLKIAKSDPPTLLTPS 246
Query: 249 PISQECRDLISRIFVADPAARITIPEIMKH 278
             S E RD +      +P  R +  ++++H
Sbjct: 247 KWSVEFRDFLKIALDKNPETRPSAAQLLEH 276

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 128/278 (46%), Gaps = 21/278 (7%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE------NVQREIIN 72
           +H  D ++ ++ IG G FG   +++ K   ++ A+K + + + +          +R+++ 
Sbjct: 71  LHRED-FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISG 131
           +   +   I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  
Sbjct: 130 NGDSKW--ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA 187
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAP 189
           +   H +   HRD+K +N L+D +   RL   DFG     +     +S+  VGTP YI+P
Sbjct: 188 IDSVHQLHYVHRDIKPDNILMDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISP 245
Query: 190 EVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
           E+L   E      G   D WS GV +Y ML G  PF      + + K +      Q+   
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQ 305
Query: 246 DTNPISQECRDLISRIFVADP--AARITIPEIMKHQWF 281
            T+ +S+  +DLI R+  +      +  I +  KH +F
Sbjct: 306 VTD-VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 130/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + +G        RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVRL 78
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------- 239
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L            
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 240 ---VQYSVPD--TNPISQ--------ECRDLISRIFVADPAARITIPEIMKHQWF 281
               +++ P    +P ++        E   L SR+    P AR+T  E   H +F
Sbjct: 252 PNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 116/255 (45%), Gaps = 24/255 (9%)
Query: 29  RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNI 81
           + IG G F     A  + D V    VA+K ++  D +D   + + I      + L HPN+
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVP---VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHA 137
           +++    +    L IV+E A  G+L   I +  +      E     +F QL S + + H+
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 138 MQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            +V HRD+K  N  +  +   +   L +  F  SK++  H    S VGTP Y++PE +  
Sbjct: 155 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTPYYMSPERIHE 210
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
           + Y+ K +D+WS G  LY M     PF    +  +     ++I    Y    ++  S+E 
Sbjct: 211 NGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 255 RDLISRIFVADPAAR 269
           R L++     DP  R
Sbjct: 268 RQLVNMCINPDPEKR 282

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 128/295 (43%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + +G        RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVRL 78
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLVG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS GV +  M+ GG  F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                         S +   PD         N + + + RDL+S++ V D + RI++ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 276 MKH 278
           ++H
Sbjct: 316 LQH 318

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 118/277 (42%), Gaps = 26/277 (9%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHP 79
           D+  Y F++ +G G F    L+         A+K I   ++ D E  QRE   HR   HP
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86
Query: 80  NIVRFKEVIL---TPTHLA-IVMEYASGGELF---ERICNAGRF-SEDEARFFFQQLISG 131
           NI+R     L      H A +++ +   G L+   ER+ + G F +ED+  +    +  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---------- 181
           +   HA    HRDLK  N LL     P L   D G    + +H +               
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLM--DLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 182 GTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
            T +Y APE+  +  H    +  DVWS G  LY M+ G  P++   +  D   ++   + 
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQ 261
Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 276
            Q S+P +   S     L++ +   DP  R  IP ++
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 82  VRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT        ++ +  G +L+ ++      S D   +F  Q++ G+ Y H+
Sbjct: 104 IGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 163 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 127/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI 197
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+ GG  F   D    + K I+++               
Sbjct: 198 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 277 KHQW 280
           +H +
Sbjct: 317 QHPY 320

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 42/292 (14%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + +G        RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK---NRELQIMRKLDHCNIVRL 78
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSED----EARFFFQQLISGVSY 134
           +    +        +L +V++Y     ++    +  R  +       + +  QL   ++Y
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVPA-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 193
            H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE++  
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFG 196
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-------------- 239
             +Y   I DVWS G  L  +L+G  P    D   D    I ++L               
Sbjct: 197 ATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 240 VQYSVPD--TNPISQ--------ECRDLISRIFVADPAARITIPEIMKHQWF 281
            +++ P    +P ++        E   L SR+    P AR+T  E   H +F
Sbjct: 255 TEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 127/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 86  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 140
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+ GG  F   D    + K I+++               
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 277 KHQW 280
           +H +
Sbjct: 318 QHPY 321

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 89/319 (27%), Positives = 137/319 (42%), Gaps = 48/319 (15%)
Query: 1   MKMDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD 60
           M + + +  V      P       Y   + IG+G+FGV    +   + ELVA+K + + D
Sbjct: 3   MSLSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-D 61
Query: 61  KIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERICNAG 114
           K  +N  RE+   R L H NIVR +    +        +L +V++Y    E   R+  A 
Sbjct: 62  KRFKN--RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--AR 115
Query: 115 RFSEDE-------ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167
            +S  +        + +  QL   ++Y H+  +CHRD+K +N LLD   A  LK+CDFG 
Sbjct: 116 HYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGS 174
Query: 168 SKSSVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
           +K  V      S + +  Y APE++    +Y   I DVWS G  L  +L+G  P    D 
Sbjct: 175 AKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDS 232
Query: 227 PKDFRKTIQRILS--VQYSVPDTNPISQECR----------------------DLISRIF 262
             D    I ++L    +  + + NP   E +                       L SR+ 
Sbjct: 233 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 292
Query: 263 VADPAARITIPEIMKHQWF 281
              P AR+T  E   H +F
Sbjct: 293 EYTPTARLTPLEACAHSFF 311

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 127/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+ GG  F   D    + K I+++               
Sbjct: 198 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 277 KHQW 280
           +H +
Sbjct: 317 QHPY 320

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 127/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+ GG  F   D    + K I+++               
Sbjct: 198 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 277 KHQW 280
           +H +
Sbjct: 317 QHPY 320

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 132/303 (43%), Gaps = 57/303 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLVG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS GV +  M+ GG  F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                         S +   PD         N + + + RDL+S++ V D + RI++ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 276 MKH 278
           ++H
Sbjct: 316 LQH 318

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 82
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 83  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 139 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 197
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 198 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 255
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 256 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 310

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 79
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 80  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 136 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 194
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 195 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 252
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 253 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 307

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 78
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDVVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 78
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 78
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 193
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 97
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 98  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 154 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 212
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 213 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 270
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 271 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 325

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 90
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 206 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 263
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 264 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 90
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 91  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 147 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 205
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 206 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 263
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 264 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 318

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 86
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 87  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 143 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 201
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 202 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 259
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 260 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 314

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 112
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSXICSRYYRAPEL 227
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+ G P    D   D    I ++L    +  + + N
Sbjct: 228 IFGATDYTSSI-DVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 55/305 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 27  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 86
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 87  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 141
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 142 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI 199
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+ GG  F   D    + K I+++               
Sbjct: 200 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 258
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 259 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 318
Query: 277 KHQWF 281
           +H + 
Sbjct: 319 QHPYI 323

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 106
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 163 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 221
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 222 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 279
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 280 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 334

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 157
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 214 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 272
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+ G P    D   D    I ++L    +  + + N
Sbjct: 273 IFGATDYTSSI-DVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 330
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 331 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 385

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 91
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 92  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 148 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 206
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 207 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 264
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 265 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 319

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 78
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 79  RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 193
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+G  P    D   D    I ++L    +  + + N
Sbjct: 194 IFGATDYTSSI-DVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 116
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 173 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 231
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+ G P    D   D    I ++L    +  + + N
Sbjct: 232 IFGATDYTSSI-DVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 289
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 290 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 344

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 114
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 171 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 229
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+ G P    D   D    I ++L    +  + + N
Sbjct: 230 IFGATDYTSSI-DVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 287
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 288 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 342

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 48/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV    +   + ELVA+K + + DK  +N  RE+   R L H NIVR 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKN--RELQIMRKLDHCNIVRL 112
Query: 85  KEVILTP------THLAIVMEYASGGELFERICNAGRFSEDE-------ARFFFQQLISG 131
           +    +        +L +V++Y    E   R+  A  +S  +        + +  QL   
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVP--ETVYRV--ARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K  V      S + +  Y APE+
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPEL 227
Query: 192 LL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSVPDTN 248
           +    +Y   I DVWS G  L  +L+ G P    D   D    I ++L    +  + + N
Sbjct: 228 IFGATDYTSSI-DVWSAGCVLAELLL-GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 249 PISQECR----------------------DLISRIFVADPAARITIPEIMKHQWF 281
           P   E +                       L SR+    P AR+T  E   H +F
Sbjct: 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 46/297 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  ++ IG G +G+     D V K  VA+K I         +   REI      RH N+
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENV 103
Query: 82  VRFKEVILTPTHLAI----VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +  ++++   T  A+    +++     +L+ ++  + + S D   +F  Q++ G+ Y H+
Sbjct: 104 IGIRDILRASTLEAMRDVYIVQDLMETDLY-KLLKSQQLSNDHICYFLYQILRGLKYIHS 162
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N L++ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 163 ANVLHRDLKPSNLLINTTCD--LKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------- 240
             +   K  D+WS G  L  ML     F      K +   +  IL +             
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPG----KHYLDQLNHILGILGSPSQEDLNCII 276
Query: 241 -------QYSVPDTNPIS---------QECRDLISRIFVADPAARITIPEIMKHQWF 281
                    S+P    ++          +  DL+ R+   +P  RIT+ E + H + 
Sbjct: 277 NMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYL 333

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 31/283 (10%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIVR 83
           ++ V  +G+G +G     R   T +L A+K ++     +E +++EI +  +   H NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 84  FKEVILTPT------HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYC 135
           +    +          L +VME+   G + + I N       E+   +  ++++ G+S+ 
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLR 194
           H  +V HRD+K +N LL  +    +K+ DFG S         ++T +GTP ++APEV+  
Sbjct: 146 HQHKVIHRDIKGQNVLL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 195 HE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF----RKTIQRILSVQYSVP 245
            E     YD K +D+WS G+T   M  G  P  D    +      R    R+ S ++   
Sbjct: 204 DENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW--- 259
Query: 246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
                S++ +  I    V + + R    ++MKH  F+++ P +
Sbjct: 260 -----SKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQPNE 296

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 130/304 (42%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLA------IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV 132
           I+    V      L       IVME   A+  ++ +   +  R S     +   Q++ G+
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLCGI 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+ GG  F   D    + K I+++               
Sbjct: 198 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 277 KHQW 280
           +H +
Sbjct: 317 QHPY 320

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 132/305 (43%), Gaps = 57/305 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLCG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  M+ GG  F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                         S +   PD         N + + + RDL+S++ V D + RI++ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 276 MKHQW 280
           ++H +
Sbjct: 316 LQHPY 320

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/303 (25%), Positives = 131/303 (43%), Gaps = 57/303 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKN 84
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + IVME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IIGLLNV-FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLVG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDAT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  M+ GG  F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPT 255
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                         S +   PD         N + + + RDL+S++ V D + RI++ E 
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 276 MKH 278
           ++H
Sbjct: 316 LQH 318

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 30/285 (10%)
Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDEN--- 65
           P   +P + D++  ++ + IG G FG+    RL++D   K +VA+K +  GD   E    
Sbjct: 9   PKSRLPTLADNE-IEYEKQIGKGGFGLVHKGRLVKD---KSVVAIKSLILGDSEGETEMI 64
Query: 66  -----VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 120
                 QRE+    +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 121 ARFFFQQLIS-GVSYCHAMQ--VCHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLH 174
            +      I+ G+ Y       + HRDL+  N     LD +     K+ DFG S+ SV H
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV-H 181
Query: 175 SQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
           S     +G   ++APE +   E  Y  K AD +S  + LY +L G  PF++    K    
Sbjct: 182 SV-SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            + R   ++ ++P+  P     R++I   +  DP  R     I+K
Sbjct: 240 NMIREEGLRPTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 7   SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV 66
           SL    A D     + DR+   R  G G FG  +L ++K T   VA+K + +  +   N 
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNR 65
Query: 67  QREIINHRS-LRHPNIVRFKEVILT-------PTHLAIVMEYASGGELFERICNAGRFSE 118
           + +I+   + L HPNIV+ +    T         +L +VMEY    +   R C    +  
Sbjct: 66  ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP--DTLHRCCR-NYYRR 122
Query: 119 DEA------RFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
             A      + F  QLI  +   H  ++ VCHRD+K  N L++ +    LK+CDFG +K 
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKK 181
Query: 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
                   + + +  Y APE++  +++     D+WS G     M++G
Sbjct: 182 LSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 10/201 (4%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
            ++++GSG FGV +L + K   + VAVK I+ G   ++   +E      L HP +V+F  
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF-FFQQLISGVSYCHAMQVCHRDL 145
           V      + IV EY S G L   + + G+  E          +  G+++  + Q  HRDL
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDL 130
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
              N L+D      +K+ DFG ++  VL  Q  S+VGT     + APEV    +Y  K +
Sbjct: 131 AARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK-S 186
Query: 203 DVWSCGVTLY-VMLVGGYPFE 222
           DVW+ G+ ++ V  +G  P++
Sbjct: 187 DVWAFGILMWEVFSLGKMPYD 207

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 145 ANVLHRDLKPSNLLLNTTSD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 80/285 (28%), Positives = 132/285 (46%), Gaps = 30/285 (10%)
Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDEN--- 65
           P   +P + D++  ++ + IG G FG+    RL++D   K +VA+K +  GD   E    
Sbjct: 9   PKSRLPTLADNE-IEYEKQIGKGGFGLVHKGRLVKD---KSVVAIKSLILGDSEGETEMI 64
Query: 66  -----VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 120
                 QRE+    +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 121 ARFFFQQLIS-GVSYCHAMQ--VCHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLH 174
            +      I+ G+ Y       + HRDL+  N     LD +     K+ DFG S+ SV H
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSV-H 181
Query: 175 SQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
           S     +G   ++APE +   E  Y  K AD +S  + LY +L G  PF++    K    
Sbjct: 182 SV-SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            + R   ++ ++P+  P     R++I   +  DP  R     I+K
Sbjct: 240 NMIREEGLRPTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 78/322 (24%), Positives = 131/322 (40%), Gaps = 59/322 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  +   +AVK + R  +     +   RE+   + ++H 
Sbjct: 51  ERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 110
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V    T L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 111 NVIGLLDVFTPATSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 169
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 170 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 223
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
           L   +     D+WS G  +  +L G   F   D     ++ ++   +   SV    P S 
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMP-SH 282
Query: 253 ECR--------------------------DLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           E R                          DL+ ++ V D   RIT  E + H +F     
Sbjct: 283 EARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYF----- 337
Query: 287 ADLVDEKTMSSQYEEPDQPMQS 308
                     SQY +PD   +S
Sbjct: 338 ----------SQYHDPDDEPES 349

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 45/297 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VAVK + R  +   + +R   E++  + + H N
Sbjct: 23  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 82
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C       D  R  +   Q++ G+ + H+
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+L   Y
Sbjct: 143 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGY 200
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  ++ G   F+  D    + K I+++                    
Sbjct: 201 KENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 238 -------LSVQYSVPDT---------NPISQECRDLISRIFVADPAARITIPEIMKH 278
                  ++ +   PD             + + RDL+S++ V DP  RI++ E ++H
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRH 316

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 130/304 (42%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLA------IVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGV 132
           I+    V      L       IVME   A+  ++ +   +  R S     +   Q++ G+
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS-----YLLYQMLCGI 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+ GG  F   D    + K I+++               
Sbjct: 198 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 277 KHQW 280
           +H +
Sbjct: 317 QHPY 320

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 123/293 (41%), Gaps = 44/293 (15%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNI 81
           Y  ++ +GSG +G      D  T   VA+K + R    +   +   RE+   + +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 82  VRFKEVILTP-------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           +   +V  TP       T   +VM +   G    ++    +  ED  +F   Q++ G+ Y
Sbjct: 87  IGLLDV-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            HA  + HRDLK  N  ++      LKI DFG ++ +   S+    V T  Y APEV+L 
Sbjct: 144 IHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQA--DSEMXGXVVTRWYRAPEVILN 199
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFE--------------------------DPDEPK 228
                +  D+WS G  +  M+ G   F+                            DE K
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259
Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
           ++ K +  +    ++   TN  S    +L+ ++ V D   R+T  E + H +F
Sbjct: 260 NYMKGLPELEKKDFASILTNA-SPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 123/297 (41%), Gaps = 45/297 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VAVK + R  +   + +R   E++  + + H N
Sbjct: 25  RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 84
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C       D  R  +   Q++ G+ + H+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS 144
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++  +      V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY 202
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  ++ G   F+  D    + K I+++                    
Sbjct: 203 AANV-DIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 238 -------LSVQYSVPDT---------NPISQECRDLISRIFVADPAARITIPEIMKH 278
                  +  +   PD             + + RDL+S++ V DP  RI++ E ++H
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRH 318

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 93/202 (46%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI    + RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENI 85
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 145 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENI 87
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 117/242 (48%), Gaps = 22/242 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEV 87
           +GSG +G      DK + E VA+K + R    +   +   RE++  + ++H N++   +V
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 88  ILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
               + L       +VM +       ++I    +FSE++ ++   Q++ G+ Y H+  V 
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQMLKGLKYIHSAGVV 148
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK  N  ++      LKI DFG ++ +   ++    V T  Y APEV+L   +  + 
Sbjct: 149 HRDLKPGNLAVNED--CELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            D+WS G  +  ML G   F+     KD+   + +IL V   VP T  + Q+  D  ++ 
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVT-GVPGTEFV-QKLNDKAAKS 258
Query: 262 FV 263
           ++
Sbjct: 259 YI 260

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCAKLTDDHVQFLIYQILRGLKY 136
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 304
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 305 ------------AQYHDPD 311

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 85
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 86  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 145 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 203 NSKGYTKSIDIWSVGCILAEML 224

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 91
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 92  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 151 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 209 NSKGYTKSIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 143 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 103
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 104 IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 163 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 221 NSKGYTKSIDIWSVGCILAEML 242

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 45/297 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 203 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKH 278
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 318

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 49/295 (16%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           Y   + IG+G+FGV       V  + VA+K + + DK  +N  RE+   R ++HPN+V  
Sbjct: 42  YTNCKVIGNGSFGVV-FQAKLVESDEVAIKKVLQ-DKRFKN--RELQIMRIVKHPNVVDL 97
Query: 85  KEVILT------PTHLAIVMEYASGGELFERICNAGRFSEDEA--------RFFFQQLIS 130
           K    +         L +V+EY       E +  A R              + +  QL+ 
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
            ++Y H++ +CHRD+K +N LLD  P+  LK+ DFG +K  +      S + +  Y APE
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLD-PPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPE 211
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS----------- 239
           ++          D+WS G  +   L+ G P    +   D    I ++L            
Sbjct: 212 LIFGATNYTTNIDIWSTGCVM-AELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270
Query: 240 ---VQYSVPDT--NPISQECR--------DLISRIFVADPAARITIPEIMKHQWF 281
              +++  P    +P S+  R        DLISR+    P+AR+T  E + H +F
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/242 (27%), Positives = 116/242 (47%), Gaps = 22/242 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHPNIVRFKEV 87
           +GSG +G      DK + E VA+K + R    +   +   RE++  + ++H N++   +V
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 88  ILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
               + L       +VM +       ++I     FSE++ ++   Q++ G+ Y H+  V 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQMLKGLKYIHSAGVV 166
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK  N  ++      LKI DFG ++ +   ++    V T  Y APEV+L   +  + 
Sbjct: 167 HRDLKPGNLAVNED--CELKILDFGLARHA--DAEMTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
            D+WS G  +  ML G   F+     KD+   + +IL V   VP T  + Q+  D  ++ 
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQILKVT-GVPGTEFV-QKLNDKAAKS 276
Query: 262 FV 263
           ++
Sbjct: 277 YI 278

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 21/263 (7%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV------QREIINHRSL 76
           D ++ ++ IG G F    +++ K T ++ A+K + + D +          +R+++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 135
           R   I +         +L +VMEY  GG+L   +   G R   + ARF+  +++  +   
Sbjct: 121 RW--ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS--TVGTPAYIAPEVL- 192
           H +   HRD+K +N LLD      +++ DFG           +S   VGTP Y++PE+L 
Sbjct: 179 HRLGYVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 193 -----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
                      G   D W+ GV  Y M  G  PF      + + K +     +   + D 
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDE 296
Query: 248 NPISQECRDLISRIFVADPAARI 270
             + +E RD I R+ +  P  R+
Sbjct: 297 G-VPEEARDFIQRL-LCPPETRL 317

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D     FV++IGSG FG+  L    + K+ VA+K I  G   +E+   E      L HP 
Sbjct: 5   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 63
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y     
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
           V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV     
Sbjct: 124 VIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 181 YSSK-SDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 147 ANVLHRDLKPSNLLLNTTXD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 145
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 146 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 204 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMXGXVATRWYRAPEIMLN 216
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 217 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 276
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 277 NYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 328
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 329 ----------AQYHDPD 335

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 139 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 197 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 145
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 146 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 203
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 204 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 262
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 263 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 321

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 203 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 183 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 241 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 261 ARNYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 314
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 315 ------------AQYHDPD 321

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 206 NSKGYTKSIDIWSVGCILAEML 227

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 24  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 143
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 144 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 201
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 202 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 319

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 30/285 (10%)
Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDEN--- 65
           P   +P + D++  ++ + IG G FG+    RL++D   K +VA+K +  GD   E    
Sbjct: 9   PKSRLPTLADNE-IEYEKQIGKGGFGLVHKGRLVKD---KSVVAIKSLILGDSEGETEMI 64
Query: 66  -----VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 120
                 QRE+    +L HPNIV+   ++  P  +  VME+   G+L+ R+ +     +  
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 121 ARFFFQQLIS-GVSYCHAMQ--VCHRDLKLENTL---LDGSPAPRLKICDFGYSKSSVLH 174
            +      I+ G+ Y       + HRDL+  N     LD +     K+ DF  S+ SV H
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSV-H 181
Query: 175 SQPKSTVGTPAYIAPEVLLRHE--YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
           S     +G   ++APE +   E  Y  K AD +S  + LY +L G  PF++    K    
Sbjct: 182 SV-SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFI 239
Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            + R   ++ ++P+  P     R++I   +  DP  R     I+K
Sbjct: 240 NMIREEGLRPTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYIVK 282

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 275 ARNYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 328
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 329 ------------AQYHDPD 335

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 138 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 196 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 145 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 203 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 139 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 196
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 197 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 314

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  IGSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNED--XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 313
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 314 ------------AQYHDPD 320

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 304
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 305 ------------AQYHDPD 311

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 274 ARNYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 327
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 328 ------------AQYHDPD 334

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREII 71
           P   + ++ D     FV++IGSG FG+  L    + K+ VA+K I+ G   +++   E  
Sbjct: 16  PRGSLHMVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIKEGSMSEDDFIEEAE 74
Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLIS 130
               L HP +V+   V L    + +V E+   G L + +    G F+ +        +  
Sbjct: 75  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 134
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYI 187
           G++Y     V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + 
Sbjct: 135 GMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWA 191
Query: 188 APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +PEV     Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 192 SPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 199 NSKGYTKSIDIWSVGCILAEML 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 45/299 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FFFQQLISGVSYCHA 137
           I+    V      L    +     EL +  +C   +   D  R  +   Q++ G+ + H+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 182
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L   Y
Sbjct: 183 AGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 240
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------------- 237
              + D+WS G  +  M+     F   D    + K I+++                    
Sbjct: 241 KENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 238 -------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIMKHQW 280
                  L+     PD+        N + + + RDL+S++ V DPA RI++ + ++H +
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 358

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 82  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 141 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 199 NSKGYTKSIDIWSVGCILAEML 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSN--LAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 310
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 311 ------------AQYHDPD 317

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 314
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 315 ------------AQYHDPD 321

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 32  ERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 91
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 92  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 150
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 151 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 204
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 264
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 265 ARNYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 318
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 319 ------------AQYHDPD 325

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 88
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 89  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 148 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 206 NSKGYTKSIDIWSVGCILAEML 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 89
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 90  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 149 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 207 NSKGYTKSIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 80
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 81  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 140 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 198 NSKGYTKSIDIWSVGCILAEML 219

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA+K I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 148 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 315
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 316 ----------AQYHDPD 322

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 137 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 192
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 253 NYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 304
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 305 ----------AQYHDPD 311

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 308
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 309 ----------AQYHDPD 315

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 148 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 315
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 316 ----------AQYHDPD 322

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  ++      LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 141 IHSADIIHRDLKPSNLAVNED--CELKILDFGLARHT--DDEMAGFVATRWYRAPEIMLN 196
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 257 NYIQSLAQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 308
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 309 ----------AQYHDPD 315

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 43/293 (14%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL- 89
           +G G FG     R+ +     A+K I   ++    +  E++   SL H  +VR+    L 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 90  ------------TPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVSYCH 136
                         + L I MEY   G L++ I +     + DE    F+Q++  +SY H
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------VLHSQP--------KSTV 181
           +  + HRDLK  N  +D S    +KI DFG +K+         L SQ          S +
Sbjct: 134 SQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 182 GTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
           GT  Y+A EVL     Y+ KI D++S G+  + M+   YPF    E  +  K + R +S+
Sbjct: 192 GTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEMI---YPFSTGMERVNILKKL-RSVSI 246
Query: 241 QYSVPDTNPISQECRDLISRIFV-ADPAARITIPEIMKHQWFLKNLPADLVDE 292
           ++  PD +    +    I R+ +  DP  R     ++   W    LP    DE
Sbjct: 247 EFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW----LPVKHQDE 294

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D     FV++IGSG FG+  L    + K+ VA+K I  G   +E+   E      L HP 
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
           V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV     
Sbjct: 122 VIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 179 YSSK-SDVWSFGVLMWEVFSEGKIPYEN 205

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I  + + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKSQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG  +    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D     FV++IGSG FG+  L    + K+ VA+K I  G   +E+   E      L HP 
Sbjct: 5   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 63
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y     
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
           V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV     
Sbjct: 124 VIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSR 180
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 181 YSSK-SDVWSFGVLMWEVFSEGKIPYEN 207

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 20/268 (7%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           R +G G FG     + + T ++ A K +E+        +   +N + +      RF   +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 89  L----TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
                T   L +V+   +GG+L   I + G+  F E  A F+  ++  G+   H  ++ +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     
Sbjct: 310 RDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-P 366
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISR 260
           D W+ G  LY M+ G  PF+   + K  R+ ++R++     VP+  +   S + R L S+
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQ 422
Query: 261 IFVADPAARI-----TIPEIMKHQWFLK 283
           +   DPA R+     +  E+ +H  F K
Sbjct: 423 LLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 148 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIMLN 203
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 264 NYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 315
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 316 ----------AQYHDPD 322

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 77/329 (23%), Positives = 140/329 (42%), Gaps = 54/329 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F + 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYFAQY 311
Query: 285 LPADLVDEKTMSSQYEEPDQPMQSVDVIM 313
              D  DE     Q    DQ  +S D+++
Sbjct: 312 HDPD--DEPVADPQ----DQSFESRDLLI 334

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 20/268 (7%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI 88
           R +G G FG     + + T ++ A K +E+        +   +N + +      RF   +
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 89  L----TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
                T   L +V+   +GG+L   I + G+  F E  A F+  ++  G+   H  ++ +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIA 202
           RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+    Y     
Sbjct: 310 RDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-P 366
Query: 203 DVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLISR 260
           D W+ G  LY M+ G  PF+   + K  R+ ++R++     VP+  +   S + R L S+
Sbjct: 367 DWWALGCLLYEMIAGQSPFQQ-RKKKIKREEVERLVK---EVPEEYSERFSPQARSLCSQ 422
Query: 261 IFVADPAARI-----TIPEIMKHQWFLK 283
           +   DPA R+     +  E+ +H  F K
Sbjct: 423 LLCKDPAERLGCRGGSAREVKEHPLFKK 450

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSN--LAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 266 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 319
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 320 ------------AQYHDPD 326

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSNLAVNED--XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 313
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 314 ------------AQYHDPD 320

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHT--DDEMTGXVATRWYRAPEIMLN 196
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 197 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 256
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 257 NYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 308
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 309 ----------AQYHDPD 315

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 137 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 190
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 304
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 305 ------------AQYHDPD 311

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 313
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 314 ------------AQYHDPD 320

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 7   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +A R    +   +  Q+
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQI 126
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 183
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 184 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 231

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D     FV++IGSG FG+  L    + K+ VA+K I  G   +E+   E      L HP 
Sbjct: 8   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 66
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y     
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
           V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV     
Sbjct: 127 VIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSR 183
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 184 YSSK-SDVWSFGVLMWEVFSEGKIPYEN 210

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/315 (22%), Positives = 130/315 (41%), Gaps = 52/315 (16%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPN 80
           R   +R +GSG +G      D   ++ VAVK + R  +         RE+   + L+H N
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 81  IVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           ++   +V    T +     + +     G     I  +   S++  +F   QL+ G+ Y H
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L   
Sbjct: 149 SAGIIHRDLKPSNVAVNED--SELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNWM 204
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----------LSVQYS--- 243
           +  +  D+WS G  +  +L G   F   D     ++ ++ +          +S +++   
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 244 VPDTNPISQE------------CRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           +    P+ Q+              DL+ R+ V D   R++  E + H +F          
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF---------- 314
Query: 292 EKTMSSQYEEP-DQP 305
                SQY +P D+P
Sbjct: 315 -----SQYHDPEDEP 324

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 314
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 315 ------------AQYHDPD 321

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 305
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 306 ------------AQYHDPD 312

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 20  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 79
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 80  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 138
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 139 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 192
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 253 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 306
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 307 ------------AQYHDPD 313

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 320
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 321 ------------AQYHDPD 327

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 33  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 92
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 93  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 151
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 152 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 205
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 265
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 266 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 319
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 320 ------------AQYHDPD 326

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 320
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 321 ------------AQYHDPD 327

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 42  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 101
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 102 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 160
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 161 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 214
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 274
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 275 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 328
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 329 ------------AQYHDPD 335

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 164 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 217
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 277
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 278 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 331
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 332 ------------AQYHDPD 338

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 86/308 (27%), Positives = 125/308 (40%), Gaps = 45/308 (14%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIV 82
           RY  ++ +G G  G+     D    + VA+K I   D +  ++  REI   R L H NIV
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIV 71
Query: 83  RFKEVILTPTHLAIVMEYASGGEL-------------FERICNAGRFSEDEARFFFQQLI 129
           +  E IL P+   +  +  S  EL                +   G   E+ AR F  QL+
Sbjct: 72  KVFE-ILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG----TPA 185
            G+ Y H+  V HRDLK  N  ++      LKI DFG ++    H   K  +     T  
Sbjct: 131 RGLKYIHSANVLHRDLKPANLFINTEDL-VLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI----------- 234
           Y +P +LL      K  D+W+ G     ML G   F    E +  +  +           
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDR 249
Query: 235 QRILSV--QYSVPD-TNP----------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
           Q +LSV   Y   D T P          IS+E  D + +I    P  R+T  E + H + 
Sbjct: 250 QELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYM 309
Query: 282 -LKNLPAD 288
            + + P D
Sbjct: 310 SIYSFPMD 317

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 10/208 (4%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D     FV++IGSG FG+  L    + K+ VA+K I  G   +E+   E      L HP 
Sbjct: 6   DPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 64
Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V L    + +V E+   G L + +    G F+ +        +  G++Y     
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
           V HRDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT     + +PEV     
Sbjct: 125 VIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSR 181
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           Y  K +DVWS GV ++ V   G  P+E+
Sbjct: 182 YSSK-SDVWSFGVLMWEVFSEGKIPYEN 208

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 310
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 311 ------------AQYHDPD 317

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 29  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 147
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 148 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 201
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 315
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 316 ------------AQYHDPD 322

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 310
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 311 ------------AQYHDPD 317

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 19  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 78
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 79  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 137
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 138 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 191
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 305
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 306 ------------AQYHDPD 312

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 41  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 100
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 101 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 159
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 160 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 213
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 273
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 274 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 327
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 328 ------------AQYHDPD 334

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKXQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 27  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 86
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 87  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 145
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 146 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 199
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 259
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 260 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 313
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 314 ------------AQYHDPD 320

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 21  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 80
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 81  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 139
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 140 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 193
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 253
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 254 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 307
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 308 ------------AQYHDPD 314

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 24  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 83
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 84  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 142
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  ++      LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 143 IHSADIIHRDLKPSNLAVNED--CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 196
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 256
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 257 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 310
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 311 ------------AQYHDPD 317

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 28  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 87
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 88  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 146
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 147 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 200
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 260
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 261 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 314
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 315 ------------AQYHDPD 321

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/317 (22%), Positives = 131/317 (41%), Gaps = 59/317 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 45  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 104
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 105 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 163
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
            H+  + HRDLK  N  L  +    LKI DFG ++ +    +    V T  Y APE++L 
Sbjct: 164 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLARHT--DDEMXGYVATRWYRAPEIMLN 219
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------PK 228
             +  +  D+WS G  +  +L G   F   D                            +
Sbjct: 220 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 279
Query: 229 DFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F     
Sbjct: 280 NYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF----- 331
Query: 287 ADLVDEKTMSSQYEEPD 303
                     +QY +PD
Sbjct: 332 ----------AQYHDPD 338

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D + K  VA++ I         +   REI      RH NI
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENI 87
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 88  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKICDFG ++ +   H         V T  Y APE++L
Sbjct: 147 ANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 205 NSKGYTKSIDIWSVGCILAEML 226

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/315 (22%), Positives = 129/315 (40%), Gaps = 52/315 (16%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPN 80
           R   +R +GSG +G      D   ++ VAVK + R  +         RE+   + L+H N
Sbjct: 29  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 88
Query: 81  IVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           ++   +V    T +     + +     G     I      S++  +F   QL+ G+ Y H
Sbjct: 89  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L   
Sbjct: 149 SAGIIHRDLKPSNVAVNED--SELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNWM 204
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----------LSVQYS--- 243
           +  +  D+WS G  +  +L G   F   D     ++ ++ +          +S +++   
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 264
Query: 244 VPDTNPISQE------------CRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           +    P+ Q+              DL+ R+ V D   R++  E + H +F          
Sbjct: 265 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF---------- 314
Query: 292 EKTMSSQYEEP-DQP 305
                SQY +P D+P
Sbjct: 315 -----SQYHDPEDEP 324

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 119/249 (47%), Gaps = 20/249 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK ++  D   E  Q    E+   R  RH NI+ F   
Sbjct: 44  IGSGSFGT--VYKGKWHGD-VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
            +T  +LAIV ++  G  L++ +     +F   +     +Q   G+ Y HA  + HRD+K
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK 159
Query: 147 LENTLLDGSPAPRLKICDFGYS--KSSVLHSQP-KSTVGTPAYIAPEVLLRHEYD--GKI 201
             N  L       +KI DFG +  KS    SQ  +   G+  ++APEV+   + +     
Sbjct: 160 SNNIFLH--EGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ 217
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +DV+S G+ LY ++ G  P+   +     R  I  ++   Y+ PD + + + C   + R+
Sbjct: 218 SDVYSYGIVLYELMTGELPYSHINN----RDQIIFMVGRGYASPDLSKLYKNCPKAMKRL 273
Query: 262 FVADPAARI 270
            VAD   ++
Sbjct: 274 -VADCVKKV 281

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+     F   D    + K I+++               
Sbjct: 198 LGMGYKENV-DIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTV 256
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 257 RNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 277 KHQW 280
           +H +
Sbjct: 317 QHPY 320

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 47/297 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYI-----ERGDKIDENVQREIINH-RSL 76
           +Y+ V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 77  RHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLI 129
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
            G+ + H+ +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPFEDPDEPKD 229
           EVLL+  Y   + D+WS G     M                     V G P E+ D P+D
Sbjct: 189 EVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE-DWPRD 246
Query: 230 FRKTIQRILS-----VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                Q   S     ++  V D + +    +DL+ +    +PA RI+    + H +F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELG---KDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 47/297 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYI-----ERGDKIDENVQREIINH-RSL 76
           +Y+ V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 77  RHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLI 129
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
            G+ + H+ +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPFEDPDEPKD 229
           EVLL+  Y   + D+WS G     M                     V G P E+ D P+D
Sbjct: 189 EVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE-DWPRD 246
Query: 230 FRKTIQRILS-----VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                Q   S     ++  V D + +    +DL+ +    +PA RI+    + H +F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELG---KDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 47/297 (15%)
Query: 24  RYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYI-----ERGDKIDENVQREIINH-RSL 76
           +Y+ V +IG G +G     RD K     VA+K +     E G  +    +  ++ H  + 
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 77  RHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLI 129
            HPN+VR  +V         T L +V E+         +++   G  +E      FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
            G+ + H+ +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 188
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML--------------------VGGYPFEDPDEPKD 229
           EVLL+  Y   + D+WS G     M                     V G P E+ D P+D
Sbjct: 189 EVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE-DWPRD 246
Query: 230 FRKTIQRILS-----VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                Q   S     ++  V D + +    +DL+ +    +PA RI+    + H +F
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELG---KDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 12  PAMDMPIMHDSDRY-DFVRDIGSGNFGVARLMR----DKVTKELVAVKYI--ERGDKIDE 64
           PA ++   H   R+   +RD+G G+FG   L R       T E VAVK +  E G     
Sbjct: 9   PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 65  NVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERI-CNAGRFSEDEA 121
           ++++EI   R+L H NIV++K +        + ++ME+   G L E +  N  + +  + 
Sbjct: 69  DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQ 128
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---K 178
             +  Q+  G+ Y  + Q  HRDL   N L++     ++KI DFG +K+     +    K
Sbjct: 129 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEXXTVK 186
Query: 179 STVGTPAY-IAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216
               +P +  APE L++ ++    +DVWS GVTL+ +L 
Sbjct: 187 DDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLT 224

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 126/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 85  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 139
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++      +  V T  Y APEV+
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+     F   D    + K I+++               
Sbjct: 198 LGMGYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 277 KHQW 280
           +H +
Sbjct: 317 QHPY 320

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F+R +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 7   PTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++ME+   G L E +  +  R    +   +  Q+
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQI 126
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 183
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 184 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 231

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI D+G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 133/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + +  +     +   RE+   + ++H 
Sbjct: 34  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHE 93
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 94  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 152
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DFG ++    H+  + T  V T  Y APE++
Sbjct: 153 IHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIM 206
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 266
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 267 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 320
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 321 ------------AQYHDPD 327

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 72/315 (22%), Positives = 129/315 (40%), Gaps = 52/315 (16%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPN 80
           R   +R +GSG +G      D   ++ VAVK + R  +         RE+   + L+H N
Sbjct: 21  RLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHEN 80
Query: 81  IVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           ++   +V    T +     + +     G     I      S++  +F   QL+ G+ Y H
Sbjct: 81  VIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +  + HRDLK  N  ++      L+I DFG ++ +    +    V T  Y APE++L   
Sbjct: 141 SAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DEEMTGYVATRWYRAPEIMLNWM 196
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI----------LSVQYS--- 243
           +  +  D+WS G  +  +L G   F   D     ++ ++ +          +S +++   
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTY 256
Query: 244 VPDTNPISQE------------CRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
           +    P+ Q+              DL+ R+ V D   R++  E + H +F          
Sbjct: 257 IQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYF---------- 306
Query: 292 EKTMSSQYEEP-DQP 305
                SQY +P D+P
Sbjct: 307 -----SQYHDPEDEP 316

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 13/202 (6%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           RY  +  IG G +G+     D V K  VA+K I         +   REI      RH NI
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +   ++I  PT +  + +     +L E    ++      S D   +F  Q++ G+ Y H+
Sbjct: 84  IGINDIIRAPT-IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP---KSTVGTPAYIAPEVLL 193
             V HRDLK  N LL+ +    LKI DFG ++ +   H         V T  Y APE++L
Sbjct: 143 ANVLHRDLKPSNLLLNTTXD--LKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 194 RHEYDGKIADVWSCGVTLYVML 215
             +   K  D+WS G  L  ML
Sbjct: 201 NSKGYTKSIDIWSVGCILAEML 222

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 19  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 79  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 133
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 134 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+     F   D    + K I+++               
Sbjct: 192 LGMGYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 251 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 310
Query: 277 KHQW 280
           +H +
Sbjct: 311 QHPY 314

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/304 (24%), Positives = 125/304 (41%), Gaps = 55/304 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D + +  VA+K + R  +   + +R   E++  + + H N
Sbjct: 30  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 89
Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGV 132
           I+    V      L       IVME          +C   +   D  R  +   Q++ G+
Sbjct: 90  IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGI 144
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 145 KHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI--------------- 237
           L   Y   + D+WS G  +  M+     F   D    + K I+++               
Sbjct: 203 LGMGYKENV-DLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 238 ------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEIM 276
                        S +   PD         N + + + RDL+S++ V D + RI++ E +
Sbjct: 262 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 321
Query: 277 KHQW 280
           +H +
Sbjct: 322 QHPY 325

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 126 QQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
           + +++  SY H    +CHRD+K  N L+D +   R+K+ DFG S+  V   + K + GT 
Sbjct: 158 KSVLNSFSYIHNEKNICHRDVKPSNILMDKNG--RVKLSDFGESEYMV-DKKIKGSRGTY 214
Query: 185 AYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPF---------------EDPDEPK 228
            ++ PE       Y+G   D+WS G+ LYVM     PF               ++ + P 
Sbjct: 215 EFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPL 274
Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
           D R      L+ + S    N +S E  D +      +PA RIT  + +KH+W
Sbjct: 275 D-RNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 130/303 (42%), Gaps = 57/303 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLXG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  M+     F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                        L+     PD+        N + + + RDL+S++ V DPA RI++ + 
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 276 MKH 278
           ++H
Sbjct: 316 LQH 318

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 131/305 (42%), Gaps = 57/305 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 78  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLXG 131
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  M+     F   D    + K I+++              
Sbjct: 190 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                        L+     PD+        N + + + RDL+S++ V DPA RI++ + 
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 276 MKHQW 280
           ++H +
Sbjct: 309 LQHPY 313

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 131/305 (42%), Gaps = 57/305 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLXG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  M+     F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                        L+     PD+        N + + + RDL+S++ V DPA RI++ + 
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 276 MKHQW 280
           ++H +
Sbjct: 316 LQHPY 320

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 130/303 (42%), Gaps = 57/303 (18%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPN 80
           RY  ++ IGSG  G+     D V    VA+K + R  +   + +R   E++  + + H N
Sbjct: 25  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 81  IVRFKEVILTPTH-------LAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           I+    V  TP         + +VME   A+  ++ +   +  R S     +   Q++ G
Sbjct: 85  IISLLNV-FTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS-----YLLYQMLCG 138
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDXT--LKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-------------- 237
           +L   Y   + D+WS G  +  M+     F   D    + K I+++              
Sbjct: 197 ILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 238 -------------LSVQYSVPDT--------NPI-SQECRDLISRIFVADPAARITIPEI 275
                        L+     PD+        N + + + RDL+S++ V DPA RI++ + 
Sbjct: 256 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 315
Query: 276 MKH 278
           ++H
Sbjct: 316 LQH 318

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 12  PAMDMPIMHDSDRY-DFVRDIGSGNFGVARLM----RDKVTKELVAVKYIER--GDKIDE 64
           PA D  + H   RY   +RD+G G+FG   L      +  T E+VAVK ++   G +   
Sbjct: 4   PASDPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS 61
Query: 65  NVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
             ++EI   R+L H +I+++K          L +VMEY   G L + +    R S   A+
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQ 118
Query: 123 F--FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQP 177
              F QQ+  G++Y HA    HR+L   N LLD      +KI DFG +K+      + + 
Sbjct: 119 LLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRV 176
Query: 178 KSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216
           +    +P  + APE L  +++    +DVWS GVTLY +L 
Sbjct: 177 REDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLT 215

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 28  VRDIGSGNFGVARLM----RDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 81
           +RD+G G+FG   L      +  T E+VAVK +  + G +     ++EI   R+L H +I
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 82  VRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHA 137
           +++K          L +VMEY   G L + +    R S   A+   F QQ+  G++Y HA
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPA-YIAPEVLL 193
               HRDL   N LLD      +KI DFG +K+     +    +    +P  + APE L 
Sbjct: 153 QHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 194 RHEYDGKIADVWSCGVTLYVMLV 216
            +++    +DVWS GVTLY +L 
Sbjct: 211 EYKFY-YASDVWSFGVTLYELLT 232

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 35  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 94
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 95  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 154
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 211
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 212 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 259

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 126/272 (46%), Gaps = 19/272 (6%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSL 76
           +D  + + ++G G +GV   MR   + +++AVK I     ++   Q+ +     I+ R++
Sbjct: 50  ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTV 107
Query: 77  RHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGR-FSEDEARFFFQQLISGVS 133
             P  V F   +     + I ME    S  + ++++ + G+   ED        ++  + 
Sbjct: 108 DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 167
Query: 134 YCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           + H+ + V HRD+K  N L++     ++K+CDFG S   V         G   Y+APE +
Sbjct: 168 HLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERI 225
Query: 193 ---LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
              L  +     +D+WS G+T+  + +  +P++    P  F++  Q +      +P  + 
Sbjct: 226 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLP-ADK 282
Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            S E  D  S+    +   R T PE+M+H +F
Sbjct: 283 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 314

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 132/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI  FG ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 19/234 (8%)
Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQR 68
           M  P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +R
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 69  EIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFF 125
           EI   +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   + 
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
            Q+  G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P 
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPG 177
Query: 186 -----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
                + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 178 ESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 228

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 132/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI DF  ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 2   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 61
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 62  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 121
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 122 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 178
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 179 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 226

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 3   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 62
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 63  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 122
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 123 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 179
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 180 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----N 65
           G  M  P  H SDRY+    +G G      L RD      VAVK + R D   +      
Sbjct: 1   GSHMTTP-SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLR 58
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEA 121
            +RE  N  +L HP IV   +     T       IVMEY  G  L + +   G  +   A
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQP 177
                     +++ H   + HRD+K  N L+  + A  +K+ DFG ++    S     Q 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANILISATNA--VKVVDFGIARAIADSGNSVXQT 176
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
            + +GT  Y++PE       D + +DV+S G  LY +L G  PF
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 9   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 68
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 69  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 128
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 129 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 185
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 186 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 233

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 10  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 69
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 70  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 129
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 130 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 186
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 187 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 234

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 7   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 66
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 67  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 126
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 127 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 183
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 184 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 231

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 8   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 67
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 68  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 127
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 128 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 184
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 185 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 232

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 180
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 181 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 228

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 126/272 (46%), Gaps = 19/272 (6%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSL 76
           +D  + + ++G G +GV   MR   + +++AVK I     ++   Q+ +     I+ R++
Sbjct: 6   ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRTV 63
Query: 77  RHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGR-FSEDEARFFFQQLISGVS 133
             P  V F   +     + I ME    S  + ++++ + G+   ED        ++  + 
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 134 YCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           + H+ + V HRD+K  N L++     ++K+CDFG S   V         G   Y+APE +
Sbjct: 124 HLHSKLSVIHRDVKPSNVLINA--LGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERI 181
Query: 193 ---LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
              L  +     +D+WS G+T+  + +  +P++    P  F++  Q +      +P  + 
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLP-ADK 238
Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            S E  D  S+    +   R T PE+M+H +F
Sbjct: 239 FSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 11  PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 70
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 71  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 130
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 131 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESP 187
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 188 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 126/293 (43%), Gaps = 43/293 (14%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL- 89
           +G G FG     R+ +     A+K I   ++    +  E++   SL H  +VR+    L 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 90  ------------TPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVSYCH 136
                         + L I MEY     L++ I +     + DE    F+Q++  +SY H
Sbjct: 74  RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------VLHSQP--------KSTV 181
           +  + HRDLK  N  +D S    +KI DFG +K+         L SQ          S +
Sbjct: 134 SQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 182 GTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
           GT  Y+A EVL     Y+ KI D++S G+  + M+   YPF    E  +  K + R +S+
Sbjct: 192 GTAMYVATEVLDGTGHYNEKI-DMYSLGIIFFEMI---YPFSTGMERVNILKKL-RSVSI 246
Query: 241 QYSVPDTNPISQECRDLISRIFV-ADPAARITIPEIMKHQWFLKNLPADLVDE 292
           ++  PD +    +    I R+ +  DP  R     ++   W    LP    DE
Sbjct: 247 EFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW----LPVKHQDE 294

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/296 (22%), Positives = 129/296 (43%), Gaps = 41/296 (13%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-P 79
           + D Y  VR +G G +       +    E V VK ++   K    ++REI    +LR  P
Sbjct: 35  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--NKIKREIKILENLRGGP 92
Query: 80  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           NI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH+
Sbjct: 93  NIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCHS 149
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++ 
Sbjct: 150 MGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 208
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---PD 246
                D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P 
Sbjct: 209 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 268
Query: 247 TNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
            N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 269 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 100/230 (43%), Gaps = 20/230 (8%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----N 65
           G  M  P  H SDRY+    +G G      L RD      VAVK + R D   +      
Sbjct: 1   GSHMTTP-SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLR 58
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEA 121
            +RE  N  +L HP IV   +     T       IVMEY  G  L + +   G  +   A
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQP 177
                     +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT 176
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF--EDPD 225
            + +GT  Y++PE       D + +DV+S G  LY +L G  PF  + PD
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPD 225

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 18/224 (8%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----N 65
           G  M  P  H SDRY+    +G G      L RD      VAVK + R D   +      
Sbjct: 1   GSHMTTP-SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLR 58
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEA 121
            +RE  N  +L HP IV   +     T       IVMEY  G  L + +   G  +   A
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQP 177
                     +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT 176
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
            + +GT  Y++PE       D + +DV+S G  LY +L G  PF
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 28  VRDIGSGNFGVARLM----RDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
           +RD+G G+FG   L      +  T E+VAVK ++ G   ++    QREI   R+L H +I
Sbjct: 13  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 82  VRFKEVI--LTPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCH 136
           V++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 73  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 128
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA-YIAPEVL 192
           A    HR L   N LLD      +KI DFG +K+      + + +    +P  + APE L
Sbjct: 129 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 193 LRHEYDGKIADVWSCGVTLYVMLV 216
              ++    +DVWS GVTLY +L 
Sbjct: 187 KECKFY-YASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 28  VRDIGSGNFGVARLM----RDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
           +RD+G G+FG   L      +  T E+VAVK ++ G   ++    QREI   R+L H +I
Sbjct: 14  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 82  VRFKEVI--LTPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFFQQLISGVSYCH 136
           V++K          + +VMEY   G L     R C        +   F QQ+  G++Y H
Sbjct: 74  VKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLH 129
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA-YIAPEVL 192
           A    HR L   N LLD      +KI DFG +K+      + + +    +P  + APE L
Sbjct: 130 AQHYIHRALAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 193 LRHEYDGKIADVWSCGVTLYVMLV 216
              ++    +DVWS GVTLY +L 
Sbjct: 188 KECKFY-YASDVWSFGVTLYELLT 210

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 18/224 (8%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----N 65
           G  M  P  H SDRY+    +G G      L RD      VAVK + R D   +      
Sbjct: 1   GSHMTTP-SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLR 58
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEA 121
            +RE  N  +L HP IV   +     T       IVMEY  G  L + +   G  +   A
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQP 177
                     +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT 176
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
            + +GT  Y++PE       D + +DV+S G  LY +L G  PF
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 16/202 (7%)
Query: 28  VRDIGSGNFGVARLMR----DKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPNI 81
           +RD+G G+FG   L R       T E VAVK +  E G     ++++EI   R+L H NI
Sbjct: 14  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 82  VRFKEVILT--PTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
           V++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  + 
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAY-IAPEVLLR 194
           Q  HRDL   N L++     ++KI DFG +K+     +    K    +P +  APE L++
Sbjct: 134 QYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQ 191
Query: 195 HEYDGKIADVWSCGVTLYVMLV 216
            ++    +DVWS GVTL+ +L 
Sbjct: 192 SKF-YIASDVWSFGVTLHELLT 212

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 132/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 12  PAMDMPIMHDSDRY-DFVRDIGSGNFGVARLM----RDKVTKELVAVKYIER--GDKIDE 64
           PA D  + H   RY   +RD+G G+FG   L      +  T E+VAVK ++   G +   
Sbjct: 4   PASDPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRS 61
Query: 65  NVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
             ++EI   R+L H +I+++K          L +VMEY   G L + +    R S   A+
Sbjct: 62  GWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQ 118
Query: 123 F--FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQP 177
              F QQ+  G++Y H+    HR+L   N LLD      +KI DFG +K+      + + 
Sbjct: 119 LLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRV 176
Query: 178 KSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216
           +    +P  + APE L  +++    +DVWS GVTLY +L 
Sbjct: 177 REDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLT 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 95/223 (42%), Gaps = 16/223 (7%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----RGDKIDENV 66
           G  M  P  H SDRY+    +G G      L RD      VAVK +     R        
Sbjct: 18  GSHMTTP-SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRF 76
Query: 67  QREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEAR 122
           +RE  N  +L HP IV   +     T       IVMEY  G  L + +   G  +   A 
Sbjct: 77  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 136
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPK 178
                    +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q  
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTA 194
Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
           + +GT  Y++PE       D + +DV+S G  LY +L G  PF
Sbjct: 195 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 236

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 27  FVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNI 81
           F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI   +SL+H NI
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 82  VRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
           V++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y    
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLL 193
           +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L 
Sbjct: 152 RYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 209 ESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 246

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 19/221 (8%)
Query: 27  FVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREIINHRSLRHPNI 81
           F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI   +SL+H NI
Sbjct: 32  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 91
Query: 82  VRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
           V++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+  G+ Y    
Sbjct: 92  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 151
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIAPEVLL 193
           +  HRDL   N L++     R+KI DFG +K  +   +    V  P      + APE L 
Sbjct: 152 RYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 209 ESKFS-VASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 246

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 132/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/319 (22%), Positives = 132/319 (41%), Gaps = 63/319 (19%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHP 79
           +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H 
Sbjct: 22  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 81
Query: 80  NIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           N++   +V      L       ++ +  G +L   I    + ++D  +F   Q++ G+ Y
Sbjct: 82  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQFLIYQILRGLKY 140
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
            H+  + HRDLK  N  L  +    LKI D G ++    H+  + T  V T  Y APE++
Sbjct: 141 IHSADIIHRDLKPSN--LAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYRAPEIM 194
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-------------------------- 226
           L   +  +  D+WS G  +  +L G   F   D                           
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 227 PKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +++ +++ ++  + ++      NP++    DL+ ++ V D   RIT  + + H +F   
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAV---DLLEKMLVLDSDKRITAAQALAHAYF--- 308
Query: 285 LPADLVDEKTMSSQYEEPD 303
                       +QY +PD
Sbjct: 309 ------------AQYHDPD 315

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 18/224 (8%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-----N 65
           G  M  P  H SDRY+    +G G      L RD      VAVK + R D   +      
Sbjct: 1   GSHMTTP-SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-RADLARDPSFYLR 58
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAGRFSEDEA 121
            +RE  N  +L HP IV         T       IVMEY  G  L + +   G  +   A
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQP 177
                     +++ H   + HRD+K  N ++  + A  +K+ DFG ++    S    +Q 
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT 176
Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
            + +GT  Y++PE       D + +DV+S G  LY +L G  PF
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPF 219

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 4   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 63
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 64  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 123
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HRDL   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENE--NRVKIGDFGLTK-VLPQDKEFFKVKEPGESP 180
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 181 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 228

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 24/210 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDE--NVQREIINHRSLRHPNIVRFKEV 87
           IG G FG  ++   +   E VA++ I+   D  D+    +RE++ +R  RH N+V F   
Sbjct: 41  IGKGRFG--QVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVSYCHAMQVCHRDLK 146
            ++P HLAI+     G  L+  + +A    + ++ R   Q+++ G+ Y HA  + H+DLK
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLK 157
Query: 147 LENTLLDGSPAPRLKICDFG-YSKSSVLHSQPKS-----TVGTPAYIAPEVLLRHEYD-- 198
            +N   D     ++ I DFG +S S VL +  +        G   ++APE++ +   D  
Sbjct: 158 SKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 199 ------GKIADVWSCGVTLYVMLVGGYPFE 222
                  K +DV++ G   Y +    +PF+
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFK 244

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERG-DKIDENVQREII 71
           P   +     F++ +G GNFG   + R       T E+VAVK ++   ++   + +REI 
Sbjct: 5   PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE 64
Query: 72  NHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQL 128
             +SL+H NIV++K V  +    +L ++MEY   G L + +  +  R    +   +  Q+
Sbjct: 65  ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI 124
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y    +  HR+L   N L++     R+KI DFG +K  +   +    V  P    
Sbjct: 125 CKGMEYLGTKRYIHRNLATRNILVENE--NRVKIGDFGLTK-VLPQDKEYYKVKEPGESP 181
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
             + APE L   ++    +DVWS GV LY +    Y  +    P +F + I
Sbjct: 182 IFWYAPESLTESKF-SVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMI 229

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + I+ EY + G      C      E   RF  QQL+         + Y  + Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSK 197
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFE 222
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 54/281 (19%)
Query: 28  VRDIGSG-NFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF-- 84
            +D+GSG  + + RL+ ++  K    ++ +    K+               HPNIV+F  
Sbjct: 47  AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG-------------HPNIVQFCS 93
Query: 85  ------KEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
                 +E         ++ E   G   E  +++ + G  S D     F Q    V + H
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 137 AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------SQPKSTV------ 181
             +  + HRDLK+EN LL  S    +K+CDFG S +++ H       +Q ++ V      
Sbjct: 154 RQKPPIIHRDLKVENLLL--SNQGTIKLCDFG-SATTISHYPDYSWSAQRRALVEEEITR 210
Query: 182 -GTPAYIAPEVL-LRHEYD-GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 238
             TP Y  PE++ L   +  G+  D+W+ G  LY++    +PFED  +         RI+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK--------LRIV 262
Query: 239 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ 279
           + +YS+P  +        LI  +   +P  R++I E++ HQ
Sbjct: 263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV-HQ 302

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 8   FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 66
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + I+ EY + G      C      E   RF  QQL+         + Y  + Q
Sbjct: 67  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 121 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFE 222
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + I+ EY + G      C      E   RF  QQL+         + Y  + Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 182
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFE 222
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 12  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 70
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + I+ EY + G      C      E   RF  QQL+         + Y  + Q
Sbjct: 71  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 124
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 125 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 181
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFE 222
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 182 FSSK-SDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 19  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 77
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + I+ EY + G      C      E   RF  QQL+         + Y  + Q
Sbjct: 78  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 131
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 132 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 188
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFE 222
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 189 FSSK-SDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + I+ EY + G      C      E   RF  QQL+         + Y  + Q
Sbjct: 87  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 140
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L++      +K+ DFG S+  VL  +  S+VG+     +  PEVL+  +
Sbjct: 141 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSK 197
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFE 222
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 198 FSSK-SDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRS 75
           +H  D Y     IG G++G   L  DK T++ VA+K + R   D ID + + REI     
Sbjct: 22  VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 76  LRHPNIVRFKEVI-----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
           L+   I+R  ++I     L    L IV+E A   +L +        +E+  +     L+ 
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLL 140
Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------------------- 170
           G ++ H   + HRDLK  N LL+   +  +K+CDFG +++                    
Sbjct: 141 GENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 171 ---SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
                L  Q  S V T  Y APE++L  E   K  D+WS G     +L
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 14/223 (6%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI------INHRSL 76
           DRY+    IG G+FG      D+V +E VA+K I+         Q E+        H + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 134
               IV  K   +   HL +V E  S   L++  R  N    S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 135 CHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
                + + H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEVL
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVL 230
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
           L   YD  I D+WS G  L  M  G   F   +E     K ++
Sbjct: 231 LGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 45/245 (18%)
Query: 12  PAMDMPIMHDS----DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-E 64
           P   MP  H      DRY+    IG+G++G      DK+ K +VA+K I R   D ID +
Sbjct: 38  PTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK 97
Query: 65  NVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNAGRF-SE 118
            + REI     L H ++V+  ++++         L +V+E A     F+++     + +E
Sbjct: 98  RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTE 155
Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------- 169
              +     L+ GV Y H+  + HRDLK  N L++   +  +K+CDFG ++         
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGN 213
Query: 170 -------------------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVT 210
                              +  L  Q    V T  Y APE++L  E   +  DVWS G  
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCI 273
Query: 211 LYVML 215
              +L
Sbjct: 274 FAELL 278

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 89/325 (27%), Positives = 129/325 (39%), Gaps = 70/325 (21%)
Query: 22  SDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI--INHRSLRH 78
           S RY+ V  +G G FG V   +  K     VAVK ++  D+  E  + EI  + H +   
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 79  PN----IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 132
           PN     V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 133 SYCHAMQVCHRDLKLENTLL---DGSPA--------------PRLKICDFGYSKSSVLHS 175
           ++ H+ ++ H DLK EN L    D + A              P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 176 QPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF---- 230
           +  ST V T  Y APEV+L   +  +  DVWS G  L    +G   F   D  +      
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 231 -------RKTIQRILSVQYSVPDT----------NPISQECR-----------------D 256
                  +  IQ+    +Y   D             +S+ C+                 D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 257 LISRIFVADPAARITIPEIMKHQWF 281
           LI ++   DPA RIT+ E +KH +F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 14/223 (6%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI------INHRSL 76
           DRY+    IG G+FG      D+V +E VA+K I+         Q E+        H + 
Sbjct: 35  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 94
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 134
               IV  K   +   HL +V E  S   L++  R  N    S +  R F QQ+ + + +
Sbjct: 95  MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 153
Query: 135 CHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
                + + H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEVL
Sbjct: 154 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVL 211
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
           L   YD  I D+WS G  L  M  G   F   +E     K ++
Sbjct: 212 LGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 253

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 14/223 (6%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI------INHRSL 76
           DRY+    IG G+FG      D+V +E VA+K I+         Q E+        H + 
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSY 134
               IV  K   +   HL +V E  S   L++  R  N    S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172
Query: 135 CHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
                + + H DLK EN LL       +KI DFG   S  L  +    + +  Y +PEVL
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRXAIKIVDFG--SSCQLGQRIYQXIQSRFYRSPEVL 230
Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
           L   YD  I D+WS G  L  M  G   F   +E     K ++
Sbjct: 231 LGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 116/271 (42%), Gaps = 27/271 (9%)
Query: 30  DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-----RSLRHPNIVRF 84
           +IG G +G    M  K + +++AVK I     +DE  Q++++       RS   P IV+F
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC--------- 135
              +       I ME  S    F++         D+     ++++  ++           
Sbjct: 87  YGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDV--IPEEILGKITLATVKALNHLK 142
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL--- 192
             +++ HRD+K  N LLD S    +K+CDFG S   V         G   Y+APE +   
Sbjct: 143 ENLKIIHRDIKPSNILLDRSG--NIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 193 -LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
             R  YD + +DVWS G+TLY +  G +P+   +   D    + +    Q S  +    S
Sbjct: 201 ASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFS 259
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFL 282
               + ++     D + R    E++KH + L
Sbjct: 260 PSFINFVNLCLTKDESKRPKYKELLKHPFIL 290

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 137/330 (41%), Gaps = 56/330 (16%)
Query: 11  GPA-----MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKI 62
           GPA     ++ P   +  +Y+ +  IG G FG     R + T + VA+K +      +  
Sbjct: 1   GPAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 60
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA- 113
                REI   + L+H N+V   E+  T           + +V ++    +L   + N  
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 119
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSS 171
            +F+  E +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++ 
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAF 175
Query: 172 VL--HSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
            L  +SQP    + V T  Y  PE+LL     G   D+W  G  +  M       +   E
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 227 PKDFRKTIQRILSVQYSV-PDTNP---------ISQECR----------------DLISR 260
                   Q   S+   V P+ +          +  + R                DLI +
Sbjct: 236 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 295
Query: 261 IFVADPAARITIPEIMKHQWFLKN-LPADL 289
           + V DPA RI   + + H +F  + +P+DL
Sbjct: 296 LLVLDPAQRIDSDDALNHDFFWSDPMPSDL 325

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 137/330 (41%), Gaps = 56/330 (16%)
Query: 11  GPA-----MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKI 62
           GPA     ++ P   +  +Y+ +  IG G FG     R + T + VA+K +      +  
Sbjct: 1   GPAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 60
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA- 113
                REI   + L+H N+V   E+  T           + +V ++    +L   + N  
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVL 119
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSS 171
            +F+  E +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++ 
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAF 175
Query: 172 VL--HSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
            L  +SQP    + V T  Y  PE+LL     G   D+W  G  +  M       +   E
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 227 PKDFRKTIQRILSVQYSV-PDTNP---------ISQECR----------------DLISR 260
                   Q   S+   V P+ +          +  + R                DLI +
Sbjct: 236 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 295
Query: 261 IFVADPAARITIPEIMKHQWFLKN-LPADL 289
           + V DPA RI   + + H +F  + +P+DL
Sbjct: 296 LLVLDPAQRIDSDDALNHDFFWSDPMPSDL 325

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 137/330 (41%), Gaps = 56/330 (16%)
Query: 11  GPA-----MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKI 62
           GPA     ++ P   +  +Y+ +  IG G FG     R + T + VA+K +      +  
Sbjct: 1   GPAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 60
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA- 113
                REI   + L+H N+V   E+  T           + +V ++    +L   + N  
Sbjct: 61  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 119
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSS 171
            +F+  E +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++ 
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAF 175
Query: 172 VL--HSQPK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
            L  +SQP    + V T  Y  PE+LL     G   D+W  G  +  M       +   E
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 227 PKDFRKTIQRILSVQYSV-PDTNP---------ISQECR----------------DLISR 260
                   Q   S+   V P+ +          +  + R                DLI +
Sbjct: 236 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 295
Query: 261 IFVADPAARITIPEIMKHQWFLKN-LPADL 289
           + V DPA RI   + + H +F  + +P+DL
Sbjct: 296 LLVLDPAQRIDSDDALNHDFFWSDPMPSDL 325

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
           IG G FG     R KV   +E+ VA+K ++ G  DK   +   E        HPNI+  +
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M   HR
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHR 155
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHEY 197
           DL   N L++ +     K+ DFG S+  VL   P++   T        + APE +   ++
Sbjct: 156 DLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFED 223
               +DVWS G+ ++ VM  G  P+ D
Sbjct: 212 TSA-SDVWSYGIVMWEVMSYGERPYWD 237

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 51/323 (15%)
Query: 13  AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQRE 69
           +++ P   +  +Y+ +  IG G FG     R + T + VA+K +      +       RE
Sbjct: 7   SVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE 66
Query: 70  IINHRSLRHPNIVRFKEVILTPTH--------LAIVMEYASGGELFERICNA-GRFSEDE 120
           I   + L+H N+V   E+  T           + +V ++    +L   + N   +F+  E
Sbjct: 67  IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSE 125
Query: 121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVL--HSQ 176
            +   Q L++G+ Y H  ++ HRD+K  N L+  DG     LK+ DFG +++  L  +SQ
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV----LKLADFGLARAFSLAKNSQ 181
Query: 177 PK---STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233
           P    + V T  Y  PE+LL     G   D+W  G  +  M       +   E       
Sbjct: 182 PNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241
Query: 234 IQRILSVQYSV-PDTNP---------ISQECR----------------DLISRIFVADPA 267
            Q   S+   V P+ +          +  + R                DLI ++ V DPA
Sbjct: 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301
Query: 268 ARITIPEIMKHQWFLKN-LPADL 289
            RI   + + H +F  + +P+DL
Sbjct: 302 QRIDSDDALNHDFFWSDPMPSDL 324

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
           IG G FG     R KV   +E+ VA+K ++ G  DK   +   E        HPNI+  +
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M   HR
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 134
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHEY 197
           DL   N L++ +     K+ DFG S+  VL   P++   T        + APE +   ++
Sbjct: 135 DLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFED 223
               +DVWS G+ ++ VM  G  P+ D
Sbjct: 191 TSA-SDVWSYGIVMWEVMSYGERPYWD 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 116/283 (40%), Gaps = 37/283 (13%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIER-GDKIDENVQREII 71
           P + +     ++  +G GNFG   L R       T  LVAVK ++  G     + QREI 
Sbjct: 1   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 60
Query: 72  NHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGG---ELFERICNAGRFSEDEARFFFQ 126
             ++L    IV+++ V   P    L +VMEY   G   +  +R  +  R        +  
Sbjct: 61  ILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSS 118
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 185
           Q+  G+ Y  + +  HRDL   N L++      +KI DFG +K   L  +    V  P  
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDXXVVREPGQ 175
Query: 186 ----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
               + APE L  + +  + +DVWS GV LY +      F   D+         R++  +
Sbjct: 176 SPIFWYAPESLSDNIFS-RQSDVWSFGVVLYEL------FTYCDKSCSPSAEFLRMMGCE 228
Query: 242 YSVPDTNPISQECR----DLISRIFVADPAARITIPEIMKHQW 280
             VP        CR        +   A PA    + E+MK  W
Sbjct: 229 RDVPAL------CRLLELLEEGQRLPAPPACPAEVHELMKLCW 265

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
           IG G FG     R KV   +E+ VA+K ++ G  DK   +   E        HPNI+  +
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+     + I+ EY   G L  F R  N GRF+  +     + + SG+ Y   M   HR
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRK-NDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHR 140
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRHEY 197
           DL   N L++ +     K+ DFG S+  VL   P++   T        + APE +   ++
Sbjct: 141 DLAARNILVNSNLV--CKVSDFGMSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFED 223
               +DVWS G+ ++ VM  G  P+ D
Sbjct: 197 TSA-SDVWSYGIVMWEVMSYGERPYWD 222

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
           F++++G+G FGV +  + +   + VA+K I+ G   ++    E     +L H  +V+   
Sbjct: 13  FLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 71
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQ 139
           V      + I+ EY + G      C      E   RF  QQL+         + Y  + Q
Sbjct: 72  VCTKQRPIFIITEYMANG------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 125
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHE 196
             HRDL   N L++      +K+ DFG S+  VL  +  S+ G+     +  PEVL+  +
Sbjct: 126 FLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSK 182
Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFE 222
           +  K +D+W+ GV ++ +  +G  P+E
Sbjct: 183 FSSK-SDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 31  IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
           IG+G FG     RL      +  VA+K ++ G    E  +RE ++  S+     HPNI+R
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNIIR 81
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 140
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP---AYIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+    +S      S++G      + APE +   
Sbjct: 141 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
           ++    +D WS G+ ++ VM  G  P+ D
Sbjct: 199 KFTSA-SDAWSYGIVMWEVMSFGERPYWD 226

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 31  IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL----RHPNIVR 83
           IG+G FG     RL      +  VA+K ++ G    E  +RE ++  S+     HPNI+R
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGG--YTERQRREFLSEASIMGQFEHPNIIR 79
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + I+ E+   G L  F R+ N G+F+  +     + + SG+ Y   M   
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLRGIASGMRYLAEMSYV 138
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPA---YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+    +S      S++G      + APE +   
Sbjct: 139 HRDLAARNILVNSNLV--CKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
           ++    +D WS G+ ++ VM  G  P+ D
Sbjct: 197 KFTSA-SDAWSYGIVMWEVMSFGERPYWD 224

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/262 (27%), Positives = 114/262 (43%), Gaps = 31/262 (11%)
Query: 29  RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVR 83
           R IG G+FGV      +     +   A+K + R  ++   E   RE +  R L HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 84  FKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQVC 141
              ++L P  L  +++ Y   G+L + I +  R  +  +   F  Q+  G+ Y    +  
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPEVLL 193
           HRDL   N +LD S    +K+ DFG ++        S   H   +  V    + A E L 
Sbjct: 147 HRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPV---KWTALESLQ 201
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP---FEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
            + +  K +DVWS GV L+ +L  G P     DP +   F    +R+   +Y       +
Sbjct: 202 TYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQV 260
Query: 251 SQECRDLISRIFVADPAARITI 272
            Q+C +       ADPA R T 
Sbjct: 261 MQQCWE-------ADPAVRPTF 275

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 120/290 (41%), Gaps = 58/290 (20%)
Query: 52  AVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGEL--- 106
           A+K IE G  I  +  REI   R L+HPN++  ++V L+     + ++ +YA        
Sbjct: 52  ALKQIE-GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII 110
Query: 107 -FERICNAGR----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--DGSPAPR 159
            F R   A +          +    Q++ G+ Y HA  V HRDLK  N L+  +G    R
Sbjct: 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170
Query: 160 LKICDFGYSKSSVLHSQPKS----TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
           +KI D G+++      +P +     V T  Y APE+LL   +  K  D+W+ G     +L
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
Query: 216 -----------------------------VGGYP----FED----PDEP---KDFRKTIQ 235
                                        V G+P    +ED    P+     KDFR+   
Sbjct: 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 290
Query: 236 RILS-VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
              S ++Y          +   L+ ++   DP  RIT  + M+  +FL++
Sbjct: 291 TNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 117/277 (42%), Gaps = 25/277 (9%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIER-GDKIDENVQREII 71
           P + +     ++  +G GNFG   L R       T  LVAVK ++  G     + QREI 
Sbjct: 17  PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 76
Query: 72  NHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 128
             ++L    IV+++ V   P    L +VMEY   G L + +  +  R        +  Q+
Sbjct: 77  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 136
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y  + +  HRDL   N L++      +KI DFG +K   L  +    V  P    
Sbjct: 137 CKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDYYVVREPGQSP 193
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243
             + APE L  + +  + +DVWS GV LY +      F   D+         R++  +  
Sbjct: 194 IFWYAPESLSDNIFS-RQSDVWSFGVVLYEL------FTYCDKSCSPSAEFLRMMGCERD 246
Query: 244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
           VP  + + +       +   A PA    + E+MK  W
Sbjct: 247 VPALSRLLEL--LEEGQRLPAPPACPAEVHELMKLCW 281

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 116/281 (41%), Gaps = 33/281 (11%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIER-GDKIDENVQREII 71
           P + +     ++  +G GNFG   L R       T  LVAVK ++  G     + QREI 
Sbjct: 5   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 64
Query: 72  NHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 128
             ++L    IV+++ V   P    L +VMEY   G L + +  +  R        +  Q+
Sbjct: 65  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 124
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y  + +  HRDL   N L++      +KI DFG +K   L  +    V  P    
Sbjct: 125 CKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDYYVVREPGQSP 181
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243
             + APE L  + +  + +DVWS GV LY +      F   D+         R++  +  
Sbjct: 182 IFWYAPESLSDNIFS-RQSDVWSFGVVLYEL------FTYCDKSCSPSAEFLRMMGCERD 234
Query: 244 VPDTNPISQECR----DLISRIFVADPAARITIPEIMKHQW 280
           VP        CR        +   A PA    + E+MK  W
Sbjct: 235 VPAL------CRLLELLEEGQRLPAPPACPAEVHELMKLCW 269

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 141 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 197 KFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 19/242 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 32  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 89  STAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYD--GKI 201
             N  L       +KI DFG +      S   Q +   G+  ++APEV+   + +     
Sbjct: 148 SNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +DV++ G+ LY ++ G  P+ + +     R  I  ++      PD + +   C   + R+
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINN----RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 262 FV 263
Sbjct: 262 MA 263

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 21/241 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 16  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 73  STAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 261 I 261
           +
Sbjct: 245 L 245

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 17  PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIER-GDKIDENVQREII 71
           P + +     ++  +G GNFG   L R       T  LVAVK ++  G     + QREI 
Sbjct: 4   PTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ 63
Query: 72  NHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQL 128
             ++L    IV+++ V   P    L +VMEY   G L + +  +  R        +  Q+
Sbjct: 64  ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQI 123
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--- 185
             G+ Y  + +  HRDL   N L++      +KI DFG +K   L  +    V  P    
Sbjct: 124 CKGMEYLGSRRCVHRDLAARNILVESE--AHVKIADFGLAKLLPL-DKDYYVVREPGQSP 180
Query: 186 --YIAPEVLLRHEYDGKIADVWSCGVTLYVMLV 216
             + APE L  + +  + +DVWS GV LY +  
Sbjct: 181 IFWYAPESLSDNIFS-RQSDVWSFGVVLYELFT 212

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 255
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 157
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 158 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 214 KFTSA-SDVWSYGIVLWEVMSYGERPY 239

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 19/240 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 16  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYD--GKI 201
             N  L       +KI DFG +      S   Q +   G+  ++APEV+   + +     
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R+
Sbjct: 190 SDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 245

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 21/241 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 16  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 73  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 131
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 132 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244
Query: 261 I 261
           +
Sbjct: 245 L 245

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGFV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 126/297 (42%), Gaps = 41/297 (13%)
Query: 13  AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQRE 69
           AM M   + ++ ++  + IGSG FG       ++   + A+K  ++   G   ++N  RE
Sbjct: 2   AMGMKSRYTTEFHELEK-IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE 60
Query: 70  IINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFF 124
           +  H  L +H ++VR+        H+ I  EY +GG L + I    R    F E E +  
Sbjct: 61  VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR-----------------LKICDFGY 167
             Q+  G+ Y H+M + H D+K  N  +  +  P                   KI D G+
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDE 226
                  S P+   G   ++A EVL  +      AD+++  +T+ V   G  P   + D+
Sbjct: 181 VTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQ 236
Query: 227 PKDFRKT-IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
             + R+  + RI  V         +SQE  +L+  +   DP  R +   ++KH   L
Sbjct: 237 WHEIRQGRLPRIPQV---------LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 283
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 19/242 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 36  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 93  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 151
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYD--GKI 201
             N  L       +KI DFG +      S   Q +   G+  ++APEV+   + +     
Sbjct: 152 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R+
Sbjct: 210 SDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 265
Query: 262 FV 263
Sbjct: 266 MA 267

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 14  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 71
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 72  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 130
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 131 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 182
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 239
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 240 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 277

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 88/325 (27%), Positives = 128/325 (39%), Gaps = 70/325 (21%)
Query: 22  SDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI--INHRSLRH 78
           S RY+ V  +G G FG V   +  K     VAVK ++  D+  E  + EI  + H +   
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTD 72
Query: 79  PN----IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 132
           PN     V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V
Sbjct: 73  PNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131
Query: 133 SYCHAMQVCHRDLKLENTLL---DGSPA--------------PRLKICDFGYSKSSVLHS 175
           ++ H+ ++ H DLK EN L    D + A              P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188
Query: 176 QPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF---- 230
           +  ST V    Y APEV+L   +  +  DVWS G  L    +G   F   D  +      
Sbjct: 189 EHHSTLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247
Query: 231 -------RKTIQRILSVQYSVPDT----------NPISQECR-----------------D 256
                  +  IQ+    +Y   D             +S+ C+                 D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307
Query: 257 LISRIFVADPAARITIPEIMKHQWF 281
           LI ++   DPA RIT+ E +KH +F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 19/242 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 32  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 89  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYD--GKI 201
             N  L       +KI DFG +      S   Q +   G+  ++APEV+   + +     
Sbjct: 148 SNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +DV++ G+ LY ++ G  P+ + +     R  I  ++      PD + +   C   + R+
Sbjct: 206 SDVYAFGIVLYELMTGQLPYSNINN----RDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 262 FV 263
Sbjct: 262 MA 263

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 32/213 (15%)
Query: 30  DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVRFK 85
           ++GSG  G    MR + T  ++AVK + R    +EN +R +++     +S   P IV+  
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN-KRILMDLDVVLKSHDCPYIVQCF 90
Query: 86  EVILTPTHLAIVMEYASG----------GELFERICNAGRFSEDEARFFFQQLISGVSYC 135
              +T T + I ME              G + ERI      +  +A ++ ++        
Sbjct: 91  GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-------- 142
Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL--- 192
               V HRD+K  N LLD     ++K+CDFG S   V       + G  AY+APE +   
Sbjct: 143 -KHGVIHRDVKPSNILLD--ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 193 --LRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
              + +YD + ADVWS G++L  +  G +P+++
Sbjct: 200 DPTKPDYDIR-ADVWSLGISLVELATGQFPYKN 231

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 43/293 (14%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVIL- 89
           +G G FG     R+ +     A+K I   ++    +  E+    SL H  +VR+    L 
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLE 73
Query: 90  ------------TPTHLAIVMEYASGGELFERICNAGRFSE-DEARFFFQQLISGVSYCH 136
                         + L I  EY     L++ I +     + DE    F+Q++  +SY H
Sbjct: 74  RRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-------VLHSQP--------KSTV 181
           +  + HR+LK  N  +D S    +KI DFG +K+         L SQ          S +
Sbjct: 134 SQGIIHRNLKPXNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAI 191
Query: 182 GTPAYIAPEVL-LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
           GT  Y+A EVL     Y+ KI D +S G+  +  +   YPF    E  +  K + R +S+
Sbjct: 192 GTAXYVATEVLDGTGHYNEKI-DXYSLGIIFFEXI---YPFSTGXERVNILKKL-RSVSI 246
Query: 241 QYSVPDTNPISQECRDLISRIFV-ADPAARITIPEIMKHQWFLKNLPADLVDE 292
           ++  PD +    +    I R+ +  DP  R     ++   W    LP    DE
Sbjct: 247 EFP-PDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGW----LPVKHQDE 294

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 21/241 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 21  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 137 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 249
Query: 261 I 261
           +
Sbjct: 250 L 250

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 10  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 67
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 68  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 126
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 127 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 178
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 235
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 236 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 273

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 167
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 168 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 224 KFTSA-SDVWSYGIVLWEVMSYGERPY 249

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 13/219 (5%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI 70
           G  + +P  H + RY+ ++ IG G+FG      D    + VA+K +    +       EI
Sbjct: 85  GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 71  INHRSLRHP------NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEAR 122
                LR        N++   E      H+ +  E  S    EL ++    G FS    R
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVR 203
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
            F   ++  +   H  ++ H DLK EN LL       +K+ DFG   S   H +  + + 
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQ 261
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
           +  Y APEV+L   Y G   D+WS G  L  +L  GYP 
Sbjct: 262 SRFYRAPEVILGARY-GMPIDMWSLGCILAELLT-GYPL 298

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 21/243 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 20  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 77  STKP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 135
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 136 SNNIFLHEDNT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++      PD + +   C   + R
Sbjct: 193 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIEMVGRGSLSPDLSKVRSNCPKRMKR 248
Query: 261 IFV 263
           +  
Sbjct: 249 LMA 251

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 19/242 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 44  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 101 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYD--GKI 201
             N  L       +KI DFG +      S   Q +   G+  ++APEV+   + +     
Sbjct: 160 SNNIFLHEDLT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R+
Sbjct: 218 SDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRL 273
Query: 262 FV 263
Sbjct: 274 MA 275

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 13/219 (5%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI 70
           G  + +P  H + RY+ ++ IG G+FG      D    + VA+K +    +       EI
Sbjct: 85  GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 71  INHRSLRHP------NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEAR 122
                LR        N++   E      H+ +  E  S    EL ++    G FS    R
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVR 203
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
            F   ++  +   H  ++ H DLK EN LL       +K+ DFG   S   H +  + + 
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTXIQ 261
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
           +  Y APEV+L   Y G   D+WS G  L  +L  GYP 
Sbjct: 262 SRFYRAPEVILGARY-GMPIDMWSLGCILAELLT-GYPL 298

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 109/242 (45%), Gaps = 21/242 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 21  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 78  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 136
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 137 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R
Sbjct: 194 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 249
Query: 261 IF 262
           + 
Sbjct: 250 LM 251

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 109/243 (44%), Gaps = 21/243 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 43  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 100 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 158
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 159 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R
Sbjct: 216 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 271
Query: 261 IFV 263
           +  
Sbjct: 272 LMA 274

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 21/241 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 18  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 75  STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 133
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 134 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R
Sbjct: 191 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 246
Query: 261 I 261
           +
Sbjct: 247 L 247

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 109/243 (44%), Gaps = 21/243 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 44  IGSGSFGT--VYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
              P  LAIV ++  G  L+  +     +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 101 STKP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLK 159
Query: 147 LENTLLDGSPAPRLKICDFGY----SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GK 200
             N  L       +KI DFG     S+ S  H Q +   G+  ++APEV+   + +    
Sbjct: 160 SNNIFLHEDLT--VKIGDFGLATVKSRWSGSH-QFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
            +DV++ G+ LY ++ G  P+ + +     R  I  ++   Y  PD + +   C   + R
Sbjct: 217 QSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 272
Query: 261 IFV 263
           +  
Sbjct: 273 LMA 275

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    S     +   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  DP +       +  +L   Y +       ++  +L+  
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 245
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 246 CWQWNPSDRPSFAEI--HQAF 264

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/325 (22%), Positives = 131/325 (40%), Gaps = 70/325 (21%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           S +Y   + +G+G+FG+   + D  + +  A+K + +  +      RE+   + L H NI
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NRELDIMKVLDHVNI 62
Query: 82  VRF-----------------------------------KEVILTPT---HLAIVMEYASG 103
           ++                                    K VI+ P+   +L ++MEY   
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 104 G--ELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
              ++ +    +GR    +    +  QL   V + H++ +CHRD+K +N L++ S    L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN-SKDNTL 181
Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGY 219
           K+CDFG +K  +      + + +  Y APE++L   EY   I D+WS G     +++G  
Sbjct: 182 KLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKP 240
Query: 220 PFEDPDEPKDFRKTIQRILS-VQYSVPDTNPISQECR----------------------D 256
            F          + IQ + +  +  +   NP   E R                      D
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID 300
Query: 257 LISRIFVADPAARITIPEIMKHQWF 281
           L+ +I   +P  RI   E M H +F
Sbjct: 301 LLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSL 76
           + RY+ V +IG G +G     RD  +   VA+K +     E G  I  +  RE+   R L
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRL 60
Query: 77  R---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQ 126
               HPN+VR  +V  T        + +V E+         ++    G    +  +   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 119
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
           Q + G+ + HA  + HRDLK EN L+       +K+ DFG ++           V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALAPVVVTLWY 177
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVML 215
            APEVLL+  Y   + D+WS G     M 
Sbjct: 178 RAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVR 83
           +  IGSG FG       ++   + A+K  ++   G   ++N  RE+  H  L +H ++VR
Sbjct: 12  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 71
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQ 139
           +        H+ I  EY +GG L + I    R    F E E +    Q+  G+ Y H+M 
Sbjct: 72  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 131
Query: 140 VCHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSVLHSQPKSTVG 182
           + H D+K  N  +  +  P                   KI D G+       S P+   G
Sbjct: 132 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEG 188
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRK-TIQRILSV 240
              ++A EVL  +      AD+++  +T+ V   G  P   + D+  + R+  + RI  V
Sbjct: 189 DSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPLPRNGDQWHEIRQGRLPRIPQV 247
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
                    +SQE  +L+  +   DP  R +   ++KH   L
Sbjct: 248 ---------LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 280

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSL 76
           + RY+ V +IG G +G     RD  +   VA+K +     E G  I  +  RE+   R L
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRL 60
Query: 77  R---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQ 126
               HPN+VR  +V  T        + +V E+         ++    G    +  +   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 119
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
           Q + G+ + HA  + HRDLK EN L+       +K+ DFG ++           V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALDPVVVTLWY 177
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVML 215
            APEVLL+  Y   + D+WS G     M 
Sbjct: 178 RAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 226
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 283
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVR 83
           +  IGSG FG       ++   + A+K  ++   G   ++N  RE+  H  L +H ++VR
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQ 139
           +        H+ I  EY +GG L + I    R    F E E +    Q+  G+ Y H+M 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 140 VCHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSVLHSQPKSTVG 182
           + H D+K  N  +  +  P                   KI D G+       S P+   G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEG 190
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRK-TIQRILSV 240
              ++A EVL  +      AD+++  +T+ V   G  P   + D+  + R+  + RI  V
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRIPQV 249
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
                    +SQE  +L+  +   DP  R +   ++KH   L
Sbjct: 250 ---------LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 122/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VGT  Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 236
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/282 (25%), Positives = 118/282 (41%), Gaps = 40/282 (14%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSL-RHPNIVR 83
           +  IGSG FG       ++   + A+K  ++   G   ++N  RE+  H  L +H ++VR
Sbjct: 14  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 73
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHAMQ 139
           +        H+ I  EY +GG L + I    R    F E E +    Q+  G+ Y H+M 
Sbjct: 74  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS 133
Query: 140 VCHRDLKLENTLLDGSPAPR-----------------LKICDFGYSKSSVLHSQPKSTVG 182
           + H D+K  N  +  +  P                   KI D G+       S P+   G
Sbjct: 134 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI---SSPQVEEG 190
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKT-IQRILSV 240
              ++A EVL  +      AD+++  +T+ V   G  P   + D+  + R+  + RI  V
Sbjct: 191 DSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPLPRNGDQWHEIRQGRLPRIPQV 249
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
                    +SQE  +L+  +   DP  R +   ++KH   L
Sbjct: 250 ---------LSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/310 (25%), Positives = 134/310 (43%), Gaps = 34/310 (10%)
Query: 27  FVRDIGSGNFGVARLMR-DKVTKELVAVKY-------IERGDKIDENVQREIINHRSLRH 78
            +  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  +
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 190
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 188
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
            L    +    +D W  GVTL+ M   G   ++P    +  + + +I      +P     
Sbjct: 189 SLKTRTF-SHASDTWMFGVTLWEMFTYG---QEPWIGLNGSQILHKIDKEGERLPRPEDC 244
Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ-PMQSV 309
            Q+  +++ + +   P  R T   +    + L+  P D+         +EEPD+  +Q  
Sbjct: 245 PQDIYNVMVQCWAHKPEDRPTF--VALRDFLLEAQPTDM----RALQDFEEPDKLHIQMN 298
Query: 310 DVIMQIIAEA 319
           DVI  I   A
Sbjct: 299 DVITVIEGRA 308

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 121/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 30  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPK-------STVGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP        S VGT  Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDXXXVVKDSQVGTVNYMPPE 198
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 255
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 111/261 (42%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I++E+ + G L +  R CN    S     +   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  DP +       +  +L   Y +       ++  +L+  
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 245
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 246 CWQWNPSDRPSFAEI--HQAF 264

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRHP 79
           D Y+    IG G++G   L  DK   + VA+K + R   D ID + + REI     L+  
Sbjct: 28  DNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 80  NIVRFKEVI-----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            I+R  ++I     L    L IV+E A   +L +        +E   +     L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------------------------ 170
            H   + HRDLK  N LL+   +  +KICDFG +++                        
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCS--VKICDFGLARTINSDKDIHIVNDLEEKEENEEPGP 204
Query: 171 --SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
               L  Q  S V T  Y APE++L  E      D+WS G     +L
Sbjct: 205 HNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG ++  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLAR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSL 76
           + RY+ V +IG G +G     RD  +   VA+K +     E G  I  +  RE+   R L
Sbjct: 3   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI--STVREVALLRRL 60
Query: 77  R---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQ 126
               HPN+VR  +V  T        + +V E+         ++    G    +  +   +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLMR 119
Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
           Q + G+ + HA  + HRDLK EN L+       +K+ DFG ++           V T  Y
Sbjct: 120 QFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALFPVVVTLWY 177
Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVML 215
            APEVLL+  Y   + D+WS G     M 
Sbjct: 178 RAPEVLLQSTYATPV-DMWSVGCIFAEMF 205

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV EY   G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG  +  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 91/219 (41%), Gaps = 13/219 (5%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI 70
           G  + +P  H + RY+ ++ IG G FG      D    + VA+K +    +       EI
Sbjct: 85  GSYVQVPHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEI 144
Query: 71  INHRSLRHP------NIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEAR 122
                LR        N++   E      H+ +  E  S    EL ++    G FS    R
Sbjct: 145 RILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVR 203
Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
            F   ++  +   H  ++ H DLK EN LL       +K+ DFG   S   H +    + 
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYXXIQ 261
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
           +  Y APEV+L   Y G   D+WS G  L  +L  GYP 
Sbjct: 262 SRFYRAPEVILGARY-GMPIDMWSLGCILAELLT-GYPL 298

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N L+D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVLIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 25  YDFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHP 79
           Y+ +  IG G  +     L R K T E V V+ I      +E V   Q E+   +   HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHA 137
           NIV ++   +    L +V  + + G   + IC       +E    +  Q ++  + Y H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 138 MQVCHRDLKLENTLL--DG-----SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 147 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 205
Query: 191 VLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 223
           VL ++   YD K +D++S G+T   +  G  PF+D
Sbjct: 206 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 239

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 18/215 (8%)
Query: 25  YDFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDKIDENV---QREIINHRSLRHP 79
           Y+ +  IG G  +     L R K T E V V+ I      +E V   Q E+   +   HP
Sbjct: 11  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 70
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHA 137
           NIV ++   +    L +V  + + G   + IC       +E    +  Q ++  + Y H 
Sbjct: 71  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 130
Query: 138 MQVCHRDLKLENTLL--DG-----SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
           M   HR +K  + L+  DG          L +   G  +  V+H  PK +V    +++PE
Sbjct: 131 MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG-QRQRVVHDFPKYSVKVLPWLSPE 189
Query: 191 VLLRH--EYDGKIADVWSCGVTLYVMLVGGYPFED 223
           VL ++   YD K +D++S G+T   +  G  PF+D
Sbjct: 190 VLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 223

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 29  RDIGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNI 81
           R IG+G FG     R K+   +EL VA+K ++ G    E  +R+ +   S+     HPNI
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNI 85
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +  + V+     + IV EY   G L   +  N G+F+  +     + + +G+ Y   M  
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGY 145
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLR 194
            HRDL   N L++ +     K+ DFG S+  VL   P++   T        + APE +  
Sbjct: 146 VHRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            ++    +DVWS G+ ++ V+  G  P+
Sbjct: 202 RKFTSA-SDVWSYGIVMWEVVSYGERPY 228

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRS 75
           + RY+ V +IG G +G     RD  +   VA+K +   +       +  +  RE+   R 
Sbjct: 8   TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 76  LR---HPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFF 125
           L    HPN+VR  +V  T        + +V E+         ++    G    +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126
Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
           +Q + G+ + HA  + HRDLK EN L+       +K+ DFG ++           V T  
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSYQMALTPVVVTLW 184
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVML 215
           Y APEVLL+  Y   + D+WS G     M 
Sbjct: 185 YRAPEVLLQSTYATPV-DMWSVGCIFAEMF 213

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 78
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    S     +   Q+ S + Y       HRDL   
Sbjct: 79  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 138
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 139 NCLVGENHL--VKVADFGLSRLMTGDTFTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 192
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  DP +       +  +L   Y +       ++  +L+  
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 245
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 246 CWQWNPSDRPSFAEI--HQAF 264

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 121/278 (43%), Gaps = 38/278 (13%)
Query: 25  YDFVRDIGSGNFG-VARLMRDKVTKELVAVKYI---ERGDKIDENVQREI--INHRSLRH 78
           Y  ++ IGSG    V +++ +K  K++ A+KY+   E  ++  ++ + EI  +N      
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEK--KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKST-------VGTPAYIAPE 190
            + H DLK  N L+ DG     LK+ DFG +       QP +T       VG   Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG----MLKLIDFGIAN----QMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 191 VL----------LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
            +                   +DVWS G  LY M  G  PF+   +  +    +  I+  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ---QIINQISKLHAIIDP 283
Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
            + +   +   ++ +D++      DP  RI+IPE++ H
Sbjct: 284 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGAV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 153
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 154 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 272
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 273 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 146
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 140
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 141 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 197 KFTSA-SDVWSYGIVLWEVMSYGERPY 222

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 147
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 20/227 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-NVQ-REIINHRSLRHPNIVRF--KE 86
           +G G        R K T +L A+K       +   +VQ RE    + L H NIV+    E
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 87  VILTPTHLAIVMEYASGGELF---ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              T  H  ++ME+   G L+   E   NA    E E     + ++ G+++     + HR
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHR 136
Query: 144 DLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV----LLRH 195
           ++K  N +     DG      K+ DFG ++      Q  S  GT  Y+ P++    +LR 
Sbjct: 137 NIKPGNIMRVIGEDGQSV--YKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRK 194
Query: 196 EYD---GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
           ++    G   D+WS GVT Y    G  PF   + P+  ++ + +I++
Sbjct: 195 DHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 28/220 (12%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLR-HP 79
           +Y+ V+ +G G +G+     D+ T E+VAVK I    +   + Q   REI+    L  H 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIV    V+       + + +         +  A        ++   QLI  + Y H+  
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGG 129
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKST-------------- 180
           + HRD+K  N LL+      +K+ DFG S+S      V ++ P S               
Sbjct: 130 LLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 181 ---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
              V T  Y APE+LL      K  D+WS G  L  +L G
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLRQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 79  PNIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PNI+   +++  P     A+V E+ +  + F+++      ++ + RF+  +++  + YCH
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           +M + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSV---P 245
                 D+WS G  L  M+    PF    +  D    I ++L  +        Y++   P
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 267
Query: 246 DTNPI---------------------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
             N I                     S E  D + ++   D  +R+T  E M+H +F
Sbjct: 268 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 31  IGSGNFGVARLMRDKV--TKEL-VAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           +G+G FG     R K+   KE+ VA+K ++ G    E  +R+ +   S+     HPNI+R
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+     + IV E    G L  F R  +A +F+  +     + + SG+ Y   M   
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMGYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++   T        + +PE +   
Sbjct: 170 HRDLAARNILINSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ L+ VM  G  P+
Sbjct: 226 KFTSA-SDVWSYGIVLWEVMSYGERPY 251

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 29/298 (9%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMR-DKVTKELVAVKY-------IERGDKI 62
           GP   +  +        +  +G G+FGV R    D  + + V+V         + + + +
Sbjct: 6   GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEA 121
           D+ + RE+    SL H N++R   V+LTP  + +V E A  G L +R+  + G F     
Sbjct: 66  DDFI-REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLH 174
             +  Q+  G+ Y  + +  HRDL   N LL  +    +KI DFG  ++        V+ 
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQ 181
Query: 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
              K      A+ APE L    +    +D W  GVTL+ M   G   ++P    +  + +
Sbjct: 182 EHRKVPF---AWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYG---QEPWIGLNGSQIL 234
Query: 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
            +I      +P      Q+  +++ + +   P  R T   +    + L+  P D+  E
Sbjct: 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF--VALRDFLLEAQPTDMRAE 290

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 31  IGSGNFG---VARLMRDKVTKEL-VAVKYIERG----DKIDENVQREIINHRSLRHPNIV 82
           IG+G FG      L      KE+ VA+K ++ G     ++D   +  I+   S  H NI+
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS--HHNII 109
Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVC 141
           R + VI     + I+ EY   G L + +    G FS  +     + + +G+ Y   M   
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLLRH 195
           HRDL   N L++ +     K+ DFG S+  VL   P++T  T        + APE +   
Sbjct: 170 HRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++    +DVWS G+ ++ VM  G  P+
Sbjct: 226 KFTSA-SDVWSFGIVMWEVMTYGERPY 251

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFK 85
           +G G FGV  + +  V    VAVK +        +++ +   +EI      +H N+V   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 86  EVILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDG 199
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE  LR E   
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEA-LRGEITP 213
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
           K +D++S GV L  ++ G    ++  EP+
Sbjct: 214 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFK 85
           +G G FGV  + +  V    VAVK +        +++ +   +EI      +H N+V   
Sbjct: 39  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 86  EVILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 156
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDG 199
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE  LR E   
Sbjct: 157 RDIKSANILLD--EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEA-LRGEITP 213
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
           K +D++S GV L  ++ G    ++  EP+
Sbjct: 214 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 126/298 (42%), Gaps = 29/298 (9%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMR-DKVTKELVAVKY-------IERGDKI 62
           GP   +  +        +  +G G+FGV R    D  + + V+V         + + + +
Sbjct: 6   GPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEA 121
           D+ + RE+    SL H N++R   V+LTP  + +V E A  G L +R+  + G F     
Sbjct: 66  DDFI-REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTL 123
Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLH 174
             +  Q+  G+ Y  + +  HRDL   N LL  +    +KI DFG  ++        V+ 
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
              K      A+ APE L    +    +D W  GVTL+ M   G   ++P    +  + +
Sbjct: 182 EHRKVPF---AWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYG---QEPWIGLNGSQIL 234
Query: 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
            +I      +P      Q+  +++ + +   P  R T   +    + L+  P D+  E
Sbjct: 235 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTF--VALRDFLLEAQPTDMRAE 290

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFK 85
           +G G FGV  + +  V    VAVK +        +++ +   +EI      +H N+V   
Sbjct: 33  MGEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 86  EVILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHAMQVCH 142
                   L +V  Y   G L +R+ C  G    S        Q   +G+++ H     H
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIH 150
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDG 199
           RD+K  N LLD   A   KI DFG +++S   +Q       VGT AY+APE  LR E   
Sbjct: 151 RDIKSANILLD--EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEA-LRGEITP 207
Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
           K +D++S GV L  ++ G    ++  EP+
Sbjct: 208 K-SDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKEL---VAVKYIERGDKIDENVQREIINHRSLR 77
           ++ R    + IGSG+ G     R +V  +    VA+K ++ G    E  +R+ ++  S+ 
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIM 104
Query: 78  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 131
               HPNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAG 163
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
           + Y   +   HRDL   N L+D +     K+ DFG S+  VL   P +   T        
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAXTTTGGKIPIR 219
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
           + APE +    +    +DVWS GV ++ +L  G
Sbjct: 220 WTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYG 251

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKEL---VAVKYIERGDKIDENVQREIINHRSLR 77
           ++ R    + IGSG+ G     R +V  +    VA+K ++ G    E  +R+ ++  S+ 
Sbjct: 47  EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIM 104
Query: 78  ----HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 131
               HPNI+R + V+       IV EY   G L  F R  + G+F+  +     + + +G
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAG 163
Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
           + Y   +   HRDL   N L+D +     K+ DFG S+  VL   P +   T        
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSR--VLEDDPDAAYTTTGGKIPIR 219
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
           + APE +    +    +DVWS GV ++ +L  G
Sbjct: 220 WTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYG 251

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 119/272 (43%), Gaps = 19/272 (6%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSL 76
           +D  + + ++G G +GV    R   + ++ AVK I     ++   Q+ +     I+ R++
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRA--TVNSQEQKRLLXDLDISXRTV 90
Query: 77  RHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGR-FSEDEARFFFQQLISGVS 133
             P  V F   +     + I  E    S  + ++++ + G+   ED        ++  + 
Sbjct: 91  DCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 150
Query: 134 YCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
           + H+ + V HRD+K  N L++     ++K CDFG S   V         G   Y APE +
Sbjct: 151 HLHSKLSVIHRDVKPSNVLINA--LGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERI 208
Query: 193 ---LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
              L  +     +D+WS G+T   + +  +P++    P  F++  Q +      +P  + 
Sbjct: 209 NPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTP--FQQLKQVVEEPSPQLP-ADK 265
Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            S E  D  S+    +   R T PE+ +H +F
Sbjct: 266 FSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 20/215 (9%)
Query: 43  RDKVTKELVAVKYIERGDKIDE-NVQ-REIINHRSLRHPNIVRF--KEVILTPTHLAIVM 98
           R K T +L A+K       +   +VQ RE    + L H NIV+    E   T  H  ++M
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88
Query: 99  EYASGGELF---ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL--- 152
           E+   G L+   E   NA    E E     + ++ G+++     + HR++K  N +    
Sbjct: 89  EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIG 148
Query: 153 -DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV----LLRHEYD---GKIADV 204
            DG      K+ DFG ++      Q     GT  Y+ P++    +LR ++    G   D+
Sbjct: 149 EDGQSV--YKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDL 206
Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
           WS GVT Y    G  PF   + P+  ++ + +I++
Sbjct: 207 WSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 32  GSGNFGVARLMRDKVTKELVAVKYIE-----RGDKIDENVQREIINHRSLRHPNIVRFKE 86
           G G FGV  + +  V    VAVK +        +++ +   +EI      +H N+V    
Sbjct: 31  GEGGFGV--VYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 87  VILTPTHLAIVMEYASGGELFERI-CNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHR 143
                  L +V  Y   G L +R+ C  G    S        Q   +G+++ H     HR
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIHR 148
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGK 200
           D+K  N LLD   A   KI DFG +++S   +Q       VGT AY APE  LR E   K
Sbjct: 149 DIKSANILLD--EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEA-LRGEITPK 205
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPK 228
            +D++S GV L  ++ G    ++  EP+
Sbjct: 206 -SDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 33/286 (11%)
Query: 13  AMDMPIMHDSDRYDFVR-------DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN 65
           AMD P   + D+++  R        +G G +G       K     VAVK ++      E 
Sbjct: 2   AMD-PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF 123
             +E    + ++HPN+V+   V        I+ E+ + G L +  R CN    S     +
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 120
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 178
              Q+ S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAK 178
Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQ 235
             +    + APE L  +++  K +DVW+ GV L+ +   G   YP  D  +       + 
Sbjct: 179 FPI---KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VY 227
Query: 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            +L   Y +       ++  +L+   +  +P+ R +  EI  HQ F
Sbjct: 228 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAF 271

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 49/250 (19%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------------DENVQ 67
           RY  VR +G G+F    L +D V    VA+K I RGDK+                D +  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 68  RE----------IINHRSLRHPNIVRFKEV--ILTPTHLAIVMEYASGGELFERICNAGR 115
           +E          +++H + + PN V    V  +L    LA++ +Y   G     +    +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 116 FSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAP----RLKICDFGYSKS 170
                      QL+ G+ Y H    + H D+K EN L++   +P    ++KI D G   +
Sbjct: 139 -----------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
                   +++ T  Y +PEVLL   + G  AD+WS    ++ ++ G + FE PDE   +
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHSY 243
Query: 231 RKTIQRILSV 240
            K    I  +
Sbjct: 244 TKDDDHIAQI 253

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 49/250 (19%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------------DENVQ 67
           RY  VR +G G+F    L +D V    VA+K I RGDK+                D +  
Sbjct: 20  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 68  RE----------IINHRSLRHPNIVRFKEV--ILTPTHLAIVMEYASGGELFERICNAGR 115
           +E          +++H + + PN V    V  +L    LA++ +Y   G     +    +
Sbjct: 79  KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 138
Query: 116 FSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAP----RLKICDFGYSKS 170
                      QL+ G+ Y H    + H D+K EN L++   +P    ++KI D G   +
Sbjct: 139 -----------QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NA 185
Query: 171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
                   +++ T  Y +PEVLL   + G  AD+WS    ++ ++ G + FE PDE   +
Sbjct: 186 CWYDEHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE-PDEGHSY 243
Query: 231 RKTIQRILSV 240
            K    I  +
Sbjct: 244 TKDDDHIAQI 253

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 26/211 (12%)
Query: 31  IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           IG+G FG      L      +  VA+K ++ G    E  +R+ ++  S+     HPN++ 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 157
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 193
           HRDL   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 158 HRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
             ++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 214 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 243

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 117/264 (44%), Gaps = 22/264 (8%)
Query: 30  DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-----RSLRHPNIVRF 84
           +IG G+F       D  T+  V V + E  D+     +R+         + L+HPNIVRF
Sbjct: 33  EIGRGSFKTVYKGLD--TETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRF 90
Query: 85  ----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ- 139
               +  +     + +V E  + G L   +           R + +Q++ G+ + H    
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 140 -VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + HRDLK +N  + G P   +KI D G + +    S  K+ +GTP + APE     +YD
Sbjct: 151 PIIHRDLKCDNIFITG-PTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEX-YEEKYD 207
Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-VQYSVPDTNPISQECRDL 257
             + DV++ G          YP+    E ++  +  +R+ S V+ +  D   I  E +++
Sbjct: 208 ESV-DVYAFGXCXLEXATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAIP-EVKEI 262
Query: 258 ISRIFVADPAARITIPEIMKHQWF 281
           I      +   R +I +++ H +F
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFF 286

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 108/258 (41%), Gaps = 19/258 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 149 NTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
           N L+  +    +K+ DFG S+  +   ++ P        + APE L  +++  K +DVW+
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVWA 198
Query: 207 CGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263
            GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+   + 
Sbjct: 199 FGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 264 ADPAARITIPEIMKHQWF 281
            +P+ R +  EI  HQ F
Sbjct: 252 WNPSDRPSFAEI--HQAF 267

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 27  FVRDIGSGNFGVARLMR-DKVTKELVAVKY-------IERGDKIDENVQREIINHRSLRH 78
            +  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  +
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 190
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF---AWCAPE 184
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG 218
            L    +    +D W  GVTL+ M   G
Sbjct: 185 SLKTRTF-SHASDTWMFGVTLWEMFTYG 211

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 78  HPNIVRF--KEVILTPTHLAIVMEYASGGELFER--ICNAGRFSEDEARFFFQQLISGVS 133
           HPN++R+   E      ++AI +  A+  E  E+    + G     E     QQ  SG++
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGL----EPITLLQQTTSGLA 132
Query: 134 YCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVL----HSQPKSTVGTPAY 186
           + H++ + HRDLK  N L+   +     +  I DFG  K   +     S+     GT  +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 187 IAPEVLLR--HEYDGKIADVWSCG-VTLYVMLVGGYPFEDPDEPKDFRKTIQR---ILSV 240
           IAPE+L     E      D++S G V  YV+  G +PF          K++QR   IL  
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG---------KSLQRQANILLG 243
Query: 241 QYSVPDTNPISQE---CRDLISRIFVADPAARITIPEIMKHQWF 281
             S+   +P   E    R+LI ++   DP  R +   ++KH +F
Sbjct: 244 ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 33/286 (11%)
Query: 13  AMDMPIMHDSDRYDFVR-------DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN 65
           AMD P   + D+++  R        +G G +G       K     VAVK ++      E 
Sbjct: 2   AMD-PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF 123
             +E    + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 178
              Q+ S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAK 178
Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQ 235
             +    + APE L  +++  K +DVW+ GV L+ +   G   YP  D  +       + 
Sbjct: 179 FPI---KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VY 227
Query: 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            +L   Y +       ++  +L+   +  +P+ R +  EI  HQ F
Sbjct: 228 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAF 271

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/258 (24%), Positives = 108/258 (41%), Gaps = 19/258 (7%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 149 NTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
           N L+  +    +K+ DFG S+  +   ++ P        + APE L  +++  K +DVW+
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK-SDVWA 199
Query: 207 CGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263
            GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+   + 
Sbjct: 200 FGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRACWQ 252
Query: 264 ADPAARITIPEIMKHQWF 281
            +P+ R +  EI  HQ F
Sbjct: 253 WNPSDRPSFAEI--HQAF 268

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I++E+ + G L +  R CN    S     +   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+  
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 248 CWQWNPSDRPSFAEI--HQAF 266

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 110/261 (42%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I++E+ + G L +  R CN    S     +   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+  
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 248 CWQWNPSDRPSFAEI--HQAF 266

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 129
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 130 SGVSYCHAMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 173
           SGV++ H++++ HRDLK +N L+            G+   R+ I DFG  K      S  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDG--------KIADVWSCGVTLYVMLV-GGYPFEDP 224
            +   +  GT  + APE+L   E +         +  D++S G   Y +L  G +PF D 
Sbjct: 186 RTNLNNPSGTSGWRAPELL--EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 225 DEPKDFRKTIQRILSV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
              +     I+ I S+ +        +  E  DLIS++   DP  R T  ++++H  F
Sbjct: 244 YSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 29  RDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR----HPNI 81
           R IG+G FG     RL         VA+K ++ G    E  +R+ +   S+     HPN+
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVG--YTEKQRRDFLCEASIMGQFDHPNV 106
Query: 82  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           V  + V+     + IV+E+   G L  F R  + G+F+  +     + + +G+ Y   M 
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRK-HDGQFTVIQLVGMLRGIAAGMRYLADMG 165
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPEVLL 193
             HRDL   N L++ +     K+ DFG S+  V+   P++   T        + APE + 
Sbjct: 166 YVHRDLAARNILVNSNLV--CKVSDFGLSR--VIEDDPEAVYTTTGGKIPVRWTAPEAIQ 221
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
             ++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 222 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 251

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 27  FVRDIGSGNFGVARLMR-DKVTKELVAVKY-------IERGDKIDENVQREIINHRSLRH 78
            +  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  +
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 190
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 184
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG 218
            L    +    +D W  GVTL+ M   G
Sbjct: 185 SLKTRTF-SHASDTWMFGVTLWEMFTYG 211

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 102/237 (43%), Gaps = 40/237 (16%)
Query: 80  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           NI++  + +  P     A+V EY +  + F+++      ++ + RF+  +L+  + YCH+
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 155
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++ 
Sbjct: 156 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSVPDTNP 249
                D+WS G  L  M+    PF    +  D    I ++L  +        Y + D +P
Sbjct: 215 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI-DLDP 273
Query: 250 -------------------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                                    +S E  DL+ ++   D   R+T  E M+H +F
Sbjct: 274 HFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 27  FVRDIGSGNFGVARLMR-DKVTKELVAVKY-------IERGDKIDENVQREIINHRSLRH 78
            +  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 16  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 74
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  +
Sbjct: 75  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 190
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 134 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 188
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG 218
            L    +    +D W  GVTL+ M   G
Sbjct: 189 SLKTRTFS-HASDTWMFGVTLWEMFTYG 215

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/237 (21%), Positives = 102/237 (43%), Gaps = 40/237 (16%)
Query: 80  NIVRFKEVILTPTHL--AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           NI++  + +  P     A+V EY +  + F+++      ++ + RF+  +L+  + YCH+
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINNTD-FKQLYQI--LTDFDIRFYMYELLKALDYCHS 150
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++ 
Sbjct: 151 KGIMHRDVKPHNVMIDHQ-QKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------YSVPDTNP 249
                D+WS G  L  M+    PF    +  D    I ++L  +        Y + D +P
Sbjct: 210 YDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHI-DLDP 268
Query: 250 -------------------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                                    +S E  DL+ ++   D   R+T  E M+H +F
Sbjct: 269 HFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    S     +   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+  
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 248 CWQWNPSDRPSFAEI--HQAF 266

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 33/286 (11%)
Query: 13  AMDMPIMHDSDRYDFVR-------DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN 65
           AMD P   + D+++  R        +G G +G       K     VAVK ++      E 
Sbjct: 2   AMD-PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARF 123
             +E    + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 120
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPK 178
              Q+ S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAK 178
Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQ 235
             +    + APE L  +++  K +DVW+ GV L+ +   G   YP  D  +       + 
Sbjct: 179 FPI---KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VY 227
Query: 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            +L   Y +       ++  +L+   +  +P+ R +  EI  HQ F
Sbjct: 228 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAF 271

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 27  FVRDIGSGNFGVARLMR-DKVTKELVAVKY-------IERGDKIDENVQREIINHRSLRH 78
            +  +G G+FGV R    D  + + V+V         + + + +D+ + RE+    SL H
Sbjct: 12  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-REVNAMHSLDH 70
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
            N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  +
Sbjct: 71  RNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------SVLHSQPKSTVGTPAYIAPE 190
            +  HRDL   N LL  +    +KI DFG  ++        V+    K      A+ APE
Sbjct: 130 KRFIHRDLAARNLLL--ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF---AWCAPE 184
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGG 218
            L    +    +D W  GVTL+ M   G
Sbjct: 185 SLKTRTF-SHASDTWMFGVTLWEMFTYG 211

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 129
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 130 SGVSYCHAMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 173
           SGV++ H++++ HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIA---DVWSCGVTLYVMLV-GGYPFEDPDEPKD 229
                +  GT  + APE LL      ++    D++S G   Y +L  G +PF D    + 
Sbjct: 204 RXNLNNPSGTSGWRAPE-LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 230 FRKTIQRILSV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
               I+ I S+ +        +  E  DLIS++   DP  R T  ++++H  F
Sbjct: 263 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 129
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 86  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 130 SGVSYCHAMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 173
           SGV++ H++++ HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIA---DVWSCGVTLYVMLV-GGYPFEDPDEPKD 229
                +  GT  + APE LL      ++    D++S G   Y +L  G +PF D    + 
Sbjct: 204 RXNLNNPSGTSGWRAPE-LLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 262
Query: 230 FRKTIQRILSV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
               I+ I S+ +        +  E  DLIS++   DP  R T  ++++H  F
Sbjct: 263 --NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 110/261 (42%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 81
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I++E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 82  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 141
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 142 NCLVGENHL--VKVADFGLSRLMTGDTXTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 195
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+  
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 248
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 249 CWQWNPSDRPSFAEI--HQAF 267

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    S     +   Q+ S + Y       HRDL   
Sbjct: 81  EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 141 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 194
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+  
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 247
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 248 CWQWNPSDRPSFAEI--HQAF 266

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 113/275 (41%), Gaps = 36/275 (13%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF------ 84
           IGSG FG     + ++  +   +K ++  +   E  +RE+     L H NIV +      
Sbjct: 19  IGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDG 75
Query: 85  ---------KEVILTPTH-LAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGV 132
                    K    + T  L I ME+   G L + I      +  +  A   F+Q+  GV
Sbjct: 76  FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            Y H+ ++ +RDLK  N  L      ++KI DFG   S     +   + GT  Y++PE +
Sbjct: 136 DYIHSKKLINRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 193 LRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
              +Y GK  D+++ G+ L  +L V    FE      D R  I            ++   
Sbjct: 194 SSQDY-GKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII-----------SDIFD 241
Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++ + L+ ++    P  R    EI++     K  P
Sbjct: 242 KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 110/259 (42%), Gaps = 21/259 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I++E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 204 VWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           VW+ GV L+ +   G  P+   D  +     +  +L   Y +       ++  +L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 263 VADPAARITIPEIMKHQWF 281
             +P+ R +  EI  HQ F
Sbjct: 255 QWNPSDRPSFAEI--HQAF 271

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 104/267 (38%), Gaps = 39/267 (14%)
Query: 30  DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFKEV 87
            IG GNFG     R +    LVAVK        D   +  +E    +   HPNIVR   V
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQV 140
                 + IVME   GG+    +   G      AR   + L+       +G+ Y  +   
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLRHEY 197
            HRDL   N L+       LKI DFG S+     +++        P  + APE L    Y
Sbjct: 235 IHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 198 DGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
             + +DVWS G+ L+     G   YP     + ++F +   R+           P  + C
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-----------PCPELC 340
Query: 255 RDLISRI----FVADPAARITIPEIMK 277
            D + R+    +  +P  R +   I +
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 30  DIGSGNFGVAR--LMRDKVTKELVAVKYIERG-DKID-ENVQREIINHRSLRHPNIVRFK 85
           ++G GNFG  R  + R +  +  VA+K +++G +K D E + RE      L +P IVR  
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYCHAMQVCH 142
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLRHEYD 198
           RDL   N LL        KI DFG SK+      +   +S    P  + APE +   ++ 
Sbjct: 134 RDLAARNVLLVNRHYA--KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 199 GKIADVWSCGVTLYVML-VGGYPFEDPDEPK 228
            + +DVWS GVT++  L  G  P++    P+
Sbjct: 192 SR-SDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/280 (23%), Positives = 115/280 (41%), Gaps = 22/280 (7%)
Query: 10  VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE 69
           V P  D   M  +D       +G G +G       K     VAVK ++      E   +E
Sbjct: 1   VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 59
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 127
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 119
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
           + S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 176
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
              + APE L  +++  K +DVW+ GV L+ +   G  P+   D  +     +  +L   
Sbjct: 177 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKD 228
Query: 242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
           Y +       ++  +L+   +  +P+ R +  EI  HQ F
Sbjct: 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAF 266

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 105/261 (40%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G   +   K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTL 99
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                IV EY   G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 100 EPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 159
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  + +  K +D
Sbjct: 160 NCLVGENHV--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNTFSIK-SD 213
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  D  +  D  +   R+   +   P    + + C      
Sbjct: 214 VWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRAC------ 267
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +   PA R +  E   HQ F
Sbjct: 268 -WKWSPADRPSFAET--HQAF 285

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 21/259 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 85
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 86  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 145
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 146 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 199
Query: 204 VWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           VW+ GV L+ +   G  P+   D  +     +  +L   Y +       ++  +L+   +
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACW 254
Query: 263 VADPAARITIPEIMKHQWF 281
             +P+ R +  EI  HQ F
Sbjct: 255 QWNPSDRPSFAEI--HQAF 271

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 26/282 (9%)
Query: 10  VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE 69
           V P  D   M  +D       +G G +G       K     VAVK ++      E   +E
Sbjct: 1   VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 59
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 127
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 119
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
           + S + Y       HRDL   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 176
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILS 239
              + APE L  +++  K +DVW+ GV L+ +   G   YP  D  +       +  +L 
Sbjct: 177 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 226
Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             Y +       ++  +L+   +  +P+ R +  EI  HQ F
Sbjct: 227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAF 266

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 21/259 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 85  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 145 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 198
Query: 204 VWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           VW+ GV L+ +   G  P+   D  +     +  +L   Y +       ++  +L+   +
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 263 VADPAARITIPEIMKHQWF 281
             +P+ R +  EI  HQ F
Sbjct: 254 QWNPSDRPSFAEI--HQAF 270

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 80/302 (26%), Positives = 132/302 (43%), Gaps = 45/302 (14%)
Query: 13  AMDMPIMHDSDRYDFV--RDIGSGNFGVARLM--------RDKVTKELVAVKYI-ERGDK 61
           AMD  + H   R++ V  R++G G FG   L         +DK+   LVAVK + +  D 
Sbjct: 2   AMDTFVQH-IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKI---LVAVKTLKDASDN 57
Query: 62  IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------- 114
             ++  RE     +L+H +IV+F  V +    L +V EY   G+L + +   G       
Sbjct: 58  ARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMA 117
Query: 115 ------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 168
                   ++ +     QQ+ +G+ Y  +    HRDL   N L+  +    +KI DFG S
Sbjct: 118 EGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMS 175
Query: 169 K---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDP 224
           +   S+  +     T+    ++ PE ++  ++  + +DVWS GV L+ +   G  P+   
Sbjct: 176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQL 234
Query: 225 DEPKDFRKTIQ-RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
              +      Q R+L      P T P  QE  +L+   +  +P  R  I  I      L+
Sbjct: 235 SNNEVIECITQGRVL----QRPRTCP--QEVYELMLGCWQREPHMRKNIKGIHT---LLQ 285
Query: 284 NL 285
           NL
Sbjct: 286 NL 287

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 21/259 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 196
Query: 204 VWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           VW+ GV L+ +   G  P+   D  +     +  +L   Y +       ++  +L+   +
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACW 251
Query: 263 VADPAARITIPEIMKHQWF 281
             +P+ R +  EI  HQ F
Sbjct: 252 QWNPSDRPSFAEI--HQAF 268

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 109/261 (41%), Gaps = 25/261 (9%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 82
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 83  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 142
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 143 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 196
Query: 204 VWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISR 260
           VW+ GV L+ +   G   YP  D  +       +  +L   Y +       ++  +L+  
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKDYRMERPEGCPEKVYELMRA 249
Query: 261 IFVADPAARITIPEIMKHQWF 281
            +  +P+ R +  EI  HQ F
Sbjct: 250 CWQWNPSDRPSFAEI--HQAF 268

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 109/259 (42%), Gaps = 21/259 (8%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   V   
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 93
Query: 91  PTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
                I+ E+ + G L +  R CN    +     +   Q+ S + Y       HRDL   
Sbjct: 94  EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 153
Query: 149 NTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           N L+  +    +K+ DFG S+     +   H+  K  +    + APE L  +++  K +D
Sbjct: 154 NCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYNKFSIK-SD 207
Query: 204 VWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
           VW+ GV L+ +   G  P+   D  +     +  +L   Y +       ++  +L+   +
Sbjct: 208 VWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEKDYRMERPEGCPEKVYELMRACW 262
Query: 263 VADPAARITIPEIMKHQWF 281
             +P+ R +  EI  HQ F
Sbjct: 263 QWNPSDRPSFAEI--HQAF 279

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 101/238 (42%), Gaps = 40/238 (16%)
Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--------FFQQLI 129
           HPN++R+     T   L I +E  +     + +  +   S++  +           +Q+ 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 130 SGVSYCHAMQVCHRDLKLENTLLD-----------GSPAPRLKICDFGYSKS-----SVL 173
           SGV++ H++++ HRDLK +N L+            G+   R+ I DFG  K         
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDG--------KIADVWSCGVTLYVMLV-GGYPFEDP 224
                +  GT  + APE+L   E +         +  D++S G   Y +L  G +PF D 
Sbjct: 186 RXNLNNPSGTSGWRAPELL--EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK 243
Query: 225 DEPKDFRKTIQRILSV-QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
              +     I+ I S+ +        +  E  DLIS++   DP  R T  ++++H  F
Sbjct: 244 YSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/267 (26%), Positives = 103/267 (38%), Gaps = 39/267 (14%)
Query: 30  DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRFKEV 87
            IG GNFG     R +    LVAVK        D   +  +E    +   HPNIVR   V
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGVSYCHAMQV 140
                 + IVME   GG+    +   G      AR   + L+       +G+ Y  +   
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLLRHEY 197
            HRDL   N L+       LKI DFG S+     + +        P  + APE L    Y
Sbjct: 235 IHRDLAARNCLVTEKNV--LKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 198 DGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
             + +DVWS G+ L+     G   YP     + ++F +   R+           P  + C
Sbjct: 293 SSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-----------PCPELC 340
Query: 255 RDLISRI----FVADPAARITIPEIMK 277
            D + R+    +  +P  R +   I +
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFSTIYQ 367

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 26/282 (9%)
Query: 10  VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE 69
           V P  D   M  +D       +G G +G       K     VAVK ++      E   +E
Sbjct: 208 VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 266
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 127
               + ++HPN+V+   V        I+ E+ + G L +  R CN    S     +   Q
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 326
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
           + S + Y       HR+L   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 327 ISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 383
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILS 239
              + APE L  +++  K +DVW+ GV L+ +   G   YP  D  +       +  +L 
Sbjct: 384 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 433
Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             Y +       ++  +L+   +  +P+ R +  EI  HQ F
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAF 473

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 31  IGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR----HPNIVR 83
           IG+G FG      L      +  VA+K ++ G    E  +R+ ++  S+     HPN++ 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 84  FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
            + V+   T + I+ E+   G L  F R  N G+F+  +     + + +G+ Y   M   
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLADMNYV 131
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA--------YIAPEVLL 193
           HR L   N L++ +     K+ DFG S+   L         T A        + APE + 
Sbjct: 132 HRALAARNILVNSNLV--CKVSDFGLSR--FLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
             ++    +DVWS G+ ++ VM  G  P+ D
Sbjct: 188 YRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 217

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 108/253 (42%), Gaps = 18/253 (7%)
Query: 27  FVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V+ +G+G FG V     +  TK  VAVK ++ G    +    E    ++L+H  +VR  
Sbjct: 17  LVKRLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+     + I+ EY + G L  F +    G+    +   F  Q+  G++Y       HR
Sbjct: 75  AVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  S +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 135 DLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 201 IADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
            +DVWS G+ LY ++  G  P+     P      +   LS  Y +P       E  D++ 
Sbjct: 192 -SDVWSFGILLYEIVTYGKIPY-----PGRTNADVMTALSQGYRMPRVENCPDELYDIMK 245
Query: 260 RIFVADPAARITI 272
             +      R T 
Sbjct: 246 MCWKEKAEERPTF 258

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F     +
Sbjct: 50  IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
              T T L +V +Y   G LF+ +       E   +       SG+++ H          
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKP 166
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEVL 
Sbjct: 167 AIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224
Query: 193 ----LRHEYDGKIADVWSCGVTLYVML----VGG------YPFED--PDEPKDFRKTIQR 236
               ++H    K AD+++ G+  + +     +GG       P+ D  P +P    + +++
Sbjct: 225 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRK 282
Query: 237 ILSVQYSVPDTNPISQECRDL------ISRIFVADPAARITIPEIMK 277
           ++  Q   P+     Q C  L      +   + A+ AAR+T   I K
Sbjct: 283 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F     +
Sbjct: 12  IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
              T T L +V +Y   G LF+ +       E   +       SG+++ H          
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKP 128
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEVL 
Sbjct: 129 AIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 186
Query: 193 ----LRHEYDGKIADVWSCGVTLYVML----VGG------YPFED--PDEPKDFRKTIQR 236
               ++H    K AD+++ G+  + +     +GG       P+ D  P +P    + +++
Sbjct: 187 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRK 244
Query: 237 ILSVQYSVPDTNPISQECRDL------ISRIFVADPAARITIPEIMK 277
           ++  Q   P+     Q C  L      +   + A+ AAR+T   I K
Sbjct: 245 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 291

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F     +
Sbjct: 37  IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
              T T L +V +Y   G LF+ +       E   +       SG+++ H          
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKP 153
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEVL 
Sbjct: 154 AIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 211
Query: 193 ----LRHEYDGKIADVWSCGVTLYVML----VGG------YPFED--PDEPKDFRKTIQR 236
               ++H    K AD+++ G+  + +     +GG       P+ D  P +P    + +++
Sbjct: 212 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRK 269
Query: 237 ILSVQYSVPDTNPISQECRDL------ISRIFVADPAARITIPEIMK 277
           ++  Q   P+     Q C  L      +   + A+ AAR+T   I K
Sbjct: 270 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 316

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F     +
Sbjct: 17  IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
              T T L +V +Y   G LF+ +       E   +       SG+++ H          
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKP 133
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEVL 
Sbjct: 134 AIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 191
Query: 193 ----LRHEYDGKIADVWSCGVTLYVML----VGG------YPFED--PDEPKDFRKTIQR 236
               ++H    K AD+++ G+  + +     +GG       P+ D  P +P    + +++
Sbjct: 192 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRK 249
Query: 237 ILSVQYSVPDTNPISQECRDL------ISRIFVADPAARITIPEIMK 277
           ++  Q   P+     Q C  L      +   + A+ AAR+T   I K
Sbjct: 250 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 296

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F     +
Sbjct: 11  IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
              T T L +V +Y   G LF+ +       E   +       SG+++ H          
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKP 127
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEVL 
Sbjct: 128 AIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 193 ----LRHEYDGKIADVWSCGVTLYVML----VGG------YPFED--PDEPKDFRKTIQR 236
               ++H    K AD+++ G+  + +     +GG       P+ D  P +P    + +++
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRK 243
Query: 237 ILSVQYSVPDTNPISQECRDL------ISRIFVADPAARITIPEIMK 277
           ++  Q   P+     Q C  L      +   + A+ AAR+T   I K
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 64  ENVQREI--INHRSLRHPNI-------VRFKEVILTPTHLAIVMEYASGGELF--ERICN 112
           + V REI  +NH    HPNI       V F+E  +   +L   +      ++   +RI  
Sbjct: 74  KRVLREIRLLNH--FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 113 AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
               S    ++F   ++ G+   H   V HRDL   N LL  +    + ICDF  ++   
Sbjct: 131 ---ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDT 185
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML----------------- 215
             +     V    Y APE++++ +   K+ D+WS G  +  M                  
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245
Query: 216 ---VGGYP-------FEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFV 263
              V G P       F  P      R ++  + +  ++  VP  +P++    DLI+++  
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL---DLIAKMLE 302
Query: 264 ADPAARITIPEIMKHQWFLKNL-PADLVDEKTMSSQYEE 301
            +P  RI+  + ++H +F     P DL +  +    ++E
Sbjct: 303 FNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDE 341

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/279 (22%), Positives = 113/279 (40%), Gaps = 52/279 (18%)
Query: 64  ENVQREI--INHRSLRHPNI-------VRFKEVILTPTHLAIVMEYASGGELF--ERICN 112
           + V REI  +NH    HPNI       V F+E  +   +L   +      ++   +RI  
Sbjct: 74  KRVLREIRLLNH--FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIV- 130
Query: 113 AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
               S    ++F   ++ G+   H   V HRDL   N LL  +    + ICDF  ++   
Sbjct: 131 ---ISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL--ADNNDITICDFNLAREDT 185
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML----------------- 215
             +     V    Y APE++++ +   K+ D+WS G  +  M                  
Sbjct: 186 ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245
Query: 216 ---VGGYP-------FEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDLISRIFV 263
              V G P       F  P      R ++  + +  ++  VP  +P++    DLI+++  
Sbjct: 246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL---DLIAKMLE 302
Query: 264 ADPAARITIPEIMKHQWFLKNL-PADLVDEKTMSSQYEE 301
            +P  RI+  + ++H +F     P DL +  +    ++E
Sbjct: 303 FNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDE 341

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 119/287 (41%), Gaps = 47/287 (16%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F     +
Sbjct: 14  IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
              T T L +V +Y   G LF+ +       E   +       SG+++ H          
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALST-ASGLAHLHMEIVGTQGKP 130
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +      I D G      S +  +   P   VGT  Y+APEVL 
Sbjct: 131 AIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 188
Query: 193 ----LRHEYDGKIADVWSCGVTLYVML----VGG------YPFED--PDEPKDFRKTIQR 236
               ++H    K AD+++ G+  + +     +GG       P+ D  P +P    + +++
Sbjct: 189 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS--VEEMRK 246
Query: 237 ILSVQYSVPDTNPISQECRDL------ISRIFVADPAARITIPEIMK 277
           ++  Q   P+     Q C  L      +   + A+ AAR+T   I K
Sbjct: 247 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 293

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 80/316 (25%), Positives = 134/316 (42%), Gaps = 54/316 (17%)
Query: 7   SLTVGPAMDMPIMHD---SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
           S T G    +P +     + +   +  +G G +G   + R     E VAVK     D+  
Sbjct: 18  SCTSGSGSGLPFLVQRTVARQITLLECVGKGRYG--EVWRGSWQGENVAVKIFSSRDEKS 75
Query: 64  ENVQREIINHRSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSED 119
              + E+ N   LRH NI+ F    +T  H    L ++  Y   G L++ +      +  
Sbjct: 76  WFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS 135
Query: 120 EARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
             R     + SG+++ H           + HRDLK +N L+  +   +  I D G    +
Sbjct: 136 CLRIVL-SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN--GQCCIADLGL---A 189
Query: 172 VLHSQPKST--------VGTPAYIAPEVLLR----HEYDG-KIADVWSCGVTLY----VM 214
           V+HSQ  +         VGT  Y+APEVL        +D  K  D+W+ G+ L+     M
Sbjct: 190 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249
Query: 215 LVGGY------PFED--PDEP--KDFRKTIQRILSVQYSVPD---TNPISQECRDLISRI 261
           +  G       PF D  P++P  +D RK +  +   + ++P+   ++P       L+   
Sbjct: 250 VSNGIVEDYKPPFYDVVPNDPSFEDMRKVVC-VDQQRPNIPNRWFSDPTLTSLAKLMKEC 308
Query: 262 FVADPAARITIPEIMK 277
           +  +P+AR+T   I K
Sbjct: 309 WYQNPSARLTALRIKK 324

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G   + R     E VAVK     D+     + E+ N   LRH NI+ F    +T
Sbjct: 16  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 91  PTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
             H    L ++  Y   G L++ +      +    R     + SG+++ H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL-SIASGLAHLHIEIFGTQGKP 132
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------VGTPAYIAPE 190
            + HRDLK +N L+  +   +  I D G    +V+HSQ  +         VGT  Y+APE
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 191 VLLR----HEYDG-KIADVWSCGVTLY----VMLVGGY------PFED--PDEP--KDFR 231
           VL        +D  K  D+W+ G+ L+     M+  G       PF D  P++P  +D R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 232 KTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIPEIMK 277
           K +  +   + ++P+   ++P       L+   +  +P+AR+T   I K
Sbjct: 248 KVVC-VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 51/289 (17%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G +G   + R     E VAVK     D+     + E+ N   LRH NI+ F    +T
Sbjct: 16  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73
Query: 91  PTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------- 138
             H    L ++  Y   G L++ +      +    R     + SG+++ H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVL-SIASGLAHLHIEIFGTQGKP 132
Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------VGTPAYIAPE 190
            + HRDLK +N L+  +   +  I D G    +V+HSQ  +         VGT  Y+APE
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGL---AVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 191 VLLR----HEYDG-KIADVWSCGVTLY----VMLVGGY------PFED--PDEP--KDFR 231
           VL        +D  K  D+W+ G+ L+     M+  G       PF D  P++P  +D R
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMR 247
Query: 232 KTIQRILSVQYSVPD---TNPISQECRDLISRIFVADPAARITIPEIMK 277
           K +  +   + ++P+   ++P       L+   +  +P+AR+T   I K
Sbjct: 248 KVVC-VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 36/227 (15%)
Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 82
           ++ ++ +G G FGV    ++KV     A+K I   ++    E V RE+     L HP IV
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 83  RFKEVILTPT------------HLAIVMEYASGGELFERICNAGRFSEDEARF---FFQQ 127
           R+    L               +L I M+      L + +       E E       F Q
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY--------SKSSVLHSQP-- 177
           +   V + H+  + HRDLK  N          +K+ DFG          + +VL   P  
Sbjct: 127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 178 ---KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
                 VGT  Y++PE +  + Y  K+ D++S G+ L+ +L   YPF
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELL---YPF 227

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 30  DIGSGNFGVAR--LMRDKVTKELVAVKYIERG-DKID-ENVQREIINHRSLRHPNIVRFK 85
           ++G GNFG  R  + R +  +  VA+K +++G +K D E + RE      L +P IVR  
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 86  EVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGVSYCHAMQVCH 142
            V      L +VME A GG L + +   G+  E           Q+  G+ Y       H
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP-AYIAPEVLLRHEYD 198
           R+L   N LL        KI DFG SK+      +   +S    P  + APE +   ++ 
Sbjct: 460 RNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 199 GKIADVWSCGVTLYVMLVGG 218
            + +DVWS GVT++  L  G
Sbjct: 518 SR-SDVWSYGVTMWEALSYG 536

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 115/282 (40%), Gaps = 26/282 (9%)
Query: 10  VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQRE 69
           V P  D   M  +D       +G G +G       K     VAVK ++      E   +E
Sbjct: 247 VSPNYDKWEMERTD-ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKE 305
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQ 127
               + ++HPN+V+   V        I+ E+ + G L +  R CN    +     +   Q
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 365
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
           + S + Y       HR+L   N L+  +    +K+ DFG S+     +   H+  K  + 
Sbjct: 366 ISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI- 422
Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDFRKTIQRILS 239
              + APE L  +++  K +DVW+ GV L+ +   G   YP  D  +       +  +L 
Sbjct: 423 --KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLE 472
Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             Y +       ++  +L+   +  +P+ R +  EI  HQ F
Sbjct: 473 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI--HQAF 512

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 101/236 (42%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-----------CNAG 114
           ++   +     +H NI+           L +++EYAS G L E +            +  
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDIN 147
Query: 115 RFSEDEARF-----FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
           R  E++  F        QL  G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 114/268 (42%), Gaps = 22/268 (8%)
Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI 70
           PA ++P     +    V+ +G+G FG V     +  TK  VAVK ++ G    +    E 
Sbjct: 5   PAWEIP----RESIKLVKKLGAGQFGEVWMGYYNNSTK--VAVKTLKPGTMSVQAFLEEA 58
Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQL 128
              ++L+H  +VR   V+     + I+ E+ + G L  F +    G+    +   F  Q+
Sbjct: 59  NLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI 118
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---A 185
             G++Y       HRDL+  N L+  S +   KI DFG ++  +  ++  +  G      
Sbjct: 119 AEGMAYIERKNYIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIK 175
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
           + APE +    +  K ++VWS G+ LY ++  G  P+     P      +   LS  Y +
Sbjct: 176 WTAPEAINFGCFTIK-SNVWSFGILLYEIVTYGKIPY-----PGRTNADVMSALSQGYRM 229
Query: 245 PDTNPISQECRDLISRIFVADPAARITI 272
           P       E  D++   +      R T 
Sbjct: 230 PRMENCPDELYDIMKMCWKEKAEERPTF 257

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 110/255 (43%), Gaps = 50/255 (19%)
Query: 13  AMDMPIMH--------DSDRYDFVRD-------IGSGNFGVARLM------RDKVTKELV 51
           AMD P++         +  +++F RD       +G G FG   +       +DK  KE V
Sbjct: 2   AMDTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK-PKEAV 60
Query: 52  AVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGEL 106
            V      D   E    ++++   +     +H NI+           L +++EYAS G L
Sbjct: 61  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 107 FE----RICNAGRFSED-----EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENT 150
            E    R      +S D     E +  F+ L+S       G+ Y  + +  HRDL   N 
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 180
Query: 151 LLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSC 207
           L+  +    +KI DFG ++  + +    K+T G     ++APE L    Y  + +DVWS 
Sbjct: 181 LVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSF 237
Query: 208 GVTLY-VMLVGGYPF 221
           GV ++ +  +GG P+
Sbjct: 238 GVLMWEIFTLGGSPY 252

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 113/288 (39%), Gaps = 49/288 (17%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF------ 84
           IGSG FG     + ++  +   ++ ++  +   E  +RE+     L H NIV +      
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDG 76
Query: 85  ----------------------KEVILTPTH-LAIVMEYASGGELFERICN--AGRFSED 119
                                 K    + T  L I ME+   G L + I      +  + 
Sbjct: 77  FDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 136
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
            A   F+Q+  GV Y H+ ++ HRDLK  N  L      ++KI DFG   S     +   
Sbjct: 137 LALELFEQITKGVDYIHSKKLIHRDLKPSNIFL--VDTKQVKIGDFGLVTSLKNDGKRTR 194
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVML-VGGYPFEDPDEPKDFRKTIQRIL 238
           + GT  Y++PE +   +Y GK  D+++ G+ L  +L V    FE      D R  I    
Sbjct: 195 SKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGII--- 250
Query: 239 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
                   ++   ++ + L+ ++    P  R    EI++     K  P
Sbjct: 251 --------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 290

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 53/289 (18%)
Query: 29  RDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNI 81
           + +G G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 82  VRFKEVILTPTHLAIVMEYASGGELF-----ERICNAGRFSE------------DEARFF 124
           ++          L +++EYA  G L       R    G                DE    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 125 FQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SS 171
              LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+      S 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSX 206
Query: 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGG--YPFEDPDEPK 228
           V  SQ +  V    ++A E L  H Y  + +DVWS GV L+ ++ +GG  YP   P+   
Sbjct: 207 VKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
           +  KT  R+       PD    S+E   L+ + +  +P  R    +I K
Sbjct: 263 NLLKTGHRM-----ERPDN--CSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENVQRE 69
           +++F RD       +G G FG         + +DK  + + VAVK + + D  +E++   
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDL 87
Query: 70  IINHRSLR----HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           +     ++    H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 53/289 (18%)
Query: 29  RDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNI 81
           + +G G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 82  VRFKEVILTPTHLAIVMEYASGGELF-----ERICNAGRFSE------------DEARFF 124
           ++          L +++EYA  G L       R    G                DE    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 125 FQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SS 171
              LIS       G+ Y   M++ HRDL   N L+  +   ++KI DFG S+      S 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSY 206
Query: 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGG--YPFEDPDEPK 228
           V  SQ +  V    ++A E L  H Y  + +DVWS GV L+ ++ +GG  YP   P+   
Sbjct: 207 VKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
           +  KT  R+       PD    S+E   L+ + +  +P  R    +I K
Sbjct: 263 NLLKTGHRM-----ERPDN--CSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 53/289 (18%)
Query: 29  RDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDE--NVQREIINHRSLRHPNI 81
           + +G G FG      A  ++ +     VAVK ++      E  ++  E    + + HP++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 82  VRFKEVILTPTHLAIVMEYASGGELF-----ERICNAGRFSE------------DEARFF 124
           ++          L +++EYA  G L       R    G                DE    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 125 FQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SS 171
              LIS       G+ Y   M + HRDL   N L+  +   ++KI DFG S+      S 
Sbjct: 149 MGDLISFAWQISQGMQYLAEMSLVHRDLAARNILV--AEGRKMKISDFGLSRDVYEEDSX 206
Query: 172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGG--YPFEDPDEPK 228
           V  SQ +  V    ++A E L  H Y  + +DVWS GV L+ ++ +GG  YP   P+   
Sbjct: 207 VKRSQGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
           +  KT  R+       PD    S+E   L+ + +  +P  R    +I K
Sbjct: 263 NLLKTGHRM-----ERPDN--CSEEMYRLMLQCWKQEPDKRPVFADISK 304

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 29/254 (11%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
           + +G+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +V+   V
Sbjct: 188 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 245
Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDL 145
           + T   + I+ E+ + G L + + +     +   +   F  Q+  G+++       HRDL
Sbjct: 246 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
           +  N L+  S     KI DFG ++           VG      + APE +    +  K +
Sbjct: 305 RAANILVSASLV--CKIADFGLAR-----------VGAKFPIKWTAPEAINFGSFTIK-S 350
Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           DVWS G+ L  ++  G  P+     P+     + R L   Y +P      +E  +++ R 
Sbjct: 351 DVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIMMRC 405
Query: 262 FVADPAARITIPEI 275
           +   P  R T   I
Sbjct: 406 WKNRPEERPTFEYI 419

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 75  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 133
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 251
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 306

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 16  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 74
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 75  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 134
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 135 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNV--MKIADFGLAR 192
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 193 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 247

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 111/251 (44%), Gaps = 19/251 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
           + +G+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +V+   V
Sbjct: 21  KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDL 145
           + T   + I+ E+ + G L + + +     +   +   F  Q+  G+++       HRDL
Sbjct: 79  V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
           +  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K +
Sbjct: 138 RAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 193
Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           DVWS G+ L  ++  G  P+     P+     + R L   Y +P      +E  +++ R 
Sbjct: 194 DVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIMMRC 248
Query: 262 FVADPAARITI 272
           +   P  R T 
Sbjct: 249 WKNRPEERPTF 259

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 18  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 76
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 77  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 136
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 137 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 194
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 195 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 249

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 --SSVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +++ + +  +    P  ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 74/326 (22%), Positives = 127/326 (38%), Gaps = 68/326 (20%)
Query: 22  SDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRS 75
            +RY+ V  +G G FG V + +  +     VA+K I+  +K  E  + EI     IN + 
Sbjct: 32  QERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKD 91
Query: 76  LRHPNI-VRFKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVS 133
             + N+ V+  +      H+ I  E        F +  N   +   + R    QL   V 
Sbjct: 92  PDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVK 151
Query: 134 YCHAMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHSQ 176
           + H  ++ H DLK EN L   S                  +  +++ DFG   ++  H  
Sbjct: 152 FLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFG--SATFDHEH 209
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR 236
             + V T  Y APEV+L   +  +  DVWS G  ++   VG   F+  D  ++    ++R
Sbjct: 210 HSTIVSTRHYRAPEVILELGW-SQPCDVWSIGCIIFEYYVGFTLFQTHDN-REHLAMMER 267
Query: 237 IL-----------------------------SVQYSVPDTNPISQ----------ECRDL 257
           IL                             + +Y   +  P+ +          +  DL
Sbjct: 268 ILGPIPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDL 327
Query: 258 ISRIFVADPAARITIPEIMKHQWFLK 283
           I  +   +PA R+T+ E ++H +F +
Sbjct: 328 IESMLEYEPAKRLTLGEALQHPFFAR 353

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/330 (23%), Positives = 121/330 (36%), Gaps = 68/330 (20%)
Query: 23  DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +RY+ V ++G G FG V   +     K  VA+K I    K  E  + EI   + ++  + 
Sbjct: 51  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 110
Query: 82  V-RFKEVILTP-----THLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVS 133
             +F  V+++       H+ I  E   G   FE +   N   +     R    QL   + 
Sbjct: 111 ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 169
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSVLHSQ 176
           + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H  
Sbjct: 170 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEH 227
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF------ 230
             + V T  Y  PEV+L   +  +  DVWS G  L+    G   F+  +  +        
Sbjct: 228 HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 286
Query: 231 -----RKTIQRILSVQY----------SVPDTNPISQECR-----------------DLI 258
                   I R    +Y          +  D   + + C+                 DL+
Sbjct: 287 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 346
Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPAD 288
            R+   DPA RIT+ E + H +F    P +
Sbjct: 347 RRMLEFDPAQRITLAEALLHPFFAGLTPEE 376

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 77/331 (23%), Positives = 121/331 (36%), Gaps = 68/331 (20%)
Query: 22  SDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
            +RY+ V ++G G FG V   +     K  VA+K I    K  E  + EI   + ++  +
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKD 77
Query: 81  IV-RFKEVILTPT-----HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGV 132
              +F  V+++       H+ I  E   G   FE +   N   +     R    QL   +
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSVLHS 175
            + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H 
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHE 194
Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF----- 230
              + V T  Y  PEV+L   +  +  DVWS G  L+    G   F+  +  +       
Sbjct: 195 HHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253
Query: 231 ------RKTIQRILSVQY----------SVPDTNPISQECR-----------------DL 257
                    I R    +Y          +  D   + + C+                 DL
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313
Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
           + R+   DPA RIT+ E + H +F    P +
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++EYAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    ++I DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MRIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/330 (23%), Positives = 121/330 (36%), Gaps = 68/330 (20%)
Query: 23  DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +RY+ V ++G G FG V   +     K  VA+K I    K  E  + EI   + ++  + 
Sbjct: 28  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 87
Query: 82  V-RFKEVILTPT-----HLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVS 133
             +F  V+++       H+ I  E   G   FE +   N   +     R    QL   + 
Sbjct: 88  ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 146
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRL-----------------KICDFGYSKSSVLHSQ 176
           + H  Q+ H DLK EN L   S    L                 ++ DFG   ++  H  
Sbjct: 147 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG--SATFDHEH 204
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF------ 230
             + V T  Y  PEV+L   +  +  DVWS G  L+    G   F+  +  +        
Sbjct: 205 HTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 263
Query: 231 -----RKTIQRILSVQY----------SVPDTNPISQECR-----------------DLI 258
                   I R    +Y          +  D   + + C+                 DL+
Sbjct: 264 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 323
Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPAD 288
            R+   DPA RIT+ E + H +F    P +
Sbjct: 324 RRMLEFDPAQRITLAEALLHPFFAGLTPEE 353

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 112/254 (44%), Gaps = 19/254 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV 87
           + +G+G FG V     +K TK  VAVK ++ G    E    E    ++L+H  +V+   V
Sbjct: 194 KKLGAGQFGEVWMATYNKHTK--VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 88  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQVCHRDL 145
           + T   + I+ E+ + G L + + +     +   +   F  Q+  G+++       HRDL
Sbjct: 252 V-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGKIA 202
           +  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K +
Sbjct: 311 RAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK-S 366
Query: 203 DVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI 261
           DVWS G+ L  ++  G  P+     P+     + R L   Y +P      +E  +++ R 
Sbjct: 367 DVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALERGYRMPRPENCPEELYNIMMRC 421
Query: 262 FVADPAARITIPEI 275
           +   P  R T   I
Sbjct: 422 WKNRPEERPTFEYI 435

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 41/229 (17%)
Query: 26  DFVRDIGSGNFGVARLMRDKVTKEL-------VAVKYI--ERGDKIDENVQREIINHRSL 76
           ++VRDIG G FG  R+ + +    L       VAVK +  E    +  + QRE       
Sbjct: 50  EYVRDIGEGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----------------------RICNAG 114
            +PNIV+   V      + ++ EY + G+L E                      R+ + G
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 115 --RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-- 170
               S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S++  
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIY 225
Query: 171 SVLHSQPKSTVGTPA-YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
           S  + +       P  ++ PE +  + Y  + +DVW+ GV L+ +   G
Sbjct: 226 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYG 273

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
           V+ +GSG FG       +   +  K  VA+K +    G K +     E +   S+ HP++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           VR   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    ++
Sbjct: 80  VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 138
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEY 197
            HRDL   N L+  SP   +KI DFG ++      +  +  G      ++A E +   ++
Sbjct: 139 VHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFE 222
             + +DVWS GVT++ +M  GG P++
Sbjct: 197 THQ-SDVWSYGVTIWELMTFGGKPYD 221

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 28  VRDIGSGNFGVARLMRDKVTKELVAVKYIE------RGDKIDENVQREIINHRSLRHPNI 81
           +R +G G FG   L +    K+  AVK +       R  KI+ ++ ++I  +  + + NI
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QNDDINNNNI 98
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           V++    +   H+ ++ E   G  L+E I   N   F  ++ + +  +++  ++Y   M 
Sbjct: 99  VKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS 157
Query: 140 VCHRDLKLENTLLDG-----------------------SPAPRLKICDFGYSK-SSVLHS 175
           + H DLK EN LLD                        + +  +K+ DFG +   S  H 
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG 217
Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
              S + T  Y APEV+L   +D   +D+WS G  L  +  G   F
Sbjct: 218 ---SIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPNI 81
           V+ +GSG FG       +   +  K  VA+K +    G K +     E +   S+ HP++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           VR   V L+PT + +V +    G L E +  +           +  Q+  G+ Y    ++
Sbjct: 103 VRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRL 161
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEY 197
            HRDL   N L+  SP   +KI DFG ++      +  +  G      ++A E +   ++
Sbjct: 162 VHRDLAARNVLVK-SPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 219
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFE 222
             + +DVWS GVT++ +M  GG P++
Sbjct: 220 THQ-SDVWSYGVTIWELMTFGGKPYD 244

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IVMEY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 84  EEPIYIVMEYMSKGCLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 137 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 195 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 248
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 249 CQCWRKDPEERPTF 262

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 116/286 (40%), Gaps = 39/286 (13%)
Query: 17  PIMHDSDRYDFVRDIGSGNFG---VARLMRDKVTKELVAVK----YIERGDKIDENVQRE 69
           P++ D +   F   IG GNFG    AR+ +D +  +  A+K    Y  + D  D   + E
Sbjct: 20  PVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELE 77
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNA 113
           ++      HPNI+          +L + +EYA  G L + +                  A
Sbjct: 78  VLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
              S  +   F   +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEV 194
Query: 174 HSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDF 230
           +   K T+G     ++A E L    Y    +DVWS GV L+ ++ +GG P+      + +
Sbjct: 195 YV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
Query: 231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 276
            K  Q      Y +        E  DL+ + +   P  R +  +I+
Sbjct: 252 EKLPQ-----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 292

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/255 (24%), Positives = 107/255 (41%), Gaps = 31/255 (12%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV+EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 84  EEPIYIVIEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYD 198
           HRDL+  N L+  +     K+ DFG ++  +  ++  +  G      + APE  L   + 
Sbjct: 137 HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFT 193
Query: 199 GKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
            K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL
Sbjct: 194 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 247
Query: 258 ISRIFVADPAARITI 272
           + + +  DP  R T 
Sbjct: 248 MCQCWRKDPEERPTF 262

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 17  PIMHDSDRYDFVRDIGSGNFG---VARLMRDKVTKELVAVK----YIERGDKIDENVQRE 69
           P++ D +   F   IG GNFG    AR+ +D +  +  A+K    Y  + D  D   + E
Sbjct: 10  PVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELE 67
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNA 113
           ++      HPNI+          +L + +EYA  G L + +                  A
Sbjct: 68  VLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 126
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
              S  +   F   +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   +
Sbjct: 127 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEV 184
Query: 174 HSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           +   K T+G     ++A E L    Y    +DVWS GV L+ ++ +GG P+
Sbjct: 185 YV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 232

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           V+ +GSG FG       +   +  K  VA+K +      K ++ +  E      +  P +
Sbjct: 22  VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQV 140
            R   + LT T + +V +    G L + +  N GR    +   +  Q+  G+SY   +++
Sbjct: 82  SRLLGICLTST-VQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRL 140
Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLRHEY 197
            HRDL   N L+  SP   +KI DFG ++   +        G      ++A E +LR  +
Sbjct: 141 VHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFE 222
             + +DVWS GVT++ +M  G  P++
Sbjct: 199 THQ-SDVWSYGVTVWELMTFGAKPYD 223

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++ YAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 129/291 (44%), Gaps = 47/291 (16%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
            V+ IG G +G   +   K   E VAVK     ++     + EI     +RH NI+ F  
Sbjct: 41  MVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 87  VIL----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---- 138
             +    + T L ++ +Y   G L++ + +    ++   +  +   +SG+ + H      
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSS-VSGLCHLHTEIFST 157
Query: 139 ----QVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPKSTVGTPAYIAP 189
                + HRDLK +N L+  +      I D G      S ++ +   P + VGT  Y+ P
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 190 EV----LLRHEYDGKI-ADVWSCGVTLYVM----LVGG------YPFED--PDEP--KDF 230
           EV    L R+ +   I AD++S G+ L+ +    + GG       P+ D  P +P  +D 
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 231 RKTIQRILSVQYSVPDTNPISQEC----RDLISRIFVADPAARITIPEIMK 277
           R+ +  I  ++ S P+    S EC      L++  +  +PA+R+T   + K
Sbjct: 276 REIVC-IKKLRPSFPNRWS-SDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 77/308 (25%), Positives = 127/308 (41%), Gaps = 63/308 (20%)
Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
            V  +G G +G   + R     E VAVK     D+     + EI N   LRH NI+ F  
Sbjct: 12  LVECVGKGRYG--EVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIA 69
Query: 87  VILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS---GVSYCHAM- 138
             +T     T L ++  Y   G L++ +    +    E     +  +S   G+++ H   
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFL----QRQTLEPHLALRLAVSAACGLAHLHVEI 125
Query: 139 -------QVCHRDLKLENTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKS--------TV 181
                   + HRD K  N L+  +    L+ C  D G    +V+HSQ            V
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSN----LQCCIADLGL---AVMHSQGSDYLDIGNNPRV 178
Query: 182 GTPAYIAPEVL---LRHEY--DGKIADVWSCGVTLYVM----LVGGY------PFED--P 224
           GT  Y+APEVL   +R +     K  D+W+ G+ L+ +    +V G       PF D  P
Sbjct: 179 GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVP 238
Query: 225 DEPKDFRKTIQRILSVQYSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKH 278
           ++P    + +++++ V    P        +P+      ++   +  +P+AR+T   I K 
Sbjct: 239 NDPS--FEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKT 296
Query: 279 QWFLKNLP 286
              + N P
Sbjct: 297 LQKISNSP 304

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV+EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 84  EEPIYIVIEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 137 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 195 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 248
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 249 CQCWRKDPEERPTF 262

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 42/236 (17%)
Query: 24  RYDFVRD-------IGSGNFGVARLM------RDKVTKELVAVKYIERGDKIDENVQREI 70
           +++F RD       +G G FG   +       +DK  KE V V      D   E    ++
Sbjct: 29  KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK-PKEAVTVAVKMLKDDATEKDLSDL 87
Query: 71  INHRSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-- 119
           ++   +     +H NI+           L +++ YAS G L E    R      +S D  
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 120 ---EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
              E +  F+ L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR 205
Query: 170 S-SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             + +    K+T G     ++APE L    Y  + +DVWS GV ++ +  +GG P+
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPY 260

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 104/247 (42%), Gaps = 15/247 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 17  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 74
Query: 91  PTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
              + IV EY S G L + +    G++    +      Q+ SG++Y   M   HRDL+  
Sbjct: 75  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 134
Query: 149 NTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
           N L+  +     K+ DFG ++      ++  +       + APE  L   +  K +DVWS
Sbjct: 135 NILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWS 191
Query: 207 CGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
            G+ L  +   G  P+     P    + +   +   Y +P      +   DL+ + +  D
Sbjct: 192 FGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKD 246
Query: 266 PAARITI 272
           P  R T 
Sbjct: 247 PEERPTF 253

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 117/283 (41%), Gaps = 38/283 (13%)
Query: 24  RYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYIERGD-KIDENVQREIINHRS 75
           R D V  R++G G FG   L     +     K LVAVK ++       ++ QRE     +
Sbjct: 14  RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 73
Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICN--------------AGRFSED 119
           L+H +IV+F  V      L +V EY   G+L  F R                  G     
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQ 176
           +      Q+ SG+ Y  +    HRDL   N L+  +    +KI DFG S+   S+  +  
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRV 191
Query: 177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQ 235
              T+    ++ PE ++  ++  + +DVWS GV L+ +   G  P+      +      Q
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 236 -RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
            R+L      P      +E  D++   +  +P  R+ I EI K
Sbjct: 251 GRVLERPRVCP------KEVYDVMLGCWQREPQQRLNIKEIYK 287

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 84  EEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 137 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 195 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 248
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 249 CQCWRKDPEERPTF 262

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 84  EEPIYIVCEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 137 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 195 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 248
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 249 CQCWRKDPEERPTF 262

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 19  MHDSDRYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYI-ERGDKIDENVQREI 70
           +H   R D V   ++G G FG   L     +  +  K LVAVK + E  +   ++ QRE 
Sbjct: 12  VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 71
Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEA--- 121
                L+H +IVRF  V      L +V EY   G+L   + + G         ED A   
Sbjct: 72  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 131
Query: 122 ------RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
                      Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   S+ 
Sbjct: 132 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTD 189
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
            +     T+    ++ PE +L  ++  + +DVWS GV L+ +   G
Sbjct: 190 YYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYG 234

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++   I   
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLSDLISEM 84
Query: 74  RSLR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARFF 124
             ++    H NI+           L +++EYAS G L E +  A R     FS + +   
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEFSFNPSHNP 143
Query: 125 FQQLIS------------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 171
            +QL S            G+ Y  + +  HRDL   N L+       +KI DFG ++   
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 201
Query: 172 VLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 202 HIDXXKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 15  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 72
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 73  EEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 125
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 126 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 184 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 237
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 238 CQCWRKDPEERPTF 251

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 19  MHDSDRYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYI-ERGDKIDENVQREI 70
           +H   R D V   ++G G FG   L     +  +  K LVAVK + E  +   ++ QRE 
Sbjct: 6   VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 65
Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEA--- 121
                L+H +IVRF  V      L +V EY   G+L   + + G         ED A   
Sbjct: 66  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 125
Query: 122 ------RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
                      Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   S+ 
Sbjct: 126 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTD 183
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
            +     T+    ++ PE +L  ++  + +DVWS GV L+ +   G
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYG 228

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 31/255 (12%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 16  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 73
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 74  EEPIXIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 126
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYD 198
           HRDL+  N L+  +     K+ DFG ++  +  ++  +  G      + APE  L   + 
Sbjct: 127 HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFT 183
Query: 199 GKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
            K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL
Sbjct: 184 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 237
Query: 258 ISRIFVADPAARITI 272
           + + +  +P  R T 
Sbjct: 238 MCQCWRKEPEERPTF 252

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 29/226 (12%)
Query: 19  MHDSDRYDFV--RDIGSGNFGVARL-----MRDKVTKELVAVKYI-ERGDKIDENVQREI 70
           +H   R D V   ++G G FG   L     +  +  K LVAVK + E  +   ++ QRE 
Sbjct: 35  VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------RFSEDEA--- 121
                L+H +IVRF  V      L +V EY   G+L   + + G         ED A   
Sbjct: 95  ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 122 ------RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
                      Q+ +G+ Y   +   HRDL   N L+       +KI DFG S+   S+ 
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTD 212
Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
            +     T+    ++ PE +L  ++  + +DVWS GV L+ +   G
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYG 257

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G+   E   +E    + LRH  +V+   V+ +
Sbjct: 193 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 250
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 251 EEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 303
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG  +      ++  +       + APE  L   +  
Sbjct: 304 HRDLRAANILVGENLV--CKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 362 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 415
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 416 CQCWRKDPEERPTF 429

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 153 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 211 QKFTTK-SDVWSFGVLLWELMTRGAP 235

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 17  PIMHDSDRYDFVRDIGSGNFG---VARLMRDKVTKELVAVK----YIERGDKIDENVQRE 69
           P++ D +   F   IG GNFG    AR+ +D +  +  A+K    Y  + D  D   + E
Sbjct: 17  PVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELE 74
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNA 113
           ++      HPNI+          +L + +EYA  G L + +                  A
Sbjct: 75  VLCKLG-HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 133
Query: 114 GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
              S  +   F   +  G+ Y    Q  HR+L   N L+  +     KI DFG S+   +
Sbjct: 134 STLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVA--KIADFGLSRGQEV 191
Query: 174 HSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           +   K T+G     ++A E L    Y    +DVWS GV L+ ++ +GG P+
Sbjct: 192 YV--KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 239

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 52  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 171
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 172 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 230 QKFTTK-SDVWSFGVLLWELMTRGAP 254

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 53  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 172
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 173 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 231 QKFTTK-SDVWSFGVLLWELMTRGAP 255

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 150
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 151 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 209 QKFTTK-SDVWSFGVLLWELMTRGAP 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 154 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 212 QKFTTK-SDVWSFGVLLWELMTRGAP 236

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + +RH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 84  EEPIYIVTEYMSKGSLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 137 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 195 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 248
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 249 CQCWRKDPEERPTF 262

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 153
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 154 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 212 QKFTTK-SDVWSFGVLLWELMTRGAP 236

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/247 (24%), Positives = 103/247 (41%), Gaps = 15/247 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
              + IV EY S G L + +    G++    +      Q+ SG++Y   M   HRDL   
Sbjct: 84  EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAA 143
Query: 149 NTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
           N L+  +     K+ DFG ++      ++  +       + APE  L   +  K +DVWS
Sbjct: 144 NILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWS 200
Query: 207 CGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
            G+ L  +   G  P+     P    + +   +   Y +P      +   DL+ + +  D
Sbjct: 201 FGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKD 255
Query: 266 PAARITI 272
           P  R T 
Sbjct: 256 PEERPTF 262

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 29  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 149 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 207 QKFTTK-SDVWSFGVLLWELMTRGAP 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 26  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 145
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 146 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 204 QKFTTK-SDVWSFGVLLWELMTRGAP 228

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 33  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 152
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 153 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 211 QKFTTK-SDVWSFGVLLWELMTRGAP 235

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 26  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 83
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 84  EEPIYIVTEYMSKGCLLD-------FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 136
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 137 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 195 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 248
Query: 259 SRIFVADPAARITI 272
            + +  DP  R T 
Sbjct: 249 CQCWRKDPEERPTF 262

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ Y  + +
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK 151
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPA-YIAPEVLLR 194
             HRDL   N +LD      +K+ DFG ++            K+    P  ++A E L  
Sbjct: 152 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYP 220
            ++  K +DVWS GV L+ ++  G P
Sbjct: 210 QKFTTK-SDVWSFGVLLWELMTRGAP 234

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 15/247 (6%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 19  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 76
Query: 91  PTHLAIVMEYASGGELFERI-CNAGRFSE-DEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
              + IV EY S G L + +    G++    +      Q+ SG++Y   M   HRDL+  
Sbjct: 77  EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 136
Query: 149 NTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWS 206
           N L+  +     K+ DFG ++      ++  +       + APE  L   +  K +DVWS
Sbjct: 137 NILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWS 193
Query: 207 CGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
            G+ L  +   G  P+     P    + +   +   Y +P      +   DL+ + +  +
Sbjct: 194 FGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKE 248
Query: 266 PAARITI 272
           P  R T 
Sbjct: 249 PEERPTF 255

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 101/263 (38%), Gaps = 66/263 (25%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--P 79
           + RY  +R +G G+F    L  D   K+ VA+K ++  +   E    EI   +S+R+  P
Sbjct: 20  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP 79
Query: 80  N------IVR----FKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQ 127
           N      +V+    FK   +  TH+ +V E   G  L + I   N         +   QQ
Sbjct: 80  NDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 138
Query: 128 LISGVSYCHA-MQVCHRDLKLENTLL-------------------DGSPAP--------- 158
           ++ G+ Y H   ++ H D+K EN LL                    G+P P         
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 159 -------------------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
                              ++KI D G   +  +H      + T  Y + EVL+   Y+ 
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 256
Query: 200 KIADVWSCGVTLYVMLVGGYPFE 222
             AD+WS     + +  G Y FE
Sbjct: 257 P-ADIWSTACMAFELATGDYLFE 278

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 281 F 281
           F
Sbjct: 318 F 318

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 107 PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 160
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 161 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 219
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 220 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRI 278
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 279 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 338
Query: 281 F 281
           F
Sbjct: 339 F 339

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 140
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 141 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 258
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 259 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 318
Query: 281 F 281
           F
Sbjct: 319 F 319

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 281 F 281
           F
Sbjct: 318 F 318

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 281 F 281
           F
Sbjct: 318 F 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 281 F 281
           F
Sbjct: 318 F 318

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 87  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 140
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 141 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 199
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 200 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 258
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 259 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 318
Query: 281 F 281
           F
Sbjct: 319 F 319

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++  ++I+ 
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLS-DLISE 76
Query: 74  RSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARF 123
             +     +H NI+           L +++EYAS G L E +  A R     +S + +  
Sbjct: 77  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHN 135
Query: 124 FFQQLIS------------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS- 170
             +QL S            G+ Y  + +  HRDL   N L+       +KI DFG ++  
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDI 193
Query: 171 SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 194 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++  ++I+ 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLS-DLISE 83
Query: 74  RSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARF 123
             +     +H NI+           L +++EYAS G L E +  A R     +S + +  
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHN 142
Query: 124 FFQQLIS------------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS- 170
             +QL S            G+ Y  + +  HRDL   N L+       +KI DFG ++  
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDI 200
Query: 171 SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 201 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  + +
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV------LHSQPKSTVGTPAYIAPEVLL 193
             HRDL   N +LD      +K+ DFG ++  +      +H++  + +    ++A E L 
Sbjct: 155 FVHRDLAARNCMLDEKFT--VKVADFGLARDMLDKEFDSVHNKTGAKLPV-KWMALESLQ 211
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP 220
             ++  K +DVWS GV L+ ++  G P
Sbjct: 212 TQKFTTK-SDVWSFGVLLWELMTRGAP 237

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++  ++I+ 
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLS-DLISE 75
Query: 74  RSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARF 123
             +     +H NI+           L +++EYAS G L E +  A R     +S + +  
Sbjct: 76  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHN 134
Query: 124 FFQQLIS------------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS- 170
             +QL S            G+ Y  + +  HRDL   N L+       +KI DFG ++  
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDI 192
Query: 171 SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 193 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 245

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 43/234 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++  ++I+ 
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLS-DLISE 72
Query: 74  RSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARF 123
             +     +H NI+           L +++EYAS G L E +  A R     +S + +  
Sbjct: 73  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHN 131
Query: 124 FFQQLIS------------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS- 170
             +QL S            G+ Y  + +  HRDL   N L+       +KI DFG ++  
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDI 189
Query: 171 SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 190 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 242

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++   I   
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLSDLISEM 84
Query: 74  RSLR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------CNAGRFSED 119
             ++    H NI+           L +++EYAS G L E +          C     + +
Sbjct: 85  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPE 144
Query: 120 EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 171
           E +   + L+S       G+ Y  + +  HRDL   N L+       +KI DFG ++   
Sbjct: 145 E-QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 201
Query: 172 VLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 101/263 (38%), Gaps = 66/263 (25%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--P 79
           + RY  +R +G G+F    L  D   K+ VA+K ++  +   E    EI   +S+R+  P
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDP 95
Query: 80  N------IVR----FKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQ 127
           N      +V+    FK   +  TH+ +V E   G  L + I   N         +   QQ
Sbjct: 96  NDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKIIQQ 154
Query: 128 LISGVSYCHAM-QVCHRDLKLENTLL-------------------DGSPAP--------- 158
           ++ G+ Y H   ++ H D+K EN LL                    G+P P         
Sbjct: 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 214
Query: 159 -------------------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
                              ++KI D G   +  +H      + T  Y + EVL+   Y+ 
Sbjct: 215 ATAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNT 272
Query: 200 KIADVWSCGVTLYVMLVGGYPFE 222
             AD+WS     + +  G Y FE
Sbjct: 273 P-ADIWSTACMAFELATGDYLFE 294

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 281 F 281
           F
Sbjct: 318 F 318

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++  ++I+ 
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLS-DLISE 83
Query: 74  RSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARFF 124
             +     +H NI+           L +++EYAS G L E    R      +S + +   
Sbjct: 84  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNP 143
Query: 125 FQQLIS------------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 171
            +QL S            G+ Y  + +  HRDL   N L+       +KI DFG ++   
Sbjct: 144 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 201
Query: 172 VLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 253

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 43/234 (18%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++  ++I+ 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLS-DLISE 68
Query: 74  RSL-----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------CNAGRFSE 118
             +     +H NI+           L +++EYAS G L E +          C     + 
Sbjct: 69  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNP 128
Query: 119 DEARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS- 170
           +E +   + L+S       G+ Y  + +  HRDL   N L+       +KI DFG ++  
Sbjct: 129 EE-QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDI 185
Query: 171 SVLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 238

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 86  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 139
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 140 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 198
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 199 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 257
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 258 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 317
Query: 281 F 281
           F
Sbjct: 318 F 318

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 31/255 (12%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 80
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY + G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 81  EEPIYIVTEYMNKGSLLD-------FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYD 198
           HRDL+  N L+  +     K+ DFG ++  +  ++  +  G      + APE  L   + 
Sbjct: 134 HRDLRAANILVGENLV--CKVADFGLAR-LIEDNEWTARQGAKFPIKWTAPEAALYGRFT 190
Query: 199 GKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
            K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL
Sbjct: 191 IK-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDL 244
Query: 258 ISRIFVADPAARITI 272
           + + +  +P  R T 
Sbjct: 245 MCQCWRKEPEERPTF 259

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 79  PNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           PNIV+  +++      TP+   ++ EY +  + F+ +      ++ + R++  +L+  + 
Sbjct: 88  PNIVKLLDIVRDQHSKTPS---LIFEYVNNTD-FKVLYPT--LTDYDIRYYIYELLKALD 141
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           YCH+  + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+
Sbjct: 142 YCHSQGIMHRDVKPHNVMID-HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 200
Query: 194 R-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------QYSV 244
              +YD  + D+WS G     M+    PF    +  D    I ++L          +Y +
Sbjct: 201 DLQDYDYSL-DMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRI 259
Query: 245 P------------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
                                    + + +S E  D + ++   D   R+T  E M H +
Sbjct: 260 ELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPY 319
Query: 281 F 281
           F
Sbjct: 320 F 320

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 112/253 (44%), Gaps = 19/253 (7%)
Query: 27  FVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            ++ +G+G FG V     +  TK  VA+K ++ G    E+   E    + L+H  +V+  
Sbjct: 13  LIKRLGNGQFGEVWMGTWNGNTK--VAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLY 70
Query: 86  EVILTPTHLAIVMEYASGGELFERICNA-GR-FSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ +   + IV EY + G L + + +  GR            Q+ +G++Y   M   HR
Sbjct: 71  AVV-SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+        KI DFG ++  +  ++  +  G      + APE  L   +  K
Sbjct: 130 DLRSANILVGNGLI--CKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI-LSVQYSVPDTNPISQECRDLIS 259
            +DVWS G+ L  ++  G     P    + R+ ++++    +   P   PIS    +L+ 
Sbjct: 187 -SDVWSFGILLTELVTKG---RVPYPGMNNREVLEQVERGYRMPCPQDCPIS--LHELMI 240
Query: 260 RIFVADPAARITI 272
             +  DP  R T 
Sbjct: 241 HCWKKDPEERPTF 253

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 250 EEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 303 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 361 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 414
Query: 259 SRIFVADPAARITI 272
            + +  +P  R T 
Sbjct: 415 CQCWRKEPEERPTF 428

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/254 (23%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 23  LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 80
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY + G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 81  EEPIYIVTEYMNKGSLLD-------FLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYV 133
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 134 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 192 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 245
Query: 259 SRIFVADPAARITI 272
            + +  +P  R T 
Sbjct: 246 CQCWRKEPEERPTF 259

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 93  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  + +
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLL 193
             HRDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L 
Sbjct: 213 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQ 269
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP 220
             ++  K +DVWS GV L+ ++  G P
Sbjct: 270 TQKFTTK-SDVWSFGVLLWELMTRGAP 295

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 250 EEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 303 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 361 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 414
Query: 259 SRIFVADPAARITI 272
            + +  +P  R T 
Sbjct: 415 CQCWRKEPEERPTF 428

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 64/233 (27%), Positives = 102/233 (43%), Gaps = 41/233 (17%)
Query: 23  DRYDFVRDIGSGNFGVARLMR---------DKVTKELVAVKYIERGDKIDENVQREIINH 73
           DR    + +G G FG   L           ++VTK  VAVK + + D  ++++   I   
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKML-KSDATEKDLSDLISEM 125
Query: 74  RSLR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEARFF 124
             ++    H NI+           L +++EYAS G L E +  A R     +S + +   
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-QARRPPGLEYSYNPSHNP 184
Query: 125 FQQLIS------------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 171
            +QL S            G+ Y  + +  HRDL   N L+       +KI DFG ++   
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIH 242
Query: 172 VLHSQPKSTVGT--PAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            +    K+T G     ++APE L    Y  + +DVWS GV L+ +  +GG P+
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPY 294

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 275 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 332
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 333 EEPIYIVTEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 385
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 386 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 444 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 497
Query: 259 SRIFVADPAARITI 272
            + +  +P  R T 
Sbjct: 498 CQCWRKEPEERPTF 511

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  + +
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLL 193
             HRDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L 
Sbjct: 154 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQ 210
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP 220
             ++  K +DVWS GV L+ ++  G P
Sbjct: 211 TQKFTTK-SDVWSFGVLLWELMTRGAP 236

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 39  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  + +
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 158
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLL 193
             HRDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L 
Sbjct: 159 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQ 215
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP 220
             ++  K +DVWS GV L+ ++  G P
Sbjct: 216 TQKFTTK-SDVWSFGVLLWELMTRGAP 241

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 35  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  + +
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 154
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLL 193
             HRDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L 
Sbjct: 155 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQ 211
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP 220
             ++  K +DVWS GV L+ ++  G P
Sbjct: 212 TQKFTTK-SDVWSFGVLLWELMTRGAP 237

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 32  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  + +
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 151
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLL 193
             HRDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L 
Sbjct: 152 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQ 208
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP 220
             ++  K +DVWS GV L+ ++  G P
Sbjct: 209 TQKFTTK-SDVWSFGVLLWELMTRGAP 234

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 17/207 (8%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNI 81
           F   IG G+FG      L+ +   K   AVK + R   I E  Q   E I  +   HPN+
Sbjct: 34  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 82  VRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHAMQ 139
           +    + L +     +V+ Y   G+L   I N     +  +   F  Q+  G+ +  + +
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 153
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKSTVGTPAYIAPEVLL 193
             HRDL   N +LD      +K+ DFG ++         +H++  + +    ++A E L 
Sbjct: 154 FVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPV-KWMALESLQ 210
Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYP 220
             ++  K +DVWS GV L+ ++  G P
Sbjct: 211 TQKFTTK-SDVWSFGVLLWELMTRGAP 236

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 93/242 (38%), Gaps = 50/242 (20%)
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           N++  K       H+ I M Y    E F  I N+  F   E R +   L   +   H   
Sbjct: 81  NVMGVKYCFRKNDHVVIAMPYLEH-ESFLDILNSLSF--QEVREYMLNLFKALKRIHQFG 137
Query: 140 VCHRDLKLENTLLDGSPAPRLK---ICDFGYSKSS------VLH-----------SQPKS 179
           + HRD+K  N L +     RLK   + DFG ++ +      +L            SQ K 
Sbjct: 138 IVHRDVKPSNFLYN----RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKC 193
Query: 180 TV------------GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
           ++            GTP + APEVL +        D+WS GV    +L G YPF    + 
Sbjct: 194 SICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253
Query: 228 ----------KDFRKTIQRILSVQYSVPDTNPI-SQECRDLISRIFVADPAARITIPEIM 276
                     +  R+TIQ   +   S+  +  + +Q+ R L  R+   D +      +I 
Sbjct: 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQ 313
Query: 277 KH 278
            H
Sbjct: 314 GH 315

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 29/254 (11%)
Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G FG   +     T   VA+K ++ G    E   +E    + LRH  +V+   V+ +
Sbjct: 192 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ---------QLISGVSYCHAMQVC 141
              + IV EY S G L +       F + E   + +         Q+ SG++Y   M   
Sbjct: 250 EEPIYIVGEYMSKGSLLD-------FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYV 302
Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   +  
Sbjct: 303 HRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 200 KIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           K +DVWS G+ L  +   G  P+     P    + +   +   Y +P      +   DL+
Sbjct: 361 K-SDVWSFGILLTELTTKGRVPY-----PGMVNREVLDQVERGYRMPCPPECPESLHDLM 414
Query: 259 SRIFVADPAARITI 272
            + +  +P  R T 
Sbjct: 415 CQCWRKEPEERPTF 428

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 105/285 (36%), Gaps = 68/285 (23%)
Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----- 78
           RY  +R +G G+F    L  D   K  VA+K ++      E    EI   + +R      
Sbjct: 32  RYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSD 91
Query: 79  PN-------IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLI 129
           PN       I  FK   +   H+ +V E   G  L + I   N         +   +Q++
Sbjct: 92  PNKDMVVQLIDDFKISGMNGIHVCMVFE-VLGHHLLKWIIKSNYQGLPVRCVKSIIRQVL 150
Query: 130 SGVSYCHA-MQVCHRDLKLENTLL-------------------DGSPAP----------- 158
            G+ Y H+  ++ H D+K EN L+                    G+P P           
Sbjct: 151 QGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPAA 210
Query: 159 ---------------RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
                          R+KI D G   +  +H      + T  Y + EVL+   Y    AD
Sbjct: 211 DLLVNPLDPRNADKIRVKIADLG--NACWVHKHFTEDIQTRQYRSIEVLIGAGYSTP-AD 267
Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKT---IQRILSVQYSVP 245
           +WS     + +  G Y FE P   +D+ +    I  I+ +  S+P
Sbjct: 268 IWSTACMAFELATGDYLFE-PHSGEDYSRDEDHIAHIIELLGSIP 311

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 26  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 83
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 84  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 142
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 143 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 200 -SDVWSFGILLTEIVTHG 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 25  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 82
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 83  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 141
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 142 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 199 -SDVWSFGILLTEIVTHG 215

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 134 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 191 -SDVWSFGILLTEIVTHG 207

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 23  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 140 DLRAANILVSDTLS--CKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 197 -SDVWSFGILLTEIVTHG 213

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 18  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 75
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 76  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 134
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 135 DLRAANILV--SDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 192 -SDVWSFGILLTEIVTHG 208

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 10/146 (6%)
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGV 132
           RHP++V           + ++ +Y   G L   +  +       S ++          G+
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAP 189
            Y H   + HRD+K  N LLD +  P  KI DFG SK      Q        GT  YI P
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML 215
           E  ++     K +DV+S GV L+ +L
Sbjct: 211 EYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 19  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 76
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 77  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 135
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 136 DLRAANILV--SDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 193 -SDVWSFGILLTEIVTHG 209

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 62/146 (42%), Gaps = 10/146 (6%)
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----RFSEDEARFFFQQLISGV 132
           RHP++V           + ++ +Y   G L   +  +       S ++          G+
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAP 189
            Y H   + HRD+K  N LLD +  P  KI DFG SK      Q        GT  YI P
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVML 215
           E  ++     K +DV+S GV L+ +L
Sbjct: 211 EYFIKGRLTEK-SDVYSFGVVLFEVL 235

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  S     KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 134 DLRAANILV--SDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 191 -SDVWSFGILLTEIVTHG 207

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 23/209 (11%)
Query: 28  VRDIGSGNFGVAR----LMRDKVTKELVAVKYIE--RGDKIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  V +K IE   G +  + V   ++   SL H +I
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 82  VRFKEVILTP-THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           VR   + L P + L +V +Y   G L + +  + G         +  Q+  G+ Y     
Sbjct: 96  VRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 153
Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLL 193
           + HR+L   N LL  SP+ ++++ DFG +         +L+S+ K+ +    ++A E + 
Sbjct: 154 MVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIH 208
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +Y  + +DVWS GVT++ +M  G  P+
Sbjct: 209 FGKYTHQ-SDVWSYGVTVWELMTFGAEPY 236

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 23  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 80
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 81  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 139
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           DL+  N L+  + +   KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 140 DLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 196
Query: 202 ADVWSCGVTLYVMLVGG 218
           +DVWS G+ L  ++  G
Sbjct: 197 SDVWSFGILLTEIVTHG 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 27  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 84
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 85  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 143
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           DL+  N L+  + +   KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 144 DLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 200
Query: 202 ADVWSCGVTLYVMLVGG 218
           +DVWS G+ L  ++  G
Sbjct: 201 SDVWSFGILLTEIVTHG 217

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 89/197 (45%), Gaps = 11/197 (5%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 22  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 79
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 80  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 138
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           DL+  N L+  + +   KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 139 DLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 195
Query: 202 ADVWSCGVTLYVMLVGG 218
           +DVWS G+ L  ++  G
Sbjct: 196 SDVWSFGILLTEIVTHG 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 15/213 (7%)
Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQRE 69
           GP  ++P     +    V  +G+G FG V     +  TK  VAVK +++G    +    E
Sbjct: 1   GPEWEVP----RETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAE 54
Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
               + L+H  +VR   V+ T   + I+ EY   G L  F +  +  + + ++      Q
Sbjct: 55  ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 113
Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPA 185
           +  G+++       HR+L+  N L+  S     KI DFG ++      ++  +       
Sbjct: 114 IAEGMAFIEERNYIHRNLRAANILV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 171
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
           + APE +    +  K +DVWS G+ L  ++  G
Sbjct: 172 WTAPEAINYGTFTIK-SDVWSFGILLTEIVTHG 203

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 27/211 (12%)
Query: 28  VRDIGSGNFGVAR----LMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHP 79
           ++ +GSG FG       +   +  K  V +K IE  DK      + + +H     SL H 
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 80  NIVRFKEVILTP-THLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
           +IVR   + L P + L +V +Y   G L + +  + G         +  Q+  G+ Y   
Sbjct: 76  HIVRL--LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEV 191
             + HR+L   N LL  SP+ ++++ DFG +         +L+S+ K+ +    ++A E 
Sbjct: 134 HGMVHRNLAARNVLLK-SPS-QVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALES 188
Query: 192 LLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           +   +Y  + +DVWS GVT++ +M  G  P+
Sbjct: 189 IHFGKYTHQ-SDVWSYGVTVWELMTFGAEPY 218

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           DL+  N L+  S     KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 134 DLRAANILV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 190
Query: 202 ADVWSCGVTLYVMLVGG 218
           +DVWS G+ L  ++  G
Sbjct: 191 SDVWSFGILLTEIVTHG 207

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 81  CRLLGICLTST-VQLIMQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 136 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 194 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 88/197 (44%), Gaps = 11/197 (5%)
Query: 27  FVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G FG V     +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 12  LVERLGAGQFGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 69
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 70  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           DL+  N L+  S     KI DFG ++      ++  +       + APE +    +  K 
Sbjct: 129 DLRAANILV--SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK- 185
Query: 202 ADVWSCGVTLYVMLVGG 218
           +DVWS G+ L  ++  G
Sbjct: 186 SDVWSFGILLTEIVTHG 202

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 32/290 (11%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRF 84
           + IG GNFG  RL ++  T E VA+K +E        +  E   ++ L      P +  F
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 85  KEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
                   + A+V+E    S  +LF+ +C+   FS         QLIS + Y H+  + +
Sbjct: 74  GPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSKNLIY 128
Query: 143 RDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQPKSTVGTPAYIAPE 190
           RD+K EN L+ G P  +    + I DFG         +K  + + + KS  GT  Y++  
Sbjct: 129 RDVKPENFLI-GRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSIN 187
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
             L  E   +  D+ + G      L G  P++   +    ++  Q+I   + +     PI
Sbjct: 188 THLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGL-KADTLKERYQKIGDTKRAT----PI 241
Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE 300
              C +            R+   E   +  +L+ L  DL D K     YE
Sbjct: 242 EVLCENFPEMATYLRYVRRLDFFEKPDYD-YLRKLFTDLFDRKGYMFDYE 290

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/199 (20%), Positives = 82/199 (41%), Gaps = 16/199 (8%)
Query: 33  SGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT 92
           SG     R   + +  +++ V+  +   +   +   E    R   HPN++       +P 
Sbjct: 23  SGELWKGRWQGNDIVVKVLKVR--DWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80
Query: 93  --HLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQ--VCHRDLK 146
             H  ++  +   G L+  +     F  D+++   F   +  G+++ H ++  +    L 
Sbjct: 81  APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140
Query: 147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG--KIADV 204
             + ++D     R+ + D  +S       Q    +  PA++APE L +   D   + AD+
Sbjct: 141 SRSVMIDEDMTARISMADVKFS------FQSPGRMYAPAWVAPEALQKKPEDTNRRSADM 194
Query: 205 WSCGVTLYVMLVGGYPFED 223
           WS  V L+ ++    PF D
Sbjct: 195 WSFAVLLWELVTREVPFAD 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 80  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 21  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 80
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 81  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 136 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 194 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 24  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 84  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 139 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 197 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 83  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 138 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 196 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 208
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 93  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 151
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 152 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 208
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 209 SK-SDVWSFGVLMW 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 82  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 137 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 195 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 101/262 (38%), Gaps = 50/262 (19%)
Query: 31  IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS-------LRHPN 80
           +G G FG      L ++  T   VAVK +    K+D + QREI    S         HPN
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTM----KLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 81  IVRFKEVILTPTHLAI-----VMEYASGGELFERICNAGRFSEDEARFFFQQLIS----- 130
           ++R   V +  +   I     ++ +   G+L   +  + R          Q L+      
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMVDI 156
Query: 131 --GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPKSTVGT 183
             G+ Y       HRDL   N +L       + +C  DFG SK   S   + Q +     
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCMLRDD----MTVCVADFGLSKKIYSGDYYRQGRIAKMP 212
Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG---YPFEDPDEPKDF---------- 230
             +IA E L    Y  K +DVW+ GVT++ +   G   YP     E  D+          
Sbjct: 213 VKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP 271
Query: 231 RKTIQRILSVQYSVPDTNPISQ 252
              +  +  + YS   T+P+ +
Sbjct: 272 EDCLDELYEIMYSCWRTDPLDR 293

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 24  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 83
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 84  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 139 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 197 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 82  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 137 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 195 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 82  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 137 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 195 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWY-APECINYYKFS 192
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 193 SK-SDVWSFGVLMW 205

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 91  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 149
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 150 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 206
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 207 SK-SDVWSFGVLMW 219

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 77  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 135
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 136 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 192
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 193 SK-SDVWSFGVLMW 205

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 73  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 132 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 188
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 189 SK-SDVWSFGVLMW 201

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 141
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 142 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 198
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 199 SK-SDVWSFGVLMW 211

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 71  MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 129
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 130 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 186
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 187 SK-SDVWSFGVLMW 199

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 80  CRLLGICLTST-VQLITQLMPFGXLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 25  YDFVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           +  ++ +GSG FG     L   +  K  + V  +E  +       +EI++      S+ +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 133
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 111 PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 165
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 190
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 166 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 223
Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
            +L   Y  + +DVWS GVT++ +M  G  P++
Sbjct: 224 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 255

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 27  FVRDIGSGNFGVARL-MRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFK 85
            V  +G+G  G   +   +  TK  VAVK +++G    +    E    + L+H  +VR  
Sbjct: 17  LVERLGAGQAGEVWMGYYNGHTK--VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 86  EVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
            V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       HR
Sbjct: 75  AVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEVLLRHEYDGK 200
           DL+  N L+  + +   KI DFG ++  +  ++  +  G      + APE +    +  K
Sbjct: 134 DLRAANILVSDTLS--CKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 201 IADVWSCGVTLYVMLVGG 218
            +DVWS G+ L  ++  G
Sbjct: 191 -SDVWSFGILLTEIVTHG 207

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 32/290 (11%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRF 84
           + IG GNFG  RL ++  T E VA+K +E        +  E   ++ L      P +  F
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73
Query: 85  KEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
                   + A+V+E    S  +LF+ +C+   FS         QLIS + Y H+  + +
Sbjct: 74  GPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSKNLIY 128
Query: 143 RDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQPKSTVGTPAYIAPE 190
           RD+K EN L+ G P  +    + I DF          +K  + + + KS  GT  Y++  
Sbjct: 129 RDVKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSIN 187
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
             L  E   +  D+ + G      L G  P++   +    ++  Q+I   + +     PI
Sbjct: 188 THLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGL-KADTLKERYQKIGDTKRAT----PI 241
Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE 300
              C +            R+   E   +  +L+ L  DL D K     YE
Sbjct: 242 EVLCENFPEMATYLRYVRRLDFFEKPDYD-YLRKLFTDLFDRKGYMFDYE 290

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 32/290 (11%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH----PNIVRF 84
           + IG GNFG  RL ++  T E VA+K +E        +  E   ++ L      P +  F
Sbjct: 36  KKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 94
Query: 85  KEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
                   + A+V+E    S  +LF+ +C+   FS         QLIS + Y H+  + +
Sbjct: 95  GPC---GKYNAMVLELLGPSLEDLFD-LCDR-TFSLKTVLMIAIQLISRMEYVHSKNLIY 149
Query: 143 RDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQPKSTVGTPAYIAPE 190
           RD+K EN L+ G P  +    + I DF          +K  + + + KS  GT  Y++  
Sbjct: 150 RDVKPENFLI-GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSIN 208
Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
             L  E   +  D+ + G      L G  P++   +    ++  Q+I   + +     PI
Sbjct: 209 THLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGL-KADTLKERYQKIGDTKRAT----PI 262
Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE 300
              C +            R+   E   +  +L+ L  DL D K     YE
Sbjct: 263 EVLCENFPEMATYLRYVRRLDFFEKPDYD-YLRKLFTDLFDRKGYMFDYE 311

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 435 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 493
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 494 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 550
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 551 SK-SDVWSFGVLMW 563

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 15/194 (7%)
Query: 29  RDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNIVR 83
           +++GSGNFG V +               I + +  D  ++ E++      + L +P IVR
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
              +    + + +VME A  G L + +       +        Q+  G+ Y       HR
Sbjct: 436 MIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 494
Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKS-----SVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           DL   N LL        KI DFG SK+     +   +Q         Y APE +  +++ 
Sbjct: 495 DLAARNVLL--VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-APECINYYKFS 551
Query: 199 GKIADVWSCGVTLY 212
            K +DVWS GV ++
Sbjct: 552 SK-SDVWSFGVLMW 564

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYI--ERGDKIDENVQREIINHRSLRH 78
           SD +     +G G FG  ++ + ++    LVAVK +  ER    +   Q E+       H
Sbjct: 37  SDNFSNKNILGRGGFG--KVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVH 94
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGE----LFERICNAGRFSEDEARFFFQQLISGVSY 134
            N++R +   +TPT   +V  Y + G     L ER  +       + +        G++Y
Sbjct: 95  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 154
Query: 135 CHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAP 189
            H     ++ HRD+K  N LLD        + DFG +K           +  GT  +IAP
Sbjct: 155 LHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAKLMDYKDXHVXXAVRGTIGHIAP 212
Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
           E L   +   K  DV+  GV L  ++ G   F+
Sbjct: 213 EYLSTGKSSEK-TDVFGYGVMLLELITGQRAFD 244

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 13  AMDMPIMHDSDRYDFVRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENV 66
           AM +  +     +  ++ +GSG FG       +   +  K  VA+K +      K ++ +
Sbjct: 2   AMALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI 61
Query: 67  QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFF 124
             E     S+ +P++ R   + LT T + ++ +    G L + +    R  +D   +++ 
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYL 116
Query: 125 FQ---QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
                Q+  G++Y    ++ HRDL   N L+  +P   +KI DFG +K      +     
Sbjct: 117 LNWCVQIAEGMNYLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAE 174
Query: 182 GTPA---YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
           G      ++A E +L   Y  + +DVWS GVT++ +M  G  P++
Sbjct: 175 GGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 218

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 30  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 89
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 90  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 145 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 203 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 231

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 97/246 (39%), Gaps = 37/246 (15%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-----------YIERGDKIDENVQREI 70
            +RY   R IGSG+FG   L  D    E VA+K           +IE   KI + +Q  +
Sbjct: 8   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKMMQGGV 65
Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQL 128
                     I   +       +  +VME    G   E + N  + +FS         Q+
Sbjct: 66  ---------GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQM 114
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKS 179
           IS + Y H+    HRD+K +N L+  G     + I DFG +K          + + + K+
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
             GT  Y +    L  E   +  D+ S G  L    +G  P++        R+  +RI  
Sbjct: 175 LTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISE 232
Query: 240 VQYSVP 245
            + S P
Sbjct: 233 KKMSTP 238

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 83  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 138 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 196 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 97/246 (39%), Gaps = 37/246 (15%)
Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVK-----------YIERGDKIDENVQREI 70
            +RY   R IGSG+FG   L  D    E VA+K           +IE   KI + +Q  +
Sbjct: 6   GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE--SKIYKMMQGGV 63
Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQL 128
                     I   +       +  +VME    G   E + N  + +FS         Q+
Sbjct: 64  ---------GIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQM 112
Query: 129 ISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKS--------SVLHSQPKS 179
           IS + Y H+    HRD+K +N L+  G     + I DFG +K          + + + K+
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
             GT  Y +    L  E   +  D+ S G  L    +G  P++        R+  +RI  
Sbjct: 173 LTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISE 230
Query: 240 VQYSVP 245
            + S P
Sbjct: 231 KKMSTP 236

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 45  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 104
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 105 CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 160 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 218 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 246

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 80  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 83  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 138 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 196 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 26  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 85
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 86  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 141 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 199 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 227

>pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 32/215 (14%)
Query: 29  RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-------PNI 81
           + IG GNFG  RL ++  T E VA+K     + I     +  + +R  +        P +
Sbjct: 10  KKIGCGNFGELRLGKNLYTNEYVAIKL----EPIKSRAPQLHLEYRFYKQLSATEGVPQV 65
Query: 82  VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
             F        + A+V+E    S  +LF+ +C+   F+         QLI+ + Y H   
Sbjct: 66  YYFGP---XGKYNAMVLELLGPSLEDLFD-LCDR-TFTLKTVLMIAIQLITRMEYVHTKS 120
Query: 140 VCHRDLKLENTLLDGSPAPR----LKICDFGY--------SKSSVLHSQPKSTVGTPAYI 187
           + +RD+K EN L+ G P  +    + I DFG         +K  + + + KS  GT  Y+
Sbjct: 121 LIYRDVKPENFLV-GRPGTKRQHAIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYM 179
Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFE 222
           +    L  E   +  D+ + G      L G  P++
Sbjct: 180 SINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQ 213

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
           F+ ++G   FG      L      ++  AV      DK +    E  + E +    L+HP
Sbjct: 30  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 89
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEAR------------F 123
           N+V    V+     L+++  Y S G+L E    R  ++   S D+ R             
Sbjct: 90  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 149
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
              Q+ +G+ Y  +  V H+DL   N L+       +KI D G  +  V  +     +G 
Sbjct: 150 LVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR-EVYAADYYKLLGN 206
Query: 184 PA----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
                 ++APE ++  ++    +D+WS GV L+ +   G
Sbjct: 207 SLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYG 244

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 23  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 82
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 83  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 138 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 196 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 224

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 25/214 (11%)
Query: 27  FVRDIGSGNFG------VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSL 76
            +R +G G FG      V+ +  D    + VAVK +       D++D  ++  II+   L
Sbjct: 35  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPEVCSEQDELDFLMEALIIS--KL 91
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 129
            H NIVR   V L      I++E  +GG+L         R       +  +     + + 
Sbjct: 92  NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 151
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 185
            G  Y       HRD+   N LL    P    KI DFG ++    +  + +    +    
Sbjct: 152 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
           ++ PE  +   +  K  D WS GV L+ +   GY
Sbjct: 212 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGY 244

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 14  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 73
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 74  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 129 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 187 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 215

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ + SG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 27  IKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++M+    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 87  CRLLGICLTST-VQLIMQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 142 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 200 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 27  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 86
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 87  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 142 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 200 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 25/214 (11%)
Query: 27  FVRDIGSGNFG------VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSL 76
            +R +G G FG      V+ +  D    + VAVK +       D++D  ++  II+    
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPEVCSEQDELDFLMEALIIS--KF 90
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 129
            H NIVR   V L      I+ME  +GG+L         R       +  +     + + 
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 150
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 185
            G  Y       HRD+   N LL    P    KI DFG ++    +  + +    +    
Sbjct: 151 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
           ++ PE  +   +  K  D WS GV L+ +   GY
Sbjct: 211 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGY 243

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 82  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 137 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 195 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 80  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 135 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 193 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 25/214 (11%)
Query: 27  FVRDIGSGNFG------VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSL 76
            +R +G G FG      V+ +  D    + VAVK +       D++D  ++  II+   L
Sbjct: 49  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPEVCSEQDELDFLMEALIIS--KL 105
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 129
            H NIVR   V L      I++E  +GG+L         R       +  +     + + 
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 185
            G  Y       HRD+   N LL    P    KI DFG ++    +  + +    +    
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
           ++ PE  +   +  K  D WS GV L+ +   GY
Sbjct: 226 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGY 258

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
           F+ ++G   FG      L      ++  AV      DK +    E  + E +    L+HP
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEAR------------F 123
           N+V    V+     L+++  Y S G+L E    R  ++   S D+ R             
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
              Q+ +G+ Y  +  V H+DL   N L+       +KI D G  +  V  +     +G 
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR-EVYAADYYKLLGN 189
Query: 184 PA----YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG 218
                 ++APE ++  ++    +D+WS GV L+ +   G
Sbjct: 190 SLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYG 227

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 25  YDFVRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRH 78
           +  ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 133
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 131
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 190
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
            +L   Y  + +DVWS GVT++ +M  G  P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 65/272 (23%), Positives = 110/272 (40%), Gaps = 38/272 (13%)
Query: 24  RYDFVRDIGSGNFGVAR---LMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSL 76
           ++   R +G G FG  R   L ++  +   VAVK + + D I     E   RE    +  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 77  RHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLI- 129
            HP++ +   V L            +++ +   G+L   +  A R  E+      Q L+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL-ASRIGENPFNLPLQTLVR 141
Query: 130 ------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK---SSVLHSQPK 178
                  G+ Y  +    HRDL   N +L    A  + +C  DFG S+   S   + Q  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCML----AEDMTVCVADFGLSRKIYSGDYYRQGC 197
Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRI 237
           ++     ++A E L  + Y    +DVW+ GVT++ +M  G  P+   +  +     I   
Sbjct: 198 ASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAE-----IYNY 251
Query: 238 LSVQYSVPDTNPISQECRDLISRIFVADPAAR 269
           L     +       +E  DL+ + + ADP  R
Sbjct: 252 LIGGNRLKQPPECMEEVYDLMYQCWSADPKQR 283

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 85/214 (39%), Gaps = 25/214 (11%)
Query: 27  FVRDIGSGNFG------VARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRSL 76
            +R +G G FG      V+ +  D    + VAVK +       D++D  ++  II+    
Sbjct: 49  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQ-VAVKTLPEVCSEQDELDFLMEALIIS--KF 105
Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 129
            H NIVR   V L      I+ME  +GG+L         R       +  +     + + 
Sbjct: 106 NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIA 165
Query: 130 SGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKS---SVLHSQPKSTVGTPA 185
            G  Y       HRD+   N LL    P    KI DFG ++    +  + +    +    
Sbjct: 166 CGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY 219
           ++ PE  +   +  K  D WS GV L+ +   GY
Sbjct: 226 WMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGY 258

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 28  VRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNI 81
           ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +P++
Sbjct: 22  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 81
Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVSYCH 136
            R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++Y  
Sbjct: 82  CRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLL 193
             ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E +L
Sbjct: 137 DRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
              Y  + +DVWS GVT++ +M  G  P++
Sbjct: 195 HRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 25  YDFVRDIGSGNFGVA----RLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRH 78
           +  ++ +GSG FG       +   +  K  VA+K +      K ++ +  E     S+ +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE--ARFFFQ---QLISGVS 133
           P++ R   + LT T + ++ +    G L + +    R  +D   +++      Q+  G++
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMN 138
Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPE 190
           Y    ++ HRDL   N L+  +P   +KI DFG +K      +     G      ++A E
Sbjct: 139 YLEDRRLVHRDLAARNVLVK-TPQ-HVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALE 196
Query: 191 VLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFE 222
            +L   Y  + +DVWS GVT++ +M  G  P++
Sbjct: 197 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 228
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	365
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	0.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-150
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-145
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-114
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-113
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-112
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-112
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-110
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-110
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-108
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-108
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-108
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-106
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-105
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-105
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-103
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-102
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-102
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-96
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-92
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-92
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-92
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-91
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-91
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-90
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-90
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-90
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-90
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-89
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-89
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-89
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-88
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-88
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-88
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-88
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-88
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-88
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-88
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-87
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-87
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-87
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-86
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-86
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-86
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-86
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-86
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-86
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-86
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-85
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-85
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-84
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-84
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-84
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	6e-84
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-84
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-82
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-80
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-79
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-78
2a19_B	284	Interferon-induced, double-stranded RNA-activated	7e-78
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-76
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-75
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-74
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-73
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-73
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-69
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-68
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-67
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-65
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-64
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-63
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	7e-62
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-61
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-60
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-60
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-60
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-60
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-60
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-59
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-59
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-59
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-58
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-58
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-57
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-57
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-57
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-56
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-56
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-56
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	9e-56
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-55
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-55
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-55
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	9e-55
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-54
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-53
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-47
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-47
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-47
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-47
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-46
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-46
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-45
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-45
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-45
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-45
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-45
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	9e-45
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-44
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-44
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-44
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-43
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	5e-43
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-42
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-42
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	8e-42
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-41
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-41
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-41
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-41
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-41
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-41
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-41
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-41
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-41
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-40
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-40
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-40
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-40
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-40
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-39
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-39
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-39
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-38
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-37
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-35
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-35
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-35
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-34
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-33
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-33
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-32
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-32
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-32
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-32
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-32
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-31
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-31
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-31
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	8e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-29
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-29
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-28
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-28
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-28
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-28
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-27
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-23
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-23
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-21
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-20
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-20
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	7e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-19
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-19
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-19
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-19
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-19
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-19
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-18
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	7e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-17
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-17
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-17
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-16
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-15
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-15
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	6e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-14
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-13
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-13
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-13
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-13
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-09
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-08
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	7e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-06

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  575 bits (1485), Expect = 0.0
 Identities = 306/363 (84%), Positives = 334/363 (92%), Gaps = 2/363 (0%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           MDRA +T GP +DMPIMHDSDRYDFV+DIGSGNFGVARLMRDK+TKELVAVKYIERG  I
Sbjct: 1   MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI 59

Query: 63  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           DENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEAR
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR 119

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 182
           FFFQQL+SGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG
Sbjct: 120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TPAYIAPEVLLR EYDGKIADVWSCGVTLYVMLVG YPFEDP+EP+D+RKTIQRILSV+Y
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S+PD   IS EC  LISRIFVADPA RI+IPEI  H WFLKNLPADL++E    SQ++EP
Sbjct: 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299

Query: 303 DQPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEII 362
           +QPMQS+D IMQII+EA+IPAV    L+ +MTDNLD+ DDDMDD DSESE+DIDSSGEI+
Sbjct: 300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDL-DDDMDDFDSESEIDIDSSGEIV 358

Query: 363 YAL 365
           YAL
Sbjct: 359 YAL 361

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  425 bits (1096), Expect = e-150
 Identities = 103/321 (32%), Positives = 162/321 (50%), Gaps = 17/321 (5%)

Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P +   + +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57

Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++        GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P +     +        +  +    
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWKEKKTYLNPWK 232

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP----DQ 304
            I      L+ +I V +P+ARITIP+I K +W+ K L       +  S    E      +
Sbjct: 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSK 292

Query: 305 PMQSVDVIMQIIAEASIPAVG 325
            +QS      + + +  P  G
Sbjct: 293 HIQSNLDFSPVNSASRTPGSG 313

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  411 bits (1060), Expect = e-145
 Identities = 97/282 (34%), Positives = 154/282 (54%), Gaps = 15/282 (5%)

Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREII 71
           M +P +   + +D V+ +G G +G  +L  ++VT+E VAVK ++    +D  EN+++EI 
Sbjct: 1   MAVPFV---EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC 57

Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            ++ L H N+V+F           + +EY SGGELF+RI       E +A+ FF QL++G
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG 117

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIA 188
           V Y H + + HRD+K EN LLD      LKI DFG +     +++        GT  Y+A
Sbjct: 118 VVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQRILSVQYSVPDT 247
           PE+L R E+  +  DVWSCG+ L  ML G  P++ P +  +++    ++    +  +   
Sbjct: 176 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK----KTYLNPW 231

Query: 248 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 289
             I      L+ +I V +P+ARITIP+I K +W+ K L    
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  333 bits (856), Expect = e-114
 Identities = 110/274 (40%), Positives = 150/274 (54%), Gaps = 14/274 (5%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
            Y     +G G FG  ++   ++T   VAVK + R  KI        ++REI N +  RH
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNR-QKIRSLDVVGKIKREIQNLKLFRH 70

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P+I++  +VI TPT   +VMEY SGGELF+ IC  GR  E EAR  FQQ++S V YCH  
Sbjct: 71  PHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH 130

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+    Y 
Sbjct: 131 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 188

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G   D+WSCGV LY +L G  PF+D   P  F+K    I    + +P+   +++    L+
Sbjct: 189 GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFYIPEY--LNRSVATLL 242

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
             +   DP  R TI +I +H+WF ++LP+ L  E
Sbjct: 243 MHMLQVDPLKRATIKDIREHEWFKQDLPSYLFPE 276

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  331 bits (850), Expect = e-113
 Identities = 105/295 (35%), Positives = 155/295 (52%), Gaps = 17/295 (5%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
            Y  ++ IG GNF   +L R  +T   VA+K I++  +++    + + RE+   + L HP
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFREVRIMKILNHP 74

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIV+  EVI T   L ++MEYASGGE+F+ +   GR  E EAR  F+Q++S V YCH  +
Sbjct: 75  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           + HRDLK EN LLD      +KI DFG+S    +  +  +  G P Y APE+    +YDG
Sbjct: 135 IVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDG 192

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
              DVWS GV LY ++ G  PF+  +  +   +    +L  +Y +P    +S +C +L+ 
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYRIPFY--MSTDCENLLK 246

Query: 260 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQ 314
           R  V +P  R T+ +IMK +W       D +          E D   Q    IM 
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELK----PFVEPELDISDQKRIDIMV 297

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  333 bits (855), Expect = e-112
 Identities = 111/295 (37%), Positives = 154/295 (52%), Gaps = 14/295 (4%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
            Y     +G G FG  ++ + ++T   VAVK + R  KI        ++REI N +  RH
Sbjct: 17  HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR-QKIRSLDVVGKIRREIQNLKLFRH 75

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P+I++  +VI TP+ + +VMEY SGGELF+ IC  GR  E E+R  FQQ++SGV YCH  
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH 135

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V HRDLK EN LLD       KI DFG S         +++ G+P Y APEV+    Y 
Sbjct: 136 MVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYA 193

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G   D+WS GV LY +L G  PF+D   P  F+K    I    +  P    ++     L+
Sbjct: 194 GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFYTPQY--LNPSVISLL 247

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIM 313
             +   DP  R TI +I +H+WF ++LP  L  E    S     D+ ++ V    
Sbjct: 248 KHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKF 302

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  322 bits (829), Expect = e-110
 Identities = 89/273 (32%), Positives = 130/273 (47%), Gaps = 15/273 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
            RY   R +G G F     + D  TKE+ A K + +         E +  EI  HRSL H
Sbjct: 15  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++V F         + +V+E      L E        +E EAR++ +Q++ G  Y H  
Sbjct: 75  QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
           +V HRDLKL N  L+      +KI DFG +       + K  + GTP YIAPEVL +  +
Sbjct: 135 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             +  DVWS G  +Y +LVG  PFE     + + +    I   +YS+P    I+     L
Sbjct: 193 SFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLR----IKKNEYSIPKH--INPVAASL 245

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKN-LPADL 289
           I ++   DP AR TI E++  ++F    +PA L
Sbjct: 246 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  324 bits (832), Expect = e-110
 Identities = 119/286 (41%), Positives = 161/286 (56%), Gaps = 15/286 (5%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRH 78
            Y     +G G+FG  +L     T++ VA+K+I R   +        V+REI   + LRH
Sbjct: 10  PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISR-QLLKKSDMHMRVEREISYLKLLRH 68

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P+I++  +VI TPT + +V+EYA GGELF+ I    R +EDE R FFQQ+I  + YCH  
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH 127

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           ++ HRDLK EN LLD +    +KI DFG S      +  K++ G+P Y APEV+    Y 
Sbjct: 128 KIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
           G   DVWSCG+ LYVMLVG  PF+D   P  F+K    + S  Y +PD   +S   + LI
Sbjct: 186 GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYVMPDF--LSPGAQSLI 239

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ 304
            R+ VADP  RITI EI +  WF  NLP  L   + +   Y +   
Sbjct: 240 RRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRI 285

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  319 bits (820), Expect = e-108
 Identities = 85/307 (27%), Positives = 142/307 (46%), Gaps = 25/307 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------DENVQREIINHRSLR 77
           +Y     +G G++G  + + D  T    AVK +++  K+      + NV++EI   R LR
Sbjct: 6   KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKK-KKLRRIPNGEANVKKEIQLLRRLR 64

Query: 78  HPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLISGVS 133
           H N+++  +V+       + +VMEY   G  E+ + +    RF   +A  +F QLI G+ 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPE 190
           Y H+  + H+D+K  N LL       LKI   G +++    +     +++ G+PA+  PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
           +      + G   D+WS GVTLY +  G YPFE  +  K F      I    Y++P    
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN----IGKGSYAIPGD-- 235

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSS-QYEEPDQPMQS 308
                 DL+  +   +PA R +I +I +H WF K  P          S   ++  + M  
Sbjct: 236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTV 295

Query: 309 VDVIMQI 315
           V  +  +
Sbjct: 296 VPYLEDL 302

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  320 bits (822), Expect = e-108
 Identities = 91/273 (33%), Positives = 131/273 (47%), Gaps = 15/273 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
            RY   R +G G F     + D  TKE+ A K + +         E +  EI  HRSL H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            ++V F         + +V+E      L E        +E EAR++ +Q++ G  Y H  
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHEY 197
           +V HRDLKL N  L+      +KI DFG +       + K  + GTP YIAPEVL +  +
Sbjct: 161 RVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             +  DVWS G  +Y +LVG  PFE        ++T  RI   +YS+P    I+     L
Sbjct: 219 SFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEYSIPKH--INPVAASL 271

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKN-LPADL 289
           I ++   DP AR TI E++  ++F    +PA L
Sbjct: 272 IQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  317 bits (816), Expect = e-108
 Identities = 80/276 (28%), Positives = 134/276 (48%), Gaps = 15/276 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRH 78
           + +     +G G+F          T   VA+K I++       + + VQ E+  H  L+H
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHA 137
           P+I+          ++ +V+E    GE+   + N    FSE+EAR F  Q+I+G+ Y H+
Sbjct: 71  PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
             + HRDL L N LL  +    +KI DFG +    +  +   T+ GTP YI+PE+  R  
Sbjct: 131 HGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           +  + +DVWS G   Y +L+G  PF+         K    ++   Y +P    +S E +D
Sbjct: 189 HGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK----VVLADYEMPSF--LSIEAKD 241

Query: 257 LISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
           LI ++   +PA R+++  ++ H +  +N      DE
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  312 bits (801), Expect = e-106
 Identities = 96/296 (32%), Positives = 141/296 (47%), Gaps = 47/296 (15%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------------- 58
           +Y    +IG G++GV +L  ++      A+K + +                         
Sbjct: 14  QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73

Query: 59  --GDKIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAG 114
                  E V +EI   + L HPN+V+  EV+  P   HL +V E  + G + E +    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLK 132

Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----K 169
             SED+ARF+FQ LI G+ Y H  ++ HRD+K  N L+       +KI DFG S      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGS 190

Query: 170 SSVLHSQPKSTVGTPAYIAPEVL--LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
            ++L     +TVGTPA++APE L   R  + GK  DVW+ GVTLY  + G  PF D    
Sbjct: 191 DALLS----NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246

Query: 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
               K    I S     PD   I+++ +DLI+R+   +P +RI +PEI  H W  +
Sbjct: 247 CLHSK----IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  311 bits (798), Expect = e-105
 Identities = 85/268 (31%), Positives = 136/268 (50%), Gaps = 14/268 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
           D +D  R +G G FG   L R+K  K ++A+K + +       ++  ++REI     LRH
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI+R          + +++E+A  GEL++ +   GRF E  +  F ++L   + YCH  
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           +V HRD+K EN L+       LKI DFG+S  +    + ++  GT  Y+ PE++    +D
Sbjct: 134 KVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGTLDYLPPEMIEGKTHD 190

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D+W  GV  Y  LVG  PF+ P   +  R+    I++V    P    +S   +DLI
Sbjct: 191 EK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLKFPPF--LSDGSKDLI 243

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLP 286
           S++    P  R+ +  +M+H W   N  
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSR 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  309 bits (793), Expect = e-105
 Identities = 87/286 (30%), Positives = 145/286 (50%), Gaps = 19/286 (6%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH 78
           + ++  R +G G FG   L R+K +K ++A+K + +       ++  ++RE+     LRH
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ 
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           +V HRD+K EN LL  +    LKI DFG+S      S+     GT  Y+ PE++    +D
Sbjct: 129 RVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGTLDYLPPEMIEGRMHD 185

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D+WS GV  Y  LVG  PFE         +T +RI  V+++ PD   +++  RDLI
Sbjct: 186 EK-VDLWSLGVLCYEFLVGKPPFEANTYQ----ETYKRISRVEFTFPDF--VTEGARDLI 238

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ 304
           SR+   +P+ R  + E+++H W   N       + +     E   +
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWITANSS-----KPSNCQNKESASK 279

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  307 bits (788), Expect = e-103
 Identities = 84/296 (28%), Positives = 124/296 (41%), Gaps = 32/296 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--------VQREIINHR 74
            +Y     +GSG FG             VA+K++E+ D+I +         V  E++  +
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLK 101

Query: 75  SLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISG 131
            +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  
Sbjct: 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 161

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAYIA 188
           V +CH   V HRD+K EN L+D +    LK+ DFG     K +V         GT  Y  
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT----DFDGTRVYSP 216

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           PE +  H Y G+ A VWS G+ LY M+ G  PFE  +           I+  Q       
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFRQR- 265

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ 304
            +S EC+ LI       P+ R T  EI  H W    L      E  + S    P +
Sbjct: 266 -VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK 320

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  305 bits (782), Expect = e-102
 Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 29/292 (9%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIINHR 74
           +Y  +  +GSG FG      DK   + V VK+I++          D     V  EI    
Sbjct: 25  KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84

Query: 75  SLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
            + H NI++  ++        +VME + SG +LF  I    R  E  A + F+QL+S V 
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           Y     + HRD+K EN ++       +K+ DFG +          +  GT  Y APEVL+
Sbjct: 145 YLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
            + Y G   ++WS GVTLY ++    PF + +E           +      P    +S+E
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAIHPP--YLVSKE 250

Query: 254 CRDLISRIFVADPAARITIPEIMKHQWFLK--NLPADLVDEKTMSSQYEEPD 303
              L+S +    P  R T+ +++   W  +  NL     +E     +  +P+
Sbjct: 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVF---RVNKPE 299

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  303 bits (779), Expect = e-102
 Identities = 75/285 (26%), Positives = 114/285 (40%), Gaps = 34/285 (11%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE--------NVQREIINHR 74
             Y     +G G FG          +  VA+K I R +++              E+    
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLW 89

Query: 75  SLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSEDEARFFFQQLI 129
            +     HP ++R  +   T     +V+E      +LF+ I   G   E  +R FF Q++
Sbjct: 90  KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVV 149

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQPKSTVGTPAY 186
           + + +CH+  V HRD+K EN L+D       K+ DFG                  GT  Y
Sbjct: 150 AAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT----DFDGTRVY 204

Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
             PE + RH+Y    A VWS G+ LY M+ G  PFE            Q IL  +   P 
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQEILEAELHFP- 253

Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
              +S +C  LI R     P++R ++ EI+   W         ++
Sbjct: 254 -AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLN 297

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  288 bits (740), Expect = 4e-96
 Identities = 61/315 (19%), Positives = 108/315 (34%), Gaps = 59/315 (18%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER------------------GDKIDE 64
           + Y  +R +  G F    L       +  A+K  E+                       +
Sbjct: 31  NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 65  NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------RF 116
           + + E+     +++   +  + +I     + I+ EY     + +                
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148

Query: 117 SEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
                +   + +++  SY H    +CHRD+K  N L+D +   R+K+ DFG S+      
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDKK 206

Query: 173 LHSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
           +      + GT  ++ PE       Y+G   D+WS G+ LYVM     PF          
Sbjct: 207 IK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SLV 259

Query: 232 KTIQRILSVQYSVPDTNP-----------------ISQECRDLISRIFVADPAARITIPE 274
           +    I +     P                     +S E  D +      +PA RIT  +
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319

Query: 275 IMKHQWFLKNLPADL 289
            +KH+W       DL
Sbjct: 320 ALKHEWLADTNIEDL 334

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  284 bits (730), Expect = 2e-95
 Identities = 93/271 (34%), Positives = 140/271 (51%), Gaps = 12/271 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHP 79
           +  Y     IG G++G  ++   K T+   A K I +   ++  +  ++EI   +SL HP
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHP 66

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NI+R  E     T + +VME  +GGELFER+ +   F E +A    + ++S V+YCH + 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126

Query: 140 VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           V HRDLK EN L    SP   LK+ DFG +         ++ VGTP Y++P+VL    Y 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y- 184

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRD 256
           G   D WS GV +YV+L G  PF  P + +   K    I    ++ P+     +S +   
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAES 240

Query: 257 LISRIFVADPAARITIPEIMKHQWFLKNLPA 287
           LI R+    P  RIT  + ++H+WF K L +
Sbjct: 241 LIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  279 bits (717), Expect = 2e-93
 Identities = 89/273 (32%), Positives = 134/273 (49%), Gaps = 11/273 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           SD YD   ++G G F V R    K T    A K I       +  + ++RE    R L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCH+ 
Sbjct: 65  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124

Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 184

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
             K  D+W+CGV LY++LVG  PF D D+ + + +    I +  Y  P    + ++ E +
Sbjct: 185 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 239

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
            LI  +   +P  RIT  + +K  W        
Sbjct: 240 SLIDSMLTVNPKKRITADQALKVPWICNRERVA 272

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  278 bits (714), Expect = 2e-92
 Identities = 87/274 (31%), Positives = 130/274 (47%), Gaps = 18/274 (6%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
            D Y   + +GSG  G  +L  ++ T + VA+K I +               NV+ EI  
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68

Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 127

Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
            Y H   + HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEV
Sbjct: 128 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 187

Query: 192 LLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-- 247
           L+        +  D WS GV L++ L G  PF +            +I S +Y+      
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---KDQITSGKYNFIPEVW 244

Query: 248 NPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             +S++  DL+ ++ V DP AR T  E ++H W 
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  277 bits (710), Expect = 5e-92
 Identities = 90/272 (33%), Positives = 137/272 (50%), Gaps = 12/272 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE-NVQREIINHRSLRHPN 80
              + F+  +GSG F    L++ ++T +L A+K I++     + +++ EI   + ++H N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV  +++  + TH  +VM+  SGGELF+RI   G ++E +A    QQ++S V Y H   +
Sbjct: 68  IVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127

Query: 141 CHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEYD 198
            HRDLK EN L        ++ I DFG SK  +  +    +  GTP Y+APEVL +  Y 
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTACGTPGYVAPEVLAQKPY- 184

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRD 256
            K  D WS GV  Y++L G  PF +  E K F K    I    Y       + IS+  +D
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKD 240

Query: 257 LISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
            I  +   DP  R T  + + H W   N    
Sbjct: 241 FICHLLEKDPNERYTCEKALSHPWIDGNTALH 272

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  276 bits (707), Expect = 5e-92
 Identities = 81/268 (30%), Positives = 131/268 (48%), Gaps = 14/268 (5%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKID-ENVQREIINHRSLRHP 79
            D + F R +GSG FG   L+ ++ +     +K I     ++  E ++ EI   +SL HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYC 135
           NI++  EV     ++ IVME   GGEL ERI          SE       +Q+++ ++Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 136 HAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
           H+  V H+DLK EN L    SP   +KI DFG ++         +  GT  Y+APEV  +
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV-FK 199

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQE 253
            +   K  D+WS GV +Y +L G  PF      +  +K        + +   +  P++ +
Sbjct: 200 RDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQ 254

Query: 254 CRDLISRIFVADPAARITIPEIMKHQWF 281
             DL+ ++   DP  R +  +++ H+WF
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  275 bits (706), Expect = 3e-91
 Identities = 60/303 (19%), Positives = 113/303 (37%), Gaps = 39/303 (12%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
           +  +     +G G        R K T +L A+K        +  +   RE    + L H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 80  NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
           NIV+   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
                + HR++K  N +       +   K+ DFG ++      Q  S  GT  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 193 LRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-- 243
            R           G   D+WS GVT Y    G  PF   + P+  ++ + +I++ + S  
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 244 -----------------VPDTNPISQECRD----LISRIFVADPAARITIPEIMKHQWFL 282
                            +P +  +S+  +     +++ I  AD        +       +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 283 KNL 285
            + 
Sbjct: 308 LHR 310

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  278 bits (714), Expect = 3e-91
 Identities = 90/290 (31%), Positives = 138/290 (47%), Gaps = 22/290 (7%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREIIN 72
            D Y   + +GSG  G  +L  ++ T + VA++ I +               NV+ EI  
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            + L HP I++ K       +  IV+E   GGELF+++    R  E   + +F Q++  V
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAV 252

Query: 133 SYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
            Y H   + HRDLK EN LL        +KI DFG+SK     S  ++  GTP Y+APEV
Sbjct: 253 QYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV 312

Query: 192 LLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-- 247
           L+        +  D WS GV L++ L G  PF +       +    +I S +Y+      
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK---DQITSGKYNFIPEVW 369

Query: 248 NPISQECRDLISRIFVADPAARITIPEIMKHQWF----LKNLPADLVDEK 293
             +S++  DL+ ++ V DP AR T  E ++H W     +K    DL+ E+
Sbjct: 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSEE 419

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  272 bits (699), Expect = 1e-90
 Identities = 84/286 (29%), Positives = 128/286 (44%), Gaps = 24/286 (8%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREI- 70
            + Y+    +G G   V R    K T +  AVK I          E   ++ E   +E+ 
Sbjct: 16  YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75

Query: 71  INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
           I  +   HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+ 
Sbjct: 76  ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 135

Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
            +   H + + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE
Sbjct: 136 VICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 193

Query: 191 VLLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
           ++     D     GK  D+WS GV +Y +L G  PF    +    R     I+S  Y   
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFG 249

Query: 246 DT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 289
               +  S   +DL+SR  V  P  R T  E + H +F + +  ++
Sbjct: 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  271 bits (696), Expect = 3e-90
 Identities = 95/269 (35%), Positives = 146/269 (54%), Gaps = 12/269 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           ++RY+ V  +G G+FG     +D++T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL    Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
           D K  DVWS GV LY++L G  PF   +E    ++    + + +Y+        IS + +
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK 254

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKN 284
           DLI ++    P+ RIT  + ++H W  K 
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKY 283

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  274 bits (703), Expect = 3e-90
 Identities = 84/279 (30%), Positives = 131/279 (46%), Gaps = 23/279 (8%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---------GDKIDENVQREI-I 71
             +YD    IG G   V R    + T    AVK +E           +++ E  +RE  I
Sbjct: 93  YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152

Query: 72  NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
             +   HP+I+   +   + + + +V +    GELF+ +      SE E R   + L+  
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           VS+ HA  + HRDLK EN LLD +    +++ DFG+S       + +   GTP Y+APE+
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270

Query: 192 LLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           L     +     GK  D+W+CGV L+ +L G  PF    +    R     I+  QY    
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS 326

Query: 247 T--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
              +  S   +DLISR+   DP AR+T  + ++H +F +
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  273 bits (700), Expect = 8e-90
 Identities = 90/273 (32%), Positives = 135/273 (49%), Gaps = 11/273 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGDKID-ENVQREIINHRSLRH 78
           SD YD   ++G G F V R    K T    A K I   +    D + ++RE    R L+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I   +   +V +  +GGELFE I     +SE +A    QQ++  ++YCH+ 
Sbjct: 88  PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147

Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HR+LK EN LL   +    +K+ DFG +             GTP Y++PEVL +  Y
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
             K  D+W+CGV LY++LVG  PF D D+ + + +    I +  Y  P    + ++ E +
Sbjct: 208 -SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAYDYPSPEWDTVTPEAK 262

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
            LI  +   +P  RIT  + +K  W        
Sbjct: 263 SLIDSMLTVNPKKRITADQALKVPWICNRERVA 295

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  272 bits (697), Expect = 1e-89
 Identities = 95/267 (35%), Positives = 132/267 (49%), Gaps = 13/267 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
           +D Y+   DIG G++ V +    K T    AVK I   DK   +   EI I  R  +HPN
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII---DKSKRDPTEEIEILLRYGQHPN 77

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           I+  K+V     ++ +V E   GGEL ++I     FSE EA      +   V Y HA  V
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137

Query: 141 CHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
            HRDLK  N L          ++ICDFG++K     +    T   T  ++APEVL R  Y
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY 197

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI-QRILSVQYSVPDT--NPISQEC 254
           D    D+WS GV LY ML G  PF   + P D  + I  RI S ++S+     N +S   
Sbjct: 198 D-AACDIWSLGVLLYTMLTGYTPFA--NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTA 254

Query: 255 RDLISRIFVADPAARITIPEIMKHQWF 281
           +DL+S++   DP  R+T   +++H W 
Sbjct: 255 KDLVSKMLHVDPHQRLTAALVLRHPWI 281

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  269 bits (689), Expect = 3e-89
 Identities = 89/271 (32%), Positives = 141/271 (52%), Gaps = 16/271 (5%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
            D Y+   ++GSG F + R  R K T +  A K+I        R     E ++RE+   R
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            +RHPNI+   ++    T + +++E  SGGELF+ +      +EDEA  F +Q++ GV Y
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHY 123

Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            H+ ++ H DLK EN +L     P PR+K+ DFG +      ++ K+  GTP ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
                 G  AD+WS GV  Y++L G  PF    + +        I +V Y   +   +  
Sbjct: 184 NYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNT 238

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWF 281
           S+  +D I R+ V DP  R+TI + ++H W 
Sbjct: 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  272 bits (697), Expect = 6e-89
 Identities = 61/336 (18%), Positives = 123/336 (36%), Gaps = 39/336 (11%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
           +  +     +G G        R K T +L A+K        +  +   RE    + L H 
Sbjct: 8   NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHK 67

Query: 80  NIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISGVSY 134
           NIV+   +    T  H  ++ME+   G L+  +    NA    E E     + ++ G+++
Sbjct: 68  NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
                + HR++K  N +       +   K+ DFG ++      Q  S  GT  Y+ P++ 
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187

Query: 193 LRHEYD-------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-- 243
            R           G   D+WS GVT Y    G  PF   + P+  ++ + +I++ + S  
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247

Query: 244 -----------------VPDTNPISQECRD----LISRIFVADPAARITIPEIMKHQWFL 282
                            +P +  +S+  +     +++ I  AD        +       +
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307

Query: 283 KNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 318
            +     V      + ++       +  +  +++ +
Sbjct: 308 LHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYK 343

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  269 bits (691), Expect = 1e-88
 Identities = 90/278 (32%), Positives = 143/278 (51%), Gaps = 8/278 (2%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           SD ++   ++G G   +    + K T++  A+K +++     + V+ EI     L HPNI
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVLLRLSHPNI 110

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           ++ KE+  TPT +++V+E  +GGELF+RI   G +SE +A    +Q++  V+Y H   + 
Sbjct: 111 IKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170

Query: 142 HRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
           HRDLK EN L    +P   LKI DFG SK        K+  GTP Y APE+L    Y G 
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GP 229

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLI 258
             D+WS G+  Y++L G  PF D    +      +RIL+ +Y       + +S   +DL+
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQF---MFRRILNCEYYFISPWWDEVSLNAKDLV 286

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 296
            ++ V DP  R+T  + ++H W        +  +    
Sbjct: 287 RKLIVLDPKKRLTTFQALQHPWVTGKAANFVHMDTAQK 324

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  268 bits (688), Expect = 1e-88
 Identities = 87/290 (30%), Positives = 142/290 (48%), Gaps = 16/290 (5%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
            D YD   ++GSG F + +  R+K T    A K+I        R     E ++RE+   R
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            + H N++   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            H  ++ H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
                 G  AD+WS GV  Y++L G  PF    +    ++T+  I SV Y   +   +  
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITSVSYDFDEEFFSHT 245

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE 300
           S+  +D I ++ V +   R+TI E ++H W         +  +      E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLE 295

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  269 bits (691), Expect = 1e-88
 Identities = 88/290 (30%), Positives = 143/290 (49%), Gaps = 16/290 (5%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
            D YD   ++GSG F + +  R+K T    A K+I        R     E ++RE+   R
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            + HPNI+   +V    T + +++E  SGGELF+ +      SE+EA  F +Q++ GV+Y
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNY 130

Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            H  ++ H DLK EN +L     P P +K+ DFG +       + K+  GTP ++APE++
Sbjct: 131 LHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIV 190

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
                 G  AD+WS GV  Y++L G  PF    +    ++T+  I +V Y   +   +  
Sbjct: 191 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANITAVSYDFDEEFFSQT 245

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYE 300
           S+  +D I ++ V +   R+TI E ++H W         +  +      E
Sbjct: 246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLE 295

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  268 bits (688), Expect = 2e-88
 Identities = 92/291 (31%), Positives = 151/291 (51%), Gaps = 16/291 (5%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
            D YD   ++GSG F V +  R+K T    A K+I        R     E+++RE+   +
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129

Query: 135 CHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE++
Sbjct: 130 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 189

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPI 250
                 G  AD+WS GV  Y++L G  PF    +    ++T+  + +V Y   D   +  
Sbjct: 190 NYEPL-GLEADMWSIGVITYILLSGASPFLGDTK----QETLANVSAVNYEFEDEYFSNT 244

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEE 301
           S   +D I R+ V DP  R+TI + ++H W         +  K  +   E+
Sbjct: 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  267 bits (685), Expect = 3e-88
 Identities = 63/292 (21%), Positives = 118/292 (40%), Gaps = 27/292 (9%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
            Y  ++ IGSG       + ++  K++ A+KY+   +  +   ++ + EI     L+  +
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 81  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
            + H DLK  N L+       LK+ DFG +             S VGT  Y+ PE +   
Sbjct: 147 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
                           +DVWS G  LY M  G  PF+           +  I+   + + 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE 260

Query: 246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL-PADLVDEKTMS 296
             +   ++ +D++      DP  RI+IPE++ H +      P + + + T  
Sbjct: 261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTE 312

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  267 bits (684), Expect = 6e-88
 Identities = 95/277 (34%), Positives = 140/277 (50%), Gaps = 14/277 (5%)

Query: 22  SDRYDF---VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLR 77
              YD     + +G G+F + R    K + +  AVK I +  +++ N Q+EI        
Sbjct: 7   YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG 64

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNIV+  EV     H  +VME  +GGELFERI     FSE EA +  ++L+S VS+ H 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 138 MQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRH 195
           + V HRDLK EN L  D +    +KI DFG+++     +QP K+   T  Y APE+L ++
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN 184

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI---QRILSVQYSVPDT--NPI 250
            YD +  D+WS GV LY ML G  PF+  D        +   ++I    +S        +
Sbjct: 185 GYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 287
           SQE +DLI  +   DP  R+ +  +  ++W       
Sbjct: 244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  266 bits (682), Expect = 7e-88
 Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 39/306 (12%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +  ++ +  +G G FG     R+ +     A+K I   ++    +  E++   SL H  +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 82  VRFKEVIL-------------TPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQ 127
           VR+    L               + L I MEY   G L++ I +       DE    F+Q
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---------------SV 172
           ++  +SY H+  + HRDLK  N  +D S    +KI DFG +K+                 
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
                 S +GT  Y+A EVL    +  +  D++S G+  + M+   YPF    E      
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGMERV---N 236

Query: 233 TIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLV 290
            ++++ SV    P    +   +  + +I  +   DP  R     ++   W       +++
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296

Query: 291 DEKTMS 296
            E   S
Sbjct: 297 KEALKS 302

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  267 bits (684), Expect = 1e-87
 Identities = 75/317 (23%), Positives = 127/317 (40%), Gaps = 58/317 (18%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDKID-ENVQREIINHRS 75
             +Y     IG G++GV R+  +  T+ + A+K + +      +  D E ++ E+   + 
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
           L HPNI R  EV     ++ +VME   GG L +++                         
Sbjct: 85  LHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE 144

Query: 116 --------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS 155
                                 E       +Q+ S + Y H   +CHRD+K EN L   +
Sbjct: 145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204

Query: 156 PAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLRHEYD-GKIADVWSCGV 209
            +  +K+ DFG SK     +        +  GTP ++APEVL       G   D WS GV
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264

Query: 210 TLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPA 267
            L+++L+G  PF   ++     +    +L+ +    +   N +S   RDL+S +   +  
Sbjct: 265 LLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVD 320

Query: 268 ARITIPEIMKHQWFLKN 284
            R      ++H W  + 
Sbjct: 321 ERFDAMRALQHPWISQF 337

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  266 bits (681), Expect = 2e-87
 Identities = 66/263 (25%), Positives = 120/263 (45%), Gaps = 8/263 (3%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
            ++Y    D+G G FG+     +  +K+    K+++        V++EI      RH NI
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI 63

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
           +   E   +   L ++ E+ SG ++FERI  +    +E E   +  Q+   + + H+  +
Sbjct: 64  LHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            H D++ EN +     +  +KI +FG ++        +     P Y APEV         
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-ST 182

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDLI 258
             D+WS G  +YV+L G  PF         ++ I+ I++ +Y+  +     IS E  D +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 259 SRIFVADPAARITIPEIMKHQWF 281
            R+ V +  +R+T  E ++H W 
Sbjct: 239 DRLLVKERKSRMTASEALQHPWL 261

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  266 bits (682), Expect = 2e-87
 Identities = 62/305 (20%), Positives = 120/305 (39%), Gaps = 26/305 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
            Y  ++ IGSG       + ++  K++ A+KY+   +  +   ++ + EI     L+  +
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 81  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRH 195
            + H DLK  N L+       LK+ DFG +             S VGT  Y+ PE +   
Sbjct: 128 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
                           +DVWS G  LY M  G  PF+           +  I+   + + 
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIE 241

Query: 246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 305
             +   ++ +D++      DP  RI+IPE++ H +            K  + + +     
Sbjct: 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 301

Query: 306 MQSVD 310
           +  ++
Sbjct: 302 LVGLN 306

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  266 bits (681), Expect = 1e-86
 Identities = 61/305 (20%), Positives = 120/305 (39%), Gaps = 26/305 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPN 80
            Y  ++ IGSG       + ++  K++ A+KY+   +  +   ++ + EI     L+  +
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 81  --IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
             I+R  +  +T  ++ +VME     +L   +         E + +++ ++  V   H  
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRH 195
            + H DLK  N L+       LK+ DFG +      +      S VG   Y+ PE +   
Sbjct: 175 GIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 196 EYD----------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
                           +DVWS G  LY M  G  PF+           +  I+   + + 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIE 288

Query: 246 DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQP 305
             +   ++ +D++      DP  RI+IPE++ H +            K  + + +     
Sbjct: 289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQ 348

Query: 306 MQSVD 310
           +  ++
Sbjct: 349 LVGLN 353

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  274 bits (701), Expect = 1e-86
 Identities = 80/339 (23%), Positives = 126/339 (37%), Gaps = 41/339 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKIDENVQREIINHRSLRHPN 80
             ++    +G+G FG       + T E VA+K   +    K  E    EI   + L HPN
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73

Query: 81  IVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAGRFSEDEARFFFQQLISG 131
           +V  +EV      LA      + MEY  GG+L + +    N     E   R     + S 
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133

Query: 132 VSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
           + Y H  ++ HRDLK EN +L  G      KI D GY+K           VGT  Y+APE
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE 193

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR-------------- 236
           +L + +Y     D WS G   +  + G  PF    +P  +   ++               
Sbjct: 194 LLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252

Query: 237 ILSVQYSVPDTNPISQECRDLISRIF----VADPAARITIPEIMKHQWF--------LKN 284
            +     +P  N +S      + R      +     R T P+      F        LK 
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKL 312

Query: 285 LPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIPA 323
           L    +    + +     ++ +Q  ++   +  +  IP 
Sbjct: 313 LSVMNMVSGRVHTYPVTENENLQ--NLKSWLQQDTGIPE 349

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  265 bits (679), Expect = 2e-86
 Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 9/270 (3%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
            D YD + ++GSG FGV     +K T  +   K+I     +D   V+ EI     L HP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQ 139
           ++   +       + +++E+ SGGELF+RI     + SE E   + +Q   G+ + H   
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           + H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R    G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDL 257
              D+W+ GV  YV+L G  PF   D+     +T+Q +    +   +   + +S E +D 
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDD----LETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPA 287
           I  +   +P  R+T+ + ++H W   +   
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  268 bits (687), Expect = 3e-86
 Identities = 96/281 (34%), Positives = 148/281 (52%), Gaps = 8/281 (2%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           ++RY+ V  +G G+FG     +D++T++  AVK I +    +K    + RE+   + L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI++  E++   +   IV E  +GGELF+ I    RFSE +A    +Q+ SG++Y H  
Sbjct: 81  PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140

Query: 139 QVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HRDLK EN LL+       +KI DFG S     +++ K  +GT  YIAPEVL    Y
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y 199

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           D K  DVWS GV LY++L G  PF   +E    ++ ++      + +P    IS + +DL
Sbjct: 200 DEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR-VETG-KYAFDLPQWRTISDDAKDL 256

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           I ++    P+ RIT  + ++H W  K            S +
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  264 bits (677), Expect = 3e-86
 Identities = 82/286 (28%), Positives = 143/286 (50%), Gaps = 11/286 (3%)

Query: 22  SDRYDFVR--DIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRH 78
           +  Y   +   +G G FG      +  T   +A K I+ RG K  E V+ EI     L H
Sbjct: 86  NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
            N+++  +   +   + +VMEY  GGELF+RI +     +E +   F +Q+  G+ + H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           M + H DLK EN L     A ++KI DFG ++      + K   GTP ++APEV + +++
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV-VNYDF 264

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECR 255
                D+WS GV  Y++L G  PF   ++     +T+  IL+ ++ + D     IS+E +
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSPFLGDND----AETLNNILACRWDLEDEEFQDISEEAK 320

Query: 256 DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEE 301
           + IS++ + + + RI+  E +KH W   +     +  +   ++  +
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGSD 366

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  266 bits (682), Expect = 5e-86
 Identities = 92/277 (33%), Positives = 140/277 (50%), Gaps = 18/277 (6%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
           ++ Y    ++G G F V R     +  +  A   I        D + ++RE    R L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNIVR  + I    H  ++ +  +GGELFE I     +SE +A    QQ++  V +CH M
Sbjct: 70  PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129

Query: 139 QVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLL 193
            V HR+LK EN LL     G+    +K+ DFG +       Q      GTP Y++PEVL 
Sbjct: 130 GVVHRNLKPENLLLASKLKGAA---VKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
           +  Y GK  D+W+CGV LY++LVG  PF D D+ + +++    I +  Y  P    + ++
Sbjct: 187 KDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVT 241

Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
            E +DLI+++   +P+ RIT  E +KH W        
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVA 278

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  267 bits (685), Expect = 5e-86
 Identities = 92/281 (32%), Positives = 142/281 (50%), Gaps = 8/281 (2%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRH 78
           S+ Y  V+ +GSG +G   L RDKVT    A+K I +       +  +  E+   + L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI++  +      +  +VME   GGELF+ I +  +F+E +A    +Q++SGV+Y H  
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155

Query: 139 QVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            + HRDLK EN LL        +KI DFG S       + K  +GT  YIAPEVL +  Y
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y 214

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
           D K  DVWS GV L+++L G  PF    + +  RK +++     +  P+   +S+  +DL
Sbjct: 215 DEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKG-KYTFDSPEWKNVSEGAKDL 271

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           I ++   D   RI+  + ++H W  +         +  S  
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLA 312

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  265 bits (680), Expect = 3e-85
 Identities = 97/284 (34%), Positives = 148/284 (52%), Gaps = 13/284 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKID-ENVQREIINHRSLR 77
           SDRY   R +G G+FG   L +DK+T +  AVK I +     K D E++ RE+   + L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPNI++  E      +  +V E  +GGELF+ I +  RFSE +A    +Q++SG++Y H 
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 144

Query: 138 MQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
            ++ HRDLK EN LL+  S    ++I DFG S       + K  +GT  YIAPEVL    
Sbjct: 145 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT- 203

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQEC 254
           YD K  DVWS GV LY++L G  PF   +E       ++++   +Y+        +S+  
Sbjct: 204 YDEK-CDVWSTGVILYILLSGCPPFNGANE----YDILKKVEKGKYTFELPQWKKVSESA 258

Query: 255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           +DLI ++    P+ RI+  + + H+W        +  +      
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  260 bits (666), Expect = 4e-85
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 15/286 (5%)

Query: 22  SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREI-INHRSL 76
           ++ Y    +++G G F V R    K T +  A K+++   RG      +  EI +   + 
Sbjct: 27  NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDEARFFFQQLISGVSY 134
             P ++   EV    + + +++EYA+GGE+F       A   SE++     +Q++ GV Y
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146

Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
            H   + H DLK +N LL    P   +KI DFG S+      + +  +GTP Y+APE+L 
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILN 206

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
                    D+W+ G+  Y++L    PF   D  + +      I  V     +   + +S
Sbjct: 207 YDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQVNVDYSEETFSSVS 261

Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSS 297
           Q   D I  + V +P  R T    + H W  +    +L   +  SS
Sbjct: 262 QLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSS 307

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  263 bits (675), Expect = 2e-84
 Identities = 91/294 (30%), Positives = 142/294 (48%), Gaps = 23/294 (7%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--------------GDKIDENVQ 67
            + Y  VR +GSG +G   L ++K      A+K I++               +K  E + 
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 68  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 127
            EI   +SL HPNI++  +V     +  +V E+  GGELFE+I N  +F E +A    +Q
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154

Query: 128 LISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
           ++SG+ Y H   + HRD+K EN LL + +    +KI DFG S       + +  +GT  Y
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214

Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS--VQYSV 244
           IAPEVL +  Y+ K  DVWSCGV +Y++L G  PF   ++    +  I+++      +  
Sbjct: 215 IAPEVLKKK-YNEK-CDVWSCGVIMYILLCGYPPFGGQND----QDIIKKVEKGKYYFDF 268

Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
            D   IS E ++LI  +   D   R T  E +  +W  K        ++     
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCG 322

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  258 bits (662), Expect = 3e-84
 Identities = 87/296 (29%), Positives = 135/296 (45%), Gaps = 22/296 (7%)

Query: 5   RASLTVGPAMDMPIMHDS--DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE----- 57
             S   G  +DM        D Y+    IG G F V R   ++ T +  AVK ++     
Sbjct: 4   GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 63

Query: 58  -RGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR- 115
                  E+++RE      L+HP+IV   E   +   L +V E+  G +L   I      
Sbjct: 64  SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA 123

Query: 116 ---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSS 171
              +SE  A  + +Q++  + YCH   + HRD+K    LL     +  +K+  FG +   
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

Query: 172 VLHSQP-KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF 230
                     VGTP ++APEV+ R  Y GK  DVW CGV L+++L G  PF    E    
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE---- 238

Query: 231 RKTIQRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +  + I+  +Y +     + IS+  +DL+ R+ + DPA RIT+ E + H W  + 
Sbjct: 239 -RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  260 bits (665), Expect = 4e-84
 Identities = 91/294 (30%), Positives = 141/294 (47%), Gaps = 16/294 (5%)

Query: 5   RASLTVGPAMDMPIMHDSDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
                V   + +      D Y    + +G G  G    + +K T+E  A+K ++      
Sbjct: 43  FPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----C 98

Query: 64  ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 116
              +RE+ ++ R+ + P+IVR  +V          L IVME   GGELF RI + G   F
Sbjct: 99  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158

Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 175
           +E EA    + +   + Y H++ + HRD+K EN L     P   LK+ DFG++K +  H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218

Query: 176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
              +   TP Y+APEVL   +YD K  D+WS GV +Y++L G  PF              
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277

Query: 236 RILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 287
           RI   QY  P+   + +S+E + LI  +   +P  R+TI E M H W +++   
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  257 bits (659), Expect = 6e-84
 Identities = 83/305 (27%), Positives = 136/305 (44%), Gaps = 33/305 (10%)

Query: 22  SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHP 79
           +D Y   +  +G G  G       + T +  A+K +          ++E+  + ++   P
Sbjct: 27  TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD----SPKARQEVDHHWQASGGP 82

Query: 80  NIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVS 133
           +IV   +V     H      I+ME   GGELF RI   G   F+E EA    + + + + 
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 134 YCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEV 191
           + H+  + HRD+K EN L         LK+ DFG++K         ++   TP Y+APEV
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEV 200

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NP 249
           L   +YD K  D+WS GV +Y++L G  PF             +RI   QY  P+   + 
Sbjct: 201 LGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSV 309
           +S++ + LI  +   DP  R+TI + M H W  +++                P  P+ + 
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV--------------PQTPLHTA 305

Query: 310 DVIMQ 314
            V+ +
Sbjct: 306 RVLQE 310

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  264 bits (677), Expect = 6e-84
 Identities = 82/267 (30%), Positives = 137/267 (51%), Gaps = 9/267 (3%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
            D YD   ++G+G FGV   + ++ T    A K++    + D E V++EI     LRHP 
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G+ + H   
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
             H DLK EN +     +  LK+ DFG +         K T GT  + APEV       G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPISQECRDL 257
              D+WS GV  Y++L G  PF   ++     +T++ + S  +++ D+  + IS++ +D 
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKN 284
           I ++ +ADP  R+TI + ++H W    
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPG 417

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  252 bits (645), Expect = 3e-82
 Identities = 79/300 (26%), Positives = 124/300 (41%), Gaps = 31/300 (10%)

Query: 22  SDRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREI-INHRSLRH 78
            D Y    D +G G     +   + +T +  AVK IE +   I   V RE+ + ++   H
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            N++   E         +V E   GG +   I     F+E EA    Q + S + + H  
Sbjct: 71  RNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNK 130

Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSVLHSQPKSTVGTPAYIA 188
            + HRDLK EN L +     +P +KICDF            S +   +  +  G+  Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 189 PEVLLRHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI---------- 234
           PEV+     +     K  D+WS GV LY++L G  PF                       
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249

Query: 235 -QRILSVQYSVPDT--NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD 291
            + I   +Y  PD     IS   +DLIS++ V D   R++  ++++H W     P + + 
Sbjct: 250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP 309

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  248 bits (635), Expect = 1e-80
 Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 26/285 (9%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHP 79
           D+  Y F++ +G G F    L+         A+K I   ++ D E  QRE   HR   HP
Sbjct: 27  DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP 86

Query: 80  NIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 131
           NI+R     L          +++ +   G L+  I          +ED+  +    +  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----------V 181
           +   HA    HRDLK  N LL      +  + D G    + +H +               
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204

Query: 182 GTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
            T +Y APE+  +  H    +  DVWS G  LY M+ G  P++   +  D   ++   + 
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVALAVQ 261

Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            Q S+P +   S     L++ +   DP  R  IP ++     L+ 
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  245 bits (628), Expect = 4e-79
 Identities = 80/311 (25%), Positives = 149/311 (47%), Gaps = 20/311 (6%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
           ++Y  ++ IG G+FG A L++         +K I          E  +RE+    +++HP
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHA 137
           NIV+++E       L IVM+Y  GG+LF+RI       F ED+   +F Q+   + + H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHE 196
            ++ HRD+K +N  L       +++ DFG ++  +      ++ +GTP Y++PE+     
Sbjct: 144 RKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP 201

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y+ K +D+W+ G  LY +    + FE        +  + +I+S  +  P +   S + R 
Sbjct: 202 YNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISGSFP-PVSLHYSYDLRS 255

Query: 257 LISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 316
           L+S++F  +P  R ++  I++  +  K +      EK +S Q    +  +++        
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRI------EKFLSPQLIAEEFCLKTFSKFGSQP 309

Query: 317 AEASIPAVGTH 327
             A  PA G +
Sbjct: 310 IPAKRPASGQN 320

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  241 bits (616), Expect = 2e-78
 Identities = 78/278 (28%), Positives = 132/278 (47%), Gaps = 23/278 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHP 79
           + Y+ +  IG+G++G  + +R K   +++  K ++ G   +   + +  E+   R L+HP
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 80  NIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
           NIVR+ + I+  T   L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYI 187
            CH        V HRDLK  N  LDG     +K+ DFG ++  +   S  K+ VGTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGK--QNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
           +PE + R  Y+ K +D+WS G  LY +     PF         ++   +I   ++     
Sbjct: 184 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQKELAGKIREGKFR-RIP 237

Query: 248 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL 285
              S E  ++I+R+       R ++ EI+++   L++ 
Sbjct: 238 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  240 bits (614), Expect = 7e-78
 Identities = 60/282 (21%), Positives = 109/282 (38%), Gaps = 34/282 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             +  +  IGSG FG     + ++  +   +K +      +E  +RE+     L H NIV
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNNEKAEREVKALAKLDHVNIV 67

Query: 83  RFKEVILTPTH----------------LAIVMEYASGGELFERI--CNAGRFSEDEARFF 124
            +        +                L I ME+   G L + I      +  +  A   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127

Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
           F+Q+  GV Y H+ ++ +RDLK  N  L  +   ++KI DFG   S     +   + GT 
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDFGLVTSLKNDGKRTRSKGTL 185

Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
            Y++PE +   +Y  +  D+++ G+ L  +L             +  K    +     S 
Sbjct: 186 RYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDT------AFETSKFFTDLRDGIIS- 237

Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
              +   ++ + L+ ++    P  R    EI++     K  P
Sbjct: 238 ---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  236 bits (603), Expect = 5e-76
 Identities = 84/303 (27%), Positives = 130/303 (42%), Gaps = 50/303 (16%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
            D     + +G G  G    + +K T+E  A+K ++         +RE+ ++ R+ + P+
Sbjct: 17  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPH 72

Query: 81  IVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
           IVR  +V          L IVME   GGELF RI + G   F+E EA    + +   + Y
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 135 CHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
            H++ + HRD+K EN L     P   LK+ DFG                     A E   
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKET-T 171

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS 251
             +YD K  D+WS GV +Y++L G  PF              RI   QY  P+   + +S
Sbjct: 172 GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 230

Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDV 311
           +E + LI  +   +P  R+TI E M H W +++                 P  P+ +  V
Sbjct: 231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV--------------PQTPLHTSRV 276

Query: 312 IMQ 314
           + +
Sbjct: 277 LKE 279

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  235 bits (601), Expect = 2e-75
 Identities = 69/314 (21%), Positives = 118/314 (37%), Gaps = 39/314 (12%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLR-HPNI 81
           R    R +  G F      +D  +    A+K +   ++     + +E+   + L  HPNI
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 82  VRF-------KEVILTPTHLAIVMEYASGGELFERICNA---GRFSEDEARFFFQQLISG 131
           V+F       KE   T     +++     G+L E +      G  S D     F Q    
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 132 VSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------- 180
           V + H  +  + HRDLK+EN LL       +K+CDFG + +   +     +         
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATTISHYPDYSWSAQRRALVEE 206

Query: 181 ----VGTPAYIAPEV--LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI 234
                 TP Y  PE+  L  +   G+  D+W+ G  LY++    +PFED           
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--------AK 258

Query: 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 294
            RI++ +YS+P  +        LI  +   +P  R++I E++     +            
Sbjct: 259 LRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318

Query: 295 MSSQYEEPDQPMQS 308
                +       +
Sbjct: 319 TELLEQNGGYGSAT 332

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  230 bits (589), Expect = 7e-74
 Identities = 61/264 (23%), Positives = 106/264 (40%), Gaps = 17/264 (6%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSL-RH 78
             +  +  +G G++G    +R K    L AVK      RG K       E+ +H  + +H
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHA 137
           P  VR ++       L +  E   G  L +     G    E +   + +  +  +++ H+
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             + H D+K  N  L   P  R K+ DFG           +   G P Y+APE+ L+  Y
Sbjct: 176 QGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL-LQGSY 232

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
               ADV+S G+T+  +         P   + +++  Q  L  ++    T  +S E R +
Sbjct: 233 GTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPPEF----TAGLSSELRSV 284

Query: 258 ISRIFVADPAARITIPEIMKHQWF 281
           +  +   DP  R T   ++     
Sbjct: 285 LVMMLEPDPKLRATAEALLALPVL 308

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  233 bits (596), Expect = 2e-73
 Identities = 75/337 (22%), Positives = 128/337 (37%), Gaps = 48/337 (14%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNI 81
           +     + +G G+ G     +       VAVK +       +    EI +   S  HPN+
Sbjct: 15  NLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNV 71

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-------EARFFFQQLISGVSY 134
           +R+     T   L I +E      L + + +     E+             +Q+ SGV++
Sbjct: 72  IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 135 CHAMQVCHRDLKLENTLLDGSPAP-----------RLKICDFGYSK-----SSVLHSQPK 178
            H++++ HRDLK +N L+  S              R+ I DFG  K      S   +   
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190

Query: 179 STVGTPAYIAPEVLLRHEYD------GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFR 231
           +  GT  + APE+L             +  D++S G   Y +L  G  PF D        
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS----- 245

Query: 232 KTIQRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
                I+   +S+ +        +  E  DLIS++   DP  R T  ++++H  F     
Sbjct: 246 -RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF-WPKS 303

Query: 287 ADLVDEKTMSSQYE-EPDQPMQSVDVIMQIIAEASIP 322
             L     +S + E E   P  ++ +     ++  IP
Sbjct: 304 KKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIP 340

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  229 bits (585), Expect = 3e-73
 Identities = 70/294 (23%), Positives = 123/294 (41%), Gaps = 17/294 (5%)

Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQ 67
           P M    +     +   + IG G F         +    VA+K ++  D +D     +  
Sbjct: 24  PDMGYNTL---ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80

Query: 68  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARF 123
           +EI   + L HPN++++    +    L IV+E A  G+L   I +  +      E     
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 182
           +F QL S + + H+ +V HRD+K  N  +  +    +K+ D G  +  S   +   S VG
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAHSLVG 198

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
           TP Y++PE +  + Y+ K +D+WS G  LY M     PF    +  +     ++I    Y
Sbjct: 199 TPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIEQCDY 255

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 296
               ++  S+E R L++     DP  R  +  +      +    A  ++     
Sbjct: 256 PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  223 bits (570), Expect = 2e-69
 Identities = 63/271 (23%), Positives = 101/271 (37%), Gaps = 21/271 (7%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPNIV 82
            +     +G G  G     R       VAVK I    +      RE+ +   S  HPN++
Sbjct: 25  SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVI 81

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVC 141
           R+           I +E      L E +          E     QQ  SG+++ H++ + 
Sbjct: 82  RYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIV 140

Query: 142 HRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVLLR 194
           HRDLK  N L+   +     +  I DFG  K         S+     GT  +IAPE+L  
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 195 HEYD--GKIADVWSCGVTLYVMLVGGY-PFEDPDEPKDFRKTIQRILSVQYSVPDTNP-I 250
              +      D++S G   Y ++  G  PF    +    R+    + +            
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ----RQANILLGACSLDCLHPEKHE 256

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWF 281
               R+LI ++   DP  R +   ++KH +F
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  215 bits (550), Expect = 3e-68
 Identities = 65/302 (21%), Positives = 113/302 (37%), Gaps = 41/302 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
             ++ ++ +G G FGV    ++KV     A+K I     +   E V RE+     L HP 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 81  IVRFKEVILT------------PTHLAIVMEYASGGELFERI---CNAGRFSEDEARFFF 125
           IVR+    L               +L I M+      L + +   C             F
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------------SSV 172
            Q+   V + H+  + HRDLK  N          +K+ DFG                   
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
            +++    VGT  Y++PE +  + Y  K  D++S G+ L+ +L   YPF    E     +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL---YPFSTQMERV---R 235

Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK-NLPADLVD 291
           T+  + ++++  P           ++  +    P  R     I+++  F   + P   V 
Sbjct: 236 TLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVL 294

Query: 292 EK 293
            +
Sbjct: 295 RQ 296

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  214 bits (547), Expect = 2e-67
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 26/272 (9%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVK-----YIERGDKIDE-NVQREIINHRSLRH 78
           + F + +G G+F    L R+  T    A+K     +I + +K+     +R++++   L H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS--RLDH 89

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
            + HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L   
Sbjct: 150 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 207

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
               K +D+W+ G  +Y ++ G  PF   +E        Q+I+ ++Y  P+      + R
Sbjct: 208 SA-CKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKIIKLEYDFPEK--FFPKAR 260

Query: 256 DLISRIFVADPAARITIP------EIMKHQWF 281
           DL+ ++ V D   R+          +  H +F
Sbjct: 261 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  210 bits (536), Expect = 4e-65
 Identities = 37/305 (12%), Positives = 75/305 (24%), Gaps = 62/305 (20%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
                  +G  +        D+ T E   V      ++      + ++ E++  R LR  
Sbjct: 74  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133

Query: 78  -----------------------HPNIVRFKEVILTPTHLAIVMEY--------ASGGEL 106
                                     ++R +        L+    Y          G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
                               Q+I  ++  H   + H  L+  + +LD      + +  F 
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE 251

Query: 167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHE----------YDGKIADVWSCGVTLYVMLV 216
                V       +  +  +  PE+  R                  D W+ G+ +Y +  
Sbjct: 252 ---HLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

Query: 217 GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIM 276
              P              +   +          I Q  R L+          R+   + M
Sbjct: 309 ADLPITKDAALGGSEWIFRSCKN----------IPQPVRALLEGFLRYPKEDRLLPLQAM 358

Query: 277 KHQWF 281
           +   +
Sbjct: 359 ETPEY 363

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  208 bits (531), Expect = 1e-64
 Identities = 45/301 (14%), Positives = 80/301 (26%), Gaps = 46/301 (15%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHP 79
           +   V  +  G+  V  L+RD    E  A+K    G +      E +         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 80  NIVRFKEVI--------------------------LTPTHLAIVMEYASG------GELF 107
           +    ++                                +  ++M  AS         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 108 ERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY 167
                 G            QLI   +   +  + H     +N  +      RL + D   
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD--GRLMLGDVS- 239

Query: 168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPD 225
             +             P   AP   L           + W  G+++Y +     PF    
Sbjct: 240 --ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 226 EPKDF---RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL 282
                   R +++   +   +     P+    + LI R    D   R+   E M+   FL
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

Query: 283 K 283
           +
Sbjct: 358 Q 358

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  201 bits (514), Expect = 6e-63
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 38/288 (13%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE---RGDKIDENVQREIINHRSL-R 77
           +  +  +  IGSG FG       ++   + A+K  +    G   ++N  RE+  H  L +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
           H ++VR+        H+ I  EY +GG L + I    R    F E E +    Q+  G+ 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 134 YCHAMQVCHRDLKLENTLLD-----------------GSPAPRLKICDFGYSKSSVLHSQ 176
           Y H+M + H D+K  N  +                   S     KI D G+       S 
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR---ISS 186

Query: 177 PKSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ 235
           P+   G   ++A EVL   + +  K AD+++  +T+           + D+  + R+   
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 245

Query: 236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
             +            SQE  +L+  +   DP  R +   ++KH   L 
Sbjct: 246 PRIPQVL--------SQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  200 bits (511), Expect = 7e-62
 Identities = 77/274 (28%), Positives = 141/274 (51%), Gaps = 27/274 (9%)

Query: 23  DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----S 75
            +++ ++ +G G+FG   + + +     ++L A+K + +   +    +      R     
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL-KKATLKVRDRVRTKMERDILVE 82

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           + HP IV+      T   L +++++  GG+LF R+     F+E++ +F+  +L   + + 
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142

Query: 136 HAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 192
           H++ + +RDLK EN LLD  G     +K+ DFG SK S+ H +   +  GT  Y+APEV+
Sbjct: 143 HSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVV 198

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
            R  +  + AD WS GV ++ ML G  PF+  D     ++T+  IL  +  +P    +S 
Sbjct: 199 NRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDR----KETMTMILKAKLGMPQF--LSP 251

Query: 253 ECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
           E + L+  +F  +PA R+      + EI +H +F
Sbjct: 252 EAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  200 bits (511), Expect = 3e-61
 Identities = 66/283 (23%), Positives = 123/283 (43%), Gaps = 17/283 (6%)

Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRHPNI 81
           + +R IG G+FG   +++   TK++ A+KY+ +   ++ N  R +         L HP +
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           V           + +V++   GG+L   +     F E+  + F  +L+  + Y    ++ 
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137

Query: 142 HRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           HRD+K +N LLD  G     + I DF  +      +Q  +  GT  Y+APE+    +  G
Sbjct: 138 HRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193

Query: 200 --KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
                D WS GVT Y +L G  P+         ++ +    +   + P     SQE   L
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFETTVVTYPSA--WSQEMVSL 250

Query: 258 ISRIFVADPAARI-TIPEIMKHQWFLKNLPADLVDEKTMSSQY 299
           + ++   +P  R   + ++    +   ++  D V +K +   +
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYM-NDINWDAVFQKRLIPGF 292

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  196 bits (500), Expect = 2e-60
 Identities = 81/272 (29%), Positives = 133/272 (48%), Gaps = 32/272 (11%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
           +  +R +G+G+FG   L+R +      A+K +    K +  V+ + + H          +
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL----KKEIVVRLKQVEHTNDERLMLSIV 63

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            HP I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y H
Sbjct: 64  THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123

Query: 137 AMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
           +  + +RDLK EN LLD  G     +KI DFG++K   +     +  GTP YIAPEV+  
Sbjct: 124 SKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVST 177

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
             Y  K  D WS G+ +Y ML G  PF D +      KT ++IL+ +   P     +++ 
Sbjct: 178 KPY-NKSIDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPPF--FNEDV 230

Query: 255 RDLISRIFVADPAARI-----TIPEIMKHQWF 281
           +DL+SR+   D + R+        ++  H WF
Sbjct: 231 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  196 bits (501), Expect = 3e-60
 Identities = 77/270 (28%), Positives = 137/270 (50%), Gaps = 24/270 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +        +N +    ++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 139 QVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
            + +RDLK EN L+D  G     +++ DFG++K   +  +  +  GTP  +APE++L   
Sbjct: 161 DLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKG 214

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y  K  D W+ GV +Y M  G  PF      + + K    I+S +   P     S + +D
Sbjct: 215 Y-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPSH--FSSDLKD 267

Query: 257 LISRIFVADPAARI-----TIPEIMKHQWF 281
           L+  +   D   R       + +I  H+WF
Sbjct: 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  197 bits (501), Expect = 3e-60
 Identities = 43/294 (14%), Positives = 93/294 (31%), Gaps = 43/294 (14%)

Query: 21  DSDRYDFVRDIGSGNFGVARL-----MRDKVTKELVAVKYIERGDKIDENVQREIIN-HR 74
            S        +G G F          + D   K+   +K  +  +  +  +  +++   +
Sbjct: 63  GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLK 122

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NAGRFSEDEARFFFQQLI 129
                  ++F    L      +V E  S G L   I            +     F  +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPR---------LKICDFGYSKSSVLHSQPKST 180
             +   H  ++ H D+K +N +L      +         L + D G S    +   PK T
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID--MKLFPKGT 240

Query: 181 V-----GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF-EDPDEPKDFRKTI 234
           +      T  +   E+L    ++ +I D +    T+Y ML G Y   ++           
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEGGECKPEGLF 299

Query: 235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH---QWFLKNL 285
           +R+           P      +    +        +   ++++    + F ++ 
Sbjct: 300 RRL-----------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  195 bits (499), Expect = 5e-60
 Identities = 84/272 (30%), Positives = 129/272 (47%), Gaps = 28/272 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
           + +   + +G G+FG   L   K T +  A+K +    K D  +  + +           
Sbjct: 17  EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL----KKDVVLMDDDVECTMVEKRVLS 72

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
            +  HP +        T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ 
Sbjct: 73  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132

Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
           + H+  + +RDLKL+N LLD  G     +KI DFG  K ++L     +T  GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           +LL  +Y     D WS GV LY ML+G  PF   DE     +    I       P    +
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDE----EELFHSIRMDNPFYPRW--L 241

Query: 251 SQECRDLISRIFVADPAARI-TIPEIMKHQWF 281
            +E +DL+ ++FV +P  R+    +I +H  F
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  195 bits (497), Expect = 8e-60
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 27/275 (9%)

Query: 23  DRYDFVRDIGSGNFG---VARLMRDKVTKELVAVKYIERGDKIDENVQRE-IINHR---- 74
           + ++ +R +G G +G     R +    T ++ A+K +++   +            R    
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            ++HP IV       T   L +++EY SGGELF ++   G F ED A F+  ++   + +
Sbjct: 77  EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136

Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 191
            H   + +RDLK EN +L+  G     +K+ DFG  K S+       T  GT  Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
           L+R  +  +  D WS G  +Y ML G  PF   +     +KTI +IL  + ++P    ++
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENR----KKTIDKILKCKLNLPPY--LT 245

Query: 252 QECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
           QE RDL+ ++   + A+R+        E+  H +F
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  194 bits (496), Expect = 1e-59
 Identities = 90/275 (32%), Positives = 143/275 (52%), Gaps = 31/275 (11%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
           + +D+++ +G G FG   L+R+K T    A+K + R + I   + ++ + H        +
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL-RKEVI---IAKDEVAHTVTESRVLQ 60

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
           + RHP +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 191
            H+  V +RD+KLEN +LD  G     +KI DFG  K  +       T  GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
           L  ++Y G+  D W  GV +Y M+ G  PF + D      +  + IL  +   P T  +S
Sbjct: 177 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRT--LS 229

Query: 252 QECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
            E + L++ +   DP  R+        E+M+H++F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  194 bits (496), Expect = 3e-59
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 31/275 (11%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
             + F++ IG G+FG   L R K  +   AVK + +   I   ++++   H         
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL-QKKAI---LKKKEEKHIMSERNVLL 93

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           ++++HP +V       T   L  V++Y +GGELF  +     F E  ARF+  ++ S + 
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153

Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
           Y H++ + +RDLK EN LLD  G     + + DFG  K ++ H+   ST  GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           VL +  Y  +  D W  G  LY ML G  PF   +      +    IL+    +     I
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKPLQLKPN--I 262

Query: 251 SQECRDLISRIFVADPAARITIP----EIMKHQWF 281
           +   R L+  +   D   R+       EI  H +F
Sbjct: 263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  193 bits (494), Expect = 5e-59
 Identities = 87/275 (31%), Positives = 132/275 (48%), Gaps = 29/275 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
           D ++F+R +G G+FG   L R K T +L AVK + + D I   +Q + +           
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL-KKDVI---LQDDDVECTMTEKRILS 78

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
            +  HP + +      TP  L  VME+ +GG+L   I  + RF E  ARF+  ++IS + 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
           + H   + +RDLKL+N LLD       K+ DFG  K  + +    +T  GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
               Y G   D W+ GV LY ML G  PFE  +E   F      IL+ +   P    + +
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPTW--LHE 249

Query: 253 ECRDLISRIFVADPAARI------TIPEIMKHQWF 281
           +   ++      +P  R+          I++H +F
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  192 bits (490), Expect = 2e-58
 Identities = 85/276 (30%), Positives = 127/276 (46%), Gaps = 32/276 (11%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
             ++F+  +G G+FG   L   K T EL AVK +    K D  +Q + +           
Sbjct: 20  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL----KKDVVIQDDDVECTMVEKRVLA 75

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
              + P + +      T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ 
Sbjct: 76  LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135

Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
           +  +  + +RDLKL+N +LD  G     +KI DFG  K ++       T  GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
           ++    Y GK  D W+ GV LY ML G  PFE  DE     +  Q I+    + P +  +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKS--M 244

Query: 251 SQECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
           S+E   +   +    P  R+        +I +H +F
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  192 bits (489), Expect = 2e-58
 Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 33/279 (11%)

Query: 26  DFVRDIGSGNFG---VARLMRDKVTKELVAVK-----YIERGDKIDENVQRE-----IIN 72
           + ++ +G+G +G   + R +    T +L A+K      I +  K  E+ + E      I 
Sbjct: 57  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116

Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
                 P +V       T T L ++++Y +GGELF  +    RF+E E + +  +++  +
Sbjct: 117 Q----SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172

Query: 133 SYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188
            + H + + +RD+KLEN LLD  G     + + DFG SK  V     ++    GT  Y+A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228

Query: 189 PEVLLRHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
           P+++   +    K  D WS GV +Y +L G  PF    E     +  +RIL  +   P  
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288

Query: 248 NPISQECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
             +S   +DLI R+ + DP  R+        EI +H +F
Sbjct: 289 --MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  190 bits (484), Expect = 1e-57
 Identities = 77/282 (27%), Positives = 127/282 (45%), Gaps = 34/282 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
             +D +R IG G++    L+R K T  + A+K + + + +      E I+          
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV-KKELV---NDDEDIDWVQTEKHVFE 64

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           ++  HP +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++
Sbjct: 65  QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124

Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
           Y H   + +RDLKL+N LLD  G     +K+ D+G  K  +      ST  GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVP 245
           +L   +Y G   D W+ GV ++ M+ G  PF+                 Q IL  Q  +P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239

Query: 246 DTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWF 281
            +  +S +   ++      DP  R+         +I  H +F
Sbjct: 240 RS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  193 bits (491), Expect = 1e-57
 Identities = 90/270 (33%), Positives = 139/270 (51%), Gaps = 20/270 (7%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           + +++++ +G G FG   L+++K T    A+K +++   + ++     +       + RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +   K    T   L  VMEYA+GGELF  +     FSED ARF+  +++S + Y H+ 
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267

Query: 139 Q-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRHE 196
           + V +RDLKLEN +LD      +KI DFG  K  +       T  GTP Y+APEVL  ++
Sbjct: 268 KNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y G+  D W  GV +Y M+ G  PF + D  K F      IL  +   P T  +  E + 
Sbjct: 326 Y-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEAKS 378

Query: 257 LISRIFVADPAARI-----TIPEIMKHQWF 281
           L+S +   DP  R+        EIM+H++F
Sbjct: 379 LLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  190 bits (483), Expect = 5e-57
 Identities = 42/325 (12%), Positives = 85/325 (26%), Gaps = 56/325 (17%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR-- 77
                  +G  +        D+ T E   V      ++      + ++ E++  R LR  
Sbjct: 79  TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138

Query: 78  --------------------HPNIVRFKEVILTPTHLAIVMEYAS-----------GGEL 106
                                P   +   V L    + ++  +             G  L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198

Query: 107 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG 166
                               Q+I  ++  H   + H  L+  + +LD      + +  F 
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFE 256

Query: 167 YSKS--SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI----ADVWSCGVTLYVMLVGGYP 220
           +     +   S        P   A  +L   ++   +     D W+ G+ +Y +     P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 221 FEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW 280
             D                          I Q  R L+          R+   + M+   
Sbjct: 317 NTDDAALGGSEWI----------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

Query: 281 FLKNLPADLVDEKTMSSQYEEPDQP 305
           + + L  +L     +     EP + 
Sbjct: 367 Y-EQLRTELSAALPLYQTDGEPTRE 390

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  189 bits (482), Expect = 1e-56
 Identities = 88/275 (32%), Positives = 131/275 (47%), Gaps = 30/275 (10%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
           Y+ V+ IG G FG  +L+R K T+++ A+K +       E ++R                
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL----SKFEMIKRSDSAFFWEERDIMAFA 126

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
             P +V+         +L +VMEY  GG+L   + +     E  ARF+  +++  +   H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR 194
           +M   HRD+K +N LLD S    LK+ DFG           +    VGTP YI+PEVL  
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243

Query: 195 HEYD---GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNP 249
              D   G+  D WS GV LY MLVG  PF           T  +I++ + S+  PD N 
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299

Query: 250 ISQECRDLISRIFVADPAARIT---IPEIMKHQWF 281
           IS+E ++LI   F+ D   R+    + EI +H +F
Sbjct: 300 ISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  188 bits (479), Expect = 2e-56
 Identities = 76/282 (26%), Positives = 127/282 (45%), Gaps = 34/282 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------- 73
             +D +R IG G++    L+R K T  + A++ + + + +      E I+          
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV-KKELV---NDDEDIDWVQTEKHVFE 107

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           ++  HP +V       T + L  V+EY +GG+L   +    +  E+ ARF+  ++   ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167

Query: 134 YCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 190
           Y H   + +RDLKL+N LLD  G     +K+ D+G  K  +      ST  GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVP 245
           +L   +Y G   D W+ GV ++ M+ G  PF+                 Q IL  Q  +P
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282

Query: 246 DTNPISQECRDLISRIFVADPAARI------TIPEIMKHQWF 281
            +  +S +   ++      DP  R+         +I  H +F
Sbjct: 283 RS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  185 bits (472), Expect = 4e-56
 Identities = 68/281 (24%), Positives = 109/281 (38%), Gaps = 19/281 (6%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT 90
           +G G+FG    M+DK T    AVK +     ++     E++    L  P IV     +  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGLSSPRIVPLYGAVRE 121

Query: 91  PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENT 150
              + I ME   GG L + I   G   ED A ++  Q + G+ Y H  ++ H D+K +N 
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 181

Query: 151 LLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADV 204
           LL      R  +CDFG++                   GT  ++APEV++    D K  D+
Sbjct: 182 LLSSD-GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK-VDI 239

Query: 205 WSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDLISRIFV 263
           WS    +  ML G +P+              +I S    + +  P  +      I     
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRG----PLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295

Query: 264 ADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQ 304
            +P  R +  E+ +           L  +     +Y+EP  
Sbjct: 296 KEPVHRASAMELRRKVGKALQEVGGL--KSPWKGEYKEPRG 334

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  192 bits (489), Expect = 9e-56
 Identities = 83/271 (30%), Positives = 130/271 (47%), Gaps = 22/271 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN------VQREIINHRSL 76
             ++F+  +G G+FG   L   K T EL AVK +++   I ++      V++ ++     
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA-LPG 399

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           + P + +      T   L  VMEY +GG+L   I   GRF E  A F+  ++  G+ +  
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRH 195
           +  + +RDLKL+N +LD      +KI DFG  K ++       T  GTP YIAPE++   
Sbjct: 460 SKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ 517

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
            Y GK  D W+ GV LY ML G  PFE  DE     +  Q I+    + P +  +S+E  
Sbjct: 518 PY-GKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVAYPKS--MSKEAV 570

Query: 256 DLISRIFVADPAARI-----TIPEIMKHQWF 281
            +   +    P  R+        +I +H +F
Sbjct: 571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  192 bits (489), Expect = 1e-55
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 18/268 (6%)

Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------SLRH 78
              R IG G FG     R   T ++ A+K +++     +  +   +N R       +   
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + H  
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 311

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL +    
Sbjct: 312 FVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAY 368

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
              AD +S G  L+ +L G  PF    + KD  +  +  L++   +PD+   S E R L+
Sbjct: 369 DSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPELRSLL 425

Query: 259 SRIFVADPAARI-----TIPEIMKHQWF 281
             +   D   R+        E+ +  +F
Sbjct: 426 EGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  189 bits (481), Expect = 4e-55
 Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 16/270 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS----LRH 78
           + +   R +G G FG     + + T ++ A K +E+        +   +N +     +  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 136
             +V       T   L +V+   +GG+L   I + G+  F E  A F+  ++  G+   H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
             ++ +RDLK EN LLD      ++I D G +         K  VGT  Y+APEV+    
Sbjct: 304 RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER 361

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y     D W+ G  LY M+ G  PF+   +     +  + +  V     +    S + R 
Sbjct: 362 Y-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQARS 418

Query: 257 LISRIFVADPAARI-----TIPEIMKHQWF 281
           L S++   DPA R+     +  E+ +H  F
Sbjct: 419 LCSQLLCKDPAERLGCRGGSAREVKEHPLF 448

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  187 bits (476), Expect = 9e-55
 Identities = 75/275 (27%), Positives = 115/275 (41%), Gaps = 23/275 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR----SLRH 78
           D +   R +G G FG     + K T +L A K + +         +  +  +     +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSY 134
             IV       T T L +VM   +GG++   I N       F E  A F+  Q++SG+ +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304

Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 191
            H   + +RDLK EN LLD  G     ++I D G +              GTP ++APE+
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
           LL  EY     D ++ GVTLY M+    PF    E  + ++  QR+L    + PD    S
Sbjct: 361 LLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK--FS 417

Query: 252 QECRDLISRIFVADPAARI-----TIPEIMKHQWF 281
              +D    +   DP  R+     +   +  H  F
Sbjct: 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  184 bits (468), Expect = 9e-55
 Identities = 66/279 (23%), Positives = 116/279 (41%), Gaps = 28/279 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------R 74
           D ++ ++ IG G F    +++ K T ++ A+K +       + ++R  ++          
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM----NKWDMLKRGEVSCFREERDVLV 116

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVS 133
           +     I +         +L +VMEY  GG+L   +   G R   + ARF+  +++  + 
Sbjct: 117 NGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID 176

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 191
             H +   HRD+K +N LLD      +++ DFG           +S   VGTP Y++PE+
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234

Query: 192 LLRHEYD------GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP 245
           L            G   D W+ GV  Y M  G  PF      + + K +     +   + 
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294

Query: 246 DTNPISQECRDLISRIFVADPAARIT---IPEIMKHQWF 281
           D   + +E RD I R  +  P  R+      +   H +F
Sbjct: 295 DEG-VPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  184 bits (468), Expect = 2e-54
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 39/291 (13%)

Query: 25  YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH--------RSL 76
           ++ ++ IG G FG   +++ K   ++ A+K +       E ++R              + 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL----NKWEMLKRAETACFREERDVLVNG 131

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 135
               I           +L +VM+Y  GG+L   +     R  E+ ARF+  +++  +   
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 193
           H +   HRD+K +N L+D +    +++ DFG     +     +S+  VGTP YI+PE+L 
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249

Query: 194 RHEYD----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP---D 246
             E      G   D WS GV +Y ML G  PF          +T  +I++ +        
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKERFQFPTQ 305

Query: 247 TNPISQECRDLISRIFVADPAARIT---IPEIMKHQWF-------LKNLPA 287
              +S+  +DLI R  +     R+    I +  KH +F       ++N  A
Sbjct: 306 VTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEA 355

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  176 bits (448), Expect = 6e-53
 Identities = 71/264 (26%), Positives = 120/264 (45%), Gaps = 26/264 (9%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G +G+    RD   +  +A+K I   D    + +  EI  H+ L+H NIV++     
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 90  TPTHLAIVMEYASGG---ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
               + I ME   GG    L        + +E    F+ +Q++ G+ Y H  Q+ HRD+K
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149

Query: 147 LENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRHE--YDGKIAD 203
            +N L++ + +  LKI DFG SK  + ++   ++  GT  Y+APE++ +    Y    AD
Sbjct: 150 GDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA-AD 207

Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------ISQECRD 256
           +WS G T+  M  G  PF +  EP           +  + V            +S E + 
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEP----------QAAMFKVGMFKVHPEIPESMSAEAKA 257

Query: 257 LISRIFVADPAARITIPEIMKHQW 280
            I + F  DP  R    +++  ++
Sbjct: 258 FILKCFEPDPDKRACANDLLVDEF 281

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  162 bits (411), Expect = 1e-47
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 22/263 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR---EIINHRSLRHPNIVRF--- 84
           IG G+F       D  T   VA   ++         QR   E    + L+HPNIVRF   
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93

Query: 85  -KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VC 141
            +  +     + +V E  + G L   +           R + +Q++ G+ + H     + 
Sbjct: 94  WESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPII 153

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++APE+    +YD   
Sbjct: 154 HRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEM-YEEKYDES- 209

Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQYSVPDTNP--ISQECRDLI 258
            DV++ G+ +  M    YP+ +       +R+    +       P +       E +++I
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK------PASFDKVAIPEVKEII 263

Query: 259 SRIFVADPAARITIPEIMKHQWF 281
                 +   R +I +++ H +F
Sbjct: 264 EGCIRQNKDERYSIKDLLNHAFF 286

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  161 bits (410), Expect = 2e-47
 Identities = 79/297 (26%), Positives = 136/297 (45%), Gaps = 29/297 (9%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
            + +  +  IG G+FG      D  T+++VA+K I  E  +   E++Q+EI        P
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
            + ++    L  T L I+MEY  GG   + +   G   E +     ++++ G+ Y H+ +
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEK 139

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
             HRD+K  N LL       +K+ DFG +         ++T VGTP ++APEV+ +  YD
Sbjct: 140 KIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------ISQ 252
            K AD+WS G+T   +  G  P  +   P          + V + +P  NP       S+
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELH-P----------MKVLFLIPKNNPPTLEGNYSK 245

Query: 253 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLP-----ADLVDEKTMSSQYEEPDQ 304
             ++ +      +P+ R T  E++KH++ L+N        +L+D        +  D 
Sbjct: 246 PLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDD 302

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  161 bits (409), Expect = 5e-47
 Identities = 61/278 (21%), Positives = 119/278 (42%), Gaps = 16/278 (5%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREI-INHRSLR 77
           + +  + + ++GSG  G    MR + T  ++AVK +      + ++ +  ++ +  +S  
Sbjct: 23  EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P IV+     +T T + I ME         +    G   E         ++  + Y   
Sbjct: 83  CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142

Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL---- 192
              V HRD+K  N LLD     ++K+CDFG S   V       + G  AY+APE +    
Sbjct: 143 KHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD 200

Query: 193 -LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPDTNPI 250
             + +YD + ADVWS G++L  +  G +P+++        + + ++L  +   +P     
Sbjct: 201 PTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTD---FEVLTKVLQEEPPLLPGHMGF 256

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
           S + +  +      D   R    ++++H +  +    +
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  160 bits (406), Expect = 6e-47
 Identities = 65/277 (23%), Positives = 124/277 (44%), Gaps = 23/277 (8%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
            +D  + + ++G G +GV   MR   + +++AVK I       E   +  ++ I+ R++ 
Sbjct: 5   KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD 64

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-AGRFSEDEARFFFQQLISGVSY 134
            P  V F   +     + I ME       + ++++ +      ED        ++  + +
Sbjct: 65  CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 135 CHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 192
            H+ + V HRD+K  N L++     ++K+CDFG S   V     K    G   Y+APE +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERI 181

Query: 193 L----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--D 246
                +  Y  K +D+WS G+T+  + +  +P++    P      ++++  V+   P   
Sbjct: 182 NPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTPFQ---QLKQV--VEEPSPQLP 235

Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
            +  S E  D  S+    +   R T PE+M+H +F  
Sbjct: 236 ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  159 bits (403), Expect = 3e-46
 Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 29/305 (9%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D    +    +G G FGV  + + K   + VA+K I   +   +    E+     + HPN
Sbjct: 6   DYKEIEVEEVVGRGAFGV--VCKAKWRAKDVAIKQI-ESESERKAFIVELRQLSRVNHPN 62

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---SGVSYCHA 137
           IV+     L P  + +VMEYA GG L+  +  A       A       +    GV+Y H+
Sbjct: 63  IVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120

Query: 138 MQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR 194
           MQ   + HRDLK  N LL       LKICDFG +    + +   +  G+ A++APEV   
Sbjct: 121 MQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----SVPDTNP 249
             Y  K  DV+S G+ L+ ++    PF+      +      RI+   +      +    P
Sbjct: 178 SNYSEK-CDVFSWGIILWEVITRRKPFD------EIGGPAFRIMWAVHNGTRPPLIKNLP 230

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKH-QWFLKNLPADLVDEKTMSSQYEEPDQPMQS 308
             +    L++R +  DP+ R ++ EI+K     ++  P      +        P +  + 
Sbjct: 231 --KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRV 288

Query: 309 VDVIM 313
              + 
Sbjct: 289 EPYVD 293

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  160 bits (406), Expect = 4e-46
 Identities = 74/305 (24%), Positives = 126/305 (41%), Gaps = 47/305 (15%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN--VQREI-INHRSLR 77
             D ++ + ++G+GN GV   +  K +  ++A K I    K      + RE+ + H    
Sbjct: 31  KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-N 89

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
            P IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y   
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 138 -MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
             ++ HRD+K  N L++      +K+CDFG S   +  S   S VGT +Y++PE L    
Sbjct: 150 KHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQLI-DSMANSFVGTRSYMSPERLQGTH 206

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI------ 250
           Y  + +D+WS G++L  M VG YP   PD  +       ++       P           
Sbjct: 207 YSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265

Query: 251 --------------------------------SQECRDLISRIFVADPAARITIPEIMKH 278
                                           S E +D +++  + +PA R  + ++M H
Sbjct: 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325

Query: 279 QWFLK 283
            +  +
Sbjct: 326 AFIKR 330

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  157 bits (400), Expect = 2e-45
 Identities = 73/325 (22%), Positives = 132/325 (40%), Gaps = 22/325 (6%)

Query: 1   MKMDR-ASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--E 57
           M ++    L + P         ++    + +IG G +G    M  K + +++AVK I   
Sbjct: 1   MSIESSGKLKISPEQHWDF--TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58

Query: 58  RGDKIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA- 113
             +K  + +  ++ +  RS   P IV+F   +       I ME  S    + ++ + +  
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVL 118

Query: 114 -GRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 171
                E+         +  +++    +++ HRD+K  N LLD S    +K+CDFG S   
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQL 176

Query: 172 VLHSQPKSTVGTPAYIAPEVL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
           V         G   Y+APE +     R  YD + +DVWS G+TLY +  G +P+   +  
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSV 235

Query: 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL--KNL 285
            D    + +    Q S  +    S    + ++     D + R    E++KH + L  +  
Sbjct: 236 FDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295

Query: 286 PADLVD--EKTMSSQYEEPDQPMQS 308
             ++     K +      P  PM  
Sbjct: 296 AVEVACYVCKILDQMPATPSSPMYV 320

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  157 bits (399), Expect = 2e-45
 Identities = 76/301 (25%), Positives = 132/301 (43%), Gaps = 35/301 (11%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
            + +D +  +G G++G       K T ++VA+K +     + E + +EI   +    P++
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE-IIKEISIMQQCDSPHV 86

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           V++       T L IVMEY   G + + I       +EDE     Q  + G+ Y H M+ 
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            HRD+K  N LL  +G      K+ DFG + + +   ++  + +GTP ++APEV+    Y
Sbjct: 147 IHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------- 249
           +   AD+WS G+T   M  G  P+ D   P          +   + +P   P        
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MRAIFMIPTNPPPTFRKPEL 250

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP-----ADLVDEKTMSSQYEEPDQ 304
            S    D + +  V  P  R T  ++++H  F+++        DL++E        +  Q
Sbjct: 251 WSDNFTDFVKQCLVKSPEQRATATQLLQHP-FVRSAKGVSILRDLINEAMDVKLKRQESQ 309

Query: 305 P 305
            
Sbjct: 310 Q 310

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  156 bits (396), Expect = 2e-45
 Identities = 77/276 (27%), Positives = 128/276 (46%), Gaps = 32/276 (11%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
             +Y     IG G  G      D  T + VA++ +  ++  K +  +  EI+  R  ++P
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-IINEILVMRENKNP 77

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIV + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ Q
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 140 VCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHE 196
           V HRD+K +N LL  DG     +K+ DFG+  + +   S+  + VGTP ++APEV+ R  
Sbjct: 137 VIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP------- 249
           Y  K  D+WS G+    M+ G  P+ + + P          L   Y +            
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRALYLIATNGTPELQNPE 240

Query: 250 -ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
            +S   RD ++R    D   R +  E+++HQ FLK 
Sbjct: 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKI 275

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  156 bits (397), Expect = 3e-45
 Identities = 83/275 (30%), Positives = 134/275 (48%), Gaps = 30/275 (10%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE-RGDKIDENVQREIINHRSLRHPN 80
               D    IG G+ G+  L R+K +   VAVK ++ R  +  E +  E++  R  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +V   +  L    L ++ME+  GG L + I +  R +E++     + ++  ++Y HA  V
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162

Query: 141 CHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
            HRD+K ++ LL  DG    R+K+ DFG+  + S    + KS VGTP ++APEV+ R  Y
Sbjct: 163 IHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-------- 249
             +  D+WS G+ +  M+ G  P+   D P          +     + D+ P        
Sbjct: 219 ATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQAMKRLRDSPPPKLKNSHK 266

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKN 284
           +S   RD + R+ V DP  R T  E++ H  FL  
Sbjct: 267 VSPVLRDFLERMLVRDPQERATAQELLDHP-FLLQ 300

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  155 bits (394), Expect = 6e-45
 Identities = 80/294 (27%), Positives = 126/294 (42%), Gaps = 24/294 (8%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRH 78
           + D Y+    IGSG   V +       KE VA+K I  E+     + + +EI       H
Sbjct: 13  NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGRFSEDEARFFFQQLIS 130
           PNIV +    +    L +VM+  SGG +         +    +G   E       ++++ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQPKSTVGTP 184
           G+ Y H     HRD+K  N LL    +  ++I DFG S           +   K+ VGTP
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 185 AYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ----RILS 239
            ++APEV+ +   YD K AD+WS G+T   +  G  P+      K    T+Q     + +
Sbjct: 191 CWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249

Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEK 293
                       +  R +IS     DP  R T  E+++H++F K    + + EK
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKEFLQEK 303

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  155 bits (394), Expect = 9e-45
 Identities = 43/238 (18%), Positives = 84/238 (35%), Gaps = 26/238 (10%)

Query: 60  DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRF 116
               +    +I         N V   +      +L I M+      L + +   C+    
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
                   F Q+   V + H+  + HRDLK  N          +K+ DFG   +     +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEE 219

Query: 177 PKST-------------VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFED 223
            ++              VGT  Y++PE +  + Y  K  D++S G+ L+ +L   Y F  
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFST 275

Query: 224 PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             E     + I  + ++++          +   ++  +    P  R    +I+++  F
Sbjct: 276 QMERV---RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 57.2 bits (138), Expect = 2e-09
 Identities = 20/66 (30%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQREIINHRSLRHPN 80
            ++ ++ +G G FGV    ++KV     A+K I   ++    E V RE+     L HP 
Sbjct: 6  TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 81 IVRFKE 86
          IVR+  
Sbjct: 66 IVRYFN 71

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  155 bits (394), Expect = 1e-44
 Identities = 81/297 (27%), Positives = 129/297 (43%), Gaps = 37/297 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           DRY  +  +G G +G      D VT E VA+K I R +  +E V     RE+   + L+H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIREVSLLKELQH 92

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
            NI+  K VI     L ++ EYA   +L + +      S    + F  QLI+GV++CH+ 
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151

Query: 139 QVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL- 193
           +  HRDLK +N LL  S A     LKI DFG +++  +  +  +  + T  Y  PE+LL 
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211

Query: 194 RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED--PDEPK--D 229
              Y   + D+WS       ML+                     G P +   P      D
Sbjct: 212 SRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPD 270

Query: 230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           ++++  +             +  E  DL++ +   DP  RI+    ++H +F  +  
Sbjct: 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF-SHND 326

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  153 bits (389), Expect = 5e-44
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 41/305 (13%)

Query: 19  MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSL 76
           M  S ++  +  +G+G +       +K T   VA+K +  +  +       REI   + L
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60

Query: 77  RHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEARFFFQQLISG 131
           +H NIVR  +VI T   L +V E+         +             +  ++F  QL+ G
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 190
           +++CH  ++ HRDLK +N L++     +LK+ DFG +++  +     S+ V T  Y AP+
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178

Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED------ 223
           VL+    Y   I D+WSCG  L  M+ G                    G P E       
Sbjct: 179 VLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237

Query: 224 --PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             P    + ++   R L          P+     D +  +   +P  R++  + + H WF
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 282 LKNLP 286
                
Sbjct: 298 -AEYY 301

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  151 bits (383), Expect = 5e-43
 Identities = 78/330 (23%), Positives = 127/330 (38%), Gaps = 40/330 (12%)

Query: 5   RASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDE 64
             S  V    +       ++Y+ +  +G G++G+    R+K T  +VA+K        D+
Sbjct: 7   HHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESDDDK 65

Query: 65  NV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSE 118
            V     REI   + LRH N+V   EV        +V E+      +  E   N      
Sbjct: 66  MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDY 123

Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 178
              + +  Q+I+G+ +CH+  + HRD+K EN L+  S    +K+CDFG++++     +  
Sbjct: 124 QVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVY 181

Query: 179 ST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 237
              V T  Y APE+L+     GK  DVW+ G  L   +  G P    D   D    I   
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIG-CLVTEMFMGEPLFPGDSDIDQLYHIMMC 240

Query: 238 L----------------SVQYSVPDTNP----------ISQECRDLISRIFVADPAARIT 271
           L                     +P+             +S+   DL  +    DP  R  
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300

Query: 272 IPEIMKHQWFLK-NLPADLVDEKTMSSQYE 300
             E++ H +F           E  +  Q +
Sbjct: 301 CAELLHHDFFQMDGFAERFSQELQLKVQKD 330

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  150 bits (381), Expect = 5e-43
 Identities = 71/295 (24%), Positives = 132/295 (44%), Gaps = 40/295 (13%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
           ++ ++ V ++G G FG     ++K T  L A K I  +  +++++    EI    +  HP
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YIVEIEILATCDHP 76

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAM 138
            IV+          L I++E+  GG +   +       +E + +   +Q++  +++ H+ 
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 139 QVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRH 195
           ++ HRDLK  N L+  +G     +++ DFG S K+     +  S +GTP ++APEV++  
Sbjct: 137 RIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192

Query: 196 E-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP- 249
                 YD K AD+WS G+TL  M     P  +   P          + V   +  ++P 
Sbjct: 193 TMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP----------MRVLLKIAKSDPP 240

Query: 250 -------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP----ADLVDEK 293
                   S E RD +      +P  R +  ++++H +           +LV E 
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEA 295

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  148 bits (376), Expect = 3e-42
 Identities = 73/314 (23%), Positives = 122/314 (38%), Gaps = 48/314 (15%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           ++Y+ +  IG G++GV    R++ T ++VA+K      + D  ++    REI   + L+H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALREIRMLKQLKH 61

Query: 79  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           PN+V   EV      L +V EY         +R        E   +    Q +  V++CH
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VGTPAYIAPEVLL 193
                HRD+K EN L+       +K+CDFG+++   L          V T  Y +PE+L+
Sbjct: 120 KHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVATRWYRSPELLV 175

Query: 194 RHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED----PDEPKD 229
                G   DVW+ G     +L G                    G             + 
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235

Query: 230 FRKT----IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK-N 284
           F        + +  ++   P+   IS     L+      DP  R+T  +++ H +F    
Sbjct: 236 FSGVKIPDPEDMEPLELKFPN---ISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292

Query: 285 LPADLVDEKTMSSQ 298
              DL  E    ++
Sbjct: 293 EIEDLAKEHDKPAE 306

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  148 bits (375), Expect = 4e-42
 Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 47/301 (15%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
            +Y+ +  IG G +G     +++ T E+VA+K + R D  DE V     REI   + L+H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALREICLLKELKH 60

Query: 79  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            NIVR  +V+ +   L +V E+      + F+     G    +  + F  QL+ G+ +CH
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-R 194
           +  V HRDLK +N L++ +    LK+ +FG +++  +  +  S  V T  Y  P+VL   
Sbjct: 119 SRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 195 HEYDGKIADVWSCGVTLYVMLVGGYPF------ED-----------PDE---P------- 227
             Y   I D+WS G     +   G P       +D           P E   P       
Sbjct: 177 KLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235

Query: 228 -KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
            K +        S+   VP    ++   RDL+  +   +P  RI+  E ++H +F  +  
Sbjct: 236 YKPYPMYPATT-SLVNVVPK---LNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFC 290

Query: 287 A 287
            
Sbjct: 291 P 291

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  147 bits (373), Expect = 8e-42
 Identities = 77/264 (29%), Positives = 119/264 (45%), Gaps = 32/264 (12%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IG+G+FG   + R +     VAVK +   D   E V    RE+   + LRHPNIV F   
Sbjct: 45  IGAGSFG--TVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102

Query: 88  ILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAM--QVCH 142
           +  P +L+IV EY S G L+  +  +G      E         +  G++Y H     + H
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYIAPEVLLRHEYDG 199
           R+LK  N L+D      +K+CDFG S+  +  S     KS  GTP ++APEVL     + 
Sbjct: 163 RNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----SVPDTNPISQEC 254
           K +DV+S GV L+ +     P+ + +         Q + +V +      +P       + 
Sbjct: 219 K-SDVYSFGVILWELATLQQPWGNLN-------PAQVVAAVGFKCKRLEIPRNLN--PQV 268

Query: 255 RDLISRIFVADPAARITIPEIMKH 278
             +I   +  +P  R +   IM  
Sbjct: 269 AAIIEGCWTNEPWKRPSFATIMDL 292

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  147 bits (374), Expect = 1e-41
 Identities = 74/320 (23%), Positives = 132/320 (41%), Gaps = 46/320 (14%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           + Y  +  +G G +      + K+T  LVA+K I  E  +       RE+   + L+H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 81  IVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           IV   ++I T   L +V EY      +  +        +    + F  QL+ G++YCH  
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQ 119

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-RHE 196
           +V HRDLK +N L++      LK+ DFG +++  + ++     V T  Y  P++LL   +
Sbjct: 120 KVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTD 177

Query: 197 YDGKIADVWSCGVTLYVMLVG--------------------GYPFED--------PD-EP 227
           Y  +I D+W  G   Y M  G                    G P E+         + + 
Sbjct: 178 YSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236

Query: 228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 287
            ++ K     L           +  +  DL++++   +   RI+  + MKH +F  +L  
Sbjct: 237 YNYPKYRAEALLSHAP-----RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF-LSLGE 290

Query: 288 DLVDEKTMSSQYEEPDQPMQ 307
            +      +S +   +  +Q
Sbjct: 291 RIHKLPDTTSIFALKEIQLQ 310

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  146 bits (370), Expect = 1e-41
 Identities = 70/274 (25%), Positives = 114/274 (41%), Gaps = 33/274 (12%)

Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV--------QREIINHRSLR 77
           ++ + IG G FG+    R    K +VA+K +  GD   E          QRE+    +L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCH 136
           HPNIV+   ++  P    +VME+   G+L+ R+ +                +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139

Query: 137 AM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
                + HRDL+  N  L     +     K+ DFG S+           +G   ++APE 
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPET 197

Query: 192 LL-RHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----SV 244
           +    E Y  K AD +S  + LY +L G  PF++    K     I+ I  ++      ++
Sbjct: 198 IGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMIREEGLRPTI 251

Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
           P+  P     R++I   +  DP  R     I+K 
Sbjct: 252 PEDCP--PRLRNVIELCWSGDPKKRPHFSYIVKE 283

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  146 bits (371), Expect = 1e-41
 Identities = 80/295 (27%), Positives = 128/295 (43%), Gaps = 48/295 (16%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ----REIINHRSLRH 78
           ++Y  +  IG G +GV    ++    E  A+K I R +K DE +     REI   + L+H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIREISILKELKH 59

Query: 79  PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
            NIV+  +VI T   L +V E+      +L +     G      A+ F  QL++G++YCH
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL-R 194
             +V HRDLK +N L++      LKI DFG +++  +  +  +  + T  Y AP+VL+  
Sbjct: 118 DRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 195 HEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED--------PDE 226
            +Y   I D+WS G     M+ G                    G P           P  
Sbjct: 176 KKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
             +F                   + +   DL+S++   DP  RIT  + ++H +F
Sbjct: 235 DPNFTVYEPLPWESFLK-----GLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  146 bits (372), Expect = 1e-41
 Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 50/321 (15%)

Query: 3   MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI 62
           M           ++      ++Y  +  +G G +GV    +D     +VA+K I R D  
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRI-RLDAE 58

Query: 63  DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRF 116
           DE +     REI   + L HPNIV   +VI +   L +V E+      ++ +   N    
Sbjct: 59  DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGL 116

Query: 117 SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 176
            + + + +  QL+ GV++CH  ++ HRDLK +N L++      LK+ DFG +++  +  +
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVR 174

Query: 177 PKST-VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG----------------- 217
             +  V T  Y AP+VL+   +Y   + D+WS G     M+ G                 
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233

Query: 218 ---GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVAD 265
              G P           P  + + F+   ++  S            QE  DL+S +   D
Sbjct: 234 SILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP-----GFCQEGIDLLSNMLCFD 288

Query: 266 PAARITIPEIMKHQWFLKNLP 286
           P  RI+  + M H +F K+L 
Sbjct: 289 PNKRISARDAMNHPYF-KDLD 308

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  149 bits (378), Expect = 2e-41
 Identities = 80/300 (26%), Positives = 120/300 (40%), Gaps = 48/300 (16%)

Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP 79
                Y   + IG+G+FGV    +   + ELVA+K +   DK  +N  RE+   R L H 
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-LQDKRFKN--RELQIMRKLDHC 107

Query: 80  NIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLIS 130
           NIVR +    +        +L +V++Y                        + +  QL  
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167

Query: 131 GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIA 188
            ++Y H+  +CHRD+K +N LLD   A  LK+CDFG +K   L     +   + +  Y A
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEPNVSYICSRYYRA 224

Query: 189 PEVLLR-HEYDGKIADVWSCGVTLYVM--LVGGYPFEDPDEPKDFRKTIQRIL------- 238
           PE++    +Y   I DVWS G    V+  L+ G P    D   D    I ++L       
Sbjct: 225 PELIFGATDYTSSI-DVWSAGC---VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280

Query: 239 -------SVQYSVPDTNPI----------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
                    ++  P                 E   L SR+    P AR+T  E   H +F
Sbjct: 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  144 bits (366), Expect = 3e-41
 Identities = 80/274 (29%), Positives = 114/274 (41%), Gaps = 37/274 (13%)

Query: 26  DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-----ENVQREIINHRSLRHPN 80
                IG G FG  ++ R     + VAVK        D     ENV++E      L+HPN
Sbjct: 10  TLEEIIGIGGFG--KVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-- 138
           I+  + V L   +L +VME+A GG L   +    R   D    +  Q+  G++Y H    
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 139 -QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
             + HRDLK  N L+             LKI DFG ++     +   S  G  A++APEV
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHRTTKMSAAGAYAWMAPEV 185

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN--- 248
           +    +    +DVWS GV L+ +L G  PF   D            L+V Y V       
Sbjct: 186 IRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDG-----------LAVAYGVAMNKLAL 233

Query: 249 PISQEC----RDLISRIFVADPAARITIPEIMKH 278
           PI   C      L+   +  DP +R +   I+  
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  146 bits (370), Expect = 3e-41
 Identities = 70/289 (24%), Positives = 127/289 (43%), Gaps = 41/289 (14%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPN 80
           +  ++ V  +G+G +G     R   T +L A+K ++     +E +++EI   +    H N
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 81  IVRF------KEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGV 132
           I  +      K        L +VME+   G + +  +        E+   +  ++++ G+
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 133 SYCHAMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 189
           S+ H  +V HRD+K +N LL  +      +K+ DFG S         ++T +GTP ++AP
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198

Query: 190 EVLLRHE-----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
           EV+   E     YD K +D+WS G+T   M  G  P  D   P          +   + +
Sbjct: 199 EVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMH-P----------MRALFLI 246

Query: 245 PDTNP-------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           P            S++ +  I    V + + R    ++MKH  F+++ P
Sbjct: 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHP-FIRDQP 294

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  146 bits (371), Expect = 3e-41
 Identities = 78/314 (24%), Positives = 132/314 (42%), Gaps = 41/314 (13%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-----ERGDKIDENVQREIINHRSL 76
              +  +R+IG G+FG     RD    E+VA+K +     +  +K  + + +E+   + L
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKL 111

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           RHPN ++++   L      +VMEY  G        +     E E        + G++Y H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 137 AMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 193
           +  + HRD+K  N LL   G     +K+ DFG +      +   S VGTP ++APEV+L 
Sbjct: 172 SHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSFVGTPYWMAPEVILA 224

Query: 194 --RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-- 249
               +YDGK  DVWS G+T   +     P  +              +S  Y +       
Sbjct: 225 MDEGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA----------MSALYHIAQNESPA 272

Query: 250 -----ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP----ADLVDEKTMSSQYE 300
                 S+  R+ +       P  R T   ++KH++ L+  P     DL+     + +  
Sbjct: 273 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVREL 332

Query: 301 EPDQPMQSVDVIMQ 314
           +  Q  +   ++ Q
Sbjct: 333 DNLQYRKMKKILFQ 346

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  146 bits (370), Expect = 6e-41
 Identities = 78/315 (24%), Positives = 131/315 (41%), Gaps = 58/315 (18%)

Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------ 67
           M + +   + RY+ +  +G G F      RDK T ++VA+K I +     E         
Sbjct: 1   MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-KLGHRSEAKDGINRTA 59

Query: 68  -REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFF 124
            REI   + L HPNI+   +     +++++V ++       + +   N+   +    + +
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAY 117

Query: 125 FQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-V 181
               + G+ Y H   + HRDLK  N LLD  G     LK+ DFG +KS    ++  +  V
Sbjct: 118 MLMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQV 173

Query: 182 GTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG--------------------GY 219
            T  Y APE+L   R  Y   + D+W+ G  L  +L+                     G 
Sbjct: 174 VTRWYRAPELLFGARM-YGVGV-DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 231

Query: 220 PFED--------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT 271
           P E+        PD    F+      + + +          +  DLI  +F+ +P ARIT
Sbjct: 232 PTEEQWPDMCSLPDY-VTFKS--FPGIPLHHIFSA---AGDDLLDLIQGLFLFNPCARIT 285

Query: 272 IPEIMKHQWFLKNLP 286
             + +K ++F  N P
Sbjct: 286 ATQALKMKYF-SNRP 299

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  145 bits (369), Expect = 8e-41
 Identities = 74/328 (22%), Positives = 125/328 (38%), Gaps = 59/328 (17%)

Query: 12  PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----Q 67
            +++ P   +  +Y+ +  IG G FG     R + T + VA+K +   +   E       
Sbjct: 6   DSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-LMENEKEGFPITAL 64

Query: 68  REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 117
           REI   + L+H N+V   E+  T             +V ++       L   +    +F+
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122

Query: 118 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 173
             E +   Q L++G+ Y H  ++ HRD+K  N L+       LK+ DFG    +S +   
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180

Query: 174 HSQP-KSTVGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG-------------- 217
                 + V T  Y  PE+LL   +Y   I D+W  G  +  M                 
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239

Query: 218 ------GYPFED--------PD-EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIF 262
                 G    +           E  +  K  +R +  +              DLI ++ 
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK---AYVRDPYALDLIDKLL 296

Query: 263 VADPAARITIPEIMKHQWFLKN-LPADL 289
           V DPA RI   + + H +F  + +P+DL
Sbjct: 297 VLDPAQRIDSDDALNHDFFWSDPMPSDL 324

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  144 bits (365), Expect = 1e-40
 Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 49/283 (17%)

Query: 31  IGSGNFGVARLMRDKVTKEL----VAVKYIERGDKIDENVQ---REIINHRSLRHPNIVR 83
           IG G FG       +V        VA++ I+     ++ ++   RE++ +R  RH N+V 
Sbjct: 41  IGKGRFG-------QVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93

Query: 84  FKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCH 142
           F    ++P HLAI+     G  L+  + +A      ++ R   Q+++ G+ Y HA  + H
Sbjct: 94  FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIAPEVL---- 192
           +DLK +N   D     ++ I DFG         +     + +   G   ++APE++    
Sbjct: 154 KDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 193 -----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----S 243
                 +  +    +DV++ G   Y +    +PF+              I  +      +
Sbjct: 211 PDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQP-------AEAIIWQMGTGMKPN 262

Query: 244 VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
           +     + +E  D++   +  +   R T  ++M     L+ LP
Sbjct: 263 LSQIG-MGKEISDILLFCWAFEQEERPTFTKLMDM---LEKLP 301

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  145 bits (368), Expect = 2e-40
 Identities = 64/331 (19%), Positives = 118/331 (35%), Gaps = 62/331 (18%)

Query: 21  DSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRS 75
           +   Y+ +  IG G  +     L R K T E V V+ I      +++   +Q E+   + 
Sbjct: 23  EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKL 82

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVS 133
             HPNIV ++   +    L +V  + + G   + IC       +E    +  Q ++  + 
Sbjct: 83  FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLHSQPKSTVGTPA 185
           Y H M   HR +K  + L+       + +     +        +  V+H  PK +V    
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200

Query: 186 YIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFED-------------------- 223
           +++PEVL +    YD K +D++S G+T   +  G  PF+D                    
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259

Query: 224 --------------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFV 263
                                        T +       S P     S      + +   
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319

Query: 264 ADPAARITIPEIMKHQWF--LKNLPADLVDE 292
            +P AR +   ++ H +F  +K   ++ + E
Sbjct: 320 RNPDARPSASTLLNHSFFKQIKRRASEALPE 350

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  143 bits (362), Expect = 2e-40
 Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 28/272 (10%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHPNIVRFKEV 87
           IGSG+FG   + + K   + VAVK +       + +Q    E+   R  RH NI+ F   
Sbjct: 32  IGSGSFG--TVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88

Query: 88  ILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLK 146
             T   LAIV ++  G  L+  +  +  +F   +     +Q   G+ Y HA  + HRDLK
Sbjct: 89  S-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLK 147

Query: 147 LENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRHE---YDGK 200
             N  L       +KI DFG +          Q +   G+  ++APEV+   +   Y  +
Sbjct: 148 SNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC----RD 256
            +DV++ G+ LY ++ G  P+ + +      + + R        PD + +   C    + 
Sbjct: 206 -SDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR----GSLSPDLSKVRSNCPKRMKR 260

Query: 257 LISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
           L++         R + P I+     ++ L  +
Sbjct: 261 LMAECLKKKRDERPSFPRILAE---IEELARE 289

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  145 bits (368), Expect = 3e-40
 Identities = 82/345 (23%), Positives = 141/345 (40%), Gaps = 70/345 (20%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
              Y   + IG+G+FGV    +   + E VA+K +   DK  +N  RE+   R ++HPN+
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV-LQDKRFKN--RELQIMRIVKHPNV 94

Query: 82  VRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSEDEARFFFQQLISGV 132
           V  K    +         L +V+EY                        + +  QL+  +
Sbjct: 95  VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
           +Y H++ +CHRD+K +N LLD      LK+ DFG +K  +L +   +   + +  Y APE
Sbjct: 155 AYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEPNVSYICSRYYRAPE 211

Query: 191 VLLR-HEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED------ 223
           ++     Y   I D+WS G  +  ++ G                    G P  +      
Sbjct: 212 LIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270

Query: 224 PD---------EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPE 274
           P+          P  F K  +         P T P   +  DLISR+    P+AR+T  E
Sbjct: 271 PNYMEHKFPQIRPHPFSKVFR---------PRTPP---DAIDLISRLLEYTPSARLTAIE 318

Query: 275 IMKHQWF--LKNLPADLVDEKTMSSQYE-EPDQPMQSVDVIMQII 316
            + H +F  L+   A + + + +   +    ++     D+I +++
Sbjct: 319 ALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLV 363

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  144 bits (365), Expect = 9e-40
 Identities = 72/327 (22%), Positives = 117/327 (35%), Gaps = 68/327 (20%)

Query: 23  DRYDFVRD-IGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
           D +++    +G G +G    A+  +D    +  A+K IE    I  +  REI   R L+H
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAK-RKDGKDDKDYALKQIEG-TGISMSACREIALLRELKH 77

Query: 79  PNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERICNAGRFSEDEARFFFQQL 128
           PN++  ++V L+     +  + +YA              +      +      +    Q+
Sbjct: 78  PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPR--LKICDFG----YSKSSVLHSQPKSTVG 182
           + G+ Y HA  V HRDLK  N L+ G    R  +KI D G    ++      +     V 
Sbjct: 138 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197

Query: 183 TPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVG----------------------- 217
           T  Y APE+LL  RH Y   I D+W+ G     +L                         
Sbjct: 198 TFWYRAPELLLGARH-YTKAI-DIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255

Query: 218 ------GYPFED------------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
                 G+P +                    R T      ++Y          +   L+ 
Sbjct: 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 315

Query: 260 RIFVADPAARITIPEIMKHQWFLKNLP 286
           ++   DP  RIT  + M+  +F    P
Sbjct: 316 KLLTMDPIKRITSEQAMQDPYF-LEDP 341

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  138 bits (351), Expect = 5e-39
 Identities = 48/259 (18%), Positives = 92/259 (35%), Gaps = 23/259 (8%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEV 87
           +   + G   L + +     + VK ++  D   +   +   E    R   HPN++     
Sbjct: 18  LNENHSG--ELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75

Query: 88  ILTP--THLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVSYCHAMQ--VC 141
             +P   H  ++  +   G L+  +     F  D+++   F   +  G+++ H ++  + 
Sbjct: 76  CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
              L   + ++D       +I       S     Q    +  PA++APE L +   D   
Sbjct: 136 RHALNSRSVMIDED--MTARISMADVKFS----FQSPGRMYAPAWVAPEALQKKPEDTNR 189

Query: 202 --ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
             AD+WS  V L+ ++    PF D        +   ++            IS     L+ 
Sbjct: 190 RSADMWSFAVLLWELVTREVPFAD----LSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245

Query: 260 RIFVADPAARITIPEIMKH 278
                DPA R     I+  
Sbjct: 246 ICMNEDPAKRPKFDMIVPI 264

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  140 bits (354), Expect = 6e-39
 Identities = 73/308 (23%), Positives = 116/308 (37%), Gaps = 55/308 (17%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ-------REIINHRS 75
            RY+ V +IG G +G     RD  +   VA+K + R                RE+   R 
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRR 67

Query: 76  LR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFSEDEARFFF 125
           L    HPN+VR  +V  T        + +V E+         ++         +  +   
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLPAETIKDLM 126

Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVG 182
           +Q + G+ + HA  + HRDLK EN L+       +K+ DFG ++    +S        V 
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQMALTPVVV 181

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFE 222
           T  Y APEVLL+  Y   + D+WS G     M                       G P E
Sbjct: 182 TLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240

Query: 223 D--PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
           D  P +          +    VQ  VP+   + +    L+  +   +P  RI+    ++H
Sbjct: 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPE---MEESGAQLLLEMLTFNPHKRISAFRALQH 297

Query: 279 QWFLKNLP 286
            +  K+  
Sbjct: 298 SYLHKDEG 305

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  138 bits (349), Expect = 4e-38
 Identities = 69/310 (22%), Positives = 131/310 (42%), Gaps = 52/310 (16%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN 80
            D Y  VR +G G +       +    E V VK ++   K  + ++REI    +LR  PN
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPN 92

Query: 81  IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           I+   +++  P     A+V E+ +  +  +        ++ + RF+  +++  + YCH+M
Sbjct: 93  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 149

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLR-H 195
            + HRD+K  N ++D     +L++ D+G ++    H   +    V +  +  PE+L+   
Sbjct: 150 GIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPF---ED-------------PDEPKDFRKTIQRILS 239
            YD  + D+WS G  L  M+    PF    D              ++  D+       L 
Sbjct: 207 MYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265

Query: 240 VQYS--------------VPDTNP--ISQECRDLISRIFVADPAARITIPEIMKHQWFLK 283
            +++              V   N   +S E  D + ++   D  +R+T  E M+H +F  
Sbjct: 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF-- 323

Query: 284 NLPADLVDEK 293
                +V ++
Sbjct: 324 ---YTVVKDQ 330

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  136 bits (344), Expect = 1e-37
 Identities = 65/299 (21%), Positives = 116/299 (38%), Gaps = 34/299 (11%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIER-GDKIDENVQREIINHRSLRHPNIVRFKEVIL 89
           +G G FG A  +  + T E++ +K + R  ++      +E+   R L HPN+++F  V+ 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 90  TPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE 148
               L  + EY  GG L   I +    +   +   F + + SG++Y H+M + HRDL   
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSH 137

Query: 149 NTLLDGSPAPRLKICDFGYSK---------------SSVLHSQPKSTVGTPAYIAPEVLL 193
           N L+  +    + + DFG ++                     +  + VG P ++APE++ 
Sbjct: 138 NCLVREN--KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMIN 195

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE 253
              YD K  DV+S G+ L  ++       D                +             
Sbjct: 196 GRSYDEK-VDVFSFGIVLCEIIGRVNADPDYL-------PRTMDFGLNVRGFLDRYCPPN 247

Query: 254 C----RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQS 308
           C      +  R    DP  R +  ++     +L+ L   L     +  Q E+ D+    
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKLE---HWLETLRMHLAGHLPLGPQLEQLDRGFWE 303

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  135 bits (342), Expect = 8e-37
 Identities = 77/319 (24%), Positives = 120/319 (37%), Gaps = 51/319 (15%)

Query: 7   SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN- 65
           SL    A D     + DR+   R  G G FG  +L ++K T   VA+K +   D    N 
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNR 65

Query: 66  VQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR--- 115
             + + +   L HPNIV+ +    T          L +VMEY     L     N  R   
Sbjct: 66  ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124

Query: 116 -FSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
                  + F  QLI  +   H  ++ VCHRD+K  N L++ +    LK+CDFG +K   
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLS 183

Query: 173 LHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG--YPFED------ 223
                 + + +  Y APE++     Y   + D+WS G     M++G   +  ++      
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 224 --------PDE-------PKDFRKTIQRILSVQYS------VPDTNPISQECRDLISRIF 262
                   P         P      +     + +S               E  DL+S + 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAK---EAYDLLSALL 299

Query: 263 VADPAARITIPEIMKHQWF 281
              P  R+   E + H +F
Sbjct: 300 QYLPEERMKPYEALCHPYF 318

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  131 bits (332), Expect = 1e-35
 Identities = 76/305 (24%), Positives = 125/305 (40%), Gaps = 52/305 (17%)

Query: 23  DRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQ----REI---INHR 74
            +Y+ V +IG G +G     RD K     VA+K + R    +E +     RE+    +  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLE 69

Query: 75  SLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQ 127
           +  HPN+VR  +V         T L +V E+         ++         +  +    Q
Sbjct: 70  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQ 128

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPA 185
           L+ G+ + H+ +V HRDLK +N L+  S   ++K+ DFG ++      Q   T  V T  
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQMALTSVVVTLW 184

Query: 186 YIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED-- 223
           Y APEVLL+  Y   + D+WS G     M                       G P E+  
Sbjct: 185 YRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 243

Query: 224 PDEPK--DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
           P +          +    ++  V D   I +  +DL+ +    +PA RI+    + H +F
Sbjct: 244 PRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

Query: 282 LKNLP 286
            ++L 
Sbjct: 301 -QDLE 304

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  129 bits (325), Expect = 5e-35
 Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 45/286 (15%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           +G G +G   + R     E VAVK     D+     + E+ N   LRH NI+ F      
Sbjct: 16  VGKGRYG--EVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMT 73

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ------- 139
              + T L ++  Y   G L++ +                 + SG+++ H          
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132

Query: 140 -VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +   +  I D G +      ++ L       VGT  Y+APEVL 
Sbjct: 133 AIAHRDLKSKNILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190

Query: 193 -----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-FRKTIQRILSVQY---- 242
                   +   +  D+W+ G+ L+ +          ++ K  F   +    S +     
Sbjct: 191 ETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV 249

Query: 243 --------SVPDT---NPISQECRDLISRIFVADPAARITIPEIMK 277
                   ++P+    +P       L+   +  +P+AR+T   I K
Sbjct: 250 VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  129 bits (327), Expect = 7e-35
 Identities = 62/312 (19%), Positives = 117/312 (37%), Gaps = 46/312 (14%)

Query: 7   SLTVGPAMDMPIMH---DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID 63
           S + G    +P++     + +   V+ IG G +G   +   K   E VAVK     ++  
Sbjct: 18  SQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYG--EVWMGKWRGEKVAVKVFFTTEEAS 75

Query: 64  ENVQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSED 119
              + EI     +RH NI+ F     +   + T L ++ +Y   G L++ + +       
Sbjct: 76  WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAK 134

Query: 120 EARFFFQQLISGVSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
                    +SG+ + H           + HRDLK +N L+  +      I D G +   
Sbjct: 135 SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVKF 192

Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPF 221
              ++ +   P + VGT  Y+ PEVL       H     +AD++S G+ L+ +       
Sbjct: 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 222 EDPDE---PKDFRKTIQRILSVQYSV-------------PDTNPISQECRDLISRIFVAD 265
              +E   P                +               ++   ++   L++  +  +
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312

Query: 266 PAARITIPEIMK 277
           PA+R+T   + K
Sbjct: 313 PASRLTALRVKK 324

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  128 bits (323), Expect = 2e-34
 Identities = 74/305 (24%), Positives = 114/305 (37%), Gaps = 50/305 (16%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
             RY  ++ +G G  G+     D    + VA+K I   D    ++  REI   R L H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 81  IVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGRFSEDEARFFFQQL 128
           IV+  E++            +           E  E     +   G   E+ AR F  QL
Sbjct: 70  IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQL 129

Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
           + G+ Y H+  V HRDLK  N  ++ +    LKI DFG ++    H   K      + T 
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 185 AYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKD 229
            Y +P +LL  + Y   I D+W+ G     ML G   F    E               ++
Sbjct: 189 WYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247

Query: 230 FRKTIQR-----ILSVQYS--------VPDTNPISQECRDLISRIFVADPAARITIPEIM 276
            R+ +       I +            +P  +    E  D + +I    P  R+T  E +
Sbjct: 248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR---EAVDFLEQILTFSPMDRLTAEEAL 304

Query: 277 KHQWF 281
            H + 
Sbjct: 305 SHPYM 309

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  127 bits (322), Expect = 3e-34
 Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 45/286 (15%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF----KE 86
           IG G FG   + R K   E VAVK     ++     + EI     LRH NI+ F     +
Sbjct: 50  IGKGRFG--EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107

Query: 87  VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------M 138
              T T L +V +Y   G LF+ + N    + +          SG+++ H          
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVL- 192
            + HRDLK +N L+  +      I D G +      +  +   P   VGT  Y+APEVL 
Sbjct: 167 AIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 224

Query: 193 ----LRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK----DFRKTIQRILSVQYS 243
               ++H E   + AD+++ G+  + +          ++ +    D   +   +  ++  
Sbjct: 225 DSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 283

Query: 244 V------------PDTNPISQECRDLISRIFVADPAARITIPEIMK 277
           V              +    +    ++   + A+ AAR+T   I K
Sbjct: 284 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  126 bits (319), Expect = 2e-33
 Identities = 66/327 (20%), Positives = 117/327 (35%), Gaps = 74/327 (22%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           S +Y   + +G+G+FG+   + D  + +  A+K + + D   +N  RE+   + L H NI
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-DPRYKN--RELDIMKVLDHVNI 62

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAG--------------------------- 114
           ++  +   T                     N G                           
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 115 --------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL 160
                             +    +  QL   V + H++ +CHRD+K +N L++      L
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN-TL 181

Query: 161 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGG- 218
           K+CDFG +K  +      + + +  Y APE++L   EY   I D+WS G     +++G  
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLWSIGCVFGELILGKP 240

Query: 219 -YPFED--------------PDE-------PKDFRKTIQRILSVQYS--VPDTNPISQEC 254
            +  E               P +       P         + +  +   +P+  P     
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP--SLA 298

Query: 255 RDLISRIFVADPAARITIPEIMKHQWF 281
            DL+ +I   +P  RI   E M H +F
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFF 325

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  124 bits (314), Expect = 9e-33
 Identities = 74/297 (24%), Positives = 125/297 (42%), Gaps = 46/297 (15%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
              Y  ++ +GSG +G      D  T   VA+K + R    ++  +   RE+   + +RH
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 79  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            N++   +V      L       +VM +  G +L  ++    +  ED  +F   Q++ G+
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
            Y HA  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTGYVVTRWYRAPE 195

Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQ 235
           V+L    Y   + D+WS G  +  M+ G   F+  D               P +F + +Q
Sbjct: 196 VILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 236 RILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
              +  Y   +P+             S    +L+ ++ V D   R+T  E + H +F
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  124 bits (313), Expect = 1e-32
 Identities = 72/297 (24%), Positives = 120/297 (40%), Gaps = 46/297 (15%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
            +RY  +  +GSG +G      D  T   VAVK + R     I  +   RE+   + ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 79  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            N++   +V      L       +V     G +L   I    + ++D  +F   Q++ G+
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
            Y H+  + HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTGYVATRWYRAPE 199

Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQ 235
           ++L    Y+  + D+WS G  +  +L G   F   D                 +  K I 
Sbjct: 200 IMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258

Query: 236 RILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
              +  Y  S+     +         +    DL+ ++ V D   RIT  + + H +F
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  123 bits (312), Expect = 1e-32
 Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 47/297 (15%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
              Y     +GSG +G      DK + E VA+K + R    +I  +   RE++  + ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 79  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            N++   +V    + L       +VM +    +L + +    +FSE++ ++   Q++ G+
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
            Y H+  V HRDLK  N  ++      LKI DFG ++     +  + T  V T  Y APE
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTGYVVTRWYRAPE 193

Query: 191 VLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQ 235
           V+L    Y+  + D+WS G  +  ML G   F+  D                 +F + + 
Sbjct: 194 VILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252

Query: 236 RILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
              +  Y  S+P T            S +  DL+ ++   D   R+T  + + H +F
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  122 bits (309), Expect = 4e-32
 Identities = 80/316 (25%), Positives = 124/316 (39%), Gaps = 68/316 (21%)

Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REII 71
           + S  +     +G G +GV      K T E+VA+K      KI+  +         REI 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIK 61

Query: 72  NHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQ 126
             +  +H NI+    +    +        I+ E     +L  R+ +    S+D  ++F  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIY 119

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKST-- 180
           Q +  V   H   V HRDLK  N L++ +    LK+CDFG      +S+  +S+P     
Sbjct: 120 QTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPTGQQS 177

Query: 181 -----VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG----------------- 217
                V T  Y APEV+L   +Y   + DVWSCG  L  + +                  
Sbjct: 178 GMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236

Query: 218 ---GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI---------SQECRDLISRIFVAD 265
              G P  D D         +  +    S+P              + +  DL+ R+ V D
Sbjct: 237 GIIGTPHSDNDLRCIESPRAREYIK---SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293

Query: 266 PAARITIPEIMKHQWF 281
           PA RIT  E ++H + 
Sbjct: 294 PAKRITAKEALEHPYL 309

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  122 bits (309), Expect = 4e-32
 Identities = 78/303 (25%), Positives = 120/303 (39%), Gaps = 54/303 (17%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID--ENVQ------REIINH 73
             RY  +  IG G +G+     D + K  VA+K      KI   E+        REI   
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKIL 79

Query: 74  RSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 128
              RH NI+   ++I  PT      + IV +     +L  ++      S D   +F  Q+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQI 137

Query: 129 ISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTP 184
           + G+ Y H+  V HRDLK  N LL+ +    LKICDFG ++ +             V T 
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 185 AYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKD 229
            Y APE++L    Y   I D+WS G  L  ML     F                    ++
Sbjct: 196 WYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254

Query: 230 FRKTIQRILSVQY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKH 278
               I  + +  Y  S+P  N +           +  DL+ ++   +P  RI + + + H
Sbjct: 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314

Query: 279 QWF 281
            + 
Sbjct: 315 PYL 317

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  122 bits (308), Expect = 6e-32
 Identities = 70/306 (22%), Positives = 119/306 (38%), Gaps = 53/306 (17%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
             RY  ++ IGSG  G+     D + +  VA+K + R   ++   +   RE++  + + H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 79  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            NI+    V      L       IVME      L  ++        +   +   Q++ G+
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERMSYLLYQMLCGI 140

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED--------- 223
           L   Y   + D+WS G  +  M+ G                    G P  +         
Sbjct: 199 LGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257

Query: 224 --------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEI 275
                         F K    +L    S       + + RDL+S++ V D + RI++ E 
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADS-EHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 276 MKHQWF 281
           ++H + 
Sbjct: 317 LQHPYI 322

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  122 bits (308), Expect = 6e-32
 Identities = 64/335 (19%), Positives = 114/335 (34%), Gaps = 72/335 (21%)

Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR 74
           +   RY  VR +G G+F    L +D V    VA+K +       E  + EI     +N  
Sbjct: 16  YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDA 75

Query: 75  SLRHP------NIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEAR 122
                      +I++  +          H+ +V E   G  L    +            +
Sbjct: 76  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVK 134

Query: 123 FFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQP 177
              +QL+ G+ Y H    + H D+K EN L++   +P     +KI D G   +       
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHY 192

Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------- 226
            +++ T  Y +PEVLL   +     D+WS    ++ ++ G + FE  +            
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251

Query: 227 ---------------------------------PKDFRKTIQRILSVQYSVPDTNPISQE 253
                                             K     ++ +L+ +Y        ++E
Sbjct: 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE--AKE 309

Query: 254 CRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
             D +S +   DP  R     ++ H W    L  +
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  123 bits (309), Expect = 2e-31
 Identities = 72/308 (23%), Positives = 119/308 (38%), Gaps = 57/308 (18%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
             RY  ++ IGSG  G+     D V    VA+K + R   ++   +   RE++  + + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 79  PNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
            NI+    V      L       +VME      L + I        +   +   Q++ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCGI 177

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPE 190
            + H+  + HRDLK  N ++       LKI DFG +++    +    T  V T  Y APE
Sbjct: 178 KHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 233

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYPFED------- 223
           V+L   Y   + D+WS G  +  M+                      G P  +       
Sbjct: 234 VILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292

Query: 224 ----------PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIP 273
                           F K     L    S  +    + + RDL+S++ V DPA RI++ 
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL-KASQARDLLSKMLVIDPAKRISVD 351

Query: 274 EIMKHQWF 281
           + ++H + 
Sbjct: 352 DALQHPYI 359

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  119 bits (301), Expect = 2e-31
 Identities = 80/260 (30%), Positives = 115/260 (44%), Gaps = 22/260 (8%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLR 77
           ++RY  V  +G G      L  D +    VA+K I    +  E      +RE+ N   L 
Sbjct: 10  NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           H NIV   +V        +VMEY  G  L E I + G  S D A  F  Q++ G+ + H 
Sbjct: 70  HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRH 195
           M++ HRD+K +N L+D      LKI DFG +K  S    +Q    +GT  Y +PE     
Sbjct: 130 MRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVPDTNP- 249
             D    D++S G+ LY MLVG  PF   +       K  + ++  + +      D    
Sbjct: 188 ATDEC-TDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDSVPNVTT------DVRKD 239

Query: 250 ISQECRDLISRIFVADPAAR 269
           I Q   ++I R    D A R
Sbjct: 240 IPQSLSNVILRATEKDKANR 259

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  120 bits (304), Expect = 2e-31
 Identities = 68/344 (19%), Positives = 120/344 (34%), Gaps = 56/344 (16%)

Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ------------ 67
                Y   R I SG++G      D      VA+K +         V             
Sbjct: 19  AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 68  REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 121
           REI       HPNI+  +++ +         L +V E     +L + I       S    
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136

Query: 122 RFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 181
           ++F   ++ G+   H   V HRDL   N LL  +    + ICDF  ++     +     V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194

Query: 182 GTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-------------EP 227
               Y APE+++    +   + D+WS G  +  M      F                  P
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 228 KDFRKTIQRILS------VQYSVPDTNPI---------SQECRDLISRIFVADPAARITI 272
           K   + +    S      ++ S+ +                  DLI+++   +P  RI+ 
Sbjct: 254 KI--EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST 311

Query: 273 PEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 316
            + ++H  + ++L  D +D     S+    D+ +  V  + +I 
Sbjct: 312 EQALRHP-YFESL-FDPLDLTEGLSERFHFDESVTDVYDMHKIF 353

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  120 bits (303), Expect = 8e-31
 Identities = 82/341 (24%), Positives = 121/341 (35%), Gaps = 75/341 (21%)

Query: 20  HDSDRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH 78
           H + RY+ ++ IG G+FG V +   D    + VA+K +    +       EI   R L H
Sbjct: 94  HVAYRYEVLKVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEI---RILEH 149

Query: 79  ---------PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQ 127
                     N++   E      H+ +  E  S   L+E I       FS    R F   
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHS 208

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 186
           ++  +   H  ++ H DLK EN LL       +K+ DFG   SS    Q   T + +  Y
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFY 265

Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVG--------------------GYP------ 220
            APEV+L   Y   I D+WS G  L  +L G                    G P      
Sbjct: 266 RAPEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 221 --------FEDPDEPKDFRKTIQRILSVQYS-----------VPDTNPISQECR------ 255
                         P+    T     SV  +            P++       +      
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 256 --DLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKT 294
             D + +    DPA R+T  + ++H W  + LP     EKT
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKT 425

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  117 bits (296), Expect = 1e-30
 Identities = 70/280 (25%), Positives = 107/280 (38%), Gaps = 36/280 (12%)

Query: 11  GPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV---- 66
           G  M  P     DRY+    +G G      L RD      VAVK +      D +     
Sbjct: 1   GSHMTTPSHLS-DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRF 59

Query: 67  QREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 122
           +RE  N  +L HP IV      +          IVMEY  G  L + +   G  +   A 
Sbjct: 60  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 178
                    +++ H   + HRD+K  N ++  S    +K+ DFG     + S    +Q  
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL 238
           + +GT  Y++PE       D + +DV+S G  LY +L G  PF   D P          +
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTG-DSP----------V 225

Query: 239 SVQY--------SVPDTNP-ISQECRDLISRIFVADPAAR 269
           SV Y             +  +S +   ++ +    +P  R
Sbjct: 226 SVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  117 bits (295), Expect = 2e-30
 Identities = 61/257 (23%), Positives = 101/257 (39%), Gaps = 22/257 (8%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRHP 79
            Y   R +G G  G      D V + +VA+K +      D       QRE      L+ P
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           ++V   +       L + M   +G +L   +   G  +   A    +Q+ S +   HA  
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
             HRD+K EN L+  S      + DFG   + +    +Q  +TVGT  Y+APE       
Sbjct: 155 ATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-VQYSVP---DTNP-ISQ 252
             + AD+++    LY  L G  P++           +  + + +  ++P      P I  
Sbjct: 213 TYR-ADIYALTCVLYECLTGSPPYQG--------DQLSVMGAHINQAIPRPSTVRPGIPV 263

Query: 253 ECRDLISRIFVADPAAR 269
               +I+R    +P  R
Sbjct: 264 AFDAVIARGMAKNPEDR 280

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (303), Expect = 4e-30
 Identities = 53/258 (20%), Positives = 88/258 (34%), Gaps = 34/258 (13%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGDKIDENVQ----REIINHRSL 76
           + +Y+    I  G  G   L  D+ V    V +K +      D   Q     E      +
Sbjct: 79  AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEV 136

Query: 77  RHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            HP+IV+    +            IVMEY  G  L        +    EA  +  +++  
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPA 194

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           +SY H++ + + DLK EN +L      +LK+ D G        +      GTP + APE+
Sbjct: 195 LSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAPEI 248

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
           +          D+++ G TL  + +               +    +              
Sbjct: 249 VRTGPTVA--TDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVL-----------KTY 294

Query: 252 QECRDLISRIFVADPAAR 269
                L+ R    DP  R
Sbjct: 295 DSYGRLLRRAIDPDPRQR 312

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  115 bits (290), Expect = 1e-29
 Identities = 63/326 (19%), Positives = 108/326 (33%), Gaps = 57/326 (17%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D D    +  IG G +G   + +  + +  VAVK     ++ +   ++ I     + H N
Sbjct: 11  DLDNLKLLELIGRGRYG--AVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68

Query: 81  IVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           I RF     +          +VMEY   G L + + +        +      +  G++Y 
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYL 127

Query: 136 HAM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHSQP 177
           H            + HRDL   N L+         I DFG S               +  
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTGNRLVRPGEEDNAA 185

Query: 178 KSTVGTPAYIAPEVL------LRHEYDGKIADVWSCGVTLYVML-----------VGGY- 219
            S VGT  Y+APEVL         E   K  D+++ G+  + +            V  Y 
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245

Query: 220 -PFEDPDEPKDFRKTIQRILSVQY---SVPDTNPISQECRDLISRIFV----ADPAARIT 271
             F+         + +Q ++S +      P+    +      +          D  AR+T
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305

Query: 272 IPEIMKHQWFLKNLPADLVDEKTMSS 297
                +    +  L       K++S 
Sbjct: 306 AQXAEER---MAELMMIWERNKSVSP 328

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  115 bits (290), Expect = 2e-29
 Identities = 74/330 (22%), Positives = 121/330 (36%), Gaps = 75/330 (22%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLR- 77
             +Y+ V+ +G G +G+     D+ T E+VAVK I     +  D +   REI+    L  
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67

Query: 78  HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
           H NIV    V+       + +V +Y    +L   +  A        ++   QLI  + Y 
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYVVYQLIKVIKYL 125

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--------------- 180
           H+  + HRD+K  N LL+      +K+ DFG S+S V   +  +                
Sbjct: 126 HSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183

Query: 181 -------VGTPAYIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG--------------- 217
                  V T  Y APE+LL   +Y   I D+WS G  L  +L G               
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLER 242

Query: 218 -----GYPFED------------------PDEPKDFRKTIQRILSVQYSVPDTNP---IS 251
                 +P  +                                   +  +   NP    +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302

Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWF 281
           +E  DL+ ++   +P  RI+  + +KH + 
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFV 332

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  114 bits (287), Expect = 1e-28
 Identities = 74/345 (21%), Positives = 120/345 (34%), Gaps = 89/345 (25%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSLRH 78
            D Y     IG G++G   L  DK T++ VA+K + R   D ID + + REI     L+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 79  PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
             I+R  ++I+    L      IV+E A   +L +        +E+  +     L+ G +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-------- 185
           + H   + HRDLK  N LL+      +K+CDFG +++                       
Sbjct: 144 FIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 186 ---------------YIAPEVLL-RHEYDGKIADVWSCGVTLYVMLVG------------ 217
                          Y APE++L +  Y   I D+WS G     +L              
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTNRF 260

Query: 218 ------------GYPFEDPDEPKDFRKTIQRILSV------------------QY--SVP 245
                                 K  R  +  I ++                  +Y    P
Sbjct: 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320

Query: 246 DTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
              PI         S +  +L+  +   +P  RITI + + H + 
Sbjct: 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  112 bits (281), Expect = 1e-28
 Identities = 51/229 (22%), Positives = 90/229 (39%), Gaps = 28/229 (12%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
            S     +     G FG   + + ++  E VAVK     DK     + E+ +   ++H N
Sbjct: 22  QSMPLQLLEVKARGRFGC--VWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHEN 79

Query: 81  IVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           I++F    K        L ++  +   G L + +  A   S +E     + +  G++Y H
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLH 138

Query: 137 AMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGT 183
                        + HRD+K +N LL  +      I DFG +           T   VGT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEAGKSAGDTHGQVGT 196

Query: 184 PAYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP 227
             Y+APEVL      + +   +  D+++ G+ L+ +       + P + 
Sbjct: 197 RRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPVDE 244

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  113 bits (284), Expect = 2e-28
 Identities = 80/333 (24%), Positives = 116/333 (34%), Gaps = 74/333 (22%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--- 79
           DRY+    IG G+FG      D+V +E VA+K I+         Q E+     +      
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTE 113

Query: 80  ---NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
               IV  K   +   HL +V E  S   L++ + N      S +  R F QQ+ + + +
Sbjct: 114 MKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 135 CHA--MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEV 191
                + + H DLK EN LL       +KI DFG   SS    Q     + +  Y +PEV
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEV 229

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVG---------------------------------- 217
           LL   YD  I D+WS G  L  M  G                                  
Sbjct: 230 LLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

Query: 218 ----------GYPFEDPDEPK-----DFRKTIQRILSVQYSVPDTNPISQECR------- 255
                      +  +   + K        + +  IL V+   P      +          
Sbjct: 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLK 348

Query: 256 --DLISRIFVADPAARITIPEIMKHQWFLKNLP 286
             DLI R+   DP  RI     ++H +F K   
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFFKKTAD 381

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  111 bits (280), Expect = 4e-28
 Identities = 73/339 (21%), Positives = 114/339 (33%), Gaps = 70/339 (20%)

Query: 23  DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP-- 79
           +RY+ V ++G G FG V   +     K  VA+K I    K  E  + EI   + ++    
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDK 78

Query: 80  ----NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 133
                 V   +      H+ I  E   G   FE +       +     R    QL   + 
Sbjct: 79  ENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 134 YCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQ 176
           + H  Q+ H DLK EN L   S                     +++ DFG   S+    +
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHE 194

Query: 177 PKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG------------------ 217
             +T V T  Y  PEV+L   +     DVWS G  L+    G                  
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 253

Query: 218 --GYP-------------FED-----PDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             G               F        +   D R   +    ++  +   +    +  DL
Sbjct: 254 ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL 313

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMS 296
           + R+   DPA RIT+ E + H +F    P +     + +
Sbjct: 314 MRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  112 bits (282), Expect = 6e-28
 Identities = 75/355 (21%), Positives = 123/355 (34%), Gaps = 97/355 (27%)

Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER--GDKID-ENVQREIINHRSL 76
              DRY+    IG+G++G      DK+ K +VA+K I R   D ID + + REI     L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109

Query: 77  RHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            H ++V+  ++++         L +V+E A   +  +        +E   +     L+ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 185
           V Y H+  + HRDLK  N L++      +K+CDFG +++        S +          
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226

Query: 186 ----------------------YIAPEVLLR-HEYDGKIADVWSCG-------------- 208
                                 Y APE++L    Y   I DVWS G              
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLNMIKENV 285

Query: 209 -------------VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV--------------- 240
                            +        +     +  R  +  I ++               
Sbjct: 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345

Query: 241 ---QY--SVPDTNPI---------SQECRDLISRIFVADPAARITIPEIMKHQWF 281
              +Y    P              S +   L+ R+ V +P  RITI E + H +F
Sbjct: 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  108 bits (272), Expect = 5e-27
 Identities = 80/325 (24%), Positives = 118/325 (36%), Gaps = 72/325 (22%)

Query: 23  DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHR-- 74
            RY+ V  +G G FG V   +  K     VAVK ++  D+  E  + EI     +N    
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDP 73

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGV 132
           +      V+  E      H+ IV E   G   ++ I   G   F  D  R    Q+   V
Sbjct: 74  NSTF-RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHS 175
           ++ H+ ++ H DLK EN L   S                   P +K+ DFG   S+    
Sbjct: 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDD 188

Query: 176 QPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------------- 217
           +  ST V T  Y APEV+L   +     DVWS G  L    +G                 
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMME 247

Query: 218 ---GYP-------------FED-----PDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
              G               F        +     R   +    ++  +   +   +   D
Sbjct: 248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD 307

Query: 257 LISRIFVADPAARITIPEIMKHQWF 281
           LI ++   DPA RIT+ E +KH +F
Sbjct: 308 LIQKMLEYDPAKRITLREALKHPFF 332

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  108 bits (272), Expect = 6e-27
 Identities = 70/331 (21%), Positives = 120/331 (36%), Gaps = 78/331 (23%)

Query: 23  DRYDFVRDIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSL 76
           + +  +R +G G FG V    +    K+  AVK +    K   + + E      I +  +
Sbjct: 35  NAFLVIRKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDI 93

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 134
            + NIV++    +   H+ ++ E   G  L+E I       F  ++ + +  +++  ++Y
Sbjct: 94  NNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 135 CHAMQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSS 171
              M + H DLK EN LLD                             +K+ DFG    +
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CA 209

Query: 172 VLHSQPKST-VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG------------- 217
              S    + + T  Y APEV+L   +D    D+WS G  L  +  G             
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHL 268

Query: 218 -------GYP---------------FEDPDEPK----DFRKTIQRILSVQYSVPDTNPIS 251
                                    + + DE K    +   +I  I  V+  +P    I 
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328

Query: 252 QEC-RDLISRIFVADPAARITIPEIMKHQWF 281
            E   D +  I   DP  R +  E++KH++ 
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  100 bits (252), Expect = 1e-24
 Identities = 37/252 (14%), Positives = 67/252 (26%), Gaps = 36/252 (14%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
            RY  +   G           D      VA+ +++    + ++         +    +  
Sbjct: 31  GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P + R  +V+ T     +V E+  GG L E        S   A    Q L +     H  
Sbjct: 91  PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA 148

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            V           +  S    +                    +  PA +           
Sbjct: 149 GVALSIDHPSRVRV--SIDGDVV-------------------LAYPATMPDA-------- 179

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-ISQECRDL 257
               D+   G +LY +LV  +P  +           +          D +  I  +   +
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239

Query: 258 ISRIFVADPAAR 269
            +R    D   R
Sbjct: 240 AARSVQGDGGIR 251

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 99.3 bits (248), Expect = 5e-24
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
           F++ +G GNFG         ++D  T E+VAVK +    ++   + +REI   +SL+H N
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72

Query: 81  IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
           IV++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+ Y   
Sbjct: 73  IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
            +  HRDL   N L+  +   R+KI DFG +K  +   +    V  P        APE L
Sbjct: 133 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 193 LRHEYDGKIADVWSCGVTLY 212
              ++    +DVWS GV LY
Sbjct: 190 TESKFSVA-SDVWSFGVVLY 208

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 99.8 bits (249), Expect = 5e-24
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 19/200 (9%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
           F++ +G GNFG         ++D  T E+VAVK +    ++   + +REI   +SL+H N
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103

Query: 81  IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
           IV++K V  +     L ++MEY   G L + +  +  R    +   +  Q+  G+ Y   
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
            +  HRDL   N L+  +   R+KI DFG +K  +   +    V  P        APE L
Sbjct: 164 KRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 193 LRHEYDGKIADVWSCGVTLY 212
              ++    +DVWS GV LY
Sbjct: 221 TESKFSVA-SDVWSFGVVLY 239

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  100 bits (250), Expect = 8e-24
 Identities = 57/206 (27%), Positives = 78/206 (37%), Gaps = 14/206 (6%)

Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ--REIINHRSLRHPNIVRF 84
               IG GNFG     R +    LVAVK        D   +  +E    +   HPNIVR 
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 85  KEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
             V      + IVME   GG+    +     R              +G+ Y  +    HR
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHR 237

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLRHEYD 198
           DL   N L+       LKI DFG S+         +  G    +     APE L    Y 
Sbjct: 238 DLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293

Query: 199 GKIADVWSCGVTLY-VMLVGGYPFED 223
            + +DVWS G+ L+    +G  P+ +
Sbjct: 294 SE-SDVWSFGILLWETFSLGASPYPN 318

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 20/230 (8%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-ERGDKIDENVQREIINHRSLRHPN 80
           ++  +G GNFG         + D  T  LVAVK +   G     + QREI   ++L    
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDN-TGALVAVKQLQHSGPDQQRDFQREIQILKALHSDF 85

Query: 81  IVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
           IV+++ V   P    L +VMEY   G L + +  +  R        +  Q+  G+ Y  +
Sbjct: 86  IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVL 192
            +  HRDL   N L+  S A  +KI DFG +K  +   +    V  P        APE L
Sbjct: 146 RRCVHRDLAARNILV-ESEA-HVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 193 LRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQRILSVQ 241
             + +  + +DVWS GV LY +            E        + + ++ 
Sbjct: 203 SDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 96.5 bits (241), Expect = 5e-23
 Identities = 55/212 (25%), Positives = 82/212 (38%), Gaps = 21/212 (9%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHP 79
            +  +G G+FGV               VAVK ++           + I       SL H 
Sbjct: 22  LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 81

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAM 138
           N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q+  G+ Y  + 
Sbjct: 82  NLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 140

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVL 192
           +  HRDL   N LL  +    +KI DFG  +   L                    APE L
Sbjct: 141 RFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWCAPESL 196

Query: 193 LRHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
               +    +D W  GVTL+ +   G  P+  
Sbjct: 197 KTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 22/202 (10%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHP 79
            +RD+G G+FG           D  T E VAVK +  E G     ++++EI   R+L H 
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDN-TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83

Query: 80  NIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCH 136
           NIV++K +        + ++ME+   G L E +  N  + +  +   +  Q+  G+ Y  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYI-----APE 190
           + Q  HRDL   N L+  S   ++KI DFG +K   + +  +  TV           APE
Sbjct: 144 SRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 191 VLLRHEYDGKIADVWSCGVTLY 212
            L++ ++    +DVWS GVTL+
Sbjct: 200 CLMQSKFYIA-SDVWSFGVTLH 220

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 96.5 bits (240), Expect = 2e-22
 Identities = 66/363 (18%), Positives = 112/363 (30%), Gaps = 108/363 (29%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-----INHRSLR 77
            RY  +R +G G+F    L  D   K+ VA+K ++  +   E    EI     + +    
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96

Query: 78  HPN---IVR----FKEVILTPTHLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQL 128
            PN   +V+    FK   +  TH+ +V E       +   +  N         +   QQ+
Sbjct: 97  DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQV 155

Query: 129 ISGVSYCHA-MQVCHRDLKLENTLLD---------------------------------- 153
           + G+ Y H   ++ H D+K EN LL                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 154 -------------GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
                         +   ++KI D G   +  +H      + T  Y + EVL+   Y+  
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273

Query: 201 IADVWSCGVTLYVMLVGGYPFE--DPDEPKDFRKTIQRILSV----------------QY 242
            AD+WS     + +  G Y FE    +E       I  I+ +                ++
Sbjct: 274 -ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 243 SVPDTNPIS------------------------QECRDLISRIFVADPAARITIPEIMKH 278
                +                               D +  +    P  R T  E ++H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392

Query: 279 QWF 281
            W 
Sbjct: 393 PWL 395

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 93.9 bits (234), Expect = 6e-22
 Identities = 63/199 (31%), Positives = 93/199 (46%), Gaps = 18/199 (9%)

Query: 27  FVRDIGSGNFGVARL----MRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
            +RD+G G+FG   L      +  T E+VAVK +  + G +     ++EI   R+L H +
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94

Query: 81  IVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           I+++K          L +VMEY   G L + +         +   F QQ+  G++Y HA 
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLL 193
              HRDL   N LL  +    +KI DFG +K +V        V           APE L 
Sbjct: 154 HYIHRDLAARNVLL-DNDR-LVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLK 210

Query: 194 RHEYDGKIADVWSCGVTLY 212
            +++    +DVWS GVTLY
Sbjct: 211 EYKFYYA-SDVWSFGVTLY 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 94.5 bits (235), Expect = 2e-21
 Identities = 49/208 (23%), Positives = 82/208 (39%), Gaps = 8/208 (3%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           +         +G G +G       K     VAVK ++      E   +E    + ++HPN
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 277

Query: 81  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           +V+   V        I+ E+ + G L  + R CN    S     +   Q+ S + Y    
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
              HR+L   N L+  +    +K+ DFG S+     +              APE L  ++
Sbjct: 338 NFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +  K +DVW+ GV L+ +   G  P+  
Sbjct: 396 FSIK-SDVWAFGVLLWEIATYGMSPYPG 422

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 50/210 (23%), Positives = 95/210 (45%), Gaps = 19/210 (9%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERGDKIDENVQREIINH----RSLRH 78
            ++ +GSG FG       + +    ++ VA+K +           +EI++      S+ +
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDN 76

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHA 137
           P++ R   + LT T + ++ +    G L + +  +           +  Q+  G++Y   
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLR 194
            ++ HRDL   N L+  +P   +KI DFG +K      +     G   P  ++A E +L 
Sbjct: 136 RRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
             Y  + +DVWS GVT++ +M  G  P++ 
Sbjct: 194 RIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 10/203 (4%)

Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
               +G G +G       K     VAVK ++      E   +E    + ++HPN+V+   
Sbjct: 17  MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76

Query: 87  VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           V        I+ E+ + G L  + R CN    S     +   Q+ S + Y       HRD
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 136

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHEYDGKI 201
           L   N L+  +    +K+ DFG S+  +      +  G   P  + APE L  +++  K 
Sbjct: 137 LAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK- 192

Query: 202 ADVWSCGVTLY-VMLVGGYPFED 223
           +DVW+ GV L+ +   G  P+  
Sbjct: 193 SDVWAFGVLLWEIATYGMSPYPG 215

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 10/208 (4%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
             +       +G G FG   +     T   VA+K ++ G    E   +E    + LRH  
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 240

Query: 81  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           +V+   V+ +   + IV EY S G L  F +          +      Q+ SG++Y   M
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
              HRDL+  N L+  +     K+ DFG ++    +               APE  L   
Sbjct: 300 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +  K +DVWS G+ L  +   G  P+  
Sbjct: 358 FTIK-SDVWSFGILLTELTTKGRVPYPG 384

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 88.4 bits (220), Expect = 3e-20
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)

Query: 27  FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           FV++IGSG FG+       +K     VA+K I  G   +E+   E      L HP +V+ 
Sbjct: 12  FVQEIGSGQFGLVHLGYWLNKDK---VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQL 68

Query: 85  KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             V L    + +V E+   G L  + R    G F+ +        +  G++Y     V H
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
           RDL   N L+  +    +K+ DFG ++  VL  Q  S+ GT   +   +PEV     Y  
Sbjct: 128 RDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
           K +DVWS GV ++ V   G  P+E+
Sbjct: 185 K-SDVWSFGVLMWEVFSEGKIPYEN 208

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 10/208 (4%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
             +       +G G FG   +     T   VA+K ++ G    E   +E    + LRH  
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 323

Query: 81  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           +V+   V+ +   + IV EY S G L  F +          +      Q+ SG++Y   M
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAPEVLLRHE 196
              HRDL+  N L+  +     K+ DFG ++    +               APE  L   
Sbjct: 383 NYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +  K +DVWS G+ L  +   G  P+  
Sbjct: 441 FTIK-SDVWSFGILLTELTTKGRVPYPG 467

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 88.1 bits (219), Expect = 7e-20
 Identities = 57/209 (27%), Positives = 90/209 (43%), Gaps = 16/209 (7%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
             + IGSG+ G     RL         VA+K ++ G  ++   +   E        HPNI
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 82  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +R + V+       IV EY   G L  F R  + G+F+  +     + + +G+ Y   + 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLRH 195
             HRDL   N L+D +     K+ DFG S+          +T G    I   APE +   
Sbjct: 172 YVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
            +    +DVWS GV ++ V+  G  P+ +
Sbjct: 230 TFSSA-SDVWSFGVVMWEVLAYGERPYWN 257

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 87.3 bits (217), Expect = 8e-20
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 29  RDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRHPNI 81
           +++GSGNFG          KV K  VAVK + + +  D  ++ E++      + L +P I
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKT-VAVKIL-KNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
           VR   +    + + +VME A  G L + +       +        Q+  G+ Y       
Sbjct: 81  VRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 139

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRH 195
           HRDL   N LL  +     KI DFG SK   L +     K+      P  + APE +  +
Sbjct: 140 HRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYAPECINYY 195

Query: 196 EYDGKIADVWSCGVTLY-VMLVGGYPFED 223
           ++  K +DVWS GV ++     G  P+  
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 56/204 (27%), Positives = 81/204 (39%), Gaps = 18/204 (8%)

Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
            ++ IG G FG   L   +  K  VAVK I + D   +    E      LRH N+V+   
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 87  VILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHR 143
           VI+     L IV EY + G L  + R         D    F   +   + Y       HR
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313

Query: 144 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGK 200
           DL   N L+        K+ DFG +K +       +       +   APE L   ++  K
Sbjct: 314 DLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALREKKFSTK 366

Query: 201 IADVWSCGVTLY-VMLVGGYPFED 223
            +DVWS G+ L+ +   G  P+  
Sbjct: 367 -SDVWSFGILLWEIYSFGRVPYPR 389

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 50/208 (24%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
            ++ +GSG FG       + +    ++ VA+K +      K ++ +  E     S+ +P+
Sbjct: 19  KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           + R   + LT T + ++ +    G L + +  +           +  Q+  G++Y    +
Sbjct: 79  VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPEVLLRHE 196
           + HRDL   N L+  +P   +KI DFG +K      +     G   P  ++A E +L   
Sbjct: 138 LVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           Y  + +DVWS GVT++ +M  G  P++ 
Sbjct: 196 YTHQ-SDVWSYGVTVWELMTFGSKPYDG 222

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 85.3 bits (212), Expect = 3e-19
 Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 27  FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
            ++++GSG FGV +    + +     VAVK I+ G   ++   +E      L HP +V+F
Sbjct: 12  LLKELGSGQFGVVKLGKWKGQYD---VAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKF 68

Query: 85  KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             V      + IV EY S G L  + R  +       +       +  G+++  + Q  H
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
           RDL   N L+D      +K+ DFG ++  VL  Q  S+VGT   +   APEV    +Y  
Sbjct: 128 RDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184

Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
           K +DVW+ G+ ++ V  +G  P++ 
Sbjct: 185 K-SDVWAFGILMWEVFSLGKMPYDL 208

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 12/203 (5%)

Query: 27  FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE 86
             + +G+G FG   +       + VAVK ++ G    E    E    ++L+H  +V+   
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 87  VILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
           V+ T   + I+ E+ + G L  F +     +    +   F  Q+  G+++       HRD
Sbjct: 251 VV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDGKI 201
           L+  N L+  S     KI DFG ++  +  ++  +  G    I   APE +    +  K 
Sbjct: 310 LRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK- 365

Query: 202 ADVWSCGVTLY-VMLVGGYPFED 223
           +DVWS G+ L  ++  G  P+  
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPG 388

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
             + +G+G FG     RL      +  VA+K ++ G  +K   +   E        HPNI
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 82  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +R + V+     + IV EY   G L  F R  +  +F+  +     + + SG+ Y   M 
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLL 193
             HRDL   N L++ +     K+ DFG  +  VL   P    +T G    I   +PE + 
Sbjct: 168 YVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 194 RHEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
             ++    +DVWS G+ L+ VM  G  P+ +
Sbjct: 224 YRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 87.7 bits (217), Expect = 4e-19
 Identities = 55/206 (26%), Positives = 84/206 (40%), Gaps = 20/206 (9%)

Query: 31  IGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFK 85
           +G GNFG          K   + VA+K +++G      E + RE      L +P IVR  
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQID-VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 86  EVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
            V      + +VME A GG L + +                 Q+  G+ Y       HR+
Sbjct: 403 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI---APEVLLRHEYD 198
           L   N LL  +     KI DFG SK   L +      +       +   APE +   ++ 
Sbjct: 462 LAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 199 GKIADVWSCGVTLY-VMLVGGYPFED 223
            + +DVWS GVT++  +  G  P++ 
Sbjct: 518 SR-SDVWSYGVTMWEALSYGQKPYKK 542

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.8 bits (213), Expect = 5e-19
 Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 19/210 (9%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
            ++ +GSG FG       + +  + ++ V +K I  + G +  + V   ++   SL H +
Sbjct: 17  KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           IVR   +    + L +V +Y   G L + +  + G         +  Q+  G+ Y     
Sbjct: 77  IVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG 135

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-----APEVLLR 194
           + HR+L   N LL  SP+ ++++ DFG +   +L    K  + + A       A E +  
Sbjct: 136 MVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWMALESIHF 191

Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
            +Y  + +DVWS GVT++ +M  G  P+  
Sbjct: 192 GKYTHQ-SDVWSYGVTVWELMTFGAEPYAG 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 85.0 bits (211), Expect = 5e-19
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 18/205 (8%)

Query: 31  IGSGNFG-VAR-LMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKE 86
           +G GNFG V + + R +  +  VA+K +++G      E + RE      L +P IVR   
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 87  VILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDL 145
           V      + +VME A GG L + +                 Q+  G+ Y       HRDL
Sbjct: 78  VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 136

Query: 146 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIAPEVLLRHEYDG 199
              N LL  +     KI DFG SK   L +      +      P  + APE +   ++  
Sbjct: 137 AARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
           + +DVWS GVT++  +  G  P++ 
Sbjct: 193 R-SDVWSYGVTMWEALSYGQKPYKK 216

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 16/205 (7%)

Query: 27  FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
            V  +G+G FG               VAVK +++G    +    E    + L+H  +VR 
Sbjct: 17  LVERLGAGQFGEVWMGYYNGHTK---VAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 85  KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             V+ T   + I+ EY   G L  F +  +  + + ++      Q+  G+++       H
Sbjct: 74  YAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
           RDL+  N L+  + +   KI DFG ++  +  ++  +  G    I   APE +    +  
Sbjct: 133 RDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
           K +DVWS G+ L  ++  G  P+  
Sbjct: 190 K-SDVWSFGILLTEIVTHGRIPYPG 213

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.0 bits (211), Expect = 6e-19
 Identities = 57/210 (27%), Positives = 83/210 (39%), Gaps = 18/210 (8%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           +      ++ IG G FG   L   +  K  VAVK I + D   +    E      LRH N
Sbjct: 19  NMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI-KNDATAQAFLAEASVMTQLRHSN 75

Query: 81  IVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           +V+   VI+     L IV EY + G L  + R         D    F   +   + Y   
Sbjct: 76  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLR 194
               HRDL   N L+  S     K+ DFG +K +       +       +   APE L  
Sbjct: 136 NNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPEALRE 188

Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
            ++  K +DVWS G+ L+ +   G  P+  
Sbjct: 189 KKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 27  FVRDIGSGNFGVAR--LMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRF 84
           F++++G+G FGV +    R +     VA+K I+ G   ++    E     +L H  +V+ 
Sbjct: 28  FLKELGTGQFGVVKYGKWRGQYD---VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQL 84

Query: 85  KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 142
             V      + I+ EY + G L  + R     RF   +     + +   + Y  + Q  H
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143

Query: 143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEYDG 199
           RDL   N L++      +K+ DFG S+  VL  +  S+VG+   +    PEVL+  ++  
Sbjct: 144 RDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 200 KIADVWSCGVTLY-VMLVGGYPFED 223
           K +D+W+ GV ++ +  +G  P+E 
Sbjct: 201 K-SDIWAFGVLMWEIYSLGKMPYER 224

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 17/210 (8%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKEL-VAVKYIERG--DKIDENVQREIINHRSLRHPN 80
             + IG+G FG      L      KE+ VA+K ++ G  +K   +   E        H N
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 81  IVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           I+R + VI     + I+ EY   G L  F R    G FS  +     + + +G+ Y   M
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---APEVLLR 194
              HRDL   N L++ +     K+ DFG S+      +   +T G    I   APE +  
Sbjct: 167 NYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 195 HEYDGKIADVWSCGVTLY-VMLVGGYPFED 223
            ++    +DVWS G+ ++ VM  G  P+ +
Sbjct: 225 RKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 81.9 bits (203), Expect = 7e-18
 Identities = 49/207 (23%), Positives = 81/207 (39%), Gaps = 15/207 (7%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
             R +G G FG          K  K  VAVK  ++       E    E +  ++L HP+I
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           V+   +I       I+ME    GEL   +  N           +  Q+   ++Y  ++  
Sbjct: 76  VKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC 134

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEVLLRHEY 197
            HRD+ + N L+       +K+ DFG S+  +          T   I   +PE +    +
Sbjct: 135 VHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 198 DGKIADVWSCGVTLY-VMLVGGYPFED 223
               +DVW   V ++ ++  G  PF  
Sbjct: 192 TTA-SDVWMFAVCMWEILSFGKQPFFW 217

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 17/208 (8%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
             R IG G FG       M  +     VA+K  +    D + E   +E +  R   HP+I
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78

Query: 82  VRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           V+   VI       I+ME  + GEL  F +              +  QL + ++Y  + +
Sbjct: 79  VKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESKR 136

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAPEVLLRHE 196
             HRD+   N L+  +    +K+ DFG S+  +  S          P  ++APE +    
Sbjct: 137 FVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRR 193

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 194 FTSA-SDVWMFGVCMWEILMHGVKPFQG 220

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 52/216 (24%), Positives = 79/216 (36%), Gaps = 24/216 (11%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
            +R +G G FG         M +  +   VAVK +       + +    E +      H 
Sbjct: 34  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
           NIVR   V L      I+ME  +GG+L   +          +      L+        G 
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI---- 187
            Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +    
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAMLPVKW 211

Query: 188 -APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             PE  +   +  K  D WS GV L+ +  +G  P+
Sbjct: 212 MPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 83.0 bits (205), Expect = 2e-17
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 17/208 (8%)

Query: 27  FVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHPNI 81
             R IG G FG       M  +     VA+K  +    D + E   +E +  R   HP+I
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           V+   VI       I+ME  + GEL   +              +  QL + ++Y  + + 
Sbjct: 454 VKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAPEVLLRHE 196
            HRD+   N L+  +    +K+ DFG S+   +      K++ G  P  ++APE +    
Sbjct: 513 VHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAPESINFRR 568

Query: 197 YDGKIADVWSCGVTLY-VMLVGGYPFED 223
           +    +DVW  GV ++ +++ G  PF+ 
Sbjct: 569 FTSA-SDVWMFGVCMWEILMHGVKPFQG 595

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 50/228 (21%), Positives = 90/228 (39%), Gaps = 35/228 (15%)

Query: 21  DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
              ++   R +G G FG    A+L ++  +   VAVK ++       +++   RE    +
Sbjct: 21  PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80

Query: 75  SLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
              HP++ +                  +++ +   G+L  F     A R  E+      Q
Sbjct: 81  EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPLQ 137

Query: 127 QLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
            L+        G+ Y  +    HRDL   N +L       + + DFG S+   ++S    
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDYY 193

Query: 180 TVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             G  + +     A E L  + Y    +DVW+ GVT++ +M  G  P+
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPY 240

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 51/216 (23%), Positives = 79/216 (36%), Gaps = 24/216 (11%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
            +R +G G FG         M +  +   VAVK +       + +    E +      H 
Sbjct: 75  LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------SGV 132
           NIVR   V L      I++E  +GG+L   +          +      L+        G 
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI---- 187
            Y       HRD+   N LL      R+ KI DFG ++   ++       G  A +    
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAMLPVKW 252

Query: 188 -APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             PE  +   +  K  D WS GV L+ +  +G  P+
Sbjct: 253 MPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 79.6 bits (197), Expect = 5e-17
 Identities = 58/223 (26%), Positives = 92/223 (41%), Gaps = 33/223 (14%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
             R++G G FG         +     K LVAVK ++          QRE     +L+H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQQLI-- 129
           IV+F  V      L +V EY   G+L +          I   G+  + +      Q++  
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 130 -----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
                SG+ Y  +    HRDL   N L+       +KI DFG S+   ++S     VG  
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYYRVGGH 194

Query: 185 AYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             +      PE ++  ++  + +DVWS GV L+ +   G  P+
Sbjct: 195 TMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 236

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 79.2 bits (196), Expect = 7e-17
 Identities = 50/227 (22%), Positives = 84/227 (37%), Gaps = 34/227 (14%)

Query: 21  DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHR 74
           D +     + +G G FG      L ++  T   VAVK ++  +     ++    E    +
Sbjct: 32  DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91

Query: 75  SLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQ 127
              HPN++R      +          +++ +   G+L  +       R          Q 
Sbjct: 92  DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQT 148

Query: 128 LI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
           L+        G+ Y       HRDL   N +L       + + DFG SK   ++S     
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYYR 204

Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            G  A +     A E L    Y  K +DVW+ GVT++ +   G  P+
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPY 250

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 78.5 bits (194), Expect = 1e-16
 Identities = 37/218 (16%), Positives = 74/218 (33%), Gaps = 29/218 (13%)

Query: 27  FVRDIGSGNFGV-------ARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRH 78
           F   +G G F               ++ +  V +K +++      E+          L H
Sbjct: 12  FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYCH 136
            ++V    V +      +V E+   G L  + +  N    +        +QL + + +  
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 137 AMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYIAPE 190
              + H ++  +N LL      +       K+ D G S + +     +  +    ++ PE
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWVPPE 187

Query: 191 VLLRHEYDGKI----ADVWSCGVTLY-VMLVGGYPFED 223
            +     + K      D WS G TL+ +   G  P   
Sbjct: 188 CIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 78.1 bits (193), Expect = 1e-16
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 20/222 (9%)

Query: 15  DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
            + I   S    F   IG G+FG      L+ +   K   AVK + R   I E  Q   E
Sbjct: 17  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 76

Query: 70  IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
            I  +   HPN++    + L       +V+ Y   G+L  F R       +  +   F  
Sbjct: 77  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 135

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA- 185
           Q+  G+ Y  + +  HRDL   N +LD      +K+ DFG ++  +   +  S       
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLAR-DMYDKEYYSVHNKTGA 192

Query: 186 -----YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
                ++A E L   ++  K +DVWS GV L+ +M  G  P+
Sbjct: 193 KLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 59/222 (26%), Positives = 88/222 (39%), Gaps = 32/222 (14%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDEN-VQREIINHRSLRHPN 80
              ++G G FG         +  +  K LVAVK ++   +      QRE      L+H +
Sbjct: 45  LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH 104

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQLI--- 129
           IVRF  V      L +V EY   G+L              AG            QL+   
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 130 ----SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
               +G+ Y   +   HRDL   N L+       +KI DFG S+   ++S     VG   
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYRVGGRT 220

Query: 186 YI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            +      PE +L  ++  + +DVWS GV L+ +   G  P+
Sbjct: 221 MLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 77.1 bits (190), Expect = 7e-16
 Identities = 59/221 (26%), Positives = 90/221 (40%), Gaps = 18/221 (8%)

Query: 15  DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
            + I   S    F   IG G+FG      L+ +   K   AVK + R   I E  Q   E
Sbjct: 81  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 140

Query: 70  IINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 126
            I  +   HPN++    + L       +V+ Y   G+L  F R       +  +   F  
Sbjct: 141 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGL 199

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 186
           Q+  G+ +  + +  HRDL   N +LD      +K+ DFG ++             T A 
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAK 257

Query: 187 I-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           +     A E L   ++  K +DVWS GV L+ +M  G  P+
Sbjct: 258 LPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 45/218 (20%), Positives = 87/218 (39%), Gaps = 28/218 (12%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERGDKIDENV--QREIINHRSLRHP 79
             R++G G+FG     VA+ +     +  VA+K +     + E +    E    +     
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFFQQLI 129
           ++VR   V+       ++ME  + G+L  + R       +                 ++ 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-- 187
            G++Y +A +  HRDL   N ++  +    +KI DFG ++   ++       G    +  
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPV 204

Query: 188 ---APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
              +PE L    +    +DVWS GV L+ +  +   P+
Sbjct: 205 RWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPY 241

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 34/224 (15%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
           F+ ++G   FG                + VA+K ++      + E  + E +    L+HP
Sbjct: 13  FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQLI- 129
           N+V    V+     L+++  Y S G+L            + +       ++       + 
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 130 ------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
                 +G+ Y  +  V H+DL   N L+       +KI D G  +   +++     +  
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYYKLLG 188

Query: 184 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
            + +     APE ++  ++    +D+WS GV L+ V   G  P+
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 20/222 (9%)

Query: 15  DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDENVQ--RE 69
           D+ I H+       R IG G+FGV      +     +   A+K + R  ++ +     RE
Sbjct: 13  DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLRE 72

Query: 70  IINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 125
            +  R L HPN++    ++L        +++ Y   G+L  F R       +  +   F 
Sbjct: 73  GLLMRGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFG 130

Query: 126 QQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 182
            Q+  G+ Y    +  HRDL   N +LD S    +K+ DFG ++       +S  +    
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHA 188

Query: 183 T-PA-YIAPEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
             P  + A E L  + +  K +DVWS GV L+ ++  G  P+
Sbjct: 189 RLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPY 229

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.8 bits (182), Expect = 6e-15
 Identities = 54/231 (23%), Positives = 84/231 (36%), Gaps = 47/231 (20%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
           F + +G+G FG      A  +        VAVK +       ER   + E  V   +   
Sbjct: 27  FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL--- 83

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSEDEAR 122
               H NIV             ++ EY   G+L                +     +DE  
Sbjct: 84  --GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
              + L+S       G+++  +    HRDL   N LL        KICDFG ++   + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKN 197

Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
                V   A +     APE +    Y  + +DVWS G+ L+ +  +G  P
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 22/213 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
           +++   R IGSG+FG   L  +  T E VA+K  E        +  E   +R L+    I
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKHPQLLYESKIYRILQGGTGI 65

Query: 82  VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
              +   +   +  +VM+    S  +LF   C+  + S         Q+I+ V + H+  
Sbjct: 66  PNVRWFGVEGDYNVLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKS 123

Query: 140 VCHRDLKLENTLLD-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 190
             HRD+K +N L+  G  A ++ I DFG +K     S+  H    + K+  GT  Y +  
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVN 183

Query: 191 VLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
             L  E    D    D+ S G  L   L G  P
Sbjct: 184 THLGIEQSRRD----DLESLGYVLMYFLRGSLP 212

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 60/233 (25%), Positives = 89/233 (38%), Gaps = 47/233 (20%)

Query: 21  DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
           D +   F   IG GNFG    AR+ +D +  +  A+K +       +  D   E  V  +
Sbjct: 23  DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCK 81

Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 120
           +       HPNI+          +L + +EYA  G L          E        +   
Sbjct: 82  L-----GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136

Query: 121 ARFFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
           +    QQL+        G+ Y    Q  HRDL   N L+  +     KI DFG S+   +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEV 194

Query: 174 HSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
           +        T   +     A E L    Y    +DVWS GV L+ ++ +GG P
Sbjct: 195 Y-----VKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 48/215 (22%), Positives = 83/215 (38%), Gaps = 24/215 (11%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
             Y   R IG G+FGV     + +  + VA+K+ E        ++ E   ++ L     I
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDAPQLRDEYRTYKLLAGCTGI 68

Query: 82  VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
                      H  +V++    S  +L   +C   +FS        +Q+++ V   H   
Sbjct: 69  PNVYYFGQEGLHNVLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 140 VCHRDLKLENTLL---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIA 188
           + +RD+K +N L+   +   A  + + DFG  K      +  H    + K+  GT  Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186

Query: 189 PEVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
               L  E    D    D+ + G      L G  P
Sbjct: 187 INTHLGREQSRRD----DLEALGHVFMYFLRGSLP 217

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 54/232 (23%), Positives = 89/232 (38%), Gaps = 42/232 (18%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
           +VRDIG G FG      A  +       +VAVK ++      +  + QRE        +P
Sbjct: 51  YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
           NIV+   V      + ++ EY + G+L                  +    A   S     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 123 FFFQQLI-------SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
               + +       +G++Y    +  HRDL   N L+       +KI DFG S++  ++S
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN--IYS 226

Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
                      I      PE +  + Y  + +DVW+ GV L+ +   G  P+
Sbjct: 227 ADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.5 bits (173), Expect = 7e-14
 Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 24/214 (11%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIV 82
            +   + IG GNFG  RL ++  T E VA+K +E        +  E   ++ L     I 
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 83  RFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +         + A+V+E    S  +LF  +C+   FS         QLIS + Y H+  +
Sbjct: 69  QVYYFGPCGKYNAMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 141 CHRDLKLENTLLDGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAP 189
            +RD+K EN L+        ++    DF  +K      +  H    + KS  GT  Y++ 
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186

Query: 190 EVLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
              L  E    D    D+ + G      L G  P
Sbjct: 187 NTHLGKEQSRRD----DLEALGHMFMYFLRGSLP 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 70.1 bits (172), Expect = 9e-14
 Identities = 58/213 (27%), Positives = 86/213 (40%), Gaps = 22/213 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
           +RY   R IGSG+FG   L  D    E VA+K  E        +  E   ++ ++    I
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKHPQLHIESKIYKMMQGGVGI 67

Query: 82  VRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
              +       +  +VME    S  +LF   C+  +FS         Q+IS + Y H+  
Sbjct: 68  PTIRWCGAEGDYNVMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKN 125

Query: 140 VCHRDLKLENTLL-DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPE 190
             HRD+K +N L+  G     + I DFG +K      +  H    + K+  GT  Y +  
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 185

Query: 191 VLLRHEY---DGKIADVWSCGVTLYVMLVGGYP 220
             L  E    D    D+ S G  L    +G  P
Sbjct: 186 THLGIEQSRRD----DLESLGYVLMYFNLGSLP 214

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 48/231 (20%), Positives = 86/231 (37%), Gaps = 43/231 (18%)

Query: 23  DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVK-------YIERGDKIDE-NVQRE 69
           +   F + +G+G FG      A  +  +     VAVK         E+   + E  +   
Sbjct: 46  NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105

Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEAR 122
           +      +H NIV           + ++ EY   G+L          +     F+   + 
Sbjct: 106 L-----GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
              + L+        G+++  +    HRD+   N LL  +     KI DFG ++   + +
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMN 216

Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
                V   A +     APE +    Y  + +DVWS G+ L+ +  +G  P
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNP 266

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 69.6 bits (171), Expect = 1e-13
 Identities = 54/232 (23%), Positives = 91/232 (39%), Gaps = 42/232 (18%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
             + +G G FG      A  ++ +     VAVK ++         ++  E    + + HP
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSEDEAR 122
           ++++          L +++EYA  G L                      ++     DE  
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 123 FFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 175
                LIS       G+ Y   M++ HRDL   N L+       +KI DFG S+   ++ 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD--VYE 202

Query: 176 QPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           +      +   I     A E L  H Y  + +DVWS GV L+ ++ +GG P+
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 68.5 bits (168), Expect = 5e-13
 Identities = 65/300 (21%), Positives = 114/300 (38%), Gaps = 49/300 (16%)

Query: 27  FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
             + +G G FG         + +DK  + + VAVK ++      +      E+   + + 
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
           +H NI+           L +++EYAS G L              +       E +  F+ 
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
           L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++   +++     
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYK 260

Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGG--YPFEDPDEPKDFRK 232
             T   +     APE L    Y  + +DVWS GV ++ +  +GG  YP    +E     K
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319

Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
              R+       P       E   ++   + A P+ R T  ++      L  +     +E
Sbjct: 320 EGHRM-----DKPANCT--NELYMMMRDCWHAVPSQRPTFKQL---VEDLDRILTLTTNE 369

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 68.1 bits (167), Expect = 6e-13
 Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 37/226 (16%)

Query: 27  FVRDIGSGNFG------VARLMRDKVTKEL-VAVKYIERGDKIDENV--QREIINHRSL- 76
             + +G G FG         + +DK  + + VAVK ++      +      E+   + + 
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 77  RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 127
           +H NI+           L +++EYAS G L              +       E +  F+ 
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 128 LIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 180
           L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++   +++     
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYK 214

Query: 181 VGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
             T   +     APE L    Y  + +DVWS GV ++ +  +GG P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 67.7 bits (166), Expect = 7e-13
 Identities = 54/235 (22%), Positives = 84/235 (35%), Gaps = 46/235 (19%)

Query: 23  DRYDFVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
           DR    + +G G FG      A  +    T   VAVK +       E    + E  +   
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86

Query: 70  IINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGEL---------FERICNAGRFSED 119
           I       H N+V        P   L +++E+   G L                      
Sbjct: 87  I-----GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141

Query: 120 EARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 172
           +     + LI        G+ +  + +  HRDL   N LL       +KICDFG ++   
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLAR--D 197

Query: 173 LHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPF 221
           ++  P       A +     APE +    Y  + +DVWS GV L+ +  +G  P+
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 58/233 (24%), Positives = 92/233 (39%), Gaps = 51/233 (21%)

Query: 27  FVRDIGSGNFG---------VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQRE 69
             + +G G FG         + +   ++VTK  VAVK +       +  D I E  + + 
Sbjct: 73  LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKM 130

Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDE 120
           I      +H NI+           L +++EYAS G L              +       E
Sbjct: 131 IG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 121 ARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 173
            +   + L+S       G+ Y  + +  HRDL   N L+  +    +KI DFG ++   +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DI 241

Query: 174 HSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
           H        T   +     APE L    Y  + +DVWS GV L+ +  +GG P
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSP 293

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 56/236 (23%), Positives = 83/236 (35%), Gaps = 52/236 (22%)

Query: 27  FVRDIGSGNFG-----VARLMRDKVTKELVAVKYI-------ERGDKIDE-NVQREIINH 73
           F + +GSG FG      A  +        VAVK +       ER   + E  +  ++   
Sbjct: 49  FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL--- 105

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNAGRFS 117
               H NIV           + ++ EY   G+L                           
Sbjct: 106 --GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163

Query: 118 EDEARFFFQQLIS-------GVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
           ED     F+ L+        G+ +       HRDL   N L+       +KICDFG ++ 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD 221

Query: 171 SVLHSQPKSTVGTPAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYP 220
             + S     V   A +     APE L    Y  K +DVWS G+ L+ +  +G  P
Sbjct: 222 --IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.0 bits (152), Expect = 3e-11
 Identities = 37/196 (18%), Positives = 57/196 (29%), Gaps = 52/196 (26%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN---------VQREIIN 72
           +++      IG G FG             VA+K I        N         +  EII 
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 73  HRSL---------RHPNIVRFKEVIL------------------------------TPTH 93
            + L         R    +    V                                    
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 94  LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLL 152
           L IV+E+  GG   E++      S   A+    QL + ++    +++  HRDL   N LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 153 DGSPAPRLKICDFGYS 168
             +   +L     G S
Sbjct: 196 KKTSLKKLHYTLNGKS 211

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 58.0 bits (141), Expect = 1e-09
 Identities = 62/214 (28%), Positives = 84/214 (39%), Gaps = 50/214 (23%)

Query: 31  IGSGNFGVARLMRDKVTK------ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIV 82
           IG G FG       KV K        VA+K         I+E  + EI      RHP++V
Sbjct: 47  IGHGVFG-------KVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLV 98

Query: 83  RF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------DEARFFFQ 126
                  E       + ++ +Y   G L   +  +   +               AR    
Sbjct: 99  SLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR---- 150

Query: 127 QLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STV--GT 183
               G+ Y H   + HRD+K  N LLD +  P  KI DFG SK      Q   STV  GT
Sbjct: 151 ----GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHLSTVVKGT 204

Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
             YI PE  ++     K +DV+S GV L+ +L  
Sbjct: 205 LGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCA 237

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.3 bits (140), Expect = 2e-09
 Identities = 55/391 (14%), Positives = 128/391 (32%), Gaps = 95/391 (24%)

Query: 25  YDFVRDIGSGNFG--VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
             FV ++   N+   ++ +  ++    ++   YIE+ D++  + Q     + S R    +
Sbjct: 80  QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYL 138

Query: 83  RFKEVI--LTPTHLAIV--MEYASGGE----LFERICNAGRFSEDEARFFFQQL-ISGVS 133
           + ++ +  L P    ++  +     G     +   +C + +    + +  F+   ++ + 
Sbjct: 139 KLRQALLELRPAKNVLIDGV----LGSGKTWVALDVCLSYKV---QCKMDFKIFWLN-LK 190

Query: 134 YCH-------AMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 185
            C+        +Q + ++      +  D S   +L+I         +L S+P        
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP-------- 242

Query: 186 YIAPEVL--LRHEYDGKIADVW--SC---------GVTLYVMLVGGYPFE--------DP 224
           Y     L  L +  + K  + +  SC          VT ++                  P
Sbjct: 243 Y--ENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300

Query: 225 DEPKD-FRKTI-QRILSVQYSVPDTNP-----ISQECRDLISRIFVADPAARITIPEIMK 277
           DE K    K +  R   +   V  TNP     I++  RD ++     D    +   ++  
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATW---DNWKHVNCDKLTT 357

Query: 278 H-QWFLKNLPADLVDEKTMSSQYEE----PDQPMQSVDVIMQIIAEASIPAVGTHGLNCY 332
             +  L  L     +       ++     P     S  +   ++   S+       +   
Sbjct: 358 IIESSLNVL-----EPAEYRKMFDRLSVFPP----SAHIPTILL---SL-------IWFD 398

Query: 333 MTDNLDMDDDDMDDLDSESELDIDSSGEIIY 363
           +  +  M    ++ L   S ++       I 
Sbjct: 399 VIKSDVM--VVVNKLHKYSLVEKQPKESTIS 427

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 55/217 (25%), Positives = 78/217 (35%), Gaps = 55/217 (25%)

Query: 31  IGSGNFGVARLMRDKVTK-----ELVAVKYIERGDKI-----DENVQREIINHRSLRHPN 80
           +G G FG        V K       VAVK +     I      +   +EI      +H N
Sbjct: 39  MGEGGFG-------VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91

Query: 81  IVRFKEVILTPTHLAIVMEYASGG----ELFER-------------ICNAGRFSEDEARF 123
           +V           L +V  Y   G     L                I       +  A  
Sbjct: 92  LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA------QGAAN- 144

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST-- 180
                  G+++ H     HRD+K  N LLD +     KI DFG ++ S        ++  
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRI 195

Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG 217
           VGT AY+APE L       K +D++S GV L  ++ G
Sbjct: 196 VGTTAYMAPEALRGEITP-K-SDIYSFGVVLLEIITG 230

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 53.0 bits (128), Expect = 4e-08
 Identities = 58/216 (26%), Positives = 83/216 (38%), Gaps = 63/216 (29%)

Query: 31  IGSGNFGVARLMRDKVTK------ELVAVKYIERGDKIDENVQRE------IINHRSLRH 78
           +G G FG       KV K       LVAVK ++      +  + +      +I+     H
Sbjct: 38  LGRGGFG-------KVYKGRLADGTLVAVKRLKEERT--QGGELQFQTEVEMISM--AVH 86

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS--------EDEARFFFQ 126
            N++R +   +TPT   +V  Y + G     L ER  +                AR    
Sbjct: 87  RNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR---- 142

Query: 127 QLISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-- 181
               G++Y H     ++ HRD+K  N LLD        + DFG +K   L     + V  
Sbjct: 143 ----GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---LMDYKDTHVTT 193

Query: 182 ---GTPAYIAPEVLLRHEYDGKI---ADVWSCGVTL 211
              GT  +IAPE L      GK     DV+  GV L
Sbjct: 194 AVRGTIGHIAPEYLST----GKSSEKTDVFGYGVML 225

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 29/167 (17%), Positives = 59/167 (35%), Gaps = 24/167 (14%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
           ++   + IGSG FG+  L       E  A   ++   + +  +  E+  ++ +   + ++
Sbjct: 38  QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97

Query: 84  FKEVILTPTHLAI-------------------VMEY--ASGGELFERICNAGRFSEDEAR 122
                    +L I                   VME       ++     N G F +    
Sbjct: 98  KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG--QN-GTFKKSTVL 154

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
               +++  + Y H  +  H D+K  N LL      ++ + D+G S 
Sbjct: 155 QLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 51.7 bits (124), Expect = 1e-07
 Identities = 26/197 (13%), Positives = 60/197 (30%), Gaps = 37/197 (18%)

Query: 24  RYDFVRDIGSGNFGV--------ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS 75
           ++         N G+                 K+  ++K ++  D    N Q      R+
Sbjct: 43  QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQN--FFQRA 99

Query: 76  LRHPNIVRFKEVILTPT---------------HLAIVMEY--ASGGELFERICNAGRFSE 118
            +   + ++K++  TP                +  +V+     S     +        SE
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDV-SPKHVLSE 158

Query: 119 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLH- 174
                   +L+  + + H  +  H ++  EN  +D     ++ +  +G++     S  H 
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

Query: 175 ----SQPKSTVGTPAYI 187
                      G   +I
Sbjct: 219 AYVEGSRSPHEGDLEFI 235

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 11/119 (9%)

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 183
           +  Q+  G+ +  + +  HRDL   N LL       +KICDFG ++   ++  P      
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253

Query: 184 PAYI-----APEVLLRHEYDGKIADVWSCGVTLY-VMLVGGYPFEDPDEPKDFRKTIQR 236
            A +     APE +    Y  + +DVWS GV L+ +  +G  P+      ++F + ++ 
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 26/169 (15%), Positives = 50/169 (29%), Gaps = 25/169 (14%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKV-----TKELVAVK---------------YIERGDKID 63
            +     IG G FG   L          +     VK               Y        
Sbjct: 36  AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 64  ENVQREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDE 120
                     + L  P             ++  ++M+   +   +++E      RFS   
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEA-NA-KRFSRKT 153

Query: 121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
                 +++  + Y H  +  H D+K  N LL+     ++ + D+G + 
Sbjct: 154 VLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	365
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.94
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.88
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.8
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.33
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.31
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.12
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.7
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.51
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.49
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.43
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.25
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.88
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.87
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.84
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.73
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.58
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.57
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.51
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.5
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.48
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.38
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.27
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.09
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.37
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.28
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	95.55
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.23
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	93.12
4drw_A	121	Protein S100-A10/annexin A2 chimeric protein; atyp	91.83
1c07_A	95	Protein (epidermal growth factor receptor pathway	91.39
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	90.72
3nso_A	101	Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta	90.07
1eh2_A	106	EPS15; calcium binding, signaling domain, NPF bind	89.67
2lnk_A	113	Protein S100-A4; EF-hand, calcium binding, all alp	88.45
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	87.81
2jq6_A	139	EH domain-containing protein 1; metal binding prot	87.06
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.74
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	86.61
3n22_A	98	Protein S100-A2; EF-hand, calcium-binding, zinc-bi	86.58
3nxa_A	100	Protein S100-A16; S100 family, calcium binding pro	85.52
2pmy_A	91	RAS and EF-hand domain-containing protein; rasef,	85.3
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	85.11
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	84.42
2h2k_A	106	Protein S100-A13; calcium binding protein, metal b	84.28
3zwh_A	104	Protein S100-A4; Ca-binding protein-motor protein	83.95
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	83.68
3rm1_A	92	Protein S100-B; alpha-helical, EF hand, metal bind	83.59
4eto_A	93	Protein S100-A4; calcium-binding protein, EF-hand,	82.88
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.84
1cb1_A	78	Calbindin D9K; calcium-binding protein; NMR {Sus s	82.74
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	82.54
1j55_A	95	S-100P protein; metal binding protein; 2.00A {Homo	82.51
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	81.91
1psr_A	100	Psoriasin, S100A7; EF-hand protein, MAD phasing, p	81.07
2kz2_A	94	Calmodulin, CAM; TR2C, metal binding protein; NMR	81.03
2kax_A	92	Protein S100-A5; EF-hand, calcium binding protien,	80.48

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.7e-69  Score=508.02  Aligned_cols=361  Identities=85%  Similarity=1.352  Sum_probs=256.1

Q ss_pred             CcCCccccCCCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcc
Q 017860            3 MDRASLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV   82 (365)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv   82 (365)
                      |.+..++.+| +..|+....++|++++.||+|+||+||+++++.+++.||+|++.......+.+.+|+.+++.++||||+
T Consensus         1 m~~~~~~~~p-~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv   79 (361)
T 3uc3_A            1 MDRAPVTTGP-LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIV   79 (361)
T ss_dssp             -----------CCCCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCCCCCCC-CCccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCC
Confidence            4565556665 667888889999999999999999999999999999999999988777778899999999999999999


Q ss_pred             eeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEE
Q 017860           83 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI  162 (365)
Q Consensus        83 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl  162 (365)
                      ++++++.....+|+||||+.+|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.+++||
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl  159 (361)
T 3uc3_A           80 RFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKI  159 (361)
T ss_dssp             CEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred             cEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEE
Confidence            99999999999999999999999999999888999999999999999999999999999999999999998777667999


Q ss_pred             ecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          163 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       163 ~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                      +|||+++...........+||+.|+|||++.+..++++++|||||||++|+|++|+.||........+.+.+..+....+
T Consensus       160 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~  239 (361)
T 3uc3_A          160 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY  239 (361)
T ss_dssp             CCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred             eecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence            99999986555555667789999999999988888777789999999999999999999987776777778888888888


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCCCcchhhhcccCCCCCCCCCCCHHHHHHHHHHhCCC
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEASIP  322 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (365)
                      ..+....+++++.+||.+||+.||.+|||+.|+++||||.+..+..........+.+..+.++.++++.+.+.+.+...+
T Consensus       240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (361)
T 3uc3_A          240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP  319 (361)
T ss_dssp             CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC
T ss_pred             CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCc
Confidence            88887789999999999999999999999999999999999888877666666677778888999999999999999998


Q ss_pred             CCCCCCcccccccCCCCCCccccccccccccCCCCCCceeecC
Q 017860          323 AVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYAL  365 (365)
Q Consensus       323 ~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~~  365 (365)
                      ............++.+.| ++++++|++++.|.|+||+|.||+
T Consensus       320 ~~~~~~~~~~~~~~~d~d-~~~~~~d~~~~~d~d~~g~~~~~~  361 (361)
T 3uc3_A          320 AVRNRCLDDFMTDNLDLD-DDMDDFDSESEIDIDSSGEIVYAL  361 (361)
T ss_dssp             -------------------------------------------
T ss_pred             ccccccchhccccccccc-cccccccchhhhccCCCCcEEecC
Confidence            876555555555555444 344445678889999999999985

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-68  Score=480.94  Aligned_cols=256  Identities=42%  Similarity=0.732  Sum_probs=212.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+..    .....+.+|+.+++.++|||||+++++|.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            48999999999999999999999999999999997643    23357899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||| +|+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.........
T Consensus        93 Ey~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~  169 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLK  169 (275)
T ss_dssp             ECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC----------
T ss_pred             eCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccC
Confidence            999 6899999999999999999999999999999999999999999999999987654  9999999998766666667


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      +.+||+.|||||++.+..|++.++|||||||++|+|++|+.||.+.+...    ..+.+....+.+|  ..+|+++++||
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~li  243 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFKNISNGVYTLP--KFLSPGAAGLI  243 (275)
T ss_dssp             -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCC--TTSCHHHHHHH
T ss_pred             CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCC--CCCCHHHHHHH
Confidence            78999999999999988887666999999999999999999998765433    3334444555444  34899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+||+.||++|||++|+++||||+..+|.
T Consensus       244 ~~~L~~dP~~R~s~~eil~hpw~k~~~p~  272 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQDDWFKVDLPE  272 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred             HHHccCChhHCcCHHHHHcCcccccCCCh
Confidence            99999999999999999999999877654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.9e-68  Score=483.74  Aligned_cols=254  Identities=29%  Similarity=0.514  Sum_probs=224.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            35799999999999999999999999999999999753    23346789999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC---
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---  174 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~---  174 (365)
                      ||||+||+|.+++.+.++++|.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....   
T Consensus       111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTC
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCc
Confidence            999999999999999999999999999999999999999999999999999999987664  999999999865332   


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ....+.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+...    ....+....+.+|.  .+|+++
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~----~~~~i~~~~~~~p~--~~s~~~  261 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGL----IFAKIIKLEYDFPE--KFFPKA  261 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCT--TCCHHH
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCCCCCCc--ccCHHH
Confidence            33456799999999999998888665 999999999999999999998766543    34444555555554  589999


Q ss_pred             HHHHHHhcccCCCCCCCHHH------HhcCcccccC
Q 017860          255 RDLISRIFVADPAARITIPE------IMKHQWFLKN  284 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~e------ll~h~~f~~~  284 (365)
                      ++||.+||++||.+|||++|      +++||||+.-
T Consensus       262 ~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          262 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             HHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             HHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            99999999999999999987      5899999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.3e-67  Score=486.50  Aligned_cols=259  Identities=28%  Similarity=0.470  Sum_probs=225.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .+.|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|+||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            357999999999999999999999999999999997543 2346688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~  179 (365)
                      |+||+|.+++.+ +++++.+++.++.||+.||+|||++|||||||||+||||+.++.  +||+|||+|+..... ....+
T Consensus       153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCC
T ss_pred             CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcccc
Confidence            999999998876 56999999999999999999999999999999999999987664  999999999865433 34567


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      .+||+.|||||++.+..|+.+ +|||||||++|||++|++||.+.+....+..+..   ......+.+..+|+++++||.
T Consensus       230 ~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHH
Confidence            899999999999988888766 9999999999999999999988765444333222   122344555678999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      +||+.||.+|||++|+|+||||++..++
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            9999999999999999999999876554

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.4e-67  Score=487.13  Aligned_cols=261  Identities=28%  Similarity=0.496  Sum_probs=219.0

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      +...++|+++++||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+++.++|||||+++++|.+++.+|
T Consensus        20 f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y   99 (350)
T 4b9d_A           20 FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLY   99 (350)
T ss_dssp             CSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence            3456799999999999999999999999999999999986532   2356889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +|||||+||+|.+++...  ..+++.+++.|+.||+.||+|||++|||||||||+||||+.++.  +||+|||+|+....
T Consensus       100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~  177 (350)
T 4b9d_A          100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNS  177 (350)
T ss_dssp             EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCH
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecC
Confidence            999999999999999754  35799999999999999999999999999999999999987664  99999999986543


Q ss_pred             CC-CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          174 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .. ...+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+....+.+    +....+. +.+..+|+
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~~-~~~~~~s~  251 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLK----IISGSFP-PVSLHYSY  251 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCC-CCCTTSCH
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCCC-CCCccCCH
Confidence            22 2345689999999999998888766 9999999999999999999988765444333    3333321 34456899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ++++||.+||+.||.+|||++|+|+||||++..+.
T Consensus       252 ~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~  286 (350)
T 4b9d_A          252 DLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK  286 (350)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGG
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCCc
Confidence            99999999999999999999999999999876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-65  Score=486.82  Aligned_cols=259  Identities=28%  Similarity=0.470  Sum_probs=226.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .+.|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            357999999999999999999999999999999997643 3346789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~  179 (365)
                      |+||+|.+++.. +++++.+++.++.||+.||+|||++|||||||||+||||+.++.  +||+|||+|+..... ....+
T Consensus       230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCC
T ss_pred             CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccccc
Confidence            999999998865 56999999999999999999999999999999999999987664  999999999865433 34567


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      .+||+.|||||++.+..|+.+ +|||||||++|||++|++||.+.+....+..+..   ......+.+..+|+++++||.
T Consensus       307 ~~GTp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             CEECTTTCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHH
Confidence            899999999999998888766 9999999999999999999988765444333222   122344556679999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      +||+.||.+|||++|+|+||||++..++
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            9999999999999999999999876544

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.5e-66  Score=471.89  Aligned_cols=252  Identities=30%  Similarity=0.559  Sum_probs=214.1

Q ss_pred             CCcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ++|++++.||+|+||+||+|++.   .+++.||+|++.+..   .....+.+|+.+++.++|||||+++++|.+++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999984   467899999997532   223468899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~  175 (365)
                      |||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.... ..
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~  181 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEK  181 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----C
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCc
Confidence            9999999999999999999999999999999999999999999999999999999987664  99999999985433 34


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ...+.+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+....    ...+....+.+|  ..+|++++
T Consensus       182 ~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~  254 (304)
T 3ubd_A          182 KAYSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKET----MTMILKAKLGMP--QFLSPEAQ  254 (304)
T ss_dssp             CCCSCCCCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTSCHHHH
T ss_pred             cccccccCcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHH----HHHHHcCCCCCC--CcCCHHHH
Confidence            4567899999999999998888766 9999999999999999999988665443    333444444444  45899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          256 DLISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      +||.+||++||.+|||     ++|+++||||+.
T Consensus       255 ~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          255 SLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            9999999999999998     479999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4e-65  Score=463.30  Aligned_cols=255  Identities=24%  Similarity=0.404  Sum_probs=215.0

Q ss_pred             CCCc-ceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe----CCE
Q 017860           22 SDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTH   93 (365)
Q Consensus        22 ~~~y-~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~   93 (365)
                      ..+| ++.++||+|+||+||+|+++.++..||+|.+.....   ..+.+.+|+.+++.++|||||+++++|.+    +..
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~  103 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence            3466 777889999999999999999999999999975432   23568899999999999999999999975    356


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  ||||||||+|||++.. .+++||+|||+|+..
T Consensus       104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~-~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESST-TSCEEECCTTGGGGC
T ss_pred             EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECC-CCCEEEEeCcCCEeC
Confidence            8999999999999999999999999999999999999999999999  9999999999999742 235999999999753


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                       ......+.+|||.|||||++.+ .|+.+ +|||||||++|||++|+.||.+......+.+.+   .........+...+
T Consensus       183 -~~~~~~~~~GTp~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i---~~~~~~~~~~~~~~  256 (290)
T 3fpq_A          183 -RASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKPASFDKVAI  256 (290)
T ss_dssp             -CTTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---TTTCCCGGGGGCCC
T ss_pred             -CCCccCCcccCccccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHH---HcCCCCCCCCccCC
Confidence             2334556789999999999864 57665 999999999999999999998776655443333   22222222234478


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +++++||.+||+.||.+|||++|+|+||||++
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.7e-64  Score=465.64  Aligned_cols=253  Identities=25%  Similarity=0.354  Sum_probs=216.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .+.|++.++||+|+||+||+|+++.+|+.||||+++....    ..+|+.+++.++|||||+++++|.++..+|||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            4568999999999999999999999999999999987533    247999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-----
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----  176 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-----  176 (365)
                      +||+|.+++.+.+++++..++.++.||+.||+|||++|||||||||+||||+.++. ++||+|||+|+.......     
T Consensus       133 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~  211 (336)
T 4g3f_A          133 EGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLL  211 (336)
T ss_dssp             TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC----------
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCccccee
Confidence            99999999999899999999999999999999999999999999999999986652 599999999986443221     


Q ss_pred             -CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC-CCCCCCCHHH
Q 017860          177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV-PDTNPISQEC  254 (365)
Q Consensus       177 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~  254 (365)
                       ....+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+....+.++..    ..... ..+..+|+++
T Consensus       212 ~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~s~~~  286 (336)
T 4g3f_A          212 TGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPSCAPLT  286 (336)
T ss_dssp             --CCCCCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTTSCHHH
T ss_pred             cCCccccCccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCccCCHHH
Confidence             234579999999999998888776 9999999999999999999988766554444333    22211 2344589999


Q ss_pred             HHHHHHhcccCCCCCCCHHHH-------------hcCcccccC
Q 017860          255 RDLISRIFVADPAARITIPEI-------------MKHQWFLKN  284 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~el-------------l~h~~f~~~  284 (365)
                      .+||.+||++||.+|||+.|+             |+|||+.+.
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~  329 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY  329 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence            999999999999999999997             578888654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-63  Score=468.51  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=221.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeC------C
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP------T   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~   92 (365)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+....   .+.+.+|+.+|+.++|||||++++++...      +
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            46899999999999999999999999999999999764332   25678999999999999999999998643      6


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|+|||||+ |+|.+++.+.+++++.+++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+...
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~  209 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLC  209 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecc
Confidence            7999999996 679999998899999999999999999999999999999999999999987664  9999999998543


Q ss_pred             C-----CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC----
Q 017860          173 L-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS----  243 (365)
Q Consensus       173 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----  243 (365)
                      .     .....+.+||++|||||++.+..+++.++||||+|||+|||++|++||.+.+....+..+..........    
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            2     2334567999999999999887766666999999999999999999999887766665555443222110    


Q ss_pred             ------------CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          244 ------------VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       244 ------------~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                                  .+.         ...+|+++++||.+||+.||.+|||++|+|+||||++...
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                        111         1246899999999999999999999999999999987543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.7e-61  Score=454.05  Aligned_cols=257  Identities=25%  Similarity=0.402  Sum_probs=208.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.++||+|+||+||+|+++   .+++.||+|.+.+.. ....+.+|+.+++.+ +|||||+++++|.+++.+|+|
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv   98 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA   98 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence            358999999999999999999985   467899999987643 346788999999988 699999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC---
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---  174 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~---  174 (365)
                      ||||+||+|.+++   +++++.+++.++.||+.||+|||++||+||||||+|||++.+. +++||+|||+|+.....   
T Consensus        99 mE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A           99 MPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             EECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCG
T ss_pred             EeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCcccc
Confidence            9999999999988   3599999999999999999999999999999999999997552 36999999999743211   


Q ss_pred             --------------------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH
Q 017860          175 --------------------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK  228 (365)
Q Consensus       175 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~  228 (365)
                                                ....+.+||++|||||++.+..+++.++||||+|||+|||++|+.||...++..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~  254 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL  254 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence                                      123456899999999999887655555999999999999999999997665543


Q ss_pred             HHHHHHHHHhc-----------------------------------cc--------------cCCCCCCCCCHHHHHHHH
Q 017860          229 DFRKTIQRILS-----------------------------------VQ--------------YSVPDTNPISQECRDLIS  259 (365)
Q Consensus       229 ~~~~~~~~~~~-----------------------------------~~--------------~~~~~~~~~s~~~~~li~  259 (365)
                      +....+..+..                                   ..              ...+.+..+|+++++||.
T Consensus       255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~  334 (361)
T 4f9c_A          255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD  334 (361)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence            32222211110                                   00              011234568999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCccccc
Q 017860          260 RIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +||+.||.+|||++|+|+||||++
T Consensus       335 ~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          335 KLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHCcCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999964

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=5.5e-61  Score=439.32  Aligned_cols=250  Identities=24%  Similarity=0.387  Sum_probs=197.7

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCC---------
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT---------   92 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~---------   92 (365)
                      +|++++.||+|+||+||+|+++.+|+.||||++.....  ..+.+.+|+.+|+.++|||||+++++|.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            59999999999999999999999999999999976442  2356889999999999999999999997544         


Q ss_pred             ---EEEEEEeecCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           93 ---HLAIVMEYASGGELFERICNAGRF---SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        93 ---~~~lv~e~~~~g~L~~~l~~~~~l---~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                         .+|+|||||+||+|.+++...+.+   ++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFG  163 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFG  163 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCc
Confidence               479999999999999999876654   45678999999999999999999999999999999987664  9999999


Q ss_pred             CcccccCCC-------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHH
Q 017860          167 YSKSSVLHS-------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT  233 (365)
Q Consensus       167 la~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  233 (365)
                      +|+......             ...+.+||+.|||||++.+..|+.+ +|||||||++|||++   ||....   .....
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~---~~~~~  236 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQM---ERVRT  236 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHH---HHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCcc---HHHHH
Confidence            998543322             2234689999999999998888766 999999999999996   886422   12222


Q ss_pred             HHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       234 ~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +..+....+. +.....++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus       237 ~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          237 LTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            3333222211 122235678899999999999999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.2e-60  Score=472.72  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=217.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHH---HHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~---~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+..    ......   .+++.+++.++|||||+++++|.++..+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            47999999999999999999999999999999997532    112223   34467778889999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      +|||||+||+|..++.+.+++++..++.++.||+.||.|||++|||||||||+||||+.++  ++||+|||+|+... ..
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G--~vKL~DFGlA~~~~-~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG--HVRISDLGLACDFS-KK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS-SC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC--CEEecccceeeecC-CC
Confidence            9999999999999999999999999999999999999999999999999999999998766  49999999998653 33


Q ss_pred             CCCCCcCCCCCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ...+.+||+.|||||++.++ .|+.+ +|||||||++|||++|++||.+.+... ..++...+......+|.  .+|+++
T Consensus       346 ~~~t~~GTp~YmAPEvl~~~~~y~~~-vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a  421 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPEL  421 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred             CCCCccCCcCccCHHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHH
Confidence            45678999999999999754 55544 999999999999999999998654322 23445555555555544  589999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          255 RDLISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      ++||.+||+.||.+|++     ++|+++||||+.
T Consensus       422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999999999999998     799999999975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.5e-60  Score=473.05  Aligned_cols=258  Identities=30%  Similarity=0.561  Sum_probs=227.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++..... ..+.+.+|+.+|+.++|||||+++++|.++..+|+|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            589999999999999999999999999999999976543 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      +||+|.+++.. .+++++.+++.++.||+.||+|||++||+||||||+|||++.+..+++||+|||+|+...........
T Consensus       237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~  316 (573)
T 3uto_A          237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT  316 (573)
T ss_dssp             CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEE
T ss_pred             CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeee
Confidence            99999999864 46799999999999999999999999999999999999998765567999999999977666666778


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCCHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDLI  258 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li  258 (365)
                      +||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+....+    ..+....+.++  .+..+|+++++||
T Consensus       317 ~GT~~y~APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dli  391 (573)
T 3uto_A          317 TGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDFI  391 (573)
T ss_dssp             CSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred             EECccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHhCCCCCCcccccCCCHHHHHHH
Confidence            99999999999998888655 99999999999999999999887664433    33444444333  3456899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .+||+.||.+|||+.|+|+||||+...
T Consensus       392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          392 RKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            999999999999999999999998643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-59  Score=429.73  Aligned_cols=255  Identities=24%  Similarity=0.340  Sum_probs=205.2

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      |-.+.+++++.++||+|+||+||+|+++   ..||||+++....   ..+.+.+|+.++++++|||||++++++.. +.+
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~  106 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL  106 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence            3445678999999999999999999864   3599999875332   23578899999999999999999998754 568


Q ss_pred             EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |+|||||+||+|.+++... +++++.++..++.||+.||+|||+++||||||||+|||++.++.  +||+|||+|+....
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~  184 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSR  184 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC---
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceeccc
Confidence            9999999999999999764 57999999999999999999999999999999999999987664  99999999985432


Q ss_pred             C---CCCCCCcCCCCCCCchhhccc---ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          174 H---SQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       174 ~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      .   ......+||+.|||||++.+.   .|+.+ +|||||||++|||+||+.||.+.+....+...+......+.....+
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~k-sDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  263 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQ-SDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLY  263 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSC
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcH-HHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccc
Confidence            2   234566899999999999643   35555 9999999999999999999998777655544443322211111234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                      ..+++++.+|+.+||+.||++|||+.|++++.
T Consensus       264 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          264 KNCPKAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            45789999999999999999999999987653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.8e-60  Score=431.21  Aligned_cols=253  Identities=25%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      .+.++|.+.++||+|+||+||+|++.     .++..||||+++... ...+.+.+|+.+|++++|||||++++++.+++.
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~   89 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   89 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            34568999999999999999999875     367899999997543 234678999999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           94 LAIVMEYASGGELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~-------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      +|+|||||++|+|.+++.+.             ..+++.++..++.||+.||+|||+++||||||||+|||++.++.  +
T Consensus        90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~  167 (299)
T 4asz_A           90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--V  167 (299)
T ss_dssp             EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--E
T ss_pred             EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--E
Confidence            99999999999999999764             35999999999999999999999999999999999999987665  9


Q ss_pred             EEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 017860          161 KICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       161 kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  236 (365)
                      ||+|||+|+.......   .....||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+....+.    .
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~----~  242 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE----C  242 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----H
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----H
Confidence            9999999975433222   234569999999999998888766 999999999999998 899999876543332    2


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      +.... ..+.+..+|+++.+|+.+||+.||++|||+.+++  +|+.
T Consensus       243 i~~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~  285 (299)
T 4asz_A          243 ITQGR-VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ  285 (299)
T ss_dssp             HHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred             HHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence            22222 2234456899999999999999999999999994  4553

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6e-59  Score=430.93  Aligned_cols=249  Identities=24%  Similarity=0.370  Sum_probs=204.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .++|.+.++||+|+||+||+|+++     .+++.||||+++... ...+.+.+|+.+|++++|||||++++++.+...+|
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            456888999999999999999865     368899999997543 23467999999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           96 IVMEYASGGELFERICNA---------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~---------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      +|||||++|+|.+++.+.               +++++.++..|+.||+.||+|||+++||||||||+|||++.++.  +
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--V  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--E
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--E
Confidence            999999999999998753               35899999999999999999999999999999999999987664  9


Q ss_pred             EEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 017860          161 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       161 kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  236 (365)
                      ||+|||+|+......   .....+||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+....+..    
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC----  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH----
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence            999999998543332   2345679999999999998888766 999999999999998 8999998766443322    


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +... ...+.+..+++++.+|+.+||+.||++|||+.|++++
T Consensus       273 i~~g-~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          273 ITQG-RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHT-CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHcC-CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            2222 1234445689999999999999999999999999874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=8.7e-59  Score=426.04  Aligned_cols=249  Identities=20%  Similarity=0.341  Sum_probs=209.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ..++++.++||+|+||+||+|+..     .+++.||||++....  ...+.+.+|+.++++++|||||++++++.++..+
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            357889999999999999999863     467899999996532  2347899999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           95 AIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      ++|||||++|+|.+++...                ..+++.++..++.||+.||+|||+++||||||||+|||++.++. 
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~-  183 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-  183 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC-
Confidence            9999999999999999643                35899999999999999999999999999999999999987665 


Q ss_pred             CEEEecCCCcccccCC---CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 017860          159 RLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~  234 (365)
                       +||+|||+|+.....   ......+||+.|||||++.+..|+.+ +|||||||++|||+| |..||.+.+....    +
T Consensus       184 -~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~----~  257 (308)
T 4gt4_A          184 -VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDV----V  257 (308)
T ss_dssp             -EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHH----H
T ss_pred             -EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHH----H
Confidence             999999999854332   23445689999999999998888766 999999999999998 8999988765332    2


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       235 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..+... ...|.+..+++++.+|+.+||+.||.+|||+.|++++
T Consensus       258 ~~i~~~-~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRNR-QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            222222 2334555689999999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-56  Score=416.65  Aligned_cols=256  Identities=39%  Similarity=0.696  Sum_probs=226.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .++|++++.||+|+||.||+|++..+|+.||+|++.+...   ..+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            3589999999999999999999999999999999976432   2356789999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+++|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.........
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGG
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccc
Confidence            99999999999998889999999999999999999999999999999999999986664  9999999998766666667


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..+||+.|+|||++.+..++++++|||||||++|+|++|+.||.+.+...    ....+....+..|.  .+|+++.+||
T Consensus       172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li  245 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE----LRERVLRGKYRIPF--YMSTDCENLL  245 (328)
T ss_dssp             TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCCT--TSCHHHHHHH
T ss_pred             cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCCCCCC--CCCHHHHHHH
Confidence            78899999999999988887777999999999999999999998765433    33334444444444  4899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .+||+.||.+|||++|+++||||....
T Consensus       246 ~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          246 KRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            999999999999999999999998654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.4e-58  Score=426.66  Aligned_cols=252  Identities=22%  Similarity=0.368  Sum_probs=212.1

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccC-----CcEEEEEEeecCCc--ccHHHHHHHHHHhcCCC-CCcceeceEEEeC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK--IDENVQREIINHRSLRH-PNIVRFKEVILTP   91 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~   91 (365)
                      .+.++|++.++||+|+||+||+|.+..+     ++.||+|.+.....  ..+.+.+|+.+|+.++| ||||+++++|..+
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            4567899999999999999999998654     36899999876432  23568899999999965 9999999998764


Q ss_pred             -CEEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 017860           92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG  154 (365)
Q Consensus        92 -~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~  154 (365)
                       ..+|+|||||++|+|.+++.+.                ..+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~  220 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  220 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence             5789999999999999999753                34899999999999999999999999999999999999987


Q ss_pred             CCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHH
Q 017860          155 SPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF  230 (365)
Q Consensus       155 ~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  230 (365)
                      ++.  +||+|||+|+.......   ....+||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+......+
T Consensus       221 ~~~--vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          221 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             GGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             CCC--EEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            765  99999999986543322   234579999999999998888766 999999999999998 99999987765555


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+.+...    ...+.+..+++++.+|+.+||+.||.+|||+.++++|
T Consensus       298 ~~~i~~g----~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcC----CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5544432    2333445589999999999999999999999999987

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.6e-57  Score=442.65  Aligned_cols=336  Identities=29%  Similarity=0.482  Sum_probs=267.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|+++++||+|+||+||+|+++.++..||+|++.+..   .....+.+|+.+++.++||||++++++|.....+|+|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            46999999999999999999999999999999997642   335778999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||.+|+|.+.+....++++..++.++.||+.||+|||++||+||||||+|||++..+ .+.+||+|||+++.........
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~  196 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK  196 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence            999999999998888999999999999999999999999999999999999997543 3469999999998766666667


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCCCCHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQECRD  256 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  256 (365)
                      ..+||+.|+|||++. ..++.+ +|||||||++|+|++|..||.+.+....+..    +....+  ..+.+..+|+.+++
T Consensus       197 ~~~gt~~y~aPE~l~-~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          197 ERLGTAYYIAPEVLR-KKYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             CCCSCTTTCCHHHHT-TCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCSGGGTTSCHHHHH
T ss_pred             ccCCCcCeeCHHHHc-ccCCCc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCchhcccCCHHHHH
Confidence            788999999999986 456655 9999999999999999999988766443333    333333  33445678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCCCC--------CcchhhhcccCCCCC--------------CCCCCCHHHHHH
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNLPA--------DLVDEKTMSSQYEEP--------------DQPMQSVDVIMQ  314 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~~~--------~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~  314 (365)
                      ||.+||+.||.+|||+.++|+||||++....        ...........+...              ......+..+.+
T Consensus       271 li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~  350 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASKLTSQEETKELTD  350 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHH
T ss_pred             HHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHhcccHHHHHHHHH
Confidence            9999999999999999999999999753110        000000001111111              113345678889


Q ss_pred             HHHHhCCCCCCCCCcccccccCCC----------CCCccccccccccccCCCCCCceeec
Q 017860          315 IIAEASIPAVGTHGLNCYMTDNLD----------MDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       315 ~~~~~~~~~~g~~~~~~~~~~~~~----------~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .|...+.+.+|.++.+++......          ....+.+..+.+...|.|++|.|+|.
T Consensus       351 ~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~~G~I~~~  410 (494)
T 3lij_A          351 IFRHIDKNGDGQLDRQELIDGYSKLSGEEVAVFDLPQIESEVDAILGAADFDRNGYIDYS  410 (494)
T ss_dssp             HHHHHCTTCSSEECHHHHHHTTHHHHSSCCCCC--CHHHHHHHHHHHHHCTTCSSSEEHH
T ss_pred             HHHHhCcCCCCeEcHHHHHHHHHHhcccccccccccccHHHHHHHHHHhCCCCCCcCcHH
Confidence            999999999999999998654321          12335566677888899999999873

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-57  Score=446.41  Aligned_cols=337  Identities=30%  Similarity=0.491  Sum_probs=270.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--------------cccHHHHHHHHHHhcCCCCCcceeceE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------------KIDENVQREIINHRSLRHPNIVRFKEV   87 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~e~~~l~~l~hpnIv~l~~~   87 (365)
                      .++|+++++||+|+||+||+|+++.+++.||+|++.+..              ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            568999999999999999999999999999999997543              234678899999999999999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEecCC
Q 017860           88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFG  166 (365)
Q Consensus        88 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~-~~vkl~Dfg  166 (365)
                      +.....+|+|||||+||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            9999999999999999999999998889999999999999999999999999999999999999986653 359999999


Q ss_pred             CcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--
Q 017860          167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--  244 (365)
Q Consensus       167 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  244 (365)
                      +++...........+||+.|+|||++. ..++.+ +|||||||++|+|++|..||.+.+....+    ..+....+..  
T Consensus       195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~  268 (504)
T 3q5i_A          195 LSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDII----KKVEKGKYYFDF  268 (504)
T ss_dssp             TCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCH
T ss_pred             CCEEcCCCCccccccCCcCCCCHHHhc-cCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCc
Confidence            998766666667778999999999986 456655 99999999999999999999886654433    3333333322  


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCCCcchh-hh------cccCCCCC--------------C
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE-KT------MSSQYEEP--------------D  303 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~~~~~-~~------~~~~~~~~--------------~  303 (365)
                      +.+..+|+++++||.+||+.||.+|||++|+|+||||++......... ..      ....+...              .
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a~l~~i~~~~  348 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKL  348 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHHHHHHHHHHT
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHHHHHHhhccC
Confidence            234568999999999999999999999999999999987654322110 00      01111111              1


Q ss_pred             CCCCCHHHHHHHHHHhCCCCCCCCCcccccccCC----------CCCCccccccccccccCCCCCCceeec
Q 017860          304 QPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDNL----------DMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~----------~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .....+..+.+.|...+.+.+|.++.+++.....          .....+.+..+.+...|.|++|.|+|.
T Consensus       349 ~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~  419 (504)
T 3q5i_A          349 TTLEERKELTDIFKKLDKNGDGQLDKKELIEGYNVLRNFKNELGELKNVEEEVDNILKEVDFDKNGYIEYS  419 (504)
T ss_dssp             SCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHHHHHHHHC--CCSCCCHHHHHHHHHHHHCTTCSSSEEHH
T ss_pred             CcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHHHHhhhcccccccccccHHHHHHHHHHhCCCCCCcEeHH
Confidence            1334567788999999999999999998754311          123445566778888999999999873

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4e-57  Score=442.24  Aligned_cols=337  Identities=31%  Similarity=0.524  Sum_probs=266.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+.   ......+.+|+.+++.++||||+++++++.....+|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            35899999999999999999999999999999998642   233467899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||.+++|.+.+...+++++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+++........
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~  180 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM  180 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence            9999999999998888999999999999999999999999999999999999996432 346999999999876666666


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--cCCCCCCCCCHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--YSVPDTNPISQECR  255 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~  255 (365)
                      ...+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+.+....+..    +....  +..+.+..+|++++
T Consensus       181 ~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~  254 (486)
T 3mwu_A          181 KDRIGTAYYIAPEVLRG-TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKYAFDLPQWRTISDDAK  254 (486)
T ss_dssp             -CCTTGGGGCCGGGGGS-CCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCSCSGGGGGSCHHHH
T ss_pred             CCCcCCCCCCCHHHhCC-CCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCCcccCCCCHHHH
Confidence            67789999999999875 46544 9999999999999999999988765443332    33333  33455567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCcccccCCCCCcc--hhhhc------ccCCCCC--------------CCCCCCHHHHH
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWFLKNLPADLV--DEKTM------SSQYEEP--------------DQPMQSVDVIM  313 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~~~--~~~~~------~~~~~~~--------------~~~~~~~~~~~  313 (365)
                      +||.+||+.||.+|||+.++|+||||++.......  +....      ...+...              ......+..+.
T Consensus       255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~  334 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLT  334 (486)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHH
Confidence            99999999999999999999999999865433210  00000      0000000              01234567788


Q ss_pred             HHHHHhCCCCCCCCCcccccccCC------CC----------CCccccccccccccCCCCCCceeec
Q 017860          314 QIIAEASIPAVGTHGLNCYMTDNL------DM----------DDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       314 ~~~~~~~~~~~g~~~~~~~~~~~~------~~----------~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.|...+.+.+|.++.+++.....      ..          ...+.+..+.+...|.|++|.|+|.
T Consensus       335 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~D~d~dG~I~~~  401 (486)
T 3mwu_A          335 EIFRKLDTNNDGMLDRDELVRGYHEFMRLKGVDSNSLIQNEGSTIEDQIDSLMPLLDMDGSGSIEYS  401 (486)
T ss_dssp             HHHHHHCTTCSSSBCHHHHHHHHHHHHHHHTCCGGGHHHHTSSCHHHHHHHHHHHHCTTCCSSBCHH
T ss_pred             HHHHHhCCCCCceeeHHHHHHHHHHhhhhhcccchhcccccchhhHHHHHHHHHHhcCCCCCcCcHH
Confidence            999999999999999988833210      01          1224556677788899999999873

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.2e-55  Score=413.66  Aligned_cols=257  Identities=32%  Similarity=0.588  Sum_probs=225.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+...       ..+.+.+|+.+++.++||||++++++|.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            4589999999999999999999999999999999976432       236789999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CCEEEecCCCccccc
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV  172 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~--~~vkl~Dfgla~~~~  172 (365)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  .++||+|||+++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            999999999999999988888999999999999999999999999999999999999976552  269999999998766


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCC
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPI  250 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  250 (365)
                      ........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....    ...+....+.++  .+..+
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQET----LANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHH----HHHHHTTCCCCCHHHHTTS
T ss_pred             CCCccccCCCCccEECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcCCCCCchhccCC
Confidence            6556677889999999999988777665 9999999999999999999988665433    333444444333  23568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      |+++++||.+||..||.+|||+.|+++||||..
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            999999999999999999999999999999974

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-57  Score=443.55  Aligned_cols=337  Identities=31%  Similarity=0.493  Sum_probs=266.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            468999999999999999999999999999999997542    2346789999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEecCCCcccccCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      |||+.+|+|.+.+...+++++..++.++.||+.||+|||++||+||||||+|||++.. ..+.+||+|||+++.......
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~  184 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK  184 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence            9999999999999988899999999999999999999999999999999999999542 234699999999886655555


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCCCCHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQEC  254 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~  254 (365)
                      ....+||+.|+|||++.+ .++.+ +|||||||++|+|++|.+||.+.+....+.    .+....+  ..+.+..+|+++
T Consensus       185 ~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          185 MKDKIGTAYYIAPEVLHG-TYDEK-CDVWSTGVILYILLSGCPPFNGANEYDILK----KVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             HHHHTTGGGTCCHHHHHT-CCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCSGGGGGSCHHH
T ss_pred             cccCCCCccccCceeecC-CCCCc-ceeHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHcCCCCCCCcccccCCHHH
Confidence            556689999999999865 56655 999999999999999999998876544333    3333332  344556789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccCCCCCcch-------hhhcccCCCC--------------CCCCCCCHHHHH
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVD-------EKTMSSQYEE--------------PDQPMQSVDVIM  313 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~~~~~-------~~~~~~~~~~--------------~~~~~~~~~~~~  313 (365)
                      ++||.+||+.||.+|||+.++|+||||+.........       ......++..              .......+..+.
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~~~~~~~~l~  338 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELT  338 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccCcHHHHHHHH
Confidence            9999999999999999999999999997643211100       0000000000              000223456778


Q ss_pred             HHHHHhCCCCCCCCCccccccc----C--CCCCCc-------cccccccccccCCCCCCceeec
Q 017860          314 QIIAEASIPAVGTHGLNCYMTD----N--LDMDDD-------DMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       314 ~~~~~~~~~~~g~~~~~~~~~~----~--~~~~~~-------d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.|...+.+.+|.++.+++...    .  ...+..       +.+..+.+...|.|++|.|+|.
T Consensus       339 ~~F~~~D~d~dG~I~~~El~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~D~d~~g~i~~~  402 (484)
T 3nyv_A          339 AIFHKMDKNGDGQLDRAELIEGYKELMRMKGQDASMLDASAVEHEVDQVLDAVDFDKNGYIEYS  402 (484)
T ss_dssp             HHHHHHCTTCSSEEEHHHHHHHHHHHHC----CGGGCSHHHHHHHHHHHHHHHTCCTTSEEEHH
T ss_pred             HHHHHhCcCCCceEeHHHHHHHHHHHhhhcccccccccccccHHHHHHHHHHhCCCCCCeEeHH
Confidence            8999999999999999988321    1  111112       4556677888899999999873

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.6e-55  Score=405.63  Aligned_cols=253  Identities=34%  Similarity=0.612  Sum_probs=221.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.    ......+.+|+.+++.++||||++++++|.....+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            35899999999999999999999999999999999763    22346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~  176 (365)
                      |||++||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++... ....
T Consensus        84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC--CEEEeeccchhhcccCCCc
Confidence            99999999999999888999999999999999999999999999999999999998665  49999999998533 2334


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|.  .+|+++.+
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~  234 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPR--TLSPEAKS  234 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHHHH
Confidence            556789999999999988888666 9999999999999999999987655333    3333334444443  58999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017860          257 LISRIFVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       257 li~~~l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      ||.+||+.||.+||     +++++++||||..
T Consensus       235 li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          235 LLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            99999999999999     9999999999975

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.5e-55  Score=408.35  Aligned_cols=256  Identities=44%  Similarity=0.752  Sum_probs=223.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.+.    ......+.+|+.+++.++||||+++++++.....+++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5899999999999999999999999999999998753    233467899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+ +|+|.+++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||++..........
T Consensus        89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTC
T ss_pred             ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccc
Confidence            999 7899999988889999999999999999999999999999999999999986654  9999999998766666677


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..+||+.|+|||++.+..+.++++|||||||++|+|++|+.||........    ...+....+.  .+..+|+++.+||
T Consensus       166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----~~~i~~~~~~--~p~~~s~~~~~li  239 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----FKKVNSCVYV--MPDFLSPGAQSLI  239 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----BCCCCSSCCC--CCTTSCHHHHHHH
T ss_pred             cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----HHHHHcCCCC--CcccCCHHHHHHH
Confidence            789999999999998888766669999999999999999999987544321    1111122222  2344899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+||+.||.+|||++|+++||||....+.
T Consensus       240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  268 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEIRRDPWFNVNLPD  268 (336)
T ss_dssp             HTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred             HHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence            99999999999999999999999876654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-55  Score=409.23  Aligned_cols=258  Identities=25%  Similarity=0.470  Sum_probs=224.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .++|++.+.||+|+||.||+|.++.+++.||+|.+.........+.+|+.+++.++||||+++++++.+...+++|||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~   83 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence            46899999999999999999999999999999999866555567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          102 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      +|++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+..+.+||+|||+++...........
T Consensus        84 ~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  163 (321)
T 1tki_A           84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence            9999999997654 699999999999999999999999999999999999998754567999999999876555545566


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCCHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDLI  258 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li  258 (365)
                      .||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+    ..+....+..+  .+..+|+++.+||
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T 1tki_A          164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQII----ENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             cCChhhcCcHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcCCCHHHHH----HHHHcCCCCCChhhhccCCHHHHHHH
Confidence            79999999999988777655 99999999999999999999886654433    33333333332  2345899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .+||..||.+|||+.|+|+||||.+.
T Consensus       239 ~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          239 DRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5e-55  Score=410.06  Aligned_cols=255  Identities=33%  Similarity=0.534  Sum_probs=216.6

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++.+..    ...+.+.+|..+++.+ +||||++++++|.+...+|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3468999999999999999999999999999999997632    2335678899999887 7999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~  174 (365)
                      +||||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++... ..
T Consensus       101 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC--
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCC
Confidence            99999999999999999889999999999999999999999999999999999999986654  9999999998533 23


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....    ...+......+|.  .+++++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~~~~~  251 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDL----FEAILNDEVVYPT--WLHEDA  251 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCC--CCCHHH
Confidence            34456789999999999988877666 9999999999999999999988765433    3344445544544  389999


Q ss_pred             HHHHHHhcccCCCCCCCH------HHHhcCcccccC
Q 017860          255 RDLISRIFVADPAARITI------PEIMKHQWFLKN  284 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~------~ell~h~~f~~~  284 (365)
                      .+||.+||+.||.+||++      +++++||||...
T Consensus       252 ~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          252 TGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             HHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             HHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999999999998      899999999753

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.2e-54  Score=410.82  Aligned_cols=257  Identities=28%  Similarity=0.488  Sum_probs=219.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++++.||+|+||+||+|+++.+++.||+|++.+...    ....+.+|..+++.+ +||||++++++|.+...+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            4589999999999999999999999999999999986432    234578888888776 89999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc-cCCC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~-~~~~  175 (365)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.. ....
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTC
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCC
Confidence            9999999999999998889999999999999999999999999999999999999987664  999999999853 3344


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH-----HHHHHHHHHhccccCCCCCCCC
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----DFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ...+.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......     ......+.+......+|.  .+
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~  285 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SL  285 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TS
T ss_pred             ccccccCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cC
Confidence            4567789999999999998888766 999999999999999999997542211     111233444445545544  48


Q ss_pred             CHHHHHHHHHhcccCCCCCCCH------HHHhcCccccc
Q 017860          251 SQECRDLISRIFVADPAARITI------PEIMKHQWFLK  283 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~------~ell~h~~f~~  283 (365)
                      |+++++||.+||+.||.+||++      +++++||||..
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            9999999999999999999985      79999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.9e-54  Score=393.65  Aligned_cols=258  Identities=27%  Similarity=0.456  Sum_probs=222.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++++.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.....+|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            4589999999999999999999999999999999875433 346688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~  179 (365)
                      +.+|+|.+++.+. .+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||++....... ....
T Consensus        99 ~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           99 LAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             CTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCC
T ss_pred             CCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCC
Confidence            9999999998765 6899999999999999999999999999999999999986664  9999999987544332 3345


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      .+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+..........   ........+..+++.+.+||.
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCcCccChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHHH
Confidence            689999999999988888766 9999999999999999999987665444333222   222233445568999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      +||+.||.+|||++|+++||||+...+
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~~~~~~  278 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFLKIAKP  278 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHccCChhHCcCHHHHhhChhhcccCc
Confidence            999999999999999999999986544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-55  Score=404.21  Aligned_cols=250  Identities=24%  Similarity=0.289  Sum_probs=191.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC----EEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~   98 (365)
                      .+|.+.++||+|+||+||+|++  +|+.||||++..........++|+..+..++|||||++++++..++    .+|+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            3688999999999999999987  5899999999765433334456777778899999999999998654    689999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~--------~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      |||++|+|.+++.+. ++++..+..++.|++.||+|||++        +||||||||+|||++.++.  +||+|||+|+.
T Consensus        81 Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~  157 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEE
T ss_pred             cCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCcc
Confidence            999999999999764 589999999999999999999987        9999999999999987765  99999999975


Q ss_pred             ccCCC-----CCCCCcCCCCCCCchhhccc------ccCCccceeehhhHHHHHHHhCCCCCCCCCC----------h-H
Q 017860          171 SVLHS-----QPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDE----------P-K  228 (365)
Q Consensus       171 ~~~~~-----~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~----------~-~  228 (365)
                      .....     .....+||+.|||||++.+.      .++ .++|||||||++|||++|.+||.....          . .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~-~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHH-HHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccC-hhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            43322     22346899999999999654      233 349999999999999999876643211          1 0


Q ss_pred             HHHHHHHHHhcccc--CCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          229 DFRKTIQRILSVQY--SVPDT---NPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       229 ~~~~~~~~~~~~~~--~~~~~---~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ........+.....  ..|..   ...++.+.+|+.+||+.||.+|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            11122222222222  22221   1123468899999999999999999999863

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-54  Score=401.89  Aligned_cols=260  Identities=36%  Similarity=0.614  Sum_probs=221.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++......|+||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            589999999999999999999999999999999875432  236688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC---CCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQP  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~---~~~~  177 (365)
                      +++++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....   ....
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             CCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCccccc
Confidence            999999999988888999999999999999999999999999999999999986654  99999999874322   2223


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||............   ........+....+++.+.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH---HHTTCTTSTTGGGSCHHHHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH---HhcccccCCccccCCHHHHHH
Confidence            46689999999999988777666699999999999999999999876654332222   222223334445689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      |.+||+.||.+|||+.|+++||||.+....
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhcccccc
Confidence            999999999999999999999999876543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-54  Score=407.23  Aligned_cols=257  Identities=34%  Similarity=0.608  Sum_probs=223.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++......   .+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            35799999999999999999999999999999999765432   256789999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~-~~vkl~Dfgla~~~~~~~~~  177 (365)
                      ||+.||+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +.+||+|||+++........
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~  187 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  187 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence            99999999999988888999999999999999999999999999999999999976532 46999999999876655555


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCCCCHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECR  255 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~  255 (365)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+    ..+....+..  +.+..+++++.
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          188 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLY----AQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCSCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             ccCCCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCCcccccCCCHHHH
Confidence            66789999999999988777766 99999999999999999999876653332    3333333333  33456899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +||.+||+.||.+|||+.++|+||||..
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999999999999999999999999964

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-53  Score=390.32  Aligned_cols=262  Identities=27%  Similarity=0.465  Sum_probs=212.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++++.||+|+||+||+|+++.+++.||+|++.....   ....+.+|+.+++.++||||+++++++..+..+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            589999999999999999999999999999999976433   23678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~  178 (365)
                      |+.++.+..+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCC
T ss_pred             cCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCcccccc
Confidence            9986444444444678999999999999999999999999999999999999987664  999999999754322 3345


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--C-------------
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--S-------------  243 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-------------  243 (365)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||............+........  .             
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            5689999999999987764445599999999999999988876554444433333322221110  0             


Q ss_pred             ---------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          244 ---------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       244 ---------~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                               ......+++++++||.+||+.||.+|||++|+|+||||.+..|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence                     0011247899999999999999999999999999999986543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.2e-54  Score=414.03  Aligned_cols=257  Identities=34%  Similarity=0.614  Sum_probs=221.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|++.....   ..+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            3589999999999999999999999999999999986542   2356789999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEecCCCcccccCCC-C
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS-Q  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-~~~~vkl~Dfgla~~~~~~~-~  176 (365)
                      |||.||+|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+.+||+|||+++...... .
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            999999999999998899999999999999999999999999999999999999854 23569999999997654332 2


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCCCCHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQEC  254 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~  254 (365)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+....+.    .+....+  ..+.+..+|+++
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~  244 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQ----QIKAGAYDFPSPEWDTVTPEA  244 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHTCCCCCTTTTTTSCHHH
T ss_pred             eecccCCcccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHH----HHHhCCCCCCccccccCCHHH
Confidence            355689999999999988888766 999999999999999999998766544333    3333333  334456789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+||.+||+.||.+|||+.|+|+||||..
T Consensus       245 ~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          245 KDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            99999999999999999999999999964

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.9e-54  Score=403.59  Aligned_cols=255  Identities=33%  Similarity=0.545  Sum_probs=220.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..++|++.+.||+|+||.||+|+++.+|+.||+|++.+.    ......+.+|..+++.+ +||||++++++|.+...+|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            356899999999999999999999999999999999764    22345677888888866 9999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-C
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-H  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~  174 (365)
                      +||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++.... .
T Consensus        95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG--HIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTT
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC--CEEEeEChhhhhcccCC
Confidence            9999999999999999888999999999999999999999999999999999999998665  499999999985432 2


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....    ...+......+|.  .+|+++
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~  245 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYPR--WLEKEA  245 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHH
T ss_pred             CcccCCCCCcccCChhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHH----HHHHHhCCCCCCc--ccCHHH
Confidence            34456789999999999988888766 9999999999999999999987665433    3333334444443  489999


Q ss_pred             HHHHHHhcccCCCCCCCHH-HHhcCcccccC
Q 017860          255 RDLISRIFVADPAARITIP-EIMKHQWFLKN  284 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~-ell~h~~f~~~  284 (365)
                      .+||.+||+.||.+||++. ++++||||...
T Consensus       246 ~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          246 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            9999999999999999998 99999999753

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-54  Score=400.34  Aligned_cols=257  Identities=33%  Similarity=0.614  Sum_probs=223.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ++|++.+.||+|+||.||+|+++.+|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++.....++
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            479999999999999999999999999999999976432       2467899999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~--~~~vkl~Dfgla~~~~~  173 (365)
                      +||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ..++||+|||+++....
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~  170 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF  170 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence            9999999999999998888899999999999999999999999999999999999997655  22599999999987655


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCC
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPIS  251 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  251 (365)
                      ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+..    +.......+  .+..++
T Consensus       171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          171 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             TSCCCCCCSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHTCCCCCHHHHTTSC
T ss_pred             CCccccccCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HHhcCCCcCccccccCC
Confidence            555667789999999999987777666 9999999999999999999987665443322    222222222  124578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +.+.+||.+||+.||.+|||+.++|+||||...
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            999999999999999999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-54  Score=396.49  Aligned_cols=251  Identities=31%  Similarity=0.593  Sum_probs=220.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+|+++.+|+.||+|++.+..    ...+.+.+|..+++.++||||+++++++.+...+|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            58999999999999999999999999999999997632    23466788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...  ....
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~Dfg~a~~~~--~~~~  161 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--HIKITDFGFAKYVP--DVTY  161 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS--CEEECCCSSCEECS--SCBC
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC--CEEEeecCcceecC--Cccc
Confidence            9999999999999988999999999999999999999999999999999999997665  49999999997543  2345


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      +.+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+    ..+......+|  ..+++++.+||
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li  234 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAELRFP--PFFNEDVKDLL  234 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHH
T ss_pred             cccCCccccCHhHhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCCHHHHHHH
Confidence            6789999999999988888766 99999999999999999999876654433    33344444444  34899999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          259 SRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       259 ~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .+||+.||.+||     +++++++||||+..
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            999999999999     99999999999753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=7.2e-54  Score=405.91  Aligned_cols=262  Identities=24%  Similarity=0.442  Sum_probs=224.4

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeC
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTP   91 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~   91 (365)
                      .......++|++++.||+|+||.||+|+++.+++.||+|++.+..    .....+.+|+.+++.++||||++++++|.+.
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            333444578999999999999999999999999999999997532    2336788999999999999999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ..+|+||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~  165 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAML  165 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeec
Confidence            999999999999999999999889999999999999999999999999999999999999986664  999999999876


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      .........+||+.|+|||++.+   ..++.+ +|||||||++|+|++|+.||....... .......+.......|  .
T Consensus       166 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~-~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p--~  241 (384)
T 4fr4_A          166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYP--S  241 (384)
T ss_dssp             CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCC--T
T ss_pred             cCCCceeccCCCccccCCeeeccCCCCCCCcc-ceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCC--C
Confidence            66666677899999999999964   345555 999999999999999999998654322 2233333333433333  4


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCC-HHHHhcCccccc
Q 017860          249 PISQECRDLISRIFVADPAARIT-IPEIMKHQWFLK  283 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t-~~ell~h~~f~~  283 (365)
                      .+|+++.+||.+||+.||.+||+ ++++++||||..
T Consensus       242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            58999999999999999999998 899999999964

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.3e-53  Score=399.34  Aligned_cols=256  Identities=29%  Similarity=0.502  Sum_probs=218.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.+....    ...+.+|..+++.+ +||||++++++|.+...+|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5899999999999999999999999999999999864322    24577899999887 899999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~~  176 (365)
                      |||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... ....
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG--HIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCGGGCBCSCCTTCC
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEEeccccccccCCCCc
Confidence            99999999999999888999999999999999999999999999999999999998665  49999999998533 3334


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh-----HHHHHHHHHHhccccCCCCCCCCC
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----KDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......     .......+.+......+|  ..+|
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p--~~~s  243 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP--RSLS  243 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC--TTSC
T ss_pred             ccccCCCccccCccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC--CCCC
Confidence            556789999999999988888665 99999999999999999999753221     111123333444444444  3589


Q ss_pred             HHHHHHHHHhcccCCCCCCCH------HHHhcCccccc
Q 017860          252 QECRDLISRIFVADPAARITI------PEIMKHQWFLK  283 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~------~ell~h~~f~~  283 (365)
                      +++++||.+||+.||.+||++      +++++||||..
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            999999999999999999995      89999999964

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-53  Score=393.55  Aligned_cols=264  Identities=28%  Similarity=0.444  Sum_probs=214.9

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ......++|+++++||+|+||+||+|++. +|+.||+|++.....   ....+.+|+.+++.++||||+++++++..+..
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            33444679999999999999999999996 689999999865332   23578899999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      +++||||+.+ +|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~  170 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFG  170 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETT
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecC
Confidence            9999999975 787777654 45999999999999999999999999999999999999987664  9999999997543


Q ss_pred             CC-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-CC-----
Q 017860          173 LH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VP-----  245 (365)
Q Consensus       173 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-----  245 (365)
                      .. .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.......... ++     
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence            22 334456799999999999775444455999999999999999999999887766665555433221110 00     


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          246 ------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       246 ------------------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                        ....+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                              012367899999999999999999999999999999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-53  Score=399.47  Aligned_cols=253  Identities=32%  Similarity=0.526  Sum_probs=220.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.+..    ...+.+.+|..+++.+ +||||++++++|.+...+|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            468999999999999999999999999999999997632    2345678899999887 79999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~  175 (365)
                      ||||++||+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.... ..
T Consensus        99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~vkL~DFG~a~~~~~~~~  176 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  176 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCCCCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC--cEEEEeCCcccccccCCc
Confidence            999999999999999888999999999999999999999999999999999999998665  499999999985332 33


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....    ...+......+|.  .+|+++.
T Consensus       177 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~  249 (353)
T 2i0e_A          177 TTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAV  249 (353)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHH
T ss_pred             ccccccCCccccChhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHH
Confidence            4456789999999999988888665 9999999999999999999987665433    3334444444443  5899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          256 DLISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      +||.+||+.||.+||+     ++++++||||..
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            9999999999999994     699999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-53  Score=414.84  Aligned_cols=258  Identities=40%  Similarity=0.726  Sum_probs=227.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|.+.+.||+|+||.||+|+++.+|+.||+|++.+..    .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            458999999999999999999999999999999997532    2345788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||++||+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++........
T Consensus        95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A           95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCB
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccc
Confidence            999999999999988888999999999999999999999999999999999999986654  999999999876555556


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||...+....+.    .+....+..|  ..+++++.+|
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~L  246 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTP--QYLNPSVISL  246 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCCCCC--TTCCHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCcCCC--ccCCHHHHHH
Confidence            677899999999999888776677999999999999999999998876644333    3333433333  3488999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      |.+||+.||.+|||+.++++||||.+..+.
T Consensus       247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  276 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIREHEWFKQDLPK  276 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHTTCCT
T ss_pred             HHHHcCCCchhCcCHHHHHhCHHhhhcCcc
Confidence            999999999999999999999999876543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.6e-53  Score=406.88  Aligned_cols=258  Identities=32%  Similarity=0.494  Sum_probs=221.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|++++.||+|+||+||+|+++.+++.||+|++.+.    ......+.+|+.+++.++||||++++++|.+...+|+
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l  146 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  146 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            346899999999999999999999999999999999752    2233568899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||||++||+|.+++.+ .++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~  223 (410)
T 3v8s_A          147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGM  223 (410)
T ss_dssp             EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSE
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCc
Confidence            9999999999998875 46999999999999999999999999999999999999986664  9999999997544332 


Q ss_pred             -CCCCCcCCCCCCCchhhcccc----cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHE----YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                       ...+.+||+.|+|||++.+..    ++. ++|||||||++|+|++|+.||.+.+....+.++....  ....+|....+
T Consensus       224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~-~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~  300 (410)
T 3v8s_A          224 VRCDTAVGTPDYISPEVLKSQGGDGYYGR-ECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDI  300 (410)
T ss_dssp             EECCSCCSCGGGCCHHHHHTTTTTCEEET-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCC
T ss_pred             ccccCCcCCccccCHHHhhccCCCcCCCC-cceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccc
Confidence             234678999999999997654    444 4999999999999999999999876655444443322  12345666679


Q ss_pred             CHHHHHHHHHhcccCCCC--CCCHHHHhcCcccccC
Q 017860          251 SQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN  284 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~~  284 (365)
                      |+++++||.+||+.+|.+  ||+++|+++||||+..
T Consensus       301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            999999999999999988  9999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.4e-53  Score=398.27  Aligned_cols=251  Identities=30%  Similarity=0.563  Sum_probs=220.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+..    ...+.+.+|+.+++.++||||+++++++.+...+|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999999999999999997532    2346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||++||+|.+++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...  ...
T Consensus       120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--~~kL~DFg~a~~~~--~~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCB
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC--CEEEcccccceecc--CCc
Confidence            99999999999999888999999999999999999999999999999999999997665  49999999997543  234


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....    ...+......+|  ..+++++.+|
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~----~~~i~~~~~~~p--~~~~~~~~~l  268 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQI----YEKIVSGKVRFP--SHFSSDLKDL  268 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTCCHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHH----HHHHHcCCCCCC--CCCCHHHHHH
Confidence            56789999999999988888766 9999999999999999999987655333    333444444444  3589999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      |.+||+.||.+||+     ++++++||||..
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            99999999999998     999999999974

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-53  Score=405.13  Aligned_cols=259  Identities=28%  Similarity=0.507  Sum_probs=223.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++..... ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            3589999999999999999999999999999999976532 235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      +.+|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+..+.+||+|||+++..........
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence            99999999987654 69999999999999999999999999999999999999865556799999999986655544555


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--CCCCCCCCHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--VPDTNPISQECRDL  257 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~l  257 (365)
                      .+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.    .+....+.  ......+++++.+|
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~l  284 (387)
T 1kob_A          210 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQ----NVKRCDWEFDEDAFSSVSPEAKDF  284 (387)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             eccCCCccCchhccCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCccccccCCHHHHHH
Confidence            689999999999988777655 999999999999999999998866543332    23333322  23345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      |.+||+.||.+|||+.++|+||||....
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          285 IKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            9999999999999999999999997643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-53  Score=402.36  Aligned_cols=259  Identities=28%  Similarity=0.391  Sum_probs=203.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCcceeceEEEeCC--EEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~--~~~l   96 (365)
                      ++|++++.||+|+||.||+|.++.+|+.||+|++....   .....+.+|+.+++.+. ||||+++++++...+  .+|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            58999999999999999999999999999999986532   22356778999999997 999999999998654  7999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC---
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~---  173 (365)
                      ||||+. ++|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....   
T Consensus        89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCC
T ss_pred             EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCccccccccccc
Confidence            999997 589888866 57999999999999999999999999999999999999986654  99999999975322   


Q ss_pred             -------------------CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHH
Q 017860          174 -------------------HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       174 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  234 (365)
                                         .......+||++|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..++
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  244 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII  244 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence                               1123446899999999999874444455999999999999999999999887766655554


Q ss_pred             HHHhcccc-----------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017860          235 QRILSVQY-----------------------------------------SVPDTNPISQECRDLISRIFVADPAARITIP  273 (365)
Q Consensus       235 ~~~~~~~~-----------------------------------------~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~  273 (365)
                      ..+.....                                         .......+++++.+||.+||+.||.+|||++
T Consensus       245 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~  324 (388)
T 3oz6_A          245 GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAN  324 (388)
T ss_dssp             HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHH
Confidence            32211110                                         0011225789999999999999999999999


Q ss_pred             HHhcCcccccCC
Q 017860          274 EIMKHQWFLKNL  285 (365)
Q Consensus       274 ell~h~~f~~~~  285 (365)
                      |+|+||||....
T Consensus       325 e~l~Hp~~~~~~  336 (388)
T 3oz6_A          325 DALKHPFVSIFH  336 (388)
T ss_dssp             HHTTSTTTTTTC
T ss_pred             HHhCCHHHHHhc
Confidence            999999997643

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=9.8e-53  Score=387.15  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=215.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC------cccHHHHHHHHHHhcCC---CCCcceeceEEEeCC
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLR---HPNIVRFKEVILTPT   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~   92 (365)
                      .++|++++.||+|+||+||+|+++.+++.||+|++....      .....+.+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            469999999999999999999999999999999987422      23456778888877764   999999999998765


Q ss_pred             -----EEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           93 -----HLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        93 -----~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                           .+++||||+. ++|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+||
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Df  164 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADF  164 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSC
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeC
Confidence                 5899999997 599999987654  999999999999999999999999999999999999986664  999999


Q ss_pred             CCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CC
Q 017860          166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV  244 (365)
Q Consensus       166 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~  244 (365)
                      |+++............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+......++......... .+
T Consensus       165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (308)
T 3g33_A          165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  243 (308)
T ss_dssp             SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccCCCcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            99987665556667789999999999988888766 99999999999999999999987776655555543322111 11


Q ss_pred             CC--------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 PD--------------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 ~~--------------------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +.                    ...+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             cchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            10                    12478999999999999999999999999999999764

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.9e-53  Score=385.09  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=210.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++++.||+|+||.||+|++ .+|+.||+|++....   .....+.+|+.+++.++||||+++++++.....+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            5899999999999999999999 578999999986543   234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCC
Q 017860          100 YASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      |+.+ +|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC-----
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCcccccc
Confidence            9975 898888764 67999999999999999999999999999999999999986654  999999998754322 233


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-C-------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-S-------------  243 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-------------  243 (365)
                      ....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......... .             
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc
Confidence            45678999999999976553445599999999999999999999987766555554443221110 0             


Q ss_pred             CC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          244 VP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       244 ~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+         ....+++++.+||.+||+.||.+|||++|+++||||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            00         11347899999999999999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=8.3e-53  Score=389.53  Aligned_cols=263  Identities=25%  Similarity=0.454  Sum_probs=204.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++....  .....+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            468999999999999999999999999999999997543  234678999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860          100 YASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus       100 ~~~~g~L~~~l~~~------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |+. ++|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGI  160 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTS
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCC
Confidence            998 5898888653      35899999999999999999999999999999999999986654  99999999875433


Q ss_pred             C-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC---------
Q 017860          174 H-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS---------  243 (365)
Q Consensus       174 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------  243 (365)
                      . .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+..........         
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  240 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP  240 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred             CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence            2 234456899999999999765433445999999999999999999999877655554444332111000         


Q ss_pred             -----C--------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          244 -----V--------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       244 -----~--------------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                           .              .....+++++.+||.+||+.||.+|||++|+|+||||.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                 0              0112478899999999999999999999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-53  Score=396.64  Aligned_cols=259  Identities=35%  Similarity=0.579  Sum_probs=206.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.....+++||||+
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  130 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV  130 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeC
Confidence            457999999999999999999999999999999997643 3456889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEecCCCcccccCCCCCCCC
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~-~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      .+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++...........
T Consensus       131 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  210 (349)
T 2w4o_A          131 TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV  210 (349)
T ss_dssp             CSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence            99999999988888999999999999999999999999999999999999975 22446999999999866555455667


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCCCCHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQECRDLI  258 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li  258 (365)
                      +||+.|+|||++.+..++.+ +|||||||++|+|++|..||..........   ..+.......  +.+..++.++.+||
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~li  286 (349)
T 2w4o_A          211 CGTPGYCAPEILRGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMF---RRILNCEYYFISPWWDEVSLNAKDLV  286 (349)
T ss_dssp             --CGGGSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHHH---HHHHTTCCCCCTTTTTTSCHHHHHHH
T ss_pred             cCCCCccCHHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHHH---HHHHhCCCccCCchhhhCCHHHHHHH
Confidence            89999999999988777666 999999999999999999998766544332   2333333322  33456899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .+||+.||.+|||+.++|+||||....
T Consensus       287 ~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          287 RKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999997654

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.5e-53  Score=412.48  Aligned_cols=258  Identities=27%  Similarity=0.416  Sum_probs=208.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeC------C
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTP------T   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~   92 (365)
                      .++|++++.||+|+||+||+|.+..+++.||||++.+..   .....+.+|+.+++.++||||++++++|...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999999999999999999997632   2335678999999999999999999999655      4


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|+||||+.++ |...+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       141 ~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~  215 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  215 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC----
T ss_pred             eEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecC
Confidence            689999999764 666654  34899999999999999999999999999999999999987654  9999999998766


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------  242 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  242 (365)
                      ........+||++|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+....+.+++..+.....          
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            6656677899999999999998888766 99999999999999999999988776666555543221100          


Q ss_pred             -----CCCCCCC---------------------CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          243 -----SVPDTNP---------------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       243 -----~~~~~~~---------------------~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                           ..+....                     .++++++||.+||+.||.+|||++|+|+||||....
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence                 0000000                     156799999999999999999999999999998654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-53  Score=388.12  Aligned_cols=255  Identities=36%  Similarity=0.605  Sum_probs=212.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------------------------ccHHHHHHHHHHh
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------------------IDENVQREIINHR   74 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------------~~~~~~~e~~~l~   74 (365)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++.....                           ..+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3589999999999999999999999999999999975431                           1246889999999


Q ss_pred             cCCCCCcceeceEEEe--CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           75 SLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        75 ~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      .++||||+++++++..  ...+|+||||+++++|.+++ ..+++++..++.++.||+.||+|||++||+||||||+|||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~  170 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV  170 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence            9999999999999987  57899999999999998754 34579999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCC-CCCCCcCCCCCCCchhhccccc--CCccceeehhhHHHHHHHhCCCCCCCCCChHH
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLRHEY--DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD  229 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  229 (365)
                      +.++.  +||+|||+++...... ......||+.|+|||++.+...  .++++|||||||++|+|++|+.||....... 
T Consensus       171 ~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-  247 (298)
T 2zv2_A          171 GEDGH--IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC-  247 (298)
T ss_dssp             CTTSC--EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred             CCCCC--EEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH-
Confidence            86654  9999999987544322 2345679999999999876542  3555899999999999999999998754422 


Q ss_pred             HHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          230 FRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       230 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                         ....+.......+....+++++.+||.+||+.||.+|||+.|+++||||.+
T Consensus       248 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          248 ---LHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             ---HHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             ---HHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence               223333444455666678999999999999999999999999999999953

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-52  Score=381.01  Aligned_cols=261  Identities=33%  Similarity=0.589  Sum_probs=225.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++.....   ....+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            5689999999999999999999999999999999976432   2256788999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~-~~vkl~Dfgla~~~~~~~~~  177 (365)
                      ||+.+++|.+.+.....+++..++.++.|++.||+|||++|++||||||+||+++.++. +.+||+|||++.........
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW  164 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence            99999999999988888999999999999999999999999999999999999975543 45999999999866655555


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............  ...+..+....+++++.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l  241 (284)
T 3kk8_A          165 HGFAGTPGYLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--AYDYPSPEWDTVTPEAKSL  241 (284)
T ss_dssp             CCSCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHHHHHH
T ss_pred             cCCCCCcCCcCchhhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc--cccCCchhhcccCHHHHHH
Confidence            66789999999999988887666 99999999999999999999876654433322221  1222334445689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      |.+||+.||.+|||++++++||||.+..
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          242 IDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHcccChhhCCCHHHHhcCccccCCh
Confidence            9999999999999999999999997653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-52  Score=406.79  Aligned_cols=262  Identities=29%  Similarity=0.422  Sum_probs=196.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC-----CE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~   93 (365)
                      .++|++++.||+|+||+||+|+++.+++.||||++.+...   ..+.+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            4789999999999999999999999999999999865322   235688999999999999999999999543     57


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +|+||||+ +++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~  208 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDY  208 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTS
T ss_pred             EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccC
Confidence            99999998 5789999988888999999999999999999999999999999999999987664  99999999985432


Q ss_pred             CC----------------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh---------
Q 017860          174 HS----------------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV---------  216 (365)
Q Consensus       174 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~---------  216 (365)
                      ..                            .....+||++|+|||++......+.++||||||||+|||++         
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence            21                            23456789999999987544433445999999999999998         


Q ss_pred             --CCCCCCCCCC--------------------hHHHHHHHHHHhcccc-----------------CC---------CCCC
Q 017860          217 --GGYPFEDPDE--------------------PKDFRKTIQRILSVQY-----------------SV---------PDTN  248 (365)
Q Consensus       217 --g~~pf~~~~~--------------------~~~~~~~~~~~~~~~~-----------------~~---------~~~~  248 (365)
                        |+++|.+...                    ...+..+. .+.....                 ..         ....
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF-NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHH-HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHH-HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence              6777766431                    11111111 1111000                 00         0123


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+++++.+||.+||+.||.+|||++|+|+||||......
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence            468999999999999999999999999999999875433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-53  Score=407.34  Aligned_cols=259  Identities=25%  Similarity=0.477  Sum_probs=219.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|+++++||+|+||+||+++++.+++.||+|++.+..    .....+.+|..+++.++||||++++++|.+...+|+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  151 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL  151 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence            3568999999999999999999999999999999997522    223447899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||+.||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus       152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTS
T ss_pred             EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCC
Confidence            9999999999999987 567999999999999999999999999999999999999986664  9999999997544332


Q ss_pred             C--CCCCcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC-
Q 017860          176 Q--PKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT-  247 (365)
Q Consensus       176 ~--~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-  247 (365)
                      .  ....+||+.|+|||++.     ...++.+ +|||||||++|||++|+.||.+.+....+.+++....  .+.+|.. 
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~-~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~  306 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPE-CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPTQV  306 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCSSC
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCc-CeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--cccCCccc
Confidence            2  34468999999999997     3456555 9999999999999999999998776555544443221  2233332 


Q ss_pred             CCCCHHHHHHHHHhcccCCCC--CCCHHHHhcCcccccC
Q 017860          248 NPISQECRDLISRIFVADPAA--RITIPEIMKHQWFLKN  284 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~--R~t~~ell~h~~f~~~  284 (365)
                      ..+|+++++||.+||..+|++  |++++|+++||||..-
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence            458999999999999988888  9999999999999753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.2e-53  Score=398.91  Aligned_cols=256  Identities=31%  Similarity=0.570  Sum_probs=216.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC------cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD------KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .++|++.+.||+|+||+||+|.++.+|+.||+|++....      ...+.+.+|+.+++.++||||+++++++.....+|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            468999999999999999999999999999999986421      23467899999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCccc
Q 017860           96 IVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS  170 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~  170 (365)
                      +|||||+|++|.+.+...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            999999999998877542    3589999999999999999999999999999999999997543 34599999999976


Q ss_pred             ccCCCC-CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CC
Q 017860          171 SVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DT  247 (365)
Q Consensus       171 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  247 (365)
                      ...... ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..  .   .....+....+..+  .+
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~--~---~~~~~i~~~~~~~~~~~~  256 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTK--E---RLFEGIIKGKYKMNPRQW  256 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSH--H---HHHHHHHHTCCCCCHHHH
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcH--H---HHHHHHHcCCCCCCcccc
Confidence            543332 445689999999999988888666 999999999999999999998742  1   22233333333222  22


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ..+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus       257 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          257 SHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             ccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            458999999999999999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-52  Score=398.07  Aligned_cols=267  Identities=23%  Similarity=0.405  Sum_probs=217.6

Q ss_pred             CCCCCCCCCcceecccccC--CCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe
Q 017860           16 MPIMHDSDRYDFVRDIGSG--NFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT   90 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~   90 (365)
                      .+++...++|++++.||+|  +||.||+|+++.+|+.||+|++.....   ..+.+.+|+.+++.++||||++++++|..
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3445567799999999999  999999999999999999999976432   23567789999999999999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           91 PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      .+.+|+||||+.+|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||.+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~--~~kl~dfg~~  175 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG--KVYLSGLRSN  175 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCGGGC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccccc
Confidence            99999999999999999999875  6799999999999999999999999999999999999998665  4999999987


Q ss_pred             ccccC--------CCCCCCCcCCCCCCCchhhcc--cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 017860          169 KSSVL--------HSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL  238 (365)
Q Consensus       169 ~~~~~--------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  238 (365)
                      .....        .......+||+.|+|||++.+  ..++.+ +|||||||++|+|++|+.||.+........+......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            53221        122344579999999999987  456655 9999999999999999999988766554433322111


Q ss_pred             cc----------------------------------------ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          239 SV----------------------------------------QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       239 ~~----------------------------------------~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..                                        ....+....+++++.+||.+||+.||.+|||++|+|+|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            00                                        00112234578999999999999999999999999999


Q ss_pred             cccccCC
Q 017860          279 QWFLKNL  285 (365)
Q Consensus       279 ~~f~~~~  285 (365)
                      |||.+..
T Consensus       335 p~f~~~~  341 (389)
T 3gni_B          335 SFFKQIK  341 (389)
T ss_dssp             GGGGGC-
T ss_pred             HHHHHHh
Confidence            9998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-52  Score=396.78  Aligned_cols=253  Identities=31%  Similarity=0.549  Sum_probs=212.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHH-HhcCCCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~-l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++++.||+|+||.||+|+++.+++.||+|++.+...    ....+.+|..+ ++.++||||++++++|.+...+|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            4689999999999999999999999999999999976432    22345566665 577899999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~  175 (365)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g--~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG--HIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCCBCGGGBCCCC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC--CEEEeeCccccccccCCC
Confidence            999999999999999888999999999999999999999999999999999999998665  49999999998533 334


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....+||+.|+|||++.+..++.+ +|||||||++|||++|..||...+....+    ..+......++  ..++.+++
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~  267 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMY----DNILNKPLQLK--PNITNSAR  267 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHH----HHHHHSCCCCC--SSSCHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHhcccCCC--CCCCHHHH
Confidence            4566789999999999988887666 99999999999999999999876654433    33334444443  34899999


Q ss_pred             HHHHHhcccCCCCCCCH----HHHhcCccccc
Q 017860          256 DLISRIFVADPAARITI----PEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~----~ell~h~~f~~  283 (365)
                      +||.+||+.||.+||++    .++++||||..
T Consensus       268 ~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          268 HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            99999999999999986    69999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.3e-52  Score=389.82  Aligned_cols=255  Identities=30%  Similarity=0.524  Sum_probs=211.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC-----cccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      ..++|++.+.||+|+||.||+|++.   .+++.||+|++.+..     .....+.+|+.+++.++||||+++++++....
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            3468999999999999999999985   689999999997642     22345778999999999999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|+||||+.+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++...
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG--HVKLTDFGLCKESI  172 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS--CEEECCCSCC----
T ss_pred             EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC--cEEEEeCCcccccc
Confidence            9999999999999999999888899999999999999999999999999999999999998665  49999999987533


Q ss_pred             C-CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          173 L-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       173 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      . .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+    ..+.......|  ..++
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~p--~~~~  245 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTI----DKILKCKLNLP--PYLT  245 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCCCC--TTSC
T ss_pred             cCCccccccCCCcCccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhCCCCCC--CCCC
Confidence            2 233455689999999999988777665 99999999999999999999876654433    33333333343  3489


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          252 QECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      +++.+||.+||..||.+||     ++.++++||||...
T Consensus       246 ~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            9999999999999999999     89999999999753

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.9e-53  Score=394.52  Aligned_cols=257  Identities=34%  Similarity=0.563  Sum_probs=217.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.+...   ...+|+.++..+ +||||+++++++.+...+|+||||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            4579999999999999999999999999999999987543   235677777776 799999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CCEEEecCCCcccccCC-CCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~--~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      |.||+|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.....  +.+||+|||+++..... ...
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            999999999998889999999999999999999999999999999999999854322  35999999999854333 334


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCCHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECR  255 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~  255 (365)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|..||...... ...+....+....+..+  .+..+|++++
T Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  255 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDD-TPEEILARIGSGKFSLSGGYWNSVSDTAK  255 (342)
T ss_dssp             CCSSCCSSCCCHHHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTTS-CHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred             eccCCCccccCHHHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCcC-CHHHHHHHHccCCcccCccccccCCHHHH
Confidence            56789999999999987777655 99999999999999999999864321 12233444444444333  3456899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +||.+||..||.+|||+.++++||||..
T Consensus       256 ~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          256 DLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999999999965

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.3e-52  Score=401.52  Aligned_cols=266  Identities=27%  Similarity=0.371  Sum_probs=208.4

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC----
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP----   91 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~----   91 (365)
                      ....++|++.+.||+|+||.||+|+++.+++.||||++.....   ..+.+.+|+.+++.++||||+++++++...    
T Consensus        22 ~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           22 VHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            3446799999999999999999999999999999999975322   235688999999999999999999999876    


Q ss_pred             -CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           92 -THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        92 -~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                       ..+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~  178 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLART  178 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccc
Confidence             57999999996 599999988888999999999999999999999999999999999999986654  99999999985


Q ss_pred             ccCCC-----------------------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhC----------
Q 017860          171 SVLHS-----------------------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG----------  217 (365)
Q Consensus       171 ~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g----------  217 (365)
                      .....                       .....+||++|+|||++......++++|||||||++|||++|          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            43321                       236678999999999975544444559999999999999984          


Q ss_pred             -CCCCCCCCC-----------------hHHHHHHHHHHh--------------------ccccCCC-----CCCCCCHHH
Q 017860          218 -GYPFEDPDE-----------------PKDFRKTIQRIL--------------------SVQYSVP-----DTNPISQEC  254 (365)
Q Consensus       218 -~~pf~~~~~-----------------~~~~~~~~~~~~--------------------~~~~~~~-----~~~~~s~~~  254 (365)
                       .++|.+.+.                 ..++..+...+.                    ......+     ....+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence             444444321                 111111111110                    0001111     013479999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+||.+||+.||.+|||++|+|+||||......
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            999999999999999999999999999875443

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-52  Score=406.35  Aligned_cols=254  Identities=35%  Similarity=0.606  Sum_probs=211.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++...    ......+.+|+.+++.++||||++++++|.....+|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46899999999999999999999999999999999753    22335677899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~  175 (365)
                      |||+++|+|..++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++  ++||+|||+++... ...
T Consensus       227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~--~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG--HIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS--CEEECCCCCCCTTCC---
T ss_pred             EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC--CEEEccCCCceeccCCCc
Confidence            9999999999999988899999999999999999999998 9999999999999998765  49999999997533 233


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.....    ..+......+|  ..+++++.
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~  377 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLGPEAK  377 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHHhCCCCCC--ccCCHHHH
Confidence            4566789999999999988888766 99999999999999999999876654333    33333444444  34899999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          256 DLISRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       256 ~li~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      +||.+||+.||.+||     |++|+++||||...
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999999     99999999999753

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-52  Score=390.70  Aligned_cols=265  Identities=30%  Similarity=0.437  Sum_probs=211.5

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ....++|+++++||+|+||+||+|++..+++.||+|++.....   ....+.+|+.+++.++||||+++++++.....+|
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3445689999999999999999999999999999999975432   2345779999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CCCEEEecCCCccccc
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSV  172 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~---~~~vkl~Dfgla~~~~  172 (365)
                      +||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++   .+.+||+|||+++...
T Consensus       110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9999997 49999999988899999999999999999999999999999999999995432   2359999999987543


Q ss_pred             C-CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CC------
Q 017860          173 L-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV------  244 (365)
Q Consensus       173 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~------  244 (365)
                      . .......+||+.|+|||++.+....+.++|||||||++|+|++|..||..........++......... .+      
T Consensus       189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            2 233455678999999999987654445599999999999999999999987776655555543221111 00      


Q ss_pred             CCC-----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 PDT-----------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 ~~~-----------------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +.+                 ..+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            000                 1167899999999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.6e-53  Score=414.62  Aligned_cols=257  Identities=27%  Similarity=0.419  Sum_probs=222.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.+.    ......+.+|+.+++.++||||++++++|.+...+|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            45799999999999999999999999999999999753    22345678999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           98 MEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      |||++||+|..++...+.  +++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g--~vKL~DFGla~~~~~~~  340 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG--HIRISDLGLAVHVPEGQ  340 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCTTC
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC--CeEEEecccceecccCc
Confidence            999999999999987544  99999999999999999999999999999999999998665  49999999998765555


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........+...+......++  ..+|++++
T Consensus       341 ~~~~~~GT~~Y~APEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~  417 (576)
T 2acx_A          341 TIKGRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQAR  417 (576)
T ss_dssp             CEECCCSCGGGCCHHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHH
T ss_pred             cccccCCCccccCHHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHH
Confidence            5566789999999999988888766 99999999999999999999876543222233333444444443  45899999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017860          256 DLISRIFVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      +||.+||+.||.+||     +++|+++||||+.
T Consensus       418 dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            999999999999999     8999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-52  Score=388.69  Aligned_cols=258  Identities=32%  Similarity=0.578  Sum_probs=223.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++.....       ..+.+.+|+.+++.++||||+++++++.....+
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            4579999999999999999999999999999999976432       246789999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC--CEEEecCCCccccc
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--RLKICDFGYSKSSV  172 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~--~vkl~Dfgla~~~~  172 (365)
                      ++||||+++++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++..  ++||+|||+++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            9999999999999999988889999999999999999999999999999999999999866522  59999999998765


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCCC
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPI  250 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  250 (365)
                      .........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.......    ..+.......+.  ...+
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          171 DGVEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             TTCCCCCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTC
T ss_pred             ccccccccCCCCCccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHhcccccChhhhccc
Confidence            5555566789999999999988777666 99999999999999999999876554332    233333332221  2457


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ++.+.+||.+||..||.+|||+.++++||||...
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            8999999999999999999999999999999753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.4e-52  Score=378.80  Aligned_cols=256  Identities=30%  Similarity=0.550  Sum_probs=210.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++.++||+|+||.||+|+++.++..||+|++....  ...+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            358999999999999999999999999999999997643  234778999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEecCCCcccccCC
Q 017860          100 YASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus       100 ~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-~~~~vkl~Dfgla~~~~~~  174 (365)
                      |+++++|.+.+..    ...+++..++.++.||+.||+|||++||+||||||+||+++.+ ..+.+||+|||+++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~  180 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD  180 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence            9999999998854    3679999999999999999999999999999999999999643 2346999999999866555


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-CCCCCCCCHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-VPDTNPISQE  253 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~  253 (365)
                      .......||+.|+|||++. ..++. ++|||||||++|+|++|+.||.+........    ........ ......++++
T Consensus       181 ~~~~~~~~t~~y~aPE~~~-~~~~~-~~Di~slG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  254 (285)
T 3is5_A          181 EHSTNAAGTALYMAPEVFK-RDVTF-KCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ----KATYKEPNYAVECRPLTPQ  254 (285)
T ss_dssp             ------CTTGGGCCHHHHT-TCCCH-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCC--CCCCHH
T ss_pred             ccCcCcccccCcCChHHhc-cCCCc-ccCeehHHHHHHHHHhCCCCCCCCCHHHHHh----hhccCCcccccccCcCCHH
Confidence            5566778999999999985 44554 4999999999999999999998765433222    11112221 1223447899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +.+||.+||+.||.+|||+.|+|+||||++
T Consensus       255 ~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          255 AVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999999999999999999999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.1e-52  Score=383.48  Aligned_cols=263  Identities=29%  Similarity=0.474  Sum_probs=212.8

Q ss_pred             CCCccee-cccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEE
Q 017860           22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .++|++. +.||+|+||.||+|+++.+++.||+|++..... ....+.+|+.+++++ +||||+++++++...+.+|+||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            4589996 789999999999999999999999999976543 346788999999884 7999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEecCCCcccccCC---
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH---  174 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~-~~vkl~Dfgla~~~~~~---  174 (365)
                      ||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ..+||+|||+++.....   
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            99999999999998888999999999999999999999999999999999999976543 35999999998754321   


Q ss_pred             -----CCCCCCcCCCCCCCchhhcc-----cccCCccceeehhhHHHHHHHhCCCCCCCCCChH-----------HHHHH
Q 017860          175 -----SQPKSTVGTPAYIAPEVLLR-----HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRKT  233 (365)
Q Consensus       175 -----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----------~~~~~  233 (365)
                           ......+||+.|+|||++.+     ..++.+ +|||||||++|+|++|+.||.......           .....
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTT-HHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcc-cccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                 11234569999999999865     445555 999999999999999999998754321           11222


Q ss_pred             HHHHhccccCCCC--CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          234 IQRILSVQYSVPD--TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       234 ~~~~~~~~~~~~~--~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ...+.......+.  +..+++++++||.+||+.||.+|||++|+++||||+...
T Consensus       250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            3333344444332  245889999999999999999999999999999998654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.3e-52  Score=382.03  Aligned_cols=261  Identities=26%  Similarity=0.417  Sum_probs=212.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++++.||+|+||+||+|++..+|+.||+|++......   .+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            5899999999999999999999999999999998654332   3567789999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~~  178 (365)
                      |+++++|..++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++.... .....
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS--VIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECC-------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC--CEEEeeCCCchhccCcccccC
Confidence            999999999988888899999999999999999999999999999999999998665  499999999875442 22334


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------ccC
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------QYS  243 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~  243 (365)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|..||.+.................               ...
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            56799999999999764444455999999999999999999998877655444333221110               001


Q ss_pred             CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          244 VPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       244 ~~~----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .+.          ...+++++.+||.+||+.||.+|||++++++||||.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            111          134788999999999999999999999999999997643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=401.04  Aligned_cols=258  Identities=26%  Similarity=0.448  Sum_probs=216.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|++.+..    .....+.+|..++..++||||++++++|.+...+|+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l  138 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL  138 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            3468999999999999999999999999999999997532    123457889999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||++||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++......
T Consensus       139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g--~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG--HIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECCTTS
T ss_pred             EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC--CEEEeechhheeccCCC
Confidence            99999999999999875 4799999999999999999999999999999999999998665  49999999997654333


Q ss_pred             C--CCCCcCCCCCCCchhhcc-------cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          176 Q--PKSTVGTPAYIAPEVLLR-------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       176 ~--~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      .  ....+||+.|+|||++..       ..++.+ +|||||||++|||++|+.||...+....+.++....  .....|.
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~  293 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE-CDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPL  293 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC-
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChH-HhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCc
Confidence            2  345689999999999973       455555 999999999999999999998876655444443321  1122332


Q ss_pred             -CCCCCHHHHHHHHHhcccCCCCC---CCHHHHhcCcccccC
Q 017860          247 -TNPISQECRDLISRIFVADPAAR---ITIPEIMKHQWFLKN  284 (365)
Q Consensus       247 -~~~~s~~~~~li~~~l~~dp~~R---~t~~ell~h~~f~~~  284 (365)
                       ...+|+++++||.+||. +|.+|   |+++|+++||||..-
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i  334 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL  334 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence             24589999999999998 99998   599999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.1e-52  Score=391.74  Aligned_cols=249  Identities=29%  Similarity=0.477  Sum_probs=217.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.....         ....+.+|+.+++.++||||++++++|.....
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            579999999999999999999999999999999986532         22356789999999999999999999999999


Q ss_pred             EEEEEeecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           94 LAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        94 ~~lv~e~~~~g-~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      +++||||+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF--TIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS--CEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC--cEEEeecccceECC
Confidence            99999999766 9999999888999999999999999999999999999999999999998665  49999999998765


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      ........+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.....          ....  ....+..+++
T Consensus       182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~--~~~~~~~~~~  249 (335)
T 3dls_A          182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEA--AIHPPYLVSK  249 (335)
T ss_dssp             TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTT--CCCCSSCCCH
T ss_pred             CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhh--ccCCCcccCH
Confidence            555556678999999999998888766669999999999999999999975322          1111  2233344899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ++.+||.+||+.||.+|||++++++||||.+..
T Consensus       250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            999999999999999999999999999998654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-52  Score=379.32  Aligned_cols=258  Identities=36%  Similarity=0.598  Sum_probs=221.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      ++|++.+.||+|+||.||+|.++.++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.....+++||||+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   88 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC   88 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence            47999999999999999999999999999999997643 23467899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEecCCCcccccCCCCCCCC
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~-~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      ++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||++.. +..+.+||+|||++............
T Consensus        89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~  168 (277)
T 3f3z_A           89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK  168 (277)
T ss_dssp             CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCC
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhcc
Confidence            99999999998888999999999999999999999999999999999999932 12335999999999876656666677


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCCCCHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLI  258 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li  258 (365)
                      .||+.|+|||++.+. ++.+ +|||||||++|+|++|+.||...........    +.......+.  +..+++.+.+||
T Consensus       169 ~~t~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li  242 (277)
T 3f3z_A          169 VGTPYYVSPQVLEGL-YGPE-CDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLI  242 (277)
T ss_dssp             CSCTTTCCHHHHTTC-BCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHHHHHH
T ss_pred             CCCCCccChHHhccc-CCch-hhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCchhhhcCCHHHHHHH
Confidence            899999999998654 5555 9999999999999999999988665443332    2233333332  235789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      .+||+.||.+|||+.++++||||++...
T Consensus       243 ~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          243 RRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             HHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            9999999999999999999999976543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-52  Score=388.91  Aligned_cols=260  Identities=26%  Similarity=0.451  Sum_probs=207.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++++.||+|+||.||+|+++.+++.||+|++.....  ....+.+|+.+++.++||||+++++++.....+++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            589999999999999999999999999999999865332  122455799999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCC
Q 017860          101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~  178 (365)
                      +. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ....
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC--------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccc
Confidence            97 58888887654 5999999999999999999999999999999999999986654  999999998754322 2334


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCC------------
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVP------------  245 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------------  245 (365)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......... .++            
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYN  238 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccc
Confidence            5678999999999977544445599999999999999999999987765554444432221110 000            


Q ss_pred             -----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          246 -----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       246 -----------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                                 ....+++++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                       1124688999999999999999999999999999998654

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=396.98  Aligned_cols=256  Identities=30%  Similarity=0.531  Sum_probs=214.5

Q ss_pred             Ccce--ecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           24 RYDF--VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        24 ~y~~--~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .|++  .+.||+|+||.||+|.++.+|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.....+++||||
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            4555  678999999999999999999999999998654 2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      +++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..+..+++||+|||+++..........
T Consensus       168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~  247 (373)
T 2x4f_A          168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV  247 (373)
T ss_dssp             CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence            9999999988654 469999999999999999999999999999999999999644455699999999987665555666


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCCHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDL  257 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  257 (365)
                      .+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+....+.++.    ...+..+  ....+++++.+|
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL----ACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----HTCCCSCSGGGTTSCHHHHHH
T ss_pred             ccCCCcEeChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hccCCCChhhhccCCHHHHHH
Confidence            789999999999987776655 999999999999999999998876654444333    2333222  234689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |.+||+.||.+|||+.|+|+||||...
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1e-52  Score=400.98  Aligned_cols=258  Identities=34%  Similarity=0.565  Sum_probs=207.2

Q ss_pred             CCccee-cccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHH-hcCCCCCcceeceEEEe----CCEEEE
Q 017860           23 DRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHLAI   96 (365)
Q Consensus        23 ~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~----~~~~~l   96 (365)
                      ++|.+. +.||+|+||+||++.++.+|+.||||++..    ...+.+|+.++ +..+||||++++++|..    ...+|+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            468777 789999999999999999999999999874    35677888876 55689999999999876    667999


Q ss_pred             EEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccC
Q 017860           97 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~  173 (365)
                      |||||.||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++....
T Consensus       137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~  216 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  216 (400)
T ss_dssp             EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence            999999999999998753  599999999999999999999999999999999999998632 35699999999986655


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCCCC
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPIS  251 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s  251 (365)
                      .......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+....+..  +.+..+|
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          217 HNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             ----------CTTCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             CCccccCCCCCCccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence            555667789999999999988887766 9999999999999999999987543221111122222333333  3446689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999999997643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.6e-52  Score=408.51  Aligned_cols=257  Identities=30%  Similarity=0.429  Sum_probs=220.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++.+..    .....+.+|+.+++.++||||++++++|.....+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            358999999999999999999999999999999997532    2335688999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           98 MEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |||++||+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g--~vkL~DFGla~~~~~  341 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG--NVRISDLGLAVELKA  341 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS--CEEECCCTTCEECCT
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC--CEEEeecceeeeccC
Confidence            9999999999998764    3699999999999999999999999999999999999998665  499999999986544


Q ss_pred             CCC-CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          174 HSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       174 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      ... ....+||+.|+|||++.+..++.+ +|||||||++|||++|+.||...............+......+|  ..+|+
T Consensus       342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~  418 (543)
T 3c4z_A          342 GQTKTKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSP  418 (543)
T ss_dssp             TCCCBCCCCSCTTTSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCH
T ss_pred             CCcccccccCCccccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCH
Confidence            333 334589999999999988888766 99999999999999999999876543223344444554444444  45899


Q ss_pred             HHHHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          253 ECRDLISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      ++.+||.+||+.||.+||+     ++++++||||+.
T Consensus       419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            9999999999999999995     589999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.4e-52  Score=400.21  Aligned_cols=270  Identities=26%  Similarity=0.382  Sum_probs=219.3

Q ss_pred             CCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC------CCCCcceeceEE
Q 017860           15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL------RHPNIVRFKEVI   88 (365)
Q Consensus        15 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l------~hpnIv~l~~~~   88 (365)
                      ..+.-....+|++++.||+|+||+||+|.+..+++.||+|++.........+.+|+.+++.+      +|+||+++++++
T Consensus        89 ~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~  168 (429)
T 3kvw_A           89 QVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF  168 (429)
T ss_dssp             CCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred             ccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence            33444456789999999999999999999999999999999987655556777888888776      678999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           89 LTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        89 ~~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                      .....+++||||+. ++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.++...+||+|||
T Consensus       169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999999999996 58999887654  4999999999999999999999999999999999999987765569999999


Q ss_pred             CcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----
Q 017860          167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----  242 (365)
Q Consensus       167 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----  242 (365)
                      +++..  .......+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+....+..++........    
T Consensus       248 ~a~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYE--HQRVYTYIQSRFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEET--TCCCCSSCSCGGGCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceec--CCcccccCCCCCccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            98643  334456789999999999988888766 99999999999999999999987766555444432111000    


Q ss_pred             ------------CCC-----------------------------C--------CCCCCHHHHHHHHHhcccCCCCCCCHH
Q 017860          243 ------------SVP-----------------------------D--------TNPISQECRDLISRIFVADPAARITIP  273 (365)
Q Consensus       243 ------------~~~-----------------------------~--------~~~~s~~~~~li~~~l~~dp~~R~t~~  273 (365)
                                  ..+                             .        ....++++.+||.+||+.||.+|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence                        000                             0        012378899999999999999999999


Q ss_pred             HHhcCcccccCCCCC
Q 017860          274 EIMKHQWFLKNLPAD  288 (365)
Q Consensus       274 ell~h~~f~~~~~~~  288 (365)
                      |+|+||||++..+..
T Consensus       405 e~L~Hpw~~~~~~~~  419 (429)
T 3kvw_A          405 QALRHPWLRRRLPKP  419 (429)
T ss_dssp             HHHTSTTTC------
T ss_pred             HHhCChhhccCCCCC
Confidence            999999998876543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.1e-52  Score=388.22  Aligned_cols=259  Identities=36%  Similarity=0.597  Sum_probs=200.0

Q ss_pred             Cccee---cccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFV---RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~---~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +|++.   +.||+|+||.||+|.++.+++.||+|++.+.  ....+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            57775   7899999999999999999999999999764  3467889999999997 9999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccCC-CCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      |+.+|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+++..... ...
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            999999999999988999999999999999999999999999999999999997654 225999999999754332 334


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccccCCCC--CCCCCH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYSVPD--TNPISQ  252 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~s~  252 (365)
                      ...+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......   ....+....+....+..+.  +..+|+
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ  245 (325)
T ss_dssp             -----------------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred             cccCCCcCccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence            56678999999999988877665 99999999999999999999865431   1123344445444443332  235899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ++++||.+||+.||.+|||+.++++||||+...
T Consensus       246 ~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             HHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            999999999999999999999999999998643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.4e-52  Score=374.32  Aligned_cols=258  Identities=40%  Similarity=0.715  Sum_probs=213.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||++.++.+|+.||+|++....    ...+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            468999999999999999999999999999999987532    2345788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||+.+++|.+++...+++++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++.........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC----
T ss_pred             EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcce
Confidence            999999999999998888999999999999999999999999999999999999986654  999999998866555555


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+..+.+.++||||||+++|+|++|..||........    ...+.......  +..++..+.+|
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~--~~~~~~~l~~l  241 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL----FKKIRGGVFYI--PEYLNRSVATL  241 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCC--CTTSCHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH----HHHhhcCcccC--chhcCHHHHHH
Confidence            5678999999999998777655669999999999999999999987554332    22222333333  33478999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      |.+||+.||.+|||+.++++||||++.++.
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h~~~~~~~~~  271 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREHEWFKQDLPS  271 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred             HHHHccCChhhCCCHHHHHhChhhccCchh
Confidence            999999999999999999999999887654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-51  Score=388.54  Aligned_cols=260  Identities=26%  Similarity=0.409  Sum_probs=210.0

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCC----
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT----   92 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----   92 (365)
                      ...++|++++.||+|+||.||+|.++.+|+.||||++.....   ..+.+.+|+.+++.++||||+++++++....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            345789999999999999999999999999999999865332   2356789999999999999999999998763    


Q ss_pred             --EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           93 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        93 --~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                        .+|+||||+ +++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~  177 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQ  177 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeecccc
Confidence              469999999 8899998876 57999999999999999999999999999999999999987654  99999999986


Q ss_pred             ccCCCCCCCCcCCCCCCCchhhcc-cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--------
Q 017860          171 SVLHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--------  241 (365)
Q Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------  241 (365)
                      ..  ......+||++|+|||++.+ ..++ .++|||||||++|+|++|+.||.+.+....+.++........        
T Consensus       178 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          178 AD--SEMTGYVVTRWYRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             CC--SSCCSSCSCGGGCCTHHHHTTTCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cc--cccCcCcCCCCcCCHHHHhCCCCCC-hhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            43  33456789999999999987 4454 449999999999999999999998776655554443221110        


Q ss_pred             -----------cCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          242 -----------YSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       242 -----------~~~------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                                 ...      ......++++.+||.+||+.||.+|||++++|+||||.+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                       000      012346899999999999999999999999999999987543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3e-51  Score=379.75  Aligned_cols=255  Identities=29%  Similarity=0.491  Sum_probs=216.9

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS  102 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~  102 (365)
                      .|+..++||+|+||.||+|+++.+|+.||||++..... ..+.+.+|+.+++.++||||+++++++.....+++||||+.
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            37888999999999999999999999999999976443 34668899999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCCCCc
Q 017860          103 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTV  181 (365)
Q Consensus       103 ~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~~~~  181 (365)
                      +++|.+++.+ .++++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||+++...... ......
T Consensus       126 ~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          126 GGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             SCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCcccccccc
Confidence            9999998764 46999999999999999999999999999999999999986654  9999999987544332 334568


Q ss_pred             CCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       182 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      ||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... +..  ...........+++.+.+||.+|
T Consensus       203 gt~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~l~~li~~~  278 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRD--SPPPKLKNSHKVSPVLRDFLERM  278 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-HHH--SSCCCCTTGGGSCHHHHHHHHHH
T ss_pred             CCccccCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhc--CCCCCcCccccCCHHHHHHHHHH
Confidence            9999999999988877766 9999999999999999999987655433222 221  11122333445789999999999


Q ss_pred             cccCCCCCCCHHHHhcCcccccCC
Q 017860          262 FVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       262 l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      |+.||.+|||+.++++||||.+..
T Consensus       279 l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          279 LVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             ccCChhhCcCHHHHhcChhhccCC
Confidence            999999999999999999998654

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-51  Score=385.48  Aligned_cols=266  Identities=26%  Similarity=0.400  Sum_probs=214.2

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEe---
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT---   90 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~---   90 (365)
                      |.....++|++++.||+|+||.||+|+++.+|+.||+|++....   .....+.+|+.+++.++||||+++++++..   
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           11 PFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             TTSCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cccccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            33344568999999999999999999999999999999986533   234678899999999999999999999987   


Q ss_pred             -----CCEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 017860           91 -----PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD  164 (365)
Q Consensus        91 -----~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~D  164 (365)
                           .+.+|+||||+.+ +|...+.. ..++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|
T Consensus        91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~D  167 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLAD  167 (351)
T ss_dssp             ------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECC
T ss_pred             ccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEcc
Confidence                 4568999999975 67666655 457999999999999999999999999999999999999986664  99999


Q ss_pred             CCCccccc-----CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc
Q 017860          165 FGYSKSSV-----LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       165 fgla~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      ||+++...     .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+......
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  247 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  247 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99987543     2223345678999999999977554445599999999999999999999987765554444333222


Q ss_pred             cccC-CCCCC-------------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          240 VQYS-VPDTN-------------------------PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       240 ~~~~-~~~~~-------------------------~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .... ++...                         ..++.+.+||.+||+.||.+|||++|+|+||||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            1111 11100                         0267899999999999999999999999999997654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.2e-51  Score=388.04  Aligned_cols=261  Identities=25%  Similarity=0.413  Sum_probs=216.2

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----CCCcceeceEEEeC
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFKEVILTP   91 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~l~~~~~~~   91 (365)
                      ++....++|+++++||+|+||+||+|++..+++.||+|++...........+|+.+++.+.     ||||+++++++...
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            3344467999999999999999999999999999999999765555567788999999886     99999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--------------
Q 017860           92 THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS--------------  155 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~--------------  155 (365)
                      ..+++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++..              
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~  187 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD  187 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccc
Confidence            9999999999 899999998754  59999999999999999999999999999999999999751              


Q ss_pred             ---------CCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC
Q 017860          156 ---------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE  226 (365)
Q Consensus       156 ---------~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  226 (365)
                               ..+.+||+|||+++...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.
T Consensus       188 ~~~~~~~~~~~~~~kl~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          188 GKKIQIYRTKSTGIKLIDFGCATFKS--DYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             CCEEEEEEESCCCEEECCCTTCEETT--SCCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccCCCCEEEEeccCceecC--CCCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcH
Confidence                     24469999999987532  33456789999999999998888766 9999999999999999999988665


Q ss_pred             hHHHHHHHHHHhccc-----------------------cCCCCCC------------------CCCHHHHHHHHHhcccC
Q 017860          227 PKDFRKTIQRILSVQ-----------------------YSVPDTN------------------PISQECRDLISRIFVAD  265 (365)
Q Consensus       227 ~~~~~~~~~~~~~~~-----------------------~~~~~~~------------------~~s~~~~~li~~~l~~d  265 (365)
                      ......+. ......                       ..+|...                  ..++.+.+||.+||+.|
T Consensus       265 ~~~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  343 (360)
T 3llt_A          265 MEHLAMME-SIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQID  343 (360)
T ss_dssp             HHHHHHHH-HHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHH-HhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCC
Confidence            44333322 211110                       0011110                  12477889999999999


Q ss_pred             CCCCCCHHHHhcCcccc
Q 017860          266 PAARITIPEIMKHQWFL  282 (365)
Q Consensus       266 p~~R~t~~ell~h~~f~  282 (365)
                      |.+|||++|+|+||||+
T Consensus       344 P~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          344 PTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGGSCCHHHHTTSGGGC
T ss_pred             hhhCCCHHHHhcCcccC
Confidence            99999999999999995

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-51  Score=386.43  Aligned_cols=266  Identities=27%  Similarity=0.417  Sum_probs=213.2

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCcceeceEEEe
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILT   90 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~   90 (365)
                      ..-...++|++.+.||+|+||.||+|+++.+|+.||+|++.....      ....+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (346)
T 1ua2_A            4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH   83 (346)
T ss_dssp             ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence            333446789999999999999999999999999999999865321      23568899999999999999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           91 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      ...+++||||+.+ +|...+... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++
T Consensus        84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~  160 (346)
T 1ua2_A           84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAK  160 (346)
T ss_dssp             TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGS
T ss_pred             CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccce
Confidence            9999999999976 888888664 46899999999999999999999999999999999999986654  9999999998


Q ss_pred             cccC-CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCCC-
Q 017860          170 SSVL-HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVPD-  246 (365)
Q Consensus       170 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-  246 (365)
                      .... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+....+.++......... .++. 
T Consensus       161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            6533 233455689999999999976554455599999999999999999999987776666555544322111 1110 


Q ss_pred             --------------------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          247 --------------------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       247 --------------------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                                          ...+++++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                                134678999999999999999999999999999998653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.1e-52  Score=401.23  Aligned_cols=257  Identities=34%  Similarity=0.570  Sum_probs=207.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------ccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      .++|++.+.||+|+||+||+|.++.+++.||+|++.+...         ....+.+|+.+++.++||||+++++++. ..
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            4689999999999999999999999999999999975321         1134789999999999999999999985 45


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~  171 (365)
                      .+|+||||+.+|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++ ...+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            5899999999999999998888999999999999999999999999999999999999997543 335999999999876


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--C
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--D  246 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  246 (365)
                      .........+||+.|+|||++.+   ..+ +.++|||||||++|+|++|+.||........+...+.   ......+  .
T Consensus       293 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~  368 (419)
T 3i6u_A          293 GETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEV  368 (419)
T ss_dssp             C-----------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHH
T ss_pred             CCCccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchh
Confidence            65555667789999999999854   334 3459999999999999999999987655443333332   2222221  2


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +..+++.+.+||.+||+.||.+|||++++|+||||+.
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            2457999999999999999999999999999999964

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-51  Score=391.39  Aligned_cols=257  Identities=25%  Similarity=0.420  Sum_probs=212.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe-----------
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----------   90 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-----------   90 (365)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++......   ..+|+.+++.++||||++++++|..           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~   82 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQP   82 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTBCCEEEEEEEC----------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCccchhheeeecCccccccccc
Confidence            56899999999999999999999999999999999765432   3479999999999999999999954           


Q ss_pred             ---------------------------CCEEEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 017860           91 ---------------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQ  139 (365)
Q Consensus        91 ---------------------------~~~~~lv~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~al~~LH~~~  139 (365)
                                                 ...+++||||+++ +|.+.+.    ..+.+++..++.++.||+.||+|||++|
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g  161 (383)
T 3eb0_A           83 PDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG  161 (383)
T ss_dssp             ---------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             ccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence                                       3348999999985 7666554    4567999999999999999999999999


Q ss_pred             CeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCC
Q 017860          140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGY  219 (365)
Q Consensus       140 ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  219 (365)
                      |+||||||+|||++.. .+.+||+|||+++............||+.|+|||++.+....+.++|||||||++|+|++|+.
T Consensus       162 i~H~Dikp~Nil~~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          162 ICHRDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             EECSCCCGGGEEEETT-TTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCccCHHHEEEcCC-CCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            9999999999999732 235999999999876666666778899999999999876533445999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhccc-------------cCCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017860          220 PFEDPDEPKDFRKTIQRILSVQ-------------YSVP----------DTNPISQECRDLISRIFVADPAARITIPEIM  276 (365)
Q Consensus       220 pf~~~~~~~~~~~~~~~~~~~~-------------~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell  276 (365)
                      ||.+.+....+.+++.......             ..++          ....+++++.+||.+||+.||.+|||+.|+|
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM  320 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            9998877666655554322110             0111          1234788999999999999999999999999


Q ss_pred             cCccccc
Q 017860          277 KHQWFLK  283 (365)
Q Consensus       277 ~h~~f~~  283 (365)
                      +||||..
T Consensus       321 ~hp~f~~  327 (383)
T 3eb0_A          321 AHPFFDH  327 (383)
T ss_dssp             TSGGGHH
T ss_pred             cCHHHHH
Confidence            9999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.3e-51  Score=385.16  Aligned_cols=269  Identities=27%  Similarity=0.417  Sum_probs=219.5

Q ss_pred             CCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeC-
Q 017860           15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-   91 (365)
Q Consensus        15 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-   91 (365)
                      ....+...++|++++.||+|+||.||+|++..+++.||+|++.....  ....+.+|+.+++.++||||+++++++... 
T Consensus        19 ~g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   98 (364)
T 3qyz_A           19 RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   98 (364)
T ss_dssp             C-CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             ccEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCC
Confidence            34445556799999999999999999999999999999999975332  235688999999999999999999999765 


Q ss_pred             ----CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           92 ----THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        92 ----~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                          ..+|+||||+. ++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+
T Consensus        99 ~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~  174 (364)
T 3qyz_A           99 IEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGL  174 (364)
T ss_dssp             TTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTT
T ss_pred             ccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcc
Confidence                46899999997 589888865 46999999999999999999999999999999999999986654  99999999


Q ss_pred             cccccCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-
Q 017860          168 SKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-  242 (365)
Q Consensus       168 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-  242 (365)
                      ++......    .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+......... 
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            87543322    2345689999999999866554445599999999999999999999988776665554432211110 


Q ss_pred             ---------------CCCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          243 ---------------SVPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       243 ---------------~~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                                     ..+.         ...+++++.+||.+||+.||.+|||+.|+|+||||.+...+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                           0010         13468999999999999999999999999999999876543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.4e-51  Score=373.06  Aligned_cols=259  Identities=36%  Similarity=0.619  Sum_probs=220.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++....  ...+.+.+|+.+++.++||||+++++++......|+||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            47999999999999999999999999999999987543  2346788999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC---CCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~---~~~  177 (365)
                      +++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++......   ...
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcc
Confidence            999999999987778999999999999999999999999999999999999986654  999999998753322   223


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+..+.+.++|||||||++|+|++|..||.............   .......+....+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH---HTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh---hhcccccCchhhcCHHHHHH
Confidence            456799999999999877765666999999999999999999998766543322222   22222233445689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      |.+||+.||.+|||++++++||||.+...
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            99999999999999999999999987653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-51  Score=374.62  Aligned_cols=254  Identities=33%  Similarity=0.627  Sum_probs=215.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||+|.++.++..||+|++....    .....+.+|+.+++.++||||+++++++......++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            358999999999999999999999999999999986532    2345688999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||+++++|.+.+....++++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||++..... ...
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~~  164 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRR  164 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC------
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-ccc
Confidence            999999999999998888999999999999999999999999999999999999976664  99999998864332 233


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+..++.+ +||||||+++|+|++|..||...+.....    ..+.......+  ..+++.+.+|
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~l  237 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETY----KRISRVEFTFP--DFVTEGARDL  237 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCC--TTSCHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHH----HHHHhCCCCCC--CcCCHHHHHH
Confidence            55679999999999988777665 99999999999999999999876543322    22333333333  3488999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      |.+||+.||.+|||+.|+++||||....
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCc
Confidence            9999999999999999999999997643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.7e-51  Score=414.71  Aligned_cols=253  Identities=32%  Similarity=0.537  Sum_probs=222.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++++.||+|+||.||+|+++.+++.||||++.+.    ....+.+.+|..++..+ +||||++++++|.+...+|+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999753    23346778899999887 79999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc-CCC
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~-~~~  175 (365)
                      ||||++||+|..++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+++... ...
T Consensus       420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g--~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG--HIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS--CEEECCCTTCEECCCTTC
T ss_pred             EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC--cEEEeecceeeccccCCc
Confidence            999999999999999988999999999999999999999999999999999999998766  49999999998533 233


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ...+.+||+.|+|||++.+..|+.+ +|||||||++|||++|+.||.+.+...    ....+......+|.  .+|+++.
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~  570 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDE----LFQSIMEHNVAYPK--SMSKEAV  570 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHSSCCCCCT--TSCHHHH
T ss_pred             ccccccCCCcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHH----HHHHHHhCCCCCCc--cCCHHHH
Confidence            4556789999999999988888766 999999999999999999998866543    34445555555554  4899999


Q ss_pred             HHHHHhcccCCCCCCCH-----HHHhcCccccc
Q 017860          256 DLISRIFVADPAARITI-----PEIMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~-----~ell~h~~f~~  283 (365)
                      +||.+||+.||.+||++     +++++||||..
T Consensus       571 ~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          571 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            99999999999999997     99999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.1e-51  Score=390.15  Aligned_cols=259  Identities=27%  Similarity=0.433  Sum_probs=202.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCC------
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------   92 (365)
                      .++|++++.||+|+||.||+|.+..+++.||+|++.....   ....+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            4689999999999999999999999999999999976432   2356789999999999999999999998765      


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|+||||+.+ +|.+.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAG  178 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-----
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccc
Confidence            78999999975 7887775  45899999999999999999999999999999999999986654  9999999998665


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------  242 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------  242 (365)
                      ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+++........          
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             cccccCCceecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            5445566789999999999988877766 99999999999999999999987765544443322110000          


Q ss_pred             -----CCCCCC---------------------CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          243 -----SVPDTN---------------------PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       243 -----~~~~~~---------------------~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                           ..+...                     ..++++++||.+||+.||.+|||++|+|+||||.....
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                 000000                     01567999999999999999999999999999986543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2e-51  Score=387.65  Aligned_cols=254  Identities=33%  Similarity=0.563  Sum_probs=217.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------ccHHHHHHHHHHhcC-CCCCcceeceEEEeCC
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSL-RHPNIVRFKEVILTPT   92 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~   92 (365)
                      ++|++.+.||+|+||.||+|+++.+|+.||||++.....         ..+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            469999999999999999999998999999999976432         134577899999998 7999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ..|+||||+.|++|.+++.....+++..++.++.||+.||.|||+.|++||||||+|||++.++.  +||+|||++....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~  251 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccC
Confidence            99999999999999999998888999999999999999999999999999999999999986654  9999999988766


Q ss_pred             CCCCCCCCcCCCCCCCchhhccc------ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--  244 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--  244 (365)
                      ........+||+.|+|||++.+.      .++.+ +|||||||++|+|++|..||...........    +....+..  
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~~~  326 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKE-VDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSS  326 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCH
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCch-hhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCC
Confidence            55556677899999999998632      35444 9999999999999999999987655433322    22232222  


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +.+..+++.+.+||.+||+.||.+|||+.++++||||.+
T Consensus       327 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            233567899999999999999999999999999999963

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.6e-52  Score=388.44  Aligned_cols=260  Identities=29%  Similarity=0.528  Sum_probs=213.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC------CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++...      ....+.+.+|+.+++.++||||+++++++.....++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            46899999999999999999999999999999998753      233467889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 017860           96 IVMEYASGGELFERICN----------------------------------------AGRFSEDEARFFFQQLISGVSYC  135 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qil~al~~L  135 (365)
                      +||||+++|+|.+++..                                        ...+++..++.++.||+.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998742                                        11246788999999999999999


Q ss_pred             HHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-----CCCCCcCCCCCCCchhhcc--cccCCccceeehhh
Q 017860          136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCG  208 (365)
Q Consensus       136 H~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG  208 (365)
                      |++||+||||||+|||++.++...+||+|||+++......     ......||+.|+|||++.+  ..++.+ +||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~DiwslG  263 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK-CDAWSAG  263 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH-HHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH-HHHHHHH
Confidence            9999999999999999987665579999999987532211     2345679999999999965  445444 9999999


Q ss_pred             HHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          209 VTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       209 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |++|+|++|+.||.+..............  ..+..+....+++++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus       264 ~il~el~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDADTISQVLNKK--LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHCCCCCCCCChHHHHHHHHhcc--cccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            99999999999998877655444333221  112223334579999999999999999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=8.4e-52  Score=375.99  Aligned_cols=257  Identities=33%  Similarity=0.619  Sum_probs=216.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ++|++.+.||+|+||.||+++++.+++.||+|++.....       ..+.+.+|+.+++.++||||+++++++.....++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            479999999999999999999999999999999876431       2467899999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~--~~~vkl~Dfgla~~~~~  173 (365)
                      +||||+.+++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++  ..++||+|||++.....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~  164 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA  164 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence            9999999999999998888899999999999999999999999999999999999997655  23699999999986555


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCC
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPIS  251 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  251 (365)
                      ........||+.|+|||++.+..++.+ +||||||+++|+|++|..||.........    ..+.......+  ....++
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~  239 (283)
T 3bhy_A          165 GNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETL----TNISAVNYDFDEEYFSNTS  239 (283)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCCHHHHTTCC
T ss_pred             CCcccccCCCcCccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHH----HHhHhcccCCcchhcccCC
Confidence            555556679999999999988777666 99999999999999999999876653322    22222222222  124578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +.+.+||.+||..||.+|||+.++++||||...
T Consensus       240 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            999999999999999999999999999999753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.5e-51  Score=373.35  Aligned_cols=257  Identities=32%  Similarity=0.522  Sum_probs=220.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----------cccHHHHHHHHHHhcCC-CCCcceeceEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----------KIDENVQREIINHRSLR-HPNIVRFKEVILT   90 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~   90 (365)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++....          ...+.+.+|+.+++.+. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999999999999999997643          12245778999999995 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      ...+++||||+.+++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++..
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~  173 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  173 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhh
Confidence            9999999999999999999998888999999999999999999999999999999999999986654  99999999986


Q ss_pred             ccCCCCCCCCcCCCCCCCchhhc------ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC-
Q 017860          171 SVLHSQPKSTVGTPAYIAPEVLL------RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS-  243 (365)
Q Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-  243 (365)
                      ...........||+.|+|||++.      ...++.+ +|||||||++|+|++|..||...+.......    +...... 
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~  248 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE-VDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQF  248 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCC
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcc-cccHhHHHHHHHHHHCCCCCcCccHHHHHHH----HhcCCccc
Confidence            65555556678999999999985      2344444 9999999999999999999987655433322    2222222 


Q ss_pred             -CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          244 -VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       244 -~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                       .+.+..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence             233456899999999999999999999999999999998654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-51  Score=379.56  Aligned_cols=249  Identities=21%  Similarity=0.256  Sum_probs=200.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc---HHHHHHHHHHh-cCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~-~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.......   ....+|+..+. ..+||||+++++++.....+|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            57999999999999999999999999999999986543222   23444554444 449999999999999999999999


Q ss_pred             eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      ||+ +++|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++........
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC-----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCC
Confidence            999 66888887664 46999999999999999999999999999999999999976664  999999998876555555


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.....   .    ..+............+++++.+|
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~el~~g~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~l~~l  284 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTA-ADVFSLGLTILEVACNMELPHGGEG---W----QQLRQGYLPPEFTAGLSSELRSV  284 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTH-HHHHHHHHHHHHHHHTCCCCSSHHH---H----HHHTTTCCCHHHHTTSCHHHHHH
T ss_pred             cccCCCccccCHhHhcC-CCCch-hhHHHHHHHHHHHHhCCCCCCCccH---H----HHHhccCCCcccccCCCHHHHHH
Confidence            66789999999999875 56555 9999999999999999777654321   1    11222111111223578999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCccccc
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      |.+||+.||.+|||++++++||||++
T Consensus       285 i~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          285 LVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-51  Score=377.01  Aligned_cols=258  Identities=35%  Similarity=0.598  Sum_probs=217.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||+|+||.||+++++.+|+.||+|++..... ....+.+|+.+++.++||||+++++++.....+|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            3589999999999999999999999999999999986533 335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~-~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      +++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||++.. +..+.+||+|||+++.... .....
T Consensus        88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~  166 (304)
T 2jam_A           88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GIMST  166 (304)
T ss_dssp             CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BTTHH
T ss_pred             CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Ccccc
Confidence            999999999988888999999999999999999999999999999999999932 2234599999999875332 22344


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCCCCHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQECRDL  257 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  257 (365)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.....  ..+.+..+++++.+|
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~l  241 (304)
T 2jam_A          167 ACGTPGYVAPEVLAQKPYSKA-VDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDF  241 (304)
T ss_dssp             HHSCCCBCCTTTBSSCSCCHH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHCCCCCCTTTTTTSCHHHHHH
T ss_pred             ccCCCCccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCCCccccccCCHHHHHH
Confidence            569999999999987777655 9999999999999999999987665433322    222322  223345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      |.+||..||.+|||+.++++||||....
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          242 ICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            9999999999999999999999997654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.1e-51  Score=386.58  Aligned_cols=261  Identities=28%  Similarity=0.455  Sum_probs=217.2

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ..++|++++.||+|+||.||++++..+++.||+|++....  .....+.+|+.+++.++||||+++++++.....+++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            3568999999999999999999999999999999997643  23357889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.  +||+|||++..... ...
T Consensus       111 e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~  187 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA  187 (360)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC-
T ss_pred             ECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccc
Confidence            9999999999999888899999999999999999999996 9999999999999987664  99999999864322 233


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHH---------------------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF---------------------------  230 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---------------------------  230 (365)
                      ....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.....                           
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK  266 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccc
Confidence            45689999999999988777655 99999999999999999999875432211                           


Q ss_pred             -----------HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          231 -----------RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       231 -----------~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                                 .+....+............++.++.+||.+||+.||.+|||++++|+||||+...
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             -------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             cccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence                       1112222222222222344789999999999999999999999999999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.9e-51  Score=371.38  Aligned_cols=253  Identities=34%  Similarity=0.638  Sum_probs=219.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||+|++..+++.||+|++...    ......+.+|+.+++.++||||+++++++.....+++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            35899999999999999999999999999999998653    22346788999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++..... ...
T Consensus        93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~  169 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPS-LRR  169 (284)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSS-SCB
T ss_pred             EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCcc-ccc
Confidence            999999999999998888999999999999999999999999999999999999976654  99999999865432 233


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ....||+.|+|||++.+..++.+ +||||||+++|+|++|..||........    ...+.......+  ..++.++.+|
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l  242 (284)
T 2vgo_A          170 RTMCGTLDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTET----HRRIVNVDLKFP--PFLSDGSKDL  242 (284)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTTCCCCC--TTSCHHHHHH
T ss_pred             ccccCCCCcCCHHHhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHH----HHHHhccccCCC--CcCCHHHHHH
Confidence            45679999999999988877666 9999999999999999999987655332    223333333333  4488999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |.+||..||.+|||+.++++||||...
T Consensus       243 i~~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          243 ISKLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            999999999999999999999999754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.9e-51  Score=379.74  Aligned_cols=262  Identities=26%  Similarity=0.430  Sum_probs=214.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++......   .+.+.+|+.+++.++||||+++++++.....+++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            456899999999999999999999999999999998764432   24577899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~  176 (365)
                      |||+.+++|..++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++  .+||+|||+++.... ...
T Consensus       103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG--VVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCCTTC---------
T ss_pred             EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC--cEEEEeCCCceeecCCccc
Confidence            99999999998888778899999999999999999999999999999999999998666  499999999875433 233


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc---------------c
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV---------------Q  241 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~---------------~  241 (365)
                      .....||+.|+|||++.+....+.++|||||||++|+|++|+.||...................               .
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG  260 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccccc
Confidence            4556799999999999876444455999999999999999999999877655554443321110               0


Q ss_pred             cCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          242 YSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       242 ~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ...+.          ...+++.+.+||.+||+.||.+|||+.|+|+||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            11111          12478999999999999999999999999999999653

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-51  Score=387.63  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=197.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC------C
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP------T   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~   92 (365)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.....   ....+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4699999999999999999999999999999999865432   235678999999999999999999999764      5


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|+|+|++ +++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~  183 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTA  183 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC--------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeecccccccc
Confidence            689999999 7899888865 57999999999999999999999999999999999999986654  9999999987543


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-----------  241 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  241 (365)
                        ......+||++|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+...+....           
T Consensus       184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  261 (367)
T 2fst_X          184 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  261 (367)
T ss_dssp             ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHH
T ss_pred             --ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence              2345568999999999998743334459999999999999999999998776655554443221110           


Q ss_pred             --------cCCCC------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          242 --------YSVPD------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       242 --------~~~~~------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                              ...+.      ....++.+.+||.+||+.||.+|||++++|+||||.+...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence                    00010      1246889999999999999999999999999999987543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-51  Score=372.12  Aligned_cols=254  Identities=30%  Similarity=0.528  Sum_probs=194.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||+|++..+|+.||+|++....    .....+.+|+.+++.++||||+++++++......++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            47999999999999999999999999999999997532    22367889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860           99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||++...... ..
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC-----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCCc
Confidence            999999999999875 56999999999999999999999999999999999999986654  999999998754322 22


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........    ..+....+.  .+..++.++.+
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~~  241 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTL----NKVVLADYE--MPSFLSIEAKD  241 (278)
T ss_dssp             -----------------------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCC--CCTTSCHHHHH
T ss_pred             ceeccCCCCcCCcchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHH----HHHhhcccC--CccccCHHHHH
Confidence            345679999999999987777655 99999999999999999999876543322    222222222  33457899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ||.+||+.||.+|||++++++||||.+..
T Consensus       242 li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          242 LIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999997643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.6e-51  Score=381.12  Aligned_cols=261  Identities=28%  Similarity=0.486  Sum_probs=216.2

Q ss_pred             CCCccee-cccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|.+. +.||+|+||.||+|+++.+++.||+|++....   .....+.+|+.+++.+. ||||+++++++.....+++
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4578888 89999999999999999999999999987532   23467889999999985 6999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccC
Q 017860           97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~  173 (365)
                      ||||+.+|+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||+++....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999988553  5699999999999999999999999999999999999997621 34699999999987655


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      ........||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.......+...  ...+..+....+++.
T Consensus       187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~  263 (327)
T 3lm5_A          187 ACELREIMGTPEYLAPEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV--NVDYSEETFSSVSQL  263 (327)
T ss_dssp             -------CCCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTTTTSCHH
T ss_pred             ccccccccCCcCccCCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--ccccCchhhcccCHH
Confidence            555566789999999999988877766 99999999999999999999887665443333221  222333444568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +.+||.+||+.||.+|||++++|+||||+...
T Consensus       264 ~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          264 ATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            99999999999999999999999999997653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.2e-50  Score=377.95  Aligned_cols=256  Identities=34%  Similarity=0.524  Sum_probs=221.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ..+|++.+.||+|+||.||++++..+++.||+|++.....    ..+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            5689999999999999999999999999999999976432    235678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      |||+.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus       120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred             EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCccc
Confidence            999999999999988888999999999999999999999999999999999999986654  999999998754422 23


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..........    .+....+..+  ..+++.+.+
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~  270 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNEYSIP--KHINPVAAS  270 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCC--TTSCHHHHH
T ss_pred             ccccCCCccccCHHHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHH----HHhcCCCCCC--ccCCHHHHH
Confidence            345679999999999988777666 999999999999999999998765433322    2233333333  357899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      ||.+||+.||.+|||++++++||||.....
T Consensus       271 li~~~l~~dp~~Rps~~ell~~~~~~~~~~  300 (335)
T 2owb_A          271 LIQKMLQTDPTARPTINELLNDEFFTSGYI  300 (335)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence            999999999999999999999999987653

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.6e-51  Score=377.89  Aligned_cols=258  Identities=24%  Similarity=0.434  Sum_probs=213.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEe--CCEEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIVM   98 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~   98 (365)
                      .++|++++.||+|+||.||+|++..+++.||+|++...  ..+.+.+|+.+++.++ ||||+++++++..  ....++||
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            56899999999999999999999999999999998753  3467899999999997 9999999999988  67799999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+.+++|..++.   .+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++.........
T Consensus       113 e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~  188 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYN  188 (330)
T ss_dssp             ECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCC
T ss_pred             eccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccc
Confidence            9999999998874   4899999999999999999999999999999999999985542 59999999998766666667


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc----------cc------
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV----------QY------  242 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------~~------  242 (365)
                      ...||+.|+|||++.+....+.++|||||||++|+|++|+.||............+......          ..      
T Consensus       189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (330)
T 3nsz_A          189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF  268 (330)
T ss_dssp             SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred             cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence            77899999999999774444455999999999999999999996654433222111111100          00      


Q ss_pred             ----------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          243 ----------------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       243 ----------------~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                                      .......+++++.+||.+||+.||.+|||++|+|+||||....
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~  327 (330)
T 3nsz_A          269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV  327 (330)
T ss_dssp             HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence                            0111223789999999999999999999999999999997643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-51  Score=379.64  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=209.9

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCC--CCcceeceEEEeCCEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRH--PNIVRFKEVILTPTHL   94 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~   94 (365)
                      ....+|++++.||+|+||.||++.+. +++.||+|++......   ...+.+|+.+++.++|  |||+++++++.....+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            34568999999999999999999985 6899999999764432   2567899999999976  9999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |+||| +.+++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.   +.+||+|||+++.....
T Consensus        85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~---~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCCC---
T ss_pred             EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC---CcEEEeecccccccCcc
Confidence            99999 558899999999889999999999999999999999999999999999999973   34999999999865433


Q ss_pred             CC---CCCCcCCCCCCCchhhcc-----------cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc
Q 017860          175 SQ---PKSTVGTPAYIAPEVLLR-----------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       175 ~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      ..   ....+||+.|+|||++.+           ..++ .++|||||||++|+|++|+.||.......   .....+...
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~  236 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDP  236 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCT
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCC-chhhHHHHHHHHHHHHhCCCcchhhhhHH---HHHHHHhcC
Confidence            22   345679999999999864           3444 44999999999999999999998755432   222333333


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       241 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ......+...+.++.+||.+||+.||.+|||+.++++||||+...
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            333344445678999999999999999999999999999997643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.9e-51  Score=390.12  Aligned_cols=258  Identities=28%  Similarity=0.427  Sum_probs=211.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeC------CEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~~l   96 (365)
                      .+|++.+.||+|+||.||+|+++.+|+.||||++.....   ...+|+.+++.++||||++++++|...      ..+++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            369999999999999999999999999999999976533   234799999999999999999998642      24789


Q ss_pred             EEeecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           97 VMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        97 v~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ||||+.+ +|...+.    ....+++..++.++.||+.||+|||++||+||||||+|||++.++ +.+||+|||+++...
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~-~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECC
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC-CeEEeccchhhhhcc
Confidence            9999976 5655543    356799999999999999999999999999999999999998543 248999999998765


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc------------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------  240 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------  240 (365)
                      ........+||++|+|||++.+....+.++|||||||++|||++|+.||.+.+....+.++++.+...            
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            55566677899999999999765333445999999999999999999999887766666555432111            


Q ss_pred             -ccCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          241 -QYSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       241 -~~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                       .+.++.          ...+++++.+||.+||+.||.+|||+.|+++||||....
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~  344 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  344 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence             111221          124689999999999999999999999999999997643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.6e-50  Score=368.48  Aligned_cols=256  Identities=34%  Similarity=0.515  Sum_probs=220.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||+++++.+++.||+|++.....    ..+.+.+|+.+++.++||||+++++++...+.+++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            4589999999999999999999999999999999876432    235678899999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      |||+.+++|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++..... ..
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCccc
Confidence            999999999999988888999999999999999999999999999999999999986654  999999998754432 23


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      .....||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.........    ..+.......  +..+++.+.+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~~  244 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETY----LRIKKNEYSI--PKHINPVAAS  244 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCC--CTTSCHHHHH
T ss_pred             cccccCCCCcCCcchhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhhccCCC--ccccCHHHHH
Confidence            345679999999999988777666 99999999999999999999876553332    2233333333  3458899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      ||.+||+.||.+|||++++++||||.+...
T Consensus       245 li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  274 (294)
T 2rku_A          245 LIQKMLQTDPTARPTINELLNDEFFTSGYI  274 (294)
T ss_dssp             HHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred             HHHHHcccChhhCcCHHHHhhChheecCCc
Confidence            999999999999999999999999987543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-50  Score=375.38  Aligned_cols=261  Identities=25%  Similarity=0.421  Sum_probs=213.5

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEe-----
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILT-----   90 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~-----   90 (365)
                      .+....++|++.+.||+|+||.||+|++..+++.||+|++.........+.+|+.+++.+ +||||+++++++..     
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            334557899999999999999999999999999999999987766678899999999998 79999999999987     


Q ss_pred             -CCEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           91 -PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        91 -~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                       ...+++||||+.+++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~  175 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGV  175 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcC
Confidence             56899999999999999999764  56999999999999999999999999999999999999986654  99999999


Q ss_pred             cccccCC-CCCCCCcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc
Q 017860          168 SKSSVLH-SQPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ  241 (365)
Q Consensus       168 a~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  241 (365)
                      +...... .......||+.|+|||++.     +..++.+ +|||||||++|+|++|..||...........    +....
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~  250 (326)
T 2x7f_A          176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNP  250 (326)
T ss_dssp             TC-------------CCGGGCCHHHHC--------CCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC
T ss_pred             ceecCcCccccccccCCccccChhhhccccccCcCCCcc-chHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCc
Confidence            8754322 2234567999999999986     3445545 9999999999999999999987665433222    22222


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       242 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ........+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            2222344578999999999999999999999999999999764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.6e-51  Score=380.71  Aligned_cols=251  Identities=23%  Similarity=0.342  Sum_probs=204.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCC--------
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--------   92 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--------   92 (365)
                      ++|++++.||+|+||.||+|+++.+|+.||||++....  ...+.+.+|+.+++.++||||++++++|.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            37999999999999999999999999999999997543  23467899999999999999999999986543        


Q ss_pred             -------------------------------------------------EEEEEEeecCCCChHHHHHhcCC---CCHHH
Q 017860           93 -------------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDE  120 (365)
Q Consensus        93 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~---l~~~~  120 (365)
                                                                       .+++|||||++++|.+++.+...   .++..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999987654   46677


Q ss_pred             HHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-------------CCCCCCcCCCCCC
Q 017860          121 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------------SQPKSTVGTPAYI  187 (365)
Q Consensus       121 ~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-------------~~~~~~~gt~~y~  187 (365)
                      ++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++.....             ......+||+.|+
T Consensus       166 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC--CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            999999999999999999999999999999998665  4999999998754433             2234457999999


Q ss_pred             CchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCC
Q 017860          188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPA  267 (365)
Q Consensus       188 aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~  267 (365)
                      |||++.+..++.+ +|||||||++|+|++|..|+..      .............. ......++++.+||.+||+.||.
T Consensus       244 aPE~~~~~~~~~~-~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~  315 (332)
T 3qd2_B          244 SPEQIHGNNYSHK-VDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPT  315 (332)
T ss_dssp             CHHHHHCCCCCTH-HHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGG
T ss_pred             ChHHhcCCCCcch-hhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCC
Confidence            9999988887666 9999999999999998776531      12222222222111 11123567889999999999999


Q ss_pred             CCCCHHHHhcCccccc
Q 017860          268 ARITIPEIMKHQWFLK  283 (365)
Q Consensus       268 ~R~t~~ell~h~~f~~  283 (365)
                      +|||+.++++||||.+
T Consensus       316 ~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          316 ERPEATDIIENAIFEN  331 (332)
T ss_dssp             GSCCHHHHHHSTTCCC
T ss_pred             cCCCHHHHhhchhhhc
Confidence            9999999999999964

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-50  Score=379.25  Aligned_cols=254  Identities=28%  Similarity=0.448  Sum_probs=214.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||.||+|++..+++.||+|++......    .+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4599999999999999999999999999999999764322    246789999999999999999999999999999999


Q ss_pred             eecCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~-~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      ||+. |+|.+.+. ....+++..++.++.|++.||+|||++||+||||||+|||++.++  .+||+|||+++....   .
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~---~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG--LVKLGDFGSASIMAP---A  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--EEEECCCTTCBSSSS---B
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC--CEEEeeccCceecCC---C
Confidence            9997 57877775 456799999999999999999999999999999999999998665  499999999875432   3


Q ss_pred             CCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          178 KSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ...+||+.|+|||++.   +..++.+ +|||||||++|+|++|+.||...+.........    ...........+++.+
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l  282 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPALQSGHWSEYF  282 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HSCCCCCCCTTSCHHH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----hcCCCCCCCCCCCHHH
Confidence            4568999999999985   3456555 999999999999999999998776544333322    2222222344578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      .+||.+||+.||.+|||++++++||||.+..++
T Consensus       283 ~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          283 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence            999999999999999999999999999876544

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-51  Score=379.20  Aligned_cols=258  Identities=21%  Similarity=0.344  Sum_probs=212.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCC--EEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~l   96 (365)
                      .+++|++.+.||+|+||+||+|+++.+++.||+|++....  ...+.+.+|+.+++.++||||+++++++....  .+++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            3568999999999999999999999999999999997543  23366789999999999999999999998765  7899


Q ss_pred             EEeecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCCCCCEEEecCCCcccc
Q 017860           97 VMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~--~~~~~~vkl~Dfgla~~~  171 (365)
                      ||||+.+++|.+++.....   +++..++.++.||+.||+|||++||+||||||+|||+.  .++.+.+||+|||+++..
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            9999999999999976443   99999999999999999999999999999999999982  122335999999999876


Q ss_pred             cCCCCCCCCcCCCCCCCchhhc--------ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLL--------RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-  242 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-  242 (365)
                      ..........||+.|+|||++.        +..++.+ +|||||||++|+|++|+.||..........+.+..+..... 
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~  245 (319)
T 4euu_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (319)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTT-HHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT
T ss_pred             CCCCceeecccCCCccCHHHhhhccccccccCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc
Confidence            6666566778999999999986        3455555 99999999999999999999865554433344444333221 


Q ss_pred             ------------------CCCCCC----CCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          243 ------------------SVPDTN----PISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       243 ------------------~~~~~~----~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                                        ..+...    .++..+.+||.+||+.||.+|||++|+|+||
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                              112111    2346789999999999999999999999997

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.5e-51  Score=383.93  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=205.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC-------EE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-------HL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------~~   94 (365)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|++...........+++..++.++||||++++++|....       .+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            46899999999999999999999999999999999877666677888899999999999999999997643       38


Q ss_pred             EEEEeecCCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEecC-CCCCCEEEecCCC
Q 017860           95 AIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDG-SPAPRLKICDFGY  167 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l----~~~~~l~~~~~~~i~~qil~al~~LH--~~~ivHrDlkp~NIli~~-~~~~~vkl~Dfgl  167 (365)
                      ++||||+.++ |...+    .....+++..++.++.|++.||.|||  ++||+||||||+|||++. ++  .+||+|||+
T Consensus       102 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~  178 (360)
T 3e3p_A          102 NVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGS  178 (360)
T ss_dssp             EEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTT
T ss_pred             EEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCC
Confidence            9999999875 43333    34567899999999999999999999  999999999999999985 43  599999999


Q ss_pred             cccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-----
Q 017860          168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----  242 (365)
Q Consensus       168 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----  242 (365)
                      ++............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.........     
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            987666666667789999999999976664445599999999999999999999987766655554442211100     


Q ss_pred             --------C-------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          243 --------S-------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       243 --------~-------------~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                              .             .......++++.+||.+||+.||.+|||+.|+|+||||.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence                    0             011122568899999999999999999999999999998653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.8e-51  Score=388.82  Aligned_cols=258  Identities=26%  Similarity=0.397  Sum_probs=209.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC------EEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~~   95 (365)
                      ..+|++.+.||+|+||+||+|++..+++ ||+|++......   ..+|+.+++.++||||++++++|....      .++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4579999999999999999999986665 888888654332   247999999999999999999996543      389


Q ss_pred             EEEeecCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCCEEEecCCCcccc
Q 017860           96 IVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        96 lv~e~~~~g~L~~~l---~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~-~~~~~~vkl~Dfgla~~~  171 (365)
                      +||||+.++.+....   .....+++..++.++.||+.||+|||++||+||||||+|||++ .++  .+||+|||+++..
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~  192 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKIL  192 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccc
Confidence            999999875443322   2356799999999999999999999999999999999999997 344  5999999999876


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------  241 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  241 (365)
                      .........+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+.+++.......          
T Consensus       193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  272 (394)
T 4e7w_A          193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN  272 (394)
T ss_dssp             CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGG
T ss_pred             cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence            6666667788999999999997765344559999999999999999999998877666655554321110          


Q ss_pred             ---cCCCC----------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          242 ---YSVPD----------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       242 ---~~~~~----------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                         ..++.          ...+++++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          273 YMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             GSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             hhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence               11111          223789999999999999999999999999999998654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-51  Score=384.33  Aligned_cols=259  Identities=29%  Similarity=0.524  Sum_probs=216.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC-----cccHHHHHHHHHHhcC-CCCCcceeceEEEeCC
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSL-RHPNIVRFKEVILTPT   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~   92 (365)
                      .++|++++.||+|+||.||++++.   .+++.||+|++.+..     ...+.+.+|+.+++.+ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            368999999999999999999984   589999999986432     2335677899999999 6999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+++||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~  210 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECC
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecc
Confidence            99999999999999999998888999999999999999999999999999999999999986654  9999999987543


Q ss_pred             CC--CCCCCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          173 LH--SQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       173 ~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ..  ......+||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...........+...+.......  +..
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~  288 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQE  288 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC--Ccc
Confidence            22  2234467999999999997532 233449999999999999999999986554333344444444443333  345


Q ss_pred             CCHHHHHHHHHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          250 ISQECRDLISRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      ++..+.+||.+||..||.+||     |++++++||||.+.
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            889999999999999999999     99999999999753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.4e-50  Score=385.19  Aligned_cols=255  Identities=24%  Similarity=0.390  Sum_probs=210.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC--CCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~~~l   96 (365)
                      ..+|++.+.||+|+||.||++.+.. ++.||||++.....   ....+.+|+.+++.++  ||||+++++++.....+|+
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            3469999999999999999999874 89999999976432   2356889999999996  5999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           97 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.   +.+||+|||+++...... 
T Consensus       134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~---~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS---SCEEECCCSSSCCC-----
T ss_pred             EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC---CeEEEEecCccccccCCCc
Confidence            999 568899999999889999999999999999999999999999999999999963   359999999998654332 


Q ss_pred             --CCCCCcCCCCCCCchhhcc-----------cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc
Q 017860          176 --QPKSTVGTPAYIAPEVLLR-----------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY  242 (365)
Q Consensus       176 --~~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  242 (365)
                        .....+||+.|+|||++.+           ..++ .++|||||||++|+|++|+.||.......   ..+..+.....
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~  285 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS-PKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNH  285 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTS
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCC-ChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccc
Confidence              2345689999999999865           2344 45999999999999999999998755432   22333444444


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ..+.+...+.++.+||.+||+.||.+|||+.++|+||||....
T Consensus       286 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          286 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            4444444688999999999999999999999999999997543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=6.3e-51  Score=371.36  Aligned_cols=256  Identities=38%  Similarity=0.649  Sum_probs=220.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|++++.||+|+||.||+|+++.+++.||+|++....   .....+.+|+.+++.++||||+++++++.....+++|||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  101 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence            48999999999999999999999999999999987532   234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |+.+++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.++ ...+||+|||++..........
T Consensus       102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~  181 (287)
T 2wei_A          102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK  181 (287)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence            999999999998888899999999999999999999999999999999999997643 3469999999988665555555


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCCCCHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQECRD  256 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  256 (365)
                      ...||+.|+|||++.+. ++.+ +||||||+++|+|++|..||...+....    ...+.....  ..+....+++++.+
T Consensus       182 ~~~~~~~y~aPE~~~~~-~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~  255 (287)
T 2wei_A          182 DRIGTAYYIAPEVLRGT-YDEK-CDVWSAGVILYILLSGTPPFYGKNEYDI----LKRVETGKYAFDLPQWRTISDDAKD  255 (287)
T ss_dssp             CHHHHHTTCCHHHHTTC-CCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCSGGGTTSCHHHHH
T ss_pred             cccCcccccChHHhcCC-CCCc-hhhHhHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCchhhhhcCHHHHH
Confidence            66799999999998654 5555 9999999999999999999987655332    222223332  33344568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ||.+||..||.+|||+.++++||||.+.
T Consensus       256 li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          256 LIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            9999999999999999999999999754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.2e-50  Score=367.08  Aligned_cols=256  Identities=23%  Similarity=0.382  Sum_probs=213.3

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe----CC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PT   92 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~   92 (365)
                      .....|++.+.||+|+||.||+|.+..++..||+|.+.....   ....+.+|+.+++.++||||+++++++..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            334568999999999999999999999999999999875432   23568899999999999999999999875    46


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEec-CCCCCCEEEecCCCcc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSK  169 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~-~~~~~~vkl~Dfgla~  169 (365)
                      .+++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|  ++||||||+|||++ .++  .+||+|||++.
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~  180 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLAT  180 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCcc
Confidence            68999999999999999998888999999999999999999999999  99999999999997 343  59999999986


Q ss_pred             cccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          170 SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ... ........||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||............+   ............
T Consensus       181 ~~~-~~~~~~~~~t~~y~aPE~~~~-~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~  254 (290)
T 1t4h_A          181 LKR-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKPASFDKV  254 (290)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---TTTCCCGGGGGC
T ss_pred             ccc-ccccccccCCcCcCCHHHHhc-cCCCc-chHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHH---hccCCccccCCC
Confidence            432 223345679999999998864 45555 999999999999999999998866655443322   222222222334


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .++++.+||.+||+.||.+|||+.++++||||++
T Consensus       255 ~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            6789999999999999999999999999999975

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-50  Score=369.59  Aligned_cols=257  Identities=24%  Similarity=0.375  Sum_probs=197.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc---HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ..++|++++.||+|+||.||+|++..+|+.||+|++.......   ..+.++...++.++||||+++++++..+...++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            3468999999999999999999999999999999987643222   2344455568889999999999999999999999


Q ss_pred             EeecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           98 MEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        98 ~e~~~~g~L~~~l~----~~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      |||+++ +|.+++.    ....+++..++.++.|++.||+|||++ |++||||||+||+++.++  ++||+|||+++...
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG--QVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC--CEEBCCC-------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC--CEEEeecCCccccc
Confidence            999975 7766654    356799999999999999999999998 999999999999998665  49999999998665


Q ss_pred             CCCCCCCCcCCCCCCCchhh----cccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          173 LHSQPKSTVGTPAYIAPEVL----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      .........||+.|+|||++    .+..++ .++|||||||++|+|++|+.||..........   ..............
T Consensus       162 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~  237 (290)
T 3fme_A          162 DDVAKDIDAGCKPYMAPERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQL---KQVVEEPSPQLPAD  237 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CC-HHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH---HHHHHSCCCCCCTT
T ss_pred             ccccccccCCCccccChhhcChhhcCcCCC-cHHHHHHHHHHHHHHHHCCCCccccCchHHHH---HHHhccCCCCcccc
Confidence            55555566899999999997    334444 45999999999999999999998754433221   12222222222334


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            589999999999999999999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.8e-51  Score=375.81  Aligned_cols=269  Identities=28%  Similarity=0.407  Sum_probs=195.1

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      .|+....++|++.+.||+|+||.||++.+..+++.||+|.+....  .....+.+|+.+++.++||||+++++++.....
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            455566789999999999999999999999899999999986532  234567899999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           94 LAIVMEYASGGELFERICN--------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~--------~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                      .++||||+.+++|.+++..        .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~df  165 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADF  165 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEec
Confidence            9999999999999999864        456899999999999999999999999999999999999986654  999999


Q ss_pred             CCcccccCCC------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc
Q 017860          166 GYSKSSVLHS------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       166 gla~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      |++.......      ......||+.|+|||++.+....+.++|||||||++|+|++|..||..................
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  245 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP  245 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence            9886433221      2234579999999999876333344499999999999999999999887665544333221110


Q ss_pred             cc----cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          240 VQ----YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       240 ~~----~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      ..    ........+++++.+||.+||+.||.+|||+.++++||||.+...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  296 (303)
T 2vwi_A          246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN  296 (303)
T ss_dssp             CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred             ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence            00    011123457899999999999999999999999999999986543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-50  Score=368.21  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++.....   ....+.+|+..+..+ +||||+++++++.....+++||
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~   90 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN   90 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            479999999999999999999999999999999986432   335678899999888 9999999999999999999999


Q ss_pred             eecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----------------C
Q 017860           99 EYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-----------------A  157 (365)
Q Consensus        99 e~~~~g~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-----------------~  157 (365)
                      ||+++++|.+++...    +.+++..++.++.||+.||+|||++||+||||||+|||++.++                 .
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~  170 (289)
T 1x8b_A           91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK  170 (289)
T ss_dssp             ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred             EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence            999999999999764    6699999999999999999999999999999999999997542                 2


Q ss_pred             CCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHH
Q 017860          158 PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI  237 (365)
Q Consensus       158 ~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  237 (365)
                      ..+||+|||++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+.....   ...    +
T Consensus       171 ~~~kl~Dfg~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~----~  240 (289)
T 1x8b_A          171 VMFKIGDLGHVTRISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE----I  240 (289)
T ss_dssp             CCEEECCCTTCEETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH----H
T ss_pred             eEEEEcccccccccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH----H
Confidence            3599999999875433   23456999999999998764444569999999999999999887754322   111    2


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       238 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ..... ...+..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus       241 ~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          241 RQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            22221 12234589999999999999999999999999999999764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.5e-51  Score=380.04  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=209.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEeCC----E
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPT----H   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~   93 (365)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.......    ..+.+|+.+++.++||||+++++++....    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999999999999999999997643322    46789999999999999999999987654    3


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      .|+||||++|++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC-----
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccc
Confidence            5999999999999999998889999999999999999999999999999999999999987665  99999999875433


Q ss_pred             CC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 HS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ..    ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..............  ..........
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~  245 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPPSARHEG  245 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCHHHHSTT
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCcccccCC
Confidence            22    2234569999999999988777665 999999999999999999998866544333322211  1111112345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      +++++.+||.+||+.||.+||++.+++.|+|++.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            8899999999999999999999999999999864

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.3e-51  Score=379.43  Aligned_cols=256  Identities=34%  Similarity=0.568  Sum_probs=210.9

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ++|++.+.||+|+||.||+|+++.+++.||+|++.....         ....+.+|+.+++.++||||+++++++..+. 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            579999999999999999999999999999999865321         1235789999999999999999999997665 


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCccccc
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV  172 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~  172 (365)
                      +|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||++.++ ...+||+|||+++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  168 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG  168 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence            899999999999999998888899999999999999999999999999999999999997654 3359999999987654


Q ss_pred             CCCCCCCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CC
Q 017860          173 LHSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DT  247 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  247 (365)
                      .........||+.|+|||++.   ...++.+ +|||||||++|+|++|..||........+...+..   ......  .+
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~  244 (322)
T 2ycf_A          169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-VDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVW  244 (322)
T ss_dssp             CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTH-HHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHHH
T ss_pred             cccccccccCCcCccCchhhccCCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchhh
Confidence            333233457999999999974   3445444 99999999999999999999876554333333322   221111  12


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ..+++.+.+||.+||..||.+|||++++++||||..
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            357899999999999999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3e-50  Score=378.83  Aligned_cols=262  Identities=24%  Similarity=0.366  Sum_probs=204.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc------------cHHHHHHHHHHhcCCCCCcceeceEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI------------DENVQREIINHRSLRHPNIVRFKEVIL   89 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~e~~~l~~l~hpnIv~l~~~~~   89 (365)
                      .++|++.+.||+|+||.||++.+. +|+.||+|++......            .+.+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            468999999999999999999986 4899999998542211            167889999999999999999999995


Q ss_pred             e-----CCEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 017860           90 T-----PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        90 ~-----~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                      .     ...+|+||||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~  176 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITIC  176 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEEC
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEE
Confidence            4     347899999997 5787777654 46999999999999999999999999999999999999976654  9999


Q ss_pred             cCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc--
Q 017860          164 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ--  241 (365)
Q Consensus       164 Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--  241 (365)
                      |||+++............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+........  
T Consensus       177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  256 (362)
T 3pg1_A          177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE  256 (362)
T ss_dssp             CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence            999998655555566678999999999997744344559999999999999999999998776555544443221110  


Q ss_pred             ------------------cCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          242 ------------------YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       242 ------------------~~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                                        ...+      .....++.+.+||.+||+.||.+|||+.++++||||.....+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          257 DVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             HHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                              0001      112468899999999999999999999999999999876544

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-50  Score=369.79  Aligned_cols=256  Identities=32%  Similarity=0.430  Sum_probs=208.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++++.||+|+||.||+|++..+++.||+|.+......    .+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46899999999999999999999999999999998654332    25678999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--  175 (365)
                      |||++|++|.+++...+++++..++.++.|++.||+|||++||+||||||+||+++.++.  +||+|||+++......  
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC------
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCcccccccccc
Confidence            999999999999998889999999999999999999999999999999999999986654  9999999987543322  


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+......+.+..... .........+++.+.
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVP-NVTTDVRKDIPQSLS  245 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCC-CHHHHSCTTSCHHHH
T ss_pred             ccCccccCccccCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCC-CcchhcccCCCHHHH
Confidence            2334579999999999988777655 99999999999999999999887654433332221100 001112345889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          256 DLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      ++|.+||..||.+||+..+.+.+.|.
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHH
Confidence            99999999999999966666666554

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.9e-50  Score=378.38  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=208.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE----
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHL----   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~----   94 (365)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++.....   ....+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4689999999999999999999999999999999976432   235678999999999999999999999877654    


Q ss_pred             --EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           95 --AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        95 --~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                        |+||||+. ++|...+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~  195 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD  195 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCcccccc
Confidence              99999997 57877763  45999999999999999999999999999999999999986654  9999999987543


Q ss_pred             CCCCCCCCcCCCCCCCchhhcc-cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLR-HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------  241 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------  241 (365)
                        ......+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.+....+..+........          
T Consensus       196 --~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          196 --AEMTGYVVTRWYRAPEVILSWMHYNQ-TVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             ------CTTCCCTTSCHHHHSCCSCCCT-THHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             --cCcCCcccCccccCHHHhcCCCCCCc-HHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence              33455689999999999987 44544 49999999999999999999998776555544433221110          


Q ss_pred             ---------cCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          242 ---------YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       242 ---------~~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                               ...+      ....+++.+.+||.+||+.||.+|||++|+|+||||.....
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence                     0000      01346899999999999999999999999999999986543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6e-50  Score=367.59  Aligned_cols=267  Identities=27%  Similarity=0.440  Sum_probs=222.4

Q ss_pred             cCCCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceE
Q 017860           10 VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEV   87 (365)
Q Consensus        10 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~   87 (365)
                      ..|.+........++|++++.||+|+||.||+|++..+++.||+|++....  ...+.+.+|+.+++.++||||++++++
T Consensus         9 ~~p~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   88 (303)
T 3a7i_A            9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS   88 (303)
T ss_dssp             ----CTTCEECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCchhcCCCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            345555555566778999999999999999999999999999999997643  234778999999999999999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           88 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        88 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      +.....+++||||+++++|.+++.. +++++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~  165 (303)
T 3a7i_A           89 YLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGV  165 (303)
T ss_dssp             EEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTT
T ss_pred             EecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeeccc
Confidence            9999999999999999999998865 57999999999999999999999999999999999999976654  99999999


Q ss_pred             cccccCCC-CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          168 SKSSVLHS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       168 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      +....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...........    +.... ....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~  239 (303)
T 3a7i_A          166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKNN-PPTL  239 (303)
T ss_dssp             CEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-CCCC
T ss_pred             ceecCccccccCccCCCcCccCHHHHhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcCC-CCCC
Confidence            87543322 2345679999999999988887766 9999999999999999999987654332221    11111 1122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ...++..+.+||.+||..||.+|||+.++++||||.+..
T Consensus       240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  278 (303)
T 3a7i_A          240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA  278 (303)
T ss_dssp             CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred             ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence            345889999999999999999999999999999997643

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-49  Score=366.63  Aligned_cols=259  Identities=25%  Similarity=0.422  Sum_probs=215.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|.+.... ....+.+|+.+++.++||||+++++++.....+|+||||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            3568999999999999999999999999999999997643 357789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCC
Q 017860          101 ASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~-~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~  178 (365)
                      +.+++|.+++. ....+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++...... ....
T Consensus       106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~  183 (314)
T 3com_A          106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRN  183 (314)
T ss_dssp             CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccC
Confidence            99999999987 4567999999999999999999999999999999999999986654  999999998754332 2234


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ...||+.|+|||++.+..++.+ +|||||||++|+|++|..||............ .  ............+++.+.+||
T Consensus       184 ~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~l~~li  259 (314)
T 3com_A          184 TVIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-P--TNPPPTFRKPELWSDNFTDFV  259 (314)
T ss_dssp             CCCSCGGGCCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-H--HSCCCCCSSGGGSCHHHHHHH
T ss_pred             ccCCCCCccChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-h--cCCCcccCCcccCCHHHHHHH
Confidence            5679999999999988877766 99999999999999999999876553332211 1  122223333445789999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      .+||..||.+|||+.++++||||.....
T Consensus       260 ~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          260 KQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             HHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             HHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            9999999999999999999999986543

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-50  Score=374.59  Aligned_cols=257  Identities=31%  Similarity=0.434  Sum_probs=212.5

Q ss_pred             CCCcceecccccCCCeEEEEEEE-ccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCC------CcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRD-KVTKELVAVKYIERGDKIDENVQREIINHRSLRHP------NIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hp------nIv~l~~~~~~~~~~   94 (365)
                      .++|++.+.||+|+||.||+|.+ +.+++.||+|++.......+.+.+|+.+++.++|+      +++++++++.....+
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            46999999999999999999998 56889999999976655557788999999888665      499999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----------------
Q 017860           95 AIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP----------------  156 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~----------------  156 (365)
                      ++||||+ +++|.+++...+  ++++..++.++.||+.||+|||++||+||||||+|||++..+                
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~  171 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL  171 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred             EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccc
Confidence            9999999 889999998765  689999999999999999999999999999999999998643                


Q ss_pred             -CCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 017860          157 -APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       157 -~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  235 (365)
                       .+.+||+|||+++...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....... +.
T Consensus       172 ~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~-~~  247 (339)
T 1z57_A          172 INPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAM-ME  247 (339)
T ss_dssp             SCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH-HH
T ss_pred             cCCCceEeeCcccccCc--cccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHH-HH
Confidence             4469999999987532  33456689999999999988887766 9999999999999999999987665443322 22


Q ss_pred             HHhcccc------------------C---------------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017860          236 RILSVQY------------------S---------------------VPDTNPISQECRDLISRIFVADPAARITIPEIM  276 (365)
Q Consensus       236 ~~~~~~~------------------~---------------------~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell  276 (365)
                      .+.....                  .                     .......++++.+||.+||+.||.+|||+.|++
T Consensus       248 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell  327 (339)
T 1z57_A          248 RILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREAL  327 (339)
T ss_dssp             HHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             HHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHh
Confidence            2211100                  0                     001112356789999999999999999999999


Q ss_pred             cCccccc
Q 017860          277 KHQWFLK  283 (365)
Q Consensus       277 ~h~~f~~  283 (365)
                      +||||..
T Consensus       328 ~hp~f~~  334 (339)
T 1z57_A          328 KHPFFDL  334 (339)
T ss_dssp             TSGGGGG
T ss_pred             cCHHHHH
Confidence            9999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.4e-51  Score=381.02  Aligned_cols=271  Identities=30%  Similarity=0.486  Sum_probs=188.9

Q ss_pred             cccCCCCCCCCCCCCCCcceec-ccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceece
Q 017860            8 LTVGPAMDMPIMHDSDRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKE   86 (365)
Q Consensus         8 ~~~~~~~~~~~~~~~~~y~~~~-~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~   86 (365)
                      .+.||.-.  .....++|++++ .||+|+||.||+|+++.+|+.||+|++....   ....+....++.++||||+++++
T Consensus        15 ~~~~p~~~--~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~   89 (336)
T 3fhr_A           15 LFQGPEPK--KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---KARQEVDHHWQASGGPHIVCILD   89 (336)
T ss_dssp             -----CCB--CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---HHHHHHHHHHHHTTSTTBCCEEE
T ss_pred             cccCCCCC--CccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---HHHHHHHHHHHhcCCCChHHHHH
Confidence            35566433  334456899966 5999999999999999999999999997642   22222334466789999999999


Q ss_pred             EEEe----CCEEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCC
Q 017860           87 VILT----PTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APR  159 (365)
Q Consensus        87 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~  159 (365)
                      ++..    ...+++||||+.+|+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.
T Consensus        90 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~  169 (336)
T 3fhr_A           90 VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAV  169 (336)
T ss_dssp             EEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCC
T ss_pred             HHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCce
Confidence            9976    456899999999999999998754  699999999999999999999999999999999999997543 346


Q ss_pred             EEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc
Q 017860          160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      +||+|||+++... ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||...............+..
T Consensus       170 ~kl~Dfg~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          170 LKLTDFGFAKETT-QNALQTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             EEECCCTTCEEC-----------------------CHHHHH-HHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             EEEeccccceecc-ccccccCCCCcCccChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            9999999987543 233455678999999999987777655 99999999999999999999876543322222222222


Q ss_pred             ccc--CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          240 VQY--SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       240 ~~~--~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ...  ..+.+..+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            222  3334456899999999999999999999999999999997643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-50  Score=384.32  Aligned_cols=261  Identities=26%  Similarity=0.394  Sum_probs=193.6

Q ss_pred             CCccee-cccccCCCeEEEEEEEc--cCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEEEE
Q 017860           23 DRYDFV-RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIV   97 (365)
Q Consensus        23 ~~y~~~-~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv   97 (365)
                      +.|++. ++||+|+||+||+|+++  .+++.||+|++... .....+.+|+.+++.++||||++++++|..  ...+|+|
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS-SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC-CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            357774 58999999999999976  57889999999754 345678999999999999999999999954  6789999


Q ss_pred             EeecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--CCCCCEEEecCC
Q 017860           98 MEYASGGELFERICNA---------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFG  166 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~---------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~--~~~~~vkl~Dfg  166 (365)
                      |||+.+ +|.+++...         ..+++..++.++.||+.||+|||++||+||||||+|||+..  +..+.+||+|||
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            999964 787776522         24899999999999999999999999999999999999943  223469999999


Q ss_pred             CcccccCC----CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh---------HHHHHH
Q 017860          167 YSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---------KDFRKT  233 (365)
Q Consensus       167 la~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---------~~~~~~  233 (365)
                      +++.....    ......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+....         ..+..+
T Consensus       178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i  257 (405)
T 3rgf_A          178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  257 (405)
T ss_dssp             CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred             CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence            99754332    23345689999999999987664456699999999999999999999765432         223333


Q ss_pred             HHHHhcccc-CC-------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          234 IQRILSVQY-SV-------------------------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       234 ~~~~~~~~~-~~-------------------------------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +..+..... .+                               ......++.+.+||.+||+.||.+|||++|+|+||||
T Consensus       258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f  337 (405)
T 3rgf_A          258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  337 (405)
T ss_dssp             HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            222111100 00                               0011237789999999999999999999999999999


Q ss_pred             ccCC
Q 017860          282 LKNL  285 (365)
Q Consensus       282 ~~~~  285 (365)
                      .+..
T Consensus       338 ~~~~  341 (405)
T 3rgf_A          338 LEDP  341 (405)
T ss_dssp             TSSS
T ss_pred             ccCC
Confidence            8754

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-50  Score=382.02  Aligned_cols=260  Identities=30%  Similarity=0.401  Sum_probs=212.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CC-----CcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hp-----nIv~l~~~~~~~~~~~   95 (365)
                      .++|++.+.||+|+||+||+|+++.+++.||||++.........+.+|+.+++.++ |+     +|+++++++.....+|
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            46899999999999999999999999999999999865544566778888888774 44     4999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCH--AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH--~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +||||+. ++|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+|||++.+..+.+||+|||+++..
T Consensus       133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~  211 (382)
T 2vx3_A          133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL  211 (382)
T ss_dssp             EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred             EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence            9999996 5999998765  45999999999999999999999  57999999999999997655567999999999754


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc---------
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY---------  242 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------  242 (365)
                      .  ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.++.........         
T Consensus       212 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  288 (382)
T 2vx3_A          212 G--QRIYQYIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA  288 (382)
T ss_dssp             T--CCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred             c--cccccccCCccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence            3  33456789999999999988887766 99999999999999999999987766655554443211100         


Q ss_pred             -----CC-------------------CCCCC-------------------------CCHHHHHHHHHhcccCCCCCCCHH
Q 017860          243 -----SV-------------------PDTNP-------------------------ISQECRDLISRIFVADPAARITIP  273 (365)
Q Consensus       243 -----~~-------------------~~~~~-------------------------~s~~~~~li~~~l~~dp~~R~t~~  273 (365)
                           ..                   +....                         .++++.+||.+||+.||.+|||++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~  368 (382)
T 2vx3_A          289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY  368 (382)
T ss_dssp             HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred             HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence                 00                   00000                         013789999999999999999999


Q ss_pred             HHhcCcccccCC
Q 017860          274 EIMKHQWFLKNL  285 (365)
Q Consensus       274 ell~h~~f~~~~  285 (365)
                      |+|+||||++..
T Consensus       369 e~L~hp~f~~~~  380 (382)
T 2vx3_A          369 YALQHSFFKKTA  380 (382)
T ss_dssp             HHTTSGGGCC--
T ss_pred             HHhcCcccccCC
Confidence            999999997653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.6e-50  Score=369.88  Aligned_cols=259  Identities=27%  Similarity=0.404  Sum_probs=205.8

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      .+....++|++.+.||+|+||+||+|++  +|+.||+|++......   .+.+.+|+.+++.++||||+++++++.....
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  108 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN  108 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence            3345567999999999999999999987  5889999998764432   2467899999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           94 LAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~---l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                      +++||||+.+|+|.+++...+.   +++..++.++.||+.||+|||++|  |+||||||+|||++.++.  +||+|||++
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a  186 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLS  186 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC--
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCC
Confidence            9999999999999999987653   999999999999999999999999  999999999999986654  999999998


Q ss_pred             ccccCC-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          169 KSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       169 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      +..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......    .+.......+.+
T Consensus       187 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~----~~~~~~~~~~~~  261 (309)
T 3p86_A          187 RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVA----AVGFKCKRLEIP  261 (309)
T ss_dssp             ---------------CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHHSCCCCCCC
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCCCCC
Confidence            753332 22345679999999999988877666 999999999999999999998766543322    221122233344


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc--CcccccC
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMK--HQWFLKN  284 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~--h~~f~~~  284 (365)
                      ..+++++.+||.+||+.||.+|||+.++++  ++++...
T Consensus       262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            568999999999999999999999999997  4555443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.2e-49  Score=371.49  Aligned_cols=263  Identities=29%  Similarity=0.403  Sum_probs=211.9

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeC-----C
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTP-----T   92 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~   92 (365)
                      ...++|++.+.||+|+||.||+|++..+|+.||+|++.....  ....+.+|+.+++.++||||+++++++...     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            345799999999999999999999999999999999965332  235677999999999999999999988764     6


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ..|+||||+. ++|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++...
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIID  163 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccc
Confidence            7999999997 589888876 56999999999999999999999999999999999999986654  9999999987543


Q ss_pred             CCC-----------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc
Q 017860          173 LHS-----------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ  241 (365)
Q Consensus       173 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  241 (365)
                      ...           .....+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            221           123457899999999987644445559999999999999999999988765444433332211110


Q ss_pred             --------------------cCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          242 --------------------YSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       242 --------------------~~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                                          ...+      ....+++++.+||.+||+.||.+|||+.++++||||+....
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD  314 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence                                0000      01357899999999999999999999999999999986543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-50  Score=370.71  Aligned_cols=268  Identities=29%  Similarity=0.409  Sum_probs=208.1

Q ss_pred             CCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEE---
Q 017860           14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVIL---   89 (365)
Q Consensus        14 ~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~---   89 (365)
                      |..+.....++|++++.||+|+||.||+|.++.+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.   
T Consensus         2 m~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   81 (320)
T 2i6l_A            2 MNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSG   81 (320)
T ss_dssp             ----CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred             CccccCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence            34455555679999999999999999999999999999999987643 23366889999999999999999999873   


Q ss_pred             -----------eCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           90 -----------TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        90 -----------~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                                 ....+|+||||+. |+|.+++.+ +++++..++.++.||+.||+|||++|++||||||+||+++.++ +
T Consensus        82 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~  158 (320)
T 2i6l_A           82 SQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-L  158 (320)
T ss_dssp             CBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-T
T ss_pred             cccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-C
Confidence                       4478999999997 599988854 5799999999999999999999999999999999999997432 3


Q ss_pred             CEEEecCCCcccccCC----CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHH
Q 017860          159 RLKICDFGYSKSSVLH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  234 (365)
                      .+||+|||+++.....    .......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+.
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            5999999998754322    223445689999999998764444555999999999999999999999877655444433


Q ss_pred             HHHhcc------------------ccCCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          235 QRILSV------------------QYSVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       235 ~~~~~~------------------~~~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ......                  ....+      ....+++++.+||.+||+.||.+|||++++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            221000                  00000      123478999999999999999999999999999999754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.3e-50  Score=375.53  Aligned_cols=255  Identities=24%  Similarity=0.427  Sum_probs=216.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----c--------------HHHHHHHHHHhcCCCCCcce
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----D--------------ENVQREIINHRSLRHPNIVR   83 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~--------------~~~~~e~~~l~~l~hpnIv~   83 (365)
                      .++|++.+.||+|+||.||+|++  +++.||+|++......    .              ..+.+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            35899999999999999999999  8999999998753211    1              78999999999999999999


Q ss_pred             eceEEEeCCEEEEEEeecCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecC
Q 017860           84 FKEVILTPTHLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDG  154 (365)
Q Consensus        84 l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~--~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~  154 (365)
                      +++++.....+|+||||+++++|.++      +..  ...+++..++.++.||+.||+|||+ +|++||||||+||+++.
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK  187 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence            99999999999999999999999988      655  5679999999999999999999999 99999999999999986


Q ss_pred             CCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhccc-ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHH
Q 017860          155 SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT  233 (365)
Q Consensus       155 ~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  233 (365)
                      ++.  +||+|||++...... ......||+.|+|||++.+. .++..++|||||||++|+|++|..||.........   
T Consensus       188 ~~~--~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---  261 (348)
T 2pml_X          188 NGR--VKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL---  261 (348)
T ss_dssp             TSC--EEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH---
T ss_pred             CCc--EEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---
Confidence            654  999999998754332 34556799999999999876 55553599999999999999999999887663332   


Q ss_pred             HHHHhccccCCCCC-----------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          234 IQRILSVQYSVPDT-----------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       234 ~~~~~~~~~~~~~~-----------------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ...+.......+..                 ..+++++.+||.+||+.||.+|||++++++||||...
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            33333343333321                 4588999999999999999999999999999999764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.2e-50  Score=385.61  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=206.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC--------CCCcceeceEEE----
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR--------HPNIVRFKEVIL----   89 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~--------hpnIv~l~~~~~----   89 (365)
                      .++|++.++||+|+||+||+|++..+++.||+|++.......+.+.+|+.+++.++        ||||++++++|.    
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~  115 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV  115 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence            46899999999999999999999999999999999876555677889999998885        788999999998    


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCC----------
Q 017860           90 TPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP----------  156 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~----------  156 (365)
                      ....+|+||||+ +++|.+.+...  +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++          
T Consensus       116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence            556899999999 55666666543  4699999999999999999999999 999999999999997653          


Q ss_pred             -------------------------------------CCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCC
Q 017860          157 -------------------------------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG  199 (365)
Q Consensus       157 -------------------------------------~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  199 (365)
                                                           ...+||+|||+++...  ......+||+.|+|||++.+..++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  272 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYNT  272 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT--BCSCSCCSCGGGCCHHHHHTSCCCT
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc--ccCccCCCCCcccCChhhcCCCCCc
Confidence                                                 1259999999987543  2345668999999999998888776


Q ss_pred             ccceeehhhHHHHHHHhCCCCCCCCCCh------HHHHHHHHHHhccc---------cC---------------------
Q 017860          200 KIADVWSCGVTLYVMLVGGYPFEDPDEP------KDFRKTIQRILSVQ---------YS---------------------  243 (365)
Q Consensus       200 ~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~---------~~---------------------  243 (365)
                      + +|||||||++|+|++|+.||...+..      .....+.. .....         +.                     
T Consensus       273 ~-~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          273 P-ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE-LLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             H-HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHH-HHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             H-HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHH-hcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            6 99999999999999999999865432      11111111 11110         00                     


Q ss_pred             -------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          244 -------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       244 -------~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                             .......++.+.+||.+||+.||.+|||++|+|+||||.
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                   000112346789999999999999999999999999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.6e-49  Score=365.82  Aligned_cols=260  Identities=28%  Similarity=0.411  Sum_probs=214.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEc-cCCcEEEEEEeecCC---cccHHHHHHHHHHhcC---CCCCcceeceEEE-----
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDK-VTKELVAVKYIERGD---KIDENVQREIINHRSL---RHPNIVRFKEVIL-----   89 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~-----   89 (365)
                      .++|++.+.||+|+||.||+|++. .+|+.||+|++....   .....+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            468999999999999999999995 678999999986532   2234566777777665   8999999999997     


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           90 TPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      ....+++||||+. |+|.+++....  .+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||+
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~  166 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL  166 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcc
Confidence            5678999999997 59999987753  4999999999999999999999999999999999999986654  99999999


Q ss_pred             cccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCCC-
Q 017860          168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSVP-  245 (365)
Q Consensus       168 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-  245 (365)
                      ++............||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+.++........ ..++ 
T Consensus       167 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (326)
T 1blx_A          167 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  245 (326)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             cccccCCCCccccccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcc
Confidence            986554445566789999999999988777666 9999999999999999999998776655555444321110 0000 


Q ss_pred             -------------------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          246 -------------------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       246 -------------------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                                         ....+++.+.+||.+||..||.+|||+.++++||||....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                               1235789999999999999999999999999999997643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-51  Score=388.30  Aligned_cols=246  Identities=14%  Similarity=0.116  Sum_probs=198.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHH---HHHhcCCCCCcceec-------e
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREI---INHRSLRHPNIVRFK-------E   86 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~---~~l~~l~hpnIv~l~-------~   86 (365)
                      ..++|++.+.||+|+||+||+|+++.+|+.||||++....    ...+.+.+|+   .+++.++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            3568999999999999999999999899999999997532    2336788999   555666899999998       6


Q ss_pred             EEEeCC-----------------EEEEEEeecCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHcCCee
Q 017860           87 VILTPT-----------------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHAMQVCH  142 (365)
Q Consensus        87 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~l~~-------~~~~~i~~qil~al~~LH~~~ivH  142 (365)
                      ++..++                 ..|+||||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            666553                 289999999 6799999987665665       788889999999999999999999


Q ss_pred             cCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhccc-----------ccCCccceeehhhHHH
Q 017860          143 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-----------EYDGKIADVWSCGVTL  211 (365)
Q Consensus       143 rDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwSlG~il  211 (365)
                      |||||+|||++.++  .+||+|||+++...  ......+| +.|+|||++.+.           .++.+ +|||||||++
T Consensus       230 rDikp~NIll~~~~--~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~-~DvwSlG~il  303 (377)
T 3byv_A          230 TYLRPVDIVLDQRG--GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS-FDAWALGLVI  303 (377)
T ss_dssp             SCCCGGGEEECTTC--CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH-HHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCC--CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChh-hhHHHHHHHH
Confidence            99999999998665  49999999988532  23345677 999999999877           66555 9999999999


Q ss_pred             HHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          212 YVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       212 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      |+|++|+.||.........    .      ........+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus       304 ~elltg~~Pf~~~~~~~~~----~------~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGS----E------WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC------CCS----G------GGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCcccccccch----h------hhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            9999999999765432111    1      111223458999999999999999999999999999999964

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.8e-50  Score=366.37  Aligned_cols=260  Identities=26%  Similarity=0.413  Sum_probs=212.0

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ...++|++++.||+|+||.||+|+++.+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.....+++||
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            44678999999999999999999999999999999986543 33467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCC
Q 017860           99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~  176 (365)
                      ||+++++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++..... ...
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  173 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQK  173 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccc
Confidence            99999999998876 466999999999999999999999999999999999999986654  99999998753211 122


Q ss_pred             CCCCcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          177 PKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      .....||+.|+|||++.     +..++.+ +|||||||++|+|++|..||...+..........   ...........++
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  249 (302)
T 2j7t_A          174 RDSFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKWS  249 (302)
T ss_dssp             -----CCGGGCCHHHHHHHHTTSTTTTTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSC
T ss_pred             cccccCChhhcCCeeeccccCCCCCCchh-hhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCccccC
Confidence            34567999999999984     4445544 9999999999999999999987665443322222   1222223345578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ..+.+||.+||..||.+|||+.++++||||....
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  283 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT  283 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence            9999999999999999999999999999997644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=365.42  Aligned_cols=256  Identities=31%  Similarity=0.525  Sum_probs=210.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC-----CcccHHHHHHHHHHhcCCCCCcceeceEEE--eCCEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLA   95 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~--~~~~~~   95 (365)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...     ......+.+|+.+++.++||||+++++++.  ....+|
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            5899999999999999999999999999999998753     233467899999999999999999999984  456799


Q ss_pred             EEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +||||+.++ |.+.+..  ...+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|||++.....
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHP  161 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCT
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccCc
Confidence            999999876 7777665  456999999999999999999999999999999999999986654  99999999875432


Q ss_pred             ---CCCCCCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 ---HSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                         ........||+.|+|||++.+.. +.+.++|||||||++|+|++|..||...+...    ....+....+..  ...
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~i~~~~~~~--~~~  235 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK----LFENIGKGSYAI--PGD  235 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHCCCCC--CSS
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH----HHHHHhcCCCCC--CCc
Confidence               12224557999999999987533 23445999999999999999999998765433    223333333333  345


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      +++.+.+||.+||..||.+|||+.++++||||++..+.
T Consensus       236 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          236 CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            78999999999999999999999999999999876554

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.1e-49  Score=368.85  Aligned_cols=258  Identities=25%  Similarity=0.390  Sum_probs=207.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE-----
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTH-----   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-----   93 (365)
                      .++|.+.+.||+|+||.||+|+++.+|+.||+|++.....   ....+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            3589999999999999999999999999999999976432   23567899999999999999999999987654     


Q ss_pred             -EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           94 -LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        94 -~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                       +|+||||+. ++|.+++.  .++++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||+++...
T Consensus       103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~  177 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHAD  177 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC--
T ss_pred             eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCC
Confidence             599999997 58887764  35999999999999999999999999999999999999986654  9999999987543


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc------------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV------------  240 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~------------  240 (365)
                        .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+.......            
T Consensus       178 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  255 (353)
T 3coi_A          178 --AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA  255 (353)
T ss_dssp             --------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHH
T ss_pred             --CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHH
Confidence              234456789999999999773333445999999999999999999999876654444433321110            


Q ss_pred             ------------ccCC-CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          241 ------------QYSV-PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       241 ------------~~~~-~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                                  ...+ .....+++++.+||.+||+.||.+|||++++++||||.....
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence                        0001 112357899999999999999999999999999999986543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-49  Score=358.78  Aligned_cols=252  Identities=25%  Similarity=0.422  Sum_probs=213.9

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      +....++|++++.||+|+||.||++++. +++.||+|++.......+.+.+|+.+++.++||||+++++++.....+++|
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (269)
T 4hcu_A            5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   83 (269)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence            3455679999999999999999999987 577899999988766678899999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC--
Q 017860           98 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--  174 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~--  174 (365)
                      |||+++++|.+++... +.+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++.....  
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG--CEEECCTTGGGGBCCHHH
T ss_pred             EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC--CEEecccccccccccccc
Confidence            9999999999999754 4589999999999999999999999999999999999997665  4999999998754322  


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+... .....+...++.
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~  235 (269)
T 4hcu_A          162 TSSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTG-FRLYKPRLASTH  235 (269)
T ss_dssp             HSTTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTT-CCCCCCTTSCHH
T ss_pred             ccccCcccccccCCHHHhcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHhcC-ccCCCCCcCCHH
Confidence            22344567889999999987777655 999999999999999 999998766543322    22222 223334457899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+++.+||+.||.+|||+.++++|
T Consensus       236 ~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          236 VYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999999976

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.5e-49  Score=363.86  Aligned_cols=255  Identities=26%  Similarity=0.425  Sum_probs=203.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe------------
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------   90 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------------   90 (365)
                      ++|++++.||+|+||.||+|++..+++.||+|++.........+.+|+.+++.++||||+++++++..            
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   85 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK   85 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence            47999999999999999999999999999999997655455678899999999999999999998865            


Q ss_pred             -CCEEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCc
Q 017860           91 -PTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYS  168 (365)
Q Consensus        91 -~~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla  168 (365)
                       ...+|+||||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~  163 (303)
T 1zy4_A           86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLA  163 (303)
T ss_dssp             CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCC
T ss_pred             cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcch
Confidence             457899999999999999998644 5889999999999999999999999999999999999976654  999999998


Q ss_pred             ccccCC---------------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHH
Q 017860          169 KSSVLH---------------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT  233 (365)
Q Consensus       169 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  233 (365)
                      +.....               .......||+.|+|||++.+....+.++|||||||++|+|++   ||......   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~---~~~  237 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER---VNI  237 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HHH
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---HHH
Confidence            754321               223455799999999999765433445999999999999998   66432222   223


Q ss_pred             HHHHhccccCCC--CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          234 IQRILSVQYSVP--DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       234 ~~~~~~~~~~~~--~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ...+.......+  .....++.+.+||.+||+.||.+|||+.++++||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            333333333332  2344678899999999999999999999999999997643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.6e-50  Score=369.44  Aligned_cols=252  Identities=31%  Similarity=0.471  Sum_probs=214.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCC--CCCcceeceEEEeC
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTP   91 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~   91 (365)
                      ..++|++.+.||+|+||.||+|+++.+++.||+|++.....       ....+.+|+.+++.++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            35689999999999999999999999999999999976432       2245678999999986  59999999999999


Q ss_pred             CEEEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           92 THLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        92 ~~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      ..+++|||++.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+++.
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~-~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN-RGELKLIDFGSGAL  199 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TTEEEECCCTTCEE
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCC-CCCEEEeeCccccc
Confidence            999999999976 8999999988899999999999999999999999999999999999999732 23599999999875


Q ss_pred             ccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ... .......||+.|+|||++.+..+.++++|||||||++|+|++|+.||....      .    +.....  .....+
T Consensus       200 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~--~~~~~~  266 (320)
T 3a99_A          200 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQV--FFRQRV  266 (320)
T ss_dssp             CCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCC--CCSSCC
T ss_pred             ccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhcccc--cccccC
Confidence            432 233456799999999999877776666899999999999999999997521      1    111222  223458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      ++++.+||.+||+.||.+|||++++++||||.+...
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  302 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  302 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence            999999999999999999999999999999987654

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-49  Score=375.62  Aligned_cols=262  Identities=24%  Similarity=0.382  Sum_probs=209.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----------CCCcceeceEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVIL   89 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~l~~~~~   89 (365)
                      ..++|++.+.||+|+||+||+|++..+++.||+|++.........+.+|+.+++.++           ||||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            356999999999999999999999999999999999866555677889999998876           899999999998


Q ss_pred             eCC----EEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCC----CC
Q 017860           90 TPT----HLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSP----AP  158 (365)
Q Consensus        90 ~~~----~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~----~~  158 (365)
                      ...    .+++||||+ +++|.+++...  ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++    .+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            654    789999999 89999999763  4599999999999999999999998 999999999999995432    23


Q ss_pred             CEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh------HHHHH
Q 017860          159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP------KDFRK  232 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~------~~~~~  232 (365)
                      .+||+|||+++...  .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......      ..+.+
T Consensus       176 ~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  252 (373)
T 1q8y_A          176 QIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  252 (373)
T ss_dssp             EEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eEEEcccccccccC--CCCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence            59999999987543  23455689999999999988887666 99999999999999999999865421      12222


Q ss_pred             HHHHHhcccc------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017860          233 TIQRILSVQY------------------------------------SVPDTNPISQECRDLISRIFVADPAARITIPEIM  276 (365)
Q Consensus       233 ~~~~~~~~~~------------------------------------~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell  276 (365)
                      +.......+.                                    ........++++.+||.+||+.||.+|||++|+|
T Consensus       253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  332 (373)
T 1q8y_A          253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  332 (373)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence            2211110000                                    0011122457889999999999999999999999


Q ss_pred             cCcccccCCC
Q 017860          277 KHQWFLKNLP  286 (365)
Q Consensus       277 ~h~~f~~~~~  286 (365)
                      +||||++...
T Consensus       333 ~hp~f~~~~~  342 (373)
T 1q8y_A          333 NHPWLKDTLG  342 (373)
T ss_dssp             TCGGGTTCTT
T ss_pred             hChhhhcccC
Confidence            9999987654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.5e-49  Score=370.72  Aligned_cols=259  Identities=27%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCC-cEEEEEEeecCCcccHHHHHHHHHHhcCCCCC------cceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTK-ELVAVKYIERGDKIDENVQREIINHRSLRHPN------IVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~l~~~~~~~~~~   94 (365)
                      .++|++.+.||+|+||+||+|.++.++ +.||+|++.......+.+.+|+.+++.++|++      ++.+++++.....+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~   97 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM   97 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence            469999999999999999999998777 68999999866555677888999999887665      99999999999999


Q ss_pred             EEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------------
Q 017860           95 AIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----------------  155 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-----------------  155 (365)
                      ++||||+ +++|.+.+...  ..+++..++.++.||+.||+|||++||+||||||+|||++..                 
T Consensus        98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~  176 (355)
T 2eu9_A           98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV  176 (355)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred             EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccccc
Confidence            9999999 56677776654  369999999999999999999999999999999999999432                 


Q ss_pred             CCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHH
Q 017860          156 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       156 ~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  235 (365)
                      ..+.+||+|||+++..  ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||..............
T Consensus       177 ~~~~~kl~Dfg~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  253 (355)
T 2eu9_A          177 KNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK  253 (355)
T ss_dssp             SCCCEEECCCTTCEET--TSCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CCCcEEEeecCccccc--cccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            2346999999998753  233456689999999999988887766 9999999999999999999988765443332222


Q ss_pred             HHhcccc---------------------------------------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHh
Q 017860          236 RILSVQY---------------------------------------SVPDTNPISQECRDLISRIFVADPAARITIPEIM  276 (365)
Q Consensus       236 ~~~~~~~---------------------------------------~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell  276 (365)
                       +.....                                       ........+.++.+||.+||+.||.+|||+.|++
T Consensus       254 -~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l  332 (355)
T 2eu9_A          254 -ILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEAL  332 (355)
T ss_dssp             -HHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred             -HcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHh
Confidence             211100                                       0001111245789999999999999999999999


Q ss_pred             cCcccccCC
Q 017860          277 KHQWFLKNL  285 (365)
Q Consensus       277 ~h~~f~~~~  285 (365)
                      +||||....
T Consensus       333 ~hp~f~~~~  341 (355)
T 2eu9_A          333 LHPFFAGLT  341 (355)
T ss_dssp             TSGGGGGCC
T ss_pred             cChhhcCCC
Confidence            999998643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.2e-49  Score=365.95  Aligned_cols=263  Identities=21%  Similarity=0.347  Sum_probs=195.3

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCc---EEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEe
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILT   90 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~   90 (365)
                      ......++|++.+.||+|+||.||+|+++.++.   .||+|++....   ...+.+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            345567799999999999999999999987765   89999987642   233678899999999999999999999988


Q ss_pred             CCEE------EEEEeecCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           91 PTHL------AIVMEYASGGELFERICNAG------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        91 ~~~~------~lv~e~~~~g~L~~~l~~~~------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      ....      ++||||+.+|+|.+++....      .+++..++.++.||+.||+|||++||+||||||+|||++.++  
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~--  174 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM--  174 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC--
Confidence            7665      99999999999999986532      589999999999999999999999999999999999998665  


Q ss_pred             CEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHH
Q 017860          159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~  234 (365)
                      .+||+|||+++.......   .....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+...........
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~  253 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI  253 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence            499999999875433322   233456789999999988777655 999999999999999 999999877655433322


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCC-------HHHHhcCcccccCCCC
Q 017860          235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARIT-------IPEIMKHQWFLKNLPA  287 (365)
Q Consensus       235 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t-------~~ell~h~~f~~~~~~  287 (365)
                          .. ...+....+++++.+|+.+||+.||.+|||       +++++.|+|+....+.
T Consensus       254 ----~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          254 ----GG-NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             ----TT-CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             ----cC-CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence                21 123344568899999999999999999999       7888999999765443

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.5e-49  Score=354.72  Aligned_cols=250  Identities=24%  Similarity=0.385  Sum_probs=212.4

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ...++|++++.||+|+||.||+++++ ++..||+|++.........+.+|+.+++.++||||+++++++.....+++|||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            45678999999999999999999886 67789999998876667889999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--C
Q 017860          100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--Q  176 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--~  176 (365)
                      |+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||++.......  .
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEE
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhc
Confidence            999999999997754 5999999999999999999999999999999999999986654  9999999987543322  1


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||............    ... .....+...++.+.
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~l~  235 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV----SQG-HRLYRPHLASDTIY  235 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTT-CCCCCCTTSCHHHH
T ss_pred             ccCCCcCcccCCHHHHhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHHH----HcC-CCCCCCCcChHHHH
Confidence            233456778999999988777766 999999999999999 99999876654433222    222 12233444789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 017860          256 DLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +++.+||+.||.+|||+.+++++
T Consensus       236 ~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          236 QIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=356.27  Aligned_cols=259  Identities=28%  Similarity=0.442  Sum_probs=208.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      ++|.....||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.....+++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            45556669999999999999999999999999997643 33467889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCC
Q 017860          102 SGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQP  177 (365)
Q Consensus       102 ~~g~L~~~l~~~~---~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~  177 (365)
                      ++++|.+++....   .+++..++.++.||+.||.|||++|++||||||+||+++.. .+.+||+|||+++..... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~-~~~~kl~Dfg~~~~~~~~~~~~  180 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY-SGVLKISDFGTSKRLAGINPCT  180 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETT-TCCEEECCTTTCEESCC-----
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECC-CCCEEEeecccccccCCCCCcc
Confidence            9999999997652   46799999999999999999999999999999999999852 235999999998754332 223


Q ss_pred             CCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||............. ......  ...+..+++++.+
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~  257 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKV-GMFKVH--PEIPESMSAEAKA  257 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHH-HHHCCC--CCCCTTSCHHHHH
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhh-cccccc--ccccccCCHHHHH
Confidence            4567999999999997643 23445999999999999999999997654433221111 111222  2233458999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ||.+||+.||.+|||+.+++.||||....
T Consensus       258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            99999999999999999999999997543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.5e-49  Score=364.69  Aligned_cols=247  Identities=25%  Similarity=0.380  Sum_probs=207.4

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ...++|++.+.||+|+||+||++.+..+++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..+..+++||
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   86 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT   86 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence            34568999999999999999999999999999999885532 33467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860           99 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus        99 e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      ||+.+++|.+++.. .+.+++.+++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++....... 
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC-----
T ss_pred             EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccc
Confidence            99999999999987 567999999999999999999999999999999999999986654  99999999875432221 


Q ss_pred             --------------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH-----HHHHHHHHH
Q 017860          177 --------------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----DFRKTIQRI  237 (365)
Q Consensus       177 --------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----~~~~~~~~~  237 (365)
                                    ....+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......     ........ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence                          125679999999999988887766 999999999999999999987643211     11111111 


Q ss_pred             hccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          238 LSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       238 ~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                             ..+..+++.+.+++.+||+.||.+|||+.++++
T Consensus       243 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          243 -------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                   112347889999999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.3e-50  Score=379.28  Aligned_cols=254  Identities=17%  Similarity=0.181  Sum_probs=190.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHH---HHHhcCCCCCcceec-------eEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREI---INHRSLRHPNIVRFK-------EVI   88 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~---~~l~~l~hpnIv~l~-------~~~   88 (365)
                      .+|++.+.||+|+||.||+|+++.+|+.||+|++.....    ..+.+.+|+   ..++. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            359999999999999999999999999999999987543    224566774   55555 799987755       555


Q ss_pred             EeC-----------------CEEEEEEeecCCCChHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHHcCCeecC
Q 017860           89 LTP-----------------THLAIVMEYASGGELFERICNAG-RFSEDEA------RFFFQQLISGVSYCHAMQVCHRD  144 (365)
Q Consensus        89 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~------~~i~~qil~al~~LH~~~ivHrD  144 (365)
                      ..+                 ..+|+||||+. |+|.+++...+ .+++...      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            443                 34899999998 89999998643 3455555      57779999999999999999999


Q ss_pred             CCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcc--cccCCccceeehhhHHHHHHHhCCCCCC
Q 017860          145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPFE  222 (365)
Q Consensus       145 lkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf~  222 (365)
                      |||+|||++.++.  +||+|||+++....  ......+|+.|+|||++.+  ..++.+ +|||||||++|+|++|+.||.
T Consensus       220 ikp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIMPDGR--LMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHA-LNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEECTTSC--EEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHH-HHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEECCCCC--EEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCcc-ccHHHHHHHHHHHHhCCCCCC
Confidence            9999999987654  99999999875432  2225567899999999976  556544 999999999999999999998


Q ss_pred             CCCChHHH--HH-HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          223 DPDEPKDF--RK-TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       223 ~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .......-  .. .........+..+....+++.+.+||.+||+.||.+|||+.++|+||||.+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            76432100  00 000011122334444578999999999999999999999999999999965

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.6e-49  Score=356.28  Aligned_cols=254  Identities=21%  Similarity=0.365  Sum_probs=212.2

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .++....++|++++.||+|+||.||++.+. ++..||+|++.......+.+.+|+.+++.++||||+++++++.....++
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            344556679999999999999999999887 6778999999877666788999999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+.+++|.+++.. ..++++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDD  173 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCH
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEcccccccccccc
Confidence            99999999999999976 567999999999999999999999999999999999999986654  999999998754322


Q ss_pred             --CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 --SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                        .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||...+.......    +... .....+...+
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~  247 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQG-LRLYRPHLAS  247 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHTT-CCCCCCTTCC
T ss_pred             ccccccCCccCcccCCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hhcc-cCCCCCCcCC
Confidence              22334457889999999987777655 999999999999998 9999988765433322    2222 2223344578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+.+||.+||+.+|.+|||+.++++|
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.7e-49  Score=360.03  Aligned_cols=256  Identities=30%  Similarity=0.491  Sum_probs=210.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~l   96 (365)
                      .++|++++.||+|+||.||+++++.+++.||+|.+.....   ..+.+.+|+.+++.++||||+++++++..  ...+|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            3589999999999999999999999999999999976432   23568899999999999999999998854  578999


Q ss_pred             EEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           97 VMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~----~~l~~~~~~~i~~qil~al~~LH~~~-----ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      ||||+++++|.+++...    ..+++..++.++.|++.||+|||++|     ++||||||+||+++.++.  +||+|||+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~  162 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  162 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCch
Confidence            99999999999998753    34999999999999999999999999     999999999999986654  99999999


Q ss_pred             cccccCCCC-CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          168 SKSSVLHSQ-PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       168 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      ++....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...+.....    ..+..... .+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~i~~~~~-~~~  236 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKF-RRI  236 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHTCC-CCC
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHH----HHHhhccc-ccC
Confidence            875432211 123468999999999988777655 99999999999999999999876543222    22222222 122


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      ...+++++.++|.+||+.||.+|||+.++++|+|+....
T Consensus       237 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          237 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            345889999999999999999999999999999997654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.8e-49  Score=365.58  Aligned_cols=249  Identities=24%  Similarity=0.363  Sum_probs=207.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCc---EEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..++|++.+.||+|+||.||++++..+++   .||+|++....  ...+.+.+|+.+++.++||||+++++++.....+|
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            45689999999999999999999986555   59999997643  23356889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++.....
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~  204 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL--VCKVSDFGLSRVLEDD  204 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC--CEEECCCSSCEECC--
T ss_pred             EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC--CEEECCCCcccccccC
Confidence            999999999999999754 5799999999999999999999999999999999999997665  4999999998754332


Q ss_pred             CC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          175 SQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       175 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ..    .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...........    +. .....+....
T Consensus       205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~  278 (325)
T 3kul_A          205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----VE-EGYRLPAPMG  278 (325)
T ss_dssp             --CCEECC---CCGGGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----HH-TTCCCCCCTT
T ss_pred             ccceeeccCCCCcccccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----HH-cCCCCCCCCC
Confidence            21    223346788999999988887766 999999999999999 9999987665433222    22 2233445556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+.+||.+||..||.+|||+.++++
T Consensus       279 ~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          279 CPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.7e-49  Score=366.33  Aligned_cols=259  Identities=24%  Similarity=0.365  Sum_probs=189.1

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHH-HHhcCCCCCcceeceEEEeCCEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ....++|++++.||+|+||.||+|.++.+|+.||+|++.....  ....+.+|+. +++.++||||+++++++......+
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~   97 (327)
T 3aln_A           18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW   97 (327)
T ss_dssp             CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence            3456799999999999999999999999999999999976432  2234555555 778889999999999999999999


Q ss_pred             EEEeecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           96 IVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +||||+.+ +|.+++..     ...+++..++.++.|++.||.|||++ |++||||||+|||++.++.  +||+|||+++
T Consensus        98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~  174 (327)
T 3aln_A           98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISG  174 (327)
T ss_dssp             EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSC
T ss_pred             EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCce
Confidence            99999975 77777653     56799999999999999999999999 9999999999999986654  9999999998


Q ss_pred             cccCCCCCCCCcCCCCCCCchhhc----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-cCC
Q 017860          170 SSVLHSQPKSTVGTPAYIAPEVLL----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-YSV  244 (365)
Q Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~  244 (365)
                      ............||+.|+|||++.    +..++.+ +|||||||++|+|++|+.||.......   .....+.... ...
T Consensus       175 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  250 (327)
T 3aln_A          175 QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQL  250 (327)
T ss_dssp             C------------------------------CCSH-HHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCC
T ss_pred             ecccccccccCCCCccccCceeeccccCcCCCCch-hhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCC
Confidence            665444445568999999999983    4455555 999999999999999999998654321   1111111111 111


Q ss_pred             --CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 --PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 --~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                        .....+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence              1224578999999999999999999999999999999754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.1e-48  Score=369.62  Aligned_cols=250  Identities=22%  Similarity=0.362  Sum_probs=208.2

Q ss_pred             CCCCcceecccccCCCeEEEEEEEc-------cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   90 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~   90 (365)
                      ..++|++.+.||+|+||.||+|++.       .++..||+|++.....  ..+.+.+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4568999999999999999999975       3456899999976432  235688999999999 89999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 017860           91 PTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG  154 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~  154 (365)
                      ...+|+||||+.+|+|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence            999999999999999999997653                4799999999999999999999999999999999999986


Q ss_pred             CCCCCEEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHH
Q 017860          155 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF  230 (365)
Q Consensus       155 ~~~~~vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  230 (365)
                      ++.  +||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|||++ |..||.+......+
T Consensus       239 ~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~  315 (370)
T 2psq_A          239 NNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELF  315 (370)
T ss_dssp             TCC--EEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred             CCC--EEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            654  9999999997543322   2234467889999999988777655 999999999999999 99999887654433


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      . .+.   . ....+.+..+++++.+||.+||+.||.+|||+.|++++
T Consensus       316 ~-~~~---~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          316 K-LLK---E-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             H-HHH---T-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H-HHh---c-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 221   1 12223344588999999999999999999999999974

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-49  Score=373.31  Aligned_cols=257  Identities=19%  Similarity=0.293  Sum_probs=211.3

Q ss_pred             CCCCcceecccccCCCeEEEEEE-----EccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ..++|++.+.||+|+||+||+|+     +..+++.||+|++....  .....+.+|+.+++.++||||+++++++.....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            35689999999999999999999     45578899999986532  223468899999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecC
Q 017860           94 LAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDF  165 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Df  165 (365)
                      .++||||+.+|+|.+++...+       .+++..++.++.||+.||+|||++||+||||||+|||++.++ ...+||+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence            999999999999999997643       489999999999999999999999999999999999998543 235999999


Q ss_pred             CCcccccC---CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccc
Q 017860          166 GYSKSSVL---HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQ  241 (365)
Q Consensus       166 gla~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  241 (365)
                      |+++....   ........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.........    ..+....
T Consensus       229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~----~~i~~~~  303 (367)
T 3l9p_A          229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----EFVTSGG  303 (367)
T ss_dssp             HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----HHHHTTC
T ss_pred             ccccccccccccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC
Confidence            99874321   223344568999999999988877665 999999999999998 99999876653322    2222222


Q ss_pred             cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          242 YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       242 ~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                       ..+....+++.+.+|+.+||+.||.+|||+.+++++.++..
T Consensus       304 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          304 -RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence             22334458899999999999999999999999999988754

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.4e-48  Score=357.89  Aligned_cols=257  Identities=24%  Similarity=0.372  Sum_probs=193.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc---HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ..++|++++.||+|+||.||+|+++.+|+.||+|++.......   ..+.++..+++.++||||+++++++.....+++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            3468999999999999999999999999999999997654322   2334455678888999999999999999999999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~-~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      |||+ ++.+..+... .+.+++..++.++.||+.||.|||++ |++||||||+||+++.++.  +||+|||++.......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDK  179 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC-------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCc
Confidence            9999 5555555543 56799999999999999999999995 9999999999999986654  9999999987655555


Q ss_pred             CCCCCcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          176 QPKSTVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ......||+.|+|||++.     ...++.+ +|||||||++|+|++|+.||............+.  .......+....+
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~  256 (318)
T 2dyl_A          180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL--QEEPPLLPGHMGF  256 (318)
T ss_dssp             -------CCTTCCHHHHC--------CCTH-HHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH--HSCCCCCCSSSCC
T ss_pred             cccccCCCccccChhhcccccccccCCccc-cchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh--ccCCCCCCccCCC
Confidence            555668999999999985     3345444 9999999999999999999987554433222221  1222334445568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ++++.+||.+||..||.+|||++++++||||.+
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            999999999999999999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-49  Score=372.34  Aligned_cols=254  Identities=22%  Similarity=0.380  Sum_probs=211.5

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEE-----EccCCcEEEEEEeecCCcc--cHHHHHHHHHHhcC-CCCCcceeceEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGDKI--DENVQREIINHRSL-RHPNIVRFKEVIL   89 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l-~hpnIv~l~~~~~   89 (365)
                      +....++|++.+.||+|+||.||+|+     +..+++.||+|++......  .+.+.+|+.+++.+ +||||+++++++.
T Consensus        17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            34557899999999999999999999     5567789999999764322  25688999999999 7899999999998


Q ss_pred             eCC-EEEEEEeecCCCChHHHHHhcCC-----------------------------------------------------
Q 017860           90 TPT-HLAIVMEYASGGELFERICNAGR-----------------------------------------------------  115 (365)
Q Consensus        90 ~~~-~~~lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  115 (365)
                      ... .+++||||+.+|+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            765 48999999999999999976543                                                     


Q ss_pred             -------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC---CCCC
Q 017860          116 -------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKS  179 (365)
Q Consensus       116 -------------l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~---~~~~  179 (365)
                                   +++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++......   ....
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccc
Confidence                         899999999999999999999999999999999999986654  9999999987543322   2344


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+...+...    ...+.+..+++++.+++
T Consensus       255 ~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG----TRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             CEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT----CCCCCCTTCCHHHHHHH
T ss_pred             cCCCceeEChhhhcCCCCCch-hhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcC----CCCCCCCCCCHHHHHHH
Confidence            568999999999988777655 999999999999998 999998877655554444332    22333445889999999


Q ss_pred             HHhcccCCCCCCCHHHHhcC
Q 017860          259 SRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+||+.||.+|||+.++++|
T Consensus       330 ~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHH
Confidence            99999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.8e-48  Score=354.32  Aligned_cols=253  Identities=19%  Similarity=0.216  Sum_probs=208.3

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++......++|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            3568999999999999999999999999999999987543 345688999999999 79999999999999999999999


Q ss_pred             ecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---CCEEEecCCCcccccCCC
Q 017860          100 YASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS  175 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~---~~vkl~Dfgla~~~~~~~  175 (365)
                      |+ +++|.+++...+ ++++..++.++.||+.||+|||++||+||||||+|||++.++.   ..+||+|||+++......
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~  165 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  165 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence            99 999999998754 5999999999999999999999999999999999999975432   349999999987543322


Q ss_pred             --------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhccccCC
Q 017860          176 --------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---FRKTIQRILSVQYSV  244 (365)
Q Consensus       176 --------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~  244 (365)
                              ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........   +............ .
T Consensus       166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~  243 (298)
T 1csn_A          166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-R  243 (298)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-H
T ss_pred             ccccccccCccCCCCCcccCCchhhcCCCCChH-HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH-H
Confidence                    2345679999999999988777655 9999999999999999999987543221   1111111111110 0


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .....+++++.+|+.+||+.||.+|||++++++
T Consensus       244 ~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            112347899999999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-48  Score=356.03  Aligned_cols=253  Identities=21%  Similarity=0.328  Sum_probs=216.0

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .+....++|++.+.||+|+||.||++.++.++..||+|.+.......+.+.+|+.+++.++||||+++++++.....+++
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            34455678999999999999999999999999999999998766666789999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||||+.+++|.+++...  ..+++..++.++.||+.||+|||++|++||||||+||+++.++.  +||+|||++......
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCC
Confidence            99999999999999864  34899999999999999999999999999999999999976654  999999998754332


Q ss_pred             CC--CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 SQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ..  .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...+..... +.+.    .....+.+..++
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~-~~~~----~~~~~~~~~~~~  238 (288)
T 3kfa_A          165 TYTAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLE----KDYRMERPEGCP  238 (288)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHH----TTCCCCCCTTCC
T ss_pred             ccccccCCccccCcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHh----ccCCCCCCCCCC
Confidence            21  233457889999999987777655 999999999999999 99999876654332 2222    223334455689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+.+|+.+||..||.+|||+.++++
T Consensus       239 ~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          239 EKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-48  Score=357.61  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=205.5

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEE----EccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeC-
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTP-   91 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-   91 (365)
                      .....++|+++++||+|+||.||+++    +..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++... 
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            34456799999999999999999998    567899999999876432 235788999999999999999999998654 


Q ss_pred             -CEEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           92 -THLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        92 -~~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                       ..+++||||+++++|.+++...+ ++++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+++
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~  162 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTK  162 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccc
Confidence             56899999999999999998754 4999999999999999999999999999999999999986654  9999999997


Q ss_pred             cccCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh-----------HHHHHHH
Q 017860          170 SSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------KDFRKTI  234 (365)
Q Consensus       170 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-----------~~~~~~~  234 (365)
                      ......    ......+++.|+|||++.+..++.+ +|||||||++|+|++|..||......           .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            543322    1233457788999999988877655 99999999999999999998653211           0111111


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       235 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..........+.+..+++++.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            2222233344556678999999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-49  Score=362.56  Aligned_cols=249  Identities=29%  Similarity=0.495  Sum_probs=204.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc-------cHHHHHHHHHHhcC----CCCCcceeceEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI-------DENVQREIINHRSL----RHPNIVRFKEVILT   90 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~e~~~l~~l----~hpnIv~l~~~~~~   90 (365)
                      .++|++.+.||+|+||.||+|+++.+++.||+|++......       ...+.+|+.+++.+    +||||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            56899999999999999999999999999999999764321       22355788888888    89999999999999


Q ss_pred             CCEEEEEEee-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCCCEEEecCCCc
Q 017860           91 PTHLAIVMEY-ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD-GSPAPRLKICDFGYS  168 (365)
Q Consensus        91 ~~~~~lv~e~-~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~-~~~~~~vkl~Dfgla  168 (365)
                      ....++|||+ +.+++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++ .++  .+||+|||++
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~  187 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSG  187 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSC
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchh
Confidence            9999999999 78999999999888899999999999999999999999999999999999997 444  5999999998


Q ss_pred             ccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          169 KSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       169 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      +.... .......||+.|+|||++.+..+...++|||||||++|+|++|+.||....      +    +.......  ..
T Consensus       188 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~--~~  254 (312)
T 2iwi_A          188 ALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHF--PA  254 (312)
T ss_dssp             EECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCC--CT
T ss_pred             hhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCC--cc
Confidence            75433 334556799999999999877776656999999999999999999997521      1    11222222  34


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .++..+.+||.+||+.||.+|||++++++||||....
T Consensus       255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            5889999999999999999999999999999997643

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3e-48  Score=350.35  Aligned_cols=249  Identities=29%  Similarity=0.419  Sum_probs=199.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..++|++.+.||+|+||.||++.+.  ++.||+|++.....     ..+.+.+|+.+++.++||||+++++++.....++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3568999999999999999999984  88999999865422     2367889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCC------CCCCEEEecCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGS------PAPRLKICDFG  166 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~---ivHrDlkp~NIli~~~------~~~~vkl~Dfg  166 (365)
                      +||||+.+++|.+++. .+++++..++.++.|++.||.|||++|   ++||||||+||+++..      ..+.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999998875 457999999999999999999999999   8999999999999752      13469999999


Q ss_pred             CcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          167 YSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       167 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      +++..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+.....    ..........+.
T Consensus       162 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~  235 (271)
T 3dtc_A          162 LAREWHRT-TKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVA----YGVAMNKLALPI  235 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHH-HHHHHHHHHHHHHHHCCCTTTTSCHHHHH----HHHHTSCCCCCC
T ss_pred             cccccccc-cccCCCCccceeCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHH----HhhhcCCCCCCC
Confidence            98754332 2335679999999999987777655 99999999999999999999876654322    223333444455


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ...+++.+.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            56689999999999999999999999999975

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-48  Score=361.84  Aligned_cols=252  Identities=23%  Similarity=0.239  Sum_probs=206.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+ +||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            4689999999999999999999999999999999876433 35688999999999 999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---CCEEEecCCCcccccCCCC
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~---~~vkl~Dfgla~~~~~~~~  176 (365)
                      + +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   ..+||+|||+++.......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence            9 9999999986 467999999999999999999999999999999999999976542   2399999999975433222


Q ss_pred             --------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--
Q 017860          177 --------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--  246 (365)
Q Consensus       177 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  246 (365)
                              .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... .+....+.......+.  
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~  243 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIEV  243 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHHH
T ss_pred             CccccccccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHHH
Confidence                    246689999999999988777655 9999999999999999999987543222 2222222221111111  


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .....+++.+++.+||..+|.+||+++++++
T Consensus       244 ~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          244 LCENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            0112349999999999999999999998876

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.9e-49  Score=373.55  Aligned_cols=255  Identities=24%  Similarity=0.356  Sum_probs=212.4

Q ss_pred             CCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        15 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      ...+....++|++.+.||+|+||.||+|+++.+++.||+|.+.....  ....+.+|+.+++.++||||+++++++....
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            34556677899999999999999999999999999999999875422  2245778999999999999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      .+|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++..
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~  263 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREE  263 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEEC
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceec
Confidence            9999999999999999997654 5999999999999999999999999999999999999986654  999999998753


Q ss_pred             cCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          172 VLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       172 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      .....   .....+++.|+|||++.+..++.+ +|||||||++|||++ |..||........ .+.+    ......+.+
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~-~~~~----~~~~~~~~~  337 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQT-REFV----EKGGRLPCP  337 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHH-HHHH----HTTCCCCCC
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH----HcCCCCCCC
Confidence            32211   122335778999999988777665 999999999999998 9999987665332 2222    222334445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..+++++.+|+.+||+.||.+|||+.++++
T Consensus       338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            568899999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.2e-48  Score=358.53  Aligned_cols=254  Identities=22%  Similarity=0.358  Sum_probs=211.7

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL   89 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~   89 (365)
                      .+....++|++.+.||+|+||.||+|.+.     .+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            34455679999999999999999999983     4568999999976432  2356889999999999999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 017860           90 TPTHLAIVMEYASGGELFERICNAGR------------------------FSEDEARFFFQQLISGVSYCHAMQVCHRDL  145 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------l~~~~~~~i~~qil~al~~LH~~~ivHrDl  145 (365)
                      ....+++||||+.+++|.+++.....                        +++..++.++.||+.||.|||++|++||||
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di  176 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL  176 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence            99999999999999999999987543                        899999999999999999999999999999


Q ss_pred             CCCcEEecCCCCCCEEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCC
Q 017860          146 KLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPF  221 (365)
Q Consensus       146 kp~NIli~~~~~~~vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf  221 (365)
                      ||+||+++.++.  +||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||
T Consensus       177 kp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          177 AARNILVAEGRK--MKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             SGGGEEEETTTE--EEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSS
T ss_pred             chheEEEcCCCC--EEEccccccccccccccceeccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCC
Confidence            999999986654  9999999987543322   2234467889999999988777655 999999999999999 99999


Q ss_pred             CCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          222 EDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+....... ..+.    .....+.+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          254 PGIPPERLF-NLLK----TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TTCCGGGHH-HHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHH-HHhh----cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            887664432 2222    112233445689999999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-47  Score=348.69  Aligned_cols=251  Identities=27%  Similarity=0.420  Sum_probs=206.3

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc--------cHHHHHHHHHHhcCCCCCcceeceEEEeC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI--------DENVQREIINHRSLRHPNIVRFKEVILTP   91 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~   91 (365)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++......        .+.+.+|+.+++.++||||+++++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            3457999999999999999999999999999999998654321        15788999999999999999999999766


Q ss_pred             CEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCC---CCEEEecC
Q 017860           92 THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPA---PRLKICDF  165 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~---~~vkl~Df  165 (365)
                      .  ++||||+.+++|.+.+... ..+++..++.++.|++.||+|||++|  ++||||||+|||++.++.   ..+||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            6  6999999999998888654 46999999999999999999999999  999999999999975442   23999999


Q ss_pred             CCcccccCCCCCCCCcCCCCCCCchhhc--ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC
Q 017860          166 GYSKSSVLHSQPKSTVGTPAYIAPEVLL--RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS  243 (365)
Q Consensus       166 gla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  243 (365)
                      |+++...  .......||+.|+|||++.  ...++. ++|||||||++|+|++|+.||.........  ...........
T Consensus       174 g~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~-~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~  248 (287)
T 4f0f_A          174 GLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTE-KADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLR  248 (287)
T ss_dssp             TTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECH-HHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCC
T ss_pred             Ccccccc--ccccccCCCccccCchhhccCCCCcCc-hhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCC
Confidence            9987432  2344567999999999984  334444 499999999999999999999876654321  12222223333


Q ss_pred             CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          244 VPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       244 ~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ......+++++.+||.+||+.||.+|||+.++++
T Consensus       249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3444568999999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5e-48  Score=356.49  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=208.6

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCC--CCCcceeceEEEeCCE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLR--HPNIVRFKEVILTPTH   93 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~   93 (365)
                      ....++|++++.||+|+||.||++.+. +++.||+|++.....   ....+.+|+.+++.++  ||||+++++++.....
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            344668999999999999999999986 588999999976432   2356789999999997  5999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++|++||||||+|||+++   +.+||+|||+++....
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~---~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD---GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET---TEEEECCCSSSCC---
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC---CeEEEeeccccccccC
Confidence            999999 568899999998889999999999999999999999999999999999999964   3599999999875433


Q ss_pred             CCC---CCCCcCCCCCCCchhhcc-----------cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhc
Q 017860          174 HSQ---PKSTVGTPAYIAPEVLLR-----------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS  239 (365)
Q Consensus       174 ~~~---~~~~~gt~~y~aPE~~~~-----------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  239 (365)
                      ...   .....||+.|+|||++.+           ..+ +.++|||||||++|+|++|..||........   ....+..
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~  254 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIID  254 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CC-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccC-CchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHh
Confidence            221   234579999999999865           234 4459999999999999999999987654322   2223333


Q ss_pred             cccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       240 ~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .......+...++++.+||.+||+.||.+|||+.++++||||....
T Consensus       255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  300 (313)
T 3cek_A          255 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  300 (313)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred             cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence            3333333445688999999999999999999999999999997643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=366.01  Aligned_cols=255  Identities=18%  Similarity=0.197  Sum_probs=201.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc---CCcEEEEEEeecCCc------------ccHHHHHHHHHHhcCCCCCcceece
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRFKE   86 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~hpnIv~l~~   86 (365)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|++.....            ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            5689999999999999999999987   788999999876432            2234667889999999999999999


Q ss_pred             EEEe----CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEE
Q 017860           87 VILT----PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKI  162 (365)
Q Consensus        87 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl  162 (365)
                      ++..    ...+|+||||+ +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+.+||
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL  194 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL  194 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence            9988    78899999999 999999998877899999999999999999999999999999999999998776557999


Q ss_pred             ecCCCcccccCCCC--------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh-HHHHHH
Q 017860          163 CDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKT  233 (365)
Q Consensus       163 ~Dfgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~  233 (365)
                      +|||+++.......        .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ......
T Consensus       195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~  273 (345)
T 2v62_A          195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA  273 (345)
T ss_dssp             CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred             EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence            99999975432211        144579999999999988777655 99999999999999999999653322 222222


Q ss_pred             HHHHhcccc----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          234 IQRILSVQY----SVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       234 ~~~~~~~~~----~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .........    .......+++++.+||.+||..||.+|||++++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            222111110    011122588999999999999999999999999873

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.8e-48  Score=365.26  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=209.9

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEcc-------CCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI   88 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~   88 (365)
                      ....++|++.+.||+|+||.||+|++..       .+..||+|++.....  ....+.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3456799999999999999999999753       335799999976432  225688999999999 899999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        89 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      .....+++||||+.+|+|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV  224 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence            99999999999999999999998753                48999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCC---CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChH
Q 017860          153 DGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK  228 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  228 (365)
                      +.++.  +||+|||+++.....   .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.......
T Consensus       225 ~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          225 TEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             CTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             cCCCc--EEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            86654  999999999854332   22344567889999999988777655 999999999999999 999998765433


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                       +.+.+.   . ......+..+++++.+||.+||+.||.+|||+.+++++
T Consensus       302 -~~~~~~---~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          302 -LFKLLK---E-GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             -HHHHHH---T-TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHH---c-CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             222222   2 22233345689999999999999999999999999975

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.8e-48  Score=358.33  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=211.3

Q ss_pred             CCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEE--EEEEeecC--CcccHHHHHHHHHHhcC-CCCCcceeceE
Q 017860           13 AMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV--AVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEV   87 (365)
Q Consensus        13 ~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~v--aiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~l~~~   87 (365)
                      .+..|.+. .++|++.+.||+|+||.||+|+++.++..+  |+|.+...  ....+.+.+|+.+++.+ +||||++++++
T Consensus        16 ~~~~p~~~-~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   94 (327)
T 1fvr_A           16 PTIYPVLD-WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA   94 (327)
T ss_dssp             CCCSSBCC-GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred             Cccccccc-HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence            33445433 468999999999999999999999888865  99988753  22345788999999999 89999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 017860           88 ILTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL  151 (365)
Q Consensus        88 ~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIl  151 (365)
                      +.....+|+||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  174 (327)
T 1fvr_A           95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL  174 (327)
T ss_dssp             EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence            999999999999999999999997654                6999999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHH
Q 017860          152 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDF  230 (365)
Q Consensus       152 i~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~  230 (365)
                      ++.++.  +||+|||+++............+++.|+|||++.+..++.+ +|||||||++|+|++ |..||...+.... 
T Consensus       175 ~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~-  250 (327)
T 1fvr_A          175 VGENYV--AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAEL-  250 (327)
T ss_dssp             ECGGGC--EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH-
T ss_pred             EcCCCe--EEEcccCcCccccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHHH-
Confidence            976654  99999999875444444455567899999999987777655 999999999999998 9999987665332 


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                         ...+. .....+....+++.+.+||.+||..||.+|||+++++++
T Consensus       251 ---~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          251 ---YEKLP-QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             ---HHHGG-GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ---HHHhh-cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               22222 222334445688999999999999999999999999985

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.8e-48  Score=352.17  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=197.5

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      .++-...++|++.++||+|+||.||++++.   ..||+|++.....   ..+.+.+|+.+++.++||||++++++. ...
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~   92 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP   92 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence            445566789999999999999999999864   3599999875432   235688999999999999999999965 566


Q ss_pred             EEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      .+++||||+.+++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++..
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~  170 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN--TVKIGDFGLATEK  170 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT--EEEECCCC-----
T ss_pred             ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC--CEEEccceecccc
Confidence            68999999999999999864 45699999999999999999999999999999999999998765  4999999998744


Q ss_pred             cC---CCCCCCCcCCCCCCCchhhc---ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 017860          172 VL---HSQPKSTVGTPAYIAPEVLL---RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       172 ~~---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  245 (365)
                      ..   ........||+.|+|||++.   +..++. ++|||||||++|+|++|+.||........+.+.+...........
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF-QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCH-HHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTS
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCc-ccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhh
Confidence            32   22234457999999999986   344444 499999999999999999999987776655555443221111111


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ....+++.+.+|+.+||..+|.+|||+.++++
T Consensus       250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            23457899999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.5e-48  Score=348.29  Aligned_cols=251  Identities=25%  Similarity=0.426  Sum_probs=212.4

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ..+.++|++.+.||+|+||.||++.+. +++.||+|.+.......+.+.+|+.+++.++||||+++++++.....+++||
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            445678999999999999999999997 6788999999877666678999999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC--C
Q 017860           99 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--S  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~--~  175 (365)
                      ||+++++|.+++... +.+++..++.++.|++.||.|||++|++||||||+||+++.++.  +||+|||+++.....  .
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHH
T ss_pred             eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEccccccccccccccc
Confidence            999999999999765 56899999999999999999999999999999999999976654  999999998754321  1


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ......+|+.|+|||++.+..++.+ +||||||+++|+|++ |+.||..........    .+... .....+...++.+
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~i~~~-~~~~~~~~~~~~l  234 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTG-FRLYKPRLASTHV  234 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTT-CCCCCCTTSCHHH
T ss_pred             ccccccccccccChhhhcCCCccch-hchhhhHHHHHHHhccCCCCCCCCCHHHHHH----HHhcC-CcCCCCccCcHHH
Confidence            2334567889999999987777655 999999999999999 899998765533222    22222 2223344578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 017860          255 RDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+++.+||+.||.+|||+.+++++
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          235 YQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.7e-48  Score=362.94  Aligned_cols=254  Identities=15%  Similarity=0.187  Sum_probs=200.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccC-----CcEEEEEEeecCCc------------ccHHHHHHHHHHhcCCCCCccee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVT-----KELVAVKYIERGDK------------IDENVQREIINHRSLRHPNIVRF   84 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~------------~~~~~~~e~~~l~~l~hpnIv~l   84 (365)
                      .++|++.+.||+|+||.||+|.++.+     ++.||+|++.....            ......+|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            45899999999999999999999764     58899999876431            11234456677788899999999


Q ss_pred             ceEEEeC----CEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           85 KEVILTP----THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        85 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      ++++...    ...|+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+..+.
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~  192 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ  192 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence            9999775    5689999999 99999999875 6799999999999999999999999999999999999998444556


Q ss_pred             EEEecCCCcccccCCCC--------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHH
Q 017860          160 LKICDFGYSKSSVLHSQ--------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR  231 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  231 (365)
                      +||+|||+++.......        ....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........
T Consensus       193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            99999999975432221        234459999999999988777655 999999999999999999998644333322


Q ss_pred             HHHHHHhcccc-----CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          232 KTIQRILSVQY-----SVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       232 ~~~~~~~~~~~-----~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...........     .......+++++.+|+.+||..+|.+||++.++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            22221111110     00112347899999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=8.4e-49  Score=363.44  Aligned_cols=256  Identities=21%  Similarity=0.266  Sum_probs=202.6

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC---
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT---   92 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~---   92 (365)
                      ..+....++|++.+.||+|+||+||+|++.  ++.||+|++...........+|+.+++.++||||+++++++....   
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            344556779999999999999999999875  789999999776555566778999999999999999999998743   


Q ss_pred             -EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecCCCCCcEEecCCCCCCEE
Q 017860           93 -HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM----------QVCHRDLKLENTLLDGSPAPRLK  161 (365)
Q Consensus        93 -~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~----------~ivHrDlkp~NIli~~~~~~~vk  161 (365)
                       .+++||||+++|+|.+++... .+++..++.++.|++.||+|||+.          ||+||||||+|||++.++  ++|
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~--~~k  171 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL--TAC  171 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC--CEE
T ss_pred             ceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC--eEE
Confidence             479999999999999999764 599999999999999999999999          999999999999998665  499


Q ss_pred             EecCCCcccccCCC---CCCCCcCCCCCCCchhhccc-----ccCCccceeehhhHHHHHHHhCCCCCCCCCChH-----
Q 017860          162 ICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRH-----EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----  228 (365)
Q Consensus       162 l~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----  228 (365)
                      |+|||+++......   ......||+.|+|||++.+.     .++ .++|||||||++|+|++|+.||.+.....     
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF-LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHH-HHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCC-ccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999997543322   23446799999999999763     333 34899999999999999999997643211     


Q ss_pred             -------HHHHHHHHHhccccCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          229 -------DFRKTIQRILSVQYSVPDT------NPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       229 -------~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                             ............. ..+..      ...++++.+||.+||+.||.+|||+.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSC-CCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhccCCchhhhhhhhhccc-CCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                   0111111111111 11111      1123569999999999999999999999863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.2e-47  Score=351.93  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=208.7

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEE----EccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEe
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT   90 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~   90 (365)
                      +......+|++++.||+|+||.||+|+    +..+++.||+|++....  ...+.+.+|+.+++.++||||+++++++..
T Consensus        15 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           15 PTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             TTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            334445679999999999999999999    56789999999987543  233678999999999999999999999987


Q ss_pred             C--CEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           91 P--THLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        91 ~--~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      .  ..+++||||+.+++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+||+++.++  ++||+|||+
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~  172 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGL  172 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTT
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC--CEEECcccc
Confidence            7  678999999999999999954 45799999999999999999999999999999999999998765  499999999


Q ss_pred             cccccCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCC-----------ChHHHHH
Q 017860          168 SKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-----------EPKDFRK  232 (365)
Q Consensus       168 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-----------~~~~~~~  232 (365)
                      ++......    ......||+.|+|||++.+..++.+ +|||||||++|+|++|..|+....           .......
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence            87544332    2345568889999999988877655 999999999999999998864321           1111222


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .... .......+.+..+++++.+||.+||..||.+|||+.++++
T Consensus       252 ~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          252 LVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            2222 2223344455668999999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-47  Score=354.08  Aligned_cols=250  Identities=24%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||++++..+++.||+|++......    .+.+.+|+.+++.++||||+++++++..+..+|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            35899999999999999999999999999999998754322    25688999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC--
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~--  175 (365)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++  .+||+|||++.......  
T Consensus       113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~--~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD--FAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS--CEEECSCCC----------
T ss_pred             EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC--CEEEecCccCccccccccc
Confidence            99999999999999888899999999999999999999999999999999999998665  49999999987543322  


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .....+....  .........+++++.
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAI--PRPSTVRPGIPVAFD  266 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCC--CCGGGTSTTCCTHHH
T ss_pred             cccccCCCcCccCHHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCC--CCccccCCCCCHHHH
Confidence            2335579999999999988777666 99999999999999999999875432 2222221111  111122345889999


Q ss_pred             HHHHHhcccCCCCCC-CHHHHhc
Q 017860          256 DLISRIFVADPAARI-TIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~-t~~ell~  277 (365)
                      ++|.+||..||.+|| |++++++
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999 7888875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-48  Score=361.71  Aligned_cols=255  Identities=23%  Similarity=0.358  Sum_probs=212.4

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCC--cccHHHHHHHHHHhcC-CCCCcceeceEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVIL   89 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~   89 (365)
                      +....++|++.+.||+|+||.||+|.+.     .++..||+|++....  ...+.+.+|+.+++.+ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3445678999999999999999999973     356789999987532  3447789999999999 8999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 017860           90 TPTHLAIVMEYASGGELFERICNAG-----------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLK  146 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlk  146 (365)
                      ....+++||||+++|+|.+++....                       .+++..++.++.||+.||+|||++||+|||||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik  199 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  199 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            9999999999999999999997643                       37999999999999999999999999999999


Q ss_pred             CCcEEecCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCC
Q 017860          147 LENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFE  222 (365)
Q Consensus       147 p~NIli~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~  222 (365)
                      |+|||++.++  .+||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.
T Consensus       200 p~NIll~~~~--~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          200 ARNVLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             GGGEEEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSST
T ss_pred             hhhEEEcCCC--cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcc
Confidence            9999998665  499999999875443322   234457889999999988777655 999999999999998 999998


Q ss_pred             CCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          223 DPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                      .......+.+.+..    ....+.+..+++++.+||.+||..||.+|||+.++++|.
T Consensus       277 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          277 GIPVDANFYKLIQN----GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             TCCCSHHHHHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             cCCcHHHHHHHHhc----CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            87765555444432    223334455789999999999999999999999999864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.8e-48  Score=346.77  Aligned_cols=245  Identities=20%  Similarity=0.293  Sum_probs=205.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC--CEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP--THLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~   95 (365)
                      ..++|++.+.||+|+||.||++++.  ++.||+|++.....   ..+.+.+|+.+++.++||||+++++++...  ..++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            4568999999999999999999984  88999999976432   235688999999999999999999999887  7889


Q ss_pred             EEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           96 IVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +||||+++|+|.+++....  .+++..++.++.||+.||+|||++|  ++||||||+||+++.++.  ++|+|||++...
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~  163 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF  163 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee
Confidence            9999999999999998765  4899999999999999999999999  999999999999986665  888888876532


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCC--ccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDG--KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                          ......||+.|+|||++.+..+..  .++|||||||++|+|++|+.||............    .......+.+..
T Consensus       164 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~  235 (271)
T 3kmu_A          164 ----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV----ALEGLRPTIPPG  235 (271)
T ss_dssp             ----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH----HHSCCCCCCCTT
T ss_pred             ----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH----HhcCCCCCCCCC
Confidence                234467899999999998765544  2599999999999999999999876654433322    223333344456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++++.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          236 ISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            8999999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.2e-48  Score=355.84  Aligned_cols=253  Identities=24%  Similarity=0.364  Sum_probs=213.8

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEE-----ccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEe
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILT   90 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~   90 (365)
                      ....++|++.+.||+|+||.||+|.+     ..+++.||+|++.....  ..+.+.+|+.+++.+ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            44567999999999999999999985     45778999999976542  236788999999999 99999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           91 PTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      ....++||||+++|+|.+++....                  .+++..++.++.||+.||+|||++|++||||||+||++
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL  178 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence            999999999999999999997654                  48999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChH
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK  228 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  228 (365)
                      +.++  .+||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.......
T Consensus       179 ~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          179 THGR--ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             ETTT--EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             cCCC--CEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            8665  499999999875543322   234557889999999987777655 999999999999998 999998877655


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ...+.+...    ...+....+++.+.+|+.+||..||.+|||+.+++++
T Consensus       256 ~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          256 KFYKMIKEG----FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHT----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccC----CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            554444332    2233345688999999999999999999999999974

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-48  Score=371.13  Aligned_cols=257  Identities=22%  Similarity=0.348  Sum_probs=208.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCC--EEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAI   96 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~l   96 (365)
                      .+++|++.+.||+|+||+||+|+++.+|+.||+|++....  ...+.+.+|+.+++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            3568999999999999999999999999999999997543  23366789999999999999999999998765  7899


Q ss_pred             EEeecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCCCCCEEEecCCCcccc
Q 017860           97 VMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~--~~~~~~vkl~Dfgla~~~  171 (365)
                      ||||+.+|+|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+.  .++.+.+||+|||+++..
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            999999999999987643   399999999999999999999999999999999999982  123335999999999876


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcc--------cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLR--------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-  242 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-  242 (365)
                      ..........||+.|+|||++.+        ..++ .++|||||||++|+|++|+.||..........+.+..+..... 
T Consensus       167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~  245 (396)
T 4eut_A          167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS  245 (396)
T ss_dssp             CCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHH-HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT
T ss_pred             cCCCccccccCCccccCHHHhhccccccccccCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc
Confidence            55555667789999999999865        3444 4499999999999999999999764433322333333333221 


Q ss_pred             ------------------CCCCCCC----CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          243 ------------------SVPDTNP----ISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       243 ------------------~~~~~~~----~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                                        ..+....    ++..+.++|.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence                              1122222    34578899999999999999999998764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.1e-48  Score=349.22  Aligned_cols=246  Identities=24%  Similarity=0.353  Sum_probs=210.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe------------
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT------------   90 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------------   90 (365)
                      .+|++++.||+|+||.||+|++..+++.||+|.+....   ..+.+|+.+++.++||||+++++++..            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~   87 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNS   87 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccc
Confidence            47999999999999999999999999999999997653   467899999999999999999999864            


Q ss_pred             ----CCEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEec
Q 017860           91 ----PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICD  164 (365)
Q Consensus        91 ----~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~D  164 (365)
                          ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||++|++||||||+||+++.++.  +||+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~D  165 (284)
T 2a19_B           88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGD  165 (284)
T ss_dssp             -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECC
T ss_pred             cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECc
Confidence                45689999999999999999754  57999999999999999999999999999999999999986654  99999


Q ss_pred             CCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC
Q 017860          165 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV  244 (365)
Q Consensus       165 fgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  244 (365)
                      ||+++............||+.|+|||++.+..++.+ +|||||||++|+|++|..||...      ......+....   
T Consensus       166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~---  235 (284)
T 2a19_B          166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDGI---  235 (284)
T ss_dssp             CTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTC---
T ss_pred             chhheeccccccccccCCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhccc---
Confidence            999887665555666789999999999988777666 99999999999999999887431      11222222211   


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                       ....++..+.+||.+||..||.+|||+.++++|.+..+.
T Consensus       236 -~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          236 -ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence             223478999999999999999999999999999887654

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.7e-48  Score=359.48  Aligned_cols=251  Identities=20%  Similarity=0.308  Sum_probs=204.2

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcE----EEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKEL----VAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~----vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      +...++|++++.||+|+||+||+|++..+++.    ||+|.+....  .....+.+|+.+++.++||||+++++++. ..
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            34567999999999999999999999888876    6777764432  22356778999999999999999999886 45


Q ss_pred             EEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ..++||||+.+|+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~  165 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLL  165 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGS
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCccccc
Confidence            689999999999999999764 57999999999999999999999999999999999999976654  999999999865


Q ss_pred             cCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          172 VLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       172 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      .....   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+....... ..+.   . ....+..
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~---~-~~~~~~~  239 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVP-DLLE---K-GERLAQP  239 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHH-HHHH---T-TCBCCCC
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHH-HHHH---c-CCCCCCC
Confidence            33322   234567889999999988777655 999999999999999 99999886654322 2222   1 1222333


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ...+.++.+++.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          240 QICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4477889999999999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.4e-48  Score=360.07  Aligned_cols=251  Identities=20%  Similarity=0.345  Sum_probs=202.2

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEE----EEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV----AVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~v----aiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      +...++|++.+.||+|+||+||+|++..+++.+    |+|.+....  .....+.+|+.+++.++||||+++++++....
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            345678999999999999999999998777754    777765432  34467899999999999999999999998765


Q ss_pred             EEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                       .++|++|+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~  167 (327)
T 3poz_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLL  167 (327)
T ss_dssp             -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHH
T ss_pred             -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEc
Confidence             7889999999999999987 456999999999999999999999999999999999999987664  999999998754


Q ss_pred             cCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          172 VLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       172 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      .....   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+...... ...+.    .....+..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~----~~~~~~~~  241 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILE----KGERLPQP  241 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGH-HHHHH----TTCCCCCC
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHH-HHHHH----cCCCCCCC
Confidence            33222   233456889999999988877655 999999999999999 9999987665432 22222    22233445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ...+.++.+++.+||+.+|.+|||+.+++++
T Consensus       242 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          242 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            5588999999999999999999999999976

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-48  Score=360.80  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=208.5

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      ...++|++.+.||+|+||.||++++.     .+++.||+|++.....  ..+.+.+|+.+++.++||||+++++++....
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            34578999999999999999999997     3558999999976432  2356889999999999999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 017860           93 HLAIVMEYASGGELFERICNA------------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLE  148 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~------------------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~  148 (365)
                      .+|+||||+.+++|.+++...                        ..+++.+++.++.||+.||.|||++||+||||||+
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~  203 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  203 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence            999999999999999999763                        56899999999999999999999999999999999


Q ss_pred             cEEecCCCCCCEEEecCCCcccccCC---CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCC
Q 017860          149 NTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDP  224 (365)
Q Consensus       149 NIli~~~~~~~vkl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~  224 (365)
                      |||++.++.  +||+|||+++.....   .......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||...
T Consensus       204 NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          204 NCLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             GEEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             eEEECCCCe--EEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCCCC
Confidence            999986654  999999998743222   22344568999999999988777655 999999999999999 99999876


Q ss_pred             CChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          225 DEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ......    ..+..... .+.+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       281 ~~~~~~----~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AHEEVI----YYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CHHHHH----HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ChHHHH----HHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            553322    22222222 22334588999999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.2e-48  Score=353.38  Aligned_cols=249  Identities=17%  Similarity=0.181  Sum_probs=203.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCC-------cEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      ..++|++.+.||+|+||.||+|+++.++       ..||+|.+.... ...+.+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            3568999999999999999999998877       479999986543 33467899999999999999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC------CEEEecC
Q 017860           93 HLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP------RLKICDF  165 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~-l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~------~vkl~Df  165 (365)
                      ..++||||+.+++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++..      .+||+||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence            99999999999999999987654 9999999999999999999999999999999999999766531      2999999


Q ss_pred             CCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC
Q 017860          166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       166 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  245 (365)
                      |++.....   .....||+.|+|||++.+....+.++|||||||++|+|++|..|+..............    ..... 
T Consensus       166 g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~----~~~~~-  237 (289)
T 4fvq_A          166 GISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE----DRHQL-  237 (289)
T ss_dssp             CSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH----TTCCC-
T ss_pred             cccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh----ccCCC-
Confidence            99864322   23346899999999998744445559999999999999996554444433332222221    22222 


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                       +...++++.+|+.+||+.||.+|||+.++++|
T Consensus       238 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          238 -PAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             -CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             -CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             23357889999999999999999999999986

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.8e-48  Score=372.61  Aligned_cols=252  Identities=22%  Similarity=0.356  Sum_probs=212.6

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..+....++|++.+.||+|+||.||++.++ ++..||||.+.......+.+.+|+.+++.++||||+++++++. ...+|
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            445566788999999999999999999986 5778999999876666788999999999999999999999986 66789


Q ss_pred             EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +||||+.+|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~--~~kl~DFG~a~~~~~  336 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL--VCKIADFGLARVIED  336 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC--CEEECSTTGGGGBCC
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC--cEEEeeCCCceEcCC
Confidence            999999999999999754  3689999999999999999999999999999999999998665  499999999975432


Q ss_pred             C--CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          174 H--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       174 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      .  .......+|+.|+|||++....++.+ +|||||||++|||++ |+.||.+.+........ .    .....+.+..+
T Consensus       337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~----~~~~~~~~~~~  410 (454)
T 1qcf_A          337 NEYTAREGAKFPIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-E----RGYRMPRPENC  410 (454)
T ss_dssp             HHHHTTCSSSSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-H----HTCCCCCCTTS
T ss_pred             CceeccCCCcccccccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-H----cCCCCCCCCCC
Confidence            2  11233456789999999987777655 999999999999999 99999887654433222 1    12344555668


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++++.+|+.+||..||.+|||+.+++.
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-47  Score=346.99  Aligned_cols=254  Identities=21%  Similarity=0.336  Sum_probs=211.5

Q ss_pred             CCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           14 MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        14 ~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ....+....++|++++.||+|+||.||++.+. ++..||+|.+.......+.+.+|+.+++.++||||+++++++. ...
T Consensus         4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             chhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            34455566789999999999999999999986 6778999999876666688999999999999999999999986 455


Q ss_pred             EEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           94 LAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      .++||||+.+++|.+++....  .+++..++.++.|++.||+|||++|++||||||+||+++.++.  +||+|||+++..
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~  159 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLI  159 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEEC
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccc
Confidence            899999999999999987543  6999999999999999999999999999999999999986654  999999998754


Q ss_pred             cCCC--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          172 VLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      ....  ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||...+......    .+.. ........
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~  233 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----NLER-GYRMVRPD  233 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT-TCCCCCCT
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHH----HHhc-ccCCCCcc
Confidence            3322  2234457889999999987777655 999999999999999 999998766543222    2221 22233445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+++++.+++.+||..||.+|||+.++++
T Consensus       234 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          234 NCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            68999999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=362.09  Aligned_cols=250  Identities=12%  Similarity=0.126  Sum_probs=205.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc--------CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcce----------
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR----------   83 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~----------   83 (365)
                      .++|++.+.||+|+||.||+|+++.        .++.||+|++...    ..+.+|+.+++.++||||++          
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            5789999999999999999999987        4889999998764    46889999999999999988          


Q ss_pred             -----eceEEEe-CCEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 017860           84 -----FKEVILT-PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS  155 (365)
Q Consensus        84 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~  155 (365)
                           +++++.. ...+|+||||+ +++|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE  195 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence                 5677766 78899999999 99999999876  779999999999999999999999999999999999999876


Q ss_pred             CCCCEEEecCCCcccccCCC--------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCC-C
Q 017860          156 PAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPD-E  226 (365)
Q Consensus       156 ~~~~vkl~Dfgla~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~-~  226 (365)
                      +...+||+|||+++......        ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~  274 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPN  274 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcC
Confidence            53359999999997543322        1234579999999999988777655 999999999999999999998765 3


Q ss_pred             hHHHHHHHHHHhccccCCC----CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          227 PKDFRKTIQRILSVQYSVP----DTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       227 ~~~~~~~~~~~~~~~~~~~----~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...+..............+    .+..+++++.+||.+||..||.+|||++++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            3444444433333222221    12357899999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.5e-48  Score=377.60  Aligned_cols=251  Identities=21%  Similarity=0.330  Sum_probs=215.0

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ....++|++.+.||+|+||.||++.++.++..||+|.+.......+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus       216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~  295 (495)
T 1opk_A          216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT  295 (495)
T ss_dssp             BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence            34556899999999999999999999988999999999876666688999999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-
Q 017860           99 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      ||+.+|+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++...... 
T Consensus       296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCE
T ss_pred             EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCce
Confidence            999999999999864  35899999999999999999999999999999999999976654  9999999998543221 


Q ss_pred             -CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          176 -QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       176 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                       ......+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+.+..... +.+    ......+.+..+++.
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~  447 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELL----EKDYRMERPEGCPEK  447 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHH----HTTCCCCCCTTCCHH
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHH----HcCCCCCCCCCCCHH
Confidence             2233456788999999988887766 999999999999999 99999887654332 222    223344455568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017860          254 CRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+||.+||+.||.+|||+.++++
T Consensus       448 l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          448 VYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCcChhHCcCHHHHHH
Confidence            999999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.9e-47  Score=368.80  Aligned_cols=247  Identities=25%  Similarity=0.374  Sum_probs=207.9

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC-EEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAI   96 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~l   96 (365)
                      +....++|++.+.||+|+||.||++.+.  |+.||||+++... ..+.+.+|+.+++.++||||+++++++.... .+|+
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            4456678999999999999999999884  7899999997654 5678999999999999999999999987665 7999


Q ss_pred             EEeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           97 VMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      ||||+.+|+|.+++...+.  +++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++.....
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~  342 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST  342 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC--
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc
Confidence            9999999999999987554  799999999999999999999999999999999999986654  999999998754322


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                        .....+++.|+|||++.+..++.+ +|||||||++|||++ |..||...+........    . .....+.+..+++.
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~-~~~~~~~p~~~~~~  414 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----E-KGYKMDAPDGCPPA  414 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----H-TTCCCCCCTTCCHH
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H-cCCCCCCCCcCCHH
Confidence              233467899999999988887766 999999999999998 99999887664433222    1 12234445568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhc
Q 017860          254 CRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+||.+||..||.+|||+.+++.
T Consensus       415 l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          415 VYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999985

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-47  Score=348.85  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=196.9

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccC---CcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ...++|++.+.||+|+||.||+|.+..+   +..||+|.+....  ...+.+.+|+.+++.++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            3456899999999999999999998653   4579999886532  23356889999999999999999999984 5678


Q ss_pred             EEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |+||||+.+++|.+++...+ .+++..++.++.|++.||.|||++|++||||||+|||++.++  .+||+|||+++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECC---------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC--CEEECccccccccCc
Confidence            99999999999999998654 699999999999999999999999999999999999998665  499999999875433


Q ss_pred             CCC--CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          174 HSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       174 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ...  .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...........+    ... ...+.+..+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~~-~~~~~~~~~  242 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNC  242 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTT-CCCCCCTTC
T ss_pred             ccccccccCCCcccccChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----HcC-CCCCCCCCC
Confidence            322  233456789999999987777655 999999999999996 99999887665433222    221 123344568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ++.+.+++.+||..||.+|||+.+++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8.3e-48  Score=357.28  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=211.5

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEE----EccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEE-
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVIL-   89 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~-   89 (365)
                      ..-+...++|++++.||+|+||.||+++    +..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            3345666799999999999999999999    567899999999876432 2356889999999999999999999987 


Q ss_pred             -eCCEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           90 -TPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        90 -~~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                       ....+++||||+++++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~  173 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGL  173 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGG
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEccccc
Confidence             45679999999999999999976 456999999999999999999999999999999999999986654  99999999


Q ss_pred             cccccCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH-----------HHHH
Q 017860          168 SKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK-----------DFRK  232 (365)
Q Consensus       168 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-----------~~~~  232 (365)
                      ++......    ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.......           ....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~  252 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR  252 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChH-HhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence            87543322    2334568889999999988777655 999999999999999999996532210           1111


Q ss_pred             HHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .. .........+....+++++.+||.+||+.||.+|||+.+++++
T Consensus       253 ~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          253 LL-ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            12 2222333444556689999999999999999999999999865

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=8.9e-47  Score=347.57  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=197.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc----ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.....    ....+.+|+.+++.++||||+++++++.....+++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            4589999999999999999999999999999999975332    235678999999999999999999999999999999


Q ss_pred             EeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           98 MEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |||+.+++|.+++..    ...+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||+++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~--~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS--CEEECCC--------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC--CEEEEeccceeeecC
Confidence            999999999998864    45689999999999999999999999999999999999998665  499999999875433


Q ss_pred             CC-CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          174 HS-QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       174 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .. ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.....  ......+....+.......+++
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCH--HHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhH--HHHHHHhhcccCCCCcccccCH
Confidence            22 2344579999999999988777655 999999999999999999997654321  1222233333332223345889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ++.+||.+||..||.+|||+.+++++
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99999999999999999999999873

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.2e-48  Score=352.60  Aligned_cols=249  Identities=25%  Similarity=0.357  Sum_probs=193.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhc--CCCCCcceeceEEEeC----CEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~~~~~~~----~~~~   95 (365)
                      .++|++.+.||+|+||+||++++  +++.||+|++....  ...+.+|..++..  ++||||+++++++...    ..++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            45899999999999999999987  68999999987643  3444555555544  8999999999987543    5689


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH--------~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      +||||+++|+|.+++.. ..+++..++.++.|++.||+|||        ++||+||||||+|||++.++  ++||+|||+
T Consensus        83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~  159 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGL  159 (301)
T ss_dssp             EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTT
T ss_pred             EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC--CEEEeeCCC
Confidence            99999999999999954 56999999999999999999999        99999999999999998665  499999999


Q ss_pred             cccccCCCC-----CCCCcCCCCCCCchhhcccccC-----CccceeehhhHHHHHHHhC----------CCCCCCCCCh
Q 017860          168 SKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVG----------GYPFEDPDEP  227 (365)
Q Consensus       168 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~ell~g----------~~pf~~~~~~  227 (365)
                      ++.......     .....||+.|+|||++.+....     ++++|||||||++|+|++|          ..||......
T Consensus       160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~  239 (301)
T 3q4u_A          160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN  239 (301)
T ss_dssp             CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCC
Confidence            864332221     2345899999999999776321     1349999999999999999          8898764332


Q ss_pred             HHHHHHHHHHhccccCCCCC------CCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          228 KDFRKTIQRILSVQYSVPDT------NPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~------~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .................+..      ...++.+.+|+.+||+.||.+|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            21122222222211111111      124578999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3e-48  Score=359.37  Aligned_cols=256  Identities=21%  Similarity=0.255  Sum_probs=205.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ..++|++.+.||+|+||.||+++++ +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.....+++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            4578999999999999999999975 78999999887543 234678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860          100 YASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~----~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      |+.+|+|.+++....    .+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++......
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF--VPKITDFGISKKGTELD  193 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC--CEEECCCTTCEECSSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC--CEEEeeccccccccccc
Confidence            999999999886543    589999999999999999999999999999999999998665  49999999987533221


Q ss_pred             ---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHH--HH-HHHHHhcccc-------
Q 017860          176 ---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDF--RK-TIQRILSVQY-------  242 (365)
Q Consensus       176 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~--~~-~~~~~~~~~~-------  242 (365)
                         ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.........  .. ..........       
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             ccccccccCCCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence               2234568999999999988877766 99999999999999999999765432211  00 0111111111       


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017860          243 -SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW  280 (365)
Q Consensus       243 -~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~  280 (365)
                       ........+..+.+++.+||+.||.+|||+.+++++..
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence             00011123467899999999999999999999998653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=354.59  Aligned_cols=251  Identities=20%  Similarity=0.342  Sum_probs=202.5

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEE----EEEEeecC--CcccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELV----AVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~v----aiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      +...++|++++.||+|+||.||+|++..+++.+    |+|.+...  ......+.+|+.+++.++||||+++++++....
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            455679999999999999999999998888765    66665432  234477899999999999999999999998765


Q ss_pred             EEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                       .++|++|+.+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLL  167 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC----
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEc
Confidence             7889999999999999976 456999999999999999999999999999999999999986654  999999999754


Q ss_pred             cCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          172 VLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       172 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      .....   .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||......... ..+.    .....+..
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~----~~~~~~~~  241 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILE----KGERLPQP  241 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHH----TTCCCCCC
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHH----cCCCCCCC
Confidence            33222   233456889999999988777655 999999999999999 99999887654422 2222    22234445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..++.++.+||.+||..||.+|||+.++++.
T Consensus       242 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          242 PICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5689999999999999999999999999973

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.4e-47  Score=362.33  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=197.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..++|++.+.||+|+||.||+++++   .++..||+|.+....  ...+.+.+|+.+++.++||||+++++++.....++
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3568999999999999999999987   467789999987643  23357889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+++|+|.+++...+ .+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.....
T Consensus       123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccC
Confidence            9999999999999998754 6999999999999999999999999999999999999986654  999999998754332


Q ss_pred             CC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          175 SQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       175 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      ..    .....+|+.|+|||++.+..++.+ +|||||||++|||++ |+.||......... +   .+ ......+....
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~-~---~i-~~~~~~~~~~~  274 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVI-K---AV-DEGYRLPPPMD  274 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHH-H---HH-HTTEECCCCTT
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H---HH-HcCCCCCCCcc
Confidence            21    122245778999999988777665 999999999999998 99999876653322 2   22 12233444556


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++..+.+|+.+||+.||.+|||+.++++
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            8899999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=7.6e-48  Score=357.56  Aligned_cols=258  Identities=20%  Similarity=0.288  Sum_probs=207.7

Q ss_pred             CCCCCcceecccccCCCeEEEEEE-----EccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMR-----DKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      ...++|++.+.||+|+||.||+++     +..++..||+|.+....  .....+.+|+.+++.++||||+++++++....
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            345799999999999999999999     55688899999986432  23356889999999999999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEec
Q 017860           93 HLAIVMEYASGGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICD  164 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~-------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~D  164 (365)
                      .+|+||||+.+++|.+++....       .+++..++.++.||+.||.|||++|++||||||+|||++.++ ...+||+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence            9999999999999999998753       489999999999999999999999999999999999998443 33599999


Q ss_pred             CCCcccccCC---CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhcc
Q 017860          165 FGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSV  240 (365)
Q Consensus       165 fgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  240 (365)
                      ||+++.....   .......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||........ .   ..+...
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~-~---~~~~~~  261 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEV-L---EFVTSG  261 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHH-H---HHHHTT
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHH-H---HHHhcC
Confidence            9998643222   22334568999999999987777655 999999999999998 9999987654322 2   222222


Q ss_pred             ccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       241 ~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      . .......+++.+.+||.+||+.||.+|||+.++++|.|+..
T Consensus       262 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          262 G-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             C-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            1 22334458899999999999999999999999999988754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.1e-47  Score=346.82  Aligned_cols=251  Identities=23%  Similarity=0.318  Sum_probs=205.3

Q ss_pred             CCCCCCCcceec-ccccCCCeEEEEEE--EccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC
Q 017860           18 IMHDSDRYDFVR-DIGSGNFGVARLMR--DKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP   91 (365)
Q Consensus        18 ~~~~~~~y~~~~-~LG~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~   91 (365)
                      +..+..+|++.+ .||+|+||.||++.  +..+++.||+|++.....   ..+.+.+|+.+++.++||||+++++++ ..
T Consensus        11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~   89 (291)
T 1xbb_A           11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA   89 (291)
T ss_dssp             CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES
T ss_pred             eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC
Confidence            344567899998 99999999999995  456788999999875432   246788999999999999999999999 56


Q ss_pred             CEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           92 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      ..+++||||+.+++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++  .+||+|||+++..
T Consensus        90 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           90 ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKAL  167 (291)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT--EEEECCCTTCEEC
T ss_pred             CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC--cEEEccCCcceee
Confidence            77899999999999999999888899999999999999999999999999999999999998665  4999999998754


Q ss_pred             cCCCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          172 VLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       172 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      .....    .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||....... ....+.   .. ...+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~~---~~-~~~~~  241 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLE---KG-ERMGC  241 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHH---TT-CCCCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChh-hhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHH---cC-CCCCC
Confidence            33222    223346789999999987777655 999999999999999 999998765533 222222   21 12233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +..+++.+.++|.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          242 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            4458999999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.3e-47  Score=346.04  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=200.6

Q ss_pred             ccCCCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEE
Q 017860            9 TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVI   88 (365)
Q Consensus         9 ~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~   88 (365)
                      +........+....++|++.+.||+|+||.||++.+  +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (278)
T 1byg_A            7 AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVI   83 (278)
T ss_dssp             --------CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred             chhhhhhccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            333344444555667999999999999999999987  48899999987543 457789999999999999999999987


Q ss_pred             EeC-CEEEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           89 LTP-THLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        89 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~--l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                      ... ..+++||||+++++|.+++...+.  +++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+||
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~~l~Df  161 (278)
T 1byg_A           84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN--VAKVSDF  161 (278)
T ss_dssp             CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS--CEEECCC
T ss_pred             EcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC--cEEEeec
Confidence            654 478999999999999999976543  89999999999999999999999999999999999998665  4999999


Q ss_pred             CCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCC
Q 017860          166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSV  244 (365)
Q Consensus       166 gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  244 (365)
                      |+++....  ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||..........    .+.. ....
T Consensus       162 g~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~----~~~~-~~~~  233 (278)
T 1byg_A          162 GLTKEASS--TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP----RVEK-GYKM  233 (278)
T ss_dssp             CC--------------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH----HHTT-TCCC
T ss_pred             cccccccc--cccCCCccccccCHHHhCCCCCCch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhc-CCCC
Confidence            99875432  2234467899999999987777655 999999999999998 999998766543322    2221 2233


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +....+++.+.++|.+||..||.+|||+.++++
T Consensus       234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            344568999999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=6.5e-48  Score=356.13  Aligned_cols=254  Identities=26%  Similarity=0.430  Sum_probs=203.8

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEe----CCE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILT----PTH   93 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~   93 (365)
                      ....++|++.+.||+|+||.||+++++.+++.||+|++.... ...+.+.+|+.+++.++||||+++++++..    ...
T Consensus        25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            345679999999999999999999999999999999986543 234678899999999999999999999973    457


Q ss_pred             EEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           94 LAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +++||||+.+++|.+++..    ...+++..++.++.||+.||+|||++|++||||||+|||++.++.  +||+|||+++
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~  182 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMN  182 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCE
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcch
Confidence            8999999999999998875    467999999999999999999999999999999999999976654  9999999876


Q ss_pred             cccCCCCC----------CCCcCCCCCCCchhhcccc---cCCccceeehhhHHHHHHHhCCCCCCCCCCh-HHHHHHHH
Q 017860          170 SSVLHSQP----------KSTVGTPAYIAPEVLLRHE---YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-KDFRKTIQ  235 (365)
Q Consensus       170 ~~~~~~~~----------~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~~~~  235 (365)
                      ........          ....||+.|+|||++.+..   ++.+ +|||||||++|+|++|+.||...... .....   
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---  258 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDER-TDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---  258 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTH-HHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH---
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCch-hhHHHHHHHHHHHHhCCCChhhhhcccchhhH---
Confidence            43221111          1235799999999986543   4444 99999999999999999999531110 00111   


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                       ........+....+++++.+||.+||+.||.+|||+.+++++-
T Consensus       259 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          259 -AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             -HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             -HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence             1122334455566899999999999999999999999999863

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.6e-47  Score=353.38  Aligned_cols=252  Identities=22%  Similarity=0.343  Sum_probs=207.7

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEc-------cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDK-------VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI   88 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~   88 (365)
                      ....++|++.+.||+|+||.||+|++.       .++..||+|++.....  ....+.+|+.+++.+ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            344679999999999999999999985       4677899999976432  235688999999999 899999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 017860           89 LTPTHLAIVMEYASGGELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL  152 (365)
Q Consensus        89 ~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli  152 (365)
                      .....+|+||||+.+|+|.+++....                .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV  190 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence            99999999999999999999997654                38999999999999999999999999999999999999


Q ss_pred             cCCCCCCEEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChH
Q 017860          153 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPK  228 (365)
Q Consensus       153 ~~~~~~~vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~  228 (365)
                      +.++.  +||+|||+++......   ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.....
T Consensus       191 ~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          191 TENNV--MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             CTTCC--EEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             cCCCC--EEEccccccccccccccccccCCCCcccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            86654  9999999987543322   2334457889999999988777655 999999999999999 999998765433


Q ss_pred             HHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      . .+.+..   . ...+....++.++.++|.+||..+|.+|||+.+++++
T Consensus       268 ~-~~~~~~---~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 L-FKLLKE---G-HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             H-HHHHHH---T-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H-HHHHhc---C-CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2 222222   1 1223344588999999999999999999999999975

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.2e-47  Score=352.27  Aligned_cols=254  Identities=19%  Similarity=0.284  Sum_probs=210.2

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL   89 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~   89 (365)
                      .+....++|++.+.||+|+||.||+|.++     .+++.||+|.+.....  ....+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   98 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   98 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence            34455678999999999999999999887     4678999999975432  2346889999999999999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           90 TPTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      .....++||||+.+|+|.+++...          ..+++..++.++.||+.||+|||++||+||||||+||+++.++  .
T Consensus        99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~--~  176 (322)
T 1p4o_A           99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--T  176 (322)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC--C
T ss_pred             cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC--e
Confidence            999999999999999999998653          3579999999999999999999999999999999999998665  4


Q ss_pred             EEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHH
Q 017860          160 LKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQ  235 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~  235 (365)
                      +||+|||+++......   ......||+.|+|||++.+..++.+ +|||||||++|+|++ |..||...+.....    .
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~----~  251 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL----R  251 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----H
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHH----H
Confidence            9999999987543322   1234467899999999987777655 999999999999999 89999876553322    2


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+.... ..+....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       252 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          252 FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            222222 123344588999999999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.1e-47  Score=354.03  Aligned_cols=255  Identities=22%  Similarity=0.376  Sum_probs=211.3

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEE-----ccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRD-----KVTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVI   88 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~   88 (365)
                      .+....++|++.+.||+|+||.||+|++     ..+++.||+|++.....  ....+.+|+.+++.+ +||||+++++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            3345567999999999999999999985     35778999999976443  234688999999999 799999999998


Q ss_pred             EeCC-EEEEEEeecCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 017860           89 LTPT-HLAIVMEYASGGELFERICNAGR----------------FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL  151 (365)
Q Consensus        89 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~----------------l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIl  151 (365)
                      .... .+++||||+.+++|.+++.....                +++..++.++.||+.||.|||++||+||||||+||+
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7754 58999999999999999987554                899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCCh
Q 017860          152 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP  227 (365)
Q Consensus       152 i~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  227 (365)
                      ++.++.  +||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||......
T Consensus       181 ~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          181 LSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             ECGGGC--EEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ECCCCC--EEECCCccccccccCccceeccCCCcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            976654  99999999875433222   234467899999999988777655 999999999999998 99999887765


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..+...+...    ...+....+++++.+++.+||+.||.+|||+.++++|
T Consensus       258 ~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          258 EEFCRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhccC----ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5544443321    1223344578999999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-47  Score=345.93  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=208.2

Q ss_pred             CCCCCCCcceec-ccccCCCeEEEEEEEc--cCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCC
Q 017860           18 IMHDSDRYDFVR-DIGSGNFGVARLMRDK--VTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPT   92 (365)
Q Consensus        18 ~~~~~~~y~~~~-~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~   92 (365)
                      +....++|.+.+ .||+|+||.||++.+.  .++..||+|++....  ...+.+.+|+.+++.++||||+++++++ ...
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            445567899987 9999999999999864  467889999997643  2346688999999999999999999999 556


Q ss_pred             EEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||+++..
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~  160 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH--YAKISDFGLSKAL  160 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT--EEEECCCTTCEEC
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC--CEEECcccceeee
Confidence            689999999999999998654 4699999999999999999999999999999999999998665  4999999998754


Q ss_pred             cCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          172 VLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       172 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      ....    ......||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||......... ..+   .... ..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~i---~~~~-~~~~  234 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVM-AFI---EQGK-RMEC  234 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-HHH---HTTC-CCCC
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHH-HHH---hcCC-cCCC
Confidence            3322    1233457899999999987777665 999999999999998 99999887664332 222   2221 2233


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                      +..+++++.++|.+||..+|.+|||+.+++++.
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            446899999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-46  Score=342.95  Aligned_cols=250  Identities=22%  Similarity=0.230  Sum_probs=203.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceE-EEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV-ILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~-~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+.. +......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence            4689999999999999999999999999999999876543 4568999999999998876665554 4677889999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCCCEEEecCCCcccccCCCC
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~---~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      + +++|.+++.. ..++++..++.++.||+.||+|||++||+||||||+|||++   .++  .+||+|||+++.......
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~  163 (296)
T 3uzp_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCccccccccc
Confidence            9 8999999974 45799999999999999999999999999999999999994   343  599999999875443322


Q ss_pred             --------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC---hHHHHHHHHHHhccccCCC
Q 017860          177 --------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE---PKDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       177 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~  245 (365)
                              .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....   ...+............. .
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~  241 (296)
T 3uzp_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-V  241 (296)
T ss_dssp             CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-H
T ss_pred             ccccccccccccccccccCChhhhcCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-H
Confidence                    345679999999999988777655 9999999999999999999987432   22222222222211110 0


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ....+++++.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            12347899999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=5.4e-47  Score=367.12  Aligned_cols=252  Identities=23%  Similarity=0.323  Sum_probs=207.0

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..+....++|++.++||+|+||.||++.++. +..||+|++.......+.+.+|+.+++.++||||+++++++.. ..+|
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            3445567789999999999999999999974 5679999998766566789999999999999999999999866 6789


Q ss_pred             EEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +||||+.+|+|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~  332 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIED  332 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC----
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCC
Confidence            99999999999999974  356999999999999999999999999999999999999976654  99999999975432


Q ss_pred             CC--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ..  ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........    .+. .....+.+..+
T Consensus       333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~----~i~-~~~~~~~~~~~  406 (452)
T 1fmk_A          333 NEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVE-RGYRMPCPPEC  406 (452)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHH-TTCCCCCCTTS
T ss_pred             CceecccCCcccccccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCC
Confidence            22  1233456789999999988777665 999999999999999 999998766543222    222 22334455568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++.+.+|+.+||+.||.+|||++++++
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.4e-47  Score=354.88  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=212.6

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCCc-----EEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL   89 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~   89 (365)
                      +....++|++.+.||+|+||.||+|.+..+++     .||+|.+.....  ..+.+.+|+.+++.+ +||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            34556789999999999999999999976664     799999876432  235688999999999 8999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 017860           90 TPTHLAIVMEYASGGELFERICNA--------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS  155 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~--------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~  155 (365)
                      ....+++||||+++|+|.+++...              ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence            999999999999999999998653              358999999999999999999999999999999999999866


Q ss_pred             CCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHH
Q 017860          156 PAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFR  231 (365)
Q Consensus       156 ~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~  231 (365)
                      +  .+||+|||+++.......   .....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+.
T Consensus       201 ~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          201 H--VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             G--EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             C--eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            5  499999999875433322   234557889999999987777655 999999999999998 999998877655554


Q ss_pred             HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       232 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +....    ....+.+...++.+.+|+.+||+.||.+|||+.+++++
T Consensus       278 ~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          278 KLVKD----GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhc----CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            44433    22333444578999999999999999999999999873

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=368.14  Aligned_cols=256  Identities=24%  Similarity=0.330  Sum_probs=197.4

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      .....+|++.+.||+|+||+|+. ....+|+.||||++.....  ..+.+|+.+++.+ +||||+++++++.....+|+|
T Consensus        20 ~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv   96 (432)
T 3p23_A           20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIA   96 (432)
T ss_dssp             EETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEE
T ss_pred             EEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEE
Confidence            34456799999999999999764 4456899999999865432  3457899999998 799999999999999999999


Q ss_pred             EeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCCCEEEecCCCcccccC
Q 017860           98 MEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~---~~~~~vkl~Dfgla~~~~~  173 (365)
                      ||||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.   ++..++||+|||+++....
T Consensus        97 ~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             EECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             EECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            99996 59999987654 4667778899999999999999999999999999999953   3334588999999876543


Q ss_pred             C----CCCCCCcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccC-C
Q 017860          174 H----SQPKSTVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYS-V  244 (365)
Q Consensus       174 ~----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~  244 (365)
                      .    ......+||+.|+|||++.+   ..++. ++|||||||++|+|++ |..||....... . ...  ....... .
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~-~~DiwSlG~il~ellt~g~~pf~~~~~~~-~-~~~--~~~~~~~~~  250 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY-TVDIFSAGCVFYYVISEGSHPFGKSLQRQ-A-NIL--LGACSLDCL  250 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCT-HHHHHHHHHHHHHHHTTSCBTTBSTTTHH-H-HHH--TTCCCCTTS
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCc-HHHHHHHHHHHHHHHcCCCCCcchhhHHH-H-HHH--hccCCcccc
Confidence            3    23345679999999999974   33443 4999999999999999 999996544322 1 111  1111111 1


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ......+..+.+||.+||+.||.+|||+.++++||||..
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            112234567899999999999999999999999999964

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.1e-47  Score=351.43  Aligned_cols=265  Identities=28%  Similarity=0.396  Sum_probs=205.5

Q ss_pred             ccccCCCCCCCCCCCCCCcceecccccCCCeEEEEEE----EccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCC
Q 017860            7 SLTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPN   80 (365)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpn   80 (365)
                      +.++.|  ..|.+.....|+++++||+|+||+||++.    +..+++.||+|++.....  ....+.+|+.+++.++|||
T Consensus        17 ~~~~~p--g~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~   94 (318)
T 3lxp_A           17 VLFQGP--GDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH   94 (318)
T ss_dssp             ---------CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTT
T ss_pred             eeecCC--CCCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcc
Confidence            445555  33444433334999999999999998775    445889999999976532  2356889999999999999


Q ss_pred             cceeceEEEe--CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           81 IVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        81 Iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      |+++++++..  ...+++||||+++++|.+++.+. .+++..++.++.||+.||+|||++||+||||||+||+++.++. 
T Consensus        95 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~-  172 (318)
T 3lxp_A           95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL-  172 (318)
T ss_dssp             BCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC-
T ss_pred             hhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC-
Confidence            9999999987  46899999999999999998765 4999999999999999999999999999999999999986654 


Q ss_pred             CEEEecCCCcccccCCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh-------
Q 017860          159 RLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-------  227 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-------  227 (365)
                       +||+|||+++......    ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||......       
T Consensus       173 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~  250 (318)
T 3lxp_A          173 -VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI  250 (318)
T ss_dssp             -EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCS
T ss_pred             -EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcc
Confidence             9999999987654332    2334568889999999988777655 99999999999999999999753211       


Q ss_pred             ---HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          228 ---KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       228 ---~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                         .................+....+++++.+||.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          251 AQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence               00111122222333344555668999999999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-47  Score=353.94  Aligned_cols=250  Identities=24%  Similarity=0.403  Sum_probs=194.6

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHh--cCCCCCcceeceEEEeC----CEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR--SLRHPNIVRFKEVILTP----THLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~--~l~hpnIv~l~~~~~~~----~~~~   95 (365)
                      .++|++.+.||+|+||.||++++.  ++.||+|++.....  ....+|..++.  .++||||+++++++...    ..+|
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            358999999999999999999885  89999999876433  33444555544  45999999999999887    7899


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM--------QVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~--------~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      +||||+.+|+|.+++... .+++..++.++.|++.||+|||++        ||+||||||+|||++.++  .+||+|||+
T Consensus       112 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kl~Dfg~  188 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGL  188 (337)
T ss_dssp             EEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS--CEEECCCTT
T ss_pred             EEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC--CEEEEeCCC
Confidence            999999999999999654 699999999999999999999999        999999999999998665  499999999


Q ss_pred             cccccCCCC-----CCCCcCCCCCCCchhhcccccCCc-----cceeehhhHHHHHHHhC----------CCCCCCCCCh
Q 017860          168 SKSSVLHSQ-----PKSTVGTPAYIAPEVLLRHEYDGK-----IADVWSCGVTLYVMLVG----------GYPFEDPDEP  227 (365)
Q Consensus       168 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~-----~~DiwSlG~il~ell~g----------~~pf~~~~~~  227 (365)
                      ++.......     .....||+.|+|||++.+..+...     ++|||||||++|+|++|          ..||......
T Consensus       189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~  268 (337)
T 3mdy_A          189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS  268 (337)
T ss_dssp             CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence            865433222     235679999999999977655443     38999999999999999          7777654322


Q ss_pred             HHHHHHHHHHhccc---cCCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          228 KDFRKTIQRILSVQ---YSVPD---TNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       228 ~~~~~~~~~~~~~~---~~~~~---~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..............   ...+.   ...+++++.+|+.+||+.||.+|||+.++++|
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            21112222222111   11111   12345779999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-47  Score=347.81  Aligned_cols=261  Identities=25%  Similarity=0.412  Sum_probs=203.0

Q ss_pred             cCCCCCCCCCCCCCCcceecccccCCCeEEEEEEEcc-CCc--EEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcc
Q 017860           10 VGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-TKE--LVAVKYIERGD----KIDENVQREIINHRSLRHPNIV   82 (365)
Q Consensus        10 ~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv   82 (365)
                      .+|.-........++|++.+.||+|+||.||++++.. +++  .||+|++....    ...+.+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~   84 (291)
T 1u46_A            5 EGPLQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI   84 (291)
T ss_dssp             ------CCEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CccccccccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4455555666777899999999999999999998753 333  68999987532    2336788999999999999999


Q ss_pred             eeceEEEeCCEEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEE
Q 017860           83 RFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLK  161 (365)
Q Consensus        83 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vk  161 (365)
                      ++++++..+. .++||||+.+++|.+++... +.+++..++.++.||+.||.|||++|++||||||+||+++.++  .+|
T Consensus        85 ~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~--~~k  161 (291)
T 1u46_A           85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD--LVK  161 (291)
T ss_dssp             CEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEE
T ss_pred             cEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC--CEE
Confidence            9999998765 78999999999999998764 5699999999999999999999999999999999999998665  499


Q ss_pred             EecCCCcccccCCCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 017860          162 ICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       162 l~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  236 (365)
                      |+|||+++.......    .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||...+...    ....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~----~~~~  236 (291)
T 1u46_A          162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHK  236 (291)
T ss_dssp             ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHH
T ss_pred             EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCcccCCHHH----HHHH
Confidence            999999875433321    234467889999999987777655 999999999999999 999998766533    3333


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.......+....+++++.++|.+||..||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          237 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            334444455566789999999999999999999999999973

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=349.56  Aligned_cols=251  Identities=22%  Similarity=0.326  Sum_probs=202.3

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCC----cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ....+|++.+.||+|+||.||+|.++.++    ..||+|.+.....  ....+.+|+.+++.++||||+++++++.....
T Consensus        41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            34568999999999999999999987554    3599999875432  23468899999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           94 LAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      +++||||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+||+|||+++...
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~--~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL--VCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCCCC-----
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC--cEEECCCCcchhhc
Confidence            99999999999999999764 5799999999999999999999999999999999999998665  49999999987543


Q ss_pred             CCCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          173 LHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       173 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      ....    .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.........    ..+.. ....+..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~----~~~~~-~~~~~~~  272 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAIND-GFRLPTP  272 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHT-TCCCCCC
T ss_pred             cccccccccCCCCccccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHH----HHHHC-CCcCCCc
Confidence            3221    122346788999999987777655 999999999999998 99999876553322    22222 2233445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..+++.+.+++.+||+.+|.+||++.+++++
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5688999999999999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.1e-46  Score=347.49  Aligned_cols=253  Identities=21%  Similarity=0.313  Sum_probs=198.9

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEcc---CCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEeC
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILTP   91 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~   91 (365)
                      +....++|++.+.||+|+||.||+|.+..   ++..||+|.+......   .+.+.+|+.+++.++||||+++++++...
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            34556789999999999999999998865   4568999998754322   25688999999999999999999999876


Q ss_pred             C-----EEEEEEeecCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCE
Q 017860           92 T-----HLAIVMEYASGGELFERIC------NAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL  160 (365)
Q Consensus        92 ~-----~~~lv~e~~~~g~L~~~l~------~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~v  160 (365)
                      .     ..++||||+.+++|.+++.      ....+++..++.++.||+.||.|||++||+||||||+||+++.++.  +
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~  186 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--V  186 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--E
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--E
Confidence            5     3599999999999999984      2356999999999999999999999999999999999999986654  9


Q ss_pred             EEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHH
Q 017860          161 KICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQR  236 (365)
Q Consensus       161 kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~  236 (365)
                      ||+|||+++......   ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.............  
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--  263 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL--  263 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH--
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH--
Confidence            999999987543322   2233457889999999988777655 999999999999999 899998876654333222  


Q ss_pred             HhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          237 ILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       237 ~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                        .. ...+....+++.+.+||.+||..||.+|||+.+++.+
T Consensus       264 --~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          264 --HG-HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             --TT-CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             --cC-CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence              11 1223345588999999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-46  Score=363.34  Aligned_cols=251  Identities=26%  Similarity=0.349  Sum_probs=193.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .+.|.+.+.||+|+||+||.+ ...+|+.||||++....  .+.+.+|+.+++.+ +||||+++++++.....+|+||||
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            446777899999999999875 45589999999987532  35678899999875 899999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------CCCCEEE
Q 017860          101 ASGGELFERICNAGRF-------SEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-----------PAPRLKI  162 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l-------~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-----------~~~~vkl  162 (365)
                      |. |+|.+++......       ++..++.++.||+.||+|||++||+||||||+|||++.+           ...++||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            96 6999999765433       233467899999999999999999999999999999753           2346999


Q ss_pred             ecCCCcccccCCC-----CCCCCcCCCCCCCchhhcc-------cccCCccceeehhhHHHHHHHh-CCCCCCCCCChHH
Q 017860          163 CDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLR-------HEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKD  229 (365)
Q Consensus       163 ~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~  229 (365)
                      +|||+++......     .....+||+.|+|||++.+       ..++ .++|||||||++|+|++ |..||....... 
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT-RSIDIFSMGCVFYYILSKGKHPFGDKYSRE-  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCC-THHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcc-hhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence            9999998544322     1234579999999999965       3444 45999999999999999 999997654432 


Q ss_pred             HHHHHHHHhccccCCCC-----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          230 FRKTIQRILSVQYSVPD-----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       230 ~~~~~~~~~~~~~~~~~-----~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                       ..+.    ......+.     ...+++++.+||.+||+.||.+|||+.++++||||..
T Consensus       248 -~~i~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          248 -SNII----RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -HHHH----HTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -HHHh----cCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence             1222    22222222     1224578999999999999999999999999999964

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.6e-46  Score=341.66  Aligned_cols=250  Identities=22%  Similarity=0.232  Sum_probs=199.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceE-EEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV-ILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~-~~~~~~~~lv~e~  100 (365)
                      .++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++|++++..+.. +......++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            4689999999999999999999999999999998765432 3458899999999998877665554 4677889999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCCCEEEecCCCcccccCCC-
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS-  175 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli---~~~~~~~vkl~Dfgla~~~~~~~-  175 (365)
                      + +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+   +.++  .+||+|||+++...... 
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred             c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCccc
Confidence            9 9999999875 4579999999999999999999999999999999999999   4444  49999999987543332 


Q ss_pred             -------CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCCh---HHHHHHHHHHhccccCCC
Q 017860          176 -------QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP---KDFRKTIQRILSVQYSVP  245 (365)
Q Consensus       176 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~  245 (365)
                             ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......   ..+............ ..
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  241 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV  241 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCCCCch-hHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hh
Confidence                   2235679999999999988777655 99999999999999999999875432   222222222111110 01


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ....+++++.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            12347899999999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.7e-47  Score=351.32  Aligned_cols=258  Identities=22%  Similarity=0.275  Sum_probs=204.7

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      ....++|++.+.||+|+||.||++++. +++.||+|++....  .....+.+|+.+++.++||||+++++++......++
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           26 QVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             HTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEE
T ss_pred             HHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEE
Confidence            345679999999999999999999865 68999999987543  223468999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           97 VMEYASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHAM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~----~l~~~~~~~i~~qil~al~~LH~~---~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      ||||+.+|+|.+++....    .+++..++.++.|++.||+|||++   ||+||||||+|||++.++.  +||+|||+++
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~  182 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAK  182 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCE
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCcccc
Confidence            999999999999997643    389999999999999999999999   9999999999999986654  9999999997


Q ss_pred             cccCCCC--CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCC----CChHHHHHHHHHHhcccc-
Q 017860          170 SSVLHSQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDP----DEPKDFRKTIQRILSVQY-  242 (365)
Q Consensus       170 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~----~~~~~~~~~~~~~~~~~~-  242 (365)
                      .......  .....||+.|+|||++.+..++.+ +|||||||++|+|++|..||...    .................. 
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL  261 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred             ccCcccccccccccCCcCccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence            5432222  334569999999999988777655 99999999999999999999521    111111111111111100 


Q ss_pred             --------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017860          243 --------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW  280 (365)
Q Consensus       243 --------~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~  280 (365)
                              ........++.+.+++.+||+.||.+|||+.++++|..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                    00011112367999999999999999999999999754

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.2e-47  Score=351.88  Aligned_cols=250  Identities=26%  Similarity=0.424  Sum_probs=187.9

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCcceeceEEE-------
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVIL-------   89 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~-hpnIv~l~~~~~-------   89 (365)
                      .....+|++.+.||+|+||.||++++..+++.||+|++..... ....+.+|+.+++.+. ||||+++++++.       
T Consensus        24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            3445689999999999999999999999999999999865432 3356889999999996 999999999994       


Q ss_pred             -eCCEEEEEEeecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEe
Q 017860           90 -TPTHLAIVMEYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        90 -~~~~~~lv~e~~~~g~L~~~l~~---~~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                       ....+++||||+. |+|.+++..   .+++++..++.++.||+.||+|||++|  |+||||||+|||++.++.  +||+
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~  180 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLC  180 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBC
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEe
Confidence             3456899999996 688888764   456999999999999999999999999  999999999999986654  9999


Q ss_pred             cCCCcccccCCCC-------------CCCCcCCCCCCCchhh---cccccCCccceeehhhHHHHHHHhCCCCCCCCCCh
Q 017860          164 DFGYSKSSVLHSQ-------------PKSTVGTPAYIAPEVL---LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEP  227 (365)
Q Consensus       164 Dfgla~~~~~~~~-------------~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  227 (365)
                      |||+++.......             .....||+.|+|||++   .+..++ .++|||||||++|+|++|+.||......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG-EKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSS-HHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCC-hHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999875433221             1245699999999998   344444 4599999999999999999999764432


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017860          228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQW  280 (365)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~  280 (365)
                      .        +.......+.....+..+.+||.+||+.||.+|||+.++++|.+
T Consensus       260 ~--------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 R--------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             H--------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1        12233344455567888999999999999999999999998753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.4e-46  Score=341.42  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=202.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc---CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV---TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++.+.||+|+||.||+|.+..   ++..||+|.+.....  ..+.+.+|+.+++.++||||+++++++..+ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4689999999999999999998754   344699999876432  346788999999999999999999998654 5689


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||+.+++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++  .+||+|||++.......
T Consensus        90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE--CVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT--EEEECCCCGGGCC----
T ss_pred             EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC--cEEeCccCCCccccccc
Confidence            99999999999999765 4599999999999999999999999999999999999998665  49999999987543322


Q ss_pred             --CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          176 --QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       176 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                        ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |+.||........... +..    ....+....+++
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~----~~~~~~~~~~~~  241 (281)
T 3cc6_A          168 YYKASVTRLPIKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEK----GDRLPKPDLCPP  241 (281)
T ss_dssp             -----CCCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHH----TCCCCCCTTCCH
T ss_pred             ccccccCCCCcceeCchhhccCCCCch-hccHHHHHHHHHHHhCCCCCcccCChHHHHHH-Hhc----CCCCCCCCCCCH
Confidence              2234457889999999987777655 999999999999998 9999987665443322 221    122344455889


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+.++|.+||..||.+|||+.+++++
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          242 VLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCCchhCcCHHHHHHH
Confidence            99999999999999999999999975

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=3.5e-47  Score=348.80  Aligned_cols=236  Identities=34%  Similarity=0.568  Sum_probs=189.8

Q ss_pred             CCccee-cccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHH-hcCCCCCcceeceEEEe----CCEEEE
Q 017860           23 DRYDFV-RDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHLAI   96 (365)
Q Consensus        23 ~~y~~~-~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~----~~~~~l   96 (365)
                      ++|.++ +.||+|+||.||++.++.+++.||+|++..    .....+|+.++ +.++||||+++++++..    ...+++
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l   92 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   92 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence            478888 789999999999999999999999999875    35677888887 67799999999999987    678999


Q ss_pred             EEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccC
Q 017860           97 VMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~  173 (365)
                      ||||+++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++... .+.+||+|||++.... 
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-  171 (299)
T 3m2w_A           93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-  171 (299)
T ss_dssp             EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred             EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence            999999999999998754  699999999999999999999999999999999999998632 3469999999886421 


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCC
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPIS  251 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s  251 (365)
                                          +..++.+ +|||||||++|+|++|+.||...............+.......+  .+..++
T Consensus       172 --------------------~~~~~~~-~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (299)
T 3m2w_A          172 --------------------GEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  230 (299)
T ss_dssp             --------------------TCGGGGH-HHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred             --------------------cccCCch-hhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCC
Confidence                                2334444 99999999999999999999765432211000011111111111  114578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +++.+||.+||+.||.+|||+.++++||||.+.
T Consensus       231 ~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          231 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            999999999999999999999999999999764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=344.11  Aligned_cols=246  Identities=30%  Similarity=0.470  Sum_probs=197.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +.++|++.+.||+|+||.||++++.  ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+  ..++||||
T Consensus         6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            3568999999999999999999874  788999998653 344678999999999999999999998864  47899999


Q ss_pred             cCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860          101 ASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~---l~~~~~~~i~~qil~al~~LH~---~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +++++|.+++.....   +++..++.++.|++.||+|||+   +||+||||||+|||++.++. .+||+|||++..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~-  158 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQT-  158 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC-------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEccccccccccc-
Confidence            999999999987553   7899999999999999999999   89999999999999986543 379999999875432 


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                       ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........  ......... ...+....+++.+
T Consensus       159 -~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~l  233 (307)
T 2eva_A          159 -HMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNG-TRPPLIKNLPKPI  233 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHHTT-CCCCCBTTCCHHH
T ss_pred             -ccccCCCCCceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHhcC-CCCCcccccCHHH
Confidence             2344579999999999988777666 9999999999999999999986544321  111111111 1223345588999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 017860          255 RDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+++.+||+.||.+|||+++++++
T Consensus       234 ~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          234 ESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999999974

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-46  Score=339.77  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=201.0

Q ss_pred             CcceecccccCCCeEEEEEEEccCCc---EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE-EEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL-AIV   97 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~-~lv   97 (365)
                      +|++.+.||+|+||+||+|.+..+++   .||+|.+.....  ..+.+.+|+.+++.++||||+++++++...... ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            46777999999999999999765544   799999875432  235688999999999999999999999876655 999


Q ss_pred             EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC---
Q 017860           98 MEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---  173 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~---  173 (365)
                      |||+.+++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++....   
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~--~~kl~Dfg~~~~~~~~~~  179 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF--TVKVADFGLARDILDREY  179 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECCTTSSCTTTTGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC--cEEeCcCCCcccccCCcc
Confidence            999999999999976 45689999999999999999999999999999999999997665  499999999874322   


Q ss_pred             --CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          174 --HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       174 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                        ........+|+.|+|||.+.+..++.+ +|||||||++|+|++|..||............+..    ....+....++
T Consensus       180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~  254 (298)
T 3pls_A          180 YSVQQHRHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----GRRLPQPEYCP  254 (298)
T ss_dssp             GCSCCSSCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT----TCCCCCCTTCC
T ss_pred             cccccCcCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc----CCCCCCCccch
Confidence              122344568899999999988777655 99999999999999955554444443333333222    22334455688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+.+|+.+||+.||.+|||+.++++
T Consensus       255 ~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          255 DSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=346.19  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=206.9

Q ss_pred             CCCCCCcceecccccCCCeEEEEEE----EccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCC-
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMR----DKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPT-   92 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-   92 (365)
                      .....+|++++.||+|+||.||+++    +..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.... 
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            4455689999999999999999998    466899999999876432 3357889999999999999999999987654 


Q ss_pred             -EEEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           93 -HLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        93 -~~~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                       .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++  ++||+|||+++.
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~--~~kL~Dfg~~~~  194 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN--RVKIGDFGLTKV  194 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT--EEEECCCTTCEE
T ss_pred             CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC--cEEEecCcchhh
Confidence             789999999999999999875 4599999999999999999999999999999999999998665  499999999875


Q ss_pred             ccCCCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCC-----------hHHHHHHHH
Q 017860          171 SVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE-----------PKDFRKTIQ  235 (365)
Q Consensus       171 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-----------~~~~~~~~~  235 (365)
                      ......    .....+++.|+|||++.+..++.+ +|||||||++|+|++|..||.....           .......+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCch-hhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            443322    233457888999999988777655 9999999999999999999864211           011111122


Q ss_pred             HHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          236 RILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       236 ~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .........+.+..+++++.+||.+||..||.+|||+.++++
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            222222334455668999999999999999999999999985

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=354.81  Aligned_cols=246  Identities=15%  Similarity=0.162  Sum_probs=198.1

Q ss_pred             CCCCCcceecccccCCCeEEEEE-----EEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC---CCCcceeceEEEeC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLM-----RDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTP   91 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~   91 (365)
                      ...++|++.+.||+|+||+||+|     .+..+++.||+|++...  ....+.+|+.+++.++   |+||+++++++...
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            44678999999999999999999     46778999999998754  3456788888888887   89999999999999


Q ss_pred             CEEEEEEeecCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---------CCC
Q 017860           92 THLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG---------SPA  157 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~-----~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~---------~~~  157 (365)
                      +..|+||||+++|+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.         ...
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence            999999999999999999974     456999999999999999999999999999999999999976         113


Q ss_pred             CCEEEecCCCccccc---CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHH
Q 017860          158 PRLKICDFGYSKSSV---LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI  234 (365)
Q Consensus       158 ~~vkl~Dfgla~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~  234 (365)
                      +.+||+|||+|+...   ........+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......      
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~------  292 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE------  292 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE------
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc------
Confidence            459999999996432   2333456789999999999998887766 999999999999999999996543311      


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       235 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                         ......++ ....++.+.+++.+||..+|.+|++..+.+.+
T Consensus       293 ---~~~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          293 ---CKPEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             ---EEECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ---eeechhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence               00111111 11346789999999999999999765555443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.4e-46  Score=367.84  Aligned_cols=252  Identities=23%  Similarity=0.325  Sum_probs=211.1

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..+....++|++.++||+|+||.||++.++. +..||||++.......+.+.+|+.+++.++||||+++++++.. ..+|
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            3445567789999999999999999999974 5679999998766566789999999999999999999999866 6789


Q ss_pred             EEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           96 IVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +||||+.+|+|.+++..  ...+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIED  415 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCC
Confidence            99999999999999974  356999999999999999999999999999999999999976654  99999999975432


Q ss_pred             C--CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          174 H--SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       174 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      .  .......+++.|+|||++.+..++.+ +|||||||++|||++ |..||.+........    .+. .....+....+
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~----~i~-~~~~~~~~~~~  489 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVE-RGYRMPCPPEC  489 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH----HHH-TTCCCCCCTTC
T ss_pred             CceecccCCcCcccccCHHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCC
Confidence            1  11233457789999999988777665 999999999999999 999998766543222    222 22334445568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ++.+.+||.+||..||.+|||+++++.
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.9e-46  Score=339.59  Aligned_cols=248  Identities=22%  Similarity=0.285  Sum_probs=198.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCC---cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEE-EeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~-~~~~~~~   95 (365)
                      ..+|++.+.||+|+||.||+|++..++   ..||+|.+.....  ..+.+.+|+.+++.++||||+++++++ ..+...+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            347999999999999999999975433   3689998875332  235688999999999999999999985 4566889


Q ss_pred             EEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+.+|+|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++  .+||+|||+++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~--~~kl~Dfg~a~~~~~~  181 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDK  181 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC--CEEECSCGGGCCCSCG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC--CEEECccccccccccc
Confidence            99999999999999976 44589999999999999999999999999999999999997665  4999999998754322


Q ss_pred             C-----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          175 S-----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       175 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      .     ......||+.|+|||++.+..++.+ +|||||||++|+|++ |.+||............    .... ....+.
T Consensus       182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~  255 (298)
T 3f66_A          182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQPE  255 (298)
T ss_dssp             GGCBC-----CCBCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTTC-CCCCCT
T ss_pred             chhccccccCCCCCccccChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcCC-CCCCCc
Confidence            2     2334567889999999988777655 999999999999999 66777665554332222    1121 223344


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+++.+.+++.+||..||.+|||+.++++
T Consensus       256 ~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          256 YCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            57899999999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.2e-46  Score=348.72  Aligned_cols=251  Identities=22%  Similarity=0.284  Sum_probs=188.0

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe-----CCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-----~~~~~   95 (365)
                      ..++|++.+.||+|+||.||++++  +++.||+|++............++..++.++||||+++++.+..     ...++
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            346899999999999999999976  68999999997654333333445555566899999999986542     34689


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEecCCCCCCEEEecCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------QVCHRDLKLENTLLDGSPAPRLKICDFG  166 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~---------~ivHrDlkp~NIli~~~~~~~vkl~Dfg  166 (365)
                      +||||+++|+|.+++.... +++..++.++.||+.||+|||++         ||+||||||+|||++.++  .+||+|||
T Consensus        89 lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~--~~kL~DFG  165 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG--TCVISDFG  165 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS--CEEECCCT
T ss_pred             EEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC--cEEEeecc
Confidence            9999999999999997654 59999999999999999999999         999999999999998665  49999999


Q ss_pred             CcccccCC---------CCCCCCcCCCCCCCchhhcc-------cccCCccceeehhhHHHHHHHhCCCCCCCCCChHH-
Q 017860          167 YSKSSVLH---------SQPKSTVGTPAYIAPEVLLR-------HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD-  229 (365)
Q Consensus       167 la~~~~~~---------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-  229 (365)
                      +++.....         ......+||+.|+|||++.+       ..++ .++|||||||++|+|++|..||........ 
T Consensus       166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~  244 (336)
T 3g2f_A          166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESAL-KQVDMYALGLIYWEIFMRCTDLFPGESVPEY  244 (336)
T ss_dssp             TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHH-HHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred             ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccc-cccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence            99754321         22234579999999999976       2333 448999999999999999776643322110 


Q ss_pred             -------------HHHHHHHHhcc--ccCCCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          230 -------------FRKTIQRILSV--QYSVPD----TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       230 -------------~~~~~~~~~~~--~~~~~~----~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                                   ...........  ...++.    ....++.+.+||.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                         00111111111  111111    1123457999999999999999999999954

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-47  Score=379.69  Aligned_cols=260  Identities=27%  Similarity=0.377  Sum_probs=208.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEe------CCEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT------PTHL   94 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~~~   94 (365)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++....  ...+.+.+|+.+++.++||||+++++++..      ....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            68999999999999999999999999999999986542  223568899999999999999999998765      6778


Q ss_pred             EEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-CCEEEecCCCccc
Q 017860           95 AIVMEYASGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKS  170 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~---~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~-~~vkl~Dfgla~~  170 (365)
                      |+||||++||+|.+++....   .+++..++.++.|++.||+|||++||+||||||+||+++.++. ..+||+|||++..
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            99999999999999998654   5899999999999999999999999999999999999986543 2489999999987


Q ss_pred             ccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHH-----HHH-----hcc
Q 017860          171 SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTI-----QRI-----LSV  240 (365)
Q Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~-----~~~-----~~~  240 (365)
                      ...........||+.|+|||++.+..++.+ +|||||||++|+|++|..||........+....     ...     ...
T Consensus       174 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g  252 (676)
T 3qa8_A          174 LDQGELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG  252 (676)
T ss_dssp             TTSCCCCCCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSS
T ss_pred             cccccccccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhcc
Confidence            666666667789999999999988887766 999999999999999999997643322110000     000     001


Q ss_pred             ccC----CCC----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          241 QYS----VPD----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       241 ~~~----~~~----~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ...    .+.    ...+++.+.+||.+||..||.+|||+.++++||||..
T Consensus       253 ~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          253 AVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             ccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            111    111    1225688999999999999999999999999999964

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-45  Score=339.61  Aligned_cols=249  Identities=25%  Similarity=0.317  Sum_probs=200.0

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-----cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      .|...+.||+|+||.||++.+  +++.||+|++....     ...+.+.+|+.+++.++||||+++++++......++||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            456669999999999999986  68899999986532     23467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           99 EYASGGELFERICN---AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~---~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||++|++||||||+||+++.++  .+||+|||+++......
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~--~~kl~Dfg~~~~~~~~~  187 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF--TAKISDFGLARASEKFA  187 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC--CEEECCCTTCEECCSCS
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC--cEEEeeccccccccccc
Confidence            99999999999874   34599999999999999999999999999999999999998665  49999999987543322


Q ss_pred             C---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--------CC
Q 017860          176 Q---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--------SV  244 (365)
Q Consensus       176 ~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~  244 (365)
                      .   .....||+.|+|||++.+ .++.+ +|||||||++|+|++|..||...............+.....        ..
T Consensus       188 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (307)
T 2nru_A          188 QTVMTSRIVGTTAYMAPEALRG-EITPK-SDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM  265 (307)
T ss_dssp             SCEECSSCCSCGGGCCHHHHTT-EECTH-HHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred             ccccccccCCCcCcCChHHhcC-CCCcc-chhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence            1   234579999999999865 45555 99999999999999999999876543322222222211110        01


Q ss_pred             -CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          245 -PDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       245 -~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                       ......++.+.+++.+||..+|.+|||+.+++++
T Consensus       266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             1112245678999999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.2e-45  Score=355.44  Aligned_cols=250  Identities=22%  Similarity=0.253  Sum_probs=202.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.++||+|+||.||++++..+++.||||++..... ...+.+|+.+++.++| ++|..+..++......++||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~   84 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL   84 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence            3689999999999999999999999999999998876443 3458899999999987 5666676777788899999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCCCEEEecCCCcccccCCCC
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ  176 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~---~~~~~~vkl~Dfgla~~~~~~~~  176 (365)
                      + +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+   .++  .+||+|||+++.......
T Consensus        85 ~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~  161 (483)
T 3sv0_A           85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTST  161 (483)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTT
T ss_pred             C-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCcc
Confidence            9 9999999975 55799999999999999999999999999999999999994   343  599999999975443322


Q ss_pred             --------CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHH---HHHHHHHHhccccCCC
Q 017860          177 --------PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKD---FRKTIQRILSVQYSVP  245 (365)
Q Consensus       177 --------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~  245 (365)
                              .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......   +.++......... ..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~  239 (483)
T 3sv0_A          162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-EA  239 (483)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-HH
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-HH
Confidence                    235679999999999988877655 9999999999999999999987654322   1122111111110 01


Q ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          246 DTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       246 ~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ....+++++.+||.+||..+|.+||++.++++
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            11347899999999999999999999998765

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-46  Score=349.93  Aligned_cols=248  Identities=21%  Similarity=0.286  Sum_probs=194.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCC---cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEE-eCCEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~l   96 (365)
                      .+|++.+.||+|+||.||+|.+..++   ..||+|.+.....  ..+.+.+|+.+++.++||||+++++++. .+...++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            35888999999999999999986443   4689998865332  3367889999999999999999999865 4567899


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      ||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++......
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC--CEEECCC----------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC--CEEEeeccccccccccc
Confidence            99999999999999764 4589999999999999999999999999999999999998665  49999999987543222


Q ss_pred             -----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          176 -----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       176 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                           ......+|+.|+|||++.+..++.+ +|||||||++|+|++ |.+||...+........    .... ..+.+..
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~-~~~~p~~  320 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGR-RLLQPEY  320 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTC-CCCCCTT
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcH-HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCC-CCCCCCC
Confidence                 1233457889999999988777655 999999999999999 77888776654433222    1221 2233445


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +++.+.+++.+||..||.+|||+.+++++
T Consensus       321 ~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          321 CPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            88999999999999999999999999974

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.6e-45  Score=370.18  Aligned_cols=240  Identities=24%  Similarity=0.324  Sum_probs=197.3

Q ss_pred             cccccCCCeEEEEEEE--ccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRD--KVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      ++||+|+||.||++.+  +.+++.||||+++....   ..+.+.+|+.+++.++|||||++++++.. ..+++||||+.+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999954  45678999999975432   34679999999999999999999999965 458899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC----CCCC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKS  179 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~----~~~~  179 (365)
                      |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++......    ....
T Consensus       454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~--~~kL~DFGla~~~~~~~~~~~~~~~  531 (635)
T 4fl3_A          454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH--YAKISDFGLSKALRADENYYKAQTH  531 (635)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCTTHHHHTTC----------
T ss_pred             CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC--CEEEEEcCCccccccCccccccccC
Confidence            99999999888899999999999999999999999999999999999998766  49999999987543322    1233


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..+|+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+....... ..+.   . ....+.+..+++++.+||
T Consensus       532 ~~~t~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-~~i~---~-~~~~~~p~~~~~~l~~li  605 (635)
T 4fl3_A          532 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-AMLE---K-GERMGCPAGCPREMYDLM  605 (635)
T ss_dssp             ---CGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-HHHH---T-TCCCCCCTTCCHHHHHHH
T ss_pred             CCCceeeeChhhhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-HHHH---c-CCCCCCCCCCCHHHHHHH
Confidence            456789999999988787766 999999999999998 99999887654322 2222   2 223334456899999999


Q ss_pred             HHhcccCCCCCCCHHHHhc
Q 017860          259 SRIFVADPAARITIPEIMK  277 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~  277 (365)
                      .+||..||.+|||++++++
T Consensus       606 ~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          606 NLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHTCSSTTTSCCHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=365.25  Aligned_cols=249  Identities=25%  Similarity=0.350  Sum_probs=201.3

Q ss_pred             CCCCCcceec-ccccCCCeEEEEEEEcc--CCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           20 HDSDRYDFVR-DIGSGNFGVARLMRDKV--TKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        20 ~~~~~y~~~~-~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      ...++|.+.+ .||+|+||.||++.++.  ++..||||++....  ...+.+.+|+.+++.++||||+++++++.. ..+
T Consensus       332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            3445666666 89999999999998763  56679999997643  234779999999999999999999999976 568


Q ss_pred             EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||+++....
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCSTTTTCC-
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC--cEEEeeccCcccccC
Confidence            9999999999999998754 4599999999999999999999999999999999999998665  499999999986433


Q ss_pred             CCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          174 HSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       174 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      ...    .....+|+.|+|||++.+..++.+ +|||||||++|||++ |+.||...+......    .+... ...+.+.
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~----~i~~~-~~~~~p~  562 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQG-KRMECPP  562 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH----HHHTT-CCCCCCT
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcC-CCCCCCC
Confidence            221    122345689999999988777766 999999999999998 999999877644322    22222 2334445


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      .+++++.+|+.+||..+|.+|||+.++++
T Consensus       563 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          563 ECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            68999999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=340.98  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=202.6

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      ++-...++|++.+.||+|+||.||++++..   .+|+|++....   ...+.+.+|+.+++.++||||+++++++.....
T Consensus        27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             GSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             cccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            344556799999999999999999999853   49999986532   233567789999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           94 LAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      +++||||+.+++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+||+++. +  .+||+|||+++...
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~-~--~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-G--KVVITDFGLFSISG  180 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC---
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-C--CEEEeecCCccccc
Confidence            999999999999999997754 6999999999999999999999999999999999999973 3  59999999976432


Q ss_pred             C------CCCCCCCcCCCCCCCchhhccc--------ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 017860          173 L------HSQPKSTVGTPAYIAPEVLLRH--------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL  238 (365)
Q Consensus       173 ~------~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  238 (365)
                      .      ........||+.|+|||++.+.        ...+.++|||||||++|+|++|..||..........    .+.
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~  256 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW----QMG  256 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH----HHH
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----Hhc
Confidence            1      1223345689999999998752        222445999999999999999999998765533222    222


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          239 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       239 ~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ...........++.++.+++.+||..||.+|||+.++++.
T Consensus       257 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          257 TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            2222222333578899999999999999999999999973

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-47  Score=355.71  Aligned_cols=245  Identities=18%  Similarity=0.226  Sum_probs=188.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------ccHHHHHHHHHHhcCC---------CCCcc
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------IDENVQREIINHRSLR---------HPNIV   82 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~---------hpnIv   82 (365)
                      ..++|++.+.||+|+||+||+|++  +|+.||||++.....         ..+.+.+|+.+++.++         ||||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            346899999999999999999998  689999999986432         1267889999988886         55555


Q ss_pred             eece-----------------EEEe-------------CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 017860           83 RFKE-----------------VILT-------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV  132 (365)
Q Consensus        83 ~l~~-----------------~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al  132 (365)
                      ++.+                 +|.+             ...+|+|||||.+|++.+.+.+ +.+++..++.++.||+.||
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence            5544                 4443             7889999999999987776644 5689999999999999999


Q ss_pred             HHHH-HcCCeecCCCCCcEEecCCCC------------------CCEEEecCCCcccccCCCCCCCCcCCCCCCCchhhc
Q 017860          133 SYCH-AMQVCHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL  193 (365)
Q Consensus       133 ~~LH-~~~ivHrDlkp~NIli~~~~~------------------~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~  193 (365)
                      +||| ++||+||||||+|||++.++.                  ..+||+|||+|+....    ...+||+.|+|||++.
T Consensus       175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~  250 (336)
T 2vuw_A          175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFT  250 (336)
T ss_dssp             HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGC
T ss_pred             HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhc
Confidence            9999 999999999999999987651                  1599999999985432    2458999999999997


Q ss_pred             ccccCCccceeehhhHH-HHHHHhCCCCCCCCCChHHHHHHHHHHhcc-ccCCC----CCCCCCHHHHHHHHHhcccCCC
Q 017860          194 RHEYDGKIADVWSCGVT-LYVMLVGGYPFEDPDEPKDFRKTIQRILSV-QYSVP----DTNPISQECRDLISRIFVADPA  267 (365)
Q Consensus       194 ~~~~~~~~~DiwSlG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~s~~~~~li~~~l~~dp~  267 (365)
                      +.. + .++||||||++ .+++++|..||.....   .......+... .....    .+..+|+++++||.+||+.|  
T Consensus       251 g~~-~-~~~Diwsl~~~~~~~~~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--  323 (336)
T 2vuw_A          251 GDG-D-YQFDIYRLMKKENNNRWGEYHPYSNVLW---LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--  323 (336)
T ss_dssp             CCS-S-HHHHHHHHHHHHHTTCTTSCCTHHHHHH---HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred             CCC-c-cceehhhhhCCCCcccccccCCCcchhh---hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence            655 4 45999998777 7788899999843110   01111222211 11111    12236789999999999976  


Q ss_pred             CCCCHHHHh-cCcccc
Q 017860          268 ARITIPEIM-KHQWFL  282 (365)
Q Consensus       268 ~R~t~~ell-~h~~f~  282 (365)
                         |++|+| +||||+
T Consensus       324 ---sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 ---SATDLLCQHSLFK  336 (336)
T ss_dssp             ---SHHHHHHHCGGGC
T ss_pred             ---CHHHHHhcCCCcC
Confidence               999999 999994

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.5e-45  Score=341.28  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=198.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhc--CCCCCcceeceEEEeCC----EEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~~~~~~~~----~~~   95 (365)
                      .++|++.+.||+|+||.||++++  +|+.||+|++....  ...+.+|..+++.  ++||||+++++++....    .++
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            35899999999999999999998  58999999986532  3567788888876  79999999999998876    899


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH--------AMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH--------~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      +||||+.+|+|.+++.+ .++++..++.++.|++.||.|||        ++||+||||||+|||++.++.  +||+|||+
T Consensus       117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~  193 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGL  193 (342)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTT
T ss_pred             EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCC
Confidence            99999999999999976 46899999999999999999999        899999999999999986654  99999999


Q ss_pred             cccccCCC-----CCCCCcCCCCCCCchhhcccccC-----CccceeehhhHHHHHHHhC----------CCCCCCCCCh
Q 017860          168 SKSSVLHS-----QPKSTVGTPAYIAPEVLLRHEYD-----GKIADVWSCGVTLYVMLVG----------GYPFEDPDEP  227 (365)
Q Consensus       168 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwSlG~il~ell~g----------~~pf~~~~~~  227 (365)
                      ++......     ......||+.|+|||++.+....     +.++|||||||++|+|++|          ..||......
T Consensus       194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~  273 (342)
T 1b6c_B          194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  273 (342)
T ss_dssp             CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred             ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcC
Confidence            87544332     23556799999999999765322     1459999999999999999          7898765332


Q ss_pred             HH-HHHHHHHHhcccc--CCCC---CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          228 KD-FRKTIQRILSVQY--SVPD---TNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       228 ~~-~~~~~~~~~~~~~--~~~~---~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .. .......+.....  ..+.   ....++.+.+|+.+||+.||.+|||+.++++|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          274 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            11 1112222222221  1111   11234578999999999999999999999975

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-45  Score=350.28  Aligned_cols=244  Identities=15%  Similarity=0.105  Sum_probs=190.3

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHHHHHHHHHhcCCC-CCccee---------c---
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENVQREIINHRSLRH-PNIVRF---------K---   85 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~h-pnIv~l---------~---   85 (365)
                      .+|++.+.||+|+||+||+|++..+|+.||||++....    ...+.+.+|+.+++.++| +|...+         .   
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34888999999999999999999999999999987322    234678999999999987 322111         1   


Q ss_pred             ---------eEEEe-----CCEEEEEEeecCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecC
Q 017860           86 ---------EVILT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHAMQVCHRD  144 (365)
Q Consensus        86 ---------~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-------~~~l~~~~~~~i~~qil~al~~LH~~~ivHrD  144 (365)
                               .++..     ...++++|+++ +++|.+++..       .+.+++..++.++.||+.||+|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                     11111     12467788776 5789888741       23478889999999999999999999999999


Q ss_pred             CCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCCCCCCCchhh----------cccccCCccceeehhhHHHHHH
Q 017860          145 LKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----------LRHEYDGKIADVWSCGVTLYVM  214 (365)
Q Consensus       145 lkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwSlG~il~el  214 (365)
                      |||+|||++.++.  +||+|||+++.....  ....+| +.|+|||++          .+..++.+ +|||||||++|+|
T Consensus       237 iKp~NILl~~~~~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~-~DvwSlGvil~el  310 (413)
T 3dzo_A          237 LRPVDIVLDQRGG--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFA-FDTWTLGLAIYWI  310 (413)
T ss_dssp             CCGGGEEECTTCC--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHH-HHHHHHHHHHHHH
T ss_pred             cccceEEEecCCe--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCch-hhHHHHHHHHHHH
Confidence            9999999987765  999999998754332  455678 999999999          44445545 9999999999999


Q ss_pred             HhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          215 LVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       215 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      ++|+.||...+.....          ...+.....+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus       311 ltg~~Pf~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          311 WCADLPNTDDAALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             HHSSCCCCTTGGGSCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHCCCCCCCcchhhhH----------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence            9999999875432211          1112333458899999999999999999999999999999965

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.4e-44  Score=360.91  Aligned_cols=249  Identities=22%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccC---CcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVT---KELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|.+.....  ..+.+.+|+.+++.++||||+++++++. ++.+|
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            356899999999999999999998653   45799998865332  2367889999999999999999999984 56689


Q ss_pred             EEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++  ++||+|||+++.....
T Consensus       467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~--~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND--CVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT--EEEECCCCCCCSCCC-
T ss_pred             EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC--CEEEEecCCCeecCCC
Confidence            9999999999999998654 689999999999999999999999999999999999998665  4999999999865333


Q ss_pred             CC--CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          175 SQ--PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       175 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      ..  .....+|+.|+|||++.+..++.+ +|||||||++|||++ |..||.+.........+    ... ...+.+..++
T Consensus       545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i----~~~-~~~~~~~~~~  618 (656)
T 2j0j_A          545 TYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNCP  618 (656)
T ss_dssp             ---------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HHT-CCCCCCTTCC
T ss_pred             cceeccCCCCCcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HcC-CCCCCCcccc
Confidence            22  223456789999999987777655 999999999999997 99999876654332222    221 1223345588


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+.+||.+||..||.+|||+.++++.
T Consensus       619 ~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          619 PTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999999863

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2e-44  Score=365.95  Aligned_cols=239  Identities=23%  Similarity=0.263  Sum_probs=196.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEcc-CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE-----
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKV-TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH-----   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-----   93 (365)
                      .++|++.+.||+|+||.||++.+.. +|+.||||++.....  ....+.+|+.+++.++||||+++++++.....     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4699999999999999999999976 789999999865332  23567899999999999999999999987655     


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      .|+||||++|++|.+++..  ++++.+++.++.||+.||.|||++||+||||||+|||++.+   .+||+|||+++....
T Consensus       159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINS  233 (681)
T ss_dssp             EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTC
T ss_pred             eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhccc
Confidence            7999999999999987755  79999999999999999999999999999999999999864   499999999875433


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      .   ...+||+.|+|||++.+..  +.++|||||||++|+|++|.+||.+.....            ..........++.
T Consensus       234 ~---~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------~~~~~~~~~~~~~  296 (681)
T 2pzi_A          234 F---GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------LPEDDPVLKTYDS  296 (681)
T ss_dssp             C---SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------CCTTCHHHHHCHH
T ss_pred             C---CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccc------------ccccccccccCHH
Confidence            2   5567999999999986543  445999999999999999999987522100            0000001114678


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      +.+||.+||+.||.+||+..+.+.|+|+.
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            99999999999999999999999998874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.9e-44  Score=323.97  Aligned_cols=226  Identities=15%  Similarity=0.140  Sum_probs=183.7

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      ...++|++.+.||+|+||.||+|++..+++.||+|++.......    +.+.+|+.+++.++||||+++++++...+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            34468999999999999999999999999999999998654433    67889999999999999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      +||||++|++|.+++.+.  ..+.++..++.||+.||+|||++||+||||||+|||++.++.  +||+++|         
T Consensus       108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~---------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA---------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC---------
T ss_pred             EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc---------
Confidence            999999999999998543  467788999999999999999999999999999999987665  8998543         


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCC--CCCCCCCHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV--PDTNPISQE  253 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~  253 (365)
                                |++|       + +.++|||||||++|+|++|+.||.+.+....+....+. .......  .....++++
T Consensus       175 ----------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          175 ----------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-TAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             ----------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-TTSCBCCHHHHCTTSCHH
T ss_pred             ----------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-hccCCCChhhcccCCCHH
Confidence                      3333       3 34499999999999999999999876542211000000 0010000  112358899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +.+||.+||+.||.+| |+.++++.
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHH
Confidence            9999999999999999 99999973

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.9e-37  Score=305.99  Aligned_cols=186  Identities=13%  Similarity=0.039  Sum_probs=136.0

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCC-----------cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEE
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-----------KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~   95 (365)
                      ...++.|++|.+..++....|+.||+|++.+..           ...+++.+|+.+|+++ .|+||++++++++++..+|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            345778888888888888899999999997642           1225688999999999 6999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-  174 (365)
                      |||||++|++|.++|.+.+++++.   .|+.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+..... 
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCC
Confidence            999999999999999999888875   47899999999999999999999999999987664  999999999865433 


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCC
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYP  220 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p  220 (365)
                      ....+.+||+.|||||++.+. +... +|+||+|++++++.++..+
T Consensus       394 ~~~~t~vGTp~YmAPE~l~g~-~~~~-~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          394 SWPTNLVQSFFVFVNELFAEN-KSWN-GFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             ccccCceechhhccHHHhCCC-CCCc-ccccccccchhhhccccch
Confidence            334556899999999999754 3334 8999999998877665433

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.2e-30  Score=257.22  Aligned_cols=180  Identities=21%  Similarity=0.124  Sum_probs=141.3

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---------cHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ..+.||+|+||.||++.  ..++.+++|........         .+.+.+|+.+++.++||||+++..++......|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35689999999999994  46788999986542211         23478999999999999999766666677778999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      |||++|++|.+++..        ++.++.|++.||.|||++||+||||||+|||++.    ++||+|||+++....... 
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCcccc
Confidence            999999999998865        6789999999999999999999999999999986    499999999986543221 


Q ss_pred             -------CCCCcCCCCCCCchhhcc--cccCCccceeehhhHHHHHHHhCCCCC
Q 017860          177 -------PKSTVGTPAYIAPEVLLR--HEYDGKIADVWSCGVTLYVMLVGGYPF  221 (365)
Q Consensus       177 -------~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG~il~ell~g~~pf  221 (365)
                             ..+.+||+.|||||++..  ..|... +|+||..+-..+.+.++.+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhcccc
Confidence                   135679999999999976  556555 89999988888877776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.94  E-value=2.9e-27  Score=214.49  Aligned_cols=143  Identities=18%  Similarity=0.161  Sum_probs=116.5

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------------------ccHHHHHHHHHHhcCCCCCcceec
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK   85 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpnIv~l~   85 (365)
                      |++.+.||+|+||.||+|.+ .+|+.||+|++..+..                   ....+.+|+.+++.++  | +++.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            44459999999999999999 7899999999864321                   1345789999999999  5 6777


Q ss_pred             eEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                      +++.. +..|+||||++|++|.+ +.      ......++.|++.||.|||++||+||||||+|||++ ++  ++||+||
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DF  236 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDF  236 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEEC
Confidence            76644 45699999999999988 41      234567999999999999999999999999999998 44  5999999


Q ss_pred             CCcccccCCCCCCCCcCCCCCCCchhhcc
Q 017860          166 GYSKSSVLHSQPKSTVGTPAYIAPEVLLR  194 (365)
Q Consensus       166 gla~~~~~~~~~~~~~gt~~y~aPE~~~~  194 (365)
                      |+|+.            +..++|||++.+
T Consensus       237 G~a~~------------~~~~~a~e~l~r  253 (282)
T 1zar_A          237 PQSVE------------VGEEGWREILER  253 (282)
T ss_dssp             TTCEE------------TTSTTHHHHHHH
T ss_pred             CCCeE------------CCCCCHHHHHHH
Confidence            99863            456899998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.88  E-value=3e-23  Score=185.63  Aligned_cols=136  Identities=15%  Similarity=0.108  Sum_probs=107.1

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcE--EEEEEeecCCcc-------------------------cHHHHHHHHHHhcC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKI-------------------------DENVQREIINHRSL   76 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-------------------------~~~~~~e~~~l~~l   76 (365)
                      -|++.+.||+|+||.||+|.+..+|+.  ||||++......                         ...+.+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            478899999999999999999778999  999987543111                         12578899999999


Q ss_pred             CCCCc--ceeceEEEeCCEEEEEEeecCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCC
Q 017860           77 RHPNI--VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLE  148 (365)
Q Consensus        77 ~hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH-~~~ivHrDlkp~  148 (365)
                      .|+++  +.++..    ...++||||+.+ |    +|.+....   .++..+..++.|++.||.||| +.||+||||||+
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~  200 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY  200 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence            88764  333332    245899999942 3    56655322   345678899999999999999 999999999999


Q ss_pred             cEEecCCCCCCEEEecCCCccc
Q 017860          149 NTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus       149 NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      |||++.    .++|+|||+|..
T Consensus       201 NILl~~----~~~liDFG~a~~  218 (258)
T 1zth_A          201 NIMYID----KVYFIDMGQAVT  218 (258)
T ss_dssp             SEEESS----SEEECCCTTCEE
T ss_pred             HEEEcC----cEEEEECccccc
Confidence            999976    499999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.80  E-value=6.2e-20  Score=171.32  Aligned_cols=137  Identities=15%  Similarity=0.113  Sum_probs=99.0

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---------------ccH--------HHHHHHHHHhcCCCCC
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---------------IDE--------NVQREIINHRSLRHPN   80 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------~~~--------~~~~e~~~l~~l~hpn   80 (365)
                      -|++.++||.|+||.||+|.+. +|+.||||+++.+..               ...        ...+|..+|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3999999999999999999986 799999998753210               001        1234666666665444


Q ss_pred             cceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC--
Q 017860           81 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP--  158 (365)
Q Consensus        81 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~--  158 (365)
                      +....-+....  .++||||+.|++|..+.      ....+..++.||+.+|.+||+.|||||||||.|||++.++.+  
T Consensus       175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          175 FPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             CSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence            32222121222  26999999998886542      223456788999999999999999999999999999866532  


Q ss_pred             ------CEEEecCCCcc
Q 017860          159 ------RLKICDFGYSK  169 (365)
Q Consensus       159 ------~vkl~Dfgla~  169 (365)
                            .+.|+||+-+.
T Consensus       247 ~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             TTSEEEEEEECCCTTCE
T ss_pred             ccccccceEEEEeCCcc
Confidence                  27899998654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=1.6e-13  Score=122.42  Aligned_cols=137  Identities=16%  Similarity=0.113  Sum_probs=109.9

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeec
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .|++...++.|+.+.||++...  ++.+++|...... .....+.+|+.+++.+. +..+.++++++...+..|+||||+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             cceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            6999999999999999999753  6789999986521 22346889999998884 677889999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------------------------------------------  137 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~--------------------------------------------  137 (365)
                      +|.+|...+     .+......++.++..+|+.||+                                            
T Consensus        93 ~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           93 DGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             CCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            999987652     1223345788999999999998                                            


Q ss_pred             ---------------cCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          138 ---------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       138 ---------------~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                                     ..++|+|++|.||+++.+.  .+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--EEEEEEchhcc
Confidence                           4589999999999997532  25699998654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.33  E-value=5.6e-12  Score=111.79  Aligned_cols=134  Identities=14%  Similarity=0.123  Sum_probs=98.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC--cceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~  100 (365)
                      ..|.+....+.|..+.||++.. .+|..+++|+....  ....+.+|+.+++.+.+.+  +.+++.+....+..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3577655545677799999965 46778999987654  2345788998888886444  56688888888889999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ-----------------------------------------  139 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~-----------------------------------------  139 (365)
                      ++|.+|.  .   ...+   ...++.++...|..||+..                                         
T Consensus        97 i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A           97 VPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             CSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            9998884  1   1122   2356677778888888643                                         


Q ss_pred             -----------------CeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          140 -----------------VCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       140 -----------------ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                                       ++|+|++|.||+++.+.  .+.|+||+.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~--~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence                             99999999999997543  25699999764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.31  E-value=6.2e-12  Score=117.37  Aligned_cols=142  Identities=14%  Similarity=0.196  Sum_probs=107.4

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEee--cCC--cccHHHHHHHHHHhcCC--CCCcceeceEEEeC---CEEE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIE--RGD--KIDENVQREIINHRSLR--HPNIVRFKEVILTP---THLA   95 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~--~~~--~~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~---~~~~   95 (365)
                      ..-++.|+.|.++.||++...  +..+++|+..  .+.  .....+.+|+.+++.+.  +..+.+++.++...   +..|
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            345788999999999998764  4678999876  432  12356788999998887  45578888888766   4479


Q ss_pred             EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 017860           96 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------------------------------------  137 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~--------------------------------------  137 (365)
                      +||||++|..+.+..  ...+++.+...++.+++.+|+.||+                                      
T Consensus       118 ~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999999998875421  2347888899999999999999997                                      


Q ss_pred             --------------------cCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860          138 --------------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus       138 --------------------~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                                          ..++|+|++|.|||++.++...+.|.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                358999999999999865433368999998763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.12  E-value=2.6e-11  Score=110.46  Aligned_cols=183  Identities=17%  Similarity=0.119  Sum_probs=120.7

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCC--cceeceEEEeCC---EEEEEEeec
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYA  101 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~e~~  101 (365)
                      ++.++.|....||++.     ..+++|+.... .....+.+|..+++.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4669999999999863     45899985432 23467889999998773 332  334444333332   348899999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------------------------------------------  137 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~--------------------------------------------  137 (365)
                      +|.+|.....  ..++..+...++.++...|+.||+                                            
T Consensus        99 ~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A           99 KGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             CCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             CCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence            9998875433  347888888999999999999996                                            


Q ss_pred             --------------cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCcCC---------------CCCCC
Q 017860          138 --------------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT---------------PAYIA  188 (365)
Q Consensus       138 --------------~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~gt---------------~~y~a  188 (365)
                                    ..++|+|++|.||+++.+....+.|.||+.+...............               .....
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                          1369999999999998642224789999987643221100000000               01111


Q ss_pred             -chhhcccccCCccceeehhhHHHHHHHhCCCCC
Q 017860          189 -PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPF  221 (365)
Q Consensus       189 -PE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf  221 (365)
                       |+......  -. .+.|++|.++|.+.+|..+|
T Consensus       257 ~~~~~~r~~--~~-~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEKYR--MK-EKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHH--HH-HHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHHHH--HH-HHHHHHHHHHHHHHcCCHHH
Confidence             22221111  11 58999999999999998776

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.70  E-value=1.2e-07  Score=86.32  Aligned_cols=135  Identities=19%  Similarity=0.139  Sum_probs=95.1

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCC---CcceeceEEE-eCCEEEEEEeecCC
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASG  103 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~e~~~~  103 (365)
                      ++.++.|....||++     |..+++|+.. .......+.+|..+++.+.+.   .+.+++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            567889999999988     5678999853 222346788999999988652   2455555553 34567899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------------------------------------------
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAM---------------------------------------------  138 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~---------------------------------------------  138 (365)
                      .++.....  ..+++.+...++.++...|+.||+.                                             
T Consensus        98 ~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~  175 (306)
T 3tdw_A           98 QILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR  175 (306)
T ss_dssp             EECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred             eECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence            88876322  2346666666667777777766642                                             


Q ss_pred             ---------------CCeecCCCCCcEEecCC-CCCC-EEEecCCCccc
Q 017860          139 ---------------QVCHRDLKLENTLLDGS-PAPR-LKICDFGYSKS  170 (365)
Q Consensus       139 ---------------~ivHrDlkp~NIli~~~-~~~~-vkl~Dfgla~~  170 (365)
                                     .++|+|++|.||+++.+ ..+. +.|.||+.+..
T Consensus       176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           24999999999999751 1123 47999997653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.51  E-value=1.3e-06  Score=77.58  Aligned_cols=132  Identities=18%  Similarity=0.208  Sum_probs=95.1

Q ss_pred             ccccCCCe-EEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeecCCCChH
Q 017860           30 DIGSGNFG-VARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF  107 (365)
Q Consensus        30 ~LG~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~  107 (365)
                      .+..|..| .||+......+..+++|+-...  ....+.+|...|+.+. +--+.+++.++...+..|+|||+++|.++.
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~  108 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF  108 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence            34445554 6899888777888999986543  2356788998888774 223677888888899999999999998887


Q ss_pred             HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------------
Q 017860          108 ERICNAGRFSEDEARFFFQQLISGVSYCHAM-------------------------------------------------  138 (365)
Q Consensus       108 ~~l~~~~~l~~~~~~~i~~qil~al~~LH~~-------------------------------------------------  138 (365)
                      +.....    ......+..++...|+.||+.                                                 
T Consensus       109 ~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  184 (272)
T 4gkh_A          109 QVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH  184 (272)
T ss_dssp             HHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred             ccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence            655331    223345666777777777741                                                 


Q ss_pred             ---------CCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          139 ---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       139 ---------~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                               .++|+|+.|.|||++.++  .+-|.||+.+.
T Consensus       185 ~~~~~~~~~~l~HGDl~~~Nil~~~~~--~~~viDwe~a~  222 (272)
T 4gkh_A          185 KLLPFSPDSVVTHGDFSLDNLIFDEGK--LIGCIDVGRVG  222 (272)
T ss_dssp             TTCCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             hcccccCCcEEEcCCCCCCeEEEECCe--EEEEEECcccc
Confidence                     158999999999997543  25699998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.49  E-value=4.7e-07  Score=85.32  Aligned_cols=76  Identities=17%  Similarity=0.086  Sum_probs=49.7

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCC--------cccHHHHHHHHHHhcCCC--CC-cceeceEEEeCCEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--------KIDENVQREIINHRSLRH--PN-IVRFKEVILTPTHLA   95 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~e~~~l~~l~h--pn-Iv~l~~~~~~~~~~~   95 (365)
                      -++.||.|..+.||++....+++.+++|......        .....+..|..+++.+..  |. +.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            3678999999999999876667889999764321        123456778888877632  33 4455543  344568


Q ss_pred             EEEeecCCC
Q 017860           96 IVMEYASGG  104 (365)
Q Consensus        96 lv~e~~~~g  104 (365)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.25  E-value=1e-05  Score=74.18  Aligned_cols=74  Identities=18%  Similarity=0.246  Sum_probs=43.0

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC-----CCCCcceec-e--EEEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL-----RHPNIVRFK-E--VILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-----~hpnIv~l~-~--~~~~~~~~~lv~e   99 (365)
                      ++.|+.|..+.||++...  +..+++|+....   ...+..|..+++.|     ..|.++.-. +  +....+..+++|+
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            456777788999998763  345999988753   23344455555444     234444311 1  1234677899999


Q ss_pred             ecCCCCh
Q 017860          100 YASGGEL  106 (365)
Q Consensus       100 ~~~~g~L  106 (365)
                      |++|..+
T Consensus       112 ~i~G~~~  118 (346)
T 2q83_A          112 WIEGRPF  118 (346)
T ss_dssp             CCCCBCC
T ss_pred             eecCccC
Confidence            9998654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=7.3e-07  Score=82.64  Aligned_cols=82  Identities=9%  Similarity=0.076  Sum_probs=55.9

Q ss_pred             ceeccc-ccCCCeEEEEEEEc--c----CCcEEEEEEeecCC---c-ccHHHHHHHHHHhcCCC---CCcceeceEEEeC
Q 017860           26 DFVRDI-GSGNFGVARLMRDK--V----TKELVAVKYIERGD---K-IDENVQREIINHRSLRH---PNIVRFKEVILTP   91 (365)
Q Consensus        26 ~~~~~L-G~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~---~-~~~~~~~e~~~l~~l~h---pnIv~l~~~~~~~   91 (365)
                      ..++.| +.|..+.+|++...  .    +++.+++|+.....   . ....+.+|+.+++.+..   -.+.+++.+....
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345778 88999999988753  1    25679999865432   1 12467888888877742   3466777776554


Q ss_pred             ---CEEEEEEeecCCCChH
Q 017860           92 ---THLAIVMEYASGGELF  107 (365)
Q Consensus        92 ---~~~~lv~e~~~~g~L~  107 (365)
                         ...|+||||++|..+.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               3468999999886653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.88  E-value=0.00013  Score=66.18  Aligned_cols=76  Identities=18%  Similarity=0.114  Sum_probs=60.3

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC---CCCcceeceEEEeCCEEEEEEeecCC
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      -++.|+.|....+|++..  ++..+++|+....  ....+.+|...|+.|.   ...+.+++.+....+..++||||++|
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            367899999999999875  4678999987653  2456788988888773   35678888888878889999999998


Q ss_pred             CCh
Q 017860          104 GEL  106 (365)
Q Consensus       104 g~L  106 (365)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.87  E-value=5.5e-05  Score=71.67  Aligned_cols=73  Identities=14%  Similarity=0.234  Sum_probs=45.1

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeec-----CCc-----ccHHHHHHHHHHh-cCCCCCcceeceEEEeCCEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GDK-----IDENVQREIINHR-SLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~-----~~~~~~~e~~~l~-~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      -++.||.|..+.||++..  +++.+++|....     ...     ....+..|+..+. ......+.+++.+.  ....+
T Consensus        38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~  113 (420)
T 2pyw_A           38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL  113 (420)
T ss_dssp             EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred             EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence            367899999999999964  567899994321     111     1123344443332 22234566666654  45678


Q ss_pred             EEEeec-CC
Q 017860           96 IVMEYA-SG  103 (365)
Q Consensus        96 lv~e~~-~~  103 (365)
                      +||||+ +|
T Consensus       114 lv~e~l~~g  122 (420)
T 2pyw_A          114 IGMRYLEPP  122 (420)
T ss_dssp             EEECCCCTT
T ss_pred             EEEeecCCc
Confidence            999999 77

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.84  E-value=4.6e-05  Score=68.74  Aligned_cols=71  Identities=13%  Similarity=0.095  Sum_probs=44.6

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEeec-CCCC
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGE  105 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~-~~g~  105 (365)
                      ++.|+.|....+|++      +.+++|+............+|..+++.+...++ .+++...  ...-++++||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            788999999999998      458999876543222233567777766642222 3454433  33346899999 6655


Q ss_pred             h
Q 017860          106 L  106 (365)
Q Consensus       106 L  106 (365)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.73  E-value=0.00031  Score=59.55  Aligned_cols=122  Identities=16%  Similarity=0.102  Sum_probs=76.5

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCCc
Q 017860          104 GELFERICN-AGRFSEDEARFFFQQLISGVSYCH-AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV  181 (365)
Q Consensus       104 g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH-~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~~  181 (365)
                      -+|.+.|.. +.+++|+++|.++.|.+.+|.-+- ++.-..+=+.|..|++..+|.  |-+.+ ..+.           .
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~   98 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A   98 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence            378888875 567999999999999999988762 222224445578999977765  55542 1110           1


Q ss_pred             CCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHh
Q 017860          182 GTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRI  261 (365)
Q Consensus       182 gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  261 (365)
                      ....+.|||... ... ..+.=|||||+++|.-+--..|=                       .....+|+.+.+||..|
T Consensus        99 ~~~~~~~pe~~~-~~~-te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~M  153 (229)
T 2yle_A           99 GEPPPVAGKLGY-SQC-METEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHM  153 (229)
T ss_dssp             --------CCSS-SSS-CHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHH
T ss_pred             cccCCCChhhcc-ccc-hHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHH
Confidence            233466888753 122 23368999999999988532221                       11234899999999999


Q ss_pred             ccc
Q 017860          262 FVA  264 (365)
Q Consensus       262 l~~  264 (365)
                      ..-
T Consensus       154 t~~  156 (229)
T 2yle_A          154 ANT  156 (229)
T ss_dssp             TTC
T ss_pred             Hhc
Confidence            865

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.58  E-value=0.00037  Score=63.37  Aligned_cols=77  Identities=9%  Similarity=0.065  Sum_probs=49.4

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCC--CcceeceE-----EEeCCEEEEEEee
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHP--NIVRFKEV-----ILTPTHLAIVMEY  100 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~-----~~~~~~~~lv~e~  100 (365)
                      ++.|+ |....||++... +|+.+++|...........+..|..+++.+...  .+++++..     ....+..+++|++
T Consensus        31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            34566 888899987653 566799999875433445677788777666321  13333332     2235667899999


Q ss_pred             cCCCCh
Q 017860          101 ASGGEL  106 (365)
Q Consensus       101 ~~~g~L  106 (365)
                      ++|..+
T Consensus       109 i~G~~~  114 (328)
T 1zyl_A          109 VGGRQF  114 (328)
T ss_dssp             CCCEEC
T ss_pred             cCCCCC
Confidence            987543

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.57  E-value=0.00015  Score=65.85  Aligned_cols=138  Identities=17%  Similarity=0.154  Sum_probs=76.3

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----CCCcceec-e--EEEeCCEEEEEE
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHLAIVM   98 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~l~-~--~~~~~~~~~lv~   98 (365)
                      -++.|+.|....+|++... + ..+++|..... .....+..|+.+++.+.     -|.++... +  +....+..++++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-K-DPLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEEECC---EEEEEEEES-S-CCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             EeeccCCCcccceEEEEeC-C-ccEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            3567888888999998764 3 36899988652 12345666777666553     23333211 1  112346678999


Q ss_pred             eecCCCChHH--------------HHHhc-CCC--------CHHHHHH---------------HHHHHHHHHHHHHH---
Q 017860           99 EYASGGELFE--------------RICNA-GRF--------SEDEARF---------------FFQQLISGVSYCHA---  137 (365)
Q Consensus        99 e~~~~g~L~~--------------~l~~~-~~l--------~~~~~~~---------------i~~qil~al~~LH~---  137 (365)
                      +|++|..+..              .++.. ..+        .......               +...+...+..++.   
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865311              11111 111        1000000               00113445555553   


Q ss_pred             ----cCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          138 ----MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       138 ----~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                          .+++|+|+.+.|||++.+.  .+.|.||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~--~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCc--eEEEecchhcc
Confidence                3689999999999997543  24799998654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.51  E-value=0.0002  Score=66.72  Aligned_cols=138  Identities=15%  Similarity=0.118  Sum_probs=80.8

Q ss_pred             ecccccCCCeEEEEEEEcc-------CCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCcceeceEEEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++.|..|-...+|++....       +++.+++|+............+|..+++.|.. .-..+++..+..    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            4567778888999988642       35789999864332234566789988887742 223556665532    38999


Q ss_pred             ecCCCChHH--------------HH---Hhc----C-CCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 017860          100 YASGGELFE--------------RI---CNA----G-RFS--EDEARFFFQQLIS-------------------GVSYCH  136 (365)
Q Consensus       100 ~~~~g~L~~--------------~l---~~~----~-~l~--~~~~~~i~~qil~-------------------al~~LH  136 (365)
                      |++|..|..              .+   ...    + ...  ..++..+..++-.                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998865421              11   111    1 111  3556666654422                   233333


Q ss_pred             ----H----cCCeecCCCCCcEEecCC--CCCCEEEecCCCcc
Q 017860          137 ----A----MQVCHRDLKLENTLLDGS--PAPRLKICDFGYSK  169 (365)
Q Consensus       137 ----~----~~ivHrDlkp~NIli~~~--~~~~vkl~Dfgla~  169 (365)
                          .    ..++|+|+.+.||+++.+  ..+.+.++||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence                2    248999999999999865  12359999998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.50  E-value=0.0007  Score=60.42  Aligned_cols=78  Identities=12%  Similarity=0.040  Sum_probs=54.3

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCC---CcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hp---nIv~l~~~~~~~~~~~lv~e   99 (365)
                      ...-++.+|.|..+.||++... +|+.|++|+..... .....+.+|...|+.|.-.   -+.+++.+  ..  -++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEE
Confidence            4556789999999999999864 78899999865433 2335678899888877422   23344433  22  368999


Q ss_pred             ecCCCCh
Q 017860          100 YASGGEL  106 (365)
Q Consensus       100 ~~~~g~L  106 (365)
                      |+.++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9977644

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.48  E-value=0.00021  Score=66.32  Aligned_cols=75  Identities=15%  Similarity=0.042  Sum_probs=45.0

Q ss_pred             ecccccCCCeEEEEEEEcc--------CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC-cceeceEEEeCCEEEEEE
Q 017860           28 VRDIGSGNFGVARLMRDKV--------TKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~   98 (365)
                      ++.|+.|....+|++....        .++.+++|+.............|..+++.+...+ +.+++..+  .+  ++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            5678888889999998653        1368899987654322122457777777664333 34566544  22  6899


Q ss_pred             eecCCCCh
Q 017860           99 EYASGGEL  106 (365)
Q Consensus        99 e~~~~g~L  106 (365)
                      +|++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.38  E-value=0.00029  Score=66.95  Aligned_cols=74  Identities=14%  Similarity=0.133  Sum_probs=50.0

Q ss_pred             ecccccCCCeEEEEEEEcc-------CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e   99 (365)
                      ++.|+.|-...||++....       .++.+++|+.... .....+.+|..+++.+...++ .++++.+.  +  .+|+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e  152 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE  152 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence            5678888899999998642       2578999987432 111566688888887753333 55666553  2  38999


Q ss_pred             ecCCCCh
Q 017860          100 YASGGEL  106 (365)
Q Consensus       100 ~~~~g~L  106 (365)
                      |++|.+|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9986443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.29  E-value=0.0015  Score=59.59  Aligned_cols=138  Identities=14%  Similarity=0.102  Sum_probs=68.9

Q ss_pred             ecccccCCCeE-EEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC--CCcceeceEEEeCCEEEEEEeecCCC
Q 017860           28 VRDIGSGNFGV-ARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGG  104 (365)
Q Consensus        28 ~~~LG~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g  104 (365)
                      ++.|+.|+... +|++.. .+++.+++|......  ...+..|+.+++.+..  -.+.+++.+....+  +++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            45676665554 566653 236678888654432  1234456666655532  23445555433333  6899999776


Q ss_pred             ChHHHHHhc--------------------------CCCCHHHHH-------H-HH------------HHHHHHHHHH---
Q 017860          105 ELFERICNA--------------------------GRFSEDEAR-------F-FF------------QQLISGVSYC---  135 (365)
Q Consensus       105 ~L~~~l~~~--------------------------~~l~~~~~~-------~-i~------------~qil~al~~L---  135 (365)
                      .+.+.+...                          ..++.....       . +.            ..+...+..+   
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            664433211                          112221111       0 00            0111222223   


Q ss_pred             ---HHcCCeecCCCCCcEEecCCC--CCCEEEecCCCccc
Q 017860          136 ---HAMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKS  170 (365)
Q Consensus       136 ---H~~~ivHrDlkp~NIli~~~~--~~~vkl~Dfgla~~  170 (365)
                         +...++|||+.+.||+++.+.  .+.+.|.||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence               124699999999999997531  13589999997763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.27  E-value=0.0014  Score=62.69  Aligned_cols=75  Identities=16%  Similarity=0.105  Sum_probs=49.0

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCc-ceeceEEEeCCEEEEEEeecCCCCh
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      ++.|+.|-...+|++.....+..+++|+........-.-.+|..+++.|...++ .++++.+.  +  ..|+||++|.+|
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            567888888999999875445789999875432221123688888888865444 56776662  2  259999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.09  E-value=0.0075  Score=55.12  Aligned_cols=68  Identities=12%  Similarity=-0.024  Sum_probs=41.7

Q ss_pred             ccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcC---CCCCcceeceE------EEeCCEEEEEEeecC
Q 017860           32 GSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSL---RHPNIVRFKEV------ILTPTHLAIVMEYAS  102 (365)
Q Consensus        32 G~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l---~hpnIv~l~~~------~~~~~~~~lv~e~~~  102 (365)
                      |.|....||++... +| .+++|+......     .+|+..++.|   .-|++++.+..      ....+..+++|+|++
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            44446899998754 44 899998766442     2444444433   22324444322      234577899999999


Q ss_pred             CCCh
Q 017860          103 GGEL  106 (365)
Q Consensus       103 ~g~L  106 (365)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.28  E-value=0.011  Score=55.65  Aligned_cols=75  Identities=15%  Similarity=0.055  Sum_probs=48.8

Q ss_pred             ecccccCCCeEEEEEEEccC-------CcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCcceeceEEEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDKVT-------KELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++.|..|-...+|++.....       ++.|++|+........-+..+|..+++.+.. .-..++++.+  .+  +.|++
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e  150 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE  150 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence            56777788889999987521       5789999875543222234678888777742 2234555433  22  68999


Q ss_pred             ecCCCCh
Q 017860          100 YASGGEL  106 (365)
Q Consensus       100 ~~~~g~L  106 (365)
                      |++|..|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9998654

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=95.55  E-value=0.0083  Score=44.32  Aligned_cols=61  Identities=15%  Similarity=0.126  Sum_probs=49.0

Q ss_pred             CCCCCHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          304 QPMQSVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+...+..+++.|...+...+|.++.+++....  ......+.+..+...+.|.|++|.|+|.
T Consensus        30 l~~~~~~el~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~ei~~l~~~~D~d~dG~I~~~   92 (100)
T 2lv7_A           30 IPEDELEEIREAFKVFDRDGNGFISKQELGTAMRSLGYMPNEVELEVIIQRLDMDGDGQVDFE   92 (100)
T ss_dssp             CCGGGHHHHHHHHHHTCSSCSSCBCHHHHHHHHHHHTCCCCTTTHHHHHHHHCSSCSSSBCHH
T ss_pred             CCHHHHHHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHHCCCCCCeEeHH
Confidence            345677889999999999999999999886653  2233456667788999999999999984

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.23  E-value=0.13  Score=47.92  Aligned_cols=30  Identities=40%  Similarity=0.606  Sum_probs=23.5

Q ss_pred             CeecCCCCCcEEecC----CCCCCEEEecCCCcc
Q 017860          140 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK  169 (365)
Q Consensus       140 ivHrDlkp~NIli~~----~~~~~vkl~Dfgla~  169 (365)
                      ++|+|+.+.|||+..    +....+.++||..|.
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            679999999999943    223359999998765

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=93.12  E-value=0.034  Score=41.75  Aligned_cols=59  Identities=5%  Similarity=-0.184  Sum_probs=49.4

Q ss_pred             CCCHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          306 MQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ......+.+.|...+...+|.++.+++..........+.+..++..+.|.|++|.|+|.
T Consensus        18 ~~~~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~I~~~   76 (110)
T 1iq3_A           18 EEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTLP   76 (110)
T ss_dssp             SSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence            45678899999999999999999998877665555566677888999999999999984

>4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens}

Probab=91.83  E-value=0.012  Score=45.07  Aligned_cols=56  Identities=11%  Similarity=0.033  Sum_probs=44.3

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCC-------CCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNL-------DMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-------~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .++.+...|...+.. +|+++..++..-..       ....++.+.++...+.|.|++|.|+|.
T Consensus        13 ~ie~l~~~F~~yd~d-dG~Is~~EL~~~l~~~~~~~l~~~~~~~~v~~~i~~~D~d~DG~IdF~   75 (121)
T 4drw_A           13 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQ   75 (121)
T ss_dssp             HHHHHHHTTGGGSCT-TCSCCHHHHHHHTTTSCHHHHTTSSCTTHHHHHHHHHCTTCSSCCCHH
T ss_pred             HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHHhhhhcccCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence            467788888888877 79999999876542       334556677888999999999999983

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=91.39  E-value=0.025  Score=41.15  Aligned_cols=57  Identities=11%  Similarity=-0.169  Sum_probs=46.0

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ....+.+.|...+.+.+|.++.+++..........+.+..+.....|.|++|.|+|.
T Consensus         8 ~~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~   64 (95)
T 1c07_A            8 EKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKD   64 (95)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETT
T ss_pred             HHHHHHHHHHHhCCCCCCcEeHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHH
Confidence            456788999999999999999988876544344456667788889999999999984

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6

Probab=90.72  E-value=0.035  Score=40.75  Aligned_cols=56  Identities=11%  Similarity=-0.171  Sum_probs=45.2

Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          309 VDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       309 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+.+.+.|...+...+|.++.+++..........+.+..++....|.|++|.|+|.
T Consensus        10 ~~~~~~~F~~~D~d~dG~Is~~el~~~l~~~~l~~~~l~~i~~~~D~d~dG~i~~~   65 (99)
T 1qjt_A           10 NPVYEKYYRQVEAGNTGRVLALDAAAFLKKSGLPDLILGKIWDLADTDGKGVLSKQ   65 (99)
T ss_dssp             CTHHHHHHHHHCCTTSSCCCSHHHHHHHHTSSSCHHHHHHHHHHHCCSSSSSCCSH
T ss_pred             HHHHHHHHHHHCCCCCCcCCHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCcCCHH
Confidence            34678889999999999999988876544444556677788899999999999984

>3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A

Probab=90.07  E-value=0.011  Score=43.84  Aligned_cols=57  Identities=14%  Similarity=-0.055  Sum_probs=43.6

Q ss_pred             CHHHHHHHHHHhC-CCCC-CCCCcccccccC-------CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEAS-IPAV-GTHGLNCYMTDN-------LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~-~~~~-g~~~~~~~~~~~-------~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ++..+...|...+ ...+ |+++.+++..-.       .....++.+.++...+.|.|++|.|+|.
T Consensus         8 ~i~~l~~aF~~fd~~dg~~G~Is~~EL~~~l~~~l~~~lg~~~~~~ev~~~i~~~D~dgDG~Idf~   73 (101)
T 3nso_A            8 AVAAIVCTFQEYAGRCGDKYKLCQAELKELLQKELATWTPTEFRECDYNKFMSVLDTNKDCEVDFV   73 (101)
T ss_dssp             HHHHHHHHHHHHHTTSSCTTEECHHHHHHHHHHHTTTCCCCTTCHHHHHHHHHHHHHCCCSCEEHH
T ss_pred             HHHHHHHHHHHHhhcCCCCCEECHHHHHHHHHHHhhhhcCCCCCHHHHHHHHHHhCCCCCCCCcHH
Confidence            4677888888886 6666 999998886532       1233456778889999999999999984

>1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A

Probab=89.67  E-value=0.043  Score=40.90  Aligned_cols=56  Identities=14%  Similarity=-0.169  Sum_probs=45.4

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ....+.+.|...+. .+|.++.+++..........+.+..++....|.|++|.|+|.
T Consensus        13 e~~~~~~~F~~~D~-~dG~Is~~el~~~l~~~gl~~~el~~i~~~~D~d~dG~id~~   68 (106)
T 1eh2_A           13 DKAKYDAIFDSLSP-VNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRD   68 (106)
T ss_dssp             HHHHHHHHHTTSCC-SSSCCBHHHHHHHHHTTTCCHHHHHHHHHHHCSSCSSBCCHH
T ss_pred             HHHHHHHHHHHhCC-CCCeEcHHHHHHHHHHcCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence            45667788989998 999999988877655455567777888999999999999983

>2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A

Probab=88.45  E-value=0.13  Score=38.75  Aligned_cols=57  Identities=16%  Similarity=0.094  Sum_probs=42.9

Q ss_pred             CHHHHHHHHHHhC-CCCCC-CCCcccccccC-------CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEAS-IPAVG-THGLNCYMTDN-------LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~-~~~~g-~~~~~~~~~~~-------~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .++.+...|...+ ...+| +++.+++....       ......+.+.++...+.|.|++|.|+|.
T Consensus        20 ~~~~l~~aF~~fD~~dgdGG~Is~~EL~~~l~~~l~~~lg~~~t~~ev~~li~~~D~dgdG~Idf~   85 (113)
T 2lnk_A           20 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQ   85 (113)
T ss_dssp             HHHHHHHHHHHTTTTTSCTTCBCHHHHHHHHHHHCGGGGTTCCCTTHHHHHHHHHCSSSSSCBCHH
T ss_pred             HHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcchhcCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence            4567888999998 77776 89988876542       1123355677788999999999999984

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens}

Probab=87.81  E-value=0.067  Score=40.11  Aligned_cols=57  Identities=14%  Similarity=-0.066  Sum_probs=44.9

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ....+...|...+...+|.++.+++..........+.+..+.....|.|++|.|+|.
T Consensus        12 ~~~~l~~~F~~~D~d~dG~I~~~El~~~l~~~~~~~~~~~~i~~~~D~d~dG~I~~~   68 (111)
T 2kgr_A           12 SRLKYRQLFNSHDKTMSGHLTGPQARTILMQSSLPQAQLASIWNLSDIDQDGKLTAE   68 (111)
T ss_dssp             HHHHHHHHHHTTSCSSCCEEEHHHHHHHHHTTCCCHHHHHHHHHHHCSSCCSEEEHH
T ss_pred             HHHHHHHHHHHHCCCCCCcCcHHHHHHHHHhCCCCHHHHHHHHHHHCCCCCCCCcHH
Confidence            456778899999999999999988876543344455667778889999999999974

>2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A

Probab=87.06  E-value=0.066  Score=41.99  Aligned_cols=57  Identities=12%  Similarity=-0.048  Sum_probs=47.3

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +....+.+.|...+ +.+|.++.+++..........+.+..++....|.|++|.|+|.
T Consensus        48 ~e~~~l~~~F~~fD-d~dG~Is~~El~~~l~~~gl~~~el~~I~~~~D~d~dG~Ld~~  104 (139)
T 2jq6_A           48 KDKPTYDEIFYTLS-PVNGKITGANAKKEMVKSKLPNTVLGKIWKLADVDKDGLLDDE  104 (139)
T ss_dssp             GTHHHHHHHHHHSC-CSSSEEEHHHHHHHHHHTTCCHHHHHHHHHHHCSSCCSEEEHH
T ss_pred             HHHHHHHHHHHHhC-CCCCeECHHHHHHHHHHhCcCHHHHHHHHHHhCCCCCCcCcHH
Confidence            45788999999999 9999999988876654445566778888999999999999984

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.74  E-value=0.087  Score=50.23  Aligned_cols=62  Identities=6%  Similarity=0.013  Sum_probs=19.5

Q ss_pred             ceecccccCCCeEEEEEEEccCCcEEEE------EEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe
Q 017860           26 DFVRDIGSGNFGVARLMRDKVTKELVAV------KYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT   90 (365)
Q Consensus        26 ~~~~~LG~G~~g~V~~~~~~~~~~~vai------K~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~   90 (365)
                      .+.++||   ||.||++........||+      |....+..   ....+.+|..+++.++|||+++.+.+...
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            4567777   999999988765568888      66543221   12356778888889999999999887653

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=86.61  E-value=0.36  Score=39.17  Aligned_cols=56  Identities=18%  Similarity=0.061  Sum_probs=43.9

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ..+.+...|...+....|.++.+++....  ......+.+.++...+.| |++|.|+|.
T Consensus        82 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~d-d~dG~I~~~  139 (176)
T 2lhi_A           82 SEQELLEAFKVFDKNGDGLISAAELKHVLTSIGEKLTDAEVDDMLREVS-DGSGEINIQ  139 (176)
T ss_dssp             HHHHHHHHHHHHCSSCSSSBCHHHHHHHHHTTTCCCCHHHHHHHHHHHH-TTSSCBCTT
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHHHHcCcccchHHHHHHHHhhc-CCCCeEeHH
Confidence            34678889999999999999999886643  233345666777888888 999999984

>3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A

Probab=85.52  E-value=0.22  Score=36.50  Aligned_cols=58  Identities=12%  Similarity=0.077  Sum_probs=43.0

Q ss_pred             CCHHHHHHHHHHhCCCC---CCCCCcccccccC-------CCCCCccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASIPA---VGTHGLNCYMTDN-------LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~~~---~g~~~~~~~~~~~-------~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+..+...|...+...   +|+++.+++..-.       .....++.+.++...+.|.|++|.|+|.
T Consensus         8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~~l~~~~~~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~   75 (100)
T 3nxa_A            8 KAVIVLVENFYKYVSKYSLVKNKISKSSFREMLQKELNHMLSDTGNRKAADKLIQNLDANHDGRISFD   75 (100)
T ss_dssp             HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHHHHHHHSTTTTCSSHHHHHHHHHHHHSCCCSSCCBCHH
T ss_pred             HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHHHHHHHccccccccccHHHHHHHHHHhCCCCCCCCcHH
Confidence            35677888999998864   6999998886532       1112235567888999999999999983

>2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens}

Probab=85.30  E-value=0.099  Score=37.31  Aligned_cols=57  Identities=14%  Similarity=0.159  Sum_probs=44.0

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ..+.+...|...+...+|.++.+++..........+.+..+.....|.|++|.|+|.
T Consensus        25 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~~~~~~~~D~d~dg~I~~~   81 (91)
T 2pmy_A           25 ELARLRSVFAACDANRSGRLEREEFRALCTELRVRPADAEAVFQRLDADRDGAITFQ   81 (91)
T ss_dssp             HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHTTCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHcCcCHHHHHHHHHHhCCCCCCCEeHH
Confidence            456788899999999999999988865432222345566778888999999999873

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=85.11  E-value=0.049  Score=39.21  Aligned_cols=56  Identities=7%  Similarity=-0.144  Sum_probs=41.7

Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          309 VDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       309 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ...+.+.|...+...+|.++.+++..........+.+..+.....|.|++|.|+|.
T Consensus         8 ~~~~~~~F~~~D~d~dG~I~~~el~~~l~~~g~~~~~~~~i~~~~D~d~dG~i~~~   63 (92)
T 1fi6_A            8 RQYYVNQFKTIQPDLNGFIPGSAAKEFFTKSKLPILELSHIWELSDFDKDGALTLD   63 (92)
T ss_dssp             HHHHHHHHTTTCCSTTCEEEHHHHHHHHHHHSSCHHHHHHHHHHHCTTCSSEEEHH
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHcCCCHHHHHHHHHHHCCCCCCCCCHH
Confidence            45677888888999999998887765432223345566778888999999999984

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens}

Probab=84.42  E-value=0.18  Score=33.57  Aligned_cols=57  Identities=11%  Similarity=0.043  Sum_probs=42.6

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCC--CCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLD--MDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~--~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ..+.+...|...+...+|.++.+++......  ....+.+........|.|++|.|+|.
T Consensus         4 ~~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~d~~~~g~i~~~   62 (71)
T 2b1u_A            4 GLEDLQVAFRAFDQDGDGHITVDELRRAMAGLGQPLPQEELDAMIREADVDQDGRVNYE   62 (71)
T ss_dssp             THHHHHHHHTTSCCSSSSEEEHHHHHHHGGGTTCSSCHHHHHHHHHHCCSSSSSEEETT
T ss_pred             cHHHHHHHHHHHCCCCCCcCcHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcCcHH
Confidence            4567788888889999999998877654322  23445566677888999999999984

>2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A

Probab=84.28  E-value=0.29  Score=36.24  Aligned_cols=57  Identities=11%  Similarity=0.114  Sum_probs=41.2

Q ss_pred             CHHHHHHHHHHhC-CCCC-CCCCcccccccC----CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEAS-IPAV-GTHGLNCYMTDN----LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~-~~~~-g~~~~~~~~~~~----~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .++.+.+.|...+ ...+ |.++.+++....    ......+.+.++...+.|.|++|.|+|.
T Consensus        20 ~~~~l~~aF~~fD~~dg~~G~Is~~EL~~~l~~~lg~~~~~~~ev~~li~~~D~d~dG~Idf~   82 (106)
T 2h2k_A           20 SIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFN   82 (106)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTEECHHHHHHHHHHHCTTTTTTCCCHHHHHHHHCTTCSSSEEHH
T ss_pred             HHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHHcCcCCCCHHHHHHHHHHHCCCCCCCCcHH
Confidence            3567888899988 6765 789998876543    1111123567788999999999999983

>3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens}

Probab=83.95  E-value=0.12  Score=38.35  Aligned_cols=57  Identities=14%  Similarity=0.039  Sum_probs=41.2

Q ss_pred             CHHHHHHHHHHhC-CCCC-CCCCcccccccCC-------CCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEAS-IPAV-GTHGLNCYMTDNL-------DMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~-~~~~-g~~~~~~~~~~~~-------~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+...|...+ ...+ |+++.+++..-..       .....+.+.++...+.|.|++|.|+|.
T Consensus        11 ~~~~l~~aF~~fD~~dgd~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~dgDG~Idf~   76 (104)
T 3zwh_A           11 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSWLGKRTDEAAFQKLMSNLDSNRDNEVDFQ   76 (104)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGSCSSCCHHHHHHHHHHHCTTCSSSBCHH
T ss_pred             HHHHHHHHHHHHhccCCCCCeECHHHHHHHHHHHcchhccCCCCHHHHHHHHHHHcCCCCCCCcHH
Confidence            4567778888876 4553 7899988865321       122356677888999999999999984

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A

Probab=83.68  E-value=0.18  Score=34.95  Aligned_cols=56  Identities=14%  Similarity=-0.064  Sum_probs=41.3

Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccccccC--CC--CCCccccccc----cccccCCCCCCceeec
Q 017860          309 VDVIMQIIAEASIPAVGTHGLNCYMTDN--LD--MDDDDMDDLD----SESELDIDSSGEIIYA  364 (365)
Q Consensus       309 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~--~~~~d~d~~~----~~~~~~~~~~g~i~~~  364 (365)
                      .+.+...|...+...+|.++.+++....  ..  ....+.+...    .....|.|++|.|+|.
T Consensus         6 ~~~l~~~F~~~D~d~~G~i~~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~~D~~~dg~I~~~   69 (83)
T 1yx7_A            6 KAELEAAFKKLDANGDGYVTALELQTFMVTLDAYKALSKDKVKEASAKLIKMADKNSDGKISKE   69 (83)
T ss_dssp             CTHHHHHHHHHSSSCSSSCSHHHHHHHHHHHTTCTTTTTTTTHHHHHHHHTTTCSSSCSCCSHH
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHHHHHccccCCCHHHHHHHHHHHHHHhCCCCCCCCcHH
Confidence            3467788999999999999998775432  11  2334555666    7888999999999873

>3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ...

Probab=83.59  E-value=0.2  Score=35.82  Aligned_cols=56  Identities=14%  Similarity=0.068  Sum_probs=40.6

Q ss_pred             CHHHHHHHHHHhCCCCCC---CCCcccccccC-------CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVG---THGLNCYMTDN-------LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g---~~~~~~~~~~~-------~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ++..+...|...+ ..+|   .++.+++....       ......+.+..+...+.|.|++|.|+|.
T Consensus         7 ~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~~l~~~~~~~lg~~~~~~~v~~~~~~~D~d~dG~I~f~   72 (92)
T 3rm1_A            7 AVVALIDVFHQYS-GREGDKHKLKKSELKELINNELSHFLEEIKEQEVVDKVMETLDSNGDGECDFQ   72 (92)
T ss_dssp             HHHHHHHHHHHHH-TSSSSTTSBCHHHHHHHHHHHCTTTSCCCCSHHHHHHHHHHHCTTSSSSBCHH
T ss_pred             HHHHHHHHHHHHc-cCCCCcCeECHHHHHHHHHHHhhhhccCcccHHHHHHHHHHHcCCCCCCCcHH
Confidence            4567778888887 6655   88888775432       2233456677788899999999999984

>4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A*

Probab=82.88  E-value=0.12  Score=37.32  Aligned_cols=57  Identities=14%  Similarity=0.046  Sum_probs=40.2

Q ss_pred             CHHHHHHHHHHhC-CCC-CCCCCcccccccCC-------CCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEAS-IPA-VGTHGLNCYMTDNL-------DMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~-~~~-~g~~~~~~~~~~~~-------~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+...|...+ ... .|+++.+++..-..       .....+.+.++...+.|.|++|.|+|.
T Consensus         8 ~~~~l~~~F~~fd~~dg~~G~Is~~EL~~~l~~~lg~~l~~~~~~~ev~~~i~~~D~d~DG~Idf~   73 (93)
T 4eto_A            8 ALDVMVSTFHKYSGKEGDKFKLNKSELKELLTRELPSFLGKRTDEAAFQKLMSNLDSNRDNEVDFQ   73 (93)
T ss_dssp             HHHHHHHHHHHHHTSSSSTTSBCHHHHHHHHHHHCGGGC---CCHHHHHHHHHHHCTTSSSSBCHH
T ss_pred             HHHHHHHHHHHHcccCCCCCeECHHHHHHHHHHHhhhhccCCCCHHHHHHHHHHHCCCCCCCCcHH
Confidence            4567778888886 455 37899988855321       112345677888999999999999984

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.84  E-value=4.2  Score=34.17  Aligned_cols=83  Identities=14%  Similarity=0.059  Sum_probs=58.7

Q ss_pred             CCCCCcceeceEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHcCCeecCCCCCcEEecC
Q 017860           76 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS-YCHAMQVCHRDLKLENTLLDG  154 (365)
Q Consensus        76 l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~-~LH~~~ivHrDlkp~NIli~~  154 (365)
                      ..||++  -..+-.+++.+.+.++.-+++.=+..+   ..++....++++.+|+.... ++  ..-+|--|.|+||+++.
T Consensus        47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR  119 (219)
T ss_dssp             GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred             ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence            367888  445556777777777765444333344   34688888998888887665 44  44588899999999987


Q ss_pred             CCCCCEEEecCCC
Q 017860          155 SPAPRLKICDFGY  167 (365)
Q Consensus       155 ~~~~~vkl~Dfgl  167 (365)
                      ++.  +++.-.|+
T Consensus       120 ~~~--p~i~hRGi  130 (219)
T 4ano_A          120 ALE--PFFLHVGV  130 (219)
T ss_dssp             TCC--EEESCCEE
T ss_pred             CCc--EEEEEcCC
Confidence            775  89987775

>1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1

Probab=82.74  E-value=0.52  Score=31.87  Aligned_cols=58  Identities=14%  Similarity=-0.011  Sum_probs=42.5

Q ss_pred             CCHHHHHHHHHHhCC-CCCC-CCCcccccccC---CCCCC-ccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASI-PAVG-THGLNCYMTDN---LDMDD-DDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~-~~~g-~~~~~~~~~~~---~~~~~-~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .....+...|...+. ..+| .++.+++....   ..... .+.+..+.....|.|++|.|+|.
T Consensus         4 ~~~~~l~~~F~~~D~~d~~G~~i~~~el~~~l~~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~   67 (78)
T 1cb1_A            4 KSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFE   67 (78)
T ss_dssp             CCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHH
T ss_pred             hHHHHHHHHHHHHhccCCCcCEeCHHHHHHHHHHHhhhhcccHHHHHHHHHHhcCCCCCCCcHH
Confidence            356778889999998 8888 88887765432   11112 45566677888999999999974

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A

Probab=82.54  E-value=0.21  Score=34.34  Aligned_cols=57  Identities=12%  Similarity=0.078  Sum_probs=43.5

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCCcccccccCCCC---CCccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDM---DDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~---~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .....+. .|...+...+|.++.+++.......   ...+.+........|.|++|.|+|.
T Consensus         6 ~~~~~l~-~F~~~D~d~~G~i~~~el~~~l~~~g~~~~~~~~~~~~~~~~D~~~dg~i~~~   65 (81)
T 1c7v_A            6 DEEEILR-AFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIP   65 (81)
T ss_dssp             -CHHHHH-HHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHH
T ss_pred             cHHHHHH-HHHHHCCCCCCcCCHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcCcHH
Confidence            3556778 9999999999999998886654332   2455666677888899999999974

>1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A

Probab=82.51  E-value=0.27  Score=35.47  Aligned_cols=57  Identities=11%  Similarity=0.068  Sum_probs=39.0

Q ss_pred             CHHHHHHHHHHhC-CCC-CCCCCcccccccCC-------CCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEAS-IPA-VGTHGLNCYMTDNL-------DMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~-~~~-~g~~~~~~~~~~~~-------~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .++.+.+.|...+ ... .|.++.+++.....       .....+.+.++...+.|.|++|.|+|.
T Consensus         7 ~~~~l~~~F~~fD~~dgd~G~I~~~El~~~l~~~~~~~lg~~~~~~~v~~l~~~~D~d~dG~I~f~   72 (95)
T 1j55_A            7 AMGMIIDVFSRYSGSEGSTQTLTKGELKVLMEKELPGFLQSGKDKDAVDKLLKDLDANGDAQVDFS   72 (95)
T ss_dssp             HHHHHHHHHHHHTTSSSCTTEECHHHHHHHHHHHSTTCC------CHHHHHHHHHCSSSSSSEEHH
T ss_pred             HHHHHHHHHHHHhccCCCCCcCCHHHHHHHHHHHhHhhcccccCHHHHHHHHHHhCCCCCCcCCHH
Confidence            3567788898988 566 47888887755421       112345567788889999999999984

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=81.91  E-value=0.24  Score=38.71  Aligned_cols=57  Identities=16%  Similarity=0.024  Sum_probs=44.4

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ..+.+...|...+...+|.++.+++....  ......+.+.++...+.|.|++|.|+|.
T Consensus        81 ~~~~l~~aF~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~  139 (148)
T 2lmt_A           81 TEEEMREAFKIFDRDGDGFISPAELRFVMINLGEKVTDEEIDEMIREADFDGDGMINYE  139 (148)
T ss_dssp             THHHHHHHHHHHHSSCSSEECHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSCCSSEEHH
T ss_pred             cHHHHHHHHHHHCCCCcCcCcHHHHHHHHHHcCccccHHHHHHHHHHhCCCCCCeEeHH
Confidence            34678889999999999999998876542  2233455667788899999999999984

>1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A

Probab=81.07  E-value=0.24  Score=36.20  Aligned_cols=56  Identities=9%  Similarity=-0.007  Sum_probs=40.2

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCC-------C--CCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLD-------M--DDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~-------~--~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+.+.|...+.. +|.++.+++......       .  ...+.+.++...+.|.|++|.|+|.
T Consensus         8 ~~~~l~~~F~~fD~~-~g~Is~~El~~~l~~~~~~~lg~~~~~~~~ev~~l~~~~D~d~dG~I~f~   72 (100)
T 1psr_A            8 SIIGMIDMFHKYTRR-DDKIDKPSLLTMMKENFPNFLSACDKKGTNYLADVFEKKDKNEDKKIDFS   72 (100)
T ss_dssp             HHHHHHHHHHHTCCT-TSCBCHHHHHHHHHHHCHHHHHHHHHTTCCGGGTHHHHHCTTCSSCBCHH
T ss_pred             HHHHHHHHHHHHhCC-CCeECHHHHHHHHHHHhHhhhccccccCHHHHHHHHHHhCCCCCCcCcHH
Confidence            356778888888865 688888877654311       1  2345567788899999999999983

>2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus}

Probab=81.03  E-value=0.43  Score=34.19  Aligned_cols=58  Identities=19%  Similarity=0.115  Sum_probs=44.5

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ...+.+...|...+...+|.++.+++....  ......+.+..+.....|.|++|.|+|.
T Consensus        26 ~~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~~g~~~~~~e~~~l~~~~D~d~dG~I~~~   85 (94)
T 2kz2_A           26 DSEEEIREAFRVEDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYE   85 (94)
T ss_dssp             SCHHHHHHHHHHHCTTCCSCBCHHHHHHHHHHHTCCCCHHHHHHHHHHHCTTCSSSBCHH
T ss_pred             CHHHHHHHHHHHHCCCCcCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence            356788899999999999999998876542  1223445566778889999999999974

>2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A

Probab=80.48  E-value=0.2  Score=35.91  Aligned_cols=57  Identities=14%  Similarity=0.043  Sum_probs=42.1

Q ss_pred             CHHHHHHHHHHhC-CCCCC-CCCcccccccCCC---C-CCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEAS-IPAVG-THGLNCYMTDNLD---M-DDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~-~~~~g-~~~~~~~~~~~~~---~-~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+...|...+ ...+| .++.+++......   . ...+.+..+...+.|.|++|.|+|.
T Consensus         8 ~~~~l~~~F~~~D~~d~dG~~I~~~El~~~l~~~~~~~~~~~~~i~~~~~~~D~d~dG~I~f~   70 (92)
T 2kax_A            8 ALTTMVTTFHKYSGREGSKLTLSRKELKELIKKELCLGEMKESSIDDLMKSLDKNSDQEIDFK   70 (92)
T ss_dssp             HHHHHHHHHHHHHTTSSCSSEEEHHHHHHHHHHHSCCTTTCCTTHHHHHHHHTTTCSSEEEHH
T ss_pred             HHHHHHHHHHHHHhhCCCCCeeCHHHHHHHHHHHcCCCCCCHHHHHHHHHHhCCCCCCcCcHH
Confidence            3567788888888 88898 9998877543211   1 1455667788899999999999984

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	365
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-82
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-81
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-80
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-79
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-79
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-78
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-75
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-75
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-74
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-74
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-73
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-73
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	8e-73
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-71
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-69
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-68
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-67
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-66
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-65
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-64
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-62
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-61
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-60
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-60
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-60
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-59
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-59
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-57
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-57
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-57
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-57
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-57
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-57
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-56
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-56
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-55
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-54
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-54
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-53
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-53
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-52
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-48
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-48
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-45
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-44
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-44
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-43
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-41
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-13

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  251 bits (641), Expect = 1e-82
 Identities = 97/269 (36%), Positives = 147/269 (54%), Gaps = 10/269 (3%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           + +D V+ +G G +G  +L  ++VT+E VAVK +  +R     EN+++EI  ++ L H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           +V+F           + +EY SGGELF+RI       E +A+ FF QL++GV Y H + +
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRHEY 197
            HRD+K EN LLD      LKI DFG +     +++ +      GT  Y+APE+L R E+
Sbjct: 125 THRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             +  DVWSCG+ L  ML G  P+   D+P D  +        +  +     I      L
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239

Query: 258 ISRIFVADPAARITIPEIMKHQWFLKNLP 286
           + +I V +P+ARITIP+I K +W+ K L 
Sbjct: 240 LHKILVENPSARITIPDIKKDRWYNKPLK 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  250 bits (640), Expect = 1e-81
 Identities = 79/290 (27%), Positives = 135/290 (46%), Gaps = 11/290 (3%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPNI 81
           D YD + ++GSG FGV     +K T  +   K+I     +D   V+ EI     L HP +
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQV 140
           +   +       + +++E+ SGGELF+RI     + SE E   + +Q   G+ + H   +
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGK 200
            H D+K EN + +   A  +KI DFG +         K T  T  + APE++ R      
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-F 207

Query: 201 IADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLI 258
             D+W+ GV  YV+L G  PF   D+     +T+Q +    +   +     +S E +D I
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDL----ETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263

Query: 259 SRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQS 308
             +   +P  R+T+ + ++H W   +     +  +  SS+Y +  Q ++ 
Sbjct: 264 KNLLQKEPRKRLTVHDALEHPWLKGDHSN--LTSRIPSSRYNKIRQKIKE 311

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  246 bits (630), Expect = 5e-80
 Identities = 87/299 (29%), Positives = 150/299 (50%), Gaps = 10/299 (3%)

Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIIN 72
           +++   H  D YD   ++G+G FGV   + ++ T    A K++    + D E V++EI  
Sbjct: 17  VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQT 76

Query: 73  HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISG 131
              LRHP +V   +       + ++ E+ SGGELFE++ +   + SEDEA  + +Q+  G
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           + + H     H DLK EN +     +  LK+ DFG +         K T GT  + APEV
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 196

Query: 192 LLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP-- 249
                      D+WS GV  Y++L G  PF   ++     +T++ + S  +++ D+    
Sbjct: 197 AEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGEND----DETLRNVKSCDWNMDDSAFSG 251

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQS 308
           IS++ +D I ++ +ADP  R+TI + ++H W      A   D +  SS+Y +    +++
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWL-TPGNAPGRDSQIPSSRYTKIRDSIKT 309

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (620), Expect = 1e-79
 Identities = 87/266 (32%), Positives = 143/266 (53%), Gaps = 14/266 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENV----QREIINHRSLRH 78
           + ++  R +G G FG   L R+K +K ++A+K + +       V    +RE+     LRH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           PNI+R        T + +++EYA  G ++  +    +F E     +  +L + +SYCH+ 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           +V HRD+K EN LL  +    LKI DFG+S  +   S+  +  GT  Y+ PE++    +D
Sbjct: 126 RVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTLCGTLDYLPPEMIEGRMHD 182

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
            K  D+WS GV  Y  LVG  PFE       +++T +RI  V+++ PD   +++  RDLI
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTFPDF--VTEGARDLI 235

Query: 259 SRIFVADPAARITIPEIMKHQWFLKN 284
           SR+   +P+ R  + E+++H W   N
Sbjct: 236 SRLLKHNPSQRPMLREVLEHPWITAN 261

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  243 bits (621), Expect = 4e-79
 Identities = 72/306 (23%), Positives = 134/306 (43%), Gaps = 10/306 (3%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIV 82
           ++Y    D+G G FG+     +  +K+    K+++        V++EI      RH NI+
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 83  RFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
              E   +   L ++ E+ SG ++FERI  +A   +E E   +  Q+   + + H+  + 
Sbjct: 65  HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124

Query: 142 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKI 201
           H D++ EN +     +  +KI +FG ++        +     P Y APEV          
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183

Query: 202 ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRDLIS 259
            D+WS G  +YV+L G  PF         ++ I+ I++ +Y+  +     IS E  D + 
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETN----QQIIENIMNAEYTFDEEAFKEISIEAMDFVD 239

Query: 260 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQIIAEA 319
           R+ V +  +R+T  E ++H W  + +    V  K + +              +  +++ A
Sbjct: 240 RLLVKERKSRMTASEALQHPWLKQKIER--VSTKVIRTLKHRRYYHTLIKKDLNMVVSAA 297

Query: 320 SIPAVG 325
            I   G
Sbjct: 298 RISCGG 303

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  239 bits (611), Expect = 8e-78
 Identities = 94/285 (32%), Positives = 144/285 (50%), Gaps = 10/285 (3%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRSLRHP 79
            D YDF   +G+G F    L  DK T++LVA+K I +   +  + +++ EI     ++HP
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIV   ++  +  HL ++M+  SGGELF+RI   G ++E +A     Q++  V Y H + 
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 140 VCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
           + HRDLK EN L        ++ I DFG SK     S   +  GTP Y+APEVL +  Y 
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--ISQECRD 256
               D WS GV  Y++L G  PF D ++     K  ++IL  +Y         IS   +D
Sbjct: 188 KA-VDCWSIGVIAYILLCGYPPFYDENDA----KLFEQILKAEYEFDSPYWDDISDSAKD 242

Query: 257 LISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEE 301
            I  +   DP  R T  + ++H W   +   D    +++S Q ++
Sbjct: 243 FIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKK 287

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  232 bits (593), Expect = 4e-75
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 17/278 (6%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLR 77
              +  +R+IG G+FG     RD    E+VA+K +    K      +++ +E+   + LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HPN ++++   L      +VMEY  G        +     E E        + G++Y H+
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH-- 195
             + HRD+K  N LL       +K+ DFG +    + +   S VGTP ++APEV+L    
Sbjct: 134 HNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGTPYWMAPEVILAMDE 188

Query: 196 -EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
            +YDGK  DVWS G+T   +     P  + +        +  I   +     +   S+  
Sbjct: 189 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPALQSGHWSEYF 243

Query: 255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
           R+ +       P  R T   ++KH++ L+  P  ++ +
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 6e-75
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 12/275 (4%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
            D ++ + ++G G FG     ++K T  L A K I+   + + E+   EI    S  HPN
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVSYCHAMQ 139
           IV+  +      +L I++E+ +GG +   +    R  +E + +   +Q +  ++Y H  +
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
           + HRDLK  N L        +K+ DFG S  +    Q + + +GTP ++APEV++     
Sbjct: 131 IIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 199 GKI----ADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC 254
            +     ADVWS G+TL  M     P  + +  +   K  +   S   ++   +  S   
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSNF 245

Query: 255 RDLISRIFVADPAARITIPEIMKHQWFLKNLPADL 289
           +D + +    +  AR T  ++++H +   +    +
Sbjct: 246 KDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (589), Expect = 1e-74
 Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 9/279 (3%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID-ENVQREIINHRSLRHPN 80
             +Y     IG G  G      D  T + VA++ +    +   E +  EI+  R  ++PN
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 140
           IV + +  L    L +VMEY +GG L + +       E +     ++ +  + + H+ QV
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137

Query: 141 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYDG 199
            HRD+K +N LL       +K+ DFG+          +ST VGTP ++APEV+ R  Y  
Sbjct: 138 IHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS 259
           K  D+WS G+    M+ G  P+ + +  +               + +   +S   RD ++
Sbjct: 196 K-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TPELQNPEKLSAIFRDFLN 251

Query: 260 RIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQ 298
           R    D   R +  E+++HQ+     P   +     +++
Sbjct: 252 RCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAK 290

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (591), Expect = 2e-74
 Identities = 76/319 (23%), Positives = 133/319 (41%), Gaps = 45/319 (14%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
           D ++ + ++G+GN GV   +  K +  ++A K I  E    I   + RE+        P 
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ- 139
           IV F     +   ++I ME+  GG L + +  AGR  E         +I G++Y      
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           + HRD+K  N L++      +K+CDFG S   ++ S   S VGT +Y++PE L    Y  
Sbjct: 126 IMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGTHYSV 182

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDE--------------------------------- 226
           + +D+WS G++L  M VG YP   PD                                  
Sbjct: 183 Q-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241

Query: 227 -----PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                P    + +  I++       +   S E +D +++  + +PA R  + ++M H + 
Sbjct: 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

Query: 282 LKNLPADLVDEKTMSSQYE 300
            ++   ++     + S   
Sbjct: 302 KRSDAEEVDFAGWLCSTIG 320

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (581), Expect = 2e-73
 Identities = 75/284 (26%), Positives = 128/284 (45%), Gaps = 21/284 (7%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH----RSLRH 78
           + + F + +G G+F    L R+  T    A+K +E+   I EN    +         L H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P  V+          L   + YA  GEL + I   G F E   RF+  +++S + Y H  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---VGTPAYIAPEVLLRH 195
            + HRDLK EN LL+      ++I DFG +K     S+       VGT  Y++PE+L   
Sbjct: 128 GIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
                 +D+W+ G  +Y ++ G  PF   +E        Q+I+ ++Y  P+      + R
Sbjct: 186 SACKS-SDLWALGCIIYQLVAGLPPFRAGNEY----LIFQKIIKLEYDFPEK--FFPKAR 238

Query: 256 DLISRIFVADPAARITIPEIMKHQW-----FLKNLPADLVDEKT 294
           DL+ ++ V D   R+   E+  +       F +++  + + ++T
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  226 bits (578), Expect = 3e-73
 Identities = 83/275 (30%), Positives = 126/275 (45%), Gaps = 20/275 (7%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----------ERGDKIDENVQREIIN 72
           + Y+    +G G   V R    K T +  AVK I          E   ++ E   +E+  
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 73  HRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
            R +  HPNI++ K+   T T   +V +    GELF+ +      SE E R   + L+  
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 191
           +   H + + HRDLK EN LLD      +K+ DFG+S       + +   GTP+Y+APE+
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 192 LLRHEYD-----GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           +     D     GK  D+WS GV +Y +L G  PF    +    R  +    + Q+  P+
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPE 238

Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
            +  S   +DL+SR  V  P  R T  E + H +F
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 8e-73
 Identities = 92/292 (31%), Positives = 150/292 (51%), Gaps = 21/292 (7%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI-------ERGDKIDENVQREIINHR 74
            D YD   ++GSG F V +  R+K T    A K+I        R     E+++RE+   +
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            ++HPN++   EV    T + +++E  +GGELF+ +      +E+EA  F +Q+++GV Y
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128

Query: 135 CHAMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            H++Q+ H DLK EN +L     P PR+KI DFG +      ++ K+  GTP ++APE++
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--I 250
                    AD+WS GV  Y++L G  PF    +     +T+  + +V Y   D      
Sbjct: 189 NYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQ----ETLANVSAVNYEFEDEYFSNT 243

Query: 251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           S   +D I R+ V DP  R+TI + ++H W           ++ +SS +  P
Sbjct: 244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWI-----KPKDTQQALSSAWSHP 290

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (573), Expect = 1e-71
 Identities = 93/307 (30%), Positives = 145/307 (47%), Gaps = 16/307 (5%)

Query: 23  DRYDFVRD-IGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREI-INHRSLRHPN 80
           D Y      +G G  G    + +K T+E  A+K ++   K     +RE+ ++ R+ + P+
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA----RREVELHWRASQCPH 66

Query: 81  IVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSY 134
           IVR  +V          L IVME   GGELF RI + G   F+E EA    + +   + Y
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126

Query: 135 CHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
            H++ + HRD+K EN L     P   LK+ DFG++K +  H+   +   TP Y+APEVL 
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 186

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP--IS 251
             +YD    D+WS GV +Y++L G  PF              RI   QY  P+     +S
Sbjct: 187 PEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDV 311
           +E + LI  +   +P  R+TI E M H W +++         T     E+ ++     + 
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 305

Query: 312 IMQIIAE 318
           +   +A 
Sbjct: 306 MTSALAT 312

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 8e-69
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 23/273 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLRHP 79
           + Y+ +  IG+G++G  + +R K   +++  K ++ G   +   Q    E+   R L+HP
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 80  NIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVS 133
           NIVR+ + I+  T T L IVMEY  GG+L   I    +      E+       QL   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 134 YCH-----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG-TPAYI 187
            CH        V HRDLK  N  LDG     +K+ DFG ++     +        TP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 188 APEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT 247
           +PE + R  Y+ K +D+WS G  LY +     PF    +    ++   +I   ++     
Sbjct: 182 SPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQ----KELAGKIREGKFRRIPY 236

Query: 248 NPISQECRDLISRIFVADPAARITIPEIMKHQW 280
              S E  ++I+R+       R ++ EI+++  
Sbjct: 237 R-YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (544), Expect = 4e-68
 Identities = 63/273 (23%), Positives = 113/273 (41%), Gaps = 16/273 (5%)

Query: 18  IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHR 74
           + +D     F  +IG G+F       D  T   VA   ++         +  + E    +
Sbjct: 4   MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63

Query: 75  SLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS 130
            L+HPNIVRF +   +       + +V E  + G L   +           R + +Q++ 
Sbjct: 64  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 131 GVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 188
           G+ + H     + HRDLK +N  + G P   +KI D G +      S  K+ +GTP ++A
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMA 181

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           PE+    +YD    DV++ G+ +  M    YP+ +           +R+ S         
Sbjct: 182 PEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQI---YRRVTSGVKPASFDK 236

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKHQWF 281
               E +++I      +   R +I +++ H +F
Sbjct: 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-67
 Identities = 83/284 (29%), Positives = 141/284 (49%), Gaps = 17/284 (5%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG-----DKIDENVQREIINHRSLR 77
           + +   + +G G+FG   L   K T +  A+K +++      D ++  +  + +   +  
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           HP +        T  +L  VMEY +GG+L   I +  +F    A F+  ++I G+ + H+
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHE 196
             + +RDLKL+N LLD      +KI DFG  K ++L     +T  GTP YIAPE+LL  +
Sbjct: 122 KGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           Y+    D WS GV LY ML+G  PF   DE     +    I       P    + +E +D
Sbjct: 180 YNHS-VDWWSFGVLLYEMLIGQSPFHGQDEE----ELFHSIRMDNPFYPRW--LEKEAKD 232

Query: 257 LISRIFVADPAARITIP-EIMKHQWFLKNLPADLVDEKTMSSQY 299
           L+ ++FV +P  R+ +  +I +H  F + +  + ++ K +   +
Sbjct: 233 LLVKLFVREPEKRLGVRGDIRQHPLF-REINWEELERKEIDPPF 275

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (531), Expect = 3e-66
 Identities = 78/269 (28%), Positives = 115/269 (42%), Gaps = 24/269 (8%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN-------VQREIINHRS 75
            +Y     +GSG FG             VA+K++E+    D         V  E++  + 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 76  LR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGV 132
           +      ++R  +    P    +++E      +LF+ I   G   E+ AR FF Q++  V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 133 SYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 192
            +CH   V HRD+K EN L+D +    LK+ DFG     +  +      GT  Y  PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWI 181

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
             H Y G+ A VWS G+ LY M+ G  PFE  +E          I+  Q        +S 
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRGQVFFRQ--RVSS 229

Query: 253 ECRDLISRIFVADPAARITIPEIMKHQWF 281
           EC+ LI       P+ R T  EI  H W 
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  208 bits (529), Expect = 9e-65
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 19/289 (6%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-------S 75
           + +   R IG G FG     R   T ++ A+K +++     +  +   +N R       +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
              P IV       TP  L+ +++  +GG+L   +   G FSE + RF+  ++I G+ + 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRH 195
           H   V +RDLK  N LLD      ++I D G +       +P ++VGT  Y+APEVL + 
Sbjct: 124 HNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTHGYMAPEVLQKG 180

Query: 196 EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR 255
                 AD +S G  L+ +L G  PF    + KD  +  +  L++   +PD+   S E R
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVELPDS--FSPELR 237

Query: 256 DLISRIFVADPAARITIP-----EIMKHQWFLKNLPADLVDEKTMSSQY 299
            L+  +   D   R+        E+ +  +F ++L   +V  +      
Sbjct: 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFF-RSLDWQMVFLQKYPPPL 285

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  202 bits (515), Expect = 8e-64
 Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 13/271 (4%)

Query: 20  HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI----ERGDKIDENVQREIINHRS 75
           H SDRY+    +G G      L RD      VAVK +     R        +RE  N  +
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 76  LRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISG 131
           L HP IV   +     T       IVMEY  G  L + +   G  +   A          
Sbjct: 64  LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123

Query: 132 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTPAYIAP 189
           +++ H   + HRD+K  N ++  + A ++         + S    +Q  + +GT  Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
           E       D + +DV+S G  LY +L G  PF          + ++       +  +   
Sbjct: 184 EQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG-- 240

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQW 280
           +S +   ++ +    +P  R      M+   
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  202 bits (514), Expect = 4e-63
 Identities = 82/289 (28%), Positives = 143/289 (49%), Gaps = 21/289 (7%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
             +  +R +G+G+FG   L+R +      A+K +++   +     E+   E +    + H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P I+R          + ++M+Y  GGELF  +  + RF    A+F+  ++   + Y H+ 
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN LLD +    +KI DFG++K   +     +  GTP YIAPEV+    Y+
Sbjct: 124 DIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
               D WS G+ +Y ML G  PF D +      KT ++IL+ +   P     +++ +DL+
Sbjct: 180 KS-IDWWSFGILIYEMLAGYTPFYDSNT----MKTYEKILNAELRFPPF--FNEDVKDLL 232

Query: 259 SRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQYEEP 302
           SR+   D + R+        ++  H WF K +  + +  + + + YE P
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPWF-KEVVWEKLLSRNIETPYEPP 280

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 4e-62
 Identities = 63/276 (22%), Positives = 110/276 (39%), Gaps = 16/276 (5%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQ---REIINHRSLR 77
              +    + IGSG+FG     +       VAVK +       + +Q    E+   R  R
Sbjct: 6   PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 78  HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCH 136
           H NI+ F     T   LAIV ++  G  L+  +     +F   +     +Q   G+ Y H
Sbjct: 63  HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLL 193
           A  + HRDLK  N  L       +KI DFG +          Q +   G+  ++APEV+ 
Sbjct: 122 AKSIIHRDLKSNNIFLHEDL--TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 194 RHEYD--GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS 251
             + +     +DV++ G+ LY ++ G  P+ + +        + R           +   
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 252 QECRDLISRIFVADPAARITIPEIMKH-QWFLKNLP 286
           +  + L++         R   P+I+   +   ++LP
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-61
 Identities = 81/342 (23%), Positives = 130/342 (38%), Gaps = 41/342 (11%)

Query: 9   TVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQR 68
           T G   D P       Y   + IG+G+FGV    +   + ELVA+K +    +      R
Sbjct: 9   TPGQGPDRP---QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR 62

Query: 69  EIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFERICNAGRFSED 119
           E+   R L H NIVR +    +        +L +V++Y                      
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122

Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
             + +  QL   ++Y H+  +CHRD+K +N LLD   A   K+CDFG +K  V      S
Sbjct: 123 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAKQLVRGEPNVS 181

Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
            + +  Y APE++          DVWS G  L  +L+G   F          + I+ + +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 240 -------------VQYSVPDTNP----------ISQECRDLISRIFVADPAARITIPEIM 276
                         ++  P                 E   L SR+    P AR+T  E  
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

Query: 277 KHQWF--LKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 316
            H +F  L++    L + +   + +    Q + S   +  I+
Sbjct: 302 AHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATIL 343

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  195 bits (495), Expect = 3e-60
 Identities = 63/294 (21%), Positives = 123/294 (41%), Gaps = 41/294 (13%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNI 81
           D Y  VR +G G +       +    E V VK ++   K  + ++REI    +LR  PNI
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNI 92

Query: 82  VRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +   +++  P     A+V E+ +  +  +        ++ + RF+  +++  + YCH+M 
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG 149

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDG 199
           + HRD+K  N ++D     +L++ D+G ++      +    V +  +  PE+L+ ++   
Sbjct: 150 IMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208

Query: 200 KIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------------- 242
              D+WS G  L  M+    PF    +  D    I ++L  +                  
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268

Query: 243 ---------------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                             + + +S E  D + ++   D  +R+T  E M+H +F
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 4e-60
 Identities = 89/287 (31%), Positives = 145/287 (50%), Gaps = 20/287 (6%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDEN----VQREIINHRSLRH 78
           + +D+++ +G G FG   L+R+K T    A+K + +   I ++       E    ++ RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +   K    T   L  VMEYA+GGELF  +     F+E+ ARF+  +++S + Y H+ 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLRHEY 197
            V +RD+KLEN +LD      +KI DFG  K  +      K+  GTP Y+APEVL  ++Y
Sbjct: 125 DVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
                D W  GV +Y M+ G  PF + D      +  + IL  +   P T  +S E + L
Sbjct: 183 GRA-VDWWGLGVVMYEMMCGRLPFYNQDH----ERLFELILMEEIRFPRT--LSPEAKSL 235

Query: 258 ISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQY 299
           ++ +   DP  R+        E+M+H++F  ++    V +K +   +
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFF-LSINWQDVVQKKLLPPF 281

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 4e-60
 Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 32/286 (11%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERG------DKIDENVQREIINHRSLRHPNIVRF 84
           +G G F      RDK T ++VA+K I+ G      D I+    REI   + L HPNI+  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 85  KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRD 144
            +     +++++V ++           N+   +    + +    + G+ Y H   + HRD
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 125

Query: 145 LKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIAD 203
           LK  N LLD +    LK+ DFG +KS    +      V T  Y APE+L      G   D
Sbjct: 126 LKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVD 183

Query: 204 VWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT---------------- 247
           +W+ G  L  +L+         +     +  + + +                        
Sbjct: 184 MWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243

Query: 248 ------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 287
                 +    +  DLI  +F+ +P ARIT  + +K ++F  N P 
Sbjct: 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF-SNRPG 288

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 2e-59
 Identities = 70/319 (21%), Positives = 119/319 (37%), Gaps = 45/319 (14%)

Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREI 70
           ++ P   +  +Y+ +  IG G FG     R + T + VA+K +      +       REI
Sbjct: 1   VECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60

Query: 71  INHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAGRFSEDEAR 122
              + L+H N+V   E+  T           + +V ++              +F+  E +
Sbjct: 61  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120

Query: 123 FFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQP 177
              Q L++G+ Y H  ++ HRD+K  N L+       LK+ DFG ++      +   ++ 
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNSQPNRY 178

Query: 178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRI 237
            + V T  Y  PE+LL     G   D+W  G  +  M       +   E        Q  
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 238 LSVQYSVPD--------------------------TNPISQECRDLISRIFVADPAARIT 271
            S+   V                                     DLI ++ V DPA RI 
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 272 IPEIMKHQWFLKN-LPADL 289
             + + H +F  + +P+DL
Sbjct: 299 SDDALNHDFFWSDPMPSDL 317

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-59
 Identities = 62/261 (23%), Positives = 101/261 (38%), Gaps = 15/261 (5%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           +      ++ IG G FG   L   +     VAVK I + D   +    E      LRH N
Sbjct: 5   NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI-KNDATAQAFLAEASVMTQLRHSN 61

Query: 81  IVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHA 137
           +V+   VI+     L IV EY + G L + + + GR     D    F   +   + Y   
Sbjct: 62  LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 138 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
               HRDL   N L+        K+ DFG +K     S   +      + APE L   ++
Sbjct: 122 NNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQDTGKLPVKWTAPEALREKKF 177

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K +DVWS G+ L+ +   G         KD    +++     Y +   +       ++
Sbjct: 178 STK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----GYKMDAPDGCPPAVYEV 232

Query: 258 ISRIFVADPAARITIPEIMKH 278
           +   +  D A R +  ++ + 
Sbjct: 233 MKNCWHLDAAMRPSFLQLREQ 253

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-57
 Identities = 78/332 (23%), Positives = 129/332 (38%), Gaps = 41/332 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI--ERGDKIDENVQREIINHRSLRHPN 80
            RY  +  IG G +G+     D V K  VA+K I         +   REI      RH N
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67

Query: 81  IVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 136
           I+   ++I  PT        ++ +  G +L++ +      S D   +F  Q++ G+ Y H
Sbjct: 68  IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKYIH 126

Query: 137 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPEVL 192
           +  V HRDLK  N LL+ +    LKICDFG ++               V T  Y APE++
Sbjct: 127 SANVLHRDLKPSNLLLNTTC--DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ----------------R 236
           L  +   K  D+WS G  L  ML     F            +                 +
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 237 ILSVQYSVPDTNP---------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA 287
             +   S+P  N             +  DL+ ++   +P  RI + + + H +  +    
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY--Y 302

Query: 288 DLVDEKTMSSQYE-EPDQPMQSVDVIMQIIAE 318
           D  DE    + ++ + +      + + ++I E
Sbjct: 303 DPSDEPIAEAPFKFDMELDDLPKEKLKELIFE 334

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 1e-57
 Identities = 55/261 (21%), Positives = 108/261 (41%), Gaps = 11/261 (4%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D     F++++G+G FGV +  + +  +  VA+K I+ G   ++    E     +L H  
Sbjct: 2   DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V      + I+ EY + G L   +     RF   +     + +   + Y  + Q
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHEY 197
             HRDL   N L++      +K+ DFG S+  +      S        +  PEVL+  ++
Sbjct: 121 FLHRDLAARNCLVNDQ--GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K +D+W+ GV ++ +   G     P E     +T + I      +   +  S++   +
Sbjct: 179 SSK-SDIWAFGVLMWEIYSLGKM---PYERFTNSETAEHIAQG-LRLYRPHLASEKVYTI 233

Query: 258 ISRIFVADPAARITIPEIMKH 278
           +   +      R T   ++ +
Sbjct: 234 MYSCWHEKADERPTFKILLSN 254

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  188 bits (478), Expect = 2e-57
 Identities = 75/286 (26%), Positives = 142/286 (49%), Gaps = 21/286 (7%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRH 78
           D++D ++ +G+G+FG   L++ K +    A+K +++   +     E+   E    +++  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 79  PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           P +V+ +      ++L +VMEY +GGE+F  +   GRFSE  ARF+  Q++    Y H++
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYD 198
            + +RDLK EN L+D      +++ DFG++K      +  +  GTP  +APE++L   Y+
Sbjct: 161 DLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYN 216

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI 258
               D W+ GV +Y M  G  PF          +  ++I+S +   P     S + +DL+
Sbjct: 217 KA-VDWWALGVLIYEMAAGYPPFFADQP----IQIYEKIVSGKVRFPS--HFSSDLKDLL 269

Query: 259 SRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQY 299
             +   D   R       + +I  H+WF        + ++ + + +
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWF-ATTDWIAIYQRKVEAPF 314

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 2e-57
 Identities = 78/330 (23%), Positives = 136/330 (41%), Gaps = 42/330 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
             Y  ++ +GSG +G      D  T   VA+K + R    +   +   RE+   + +RH 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 80  NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           N++   +V          T   +VM +   G    ++    +  ED  +F   Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           Y HA  + HRDLK  N  ++      LKI DFG ++     S+    V T  Y APEV+L
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ--ADSEMTGYVVTRWYRAPEVIL 191

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE--------------PKDFRKTIQRILS 239
                 +  D+WS G  +  M+ G   F+  D               P +F + +Q   +
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251

Query: 240 VQY--SVPDTNP---------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
             Y   +P+             S    +L+ ++ V D   R+T  E + H +F ++L  D
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-ESLH-D 309

Query: 289 LVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 318
             DE  +    +  D   +++D   ++  +
Sbjct: 310 TEDEPQVQKYDDSFDDVDRTLDEWKRVTYK 339

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 4e-57
 Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 30/287 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
           + +  V  IG G +GV    R+K+T E+VA+K I      + +     REI   + L HP
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 80  NIVRFKEVILTPTHLAIVMEYAS-GGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           NIV+  +VI T   L +V E+     + F              + +  QL+ G+++CH+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEY 197
           +V HRDLK +N L++      +K+ DFG +++  +  +  +  V T  Y APE+LL  +Y
Sbjct: 122 RVLHRDLKPQNLLINTEG--AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQ-------RILSVQYSVPDTNP- 249
                D+WS G     M+     F    E     +  +        +     S+PD  P 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 250 ---------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                          + ++ R L+S++   DP  RI+    + H +F
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-57
 Identities = 60/261 (22%), Positives = 104/261 (39%), Gaps = 11/261 (4%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           D     FV++IGSG FG+  L      K+ VA+K I  G   +E+   E      L HP 
Sbjct: 3   DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK 61

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           +V+   V L    + +V E+   G L +      G F+ +        +  G++Y     
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHEY 197
           V HRDL   N L+  +    +K+ DFG ++      ++    T     + +PEV     Y
Sbjct: 122 VIHRDLAARNCLVGEN--QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 198 DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL 257
             K +DVWS GV ++ +   G    +     +  + I       + +      S     +
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST----GFRLYKPRLASTHVYQI 234

Query: 258 ISRIFVADPAARITIPEIMKH 278
           ++  +   P  R     +++ 
Sbjct: 235 MNHCWKERPEDRPAFSRLLRQ 255

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 9e-57
 Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 30/292 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
            +Y+ +  IG G +G     +++ T E+VA+K +   +  + +  +  REI   + L+H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIVR  +V+ +   L +V E+             G    +  + F  QL+ G+ +CH+  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVLLRHEYD 198
           V HRDLK +N L++ +    LK+ +FG +++  +  +  S  V T  Y  P+VL   +  
Sbjct: 122 VLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL--------SVQYSVPDTNP- 249
               D+WS G     +   G P    ++  D  K I R+L             +PD  P 
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 250 ---------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
                          ++   RDL+  +   +P  RI+  E ++H +F    P
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  183 bits (464), Expect = 4e-56
 Identities = 56/279 (20%), Positives = 112/279 (40%), Gaps = 13/279 (4%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
           +         +G G +G       K     VAVK ++      E   +E    + ++HPN
Sbjct: 15  ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPN 74

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHAM 138
           +V+   V        I+ E+ + G L + +    R   S     +   Q+ S + Y    
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
              HRDL   N L+  +    +K+ DFG S+  +   ++          + APE L  ++
Sbjct: 135 NFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           +  K +DVW+ GV L+ +   G       +     + +++     Y +       ++  +
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----DYRMERPEGCPEKVYE 247

Query: 257 LISRIFVADPAARITIPEIMK--HQWFLKNLPADLVDEK 293
           L+   +  +P+ R +  EI +     F ++  +D V+++
Sbjct: 248 LMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKE 286

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 5e-56
 Identities = 60/272 (22%), Positives = 105/272 (38%), Gaps = 15/272 (5%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
             +       +G G FG   +     T   VA+K ++ G    E   +E    + LRH  
Sbjct: 15  PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK 73

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHAM 138
           +V+   V+ +   + IV EY S G L +  +          +      Q+ SG++Y   M
Sbjct: 74  LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRHE 196
              HRDL+  N L+  +     K+ DFG ++      ++  +       + APE  L   
Sbjct: 133 NYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           +  K +DVWS G+ L  +   G         ++    ++R     Y +P      +   D
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPESLHD 245

Query: 257 LISRIFVADPAARITIPEIMK--HQWFLKNLP 286
           L+ + +  +P  R T   +      +F    P
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  180 bits (457), Expect = 4e-55
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 30/286 (10%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI---ERGDKIDENVQREIINHRSLRHP 79
           ++Y  +  IG G +GV    ++    E  A+K I   +  + I     REI   + L+H 
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60

Query: 80  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 139
           NIV+  +VI T   L +V E+             G      A+ F  QL++G++YCH  +
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 140 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLRHEYD 198
           V HRDLK +N L++      LKI DFG +++  +  +  +  + T  Y AP+VL+  +  
Sbjct: 121 VLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 199 GKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------YSVPDTNP-- 249
               D+WS G     M+ G   F    E     +  + + +           +P  +P  
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 250 --------------ISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                         + +   DL+S++   DP  RIT  + ++H +F
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 7e-55
 Identities = 73/292 (25%), Positives = 135/292 (46%), Gaps = 18/292 (6%)

Query: 23  DRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGD-----KIDENVQREIINHR 74
           + ++ ++ +G+G +G     R +    T +L A+K +++       K  E+ + E     
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 75  SLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
            +R  P +V       T T L ++++Y +GGELF  +    RF+E E + +  +++  + 
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           + H + + +RD+KLEN LLD +    L          +    +     GT  Y+AP+++ 
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 194 RHEY-DGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
             +    K  D WS GV +Y +L G  PF    E     +  +RIL  +   P    +S 
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSA 261

Query: 253 ECRDLISRIFVADPAARI-----TIPEIMKHQWFLKNLPADLVDEKTMSSQY 299
             +DLI R+ + DP  R+        EI +H +F + +  D +  K + + +
Sbjct: 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF-QKINWDDLAAKKVPAPF 312

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-54
 Identities = 61/274 (22%), Positives = 103/274 (37%), Gaps = 17/274 (6%)

Query: 16  MPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKID----ENVQR 68
           +  +        +  +G G+FGV               VAVK ++          ++  R
Sbjct: 1   LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60

Query: 69  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQ 127
           E+    SL H N++R   V+LTP  + +V E A  G L +R+  + G F       +  Q
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 184
           +  G+ Y  + +  HRDL   N LL       +KI DFG  +    +  H   +     P
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSV 244
                   L+       +D W  GVTL+ M   G     P    +  + + +I      +
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE---PWIGLNGSQILHKIDKEGERL 234

Query: 245 PDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
           P      Q+  +++ + +   P  R T   +   
Sbjct: 235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 2e-54
 Identities = 54/267 (20%), Positives = 102/267 (38%), Gaps = 15/267 (5%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN 80
             +    V  +G+G FG   +         VAVK +++G    +    E    + L+H  
Sbjct: 11  PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR 69

Query: 81  IVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGVSYCHAM 138
           +VR   V+ T   + I+ EY   G L + +   +  + + ++      Q+  G+++    
Sbjct: 70  LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128

Query: 139 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRHE 196
              HRDL+  N L+        KI DFG ++    +             + APE +    
Sbjct: 129 NYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 197 YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD 256
           +  K +DVWS G+ L  ++  G          +  + ++R     Y +   +   +E   
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER----GYRMVRPDNCPEELYQ 241

Query: 257 LISRIFVADPAARITIPEIMK--HQWF 281
           L+   +   P  R T   +      +F
Sbjct: 242 LMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 5e-54
 Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 37/293 (12%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYI---ERGDKIDENVQREIINHRSL-- 76
            +Y+ V +IG G +G     RD       VA+K +      + +  +  RE+   R L  
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 77  -RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLI 129
             HPN+VR  +V         T L +V E+       +           +  +    QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 189
            G+ + H+ +V HRDLK +N L+  S   ++K+ DFG ++         S V T  Y AP
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL----------- 238
           EVLL+  Y     D+WS G     M      F    +     K +  I            
Sbjct: 185 EVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 239 ----------SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWF 281
                     S Q        I +  +DL+ +    +PA RI+    + H +F
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-53
 Identities = 62/266 (23%), Positives = 110/266 (41%), Gaps = 16/266 (6%)

Query: 21  DSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERG--DKIDENVQREIINHRS 75
             +R +  R IG G FG       M  +     VA+K  +    D + E   +E +  R 
Sbjct: 5   QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQ 64

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSY 134
             HP+IV+   VI T   + I+ME  + GEL   +              +  QL + ++Y
Sbjct: 65  FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 192
             + +  HRD+   N L+  +    +K+ DFG S+     +  K++       ++APE +
Sbjct: 124 LESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 193 LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ 252
               +    +DVW  GV ++ +L+ G     P +       I RI + +  +P       
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRIENGER-LPMPPNCPP 236

Query: 253 ECRDLISRIFVADPAARITIPEIMKH 278
               L+++ +  DP+ R    E+   
Sbjct: 237 TLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 7e-53
 Identities = 55/292 (18%), Positives = 100/292 (34%), Gaps = 40/292 (13%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKEL-----VAVKYI--ERGDKIDENVQREIINH 73
             +  +F + +GSG FG           +      VAVK +  +      E +  E+   
Sbjct: 35  PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 74  RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---------------------- 110
             L  H NIV           + ++ EY   G+L   +                      
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 111 -CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 169
             +    + ++   F  Q+  G+ +       HRDL   N L+       +KICDFG ++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KVVKICDFGLAR 212

Query: 170 ---SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDE 226
              S   +    +      ++APE L    Y  K +DVWS G+ L+ +   G     P  
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVN---PYP 268

Query: 227 PKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
                    +++   + +      ++E   ++   +  D   R + P +   
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 8e-53
 Identities = 67/330 (20%), Positives = 124/330 (37%), Gaps = 40/330 (12%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID---ENVQREIINHRSLRH 78
            +RY  +  +GSG +G      D  T   VAVK + R  +     +   RE+   + ++H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 79  PNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
            N++   +V      L       ++ +  G      I    + ++D  +F   Q++ G+ 
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           Y H+  + HRDLK  N  ++      LKI DFG ++      +    V T  Y APE++L
Sbjct: 136 YIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMTGYVATRWYRAPEIML 191

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP---- 249
              +  +  D+WS G  +  +L G   F   D     +  ++ + +    +         
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 250 ---------------------ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPAD 288
                                 +    DL+ ++ V D   RIT  + + H +F +    D
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

Query: 289 LVDEKTMSSQYEEPDQPMQSVDVIMQIIAE 318
             DE       +  +     +D    +  +
Sbjct: 312 --DEPVADPYDQSFESRDLLIDEWKSLTYD 339

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  175 bits (443), Expect = 8e-53
 Identities = 60/291 (20%), Positives = 108/291 (37%), Gaps = 22/291 (7%)

Query: 14  MDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINH 73
           M++ +    +RY   R IGSG+FG   L  D    E VA+K +E        +  E   +
Sbjct: 1   MELRV---GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQLHIESKIY 56

Query: 74  RSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV 132
           + ++    I   +       +  +VME             + +FS         Q+IS +
Sbjct: 57  KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116

Query: 133 SYCHAMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK--------SSVLHSQPKSTVGT 183
            Y H+    HRD+K +N L+  G     + I DFG +K          + + + K+  GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 184 PAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS 243
             Y +    L  E   +  D+ S G  L    +G  P++        +K  +RI   + S
Sbjct: 177 ARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMS 234

Query: 244 VPD---TNPISQECRDLISRIFVADPAARIT---IPEIMKHQWFLKNLPAD 288
            P          E    ++         +     + ++ ++ +  +    D
Sbjct: 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  174 bits (441), Expect = 2e-52
 Identities = 57/270 (21%), Positives = 105/270 (38%), Gaps = 19/270 (7%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERG--DKIDENVQREIINHRS 75
           D       + IG+G FG       K+  +    VA+K ++ G  +K   +   E      
Sbjct: 24  DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 83

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSY 134
             HPN++  + V+   T + I+ E+   G L      N G+F+  +     + + +G+ Y
Sbjct: 84  FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPKSTVGTPAYIA 188
              M   HRDL   N L++ +     K+ DFG S+      S   ++          + A
Sbjct: 144 LADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201

Query: 189 PEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN 248
           PE +   ++    +DVWS G+ ++ ++  G         +D    I++     Y +P   
Sbjct: 202 PEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ----DYRLPPPM 256

Query: 249 PISQECRDLISRIFVADPAARITIPEIMKH 278
                   L+   +  D   R    +I+  
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 3e-52
 Identities = 64/274 (23%), Positives = 107/274 (39%), Gaps = 23/274 (8%)

Query: 23  DRYDFV---RDIGSGNFGVARLMRDKVTKE--LVAVKYIERGDKID--ENVQREIINHRS 75
            R + +    ++G GNFG  R    ++ K+   VA+K +++G +    E + RE      
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSY 134
           L +P IVR   V      L +VME A GG L + +                 Q+  G+ Y
Sbjct: 66  LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY 124

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 190
                  HRDL   N LL      +  I DFG SK        ++   +      + APE
Sbjct: 125 LEEKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
            +   ++  + +DVWS GVT++  L  G     P +     + +  I   +  +      
Sbjct: 183 CINFRKFSSR-SDVWSYGVTMWEALSYGQK---PYKKMKGPEVMAFIEQGKR-MECPPEC 237

Query: 251 SQECRDLISRIFVADPAARITIPEI---MKHQWF 281
             E   L+S  ++     R     +   M+  ++
Sbjct: 238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 4e-52
 Identities = 55/280 (19%), Positives = 107/280 (38%), Gaps = 17/280 (6%)

Query: 16  MPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYI------ERGDKIDENVQRE 69
           + I+ +++ +  ++ +GSG FG           E V +             K ++ +  E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 70  IINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 129
                S+ +P++ R   + LT T   I      G  L     +           +  Q+ 
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 130 SGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAY 186
            G++Y    ++ HRDL   N L+       +KI DFG +K   +       +       +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179

Query: 187 IAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD 246
           +A E +L   Y  + +DVWS GVT++ ++  G    D     +    I  IL     +P 
Sbjct: 180 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGERLPQ 234

Query: 247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP 286
               + +   ++ + ++ D  +R    E++     +   P
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 5e-52
 Identities = 58/278 (20%), Positives = 104/278 (37%), Gaps = 22/278 (7%)

Query: 23  DRYDFV---RDIGSGNFGVARL--MRDKVTKELVAVKYIERG---DKIDENVQREIINHR 74
           DR       +++GSGNFG  +    + K   + VAVK ++       + + +  E    +
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQ 63

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 134
            L +P IVR   +    + + +VME A  G L + +       +        Q+  G+ Y
Sbjct: 64  QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 135 CHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVGTPAYIAPE 190
                  HRDL   N LL        KI DFG SK+       +           + APE
Sbjct: 123 LEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI 250
            +  +++  K +DVWS GV ++     G       +  +    +++       +      
Sbjct: 181 CINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK----GERMGCPAGC 235

Query: 251 SQECRDLISRIFVADPAARITIPEI--MKHQWFLKNLP 286
            +E  DL++  +  D   R     +      ++   + 
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 9e-51
 Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 28/279 (10%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGDKID--ENVQREIINHRSL 76
           D +   F   IG GNFG     R K        A+K ++     D   +   E+     L
Sbjct: 8   DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 77  -RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAGRFSED 119
             HPNI+          +L + +EYA  G L + +                  A   S  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 120 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 179
           +   F   +  G+ Y    Q  HRDL   N L+  +     KI DFG S+   ++ +   
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSRGQEVYVKKTM 185

Query: 180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS 239
                 ++A E L    Y    +DVWS GV L+ ++  G          +  + + +   
Sbjct: 186 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--- 241

Query: 240 VQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
             Y +        E  DL+ + +   P  R +  +I+  
Sbjct: 242 -GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 3e-50
 Identities = 57/290 (19%), Positives = 105/290 (36%), Gaps = 22/290 (7%)

Query: 15  DMPIMHDSDRYDFVRDIGSGNFGV---ARLMRDKVTKELVAVKYIERGDKIDE--NVQRE 69
            + I   S    F   IG G+FG      L+ +   K   AVK + R   I E      E
Sbjct: 19  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78

Query: 70  IINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQ 127
            I  +   HPN++    + L +     +V+ Y   G+L           +  +   F  Q
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138

Query: 128 LISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG 182
           +  G+ +  + +  HRDL   N +LD      +K+ DFG ++                  
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKF--TVKVADFGLARDMYDKEFDSVHNKTGAKL 196

Query: 183 TPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY 242
              ++A E L   ++  K +DVWS GV L+ ++  G P        D    + +      
Sbjct: 197 PVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ----GR 251

Query: 243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDE 292
            +           +++ + +      R +  E++     +  + +  + E
Sbjct: 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR---ISAIFSTFIGE 298

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (423), Expect = 7e-50
 Identities = 64/289 (22%), Positives = 109/289 (37%), Gaps = 41/289 (14%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYI--ERGDKIDENVQREIINHRS 75
           +  ++VRDIG G FG     R           +VAVK +  E    +  + QRE      
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 76  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------------------- 115
             +PNIV+   V      + ++ EY + G+L E + +                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 116 ----FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 169
                S  E     +Q+ +G++Y    +  HRDL   N L+  +    +KI DFG S+  
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM--VVKIADFGLSRNI 190

Query: 170 -SSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK 228
            S+  +    +      ++ PE +  + Y  + +DVW+ GV L+ +   G     P    
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQ---PYYGM 246

Query: 229 DFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
              + I  +          N    E  +L+   +   PA R +   I +
Sbjct: 247 AHEEVIYYVRDGNILACPEN-CPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-48
 Identities = 58/286 (20%), Positives = 101/286 (35%), Gaps = 35/286 (12%)

Query: 21  DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKID--ENVQREIINH 73
             +R  F + +G+G FG      A  +        VAVK ++    +   E +  E+   
Sbjct: 21  PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 74  RSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------------------NAG 114
             L  H NIV             ++ EY   G+L   +                   +  
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 174
               ++   F  Q+  G+++  +    HRDL   N LL        KICDFG ++     
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICDFGLARDIKND 198

Query: 175 SQPKST---VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR 231
           S             ++APE +    Y  + +DVWS G+ L+ +   G             
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255

Query: 232 KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK 277
               +++   + +        E  D++   + ADP  R T  +I++
Sbjct: 256 -KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  161 bits (409), Expect = 6e-48
 Identities = 49/270 (18%), Positives = 93/270 (34%), Gaps = 18/270 (6%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNI 81
             Y   R IG G+FGV     + +  + VA+K+  R       ++ E   ++ L     I
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 82  VRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC 141
                      H  +V++               +FS        +Q+++ V   H   + 
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123

Query: 142 HRDLKLENTLLDGSPAP---RLKICDFGYSK--------SSVLHSQPKSTVGTPAYIAPE 190
           +RD+K +N L+    +     + + DFG  K          + + + K+  GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 191 VLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP- 249
             L  E   +  D+ + G      L G  P++      + +K  +RI   + S P     
Sbjct: 184 THLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQK-YERIGEKKQSTPLRELC 241

Query: 250 --ISQECRDLISRIFVADPAARITIPEIMK 277
               +E    +         A      +  
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (412), Expect = 1e-47
 Identities = 71/339 (20%), Positives = 129/339 (38%), Gaps = 51/339 (15%)

Query: 23  DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIER---GDKIDENVQREIINHRSLRHP 79
            RY  ++ IGSG  G+     D V    VA+K + R        +   RE++  + + H 
Sbjct: 17  KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 80  NIVRFKEVILTP------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 133
           NI+    V            + +VME                   +   +   Q++ G+ 
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIK 133

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 193
           + H+  + HRDLK  N ++       LKI DFG ++++         V T  Y APEV+L
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDC--TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191

Query: 194 RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILS-------------- 239
              Y   + D+WS G  +  M+     F   D    + K I+++ +              
Sbjct: 192 GMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 240 ---------VQYSVPDTNP-------------ISQECRDLISRIFVADPAARITIPEIMK 277
                       + P   P              + + RDL+S++ V DPA RI++ + ++
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 278 HQWFLKNLPADLVDEKTMSSQYEEPDQPMQSVDVIMQII 316
           H +         V+        ++ D+   +++   ++I
Sbjct: 311 HPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELI 349

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 61/288 (21%), Positives = 106/288 (36%), Gaps = 21/288 (7%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHR 74
                   + IG+G FG       K +       VA+K ++ G  +K   +   E     
Sbjct: 5   HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMG 64

Query: 75  SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVS 133
              H NI+R + VI     + I+ EY   G L + +    G FS  +     + + +G+ 
Sbjct: 65  QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 134 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAP 189
           Y   M   HRDL   N L++ +     K+ DFG S+                    + AP
Sbjct: 125 YLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 190 EVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP 249
           E +   ++    +DVWS G+ ++ ++  G          +  K I       + +P    
Sbjct: 183 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----GFRLPTPMD 237

Query: 250 ISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPADLVDEKTMSS 297
                  L+ + +  + A R    +I+     L   P  L   KT++ 
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL---KTLAD 282

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 7e-45
 Identities = 53/285 (18%), Positives = 104/285 (36%), Gaps = 32/285 (11%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDKVTKE-------LVAVKYI--ERGDKIDENVQREII 71
             DR    + +G G FG   L       +        VAVK +  +  +K   ++  E+ 
Sbjct: 11  PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 70

Query: 72  NHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------------CNAG 114
             + + +H NI+           L +++EYAS G L E +                    
Sbjct: 71  MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130

Query: 115 RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVL 173
           + S  +      Q+  G+ Y  + +  HRDL   N L+      ++              
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190

Query: 174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT 233
           + +  +      ++APE L    Y  + +DVWS GV L+ +   G         ++  K 
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249

Query: 234 IQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
           ++      + +   +  + E   ++   + A P+ R T  ++++ 
Sbjct: 250 LKE----GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-44
 Identities = 65/294 (22%), Positives = 112/294 (38%), Gaps = 43/294 (14%)

Query: 22  SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNI 81
           +        IG G FG     +     E VAVK     ++     + EI     LRH NI
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59

Query: 82  VRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA 137
           + F         T T L +V +Y   G LF+ + N    + +          SG+++ H 
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHM 118

Query: 138 --------MQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQPKSTVGTP 184
                     + HRDLK +N L+  +      I D G      S +  +   P   VGT 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 185 AYIAPEVL-----LRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR-------- 231
            Y+APEVL     ++H    K AD+++ G+  + +          ++ +           
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236

Query: 232 --KTIQRILSVQYSVPD------TNPISQECRDLISRIFVADPAARITIPEIMK 277
             + +++++  Q   P+      +    +    ++   + A+ AAR+T   I K
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 3e-44
 Identities = 59/286 (20%), Positives = 104/286 (36%), Gaps = 34/286 (11%)

Query: 21  DSDRYDFVRDIGSGNFGV-----ARLMRDKVTKELVAVKYIERGDKIDEN---VQREIIN 72
             DR    + +G G FG      A  +    T   VAVK ++ G    E+   +    I 
Sbjct: 11  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 73  HRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---------------- 115
                H N+V        P   L +++E+   G L   + +                   
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 116 FSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 172
            + +    +  Q+  G+ +  + +  HRDL   N LL       +KICDFG ++      
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKICDFGLARDIYKDP 188

Query: 173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK 232
            + +         ++APE +    Y  + +DVWS GV L+ +   G     P       +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS---PYPGVKIDE 244

Query: 233 TIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
              R L     +   +  + E    +   +  +P+ R T  E+++H
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-43
 Identities = 48/278 (17%), Positives = 104/278 (37%), Gaps = 27/278 (9%)

Query: 21  DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDKIDE--NVQREIINH 73
             ++    R++G G+FG+      K       +  VA+K +     + E      E    
Sbjct: 18  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 74  RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF----------SEDEARF 123
           +     ++VR   V+       ++ME  + G+L   + +              S  +   
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 124 FFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 180
              ++  G++Y +A +  HRDL   N ++       +KI DFG ++    +  + +    
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV 240
           +    +++PE L    +     DVWS GV L+ +         P +     + ++ ++  
Sbjct: 196 LLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSNEQVLRFVMEG 251

Query: 241 QYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH 278
              +   +       +L+   +  +P  R +  EI+  
Sbjct: 252 GL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  145 bits (366), Expect = 6e-41
 Identities = 61/326 (18%), Positives = 110/326 (33%), Gaps = 62/326 (19%)

Query: 24  RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVR 83
           RY  VR +G G+F    L +D V    VA+K +       E  + EI   + +   +  +
Sbjct: 14  RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 84  ---------------FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQ 127
                          F        H+ +V E      L   +            +   +Q
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 128 LISGVSYCHAMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 184
           L+ G+ Y H    + H D+K EN L++   SP   ++I       +        +++ T 
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193

Query: 185 AYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRK--TIQRILSVQY 242
            Y +PEVLL   +    AD+WS    ++ ++ G + FE  +     +    I +I+ +  
Sbjct: 194 EYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 243 SVPD----------------------------------------TNPISQECRDLISRIF 262
            +P                                         +   ++E  D +S + 
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 263 VADPAARITIPEIMKHQWFLKNLPAD 288
             DP  R     ++ H W    L  +
Sbjct: 313 QLDPRKRADAGGLVNHPWLKDTLGME 338

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 66.3 bits (161), Expect = 1e-13
 Identities = 22/155 (14%), Positives = 43/155 (27%), Gaps = 26/155 (16%)

Query: 31  IGSGNFGVARLMRDKVTKELVAVKYIERG-----------DKIDENVQREIINHRSLRHP 79
           +G G          +       VK+ + G           D  D +     I        
Sbjct: 8   MGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 80  NIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 135
            + + + + +   +     A++ME               R   +        ++  V+  
Sbjct: 67  ALQKLQGLAVPKVYAWEGNAVLMEL-------IDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 136 HAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 170
           +   + H DL   N L+       + I DF  S  
Sbjct: 120 YHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	365
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.53
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.2
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.92
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.6
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.31
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.45
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	94.03
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	93.27
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	93.15
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	92.61
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	92.51
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	92.34
d1qx2a_	76	Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}	91.91
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	91.9
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	91.53
d1cb1a_	78	Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}	91.19
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	91.05
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	90.95
d1rroa_	108	Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116	90.48
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	89.97
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	89.93
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	89.84
d1wrka1	82	Troponin C {Human (Homo sapiens), cardiac isoform	89.81
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	89.59
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	89.41
d1rwya_	109	Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}	88.63
d1yuta1	98	Calcyclin (S100) {Human (Homo sapiens), s100a13 [T	87.72
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	87.56
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	87.04
d1a4pa_	92	Calcyclin (S100) {Human (Homo sapiens), P11 s100a1	86.14
d1iq3a_	110	Pob1 {Human (Homo sapiens) [TaxId: 9606]}	84.54
d2sasa_	185	Sarcoplasmic calcium-binding protein {Amphioxus (B	83.2

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-66  Score=467.70  Aligned_cols=260  Identities=36%  Similarity=0.616  Sum_probs=223.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      ++|+++++||+|+||+||+|+++.+|+.||||++....  ...+.+.+|+.+++.++|||||++++++.+++.+|+||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            47999999999999999999999999999999997643  2335688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC---CCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQP  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~---~~~  177 (365)
                      |+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....   ...
T Consensus        85 ~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          85 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECCB
T ss_pred             cCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccccc
Confidence            999999999988888999999999999999999999999999999999999986654  999999999854322   234


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|||||++.+..++++++|||||||++|+|++|+.||.............   .......+.+..+|+++++|
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---KEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH---HTTCTTSTTGGGSCHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH---hcCCCCCCccccCCHHHHHH
Confidence            567899999999999888887777999999999999999999998765543332222   22223334455689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      |.+||+.||.+|||++|+|+||||++.++.
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~~l~k  269 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNKPLKK  269 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCcCCCC
Confidence            999999999999999999999999877653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-65  Score=457.39  Aligned_cols=251  Identities=34%  Similarity=0.636  Sum_probs=222.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||+||+|+++.+++.||+|++.+.    ....+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999998752    234467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |||++|+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+... .....
T Consensus        86 Ey~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~-~~~~~  162 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SSRRT  162 (263)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCC-CCCCE
T ss_pred             eecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecC-CCccc
Confidence            99999999999999889999999999999999999999999999999999999987654  9999999997543 33345


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..+||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+...    ....+....+.+|.  .+|+++++||
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li  235 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRVEFTFPD--FVTEGARDLI  235 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCCT--TSCHHHHHHH
T ss_pred             ccCCCCcccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCc--cCCHHHHHHH
Confidence            6689999999999998888766 999999999999999999998765433    33444455554444  4899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCccccc
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                      .+||+.||.+|||++|+|+||||++
T Consensus       236 ~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         236 SRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999999965

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-64  Score=458.80  Aligned_cols=258  Identities=27%  Similarity=0.453  Sum_probs=223.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|+++++||+|+||+||+|+++.+|+.||||++..... ..+.+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4689999999999999999999999999999999976433 346789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~  179 (365)
                      |+||+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+..... .....
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~--~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG--SVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC--CEEECCCTTCEECCSTTCCBCC
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC--cEeeccchhheeeccccccccc
Confidence            999999988765 4699999999999999999999999999999999999998665  4999999999865433 33456


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLIS  259 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  259 (365)
                      .+||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+..........   ...+..+.+..+|+++++||.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHH
Confidence            689999999999998888766 9999999999999999999988766544433332   223344455668999999999


Q ss_pred             HhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          260 RIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       260 ~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                      +||+.||.+|||++|+|+||||+...|
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~~~~  278 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKIAKP  278 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCCCC
Confidence            999999999999999999999975443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-64  Score=461.72  Aligned_cols=258  Identities=36%  Similarity=0.636  Sum_probs=208.8

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+..  .....+.+|+.+++.++|||||+++++|.+++.+|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            457999999999999999999999999999999997643  233567899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCCCEEEecCCCcccccCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~-~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+||+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+|||+.. +..+++||+|||+|+.........
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~  167 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS  167 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence            9999999999999889999999999999999999999999999999999999964 234569999999998766666667


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--CCCCCCCCCHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--SVPDTNPISQECRD  256 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  256 (365)
                      +.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.......    ..+.....  ..+.+..+|+++++
T Consensus       168 ~~~GT~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         168 TACGTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLF----EQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             -----CTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             eeeeCccccCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHhccCCCCCCccccCCCHHHHH
Confidence            7889999999999998888766 99999999999999999999876654333    33333333  33445678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ||.+||+.||.+|||++|+++||||+..
T Consensus       243 li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-64  Score=463.73  Aligned_cols=260  Identities=28%  Similarity=0.463  Sum_probs=217.9

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ..++|+++++||+|+||+||+|+++.+|+.||+|++....  .....+.+|+.+++.++|||||+++++|.++..+|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3578999999999999999999999999999999997643  23467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      |||+||+|.+++.+.+++++..++.++.||+.||+|||+ +||+||||||+|||++.++.  +||+|||+|+.... ...
T Consensus        84 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~  160 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMA  160 (322)
T ss_dssp             ECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-Ccc
Confidence            999999999999998899999999999999999999997 59999999999999986654  99999999985432 334


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHH--------------------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFR--------------------------  231 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--------------------------  231 (365)
                      .+.+||++|+|||++.+..|+.+ +|||||||++|||++|+.||.+.+......                          
T Consensus       161 ~~~~GT~~Y~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         161 NSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             ---CCSSCCCCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             ccccCCccccCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            56799999999999999888776 999999999999999999998765432110                          


Q ss_pred             ------------HHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          232 ------------KTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       232 ------------~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                  +....+............+|.++++||.+||+.||.+|||++|+|+||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                        01111111111111123468999999999999999999999999999999754

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-63  Score=454.72  Aligned_cols=258  Identities=33%  Similarity=0.613  Sum_probs=226.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+...       ..+.+.+|+.+++.++|||||+++++|.++..+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3689999999999999999999999999999999975321       236789999999999999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--CCEEEecCCCccccc
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSV  172 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~--~~vkl~Dfgla~~~~  172 (365)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  .++||+|||+|+...
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            999999999999999998889999999999999999999999999999999999999976553  359999999998776


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCC
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPI  250 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  250 (365)
                      ......+..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+    ..+.......+  .+..+
T Consensus       169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         169 FGNEFKNIFGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETL----ANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             TSCBCSCCCCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTCCCCCHHHHTTS
T ss_pred             CCccccccCCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHH----HHHHhcCCCCCchhcCCC
Confidence            6666777889999999999988888766 99999999999999999999886654433    33334433333  23458


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |+++++||.+||+.||.+|||++|+|+||||+..
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999999753

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-64  Score=453.84  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=220.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC-cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD-KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .+.|+++++||+|+||+||+|+++.+|+.||+|++.... ...+.+.+|+.+++.++|||||++++++.+++.+|+||||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            467999999999999999999999999999999997643 3346789999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCC
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  178 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~  178 (365)
                      |++|+|.+++.+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+..... ....
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHT
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCccccc
Confidence            999999998765 456999999999999999999999999999999999999987664  999999998743322 2234


Q ss_pred             CCcCCCCCCCchhhc-----ccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHH
Q 017860          179 STVGTPAYIAPEVLL-----RHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQE  253 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~-----~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  253 (365)
                      +.+||+.|+|||++.     +..|+.+ +|||||||++|+|++|+.||.+.+....+.++...   .....+.+..+|++
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k-~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~  244 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSN  244 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTH-HHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChh-hhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHH
Confidence            678999999999984     3345555 99999999999999999999988776655443332   22233444568999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          254 CRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       254 ~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      +++||.+||+.||.+|||++|+|+||||+..
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-63  Score=463.51  Aligned_cols=258  Identities=31%  Similarity=0.567  Sum_probs=225.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++++.||+|+||+||+|+++.+|+.||||++..... ..+.+.+|+.+++.++|||||+++++|.+++.+|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3589999999999999999999999999999999976543 235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      |+||+|.+++.+ .+++++..++.++.||+.||+|||++|||||||||+|||++.+..+.+||+|||+|+.........+
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  184 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV  184 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccce
Confidence            999999999854 5679999999999999999999999999999999999999765556799999999987666666667


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCCHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDL  257 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  257 (365)
                      .+||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..    +....+..+  ....+|+++++|
T Consensus       185 ~~gT~~Y~aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~l  259 (350)
T d1koaa2         185 TTGTAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDF  259 (350)
T ss_dssp             ECSCTTTCCHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCSCCGGGGGCCHHHHHH
T ss_pred             ecCcccccCHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHH
Confidence            889999999999998888755 9999999999999999999987765443333    333333332  234689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |.+||+.||.+|||++|+|+||||+..
T Consensus       260 i~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         260 IRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             HHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.8e-63  Score=462.42  Aligned_cols=258  Identities=28%  Similarity=0.509  Sum_probs=226.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+|+.+++.++|||||+++++|.++..+|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3579999999999999999999999999999999986543 235678999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      |+||+|.+.+... .++++.+++.++.||+.||+|||++||+||||||+|||++....+++||+|||+|+..........
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~  187 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  187 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceee
Confidence            9999999887654 469999999999999999999999999999999999999865566799999999987766666667


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCC--CCCCCCHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVP--DTNPISQECRDL  257 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  257 (365)
                      ..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.    .+....+..+  .+..+|+++++|
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~l  262 (352)
T d1koba_         188 TTATAEFAAPEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQ----NVKRCDWEFDEDAFSSVSPEAKDF  262 (352)
T ss_dssp             ECSSGGGCCHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred             ccCcccccCHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCcccccCCCHHHHHH
Confidence            789999999999988888766 999999999999999999998876654433    3333333333  345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          258 ISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      |.+||+.||.+|||++|+|+||||+..
T Consensus       263 i~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         263 IKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             HHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            999999999999999999999999764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-63  Score=450.29  Aligned_cols=252  Identities=30%  Similarity=0.520  Sum_probs=218.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999999999999999999753    233467899999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC---C
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---S  175 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~---~  175 (365)
                      |||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||+|+.....   .
T Consensus        88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC------
T ss_pred             EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCccc
Confidence            99999999999999999999999999999999999999999999999999999987664  999999999865332   2


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ...+.+||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+...    ....+....+.+|  ..+|++++
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~  238 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYL----IFQKIIKLEYDFP--EKFFPKAR  238 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHTTCCCCC--TTCCHHHH
T ss_pred             ccccccCCccccCceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHH----HHHHHHcCCCCCC--ccCCHHHH
Confidence            3345689999999999988888665 999999999999999999998765533    3344455555554  35899999


Q ss_pred             HHHHHhcccCCCCCCCHHH------HhcCccccc
Q 017860          256 DLISRIFVADPAARITIPE------IMKHQWFLK  283 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~e------ll~h~~f~~  283 (365)
                      +||.+||+.||.+|||++|      +++||||..
T Consensus       239 ~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         239 DLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             HHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            9999999999999999987      578999965

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-62  Score=453.96  Aligned_cols=252  Identities=34%  Similarity=0.621  Sum_probs=223.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+|+.++||||++++++|.++..+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            4799999999999999999999999999999999753    223467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  177 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~  177 (365)
                      |||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++  ++||+|||+|+.... ....
T Consensus        85 ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g--~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG--HIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS--CEEECCCTTCBCSCCTTCCB
T ss_pred             eccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC--CEEEeecccccccccCCccc
Confidence            9999999999999999999999999999999999999999999999999999998765  499999999986543 3445


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...+||+.|+|||++.+..|+.+ +|||||||++|||++|++||.+.+...    ....+....+.+|  ..+|+++++|
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~dl  235 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHER----LFELILMEEIRFP--RTLSPEAKSL  235 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred             ccceeCHHHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHH----HHHHHhcCCCCCC--ccCCHHHHHH
Confidence            66789999999999999888766 999999999999999999999876543    3334444555444  4589999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          258 ISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       258 i~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      |.+||++||.+|++     ++|+++||||..
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHhhccCCchhhcccccccHHHHHcCccccc
Confidence            99999999999994     999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-62  Score=450.87  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=219.8

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCccc----HHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +|+++++||+|+||+||+|+++.+|+.||||++.......    +.+.+|+.+++.++|||||+++++|.+++.+|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            5999999999999999999999999999999998654322    457899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  179 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~  179 (365)
                      ||.+|+|..++...+++++.+++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+|+....   ...
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~  170 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANS  170 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCC
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCc
Confidence            9999999888888888999999999999999999999999999999999999987654  99999999985432   345


Q ss_pred             CcCCCCCCCchhhcc---cccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          180 TVGTPAYIAPEVLLR---HEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~---~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      .+||+.|||||++.+   +.|+.+ +|||||||++|||++|..||.+.+....+.+    +............+|+++++
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~-~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~s~~~~~  245 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRN  245 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCTTSCHHHHH
T ss_pred             cccCccccCHHHHhccCCCCcCch-hhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCCCCCCCHHHHH
Confidence            789999999999864   346555 9999999999999999999988765444333    33333333344568999999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          257 LISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                      ||.+||+.||.+|||++|+|+||||.+..++
T Consensus       246 li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence            9999999999999999999999999876544

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-62  Score=441.12  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=213.9

Q ss_pred             CCCc-ceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEe----CCE
Q 017860           22 SDRY-DFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILT----PTH   93 (365)
Q Consensus        22 ~~~y-~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~   93 (365)
                      ..|| ++.++||+|+||+||+|+++.+++.||+|.+.....   ..+.+.+|+.++++++|||||+++++|..    +..
T Consensus         7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            4466 677899999999999999999999999999876432   23568899999999999999999999875    456


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~--ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      +|+|||||++|+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++.. .+.+||+|||+|+..
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~-~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESST-TSCEEECCTTGGGGC
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCC-CCCEEEeecCcceec
Confidence            8999999999999999999889999999999999999999999999  9999999999999642 235999999999753


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      . .....+.+||+.|||||++.+ .++.+ +|||||||++|+|++|+.||........+.+.+   .........+...+
T Consensus       166 ~-~~~~~~~~GT~~Y~aPE~~~~-~~~~~-~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i---~~~~~~~~~~~~~~  239 (270)
T d1t4ha_         166 R-ASFAKAVIGTPEFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKPASFDKVAI  239 (270)
T ss_dssp             C-TTSBEESCSSCCCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHH---TTTCCCGGGGGCCC
T ss_pred             c-CCccCCcccCccccCHHHhCC-CCCCc-CchhhHHHHHHHHHHCCCCCCCcccHHHHHHHH---HcCCCCcccCccCC
Confidence            2 333456789999999999865 56655 999999999999999999998776655443333   22222222234578


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFL  282 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~  282 (365)
                      +++.+||.+||+.||++|||++|+|+||||+
T Consensus       240 ~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         240 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            9999999999999999999999999999995

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-63  Score=457.23  Aligned_cols=259  Identities=25%  Similarity=0.476  Sum_probs=228.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.........+.+|+.+|+.++|||||+++++|.+++.+|+|||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            46899999999999999999999999999999999876655567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCCCC
Q 017860          102 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  180 (365)
Q Consensus       102 ~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~~~  180 (365)
                      +||+|.+++...+ ++++.+++.++.||+.||+|||++||+||||||+|||++.++...+||+|||+++...........
T Consensus        84 ~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~  163 (321)
T d1tkia_          84 SGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL  163 (321)
T ss_dssp             CCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccccc
Confidence            9999999998655 799999999999999999999999999999999999998776667999999999876555555667


Q ss_pred             cCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC--CCCCCHHHHHHH
Q 017860          181 VGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD--TNPISQECRDLI  258 (365)
Q Consensus       181 ~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li  258 (365)
                      .||+.|+|||.+.+..++.+ +|||||||++|+|++|..||...+....+    ..+....+.++.  +..+|+++++||
T Consensus       164 ~~t~~y~ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~~li  238 (321)
T d1tkia_         164 FTAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQII----ENIMNAEYTFDEEAFKEISIEAMDFV  238 (321)
T ss_dssp             ESCGGGSCHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred             ccccccccchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHH----HHHHhCCCCCChhhccCCCHHHHHHH
Confidence            89999999999988888765 99999999999999999999887664433    333444443332  345899999999


Q ss_pred             HHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          259 SRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      .+||+.||.+|||++|+|+||||++..
T Consensus       239 ~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         239 DRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHccCChhHCcCHHHHhcCHhhccCc
Confidence            999999999999999999999997653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-62  Score=441.71  Aligned_cols=252  Identities=31%  Similarity=0.499  Sum_probs=203.9

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEe--CCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT--PTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~l   96 (365)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++......   .+.+.+|+.+++.++|||||++++++.+  +..+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            36899999999999999999999999999999999765432   2568899999999999999999999965  456899


Q ss_pred             EEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           97 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHAMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~----~~~l~~~~~~~i~~qil~al~~LH~~~-----ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                      |||||++|+|.+++.+    .+.+++..++.++.||+.||+|||++|     |+||||||+|||++.++.  +||+|||+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~  160 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGL  160 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccc
Confidence            9999999999998864    457999999999999999999999977     999999999999987654  99999999


Q ss_pred             cccccCC-CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCC
Q 017860          168 SKSSVLH-SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPD  246 (365)
Q Consensus       168 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  246 (365)
                      |+..... ......+||+.|||||++.+..|+.+ +|||||||++|||++|+.||.+.+...    ....+....+. +.
T Consensus       161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~----~~~~i~~~~~~-~~  234 (269)
T d2java1         161 ARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKE----LAGKIREGKFR-RI  234 (269)
T ss_dssp             HHHC-----------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHTCCC-CC
T ss_pred             eeecccCCCccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHH----HHHHHHcCCCC-CC
Confidence            9865433 23456789999999999988888755 999999999999999999998765533    22333333332 23


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +..+|+++.+||.+||+.||.+|||++|+|+|||+
T Consensus       235 ~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         235 PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            34689999999999999999999999999999995

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-61  Score=436.28  Aligned_cols=256  Identities=32%  Similarity=0.507  Sum_probs=222.4

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----------cHHHHHHHHHHhcCC-CCCcceeceEEEe
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----------DENVQREIINHRSLR-HPNIVRFKEVILT   90 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~e~~~l~~l~-hpnIv~l~~~~~~   90 (365)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+....          .+.+.+|+.++++++ ||||++++++|.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36899999999999999999999999999999999764321          235778999999997 9999999999999


Q ss_pred             CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           91 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      ++.+|+|||||++|+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++.
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~  159 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQ  159 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeE
Confidence            9999999999999999999999899999999999999999999999999999999999999976654  99999999987


Q ss_pred             ccCCCCCCCCcCCCCCCCchhhccc------ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc--
Q 017860          171 SVLHSQPKSTVGTPAYIAPEVLLRH------EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY--  242 (365)
Q Consensus       171 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--  242 (365)
                      ..........+||+.|+|||++.+.      .++ .++||||+||++|+|++|+.||.+.+.......    +.....  
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~-~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~----i~~~~~~~  234 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYG-KEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQF  234 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCC
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCC-chheEcccchhhhhhccCCCCCCCCCHHHHHHH----HHhCCCCC
Confidence            6666666778899999999998642      233 449999999999999999999998765443333    333333  


Q ss_pred             CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          243 SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       243 ~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ..+....+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus       235 ~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         235 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            334445689999999999999999999999999999999763

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.8e-61  Score=444.18  Aligned_cols=251  Identities=31%  Similarity=0.591  Sum_probs=221.8

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4799999999999999999999999999999999753    233467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      |||.||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...  ....
T Consensus        84 E~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~--~~~~  159 (316)
T d1fota_          84 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVP--DVTY  159 (316)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECS--SCBC
T ss_pred             eecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEec--cccc
Confidence            99999999999999999999999999999999999999999999999999999987654  9999999998643  3345


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      +.+||+.|||||++.+..|+.+ +|||||||++|+|++|+.||.+.+.....    ..+.......|  ..+|++++++|
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~li  232 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAELRFP--PFFNEDVKDLL  232 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHH
T ss_pred             cccCcccccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCC--CCCCHHHHHHH
Confidence            6789999999999988888766 99999999999999999999886654433    33444444444  35899999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          259 SRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       259 ~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .+||+.||.+|+     |++++++||||++-
T Consensus       233 ~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         233 SRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             HHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            999999999996     99999999999763

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-61  Score=446.49  Aligned_cols=251  Identities=30%  Similarity=0.565  Sum_probs=221.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   98 (365)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|+.+++.++|||||+++++|.....+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5899999999999999999999999999999999753    233467889999999999999999999999999999999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCCC
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK  178 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~~  178 (365)
                      ||+.+|+|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++  ++||+|||+|+...  ....
T Consensus       121 e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--~ikL~DFG~a~~~~--~~~~  196 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--YIQVTDFGFAKRVK--GRTW  196 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS--CEEECCCTTCEECS--SCBC
T ss_pred             ccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC--CEEeeeceeeeecc--cccc
Confidence            9999999999999989999999999999999999999999999999999999998665  49999999998653  3345


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      +.+||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.+...    ....+....+..|  ..+|+++.+||
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~i~~~~~~~p--~~~s~~~~~li  269 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQ----IYEKIVSGKVRFP--SHFSSDLKDLL  269 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHCCCCCC--TTCCHHHHHHH
T ss_pred             cccCccccCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHH----HHHHHhcCCCCCC--ccCCHHHHHHH
Confidence            6789999999999998888766 999999999999999999998765533    3333444444443  45899999999


Q ss_pred             HHhcccCCCCCC-----CHHHHhcCcccccC
Q 017860          259 SRIFVADPAARI-----TIPEIMKHQWFLKN  284 (365)
Q Consensus       259 ~~~l~~dp~~R~-----t~~ell~h~~f~~~  284 (365)
                      .+||+.||.+|+     |++++++||||+..
T Consensus       270 ~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             HHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            999999999995     99999999999753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-61  Score=448.11  Aligned_cols=258  Identities=34%  Similarity=0.549  Sum_probs=218.4

Q ss_pred             CCcceec-ccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHh-cCCCCCcceeceEEEe----CCEEEE
Q 017860           23 DRYDFVR-DIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHR-SLRHPNIVRFKEVILT----PTHLAI   96 (365)
Q Consensus        23 ~~y~~~~-~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~-~l~hpnIv~l~~~~~~----~~~~~l   96 (365)
                      ++|++++ .||+|+||+||+|+++.+++.||||+++.    ...+.+|+.++. .++|||||+++++|.+    +..+|+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~i   86 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI   86 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEE
Confidence            5899986 59999999999999999999999999975    356788998864 5689999999999976    467999


Q ss_pred             EEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CCCEEEecCCCcccccC
Q 017860           97 VMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVL  173 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~-~~~vkl~Dfgla~~~~~  173 (365)
                      |||||+||+|.+++.+.  .++++.+++.++.||+.||+|||++||+||||||+|||++... .+++||+|||+|+....
T Consensus        87 vmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~  166 (335)
T d2ozaa1          87 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS  166 (335)
T ss_dssp             EEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCC
T ss_pred             EEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccC
Confidence            99999999999999864  3699999999999999999999999999999999999998643 45799999999987777


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC--CCCC
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT--NPIS  251 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s  251 (365)
                      .......+||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+...........+....+.+|..  ..+|
T Consensus       167 ~~~~~~~~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  245 (335)
T d2ozaa1         167 HNSLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  245 (335)
T ss_dssp             CCCCCCCSCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSC
T ss_pred             CCccccccCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCC
Confidence            777778899999999999988888766 9999999999999999999987765544444444444444444432  3589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +++.+||.+||+.||.+|||+.|+++||||.+..
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            9999999999999999999999999999997654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.8e-61  Score=448.09  Aligned_cols=256  Identities=27%  Similarity=0.405  Sum_probs=216.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC----cccHHH---HHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD----KIDENV---QREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~---~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+..    .....+   .+++.+++.++|||||+++++|.+++.+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            358999999999999999999999999999999997532    112223   3457788888999999999999999999


Q ss_pred             EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           95 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++.  +||+|||+|+.... 
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~-  159 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-  159 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSS-
T ss_pred             EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCC-
Confidence            999999999999999999999999999999999999999999999999999999999986664  99999999985533 


Q ss_pred             CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          175 SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ......+||+.|+|||++.++..+++++|||||||++|+|++|+.||........ .............  .+..+|+++
T Consensus       160 ~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~--~~~~~s~~~  236 (364)
T d1omwa3         160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVE--LPDSFSPEL  236 (364)
T ss_dssp             SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCCC--CCSSSCHHH
T ss_pred             CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCCC--CCCCCCHHH
Confidence            3456678999999999997654434459999999999999999999987654332 2333333333333  344589999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHhcCccccc
Q 017860          255 RDLISRIFVADPAARIT-----IPEIMKHQWFLK  283 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t-----~~ell~h~~f~~  283 (365)
                      ++||.+||+.||.+|||     ++|+++||||+.
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            99999999999999999     799999999975

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-60  Score=436.56  Aligned_cols=252  Identities=33%  Similarity=0.556  Sum_probs=217.7

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC----CcccHHHHHHHHHH-hcCCCCCcceeceEEEeCCEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG----DKIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIV   97 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~~~~~~lv   97 (365)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++.+.    ....+.+.+|..++ +.++|||||++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5899999999999999999999999999999999753    22234556666655 578999999999999999999999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQ  176 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~  176 (365)
                      ||||++|+|..++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+++..... ..
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhccccccc
Confidence            999999999999999999999999999999999999999999999999999999986654  999999999865433 33


Q ss_pred             CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          177 PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       177 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....+||+.|+|||++.+..|+.+ +|||||||++|+|++|+.||.+.+....    ...+....+..|  ..+|+++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~----~~~i~~~~~~~p--~~~s~~~~d  232 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEEL----FHSIRMDNPFYP--RWLEKEAKD  232 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCC--TTSCHHHHH
T ss_pred             ccccCCCCCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCC--ccCCHHHHH
Confidence            445689999999999999888866 9999999999999999999988665433    333334444444  348999999


Q ss_pred             HHHHhcccCCCCCCCHH-HHhcCccccc
Q 017860          257 LISRIFVADPAARITIP-EIMKHQWFLK  283 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~-ell~h~~f~~  283 (365)
                      ||.+||+.||.+|||+. ++++||||++
T Consensus       233 li~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         233 LLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            99999999999999995 8999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-60  Score=434.09  Aligned_cols=256  Identities=26%  Similarity=0.388  Sum_probs=213.7

Q ss_pred             eecccccCCCeEEEEEEEccCCcEEEEEEeecCCc------ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           27 FVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        27 ~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++.||+|+||+||+|+++.+|+.||||++.....      ..+.+.+|+.+++.++|||||+++++|..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            57899999999999999999999999999865322      235688999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCCC
Q 017860          101 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKS  179 (365)
Q Consensus       101 ~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~~  179 (365)
                      +.++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+..... .....
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~  159 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTH  159 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCC
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccc
Confidence            999888877776778999999999999999999999999999999999999986654  999999999765433 33456


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CCC-------------
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SVP-------------  245 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-------------  245 (365)
                      .+||+.|+|||++.+...++.++|||||||++|||++|.+||.+.+....+.++......... .++             
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (299)
T d1ua2a_         160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS  239 (299)
T ss_dssp             SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred             eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence            789999999999977665556699999999999999999999988776666555543322110 000             


Q ss_pred             --C------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          246 --D------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       246 --~------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                        .      ...+|+++++||.+||+.||++|||++|+|+||||++.
T Consensus       240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~  286 (299)
T d1ua2a_         240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  286 (299)
T ss_dssp             CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence              0      12468999999999999999999999999999999754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-59  Score=428.87  Aligned_cols=260  Identities=28%  Similarity=0.452  Sum_probs=216.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|+++++||+|+||+||+|+++.+|+.||||++....   ...+.+.+|+.+++.++|||||+++++|.++..+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999999999999999996532   245788999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC-CCCC
Q 017860          100 YASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQP  177 (365)
Q Consensus       100 ~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~-~~~~  177 (365)
                      |+.++.+...... .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+.... ....
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCT
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccc
Confidence            9976544443333 456999999999999999999999999999999999999986654  99999999975533 3445


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------------  243 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  243 (365)
                      ...+||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+....+.++..........              
T Consensus       160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS  239 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc
Confidence            566899999999999888877777999999999999999999999877666555554432221110              


Q ss_pred             CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          244 VPD---------TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       244 ~~~---------~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .+.         ...+|+++++||.+||+.||.+|||++|+|+||||++-
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence            000         12468999999999999999999999999999999753

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-60  Score=428.51  Aligned_cols=250  Identities=31%  Similarity=0.494  Sum_probs=215.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------ccHHHHHHHHHHhcCC--CCCcceeceEEEeCC
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------IDENVQREIINHRSLR--HPNIVRFKEVILTPT   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~   92 (365)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+...       ....+.+|+.+++.++  |||||+++++|.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            4689999999999999999999999999999999975321       1234678999999886  899999999999999


Q ss_pred             EEEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccc
Q 017860           93 HLAIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS  171 (365)
Q Consensus        93 ~~~lv~e~~~~-g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~  171 (365)
                      .+|+||||+.+ +++.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+..
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALL  161 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEEC
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceec
Confidence            99999999976 68888888888999999999999999999999999999999999999998543 35999999999754


Q ss_pred             cCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          172 VLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      . .....+.+||+.|+|||++.+..++++++|||||||++|+|++|+.||...+          .+......++  ..+|
T Consensus       162 ~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~--~~~s  228 (273)
T d1xwsa_         162 K-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFR--QRVS  228 (273)
T ss_dssp             C-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCS--SCCC
T ss_pred             c-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCC--CCCC
Confidence            3 3344567899999999999888887777899999999999999999997521          1222333333  4589


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          252 QECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                      +++++||.+||+.||.+|||++|+|+||||++..
T Consensus       229 ~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         229 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            9999999999999999999999999999997654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.1e-58  Score=420.77  Aligned_cols=258  Identities=28%  Similarity=0.427  Sum_probs=215.0

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      +||+++++||+|+||+||+|+++ +|+.||||++....   ...+.+.+|+.+++.++||||++++++|..++..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            69999999999999999999996 88999999996542   335789999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC-CCCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~-~~~~  178 (365)
                      ++.++.+..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|...... ....
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccc
Confidence            9998888777777888999999999999999999999999999999999999987655  999999998754332 2345


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccC--------------C
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYS--------------V  244 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------------~  244 (365)
                      ...|++.|+|||++.+..+.+.++|||||||++|||++|+.||.+.+....+.++..........              .
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence            55799999999999877766666999999999999999999998877655555544332211100              0


Q ss_pred             ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          245 ---------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       245 ---------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                               .....+|+++.+||.+||+.||++|||++|+|+||||++
T Consensus       239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                     012346899999999999999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=423.44  Aligned_cols=261  Identities=27%  Similarity=0.379  Sum_probs=214.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccC-CcEEEEEEeecC---CcccHHHHHHHHHHhcC---CCCCcceeceEEEe---
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVT-KELVAVKYIERG---DKIDENVQREIINHRSL---RHPNIVRFKEVILT---   90 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~-~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~---   90 (365)
                      ..++|+++++||+|+||+||+|+++.+ ++.||||++...   ......+.+|+.+++.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            357999999999999999999999765 667999998653   22334566777776655   89999999999863   


Q ss_pred             --CCEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCC
Q 017860           91 --PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGY  167 (365)
Q Consensus        91 --~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgl  167 (365)
                        ...++++|||+.++.+...... ...+++..++.++.|++.||+|||++||+||||||+|||++..+.  +||+|||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~  162 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGL  162 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCS
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhh
Confidence              3578999999998877654443 456999999999999999999999999999999999999986664  99999999


Q ss_pred             cccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-CC--
Q 017860          168 SKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-SV--  244 (365)
Q Consensus       168 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~--  244 (365)
                      ++...........+||+.|+|||++.+..|+.+ +|||||||++|||++|++||.+.+....+.++......... .+  
T Consensus       163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  241 (305)
T d1blxa_         163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR  241 (305)
T ss_dssp             CCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred             hhhhcccccCCCcccChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccc
Confidence            987766666778899999999999998888776 99999999999999999999988776665555443221110 00  


Q ss_pred             ------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          245 ------------------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       245 ------------------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                                        .....+|+.+++||.+||+.||.+|||++|+|+||||++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                              1123478999999999999999999999999999999753

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-58  Score=419.50  Aligned_cols=251  Identities=21%  Similarity=0.300  Sum_probs=216.6

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      .+.++|++.++||+|+||+||+|+++.+|+.||||++..+....+.+.+|+.+++.++|||||+++++|.++..+|+|||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            45578999999999999999999999999999999998776667889999999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC-
Q 017860          100 YASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-  176 (365)
Q Consensus       100 ~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~-  176 (365)
                      ||++|+|.+++.+.  ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+....... 
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCce
Confidence            99999999998764  46899999999999999999999999999999999999987664  99999999986543322 


Q ss_pred             -CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          177 -PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       177 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                       .....||+.|+|||++.+..|+.+ +|||||||++|||++|..||........+.+.+.    .....+.+..+|+++.
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~----~~~~~~~~~~~~~~l~  246 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KDYRMERPEGCPEKVY  246 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----TTCCCCCCTTCCHHHH
T ss_pred             eeccccccccccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh----cCCCCCCCccchHHHH
Confidence             233458999999999988888765 9999999999999998777666555554444333    2334455566899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhc
Q 017860          256 DLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +||.+||+.||.+|||++++++
T Consensus       247 ~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         247 ELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHH
Confidence            9999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-58  Score=420.83  Aligned_cols=268  Identities=25%  Similarity=0.359  Sum_probs=216.0

Q ss_pred             CCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecC---CcccHHHHHHHHHHhcCCCCCcceeceEEEe-
Q 017860           15 DMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERG---DKIDENVQREIINHRSLRHPNIVRFKEVILT-   90 (365)
Q Consensus        15 ~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-   90 (365)
                      ..|...+.+||+++++||+|+||+||+|+++.+|+.||||++...   ......+.+|+.+|+.++||||+++++++.. 
T Consensus         2 ~~~~~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~   81 (318)
T d3blha1           2 ECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   81 (318)
T ss_dssp             CCTTSCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred             CCCCCCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecc
Confidence            445566678999999999999999999999999999999998653   2345678999999999999999999999865 


Q ss_pred             -------CCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEe
Q 017860           91 -------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKIC  163 (365)
Q Consensus        91 -------~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~  163 (365)
                             +..+|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+
T Consensus        82 ~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~  159 (318)
T d3blha1          82 ASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLA  159 (318)
T ss_dssp             ---------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEEC
T ss_pred             cccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEee
Confidence                   3468999999988877766666778999999999999999999999999999999999999987665  9999


Q ss_pred             cCCCcccccC-----CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 017860          164 DFGYSKSSVL-----HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL  238 (365)
Q Consensus       164 Dfgla~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  238 (365)
                      |||+++....     .....+.+||++|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999864332     22334567999999999998765444559999999999999999999988766555444433332


Q ss_pred             ccccCCCCC--------------------------CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          239 SVQYSVPDT--------------------------NPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       239 ~~~~~~~~~--------------------------~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      .........                          ...++++++||.+||+.||++|||++|+|+||||+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            211110000                          0136788999999999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-58  Score=415.31  Aligned_cols=255  Identities=24%  Similarity=0.325  Sum_probs=206.3

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCC---cccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGD---KIDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      |-.+.++|++.++||+|+||+||+|+.+   ..||||++....   ...+.+.+|+.++++++|||||++++++. ...+
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~   78 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL   78 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence            3345679999999999999999999754   359999986532   23367889999999999999999999875 4568


Q ss_pred             EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      ++|||||++|+|.+++... .++++..+..++.||+.||+|||++|||||||||+|||++.++.  +||+|||+|+....
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~  156 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSR  156 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC---
T ss_pred             EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccc
Confidence            9999999999999999764 56999999999999999999999999999999999999987664  99999999975433


Q ss_pred             C---CCCCCCcCCCCCCCchhhccc---ccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          174 H---SQPKSTVGTPAYIAPEVLLRH---EYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       174 ~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      .   ....+..||+.|||||++.+.   .|+ .++|||||||++|||++|+.||.+.+....+...+......+.....+
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~-~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~  235 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYS-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR  235 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSC
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCC-chhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcc
Confidence            2   233456799999999999643   344 449999999999999999999998877666555544422221111234


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                      ..+++++.+|+.+||+.||++|||+++++++-
T Consensus       236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~L  267 (276)
T d1uwha_         236 SNCPKAMKRLMAECLKKKRDERPLFPQILASI  267 (276)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            45789999999999999999999999999873

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-58  Score=413.88  Aligned_cols=262  Identities=20%  Similarity=0.300  Sum_probs=217.4

Q ss_pred             CCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeC
Q 017860           12 PAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTP   91 (365)
Q Consensus        12 ~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~   91 (365)
                      |.....|-.+.++|++.++||+|+||+||+|+++ +++.||||++.......+.+.+|+.++++++|||||++++++.. 
T Consensus         2 p~~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-   79 (272)
T d1qpca_           2 PWWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-   79 (272)
T ss_dssp             CTTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCCCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-
Confidence            5556666667789999999999999999999986 67889999998776667889999999999999999999998754 


Q ss_pred             CEEEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           92 THLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        92 ~~~~lv~e~~~~g~L~~~l~~~--~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +.+|+|||||++|+|.+++...  .++++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+
T Consensus        80 ~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~  157 (272)
T d1qpca_          80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLAR  157 (272)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCE
T ss_pred             CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceE
Confidence            5679999999999999877543  35999999999999999999999999999999999999987664  9999999998


Q ss_pred             cccCCC--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          170 SSVLHS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      ......  ......||+.|+|||++.+..++.+ +|||||||++|||+||..||............+.   . ....+.+
T Consensus       158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~---~-~~~~~~p  232 (272)
T d1qpca_         158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---R-GYRMVRP  232 (272)
T ss_dssp             ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T-TCCCCCC
T ss_pred             EccCCccccccccCCcccccChHHHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h-cCCCCCc
Confidence            654322  2345678999999999988888765 9999999999999996555544444333333322   2 2233445


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHHhc--Ccccc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEIMK--HQWFL  282 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~ell~--h~~f~  282 (365)
                      ..+++++.+|+.+||+.||++|||++++++  |+||.
T Consensus       233 ~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            568999999999999999999999999998  78874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-58  Score=409.92  Aligned_cols=249  Identities=24%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEee
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      +.++|++.++||+|+||+||+|+++ +++.||||++.......+.+.+|+.+++.++|||||++++++..++.+++||||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            3468999999999999999999986 677899999988777778899999999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--C
Q 017860          101 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--P  177 (365)
Q Consensus       101 ~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--~  177 (365)
                      |++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.  +||+|||+++.......  .
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC-------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceee
Confidence            9999999988754 56899999999999999999999999999999999999987665  99999999986543322  2


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhC-CCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHH
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRD  256 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  256 (365)
                      ....||+.|+|||++.+..++.+ +|||||||++|||+|+ .+||...+. ..+.+.+..    ....+.+...++++.+
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~----~~~~~~p~~~~~~l~~  233 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDIST----GFRLYKPRLASTHVYQ  233 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHH----TCCCCCCTTSCHHHHH
T ss_pred             cceecCcccCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCH-HHHHHHHHh----cCCCCCccccCHHHHH
Confidence            34578999999999998888766 9999999999999995 555655443 333333222    2223344557899999


Q ss_pred             HHHHhcccCCCCCCCHHHHhcC
Q 017860          257 LISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       257 li~~~l~~dp~~R~t~~ell~h  278 (365)
                      |+.+||+.||++|||++++++|
T Consensus       234 li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         234 IMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-58  Score=426.64  Aligned_cols=272  Identities=28%  Similarity=0.398  Sum_probs=218.0

Q ss_pred             cccCCCCCCCCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceE
Q 017860            8 LTVGPAMDMPIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEV   87 (365)
Q Consensus         8 ~~~~~~~~~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~   87 (365)
                      |.+.|.+ .|.....-+|+.+++||+|+||+||+|+++.+|+.||||++.+....   ..+|+.+|+.++||||++++++
T Consensus         6 ~~~~~~~-~p~~~~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~niv~~~~~   81 (350)
T d1q5ka_           6 VVATPGQ-GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNIVRLRYF   81 (350)
T ss_dssp             EEEEESS-SSCCCEEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCCCC-CCCCcccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCCCcEEEE
Confidence            3333433 33333333799999999999999999999999999999999875433   3479999999999999999999


Q ss_pred             EEeC------CEEEEEEeecCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           88 ILTP------THLAIVMEYASGGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        88 ~~~~------~~~~lv~e~~~~g~L~~~---l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      |...      .++|+|||||+++.+..+   ......+++.+++.++.||+.||+|||++||+||||||+|||++.++. 
T Consensus        82 ~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-  160 (350)
T d1q5ka_          82 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-  160 (350)
T ss_dssp             EEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-
T ss_pred             EEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-
Confidence            9643      358999999987644333   234567999999999999999999999999999999999999986542 


Q ss_pred             CEEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHh
Q 017860          159 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRIL  238 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  238 (365)
                      .+||+|||+++.........+.+||+.|+|||++.+...++.++|||||||++|||++|+.||...+....+.++.+...
T Consensus       161 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g  240 (350)
T d1q5ka_         161 VLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG  240 (350)
T ss_dssp             CEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred             ceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhC
Confidence            49999999998776667777889999999999987655444559999999999999999999998776655555443221


Q ss_pred             cc-------------ccCCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccC
Q 017860          239 SV-------------QYSVP----------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKN  284 (365)
Q Consensus       239 ~~-------------~~~~~----------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~  284 (365)
                      ..             ....+          ....+|+++.+||.+||+.||.+|||+.|+|+||||.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         241 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            10             00111          123478999999999999999999999999999999764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.1e-58  Score=415.00  Aligned_cols=255  Identities=25%  Similarity=0.360  Sum_probs=206.2

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc----cHHHHHHHHHHhcCCCCCcceeceEEEeCC----E
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI----DENVQREIINHRSLRHPNIVRFKEVILTPT----H   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~   93 (365)
                      .++|++.+.||+|+||+||+|+++.+|+.||||++.+....    ...+.+|+.+++.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            56899999999999999999999999999999999764332    246889999999999999999999998654    4


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +|+|||||+|++|..++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.  ++|+|||.+.....
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC-
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcc
Confidence            8999999999999999999999999999999999999999999999999999999999987665  99999998764332


Q ss_pred             C----CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCC
Q 017860          174 H----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNP  249 (365)
Q Consensus       174 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (365)
                      .    ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.+.+...  ..........
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~~~  240 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPPSARHEG  240 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCGGGTSSS
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC--CCCCchhccC
Confidence            2    23455689999999999988877665 999999999999999999998876655444433321  1111223456


Q ss_pred             CCHHHHHHHHHhcccCCCCCCCHHHHhcCccc
Q 017860          250 ISQECRDLISRIFVADPAARITIPEIMKHQWF  281 (365)
Q Consensus       250 ~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f  281 (365)
                      +|+++.+||.+||+.||.+||+..+.+.|+|.
T Consensus       241 ~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         241 LSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            89999999999999999999954444456664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-57  Score=410.39  Aligned_cols=262  Identities=27%  Similarity=0.461  Sum_probs=221.5

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEe
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   99 (365)
                      ++|+++++||+|+||+||+|+++.+|+.||||+++....   ....+.+|+.+++.++||||++++++|.....+++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            589999999999999999999999999999999975432   34678899999999999999999999999999999999


Q ss_pred             ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-CCC
Q 017860          100 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK  178 (365)
Q Consensus       100 ~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-~~~  178 (365)
                      ++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.  +||+|||.|+...... ...
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccce
Confidence            9999999998888889999999999999999999999999999999999999986654  9999999998654433 334


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc----------------
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY----------------  242 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------  242 (365)
                      ...+++.|+|||++.+..+.+.++|||||||++|+|++|+.||....+..+....+........                
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            4567889999999987776556699999999999999999997766655544444433322211                


Q ss_pred             --------CCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCC
Q 017860          243 --------SVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLP  286 (365)
Q Consensus       243 --------~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~  286 (365)
                              .......+|+.+++||.+||+.||.+|||++|+|+||||++..|
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             ccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                    00112346889999999999999999999999999999986544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-57  Score=420.25  Aligned_cols=258  Identities=26%  Similarity=0.399  Sum_probs=208.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCC------
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPT------   92 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------   92 (365)
                      .++|+++++||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+|+.++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            5699999999999999999999999999999999976432   2356789999999999999999999998664      


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      .+|+||||| +.+|..++ +.+++++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...
T Consensus        97 ~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~  172 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQAD  172 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECC
T ss_pred             eEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccC
Confidence            579999999 55666655 4567999999999999999999999999999999999999987665  9999999998643


Q ss_pred             CCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-----------
Q 017860          173 LHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-----------  241 (365)
Q Consensus       173 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-----------  241 (365)
                        ...+..+||+.|+|||++.+..+.+.++|||||||++|+|++|++||.+.+....+...........           
T Consensus       173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             --CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence              3456778999999999998766656669999999999999999999988766544433332211100           


Q ss_pred             --------cCC------CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          242 --------YSV------PDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       242 --------~~~------~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                              ...      .....+|+++.+||.+||+.||.+|||++|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                    000      11235789999999999999999999999999999998643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.5e-57  Score=419.63  Aligned_cols=257  Identities=24%  Similarity=0.455  Sum_probs=215.5

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-CCCcceeceEEEeC--CEEEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIV   97 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv   97 (365)
                      ..++|+++++||+|+||+||+|+++.+|+.||||+++...  .+.+.+|+.+|+.++ ||||++++++|...  ..+++|
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            4578999999999999999999999999999999987543  467889999999995 99999999999854  569999


Q ss_pred             EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCCC
Q 017860           98 MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP  177 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~~  177 (365)
                      ||||.+++|....   +++++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+........
T Consensus       111 ~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         111 FEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             EECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCC
T ss_pred             EeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcc
Confidence            9999999997653   56999999999999999999999999999999999999985542 4899999999877666667


Q ss_pred             CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc----------------
Q 017860          178 KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ----------------  241 (365)
Q Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~----------------  241 (365)
                      ...+||+.|+|||++.+....+.++|||||||++|+|++|+.||............+.......                
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            7888999999999988766545559999999999999999999987765443322222211100                


Q ss_pred             ----------------cCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCccccc
Q 017860          242 ----------------YSVPDTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLK  283 (365)
Q Consensus       242 ----------------~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~  283 (365)
                                      ...+....+|+++++||++||+.||.+|||++|+|+||||+.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence                            011122347899999999999999999999999999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-57  Score=402.97  Aligned_cols=248  Identities=21%  Similarity=0.380  Sum_probs=215.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeec
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      -++|++.++||+|+||+||+++++ +++.||||.++++....+.+.+|+.+++.++||||+++++++.+++.+++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            368999999999999999999985 7889999999987777789999999999999999999999999999999999999


Q ss_pred             CCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCCC--CC
Q 017860          102 SGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PK  178 (365)
Q Consensus       102 ~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~~--~~  178 (365)
                      ++|+|..++.. ...+++..++.++.|+++||+|||++||+||||||+|||++.++.  +||+|||+++.......  ..
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~  159 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSV  159 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCC
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeec
Confidence            99999998765 456899999999999999999999999999999999999987654  99999999975443332  33


Q ss_pred             CCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHH
Q 017860          179 STVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDL  257 (365)
Q Consensus       179 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  257 (365)
                      ...||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+..+..    ..+.. ....+.+...++++.+|
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~----~~i~~-~~~~~~p~~~~~~l~~l  233 (258)
T d1k2pa_         160 GSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETA----EHIAQ-GLRLYRPHLASEKVYTI  233 (258)
T ss_dssp             CSCCCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHH----HHHHT-TCCCCCCTTCCHHHHHH
T ss_pred             ccCCCCCcCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHH----HHHHh-CCCCCCcccccHHHHHH
Confidence            4678999999999998888765 999999999999998 89999887754322    22222 22344555688999999


Q ss_pred             HHHhcccCCCCCCCHHHHhcC
Q 017860          258 ISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       258 i~~~l~~dp~~R~t~~ell~h  278 (365)
                      |.+||+.||++|||++++++|
T Consensus       234 i~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         234 MYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCCHhHCcCHHHHHHH
Confidence            999999999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=417.74  Aligned_cols=266  Identities=27%  Similarity=0.417  Sum_probs=211.0

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCC----
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPT----   92 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----   92 (365)
                      ...++||+++++||+|+||+||+|+++.+|+.||||++.+...  ..+.+.+|+.+|+.++||||+++++++....    
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            3456799999999999999999999999999999999975432  2356789999999999999999999997653    


Q ss_pred             EEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           93 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      ..+++++++.+|+|.+++.. +++++..++.++.||+.||+|||++|||||||||+|||++.++  .+||+|||+|+...
T Consensus        84 ~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~--~~kl~DfG~a~~~~  160 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLARVAD  160 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--CEEECCCTTCEECC
T ss_pred             ceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC--CEEEcccCceeecc
Confidence            23444456669999999865 4699999999999999999999999999999999999998665  49999999987543


Q ss_pred             CC----CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccc-------
Q 017860          173 LH----SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQ-------  241 (365)
Q Consensus       173 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------  241 (365)
                      ..    ......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+................       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            32    2245567999999999987666556669999999999999999999988765444333322111110       


Q ss_pred             ---------cCCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCCCC
Q 017860          242 ---------YSVP---------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNLPA  287 (365)
Q Consensus       242 ---------~~~~---------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~~~  287 (365)
                               ...+         ....+|+++++||.+||+.||.+|||++|+|+||||.+....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                     0011         123478899999999999999999999999999999866543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-57  Score=418.74  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=211.8

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCc-----EEEEEEeecC--CcccHHHHHHHHHHhcC-CCCCcceeceEEEeCC
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKE-----LVAVKYIERG--DKIDENVQREIINHRSL-RHPNIVRFKEVILTPT   92 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~-----~vaiK~~~~~--~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~   92 (365)
                      +.++|++.++||+|+||+||+|++..+++     .||+|.+...  ......+.+|+.+++++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            45789999999999999999999876554     6999988643  33446789999999988 8999999999999999


Q ss_pred             EEEEEEeecCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 017860           93 HLAIVMEYASGGELFERICNA-----------------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN  149 (365)
Q Consensus        93 ~~~lv~e~~~~g~L~~~l~~~-----------------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~N  149 (365)
                      .+|+|||||++|+|.+++...                       ..+++..++.++.||+.||+|||++|||||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            999999999999999999754                       248999999999999999999999999999999999


Q ss_pred             EEecCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCC
Q 017860          150 TLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPD  225 (365)
Q Consensus       150 Ili~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~  225 (365)
                      ||++.++  ++||+|||+|+.......   ..+..||+.|||||++.+..++.+ +|||||||++|||++ |..||.+.+
T Consensus       195 ill~~~~--~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         195 VLVTHGK--VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             EEEETTT--EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccccCC--eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCC
Confidence            9998765  499999999986544332   234568999999999988888766 999999999999997 899999877


Q ss_pred             ChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          226 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ....+.+.+.    .....+.+..+|+++.+||.+||+.||++|||++|+++|
T Consensus       272 ~~~~~~~~~~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         272 VDANFYKLIQ----NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSHHHHHHHH----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHh----cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6655555443    333445556689999999999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-56  Score=404.52  Aligned_cols=261  Identities=23%  Similarity=0.323  Sum_probs=212.5

Q ss_pred             CCCCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           17 PIMHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        17 ~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .|-.+.++|++.+.||+|+||+||+|+++. ++.||||++.......+.+.+|+.+++.++|||||++++++.. +.+++
T Consensus        11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l   88 (285)
T d1fmka3          11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI   88 (285)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence            344556899999999999999999999974 4679999998776666889999999999999999999999854 56789


Q ss_pred             EEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           97 VMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~--~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      |||||++|+|..++..  .+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.  +||+|||+|+.....
T Consensus        89 v~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~  166 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDN  166 (285)
T ss_dssp             EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC-----
T ss_pred             EEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCC
Confidence            9999999999988754  456999999999999999999999999999999999999987654  999999999864332


Q ss_pred             C--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCH
Q 017860          175 S--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQ  252 (365)
Q Consensus       175 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  252 (365)
                      .  ......||+.|+|||++.+..++.+ +|||||||++|||++|..||........+...+..    ....+.+..+|+
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~----~~~~~~~~~~~~  241 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER----GYRMPCPPECPE  241 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT----TCCCCCCTTSCH
T ss_pred             CceeeccccccccccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCCCCCcccCH
Confidence            2  2344678999999999988888765 99999999999999976666555554444333332    223445566899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHhc--CcccccCCC
Q 017860          253 ECRDLISRIFVADPAARITIPEIMK--HQWFLKNLP  286 (365)
Q Consensus       253 ~~~~li~~~l~~dp~~R~t~~ell~--h~~f~~~~~  286 (365)
                      ++.+||.+||+.||++|||++++++  ++||....|
T Consensus       242 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p  277 (285)
T d1fmka3         242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  277 (285)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence            9999999999999999999999988  888876543

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.9e-57  Score=409.70  Aligned_cols=249  Identities=22%  Similarity=0.355  Sum_probs=199.0

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCc---EEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKE---LVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      .++|++.+.||+|+||+||+|+++.+++   .||||.+.....  ..+.+.+|+.+|++++|||||++++++..+..+|+
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            4589999999999999999999987665   588998765332  33578999999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      |||||++|+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~  182 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDT  182 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC----------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCC
Confidence            99999999999988774 56999999999999999999999999999999999999987664  9999999998543322


Q ss_pred             CC------CCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCC
Q 017860          176 QP------KSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTN  248 (365)
Q Consensus       176 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (365)
                      ..      ....||+.|||||++.+..++.+ +|||||||++|||++ |+.||.+.+.....    ..+. .....+.+.
T Consensus       183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~----~~i~-~~~~~~~~~  256 (299)
T d1jpaa_         183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVI----NAIE-QDYRLPPPM  256 (299)
T ss_dssp             -------------CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHH-TTCCCCCCT
T ss_pred             CcceeeecccccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHH----HHHH-cCCCCCCCc
Confidence            21      22457899999999988888766 999999999999998 89999887654322    2222 223345556


Q ss_pred             CCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          249 PISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       249 ~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+++++.+|+.+||+.||.+|||+.|++++
T Consensus       257 ~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            689999999999999999999999999864

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=417.20  Aligned_cols=257  Identities=26%  Similarity=0.409  Sum_probs=200.4

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcc---cHHHHHHHHHHhcCCCCCcceeceEEEe------CCE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKI---DENVQREIINHRSLRHPNIVRFKEVILT------PTH   93 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~~   93 (365)
                      ++|+++++||+|+||+||+|+++.+|+.||||++.+....   ...+.+|+.+++.++||||++++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5899999999999999999999999999999999764322   2457899999999999999999999964      368


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +|+|||||.++.+ ..+  ...+++..++.++.||+.||+|||++||+||||||+|||++.++.  +|++|||+++....
T Consensus        97 ~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~  171 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC------
T ss_pred             eEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhcccc
Confidence            9999999976544 444  356899999999999999999999999999999999999986654  99999999987777


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcc-------------
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSV-------------  240 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------------  240 (365)
                      .......+||+.|+|||++.+..++.+ +||||+||++|+|++|++||.+.+......+++......             
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            777778889999999999988877766 999999999999999999998876655444443322111             


Q ss_pred             -----ccCCC--------------C----CCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          241 -----QYSVP--------------D----TNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       241 -----~~~~~--------------~----~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                           .....              .    ....|+++++||++||..||++||||+|+|+||||++..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                 00000              0    011367899999999999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=404.58  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=199.4

Q ss_pred             cccccCCCeEEEEEEEc--cCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEEEEeecCC
Q 017860           29 RDIGSGNFGVARLMRDK--VTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG  103 (365)
Q Consensus        29 ~~LG~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~  103 (365)
                      ++||+|+||+||+|.+.  .+++.||||++.....   ..+.+.+|+.++++++|||||++++++..+ .+++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            47999999999999864  3567899999865332   235789999999999999999999999654 57899999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC----CCCC
Q 017860          104 GELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKS  179 (365)
Q Consensus       104 g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~----~~~~  179 (365)
                      |+|.+++.+..++++..+..++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+......    ....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~  169 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTH  169 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC---
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhccccccccccccc
Confidence            999999999889999999999999999999999999999999999999987664  9999999997543322    2234


Q ss_pred             CcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHHHHH
Q 017860          180 TVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECRDLI  258 (365)
Q Consensus       180 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  258 (365)
                      ..||+.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+... +...+   ... ...+.+..+|+++.+|+
T Consensus       170 ~~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-~~~~i---~~~-~~~~~p~~~~~~~~~li  243 (277)
T d1xbba_         170 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAML---EKG-ERMGCPAGCPREMYDLM  243 (277)
T ss_dssp             -CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHH---HTT-CCCCCCTTCCHHHHHHH
T ss_pred             cCCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHH-HHHHH---HcC-CCCCCCcccCHHHHHHH
Confidence            568999999999988888766 999999999999998 899998866532 22222   222 23344456899999999


Q ss_pred             HHhcccCCCCCCCHHHHh---cCccc
Q 017860          259 SRIFVADPAARITIPEIM---KHQWF  281 (365)
Q Consensus       259 ~~~l~~dp~~R~t~~ell---~h~~f  281 (365)
                      .+||+.||.+|||+++++   +|+|+
T Consensus       244 ~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         244 NLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             HHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            999999999999999985   45543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=413.03  Aligned_cols=257  Identities=30%  Similarity=0.539  Sum_probs=219.1

Q ss_pred             CCcceecccccCCCeEEEEEEEc---cCCcEEEEEEeecCC-----cccHHHHHHHHHHhcCCC-CCcceeceEEEeCCE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDK---VTKELVAVKYIERGD-----KIDENVQREIINHRSLRH-PNIVRFKEVILTPTH   93 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~   93 (365)
                      ++|++++.||+|+||+||+|++.   .+|+.||||++.+..     ...+.+.+|+.++++++| |||+++++++.....
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            57999999999999999999874   478999999986432     234668899999999976 899999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      +++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++....
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCG
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhcc
Confidence            9999999999999999999999999999999999999999999999999999999999987654  99999999875432


Q ss_pred             --CCCCCCCcCCCCCCCchhhcccc-cCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          174 --HSQPKSTVGTPAYIAPEVLLRHE-YDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       174 --~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                        .....+..|++.|+|||.+.+.. +.+.++|||||||++|+|++|+.||.+.+.......+...........  +..+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~--~~~~  259 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEM  259 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTTS
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCC--cccC
Confidence              33345678999999999997653 334459999999999999999999988776655555555554444433  3458


Q ss_pred             CHHHHHHHHHhcccCCCCCC-----CHHHHhcCccccc
Q 017860          251 SQECRDLISRIFVADPAARI-----TIPEIMKHQWFLK  283 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~-----t~~ell~h~~f~~  283 (365)
                      |+++.+||.+||++||.+||     |++|+++||||++
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            99999999999999999999     5899999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=403.02  Aligned_cols=254  Identities=26%  Similarity=0.364  Sum_probs=208.5

Q ss_pred             CCCCCCcceec-ccccCCCeEEEEEEEcc--CCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           19 MHDSDRYDFVR-DIGSGNFGVARLMRDKV--TKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        19 ~~~~~~y~~~~-~LG~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      +...++|.+.+ +||+|+||+||+|.++.  ++..||||+++....  ..+.+.+|+.++++++|||||++++++..+ .
T Consensus         4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e
Confidence            34556888888 49999999999998754  445799999976432  236789999999999999999999998754 5


Q ss_pred             EEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCccccc
Q 017860           94 LAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  172 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~  172 (365)
                      +|+|||||++|+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+...
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~  160 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALG  160 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECT
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccc
Confidence            7899999999999998865 457999999999999999999999999999999999999987664  9999999998543


Q ss_pred             CCC----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCC
Q 017860          173 LHS----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDT  247 (365)
Q Consensus       173 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (365)
                      ...    ......||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+..+. ...+   ... ...+.+
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~-~~~i---~~~-~~~~~p  234 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEV-MAFI---EQG-KRMECP  234 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHH-HHHH---HTT-CCCCCC
T ss_pred             ccccccccccccccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHH-HHHH---HcC-CCCCCC
Confidence            322    2334568999999999988888766 999999999999998 8999998765432 2222   222 223344


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHHHH---hcCccc
Q 017860          248 NPISQECRDLISRIFVADPAARITIPEI---MKHQWF  281 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~el---l~h~~f  281 (365)
                      ..+|+++.+||.+||+.||++|||+.++   |+|+|+
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            5689999999999999999999999888   567766

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-56  Score=414.83  Aligned_cols=259  Identities=24%  Similarity=0.400  Sum_probs=211.3

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc---ccHHHHHHHHHHhcCCCCCcceeceEEEeC-----CE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK---IDENVQREIINHRSLRHPNIVRFKEVILTP-----TH   93 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~   93 (365)
                      .+||+++++||+|+||+||+|+++.+|+.||||++.+...   ..+.+.+|+.+++.++|||||+++++|...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            4689999999999999999999999999999999976432   224678999999999999999999999643     33


Q ss_pred             EEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           94 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      .+++++|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++.  +|++|||++...  
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~--  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHT--  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CC--
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhccc--
Confidence            4666777889999998854 57999999999999999999999999999999999999987665  999999998754  


Q ss_pred             CCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhcccc-----------
Q 017860          174 HSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQY-----------  242 (365)
Q Consensus       174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------  242 (365)
                      .....+..||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+.........           
T Consensus       172 ~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             CcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence            333456789999999999887776666699999999999999999999987765554444433221110           


Q ss_pred             --------CCC------CCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCcccccCC
Q 017860          243 --------SVP------DTNPISQECRDLISRIFVADPAARITIPEIMKHQWFLKNL  285 (365)
Q Consensus       243 --------~~~------~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~~f~~~~  285 (365)
                              ..+      ....+|+++++||.+||+.||.+|||++|+|+||||++..
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence                    001      0234789999999999999999999999999999998754

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-55  Score=394.97  Aligned_cols=250  Identities=22%  Similarity=0.343  Sum_probs=198.6

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEccCC---cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEE
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   94 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~   94 (365)
                      .+.++|++.+.||+|+||+||+|++..++   ..||+|.+.....  ..+.+.+|+.+++.++|||||++++++. ++.+
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            34579999999999999999999987543   4688998864332  2356889999999999999999999995 5678


Q ss_pred             EEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccC
Q 017860           95 AIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  173 (365)
Q Consensus        95 ~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~  173 (365)
                      |+||||+++|+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.  +||+|||+|+....
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC---------
T ss_pred             EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccC
Confidence            999999999999988765 456999999999999999999999999999999999999987665  99999999986433


Q ss_pred             CC--CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          174 HS--QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       174 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ..  ......||+.|+|||++.+..++.+ +|||||||++|||++ |.+||...+......++    ... ...+.+..+
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~~-~~~~~~~~~  234 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENG-ERLPMPPNC  234 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTT-CCCCCCTTC
T ss_pred             CcceeccceecCcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----HcC-CCCCCCCCC
Confidence            22  2344568999999999988887665 999999999999998 89999887765443332    222 223445568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      |+++.+||.+||..||.+|||+.|+++|
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=391.21  Aligned_cols=248  Identities=22%  Similarity=0.303  Sum_probs=200.6

Q ss_pred             CCcceecccccCCCeEEEEEEEccCC----cEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTK----ELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l   96 (365)
                      +.|++.+.||+|+||.||+|.++.++    ..||||++.....  ....+.+|+.+++.++|||||++++++.+...+++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            47999999999999999999987654    4799999865432  23468899999999999999999999999999999


Q ss_pred             EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           97 VMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        97 v~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      |||||.++++.+.+... +.+++.++..++.||+.||+|||+++|+||||||+||||+.++.  +||+|||+|+......
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC--------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCC
Confidence            99999999999887654 56999999999999999999999999999999999999987664  9999999998543322


Q ss_pred             C----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCC
Q 017860          176 Q----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPIS  251 (365)
Q Consensus       176 ~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  251 (365)
                      .    .....||+.|+|||++.+..++.+ +|||||||++|||++|..||........+.+.+.    .....+.+..++
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~----~~~~~~~~~~~~  239 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN----DGFRLPTPMDCP  239 (283)
T ss_dssp             ---------CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH----TTCCCCCCTTCB
T ss_pred             ccceEeccCCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHHHh----ccCCCCCchhhH
Confidence            1    233468999999999988888766 9999999999999997666555444444433332    223445555688


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          252 QECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       252 ~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +++.+||.+||+.||++|||+.++++
T Consensus       240 ~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         240 SAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=398.09  Aligned_cols=250  Identities=20%  Similarity=0.348  Sum_probs=203.1

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCc----EEEEEEeecC--CcccHHHHHHHHHHhcCCCCCcceeceEEEeCCEEE
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKE----LVAVKYIERG--DKIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~----~vaiK~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~   95 (365)
                      .++|++++.||+|+||+||+|++..+|+    .||+|.+...  ....+.+.+|+.+++.++|||||++++++.++. .+
T Consensus         8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~   86 (317)
T d1xkka_           8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   86 (317)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EE
T ss_pred             HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ee
Confidence            4579999999999999999999988776    5888887643  234567999999999999999999999998754 57


Q ss_pred             EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCC
Q 017860           96 IVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  174 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~  174 (365)
                      +++||+.+|+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.  +||+|||+|+.....
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~  164 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTT
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceecccc
Confidence            788999999998887664 56999999999999999999999999999999999999987664  999999999864433


Q ss_pred             CC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCC
Q 017860          175 SQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPI  250 (365)
Q Consensus       175 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (365)
                      ..   .....||+.|+|||++.+..++.+ +|||||||++|||+| |.+||.+.+... +...+..    ....+.+..+
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~-~~~~i~~----~~~~~~p~~~  238 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEK----GERLPQPPIC  238 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGG-HHHHHHH----TCCCCCCTTB
T ss_pred             cccccccccccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHH-HHHHHHc----CCCCCCCccc
Confidence            32   233468999999999988888665 999999999999998 789998766543 3333322    2233445568


Q ss_pred             CHHHHHHHHHhcccCCCCCCCHHHHhcCcc
Q 017860          251 SQECRDLISRIFVADPAARITIPEIMKHQW  280 (365)
Q Consensus       251 s~~~~~li~~~l~~dp~~R~t~~ell~h~~  280 (365)
                      ++++.+|+.+||+.||.+|||+.|++.|..
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999999998843

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=395.82  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=208.1

Q ss_pred             CCCCcceecccccCCCeEEEEEEEccCCcE--EEEEEeecCC--cccHHHHHHHHHHhcC-CCCCcceeceEEEeCCEEE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDKVTKEL--VAVKYIERGD--KIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA   95 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~--vaiK~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~   95 (365)
                      +.++|++.++||+|+||+||+|+++.+|..  ||||.+....  ...+.+.+|+.+++.+ +|||||++++++..++.+|
T Consensus         8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_           8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence            457899999999999999999999988874  6778775432  2345789999999998 7999999999999999999


Q ss_pred             EEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCC
Q 017860           96 IVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPR  159 (365)
Q Consensus        96 lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~  159 (365)
                      +||||+++|+|.+++...                ..+++..++.++.||+.||.|||++||+||||||+|||++.++.  
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--  165 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--  165 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--
T ss_pred             EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--
Confidence            999999999999998654                56899999999999999999999999999999999999987664  


Q ss_pred             EEEecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCC-CCCCCCCChHHHHHHHHHHh
Q 017860          160 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTIQRIL  238 (365)
Q Consensus       160 vkl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~  238 (365)
                      +||+|||+|+............||+.|+|||.+.+..++.+ +|||||||++|||++|. +||.+.+...    ....+.
T Consensus       166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~----~~~~i~  240 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAE----LYEKLP  240 (309)
T ss_dssp             EEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHH----HHHHGG
T ss_pred             eEEccccccccccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHH----HHHHHH
Confidence            99999999987666555666789999999999998888766 99999999999999975 5676654432    222322


Q ss_pred             ccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          239 SVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       239 ~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      . ....+.+..+++++.+||.+||+.||++|||+.++++|
T Consensus       241 ~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         241 Q-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             G-TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             h-cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2 23344455689999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=390.73  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=200.6

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccC-C--cEEEEEEeecCC----cccHHHHHHHHHHhcCCCCCcceeceEEEe
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVT-K--ELVAVKYIERGD----KIDENVQREIINHRSLRHPNIVRFKEVILT   90 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~   90 (365)
                      .+.+.++|++++.||+|+||+||+|++... +  ..||||++.+..    ...+.+.+|+.+++.++||||+++++++.+
T Consensus         3 ~~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           3 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             eEEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            344567899999999999999999987533 2  378999987532    223578999999999999999999999976


Q ss_pred             CCEEEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860           91 PTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus        91 ~~~~~lv~e~~~~g~L~~~l~~-~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      + .+++|||||++|++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~  159 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMR  159 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCE
T ss_pred             c-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhh
Confidence            4 67899999999999987765 456999999999999999999999999999999999999987664  9999999998


Q ss_pred             cccCCCC----CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCC
Q 017860          170 SSVLHSQ----PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSV  244 (365)
Q Consensus       170 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  244 (365)
                      .......    .....|++.|+|||++.+..++.+ +|||||||++|||++ |+.||.+.+....    ...+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----~~~i~~~~~~~  234 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGERL  234 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCCCC
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHH----HHHHHhCCCCC
Confidence            6533322    233457889999999988877655 999999999999998 8999988766443    34444455555


Q ss_pred             CCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          245 PDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       245 ~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      +.+..+|+++.+||.+||..||++|||++++++
T Consensus       235 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         235 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            666779999999999999999999999999964

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=392.79  Aligned_cols=252  Identities=22%  Similarity=0.360  Sum_probs=198.6

Q ss_pred             CCCCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEEeC
Q 017860           20 HDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVILTP   91 (365)
Q Consensus        20 ~~~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~   91 (365)
                      .+.++|++.++||+|+||.||+|++..     +++.||+|++.....  ..+.+.+|..++.++ +||||+.+++++..+
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~   89 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   89 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence            345789999999999999999999754     456899999875432  234566777777665 689999999987654


Q ss_pred             -CEEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 017860           92 -THLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG  154 (365)
Q Consensus        92 -~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~  154 (365)
                       ..+++|||||++|+|.+++...                ..+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus        90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  169 (299)
T ss_dssp             TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred             CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence             5689999999999999998653                24899999999999999999999999999999999999986


Q ss_pred             CCCCCEEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhC-CCCCCCCCChHHH
Q 017860          155 SPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVG-GYPFEDPDEPKDF  230 (365)
Q Consensus       155 ~~~~~vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~~~~~~  230 (365)
                      ++.  +||+|||+|+......   ......||+.|+|||++.+..++.+ +|||||||++|||++| .+||........+
T Consensus       170 ~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         170 KNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             GGC--EEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCc--EEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            664  9999999997543322   2345679999999999988887665 9999999999999986 5688877766655


Q ss_pred             HHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          231 RKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+.+...    ...+.+..+++++.+|+.+||+.||++|||++|+++|
T Consensus       247 ~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEG----TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcC----CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5544432    2234445589999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=384.41  Aligned_cols=247  Identities=24%  Similarity=0.367  Sum_probs=199.7

Q ss_pred             CCCCCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEe-CCEEEEE
Q 017860           19 MHDSDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIV   97 (365)
Q Consensus        19 ~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv   97 (365)
                      ..+.++|++.++||+|+||.||+|++  +|+.||||+++.+ ...+.+.+|+.++++++||||+++++++.+ +..+|+|
T Consensus         3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             ccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence            44567899999999999999999998  4788999999764 345789999999999999999999998865 4668999


Q ss_pred             EeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC
Q 017860           98 MEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  175 (365)
Q Consensus        98 ~e~~~~g~L~~~l~~~~--~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~  175 (365)
                      |||+++|+|.+++...+  .+++..++.++.||+.||+|||+++|+||||||+|||++.++.  +||+|||+++...  .
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~--~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS--S  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecC--C
Confidence            99999999999986543  4899999999999999999999999999999999999987665  9999999988543  2


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQEC  254 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  254 (365)
                      ......+|+.|+|||++.+..++.+ +|||||||++|||+| |++||...+...... .   +.. ....+.+..+++++
T Consensus       156 ~~~~~~~~~~y~aPE~l~~~~~t~~-sDIwSfG~il~el~t~~~~p~~~~~~~~~~~-~---i~~-~~~~~~~~~~~~~~  229 (262)
T d1byga_         156 TQDTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-R---VEK-GYKMDAPDGCPPAV  229 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHH-H---HTT-TCCCCCCTTCCHHH
T ss_pred             CCccccccccCCChHHHhCCCCChH-HHHHhHHHHHHHHHHCCCCCCCCCCHHHHHH-H---HHc-CCCCCCCccCCHHH
Confidence            3345578999999999988887655 999999999999998 788888765543322 2   222 22334445688999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHhcC
Q 017860          255 RDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       255 ~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      .+||.+||..||.+|||+.+++++
T Consensus       230 ~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         230 YEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcccCHhHCcCHHHHHHH
Confidence            999999999999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-53  Score=388.35  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=206.4

Q ss_pred             CCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcCCCCCcceeceEEEeCCE
Q 017860           21 DSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSLRHPNIVRFKEVILTPTH   93 (365)
Q Consensus        21 ~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~   93 (365)
                      +.++|++.++||+|+||+||+|+++     .+++.||||++.....  ..+.+.+|+.+++.++||||+++++++.....
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3578999999999999999999975     3567999999875432  23578999999999999999999999999999


Q ss_pred             EEEEEeecCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 017860           94 LAIVMEYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLEN  149 (365)
Q Consensus        94 ~~lv~e~~~~g~L~~~l~~~~------------------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~N  149 (365)
                      .++||||+.+|+|.+++....                        .+++..+..++.||+.||+|||++++|||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            999999999999999986432                        37899999999999999999999999999999999


Q ss_pred             EEecCCCCCCEEEecCCCcccccCC---CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCC-CCCCCCC
Q 017860          150 TLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPD  225 (365)
Q Consensus       150 Ili~~~~~~~vkl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~  225 (365)
                      ||++.++.  +||+|||+|+.....   ....+..||+.|+|||++.+..++.+ +|||||||++|||++|. +||.+.+
T Consensus       171 ILld~~~~--~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         171 CLVGENMV--VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             EEECGGGC--EEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             eEECCCCc--EEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCC
Confidence            99987654  999999998743222   22345678999999999998888765 99999999999999986 6777665


Q ss_pred             ChHHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          226 EPKDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..+..    ..+.... ..+.+..+++++.+||.+||+.+|++|||+.|+++
T Consensus       248 ~~e~~----~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         248 HEEVI----YYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHH----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHH----HHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            54322    2233332 23344568999999999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-53  Score=387.69  Aligned_cols=252  Identities=23%  Similarity=0.351  Sum_probs=205.2

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEccCC-------cEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDKVTK-------ELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEV   87 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~   87 (365)
                      |..+.++|++.+.||+|+||.||+|++..++       ..||||++.++..  ....+.+|...+.++ +|||||+++++
T Consensus         8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_           8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            3455689999999999999999999986554       4799999976543  235677888888777 89999999999


Q ss_pred             EEeCCEEEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 017860           88 ILTPTHLAIVMEYASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL  151 (365)
Q Consensus        88 ~~~~~~~~lv~e~~~~g~L~~~l~~~----------------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIl  151 (365)
                      |.++..+++|||||.+|+|.+++...                .++++.+++.++.||+.||+|||+++||||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            99999999999999999999999644                35899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCcccccCCC---CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCCh
Q 017860          152 LDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP  227 (365)
Q Consensus       152 i~~~~~~~vkl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  227 (365)
                      ++.++.  +||+|||+++......   ......||+.|+|||++.+..|+.+ +|||||||++|||++ |.+||.+.+..
T Consensus       168 l~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~  244 (299)
T d1fgka_         168 VTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVE  244 (299)
T ss_dssp             ECTTCC--EEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             ecCCCC--eEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHH
Confidence            987765  9999999998554332   2345678999999999988888766 999999999999998 78888776553


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      . ..+.+.    .....+.+..+|+++.+||.+||+.||.+|||+.|+++
T Consensus       245 ~-~~~~i~----~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         245 E-LFKLLK----EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             H-HHHHHH----TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             H-HHHHHH----cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            3 222222    22334445568999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=383.86  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=212.1

Q ss_pred             CCCCCCCcceecccccCCCeEEEEEEEc-----cCCcEEEEEEeecCCc--ccHHHHHHHHHHhcC-CCCCcceeceEEE
Q 017860           18 IMHDSDRYDFVRDIGSGNFGVARLMRDK-----VTKELVAVKYIERGDK--IDENVQREIINHRSL-RHPNIVRFKEVIL   89 (365)
Q Consensus        18 ~~~~~~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l-~hpnIv~l~~~~~   89 (365)
                      |-.+.++|++.++||+|+||.||+|++.     .+++.||||++.....  ....+.+|+.+++.+ +|||||++++++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            3345679999999999999999999863     4667999999976432  234688999999998 6999999999999


Q ss_pred             eCCEEEEEEeecCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 017860           90 TPTHLAIVMEYASGGELFERICNAG------------------RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTL  151 (365)
Q Consensus        90 ~~~~~~lv~e~~~~g~L~~~l~~~~------------------~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIl  151 (365)
                      ....+++|||||++|+|.+++.+..                  .+++..++.++.||+.||+|||++|+|||||||+||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            9999999999999999999987543                  5899999999999999999999999999999999999


Q ss_pred             ecCCCCCCEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHh-CCCCCCCCCCh
Q 017860          152 LDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLV-GGYPFEDPDEP  227 (365)
Q Consensus       152 i~~~~~~~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~-g~~pf~~~~~~  227 (365)
                      ++.++.  +||+|||+++.......   ....+||+.|+|||++.+..++.+ +|||||||++|||++ |.+||......
T Consensus       178 ~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         178 LTHGRI--TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             EETTTE--EEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             ccccCc--ccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            986654  99999999986543222   244578999999999988777665 999999999999998 66777776665


Q ss_pred             HHHHHHHHHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          228 KDFRKTIQRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ..+.+.+..    ....+.+..+|+++.+||.+||+.||.+|||++++++
T Consensus       255 ~~~~~~i~~----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 SKFYKMIKE----GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHHH----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhc----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            555555443    2333444568999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=383.31  Aligned_cols=255  Identities=18%  Similarity=0.276  Sum_probs=210.5

Q ss_pred             CCCCCCCCCcceecccccCCCeEEEEEEEcc-----CCcEEEEEEeecCCccc--HHHHHHHHHHhcCCCCCcceeceEE
Q 017860           16 MPIMHDSDRYDFVRDIGSGNFGVARLMRDKV-----TKELVAVKYIERGDKID--ENVQREIINHRSLRHPNIVRFKEVI   88 (365)
Q Consensus        16 ~~~~~~~~~y~~~~~LG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~--~~~~~e~~~l~~l~hpnIv~l~~~~   88 (365)
                      ..|-.+.++|++.++||+|+||+||+|.++.     ++..||||+++......  ..+.+|+.++++++||||+++++++
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            3455567899999999999999999998853     45789999997643222  4578999999999999999999999


Q ss_pred             EeCCEEEEEEeecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCC
Q 017860           89 LTPTHLAIVMEYASGGELFERICNA----------GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAP  158 (365)
Q Consensus        89 ~~~~~~~lv~e~~~~g~L~~~l~~~----------~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~  158 (365)
                      ..+..+++|||||.+|+|.+++...          ..+++..+..++.|++.||+|||+++|+||||||+|||++.++. 
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~-  171 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-  171 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC-
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce-
Confidence            9999999999999999999987532          24689999999999999999999999999999999999986654 


Q ss_pred             CEEEecCCCcccccCCCC---CCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCC-CCCCCCCChHHHHHHH
Q 017860          159 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGG-YPFEDPDEPKDFRKTI  234 (365)
Q Consensus       159 ~vkl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~~~~~~~~  234 (365)
                       +||+|||+|+.......   .....||+.|+|||.+.+..++.+ +|||||||++|||++|. +||.+.+....+    
T Consensus       172 -~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----  245 (308)
T d1p4oa_         172 -VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL----  245 (308)
T ss_dssp             -EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----
T ss_pred             -EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHH----
Confidence             99999999985433322   344578999999999988888765 99999999999999984 778766554333    


Q ss_pred             HHHhccccCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          235 QRILSVQYSVPDTNPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       235 ~~~~~~~~~~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..+.... ..+.+..+++.+.+||.+||+.+|++|||+.+++++
T Consensus       246 ~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~  288 (308)
T d1p4oa_         246 RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  288 (308)
T ss_dssp             HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2222222 233445688999999999999999999999999983

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-52  Score=379.35  Aligned_cols=261  Identities=21%  Similarity=0.224  Sum_probs=202.7

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC-cceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~  100 (365)
                      +++|++.++||+|+||+||+|+++.+|+.||||++..... ...+.+|+.+++.++|+| |+.+..++......++||||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            4689999999999999999999999999999999876443 356889999999998766 55566777888999999999


Q ss_pred             cCCCChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCCCEEEecCCCcccccCCC---
Q 017860          101 ASGGELFERI-CNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHS---  175 (365)
Q Consensus       101 ~~~g~L~~~l-~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~-~~~~vkl~Dfgla~~~~~~~---  175 (365)
                      +.+ +|...+ ...+.+++..+..++.|++.||+|||++||+||||||+|||++.. ....+||+|||+|+......   
T Consensus        85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            955 555554 446679999999999999999999999999999999999998643 23469999999998543221   


Q ss_pred             -----CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHH---HhccccCCCCC
Q 017860          176 -----QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQR---ILSVQYSVPDT  247 (365)
Q Consensus       176 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~  247 (365)
                           .....+||+.|+|||++.+..++.+ +|||||||++|||++|+.||...............   ....+. ....
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  241 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLC  241 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH-HHHT
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh-hHhc
Confidence                 2345679999999999988877655 99999999999999999999876554332222111   111110 0112


Q ss_pred             CCCCHHHHHHHHHhcccCCCCCCCHH---HHhcCcccccCCC
Q 017860          248 NPISQECRDLISRIFVADPAARITIP---EIMKHQWFLKNLP  286 (365)
Q Consensus       248 ~~~s~~~~~li~~~l~~dp~~R~t~~---ell~h~~f~~~~~  286 (365)
                      ..+|+++.+|+.+||+.+|++||++.   ++|+|+|..+...
T Consensus       242 ~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~  283 (299)
T d1ckia_         242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  283 (299)
T ss_dssp             TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             cCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence            35789999999999999999999987   4567777655443

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-51  Score=373.48  Aligned_cols=244  Identities=21%  Similarity=0.282  Sum_probs=196.6

Q ss_pred             ecccccCCCeEEEEEEEccCC---cEEEEEEeecCC--cccHHHHHHHHHHhcCCCCCcceeceEEEe-CCEEEEEEeec
Q 017860           28 VRDIGSGNFGVARLMRDKVTK---ELVAVKYIERGD--KIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYA  101 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~---~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~  101 (365)
                      -++||+|+||+||+|++..++   ..||||.+++..  ...+.+.+|+.++++++||||+++++++.. +..+++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            578999999999999986543   368999987532  233679999999999999999999999765 56899999999


Q ss_pred             CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecCCCcccccCCC-----
Q 017860          102 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----  175 (365)
Q Consensus       102 ~~g~L~~~l~~~-~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~~~~~~-----  175 (365)
                      ++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.  +||+|||+++......     
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~  189 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVH  189 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccce
Confidence            999999988754 45788999999999999999999999999999999999986654  9999999998543322     


Q ss_pred             CCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHHHHHHhccccCCCCCCCCCHHHH
Q 017860          176 QPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKTIQRILSVQYSVPDTNPISQECR  255 (365)
Q Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  255 (365)
                      ......||+.|+|||++.+..++.+ +|||||||++|||++|..||.......++...   +.... ..+.+..+++++.
T Consensus       190 ~~~~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~~---i~~g~-~~~~p~~~~~~l~  264 (311)
T d1r0pa_         190 NKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQGR-RLLQPEYCPDPLY  264 (311)
T ss_dssp             CTTCSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHHH---HHTTC-CCCCCTTCCHHHH
T ss_pred             ecccccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH---HHcCC-CCCCcccCcHHHH
Confidence            2233568999999999988888666 99999999999999988887665443333222   22222 2234455889999


Q ss_pred             HHHHHhcccCCCCCCCHHHHhcC
Q 017860          256 DLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       256 ~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      +|+.+||+.||++|||+.|+++|
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999987

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.6e-50  Score=366.30  Aligned_cols=253  Identities=20%  Similarity=0.206  Sum_probs=204.5

Q ss_pred             CCCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-CCcceeceEEEeCCEEEEEEee
Q 017860           22 SDRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY  100 (365)
Q Consensus        22 ~~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~  100 (365)
                      .++|++.++||+|+||+||+|+++.+|+.||||++.... ....+.+|+..++.++| +|++.+++++......++||||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            368999999999999999999999999999999886643 23457889999999975 8999999999999999999999


Q ss_pred             cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCCCEEEecCCCcccccCC--
Q 017860          101 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH--  174 (365)
Q Consensus       101 ~~~g~L~~~l~~~~-~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~---~~~~vkl~Dfgla~~~~~~--  174 (365)
                      + +++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++..   ..+.+||+|||+|+.....  
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            9 689988887654 69999999999999999999999999999999999999742   2346999999999753321  


Q ss_pred             ------CCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChHHHHHH--HHHHhccccCCCC
Q 017860          175 ------SQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPKDFRKT--IQRILSVQYSVPD  246 (365)
Q Consensus       175 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~  246 (365)
                            ......+||+.|||||++.+..++.+ +|||||||++|||++|+.||.+..........  +............
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l  240 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL  240 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence                  12345679999999999988877655 99999999999999999999876543322211  1111111100011


Q ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCHHHHhc
Q 017860          247 TNPISQECRDLISRIFVADPAARITIPEIMK  277 (365)
Q Consensus       247 ~~~~s~~~~~li~~~l~~dp~~R~t~~ell~  277 (365)
                      ...+++++.+++..|+..+|++||+++.+.+
T Consensus       241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2347899999999999999999999877653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-51  Score=370.97  Aligned_cols=250  Identities=24%  Similarity=0.274  Sum_probs=191.2

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCCcceeceEEEeCC----EEEEEE
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVM   98 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~lv~   98 (365)
                      .+|.+.++||+|+||+||+|++  +|+.||||++..........+.|+..++.++|||||++++++..++    .+|+||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4689999999999999999986  6899999999765433333455666777889999999999998654    689999


Q ss_pred             eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCcEEecCCCCCCEEEecCCCccc
Q 017860           99 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHA--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS  170 (365)
Q Consensus        99 e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~--------~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~~  170 (365)
                      |||++|+|.+++.+. ++++..++.++.|++.||+|||+        +||+||||||+||||+.++  ++||+|||+++.
T Consensus        81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~--~~Kl~DFGl~~~  157 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVR  157 (303)
T ss_dssp             ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS--CEEECCCTTCEE
T ss_pred             ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC--CeEEEecCcccc
Confidence            999999999999765 68999999999999999999996        5999999999999998665  499999999875


Q ss_pred             ccCCC-----CCCCCcCCCCCCCchhhcccc------cCCccceeehhhHHHHHHHhCCCCCCCCCCh-----------H
Q 017860          171 SVLHS-----QPKSTVGTPAYIAPEVLLRHE------YDGKIADVWSCGVTLYVMLVGGYPFEDPDEP-----------K  228 (365)
Q Consensus       171 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~------~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-----------~  228 (365)
                      .....     .....+||+.|+|||++.+..      ++ +++|||||||++|||++|..||......           .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHH-HHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcC-cchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            43322     234567999999999986542      33 3489999999999999998877432211           0


Q ss_pred             HHHHHHHHHhcccc--CCCCC---CCCCHHHHHHHHHhcccCCCCCCCHHHHhcC
Q 017860          229 DFRKTIQRILSVQY--SVPDT---NPISQECRDLISRIFVADPAARITIPEIMKH  278 (365)
Q Consensus       229 ~~~~~~~~~~~~~~--~~~~~---~~~s~~~~~li~~~l~~dp~~R~t~~ell~h  278 (365)
                      ..............  ..+..   ......+.+|+.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            11112222222222  11111   1122458899999999999999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-49  Score=368.85  Aligned_cols=260  Identities=24%  Similarity=0.402  Sum_probs=199.1

Q ss_pred             CCcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----------CCCcceeceEEEe-
Q 017860           23 DRYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----------HPNIVRFKEVILT-   90 (365)
Q Consensus        23 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~l~~~~~~-   90 (365)
                      .||+++++||+|+||+||+|+++.+|+.||||++.+.....+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            5799999999999999999999999999999999876555567788998888775           5789999998864 


Q ss_pred             -CCEEEEEEeecCCCChHHH-H--HhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCC----CEE
Q 017860           91 -PTHLAIVMEYASGGELFER-I--CNAGRFSEDEARFFFQQLISGVSYCHA-MQVCHRDLKLENTLLDGSPAP----RLK  161 (365)
Q Consensus        91 -~~~~~lv~e~~~~g~L~~~-l--~~~~~l~~~~~~~i~~qil~al~~LH~-~~ivHrDlkp~NIli~~~~~~----~vk  161 (365)
                       ....+++++++..+..... .  .....+++..++.++.||+.||+|||+ .||+||||||+|||++.++..    .+|
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence             4567777777755443322 2  234568999999999999999999998 899999999999999755432    489


Q ss_pred             EecCCCcccccCCCCCCCCcCCCCCCCchhhcccccCCccceeehhhHHHHHHHhCCCCCCCCCChH------HHHHHHH
Q 017860          162 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRHEYDGKIADVWSCGVTLYVMLVGGYPFEDPDEPK------DFRKTIQ  235 (365)
Q Consensus       162 l~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~------~~~~~~~  235 (365)
                      ++|||.+....  ......+||+.|+|||++.+..++.+ +||||+||++++|++|+.||.......      .....+.
T Consensus       173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~  249 (362)
T d1q8ya_         173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE  249 (362)
T ss_dssp             ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred             Eeecccccccc--cccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence            99999987543  34466789999999999998888766 999999999999999999997543211      1111111


Q ss_pred             HHhcc--------------------ccC----------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHhcCc
Q 017860          236 RILSV--------------------QYS----------------VPDTNPISQECRDLISRIFVADPAARITIPEIMKHQ  279 (365)
Q Consensus       236 ~~~~~--------------------~~~----------------~~~~~~~s~~~~~li~~~l~~dp~~R~t~~ell~h~  279 (365)
                      .+...                    ...                .......++++.+||.+||+.||.+|||++|+|+||
T Consensus       250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp  329 (362)
T d1q8ya_         250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHP  329 (362)
T ss_dssp             HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCG
T ss_pred             HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            10000                    000                001112357899999999999999999999999999


Q ss_pred             ccccCC
Q 017860          280 WFLKNL  285 (365)
Q Consensus       280 ~f~~~~  285 (365)
                      ||++..
T Consensus       330 ~f~~~~  335 (362)
T d1q8ya_         330 WLKDTL  335 (362)
T ss_dssp             GGTTCT
T ss_pred             ccCCCC
Confidence            998554

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=3.3e-27  Score=199.79  Aligned_cols=131  Identities=17%  Similarity=0.160  Sum_probs=106.1

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-------------------ccHHHHHHHHHHhcCCCCCcceec
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-------------------IDENVQREIINHRSLRHPNIVRFK   85 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------------~~~~~~~e~~~l~~l~hpnIv~l~   85 (365)
                      |.+.++||+|+||+||+|++. +|+.||||++..+..                   ......+|..++..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            467899999999999999986 789999998753211                   012345688899999999999887


Q ss_pred             eEEEeCCEEEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCCCEEEecC
Q 017860           86 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDF  165 (365)
Q Consensus        86 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~~ivHrDlkp~NIli~~~~~~~vkl~Df  165 (365)
                      ++.  .  .+++|||+++..+..       +++..+..++.|++.+|+|||++||+||||||+|||++.++   ++|+||
T Consensus        81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDF  146 (191)
T d1zara2          81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDF  146 (191)
T ss_dssp             EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCC
T ss_pred             Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEEC
Confidence            653  2  279999998876543       56667788999999999999999999999999999998543   899999


Q ss_pred             CCccc
Q 017860          166 GYSKS  170 (365)
Q Consensus       166 gla~~  170 (365)
                      |+|+.
T Consensus       147 G~a~~  151 (191)
T d1zara2         147 PQSVE  151 (191)
T ss_dssp             TTCEE
T ss_pred             CCccc
Confidence            98864

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.53  E-value=3.4e-07  Score=78.84  Aligned_cols=137  Identities=17%  Similarity=0.125  Sum_probs=92.2

Q ss_pred             CcceecccccCCCeEEEEEEEccCCcEEEEEEeecCCc-ccHHHHHHHHHHhcCC-CCCcceeceEEEeCCEEEEEEeec
Q 017860           24 RYDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDK-IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA  101 (365)
Q Consensus        24 ~y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~  101 (365)
                      .|+.++..+.++.+.||++..  +++.+++|+...... ....+.+|...++.+. +--+.+++.+...++..++||+++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l   92 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence            688888776666789998853  566788998765432 2345778888877664 333567788888889999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-------------------------------------------
Q 017860          102 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAM-------------------------------------------  138 (365)
Q Consensus       102 ~~g~L~~~l~~~~~l~~~~~~~i~~qil~al~~LH~~-------------------------------------------  138 (365)
                      +|.++......     ......++.++...++.||+.                                           
T Consensus        93 ~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T d1j7la_          93 DGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred             ccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence            99887554311     111222344444444445421                                           


Q ss_pred             ----------------CCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          139 ----------------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       139 ----------------~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                                      .++|+|+.|.|||+++++  .+-|.||+.+.
T Consensus       168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~--~~~lIDwe~a~  212 (263)
T d1j7la_         168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--VSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred             HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc--eEEEeechhcc
Confidence                            168999999999997543  24599998654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.20  E-value=3.4e-06  Score=77.08  Aligned_cols=77  Identities=18%  Similarity=0.139  Sum_probs=48.4

Q ss_pred             ecccccCCCeEEEEEEEccCCcEEEEEEeec-----CC---cccHHHHHHHHHHhcCC-C--CCcceeceEEEeCCEEEE
Q 017860           28 VRDIGSGNFGVARLMRDKVTKELVAVKYIER-----GD---KIDENVQREIINHRSLR-H--PNIVRFKEVILTPTHLAI   96 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~---~~~~~~~~e~~~l~~l~-h--pnIv~l~~~~~~~~~~~l   96 (365)
                      .+.||.|....||++.+..+++.+++|.-..     ++   ........|...++.+. +  ..+.+++.+  ++...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            5679999999999999887788999997432     11   12234566777776552 2  345555543  4445578


Q ss_pred             EEeecCCCCh
Q 017860           97 VMEYASGGEL  106 (365)
Q Consensus        97 v~e~~~~g~L  106 (365)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.92  E-value=3.4e-05  Score=65.40  Aligned_cols=74  Identities=14%  Similarity=0.068  Sum_probs=51.9

Q ss_pred             ccccCC-CeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC--CCcceeceEEEeCCEEEEEEeecCCCCh
Q 017860           30 DIGSGN-FGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        30 ~LG~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      .+..|. -+.||++... ++..+++|......  ...+.+|...++.+..  -.+.+++.+...++..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            444554 3678988764 56678999765543  2346777777776643  2356678888888889999999988665

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.60  E-value=0.00015  Score=64.07  Aligned_cols=72  Identities=13%  Similarity=0.119  Sum_probs=48.9

Q ss_pred             CCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCCC-----CCccee--ceEEEeCCEEEEEEeecCCCCh
Q 017860           34 GNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLRH-----PNIVRF--KEVILTPTHLAIVMEYASGGEL  106 (365)
Q Consensus        34 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-----pnIv~l--~~~~~~~~~~~lv~e~~~~g~L  106 (365)
                      +.--.||++... +|..|++|+...+....+.+..|+..+..|..     +..+..  -..+......+.+++++.|..+
T Consensus        33 s~EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cccceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            334689999875 78889999987766566778888887766632     211221  1233456778999999987443

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.31  E-value=0.00029  Score=63.89  Aligned_cols=74  Identities=14%  Similarity=0.104  Sum_probs=50.9

Q ss_pred             ecccccCCCeEEEEEEEcc-------CCcEEEEEEeecCCcccHHHHHHHHHHhcCCCCC-cceeceEEEeCCEEEEEEe
Q 017860           28 VRDIGSGNFGVARLMRDKV-------TKELVAVKYIERGDKIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVME   99 (365)
Q Consensus        28 ~~~LG~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e   99 (365)
                      +++|+.|---.+|++....       ..+.|.+++... ........+|..+++.+.-.+ ..+++.++..    ++|+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            4678888889999998753       345677887653 333345678888888775334 4467776642    67899


Q ss_pred             ecCCCCh
Q 017860          100 YASGGEL  106 (365)
Q Consensus       100 ~~~~g~L  106 (365)
                      |++|..|
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987554

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.45  E-value=0.0027  Score=55.11  Aligned_cols=140  Identities=16%  Similarity=0.080  Sum_probs=71.8

Q ss_pred             cceecccccCCCeEEEEEEEccCCcEEEEEEeecCCcccHHHHHHHHHHhcCC-----CCCcceec---eEEEeCCEEEE
Q 017860           25 YDFVRDIGSGNFGVARLMRDKVTKELVAVKYIERGDKIDENVQREIINHRSLR-----HPNIVRFK---EVILTPTHLAI   96 (365)
Q Consensus        25 y~~~~~LG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~l~---~~~~~~~~~~l   96 (365)
                      ..-++.|..|---+.|++... + ..+++|++.... ..+.+..|+.++..|.     .|..+...   .+.......+.
T Consensus        20 ~~~~~~i~~G~~N~ny~v~t~-~-g~yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~   96 (316)
T d2ppqa1          20 LTSYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA   96 (316)
T ss_dssp             EEEEEEECC---EEEEEEEES-S-CCEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred             ceEeecCCCCcccCeEEEEEC-C-CcEEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccce
Confidence            334556667777889998764 3 459999986542 3345666666665553     23322211   11223455666


Q ss_pred             EEeecCCCChHH--------------HHHhc-C--------CCCH------------------HHHHHHHHHHHHHHHHH
Q 017860           97 VMEYASGGELFE--------------RICNA-G--------RFSE------------------DEARFFFQQLISGVSYC  135 (365)
Q Consensus        97 v~e~~~~g~L~~--------------~l~~~-~--------~l~~------------------~~~~~i~~qil~al~~L  135 (365)
                      ++.+..|.....              .+... .        ....                  ......+..+...+...
T Consensus        97 ~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  176 (316)
T d2ppqa1          97 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  176 (316)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             eeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhcc
Confidence            777666543311              01000 0        0000                  11111222233333332


Q ss_pred             H----HcCCeecCCCCCcEEecCCCCCCEEEecCCCcc
Q 017860          136 H----AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK  169 (365)
Q Consensus       136 H----~~~ivHrDlkp~NIli~~~~~~~vkl~Dfgla~  169 (365)
                      +    ..|+||+|+.+.||+++.+.  ..-+.||+.+.
T Consensus       177 ~~~~L~~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~  212 (316)
T d2ppqa1         177 WPKDLPAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC  212 (316)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred             CccccccccccCCcchhhhhccccc--ceeEecccccc
Confidence            2    24699999999999998654  25799999764

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=94.03  E-value=0.0058  Score=38.97  Aligned_cols=55  Identities=16%  Similarity=0.135  Sum_probs=45.3

Q ss_pred             HHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          310 DVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       310 ~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+.+.|...+....|.++..++....  .....++.+........|.|++|.|+|.
T Consensus         1 Eel~~aF~~fD~~~~G~I~~~el~~~l~~~g~~~~~~ei~~l~~~~D~d~dg~I~~~   57 (61)
T d2fcea1           1 EDFVKAFQVFDKESTGKVSVGDLRYMLTGLGEKLTDAEVDELLKGVEVDSNGEIDYK   57 (61)
T ss_dssp             HHHHHHHHHHCTTCCSCEEHHHHHHHHHHTTCCCCHHHHHHHHTTCCCCTTSEECHH
T ss_pred             ChHHHHHHHHCCCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCcEeHH
Confidence            357788999999999999998887653  3445667778888999999999999983

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=93.27  E-value=0.005  Score=41.82  Aligned_cols=57  Identities=12%  Similarity=0.038  Sum_probs=46.2

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCCC-CCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDM-DDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~-~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+.++|...+...+|.++..++....... ...+.+..+...+.|.|++|.|+|.
T Consensus         4 e~~e~~~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~ei~~~~~~~D~d~~G~I~~~   61 (81)
T d2opoa1           4 DIADRERIFKRFDTNGDGKISSSELGDALKTLGSVTPDEVRRMMAEIDTDGDGFISFD   61 (81)
T ss_dssp             HHHHHHHHHHHHCTTCSSEEEHHHHHHHHHTTTTCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhhcCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            45678899999999999999998886653222 3466678888999999999999984

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=93.15  E-value=0.018  Score=38.86  Aligned_cols=58  Identities=14%  Similarity=0.033  Sum_probs=47.5

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+-+.+.+.|...+...+|.++..++....  ......+.+.++.....|.|++|+|+|.
T Consensus        12 ~~ee~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~ev~~~~~~~D~d~dg~I~~~   71 (81)
T d1fi5a_          12 KTEEELSDLFRMFDKNADGYIDLEELKIMLQATGETITEDDIEELMKDGDKNNDGRIDYD   71 (81)
T ss_dssp             CCHHHHHHHHHHHCSSCSSEECHHHHHHHHHTSSSCCCHHHHHHHHHHHCSSSSSSEEHH
T ss_pred             CCHHHHHHHHHHHcCCCCCcccHHHHHHHHHhcCCCCCHHHHHHHHHHHCCCCCCcEeHH
Confidence            355788999999999999999999886653  3334566777888999999999999984

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=92.61  E-value=0.011  Score=38.16  Aligned_cols=55  Identities=18%  Similarity=0.100  Sum_probs=45.1

Q ss_pred             HHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          310 DVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       310 ~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+++.|...+....|.++.+++....  ......+.+......+.|.|++|.|+|.
T Consensus         3 eel~~aF~~fD~d~~G~I~~~el~~~l~~lg~~~~~~e~~~l~~~~D~d~~g~I~~~   59 (65)
T d1fw4a_           3 EEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYE   59 (65)
T ss_dssp             HHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCSSSEEHH
T ss_pred             HHHHHHHHHHcCCCCCcCCHHHHHHHHHHhCCCCCHHHHHHHHHHcCCCCCCcEeHH
Confidence            568899999999999999998887653  3334566677788999999999999984

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=92.51  E-value=0.016  Score=38.57  Aligned_cols=58  Identities=14%  Similarity=-0.008  Sum_probs=48.2

Q ss_pred             CCHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+.+.+.+.|...+....|.++..++....  ......+.+..+...+.|.|++|.|+|.
T Consensus         6 ~~eeel~~~F~~fD~~~~G~I~~~el~~~l~~lg~~~~~~e~~~~~~~~D~d~dg~I~~~   65 (75)
T d1jc2a_           6 KSEEELANCFRIFDKNADGFIDIEELGEILRATGEHVIEEDIEDLMKDSDKNNDGRIDFD   65 (75)
T ss_dssp             CCHHHHHHHHHHHCCSTTSSEEHHHHHHHHHHSSSCCCHHHHHHHHHHHCSSSCSEECHH
T ss_pred             CcHHHHHHHHHHHcCCCcCeEcHHHHHHHHHhcCCCccHHHHHHHHHHhCCCCCCcEeHH
Confidence            455788999999999999999998887653  4445667778889999999999999984

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=92.34  E-value=0.026  Score=40.54  Aligned_cols=57  Identities=12%  Similarity=-0.036  Sum_probs=45.0

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC-----CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN-----LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~-----~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+.+...|...+.+..|.++.+++....     ......+.+.++...+.|.|++|.|+|.
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~~~~~e~~~~~~~~D~d~dG~I~~~  100 (109)
T d5pala_          39 TDAQVKEVFEILDKDQSGFIEEEELKGVLKGFSAHGRDLNDTETKALLAAGDSDHDGKIGAD  100 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHH
T ss_pred             CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHhhhccCcCCHHHHHHHHHHhCCCCCCCEeHH
Confidence            45678899999999999999999875431     2233456667788899999999999983

>d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Cow (Bos taurus) [TaxId: 9913]

Probab=91.91  E-value=0.023  Score=37.78  Aligned_cols=58  Identities=10%  Similarity=-0.019  Sum_probs=41.4

Q ss_pred             CCHHHHHHHHHHhCCC--CCCCCCcccccccC----CCCCCccccccccccccCCCCCCceeec
Q 017860          307 QSVDVIMQIIAEASIP--AVGTHGLNCYMTDN----LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       307 ~~~~~~~~~~~~~~~~--~~g~~~~~~~~~~~----~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ++.+.+.++|...+..  ..|+++.+++....    .....++.+..+...+.|.|++|.|+|.
T Consensus         2 ~s~eel~~~F~~fd~~~~~~G~I~~~El~~~l~~lg~~~~~~~~ei~~~~~~~D~d~dG~I~f~   65 (76)
T d1qx2a_           2 KSPEEIKGAFEVFAAKEGDPNQISKEELKLVMQTLGPSLLKGMSTLDEMIEEVDKNGDGEVSFE   65 (76)
T ss_dssp             CCHHHHHHHHHHHHTSSSCTTSEEHHHHHHHHHHHGGGSCTTSCSHHHHHHHHCTTCSSEECHH
T ss_pred             cCHHHHHHHHHHHcccCCCCCEECHHHHHHHHHHhCCcCCCCHHHHHHHHHHhhcCCCCcCcHH
Confidence            4667788888876433  46889988876543    1222344566788999999999999984

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=91.90  E-value=0.027  Score=40.44  Aligned_cols=57  Identities=16%  Similarity=0.027  Sum_probs=44.5

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCC-----CCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNL-----DMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-----~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+.+++.|...+...+|.++.+++.....     .....+.+..+.....|.|++|.|+|.
T Consensus        39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~g~~ls~~ev~~~~~~~D~d~dG~I~~~  100 (109)
T d1pvaa_          39 SANDVKKVFKAIDADASGFIEEEELKFVLKSFAADGRDLTDAETKAFLKAADKDGDGKIGID  100 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTCCCCCHHHHHHHHHHHCTTCSSSBCHH
T ss_pred             CHHHHHHHhhCccCCCcCeEcHHHHHHHHHHhhhcCCCCCHHHHHHHHHHHCCCCcCcEeHH
Confidence            446788999999999999999988754421     123455666778889999999999983

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=91.53  E-value=0.013  Score=38.21  Aligned_cols=55  Identities=15%  Similarity=0.099  Sum_probs=44.5

Q ss_pred             HHHHHHHHHhCCCCCCCCCcccccccCCCC---CCccccccccccccCCCCCCceeec
Q 017860          310 DVIMQIIAEASIPAVGTHGLNCYMTDNLDM---DDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       310 ~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~---~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.++..|...+.+..|.++..++.......   ...+.+..+...+.|.|++|.|+|.
T Consensus         2 eel~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~   59 (68)
T d1c7va_           2 EEILRAFKVFDANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIP   59 (68)
T ss_dssp             HHHHHHHHHHSCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHH
T ss_pred             HHHHHHHHHHcCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence            457889999999999999999987654333   2356677788999999999999983

>d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calbindin D9K
domain: Calbindin D9K
species: Pig (Sus scrofa) [TaxId: 9823]

Probab=91.19  E-value=0.052  Score=36.20  Aligned_cols=59  Identities=14%  Similarity=0.022  Sum_probs=41.8

Q ss_pred             CCCHHHHHHHHHHhCC--CCCCCCCcccccccC----CCCCCccccccccccccCCCCCCceeec
Q 017860          306 MQSVDVIMQIIAEASI--PAVGTHGLNCYMTDN----LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       306 ~~~~~~~~~~~~~~~~--~~~g~~~~~~~~~~~----~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ..+.+.+..+|...+.  ...|+++.+++..-.    .....++.+.++...+.|.|++|.|+|.
T Consensus         3 e~~~~~l~~~F~~y~~~d~~~g~is~~Elk~ll~~~~~~~~~~~~~v~~~~~~~D~d~dG~Idf~   67 (78)
T d1cb1a_           3 QKSPAELKSIFEKYAAKEGDPNQLSKEELKQLIQAEFPSLLKGPRTLDDLFQELDKNGDGEVSFE   67 (78)
T ss_dssp             SCCHHHHHHHHHHHHTTSSSTTEECHHHHHHHHHHHCSSCCSSCCCSSHHHHHTCCCSSSSEEHH
T ss_pred             hhhHHHHHHHHHHHccCCCCCCEECHHHHHHHHHHHcCCCCCCHHHHHHHHHHHcCCCCCcCcHH
Confidence            3467788888887644  345788887765432    2233345567788999999999999984

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=91.05  E-value=0.026  Score=37.14  Aligned_cols=57  Identities=18%  Similarity=0.135  Sum_probs=47.7

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..++..|...+....|.++..++....  ......+.+........|.|++|.|+|.
T Consensus         6 ei~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~~~~~~~~~~D~d~~g~I~f~   64 (73)
T d2pq3a1           6 QIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFP   64 (73)
T ss_dssp             HHHHHHHHHHHTCTTSSSEEEGGGHHHHHHHTTCCCCHHHHHHHHHHHCTTCSSEEEHH
T ss_pred             HHHHHHHHHHHHcCCCCceEeHHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            46788899999999999999999887764  3344567778888999999999999984

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=90.95  E-value=0.018  Score=38.42  Aligned_cols=57  Identities=16%  Similarity=0.174  Sum_probs=46.9

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+++.|...+...+|.++.+++....  ......+.+..+.....|.|++|.|+|.
T Consensus         8 qi~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~t~~e~~~~~~~~D~~~~g~I~~~   66 (77)
T d1f54a_           8 QIAEFKEAFALFDKDNNGSISSSELATVMRSLGLSPSEAEVNDLMNEIDVDGNHQIEFS   66 (77)
T ss_dssp             HHHHHHHHHHHTCTTCSSEEEHHHHHHHHHHHTCCCCHHHHHHHHHTTCCSSCCEEEHH
T ss_pred             HHHHHHHHHHHHcCCCCCeEChHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            45678899999999999999998887653  3334566777888999999999999983

>d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Oncomodulin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=90.48  E-value=0.037  Score=39.53  Aligned_cols=57  Identities=12%  Similarity=-0.043  Sum_probs=45.8

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCC-----CCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLD-----MDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~-----~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+.+++.|...+....|.++.+++......     ...++.+..+.....|.|++|.|+|.
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~l~~~~~~~~~~~~D~d~dG~I~~~  100 (108)
T d1rroa_          39 SASQVKDIFRFIDNDQSGYLDGDELKYFLQKFQSDARELTESETKSLMDAADNDGDGKIGAD  100 (108)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECTHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCCSSSSSEEHH
T ss_pred             CHHHHHHHHhhhcCCCCCeEcHHHHHHHHHHHHhccCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            5578889999999999999999998655321     22456667788999999999999984

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=89.97  E-value=0.021  Score=38.10  Aligned_cols=57  Identities=16%  Similarity=0.041  Sum_probs=45.8

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+.+++.|...+...+|.++..++....  ......+.+..+...+.|.|++|.|+|.
T Consensus         7 ~~e~l~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~~~~e~~~~~~~~D~d~~G~I~~~   65 (77)
T d1oqpa_           7 SREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDED   65 (77)
T ss_dssp             HHHHHHHHHHHHCTTCSSSEEHHHHHHHHHHHTCCCCHHHHHHHHHHHCCSSSSEECHH
T ss_pred             HHHHHHHHHHHHcCCCCCEechHHHHHHHHHhCCCCCHHHHHHHHHHhCCCCCCcEeHH
Confidence            44678899999999999999998886653  2233456677788999999999999984

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=89.93  E-value=0.023  Score=36.73  Aligned_cols=53  Identities=15%  Similarity=0.136  Sum_probs=43.0

Q ss_pred             HHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          312 IMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       312 ~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +++.|...+...+|.++..++....  ......+++....+...|.|++|.|+|.
T Consensus         3 ~r~~F~~~D~d~~G~I~~~El~~~l~~lg~~~~~~~i~~~~~~~D~d~dg~I~~~   57 (67)
T d1tiza_           3 AKRVFEKFDKNKDGKLSLDEFREVALAFSPYFTQEDIVKFFEEIDVDGNGELNAD   57 (67)
T ss_dssp             HHHHHHHHCTTSSSCEEHHHHHHHHHHTCTTSCHHHHHHHHHHHCCSSSSEECHH
T ss_pred             HHHHHHHHCCCCcCcCcHHHHHHHHHHhccccchHHHHHHHHHhCCCCCCeEeHH
Confidence            4678899999999999998887653  3344566777888999999999999973

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=89.84  E-value=0.049  Score=38.80  Aligned_cols=57  Identities=14%  Similarity=-0.044  Sum_probs=45.2

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCC-----CCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLD-----MDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~-----~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+.++..|...+....|.++.+++..-...     ....+++..+...+.|.|++|.|+|.
T Consensus        38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l~~l~~~~~~~~~~~~~~l~~~~D~d~dG~I~~~   99 (107)
T d2pvba_          38 SLDDVKKAFYVIDQDKSGFIEEDELKLFLQNFSPSARALTDAETKAFLADGDKDGDGMIGVD   99 (107)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHTGGGGTCTTSCCCCHHHHHHHHHHHCTTCSSSBCHH
T ss_pred             CHHHHHHHHHhhccCCCCcCcHHHHHHHHHHhhcccccCCHHHHHHHHHHhCCCCCCcEeHH
Confidence            4567899999999999999999888654211     23455667788899999999999983

>d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=89.81  E-value=0.045  Score=36.90  Aligned_cols=57  Identities=14%  Similarity=0.064  Sum_probs=46.5

Q ss_pred             CHHHHHHHHHHhCCCC-CCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPA-VGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~-~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+++.|...+... +|+++..++....  ......+.+..+...+.|.|++|.|+|.
T Consensus        13 q~~~~~~~F~~fD~d~~~G~I~~~el~~~l~~lg~~~t~~el~~~i~~~D~d~~G~I~f~   72 (82)
T d1wrka1          13 QKNEFKAAFDIFVLGAEDGSISTKELGKVMRMLGQNPTPEELQEMIDEVDEDGSGTVDFD   72 (82)
T ss_dssp             HHHHHHHHHHHHTTTCTTSSBCHHHHHHHHHHTTCCCCHHHHHHHHHTTCTTCCSSBCHH
T ss_pred             HHHHHHHHHHHHcCcCCCCeEeHHHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            4567888999999985 7999998887764  3344667788899999999999999984

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=89.59  E-value=0.034  Score=37.40  Aligned_cols=57  Identities=16%  Similarity=0.035  Sum_probs=46.0

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..++..|...+...+|.++..++....  ......+.+..+...+.|.|++|.|+|.
T Consensus        12 ~i~el~~~F~~~D~d~~G~I~~~el~~~l~~~g~~~s~~e~~~~~~~~D~d~~g~I~~~   70 (81)
T d1avsa_          12 MIAEFKAAFDMFDADGGGDISTKELGTVMRMLGQNPTKEELDAIIEEVDEDGSGTIDFE   70 (81)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHHTTCCCCHHHHHHHHHHHCTTCCSSEEHH
T ss_pred             HHHHHHHHHHHHcCCCCCeEchhHHHHHHHHcCCCCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            35567888999999999999998876642  3344566777889999999999999984

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.41  E-value=0.021  Score=39.83  Aligned_cols=57  Identities=11%  Similarity=-0.169  Sum_probs=47.2

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ......++|...+.+.+|.++.+++..-.......+.+..++.+..|.|++|.|+|.
T Consensus         8 e~~~~~~~F~~~D~d~~G~is~~e~~~~l~~~~l~~~~l~~i~~~~D~d~dG~l~~~   64 (95)
T d1c07a_           8 EKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKD   64 (95)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHHHTTTCCHHHHHHHHHHHCTTCSSSEETT
T ss_pred             HHHHHHHHHHHHCCCCCCCCcHHHHHHHHHhcCCCHHHHHHHHHHhCCCCCCeEcHH
Confidence            345677899999999999999988877665556667777888999999999999973

>d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Rat (Rattus rattus) [TaxId: 10117]

Probab=88.63  E-value=0.078  Score=37.80  Aligned_cols=57  Identities=14%  Similarity=-0.038  Sum_probs=45.0

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC-----CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN-----LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~-----~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +.+.++..|...+...+|.++..++....     ......+.+........|.|++|+|+|.
T Consensus        39 ~~~~~~~~F~~~D~d~~G~I~~~El~~~l~~l~~~~~~~~~~e~~~~~~~~D~d~dG~i~~~  100 (109)
T d1rwya_          39 SADDVKKVFHILDKDKSGFIEEDELGSILKGFSSDARDLSAKETKTLMAAGDKDGDGKIGVE  100 (109)
T ss_dssp             CHHHHHHHHHHHSTTCSSEECHHHHHTHHHHHCTTCCCCCHHHHHHHHHHHCTTCSSSEEHH
T ss_pred             CHHHHHHHhhcccCCCCCcCcHHHHHHHHHHhccccccCCHHHHHHHHHHhCCCCCCeEeHH
Confidence            45677889999999999999999876632     2223456667788999999999999983

>d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), s100a13 [TaxId: 9606]

Probab=87.72  E-value=0.11  Score=36.14  Aligned_cols=57  Identities=11%  Similarity=0.109  Sum_probs=40.2

Q ss_pred             CHHHHHHHHHHh-CCCC-CCCCCcccccccC----CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEA-SIPA-VGTHGLNCYMTDN----LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~-~~~~-~g~~~~~~~~~~~----~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      .+..+...|... +... .|+++..++..-.    ...-.++.+.++...+.|.|++|.|+|.
T Consensus        12 ~i~~l~~vF~~y~d~dg~~g~is~~El~~~l~~~~~~~~~~~~~v~~l~~~~D~d~DG~IdF~   74 (98)
T d1yuta1          12 SIETVVTTFFTFARQEGRKDSLSVNEFKELVTQQLPHLLKDVGSLDEKMKSLDVNQDSELKFN   74 (98)
T ss_dssp             HHHHHHHHHHHHHTTSSSSSCBCHHHHHHHHHHHCTTTTCCSSCHHHHHHHHCTTCCSCBCHH
T ss_pred             HHHHHHHHHHHHcccCCCCCEEcHHHHHHHHHHhccccCCCHHHHHHHHHHhcCCCCCcCCHH
Confidence            456777888775 5554 4899998875532    2222344556788999999999999983

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.56  E-value=0.071  Score=35.82  Aligned_cols=56  Identities=13%  Similarity=-0.009  Sum_probs=45.9

Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          309 VDVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       309 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ...+.+.|...+....|.++.+++....  ......+.+........|.|++|.|+|.
T Consensus        19 ~~~l~~~F~~~D~~~~G~i~~~ef~~~l~~~~~~l~~~e~~~l~~~~d~~~~g~I~y~   76 (83)
T d1wlza1          19 YHAITQEFENFDTMKTNTISREEFRAICNRRVQILTDEQFDRLWNEMPVNAKGRLKYP   76 (83)
T ss_dssp             HHHHHHHHHHHCTTCSSCBCHHHHHHHHHHHTCCCCHHHHHHHHTTSCBCTTSCBCHH
T ss_pred             HHHHHHHHHHHCCCCCceEChhHHHHHHHHhCCCCChhHHHHHhhccccCCCCcEeHH
Confidence            4567889999999999999998887753  3334567777888999999999999984

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=87.04  E-value=0.024  Score=38.84  Aligned_cols=55  Identities=18%  Similarity=0.160  Sum_probs=45.1

Q ss_pred             HHHHHHHHHhCCCCCCCCCcccccccC--CCCCCccccccccccccCCCCCCceeec
Q 017860          310 DVIMQIIAEASIPAVGTHGLNCYMTDN--LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       310 ~~~~~~~~~~~~~~~g~~~~~~~~~~~--~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      ..+.+.|...+....|.++..++....  ......+.+..+...+.|.|++|.|+|.
T Consensus        23 ~~l~~~F~~~D~d~~G~I~~~el~~~l~~lg~~~s~~e~~~l~~~~D~d~~g~I~~~   79 (87)
T d1s6ja_          23 GGLKELFKMIDTDNSGTITFDELKDGLKRVGSELMESEIKDLMDAADIDKSGTIDYG   79 (87)
T ss_dssp             TTTTTHHHHHCTTCSSCEEHHHHHHHHHTTTSSCCHHHHHHHHHHHCTTCSSEECHH
T ss_pred             HHHHHHHHHHcCCCCCcCcHHHHHHHHHHcCCCCCHHHHHHHHHHcCCCCCCeEeHH
Confidence            346788999999999999999987754  3344567778889999999999999983

>d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: S100 proteins
domain: Calcyclin (S100)
species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]

Probab=86.14  E-value=0.009  Score=41.63  Aligned_cols=56  Identities=13%  Similarity=0.073  Sum_probs=42.0

Q ss_pred             CHHHHHHHHHHhCCCCCCCCCcccccccC-------CCCCCccccccccccccCCCCCCceeec
Q 017860          308 SVDVIMQIIAEASIPAVGTHGLNCYMTDN-------LDMDDDDMDDLDSESELDIDSSGEIIYA  364 (365)
Q Consensus       308 ~~~~~~~~~~~~~~~~~g~~~~~~~~~~~-------~~~~~~d~d~~~~~~~~~~~~~g~i~~~  364 (365)
                      +++.+..+|...+.. +|+++.+++....       .....++...+....+.|.|++|.|+|.
T Consensus         7 ~ie~l~~~F~~yd~d-dG~is~~El~~~l~~~~~~~~~~~~~~~~v~~~~~~~D~n~DG~I~F~   69 (92)
T d1a4pa_           7 AMETMMFTFHKFAGD-KGYLTKEDLRVLMEKEFPGFLENQKDPLAVDKIMKDLDQCRDGKVGFQ   69 (92)
T ss_dssp             HHHHHHHHHHHHHGG-GCSBCHHHHHHHHHHHCHHHHHHSCCTTHHHHHHHHHCTTSSSCBCHH
T ss_pred             HHHHHHHHHHHHcCC-CCEEcHHHHHHHHHHhccccccccCCHHHHHHHHHHHhCCCCCCCcHH
Confidence            467788888888866 7999998886643       1222345566788999999999999973

>d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Pob1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=84.54  E-value=0.18  Score=35.87  Aligned_cols=58  Identities=5%  Similarity=-0.189  Sum_probs=50.0

Q ss_pred             CCCHHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceee
Q 017860          306 MQSVDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIY  363 (365)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~  363 (365)
                      .+......++|...+....|.++.++...-......+..+..++....|.|++|.|++
T Consensus        18 ~ee~~~y~~lF~~~D~d~~G~Is~~e~~~~l~~s~L~~~~L~~Iw~l~D~d~dG~l~~   75 (110)
T d1iq3a_          18 EEQREYYVNQFRSLQPDPSSFISGSVAKNFFTKSKLSIPELSYIWELSDADCDGALTL   75 (110)
T ss_dssp             SSSHHHHHHHHHHHCCSSSSEEEHHHHHHHCCSSSCSSCCHHHHHHHHCSSSCSEEEH
T ss_pred             HHHHHHHHHHHHHhCCCcccchhHHHHHHHHHhhccchHHHHHHHHHhccCCCCeECH
Confidence            4567888999999999999999998888777666667777888899999999999986

>d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Sarcoplasmic calcium-binding protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=83.20  E-value=0.17  Score=39.13  Aligned_cols=55  Identities=7%  Similarity=-0.054  Sum_probs=45.8

Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccccccCCCCCCccccccccccccCCCCCCceee
Q 017860          309 VDVIMQIIAEASIPAVGTHGLNCYMTDNLDMDDDDMDDLDSESELDIDSSGEIIY  363 (365)
Q Consensus       309 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~d~d~~~~~~~~~~~~~g~i~~  363 (365)
                      ...+...+...+...+|.++.+++..-.......+.+....++..|.|++|.|+|
T Consensus       104 ~~~~~~~F~~~D~d~~G~Is~~E~~~~l~~~~l~~~~~~~~f~~~D~d~dG~i~~  158 (185)
T d2sasa_         104 QNRIPFLFKGMDVSGDGIVDLEEFQNYCKNFQLQCADVPAVYNVITDGGKVTFDL  158 (185)
T ss_dssp             HHHHHHHHHHHCTTSSSCCCHHHHHHHTTSSCCCCSSHHHHHHHHHTTTTSCCSH
T ss_pred             HHHHHHHHHHHccCCCccCCHHHHHHHHHHcCCCHHHHHHHHHHcCCCCCCCCcH
Confidence            3567788999999999999999987755545556667778899999999999997